PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Chihara, H				Chihara, Hiroyuki			Fourth-order dispersive systems on the one-dimensional torus	JOURNAL OF PSEUDO-DIFFERENTIAL OPERATORS AND APPLICATIONS			English	Article						Dispersive system; Initial value problem; Well-posedness; Gauge transform; Energy method	VORTEX FILAMENT EQUATION; INITIAL-VALUE PROBLEM; RIEMANNIAN MANIFOLD; HERMITIAN-MANIFOLDS; CAUCHY-PROBLEM; CLOSED CURVES; 3RD-ORDER; FLOW; EXISTENCE; SPACE	We present the necessary and sufficient conditions of the well-posedness of the initial value problem for certain fourth-order linear dispersive systems on the one-dimensional torus. This system is related with a dispersive flow for closed curves into compact Riemann surfaces. For this reason, we study not only the general case but also the corresponding special case in detail. We apply our results on the linear systems to the fourth-order dispersive flows. We see that if the sectional curvature of the target Riemann surface is constant, then the equation of the dispersive flow satisfies our conditions of the well-posedness.	Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3058571, Japan	Chihara, H (reprint author), Univ Tsukuba, Inst Math, Tsukuba, Ibaraki 3058571, Japan.	chihara@math.tsukuba.ac.jp			JSPS [23340033]	The author would like to thank Eiji Onodera for invaluable comments and helpful information on the holomomy. The author is also grateful to the referees for careful reading the first version of the manuscript of this paper. The author was supported by JSPS Grant-in-Aid for Scientific Research #23340033.	Chang NH, 2000, COMMUN PUR APPL MATH, V53, P590; Chihara H, 2005, P AM MATH SOC, V133, P2083, DOI 10.1090/S0002-9939-05-07783-X; Chihara H., 2015, Z ANAL ANWE IN PRESS; Chihara H, 2013, B LOND MATH SOC, V45, P37, DOI 10.1112/blms/bds060; Chihara H, 2009, J FUNCT ANAL, V257, P388, DOI 10.1016/j.jfa.2009.04.006; Chihara H, 2002, INT MATH RES NOTICES, P789; Doi SI, 1996, DUKE MATH J, V82, P679, DOI 10.1215/S0012-7094-96-08228-9; Koiso N, 1997, OSAKA J MATH, V34, P199; Koiso N, 2008, OSAKA J MATH, V45, P265; Koiso N, 2003, TOHOKU MATH J, V55, P311, DOI 10.2748/tmj/1113246943; Kumano-go H., 1981, PSEUDO DIFFERENTIAL; Mizohata S., 1985, CAUCHY PROBLEM; Mizuhara R, 2006, FUNKC EKVACIOJ-SER I, V49, P1, DOI 10.1619/fesi.49.1; Nicola F, 2010, PSEUDO DIFFER OPER, V4, P1, DOI 10.1007/978-3-7643-8512-5; Onodera E, 2008, J GEOM ANAL, V18, P889, DOI 10.1007/s12220-008-9023-1; Onodera E, 2010, COMMUN PART DIFF EQ, V35, P1130, DOI 10.1080/03605301003717134; Onodera E, 2008, SIGMA SYMMETRY INTEG, V4; Onodera E., 2012, FUNKC EKVACIOJ-SER I, V55, P137; Singer I.M., 1967, LECT NOTES ELEMENTAR; TAKEUCHI J, 1974, P JPN ACAD, V50, P133; Tarama S, 1997, J MATH KYOTO U, V37, P757; Tarama S., 2011, ELECTRON J DIFFER EQ, V2011, P1; Taylor M. E., 1981, PSEUDODIFFERENTIAL O	23	0	0	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1662-9981	1662-999X		J PSEUDO-DIFFER OPER	J. Pseudo-Differ. Oper. Appl.	JUN	2015	6	2					237	263		10.1007/s11868-015-0112-1		27	Mathematics, Applied; Mathematics	Mathematics	CJ1HK	WOS:000355234500007		
J	Hatta, K				Hatta, K.			Preventive effects of ramelteon on delirium	JOURNAL OF PSYCHOSOMATIC RESEARCH			English	Meeting Abstract									[Hatta, K.] Juntendo Univ, Dept Psychiat, Nerima Hosp, Tokyo, Japan								0	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0022-3999	1879-1360		J PSYCHOSOM RES	J. Psychosomat. Res.	JUN	2015	78	6					602	602		10.1016/j.jpsychores.2015.03.055		1	Psychiatry	Psychiatry	CI8ZP	WOS:000355060500054		
J	Yamada, H; Deguchi, M; Maesawa, Y; Nakajima, Y; Nishino, Y; Tanimura, K; Ebina, Y				Yamada, Hideto; Deguchi, Masashi; Maesawa, Yoko; Nakajima, Yuki; Nishino, Yukari; Tanimura, Kenji; Ebina, Yasuhiko			Medium-dose intravenous immunoglobulin therapy for women with six or more recurrent miscarriages	JOURNAL OF REPRODUCTIVE IMMUNOLOGY			English	Article						Etiology; Immunoglobulin; Recurrent miscarriage	UNEXPLAINED ETIOLOGY; ABORTIONS; CELLS	This study aimed to evaluate changes in natural killer (NK) cell activity and the percentage of monocytes in women with recurrent miscarriage who received medium-dose intravenous immunoglobulin (IVIg) therapy. Fourteen women with a history of six or more recurrent miscarriages of unexplained etiology received 60-g IVIg therapy (20 g daily, for three days) during early gestation. NI( cell activity in the peripheral blood decreased to 12% one week after therapy compared with before therapy (median, 22%, P<0.001) and the percentage of monocytes increased from 5.2% to 7.5% (P < 0.005). Four pregnancies ended in live births of healthy neonates, whereas the other ten pregnancies ended in miscarriages. Excluding one miscarriage with a chromosomal abnormality, the live birth rate was 30.8% (4/13). The rate of reduction of NI( cell activity in the success group (-58.8%) tended to be greater than that in the failure group (-14.8%, P = 0.057). (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Yamada, Hideto; Deguchi, Masashi; Maesawa, Yoko; Nakajima, Yuki; Nishino, Yukari; Tanimura, Kenji; Ebina, Yasuhiko] Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Kobe, Hyogo 6500017, Japan	Yamada, H (reprint author), Kobe Univ, Grad Sch Med, Dept Obstet & Gynecol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	yhideto@med.kobe-u.ac.jp			Japan Society for the Promotion of Science [23592403, 26462489]	This work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (Nos. 23592403 and 26462489).	Shimada S, 2009, AM J REPROD IMMUNOL, V62, P301, DOI 10.1111/j.1600-0897.2009.00739.x; Toth B, 2010, J REPROD IMMUNOL, V85, P25, DOI 10.1016/j.jri.2009.12.006; Ata B, 2011, FERTIL STERIL, V95, P1080, DOI 10.1016/j.fertnstert.2010.12.021; Hutton B, 2007, BJOG-INT J OBSTET GY, V114, P134, DOI 10.1111/j.1471-0528.2006.01201.x; Laird SM, 2003, HUM REPROD UPDATE, V9, P163, DOI 10.1093/humupd/dmg013; Christiansen OB, 2011, FERTIL STERIL, V95, pE35, DOI 10.1016/j.fertnstert.2011.03.040; Kazatchkine MD, 2001, NEW ENGL J MED, V345, P747; Morikawa M, 2001, AM J REPROD IMMUNOL, V46, P399, DOI 10.1034/j.1600-0897.2001.d01-31.x; Practice Committee of the American Society for Reproductive Medicine, 2006, FERTILITY STERILI S4, V86, pS226; Yamada H, 1998, HUM REPROD, V13, P2620, DOI 10.1093/humrep/13.9.2620; Yamada H, 2012, ISRN OBSTET GYNECOL, V2012	11	1	1	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-0378			J REPROD IMMUNOL	J. Reprod. Immunol.	JUN	2015	109						48	51		10.1016/j.jri.2015.01.008		4	Immunology; Reproductive Biology	Immunology; Reproductive Biology	CJ3DW	WOS:000355364600008		
J	Kageyama, M; Sugiyama, T; Kanehisa, H; Maeda, A				Kageyama, Masahiro; Sugiyama, Takashi; Kanehisa, Hiroaki; Maeda, Akira			Difference between Adolescent and Collegiate Baseball Pitchers in the Kinematics and Kinetics of the Lower Limbs and Trunk during Pitching Motion	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Pitching ball velocity; the open kinetic chain; joint moment; ground-reaction force; motion analysis	CURVEBALL; VELOCITY; BIOMECHANICS; MOVEMENT; SHOULDER; FASTBALL	The purpose of this study was to clarify the differences between adolescent and collegiate baseball pitchers in the kinematic and kinetic profiles of the trunk and lower limbs during the pitching motion. The subjects were thirty-two adolescent baseball pitchers aged 12-15 years (APG) and thirty collegiate baseball pitchers aged 18-22 years (CPG). Three-dimensional motion analysis with a comprehensive lower-extremity model was used to evaluate kinematic and kinetic parameters during baseball pitching. The ground reaction forces (GRFs) of the pivot and stride legs during pitching were determined using two multicomponent force plates. The joint torques of hip, knee, and ankle were calculated by the inverse-dynamics computation of musculoskeletal human models using motion-capture data. To eliminate any effect of variation in body size, kinetic and GRFs data were normalized by dividing them by body mass. The velocity of a pitched ball was significantly higher (p < 0.01) in CPG (35.2 +/- 1.9 m.s(-1)) than in the APG (30.7 +/- 2.7 m.s(-1)). Most kinematic parameters for the lower limbs were similar between the CPG and the APG. Maximum Fy (toward the throwing direction) on the pivot leg and Fy and resultant forces on the stride leg at ball release were significantly greater in the CPG than in the APG (p < 0.05). Hip and knee joint torques on the lower limbs were significantly greater in the CPG than in the APG (p < 0.05). The present study indicates that the kinematics of lower limbs during baseball pitching are similar between adolescent and collegiate pitchers, but the momentum of the lower limbs during pitching is lower in adolescent pitchers than in collegiate ones, even when the difference in body mass is considered.	[Kageyama, Masahiro; Sugiyama, Takashi] Natl Inst Fitness & Sports Kanoya, Grad Sch Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Kanehisa, Hiroaki; Maeda, Akira] Natl Inst Fitness & Sports Kanoya, Kanoya, Kagoshima 8912393, Japan	Maeda, A (reprint author), Natl Inst Fitness & Sports Kanoya, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	m127003@sky.nifs-k.ac.jp; m127004@sky.nifs-k.ac.jp; hkane@nifs-k.ac.jp; amaeda@nifs-k.ac.jp					Fleisig GS, 1999, J BIOMECH, V32, P1371, DOI 10.1016/S0021-9290(99)00127-X; Matsuo T, 2001, J APPL BIOMECH, V17, P1; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Fleisig GS, 2006, AM J SPORT MED, V34, P423, DOI 10.1177/0363546505280431; MacWilliams BA, 1998, AM J SPORT MED, V26, P66; Campbell BM, 2010, J STRENGTH COND RES, V24, P964, DOI 10.1519/JSC.0b013e3181cb241b; FELTNER M, 1986, INT J SPORT BIOMECH, V2, P235; Burkhart SS, 2003, ARTHROSCOPY, V19, P404, DOI 10.1053/jars.2003.50128; SAKURAI S, 1993, J APPL BIOMECH, V9, P47; Fleisig GS, 1996, J APPL BIOMECH, V12, P207; Escamilla RF, 1998, J APPL BIOMECH, V14, P1; Dun SC, 2008, AM J SPORT MED, V36, P686, DOI 10.1177/0363546507310074; Atwater A E, 1979, Exerc Sport Sci Rev, V7, P43; ELLIOTT B, 1988, INT J SPORT BIOMECH, V4, P59; Ishida K., 2004, INT J SPORT HLTH SCI, V2, P119, DOI 10.5432/ijshs.2.119; Kageyama M, 2014, J SPORT SCI MED, V13, P742; Kibler WB, 1991, CONT ORTHOP, V22, P525; Kibler W. Ben, 1995, Arthroscopy, V11, P296, DOI 10.1016/0749-8063(95)90006-3; Kreighbaum E., 1985, BIOMECHANICS QUANTIT, V2nd, P585; Milewski MD, 2012, J APPL BIOMECH, V28, P491; Nakamura Y, 2005, IEEE T ROBOT, V21, P58, DOI 10.1109/TRO.2004.833798; Robb AJ, 2010, AM J SPORT MED, V38, P2487, DOI 10.1177/0363546510375535; Stodden DF, 2001, J APPL BIOMECH, V17, P164	23	0	0	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	JUN	2015	14	2					246	255				10	Sport Sciences	Sport Sciences	CJ1UY	WOS:000355271300002		
J	Fujiya, H; Ogura, Y; Ohno, Y; Goto, A; Nakamura, A; Ohashi, K; Uematsu, D; Aoki, H; Musha, H; Goto, K				Fujiya, Hiroto; Ogura, Yuji; Ohno, Yoshitaka; Goto, Ayumi; Nakamura, Ayane; Ohashi, Kazuya; Uematsu, Daiki; Aoki, Haruhito; Musha, Haruki; Goto, Katsumasa			Microcurrent Electrical Neuromuscular Stimulation Facilitates Regeneration of Injured Skeletal Muscle in Mice	JOURNAL OF SPORTS SCIENCE AND MEDICINE			English	Article						Muscle injury; regenerative potential; muscle satellite cell; central nuclei; physiotherapy; sports injury	MYOGENIC SATELLITE CELLS; ATROPHIED SOLEUS MUSCLE; HEAT-STRESS; MDX MOUSE; REPAIR; SKIN; ELECTROTHERAPY; SPECIFICATION; REGROWTH; RATS	Conservative therapies, mainly resting care for the damaged muscle, are generally used as a treatment for skeletal muscle injuries (such as muscle fragmentation). Several past studies reported that microcurrent electrical neuromuscular stimulation (MENS) facilitates a repair of injured soft tissues and shortens the recovery period. However, the effects of MENS on the regeneration in injured skeletal muscle are still unclear. The purpose of this study was to investigate the effect of MENS on the regenerative process of injured skeletal muscle and to elucidate whether satellite cells in injured skeletal muscle are activated by MENS by using animal models. Male C57BL/6J mice, aged 7 weeks old, were used (n = 30). Mice were randomly divided into two groups: (1) cardiotoxin (CTX)-injected (CX, n = 15) and (2) CTX-injected with MENS treatment (MX, n = 15) groups. CTX was injected into tibialis anterior muscle (TA) of mice in CX and MX groups to initiate the necrosis-regeneration cycle of the muscle. TA was dissected 1, 2, and 3 weeks after the injection. Muscle weight, muscle protein content, the mean cross-sectional areas of muscle fibers, the relative percentage of fibers having central nuclei, and the number of muscle satellite cells were evaluated. MENS facilitated the recovery of the muscle dry weight and protein content relative to body weight, and the mean cross-sectional areas of muscle fibers in CTX-induced injured TA muscle. The number of Pax7-positive muscle satellite cells was increased by MENS during the regenerating period. Decrease in the percentages of fibers with central nuclei after CTX-injection was facilitated by MENS. MENS may facilitate the regeneration of injured skeletal muscles by activating the regenerative potential of skeletal muscles.	[Fujiya, Hiroto; Musha, Haruki] St Marianna Univ, Sch Med, Dept Sports Med, Kawasaki, Kanagawa 2168511, Japan; [Ogura, Yuji] St Marianna Univ, Sch Med, Dept Physiol, Kawasaki, Kanagawa 2168511, Japan; [Ohno, Yoshitaka; Uematsu, Daiki; Goto, Katsumasa] Toyohashi SOZO Univ, Sch Hlth Sci, Lab Physiol, Toyohashi, Aichi, Japan; [Goto, Ayumi; Nakamura, Ayane; Ohashi, Kazuya; Goto, Katsumasa] Toyohashi SOZO Univ, Grad Sch Hlth Sci, Dept Physiol, Toyohashi, Aichi, Japan; [Fujiya, Hiroto; Aoki, Haruhito] St Marianna Univ, Sch Med, FIFA Med Ctr Excellence Kawasaki, Kawasaki, Kanagawa 2168511, Japan	Fujiya, H (reprint author), St Marianna Univ, Sch Med, Dept Sports Med, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	fujiya-1487@marianna-u.ac.jp; yuji_ogura@marianna-u.ac.jp; yohno@sozo.ac.jp; r0772710@sc.sozo.ac.jp; gotok@sepia.ocn.ne.jp; asuno10k@tahoo.co.jp; gotok@sepia.ocn.ne.jp; h2aoki@marianna-u.ac.jp; musha@marianna-u.ac.jp; gotok@sepia.ocn.ne.jp			Japan Society for the Promotion of Science [21500639, 24500802, 26350818, 26560372]; Uehara Memorial Foundation; Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan; Ito Co., Ltd.	This study was supported, in part, by the Japan Society for the Promotion of Science (21500639, HF; 24500802, HF; 26350818, KG; 26560372, KG), the Uehara Memorial Foundation, and the Science Research Promotion Fund from the Promotion and Mutual Aid Corporation for Private Schools of Japan (KG). KG got research fund from Ito Co., Ltd., who supported this study, in part. However, the sponsor had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There are no patents, products in development or marketed products to declare. The authors have no conflict of interest. The results of the present study do not constitute endorsement by the American College of Sports Medicine.	Hill M, 2003, J ANAT, V203, P89, DOI 10.1046/j.1469-7580.2003.00195.x; Huard J, 2002, J BONE JOINT SURG AM, V84A, P822; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Naito H, 2000, J APPL PHYSIOL, V88, P359; FLETCHER JE, 1993, TOXICON, V31, P669, DOI 10.1016/0041-0101(93)90375-S; Goto K, 2003, PFLUG ARCH EUR J PHY, V447, P247, DOI 10.1007/s00424-003-1177-x; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Yasuhara K, 2011, J APPL PHYSIOL, V111, P1142, DOI 10.1152/japplphysiol.00471.2011; Morioka S, 2008, J PHYSIOL SCI, V58, P397, DOI 10.2170/physiolsci.RP004008; GARRETT WE, 1990, MED SCI SPORT EXER, V22, P436; Tidball JG, 2007, J PHYSIOL-LONDON, V578, P327, DOI 10.1113/jphysiol.2006.118265; LEHTO MUK, 1991, ANN CHIR GYNAECOL FE, V80, P102; Kojima A, 2007, J ORTHOP SCI, V12, P74, DOI 10.1007/s00776-006-1083-0; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; WOLCOTT LE, 1969, SOUTHERN MED J, V62, P795; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534; Ohno Y, 2013, INT J MED SCI, V10, P1286, DOI 10.7150/ijms.5985; Matsuba Y, 2009, ACTA PHYSIOL, V196, P329, DOI 10.1111/j.1748-1716.2008.01943.x; CARLEY PJ, 1985, ARCH PHYS MED REHAB, V66, P443; Best T M, 2000, Phys Med Rehabil Clin N Am, V11, P251; BYL NN, 1994, PHYS THER, V74, P201; CHENG N, 1982, CLIN ORTHOP RELAT R, P264; Conteaux R., 1988, BIOL CELL, V62, P171; Curtis Denise, 2010, J Bodyw Mov Ther, V14, P272, DOI 10.1016/j.jbmt.2010.01.009; Gault W R, 1976, Phys Ther, V56, P265; Grounds MD, 1999, CURR OPIN NEUROL, V12, P535, DOI 10.1097/00019052-199910000-00007; Guo BS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030348; Huckfeldt R, 2007, J BURN CARE RES, V28, P703, DOI 10.1097/BCR.0B013E318148C945; Lambert MI, 2002, MED SCI SPORT EXER, V34, P602, DOI 10.1097/00005768-200204000-00007; Larner F.N., 1981, J AM CHIROPRACTIC AS, V15, P101; Miyazaki S., 2007, B SCH PHYS ED TOKAI, V37, P91; Morinaga T., 2007, MICROCURRENT ELECTRO, V9th, P11; NESSLER JP, 1987, CLIN ORTHOP RELAT R, P303; Nishizawa S, 2013, PHYSL REP, V1, DOI 10.1002/phy2.71; OWOEYE I, 1987, ARCH PHYS MED REHAB, V68, P415; Peterson L., 2001, SPORTS INJURIES THEI, V3rd, P4; Reed P, 2005, NEUROMUSCULAR DISORD, V15, P552, DOI 10.1016/j.nmd.2005.03.007; SAITO Y, 1994, ACTA NEUROPATHOL, V88, P252	42	0	0	JOURNAL SPORTS SCIENCE & MEDICINE	BURSA	MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY	1303-2968			J SPORT SCI MED	J. Sport. Sci. Med.	JUN	2015	14	2					297	303				7	Sport Sciences	Sport Sciences	CJ1UY	WOS:000355271300009		
J	Komatsu, TS; Nakagawa, N; Sasa, S; Tasaki, H				Komatsu, Teruhisa S.; Nakagawa, Naoko; Sasa, Shin-ichi; Tasaki, Hal			Exact Equalities and Thermodynamic Relations for Nonequilibrium Steady States	JOURNAL OF STATISTICAL PHYSICS			English	Article							FREE-ENERGY DIFFERENCES; ENTROPY PRODUCTION; QUANTUM-SYSTEMS; EQUILIBRIUM	We study thermodynamic operations which bring a nonequilibrium steady state (NESS) to another NESS in physical systems under nonequilibrium conditions. We model the system by a suitable Markov jump process, and treat thermodynamic operations as protocols according to which the external agent varies parameters of the Markov process. Then we prove, among other relations, a NESS version of the Jarzynski equality and the extended Clausius relation. The latter can be a starting point of thermodynamics for NESS. We also find that the corresponding nonequilibrium entropy has a microscopic representation in terms of symmetrized Shannon entropy in systems where the microscopic description of states involves "momenta". All the results in the present paper are mathematically rigorous.	[Komatsu, Teruhisa S.] RIKEN QBiC, Lab Computat Mol Design, Kobe, Hyogo 6500047, Japan; [Nakagawa, Naoko] Ibaraki Univ, Coll Sci, Mito, Ibaraki 3108512, Japan; [Sasa, Shin-ichi] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Tasaki, Hal] Gakushuin Univ, Dept Phys, Toshima Ku, Tokyo 1718588, Japan	Tasaki, H (reprint author), Gakushuin Univ, Dept Phys, Toshima Ku, Tokyo 1718588, Japan.	hal.tasaki@gakushuin.ac.jp			KAKENHI [22340109, 23540435, 25103002]; JSPS Core-to-Core program "Non-equilibrium dynamics of soft-matter and information"; JSPS; NSERC; ANR; DFG; RFBR; RCUK; NSF as Partner Organizations under the G8 Research Councils Initiative	It is a pleasure to thank Hisao Hayakawa, Masato Itami, Nobuyasu Ito, Chris Jarzynski, Gianni Jona-Lasinio, Joel Lebowitz, Christian Maes, Karel Netocny, Yoshi Oono, Glenn Paquette, Takahiro Sagawa, Keiji Saito, Herebert Spohn, and Akira Shimizu for valuable discussions. The present study was supported by KAKENHI Nos. 22340109, 23540435, and 25103002, by the JSPS Core-to-Core program "Non-equilibrium dynamics of soft-matter and information", and partially by JSPS and Leading Research Organizations, namely NSERC, ANR, DFG, RFBR, RCUK and NSF as Partner Organizations under the G8 Research Councils Initiative for Multilateral Research Funding.	Bertini L, 2009, J STAT PHYS, V135, P857, DOI 10.1007/s10955-008-9670-4; Mandal D, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.062135; Baerts P, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.052109; Baiesi M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.010602; Lieb EH, 2013, P ROY SOC A-MATH PHY, V469, DOI 10.1098/rspa.2013.0408; Komatsu TS, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.030601; Jarzynski C, 1997, PHYS REV LETT, V78, P2690, DOI 10.1103/PhysRevLett.78.2690; Hatano T, 2001, PHYS REV LETT, V86, P3463, DOI 10.1103/PhysRevLett.86.3463; Bertini L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.020601; Bertini L, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.040601; Bodineau T, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.180601; Pradhan P, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.150601; Seifert U, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/12/126001; Crooks GE, 1999, PHYS REV E, V60, P2721, DOI 10.1103/PhysRevE.60.2721; Maes C, 2014, J STAT PHYS, V154, P188, DOI 10.1007/s10955-013-0822-9; Komatsu TS, 2009, J STAT PHYS, V134, P401, DOI 10.1007/s10955-009-9678-4; Bertini L, 2012, J STAT PHYS, V149, P773, DOI 10.1007/s10955-012-0624-5; Derrida B, 2003, J STAT PHYS, V110, P775, DOI 10.1023/A:1022111919402; Maes C, 2003, J STAT PHYS, V110, P269, DOI 10.1023/A:1021026930129; Yuge T, 2013, J STAT PHYS, V153, P412, DOI 10.1007/s10955-013-0829-2; Crooks GE, 2000, PHYS REV E, V61, P2361, DOI 10.1103/PhysRevE.61.2361; Komatsu TS, 2011, J STAT PHYS, V142, P127, DOI 10.1007/s10955-010-0095-5; Spinney RE, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.170603; Sagawa T, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.051110; Bertini L, 2006, B BRAZ MATH SOC, V37, P611, DOI 10.1007/s00574-006-0031-0; Derrida B, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.150601; Seifert U, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.040602; Sasa SI, 2006, J STAT PHYS, V125, P125, DOI 10.1007/s10955-005-9021-7; Boksenbojm E, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/40001; Cover T. M., 2006, ELEMENTS INFORM THEO; Dickman R., 2014, ARXIV14011678; Itami M, 2015, J STAT PHYS, V158, P37, DOI 10.1007/s10955-014-1115-7; Jona-Lasinio G, 2010, PROG THEOR PHYS SUPP, P262; Jona-Lasinio Giovanni, 2014, Journal of Statistical Mechanics: Theory and Experiment, V2014, DOI 10.1088/1742-5468/2014/02/P02004; Komatsu S.T., 2008, PHYS REV LETT, V100; LANDAUER R, 1978, PHYS REV A, V18, P255, DOI 10.1103/PhysRevA.18.255; Nakagawa N, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.051115; Nakagawa N., 2014, ARXIV14014242; Maes C, 2010, J MATH PHYS, V51, DOI 10.1063/1.3274819; Oono Y, 1998, PROG THEOR PHYS SUPP, P29; Pradhan P, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.041104; Ruelle DP, 2003, P NATL ACAD SCI USA, V100, P3054, DOI 10.1073/pnas.0630567100; Saito K, 2011, J STAT PHYS, V145, P1275, DOI 10.1007/s10955-011-0346-0; Sasa S, 2014, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2014/01/P01004; Zeitouni O, 1998, LARGE DEVIATIONS TEC	45	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	JUN	2015	159	6					1237	1285		10.1007/s10955-015-1221-1		49	Physics, Mathematical	Physics	CJ1CE	WOS:000355218600001		
J	Hansen, F				Hansen, Frank			Golden-Thompson's Inequality for Deformed Exponentials	JOURNAL OF STATISTICAL PHYSICS			English	Article						Deformed exponentials; Golden-Thompson's trace inequality; Concave trace function	STATISTICAL-MECHANICS; TRACE FUNCTIONS; ENTROPY	Deformed logarithms and their inverse functions, the deformed exponentials, are important tools in the theory of non-additive entropies and non-extensive statistical mechanics. We formulate and prove counterparts of Golden-Thompson's trace inequality for -exponentials with parameter in the interval .	Tohoku Univ, Inst Excellence Higher Educ, Sendai, Miyagi 980, Japan	Hansen, F (reprint author), Tohoku Univ, Inst Excellence Higher Educ, Sendai, Miyagi 980, Japan.	frank.hansen@m.tohoku.ac.jp					LIEB EH, 1973, ADV MATH, V11, P267, DOI 10.1016/0001-8708(73)90011-X; Carlen EA, 2008, LETT MATH PHYS, V83, P107, DOI 10.1007/s11005-008-0223-1; GOLDEN S, 1965, PHYS REV, V137, P1127; Hansen F, 2014, J STAT PHYS, V154, P807, DOI 10.1007/s10955-013-0890-x; Lieb EH, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.062329; THOMPSON CJ, 1965, J MATH PHYS, V6, P1812, DOI 10.1063/1.1704727; Tsallis C, 2009, BRAZ J PHYS, V39, P337, DOI 10.1590/S0103-97332009000400002	7	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	JUN	2015	159	6					1300	1305		10.1007/s10955-015-1237-6		6	Physics, Mathematical	Physics	CJ1CE	WOS:000355218600003		
J	Bernardin, C; Goncalves, P; Jara, M; Sasada, M; Simon, M				Bernardin, Cedric; Goncalves, Patricia; Jara, Milton; Sasada, Makiko; Simon, Marielle			From Normal Diffusion to Superdiffusion of Energy in the Evanescent Flip Noise Limit	JOURNAL OF STATISTICAL PHYSICS			English	Article						Anomalous diffusion; Fourier's law; Equilibrium fluctuations	FOURIERS LAW; SYSTEMS; MODEL; FLUCTUATIONS; CONDUCTION; EVOLUTION	We consider a harmonic chain perturbed by a stochastic noise which conserves the energy and a second quantity called the volume, and destroys all the other ones. We then add to this model a second energy conserving noise depending on a parameter , that annihilates the volume conservation. When is of order one, the energy diffuses according to the standard heat equation after a space-time diffusive scaling. On the other hand, when , the energy superdiffuses according to a -fractional heat equation after a subdiffusive space-time scaling. In this paper, we study the existence of a crossover between these two regimes as a function of gamma.	[Bernardin, Cedric] Univ Nice Sophia Antipolis, UMR CNRS 7351, Lab JA Dieudonne, F-06108 Nice 02, France; [Goncalves, Patricia; Simon, Marielle] Pontificia Univ Catolica Rio de Janeiro, Dept Matemat, BR-22453900 Rio de Janeiro, RJ, Brazil; [Goncalves, Patricia] Univ Minho, Ctr Matemat, CMAT, P-4710057 Braga, Portugal; [Jara, Milton] IMPA, BR-22460340 Rio De Janeiro, Brazil; [Sasada, Makiko] Keio Univ, Dept Math, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Simon, Marielle] UMPA ENS Lyon, F-69007 Lyon, France	Bernardin, C (reprint author), Univ Nice Sophia Antipolis, UMR CNRS 7351, Lab JA Dieudonne, Parc Valrose, F-06108 Nice 02, France.	cbernard@unice.fr; patg@math.uminho.pt; mjara@impa.br; sasada@math.keio.ac.jp; marielle.simon@mat.puc-rio.br					FRITZ J, 1994, PROBAB THEORY REL, V99, P211, DOI 10.1007/BF01199023; Bonetto F, 2004, J STAT PHYS, V116, P783, DOI 10.1023/B:JOSS.0000037232.14365.10; Dhar A, 2008, ADV PHYS, V57, P457, DOI 10.1080/00018730802538522; Basile G, 2009, COMMUN MATH PHYS, V287, P67, DOI 10.1007/s00220-008-0662-7; Simon M, 2013, STOCH PROC APPL, V123, P3623, DOI 10.1016/j.spa.2013.05.005; LANFORD OE, 1977, J STAT PHYS, V16, P453, DOI 10.1007/BF01152283; BROX T, 1984, ANN PROBAB, V12, P742, DOI 10.1214/aop/1176993225; Bernardin C, 2005, J STAT PHYS, V121, P271, DOI 10.1007/s10955-005-7578-9; Lepri S, 2003, PHYS REP, V377, P1, DOI 10.1016/S0370-1573(02)00558-6; Basile G, 2014, J STAT PHYS, V155, P1126, DOI 10.1007/s10955-013-0908-4; Bernardin C, 2012, NONLINEARITY, V25, DOI 10.1088/0951-7715/25/4/1099; Bernardin C., ARCH RATION IN PRESS; Bernardin C, 2014, COMMUN MATH PHYS, V325, P291, DOI 10.1007/s00220-013-1860-5; Bernardin C., 2014, SPRINGER P MATH STAT, V75; DAWSON DA, 1990, APPL MATH OPT, V22, P241, DOI 10.1007/BF01447330; Jara M, 2014, ARXIV09010229; Kipnis C., 1999, SCALING LIMITS INTER; Komorowski T., 2012, TIME SYMMETRY MARTIN, V345; Spohn H., 2014, J STAT PHYS, V154, P11911	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0022-4715	1572-9613		J STAT PHYS	J. Stat. Phys.	JUN	2015	159	6					1327	1368		10.1007/s10955-015-1235-8		42	Physics, Mathematical	Physics	CJ1CE	WOS:000355218600005		
J	Shimoda, M; Enomoto, M; Horie, M; Miyakawa, S; Yagishita, K				Shimoda, Manabu; Enomoto, Mitsuhiro; Horie, Masaki; Miyakawa, Shumpei; Yagishita, Kazuyoshi			EFFECTS OF HYPERBARIC OXYGEN ON MUSCLE FATIGUE AFTER MAXIMAL INTERMITTENT PLANTAR FLEXION EXERCISE	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						repetitive exercise; voluntary contraction; twitch interpolation; plantar flexion torque; surface electromyography; single-blind design	VOLUNTARY CONTRACTIONS; KNEE EXTENSIONS; HUMANS; INJURY; THERAPY; RECRUITMENT; PERFORMANCE; ACTIVATION; HYPEROXIA; RECOVERY	The purpose of this study was to investigate the effects of hyperbaric oxygen (HBO) treatment on muscle fatigue after maximal intermittent plantar flexion exercise. Twenty healthy male volunteers (aged from 21 to 24 years) were randomly assigned to either HBO or normoxic group and were blinded to their treatment and group assignment. The HBO group breathed 100% oxygen under 2.5 atmosphere absolute (ATA) for 60 minutes, whereas the normoxic group breathed room air under 1.2 ATA for 70 minutes. The subjects performed a fatigue test, which consisted of 50 maximal unilateral isometric plantar flexions, before and after intervention. Surface electromyography was recorded from triceps surae muscle. Subjects performed maximal voluntary contractions of isometric plantar flexions, and voluntary activation and twitch contractile properties were evaluated with cutaneous tibial nerve stimuli before and after intervention. Compared with initial values during repetitions 4-10, the plantar flexion torque during repetitions 41-50 decreased to 88.5 and 83.2% after HBO and normoxic treatment, respectively. A smaller decrease in muscle force was observed in the HBO group compared with the normoxic group. No differences in function between treatment groups were observed after nerve stimulation. These results suggest that HBO contributes to sustained force production due to suppressing the muscle fatigue progression. In practice, HBO can contribute to the prevention of excess fatigue of agonist muscles for specific exercises involving repeated jumping.	[Shimoda, Manabu; Enomoto, Mitsuhiro; Horie, Masaki; Yagishita, Kazuyoshi] Tokyo Med & Dent Univ, Hosp Med, Hyperbar Med Ctr, Tokyo, Japan; [Horie, Masaki] Univ Tsukuba, Fac Med, Tsukuba, Ibaraki, Japan; [Miyakawa, Shumpei] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Yagishita, Kazuyoshi] Tokyo Med & Dent Univ, Hosp Med, Sports Med Clin Ctr, Tokyo, Japan	Yagishita, K (reprint author), Tokyo Med & Dent Univ, Hosp Med, Hyperbar Med Ctr, Tokyo, Japan.	yagishita.orth@tmd.ac.jp					Amann M, 2008, J PHYSIOL-LONDON, V586, P161, DOI 10.1113/jphysiol.2007.141838; Amann M, 2008, J APPL PHYSIOL, V104, P861, DOI 10.1152/japplphysiol.01008.2007; Hogan MC, 1999, J APPL PHYSIOL, V86, P1367; Amann M, 2006, J APPL PHYSIOL, V101, P119, DOI 10.1152/jappalphysiol.01596.2005; Calbet JAL, 2003, AM J PHYSIOL-REG I, V284, pR291, DOI 10.1152/ajpregu.00155.2002; Taylor JL, 2000, J APPL PHYSIOL, V89, P305; MATON B, 1989, EUR J APPL PHYSIOL O, V58, P369, DOI 10.1007/BF00643511; Rasmussen P, 2007, J CEREBR BLOOD F MET, V27, P1082, DOI 10.1038/sj.jcbfm.9600416; [Anonymous], 2008, J PHYSIOL-LONDON, DOI DOI 10.1113/JPHYSIOL.2007.139477; Nordlund MM, 2004, J APPL PHYSIOL, V96, P218, DOI 10.1152/japplphysiol.00650.2003; Arbogast S, 2000, MUSCLE NERVE, V23, P1187, DOI 10.1002/1097-4598(200008)23:8<1187::AID-MUS5>3.0.CO;2-9; Babault N, 2006, J APPL PHYSIOL, V100, P780, DOI 10.1152/japplphysiol.00737.2005; Babul S, 2003, CLIN J SPORT MED, V13, P138, DOI 10.1097/00042752-200305000-00003; BIGLANDRITCHIE B, 1986, J APPL PHYSIOL, V61, P421; Clarkson PM, 2002, AM J PHYS MED REHAB, V81, pS52, DOI 10.1097/01.PHM.0000029772.45258.43; Crenshaw AG, 2000, ACTA PHYSIOL SCAND, V170, P119, DOI 10.1046/j.1365-201x.2000.00765.x; FALLENTIN N, 1993, EUR J APPL PHYSIOL O, V67, P335, DOI 10.1007/BF00357632; FUGLEVAND AJ, 1993, J PHYSIOL-LONDON, V460, P549; Fulco CS, 1996, J APPL PHYSIOL, V81, P1891; Gosselin N, 2004, ACTA PHYSIOL SCAND, V181, P333, DOI 10.1111/j.1365-201X.2004.01290.x; HAGG GM, 1992, J APPL PHYSIOL, V73, P1211; Harrison BC, 2001, MED SCI SPORT EXER, V33, P36; Houssiere A, 2006, AM J PHYSIOL-HEART C, V291, pH210, DOI 10.1152/ajpheart.01168.2005; Mekjavic IB, 2000, MED SCI SPORT EXER, V32, P558, DOI 10.1097/00005768-200003000-00002; SHELLOCK FG, 1991, RADIOLOGY, V179, P659; Staples J, 1996, SPORTS MED, V22, P219, DOI 10.2165/00007256-199622040-00002; Staples JR, 1999, AM J SPORT MED, V27, P600; Tibbles PM, 1996, NEW ENGL J MED, V334, P1642, DOI 10.1056/NEJM199606203342506; Webster AL, 2002, CLIN J SPORT MED, V12, P139, DOI 10.1097/01.JSM.0000017379.22348.0C	29	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	JUN	2015	29	6					1648	1656				9	Sport Sciences	Sport Sciences	CJ2NS	WOS:000355322300026		
J	Akagi, R; Iwanuma, S; Hashizume, S; Kanehisa, H; Fukunaga, T; Kawakami, Y				Akagi, Ryota; Iwanuma, Soichiro; Hashizume, Satoru; Kanehisa, Hiroaki; Fukunaga, Tetsuo; Kawakami, Yasuo			DETERMINATION OF CONTRACTION-INDUCED CHANGES IN ELBOW FLEXOR CROSS-SECTIONAL AREA FOR EVALUATING MUSCLE SIZE-STRENGTH RELATIONSHIP DURING CONTRACTION	JOURNAL OF STRENGTH AND CONDITIONING RESEARCH			English	Article						biceps brachii; brachialis; brachioradialis; isometric contraction; magnetic resonance imaging	IN-VIVO MEASUREMENTS; BICEPS-BRACHII; VOLUME; ACTIVATION; THICKNESS; INDEXES; FORCE; YOUNG; MEN	The aims of this study were to determine contraction-induced changes in the elbow flexor cross-sectional area (CSA) and to examine whether the maximal CSA during a high-intensity contraction is more closely related to the strength than that at rest in the elbow flexors. Fourteen young male subjects participated in this study. The elbow flexor CSAs were measured at sites from 1 cm proximal to 6 cm distal to the reference site (60% of the upper arm length from the acromial process of the scapula to the lateral epicondyle of the humerus) (every 1 cm; 8 sampling sites) using magnetic resonance imaging, at rest and during 10, 20, 40, 60, and 80% of maximal voluntary contraction (MVC) of isometric elbow flexion. The elbow flexor CSA changed greatly during low-intensity contractions, and this contraction-induced change was small over 60% MVC. Compared with at rest, greater CSA around the muscle belly and smaller CSA in the distal portion of the elbow flexors were found in contracted conditions. The MVC strength was significantly correlated with the maximal CSAs at rest and each contraction level, but stepwise multiple regression analysis selected only that during 80% MVC as a significant contributor for estimating the MVC strength. These results suggest that, in the elbow flexors, the contraction-induced change in the CSA reaches its peak under high contractile level and that the maximal CSA during 80% MVC is more closely related to the MVC strength than that at rest.	[Akagi, Ryota] Shibaura Inst Technol, Coll Syst Engn & Sci, Saitama, Japan; [Iwanuma, Soichiro] Teikyo Univ Sci, Ctr Fundamental Educ, Tokyo, Japan; [Hashizume, Satoru] Japan Soc Promot Sci, Tokyo, Japan; [Hashizume, Satoru] Juntendo Univ, Fac Hlth & Sports Sci, Chiba, Japan; [Kanehisa, Hiroaki; Fukunaga, Tetsuo] Natl Inst Fitness & Sports Kanoya, Kagoshima, Japan; [Kawakami, Yasuo] Waseda Univ, Fac Sport Sci, Saitama, Japan	Akagi, R (reprint author), Shibaura Inst Technol, Coll Syst Engn & Sci, Saitama, Japan.	rakagi12@sic.shibaura-it.ac.jp			JSPS KAKENHI [22800089, 24700689]	This study was partly supported by JSPS KAKENHI Grant Number 22800089 (Grant-in-Aid for Research Activity Start-up) and 24700689 (Grant-in-Aid for Young Scientists (B)).	Akagi R, 2011, J PHYSIOL ANTHROPOL, V30, P169, DOI 10.2114/jpa2.30.169; Akagi R, 2014, J APPL BIOMECH, V30, P134, DOI 10.1123/jab.2012-0145; Finni T, 2008, J APPL PHYSIOL, V104, P1320, DOI 10.1152/japplphysiol.01069.2007; Fukunaga T, 2001, ACTA PHYSIOL SCAND, V172, P249, DOI 10.1046/j.1365-201x.2001.00867.x; NARICI MV, 1992, EUR J APPL PHYSIOL O, V65, P438, DOI 10.1007/BF00243511; Klein CS, 2001, J APPL PHYSIOL, V91, P1341; O'Brien TD, 2010, EXP PHYSIOL, V95, P202, DOI 10.1113/expphysiol.2009.048967; Akagi R, 2008, J STRENGTH COND RES, V22, P82, DOI 10.1519/JSC.0b013e31815ef675; Wokke BH, 2014, NEUROMUSCULAR DISORD, V24, P409, DOI 10.1016/j.nmd.2014.01.015; Akagi R, 2012, J APPL BIOMECH, V28, P63; Bamman MM, 2000, MED SCI SPORT EXER, V32, P1307, DOI 10.1097/00005768-200007000-00019; Akagi R, 2009, J STRENGTH COND RES, V23, P1258, DOI 10.1519/JSC.0b013e3181918a9b; Morse CI, 2008, J APPL PHYSIOL, V104, P469, DOI 10.1152/japplphysiol.00697.2007; BASKIN RJ, 1967, AM J PHYSIOL, V213, P1025; Fukunaga T, 2005, INT J SPORT HLTH SCI, V3, P296, DOI 10.5432/ijshs.3.296; Ito Masamitsu, 1998, Journal of Applied Physiology, V85, P1230; Gadeberg P, 1999, J APPL PHYSIOL, V86, P1670; Kent-Braun JA, 1999, J APPL PHYSIOL, V87, P22; Pappas GP, 2002, J APPL PHYSIOL, V92, P2381, DOI 10.1152/japplphysiol.00843.2001	19	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1064-8011	1533-4287		J STRENGTH COND RES	J. Strength Cond. Res.	JUN	2015	29	6					1741	1747				7	Sport Sciences	Sport Sciences	CJ2NS	WOS:000355322300037		
J	Osozawa, S; Wakabayashi, J				Osozawa, Soichi; Wakabayashi, John			Late stage exhumation of HP metamorphic rocks, progressive localization of strain, and changes in transport direction, Sambagawa belt, Japan	JOURNAL OF STRUCTURAL GEOLOGY			English	Article						Sambagawa HP metamorphic rock exhumation; Strain localization; Extrusional wedge; Out-of-sequence thrust; Duplex; Upright anticline	FRANCISCAN SUBDUCTION COMPLEX; YOUNGEST BLUESCHIST BELT; FISSION-TRACK ANALYSIS; SOUTH-WEST JAPAN; CENTRAL SHIKOKU; SW JAPAN; DUCTILE DEFORMATION; DIABLO RANGE; ISLAND-ARC; PRESSURE	New geologic mapping delimits major structures associated with the later stages of exhumation of high-pressure (HP) metamorphic rocks of the Sambagawa belt of central Shikoku. The main sets of structures define an inclined N-dipping wedge, bounded by S-vergent thrust faults below and N-vergent normal faults above. Such faults bound every metamorphic mineral zone of the Sambagawa belt. Faults also occur within metamorphic mineral zones, such as the Asemigawa detachment, which is entirely within the oligoclase-biotite zone, the highest-grade metamorphic zone. This fault is the structurally lowest of the N-vergent normal faults. These D2 structures accommodate the exhumation of the higher-grade rocks relative to the lower-grade rocks within the Sambagawa belt, rather than relative to units bounding the belt, so they are termed art "internal" extrusional wedge. The extrusional wedge is truncated to the east against footwall chlorite zone rocks by the Hamegano out-of-sequence thrust (OOST). The OOST divides the traditional chlorite zone into an upper unit consisting of varicolored schist (L tectonite), and a lower unit consisting of regionally extensive pelitic schist. To the north, the metamorphic mineral zones are stacked over the OOST, forming the Tomisato duplex, and these structures are further modified by the Oboke anticline and Tsuneyama syncline. The evolution of exhumation structures of the Sambagawa suggests progressive localization of strain as exhumation proceeded, as well as a change in movement direction from D1 oblique (orogen-subparallel) exhumation to the D2 structures with dip-parallel (orogen-normal) transport that we describe in detail. The evolution of exhumation structures in the Sambagawa belt differs from that of the HP rocks of the Franciscan Complex of California in that the exhumation of the latter is accommodated entirely by discrete faults and the Franciscan lacks internal normal faults. The internal extrusional wedge structure of the Sambagawa HP rocks resembles that of HP rocks of Leti Island of eastern Indonesia. (C) 2015 Elsevier Ltd. All rights reserved.	[Osozawa, Soichi] Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Sendai, Miyagi 9808578, Japan; [Wakabayashi, John] Calif State Univ Fresno, Dept Earth & Environm Sci, Fresno, CA 93740 USA	Osozawa, S (reprint author), Tohoku Univ, Grad Sch Sci, Dept Earth Sci, Sendai, Miyagi 9808578, Japan.	osozawa@m.tohoku.ac.jp			 [20540441]	The base map at 1: 50,000 was published by Ehime Prefectural Science Museum. This research was financially supported by Grants-in-Aid for Scientific Research Japan, Extrusion wedge of the Sambagawa high P-T metamorohic rocks, no. 20540441. We thank T. Takeshita, H. Yamamoto, and D. M. Robinson for their helpful reviews. S. Kanisawa helped identification of thin sections. Y. Ito helped with EMPA, and M. Abe made thin sections.	Aoki K, 2011, J ASIAN EARTH SCI, V42, P355, DOI 10.1016/j.jseaes.2011.05.001; ITAYA T, 1988, CONTRIB MINERAL PETR, V100, P281, DOI 10.1007/BF00379739; Mouri T, 2008, GEOLOGY, V36, P503, DOI 10.1130/G24599A.1; Takeshita T, 2004, GEOL SOC SPEC PUBL, V227, P279, DOI 10.1144/GSL.SP.2004.227.01.14; EVANS BW, 1977, ANNU REV EARTH PL SC, V5, P397, DOI 10.1146/annurev.ea.05.050177.002145; Yagi K, 2002, J METAMORPH GEOL, V20, P633, DOI 10.1046/j.1525-1314.2002.00392.x; Wallis SR, 2009, J METAMORPH GEOL, V27, P93, DOI 10.1111/j.1525-1314.2008.00806.x; CLOOS M, 1985, TECTONICS, V4, P421, DOI 10.1029/TC004i005p00421; PLATT JP, 1993, TERRA NOVA, V5, P119, DOI 10.1111/j.1365-3121.1993.tb00237.x; PLATT JP, 1986, GEOL SOC AM BULL, V97, P1037, DOI 10.1130/0016-7606(1986)97<1037:DOOWAT>2.0.CO;2; Fukunari T, 2007, ISL ARC, V16, P243, DOI 10.1111/j.1440-1738.2007.00570.x; Wakabayashi J, 2007, INT GEOL REV, V49, P873, DOI 10.2747/0020-6814.49.10.873; Wallis S, 1998, J METAMORPH GEOL, V16, P83, DOI 10.1111/j.1525-1314.1998.00072.x; OSOZAWA S, 1994, GEOLOGY, V22, P1135, DOI 10.1130/0091-7613(1994)022<1135:PRBUAD>2.3.CO;2; ENAMI M, 1994, CONTRIB MINERAL PETR, V116, P182, DOI 10.1007/BF00310699; Kawakami T, 2013, CONTRIB MINERAL PETR, V165, P575, DOI 10.1007/s00410-012-0824-7; Aoki K, 2009, LITHOS, V113, P393, DOI 10.1016/j.lithos.2009.04.033; Wallis S, 2004, J METAMORPH GEOL, V22, P17, DOI 10.1111/j.1525-1314.2003.00493.x; Ring U, 1999, GEOL SOC SPEC PUBL, V154, P55, DOI 10.1144/GSL.SP.1999.154.01.03; Unruh JR, 2007, GEOL SOC AM BULL, V119, P1347, DOI 10.1130/B26057.1; TAKASU A, 1990, TECTONOPHYSICS, V185, P111, DOI 10.1016/0040-1951(90)90408-Z; Wakabayashi J, 2015, INT GEOL REV, V57, P669, DOI 10.1080/00206814.2014.998728; Aoki K, 2008, J METAMORPH GEOL, V26, P583, DOI 10.1111/j.1525-1314.2008.00777.x; DUMITRU TA, 1989, TECTONICS, V8, P197, DOI 10.1029/TC008i002p00197; El-Fakharani AH, 2008, J ASIAN EARTH SCI, V33, P303, DOI 10.1016/j.jseaes.2008.02.001; Ernst W. G., 1993, GEOL SOC AM BULL, V105, P618, DOI DOI 10.1130/0016-7606(1993)105<LESS; Ernst W.G., 1970, GEOL SOC AM MEM, V124, P276; Ernst WG, 2009, TECTONICS, V28, DOI 10.1029/2008TC002352; HIGASHINO T, 1990, J METAMORPH GEOL, V8, P413, DOI 10.1111/j.1525-1314.1990.tb00628.x; Higashino T., 1990, J GEOL SOC JPN, V96, P703; Kadarusman A, 2010, GONDWANA RES, V18, P189, DOI 10.1016/j.gr.2010.02.009; Kubota K., 2008, ISL ARC, V17, P129; Maruyama S, 1996, INT GEOL REV, V38, P485, DOI DOI 10.1080/00206819709465347; Mori H, 2010, ISL ARC, V19, P357, DOI 10.1111/j.1440-1738.2010.00713.x; Narita Koichiro, 1999, Journal of the Geological Society of Japan, V105, P305; Okamoto K., 2000, J GEOLOGICAL SOC JAP, V106, P70; Okudaira T, 1996, J METAMORPH GEOL, V14, P427, DOI 10.1046/j.1525-1314.1996.05983.x; Osozawa S, 1997, ISL ARC, V6, P361, DOI 10.1111/j.1440-1738.1997.tb00046.x; Osozawa S., 2011, GEOLOGY NAGO CITY KU, P208; Osozawa S, 2012, J ASIAN EARTH SCI, V59, P70, DOI 10.1016/j.jseaes.2012.04.001; Osozawa S, 2007, J STRUCT GEOL, V29, P1131, DOI 10.1016/j.jsg.2007.03.014; Schoonover M, 2004, TECTONOPHYSICS, V393, P221, DOI 10.1016/j.tecto.2004.07.036; SHINJOE H, 1994, TECTONOPHYSICS, V239, P73, DOI 10.1016/0040-1951(94)90108-2; Tagami T, 1996, J GEOPHYS RES-SOL EA, V101, P11353, DOI 10.1029/96JB00407; Takeshita T, 2013, J STRUCT GEOL, V46, P142, DOI 10.1016/j.jsg.2012.09.014; Takeshita T., 2015, ISL ARC IN PRESS; Takeshita T, 2005, J METAMORPH GEOL, V23, P279, DOI 10.1111/j.1525-1314.2005.00576.x; Terabayashi M, 1996, J GEOL, V104, P617; Wallis S. R., 1992, ISL ARC, V1, P176, DOI 10.1111/j.1440-1738.1992.tb00068.x; Wintsch RP, 1999, GEOL SOC SPEC PUBL, V154, P129, DOI 10.1144/GSL.SP.1999.154.01.06; Yamamoto H, 2004, TECTONOPHYSICS, V387, P151, DOI 10.1016/j.tecto.2004.06.014	51	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0191-8141			J STRUCT GEOL	J. Struct. Geol.	JUN	2015	75						1	16		10.1016/j.jsg.2015.03.006		16	Geosciences, Multidisciplinary	Geology	CJ2YS	WOS:000355351200002		
J	Barnard, ND; Levin, SM; Yokoyama, Y				Barnard, Neal D.; Levin, Susan M.; Yokoyama, Yoko			A Systematic Review and Meta-Analysis of Changes in Body Weight in Clinical Trials of Vegetarian Diets	JOURNAL OF THE ACADEMY OF NUTRITION AND DIETETICS			English	Review						Dietary intervention; Overweight; Plant based; Vegan; Vegetarian	RANDOMIZED CONTROLLED-TRIAL; FAT VEGAN DIET; RHEUMATOID-ARTHRITIS; INSULIN SENSITIVITY; PREMENOPAUSAL WOMEN; CARDIOVASCULAR RISK; NUTRITION PROGRAM; BLOOD-PRESSURE; HEART-DISEASE; MASS INDEX	In observational studies, vegetarians generally have lower body weights compared with omnivores. However, weight changes that occur when vegetarian diets are prescribed have not beenwell quantified. We estimated the effect on body weight when vegetarian diets are prescribed. We searched PubMed, EMBASE, and the Cochrane Central Register of Controlled Trials for articles through December 31, 2013. Additional articles were identified from reference lists. We included intervention trials in which participants were adults, interventions included vegetarian diets of >= 4 weeks' duration without energy intake limitations, and effects on body weight were reported. Two investigators independently extracted data using predetermined fields. Estimates of body weight change, comparing intervention groups to untreated control groups, were derived using a random effects model to estimate the weighted mean difference. To quantify effects on body weight of baseline weight, sex, age, study duration, study goals, type of diet, and study authorship, additional analyses examined within-group changes for all studies reporting variance data. We identified 15 trials (17 intervention groups), of which 4 included untreated controls. Prescription of vegetarian diets was associated with a mean weight change of -3.4 kg (95% CI -4.4 to -2.4; P<0.001) in an intention-to-treat analysis and -4.6 kg (95% CI -5.4 to -3.8; P<0.001) in a completer analysis (omitting missing post-intervention values). Greater weight loss was reported in studies with higher baseline weights, smaller proportions of female participants, older participants, or longer durations, and in studies in which weight loss was a goal. Using baseline data for missing values, I-2 equaled 52.3 (P=0.10), indicating moderate heterogeneity. When missing data were omitted, I2 equaled 0 (P=0.65), indicating low heterogeneity. Studies are relatively few, with variable quality. The prescription of vegetarian diets reduces mean body weight, suggesting potential value for prevention and management of weight-related conditions.	[Barnard, Neal D.] George Washington Univ, Sch Med, Washington, DC USA; [Levin, Susan M.] Physicians Comm Responsible Med, Washington, DC 20016 USA; [Yokoyama, Yoko] Keio Univ, Grad Sch Media & Governance, Kanagawa, Japan; [Yokoyama, Yoko] Japan Soc Promot Sci, Osaka, Japan; [Yokoyama, Yoko] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol, Osaka, Japan	Levin, SM (reprint author), Physicians Comm Responsible Med, 5100 Wisconsin Ave NW, Washington, DC 20016 USA.	slevin@pcrm.org					Mishra S, 2013, EUR J CLIN NUTR, V67, P718, DOI 10.1038/ejcn.2013.92; Burke LE, 2007, AM J CLIN NUTR, V86, P588; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Barnard ND, 2000, AM J CARDIOL, V85, P969, DOI 10.1016/S0002-9149(99)00911-X; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Craig WJ, 2009, J AM DIET ASSOC, V109, P1266, DOI 10.1016/j.jada.2009.05.027; Barnard ND, 2009, J AM DIET ASSOC, V109, P263, DOI 10.1016/j.jada.2008.10.049; Yokoyama Y, 2014, JAMA INTERN MED, V174, P577, DOI 10.1001/jamainternmed.2013.14547; Nicholson AS, 1999, PREV MED, V29, P87, DOI 10.1006/pmed.1999.0529; Moher D, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000097; Berkow SE, 2006, NUTR REV, V64, P175, DOI 10.1301/nr.2006.apr.175-188; Katcher HI, 2010, ANN NUTR METAB, V56, P245, DOI 10.1159/000288281; Lewis CE, 2009, CIRCULATION, V119, P3263, DOI 10.1161/CIRCULATIONAHA.109.192574; Jenkins DJA, 2009, ARCH INTERN MED, V169, P1046, DOI 10.1001/archinternmed.2009.115; ROUSE IL, 1983, LANCET, V1, P5; Egger M, 1997, BRIT MED J, V315, P1533; Egger M, 1997, BRIT MED J, V315, P629; Hua NW, 2001, BRIT J NUTR, V86, P515, DOI 10.1079/BJN2001421; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; KJELDSENKRAGH J, 1991, LANCET, V338, P899, DOI 10.1016/0140-6736(91)91770-U; Turner-McGrievy GM, 2007, OBESITY, V15, P2276, DOI 10.1038/oby.2007.270; Rizzo NS, 2013, J ACAD NUTR DIET, V113, P1610, DOI [10.1016/j.jand.2013.06.349, 10.1016/j.jand.2013.06349]; RAVUSSIN E, 1985, J CLIN INVEST, V76, P1268, DOI 10.1172/JCI112083; Ornish D, 1998, JAMA-J AM MED ASSOC, V280, P2001, DOI 10.1001/jama.280.23.2001; Jenkins DJA, 2005, AM J CLIN NUTR, V81, P380; Spencer EA, 2003, INT J OBESITY, V27, P728, DOI 10.1038/sj.ijo.0802300; Barnard ND, 2009, AM J CLIN NUTR, V89, pS1588, DOI 10.3945/ajcn.2009.26736H; Barnard ND, 1992, J CARDIOPULM REHABIL, V12, P423, DOI 10.1097/00008483-199211000-00009; Barnard Neal D, 2004, J Cardiopulm Rehabil, V24, P229, DOI 10.1097/00008483-200407000-00004; Barnard ND, 2005, AM J MED, V118, P991, DOI 10.1016/j.amjmed.2005.03.039; Bell EA, 2001, AM J CLIN NUTR, V73, P1010; Delgado M, 1996, ANN NUTR METAB, V40, P202, DOI 10.1159/000177915; Diabetes Prevention Program ( DPP) Research Group, 2002, DIABETES CARE, V25, P2165, DOI DOI 10.2337/DIACARE.25.12.2165.PMID:12453955; Ferdowsian HR, 2010, AM J HEALTH PROMOT, V24, P384, DOI 10.4278/ajhp.081027-QUAN-255; Higgins JPT, 2011, COCHRANE HDB SYSTEMA; Hooper L, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e7666; JOHANSSON G, 1992, CARCINOGENESIS, V13, P153, DOI 10.1093/carcin/13.2.153; LINDAHL O, 1984, BRIT J NUTR, V52, P11, DOI 10.1079/BJN19840066; Lisowska ACM, 2010, PEDIAT WSPOLCZESNA, V12, P121; Look ARG, 2014, OBESITY SILVER SPRIN, V22, P5, DOI [10.1002/oby.20662, DOI 10.1002/OBY.20662]; Lovejoy JC, 1998, METABOLISM, V47, P1520, DOI 10.1016/S0026-0495(98)90080-4; MARGETTS BM, 1985, J HYPERTENS, V3, pS429; McDougall J, 2002, J ALTERN COMPLEM MED, V8, P71, DOI 10.1089/107555302753507195; Dansinger ML, 2005, JAMA-J AM MED ASSOC, V293, P43, DOI 10.1001/jama.293.1.43; Nenonen MT, 1998, BRIT J RHEUMATOL, V37, P274; Ornish D., 1993, EAT MORE WEIGH LESS; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037//0033-2909.86.3.638; Smith CF, 2000, OBES RES, V8, P123, DOI 10.1038/oby.2000.13	49	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2212-2672	2212-2680		J ACAD NUTR DIET	J. Acad. Nutr. Diet.	JUN	2015	115	6					954	969		10.1016/j.jand.2014.11.016		16	Nutrition & Dietetics	Nutrition & Dietetics	CJ0BM	WOS:000355137100013		
J	Nagata, Y; Takeuchi, M; Mizukoshi, K; Wu, VCC; Lin, FC; Negishi, K; Nakatani, S; Otsuji, Y				Nagata, Yasufumi; Takeuchi, Masaaki; Mizukoshi, Kei; Wu, Victor Chien-Chia; Lin, Fen-Chiung; Negishi, Kazuaki; Nakatani, Satoshi; Otsuji, Yutaka			Intervendor Variability of Two-Dimensional Strain Using Vendor-Specific and Vendor-Independent Software	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Intervendor variability; Speckle-tracking echocardiography; 2D strain	SPECKLE-TRACKING SOFTWARE; LEFT-VENTRICULAR FUNCTION; MYOCARDIAL DEFORMATION; ECHOCARDIOGRAPHY; STANDARDIZATION; CHEMOTHERAPY	Background: Although two-dimensional (2D) strain is widely used to assess left ventricular mechanics, the strain values derived from vendor-specific 2D speckle-tracking software are different even for the same subjects and are therefore not interchangeable. The aim of this study was to test the hypothesis that vendor-independent software would produce lower intervendor variability between 2D strain measurements and overcome this limitation. Methods: Two sets of three apical images were acquired using two of three types of ultrasound machines (GE, Philips, and Toshiba) in 81 healthy volunteers (GE vs Philips in 26 subjects, Philips vs Toshiba in 31 subjects, and GE vs Toshiba in 24 subjects). Two-dimensional global longitudinal strain (GLS) was measured using vendor-specific software and two vendor-independent software packages (TomTec and Epsilon) in each set of apical images, and GLS values were directly compared with one another. Results: The upgrades of vendor-specific software yielded different values of GLS compared with the previous versions of the software. The correlations between the GLS values determined using vendor-specific software exhibited a wide range of r values (r = 0.23, r = 0.42, and r = 0.72), with significant bias, with the exception of one comparison. The vendor-independent software provided modest degrees of correlation (TomTec: r = 0.65, r = 0.65, and r = 0.77; Epsilon: r = 0.65, r = 0.74, and r = 0.77), with limits of agreement (range, +/- 3% to +/- 4.5%) that were not negligible. Conclusions: Although the vendor-independent 2D strain software provided moderate correlations between the GLS values of the ultrasound images obtained from the same subjects using different vendors, relatively large limits of agreement remain a relevant problem. These results suggest that the same ultrasound machine and the same 2D speckle-tracking software should be used for longitudinal analysis of strain values in the same subjects and for cross-sectional studies.	[Nagata, Yasufumi; Takeuchi, Masaaki; Mizukoshi, Kei; Otsuji, Yutaka] Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, Kitakyushu, Fukuoka 8078555, Japan; [Wu, Victor Chien-Chia; Lin, Fen-Chiung] Chang Gung Univ, Chang Gung Mem Hosp, Dept Cardiol, Coll Med, Taipei, Taiwan; [Negishi, Kazuaki] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia; [Nakatani, Satoshi] Osaka Univ, Grad Sch Med, Dept Hlth Sci, Suita, Osaka, Japan	Takeuchi, M (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 2, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	takeuchi@med.uoeh-u.ac.jp	Negishi, Kazuaki/J-7242-2014	Negishi, Kazuaki/0000-0002-9086-2565			Carasso S, 2011, AM J CARDIOL, V107, P1052, DOI 10.1016/j.amjcard.2010.11.032; Marwick TH, 2012, J AM SOC ECHOCARDIOG, V25, P1204, DOI 10.1016/j.echo.2012.09.017; Manovel A, 2010, EUR J ECHOCARDIOGR, V11, P417, DOI 10.1093/ejechocard/jep226; Delgado V, 2009, EUR HEART J, V30, P3037, DOI 10.1093/eurheartj/ehp351; Cheng S, 2013, J AM SOC ECHOCARDIOG, V26, P1258, DOI 10.1016/j.echo.2013.07.002; Biaggi P, 2011, ECHOCARDIOGR-J CARD, V28, P539, DOI 10.1111/j.1540-8175.2011.01386.x; Risum N, 2012, J AM SOC ECHOCARDIOG, V25, P1195, DOI 10.1016/j.echo.2012.08.007; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Costa SP, 2014, J AM SOC ECHOCARDIOG, V27, P50, DOI 10.1016/j.echo.2013.08.021; Drafts BC, 2013, JACC-CARDIOVASC IMAG, V6, P877, DOI 10.1016/j.jcmg.2012.11.017; Nelson MR, 2012, J AM SOC ECHOCARDIOG, V25, P1189, DOI 10.1016/j.echo.2012.08.006; Koopman LP, 2011, J AM SOC ECHOCARDIOG, V24, P37, DOI 10.1016/j.echo.2010.09.018; Thomas JD, 2013, EUR HEART J-CARD IMG, V14, P1039, DOI 10.1093/ehjci/jet184; Haruki N, 2010, EUR J ECHOCARDIOGR, V11, P352, DOI 10.1093/ejechocard/jep215; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; Koopman LP, 2010, J AM SOC ECHOCARDIOG, V23, P919, DOI 10.1016/j.echo.2010.06.014; Negishi K, 2013, ULTRASOUND MED BIOL, V39, P714, DOI 10.1016/j.ultrasmedbio.2012.11.021; Kurosawa K, 2013, J ECHOCARDIOGR, V11, P50; Marwick TH, 2010, EUR J ECHOCARDIOGR, V11, P414, DOI 10.1093/ejechocard/jeq006; Mizukoshi K, 2013, J ECHOCARDIOGR, V11, P9; Negishi K, 2014, EUR HEART J-CARD IMG, V15, P324, DOI 10.1093/ehjci/jet159; Sun JP, 2013, INT J CARDIOL, V167, P495, DOI 10.1016/j.ijcard.2012.01.071	23	2	2	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	JUN	2015	28	6					630	641		10.1016/j.echo.2015.01.021		12	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ3JE	WOS:000355378400006		
J	Yang, H; Marwick, TH; Fukuda, N; Oe, H; Saito, M; Thomas, JD; Negishi, K				Yang, Hong; Marwick, Thomas H.; Fukuda, Nobuaki; Oe, Hiroki; Saito, Makoto; Thomas, James D.; Negishi, Kazuaki			Improvement in Strain Concordance between Two Major Vendors after the Strain Standardization Initiative	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Strain; Ejection fraction; EACVI-ASE strain standardization; Concordance; Vendor difference	SPECKLE-TRACKING SOFTWARE; MYOCARDIAL DEFORMATION; MAGNETIC-RESONANCE; ECHOCARDIOGRAPHY; QUANTIFICATION; VARIABILITY; SOCIETY	Background: Disagreement of strain measurements among different vendors has provided an obstacle to the clinical use of strain. A joint standardization task force between professional societies and industry was initiated to reduce intervendor variability of strain. Although feedback from this process has been used in software upgrades, little is known about the effects of efforts to improve conformity. The aim of this study was to assess whether intervendor agreement for global longitudinal strain (GLS) has improved after standardization initiatives. Methods: Eighty-two subjects (mean age, 52 +/- 21 years; 55% men) prospectively underwent two sequential examinations using two most common ultrasound systems (Vivid E9 and iE33). GLS was calculated using proprietary software (EchoPAC-PC BT12 [E12] and BT13 [E13] vs QLAB version 8.0 [Q8], QLAB version 9.0 [Q9], and QLAB version 10.0 [Q10]). Agreements in GLS were evaluated with Bland-Altman plots. Coefficients of variation (CVs) were compared using the Friedman test and compared with CVs of left ventricular volumes and ejection fraction (LVEF). Results: Median GLS using E12 was -19.2% (interquartile range [IQR], -15.2% to -23.2%), compared with -19.3% (IQR, -14.9% to -23.7%) for E13, -15.7% (IQR, -11.4% to -20%) for Q8, -19% (IQR, -15.7% to -22.3%) for Q9, and -18.7% (IQR, -15.7% to -21.7%) for Q10. The CVs of prestandardization GLS (12 +/- 8% [E12/Q8] and 14 +/- 8 [E13/Q8]) were significantly larger than that of LVEF (5 +/- 5) (P < .001). Since standardization, the CVs of GLS have shown improvement (6 +/- 4 [E12/Q9], 7 +/- 4 [E12/Q10], 6 +/- 4 [E13/Q9], and 7 +/- 4 [E13/Q10]) and are similar to those of LVEF. Conclusions: Subsequent to the joint standardization task force, there has been improvement in between-vendor concordance in GLS between two leading ultrasound manufactures, the variability of which is now analogous to that of LVEF. The removal of concerns about measurement variability should allow wider use of GLS.	[Yang, Hong; Marwick, Thomas H.; Saito, Makoto; Negishi, Kazuaki] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia; [Fukuda, Nobuaki] Natl Hosp Org Takasaki, Gen Med Ctr, Takasaki, Gumma, Japan; [Oe, Hiroki] Okayama Univ Hosp, Okayama, Japan; [Thomas, James D.] Northwestern Univ, Bluhm Cardiovasc Inst, Chicago, IL 60611 USA	Negishi, K (reprint author), Univ Tasmania, Menzies Inst Med Res, Private Bag 23, Hobart, Tas 7000, Australia.	kazuaki.negishi@utas.edu.au	Negishi, Kazuaki/J-7242-2014	Negishi, Kazuaki/0000-0002-9086-2565	National Heart Foundation of Australia [100307]; GE Medical Systems; Siemens; Select Foundation	The following authors reported no actual or potential conflicts of interest in relation to this document: Nobuaki Fukuda, MD, Hiroki Oe, MD, PhD, Makoto Saito, MD, PhD, and James D. Thomas, MD, PhD. The following authors reported relationships with one or more commercial interests: Hong Yang, BMed, is supported by a Health Professional Scholarship from the National Heart Foundation of Australia (100307); Thomas H. Marwick, MBBS, PhD, MPH, has received research grants from GE Medical Systems and Siemens; and Kazuaki Negishi, MD, PhD, is supported by an award from the Select Foundation.	Bellenger NG, 2000, EUR HEART J, V21, P1387, DOI 10.1053/euhj.2000.2011; Kaul S, 2011, J AM SOC ECHOCARDIOG, V24, P455, DOI 10.1016/j.echo.2011.02.017; Brown J, 2009, AM HEART J, V157, P102, DOI 10.1016/j.ahj.2008.08.032; Marwick TH, 2012, J AM SOC ECHOCARDIOG, V25, P1204, DOI 10.1016/j.echo.2012.09.017; Manovel A, 2010, EUR J ECHOCARDIOGR, V11, P417, DOI 10.1093/ejechocard/jep226; Biaggi P, 2011, ECHOCARDIOGR-J CARD, V28, P539, DOI 10.1111/j.1540-8175.2011.01386.x; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Risum N, 2012, J AM SOC ECHOCARDIOG, V25, P1195, DOI 10.1016/j.echo.2012.08.007; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; Costa SP, 2014, J AM SOC ECHOCARDIOG, V27, P50, DOI 10.1016/j.echo.2013.08.021; Castel AL, 2014, ARCH CARDIOVASC DIS, V107, P96, DOI 10.1016/j.acvd.2014.01.007; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Nelson MR, 2012, J AM SOC ECHOCARDIOG, V25, P1189, DOI 10.1016/j.echo.2012.08.006; Koopman LP, 2011, J AM SOC ECHOCARDIOG, V24, P37, DOI 10.1016/j.echo.2010.09.018; Thomas JD, 2013, EUR HEART J-CARD IMG, V14, P1039, DOI 10.1093/ehjci/jet184; Mor-Avi V, 2011, J AM SOC ECHOCARDIOG, V24, P277, DOI 10.1016/j.echo.2011.01.015; Negishi K, 2013, ULTRASOUND MED BIOL, V39, P714, DOI 10.1016/j.ultrasmedbio.2012.11.021; Bansal M, 2008, J AM SOC ECHOCARDIOG, V21, P1318, DOI 10.1016/j.echo.2008.09.021; BLAND JM, 1986, LANCET, V1, P307; Marwick TH, 2010, EUR J ECHOCARDIOGR, V11, P414, DOI 10.1093/ejechocard/jeq006; Molnar Z, 2007, INTENS CARE MED, V33, P1767, DOI 10.1007/s00134-007-0743-7; National Health and Medical Research Council, 2007, NAT STAT ETH COND HU; Sun JP, 2013, INT J CARDIOL, V167, P495, DOI 10.1016/j.ijcard.2012.01.071	23	6	6	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	JUN	2015	28	6					642	+		10.1016/j.echo.2014.12.009		14	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ3JE	WOS:000355378400007		
J	Orii, M; Hirata, K; Tanimoto, T; Shiono, Y; Shimamura, K; Yamano, T; Ino, Y; Yamaguchi, T; Kubo, T; Tanaka, A; Imanishi, T; Akasaka, T				Orii, Makoto; Hirata, Kumiko; Tanimoto, Takashi; Shiono, Yasutsugu; Shimamura, Kunihiro; Yamano, Takashi; Ino, Yasushi; Yamaguchi, Tomoyuki; Kubo, Takashi; Tanaka, Atsushi; Imanishi, Toshio; Akasaka, Takashi			Myocardial Damage Detected by Two-Dimensional Speckle-Tracking Echocardiography in Patients with Extracardiac Sarcoidosis: Comparison with Magnetic Resonance Imaging	JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY			English	Article						Two-dimensional speckle-tracking echocardiography; Sarcoidosis; Delayed enhancement magnetic resonance imaging	VENTRICULAR SYSTOLIC FUNCTION; CANINE LEFT-VENTRICLE; CARDIAC SARCOIDOSIS; STRAIN; INFARCTION; DEFORMATION; FIBER; DYSFUNCTION; VALIDATION; FIBROSIS	Background: The aim of this study was to determine whether two-dimensional speckle-tracking echocardiography can identify the myocardial damage detected by delayed enhancement (DE) magnetic resonance imaging via the differences in myocardial deformation in patients with extracardiac sarcoidosis who showed no structural and functional abnormalities in the heart. Methods: Forty-five patients with biopsy-proven extracardiac sarcoidosis were analyzed retrospectively. Patients with abnormal electrocardiographic and echocardiographic findings, including ventricular arrhythmias, heart block, regional wall motion abnormalities, valvular heart disease, and cardiomyopathy, were excluded. Ten age-matched healthy control subjects were recruited as a control group. Comprehensive echocardiography and DE magnetic resonance imaging were performed, and circumferential, longitudinal, and radial strain were consecutively assessed using two-dimensional speckle-tracking echocardiographic software in a 16-segment model of the left ventricle in accordance to the presence (DE+) or absence (DE-) of DE. Results: Among the 45 patients, 36 segments in 13 patients showed DE. DE+ segments had lower peak circumferential strain than DE- and control segments (-14 +/- 5% vs -28 +/- 7% vs -30 +/- 7%, P < .0001). Peak longitudinal strain in DE+ segments was significantly decreased compared with control segments (-19 +/- 4% vs -23 +/- 5%, P = .005). However, peak radial strain was similar among the three groups: 41 +/- 17% in DE+ segments, 45 +/- 23% in DE-segments, and 46 +/- 18% in control segments (P = .50). Conclusions: Circumferential and longitudinal strain via two-dimensional speckle-tracking echocardiography can identify the myocardial damage detected by DE magnetic resonance imaging in patients with extracardiac sarcoidosis.	[Orii, Makoto; Hirata, Kumiko; Tanimoto, Takashi; Shiono, Yasutsugu; Shimamura, Kunihiro; Yamano, Takashi; Ino, Yasushi; Yamaguchi, Tomoyuki; Kubo, Takashi; Tanaka, Atsushi; Imanishi, Toshio; Akasaka, Takashi] Wakayama Med Univ, Dept Cardiovasc Med, Wakayama 6418510, Japan	Hirata, K (reprint author), Wakayama Med Univ, Dept Cardiovasc Med, 811-1 Kimiidera, Wakayama 6418510, Japan.	hiratakumiko@aol.com					Bondarenko O, 2005, J CARDIOV MAGN RESON, V7, P481, DOI 10.1081/JCMR-200053623; ROBERTS WC, 1977, AM J MED, V63, P86, DOI 10.1016/0002-9343(77)90121-8; Chan J, 2006, J AM COLL CARDIOL, V48, P2026, DOI 10.1016/j.jacc.2006.07.050; WALDMAN LK, 1985, CIRC RES, V57, P152; WALDMAN LK, 1988, CIRC RES, V63, P550; Langeland S, 2005, CIRCULATION, V112, P2157, DOI 10.1161/CIRCULATIONAHA.105.554006; Yingchoncharoen T, 2013, J AM SOC ECHOCARDIOG, V26, P185, DOI 10.1016/j.echo.2012.10.008; Tavora F, 2009, AM J CARDIOL, V104, P571, DOI 10.1016/j.amjcard.2009.03.068; Takigiku K, 2012, CIRC J, V76, P2623, DOI 10.1253/circj.CJ-12-0264; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Amundsen BH, 2006, J AM COLL CARDIOL, V47, P789, DOI 10.1016/j.jacc.2005.10.040; Patel AR, 2011, EUR J HEART FAIL, V13, P1231, DOI 10.1093/eurjhf/hfr099; Sjoli B, 2009, JACC-CARDIOVASC IMAG, V2, P24, DOI 10.1016/j.jcmg.2008.10.007; Tanimoto T, 2010, CIRCULATION, V122, P2281, DOI 10.1161/CIRCULATIONAHA.109.935338; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; RADEMAKERS FE, 1994, CIRCULATION, V89, P1174; Kitabata H, 2009, JACC-CARDIOVASC IMAG, V2, P263, DOI 10.1016/j.jcmg.2008.11.013; Smedema JP, 2005, J AM COLL CARDIOL, V45, P1683, DOI 10.1016/j.jacc.2005.01.047; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; Kim RJ, 1999, CIRCULATION, V100, P1992; Fallah-Rad N, 2011, J AM COLL CARDIOL, V57, P2263, DOI 10.1016/j.jacc.2010.11.063; Ishige I, 1999, LANCET, V354, P120, DOI 10.1016/S0140-6736(98)12310-3; Kramer J, 2013, EUR HEART J, V34, P1587, DOI 10.1093/eurheartj/eht098; Aso H, 1998, INVEST RADIOL, V33, P22, DOI 10.1097/00004424-199801000-00004; Uemura A, 1999, AM HEART J, V138, P299, DOI 10.1016/S0002-8703(99)70115-8; Geyer H, 2010, J AM SOC ECHOCARDIOG, V23, P351, DOI 10.1016/j.echo.2010.02.015; MacGowan GA, 1997, CIRCULATION, V96, P535; Reisner SA, 2004, J AM SOC ECHOCARDIOG, V17, P630, DOI 10.1016/j.echo.2004.02.011; BRUNVAND H, 1995, CARDIOVASC RES, V30, P138; GREENBAUM RA, 1981, BRIT HEART J, V45, P248; HANLEY JA, 1983, RADIOLOGY, V148, P839; Hiraga H, 1993, JPN MINISTRY HLTH WE, P23; Schulz-Menger J, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-35; Sharma OP, 1997, CLIN CHEST MED, V18, P813, DOI 10.1016/S0272-5231(05)70420-2; Torrent-Guasp F, 2001, Semin Thorac Cardiovasc Surg, V13, P301	35	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0894-7317			J AM SOC ECHOCARDIOG	J. Am. Soc. Echocardiogr.	JUN	2015	28	6					683	691		10.1016/j.echo.2015.02.018		9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CJ3JE	WOS:000355378400012		
J	Saeki, H; Nakagawa, H; Ishii, T; Morisaki, Y; Aoki, T; Berclaz, PY; Heffernan, M				Saeki, H.; Nakagawa, H.; Ishii, T.; Morisaki, Y.; Aoki, T.; Berclaz, P. -Y.; Heffernan, M.			Efficacy and safety of open-label ixekizumab treatment in Japanese patients with moderate-to-severe plaque psoriasis, erythrodermic psoriasis and generalized pustular psoriasis	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Article							VISUAL ANALOG SCALE; RATING-SCALE; INDEX	BackgroundIxekizumab, an anti-IL-17A monoclonal antibody, demonstrated a high level of efficacy in moderate-to-severe plaque psoriasis (PP) patients. ObjectiveTo evaluate the efficacy and safety of open-label ixekizumab in Japanese patients with moderate-to-severe PP, erythrodermic psoriasis (EP) and generalized pustular psoriasis (GPP). MethodsPatients received 160-mg subcutaneous ixekizumab injection at Week 0, 80-mg every 2weeks through Week 12 and 80-mg every 4weeks through Week 24. Efficacy and safety are reported through 24weeks; additional safety data are available for some patients. ResultsA total of 78 patients with PP, 8 with EP and 5 with GPP enrolled. In PP patients, PASI75 and PASI90 response rates were 98.7% (77/78) and 83.3% (65/78) at Week 12 respectively. In EP patients, PASI75 and PASI90 were 100.0% (8/8) and 62.5% (5/8) and in GPP patients were 80.0% (4/5) and 60.0% (3/5). Overall, 84.0% (76/91) had a treatment-emergent AE through 24weeks. There were no serious AEs, deaths, cases of tuberculosis or invasive fungal infections. LimitationsNo control group and small sample sizes, especially for EP and GPP. ConclusionBy Week 12, nearly all patients with PP, EP and GPP achieved PASI75. The safety profile was consistent with reported results and no unexpected safety signals were observed.	[Saeki, H.] Nippon Med Sch, Dept Dermatol, Tokyo 113, Japan; [Nakagawa, H.] Jikei Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Ishii, T.; Morisaki, Y.; Aoki, T.] Eli Lilly Japan KK, Lilly Res Labs, Kobe, Hyogo, Japan; [Berclaz, P. -Y.; Heffernan, M.] Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA	Heffernan, M (reprint author), Eli Lilly & Co, Lilly Res Lab, Indianapolis, IN 46285 USA.	mpheffernanmd@gmail.com			Eli Lilly and Company	Eli Lilly and Company.	Phan NQ, 2012, ACTA DERM-VENEREOL, V92, P502, DOI 10.2340/00015555-1246; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; Bagel J, 2012, J AM ACAD DERMATOL, V67, P86, DOI 10.1016/j.jaad.2011.07.034; FREDRIKSSON T, 1978, DERMATOLOGICA, V157, P238; Capon F, 2013, J INVEST DERMATOL, V133, P2503, DOI 10.1038/jid.2013.361; Rich P, 2003, J AM ACAD DERMATOL, V49, P206, DOI 10.1067/S0190-9622(03)00910-1; Raychaudhuri SP, 2001, J EUR ACAD DERMATOL, V15, P16, DOI 10.1046/j.1468-3083.2001.00192.x; Sugiura K, 2013, J INVEST DERMATOL, V133, P2514, DOI 10.1038/jid.2013.230; Leonardi C, 2012, NEW ENGL J MED, V366, P1190, DOI 10.1056/NEJMoa1109997; FINLAY AY, 1994, CLIN EXP DERMATOL, V19, P210, DOI 10.1111/j.1365-2230.1994.tb01167.x; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; DisCesare A, 2009, J INVEST DERMATOL, V129, P1339; Fitch Erin, 2007, Curr Rheumatol Rep, V9, P461, DOI 10.1007/s11926-007-0075-1; Iwatsuki K, 2010, JPN J DERMATOL, V120, P815; Kim IH, 2012, AM J CLIN DERMATOL, V13, P365, DOI 10.2165/11633110-000000000-00000	15	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	JUN	2015	29	6					1148	1155		10.1111/jdv.12773		8	Dermatology	Dermatology	CI9ZG	WOS:000355129600015		
J	Yanagishita, T; Tamada, Y; Watanabe, D				Yanagishita, T.; Tamada, Y.; Watanabe, D.			Bucillamine-induced pemphigus vulgaris	JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY			English	Letter							DRUG-INDUCED PEMPHIGUS; FOLIACEUS		[Yanagishita, T.; Tamada, Y.; Watanabe, D.] Aichi Med Univ, Sch Med, Dept Dermatol, Aichi, Japan	Yanagishita, T (reprint author), Aichi Med Univ, Sch Med, Dept Dermatol, Aichi, Japan.	takeshit@aichi-med-u.ac.jp					Anadolu RY, 2002, J EUR ACAD DERMATOL, V16, P152, DOI 10.1046/j.1468-3083.2002.00393.x; WOLF R, 1994, DERMATOLOGY, V189, P1; Brenner S, 1997, J AM ACAD DERMATOL, V36, P919, DOI 10.1016/S0190-9622(97)80273-3; YOKEL BK, 1989, ARCH DERMATOL, V125, P1367, DOI 10.1001/archderm.125.10.1367; BRENNER S, 1993, CLIN DERMATOL, V11, P501, DOI 10.1016/0738-081X(93)90157-8; Fujita H, 2007, EUR J DERMATOL, V17, P98; Hur JW, 2006, J KOREAN MED SCI, V21, P585, DOI 10.3346/jkms.2006.21.3.585; Kishimoto K, 2001, EUR J DERMATOL, V11, P41; Ogata K, 2001, BRIT J DERMATOL, V144, P421, DOI 10.1046/j.1365-2133.2001.04043.x; OGAWA H, 1979, J HISTOCHEM CYTOCHEM, V27, P942	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0926-9959	1468-3083		J EUR ACAD DERMATOL	J. Eur. Acad. Dermatol. Venereol.	JUN	2015	29	6					1242	1243		10.1111/jdv.12472		2	Dermatology	Dermatology	CI9ZG	WOS:000355129600035		
J	Ito, K; Kuriki, H; Enoki, M				Ito, K.; Kuriki, H.; Enoki, M.			A Numerical Study on Generation Mechanism of Vertical Cracks in Top Coat of TBCs During APS Deposition	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						accoustic emission; finite element modeling; fracture; heat transfer; in situ monitoring; segmented coatings; thermal stress	THERMAL BARRIER COATINGS; RESIDUAL-STRESSES; SPRAYED COATINGS; FRACTURE; SHOCK; BEHAVIOR	Clarification of crack generation mechanism in the top coat of the thermal barrier coatings (TBCs) during atmospheric plasma spray process is important to improve the reliability of TBC. In this study, finite element analyses of stress and strain during the deposition process were conducted with layer-by-layer method to understand the cracking behaviors. Stress relaxation by generation of vertical cracks was expressed as an elasto-plastic behavior of the coating. The effects of pre-heating temperature of the substrate and plasma power on crack development were analyzed by changing of the initial and atmospheric temperatures in simulation, respectively. The simulation results of radial strain explained the experimental results of crack monitoring by non-contact laser acoustic emission method.	[Ito, K.; Kuriki, H.; Enoki, M.] Univ Tokyo, Tokyo, Japan	Ito, K (reprint author), Univ Tokyo, Tokyo, Japan.	ito@rme.mm.t.u-tokyo.ac.jp			MEXT/JSPS KAKENHI [23246124]	We are deeply grateful to Dr. Seiji Kuroda, Mr. Hiroshi Araki, Mr. Toshio Hiraoka, and Mr. Masayuki Komatsu for supporting experiments and analyses of APS. This work was partially supported by MEXT/JSPS KAKENHI Grant Number 23246124.	Gilbert A, 2008, SURF COAT TECH, V203, P91, DOI 10.1016/j.surfcoat.2008.08.003; Widjaja S, 2003, THIN SOLID FILMS, V434, P216, DOI 10.1016/S0040-6090(03)00427-9; KURODA S, 1991, THIN SOLID FILMS, V200, P49, DOI 10.1016/0040-6090(91)90029-W; Teixeira V, 1999, J MATER PROCESS TECH, V93, P209; Ranjbar-Far M, 2010, MATER DESIGN, V31, P772, DOI 10.1016/j.matdes.2009.08.005; Guo HB, 2005, SURF COAT TECH, V192, P48, DOI 10.1016/j.surfcoat.2004.02.004; Gilbert A, 2008, SURF COAT TECH, V202, P2152, DOI 10.1016/j.surfcoat.2007.09.001; WATANABE T, 1992, CHEM ENG SCI, V47, P3059, DOI 10.1016/0009-2509(92)87006-C; Bengtsson P, 1997, SURF COAT TECH, V92, P78, DOI 10.1016/S0257-8972(97)00082-0; Chen YX, 2010, INT J HEAT MASS TRAN, V53, P2012, DOI 10.1016/j.ijheatmasstransfer.2009.12.055; Ito K., J THERM SPRAY UNPUB; Ito K, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/3/035007; Ito K, 2010, MATER TRANS, V51, P1272, DOI 10.2320/matertrans.M2010004; Ito K, 2012, MATER TRANS, V53, P671, DOI 10.2320/matertrans.MBW201118; Ng HW, 2005, FINITE ELEM ANAL DES, V41, P1235, DOI 10.1016/j.finel.2005.02.002; Nishinoiri S., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.12.011; Rangaraj S, 2003, SURF COAT TECH, V173, P201, DOI 10.1016/S0257-8972(03)00515-2; Sfar K, 2002, MAT SCI ENG A-STRUCT, V333, P351, DOI 10.1016/S0921-5093(01)01859-7; Taniguchi K, 2009, J MATER RES, V24, P3182, DOI 10.1557/JMR.2009.0364; Waki H., 2009, J SOLID MECH MAT ENG, V3, P199	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	JUN	2015	24	5					730	738		10.1007/s11666-015-0232-4		9	Materials Science, Coatings & Films	Materials Science	CJ1CL	WOS:000355219400002		
J	Sienkiewicz, J; Kuroda, S; Minagawa, K; Murakami, H; Araki, H; Kurzydowski, KJ				Sienkiewicz, J.; Kuroda, S.; Minagawa, K.; Murakami, H.; Araki, H.; Kurzydowski, K. J.			Effects of Al Content and Addition of Third Element on Fabrication of Ti-Al Intermetallic Coatings by Heat Treatment of Warm-Sprayed Precursors	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						coatings; diffusion; Ti-Al intermetallics; warm spray	MICROSTRUCTURE; DEPOSITS	Four powder mixtures of titanium and aluminum with 50:50, 40:60, 30:70, and 20:80 atomic ratios were used as feedstock for Warm Spray process to produce composite coatings. A two-stage heat treatment at 600 and 1000 A degrees C was applied to the deposits in order to obtain titanium aluminide intermetallic phases. The microstructure, chemical, and phase composition of the as-deposited and heat-treated coatings were investigated using SEM, EDS, and XRD. It was found that the Al content affects on the thickness expansion of the heat-treated Ti-Al coatings significantly and also has a major influence on the porosity development, which is caused by the Kirkendall effect. The effects of adding a third element Si and heat treatment with pressure to produce denser Ti-Al intermetallic coating were also examined. The investigated hot-pressed coatings with addition of Si exhibited much denser microstructure and contained Ti-Al intermetallic phases with titanium silicide precipitates.	[Sienkiewicz, J.; Kuroda, S.; Minagawa, K.; Murakami, H.; Araki, H.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Kurzydowski, K. J.] Warsaw Univ Technol, Warsaw, Poland	Sienkiewicz, J (reprint author), Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan.	judyta.sienkiewicz@gmail.com					Chaudhari GP, 2010, INTERMETALLICS, V18, P472, DOI 10.1016/j.intermet.2009.09.008; KATTNER UR, 1992, METALL TRANS A, V23, P2081, DOI 10.1007/BF02646001; Sienkiewicz J, 2014, INTERMETALLICS, V49, P57, DOI 10.1016/j.intermet.2013.12.011; Novoselova T, 2007, J ALLOY COMPD, V436, P69, DOI 10.1016/j.jallcom.2006.06.101; Molak RM, 2014, J THERM SPRAY TECHN, V23, P197, DOI 10.1007/s11666-013-0024-7; Kawakita J, 2008, SURF COAT TECH, V202, P4369, DOI 10.1016/j.surfcoat.2008.04.011; Tetsui T, 2002, MAT SCI ENG A-STRUCT, V329, P582, DOI 10.1016/S0921-5093(01)01584-2; Noda T, 1998, INTERMETALLICS, V6, P709, DOI 10.1016/S0966-9795(98)00060-0; Bewlay B.P., 2012 MRS FALL M; Dewald D, 2001, J THERM SPRAY TECHN, V10, P111, DOI 10.1361/105996301770349574; Draper SL, 2007, MAT SCI ENG A-STRUCT, V464, P330, DOI 10.1016/j.msea.2007.02.020; Hsu FY, 1996, MATER CHARACT, V36, P371, DOI 10.1016/S1044-5803(96)00040-X; Khor KA, 1996, J MATER SCI LETT, V15, P1801, DOI 10.1007/BF00275347; Kuroda S, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/033002; Kuroda S., 2013, THERM SPRAY 2013 P I, V6, P263; MACKOWIA.J, 1968, J LESS-COMMON MET, V15, P341, DOI 10.1016/0022-5088(68)90193-8; Novoselova T, 2006, SURF COAT TECH, V200, P2775, DOI 10.1016/j.surfcoat.2004.10.133	17	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	JUN	2015	24	5					749	757		10.1007/s11666-015-0245-z		9	Materials Science, Coatings & Films	Materials Science	CJ1CL	WOS:000355219400004		
J	Cizek, J; Matejkova, M; Dlouhy, I; Siska, F; Kay, CM; Karthikeyan, J; Kuroda, S; Kovarik, O; Siegl, J; Loke, K; Khor, KA				Cizek, J.; Matejkova, M.; Dlouhy, I.; Siska, F.; Kay, C. M.; Karthikeyan, J.; Kuroda, S.; Kovarik, O.; Siegl, J.; Loke, K.; Khor, Khiam Aik			Influence of Cold-Sprayed, Warm-Sprayed, and Plasma-Sprayed Layers Deposition on Fatigue Properties of Steel Specimens	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						cold spray; fatigue; grit-blast; plasma spray; residual stresses; titanium; warm spray	SURFACE PREPARATION; BEHAVIOR; COATINGS; DIFFRACTION; RESISTANCE; VELOCITY; LIFE	Titanium powder was deposited onto steel specimens using four thermal spray technologies: plasma spray, low-pressure cold spray, portable cold spray, and warm spray. The specimens were then subjected to strain-controlled cyclic bending test in a dedicated in-house built device. The crack propagation was monitored by observing the changes in the resonance frequency of the samples. For each series, the number of cycles corresponding to a pre-defined specimen cross-section damage was used as a performance indicator. It was found that the grit-blasting procedure did not alter the fatigue properties of the steel specimens (1% increase as compared to as-received set), while the deposition of coatings via all four thermal spray technologies significantly increased the measured fatigue lives. The three high-velocity technologies led to an increase of relative lives to 234% (low-pressure cold spray), 210% (portable cold spray), and 355% (warm spray) and the deposition using plasma spray led to an increase of relative lives to 303%. The observed increase of high-velocity technologies (cold and warm spray) could be attributed to a combination of homogeneous fatigue-resistant coatings and induction of peening stresses into the substrates via the impingement of the high-kinetic energy particles. Given the intrinsic character of the plasma jet (low-velocity impact of semi/molten particles) and the mostly ceramic character of the coating (oxides, nitrides), a hypothesis based on non-linear coatings behavior is provided in the paper.	[Cizek, J.; Matejkova, M.; Dlouhy, I.] Brno Univ Technol, Inst Mat Sci & Engn, Netme Ctr, CS-61090 Brno, Czech Republic; [Siska, F.] Acad Sci Czech Republic, Inst Phys Mat, Brno, Czech Republic; [Kay, C. M.; Karthikeyan, J.] ASB Ind Inc, Barberton, OH USA; [Kuroda, S.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan; [Kovarik, O.; Siegl, J.] Czech Tech Univ, CR-16635 Prague, Czech Republic; [Loke, K.] Singapore Technol Kinet, Tuas, Singapore; [Khor, Khiam Aik] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore	Cizek, J (reprint author), Brno Univ Technol, Inst Mat Sci & Engn, Netme Ctr, CS-61090 Brno, Czech Republic.	cizek@fme.vutbr.cz	CIZEK, Jan/B-9391-2012; Siska, Filip/G-7984-2014; 	Kovarik, Ondrej/0000-0001-7096-6220	European Regional Development Fund under the Operational Programme Research and Development for Innovation; Ministry of Education, Youth and Sports; Czech Science Foundation [GACR 13-35890S, GACR 108/12/1872]	The present work has been carried out in NETME Centre, and the authors acknowledge the financial support of European Regional Development Fund under the Operational Programme Research and Development for Innovation. The presented results have been obtained in Netme Centre Plus (LO1202) project co-funded by the Ministry of Education, Youth and Sports in the support programme "National Sustainability Programme I". The support of Czech Science Foundation projects GACR 13-35890S (sample preparation and evaluation) and GACR 108/12/1872 (fatigue testing) is further acknowledged. The main author would like to thank Michal Cizek for providing the schematics of the fatigue test device.	Ahmed R, 2010, MATER SCI FORUM, V652, P309, DOI 10.4028/www.scientific.net/MSF.652.309; Leinenbach C, 2006, BIOMATERIALS, V27, P1200, DOI 10.1016/j.biomaterials.2005.08.012; Fauchais P, 2004, J THERM SPRAY TECHN, V13, P337, DOI 10.1361/10599630419670; Kovarik O, 2008, J THERM SPRAY TECHN, V17, P525, DOI 10.1007/s11666-008-9205-1; Schmidt T, 2009, J THERM SPRAY TECHN, V18, P794, DOI 10.1007/s11666-009-9357-7; Kovarik O, 2005, J THERM SPRAY TECHN, V14, P231, DOI 10.1361/105996304523809; Ghelichi R, 2012, ACTA MATER, V60, P6555, DOI 10.1016/j.actamat.2012.08.020; Fukanuma H, 2006, SURF COAT TECH, V201, P1935, DOI 10.1016/j.surfcoat.2006.04.035; Xiao L, 2007, APPL SURF SCI, V253, P7535, DOI 10.1016/j.apsusc.2007.03.062; Chander KP, 2009, MATER DESIGN, V30, P2895, DOI 10.1016/j.matdes.2009.01.014; Meggiolaro MA, 2004, INT J FATIGUE, V26, P463, DOI 10.1016/j.ijfatigue.2003.10.003; Musalek R, 2010, INTERMETALLICS, V18, P1415, DOI 10.1016/j.intermet.2010.02.001; Assadi H, 2003, ACTA MATER, V51, P4379, DOI [10.1016/S1359-6454(03)00274-X, 10.1016/S1359-6465(03)00274-X]; Cizek J, 2013, SURF COAT TECH, V217, P23, DOI 10.1016/j.surfcoat.2012.11.067; [Anonymous], 1997, 4287 ISO; Kovarik O, 2014, SURF COAT TECH, V251, P143, DOI 10.1016/j.surfcoat.2014.04.018; Mellali M, 1997, J THERM SPRAY TECHN, V6, P217, DOI 10.1007/s11666-997-0016-6; RIETVELD HM, 1967, ACTA CRYSTALLOGR, V22, P151, DOI 10.1107/S0365110X67000234; Binder K, 2011, J THERM SPRAY TECHN, V20, P234, DOI 10.1007/s11666-010-9557-1; Fauchais P, 2004, J PHYS D APPL PHYS, V37, pR86, DOI 10.1088/0022-3727/37/9/R02; Brunette D.M., 2001, TITANIUM MED; Chicot D., 2014, SURF COAT TECHNOL; Cizek J, 2013, J THERM SPRAY TECHN, V22, P1320, DOI 10.1007/s11666-013-9993-9; Degarmo E. Paul, 2003, MAT PROCESSES MANUFA; De Strycker M, 2010, OPT LASER ENG, V48, P978, DOI 10.1016/j.optlaseng.2010.05.008; Goldbaum D, 2011, MAT SCI ENG A-STRUCT, V530, P253, DOI 10.1016/j.msea.2011.09.083; Helfritsch D., 2011, N AM COLD SPRAY C; Hummer DR, 2007, POWDER DIFFR, V22, P352, DOI 10.1154/1.2790965; Kobayashi A, 2000, SURF COAT TECH, V132, P152, DOI 10.1016/S0257-8972(00)00725-8; Kroupa F, 2007, J THERM SPRAY TECHN, V16, P84, DOI 10.1007/s11666-006-9009-0; Kuroda S, 2008, SCI TECHNOL ADV MAT, V9, DOI 10.1088/1468-6996/9/3/033002; Lutjering G., 2007, TITANIUM; Musalek R, 2010, J THERM SPRAY TECHN, V19, P422, DOI 10.1007/s11666-009-9362-x; Papyrin A, 2007, WOODHEAD PUBL MATER, P11, DOI 10.1533/9781845693787.1.11; Price TS, 2006, J THERM SPRAY TECHN, V15, P507, DOI 10.1361/105996306X147108; Souza RC, 2003, CORROS REV, V21, P75; Suhonen T, 2013, ACTA MATER, V61, P6329, DOI 10.1016/j.actamat.2013.06.033; Tucker R., 2013, ASM HDB THERMAL SPRA; WIGREN J, 1988, SURF COAT TECH, V34, P101, DOI 10.1016/0257-8972(88)90093-X; Zhu L, 2011, APPL SURF SCI, V257, P8722, DOI 10.1016/j.apsusc.2011.05.056; Zou Y., 2010, THESIS MCGILL U	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	JUN	2015	24	5					758	768		10.1007/s11666-015-0240-4		11	Materials Science, Coatings & Films	Materials Science	CJ1CL	WOS:000355219400005		
J	Ito, K; Kuriki, H; Araki, H; Kuroda, S; Enoki, M				Ito, K.; Kuriki, H.; Araki, H.; Kuroda, S.; Enoki, M.			Evaluation of Generation Mechanism of Vertical Cracks in Top Coat of TBCs During APS Deposition by Laser AE Method	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Article						acoustic emission; atmospheric plasma spray (APS); segmented coatings; thermal stress	THERMAL BARRIER COATINGS; ACOUSTIC-EMISSION METHOD; CERAMIC COATINGS; SPRAYED COATINGS; BEHAVIOR; STRESS	Vertical cracks can be generated in the top coat of thermal barrier coatings (TBCs) deposited by atmospheric plasma spraying (APS). Since they are known to improve the durability of TBCs such as in the case of dense vertically cracked TBC, clarification of the mechanism and the criteria of cracking are very important. In this study, generation of such vertical cracks was monitored during APS process by laser acoustic emission (AE) method, which is an in situ, non-contact, and non-destructive technique. Temperature was also monitored inside and on the surface of a specimen during APS process for estimation of the temperature field in the top coat. Results of the AE and temperature monitoring were combined to evaluate the relationship between cracking and thermal stress in the top coat. Most of the AE events due to the generation of vertical cracks were detected during rapid heating of the surface of the top coat by the heat flux from the torch. It showed that the vertical cracks were induced due to the tensile stress caused by the temperature difference in the top coat from the rapid heating. Furthermore, the estimated critical thermal stress for vertical cracking from the monitoring results was consistent with a previously reported strength of YSZ coating deposited by thermal spray.	[Ito, K.; Kuriki, H.; Enoki, M.] Univ Tokyo, Tokyo, Japan; [Araki, H.; Kuroda, S.] Natl Inst Mat Sci, Tsukuba, Ibaraki, Japan	Ito, K (reprint author), Univ Tokyo, Tokyo, Japan.	ito@rme.mm.t.u-tokyo.ac.jp			MEXT/JSPS KAKENHI [23246124]	We thank Mr. Hiraoka and Mr. Komatsu for supporting fabrication of our equipment and operation of the APS system. This work was partially supported by MEXT/JSPS KAKENHI Grant Number 23246124.	Padture NP, 2002, SCIENCE, V296, P280, DOI 10.1126/science.1068609; Guo HB, 2006, J AM CERAM SOC, V89, P1432, DOI 10.1111/j.1551-2916.2006.00912.x; Evans AG, 2001, PROG MATER SCI, V46, P505, DOI 10.1016/S0079-6425(00)00020-7; KURODA S, 1991, THIN SOLID FILMS, V200, P49, DOI 10.1016/0040-6090(91)90029-W; Khor KA, 2001, SURF COAT TECH, V139, P200, DOI 10.1016/S0257-8972(01)00997-5; MILLER RA, 1987, SURF COAT TECH, V30, P1, DOI 10.1016/0257-8972(87)90003-X; Karger M, 2011, SURF COAT TECH, V206, P16, DOI 10.1016/j.surfcoat.2011.06.032; Gray D.M., 1996, US Patent, Patent No. 5830586; Guo HB, 2006, THIN SOLID FILMS, V506, P136, DOI 10.1016/j.tsf.2005.08.142; Ito K, 2007, MATER TRANS, V48, P1221, DOI 10.2320/matertrans.I-MRA2007850; Ito K, 2014, SCI TECHNOL ADV MAT, V15, DOI 10.1088/1468-6996/15/3/035007; Ito K, 2010, MATER TRANS, V51, P1272, DOI 10.2320/matertrans.M2010004; Ito K, 2012, MATER TRANS, V53, P671, DOI 10.2320/matertrans.MBW201118; Ito Kaita, 2011, Strength, Fracture and Complexity, V7, DOI 10.3233/SFC-2011-0136; Ng HW, 2005, FINITE ELEM ANAL DES, V41, P1235, DOI 10.1016/j.finel.2005.02.002; Nishinoiri S, 2004, MATER TRANS, V45, P92, DOI 10.2320/matertrans.45.92; Nishinoiri S., 2003, Science and Technology of Advanced Materials, V4, DOI 10.1016/j.stam.2003.12.011; Rangaraj S, 2003, SURF COAT TECH, V173, P201, DOI 10.1016/S0257-8972(03)00515-2; Sfar K, 2002, MAT SCI ENG A-STRUCT, V333, P351, DOI 10.1016/S0921-5093(01)01859-7; T.A. Taylor, 1989, Conn. U.S. Patent, Patent No. [5,073,433,, 5073433]; Taniguchi K, 2009, J MATER RES, V24, P3182, DOI 10.1557/JMR.2009.0364; Watanabe M, 2003, MAT SCI ENG A-STRUCT, V359, P368, DOI 10.1016/S0921-5093(03)00394-0	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	JUN	2015	24	5					848	856		10.1007/s11666-015-0247-x		9	Materials Science, Coatings & Films	Materials Science	CJ1CL	WOS:000355219400014		
J	Maruyama, D; Fukuda, K; Kataoka, H; Morita, Y; Nishimura, K; Kawamura, Y; Iihara, K				Maruyama, Daisuke; Fukuda, Kenji; Kataoka, Hiroharu; Morita, Yoshiaki; Nishimura, Kunihiro; Kawamura, Yoichiro; Iihara, Koji			Evaluation of carotid artery outward remodeling by T1-weighted magnetic resonance imaging in carotid endarterectomy and stenting	JOURNAL OF VASCULAR SURGERY			English	Article							GRADIENT-ECHO SEQUENCE; INTRAPLAQUE HEMORRHAGE; PLAQUE VULNERABILITY; INTRAVASCULAR ULTRASOUND; CLINICAL PRESENTATION; ATHEROSCLEROSIS RISK; STENOSIS; DISEASE; ASSOCIATION; ENLARGEMENT	Objective: We evaluated carotid artery outward remodeling and plaque relative signal intensity (rSI) using T1-weighted magnetic resonance imaging (T1-MRI) to investigate their clinical significance in carotid revascularization. Methods: From 86 patients undergoing carotid endarterectomy (CEA) or carotid artery stenting (CAS), 88 lesions (51 lesions treated with CEA and 37 lesions treated with CAS) were analyzed retrospectively. We evaluated the pre-operative carotid artery remodeling index (CRI), determined by a ratio of the external cross-sectional vessel area at maximum stenosis and the reference cross-sectional vessel area at the distal portion of the internal carotid artery, and the plaque rSI, which is quantified as the ratio between the signal intensities of plaque and adjacent muscle using T1-MRI. We divided carotid lesions into four groups using the median values of CRI and rSI: L/L (CRI < 1.8, rSI < 2.5), H/L (CRI >= 1.8, rSI < 2.5), L/H (CRI < 1.8, rSI >= 2.5), and H/H (CRI >= 1.8, rSI >= 2.5). The primary end point was detection of acute ipsilateral ischemia on diffusion-weighted imaging (DWI) within 72 hours of treatment. Results: Mean CRI and rSI were significantly higher in lesions treated with CEA than in those treated with CAS. Post-operative DWI abnormalities were observed in 4 CEA cases (7.8%) and 10 CAS cases (27.0%) (P = .01). In the CAS group, the frequency of DWI abnormalities was 5.5% for the L/L, 40.0% for the H/L and L/H, and 55.5% for the H/H group (P = .009). Multivariate analysis showed that the degree of stenosis and H/H lesion were independent risk factors for cerebral embolism. No correlation was found between plaque parameters and postoperative DWI findings in the CEA group. Conclusions: CRI and rSI provide complementary information for the prediction of high-risk plaques associated with CAS but not with CEA. Preoperative evaluation with T1-MRI facilitates the selection of a treatment strategy for carotid artery stenosis.	[Maruyama, Daisuke; Kataoka, Hiroharu] Natl Cerebral & Cardiovasc Ctr, Dept Neurosurg, Suita, Osaka, Japan; [Morita, Yoshiaki] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka, Japan; [Nishimura, Kunihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Med & Epidemiol Informat, Suita, Osaka, Japan; [Fukuda, Kenji] Fukuoka Univ, Fac Med, Dept Neurosurg, Fukuoka 81401, Japan; [Kawamura, Yoichiro; Iihara, Koji] Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Fukuoka 8128582, Japan	Iihara, K (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Neurosurg, Higashi Ku, 3-1-1 Maida Shi, Fukuoka 8128582, Japan.	kiihara@ns.med.kyushu-u.ac.jp					Altaf N, 2007, STROKE, V38, P1633, DOI 10.1161/STROKEAHA.106.473066; Yoshida K, 2012, NEUROSURGERY, V70, P1143, DOI 10.1227/NEU.0b013e31823fe50b; Kim WY, 2002, CIRCULATION, V106, P296, DOI 10.1161/01.CIR.0000025629.85631.1E; Nakamura M, 2001, J AM COLL CARDIOL, V37, P63, DOI 10.1016/S0735-1097(00)01097-4; Altaf N, 2007, J VASC SURG, V46, P31, DOI 10.1016/j.jvs.2007.02.072; Yamada K, 2011, ATHEROSCLEROSIS, V215, P399, DOI 10.1016/j.atherosclerosis.2011.01.002; Pasterkamp G, 1998, J AM COLL CARDIOL, V32, P655, DOI 10.1016/S0735-1097(98)00304-0; Schoenhagen P, 2000, CIRCULATION, V101, P598; Yuan C, 2001, CIRCULATION, V104, P2051, DOI 10.1161/hc4201.097839; Yoshimura S, 2011, STROKE, V42, P3132, DOI 10.1161/STROKEAHA.111.615708; Brott TG, 2011, J AM COLL CARDIOL, V57, P1002, DOI 10.1016/j.jacc.2010.11.005; Saito A, 2012, NEURORADIOLOGY, V54, P1187, DOI 10.1007/s00234-012-1025-9; Yamada N, 2007, AM J NEURORADIOL, V28, P287; Akutsu N, 2012, AM J NEURORADIOL, V33, P1557, DOI 10.3174/ajnr.A3002; Varnava AM, 2002, CIRCULATION, V105, P939, DOI 10.1161/hc0802.104327; Moody AR, 2003, CIRCULATION, V107, P3047, DOI 10.1161/01.CIR.0000074222.61572.44; Abbott AL, 2009, STROKE, V40, pE573, DOI 10.1161/STROKEAHA.109.556068; Takaya N, 2006, STROKE, V37, P818, DOI 10.1161/01.STR.0000204638.91099.91; Cappendijk VC, 2005, RADIOLOGY, V234, P487, DOI 10.1148/radiol.2342032101; Hardie AD, 2007, AM J NEURORADIOL, V28, P1067, DOI 10.3174/ajnr.A0508; Astor BC, 2010, RADIOLOGY, V256, P879, DOI 10.1148/radiol.10091162; CROUSE JR, 1994, STROKE, V25, P1354; Fukuda K, 2014, J STROKE CEREBROVASC, V23, P1462, DOI 10.1016/j.jstrokecerebrovasdis.2013.12.010; GLAGOV S, 1987, NEW ENGL J MED, V316, P1371, DOI 10.1056/NEJM198705283162204; Hishikawa T, 2010, J NEUROSURG, V113, P890, DOI 10.3171/2010.3.JNS091057; Iihara K, 2006, J NEUROSURG, V105, P546, DOI 10.3171/jns.2006.105.4.546; Miura Toshiyasu, 2011, Cerebrovasc Dis Extra, V1, P54, DOI 10.1159/000328645; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Tanemura H, 2013, STROKE, V44, P105, DOI 10.1161/STROKEAHA.112.663138; Timaran CH, 2011, J VASC SURG, V53, P1679, DOI 10.1016/j.jvs.2010.11.122; Yoshida K, 2012, NEUROSURGERY, V70, P1150	31	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JUN	2015	61	6					1464	U127		10.1016/j.jvs.2015.01.029		9	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CI8JL	WOS:000355018500011		
J	Kan-o, M; Kado, Y; Sadanaga, A; Tamiya, S; Toyoshima, S; Sakamoto, M				Kan-o, Meikun; Kado, Yuichiro; Sadanaga, Atsushi; Tamiya, Sadafumi; Toyoshima, Satoshi; Sakamoto, Masato			Immunoglobulin G4-related multiple cardiovascular lesions successfully treated with a combination of open surgery and corticosteroid therapy	JOURNAL OF VASCULAR SURGERY			English	Article							ABDOMINAL AORTIC-ANEURYSM; IGG4-RELATED SCLEROSING DISEASE; CORONARY-ARTERY; ENDOVASCULAR REPAIR; PERIARTERITIS	Immunoglobulin G4-related disease, a newly emerging systemic autoimmune disorder, can potentially involve the cardiovascular system. The standard treatment for immunoglobulin G4-related cardiovascular disease has not been established. We encountered a very rare case of an immunoglobulin G4-related inflammatory abdominal aortic aneurysm coexisting with a coronary artery aneurysm and periarteritis. The patient underwent surgical resection for the abdominal aortic aneurysm, followed by successful corticosteroid therapy for the coronary artery lesions. This is the first report of steroid-sensitive immunoglobulin G4-related coronary artery disease. A carefully planned treatment strategy for the multiple cardiovascular lesions was invaluable in the present case.	[Kan-o, Meikun; Kado, Yuichiro; Sakamoto, Masato] Kitakyushu Municipal Med Ctr, Dept Cardiovasc Surg, Kitakyushu, Fukuoka 8020077, Japan; [Sadanaga, Atsushi] Kitakyushu Municipal Med Ctr, Dept Internal Med, Kitakyushu, Fukuoka 8020077, Japan; [Tamiya, Sadafumi; Toyoshima, Satoshi] Kitakyushu Municipal Med Ctr, Dept Pathol, Kitakyushu, Fukuoka 8020077, Japan	Kan-o, M (reprint author), Kitakyushu Municipal Med Ctr, Dept Cardiovasc Surg, Kokurakita Ku, 2-1-1 Bashaku, Kitakyushu, Fukuoka 8020077, Japan.	kanomeikun@gmail.com					Ishizaka N, 2013, CLIN CHIM ACTA, V415, P220, DOI 10.1016/j.cca.2012.11.003; Kasashima S, 2009, J VASC SURG, V49, P1264, DOI 10.1016/j.jvs.2008.11.072; van Bommel EFH, 2008, VASC MED, V13, P293, DOI 10.1177/1358863X08091147; Ikutomi M, 2011, CARDIOLOGY, V120, P22, DOI 10.1159/000332996; Tanigawa J, 2012, HUM PATHOL, V43, P1131, DOI 10.1016/j.humpath.2011.09.019; Umehara H, 2012, MOD RHEUMATOL, V22, P1, DOI 10.1007/s10165-011-0508-6; Hellmann DB, 2007, JAMA-J AM MED ASSOC, V297, P395, DOI 10.1001/jama.297.4.395; Paravastu SCV, 2009, EUR J VASC ENDOVASC, V38, P291, DOI 10.1016/j.ejvs.2009.05.005; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Deshpande V, 2012, NEW ENGL J MED, V6, P539; Lange C, 2005, EUR J VASC ENDOVASC, V29, P363, DOI 10.1016/j.ejvs.2005.01.004; Matsuki Y, 2010, MOD RHEUMATOL, V20, P306, DOI 10.1007/s10165-010-0272-z; Matsumoto Y, 2008, HUM PATHOL, V39, P975, DOI 10.1016/j.humpath.2007.10.023; Raparia K, 2013, INT J CLIN EXP PATHO, V6, P469; Stone WM, 2012, J VASC SURG, V56, P951, DOI 10.1016/j.jvs.2012.03.253; Takei H, 2012, INTERNAL MED, V51, P963, DOI 10.2169/internalmedicine.51.6944	16	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0741-5214			J VASC SURG	J. Vasc. Surg.	JUN	2015	61	6					1599	1603		10.1016/j.jvs.2013.10.106		5	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CI8JL	WOS:000355018500028		
J	Tsuchikawa, S; Kobori, H				Tsuchikawa, Satoru; Kobori, Hikaru			A review of recent application of near infrared spectroscopy to wood science and technology	JOURNAL OF WOOD SCIENCE			English	Review						Near infrared spectroscopy; Non-destructive measurement; Chemometrics; On-line measurement; Physico-chemical properties	EUCALYPTUS-GLOBULUS WOOD; NORWAY SPRUCE WOOD; LOBLOLLY-PINE WOOD; KRAFT PULP YIELD; MECHANICAL-PROPERTIES; MOISTURE-CONTENT; LIGNIN CONTENT; NIR SPECTROSCOPY; BASIC DENSITY; D. DON	This review article introduces recent scientific and technical reports due to near infrared spectroscopy (NIRS) at wood science and technology, most of which was published between 2006 and 2013. Many researchers reported that NIR technique was useful to detect multi traits of chemical, physical, mechanical and anatomical properties of wood materials although it was widely used in a state where characteristic cellular structure was retained. However, we should be sensitive and careful for application of NIRS, when spectra coupled with chemometrics presents unexpected good results (especially, for mechanical physical and anatomical properties). The real application for on-line or at-line monitoring in wood industry is desired as next step. Basic spectroscopic research for wooden material is also progressed. It should be a powerful and meaningful analytical spectroscopic tool.	[Tsuchikawa, Satoru] Nagoya Univ, Grad Sch Bioagri Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Kobori, Hikaru] Shizuoka Univ, Grad Sch Agr, Suruga ku, Shizuoka 4228529, Japan	Tsuchikawa, S (reprint author), Nagoya Univ, Grad Sch Bioagri Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	st3842@agr.nagoya-u.ac.jp					Alves AMM, 2012, J NEAR INFRARED SPEC, V20, P275, DOI 10.1255/jnirs.987; Andrade CR, 2012, J NEAR INFRARED SPEC, V20, P657, DOI 10.1255/jnirs.1028; Alves A, 2012, WOOD SCI TECHNOL, V46, P157, DOI 10.1007/s00226-010-0383-x; Kobori H, 2013, HOLZFORSCHUNG, V67, P307, DOI 10.1515/hf-2012-0054; Tyson JA, 2012, J NEAR INFRARED SPEC, V20, P287, DOI 10.1255/jnirs.988; Xu QH, 2011, CAN J FOREST RES, V41, P352, DOI 10.1139/X10-215; Tsuchikawa S, 2013, APPL SPECTROSC REV, V48, P560, DOI 10.1080/05704928.2011.621079; Lestander TA, 2012, FUEL PROCESS TECHNOL, V95, P73, DOI 10.1016/j.fuproc.2011.11.024; Alves A, 2011, J NEAR INFRARED SPEC, V19, P343, DOI 10.1255/jnirs.946; Downes GM, 2012, CAN J FOREST RES, V42, P1577, DOI [10.1139/X2012-083, 10.1139/x2012-083]; BIRKETT MD, 1989, TAPPI J, V72, P193; He WM, 2013, J WOOD CHEM TECHNOL, V33, P52, DOI 10.1080/02773813.2012.731463; Watanabe K, 2011, J WOOD SCI, V57, P288, DOI 10.1007/s10086-011-1181-2; Inagaki T, 2012, WOOD SCI TECHNOL, V46, P143, DOI 10.1007/s00226-010-0379-6; Espinoza JA, 2012, J NEAR INFRARED SPEC, V20, P437, DOI 10.1255/jnirs.1006; Mora CR, 2011, J NEAR INFRARED SPEC, V19, P401, DOI 10.1255/jnirs.948; Braga JWB, 2011, IAWA J, V32, P285; Yang Z, 2012, SPECTROSC SPECT ANAL, V32, P2405, DOI 10.3964/j.issn.1000-0593(2012)09-2405-04; Tsuchikawa S, 2007, APPL SPECTROSC REV, V42, P43, DOI 10.1080/05704920601036707; Meder R, 2011, J NEAR INFRARED SPEC, V19, P421, DOI 10.1255/jnirs.954; Fujimoto T, 2012, J NEAR INFRARED SPEC, V20, P353, DOI 10.1255/jnirs.994; Belini UL, 2011, BIORESOURCES, V6, P1816; CASTILLO RD, 2012, BIOTECHNOL APPL BIOC, V168, P2028; Cooper PA, 2011, CAN J FOREST RES, V41, P2150, DOI [10.1139/X11-088, 10.1139/x11-088]; da Silva AR, 2013, HOLZFORSCHUNG, V67, P1, DOI 10.1515/hf-2011-0207; de Sousa LC, 2011, CIENC FLOREST, V21, P591; Eom CD, 2013, WOOD FIBER SCI, V45, P76; Fernandes A, 2013, HOLZFORSCHUNG, V67, P59, DOI 10.1515/hf-2011-0258; Gigac J, 2011, WOOD RES-SLOVAKIA, V56, P189; Gosselin R, 2011, COMPUT CHEM ENG, V35, P296, DOI 10.1016/j.compchemeng.2010.07.020; Green B, 2011, WOOD SCI TECHNOL, V45, P583, DOI 10.1007/s00226-010-0368-9; Green B, 2012, HOLZFORSCHUNG, V66, P515, DOI [10.1515/HF.2012-0501, 10.1515/hf-2012-0501]; Hein PRG, 2011, EUR J WOOD WOOD PROD, V69, P431, DOI 10.1007/s00107-010-0471-5; Hein PRG, 2012, J NEAR INFRARED SPEC, V20, P427, DOI 10.1255/jnirs.1005; HORIKAWA Y, 2012, BIOTECHNOL APPL BIOC, V166, P711; Horvath L, 2011, WOOD SCI TECHNOL, V45, P303, DOI 10.1007/s00226-010-0330-x; Isik F, 2011, ANN FOREST SCI, V68, P283, DOI 10.1007/s13595-011-0035-9; Jones T, 2011, J NEAR INFRARED SPEC, V19, P381, DOI 10.1255/jnirs.952; Kohan NJ, 2012, BIORESOURCES, V7, P2996; Kothiyal V, 2011, HOLZFORSCHUNG, V65, P757, DOI 10.1515/HF.2011.055; Kurata Y, 2011, HOLZFORSCHUNG, V65, P389, DOI 10.1515/HF.2011.034; Lepoittevin C, 2011, ANN FOREST SCI, V68, P873, DOI 10.1007/s13595-011-0084-0; Lestander TA, 2012, J NEAR INFRARED SPEC, V20, P591, DOI 10.1255/jnirs.992; McDonough TJ, 2011, TAPPI J, V10, P45; Meder R, 2012, J NEAR INFRARED SPEC, V20, P583, DOI 10.1255/jnirs.1001; NORRIS KH, 1961, IRE T BIOMED ELECTR, VBME8, P153, DOI 10.1109/TBMEL.1961.4322890; Pfautsch S, 2012, TREES-STRUCT FUNCT, V26, P963, DOI 10.1007/s00468-011-0674-3; Prades C, 2012, J WOOD CHEM TECHNOL, V32, P54, DOI 10.1080/02773813.2011.599697; Russ A, 2011, WOOD RES-SLOVAKIA, V56, P93; Sandak A, 2011, J NEAR INFRARED SPEC, V19, P369, DOI 10.1255/jnirs.951; Santos AJA, 2012, J NEAR INFRARED SPEC, V20, P267, DOI [10.1255/jnirs.386, 10.1255/jnirs.986]; Schimleck LR, 2011, J NEAR INFRARED SPEC, V19, P411, DOI 10.1255/jnirs.953; Schwanninger M, 2011, J NEAR INFRARED SPEC, V19, P331, DOI 10.1255/jnirs.945; Schwanninger M, 2011, J NEAR INFRARED SPEC, V19, P349, DOI 10.1255/jnirs.942; Schwanninger M, 2011, J NEAR INFRARED SPEC, V19, P319, DOI 10.1255/jnirs.944; Sun BL, 2011, SPECTROSC SPECT ANAL, V31, P3251, DOI 10.3964/j.issn.1000-0593(2011)12-3251-05; Uner B, 2011, WOOD SCI TECHNOL, V45, P121, DOI 10.1007/s00226-010-0312-z; Watanabe K, 2012, J WOOD SCI, V58, P267, DOI 10.1007/s10086-011-1238-2; White DE, 2011, TAPPI J, V10, P36; Yang Z, 2012, SPECTROSC SPECT ANAL, V32, P1785, DOI 10.3964/j.issn.1000-0593(2012)07-1785-05	60	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					213	220		10.1007/s10086-015-1467-x		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600001		
J	Sawata, K				Sawata, Kei			Strength of bolted timber joints subjected to lateral force	JOURNAL OF WOOD SCIENCE			English	Review						Material characteristic; Joint geometry; Assembly condition; Yield load; Ultimate load	DOWEL-TYPE FASTENERS; DRIFT-PIN JOINTS; EMBEDDING STRENGTH; FRACTURE-MECHANICS; BEARING STRENGTH; MOISTURE-CONTENT; GRAIN LOADINGS; MAXIMUM LOADS; YIELD THEORY; WOOD-JOINTS	The safety and serviceability of timber structures are frequently governed by the performance of joints. Bolted joints are a very commonly used form of joints and are effective from the viewpoint of the load-slip characteristics when subjected to a lateral force. The shear strength of a bolted joint is affected by various factors. Some of the factors affecting the shear strength of a bolted joint are classified into four categories in this paper: the material characteristics, geometrical factors, assembly conditions for the bolted joint, and factors that act during its service. This paper reviews the effects of these factors on the shear strength of a bolted joint. Numerous experimental studies were performed on the shear strength of a bolted joint. The effects of these factors on the shear strength varied according to the kind of shear strength and loading direction to the grain. In addition to the experimental investigations, analytical investigations to estimate the shear strength of a bolted joint are also discussed in this paper. Estimations of the yield strengths of bolted joints have been performed by numerous researchers; and in recent years, there has been an increase in studies to predict the load at failure.	Hokkaido Univ, Res Fac Agr, Sapporo, Hokkaido 0608589, Japan	Sawata, K (reprint author), Hokkaido Univ, Res Fac Agr, N9 W9, Sapporo, Hokkaido 0608589, Japan.	ksawata@for.agr.hokudai.ac.jp					Daudeville L, 1996, MATER STRUCT, V29, P418, DOI 10.1007/BF02485992; Moses DM, 2003, CAN J CIVIL ENG, V30, P555, DOI 10.1139/L03-009; Xu BH, 2009, ENG STRUCT, V31, P2357, DOI 10.1016/j.engstruct.2009.05.013; Sjodin J, 2008, HOLZ ROH WERKST, V66, P363, DOI 10.1007/s00107-008-0267-z; Yasumura M, 2000, J WOOD SCI, V46, P187, DOI 10.1007/BF00776448; [Anonymous], 2003, ISO16670; Dorn M, 2013, ENG STRUCT, V47, P67, DOI 10.1016/j.engstruct.2012.09.010; [Anonymous], 2007, D5764 ASTM; Jensen JL, 2011, CONSTR BUILD MATER, V25, P2420, DOI 10.1016/j.conbuildmat.2010.11.050; [Anonymous], 1993, EN383; Rammer DR, 2001, WOOD FIBER SCI, V33, P126; [Anonymous], 2001, PREN12512; Blass HJ, 2000, P CIB W18 M DELFT NE; Daudeville L, 1999, WOOD SCI TECHNOL, V33, P15, DOI 10.1007/s002260050095; Ehlbeck J, 1992, P CIB W18 M HUS SWED; Gattesco N, 2004, MATER STRUCT, V37, P129, DOI 10.1007/BF02486609; Goodell HR, 1944, 1523 USDA FOR PROD L; Harada M, 2005, J WOOD SCI, V51, P282, DOI 10.1007/s10086-004-0656-9; HIRAI T, 1983, MOKUZAI GAKKAISHI, V29, P118; HIRAI T, 1991, MOKUZAI GAKKAISHI, V37, P517; HIRAI T, 1993, MOKUZAI GAKKAISHI, V39, P1027; Hirai T, 1982, MOKUZAI GAKKAISHI J, V28, P137; HIRAI T, 1984, MOKUZAI GAKKAISHI, V30, P965; Hirai T, 1982, MOKUZAI GAKKAISHI J, V28, P695; Hirai T, 1982, MOKUZAI GAKKAISHI J, V28, P685; Jensen JL, 2010, WOOD SCI TECHNOL, V44, P639, DOI 10.1007/s00226-009-0295-9; Johansen K. W, 1949, INT ASS BRIDGE STRUC, V9, P249; Jorissen AJM, 1998, DOUBLE SHEAR TIMBER; Kamachi K, 2006, P 9 WORLD C TIMB ENG; KAWAMOTO N, 1992, MOKUZAI GAKKAISHI, V38, P37; KAWAMOTO N, 1992, MOKUZAI GAKKAISHI, V38, P1111; Kharouf N, 1999, J MATER CIVIL ENG, V11, P345, DOI 10.1061/(ASCE)0899-1561(1999)11:4(345); Kuwamura H, 2013, J STRUCT CONSTR ENG, V685, P529; Larsen HJ, 1974, R52 TU DENM STRUCT R; Longworth J., 1963, Forest Products Journal, V13, P104; Marlor RA, 2005, J STRUCT ENG-ASCE, V131, P1434, DOI 10.1061/(ASCE)0733-9445(2005)131:9(1434); Matsubara D, 2012, TOKYO METRO IND TECH, V7, P54; MCLAIN TE, 1983, J STRUCT ENG-ASCE, V109, P1820; Moss PJ, 1997, FPLGTR97 USDA; Pope D. J., 1995, Journal of the Institute of Wood Science, V13, P568; Quenneville P, 2008, P 10 WORLD C TIMB EN; Reynolds T, 2014, ENG STRUCT, V65, P21, DOI 10.1016/j.engstruct.2014.01.024; ROWLANDS RE, 1982, COMPOSITES, V13, P273, DOI 10.1016/0010-4361(82)90010-6; Sawata K, 2003, J WOOD SCI, V49, P383, DOI 10.1007/s10086-002-0497-3; Sawata K., 2010, Research Bulletin of the Hokkaido University Forests, V67, P35; Sawata K, 2003, P TIMB ENG FOR 2003, P66; Sawata K, 2008, J WOOD SCI, V54, P356, DOI 10.1007/s10086-008-0963-7; Sawata K, 2002, J WOOD SCI, V48, P138, DOI 10.1007/BF00767291; Sawata K, 2006, J WOOD SCI, V52, P496, DOI 10.1007/s10086-006-0800-9; Sawata K, 2003, THESIS GIFU U JAPAN; Schoenmakers JCM, 2011, ENG STRUCT, V33, P3054, DOI 10.1016/j.engstruct.2011.05.018; Sjodin J, 2006, HOLZFORSCHUNG, V60, P694, DOI 10.1515/HF.2006.117; Sjodin J, 2008, HOLZFORSCHUNG, V62, P243, DOI 10.1515/HF.2008.020; Smith I, 2002, J STRUCT ENG, V128, P4859; Soltis L.A., 1987, FPLGTR54 USDA; SOLTIS LA, 1986, J STRUCT ENG-ASCE, V112, P2141; SOLTIS LA, 1987, WOOD FIBER SCI, V19, P68; Takiuchi H, 2007, MOKUZAI GAKKAISHI, V53, P46, DOI 10.2488/jwrs.53.46; Tanaka M, 2005, J STRUCT CONSTR ENG, V589, P143; Thelandersson S, 2003, TIMBER ENG, P303; Trayer GW, 1932, USDA TECH B, V332; Van der Put TACM, 2000, P CIB W18 M DELFT NE; Whale LRJ, 1987, P 20 CIB W18 M DUBL; Whale L. R. J., 1989, Journal of the Institute of Wood Science, V11, P156; Wilkinson TL, 1978, FPL314 USDA; Wilkinson TL, 1991, FPLRP505 USDA; Yasumura M, 1998, P CIB W18 M SAV FINL; Yasumura M, 1993, P INT WORKSH WOOD CO, P114; Yasumura M, 2002, P CIB W18 M KYOT JAP; Yasumura M, 1987, P CIB W18 M DUBL IR; Yasumura M, 1996, MOKUZAI GAKKAISHI, V42, P225; Zhou T, 2006, PROG STRUCT ENG MAT, V8, P49, DOI 10.1002/pse.213	72	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					221	229		10.1007/s10086-015-1469-8		9	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600002		
J	Matsushita, Y				Matsushita, Yasuyuki			Conversion of technical lignins to functional materials with retained polymeric properties	JOURNAL OF WOOD SCIENCE			English	Review						Technical lignin; Functional material; Lignin-based materials	RIGID POLYURETHANE FOAMS; SULFURIC-ACID LIGNIN; AQUEOUS ACETIC-ACID; WATER-SOLUBILIZED LIGNIN; SOFTWOOD KRAFT LIGNIN; STRAW SODA LIGNIN; CARBON-FIBERS; ENGINEERING PLASTICS; MODEL COMPOUNDS; SODIUM LIGNOSULFONATE	A significant amount of technical lignins is produced in the pulp and paper industries. However, most technical lignins are burned for thermal recycling and a few percent are used as materials, such as lignosulfonate as a dispersant. Native lignin has a highly complex structure and is susceptible to structural variations depending on the pulping process, thus hindering the effective utilization of lignins. The procedures used to convert lignins into functional materials include depolymerization to monomeric fragments followed by re-building to functional materials, and chemical modifications to generate functional polymers with retained polymeric properties. In this paper, the latter is disserted. The characteristics of technical lignins, which include kraft lignin, lignosulfonate, and organosolv lignin, and their conversion to functional materials such as polyesters, polyethers, polyurethanes, etc. and the applications of lignin-based materials in some fields are discussed.	Nagoya Univ, Grad Sch Bioagri Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan	Matsushita, Y (reprint author), Nagoya Univ, Grad Sch Bioagri Sci, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648601, Japan.	ysmatsu@agr.nagoya-u.ac.jp					An Xinnan, 1995, Chemistry and Industry of Forest Products, V15, P36; Brodin I, 2012, HOLZFORSCHUNG, V66, P141, DOI 10.1515/HF.2011.133; Uraki Y, 2001, J WOOD SCI, V47, P301, DOI 10.1007/BF00766717; Foston M, 2013, CARBON, V52, P65, DOI 10.1016/j.carbon.2012.09.006; Saito T, 2012, GREEN CHEM, V14, P3295, DOI 10.1039/c2gc35933b; MEISTER JJ, 1991, MACROMOLECULES, V24, P6843, DOI 10.1021/ma00026a007; Gao GZ, 2012, BIOMACROMOLECULES, V13, P3602, DOI 10.1021/bm301039f; Huang J, 2002, POLYMER, V43, P2287, DOI 10.1016/S0032-3861(02)00028-9; Alonso MV, 2001, J APPL POLYM SCI, V82, P2661, DOI 10.1002/app.2119; Balakshin MY, 2003, J AGR FOOD CHEM, V51, P6116, DOI 10.1021/jf034372d; Maradur SP, 2012, SYNTHETIC MET, V162, P453, DOI 10.1016/j.synthmet.2012.01.017; Kubo S, 1997, MOKUZAI GAKKAISHI, V43, P655; SARAF VP, 1985, J APPL POLYM SCI, V30, P2207, DOI 10.1002/app.1985.070300533; Kubo S, 1998, CARBON, V36, P1119, DOI 10.1016/S0008-6223(98)00086-4; Keshk S, 2006, ENZYME MICROB TECH, V40, P4, DOI 10.1016/j.enzmictec.2006.07.037; Kubo S, 2005, J APPL POLYM SCI, V98, P1437, DOI 10.1002/app.22245; Matsushita Y, 2005, BIORESOURCE TECHNOL, V96, P465, DOI 10.1016/j.biortech.2004.05.023; WU LCF, 1984, J APPL POLYM SCI, V29, P1111, DOI 10.1002/app.1984.070290408; GARDON JL, 1955, CAN J CHEM, V33, P1491, DOI 10.1139/v55-182; CHEN R, 1980, J APPL POLYM SCI, V25, P2211, DOI 10.1002/app.1980.070251008; Lin J, 2012, BIORESOURCES, V7, P5634; Laurichesse S, 2014, PROG POLYM SCI, V39, P1266, DOI 10.1016/j.progpolymsci.2013.11.004; FORSS KG, 1979, FOREST PROD J, V29, P39; Brodin I, 2010, J ANAL APPL PYROL, V87, P70, DOI 10.1016/j.jaap.2009.10.005; Delmas GH, 2013, J APPL POLYM SCI, V127, P1863, DOI 10.1002/app.37921; Chung YL, 2013, ACS SUSTAIN CHEM ENG, V1, P1231, DOI 10.1021/sc4000835; Zhao BY, 2001, J MATER SCI LETT, V20, P859, DOI 10.1023/A:1010975132530; Nordstrom Y, 2013, J APPL POLYM SCI, V129, P1274, DOI 10.1002/app.38795; Kim YS, 2010, BIOMACROMOLECULES, V11, P981, DOI 10.1021/bm901455p; GELLERSTEDT G, 1984, HOLZFORSCHUNG, V38, P151, DOI 10.1515/hfsg.1984.38.3.151; KAZAYAWOKO JSM, 1992, HOLZFORSCHUNG, V46, P257, DOI 10.1515/hfsg.1992.46.3.257; KELLEY SS, 1988, J APPL POLYM SCI, V36, P759, DOI 10.1002/app.1988.070360403; Lutnaes BF, 2008, MAGN RESON CHEM, V46, P299, DOI 10.1002/mrc.2184; Nordstrom Y, 2013, J APPL POLYM SCI, V130, P3689, DOI 10.1002/app.39627; GIERER J, 1987, HOLZFORSCHUNG, V41, P79, DOI 10.1515/hfsg.1987.41.2.79; Sarkar S, 2001, POLYM DEGRAD STABIL, V73, P169, DOI 10.1016/S0141-3910(01)00084-2; Baker DA, 2013, J APPL POLYM SCI, V130, P713, DOI 10.1002/app.39273; URAKI Y, 1995, HOLZFORSCHUNG, V49, P343, DOI 10.1515/hfsg.1995.49.4.343; Moubarik A, 2013, IND CROP PROD, V45, P296, DOI 10.1016/j.indcrop.2012.12.040; Baker DA, 2012, J APPL POLYM SCI, V124, P227, DOI 10.1002/app.33596; West MA, 2014, BIORESOURCES, V9, P2782; FREUDENBERG K, 1959, NATURE, V183, P1152, DOI 10.1038/1831152a0; Hatakeyama T, 2003, MACROMOL SYMP, V197, P171, DOI 10.1002/masy.200350716; HOFMANN K, 1993, J WOOD CHEM TECHNOL, V13, P73, DOI 10.1080/02773819308020508; PYE EK, 1991, TAPPI J, V74, P113; Mollah MYA, 2000, CEMENT CONCRETE RES, V30, P267, DOI 10.1016/S0008-8846(99)00243-4; Nadif A, 2002, BIORESOURCE TECHNOL, V84, P49, DOI 10.1016/S0960-8524(02)00020-2; Homma H, 2008, J WOOD CHEM TECHNOL, V28, P270, DOI 10.1080/02773810802510688; SUZUKI H, 1990, AGR BIOL CHEM TOKYO, V54, P479; Sarkar S, 2001, EUR POLYM J, V37, P1391, DOI 10.1016/S0014-3057(00)00264-0; Lin J, 2014, J WOOD CHEM TECHNOL, V34, P111, DOI 10.1080/02773813.2013.839707; Hatakeyama T, 2002, POLYMER, V43, P1177, DOI 10.1016/S0032-3861(01)00714-5; Zhang T, 2001, CEMENT CONCRETE RES, V31, P1009, DOI 10.1016/S0008-8846(01)00511-7; Cheng SN, 2013, IND CROP PROD, V44, P315, DOI 10.1016/j.indcrop.2012.10.033; NIEMELA K, 1985, HOLZFORSCHUNG, V39, P167, DOI 10.1515/hfsg.1985.39.3.167; Alonso MV, 2004, J APPL POLYM SCI, V94, P643, DOI 10.1002/app.20887; Braun JL, 2005, CARBON, V43, P385, DOI 10.1016/j.carbon.2004.09.027; Gao GZ, 2014, GREEN CHEM, V16, P3890, DOI 10.1039/c4gc00757c; Shukry N, 2008, J APPL POLYM SCI, V109, P434, DOI 10.1002/app.28059; Sannigrahi P, 2010, ENERG FUEL, V24, P683, DOI 10.1021/ef900845t; Lin XL, 2014, ACS SUSTAIN CHEM ENG, V2, P1902, DOI 10.1021/sc500241g; SUDO K, 1993, J APPL POLYM SCI, V48, P1485, DOI 10.1002/app.1993.070480817; [Anonymous], 2008, [No title captured], Patent No. 2081642; TSUTSUMI Y, 1993, J WOOD CHEM TECHNOL, V13, P25, DOI 10.1080/02773819308020505; Lou HM, 2014, CELLULOSE, V21, P1351, DOI 10.1007/s10570-014-0237-z; Evtuguin DV, 1998, EUR POLYM J, V34, P1163, DOI 10.1016/S0014-3057(97)00245-0; Benar P, 1999, BIORESOURCE TECHNOL, V68, P11, DOI 10.1016/S0960-8524(98)00076-5; GIERER J, 1984, HOLZFORSCHUNG, V38, P181, DOI 10.1515/hfsg.1984.38.4.181; KELLEY SS, 1988, J WOOD CHEM TECHNOL, V8, P341, DOI 10.1080/02773818808070689; YOSHIDA H, 1987, J APPL POLYM SCI, V34, P1187, DOI 10.1002/app.1987.070340326; Myrvold BO, 2008, IND CROP PROD, V27, P214, DOI 10.1016/j.indcrop.2007.07.010; Ahvazi B, 2011, J AGR FOOD CHEM, V59, P10505, DOI 10.1021/jf202452m; Zhou HF, 2013, IND ENG CHEM RES, V52, P8464, DOI 10.1021/ie401085k; SARAF VP, 1985, J APPL POLYM SCI, V30, P3809, DOI 10.1002/app.1985.070300921; Uchikawa H, 1997, CEMENT CONCRETE RES, V27, P37, DOI 10.1016/S0008-8846(96)00207-4; Vazquez G, 1997, BIORESOURCE TECHNOL, V60, P191, DOI 10.1016/S0960-8524(97)00030-8; Pan XJ, 2005, BIOTECHNOL BIOENG, V90, P473, DOI 10.1002/bit.20453; Ekeberg D, 2006, ANAL CHIM ACTA, V565, P121, DOI 10.1016/j.aca.2006.02.008; KRINGSTAD KP, 1983, HOLZFORSCHUNG, V37, P237, DOI 10.1515/hfsg.1983.37.5.237; GLASSER WG, 1984, J APPL POLYM SCI, V29, P1815, DOI 10.1002/app.1984.070290533; Nonaka Y, 1997, HOLZFORSCHUNG, V51, P183, DOI 10.1515/hfsg.1997.51.2.183; Nishida M, 2003, BIORESOURCE TECHNOL, V88, P81, DOI 10.1016/S0960-8524(02)00264-X; NIMZ H, 1969, HOLZFORSCHUNG, V23, P84, DOI 10.1515/hfsg.1969.23.3.84; Kadla JF, 2002, CARBON, V40, P2913, DOI 10.1016/S0008-6223(02)00248-8; Malutan T, 2008, BIORESOURCES, V3, P13; Kubo S, 2007, CHEM LETT, V36, P502, DOI 10.1246/cl.2007.502; SARAF VP, 1984, J APPL POLYM SCI, V29, P1831, DOI 10.1002/app.1984.070290534; Yang D, 2007, ENERG CONVERS MANAGE, V48, P2433, DOI 10.1016/j.enconman.2007.04.007; Ismail TNMT, 2010, POLYM INT, V59, P181, DOI 10.1002/pi.2705; SAKAKIBARA A, 1980, WOOD SCI TECHNOL, V14, P89; Zhou HF, 2013, APPL MICROBIOL BIOT, V97, P10309, DOI 10.1007/s00253-013-5267-1; OLIVARES M, 1988, WOOD SCI TECHNOL, V22, P157; Ponomarenko J, 2014, BIORESOURCES, V9, P2051; Nadji H, 2005, MACROMOL MATER ENG, V290, P1009, DOI 10.1002/mame.200500200; Hatakeyama H, 2005, MACROMOL SYMP, V224, P219, DOI 10.1002/masy.200550619; Auad ML, 2007, J APPL POLYM SCI, V104, P1399, DOI 10.1002/app.24405; Matsushita Y, 2013, IND CROP PROD, V42, P181, DOI 10.1016/j.indcrop.2012.05.030; Araki H, 1977, MOKUZAI GAKKAISHI, V23, P348; Asano Y, 2003, SEN-I GAKKAISHI, V59, P465; Aso T, 2013, J WOOD CHEM TECHNOL, V33, P286, DOI 10.1080/02773813.2013.794841; Ayla VC, 1982, HOLZFORSCHUNG, V36, P93; Bardant TB, 2010, MOKUZAI GAKKAISHI, V56, P420; Berthold F, 1993, P 7 INT S WOOD PULP, V3, P160; Brudin S, 2010, J SEP SCI, V33, P439, DOI 10.1002/jssc.200900691; BUDIN D, 1990, J WOOD CHEM TECHNOL, V10, P531, DOI 10.1080/02773819008050255; Capanema EA, 2001, HOLZFORSCHUNG, V55, P302, DOI 10.1515/HF.2001.050; CHEN CM, 1995, HOLZFORSCHUNG, V49, P153, DOI 10.1515/hfsg.1995.49.2.153; CHEN R, 1979, J APPL POLYM SCI, V24, P1609, DOI 10.1002/app.1979.070240704; Cunha CD, 1993, J APPL POLYM SCI, V48, P819; DAVIS JL, 1987, MOKUZAI GAKKAISHI, V33, P478; DAVIS JL, 1986, MOKUZAI GAKKAISHI, V32, P905; Delmas GH, 2011, J APPL POLYM SCI, V121, P491, DOI 10.1002/app.33592; DOLENKO AJ, 1978, FOREST PROD J, V28, P41; EI Mansouri NE, 2007, IND CROP PROD, V26, P116; ERISMANN ND, 1994, BIORESOURCE TECHNOL, V47, P247, DOI 10.1016/0960-8524(94)90188-0; Ernsberger FM, 1945, IND ENG CHEM, V37, P596; Fang R, 2011, BIORESOURCES, V6, P2874; Forss FG, 1976, PAP PUU, V58, P817; Fukushima K, 1991, HOLZFORSCHUNG, V45, P87; Fukushima K, 1991, J WOOD SCI TECHNOL, V25, P371; Funaoka M, 1996, HOLZFORSCHUNG, V50, P245, DOI 10.1515/hfsg.1996.50.3.245; FUNAOKA M, 1987, WOOD SCI TECHNOL, V21, P261; GELLERST.G, 1971, SVEN PAPPERSTIDN, V74, P117; GIERER J, 1986, HOLZFORSCHUNG, V40, P347, DOI 10.1515/hfsg.1986.40.6.347; GIERER J, 1979, ACTA CHEM SCAND B, V33, P580, DOI 10.3891/acta.chem.scand.33b-0580; GIERER J, 1980, ACTA CHEM SCAND B, V34, P161, DOI 10.3891/acta.chem.scand.34b-0161; GIERER J, 1970, SVEN PAPPERSTIDN, V73, P571; GIERER J, 1977, CAN J CHEM, V55, P593, DOI 10.1139/v77-084; Glennie D.W., 1971, LIGNINS OCCURRENCE F, P597; Goliath M, 1961, SVENSK PAPERSTID, V64, P469; Goring D. A. I., 1971, LIGNINS OCCURRENCE F, P695; GUO ZX, 1991, EUR POLYM J, V27, P1177, DOI 10.1016/0014-3057(91)90053-Q; GUO ZX, 1992, POLYM INT, V27, P17, DOI 10.1002/pi.4990270104; Gupta RC, 1978, HOLZFORSCH HOLZVERW, V30, P6; GUPTA RC, 1979, HOLZFORSCH HOLZVERW, V31, P7; Hamidreza S, 2014, INT J ADHES ADHES, V48, P92; Hatakeyama H, 2012, J MATER SCI, V47, P7254, DOI 10.1007/s10853-012-6674-x; Hayashi A, 1967, MOKUZAI GAKKAISHI, V13, P194; Helm RF, 1997, J CHEM SOC PERK T 1, P533, DOI 10.1039/a603786k; Hirose S, 2005, MACROMOL SYMP, V224, P343, DOI 10.1002/masy.200550630; Hirose S, 2002, J THERM ANAL CALORIM, V70, P853, DOI 10.1023/A:1022212421525; Homma H, 2010, J WOOD CHEM TECHNOL, V30, P164, DOI 10.1080/02773810903349713; Hu L., 2011, BIORESOURCES, V6, P1; Hu LH, 2013, IND CROP PROD, V44, P364, DOI 10.1016/j.indcrop.2012.11.034; Hu LH, 2012, BIORESOURCES, V7, P554; Ji D, 2012, CEMENT CONCRETE RES, V42, P1199, DOI 10.1016/j.cemconres.2012.05.010; JOHNSON DJ, 1975, CARBON, V13, P321, DOI 10.1016/0008-6223(75)90037-8; Kabayashi A, 1966, MOKUZAI GAKKAISHI, V12, P305; Kabayashi A, 1967, MOKUZAI GAKKAISHI, V13, P312; Kabayashi A, 1967, MOKUZAI GAKKAISHI, V13, P306; KELLEY SS, 1990, J APPL POLYM SCI, V41, P2813, DOI 10.1002/app.1990.070411124; KIN Z, 1990, TAPPI J, V73, P237; KLASNJA B, 1992, HOLZ ROH WERKST, V50, P282, DOI 10.1007/BF02615352; Koch VH, 1983, STARCH, V35, P304; KONDO R, 1985, J WOOD CHEM TECHNOL, V5, P37, DOI 10.1080/02773818508085180; KONTTURI AK, 1991, J CHEM SOC FARADAY T, V87, P1779, DOI 10.1039/ft9918701779; Koshijima T, 1967, MOKUZAI GAKKAISHI, V13, P355; Koshijima T, 1966, MOKUZAI GAKKAISHI, V12, P139; KOSHIJIM.T, 1968, J POLYM SCI A1, V6, P1431, DOI 10.1002/pol.1968.150060602; Koshijima T, 1964, MOKUZAI GAKKAISHI, V10, P116; Koshijima T, 1964, MOKUZAI GAKKAISHI, V10, P110; Koshijima T, 1966, MOKUZAI GAKKAISHI, V12, P144; KRATZL K, 1980, HOLZFORSCHUNG, V34, P191, DOI 10.1515/hfsg.1980.34.6.191; KRATZL K, 1980, HOLZFORSCHUNG, V34, P11, DOI 10.1515/hfsg.1980.34.1.11; Kubo S, 2005, J POLYM ENVIRON, V13, P97, DOI 10.1007/s10924-005-2941-0; Lin LZ, 2001, HOLZFORSCHUNG, V55, P617, DOI 10.1515/HF.2001.101; Lindberg J.J., 1964, PAPERI PUU, V46, P521; Liu Y, 2000, ACS SYM SER, V742, P447; Lou HM, 2012, CEMENT CONCRETE RES, V42, P1043, DOI 10.1016/j.cemconres.2011.11.002; LOWENDAHL L, 1978, SVEN PAPPERSTIDN, V81, P392; Lundquist K, 2001, P 11 INT S WOOD PULP, V1, P1; Luong ND, 2012, POLYM BULL, V68, P879, DOI 10.1007/s00289-011-0658-x; LUSCOMBE DK, 1973, FOOD COSMET TOXICOL, V11, P229, DOI 10.1016/S0015-6264(73)80489-4; MANSSON P, 1983, HOLZFORSCHUNG, V37, P143, DOI 10.1515/hfsg.1983.37.3.143; Mark JG, 1938, US Patent, Patent No. [2,141,570, 2169980]; Marton J, 1966, ADV CHEM SER AM CHEM, V59, P125; Matsushita Y, 2009, BIORESOURCE TECHNOL, V100, P1024, DOI 10.1016/j.biortech.2008.07.026; Matsushita Y, 2011, J WOOD SCI, V57, P214, DOI 10.1007/s10086-010-1158-6; Matsushita Y, 2008, BIORESOURCE TECHNOL, V99, P3024, DOI 10.1016/j.biortech.2007.06.015; MEISTER JJ, 1984, J APPL POLYM SCI, V29, P3457, DOI 10.1002/app.1984.070291122; MESHITSU.G, 1972, PULP PAPER MAG CAN, V73, P61; Mitsuhashi S, 2008, BIOORGAN MED CHEM, V16, P2645, DOI 10.1016/j.bmc.2007.11.041; Mollah M, 1995, CEMENT CONCRETE RES, V25, P671; MORCK R, 1986, HOLZFORSCHUNG, V40, P51; Mortimer RD, 1982, J WOOD CHEM TECHNOL, V2, P383, DOI 10.1080/02773818208085142; NAKASHIMA H, 1992, CHEM PHARM BULL, V40, P2102; NAM C, 1971, J POLYM SCI A1, V9, P855, DOI 10.1002/pol.1971.150090402; NIEMELA K, 1985, HOLZFORSCHUNG, V39, P365; Nilvebrant NO, 2001, P 11 INT S WOOD PULP, V1, P139; NORBERG I, 2012, J APPL POLYM SCI, V128, P3824; Oliveira W, 1994, MACROMOLECULES, V27, P5; Pan XJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-12; PARAJO JC, 1993, BIORESOURCE TECHNOL, V46, P233, DOI 10.1016/0960-8524(93)90126-V; PENG W, 1993, J APPL POLYM SCI, V48, P1757, DOI 10.1002/app.1993.070481009; Phillips PB, 1971, J APPL POLYM SCI, V15, P2929; Phillips PB, 1972, J APPL POLYM SCI, V16, P1; Premjet S, 1994, SEN-I GAKKAISHI, V50, P458; Premjet S, 1994, SEN-I GAKKAISHI, V50, P124; Premjet S, 1996, SEN-I GAKKAISHI, V52, P169; RAIHA M, 1975, ARCH MICROBIOL, V105, P73, DOI 10.1007/BF00447116; Rezanowich A., 1960, J COLLOID SCI, V15, P452, DOI http://dx.doi.org/10.1016/0095-8522(60)90049-0; SAKAGAMI H, 1991, CHEM PHARM BULL, V39, P950; Salvado J, 2006, IND CROP PROD, V24, P8; SANO Y, 1989, MOKUZAI GAKKAISHI, V35, P991; SANO Y, 1990, MOKUZAI GAKKAISHI, V36, P207; SANO Y, 1987, MOKUZAI GAKKAISHI, V33, P42; SANO Y, 1987, MOKUZAI GAKKAISHI, V33, P47; Sarkanen KV, 1971, LIGNINS OCCURRENCE F, P43; SARKANEN KV, 1990, TAPPI J, V73, P215; Scripture Jr ED, 1941, 69 M JOINT FAO WHO E, Patent No. 2(229):311; Scripture Jr ED, 1939, US Patent, Patent No. [2,169,980, 2229311]; Scripture Jr ED, 1937, US Patent, Patent No. [2,081,642, 2127451]; Scripture Jr ED, 1938, US Patent, Patent No. [2,127,451, 2141570]; Sebok T, 2000, CEMENT CONCRETE RES, V30, P511, DOI 10.1016/S0008-8846(99)00244-6; Sebok T, 1999, CEMENT CONCRETE RES, V29, P591, DOI 10.1016/S0008-8846(99)00050-2; Shandra S, 2002, CEMENT CONCRETE RES, V32, P1605; Shashi JSP, 1982, CELL CHEM TECHNOL, V16, P511; Shimada K, 1997, J WOOD CHEM TECHNOL, V17, P57, DOI 10.1080/02773819708003118; Shintani K, 1995, HOLZFORSCHUNG, V49, P351; Shintani K, 1994, HOLZFORSCHUNG, V48, P337; SIMIONESCU CI, 1987, CELL CHEM TECHNOL, V21, P525; SIMIONESCU CI, 1993, CELL CHEM TECHNOL, V27, P627; Sipila J, 1997, P 9 INT S WOOD PULP, pB2; Sipila J, 1999, P 10 INT S WOOD PULP, V1, P364; Sipila J, 2001, P INT S WOOD PULP CH, V1, P9; Sivasankarapillai G, 2012, BIOMASS BIOENERG, V47, P99, DOI 10.1016/j.biombioe.2012.09.057; Sivasankarapillai G, 2011, BIOMASS BIOENERG, V35, P919, DOI 10.1016/j.biombioe.2010.11.002; Sjostrom E, 1992, WOOD CHEM FUNDAMENTA, P71; Sjotrom E, 1992, WOOD CHEM FUNDAMENTA, P114; Stranel O, 1999, CEMENT CONCRETE RES, V29, P1769, DOI 10.1016/S0008-8846(99)00165-9; Stranel O, 1997, CEMENT CONCRETE RES, V27, P185, DOI 10.1016/S0008-8846(97)00007-0; SUDO K, 1992, J APPL POLYM SCI, V44, P127, DOI 10.1002/app.1992.070440113; SUZUKI H, 1989, AGR BIOL CHEM TOKYO, V53, P1197; SUZUKI H, 1989, AGR BIOL CHEM TOKYO, V53, P3369; Takahashi S, 2014, J WOOD CHEM TECHNOL, V34, P31, DOI 10.1080/02773813.2013.820322; Tan TTM, 1996, POLYM INT, V41, P13, DOI 10.1002/(SICI)1097-0126(199609)41:1<13::AID-PI557>3.0.CO;2-8; TANEDA H, 1987, J WOOD CHEM TECHNOL, V7, P485; Terashima N, 1977, MOKUZAI GAKKAISHI, V23, P343; Tollner TL, 2002, J ANDROL, V23, P889; Tomizuka I., 1971, Yogyo-Kyokai-Shi, V79; VAZQUEZ G, 1995, BIORESOURCE TECHNOL, V51, P187, DOI 10.1016/0960-8524(94)00120-P; Vilaseca J F, 2012, J APPL POLYM SCI, V126, pE213; VOCAC JA, 1968, EUR J PHARMACOL, V4, P99, DOI 10.1016/0014-2999(68)90016-2; Wang ZJ, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-156; WESTERMARK U, 1995, RES CHEM INTERMEDIAT, V21, P343; Wu SB, 2001, CELL CHEM TECHNOL, V35, P253; YASUDA S, 1988, J WOOD CHEM TECHNOL, V8, P155, DOI 10.1080/02773818808070677; YASUDA S, 1989, MOKUZAI GAKKAISHI, V35, P513; YASUDA S, 1987, MOKUZAI GAKKAISHI, V33, P708; Ye DZ, 2013, INT J BIOL MACROMOL, V60, P77, DOI 10.1016/j.ijbiomac.2013.05.016; YOUNG RA, 1986, HOLZFORSCHUNG, V40, P99, DOI 10.1515/hfsg.1986.40.2.99; Zarubin YM, 1989, TAPPI J, V72; Zhang LH, 2013, STARCH-STARKE, V65, P666, DOI 10.1002/star.201200220; ZHAO LW, 1994, J WOOD CHEM TECHNOL, V14, P127, DOI 10.1080/02773819408003090	254	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					230	250		10.1007/s10086-015-1470-2		21	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600003		
J	Horikawa, Y; Mizuno-Tazuru, S; Sugiyama, J				Horikawa, Yoshiki; Mizuno-Tazuru, Suyako; Sugiyama, Junji			Near-infrared spectroscopy as a potential method for identification of anatomically similar Japanese diploxylons	JOURNAL OF WOOD SCIENCE			English	Article						Discriminant analysis; NIR spectroscopy; Japanese diploxylons; Wood identification; Aging wood	DEUTERIUM-LABELED MOLECULES; RADIAL WOOD STRIPS; NONDESTRUCTIVE ESTIMATION; DIFFUSION PROCESS; NIR SPECTROSCOPY; CLASSIFICATION; HEARTWOOD; STIFFNESS; SECTIONS	A reliable technique for distinguishing anatomically similar diploxylons, Pinus densiflora and P. thunbergii, was designed by employing near-infrared (NIR) spectroscopy in combination with multivariate analysis. In total, 24 wood blocks, with half of them being of P. densiflora and the rest of P. thunbergii, were selected from the collections of the Kyoto University xylarium and scrutinized to build an acceptable model for discriminating between the two species. The prediction model was constructed only from heartwood, and the best performance was obtained for wavenumbers of 7,300-4,000 cm(-1) in the second derivative spectra. To apply this model to actual materials obtained from historical wooden buildings, 12 aging wood samples were analyzed and compared by microscopic identification. Unexpectedly, the spectral differences between the species were smaller than those caused by aging, and the prediction error was approximately 50 %. The spectra of the aging samples were quite distinct in the specific region characteristic of absorbed water (5,220 cm(-1)); this was demonstrated clearly by principal component analysis. Therefore, for the proposed model to be suitable for use in practical applications, further investigations of aging wood samples and the corresponding spectroscopic data are necessary to understand the effects of aging on the spectral data.	[Horikawa, Yoshiki; Mizuno-Tazuru, Suyako; Sugiyama, Junji] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji 6110011, Japan	Horikawa, Y (reprint author), Kyoto Univ, Res Inst Sustainable Humanosphere, Uji 6110011, Japan.	yhorikawa@rish.kyoto-u.ac.jp	Horikawa, Yoshiki/P-1558-2015		Japan Society for the Promotion of Science (JSPS) [25252033, 22300309, 24780169]	The study was supported in parts by Grants-in-Aid for Scientific Research (Grant Numbers 25252033, 22300309, and 24780169) from the Japan Society for the Promotion of Science (JSPS). The authors thank Ms. Izumi Kanai and Mr. Akio Adachi for their technical support.	Sandberg K, 2009, EUR J FOREST RES, V128, P475, DOI 10.1007/s10342-009-0296-0; Watanabe A, 2006, APPL SPECTROSC, V60, P1054, DOI 10.1366/000370206778397452; Gierlinger N, 2004, J NEAR INFRARED SPEC, V12, P113; Pastore TCM, 2011, HOLZFORSCHUNG, V65, P73, DOI 10.1515/HF.2011.010; Schimleck LR, 1996, APPITA J, V49, P319; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Adedipe OE, 2008, J NEAR INFRARED SPEC, V16, P49, DOI 10.1255/jnirs.760; Schimleck LR, 2005, IAWA J, V26, P175; Inagaki T, 2012, WOOD SCI TECHNOL, V46, P143, DOI 10.1007/s00226-010-0379-6; Tsuchikawa S, 2003, APPL SPECTROSC, V57, P667, DOI 10.1366/000370203322005364; Braga JWB, 2011, IAWA J, V32, P285; Hauksson JB, 2001, WOOD SCI TECHNOL, V35, P475, DOI 10.1007/s00226-001-0123-3; Horikawa Y, 2011, APPL BIOCHEM BIOTECH, V164, P194, DOI 10.1007/s12010-010-9127-5; Horikawa Y, 2012, APPL BIOCHEM BIOTECH, V166, P711, DOI 10.1007/s12010-011-9460-3; Jones PD, 2006, WOOD SCI TECHNOL, V40, P709, DOI 10.1007/s00226-006-0085-6; Leinonen A, 2008, HOLZFORSCHUNG, V62, P284, DOI 10.1515/HF.2008.033; Mizuno S, 2011, J SOC ARCHITECT HITS, V56, P124; Schimleck LR, 2002, CAN J FOREST RES, V32, P129, DOI 10.1139/x01-176; Schimleck LR, 2004, HOLZFORSCHUNG, V58, P375, DOI 10.1515/HF.2004.057; Siesler H. W., 2002, NEAR INFRARED SPECTR; Tsuchikawa S, 2003, APPL SPECTROSC, V57, P675, DOI 10.1366/000370203322005373; Tsuchikawa S, 2005, ANALYST, V130, P379, DOI 10.1039/b412759e; Watanabe K, 2011, JPN J HIST BOT, V19, P117; Yokoyama M, 2009, CR PHYS, V10, P601, DOI 10.1016/j.crhy.2009.08.009	24	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					251	261		10.1007/s10086-015-1462-2		11	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600004		
J	Ishihara, M; Ootao, Y; Kameo, Y				Ishihara, Masayuki; Ootao, Yoshihiro; Kameo, Yoshitaka			Analytical technique for electroelastic field in piezoelectric bodies belonging to point group D-infinity	JOURNAL OF WOOD SCIENCE			English	Article						Piezoelectric body; Point group D-infinity; Electroelastic problem; General solution technique	ISOTROPIC CIRCULAR-CYLINDER; COMBINED COMPRESSION; VIBRATION STRESSES; SPHERICAL CAVITY; STRUCTURAL TIMBER; HOLLOW CYLINDER; STRAIN CURVE; WOOD; BEHAVIOR; DEFORMATION	To elucidate the electroelastic field in woods, which are piezoelectric bodies belonging to point group D (a), we construct an analytical technique for general solutions to electroelastic problems in these bodies. First, the constitutive equations are derived considering the microstructures and their combined behaviors. Then, the displacement and electric field are expressed in terms of two types of displacement potential functions and the electric potential function, and their governing equations are obtained using the fundamental equations for the electroelastic field. As a result, the electroelastic field quantities are found to be expressed in terms of four functions, namely two elastic displacement potential functions and two piezoelastic displacement potential functions, each of which satisfies a Laplace equation with respect to the appropriately transformed spatial coordinates. As an application of the technique, the electroelastic field in a semi-infinite body subjected to a prescribed electric potential on its surface is analyzed, and the numerical results are illustrated. This novel technique serves to investigate the electroelastic field inside wooden materials.	[Ishihara, Masayuki; Ootao, Yoshihiro; Kameo, Yoshitaka] Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, Sakai, Osaka 5998531, Japan	Ishihara, M (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Naka Ku, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	ishihara@me.osakafu-u.ac.jp					CHEN WT, 1968, J APPL MECH, V35, P770; NORIMOTO M, 1978, HOLZFORSCHUNG, V32, P167, DOI 10.1515/hfsg.1978.32.5.167; ATSUMI A, 1974, J APPL MECH-T ASME, V41, P708; ATSUMI A, 1973, J APPL MECH-T ASME, V40, P752; ATSUMI A, 1974, J APPL MECH-T ASME, V41, P507; Bhuiyan MTR, 2002, J WOOD SCI, V48, P1, DOI 10.1007/BF00766230; CHEN WT, 1966, J APPL MECH, V33, P347; Elliott HA, 1949, MATH P CAMBRIDGE PHI, V45, P621, DOI 10.1017/S0305004100025305; FUKADA E, 1955, J PHYS SOC JPN, V10, P149, DOI 10.1143/JPSJ.10.149; GREEN AE, 1945, PROC R SOC LON SER-A, V184, P181, DOI 10.1098/rspa.1945.0016; GREEN AE, 1945, PROC R SOC LON SER-A, V184, P231, DOI 10.1098/rspa.1945.0019; Hirai N, 1973, J SOC MATER SCI JPN, V22, P948; Hirai N, 2011, J WOOD SCI, V57, P1, DOI 10.1007/s10086-010-1133-2; Ishibara K., 1978, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V24, P375; KASANO H, 1982, B JSME, V25, P143; KASANO H, 1984, B JSME, V27, P1323; KASANO H, 1986, B JSME, V29, P2386; KASANO H, 1980, B JSME, V23, P170; KASANO H, 1986, B JSME, V29, P3286; Kim S. K., 1999, GROUP THEORETICAL ME; KNUFFEL W, 1986, HOLZFORSCHUNG, V40, P157, DOI 10.1515/hfsg.1986.40.3.157; KNUFFEL WE, 1988, HOLZFORSCHUNG, V42, P247, DOI 10.1515/hfsg.1988.42.4.247; Kretschmann DE, 2010, WOOD HDB WOOD ENG MA, P51; Lekhnitskii S.G., 1981, THEORY ELASTICITY AN; Mirsky L, 2011, INTRO LINEAR ALGEBRA; Nakai T, 2004, J WOOD SCI, V50, P97, DOI 10.1007/s10086-003-0590-2; Nakai T, 1998, J WOOD SCI, V44, P255, DOI 10.1007/BF00581304; Nakai T, 2006, J WOOD SCI, V52, P539, DOI 10.1007/s10086-005-0801-0; Nakai T, 1998, J WOOD SCI, V44, P28, DOI 10.1007/BF00521871; Norimoto M, 1976, WOOD RES, V59, P106; Nye J F, 1985, PHYS PROPERTIES CRYS; Payne LE, 1954, MATH P CAMB PHIL SOC, V50, P466, DOI 10.1017/S0305004100029571; Shield RT, 1951, MATH P CAMBRIDGE PHI, V47, P401, DOI 10.1017/S0305004100026748; Smetana J. A., 1971, Wood Science, V3, P161; Sneddon I. N., 1972, USE INTEGRAL TRANSFO; Sobue N., 1976, Mokuzai Gakkaishi (Journal of the Japan Wood Research Society), V22, P211; Yokoyama M, 1997, WOOD RES TECH NOTES, V33, P71	37	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					270	284		10.1007/s10086-015-1468-9		15	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600006		
J	Ogawa, S; Miyafuji, H				Ogawa, Shintaro; Miyafuji, Hisashi			Reaction behavior of milled wood lignin in an ionic liquid, 1-ethyl-3-methylimidazolium chloride	JOURNAL OF WOOD SCIENCE			English	Article						Milled wood lignin; Ionic liquid; 1-ethyl-3-methylimidazolium chloride; Reaction behavior; Heating method	1-H-3-METHYLIMIDAZOLIUM CHLORIDE; DEPOLYMERIZATION; PRETREATMENT; HYDROLYSIS; SOLVENT	We investigated the reaction behavior of milled wood lignin (MWL) obtained from Japanese cedar (Cryptomeria japonica) and Japanese beech (Fagus crenata) in an ionic liquid, 1-ethyl-3-methylimidazolium chloride ([C2mim][Cl]). This solvent can liquefy wood. The sample was treated with [C2mim][Cl] at 120 A degrees C using an oil bath or microwave irradiation. MWL easily dissolved in [C2mim][Cl]. Although solubilized, MWL was slightly depolymerized and it retained its high molecular weight after 96 h of treatment. Only small amounts of low molecular weight compounds such as vanillin, coniferylaldehyde, syringaldehyde and sinapylaldehyde were produced. As the treatment time was extended the chlorine from [C2mim][Cl] reacted with the MWL. These results indicate that MWL is stable in [C2mim][Cl] although limited depolymerization and modification by [C2mim][Cl] occurred.	[Ogawa, Shintaro; Miyafuji, Hisashi] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Miyafuji, H (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyafuji@kpu.ac.jp			JSPS [25450246]	This research was partly supported by a Grant-in-Aid for Scientific Research (c) (25450246) from JSPS, for which the authors are grateful.	Kubo S, 2008, J WOOD CHEM TECHNOL, V28, P84, DOI [10.1080/02773810802124845, 10.1080/02773810802124928]; Nakamura A, 2010, J WOOD SCI, V56, P256, DOI 10.1007/s10086-009-1081-x; Nakamura A, 2010, HOLZFORSCHUNG, V64, P289, DOI 10.1515/HF.2010.042; Jia SY, 2010, CHEMSUSCHEM, V3, P1078, DOI 10.1002/cssc.201000112; Miyafuji H, 2009, J WOOD SCI, V55, P215, DOI 10.1007/s10086-009-1020-x; ROBERTS AF, 1970, COMBUST FLAME, V14, P261, DOI 10.1016/S0010-2180(70)80037-2; Cox BJ, 2012, BIORESOURCE TECHNOL, V118, P584, DOI 10.1016/j.biortech.2012.05.012; Stark K, 2010, CHEMSUSCHEM, V3, P719, DOI 10.1002/cssc.200900242; Pu YQ, 2007, J WOOD CHEM TECHNOL, V27, P23, DOI 10.1080/02773810701282330; Sun N, 2009, GREEN CHEM, V11, P646, DOI 10.1039/b822702k; Binder JB, 2009, BIOMASS BIOENERG, V33, P1122, DOI 10.1016/j.biombioe.2009.03.006; Wen JL, 2014, GREEN CHEM, V16, P181, DOI 10.1039/c3gc41752b; Cox BJ, 2013, BIORESOURCE TECHNOL, V134, P59, DOI 10.1016/j.biortech.2013.01.081; Nguyen QA, 1999, APPL BIOCHEM BIOTECH, V77-9, P133, DOI 10.1385/ABAB:77:1-3:133; Somerville C, 2004, SCIENCE, V306, P2206, DOI 10.1126/science.1102765; Bjorkman A., 1956, SVENSK PAPPERSTIDN, V59, P477, DOI DOI 10.1016/J.CHROMA.2003.08.046; FUJITA H, 1955, J POLYM SCI, V15, P277, DOI 10.1002/pol.1955.120157923; JIS K, 1995, 7229 JIS K; Li L, 1988, IND ENG CHEM RES, V27, P1301, DOI 10.1021/ie00079a035; Nakano J, 1990, CHEM LIGNIN FUNDAMEN, P176; SADDLER JN, 1982, BIOTECHNOL BIOENG, V24, P1389, DOI 10.1002/bit.260240611; SARKANEN KV, 1960, J ORG CHEM, V25, P715, DOI 10.1021/jo01075a010	22	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					285	291		10.1007/s10086-015-1461-3		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600007		
J	Rizaluddin, AT; Liu, Q; Panggabean, PR; Ohi, H; Nakamata, K				Rizaluddin, Andri Taufick; Liu, Qiang; Panggabean, Posma R.; Ohi, Hiroshi; Nakamata, Keiichi			Application of peroxymonosulfuric acid as a modification of the totally chlorine-free bleaching of acacia wood prehydrolysis-kraft pulp	JOURNAL OF WOOD SCIENCE			English	Article						Peroxymonosulfuric acid; Prehydrolysiskraft pulp; Totally chlorine-free bleaching; Hexenuronic acid; Hardwood pulp	HYDROGEN-PEROXIDE; DISSOLVING PULP; DELIGNIFICATION; REMOVAL	The totally chlorine-free (TCF) bleaching process avoids the generation of organochlorine substances. In this study, the application of peroxymonosulfuric acid (H2SO5: P-sa) to TCF bleaching was proposed as a modification of the bleaching process of hardwood prehydrolysis-kraft pulp. Acacia mearnsii pulps were treated by oxygen bleaching, followed by P-sa treatment, ozone bleaching, alkali extraction, and finally, hydrogen peroxide bleaching. The P-sa treatment was conducted with 10 % pulp consistency at pH 3 and 70 A degrees C. The use of P-sa increased the removal of hexenuronic acid from the pulp and improved pulp brightness. After the final hydrogen peroxide bleaching, pulp brightness increased to 86.0 % ISO with a 0.6 % P-sa dosage. The P-sa treatment showed better selectivity, i.e., kappa number decrement per unit of viscosity, compared with ozone bleaching. A dosage of 0.2 % P-sa afforded a 3.4 kappa number decrement with a 10.9 cP viscosity loss, while ozone treatment with a dosage of 0.5 % resulted in a 2.6 kappa number decrement with a 12.5 cP viscosity loss. The results showed that the P-sa treatment can enhance pulp quality in terms of brightness and reduce ozone consumption, which improves the TCF bleaching process.	[Rizaluddin, Andri Taufick; Liu, Qiang; Ohi, Hiroshi] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Rizaluddin, Andri Taufick; Panggabean, Posma R.] Minist Ind, Ctr Pulp & Paper, Bandung 40258, Indonesia; [Nakamata, Keiichi] Hokuetsu Kishu Paper Co Ltd, Tech & Dev Div, Chuo Ku, Tokyo 1030021, Japan	Ohi, H (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.	oi.hiroshi.gm@u.tsukuba.ac.jp					ALLISON RW, 1995, TAPPI J, V78, P134; Cadena EM, 2010, BIORESOURCE TECHNOL, V101, P3554, DOI 10.1016/j.biortech.2009.11.105; Gellerstedt G, 1996, CARBOHYD RES, V294, P41; Jafari V, 2014, HOLZFORSCHUNG, V68, P497, DOI 10.1515/hf-2013-0148; Sun R, 2000, J AGR FOOD CHEM, V48, P1253, DOI 10.1021/jf990646e; Li HM, 2010, J WOOD CHEM TECHNOL, V30, P48, DOI 10.1080/02773810903419227; Ma XJ, 2011, BIORESOURCES, V6, P1428; Brasileiro LB, 2002, APPITA J, V55, P461; Dence C. W., 1992, METHODS LIGNIN CHEM, P33; Juuti S, 1996, CHEMOSPHERE, V33, P437, DOI 10.1016/0045-6535(96)00208-1; Kronis JD, 1998, TAPPI PULPING C P, V2, P863; Kuwabara E, 2011, JPN TAPPI J, V65, P1071; Kuwabara E, 2012, JPN TAPPI J, V66, P743; Nakamata K, 2004, J WOOD SCI, V50, P242, DOI 10.1007/s10086-003-0553-7; Petit-Breuilh X, 2004, J CHIL CHEM SOC, V49, P355, DOI 10.4067/S0717-97072004000400016; Silva VL, 2011, BIORESOURCES, V6, P4801; SPRINGER EL, 1990, TAPPI J, V73, P175; Stauber J, 1996, APPITA J, V49, P184; Suess UH, 2000, 5 IPW, V5, pT69; Takagi H, 2009, JPN TAPPI J, V63, P1091; Takahashi S, 2010, J WOOD SCI, V57, P27; Tanifuji K, 2011, JPN TAPPI J, V65, P494; TAPPI, 2015, PAP PAP TEST; Tomoda I, 2008, INT PULP BLEACH C QU, P177; Van Lierop B, 1996, PULP BLEACHING PRINC, P32; Vourinen T, 1996, INT PULP BLEACH C, V1, P43; Yoon K, 2012, 2012 PULP PAP RES C, P48; Yoshida K, 2008, INT PULP BLEACH C QU, P165	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					292	298		10.1007/s10086-015-1465-z		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600008		
J	Takada, M; Saka, S				Takada, Masatsugu; Saka, Shiro			Characterization of lignin-derived products from Japanese cedar as treated by semi-flow hot-compressed water	JOURNAL OF WOOD SCIENCE			English	Article						Japanese cedar; Hot-compressed water; Lignin-derived products; Condensed type lignin	SUPERCRITICAL WATER; GC-MS; PHENOL MIXTURES; DECOMPOSITION; METHANOL; HYDROLYSIS; CONVERSION; RECOVERY; SOFTWOOD; HARDWOOD	In order to elucidate the decomposition behavior of lignin from Japanese cedar (Cryptomeria japonica) as treated by two-step semi-flow hot-compressed water (1st stage: 230 A degrees C/10 MPa/15 min, 2nd stage: 270 A degrees C/10 MPa/15 min), water-soluble portion, precipitate, and water-insoluble residue obtained by hot-compressed water treatment were separated and characterized. Consequently, the water-soluble portion was found to contain lignin-derived monomeric compounds such as coniferyl alcohol and coniferyl aldehyde and beta-1, beta-5, and 5-5' linked dimeric compounds. These lignin-derived compounds maintained methoxyl and phenolic hydroxyl groups in aromatic rings. The water-soluble portion also contained lignin-derived oligomeric compounds up to heptamers. In contrast, the precipitate was found out to consist of higher molecular weight lignin with high ether type linkages. The water-insoluble residue, however, consisted mostly of lignin with high condensed type linkages. Based on these lines of evidence, condensed type lignin must be resistant to hot-compressed water and remain as water-insoluble residue after two-step treatment. Such information provides a clue as to efficient utilization of lignin-derived products.	[Takada, Masatsugu; Saka, Shiro] Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Kyoto 6068501, Japan	Saka, S (reprint author), Kyoto Univ, Grad Sch Energy Sci, Dept Socioenvironm Energy Sci, Sakyo Ku, Yoshida Honmachi, Kyoto 6068501, Japan.	saka@energy.kyoto-u.ac.jp					Okuda K, 2004, FUEL PROCESS TECHNOL, V85, P803, DOI 10.1016/j.fuproc.2003.11.027; Minami E, 2003, J WOOD SCI, V49, P73, DOI 10.1007/s100860300012; Yamauchi K, 2013, J WOOD SCI, V59, P149, DOI 10.1007/s10086-012-1313-3; Ehara K, 2002, J WOOD SCI, V48, P320, DOI 10.1007/BF00831354; Rogalinski T, 2008, J SUPERCRIT FLUID, V47, P54, DOI 10.1016/j.supflu.2008.05.003; Brosse N, 2010, POLYM DEGRAD STABIL, V95, P1721, DOI 10.1016/j.polymdegradstab.2010.05.018; Ando H, 2000, IND ENG CHEM RES, V39, P3688, DOI 10.1021/ie0000257; Ehara K, 2005, J WOOD SCI, V51, P256, DOI 10.1007/s10086-004-0653-z; Lu X, 2009, J WOOD SCI, V55, P367, DOI 10.1007/s10086-009-1040-6; Ehara K, 2002, CELLULOSE, V9, P301, DOI 10.1023/A:1021192711007; Liu CG, 2003, IND ENG CHEM RES, V42, P5409, DOI 10.1021/ie030458k; Saisu M, 2003, ENERG FUEL, V17, P922, DOI 10.1021/ef0202844; TOWNSEND SH, 1988, IND ENG CHEM RES, V27, P143, DOI 10.1021/ie00073a026; Phaiboonsilpa N, 2010, J WOOD SCI, V56, P331, DOI 10.1007/s10086-009-1099-0; Chen C.L., 1992, METHODS LIGNIN CHEM, P301; Dence C. W., 1992, METHODS LIGNIN CHEM, P33; Martino CJ, 1997, IND ENG CHEM RES, V36, P1385, DOI 10.1021/ie960698i; Meier D., 1992, METHODS LIGNIN CHEM, P177; Minami E, 2003, J WOOD SCI, V49, P158, DOI 10.1007/s100860300025; Nakamura Y, 2011, J WOOD SCI, V57, P331, DOI 10.1007/s10086-010-1169-3; Sarkanen KV, 1971, LIGNINS OCCURRENCE F, P43; Sasaki T, 2002, IND ENG CHEM RES, V41, P661; Sato T, 2004, CHEM ENG SCI, V59, P1247, DOI 10.1016/j.ces.2003.12.018; Takada D, 2004, J WOOD SCI, V50, P253, DOI 10.1007/s10086-003-0562-6; TANAHASHI M, 1989, MOKUZAI GAKKAISHI, V35, P135; THORNTON TD, 1992, AICHE J, V38, P321, DOI 10.1002/aic.690380302; TIRTOWIDJOJO S, 1988, HOLZFORSCHUNG, V42, P177, DOI 10.1515/hfsg.1988.42.3.177; Vane CH, 2003, INT BIODETER BIODEGR, V51, P67, DOI 10.1016/S0964-8305(02)00089-6; Yokoyama C, 1998, SEKIYU GAKKAISHI, V41, P243; Yokoyama C, 1994, SEKIYU GAKKAISHI, V37, P34; Yokoyama C, 1996, SEKIYU GAKKAISHI, V39, P395; Yoshioka K, 2011, PHYTOCHEM ANALYSIS, V23, P248	32	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					299	307		10.1007/s10086-015-1464-0		9	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600009		
J	Tsujimura, M; Tsuji, M; Kofujita, H; Ohira, T				Tsujimura, Maiko; Tsuji, Minori; Kofujita, Hisayoshi; Ohira, Tatsuro			New separation method for terpenoids in byproducts discharged during sugi wood-drying process, and purification of ferruginol	JOURNAL OF WOOD SCIENCE			English	Article						Cryptomeria japonica; Ferruginol; Terpenoids	CRYPTOMERIA-JAPONICA; ESSENTIAL OILS; HIGH-TEMPERATURE; HEARTWOOD; CONSTITUENTS; TREES; BARK	In this study, we developed a new method to separate terpenoids from byproducts discharged during sugi wood-drying process by solvent-assisted-distillation (SAD). First, the sample was distillated from a mixed solvent, of water and triethylene glycol. Then, the volatile compounds in the sample were fractionated sequentially according to boiling point. Using SAD, we separated compounds like sesuquiterpenes from the water distillates (WD) fraction by conventional distillation methods. In addition, high boiling point compounds, such as diterpenes, were separated from the triethylene glycol distillates (TGD) fraction. Based on gas chromatography/mass spectrometry (GC/MS) analysis, the main components of the byproducts were sandaracopimarinol (18.74 %), ferruginol (16.45 %), 6,7-dehydroferruginol (7.97 %), abietadiene (6.39 %), and sandaracopimarinal (6.08 %). We purified ferruginol from these sugi wood-drying byproducts using SAD and chromatography; the yield was 5.3 % and the purity was 99.8 %.	[Tsujimura, Maiko; Kofujita, Hisayoshi] Iwate Univ, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Tsuji, Minori] Iwate Univ, Fac Agr, Morioka, Iwate 0208550, Japan; [Ohira, Tatsuro] FFPRI, Tsukuba, Ibaraki 3058687, Japan	Tsujimura, M (reprint author), Iwate Univ, United Grad Sch Agr Sci, 18-8 Ueda 3 Chome, Morioka, Iwate 0208550, Japan.	kofujita@iwate-u.ac.jp					Adams R.P., 2012, IDENTIFICATION ESSEN; Gu HJ, 2009, J AGR FOOD CHEM, V57, P11127, DOI 10.1021/jf9024486; Kusumoto N, 2010, J CHEM ECOL, V36, P1381, DOI 10.1007/s10886-010-9875-2; Kofujita H, 2001, MOKUZAI GAKKAISHI, V47, P479; Cheng WW, 2009, J WOOD SCI, V55, P27, DOI 10.1007/s10086-008-0984-2; Cheng SS, 2007, BIORESOURCE TECHNOL, V98, P456, DOI 10.1016/j.biortech.2006.01.006; Sogabe A, 2000, MOKUZAI GAKKAISHI, V46, P124; Cha JD, 2012, MOLECULES, V17, P3890, DOI 10.3390/molecules17043890; Bakkali F, 2008, FOOD CHEM TOXICOL, V46, P446, DOI 10.1016/j.fct.2007.09.106; Cheng SS, 2005, J AGR FOOD CHEM, V53, P614, DOI 10.1021/jf048529; Ozek G, 2010, J CHROMATOGR A, V1217, P741, DOI 10.1016/j.chroma.2009.11.086; Arihara S, 2004, MOKUZAI GAKKAISHI, V50, P413; Gu HJ, 2009, PARASITOL RES, V105, P1455, DOI 10.1007/s00436-009-1550-6; Kano H, 2004, MOKUZAI GAKKAISHI, V50, P91; Li WH, 2008, NAT PROD RES, V22, P1085, DOI 10.1080/14786410802267510; Matsushita Y, 2008, J WOOD SCI, V54, P476, DOI 10.1007/s10086-008-0980-6; Matui T, 2001, MOKUZAI GAKKAISHI, V47, P58; Matushita Y, 2006, J WOOD SCI, V52, P552; NAGAHAMA S, 1993, MOKUZAI GAKKAISHI, V39, P1077; Ohira T., 2010, Aroma Research, V11, P148; Ohira T, 2009, J JPN ASS ODOR ENV, V40, P400; Rodriguez JA, 2006, LIFE SCI, V78, P2503, DOI 10.1016/j.lfs.2005.10.018; Saito K, 1995, AROMATOPIA, V10, P49; Sakamaki S., 2013, Aroma Research, V14, P64; Tezuka Y, 1998, CHEM PHARM BULL, V46, P107; Tsuruta K, 2011, J WOOD SCI, V57, P520, DOI 10.1007/s10086-011-1209-7; Wang SY, 2002, HOLZFORSCHUNG, V56, P487, DOI 10.1515/HF.2002.075	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	JUN	2015	61	3					308	315		10.1007/s10086-015-1471-1		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CJ1OY	WOS:000355254600010		
J	Iseki, K; Collins, AJ				Iseki, Kunitoshi; Collins, Allan J.			Sharing knowledge on dialysis registries worldwide	KIDNEY INTERNATIONAL SUPPLEMENTS			English	Editorial Material							JAPAN		[Iseki, Kunitoshi] Univ Hosp Ryukyus, Dialysis Unit, Okinawa 9030215, Japan; [Collins, Allan J.] Univ Minnesota, USRDS, Chron Dis Res Grp, Minneapolis, MN USA	Iseki, K (reprint author), Univ Hosp Ryukyus, Dialysis Unit, Okinawa 9030215, Japan.	chihokun@med.u-ryukyu.ac.jp					Goodkin DA, 2003, J AM SOC NEPHROL, V14, P3270, DOI 10.1097/01.ASN.0000100127.54107.57; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Fukagawa M, 2013, KIDNEY INT SUPPL, V3, P419, DOI 10.1038/kisup.2013.87; Japanese Society for Dialysis Therapy Working Group for Guideline of Hemodialysis Therapy and Discussion Subgroup for Dialysis-Non Initiation and Withdrawal, 2014, TOUSEKI KAISHI, V47, P269	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2157-1724	2157-1716		KIDNEY INT SUPPL	Kidney Int. Suppl.	JUN	2015	5	1					1	1		10.1038/kisup.2015.1		1	Urology & Nephrology	Urology & Nephrology	CJ2QR	WOS:000355330100001		
J	Hanafusa, N; Nakai, S; Iseki, K; Tsubakihara, Y				Hanafusa, Norio; Nakai, Shigeru; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			Japanese society for dialysis therapy renal data registry-a window through which we can view the details of Japanese dialysis population	KIDNEY INTERNATIONAL SUPPLEMENTS			English	Article						aging population; demographics; The Japanese Society for Dialysis Therapy Renal Data Registry (JRDR)	CHRONIC-HEMODIALYSIS PATIENTS; CLINICAL-PRACTICE GUIDELINE; CHRONIC KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; HIP FRACTURE; MANAGEMENT; MORTALITY; SURVIVAL; PREDICTOR; STANDARD	The Japanese Society for Dialysis Therapy (JSDT) collects the clinical data from all the facilities to create a nation-wide registry system named JSDT Renal Data Registry (JRDR). This survey was begun in 1966 as a form of facility survey. Patient survey started in 1983. More than 95% of facilities respond to the survey on the basis of voluntary work of facility staffs. Therefore, JRDR has the longest history and the most comprehensive coverage. As for the prevalent patients, 304,856 patients are treated by dialysis therapy in Japan as of the year 2011. The demographics of the Japanese dialysis population have been markedly changing in terms of age, primary diagnoses and dialysis vintage. The mean age of prevalent population reaches 66.55 years at the end of 2011. The increase in the numbers of dialysis population is due to the growth of those older than 65 years old. Patients with the vintage longer than 20 years account for 8% of the entire population. Around 38 thousands patients started their dialysis treatments, whereas 31 thousands deceased. The disease burden of cardiovascular diseases as well as infection is substantial due to the demographic changes. Many evidences have been reported from the data obtained from JRDR to date. These findings covers a wide range of dialysis practice and are utilized for the development of JSDT guidelines. Therefore, JRDR has provided indispensable and fundamental data of Japanese dialysis population.	[Hanafusa, Norio; Nakai, Shigeru; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan	Hanafusa, N (reprint author), Tokyo Univ Hosp, Div Total Renal Care Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	hanafusa-tky@umin.ac.jp			59th Annual Meeting of the JSDT	Data shown in this review were adopted from the annual reports of JRDR with permission of the publisher and the Committee of Renal Data Registry of the JSDT. The opinions reflected in this manuscript are those of the authors alone and do not reflect an official position of the JSDT. This supplement was supported by a grant from the 59th Annual Meeting of the JSDT. We are also grateful to all of the staffs and doctors in charge of dialysis patients and responded questionnaires for all the time and attention they have devoted to JRDR.	Akiba T, 2012, THER APHER DIAL, V16, P289, DOI 10.1111/j.1744-9987.2012.01078.x; Akizawa T, 2013, J JPN SOC DIAL THER, V46, P1107; Ohira S, 2006, THER APHER DIAL, V10, P449, DOI 10.1111/j.1744-9987.2006.00410.x; [Anonymous], 2010, THER APHER DIAL, V14, P489; Hoshino J, 2014, AM J NEPHROL, V39, P449, DOI 10.1159/000362567; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Nakai S, 2008, THER APHER DIAL, V12, P49, DOI 10.1111/j.1744-9987.2007.00540.x; [Anonymous], 2013, ILL AN OV OF REG DIA; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; Wakasugi M, 2013, J BONE MINER METAB, V31, P315, DOI 10.1007/s00774-012-0411-z; Fukuma S, 2012, AM J KIDNEY DIS, V59, P108, DOI 10.1053/j.ajkd.2011.07.014; Gejyo F, 2004, THER APHER DIAL, V8, P443, DOI 10.1111/j.1774-9987.2004.00199.x; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; Shoji T, 2011, CLIN J AM SOC NEPHRO, V6, P1112, DOI 10.2215/CJN.09961110; Sakaguchi Y, 2014, KIDNEY INT, V85, P174, DOI 10.1038/ki.2013.327; Hirakata H, 2012, THER APHER DIAL, V16, P387, DOI 10.1111/j.1744-9987.2012.01088.x; Taniguchi M, 2013, THER APHER DIAL, V17, P221, DOI 10.1111/1744-9987.12030; Clayton P, 2013, THE 36 ANN ANZDATA R; Collins A, 2014, AM J KIDNEY DIS, V63, pE1; Fukagawa M, 2008, THER APHER DIAL, V12, P514, DOI 10.1111/j.1744-9987.2008.00648.x; Iseki K, 2005, THER APHER DIAL, V9, P407, DOI 10.1111/j.1744-9987.2005.00318.x; Iseki K, 2011, NEPHROL DIAL TRANSPL, V26, P963, DOI 10.1093/ndt/gfq507; Iseki K, 2009, NEPHRON CLIN PRACT, V113, pC183, DOI 10.1159/000232600; Iseki K, 2007, THER APHER DIAL, V11, P183, DOI 10.1111/j.1744-9987.2007.00479.x; Kawanishi H, 2009, THER APHER DIAL, V13, P161, DOI 10.1111/j.1744-9987.2009.00674.x; Kimura K, 2013, JPN J NEPHROL, V55, P585; Maruyama Y, 2014, NEPHROL DIAL TRANSPL, V29, P1532, DOI 10.1093/ndt/gfu055; Masakane I, 2013, THER APHER DIAL, V17, P229, DOI 10.1111/1744-9987.12031; Masakane I, 2009, BLOOD PURIFICAT, V27, P11, DOI 10.1159/000213491; Masakane I, 2008, THER APHER DIAL, V12, P457, DOI 10.1111/j.1744-9987.2008.00635.x; Nakai S., 2010, J JPN SOC DIAL THER, V43, P119; Odaka M, 1982, J JPN SOC DIAL THER, V14, P295; Ogata S, 2013, CLIN EXP NEPHROL, V17, P890, DOI 10.1007/s10157-013-0786-8; Shinzato T, 1997, NEPHROL DIAL TRANSPL, V12, P884, DOI 10.1093/ndt/12.5.884; Wakai K, 2004, NEPHROL DIAL TRANSPL, V19, P2044, DOI 10.1093/ndt/gfh317; Wakasugi M, 2014, THER APHER DIAL, V18, P162, DOI 10.1111/1744-9987.12074; Yamagata K, 2012, THER APHER DIAL, V16, P54, DOI 10.1111/j.1744-9987.2011.01005.x	39	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2157-1724	2157-1716		KIDNEY INT SUPPL	Kidney Int. Suppl.	JUN	2015	5	1					15	22		10.1038/kisup.2015.5		8	Urology & Nephrology	Urology & Nephrology	CJ2QR	WOS:000355330100005		
J	Hamano, T; Fujii, N; Hayashi, T; Yamamoto, H; Iseki, K; Tsubakihara, Y				Hamano, Takayuki; Fujii, Naohiko; Hayashi, Terumasa; Yamamoto, Hiroyasu; Iseki, Kunitoshi; Tsubakihara, Yoshiharu			Thresholds of iron markers for iron deficiency erythropoiesis-finding of the Japanese nationwide dialysis registry	KIDNEY INTERNATIONAL SUPPLEMENTS			English	Article						ESA response; ferritin; inflammation; TSAT	CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; MAINTENANCE HEMODIALYSIS-PATIENTS; SERUM FERRITIN; STIMULATING AGENTS; EPOETIN-ALPHA; HEMOGLOBIN LEVELS; HEART-FAILURE; ANEMIA; RESISTANCE	Reportedly, serum ferritin levels are much lower in Japanese hemodialysis (HD) patients than their Western counterparts. Therefore, the cutoff values of ferritin and transferrin saturation (TSAT) for iron deficiency might differ from other countries. We conducted a cross-sectional observational study using the Japanese nationwide registry data. We enrolled 142,339 maintenance HD patients and assessed the association between these markers, hemoglobin (Hb), and erythropoiesis-stimulating agent (ESA) resistance index (ERI) utilizing restricted cubic spline analyses. Median ferritin and TSAT levels were 73 (IQR: 31-158) ng/ml and 23.7 (16.8-32.0)%, respectively. These lower ferritin ranges may possibly stem from a lower inflammatory state in Japanese patients, as shown in median CRP of 1.0 mg/l. An adjusted nonlinear association between Hb and TSAT showed that Hb levels drop with the decrease in TSAT below 20%, regardless of serum ferritin levels, suggesting the absolute iron deficiency cutoff as 20% for TSAT. In patients with TSAT >20%, the association between Hb and ferritin levels is nearly flat, whereas in patients with TSAT <20%, ferritin <50 ng/ml was associated with low Hb. In long-acting ESAs-users with TSAT 420%, U-shaped relationship was observed between ERI and ferritin with the bottom of ERI around 100 ng/ml of ferritin, possibly because high ferritin levels reflected an inflamed state leading to hyporesponsiveness to ESA. The patient subgroup with TSAT <20% and ferritin 4100 ng/ml had significantly higher ERIs compared with the subgroup with TSAT >20% and ferritin <100 ng/ml, implying that TSAT, rather than ferritin, should be a primary iron marker predicting ESA response.	[Hamano, Takayuki; Fujii, Naohiko; Iseki, Kunitoshi; Tsubakihara, Yoshiharu] Japanese Soc Dialysis Therapy, Comm Renal Data Registry, Tokyo, Japan; [Hayashi, Terumasa] Osaka Gen Med Ctr, Dept Hypertens & Nephrol, Osaka, Japan; [Yamamoto, Hiroyasu] Atsugi City Hosp, Dept Internal Med, Kanagawa, Japan	Hamano, T (reprint author), Osaka Univ, Sch Med, Dept Comprehens Kidney Dis, 2-2 Yamadaoka,B6, Suita, Osaka 565, Japan.	hamatea@kid.med.osaka-u.ac.jp			59th Annual Meeting of the JSDT	Data were obtained with the permission of the Committee of Renal Data Registry of the JSDT. The opinions reflected in this manuscript are those of the authors alone and do not reflect an official position of the JSDT. This supplement was supported by a grant from the 59th Annual Meeting of the JSDT.	Agarwal R, 2008, CLIN J AM SOC NEPHRO, V3, P98, DOI 10.2215/CJN.03330807; ALJAMA P, 1978, CLIN NEPHROL, V10, P101; Toblli JE, 2007, J AM COLL CARDIOL, V50, P1657, DOI 10.1016/j.jacc.2007.07.029; Bazeley J, 2011, CLIN J AM SOC NEPHRO, V6, P2452, DOI 10.2215/CJN.00710111; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Bailie GR, 2013, NEPHROL DIAL TRANSPL, V28, P2570, DOI 10.1093/ndt/gft062; Kalantar-Zadeh K, 2009, AM J KIDNEY DIS, V53, P823, DOI 10.1053/j.ajkd.2008.12.040; Tsubakihara Y, 2010, THER APHER DIAL, V14, P240, DOI 10.1111/j.1744-9987.2010.00836.x; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; KALANTARZADEH K, 1995, AM J KIDNEY DIS, V26, P292, DOI 10.1016/0272-6386(95)90649-5; McFarlane PA, 2010, KIDNEY INT, V78, P215, DOI 10.1038/ki.2010.108; Nakai S, 2013, THER APHER DIAL, V17, P567, DOI 10.1111/1744-9987.12147; SHINZATO T, 1994, NEPHRON, V67, P280; Kalantar-Zadeh K, 2003, AM J KIDNEY DIS, V42, P761, DOI 10.1053/S0272-6386(03)00915-6; Nakanishi T, 2012, CLIN EXP NEPHROL, V16, P819, DOI 10.1007/s10157-012-0694-3; Fukagawa M, 2013, THER APHER DIAL, V17, P247, DOI 10.1111/1744-9987.12058; [Anonymous], 2001, AM J KIDNEY DIS, V37, pS182; Locatelli F, 2006, NEPHROL DIAL TRANSPL, V21, P991, DOI 10.1093/ndt/gfk011; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; Anker SD, 2009, NEW ENGL J MED, V361, P2436, DOI 10.1056/NEJMoa0908355; Locatelli F, 2004, NEPHROL DIAL TRANSPL, V19, P1, DOI 10.1093/ndt/gfh1024; Bross R, 2009, AM J NEPHROL, V29, P571, DOI 10.1159/000191470; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Brookhart MA, 2013, J AM SOC NEPHROL, V24, P1151, DOI 10.1681/ASN.2012121164; Drueke TB, 2002, NEPHROL DIAL TRANSPL, V17, P28, DOI 10.1093/ndt/17.suppl_5.28; Gaweda AE, 2014, HEMODIAL INT, V18, P38, DOI 10.1111/hdi.12078; Gaweda AE, 2010, CLIN J AM SOC NEPHRO, V5, P576, DOI 10.2215/CJN.04710709; HUSSEIN S, 1975, BRIT MED J, V1, P546; Kato A, 2008, AM J NEPHROL, V28, P115, DOI 10.1159/000109968; KDOQI; National Kidney Foundation, 2006, AM J KIDNEY DIS S, V47, pS11; Kidney Disease: Improving Global Outcomes (KDIGO) Anemia Work Group, 2012, KIDNEY INT S, V2, P279, DOI DOI 10.1038/KISUP.2012.37; LIPSCHIT.DA, 1974, NEW ENGL J MED, V290, P1213, DOI 10.1056/NEJM197405302902201; Locatelli F, 2012, NEPHROL DIAL TRANSPL, V27, P3594, DOI 10.1093/ndt/gfs117; Maruyama Y, 2007, NEPHROL DIAL TRANSPL, V22, P1407, DOI 10.1093/ndt/gfl789; MIRAHMADI KS, 1977, JAMA-J AM MED ASSOC, V238, P601, DOI 10.1001/jama.238.7.601; Movilli E, 2001, NEPHROL DIAL TRANSPL, V16, P111, DOI 10.1093/ndt/16.1.111; Pollak VE, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-6; Roger Simon, 2006, Nephrology (Carlton), V11 Suppl 1, pS217, DOI 10.1111/j.1440-1797.2006.00647.x; RAO DS, 1993, NEW ENGL J MED, V328, P171, DOI 10.1056/NEJM199301213280304; Tessitore N, 2010, NEPHROL DIAL TRANSPL, V25, P3996, DOI 10.1093/ndt/gfq321	40	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2157-1724	2157-1716		KIDNEY INT SUPPL	Kidney Int. Suppl.	JUN	2015	5	1					23	32		10.1038/kisup.2015.6		10	Urology & Nephrology	Urology & Nephrology	CJ2QR	WOS:000355330100006		
J	Yamada, Y; Tomaru, U; Ishizu, A; Ito, T; Kiuchi, T; Ono, A; Miyajima, S; Nagai, K; Higashi, T; Matsuno, Y; Dosaka-Akita, H; Nishimura, M; Miwa, S; Kasahara, M				Yamada, Yosuke; Tomaru, Utano; Ishizu, Akihiro; Ito, Tomoki; Kiuchi, Takayuki; Ono, Ayako; Miyajima, Syota; Nagai, Katsura; Higashi, Tsunehito; Matsuno, Yoshihiro; Dosaka-Akita, Hirotoshi; Nishimura, Masaharu; Miwa, Soichi; Kasahara, Masanori			Decreased proteasomal function accelerates cigarette smoke-induced pulmonary emphysema in mice	LABORATORY INVESTIGATION			English	Article							ENDOPLASMIC-RETICULUM STRESS; HUMAN LUNG FIBROBLASTS; UNFOLDED PROTEIN RESPONSE; ENDOTHELIAL GROWTH-FACTOR; EPITHELIAL-CELLS; AGGRESOME FORMATION; INDUCED APOPTOSIS; UP-REGULATION; T-CELL; DISEASE	Chronic obstructive pulmonary disease (COPD) is a disease common in elderly people, characterized by progressive destruction of lung parenchyma and chronic inflammation of the airways. The pathogenesis of COPD remains unclear, but recent studies suggest that oxidative stress-induced apoptosis in alveolar cells contributes to emphysematous lung destruction. The proteasome is a multicatalytic enzyme complex that plays a critical role in proteostasis by rapidly destroying misfolded and modified proteins generated by oxidative and other stresses. Proteasome activity decreases with aging in many organs including lungs, and an age-related decline in proteasomal function has been implicated in various age-related pathologies. However, the role of the proteasome system in the pathogenesis of COPD has not been investigated. Recently, we have established a transgenic (Tg) mouse model with decreased proteasomal chymotrypsin-like activity, showing age-related phenotypes. Using this model, we demonstrate here that decreased proteasomal function accelerates cigarette smoke (CS)-induced pulmonary emphysema. CS-exposed Tg mice showed remarkable airspace enlargement and increased foci of inflammation compared with wild-type controls. Importantly, apoptotic cells were found in the alveolar walls of the affected lungs. Impaired proteasomal activity also enhanced apoptosis in cigarette smoke extract (CSE)-exposed fibroblastic cells derived from mice and humans in vitro. Notably, aggresome formation and prominent nuclear translocation of apoptosis-inducing factor were observed in CSE-exposed fibroblastic cells isolated from Tg mice. Collective evidence suggests that CS exposure and impaired proteasomal activity coordinately enhance apoptotic cell death in the alveolar walls that may be involved in the development and progression of emphysema in susceptible individuals such as the elderly.	[Yamada, Yosuke; Tomaru, Utano; Ito, Tomoki; Kiuchi, Takayuki; Ono, Ayako; Miyajima, Syota; Kasahara, Masanori] Hokkaido Univ, Grad Sch Med, Dept Pathol, Sapporo, Hokkaido 0608638, Japan; [Yamada, Yosuke] Hokkaido Univ Hosp, Dept Surg Pathol, Sapporo, Hokkaido 060, Japan; [Ishizu, Akihiro] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido 0608638, Japan; [Nagai, Katsura; Nishimura, Masaharu] Hokkaido Univ, Sch Med, Dept Med 1, Sapporo, Hokkaido 060, Japan; [Higashi, Tsunehito; Miwa, Soichi] Hokkaido Univ, Grad Sch Med, Dept Cellular Pharmacol, Sapporo, Hokkaido 0608638, Japan; [Dosaka-Akita, Hirotoshi] Hokkaido Univ, Grad Sch Med, Dept Med Oncol, Sapporo, Hokkaido 0608638, Japan	Tomaru, U (reprint author), Hokkaido Univ, Grad Sch Med, Dept Pathol, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	tomaruu@med.hokudai.ac.jp	Kasahara, Masanori/G-7651-2011; Nishimura, Masaharu/A-4062-2012		Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	We are grateful to Ms Junko Tamba, Department of Pathology, Hokkaido University Graduate School of Medicine, for technical support. We also thank all the staff of the Institute for Animal Experimentation, Hokkaido University Graduate School of Medicine, for maintenance of mice. This work was supported in part by Takeda Science Foundation and Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan.	Adair-Kirk TL, 2008, NAT MED, V14, P1024, DOI 10.1038/nm1008-1024; Malhotra D, 2009, AM J RESP CRIT CARE, V180, P1196, DOI 10.1164/rccm.200903-0324OC; Rao RV, 2004, CURR OPIN CELL BIOL, V16, P653, DOI 10.1016/j.ceb.2004.09.012; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Breusing N, 2009, MECH AGEING DEV, V130, P748, DOI 10.1016/j.mad.2009.09.004; Somborac-Bacura A, 2013, EXP PHYSIOL, V98, P316, DOI 10.1113/expphysiol.2012.067249; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; McCullough KD, 2001, MOL CELL BIOL, V21, P1249, DOI 10.1128/MCB.21.4.1249-1259.2001; Carnevali S, 2003, AM J PHYSIOL-LUNG C, V284, pL955, DOI 10.1152/ajplung.00466.2001; Gross A, 1999, GENE DEV, V13, P1899, DOI 10.1101/gad.13.15.1899; Lin JH, 2008, ANNU REV PATHOL-MECH, V3, P399, DOI 10.1146/annurev.patho1.3.121806.151434; Noya Y, 2013, TOXICOLOGY, V314, P1, DOI [10.1016/j.tox.2013.08.015, 10.1016/j.cox.2013.08.015]; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI 10.1089/ARS.2009.2485; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Segura-Valdez L, 2000, CHEST, V117, P684, DOI 10.1378/chest.117.3.684; Hodge S, 2005, EUR RESPIR J, V25, P447, DOI 10.1183/09031936.05.00077604; Buchberger A, 2010, MOL CELL, V40, P238, DOI 10.1016/j.molcel.2010.10.001; Ko JK, 2011, NEUROCHEM RES, V36, P722, DOI 10.1007/s11064-010-0387-9; Olzmann JA, 2008, CURR MED CHEM, V15, P47; Min T, 2011, J MOL MED, V89, P577, DOI 10.1007/s00109-011-0732-8; Suzuki M, 2009, AM J PHYSIOL-LUNG C, V296, pL614, DOI 10.1152/ajplung.90443.2008; Bodas M, 2012, CURR MOL MED, V12, P807; Kelsen SG, 2008, AM J RESP CELL MOL, V38, P541, DOI 10.1165/rcmb.2007-0221OC; Chen ZH, 2010, P NATL ACAD SCI USA, V107, P18880, DOI 10.1073/pnas.1005574107; Tagawa Y, 2008, FREE RADICAL BIO MED, V45, P50, DOI 10.1016/j.freeradbiomed.2008.03.003; Salvesen GS, 1997, CELL, V91, P443, DOI 10.1016/S0092-8674(00)80430-4; Joza N, 2001, NATURE, V410, P549, DOI 10.1038/35069004; van Rijt SH, 2012, AM J PHYSIOL-LUNG C, V303, pL814, DOI 10.1152/ajplung.00128.2012; An CH, 2012, AM J PHYSIOL-LUNG C, V303, pL748, DOI 10.1152/ajplung.00102.2012; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Buist AS, 2007, LANCET, V370, P741, DOI 10.1016/S0140-6736(07)61377-4; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; Susin SA, 1999, NATURE, V397, P441; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Tomaru U, 2012, AM J PATHOL, V180, P963, DOI 10.1016/j.ajpath.2011.11.012; Chauhan D, 2008, BLOOD, V111, P1654, DOI 10.1182/blood-2006-10-050476; Calabrese F, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-14; Chondrogianni N, 2005, EXP GERONTOL, V40, P931, DOI 10.1016/j.exger.2005.09.004; Baglole CJ, 2006, AM J PHYSIOL-LUNG C, V291, pL19, DOI 10.1152/ajplung.00306.2005; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Ishii T, 2001, AM J PHYSIOL-LUNG C, V280, pL1189; Kincaid MM, 2007, ANTIOXID REDOX SIGN, V9, P2373, DOI 10.1089/ars.2007.1817; Yuan T, 2012, ARCH MED RES, V43, P522, DOI 10.1016/j.arcmed.2012.10.002; Lowery EM, 2013, CLIN INTERV AGING, V8, P1489, DOI 10.2147/CIA.S51152; Simon HU, 2000, APOPTOSIS, V5, P415, DOI 10.1023/A:1009616228304; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; Damico R, 2011, AM J RESP CELL MOL, V44, P323, DOI 10.1165/rcmb.2009-0379OC; Asano H, 2012, J PHARMACOL SCI, V118, P275, DOI 10.1254/jphs.11166FP; Bazzini C, 2013, CELL PHYSIOL BIOCHEM, V32, P129, DOI 10.1159/000356633; Chen LJ, 2005, TOXICOL SCI, V83, P372, DOI 10.1093/toxsci/kfi019; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Dahlmann B, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S3; Imai K, 2005, EUR RESPIR J, V25, P250, DOI 10.1183/09031936.05.00023704; Löw Peter, 2011, Gen Comp Endocrinol, V172, P39, DOI 10.1016/j.ygcen.2011.02.005; Park JW, 2013, EUR J PHARMACOL, V706, P76, DOI 10.1016/j.ejphar.2013.02.049; Park Jeong-Woong, 2007, COPD, V4, P347, DOI 10.1080/15412550701603775; Poppek D, 2006, ANTIOXID REDOX SIGN, V8, P173, DOI 10.1089/ars.2006.8.173; Sakao S, 2003, CHEST, V124, P323, DOI 10.1378/chest.124.1.323; Yoshiyama S, 2011, J PHARMACOL SCI, V115, P532, DOI 10.1254/jphs.10283SC; Zaman F, 2007, CANCER RES, V67, P10078, DOI 10.1158/0008-5472.CAN-06-3982; Zavitz CCJ, 2008, CELL IMMUNOL, V253, P38, DOI 10.1016/j.cellimm.2008.04.012	66	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0023-6837	1530-0307		LAB INVEST	Lab. Invest.	JUN	2015	95	6					625	634		10.1038/labinvest.2015.43		10	Medicine, Research & Experimental; Pathology	Research & Experimental Medicine; Pathology	CJ0DZ	WOS:000355145600005		
J	Lin, NU; Lee, EQ; Aoyama, H; Barani, IJ; Barboriak, DP; Baumert, BG; Bendszus, M; Brown, PD; Camidge, DR; Chang, SM; Dancey, J; de Vries, EGE; Gaspar, LE; Harris, GJ; Hodi, FS; Kalkanis, SN; Linskey, ME; Macdonald, DR; Margolin, K; Mehta, MP; Schiff, D; Soffietti, R; Suh, JH; van den Bent, MJ; Vogelbaum, MA; Wen, PY				Lin, Nancy U.; Lee, Eudocia Q.; Aoyama, Hidefumi; Barani, Igor J.; Barboriak, Daniel P.; Baumert, Brigitta G.; Bendszus, Martin; Brown, Paul D.; Camidge, D. Ross; Chang, Susan M.; Dancey, Janet; de Vries, Elisabeth G. E.; Gaspar, Laurie E.; Harris, Gordon J.; Hodi, F. Stephen; Kalkanis, Steven N.; Linskey, Mark E.; Macdonald, David R.; Margolin, Kim; Mehta, Minesh P.; Schiff, David; Soffietti, Riccardo; Suh, John H.; van den Bent, Martin J.; Vogelbaum, Michael A.; Wen, Patrick Y.		Response Assessment Neuro-Oncology	Response assessment criteria for brain metastases: proposal from the RANO group	LANCET ONCOLOGY			English	Review							GAMMA-KNIFE RADIOSURGERY; VOLUMETRIC DATA ERRORS; SOLID TUMORS; CLINICAL-TRIALS; BREAST-CANCER; PHASE-II; GUIDELINES; MR	CNS metastases are the most common cause of malignant brain tumours in adults. Historically, patients with brain metastases have been excluded from most clinical trials, but their inclusion is now becoming more common. The medical literature is difficult to interpret because of substantial variation in the response and progression criteria used across clinical trials. The Response Assessment in Neuro-Oncology Brain Metastases (RANO-BM) working group is an international, multidisciplinary effort to develop standard response and progression criteria for use in clinical trials of treatment for brain metastases. Previous efforts have focused on aspects of trial design, such as patient population, variations in existing response and progression criteria, and challenges when incorporating neurological, neuro-cognitive, and quality-of-life endpoints into trials of patients with brain metastases. Here, we present our recommendations for standard response and progression criteria for the assessment of brain metastases in clinical trials. The proposed criteria will hopefully facilitate the development of novel approaches to this difficult problem by providing more uniformity in the assessment of CNS metastases across trials.	[Lin, Nancy U.; Hodi, F. Stephen] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Lee, Eudocia Q.; Wen, Patrick Y.] Dana Farber Canc Inst, Ctr Neurooncol, Boston, MA 02215 USA; [Aoyama, Hidefumi] Niigata Univ, Grad Sch Med & Dent Sci, Dept Radiol, Chuo Ku, Niigata, Japan; [Barani, Igor J.] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [Barboriak, Daniel P.] Duke Univ, Med Ctr, Dept Radiol, Durham, NC 27710 USA; [Baumert, Brigitta G.] MediClin Robert Janker Clin, Dept Radiat Oncol, Bonn, Germany; [Baumert, Brigitta G.] Univ Bonn, Med Ctr, Cooperat Unit Neurooncol, Bonn, Germany; [Bendszus, Martin] Heidelberg Univ, Dept Neuroradiol, Heidelberg, Germany; [Brown, Paul D.] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA; [Camidge, D. Ross] Univ Colorado, Sch Med, Div Med Oncol, Denver, CO USA; [Chang, Susan M.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA USA; [Dancey, Janet] Queens Univ, Ontario Inst Canc Res, NCIC Clin Trials Grp, Kingston, ON, Canada; [de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands; [Gaspar, Laurie E.] Univ Colorado Denver, Dept Radiat Oncol, Aurora, CO USA; [Harris, Gordon J.] Massachusetts Gen Hosp, MGH Imaging Lab 3D, Boston, MA 02114 USA; [Kalkanis, Steven N.] Henry Ford Hlth Syst, Dept Neurosurg, Detroit, MI USA; [Linskey, Mark E.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA USA; [Linskey, Mark E.] UC Irvine Med Ctr, Orange, CA USA; [Macdonald, David R.] Univ Western Ontario, Dept Oncol, London Reg Canc Program, London Hlth Sci Ctr, London, ON, Canada; [Margolin, Kim] Stanford Univ, Div Oncol, Stanford, CA 94305 USA; [Mehta, Minesh P.] Univ Maryland, Sch Med, Maryland Proton Treatment Ctr, Baltimore, MA USA; [Schiff, David] Univ Virginia, Div Neurooncol, Charlottesville, VA USA; [Soffietti, Riccardo] Univ Turin, Dept Neurol Neurooncol, Turin, Italy; [Suh, John H.] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Dept Radiat Oncol T28, Cleveland, OH 44106 USA; [Vogelbaum, Michael A.] Cleveland Clin, Rose Ella Burkhardt Brain Tumor & Neurooncol Ctr, Dept Neurosurg ND40, Cleveland, OH 44106 USA; [van den Bent, Martin J.] Erasmus Univ, Med Ctr, Dr Daniel Den Hoed Canc Ctr, Neurooncol Unit, Rotterdam, Netherlands	Lin, NU (reprint author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.	nlin@partners.org			Breast Cancer Research Foundation	We thank Patricia Cortazar, Suzanne Demko, Ruthann Giusti, Patricia Keegan, and Richard Pazdur from the US Food and Drug Administration for their feedback regarding these proposed radiographic criteria. This work was supported in part by the Breast Cancer Research Foundation (grant to NUL), but this support did not directly influence the writing of this manuscript or the decision to submit it for publication.	American Cancer Society, 2007, CANC FACTS FIG; Pan HC, 2007, STEREOT FUNCT NEUROS, V85, P184, DOI 10.1159/000101297; Schellinger PD, 1999, J NEURO-ONCOL, V44, P275, DOI 10.1023/A:1006308808769; MACDONALD DR, 1990, J CLIN ONCOL, V8, P1277; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Harris GJ, 2008, NEUROSURGERY, V62, P1314, DOI [10.1227/01.neu.0000333303.79931.83, 10.1227/01.NEU.0000316858.25606.8F]; Wolchok JD, 2009, CLIN CANCER RES, V15, P7412, DOI 10.1158/1078-0432.CCR-09-1624; Shah R, 2012, RADIOGRAPHICS, V32, P1343, DOI 10.1148/rg.325125002; Yang DY, 2009, STEREOT FUNCT NEUROS, V87, P1, DOI 10.1159/000177622; Patel TR, 2011, AM J NEURORADIOL, V32, P1885, DOI 10.3174/ajnr.A2668; Lin NU, 2009, CLIN CANCER RES, V15, P1452, DOI 10.1158/1078-0432.CCR-08-1080; MILLER AB, 1981, CANCER, V47, P207, DOI 10.1002/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6; Hudis CA, 2007, J CLIN ONCOL, V25, P2127, DOI 10.1200/JCO.2006.10.3523; Davis FG, 2012, NEURO-ONCOLOGY, V14, P1171, DOI 10.1093/neuonc/nos152; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Bauknecht HC, 2010, INVEST RADIOL, V45, P49, DOI 10.1097/RLI.0b013e3181c02ed5; Lin NU, 2013, LANCET ONCOL, V14, pE407, DOI 10.1016/S1470-2045(13)70308-5; Lin NU, 2013, LANCET ONCOL, V14, pE396, DOI 10.1016/S1470-2045(13)70311-5; SZE G, 1990, AM J NEURORADIOL, V11, P785; Sze G, 2001, P AM SOC CLIN ONCO S, V20; van der Weide HL, 2011, STRAHLENTHER ONKOL, V187, P523	22	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1470-2045	1474-5488		LANCET ONCOL	Lancet Oncol.	JUN	2015	16	6					E270	E278				9	Oncology	Oncology	CJ1MB	WOS:000355246600024		
J	Okamura, M; Sekine, M; Ikeda, S; Kanesue, T; Kumaki, M; Fuwa, Y				Okamura, Masahiro; Sekine, Megumi; Ikeda, Shunsuke; Kanesue, Takeshi; Kumaki, Masafumi; Fuwa, Yasuhiro			Preliminary result of rapid solenoid for controlling heavy-ion beam parameters of laser ion source	LASER AND PARTICLE BEAMS			English	Article						Emittance; Heavy-ion fusion; Inertial confinement fusion; Laser ion source	INERTIAL FUSION; ABLATION; PLASMA	To realize a heavy-ion inertial fusion (HIF) driver, we have studied a possibility of laser ion source (LIS). A LIS can provide high-current high-brightness heavy-ion beams; however, it was difficult to manipulate the beam parameters. To overcome the issue, we employed a pulsed solenoid in the plasma drift section and investigated the effect of the solenoid field on singly charged iron beams. The rapid ramping magnetic field could enhance limited time slice of the current and simultaneously the beam emittance changed accordingly. This approach may also be useful to realize an ion source for HIF power plant.	[Okamura, Masahiro; Kanesue, Takeshi] Brookhaven Natl Lab, Upton, NY 11973 USA; [Sekine, Megumi] Tokyo Inst Technol, Tokyo, Japan; [Sekine, Megumi; Ikeda, Shunsuke; Kumaki, Masafumi; Fuwa, Yasuhiro] RIKEN, Saitama, Japan; [Ikeda, Shunsuke] Tokyo Inst Technol, Knagawa, Japan; [Kumaki, Masafumi] Waseda Univ, Tokyo, Japan; [Fuwa, Yasuhiro] Kyoto Univ, Kyoto, Japan	Okamura, M (reprint author), Brookhaven Natl Lab, Upton, NY 11973 USA.	oka-mura@bnl.gov			NASA; DOE of the USA; JRA system from RIKEN of the Japan	This research was supported by NASA, DOE of the USA, JRA system from RIKEN of the Japan, and their supports are gratefully acknowledged.	Alessi JG, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3292937; Okamura M, 2014, NUCL INSTRUM METH A, V733, P97, DOI 10.1016/j.nima.2013.10.026; Benilov MS, 2009, PLASMA SOURCES SCI T, V18, DOI 10.1088/0963-0252/18/1/014005; Esposito M, 2010, J OPTOELECTRON ADV M, V12, P677; Haseroth H., 1996, LASER PART BEAMS, V14, P339; Hora H, 2004, LASER PART BEAMS, V22, P439, DOI 10.1017/S0263034604223242; Kanesue T., 2014, P IPAC2014; Kondo K, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3675388; Takahashi K, 2013, AIP CONF PROC, V1525, P241, DOI 10.1063/1.4802327	9	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	JUN	2015	33	2					137	141		10.1017/S026303461500004X		5	Physics, Applied	Physics	CJ1ZV	WOS:000355284700001		
J	Nakamura, T; Hayakawa, T				Nakamura, Tatsufumi; Hayakawa, Takehito			Numerical modeling of quantum beam generation from ultra-intense laser-matter interactions	LASER AND PARTICLE BEAMS			English	Article						Gamma-ray transport; Intense laser; Particle-in-Cell simulation; Quantum beam generation	PULSES; RADIATION; ELECTRONS	When intense laser beams interact with solid targets, high-energy photons are effectively generated via radiation reaction effect. These photons receive a large portion of the incident laser energy, and the energy transport by photons through the target is crucial for the understanding of the laser-matter interactions. In order to understand the energy transport, we newly developed a Particle-in-Cell code which includes the photon-matter interactions by introducing photon macro-particles. Test simulations are performed and compared with simulations using a particle transport code, which shows a good agreement.	[Nakamura, Tatsufumi] Fukuoka Inst Technol, Fukuoka 8110295, Japan; [Hayakawa, Takehito] Japan Atom Energy Agcy, Tokai, Ibaraki, Japan	Nakamura, T (reprint author), Fukuoka Inst Technol, Fukuoka 8110295, Japan.	t-nakamura@fit.ac.jp	Hayakawa, Takehito/K-8478-2015		KAKENHI [25400540]; HPIC System Research Project [hp120037, hp140122]	Authors thank Drs S. Bulanov, T. Esikepov, M, Kando, and J. Koga for discussions. This work is partially supported by KAKENHI (grant no. 25400540). This research used computational resources of the K computer and other computers of the HPCI system provided by the AICS and through the HPIC System Research Project (Project ID: hp120037, hp140122).	Nakamura T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.195001; Ridgers CP, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.165006; MURNANE MM, 1991, SCIENCE, V251, P531, DOI 10.1126/science.251.4993.531; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Zhidkov A, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.185002; Naumova N, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.025002; Hatchett SP, 2000, PHYS PLASMAS, V7, P2076, DOI 10.1063/1.874030; TABAK M, 1994, PHYS PLASMAS, V1, P1626, DOI 10.1063/1.870664; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; Bethe H, 1934, P R SOC LOND A-CONTA, V146, P0083, DOI 10.1098/rspa.1934.0140; Remington BA, 1999, SCIENCE, V284, P1488, DOI 10.1126/science.284.5419.1488; Tamburini M, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/12/123005; Klein O, 1929, Z PHYS, V52, P853, DOI 10.1007/BF01366453; Landau L. D., 1975, CLASSICAL THEORY FIE; Langdon A.B., 1985, PLASMA PHYS VIA COMP; Nakamura T, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3507294; Weinberg S, 1995, QUANTUM THEORY FIELD, V1	17	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	JUN	2015	33	2					151	155		10.1017/S0263034615000269		5	Physics, Applied	Physics	CJ1ZV	WOS:000355284700003		
J	Hayashi, R; Ito, T; Tamura, F; Kudo, T; Takakura, N; Kashine, K; Takahashi, K; Sasaki, T; Kikuchi, T; Harada, N; Jiang, W; Tokuchi, A				Hayashi, Ryota; Ito, Tomoaki; Tamura, Fumihiro; Kudo, Takahiro; Takakura, Naoto; Kashine, Kenji; Takahashi, Kazumasa; Sasaki, Toru; Kikuchi, Takashi; Harada, Nob; Jiang, Weihua; Tokuchi, Akira			Impedance control using electron beam diode in intense pulsed-power generator	LASER AND PARTICLE BEAMS			English	Article						Electron beam diode; Inertial confinement fusion; Impedance control; Pulsed-power generator; Warm dense matter	WARM-DENSE-MATTER; HIGH-ENERGY DENSITY; LIGHT-ION-BEAM; HEAVY-ION; PLASMAS; TARGETS; DISCHARGES; PRESSURE; ABLATION	To control an input energy for a load, an impedance control with a gap distance of an electron beam diode was studied using an intense pulsed-power generator. The output current of the pulsed-power generator as a function of the gap distance of electron beam diode was measured. It indicated that the behaviors of the experimentally obtained peak current and the theoretically obtained space-charge limited current were found to decrease with an increase in the gap distance. The input energy for the load was estimated from the output current, which decreased with an increase in the gap distance. It also revealed the space-charge limited current suppresses the input energy for the load with a decade.	[Hayashi, Ryota] Nagaoka Univ Technol, Dept Energy & Environm Sci, Nagaoka, Niigata 9402188, Japan; [Ito, Tomoaki; Tamura, Fumihiro; Kudo, Takahiro; Takakura, Naoto; Takahashi, Kazumasa; Sasaki, Toru; Kikuchi, Takashi; Harada, Nob] Nagaoka Univ Technol, Dept Elect Engn, Nagaoka, Niigata 9402188, Japan; [Kashine, Kenji] Kagoshima Coll, Natl Inst Technol, Dept Elect & Elect Engn, Kirishima, Japan; [Kikuchi, Takashi] Nagaoka Univ Technol, Dept Nucl Syst Safety Engn, Nagaoka, Niigata 9402188, Japan; [Jiang, Weihua; Tokuchi, Akira] Nagaoka Univ Technol, Extreme Energy Dens Res Inst, Nagaoka, Niigata 9402188, Japan; [Tokuchi, Akira] Pulsed Power Japan Lab Ltd, Kusatsu, Japan	Hayashi, R (reprint author), Nagaoka Univ Technol, Nagaoka, Niigata 9402188, Japan.	r_hayashi@stn.nagaokaut.ac.jp			MEXT; Program for High Reliable Materials Design and Manufacturing in Nagaoka University of Technology; JSPS [25630418]	This work was supported by MEXT Grant-in-Aid for Scientific Research, and by Program for High Reliable Materials Design and Manufacturing in Nagaoka University of Technology, and by JSPS Grant-in-Aid for Challenging Exploratory Research No. 25630418.	Abdullin EN, 2013, LASER PART BEAMS, V31, P697, DOI 10.1017/S026303461300075X; Amano Y, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4742986; Devyatkov VN, 2003, LASER PART BEAMS, V21, P243, DOI 10.1017/S026303460321212X; Yatsui K, 1997, JPN J APPL PHYS 1, V36, P4928, DOI 10.1143/JJAP.36.4928; Tarasenko VF, 2005, LASER PART BEAMS, V23, P545, DOI 10.1017/S0263034605050731; YATSUI K, 1985, LASER PART BEAMS, V3, P119; Ng A, 2005, LASER PART BEAMS, V23, P527, DOI 10.1017/S0263034605050718; Clerouin J, 2012, PHYS PLASMAS, V19, DOI 10.1063/1.4742317; Glenzer SH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.065002; Saleem S, 2001, PHYS REV E, V64, part. no., DOI 10.1103/PhysRevE.64.056403; Hoffmann DHH, 2005, LASER PART BEAMS, V23, P47, DOI 10.1017/S026303460505010X; Atzeni S., 2004, PHYS INERTIAL FUSION, P302; Constantin C, 2004, LASER PART BEAMS, V22, P59, DOI 10.1017/S0263034604221115; DESILVA AW, 1994, PHYS REV E, V49, P4448, DOI 10.1103/PhysRevE.49.4448; Dewald E, 2002, LASER PART BEAMS, V20, P399, DOI 10.1017/S0263034602203055; Drake RP, 2009, PHYS PLASMAS, V16, DOI 10.1063/1.3078101; Jiang W, 1998, NUCL INSTRUM METH A, V415, P533, DOI 10.1016/S0168-9002(98)00364-7; JIANG WH, 1993, JPN J APPL PHYS 2, V32, pL752, DOI 10.1143/JJAP.32.L752; Kashine K, 2002, JPN J APPL PHYS 1, V41, P4014, DOI 10.1143/JJAP.41.4014; Li LM, 2012, LASER PART BEAMS, V30, P541, DOI 10.1017/S0263034612000468; Miki Y, 2014, NUCL INSTRUM METH A, V733, P8, DOI 10.1016/j.nima.2013.05.103; Niu K., 1989, NUCL FUSION, P142; Niu K, 1997, LASER PART BEAMS, V15, P151; Redmer R, 2010, CONTRIB PLASM PHYS, V50, P970, DOI 10.1002/ctpp.201000079; Sasaki Toru, 2011, IOP Conference Series: Materials Science and Engineering, V21, DOI 10.1088/1757-899X/21/1/012016; Sasaki T, 2006, LASER PART BEAMS, V24, P371, DOI 10.1017/S0263034606060538; Sasaki T, 2014, NUCL INSTRUM METH A, V733, P28, DOI 10.1016/j.nima.2013.05.099; Yoneda H, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.075004	28	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	JUN	2015	33	2					163	167		10.1017/S0263034615000051		5	Physics, Applied	Physics	CJ1ZV	WOS:000355284700005		
J	Liu, X; Yoshimoto, T; Takayama, K; Adachi, T; Kadokura, E; Munemoto, N; Takano, S; Kawakubo, T; Okamura, K; Kobayashi, H; Hirose, M				Liu, X.; Yoshimoto, T.; Takayama, K.; Adachi, T.; Kadokura, E.; Munemoto, N.; Takano, S.; Kawakubo, T.; Okamura, K.; Kobayashi, H.; Hirose, M.			Injection and induction acceleration of Ar3+ in the KEK Digital Accelerator	LASER AND PARTICLE BEAMS			English	Article						Beam manipulation; Heavy-ion acceleration; Induction synchrotron	INERTIAL FUSION	Four microseconds long Ar3+ beam with injection energy of 15keV/u has been injected into the Digital Accelerator of the High-Energy Accelerator Research Organization. Beam production, transportation, and injection are described as well as machine properties. Results of a free running experiment under static magnetic field and longitudinal confinement and acceleration under a fast ramping magnetic field are presented in detail with a brief discussion on the beam lifetime.	[Liu, X.; Yoshimoto, T.; Takayama, K.; Munemoto, N.] Tokyo Inst Technol, Yokohama, Kanagawa 227, Japan; [Liu, X.; Yoshimoto, T.; Takayama, K.; Adachi, T.; Kadokura, E.; Munemoto, N.; Takano, S.; Kawakubo, T.; Okamura, K.] High Energy Accelerator Res Org KEK, Tsukuba, Ibaraki 3050801, Japan; [Takayama, K.; Adachi, T.; Okamura, K.] Grad Univ Adv Studies, Miura, Kanagawa, Japan; [Kobayashi, H.; Hirose, M.] Tokyo City Univ, Setagaya Ku, Tokyo, Japan	Liu, X (reprint author), High Energy Accelerator Res Org KEK, Oho 1-1, Tsukuba, Ibaraki 3050801, Japan.	liuxg@post.kek.jp					Adachi T, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.053501; Adachi T, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3626932; BANGERTER RO, 1993, NUOVO CIMENTO A, V106, P1445, DOI 10.1007/BF02821239; Dixit TS, 2009, NUCL INSTRUM METH A, V602, P326, DOI 10.1016/j.nima.2009.01.023; Friedman A, 2010, PHYS PLASMAS, V17, DOI 10.1063/1.3292634; Hofmann I, 1998, NUCL INSTRUM METH A, V415, P11, DOI 10.1016/S0168-9002(98)00512-9; Iwashita T, 2011, PHYS REV SPEC TOP-AC, V14, DOI 10.1103/PhysRevSTAB.14.071301; Leo KW, 2013, PHYS REV SPEC TOP-AC, V16, DOI 10.1103/PhysRevSTAB.16.043502; Liu X., 2011, REC PROGR IND ACC CH; Munemoto N, 2014, REV SCI INSTRUM, V85, DOI 10.1063/1.4862211; Takayama K, 2000, NUCL INSTRUM METH A, V451, P304, DOI 10.1016/S0168-9002(00)00557-X; Takayama K., 2013, J PLASMA FUSION RES, V89, P102; Takayama K, 2014, PHYS REV SPEC TOP-AC, V17, DOI 10.1103/PhysRevSTAB.17.010101; Takayama K, 2007, J APPL PHYS, V101, DOI 10.1063/1.2697259; Wake M, 2007, 2007 IEEE Particle Accelerator Conference, DOI 10.1109/PAC.2007.4440175; Waldron WL, 2014, NUCL INSTRUM METH A, V733, P226, DOI 10.1016/j.nima.2013.05.063; Yoshimoto T, 2014, NUCL INSTRUM METH A, V733, P141, DOI 10.1016/j.nima.2013.05.082	17	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	JUN	2015	33	2					237	243		10.1017/S0263034615000038		7	Physics, Applied	Physics	CJ1ZV	WOS:000355284700014		
J	Koester, P; Bussolino, GC; Cristoforetti, G; Faenov, A; Giulietti, A; Giulietti, D; Labate, L; Levato, T; Pikuz, T; Gizzi, LA				Koester, P.; Bussolino, G. C.; Cristoforetti, G.; Faenov, A.; Giulietti, A.; Giulietti, D.; Labate, L.; Levato, T.; Pikuz, T.; Gizzi, L. A.			High-charge divergent electron beam generation from high-intensity laser interaction with a gas-cluster target	LASER AND PARTICLE BEAMS			English	Article						Electron acceleration; Clusters; Femtosecond lasers; Electron radiography	PLASMA ACCELERATION; X-RAYS; PULSE; RADIOGRAPHY; IONS; AR; SUPERINTENSE; IRRADIATION; EXPANSION; SPECTRA	We report on an experimental study on the interaction of a high-contrast 40 fs duration 2 TW laser pulse with an argon-cluster target. A high-charge, homogeneous, large divergence electron beam with moderate kinetic energy (similar to 2 MeV) is observed in the forward direction. The results show that an electron beam with a charge as high as 12 nC can be obtained using a table-top laser system. It was demonstrated that the accelerated electron beam is suitable for a variety of applications such as micro-radiography of thin samples in a wide field of view. It can also be applied for in vitro dosimetry studies.	[Koester, P.; Bussolino, G. C.; Cristoforetti, G.; Giulietti, A.; Labate, L.; Levato, T.; Gizzi, L. A.] CNR, Ist Nazl Ott, Intense Laser Irradiat Lab, Pisa, Italy; [Faenov, A.; Pikuz, T.] Russian Acad Sci, Joint Inst High Temp, Moscow, Russia; [Faenov, A.] Osaka Univ, Inst Acad Initiat, Div Photon Sci & Technol, Osaka, Japan; [Pikuz, T.] Osaka Univ, Grad Sch Engn, Osaka, Japan; [Giulietti, D.] Univ Pisa, Dipartimento Fis, Pisa, Italy; [Giulietti, D.; Labate, L.; Gizzi, L. A.] Ist Nazl Fis Nucl, Sez Pisa, Pisa, Italy; [Levato, T.] Fyzikalni Ustav AV CR Vvi, Prague, Czech Republic	Koester, P (reprint author), CNR, Ist Nazl Ott, Via Moruzzi 1, I-56124 Pisa, Italy.	petra.koester@ino.it		Gizzi, Leonida A./0000-0001-6572-6492; CRISTOFORETTI, GABRIELE/0000-0001-9420-9080	RFBR [14-22-02089, 14-02-91171-GFEN_a]; Italian Ministry of Health [GR-2009-1608935]	The work of A. Faenov and T. Pikuz was partially supported by the RFBR projects 14-22-02089 and 14-02-91171-GFEN_a. The activity of the INO-CNR Pisa group was partially supported from the Italian Ministry of Health through the Project No. GR-2009-1608935 ("Study of Radiobiological and Radiotherapic Effects of a Novel Laser-Driven Electron Accelerator", D.I. AgeNaS).	Abdallah J, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.032706; Kishimoto Y, 2002, PHYS PLASMAS, V9, P589, DOI 10.1063/1.1418433; Sherrill ME, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.066404; Hayashi Y, 2011, OPT LETT, V36, P1614, DOI 10.1364/OL.36.001614; Jinno S, 2013, OPT EXPRESS, V21, P20656, DOI 10.1364/OE.21.020656; Gahn C, 1999, PHYS REV LETT, V83, P4772, DOI 10.1103/PhysRevLett.83.4772; Tajima T, 1999, PHYS PLASMAS, V6, P3759, DOI 10.1063/1.873638; TAJIMA T, 1979, PHYS REV LETT, V43, P267, DOI 10.1103/PhysRevLett.43.267; Zhang L, 2011, OPT EXPRESS, V19, P25812, DOI 10.1364/OE.19.025812; Colgan J, 2011, HIGH ENERG DENS PHYS, V7, P77, DOI 10.1016/j.hedp.2011.01.004; Colgan J, 2008, LASER PART BEAMS, V26, P83, DOI 10.1017/S0263034608000116; Schumaker W, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.015003; Malka V, 2002, SCIENCE, V298, P1596, DOI 10.1126/science.1076782; Boldarev AS, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2336105; Bussolino GC, 2013, J PHYS D APPL PHYS, V46, DOI 10.1088/0022-3727/46/24/245501; Chair A. N. R., 1998, MED PHYS, V25, P2093, DOI 10.1118/1.5984079829234; Chen LM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01912; Faenov AY, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3210785; Faenov AY, 2008, LASER PART BEAMS, V26, P69, DOI 10.1017/S0263034608000104; Faenov AY, 2013, CONTRIB PLASM PHYS, V53, P148, DOI 10.1002/ctpp.201310027; Faenov AY, 2012, LASER PART BEAMS, V30, P481, DOI 10.1017/S0263034612000419; Fukuda Y, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.165002; Fukuda Y, 2004, LASER PART BEAMS, V22, P215, DOI 10.1017/S0263034604223047; Fukuda Y, 2007, PHYS LETT A, V363, P130, DOI 10.1016/j.physleta.2006.12.061; Gavrilenko VP, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.013203; Giulietti D, 2010, SPRINGER SER CHEM PH, V98, P165; Kim K. Y., 2006, PHYS REV E, V78; Kishimoto Y, 2000, HIGH-FIELD SCIENCE, P83; Kugland NL, 2008, REV SCI INSTRUM, V79, DOI 10.1063/1.2955709; Kugland NL, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945795; Magunov AI, 2003, LASER PART BEAMS, V21, P73, DOI 10.1017/S0263034603211149; Magunov AI, 2001, JETP LETT+, V74, P375, DOI 10.1134/1.1427125; Mangles SPD, 2006, LASER PART BEAMS, V24, P185, DOI 10.1017/S0263034606050373; Mangles SPD, 2012, PHYS REV SPEC TOP-AC, V15, DOI 10.1103/PhysRevSTAB.15.011302; Merrill F, 2007, NUCL INSTRUM METH B, V261, P382, DOI 10.1016/j.nimb.2007.04.127; MODENA A, 1995, NATURE, V377, P606, DOI 10.1038/377606a0; Najmudin Z, 2003, PHYS PLASMAS, V10, P2071, DOI 10.1063/1.1564083; Sakabe S, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.023203; Serbanescu CG, 2006, APPL PHYS B-LASERS O, V83, P521, DOI 10.1007/s00340-006-2228-8; Zhang L, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3673911	40	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0263-0346	1469-803X		LASER PART BEAMS	Laser Part. Beams	JUN	2015	33	2					331	338		10.1017/S0263034615000014		8	Physics, Applied	Physics	CJ1ZV	WOS:000355284700025		
J	Funaki, T; Shoji, K; Miyata, I; Sakamoto, S; Kasahara, M; Yoshii, H; Miyairi, I; Saitoh, A				Funaki, Takanori; Shoji, Kensuke; Miyata, Ippei; Sakamoto, Seisuke; Kasahara, Mureo; Yoshii, Hironori; Miyairi, Isao; Saitoh, Akihiko			Serostatus following live attenuated vaccination administered before pediatric liver transplantation	LIVER TRANSPLANTATION			English	Article							IMMUNIZATION PROGRAM; SAFE IMMUNIZATIONS; VARICELLA VACCINE; HUMORAL IMMUNITY; RECIPIENTS; CHILDREN; ANTIGENS; FAILURE; MEASLES; LEPTIN	After liver transplantation (LT), live attenuated vaccines (LAVs) are generally contraindicated. LAVs are recommended before LT for patients6 months of age. However, the evidence supporting this practice is limited. Patients were enrolled before and after LT. Clinical data for patients were obtained from medical records. Serum antibody titers were evaluated at the time of enrollment and prospectively. Serum antibody titers were measured with a hemagglutination inhibition test for measles and rubella and with an enzyme-linked immunosorbent assay for varicella and mumps. Univariate and multivariate analyses were performed to investigate the factors that affect the serostatus. Serological analyses of 49 patients immunized before LT (median age, 45 months; male, 35%) were performed. Underlying diseases were biliary atresia (n=27; 55%), metabolic diseases (n=13; 27%), fulminant hepatic failure (n=5; 10%), and others (n=4; 8%). The seropositivity rate after each vaccine was 46.9% (measles), 89.4% (rubella), 67.5% (varicella), and 48.8% (mumps). Factors independently associated with seronegativity were a vaccination age<12 months for measles (P=.002), a lower body weight for varicella (P=0.01), and underlying diseases other than biliary atresia for mumps (P=.004). No serious adverse event was observed during the study period. The immunogenicity of LAVs before LT was high for rubella but low for the others. Before LT, further vaccination strategies are needed for patients. In addition, serological follow-up may be indicated for patients with factors associated with seronegativity. Liver Transpl 21:774-783, 2015. (c) 2015 AASLD.	[Funaki, Takanori; Shoji, Kensuke; Miyata, Ippei; Miyairi, Isao; Saitoh, Akihiko] Natl Ctr Child Hlth & Dev, Dept Med Subspecialties, Div Infect Dis, Tokyo, Japan; [Sakamoto, Seisuke; Kasahara, Mureo] Natl Ctr Child Hlth & Dev, Ctr Transplant Surg, Div Transplant Surg, Tokyo, Japan; [Yoshii, Hironori] Osaka Univ, Res Fdn Microbial Dis, Kanonj, Kagawa, Japan; [Saitoh, Akihiko] Niigata Univ, Grad Sch Med & Dent Sci, Dept Pediat, Niigata, Japan	Saitoh, A (reprint author), Niigata Grad Sch Med & Dent Sci, Dept Pediat, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	asaitoh@med.niigata-u.ac.jp			Ministry of Health, Labor, and Welfare of Japan [H25-Shinko-Ippan-009]	This study was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan (H25-Shinko-Ippan-009) awarded to Akihiko Saitoh.	Posfay-Barbe KM, 2012, AM J TRANSPLANT, V12, P2974, DOI 10.1111/j.1600-6143.2012.04273.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Galil K, 2002, J INFECT DIS, V186, P102, DOI 10.1086/341089; Saitoh A, 2014, VACCINE, V32, P4253, DOI 10.1016/j.vaccine.2014.06.022; Kano H, 2002, TRANSPLANTATION, V74, P543, DOI 10.1097/00007890-200208270-00020; Shinjoh M, 2008, VACCINE, V26, P6859, DOI 10.1016/j.vaccine.2008.09.076; Rubin LG, 2014, CLIN INFECT DIS, V58, pE44, DOI 10.1093/cid/cit684; Ahima RS, 1996, NATURE, V382, P250, DOI 10.1038/382250a0; Levin MJ, 2003, J INFECT DIS, V188, P1336, DOI 10.1086/379048; PROVOST PJ, 1991, VACCINE, V9, P111, DOI 10.1016/0264-410X(91)90266-9; KAPLAN LJ, 1992, JAMA-J AM MED ASSOC, V267, P1237, DOI 10.1001/jama.267.9.1237; Danzinger-Isakov L, 2009, AM J TRANSPLANT, V9, pS258, DOI 10.1111/j.1600-6143.2009.02917.x; Abuali MM, 2011, PEDIATR TRANSPLANT, V15, P770, DOI 10.1111/j.1399-3046.2011.01593.x; Matarese G, 2000, EUR CYTOKINE NETW, V11, P7; CHRISTADOSS P, 1984, CELL IMMUNOL, V88, P1, DOI 10.1016/0008-8749(84)90046-7; Donati M, 2000, TRANSPLANTATION, V70, P1401, DOI 10.1097/00007890-200011150-00023; Fabrizi F, 2012, DIGEST DIS SCI, V57, P1366, DOI 10.1007/s10620-011-1987-1; Japan Pediatric Society, MAIN CHARG VACC SCHE; Kasahara M, 2002, TRANSPLANTATION, V74, P1175, DOI 10.1097/01.TP.0000030636.35519.EA; Pandya A, 2001, PEDIATR TRANSPLANT, V5, P153, DOI 10.1034/j.1399-3046.2001.00048.x; Plotkin SA OW, 2012, VACCINES; Saitoh A, 2012, VACCINE, V30, P4752, DOI 10.1016/j.vaccine.2012.04.026; Shigeta T, 2014, PEDIATR TRANSPLANT, V18, P860, DOI 10.1111/petr.12373; Shinjoh M, 2015, VACCINE, V33, P701, DOI 10.1016/j.vaccine.2014.11.052; Wu JF, 2009, VACCINE, V27, P2812, DOI 10.1016/j.vaccine.2009.02.094	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1527-6465	1527-6473		LIVER TRANSPLANT	Liver Transplant.	JUN	2015	21	6					774	783		10.1002/lt.24104		10	Gastroenterology & Hepatology; Surgery; Transplantation	Gastroenterology & Hepatology; Surgery; Transplantation	CJ1GJ	WOS:000355231400008		
J	Khonyoung, D; Yamauchi, K; Suzuki, K				Khonyoung, D.; Yamauchi, K.; Suzuki, K.			Influence of dietary fat sources and lysolecithin on growth performance, visceral organ size, and histological intestinal alteration in broiler chickens	LIVESTOCK SCIENCE			English	Article						Lysolecithin; Intestinal alteration; Anti-cluster of differentiation 36; Broiler chicken; Fat sources	SEGMENTED FILAMENTOUS BACTERIA; MUCOSAL IMMUNE-SYSTEM; NUTRIENT DIGESTIBILITY; GASTROINTESTINAL-TRACT; EPITHELIAL-CELLS; ACID TRANSPORT; ABSORPTION; CD36; MICROFLORA; LIPIDS	The aim of this study was to investigate the influence of dietary fat sources and lysolecithin on growth performance, visceral organ size, and histological intestinal alterations in broiler chickens. Ninety-six 7-d-old male broiler chickens were assigned to 8 treatments in a 2 x 4 factorial arrangement of treatments with 2 levels of lysolecithin (0 and 145 mg/kg) and 4 different fat sources [poultry fat (PF), yellow grease from Kagoshima (YG1), yellow grease from Kashima (YG2), and yellow grease from Hachinohe (YG3)]. Each treatment had 4 replicates of 3 broiler chickens per cage until 49 d of age. There was no difference in BW gain due to fat sources, lysolecithin, or lysolecithin x fat source interaction throughout the experiment. By feeding lysolecithin, feed efficiency increased (P < 0.05) during the growth period of 7 to 21 d of age, and the weights of the duodenum, ileum, and total intestine decreased (P < 0.05). Intestinal villus height, villus area, and cell area were not different among treatment groups, except that ileal villus height tended to decrease and ileal cell area tended to increase (P=0.077) by feeding lysolecithin. Increased duodenal cell mitosis and decreased jejunal tunica muscularis thickness were observed (P < 0.05) by feeding lysolecithin. Furthermore, on the villus apical surface, more protuberated cells, cell clusters, and deeper cells at the sites of recently exfoliated cells were observed by feeding lysolecithin. However, the protuberant cells were not different among treatment groups. The Integrated Fluorescence Density Values of Anti-Cluster of Differentiation 36 reaction in the jejunum were significantly greater in the lysolecithin-fed groups, except YG2. These results indicate that feeding lysolecithin improves feed efficiency during 7 to 21 d of age regardless of the fat type, and causes epithelial hypertrophy. (C) 2015 Elsevier B.V. All rights reserved.	[Khonyoung, D.; Yamauchi, K.] Kagawa Univ, Fac Agr, Lab Anim Sci, Miki, Kagawa 7610795, Japan; [Suzuki, K.] Kemin Japan KK, Chiyoda Ku, Tokyo 1020076, Japan	Yamauchi, K (reprint author), Kagawa Univ, Fac Agr, Lab Anim Sci, Miki, Kagawa 7610795, Japan.	yamauchi@ag.kagawa-u.ac.jp					ALTMANN GG, 1970, AM J ANAT, V127, P15, DOI 10.1002/aja.1001270104; Febbraio M, 1999, J BIOL CHEM, V274, P19055, DOI 10.1074/jbc.274.27.19055; Tancharoenrat P, 2014, POULTRY SCI, V93, P371, DOI 10.3382/ps.2013-03344; Xing JJ, 2004, J ANIM SCI, V82, P2601; UMESAKI Y, 1995, MICROBIOL IMMUNOL, V39, P555; Talham GL, 1999, INFECT IMMUN, V67, P1992; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/h.gastro.2006.08.012; Uni Z, 2001, POULTRY SCI, V80, P438; Zhang BK, 2011, ANIM FEED SCI TECH, V163, P177, DOI 10.1016/j.anifeedsci.2010.10.004; Drover VA, 2005, J CLIN INVEST, V115, P1290, DOI 10.1172/JCI200521514; Chen M, 2001, AM J PHYSIOL-ENDOC M, V281, pE916; Van Leeuwen P, 2004, BRIT POULTRY SCI, V45, P41, DOI 10.1080/00071660410001668842; Iji PA, 2001, BRIT POULTRY SCI, V42, P505, DOI 10.1080/00071660120073151; Han YK, 2010, J ANIM VET ADV, V9, P2583; Potten CS, 1998, PHILOS T R SOC B, V353, P821, DOI 10.1098/rstb.1998.0246; Yamauchi KE, 2000, INFECT IMMUN, V68, P6496, DOI 10.1128/IAI.68.11.6496-6504.2000; Lobo MVT, 2001, J HISTOCHEM CYTOCHEM, V49, P1253; KLAASEN HLBM, 1993, INFECT IMMUN, V61, P303; KROGDAHL A, 1985, J NUTR, V115, P675; JONES DB, 1992, J ANIM SCI, V70, P3473; AOCS, 1998, OFFICIAL METHODS REC; FERNANDES J, 1962, J CLIN INVEST, V41, P488, DOI 10.1172/JCI104502; Firman J. D., 2008, International Journal of Poultry Science, V7, P1152; Guerreiro Neto A.C., 2011, REV BRAS CIENC AVICO, V13, P119; IMONDI AR, 1965, POULTRY SCI, V44, P916; IMONDI AR, 1966, POULTRY SCI, V45, P142; Isshiki Y., 1989, ANIM SCI J, V60, P1082; Lokaewmanee K, 2013, J ANIM PHYSIOL AN N, V97, P986, DOI 10.1111/jpn.12011; Maisonnier S, 2003, POULTRY SCI, V82, P805; Maneewan B., 2003, POULTRY SCI, V40, P254; Melegy T, 2010, AFR J AGR RES, V5, P2886; OUART MD, 1992, POULTRY SCI, V71, P821; Poirier H, 1996, EUR J BIOCHEM, V238, P368, DOI 10.1111/j.1432-1033.1996.0368z.x; Poirier H, 2001, BIOCHEM J, V355, P481, DOI 10.1042/0264-6021:3550481; ROLLS BA, 1978, BRIT J NUTR, V39, P91, DOI 10.1079/BJN19780015; Roy A. V., 2010, VET MED INT, V2010; Ruttanavut J, 2012, HISTOL HISTOPATHOL, V27, P1333; Sukhotnik I, 2001, PEDIATR SURG INT, V17, P259, DOI 10.1007/s003830100590; Tarachai P, 2000, POULTRY SCI, V79, P1578; VANNIEUWENHUYZEN W, 1981, J AM OIL CHEM SOC, V58, P886; Xie P, 2012, POULTRY SCI, V91, P1670, DOI 10.3382/ps.2011-02097; Yamauchi K, 2007, ANIM SCI J, V78, P356, DOI 10.1111/j.1740-0929.2007.00448.x; Yamauchi KE, 2010, ANAT REC, V293, P2071, DOI 10.1002/ar.21268	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1871-1413	1878-0490		LIVEST SCI	Livest. Sci.	JUN	2015	176						111	120		10.1016/j.livsci.2015.03.011		10	Agriculture, Dairy & Animal Science	Agriculture	CJ3EC	WOS:000355365200013		
J	Hirawatari, K; Hanzawa, N; Miura, I; Wakana, S; Gotoh, H				Hirawatari, Keitaro; Hanzawa, Naoto; Miura, Ikuo; Wakana, Shigeharu; Gotoh, Hideo			A Cascade of epistatic interactions regulating teratozoospermia in mice	MAMMALIAN GENOME			English	Article							SPERM MORPHOLOGY; MOUSE STRAIN; FERTILITY; TESTS	Infertility in humans and subfertility in domestic animals are two major reproductive problems. Among human couples, 15 % are diagnosed as infertile, and males are considered responsible in about 50 % of the cases. To examine male fertility, various sperm tests including analyses of sperm morphology, sperm count and sperm mobility are usually performed. Teratozoospermia, a condition characterized by the presence of morphologically abnormal sperm, is considered as a symptom of infertility. B10.MOL-TEN1 (TEN1) mice (Mus musculus) show inherited teratozoospermia at high frequencies (50 %). In this study, the polygenic control of teratozoospermia in the TEN1 strain was analysed. A quantitative trait loci analysis indicated three statistically significant loci, Sperm-head morphology 3 (Shm3; logarithm of the odds (LOD) score, 29.25), Shm4 (LOD score, 6.80), and Shm5 (LOD score, 3.58). These three QTL peaks were mapped to 24.3 centimorgans (cM) on chromosome 1, 32.0 cM on chromosome X, and 63.8 cM on chromosome 6, respectively. Another locus that is yet to be determined was also predicted. Shm3 was found to be the major locus responsible for teratozoospermia, and a sequential cascade of interactions of the other three loci was apparent. These results are expected to help understand the mechanisms underlying reproductive problems in humans or domestic animals.	[Hirawatari, Keitaro; Gotoh, Hideo] Natl Inst Agrobiol Sci, Agrogen Res Ctr, Anim Genome Res Unit, Tsukuba, Ibaraki 3058634, Japan; [Hirawatari, Keitaro; Hanzawa, Naoto] Yamagata Univ, Grad Sch Sci & Engn, Yamagata 9908560, Japan; [Miura, Ikuo; Wakana, Shigeharu] RIKEN BioResource Ctr, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki 3050074, Japan	Gotoh, H (reprint author), Natl Inst Agrobiol Sci, Agrogen Res Ctr, Anim Genome Res Unit, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	gotoh@affrc.go.jp			Ministry of Agriculture, Forestry, and Fisheries, Japan	The authors acknowledge the assistance of Mr. Heiichi Uchiyama with the experiments. We thank Dr. Shiroishi for providing the B10.MOL-TEN1 mouse strain. This work was supported by the Ministry of Agriculture, Forestry, and Fisheries, Japan.	Vyskocilova M, 2009, MAMM GENOME, V20, P83, DOI 10.1007/s00335-008-9164-3; Jamsai D, 2011, ASIAN J ANDROL, V13, P139, DOI 10.1038/aja.2010.101; Matzuk MM, 2008, NAT MED, V14, P1197, DOI 10.1038/nm.f.1895; Massart A, 2012, ASIAN J ANDROL, V14, P40, DOI 10.1038/aja.2011.67; Guzick DS, 2001, NEW ENGL J MED, V345, P1388, DOI 10.1056/NEJMoa003005; Storchova R, 2004, MAMM GENOME, V15, P515, DOI 10.1007/s00335-004-2386-0; Lewis SEM, 2007, REPRODUCTION, V134, P31, DOI 10.1530/REP-07-0152; Lucy MC, 2001, J DAIRY SCI, V84, P1277; Gotoh H, 2010, REPROD FERT DEVELOP, V22, P1066, DOI 10.1071/RD09295; Aitken RJ, 2006, INT J ANDROL, V29, P69, DOI 10.1111/j.1365-2605.2005.00630.x; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Browman KW, 2003, BIOINFORMATICS, V19, P889; Flachs P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003044; Furuse T, 2012, BEHAV BRAIN RES, V227, P167, DOI 10.1016/j.bbr.2011.11.002; Gotoh H, 2012, MAMM GENOME, V23, P399, DOI 10.1007/s00335-012-9395-1; Gotoh H, 2012, CONGENIT ANOM, V52, P186, DOI 10.1111/j.1741-4520.2012.00379.x; Handel MA, 2006, MOL CELL ENDOCRINOL, V250, P201, DOI 10.1016/j.mce.2005.12.046; Hirawatari K, 2015, CONGENIT ANOM, V55, P92, DOI 10.1111/cga.12102; Maas JA, 2009, VET J, V180, P356, DOI 10.1016/j.tvjl.2008.02.003; Oehninger S, 2014, FERTIL STERIL, V102, P1528, DOI 10.1016/j.fertnstert.2014.09.044; Oka A, 2004, GENETICS, V166, P913, DOI 10.1534/genetics.166.2.913; Peripato AC, 2004, J EVOLUTION BIOL, V17, P593, DOI 10.1111/j.1420-9101.2004.00702.x; Royal MD, 2008, ANIMAL, V2, P1101, DOI 10.1017/S1751731108002693; SHIROISHI T, 1982, NATURE, V300, P370, DOI 10.1038/300370a0; SNELL GD, 1958, J NATL CANCER I, V21, P843; Visser L, 2010, REPRODUCTION, V139, P230; WYROBEK AJ, 1983, MUTAT RES, V115, P1, DOI 10.1016/0165-1110(83)90014-3	27	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0938-8990	1432-1777		MAMM GENOME	Mamm. Genome	JUN	2015	26	5-6					248	256		10.1007/s00335-015-9566-y		9	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CJ2WI	WOS:000355345000005		
J	Hongo, H; Nanishi, K; Shibanuma, A; Jimba, M				Hongo, Hiroko; Nanishi, Keiko; Shibanuma, Akira; Jimba, Masamine			Is Baby-Friendly Breastfeeding Support in Maternity Hospitals Associated with Breastfeeding Satisfaction Among Japanese Mothers?	MATERNAL AND CHILD HEALTH JOURNAL			English	Article						Perinatal care; Postpartum period; Intention; Japan; Maternal breastfeeding evaluation	RANDOMIZED CONTROLLED-TRIAL; CARE PRACTICES; WOMEN; DURATION; AUSTRALIA; INTENTION; FORMULA; VERSION; EVENTS; SYSTEM	While the World Health Organization's Baby-Friendly Hospital Initiative has increased breastfeeding duration and exclusivity, a survey found that only 8.5 % of maternity hospitals in 31 developed countries could be designated baby-friendly. Baby-friendly breastfeeding support is sometimes criticized as mother unfriendly. This study examined whether baby-friendly breastfeeding support was associated with breastfeeding satisfaction, duration, and exclusivity among Japanese mothers. In this cross-sectional study, 601 breastfeeding Japanese mothers completed questionnaires at their infants' 4-month health checkups at two wards in Yokohama, Japan; 363 were included in the analysis. Baby-friendly breastfeeding support was measured based on the WHO's "Ten Steps to Successful Breastfeeding." We measured satisfaction using two subscales of the Japanese version of the Maternal Breastfeeding Evaluation Scale. The association of baby-friendly support with maternal satisfaction was assessed using multiple linear regression, while the prevalence ratios (PRs) for breastfeeding were estimated using Poisson regression. Mothers were stratified by prepartum exclusive breastfeeding intention (yes, n = 256; no, n = 107). Mothers who experienced early skin-to-skin contact with their infants were more likely to report breastfeeding satisfaction than those who did not. Among mothers without exclusive breastfeeding intention, those who were encouraged to feed on demand were more likely to be breastfeeding without formula at 1 month (PR 2.66 [95 % CI 1.32, 5.36]) and to perceive breastfeeding as beneficial for their baby (regression coefficient = 3.14 [95 % CI 0.11, 6.17]) than those who were not so encouraged. Breastfeeding satisfaction was a useful measure of breastfeeding outcome. Early skin-to-skin contact and encouragement to feed on demand in the hospital facilitate breastfeeding satisfaction.	[Hongo, Hiroko; Nanishi, Keiko; Shibanuma, Akira; Jimba, Masamine] Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, Tokyo 1130033, Japan	Nanishi, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Community & Global Hlth, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	keiko50@m.u-tokyo.ac.jp			Academic Research Grant Program at the University of Tokyo	We would like to thank Dr. Junko Yasuoka and Dr. Yutaka Matsuyama at the Graduate School of Medicine at the University of Tokyo for their advice on research planning and analysis. We are grateful to Mr. Donald Halstead at Harvard School of Public Health for his comments on the manuscript. We are thankful to Dr. Kazuo Seki at Yokohama City University Medical Center for his support on data collection. We also thank the mothers who participated and the Public Health and Welfare Centers in Asahi and Minami Wards, Yokohama, for allowing us to conduct the study during infant health checkups. Finally, we are grateful for the financial support received through the Academic Research Grant Program at the University of Tokyo.	Ahluwalia IB, 2012, MATERN CHILD HLTH J, V16, P1672, DOI 10.1007/s10995-011-0871-0; Moore ER, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003519.pub3; Labbok MH, 2012, BREASTFEED MED, V7, P210, DOI 10.1089/bfm.2012.0066; Semenic S, 2008, RES NURS HEALTH, V31, P428, DOI 10.1002/nur.20275; DiGirolamo AM, 2008, PEDIATRICS, V122, pS43, DOI 10.1542/peds.2008-1315e; Merten S, 2005, PEDIATRICS, V116, pE702, DOI 10.1542/peds.2005-0537; Ludvigsson JF, 2005, ACTA PAEDIATR, V94, P1310, DOI 10.1080/08035250510037588; Walsh AD, 2011, MATERN CHILD HLTH J, V15, P597, DOI 10.1007/s10995-010-0628-1; PEREZESCAMILLA R, 1992, EARLY HUM DEV, V31, P25, DOI 10.1016/0378-3782(92)90012-6; Semenic S, 2012, J HUM LACT, V28, P317, DOI 10.1177/0890334412445195; Dennis CL, 2002, CAN MED ASSOC J, V166, P21; Yawn BP, 1998, J CLIN EPIDEMIOL, V51, P399, DOI 10.1016/S0895-4356(97)00304-1; Hannula L, 2008, J CLIN NURS, V17, P1132, DOI 10.1111/j.1365-2702.2007.02239.x; Rosenberg KD, 2008, AM J PUBLIC HEALTH, V98, P290, DOI 10.2105/AJPH.2006.103218; Wilber ST, 2010, ACAD EMERG MED, V17, P649, DOI 10.1111/j.1553-2712.2010.00773.x; Martens PJ, 2012, J HUM LACT, V28, P335, DOI 10.1177/0890334412438264; Chalmers B, 2009, BIRTH-ISS PERINAT C, V36, P122, DOI 10.1111/j.1523-536X.2009.00309.x; Cooke M, 2007, MIDWIFERY, V23, P66, DOI 10.1016/j.midw.2005.12.003; Perrine CG, 2012, PEDIATRICS, V130, P54, DOI 10.1542/peds.2011-3633; Declercq E, 2009, AM J PUBLIC HEALTH, V99, P929, DOI 10.2105/AJPH.2008.135236; Duijts L, 2009, MATERN CHILD NUTR, V5, P199, DOI 10.1111/j.1740-8709.2008.00176.x; Awano M., 2008, J JAPANESE SOC BREAS, V2, P93; Barros Aluísio J D, 2003, BMC Med Res Methodol, V3, P21, DOI 10.1186/1471-2288-3-21; City of Yokohama, STAT INFORM; City of Yokohama, MATERNITY FACILITIES; Cooke Margaret, 2003, J Hum Lact, V19, P145, DOI 10.1177/0890334403252472; Gagne M P, 1992, Health Care Women Int, V13, P249; Grassley J., 2008, BIRTH-ISS PERINAT C, V35, P229; Hoddinott P, 2009, BRIT MED J, V338, DOI 10.1136/bmj.a3026; Hongo H, 2013, J HUM LACT, V29, P611, DOI 10.1177/0890334413491142; Japan Breastfeeding Association, 2008, BAB FRIENDL HOSP DAT; Japan Breastfeeding Association, DES BAB FRIENDL HOSP; Kaneko A, 2006, J EPIDEMIOL, V16, P57, DOI 10.2188/jea.16.57; KURINIJ N, 1991, PEDIATRICS, V88, P745; Leff E W, 1994, J Hum Lact, V10, P99, DOI 10.1177/089033449401000216; Leff E W, 1994, J Hum Lact, V10, P105, DOI 10.1177/089033449401000217; Ministry of Education Culture Sports Science and Technology, 2012, SHOG SEIDO NO JUJ; Ministry of Health Labor and Welfare, 2008, SIT SAL COL IND BAS, P24; Ministry of Health Labour and Welfare, 2011, SURV GROWTH INF PRES; Mothers' and Children's Health and Welfare Association, 2009, MAT CHILD HLTH STAT; Murai F., 2008, BOSEIEISEI, V48, P496; Nanishi K, 2014, J HUM LACT, V30, P346, DOI 10.1177/0890334414534321; Netsu Y., 2001, OBSTET GYNECOLOGY TR, V82, P78; Riordan J M, 1994, J Hum Lact, V10, P231, DOI 10.1177/089033449401000416; Schlomer J A, 1999, J Hum Lact, V15, P35, DOI 10.1177/089033449901500110; Schmied V, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-208; Sheehan A, 1999, MIDWIFERY, V15, P274, DOI 10.1054/midw.1999.0186; The Ministry of Health Labor and Welfare, 2007, JUNY RIN NO SHIEN GU; The World Health Organization; UNICEF, 2009, IN REV UPD EXP INT C; United Nations Children's Fund, 2009, UNICEF WHO AK TO OK, P361; WHO, 1981, INT COD MARK BREAST; World Health Organization & United Nations Children's Fund, 2009, BAB FRIENDL HOSP IN; World Health Organization, 1998, EV 10 STEPS SUCC BRE; World Health Organization, 2003, GLOB STRAT INF YOUNG; World Health Organization, 2010, IND ASS INF YOUNG 2; YAMAUCHI Y, 1990, ACTA PAEDIATR SCAND, V79, P1017, DOI 10.1111/j.1651-2227.1990.tb11377.x; Yoda T, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-207	57	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1092-7875	1573-6628		MATERN CHILD HLTH J	Matern. Child Health J.	JUN	2015	19	6					1252	1262		10.1007/s10995-014-1631-8		11	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CJ1CU	WOS:000355220400010		
J	Mori, I				Mori, Isamu			Anti-herpesviral activity of curcumin may attenuate the development of Alzheimer's disease	MEDICAL HYPOTHESES			English	Letter							EXPRESSION		Shubun Univ, Fac Hlth & Nutr, Ichinomiya, Aichi 4910938, Japan	Mori, I (reprint author), Shubun Univ, Fac Hlth & Nutr, Ichinomiya, Aichi 4910938, Japan.	mori@shubun-ac.jp					Lv YL, 2014, ENVIRON TOXICOL PHAR, V37, P1140, DOI 10.1016/j.etap.2014.04.017; Kutluay SB, 2008, VIROLOGY, V373, P239, DOI [10.1016/j.virol.2007.11.028, 10.1016/j.virot.2007.11.028]; Ball MJ, 2013, ALZHEIMERS DEMENT, V9, P169, DOI 10.1016/j.jalz.2012.07.005; Lee WH, 2013, CURR NEUROPHARMACOL, V11, P338, DOI 10.2174/1570159X11311040002; Mori I, 2010, J NEUROVIROL, V16, P203, DOI 10.3109/13550281003739040	5	0	0	CHURCHILL LIVINGSTONE	EDINBURGH	JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND	0306-9877	1532-2777		MED HYPOTHESES	Med. Hypotheses	JUN	2015	84	6					603	603		10.1016/j.mehy.2015.03.014		1	Medicine, Research & Experimental	Research & Experimental Medicine	CJ3BE	WOS:000355357600018		
J	Watanabe, K; Kimura, C; Iwasaki, A; Mori, T; Matsushita, H; Shinohara, K; Wakatsuki, A; Gosho, M; Miyano, I				Watanabe, Kazushi; Kimura, Chiharu; Iwasaki, Ai; Mori, Toshitaka; Matsushita, Hiroshi; Shinohara, Koichi; Wakatsuki, Akihiko; Gosho, Masahiko; Miyano, Ichiro			Pregnancy-induced hypertension is associated with an increase in the prevalence of cardiovascular disease risk factors in Japanese women	MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY			English	Article						Cardiovascular disease; Diabetes mellitus; Dyslipidemia; Hypertension; Pregnancy-induced hypertension	ISCHEMIC-HEART-DISEASE; POST HOC ANALYSIS; LATER LIFE; PRAVASTATIN TREATMENT; VASCULAR REACTIVITY; METABOLIC SYNDROME; PREECLAMPSIA; COHORT; COMPLICATIONS; METAANALYSIS	Objective: This study assessed whether pregnancy-induced hypertension (PIH) affects the prevalence of cardiovascular disease (CVD) risk factors in later life among Japanese women. Methods: Study participants were 1,185 women (mean [SD] age, 46.5 [5.6] y; range, 38-73 y) aged 40 years or older who underwent a health checkup at a periodic health examination facility between January 2012 and December 2013 and had experienced giving birth. Questionnaires were sent to potential participants, and they were encouraged to provide their Maternal and Child Health Handbook (handbook). We recruited 101 women with a history of PIH (PIH group) and 1,084 women with uncomplicated pregnancy at delivery (control group). Groupings were based on information from the handbook. We assessed the association between PIH and CVD in later life among Japanese women by focusing on hypertension, diabetes mellitus, and dyslipidemia as risk factors for CVD. Odds ratios (ORs) for the use of antihypertensive, diabetes mellitus, and dyslipidemic medications in the PIH group were determined. Results: Women with PIH had increased risk of antihypertensive medication use compared with women without PIH (2.9% vs 13.9%; OR, 4.28; 95% CI, 2.14-8.57). Triglycerides were significantly higher and high-density lipoprotein cholesterol was significantly lower in the PIH group than in the control group. The OR for dyslipidemic medication use in the PIH group relative to the control group was 3.20 (95% CI, 1.42-7.22). Conclusions: Our findings suggest that a history of PIH may be associated with an increased risk of hypertension (a risk factor for CVD) in later life among Japanese women.	[Watanabe, Kazushi; Kimura, Chiharu; Iwasaki, Ai; Mori, Toshitaka; Matsushita, Hiroshi; Shinohara, Koichi; Wakatsuki, Akihiko] Aichi Med Univ Sch Med, Dept Obstet & Gynecol, Nagakute, Aichi 4801195, Japan; [Gosho, Masahiko] Aichi Med Univ, Adv Med Res Ctr, Unit Biostat, Nagakute, Aichi, Japan; [Miyano, Ichiro] Kochi Med Sch, Dept Publ Hlth, Kochi, Japan	Watanabe, K (reprint author), Aichi Med Univ Sch Med, Dept Obstet & Gynecol, Nagakute, Aichi 4801195, Japan.	kw446433@yahoo.co.jp			Japan Society for the Study of Hypertension in Pregnancy	This study received foundational support from the Japan Society for the Study of Hypertension in Pregnancy.	Mori T, 2014, HYPERTENS RES, V37, P145, DOI 10.1038/hr.2013.131; Ramsay JE, 2003, BJOG-INT J OBSTET GY, V110, P1029, DOI 10.1111/j.1471-0528.2003.02069.x; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)17987-2; Sattar N, 2002, BRIT MED J, V325, P157, DOI 10.1136/bmj.325.7356.157; Nishiwaki M, 2013, J CARDIOL, V61, P196, DOI 10.1016/j.jjcc.2012.10.005; Rodie VA, 2004, ATHEROSCLEROSIS, V175, P189, DOI 10.1016/j.atherosclerosis.2004.01.038; Berks D, 2013, BJOG-INT J OBSTET GY, V120, P924, DOI 10.1111/1471-0528.12191; Watanabe K, 2013, HYPERTENS RES, V36, P356, DOI 10.1038/hr.2012.208; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1016/01.CIR.0000131515.03336.f8; Jonsdottir LS, 1995, ACTA OBSTET GYN SCAN, V74, P772; MacKay AP, 2001, OBSTET GYNECOL, V97, P533, DOI 10.1016/S0029-7844(00)01223-0; Nishimura R, 2013, DIABETES RES CLIN PR, V100, pE31, DOI 10.1016/j.diabres.2013.02.003; Verma S, 2002, CIRCULATION, V105, P546, DOI 10.1161/hc0502.104540; Brown MC, 2013, EUR J EPIDEMIOL, V28, P1, DOI 10.1007/s10654-013-9762-6; Williams D, 2003, CURR OPIN OBSTET GYN, V15, P465, DOI 10.1097/01.gco.0000103846.69273.ba; Bellamy L, 2007, BRIT MED J, V335, P974, DOI 10.1136/bmj.39335.85301.BE; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200; Austin MA, 1988, AM J HUM GENET, V43, P836; Harskamp RE, 2007, AM J MED SCI, V334, P291, DOI 10.1097/MAJ.0b013e3180a6f094; Haukkamaa L, 2004, AM J CARDIOL, V93, P805, DOI 10.1016/j.amjcard.2003.11.065; Hermes W, 2013, AM J OBSTET GYNECOL, V208; Ikenoue N, 1999, OBSTET GYNECOL, V93, P566, DOI 10.1016/S0029-7844(98)00481-5; Irgens HU, 2001, BRIT MED J, V323, P1213, DOI 10.1136/bmj.323.7323.1213; Koba S, 2006, J ATHEROSCLER THROMB, V13, P267; Kurabayashia T, 2013, MATURITAS, V75, P227, DOI 10.1016/j.maturitas.2013.04.002; Mori T, 2010, HYPERTENS RES, V33, P250, DOI 10.1038/hr.2009.222; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Srinivas SK, 2009, J MATERN-FETAL NEO M, V22, P501, DOI 10.1080/14767050902794642; Thom T, 2006, CIRCULATION, V113, P85; Watanabe K, 2013, HYPERTENS RES PREGNA, V1, P3; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; YANO K, 1984, AM J EPIDEMIOL, V119, P653	32	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1072-3714	1530-0374		MENOPAUSE	Menopause-J. N. Am. Menopause Soc.	JUN	2015	22	6					656	659		10.1097/gme.0000000000000361		4	Obstetrics & Gynecology	Obstetrics & Gynecology	CJ1IU	WOS:000355238100012		
J	Mukai, M; Okunishi, E; Ashino, M; Omoto, K; Fukuda, T; Ikeda, A; Somehara, K; Kaneyama, T; Saitoh, T; Hirayama, T; Ikuhara, Y				Mukai, Masaki; Okunishi, Eiji; Ashino, Masanori; Omoto, Kazuya; Fukuda, Tomohisa; Ikeda, Akihiro; Somehara, Kazunori; Kaneyama, Toshikatsu; Saitoh, Tomohiro; Hirayama, Tsukasa; Ikuhara, Yuichi			Development of a monochromator for aberration-corrected scanning transmission electron microscopy	MICROSCOPY			English	Article						monochromator; Wien filter; aberration corrector; high-resolution EELS; high-resolution STEM; atomic-resolution EELS mapping	ENERGY-LOSS SPECTROSCOPY; WIEN FILTERS; RESOLUTION; DIAMOND; STEM; GAP	In this article, we report the development of a new 200-kV analytical electron microscope equipped with a monochromator with an integrated double Wien-filter system. It enables us to study the electronic structures of materials in detail using electron energy-loss spectroscopy (EELS) analysis at an atomic scale. A highly monochromated and isotropically round electron probe is produced on the specimen plane. The ultimate energy resolutions with 0.1-s acquisition times are measured to be 36 meV at 200 kV and 30 meV at 60 kV. In an EELS mapping experiment performed on SrTiO3 with a monochromated electron probe whose energy resolution is 146 meV, an elemental map exhibits atomic resolution.	[Mukai, Masaki; Okunishi, Eiji; Ashino, Masanori; Omoto, Kazuya; Fukuda, Tomohisa; Ikeda, Akihiro; Somehara, Kazunori; Kaneyama, Toshikatsu] JEOL Ltd, Akishima, Tokyo 1968558, Japan; [Saitoh, Tomohiro; Hirayama, Tsukasa; Ikuhara, Yuichi] Japan Fine Ceram Ctr, Atsuta Ku, Nagoya, Aichi 4568587, Japan; [Ikuhara, Yuichi] Univ Tokyo, Bunkyo Ku, Tokyo 1138656, Japan	Mukai, M (reprint author), JEOL Ltd, 3-1-2 Musashino, Akishima, Tokyo 1968558, Japan.	mmukai@jeol.co.jp	Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 			ASPNES DE, 1983, PHYS REV B, V27, P985, DOI 10.1103/PhysRevB.27.985; Haider M, 2000, ULTRAMICROSCOPY, V81, P163, DOI 10.1016/S0304-3991(99)00194-1; Essers E, 2010, ULTRAMICROSCOPY, V110, P971, DOI 10.1016/j.ultramic.2010.02.009; MORAR JF, 1985, PHYS REV LETT, V54, P1960, DOI 10.1103/PhysRevLett.54.1960; Mukai M, 2014, ULTRAMICROSCOPY, V140, P37, DOI 10.1016/j.ultramic.2014.02.004; Lazar S, 2006, ULTRAMICROSCOPY, V106, P1091, DOI 10.1016/j.ultramic.2006.04.024; Tiemeijer PC, 1999, ULTRAMICROSCOPY, V78, P53, DOI 10.1016/S0304-3991(99)00027-3; Muller DA, 2008, SCIENCE, V319, P1073, DOI 10.1126/science.1148820; Krivanek OL, 2013, MICROSCOPY-JPN, V62, P3, DOI 10.1093/jmicro/dfs089; Rafferty B, 1998, PHYS REV B, V58, P10326, DOI 10.1103/PhysRevB.58.10326; Terauchi M, 1999, J MICROSC-OXFORD, V194, P203; Brink HA, 2003, ULTRAMICROSCOPY, V96, P367, DOI 10.1016/S0304-3991(03)00102-5; CURTIS GH, 1971, REV SCI INSTRUM, V42, P630, DOI 10.1063/1.1685189; Ishikawa I, 2009, MICROSC MICROANAL, V15, P188, DOI 10.1017/S1431927609093829; Lupini AR, 2003, ULTRAMICROSCOPY, V96, P313, DOI 10.1016/S0304-3991(03)00096-2; Martinez G, 2002, ULTRAMICROSCOPY, V93, P253, DOI 10.1016/S0304-3991(02)00282-6; Mukai M, 2013, MICROSC MICROANAL S2, V19, P1126; Okunishi E, 2006, MICROSC MICROANAL S2, V13, P1150; ROUSE J, 1989, J VAC SCI TECHNOL B, V7, P1891, DOI 10.1116/1.584687; Sato Y, 2012, DIAM RELAT MATER, V25, P40, DOI 10.1016/j.diamond.2012.02.013; Tsuno K, 2005, J MICROSC-OXFORD, V217, P205, DOI 10.1111/j.1365-2818.2005.01443.x; TSUNO K, 1991, OPTIK, V89, P31; Varela M, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.095502	23	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					151	158		10.1093/jmicro/dfv001		8	Microscopy	Microscopy	CJ0WW	WOS:000355201200001		
J	Tsuda, T; Kanetsuku, T; Sano, T; Oshima, Y; Ui, K; Yamagata, M; Ishikawa, M; Kuwabata, S				Tsuda, Tetsuya; Kanetsuku, Tsukasa; Sano, Teruki; Oshima, Yoshifumi; Ui, Koichi; Yamagata, Masaki; Ishikawa, Masashi; Kuwabata, Susumu			In situ SEM observation of the Si negative electrode reaction in an ionic-liquid-based lithium-ion secondary battery	MICROSCOPY			English	Article						scanning electron microscope; ionic liquid; in situ SEM observation; negative electrode; silicon; lithium-ion battery	STRUCTURAL-CHANGES; SULFUR BATTERIES; PHOTOELECTRON-SPECTROSCOPY; ELECTROCHEMICAL LITHIATION; SPUTTERING METHOD; COMPOSITE ANODE; MICROSCOPY; SILICON; LI; NANOPARTICLES	By exploiting characteristics such as negligible vapour pressure and ion-conductive nature of an ionic liquid (IL), we established an in situ scanning electron microscope (SEM) method to observe the electrode reaction in the IL-based Li-ion secondary battery (LIB). When 1-ethyl-3-methylimidazolium bis(fluorosulfonyl)amide ([C(2)mim][FSA]) with lithium bis(trifluoromethanesulfonyl) amide (Li[TFSA]) was used as the electrolyte, the Si negative electrode exhibited a clear morphology change during the charge process, without any solid electrolyte interphase (SEI) layer formation, while in the discharge process, the appearance was slightly changed, suggesting that a morphology change is irreversible in the charge-discharge process. On the other hand, the use of 1-ethyl-3-methylimidazolium bis(trifluoromethanesulfonyl) amide ([C(2)mim][TFSA]) with Li[TFSA] did not induce a change in the Si negative electrode. It is interesting to note this distinct contrast, which could be attributed to SEI layer formation from the electrochemical breakdown of [C(2)mim](+) at the Si negative electrode vertical bar separator interface in the [C(2)mim][TFSA]based LIB. This in situ SEM observation technique could reveal the effect of the IL species electron-microscopically on the Si negative electrode reaction.	[Tsuda, Tetsuya; Kanetsuku, Tsukasa; Sano, Teruki; Kuwabata, Susumu] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka 5650871, Japan; [Oshima, Yoshifumi] Japan Adv Inst Sci & Technol, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Ui, Koichi] Iwate Univ, Grad Sch Engn, DepT Frontier Mat & Funct Engn, Morioka, Iwate 0208551, Japan; [Yamagata, Masaki; Ishikawa, Masashi] Kansai Univ, Fac Chem Mat & Bioengn, Dept Chem & Mat Engn, Suita, Osaka 5648680, Japan	Tsuda, T (reprint author), Osaka Univ, Grad Sch Engn, Dept Appl Chem, 2-1 Yamada Oka, Suita, Osaka 5650871, Japan.	ttsuda@chem.eng.osaka-u.ac.jp; kuwabata@chem.eng.osaka-u.ac.jp	Yamagata, Masaki/A-7501-2012	Yamagata, Masaki/0000-0001-7565-8251	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24350071]; Japan Science and Technology Agency (JST)	Part of this study was supported by a Grant-in-Aid for Scientific Research (B), grant no. 24350071, from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT), and by the Advanced Low Carbon Technology Research and Development Program (ALCA) for Specially Promoted Research for Innovative Next Generation Batteries (SPRING) from the Japan Science and Technology Agency (JST).	Guo BK, 2013, CHEM COMMUN, V49, P4905, DOI 10.1039/c3cc41518j; Ramdon S, 2014, J POWER SOURCES, V249, P373, DOI 10.1016/j.jpowsour.2013.10.099; INABA M, 1995, J ELECTROCHEM SOC, V142, P20, DOI 10.1149/1.2043869; Key B, 2009, J AM CHEM SOC, V131, P9239, DOI 10.1021/ja8086278; Orikasa Y, 2013, J AM CHEM SOC, V135, P5497, DOI 10.1021/ja312527x; Torimoto T, 2010, ADV MATER, V22, P1196, DOI 10.1002/adma.200902184; Arimoto S, 2008, ELECTROCHIM ACTA, V53, P6228, DOI 10.1016/j.electacta.2008.01.001; Yamagata M, 2013, ELECTROCHIM ACTA, V110, P181, DOI 10.1016/j.electacta.2013.03.018; Verma P, 2010, ELECTROCHIM ACTA, V55, P6332, DOI 10.1016/j.electacta.2010.05.072; Torimoto T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2404975; Dupont J, 2010, CHEM SOC REV, V39, P1780, DOI 10.1039/b822551f; Lovelock KRJ, 2010, CHEM REV, V110, P5158, DOI 10.1021/cr100114t; Dokko K, 2013, J ELECTROCHEM SOC, V160, pA1304, DOI 10.1149/2.111308jes; Sugimoto T, 2010, J POWER SOURCES, V195, P6153, DOI 10.1016/j.jpowsour.2010.01.011; Iwamura S, 2012, J PHYS CHEM C, V116, P6004, DOI 10.1021/jp2093669; Park JW, 2013, J PHYS CHEM C, V117, P4431, DOI 10.1021/jp400153m; Antolini E, 2004, SOLID STATE IONICS, V170, P159, DOI 10.1016/j.ssi.2004.04.003; Steinruck HP, 2011, ADV MATER, V23, P2571, DOI 10.1002/adma.201100211; Amatucci GG, 1996, J ELECTROCHEM SOC, V143, P1114, DOI 10.1149/1.1836594; Usui H, 2012, CHEM LETT, V41, P521, DOI 10.1246/cl.2012.521; Kuwabata S, 2010, J PHYS CHEM LETT, V1, P3177, DOI 10.1021/jz100876m; Tsuda T, 2011, CHEMBIOCHEM, V12, P2547, DOI 10.1002/cbic.201100476; Matsumoto H, 2006, J POWER SOURCES, V160, P1308, DOI 10.1016/j.jpowsour.2006.02.018; Jeong G, 2011, ENERG ENVIRON SCI, V4, P1986, DOI 10.1039/c0ee00831a; Arimoto S, 2008, CHEMPHYSCHEM, V9, P763, DOI 10.1002/cphc.200700758; Saito M, 2012, SOLID STATE IONICS, V225, P506, DOI 10.1016/j.ssi.2011.12.016; Smith EF, 2005, CHEM COMMUN, P5633, DOI 10.1039/b512311a; Huang JY, 2010, SCIENCE, V330, P1515, DOI 10.1126/science.1195628; Iwamura S, 2013, J POWER SOURCES, V222, P400, DOI 10.1016/j.jpowsour.2012.09.003; Nagao M, 2013, PHYS CHEM CHEM PHYS, V15, P18600, DOI 10.1039/c3cp51059j; Nara H, 2012, ENERG ENVIRON SCI, V5, P6500, DOI 10.1039/c2ee03278c; Nishikawa K, 2013, J POWER SOURCES, V243, P630, DOI 10.1016/j.jpowsour.2013.06.052; Yoshii K, 2012, RSC ADV, V2, P8262, DOI 10.1039/c2ra21243a; Sharma N, 2010, J POWER SOURCES, V195, P8258, DOI 10.1016/j.jpowsour.2010.06.114; Hovington P, 2014, J POWER SOURCES, V248, P457, DOI 10.1016/j.jpowsour.2013.09.069; Ueno K, 2013, J PHYS CHEM C, V117, P20509, DOI 10.1021/jp407158y; Kuwabata S, 2006, CHEM LETT, V35, P600, DOI 10.1246/cl.2006.600; McDowell MT, 2013, NANO LETT, V13, P758, DOI 10.1021/nl3044508; McDowell MT, 2012, ADV MATER, V24, P6034, DOI 10.1002/adma.201202744; Bhattacharyya R, 2010, NAT MATER, V9, P504, DOI [10.1038/nmat2764, 10.1038/NMAT2764]; Liu XH, 2012, NAT NANOTECHNOL, V7, P749, DOI [10.1038/nnano.2012.170, 10.1038/NNANO.2012.170]; Ishikawa M, 2006, J POWER SOURCES, V162, P658, DOI 10.1016/j.jpowsour.2006.02.077; Arimoto S, 2008, ELECTROCHEM COMMUN, V10, P1901, DOI 10.1016/j.elecom.2008.10.003; Chen D, 2011, J POWER SOURCES, V196, P6382, DOI 10.1016/j.jpowsour.2011.04.009; Courtney I A, 1997, J ELECTROCHEM SOC, V144, P2045; Dwiranti A, 2012, MICROSC RES TECHNIQ, V75, P1113, DOI 10.1002/jemt.22038; Freemantle M, 2010, INTRODUCTION TO IONIC LIQUIDS, P1; Hayakawa E H, 2013, PLOS ONE, V8; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P1024, DOI 10.1002/jemt.20989; Johnston M, 2005, J PHYS CHEM B, V109, P11296, DOI 10.1021/jp051243m; Kawai K, 2011, LANGMUIR, V27, P9671, DOI 10.1021/la201914h; Kuwabata S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03722; Li J, 2007, J ELECTROCHEM SOC, V154, pA156, DOI 10.1149/1.2409862; Obrovac MN, 2004, ELECTROCHEM SOLID ST, V7, pA93, DOI 10.1149/1.1652421; Ohno H., 2011, ELECTROCHEMICAL ASPE; Okazaki KI, 2008, CHEM COMMUN, P691, DOI 10.1039/b714761a; Shima F, 2013, B CHEM SOC JPN, V86, P153, DOI 10.1246/bcsj.20120227; Sugimoto T, 2009, J POWER SOURCES, V189, P802, DOI 10.1016/j.jpowsour.2008.07.053; Takahashi C, 2013, MATER CHEM PHYS, V141, P657, DOI 10.1016/j.matchemphys.2013.05.051; Takamatsu D, 2012, ANGEW CHEM INT EDIT, V51, P11597, DOI 10.1002/anie.201203910; Tsuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091193; Tsuda T, 2013, ELECTROCHIM ACTA, V100, P285, DOI 10.1016/j.electacta.2012.05.156; Tsuda T, 2009, MOD ASP ELECTROCHEM, P63, DOI 10.1007/978-1-4419-0655-7_2; Tsuda T, 2009, ELECTROCHEMISTRY, V77, P693; Tsuda T, 2011, CHEM-EUR J, V17, P11122, DOI 10.1002/chem.201101240; Tsuda T, 2010, J POWER SOURCES, V195, P5980, DOI 10.1016/j.jpowsour.2009.11.027; Tsuda T, 2012, ELECTROCHEMISTRY, V80, P308, DOI 10.5796/electrochemistry.80.308; Uematsu T, 2012, J PHYS CHEM C, V116, P20902, DOI 10.1021/jp306241p; Wasserscheid P., 2008, IONIC LIQUIDS SYNTHE; Yanaga K, 2012, MYCOL PROG, V11, P343, DOI 10.1007/s11557-011-0794-6	70	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					159	168		10.1093/jmicro/dfv003		10	Microscopy	Microscopy	CJ0WW	WOS:000355201200002		
J	Takahashi, C; Ogawa, N; Kawashima, Y; Yamamoto, H				Takahashi, Chisato; Ogawa, Noriko; Kawashima, Yoshiaki; Yamamoto, Hiromitsu			Observation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquid	MICROSCOPY			English	Article						ionic liquid; poly(DL-lactide-co-glycolide); drug delivery system; biofilm; clarithromycin; electron microscopy	ENHANCED ANTITUMOR EFFICACY; ELECTRON-MICROSCOPY; GREEN BODIES; NUCLEIC-ACID; DELIVERY; PLATFORM; SYSTEM; WATER; AIR	We successfully visualized the antibacterial behavior of biodegradable polymeric nanoparticles (NPs) on a biofilm formed by Staphylococcus epidermidis using field emission scanning electron microscopy (FE-SEM). A hydrophilic ionic liquid, 1-butyl-3-methylimidazolium tetrafluoroborate ([BMIM][BF4]), was applied for observation using FE-SEM. The differences in adherence and penetration behavior of three types of NPs were revealed using this method and confocal laser scanning microscopy. Biodegradable poly(D-Llactide-co-glycolide) (PLGA) NPs were prepared by the emulsion solvent diffusion method. In this study, we treated the biofilm with three PLGA NPs: unmodified PLGA, PLGA modified with chitosan (CS) and clarithromycin (CAM)-loaded + CS-modified PLGA. The viability of S. epidermidis cells treated with PLGA NPs was estimated using the LIVE/DEAD BacLight kit to understand the antibacterial ability of each NP sample in a quantitative way. The results confirmed that CAM-loaded + CS-modified PLGA had high antibacterial ability on the biofilm. This novel observation technique would be useful in the development of drug formations and medical agents.	[Takahashi, Chisato; Ogawa, Noriko; Kawashima, Yoshiaki; Yamamoto, Hiromitsu] Aichi Gakuin Univ, Sch Pharm Pharmaceut Engn, Chikusa Ku, Nagoya, Aichi 4648650, Japan	Takahashi, C (reprint author), Aichi Gakuin Univ, Sch Pharm Pharmaceut Engn, Chikusa Ku, 1-100 Kusumoto Cho, Nagoya, Aichi 4648650, Japan.	chisato@dpc.agu.ac.jp			Institute of Pharmaceutical Life Sciences, Aichi Gakuin University; 18th International Microscopy Congress Grant from the Japanese Society of Microscopy	This study was partially supported by the research Grant from the Institute of Pharmaceutical Life Sciences, Aichi Gakuin University and the 18th International Microscopy Congress Grant from the Japanese Society of Microscopy.	Jiang XY, 2014, J PHARM SCI-US, V103, P1487, DOI 10.1002/jps.23928; Tahara K, 2008, INT J PHARM, V354, P210, DOI 10.1016/j.ijpharm.2007.11.002; Donlan RM, 2001, EMERG INFECT DIS, V7, P277; Ishigaki Y, 2011, MICROSC RES TECHNIQ, V74, P415, DOI 10.1002/jemt.20924; Kuwabata S, 2010, J PHYS CHEM LETT, V1, P3177, DOI 10.1021/jz100876m; HURLEY FH, 1951, J ELECTROCHEM SOC, V98, P203, DOI 10.1149/1.2778132; Dinarvand R, 2011, INT J NANOMED, V6, P877, DOI 10.2147/IJN.S18905; Clauss M, 2010, ACTA BIOMATER, V6, P3791, DOI 10.1016/j.actbio.2010.03.011; Yamamoto H, 2012, J MICROENCAPSUL, V29, P54, DOI 10.3109/02652048.2011.629745; Cue D, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00038; Dwiranti A, 2012, MICROSC RES TECHNIQ, V75, P1113, DOI 10.1002/jemt.22038; Kawashima Y, 1998, EUR J PHARM BIOPHARM, V45, P41, DOI 10.1016/S0939-6411(97)00121-5; Kishita K, 2009, J ELECTRON MICROSC, V58, P331, DOI 10.1093/jmicro/dfp028; Murphy CN, 2012, FUTURE MICROBIOL, V7, P991, DOI [10.2217/fmb.12.74, 10.2217/FMB.12.74]; Pavan P, 2014, J CLIN PERIODONTOL, V41, P1061, DOI 10.1111/jcpe.12306; Sato M, 1994, KANSEN ZAS-J JPN ASS, V68, P1306; Tahara K, 2010, INT J PHARMACEUT, V15, P311; Takahashi C, 2015, ANAL BIOANAL CHEM, V407, P1607, DOI 10.1007/s00216-014-8391-6; Takahashi C, 2013, J EUR CERAM SOC, V33, P629, DOI 10.1016/j.jeurceramsoc.2012.10.037; Takahashi C, 2012, MATER CHEM PHYS, V133, P565, DOI 10.1016/j.matchemphys.2012.01.089; Takahashi C, 2014, RSC ADV, V4, P27322, DOI 10.1039/c4ra02359e; Takahashi C, 2015, J ELECT MIC IN PRESS; Tsuda T, 2010, CHEMBIOCHEM, V12, P2547; Wang HX, 2014, ANGEW CHEM INT EDIT, V53, P11532, DOI 10.1002/anie.201406685; WILKES JS, 1992, J CHEM SOC CHEM COMM, P965, DOI 10.1039/c39920000965; Yaguchi T, 2012, J ELECTRON MICROSC, V61, P199, DOI 10.1093/jmicro/dfs041	26	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					169	180		10.1093/jmicro/dfv010		12	Microscopy	Microscopy	CJ0WW	WOS:000355201200003		
J	Minoda, H; Tamai, T; Iijima, H; Hosokawa, F; Kondo, Y				Minoda, Hiroki; Tamai, Takayuki; Iijima, Hirofumi; Hosokawa, Fumio; Kondo, Yukihito			Phase-contrast scanning transmission electron microscopy	MICROSCOPY			English	Article						phase plate; STEM; phase contrast; contrast transfer function; the principles of reciprocity; Ronchigram	PLATE	This report introduces the first results obtained using phase-contrast scanning transmission electron microscopy (P-STEM). A carbon-film phase plate (PP) with a small center hole is placed in the condenser aperture plane so that a phase shift is introduced in the incident electron waves except those passing through the center hole. A cosine-type phase-contrast transfer function emerges when the phase-shifted scattered waves interfere with the non-phase-shifted unscattered waves, which passed through the center hole before incidence onto the specimen. The phase contrast resulting in P-STEM is optically identical to that in phase-contrast transmission electron microscopy that is used to provide high contrast for weak phase objects. Therefore, the use of PPs can enhance the phase contrast of the STEM images of specimens in principle. The phase shift resulting from the PP, whose thickness corresponds to a phase shift of pi, has been confirmed using interference fringes displayed in the Ronchigram of a silicon single crystal specimen. The interference fringes were found to abruptly shift at the edge of the PP hole by pi.	[Minoda, Hiroki; Tamai, Takayuki] Tokyo Univ Agr & Technol, Dept Appl Phys, Koganei, Tokyo 1848588, Japan; [Iijima, Hirofumi; Hosokawa, Fumio; Kondo, Yukihito] JEOL Ltd, Akishima, Tokyo 1968558, Japan	Minoda, H (reprint author), Tokyo Univ Agr & Technol, Dept Appl Phys, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	hminoda@cc.tuat.ac.jp	Minoda, Hiroki/C-8970-2013		SENTAN, JST	This work was supported by SENTAN, JST.	Danev R, 2009, ULTRAMICROSCOPY, V109, P312, DOI 10.1016/j.ultramic.2008.12.006; Buijsse B, 2011, ULTRAMICROSCOPY, V111, P1688, DOI 10.1016/j.ultramic.2011.09.015; Majorovits E, 2007, ULTRAMICROSCOPY, V107, P213, DOI 10.1016/j.ultramic.2006.07.006; Evans JE, 2012, MICRON, V43, P1085, DOI 10.1016/j.micron.2012.01.018; Aoyama K, 2008, ULTRAMICROSCOPY, V109, P70, DOI 10.1016/j.ultramic.2008.08.005; Cuambie R, 2007, ULTRAMICROSCOPY, V107, P329; Danev R, 2002, J BIOL PHYS, V28, P627, DOI 10.1023/A:1021234621466; Danev R, 2001, J PHYS SOC JPN, V70, P696, DOI 10.1143/JPSJ.70.696; Hosokawa F, 2005, J ELECTRON MICROSC, V54, P317, DOI 10.1093/jmicro/dfi049; Huang SH, 2006, J ELECTRON MICROSC, V55, P273, DOI 10.1093/jmicro/dfl037; Inayoshi Y, 2012, MICRON, V43, P1091, DOI 10.1016/j.micron.2012.02.001; Matsumoto T, 1996, ULTRAMICROSCOPY, V63, P5, DOI 10.1016/0304-3991(96)00033-2; Minoda H, 2011, J ELECTRON MICROSC, V60, P337, DOI 10.1093/jmicro/dfr067	13	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					181	187		10.1093/jmicro/dfv011		7	Microscopy	Microscopy	CJ0WW	WOS:000355201200004		
J	Shimo, S; Saitoh, S; Saitoh, Y; Ohno, N; Ohno, S				Shimo, Satoshi; Saitoh, Sei; Saitoh, Yurika; Ohno, Nobuhiko; Ohno, Shinichi			Morphological and immunohistochemical analyses of soluble proteins in mucous membranes of living mouse intestines by cryotechniques	MICROSCOPY			English	Article						small intestine; in vivo cryotechnique; ultrastructure; immunohistochemistry; immunoglobulin A	IN-VIVO CRYOTECHNIQUE; IGA-PRODUCING CELLS; EPITHELIAL-CELLS; ANTIGEN RETRIEVAL; HISTOCHEMICAL ANALYSES; SECRETORY COMPONENT; FINE STRUCTURE; EPOXY-RESIN; IMMUNOGLOBULIN; LOCALIZATION	We have performed immunohistochemical or ultrastructural analyses of living mouse small intestines using Epon blocks prepared by 'in vivo cryotechnique' (IVCT). By electron microscopy, intracellular ultrastructures of epithelial cells were well preserved in tissue areas 5-10 mu m away from cryogen-contact surface tissues. Their microvilli contained dynamically waving actin filaments, and highly electron-dense organelles, such as mitochondria, were seen under the widely organized terminal web. By quick-freezing of fresh resected tissues (FT-QF), many erythrocytes were congested within blood vessels due to loss of blood pressure. By immersion-fixation (IM-DH) and perfusion-fixation (PF-DH), small vacuoles were often seen in the cytoplasm of epithelial cells, and their intercellular spaces were also dilated. Moreover, actin filament bundles were irregular in cross sections of microvilli, compared with those with IVCT. Epon-embedded thick sections were treated with sodium ethoxide, followed by antigen retrieval and immunostained for immunoglobulin A (IgA), Ig kappa light chain (Ig.), J-chain and albumin. By cryotechniques, IgA immunoreactivitywas detected as tiny dotlike patterns in cytoplasm of some epithelial cells. Both J-chain and Ig. immunoreactivities were detected in the same local areas as those of IgA. By FT-QF, however, the IgA immunoreactivity was more weakly detected, compared with that with IVCT. In thick sections prepared by IM-DH and PF-DH, it was rarely observed in both plasma and epithelial cells. Another albumin was diffusely immunolocalized in extracellular matrices of mucous membranes and also within blood vessels. Thus, IVCT was useful for preservation of soluble proteins and ultrastructural analyses of dynamically changing epithelial cells of livingmouse small intestines.	[Shimo, Satoshi; Saitoh, Sei; Saitoh, Yurika; Ohno, Nobuhiko; Ohno, Shinichi] Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, Chuo Ku, Yamanashi 4093898, Japan	Ohno, S (reprint author), Univ Yamanashi, Interdisciplinary Grad Sch Med & Engn, Dept Anat & Mol Histol, Chuo Ku, 1110 Shimokato, Yamanashi 4093898, Japan.	sohno@yamanashi.ac.jp					Fagarasan S, 2001, NATURE, V413, P639, DOI 10.1038/35098100; BROWNING TH, 1969, J CLIN INVEST, V48, P1423, DOI 10.1172/JCI106108; BROWN AL, 1962, J CELL BIOL, V12, P623, DOI 10.1083/jcb.12.3.623; de Kort S, 2011, OBES REV, V12, P449, DOI 10.1111/j.1467-789X.2010.00845.x; TRAPP BD, 1981, J CELL BIOL, V90, P1, DOI 10.1083/jcb.90.1.1; HIROKAWA N, 1981, J CELL BIOL, V91, P399, DOI 10.1083/jcb.91.2.399; Brandtzaeg P, 2003, INT J MED MICROBIOL, V293, P3, DOI 10.1078/1438-4221-00241; Kato LM, 2014, IMMUNOL REV, V260, P67, DOI 10.1111/imr.12185; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203; Tezuka H, 2007, NATURE, V448, P929, DOI 10.1038/nature06033; SPECIAN RD, 1980, J CELL BIOL, V85, P626, DOI 10.1083/jcb.85.3.626; Wines BD, 2006, TISSUE ANTIGENS, V68, P103, DOI 10.1111/j.1399-0039.2006.00613.x; Shi SR, 2011, J HISTOCHEM CYTOCHEM, V59, P13, DOI 10.1369/jhc.2010.957191; ASHWORTH CT, 1963, J CELL BIOL, V17, P1, DOI 10.1083/jcb.17.1.1; Bai YQ, 2011, MED MOL MORPHOL, V44, P93, DOI 10.1007/s00795-010-0512-5; BASKIN DG, 1979, J HISTOCHEM CYTOCHEM, V27, P867; BRANDTZAEG P, 1985, SCAND J IMMUNOL, V22, P111, DOI 10.1111/j.1365-3083.1985.tb01866.x; BRANDTZA.P, 1974, J IMMUNOL, V112, P1553; Brorson SH, 1998, MICRON, V29, P89, DOI 10.1016/S0968-4328(98)00010-9; BROWN WR, 1977, CANCER, V40, P2497, DOI 10.1002/1097-0142(197711)40:5+<2497::AID-CNCR2820400916>3.0.CO;2-Q; BROWN WR, 1973, J IMMUNOL METHODS, V2, P303, DOI 10.1016/0022-1759(73)90056-2; Chen JR, 2013, HISTOCHEM CELL BIOL, V140, P491, DOI 10.1007/s00418-013-1113-x; Coskun Mehmet, 2014, Front Med (Lausanne), V1, P24, DOI 10.3389/fmed.2014.00024; DRENCKHAHN D, 1980, J CELL BIOL, V86, P475, DOI 10.1083/jcb.86.2.475; FRIEDMAN HI, 1972, J CELL BIOL, V52, P15, DOI 10.1083/jcb.52.1.15; FRIEND DS, 1965, J CELL BIOL, V25, P563, DOI 10.1083/jcb.25.3.563; Fujita A, 2010, NAT PROTOC, V5, P661, DOI 10.1038/nprot.2010.20; GLENNEY JR, 1983, CELL MOTIL CYTOSKEL, V3, P671; HALLY AD, 1958, J ANAT, V92, P268; HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425; Hosoe N, 2004, AM J PHYSIOL-GASTR L, V286, P458; Huang Z, 2013, HISTOCHEM CELL BIOL, V140, P477, DOI 10.1007/s00418-013-1084-y; ITO S, 1965, J CELL BIOL, V27, P475, DOI 10.1083/jcb.27.3.475; Li Z, 2005, HISTOL HISTOPATHOL, V20, P807; MUL NAJ, 1975, EUR J CLIN INVEST, V5, P63, DOI 10.1111/j.1365-2362.1975.tb00429.x; NAGURA H, 1980, SCAND J IMMUNOL, V12, P359, DOI 10.1111/j.1365-3083.1980.tb00078.x; Ohno N, 2008, CANCER, V113, P1068, DOI 10.1002/cncr.23701; Ohno N, 2007, J COMP NEUROL, V505, P292, DOI 10.1002/cne.21498; Ohno N, 2006, HISTOCHEM CELL BIOL, V126, P389, DOI 10.1007/s00418-006-0173-6; Ohno N, 2005, J HISTOCHEM CYTOCHEM, V53, P55, DOI 10.1039/jhc.4A6343.2005; Ohno S, 1996, VIRCHOWS ARCH, V427, P519; Ohno S, 2010, J ELECTRON MICROSC, V59, P395, DOI 10.1093/jmicro/dfq058; O'Leary TJ, 2004, AM J CLIN PATHOL, V122, P154; RODEWALD R, 1980, J CELL BIOL, V85, P18, DOI 10.1083/jcb.85.1.18; RODNING CB, 1980, J HISTOCHEM CYTOCHEM, V28, P199; Saitoh S, 2008, J IMMUNOL METHODS, V331, P114, DOI 10.1016/j.jim.2007.12.003; Saitoh S, 2009, MED MOL MORPHOL, V42, P24, DOI 10.1007/s00795-008-0430-y; Saitoh Y, 2014, MICROVASC RES, V91, P73, DOI 10.1016/j.mvr.2013.11.004; Saitoh Y, 2012, HISTOCHEM CELL BIOL, V137, P137, DOI 10.1007/s00418-011-0892-1; Shimo S, 2010, J IMMUNOL METHODS, V361, P64, DOI 10.1016/j.jim.2010.07.013; TAMAKI H, 1994, J HISTOCHEM CYTOCHEM, V42, P1285; TAYLOR CR, 1974, CLIN EXP IMMUNOL, V18, P417; Zhou H, 2008, REPRODUCTION, V136, P599, DOI 10.1530/REP-08-0022	53	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					189	203		10.1093/jmicro/dfv012		15	Microscopy	Microscopy	CJ0WW	WOS:000355201200005		
J	Higuchi, T; Nishiyama, H; Suga, M; Watanabe, H; Takahara, A; Jinnai, H				Higuchi, Takeshi; Nishiyama, Hidetoshi; Suga, Mitsuo; Watanabe, Hirohmi; Takahara, Atsushi; Jinnai, Hiroshi			One-step nanopatterning of conjugated polymers by electron-beam-assisted electropolymerization	MICROSCOPY			English	Article						nanopatterning; conjugated polymer; electropolymerization; atmospheric scanning electron microscopy	ORDERED BULK-HETEROJUNCTION; ORGANIC SOLAR-CELLS; NANOROD ARRAYS; PHOTOVOLTAIC CELLS; CHARGE-TRANSPORT; FABRICATION; FILMS; POLYACETYLENE; MOBILITY; DEVICES	We propose a one-step nanopatterning method where liquid monomers are polymerized directly with an electron beam under an atmospheric pressure. The method allows precise positional control of an electron beam that induces electropolymerization based on an anodic oxidation only in the irradiated areas. Various versatile conjugated polymers, including polypyrrole, polyaniline and poly(3-hexylthiophene), have been directly polymerized from monomers without solvents and patterned by our one-step nanopatterning method. Vertically oriented arrays of nanorods several hundred nanometers in diameter with an aspect ratio (height to diameter) of around two were fabricated.	[Higuchi, Takeshi; Watanabe, Hirohmi; Takahara, Atsushi; Jinnai, Hiroshi] Japan Sci & Technol Agcy JST, Takahara Soft Interfaces Project, Exploratory Res Adv Technol ERATO, Nishi Ku, Fukuoka 8190395, Japan; [Higuchi, Takeshi; Watanabe, Hirohmi; Takahara, Atsushi; Jinnai, Hiroshi] Kyushu Univ, IMCE, Nishi Ku, Fukuoka 8190395, Japan; [Nishiyama, Hidetoshi; Suga, Mitsuo] JEOL Ltd, Akishima, Tokyo 1968558, Japan	Jinnai, H (reprint author), Japan Sci & Technol Agcy JST, Takahara Soft Interfaces Project, Exploratory Res Adv Technol ERATO, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	hjinnai@cstf.kyushu-u.ac.jp	Jinnai, Hiroshi/F-8456-2014		MEXT, Japan [24310092]; Japan Science and Technology Agency	H.J. gratefully acknowledges financial support received through Grant-in-Aid no. 24310092 from MEXT, Japan. Funding to pay the Open Access publication charges for this article was provided by Japan Science and Technology Agency.	Ahn HJ, 2003, J MACROMOL SCI PURE, VA40, P1357, DOI 10.1081/MA-120025315; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Yoo SH, 2007, ADV MATER, V19, P1612, DOI 10.1002/adma.200602551; Nishiyama H, 2010, J STRUCT BIOL, V172, P191, DOI 10.1016/j.jsb.2010.08.006; Xia YN, 1999, CHEM REV, V99, P1823, DOI 10.1021/cr980002q; Haberkorn N, 2009, ACS NANO, V3, P1415, DOI 10.1021/nn900207a; Lipomi DJ, 2008, ADV FUNCT MATER, V18, P3469, DOI 10.1002/adfm.200800578; Guo LJ, 2007, ADV MATER, V19, P495, DOI 10.1002/adma.200600882; Steinhart M, 2002, SCIENCE, V296, P1997, DOI 10.1126/science.1071210; DIAZ AF, 1981, J ELECTROANAL CHEM, V129, P115, DOI 10.1016/S0022-0728(81)80008-3; Kim JS, 2010, ADV FUNCT MATER, V20, P540, DOI 10.1002/adfm.200901760; CHOU SY, 1995, APPL PHYS LETT, V67, P3114, DOI 10.1063/1.114851; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; Kim JH, 2014, ACS APPL MATER INTER, V6, P5640, DOI 10.1021/am501358k; Kolmakov A, 2003, ADV MATER, V15, P997, DOI 10.1002/adma.200304889; RONCALI J, 1992, CHEM REV, V92, P711, DOI 10.1021/cr00012a009; Cai WZ, 2010, SOL ENERG MAT SOL C, V94, P114, DOI 10.1016/j.solmat.2009.10.005; Jung SW, 2003, ADV MATER, V15, P1358, DOI 10.1002/adma.200305172; Sirringhaus H, 1998, SCIENCE, V280, P1741, DOI 10.1126/science.280.5370.1741; Tang YB, 2008, NANO LETT, V8, P4191, DOI 10.1021/nl801728d; HOTTA S, 1987, MACROMOLECULES, V20, P212, DOI 10.1021/ma00167a038; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835; Donev EU, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/50/505302; Matsui S, 1996, NANOTECHNOLOGY, V7, P247, DOI 10.1088/0957-4484/7/3/013; ITO T, 1974, J POLYM SCI POL CHEM, V12, P11, DOI 10.1002/pol.1974.170120102; Wang GM, 2003, J APPL PHYS, V93, P6137, DOI 10.1063/1.1568526; Sundarrajan S, 2010, MATER LETT, V64, P2369, DOI 10.1016/j.matlet.2010.07.054; Aryal M, 2009, ACS NANO, V3, P3085, DOI 10.1021/nn900831m; Kim HM, 2004, NANO LETT, V4, P1059, DOI 10.1021/nl049615a; Friend RH, 1999, NATURE, V397, P121, DOI 10.1038/16393; BROERS AN, 1976, APPL PHYS LETT, V29, P596, DOI 10.1063/1.89155; Djenizian T, 2010, J ELECTROCHEM SOC, V157, pH534, DOI 10.1149/1.3355855; Gibson JM, 1997, PHYS TODAY, V50, P56; Higuchi T, 2014, ELECTROCHEMISTRY, V82, P359, DOI 10.5796/electrochemistry.82.359; Kim M, 2013, ADV ENERGY MATER, V4; Kuwabata S, 2014, SCI REP-UK, V4, DOI 10.1038/srep03722; Moon SI, 2003, MACROMOLECULES, V36, P4253, DOI 10.1021/ma0300239; Patel RJ, 2011, J POLYM SCI POL PHYS, V49, P1269, DOI 10.1002/polb.22307; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Suga M, 2011, ULTRAMICROSCOPY, V111, P1650, DOI 10.1016/j.ultramic.2011.08.001; Whitten JE, 1996, SURF SCI, V347, P280, DOI 10.1016/0039-6028(95)00987-6	42	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					205	212		10.1093/jmicro/dfv013		8	Microscopy	Microscopy	CJ0WW	WOS:000355201200006		
J	Sawada, H; Shimura, N; Hosokawa, F; Shibata, N; Ikuhara, Y				Sawada, Hidetaka; Shimura, Naoki; Hosokawa, Fumio; Shibata, Naoya; Ikuhara, Yuichi			Resolving 45-pm-separated Si-Si atomic columns with an aberration-corrected STEM	MICROSCOPY			English	Article						Sub-50 pm resolution; aberration correction; cold field emission gun; scanning transmission electron microscope; high-angle annular dark field image	ELECTRON-MICROSCOPE; RESOLUTION; FIELD	Si-Si atomic columns separated by 45 pm were successfully resolved with a 300-kV aberration-corrected scanning transmission electron microscope (STEM) equipped with a cold-field emission gun. Using a sufficiently small Gaussian effective source size and a 0.4-eV energy spread at 300 kV, the focused electron probe on the specimen was simulated to be sub-50 pm. Image simulation showed that the present probe condition was sufficient to resolve 45 pm Si-Si dumbbells. A silicon crystalline specimen was observed from the [114] direction with a high-angle annular dark field STEM and the intensity profile showed 45 pm separation. A spot corresponding to (45 pm)(-1) was confirmed in the power spectrum of the Fourier transform.	[Sawada, Hidetaka; Shimura, Naoki; Hosokawa, Fumio] JEOL Ltd, Akishima, Tokyo 1968558, Japan; [Shibata, Naoya; Ikuhara, Yuichi] Univ Tokyo, Inst Engn Innovat, Tokyo 1138656, Japan; [Shibata, Naoya] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	Sawada, H (reprint author), JEOL Ltd, 3-1-2 Musashino, Akishima, Tokyo 1968558, Japan.	hsawada@jeol.co.jp	Shibata, Naoya/E-5327-2013; Ikuhara, Yuichi/N-1001-2015; Ikuhara, Yuichi/F-3066-2010	Ikuhara, Yuichi/0000-0003-3886-005X; 	Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)	Part of this work was supported by the Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program).	Haider M, 2000, ULTRAMICROSCOPY, V81, P163, DOI 10.1016/S0304-3991(99)00194-1; Hosokawa F, 2013, MICROSCOPY-JPN, V62, P23, DOI 10.1093/jmicro/dfs134; Sawada H, 2009, J ELECTRON MICROSC, V58, P357, DOI 10.1093/jmicro/dfp030; Nellist PD, 2004, SCIENCE, V305, P1741, DOI 10.1126/science.1100965; Krivanek OL, 1999, ULTRAMICROSCOPY, V78, P1, DOI 10.1016/S0304-3991(99)00013-3; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; O'Keefe MA, 2005, J ELECTRON MICROSC, V54, P169, DOI 10.1093/jmicro/dfi036; Sawada H, 2009, J ELECTRON MICROSC, V58, P341, DOI 10.1093/jmicro/dfp033; Sawada H, 2007, JPN J APPL PHYS 2, V46, pL568, DOI 10.1143/JJAP.46.L568	9	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0022-0744	1477-9986		MICROSCOPY-JPN	Microscopy	JUN	2015	64	3					213	217		10.1093/jmicro/dfv014		5	Microscopy	Microscopy	CJ0WW	WOS:000355201200007		
J	Polley, MYC; YLeung, SC; Gao, D; Mastropasqua, MG; Zabaglo, LA; Bartlett, JMS; McShane, LM; Enos, RA; Badve, SS; Bane, AL; Borgquist, S; Fineberg, S; Lin, MG; Gown, AM; Grabau, D; Gutierrez, C; Hugh, JC; Moriya, T; Ohi, Y; Osborne, CK; Penault-Llorca, FM; Piper, T; Porter, PL; Sakatani, T; Salgado, R; Starczynski, J; Laenkholm, AV; Viale, G; Dowsett, M; Hayes, DF; Nielsen, TO				Polley, Mei-Yin C.; YLeung, Samuel C.; Gao, Dongxia; Mastropasqua, Mauro G.; Zabaglo, Lila A.; Bartlett, John M. S.; McShane, Lisa M.; Enos, Rebecca A.; Badve, Sunil S.; Bane, Anita L.; Borgquist, Signe; Fineberg, Susan; Lin, Ming-Gang; Gown, Allen M.; Grabau, Dorthe; Gutierrez, Carolina; Hugh, Judith C.; Moriya, Takuya; Ohi, Yasuyo; Osborne, C. Kent; Penault-Llorca, Frederique M.; Piper, Tammy; Porter, Peggy L.; Sakatani, Takashi; Salgado, Roberto; Starczynski, Jane; Laenkholm, Anne-Vibeke; Viale, Giuseppe; Dowsett, Mitch; Hayes, Daniel F.; Nielsen, Torsten O.		Int Ki67 Breast Canc Working Grp; North American Breast Canc Grp BIG	An international study to increase concordance in Ki67 scoring	MODERN PATHOLOGY			English	Article							PRACTICE GUIDELINE UPDATE; BREAST-CANCER HIGHLIGHTS; AMERICAN SOCIETY; CLINICAL ONCOLOGY/COLLEGE; EXPERT CONSENSUS; PRIMARY THERAPY; RECOMMENDATIONS; INDEX; ESTROGEN; WOMEN	Although an important biomarker in breast cancer, Ki67 lacks scoring standardization, which has limited its clinical use. Our previous study found variability when laboratories used their own scoring methods on centrally stained tissue microarray slides. In this current study, 16 laboratories from eight countries calibrated to a specific Ki67 scoring method and then scored 50 centrally MIB-1 stained tissue microarray cases. Simple instructions prescribed scoring pattern and staining thresholds for determination of the percentage of stained tumor cells. To calibrate, laboratories scored 18 'training' and 'test' web-based images. Software tracked object selection and scoring. Success for the calibration was prespecified as Root Mean Square Error of scores compared with reference <0.6 and Maximum Absolute Deviation from reference <1.0 (log2-transformed data). Prespecified success criteria for tissue microarray scoring required intraclass correlation significantly >0.70 but aiming for observed intraclass correlation >= 0.90. Laboratory performance showed non-significant but promising trends of improvement through the calibration exercise (mean Root Mean Square Error decreased from 0.6 to 0.4, Maximum Absolute Deviation from 1.6 to 0.9; paired t-test: P=0.07 for Root Mean Square Error, 0.06 for Maximum Absolute Deviation). For tissue microarray scoring, the intraclass correlation estimate was 0.94 (95% credible interval: 0.90-0.97), markedly and significantly >0.70, the prespecified minimum target for success. Some discrepancies persisted, including around clinically relevant cutoffs. After calibrating to a common scoring method via a web-based tool, laboratories can achieve high inter-laboratory reproducibility in Ki67 scoring on centrally stained tissue microarray slides. Although these data are potentially encouraging, suggesting that it may be possible to standardize scoring of Ki67 among pathology laboratories, clinically important discrepancies persist. Before this biomarker could be recommended for clinical use, future research will need to extend this approach to biopsies and whole sections, account for staining variability, and link to outcomes.	[Polley, Mei-Yin C.] NCI, Biometr Res Branch, Div Canc Treatment & Diag, Bethesda, MD 20892 USA; [YLeung, Samuel C.; Gao, Dongxia; Nielsen, Torsten O.] Univ British Columbia, Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Mastropasqua, Mauro G.] European Inst Oncol, Div Pathol, Milan, Italy; [Mastropasqua, Mauro G.] European Inst Oncol, Lab Med, Milan, Italy; [Zabaglo, Lila A.; McShane, Lisa M.] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London, England; [Bartlett, John M. S.] Ontario Inst Canc Res, Transformat Pathol, Toronto, ON, Canada; [Enos, Rebecca A.] Emmes Corp, Rockville, MD USA; [Badve, Sunil S.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Bane, Anita L.] McMaster Univ, Juravinski Hosp, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Bane, Anita L.] McMaster Univ, Ctr Canc, Hamilton, ON, Canada; [Borgquist, Signe; Grabau, Dorthe] Lund Univ, Div Oncol & Pathol, Dept Clin Sci, Lund, Sweden; [Fineberg, Susan] Montefiore Med Ctr, Bronx, NY 10467 USA; [Fineberg, Susan] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Lin, Ming-Gang; Porter, Peggy L.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA; [Gown, Allen M.] PhenoPath Labs, Seattle, WA USA; [Gutierrez, Carolina; Osborne, C. Kent] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Gutierrez, Carolina; Osborne, C. Kent] Baylor Coll Med, Dan L Duncan Canc Ctr, Houston, TX 77030 USA; [Hugh, Judith C.] Univ Alberta, Dept Lab Med & Pathol, Edmonton, AB T6G 2M7, Canada; [Moriya, Takuya] Kawasaki Med Univ, Dept Pathol, Kurashiki, Okayama, Japan; [Ohi, Yasuyo] Hakuaikai Sagara Hosp, Dept Pathol, Kagoshima, Japan; [Penault-Llorca, Frederique M.] Ctr Jean Perrin, Dept Pathol, Clermont Ferrand, France; [Penault-Llorca, Frederique M.] Univ Auvergne, Clermont Ferrand, France; [Piper, Tammy] Western Gen Hosp, Edinburgh Canc Res Ctr, Edinburgh EH4 2XU, Midlothian, Scotland; [Sakatani, Takashi] Jichi Med Univ, Dept Pathol, Shimotsuke, Tochigi, Japan; [Salgado, Roberto] Inst Jules Bordet, B-1000 Brussels, Belgium; [Starczynski, Jane] Natl Hlth Serv, Birmingham Heart England, Birmingham, W Midlands, England; [Laenkholm, Anne-Vibeke] Slagelse Hosp, Slagelse, Denmark; [Viale, Giuseppe] European Inst Oncol, Div Pathol, Milan, Italy; [Viale, Giuseppe] European Inst Oncol, Lab Med, Milan, Italy; [Viale, Giuseppe] Univ Milan, Milan, Italy; [Dowsett, Mitch] Royal Marsden Hosp, Acad Dept Biochem, London SW3 6JJ, England; [Hayes, Daniel F.] Univ Michigan, Breast Oncol Program, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA	Nielsen, TO (reprint author), Univ British Columbia, Pathol & Lab Med, Anat Pathol, Vancouver Hosp & Hlth Sci Ctr, JP 1401,855 W 12th Ave,, Vancouver, BC V5Z 1M9, Canada.	torsten@mail.ubc.ca			Breast Cancer Research Foundation; Breakthrough Breast Cancer; National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital; Government of Ontario	This work was supported by the Breast Cancer Research Foundation. Additional funding for the UK laboratories was received from Breakthrough Breast Cancer and the National Institute for Health Research Biomedical Research Centre at the Royal Marsden Hospital. Funding for the Ontario Institute for Cancer Research is provided by the Government of Ontario. Judith Hugh is the Lilian McCullough Chair in Breast Cancer Surgery Research and the CBCF Prairies/NWT Chapter. We are grateful to the Breast International Group and North American Breast Cancer Group (BIG-NABCG) collaboration, including the leadership of Dr Nancy Davidson, Dr Martine Piccart, and Dr Larry Norton, and for the support of the Breast Cancer Research Foundation.	Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Yerushalmi R, 2010, LANCET ONCOL, V11, P174, DOI 10.1016/S1470-2045(09)70262-1; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Tang LH, 2012, AM J SURG PATHOL, V36, P1761, DOI 10.1097/PAS.0b013e318263207c; Inwald EC, 2013, BREAST CANCER RES TR, V139, P539, DOI 10.1007/s10549-013-2560-8; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Dowsett M, 2011, J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI 10.1043/1543-2165-134.6.907; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; FLEISS JL, 1971, PSYCHOL BULL, V76, P378, DOI 10.1037/h0031619; Hayes DF, 2013, BREAST, V22, pS22, DOI 10.1016/j.breast.2013.07.004; Mikami Y, 2013, CANCER SCI, V104, P1539, DOI 10.1111/cas.12245; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379	21	6	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JUN	2015	28	6					778	786		10.1038/modpathol.2015.38		9	Pathology	Pathology	CJ1ZW	WOS:000355284800004		
J	Hakimi, AA; Tickoo, SK; Jacobsen, A; Sarungbam, J; Sfakianos, JP; Sato, Y; Morikawa, T; Kume, H; Fukayama, M; Homma, Y; Chen, YB; Sankin, AI; Mano, R; Coleman, JA; Russo, P; Ogawa, S; Sander, C; Hsieh, JJ; Reuter, VE				Hakimi, A. Ari; Tickoo, Satish K.; Jacobsen, Anders; Sarungbam, Judy; Sfakianos, John P.; Sato, Yusuke; Morikawa, Teppei; Kume, Haruki; Fukayama, Masashi; Homma, Yukio; Chen, Ying-Bei; Sankin, Alexander I.; Mano, Roy; Coleman, Jonathan A.; Russo, Paul; Ogawa, Seishi; Sander, Chris; Hsieh, James J.; Reuter, Victor E.			TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype	MODERN PATHOLOGY			English	Article							HIPPEL-LINDAU GENE; EXPRESSION; MUTATIONS; PBRM1; BAP1	Integrated sequencing analysis identified a group of tumors among clear cell renal cell carcinomas characterized by hotspot mutations in TCEB1 (a gene that contributes to the VHL complex to ubiquitinate hypoxia-inducible factor). We analyzed 11 tumors from two distinct cohorts with TCEB1 mutations along with an expanded cohort to assess whether these should be considered an entity distinct from clear cell renal cell carcinoma and clear cell papillary renal cell carcinoma. All tumors were characterized by hotspot mutations in TCEB1 Y79C/S/F/N or A100P. Morphological and immunohistochemical characteristics of the tumors were assessed by two experienced genitourinary pathologists. Clinical and pathological variables, copy number alterations, mutations, and expression signatures were compared with a cohort of TCEB1 wild-type tumors. All TCEB1-mutated tumors were VHL and PBRM1 wild type and contained distinct copy number profiles including loss of heterozygosity of chromosome 8, the location of TCEB1 (8q21.11). All tumors lacked the clear cell renal cell carcinoma signature 3p loss and contained distinct gene expression signatures. None of the clear cell papillary tumors harbored TCEB1 mutations. Pathologically, all TCEB1-mutated tumors shared characteristic features including thick fibromuscular bands transecting the tumor, pure clear cell cytology frequently with cells showing voluminous cytoplasm, and clear cell renal cell carcinoma-like acinar areas associated with infolding tubular and focally papillary architecture. The presence of voluminous cytoplasm, absence of luminal polarization of tumor nuclei, and lack of extensive cup-like distribution of carbonic anhydrase-IX expression distinguish it from clear cell papillary carcinoma. None of the patients developed metastases at last follow-up (median 48 months). In sum, TCEB1-mutated renal cell carcinoma is a distinct entity with recurrent hotspot mutations, specific copy number alterations, pathway activation, and characteristic morphological features. Further clinical follow-up is needed to determine whether these tumors are more indolent compared with the conventional clear cell renal cell carcinoma.	[Hakimi, A. Ari; Sfakianos, John P.; Sankin, Alexander I.; Mano, Roy; Coleman, Jonathan A.; Russo, Paul] Mem Sloan Kettering Canc Ctr, Dept Surg, Urol Serv, New York, NY 10021 USA; [Hakimi, A. Ari; Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA; [Tickoo, Satish K.; Sarungbam, Judy; Chen, Ying-Bei; Reuter, Victor E.] Mem Sloan Kettering Canc Ctr, Pathol, New York, NY 10021 USA; [Jacobsen, Anders; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol, New York, NY 10021 USA; [Sato, Yusuke; Kume, Haruki; Homma, Yukio] Univ Tokyo, Dept Urol, Grad Sch Med, Tokyo, Japan; [Sato, Yusuke; Ogawa, Seishi] Kyoto Univ, Grad Sch Med, Dept Tumor Biol, Kyoto, Japan; [Morikawa, Teppei; Fukayama, Masashi] Univ Tokyo, Dept Pathol, Grad Sch Med, Tokyo, Japan; [Hsieh, James J.] Mem Sloan Kettering Canc Ctr, Med, New York, NY 10021 USA	Hakimi, AA (reprint author), Dept Surg, Urol Serv, 353 E 68th St, New York, NY 10065 USA.	hakimia@mskcc.org	Jacobsen, Anders/K-1081-2013	Jacobsen, Anders/0000-0001-6847-4980	Sidney Kimmel Center for Prostate and Urologic Cancers; J. Randall & Kathleen L. MacDonald Research Fund in Honor of Louis V. Gerstner, Jr; Tuttle Cancer Research Fund; Danish Research Council; MSKCC Center for Translational Cancer Genomic Analysis; PI Sander [U24 CA143840]	Funded by the Sidney Kimmel Center for Prostate and Urologic Cancers (AAH); J. Randall & Kathleen L. MacDonald Research Fund in Honor of Louis V. Gerstner, Jr (JJH); Tuttle Cancer Research Fund (JJH); Danish Research Council (AJ); MSKCC Center for Translational Cancer Genomic Analysis; and U24 CA143840 (PI Sander).	Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; Martignoni G, 2014, MODERN PATHOL, V27, P765, DOI 10.1038/modpathol.2013.180; Beroukhim R, 2009, CANCER RES, V69, P4674, DOI 10.1158/0008-5472.CAN-09-0146; Sato Y, 2013, NAT GENET, V45, P860, DOI 10.1038/ng.2699; Rohan SM, 2011, MODERN PATHOL, V24, P1207, DOI 10.1038/modpathol.2011.80; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Kapur P, 2013, LANCET ONCOL, V14, P159, DOI 10.1016/S1470-2045(12)70584-3; Hakimi AA, 2013, CLIN CANCER RES, V19, P3259, DOI 10.1158/1078-0432.CCR-12-3886; KIBEL A, 1995, SCIENCE, V269, P1444, DOI 10.1126/science.7660130; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Nickerson ML, 2008, CLIN CANCER RES, V14, P4726, DOI 10.1158/1078-0432.CCR-07-4921; Ramphal R, 2006, AM J CLIN PATHOL, V126, P349, DOI 10.1309/98YE9E442ARLX2X; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Cancer Genome Atlas Research Network, 2013, NATURE, V499, P43, DOI 10. 1038/ nature12222; Medendorp K, 2007, CYTOGENET GENOME RES, V118, P157, DOI 10.1159/000108296; Michal M, 2009, VIRCHOWS ARCH, V454, P719, DOI 10.1007/s00428-009-0788-9; Srigley JR, 2013, AM J SURG PATHOL, V37, P1469, DOI 10.1097/PAS.0b013e318299f2d1	17	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JUN	2015	28	6					845	853		10.1038/modpathol.2015.6		9	Pathology	Pathology	CJ1ZW	WOS:000355284800011		
J	Ooi, A; Oyama, T; Nakamura, R; Tajiri, R; Ikeda, H; Fushida, S; Nakamura, H; Dobashi, Y				Ooi, Akishi; Oyama, Takeru; Nakamura, Ritsuko; Tajiri, Ryosuke; Ikeda, Hiroko; Fushida, Sachio; Nakamura, Hiroyuki; Dobashi, Yoh			Semi-comprehensive analysis of gene amplification in gastric cancers using multiplex ligation-dependent probe amplification and fluorescence in situ hybridization	MODERN PATHOLOGY			English	Article							GROWTH-FACTOR RECEPTOR; BREAST-CANCER; MET AMPLIFICATION; HER2; SENSITIVITY; CARCINOMAS; COAMPLIFICATION; RECOMMENDATIONS; OVEREXPRESSION; EXPRESSION	The prognosis of patients with gastric carcinomas at an advanced stage still remains dismal, and therefore novel therapeutic modalities are urgently needed. Since the successful targeting of amplified ERBB2 with a humanized monoclonal antibody, the amplified genes of other receptor tyrosine kinases such as EGFR, FGFR2, and MET, as well as those of other cell regulator genes, are being considered as candidate targets of molecular therapy. The aim of the present study was to determine the amplification status of 26 genes, which are frequently amplified in solid cancers, in advanced gastric cancers. A total of 93 formalin-fixed and paraffin-embedded advanced gastric cancer tissues were examined by multiple ligation-dependent probe amplification, and 32 cases with 'gain' or 'amplified' status of 16 genes were further examined for the respective gene amplification by fluorescence in situ hybridization (FISH) and for the respective protein overexpression by immunohistochemistry. The frequencies of gene amplifications in advanced gastric cancers were as follows: ERBB2 (13 cases, 14%), FGFR2 (7 cases, 8%), MYC (7 cases, 8%), TOP2A (7 cases, 8%), MET (4 cases, 4%), MDM2 (4 cases, 4%), CCND1 (3 cases, 3%), FGF10 (2 cases, 3%), and EGFR (1 case, 1%). Amplification of the receptor tyrosine kinases genes occurred in a mutually exclusive manner except for one tumor in which ERBB2 and FGFR2 were both amplified but in different cancer cells. Co-amplification of ERBB2 and MYC, and EGFR and CCND1, in single nuclei but on different amplicons, was confirmed in one case each. Attempts at correlating the FISH status with the immunohistochemical staining pattern showed variable results from complete concordance to no correlation. In conclusion, combination of multiple ligation-dependent probe amplification and FISH analysis is a feasible approach for obtaining the semi-comprehensive genetic information that is necessary for personalized molecular targeted therapy.	[Ooi, Akishi; Oyama, Takeru; Nakamura, Ritsuko; Tajiri, Ryosuke] Kanazawa Univ, Dept Mol & Cellular Pathol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Ooi, Akishi; Ikeda, Hiroko] Kanazawa Univ, Univ Hosp, Pathol Sect, Kanazawa, Ishikawa 9208641, Japan; [Fushida, Sachio] Kanazawa Univ, Dept Surg, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Nakamura, Hiroyuki] Kanazawa Univ, Dept Environm & Prevent Med, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan; [Dobashi, Yoh] Jichi Med Univ, Saitama Med Ctr, Dept Pathol, Saitama, Japan	Ooi, A (reprint author), Kanazawa Univ, Dept Mol & Cellular Pathol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan.	aooi@med.kanazawa-u.ac.jp			Japanese Ministry of Education, Sports, Science, and Culture [C2546015, C25460452, C26460438, 25860266, 26860235]; Smoking Research Foundation	This work was financially supported by the Japanese Ministry of Education, Sports, Science, and Culture (C2546015 (SF), C25460452 (AO), C26460438 (YD), and Young Scientists (B) (25860266) (TO) and (26860235) (RN)), and Smoking Research Foundation (YD).	Nashimoto A, 2013, GASTRIC CANCER, V16, P1, DOI 10.1007/s10120-012-0163-4; Tajiri R, 2014, HUM PATHOL, V45, P725, DOI 10.1016/j.humpath.2013.11.004; Kobayashi M, 2002, HUM PATHOL, V33, P21, DOI 10.1053/hupa.2002.30185; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Lee HE, 2012, BRIT J CANCER, V107, P325, DOI 10.1038/bjc.2012.237; Xie L, 2013, CLIN CANCER RES, V19, P2572, DOI 10.1158/1078-0432.CCR-12-3898; Mitsui F, 2007, MODERN PATHOL, V20, P622, DOI 10.1038/modpathol.3800777; Rohmann E, 2006, NAT GENET, V38, P414, DOI 10.1038/ng1757; Perez EA, 2011, J CLIN ONCOL, V29, P651, DOI 10.1200/JCO.2010.30.2125; Jung EJ, 2012, HUM PATHOL, V43, P1559, DOI 10.1016/j.humpath.2011.12.002; Noel EE, 2010, AM J PATHOL, V176, P2607, DOI 10.2353/ajpath.2010.090780; Starczynski J, 2012, AM J CLIN PATHOL, V137, P595, DOI 10.1309/AJCPATBZ2JFN1QQC; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Ooi A, 2012, J PATHOL, V227, P8, DOI 10.1002/path.3974; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Smolen GA, 2006, P NATL ACAD SCI USA, V103, P2316, DOI 10.1073/pnas.0508776103; McInnes C, 2004, CHEM BIOL, V11, P525, DOI 10.1016/j.chembiol.2004.03.022; Lennerz JK, 2011, J CLIN ONCOL, V29, P4803, DOI 10.1200/JCO.2011.35.4928; An X, 2014, CANCER-AM CANCER SOC, V120, P675; Hara T, 1998, LAB INVEST, V78, P1143; Muller CR, 2007, INT J CANCER, V121, P199, DOI 10.1002/ijc.22643; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Deng N, 2012, GUT, V1, P73; Di Leo A, 2002, CLIN CANCER RES, V8, P1107; Fenoglio-Preiser C., 2000, WHO CLASSIFICATION T, P37; Flemming ID, 1997, AJCC CANC STAGING MA, V5th, P71; KAJITANI T, 1981, JPN J SURG, V11, P127; Kim C, 2005, BREAST CANCER RES TR, V94, pS6; Lee J, 2013, DISCOV MED, V86, P7; Matsumoto K, 2012, BRIT J CANCER, V106, P727, DOI 10.1038/bjc.2011.603; Moelans CB, 2012, CELL ONCOL, V32, P311; Nair R, 2013, ONCOGENE, V33, P3992; Spencer-Dene B, 2006, GASTROENTEROLOGY, V130, P1233, DOI 10.1053/j.gastro.2006.02.018; Takehana T, 2003, CLIN GASTROENTEROL H, V1, P438, DOI 10.1053/S1542-3565(03)00219-2	35	2	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JUN	2015	28	6					861	871		10.1038/modpathol.2015.33		11	Pathology	Pathology	CJ1ZW	WOS:000355284800013		
J	Kawachi, H; Eishi, Y; Ueno, H; Nemoto, T; Fujimori, T; Iwashita, A; Ajioka, Y; Ochiai, A; Ishiguro, S; Shimoda, T; Mochizuki, H; Kato, Y; Watanabe, H; Koike, M; Sugihara, K				Kawachi, Hiroshi; Eishi, Yoshinobu; Ueno, Hideki; Nemoto, Tetsuo; Fujimori, Takahiro; Iwashita, Akinori; Ajioka, Yoichi; Ochiai, Atsushi; Ishiguro, Shingo; Shimoda, Tadakazu; Mochizuki, Hidetaka; Kato, Yo; Watanabe, Hidenobu; Koike, Morio; Sugihara, Kenichi		Japanese Soc Canc Colon Rectum JSC	A three-tier classification system based on the depth of submucosal invasion and budding/sprouting can improve the treatment strategy for T1 colorectal cancer: a retrospective multicenter study	MODERN PATHOLOGY			English	Article							LYMPH-NODE METASTASIS; ENDOSCOPIC MUCOSAL RESECTION; EARLY COLON-CANCER; RISK-FACTORS; CARCINOMA; RECTUM; POLYPECTOMY; PROGNOSIS; THERAPY	More than 85% of patients with T1 colorectal cancer have no lymph node metastasis and can be cured by endoscopic resection. To avoid unnecessary surgery after complete endoscopic resection, accurate histologic methods for evaluating resected specimens are needed to discriminate those at high risk for lymph node metastasis. A retrospective multi-institutional, cross-sectional study of 806 T1 colorectal cancer patients was conducted. A budding/sprouting score was incorporated for predicting lymph node metastasis in addition to other parameters, including the depth of submucosal invasion, histologic grade, and lymphovascular invasion. Lymph node metastasis was detected in 97 patients. Independent predictors of lymph node metastasis by multivariate analysis were depth of submucosal invasion >= 1000 mu m (odds ratio (95% confidence interval)=5.56 (2.14-19.10)) and high-grade budding/sprouting (3.14 (1.91-5.21)). Among lesions with a depth of submucosal invasion >= 1000 mu m, lymph node metastasis was detected in 59 (29%) of 207 patients with high-grade budding/sprouting, and in 34 (9%) of 396 with low-grade budding/sprouting. Lymph node metastasis was detected in only 4 (2%) of 203 lesions with a depth of submucosal invasion < 1000 mu m. Of these four tumors, three invaded lymphatic and/or venous vessels. Thus, the risk for lymph node metastasis can be classified into three groups: high risk with a depth of submucosal invasion >= 1000 mu m and high-grade budding/sprouting, intermediate-risk with a depth of submucosal invasion >= 1000 mu m and low-grade budding/sprouting, and low-risk with a depth of submucosal invasion < 1000 mu m. These findings revealed that a depth of submucosal invasion >= 1000 mu m and high-grade budding/sprouting are powerful predictive parameters for lymph node metastasis in T1 colorectal cancer. This three-tier risk classification system will facilitate the decision for additional major surgery for T1 colorectal cancer patients after successful endoscopic treatment.	[Kawachi, Hiroshi; Eishi, Yoshinobu; Koike, Morio] Tokyo Med & Dent Univ, Dept Human Pathol, Tokyo 1138519, Japan; [Ueno, Hideki; Mochizuki, Hidetaka] Natl Def Med Coll, Dept Surg, Tokorozawa, Saitama 359, Japan; [Nemoto, Tetsuo] Komagome Hosp, Dept Pathol, Tokyo Metropolitan Canc & Infect Dis Ctr, Tokyo, Japan; [Fujimori, Takahiro] Dokkyo Med Univ, Dept Surg & Mol Pathol, Mibu, Tochigi, Japan; [Iwashita, Akinori] Fukuoka Univ, Dept Pathol, Chikushi Hosp, Fukuoka, Japan; [Ajioka, Yoichi] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Diagnost Pathol, Niigata, Japan; [Ochiai, Atsushi] Natl Canc Ctr Hosp East, Div Pathol, Res Ctr Innovat Oncol, Kashiwa, Chiba, Japan; [Ishiguro, Shingo; Watanabe, Hidenobu] PCL Japan, Tokyo, Japan; [Shimoda, Tadakazu] Natl Canc Ctr, Clin Lab Div, Tokyo, Japan; [Kato, Yo] Canc Inst Hosp, Dept Pathol, Tokyo, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Tokyo, Japan	Kawachi, H (reprint author), Tokyo Med & Dent Univ, Dept Human Pathol, Bunkyo Ku, Yushima 1-5-45, Tokyo 1138519, Japan.	kawapth1@tmd.ac.jp			Japanese Society for Cancer of the Colon and Rectum	We thank Dr Tetsuji Yokoyama for assistance of the statistical analysis. This study was financially supported by the Japanese Society for Cancer of the Colon and Rectum.	Tominaga K, 2005, DIS COLON RECTUM, V48, P92, DOI 10.1007/S10350-004-0751-4; Ogawa T, 2009, SCAND J GASTROENTERO, V44, P605, DOI 10.1080/00365520902718911; Egashira Y, 2004, MODERN PATHOL, V17, P503, DOI 10.1038/modpathol.3800030; Yasuda K, 2007, DIS COLON RECTUM, V50, P1370, DOI 10.1007/s10350-007-0263-0; Tateishi Y, 2010, MODERN PATHOL, V23, P1068, DOI 10.1038/modpathol.2010.88; Matsuda T, 2011, CANCER SCI, V102, P1693, DOI 10.1111/j.1349-7006.2011.01997.x; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Nascimbeni R, 2002, DIS COLON RECTUM, V45, P200, DOI 10.1007/s10350-004-6147-7; Bosch SL, 2013, ENDOSCOPY, V45, P827, DOI 10.1055/s-0033-1344238; Beaton C, 2013, COLORECTAL DIS, V15, P788, DOI 10.1111/codi.12129; Labianca R, 2013, ANN ONCOL, V24, P64, DOI 10.1093/annonc/mdt354; Sakuragi M, 2003, DIS COLON RECTUM, V46, P1626, DOI 10.1097/01.DCR.0000100821.53077.DD; Nakadoi K, 2012, J GASTROEN HEPATOL, V27, P1057, DOI 10.1111/j.1440-1746.2011.07041.x; Ueno H, 2004, GASTROENTEROLOGY, V127, P385, DOI 10.1053/S0016-5085(04)00717-6; Okabe S, 2004, J GASTROINTEST SURG, V8, P1032, DOI 10.1016/j.gassur.2004.09.038; HASE K, 1993, DIS COLON RECTUM, V36, P627, DOI 10.1007/BF02238588; Yamamoto S, 2004, HEPATO-GASTROENTEROL, V51, P998; Choi DH, 2009, DIS COLON RECTUM, V52, P438, DOI 10.1007/DCR.0b013e318197e37f; MORODOMI T, 1989, CANCER, V63, P539, DOI 10.1002/1097-0142(19890201)63:3<539::AID-CNCR2820630323>3.0.CO;2-S; Mitrovic B, 2012, MODERN PATHOL, V25, P1315, DOI 10.1038/modpathol.2012.94; Araki Yasumi, 1993, Kurume Medical Journal, V40, P123; COLACCHIO TA, 1981, ANN SURG, V194, P704, DOI 10.1097/00000658-198112000-00008; HAGGITT R C, 1985, Gastroenterology, V89, P328; Hori H, 2005, DIS COLON RECTUM, V48, P938, DOI 10.1007/s10350-004-0883-6; Japanese Society for Cancer of the Colon and Rectum, 2005, JAP SOC CANC COL REC; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC, V2nd, p[6, 37, 57]; KARITA M, 1991, GASTROINTEST ENDOSC, V37, P128, DOI 10.1016/S0016-5107(91)70669-X; KUDO S, 1993, ENDOSCOPY, V25, P455, DOI 10.1055/s-2007-1010367; Lockhart-Mummery HE, 1952, LANCET, V260, P751, DOI 10.1016/S0140-6736(52)91235-X; Masaki T, 2000, J GASTROENTEROL, V35, P195, DOI 10.1007/s005350050330; MORSON BC, 1966, P ROY SOC MED, V59, P607; Shimomura T, 2004, J GASTROEN HEPATOL, V19, P48, DOI 10.1111/j.1440-1746.2004.03261.x; Sobin LH, 2009, TNM CLASSIFICATION M, P100; WILLIAMS C, 1973, BRIT MED J, V1, P451	35	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0893-3952	1530-0285		MODERN PATHOL	Mod. Pathol.	JUN	2015	28	6					872	879		10.1038/modpathol.2015.36		8	Pathology	Pathology	CJ1ZW	WOS:000355284800014		
J	Kuwahara, K; Harada, K; Yamagoshi, R; Yamamoto, T; Shinohara, Y				Kuwahara, Kana; Harada, Kazuki; Yamagoshi, Ryohei; Yamamoto, Takenori; Shinohara, Yasuo			Effects of employment of distinct strategies to capture antibody on antibody delivery into cultured cells	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Antibody delivery; Cell-penetrating peptide; Protein A; Hydrophobic motif	INTRACELLULAR DELIVERY; PROTEINS; TRANSDUCTION; PEPTIDES	The characteristics of antibody delivery into cultured HeLa cells were examined using two delivery systems. Both systems used a cell-penetrating peptide as a tool for intrusion of an antibody into the cells, but either a "protein A derivative'' or "hydrophobic motif'' was employed to capture the antibody. When we examined the uptake of the Alexa Fluor-labeled antibody by the use of these two systems, both systems were found to effectively deliver the antibody into the cultured cells. However, when we compared the amount of antibody delivered by these systems with the amount of transferrin uptake, the former was 10 times smaller than the latter. The lower efficiency of antibody delivery than transferrin uptake seemed to be attributable to the involvement of the antibody delivery reagent, which failed to catch the antibody molecule. This interpretation was validated by an experiment using a larger amount of antibody, and the amount of antibody delivered by the "protein A derivative'' system under this condition was determined to be 13 ng proteins/10(5) cells. The antibody delivery achieved by the "protein A derivative'' or "hydrophobic motif'' showed two differences, i.e., a difference in intracellular distribution of the delivered antibody molecules and a difference in the fluorescence spectrum observed with cellular lysates. Possible reasons for these differences between the two delivery systems are discussed.	[Kuwahara, Kana; Harada, Kazuki; Yamagoshi, Ryohei; Yamamoto, Takenori; Shinohara, Yasuo] Univ Tokushima, Inst Genome Res, Tokushima 7708503, Japan; [Kuwahara, Kana; Harada, Kazuki; Yamagoshi, Ryohei; Yamamoto, Takenori; Shinohara, Yasuo] Univ Tokushima, Fac Pharmaceut Sci, Tokushima 7708505, Japan	Shinohara, Y (reprint author), Univ Tokushima, Inst Genome Res, Kuramoto Cho 3, Tokushima 7708503, Japan.	yshinoha@genome.tokushima-u.ac.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry	This study was supported by the grant from the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries, and Food Industry.	Mussbach F, 2011, J CELL BIOCHEM, V112, P3824, DOI 10.1002/jcb.23313; Zelphati O, 2001, J BIOL CHEM, V276, P35103, DOI 10.1074/jbc.M104920200; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Marschall ALJ, 2014, MABS-AUSTIN, V6, P943, DOI 10.4161/mabs.29268; Mie M, 2003, BIOCHEM BIOPH RES CO, V310, P730, DOI 10.1016/j.bbrc.2003.09.071; Kameyama S, 2007, BIOPOLYMERS, V88, P98, DOI 10.1002/bip.20689; Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173; Futaki S, 2002, INT J PHARM, V245, P1, DOI 10.1016/S0378-5173(02)00337-X; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Hada T, 2012, PROTEIN EXPRES PURIF, V82, P192, DOI 10.1016/j.pep.2012.01.006; Hirano K, 2004, FEBS LETT, V570, P149, DOI 10.1016/j.febslet.2004.05.084; Itakura S, 2014, FEBS J IN PRESS; Kato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082876; Mellert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052473; Oba M, 2012, BIOL PHARM BULL, V35, P1064; Rawe VY, 2008, HUM REPROD, V23, P573, DOI 10.1093/humrep/dem385; Remacle AG, 2005, J CELL SCI, V118, P4975, DOI 10.1242/jcs.02610; Torricelli C, 2011, IN VITRO CELL DEV-AN, V47, P73, DOI 10.1007/s11626-010-9355-6; van der Gun BTF, 2007, J CONTROL RELEASE, V123, P228, DOI 10.1016/j.jconrel.2007.08.014; Yamaguchi K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/872065	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	JUN	2015	404	1-2					25	30		10.1007/s11010-015-2362-x		6	Cell Biology	Cell Biology	CJ4DE	WOS:000355433900004		
J	San-Jose, LM; Ducrest, AL; Ducret, V; Beziers, P; Simon, C; Wakamatsu, K; Roulin, A				San-Jose, Luis M.; Ducrest, Anne-Lyse; Ducret, Valerie; Beziers, Paul; Simon, Celine; Wakamatsu, Kazumasa; Roulin, Alexandre			Effect of the MC1R gene on sexual dimorphism in melanin-based colorations	MOLECULAR ECOLOGY			English	Article						adaptive coloration; barn owl; genetic basis of coloration; natural selection; pigmentation; sexual selection	OWLS TYTO-ALBA; MELANOCORTIN-1 RECEPTOR GENE; GYRFALCON FALCO-RUSTICOLUS; PLUMAGE COLOR; BARN OWL; LOCAL ADAPTATION; NATURAL-SELECTION; FEMALE ORNAMENT; MOLECULAR-BASIS; POLYMORPHISM	Variants of the melanocortin-1 receptor (MC1R) gene result in abrupt, naturally selected colour morphs. These genetic variants may differentially affect sexual dimorphism if one morph is naturally selected in the two sexes but another morph is naturally or sexually selected only in one of the two sexes (e.g. to confer camouflage in reproductive females or confer mating advantage in males). Therefore, the balance between natural and sexual selections can differ between MC1R variants, as suggest studies showing interspecific correlations between sexual dimorphism and the rate of nonsynonymous vs. synonymous amino acid substitutions at the MC1R. Surprisingly, how MC1R is related to within-species sexual dimorphism, and thereby to sex-specific selection, has not yet been investigated. We tackled this issue in the barn owl (Tyto alba), a species showing pronounced variation in the degree of reddish pheomelanin-based coloration and in the number and size of black feather spots. We found that a valine (V)-to-isoleucine (I) substitution at position 126 explains up to 30% of the variation in the three melanin-based colour traits and in feather melanin content. Interestingly, MC1R genotypes also differed in the degree of sexual colour dimorphism, with individuals homozygous for the II MC1R variant being 2 times redder and 2.5 times less sexually dimorphic than homozygous individuals for the VV MC1R variant. These findings support that MC1R interacts with the expression of sexual dimorphism and suggest that a gene with major phenotypic effects and weakly influenced by variation in body condition can participate in sex-specific selection processes.	[San-Jose, Luis M.; Ducrest, Anne-Lyse; Ducret, Valerie; Beziers, Paul; Simon, Celine; Roulin, Alexandre] Univ Lausanne, Dept Ecol & Evolut, CH-1015 Lausanne, Switzerland; [Wakamatsu, Kazumasa] Fujita Hlth Univ, Sch Hlth Sci, Dept Chem, Toyoake, Aichi 4701192, Japan	Roulin, A (reprint author), Univ Lausanne, Dept Ecol & Evolut, Biophore Bldg, CH-1015 Lausanne, Switzerland.	alexandre.roulin@unil.ch		Wakamatsu, Kazumasa/0000-0003-1748-9001	Swiss National Science Foundation [31003A-120517]	We thank three anonymous reviewers for their constructive comments and the Swiss National Science Foundation for funding this study (31003A-120517 to AR). The study was performed under legal authorization of the 'Service veterinaire du canton de Vaud'.	Py I, 2006, EVOL ECOL RES, V8, P483; Hubbard JK, 2010, TRENDS GENET, V26, P231, DOI 10.1016/j.tig.2010.02.002; Nachman MW, 2003, P NATL ACAD SCI USA, V100, P5268, DOI 10.1073/pnas.0421157100; Ito S, 2011, PIGM CELL MELANOMA R, V24, P63, DOI 10.1111/j.1755-148X.2010.00755.x; Dreiss AN, 2012, J EVOLUTION BIOL, V25, P103, DOI 10.1111/j.1420-9101.2011.02407.x; Doucet SM, 2004, P ROY SOC B-BIOL SCI, V271, P1663, DOI 10.1098/rspb.2004.2779; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Roulin A, 2010, ECOL LETT, V13, P616, DOI 10.1111/j.1461-0248.2010.01459.x; Mogil JS, 2003, P NATL ACAD SCI USA, V100, P4867, DOI 10.1073/pnas.0730053100; Jablonski NG, 2010, P NATL ACAD SCI USA, V107, P8962, DOI 10.1073/pnas.0914628107; Baiao PC, 2012, J HERED, V103, P322, DOI 10.1093/jhered/esr151; Clusella Trullas S, 2007, J THERM BIOL, V32, P235, DOI 10.1016/j.jtherbio.2007.01.003; Garcia-Borron JC, 2005, PIGM CELL RES, V18, P393, DOI 10.1111/j.1600-0749.2005.00278.x; Cotton S, 2004, P ROY SOC B-BIOL SCI, V271, P771, DOI 10.1098/rspb.2004.2688; Nowacka-Woszuk J, 2013, J ANIM BREED GENET, V130, P136, DOI 10.1111/jbg.12005; Manceau M, 2010, PHILOS T R SOC B, V365, P2439, DOI 10.1098/rstb.2010.0104; Hoekstra HE, 2005, HEREDITY, V94, P217, DOI 10.1038/sj.hdy.6800600; Roulin A, 2011, EUR J PHARMACOL, V660, P226, DOI 10.1016/j.ejphar.2011.01.036; Kerje S, 2003, ANIM GENET, V34, P241, DOI 10.1046/j.1365-2052.2003.00991.x; Oliva ABP, 2009, HUM MUTAT, V30, P811, DOI 10.1002/humu.20971; Wakamatsu K, 2002, PIGM CELL RES, V15, P225, DOI 10.1034/j.1600-0749.2002.02009.x; Roulin A, 2015, J EVOLUTION BIOL, V28, P655, DOI 10.1111/jeb.12596; Uy JAC, 2009, AM NAT, V174, P244, DOI 10.1086/600084; Roulin A, 2013, SEMIN CELL DEV BIOL, V24, P594, DOI 10.1016/j.semcdb.2013.05.005; Rosenblum EB, 2004, EVOLUTION, V58, P1794, DOI 10.1111/j.0014-3820.2004.tb00462.x; Antoniazza S, 2010, EVOLUTION, V64, P1944, DOI 10.1111/j.1558-5646.2010.00969.x; Dessinioti C, 2011, PHOTOCHEM PHOTOBIOL, V87, P978, DOI 10.1111/j.1751-1097.2011.00970.x; KAUFMAN DW, 1974, J MAMMAL, V55, P271, DOI 10.2307/1378997; Dreiss AN, 2010, BIOL J LINN SOC, V101, P689, DOI 10.1111/j.1095-8312.2010.01503.x; Kronforst MR, 2012, PIGM CELL MELANOMA R, V25, P411, DOI 10.1111/j.1755-148X.2012.01014.x; Nadeau NJ, 2007, P R SOC B, V274, P1807, DOI 10.1098/rspb.2007.0174; Theron E, 2001, CURR BIOL, V11, P550, DOI 10.1016/S0960-9822(01)00158-0; Mundy NI, 2005, P ROY SOC B-BIOL SCI, V272, P1633, DOI 10.1098/rspb.2005.3107; Antoniazza S, 2014, MOL ECOL, V23, P5508, DOI 10.1111/mec.12957; Charter M, 2012, BIRD STUDY, V59, P368, DOI 10.1080/00063657.2012.669360; Cibois A, 2012, J AVIAN BIOL, V43, P3, DOI 10.1111/j.1600-048X.2011.05546.x; Davila SG, 2014, POULTRY SCI, V93, P1089, DOI 10.3382/ps.2013-03611; Gangoso L, 2011, J EVOLUTION BIOL, V24, P2055, DOI 10.1111/j.1420-9101.2011.02336.x; Janssen K, 2013, MOL ECOL, V22, P4634, DOI 10.1111/mec.12428; Johnson JA, 2012, J HERED, V103, P315, DOI 10.1093/jhered/ess023; Linderholm A, 2013, SEMIN CELL DEV BIOL, V24, P587, DOI 10.1016/j.semcdb.2013.03.015; Mundy NI, 2004, SCIENCE, V303, P1870, DOI 10.1126/science.1093834; Pinheiro J. C., 2000, MIXED EFFECTS MODELS; Roulin A, 2004, OECOLOGIA, V140, P668, DOI 10.1007/s00442-004-1636-x; Roulin A, 1999, BEHAV ECOL, V10, P688, DOI 10.1093/beheco/10.6.688; Roulin A, 2004, EVOL ECOL RES, V6, P1253; Roulin A, 2013, BIOL J LINN SOC, V109, P562, DOI 10.1111/bij.12078; Roulin A, 2003, J AVIAN BIOL, V34, P251, DOI 10.1034/j.1600-048X.2003.03022.x; Roulin A, 2009, J EVOLUTION BIOL, V22, P345, DOI 10.1111/j.1420-9101.2008.01651.x; Roulin A, 2003, HEREDITY, V90, P359, DOI 10.1038/sj.hdy.6800260; Saino N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060426; Yu WH, 2013, ANIM GENET, V44, P214, DOI 10.1111/j.1365-2052.2012.02377.x; Zhan XJ, 2012, ANIM GENET, V43, P460, DOI 10.1111/j.1365-2052.2011.02263.x	53	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0962-1083	1365-294X		MOL ECOL	Mol. Ecol.	JUN	2015	24	11					2794	2808		10.1111/mec.13193		15	Biochemistry & Molecular Biology; Ecology; Evolutionary Biology	Biochemistry & Molecular Biology; Environmental Sciences & Ecology; Evolutionary Biology	CJ1FS	WOS:000355228800016		
J	Matsuoka, M				Matsuoka, Masaaki			Protective Effects of Humanin and Calmodulin-Like Skin Protein in Alzheimer's Disease and Broad Range of Abnormalities	MOLECULAR NEUROBIOLOGY			English	Review						Calmodulin-like skin protein; Humanin; Alzheimer's disease; Diabetes mellitus	CYTOPROTECTIVE PEPTIDE HUMANIN; NEURONAL CELL-DEATH; APOE DEFICIENT MICE; IN-VIVO; MEMORY IMPAIRMENT; RELEVANT INSULTS; EPIDERMAL DIFFERENTIATION; MEDIATED NEUROPROTECTION; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR	Humanin is a 24-amino acid, secreted bioactive peptide that prevents various types of cell death and improves some types of cell dysfunction. Humanin inhibits neuronal cell death that is caused by a familial Alzheimer's disease (AD)-linked gene via binding to the heterotrimeric Humanin receptor (htHNR). This suggests that Humanin may play a protective role in AD-related pathogenesis. Calmodulin-like skin protein (CLSP) has recently been identified as a physiological agonist of htHNR with 10(5)-fold more potent anti-cell death activity than Humanin. Humanin has also shown to have protective effects against some metabolic disorders. In this review, the broad range of functions of Humanin and the functions of CLSP that have been characterized thus far are summarized.	Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, Tokyo 1608402, Japan	Matsuoka, M (reprint author), Tokyo Med Univ, Dept Pharmacol, Shinjuku Ku, 6-1-1 Shinjuku, Tokyo 1608402, Japan.	sakimatu@tokyo-med.ac.jp					Wang T, 2013, BEHAV BRAIN RES, V247, P132, DOI 10.1016/j.bbr.2013.03.023; Caricasole A, 2002, FASEB J, V16, P1331, DOI 10.1096/fj.02-0018fje; Zhang WJ, 2012, PHARMACOL BIOCHEM BE, V100, P361, DOI 10.1016/j.pbb.2011.09.012; Ikonen M, 2003, P NATL ACAD SCI USA, V100, P13042, DOI 10.1073/pnas.2135111100; Wang T, 2013, NEUROSCIENCE, V231, P70, DOI 10.1016/j.neuroscience.2012.11.019; Muzumdar RH, 2010, ARTERIOSCL THROM VAS, V30, P1940, DOI 10.1161/ATVBAHA.110.205997; Hashimoto Y, 2001, J NEUROSCI, V21, P9235; Xu XS, 2006, STROKE, V37, P2613, DOI 10.1161/01.STR.0000242772.94277.1f; Lee CH, 2013, TRENDS ENDOCRIN MET, V24, P222, DOI 10.1016/j.tem.2013.01.005; Mehul B, 2000, J BIOL CHEM, V275, P12841, DOI 10.1074/jbc.275.17.12841; Niikura T, 2004, MOL NEUROBIOL, V30, P327, DOI 10.1385/MN:30:3:327; Hwang M, 2003, J BIOL CHEM, V278, P47827, DOI 10.1074/jbc.M306561200; Donovan M, 2013, EXP DERMATOL, V22, P836, DOI 10.1111/exd.12274; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Hashimoto Y, 2009, MOL BIOL CELL, V20, P2864, DOI 10.1091/mbc.E09-02-0168; Chiba T, 2005, J NEUROSCI, V25, P10252, DOI 10.1523/JNEUROSCI.3348-05.2005; Oh YK, 2011, ATHEROSCLEROSIS, V219, P65, DOI 10.1016/j.atherosclerosis.2011.06.038; Nishimoto I, 2004, TRENDS MOL MED, V10, P102, DOI 10.1016/j.molmed.2004.01.001; Xu XS, 2010, BRAIN RES, V1355, P189, DOI 10.1016/j.brainres.2010.07.080; Matsuoka M, 2010, MOL NEUROBIOL, V41, P22, DOI 10.1007/s12035-009-8090-z; Yamada M, 2008, NEUROPSYCHOPHARMACOL, V33, P2020, DOI 10.1038/sj.npp.1301591; Luciano F, 2005, J BIOL CHEM, V280, P15825, DOI 10.1074/jbc.M413062200; Rossini L, 2011, FASEB J, V25, P1983, DOI 10.1096/fj.10-163535; Hoang PT, 2010, METABOLISM, V59, P343, DOI 10.1016/j.metabol.2009.08.001; Maximov V, 2002, MED HYPOTHESES, V59, P670, DOI 10.1016/S0306-9877(02)00223-2; Kariya S, 2005, NEUROPEPTIDES, V39, P97, DOI 10.1016/j.npep.2004.11.004; Guo B, 2003, NATURE, V423, P456, DOI 10.1038/nature01627; Kariya S, 2005, ACTA NEUROPATHOL, V109, P367, DOI 10.1007/s00401-004-0965-5; Kunesova G, 2008, PEPTIDES, V29, P1982, DOI 10.1016/j.peptides.2008.06.019; Ying GG, 2004, J IMMUNOL, V172, P7078; Zhai DY, 2005, J BIOL CHEM, V280, P15815, DOI 10.1074/jbc.M411902200; Guo F, 2010, SYNAPSE, V64, P83, DOI 10.1002/syn.20707; Sponne I, 2004, MOL CELL NEUROSCI, V25, P95, DOI 10.1016/j.mcn.2003.09.017; Tajima H, 2002, NEUROSCI LETT, V324, P227, DOI 10.1016/S0304-3940(02)00199-4; Jin H, 2010, NEUROCHEM INT, V56, P417, DOI 10.1016/j.neuint.2009.11.015; Hashimoto Y, 2005, LIFE SCI, V77, P3092, DOI 10.1016/j.lfs.2005.03.031; Niikura T, 2004, J NEUROSCI RES, V77, P54, DOI 10.1002/jnr.20139; Arakawa T, 2011, CURR MED CHEM, V18, P5554; Bachar AR, 2010, CARDIOVASC RES, V91, P199, DOI [10.1016/j.lfs.2012.07.010, DOI 10.1016/J.LFS.2012.07.010]; Bodzioch M, 2009, GENOMICS, V94, P247, DOI 10.1016/j.ygeno.2009.05.006; Chin YP, 2013, ENDOCRINOLOGY, V154, P3739, DOI 10.1210/en.2012-2004; Colon E, 2006, J CELL PHYSIOL, V208, P373, DOI 10.1002/jcp.20672; Eriksson E, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/djt459; Hashimoto Y, 2009, BIOCHEM BIOPH RES CO, V389, P95, DOI 10.1016/j.bbrc.2009.08.095; Hashimoto Y, 2001, P NATL ACAD SCI USA, V98, P6336, DOI 10.1073/pnas.101133498; Hashimoto Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.80; Hayashi M, 2014, NEUROREPORT, V25, P731, DOI [10.1097/WNR.0b013e328362d9fe, DOI 10.1097/WNR.0B013E328362D9FE]; Hwang M, 2005, GENE EXPR PATTERNS, V5, P801, DOI 10.1016/j.modgep.2005.03.010; Jia Y, 2013, ANDROLOGY-US, V1, P651, DOI 10.1111/j.2047-2927.2013.00091.x; Kariya S, 2003, MOL CELL BIOCHEM, V254, P83, DOI 10.1023/A:1027372519726; Kariya S, 2005, J MOL NEUROSCI, V25, P165, DOI 10.1385/JMN:25:2:165; Kiemnec-Tyburczy KM, 2011, GENES GENET SYST, V86, P131; Kin T, 2006, J HUM GENET, V51, P555, DOI 10.1007/s10038-006-0397-2; Klein LE, 2013, BIOCHEM BIOPH RES CO, V440, P197, DOI 10.1016/j.bbrc.2013.08.055; Krejcova G, 2004, J PEPT SCI, V10, P636, DOI 10.1002/psc.569; Kuliawat R, 2013, FASEB J, V27, P4890, DOI 10.1096/fj.13-231092; Lue YH, 2010, ENDOCRINOLOGY, V151, P350, DOI 10.1210/en.2009-0577; Mahboobi H, 2014, CNS NEUROL DISORD-DR, V13, P543; Mamiya T, 2001, BRIT J PHARMACOL, V134, P1597, DOI 10.1038/sj.bjp.0704429; Matsuoka Masaaki, 2009, Recent Pat CNS Drug Discov, V4, P37; Matsuoka M, 2011, J ALZHEIMERS DIS, V24, P27, DOI 10.3233/JAD-2011-102076; Men J, 2012, J MOL NEUROSCI, V47, P144, DOI 10.1007/s12031-011-9701-5; Miao JT, 2008, NEUROPEPTIDES, V42, P557, DOI 10.1016/j.npep.2008.08.004; Moretti E, 2010, FERTIL STERIL, V94, P2888, DOI 10.1016/j.fertnstert.2010.04.075; Muzumdar RH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006334; Niikura T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016259; Niikura T, 2003, EUR J NEUROSCI, V17, P1150, DOI 10.1046/j.1460-9568.2003.02553.x; Park TY, 2013, J CONTROL RELEASE, V166, P307, DOI 10.1016/j.jconrel.2012.12.022; Rogers MS, 2001, EXP CELL RES, V267, P216, DOI 10.1006/excr.2001.5254; Tajima H, 2005, J NEUROSCI RES, V79, P714, DOI 10.1002/jnr.20391; Takeshita Y, 2013, J BIOL CHEM, V288, P24691, DOI 10.1074/jbc.M113.469692; Wang ZJ, 2014, HIPPOCAMPUS, V24, P44, DOI 10.1002/hipo.22202; Yen K, 2013, J MOL ENDOCRINOL, V50, pR11, DOI 10.1530/JME-12-0203; Zacharias DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031065; Zhang W, 2009, PEPTIDES, V30, P1197, DOI 10.1016/j.peptides.2009.02.017; Zhang W, 2013, J PEPT SCI, V19, P159, DOI 10.1002/psc.2484; Zhang X, 2012, LIFE SCI, V91, P199, DOI 10.1016/j.lfs.2012.07.010; Zhao ST, 2013, NEUROCHEM RES, V38, P581, DOI 10.1007/s11064-012-0951-6; Zhao ST, 2012, NEUROCHEM RES, V37, P153, DOI 10.1007/s11064-011-0593-0; Zou P, 2003, PEPTIDES, V24, P679, DOI 10.1016/S0196-9781(03)00131-1	80	0	0	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUN	2015	51	3					1232	1239		10.1007/s12035-014-8799-1		8	Neurosciences	Neurosciences & Neurology	CI3CM	WOS:000354625100033		
J	Nagasaka, K; Hirota, T				Nagasaka, Kota; Hirota, Toru			Clarifying the role of condensin in shaping chromosomes	NATURE CELL BIOLOGY			English	Editorial Material							STRUCTURAL INTEGRITY; TOPOISOMERASE-II; CELLS; DNA; DECATENATION	A major controversy in the field of chromosome research has been whether condensin is required for achieving the highly compacted state of chromatin fibres in mitosis and meiosis. Through genetic experiments in mouse oocytes, condensin is now found to be indispensable for meiotic chromosome assembly by mediating chromosome compaction and disentanglement of sister chromatids and by conferring rigidity to chromosomes.	[Nagasaka, Kota; Hirota, Toru] Japanese Fdn Canc Res, Inst Canc, Div Expt Pathol, Koto Ku, Tokyo 1358550, Japan	Nagasaka, K (reprint author), Japanese Fdn Canc Res, Inst Canc, Div Expt Pathol, Koto Ku, Ariake 3-8-31, Tokyo 1358550, Japan.	thirota@jfcr.or.jp					Thadani R, 2012, CURR BIOL, V22, pR1012, DOI 10.1016/j.cub.2012.10.023; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Houlard M, 2015, NAT CELL BIOL, V17, P771, DOI 10.1038/ncb3167; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Baxter J, 2011, SCIENCE, V331, P1328, DOI 10.1126/science.1201538; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Cuylen S, 2011, TRENDS CELL BIOL, V21, P552, DOI 10.1016/j.tcb.2011.06.003; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; Hirano T, 2012, GENE DEV, V26, P1659, DOI 10.1101/gad.194746.112; Nishide K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004847; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Savvidou E, 2005, J CELL SCI, V118, P2529, DOI 10.1242/jcs.02392; Strick TR, 2004, CURR BIOL, V14, P874, DOI 10.1016/j.cub.2004.04.038	16	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					711	713				4	Cell Biology	Cell Biology	CJ1XD	WOS:000355277500003		
J	Tsujita, K; Takenawa, T; Itoh, T				Tsujita, Kazuya; Takenawa, Tadaomi; Itoh, Toshiki			Feedback regulation between plasma membrane tension and membrane-bending proteins organizes cell polarity during leading edge formation	NATURE CELL BIOLOGY			English	Article							WASP-WIP COMPLEX; ACTIN POLYMERIZATION; BAR PROTEINS; CYTOSKELETON; MIGRATION; INVAGINATION; CURVATURE; ADHESION; DOMAINS; ENDOCYTOSIS	Tension applied to the plasma membrane (PM) is a global mechanical parameter involved in cell migration. However, how membrane tension regulates actin assembly is unknown. Here, we demonstrate that FBP17, a membrane-bending protein and an activator of WASP/N-WASP-dependent actin nucleation, is a PM tension sensor involved in leading edge formation. In migrating cells, FBP17 localizes to short membrane invaginations at the leading edge, while diminishing from the cell rear in response to PM tension increase. Conversely, following reduced PM tension, FBP17 dots randomly distribute throughout the cell, correlating with loss of polarized actin assembly on PM tension reduction. Actin protrusive force is required for the polarized accumulation, indicating a role for FBP17-mediated activation of WASP/N-WASP in PM tension generation. In vitro experiments show that FBP17 membrane-bending activity depends on liposomal membrane tension. Thus, FBP17 is the local activator of actin polymerization that is inhibited by PM tension in the feedback loop that regulates cell migration.	[Tsujita, Kazuya; Itoh, Toshiki] Kobe Univ, Org Adv Sci & Technol, Biosignal Res Ctr, Nada Ku, Kobe, Hyogo 6578501, Japan; [Itoh, Toshiki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Itoh, T (reprint author), Kobe Univ, Org Adv Sci & Technol, Biosignal Res Ctr, Nada Ku, 1-1 Rokkodai Cho, Kobe, Hyogo 6578501, Japan.	titoh@people.kobe-u.ac.jp			Japan Society for the Promotion of Science (JSPS); JSPS; Uehara a Memorial Foundation	We would like to thank T. Inoue for discussions, M. Ichikawa for technical assistance and H. Yamamoto for help with plasmid constructions. This study was supported by a Grant-in-Aid for Scientific Research (C) from the Japan Society for the Promotion of Science (JSPS) to K.T. and T.I., a Grant-in-Aid for Scientific Research (S) from JSPS to T.T amd a Uehara a Memorial Foundation grant K.T.	Allard J., 2012, CURR OPIN CELL BIOL, V25, P107; Frost A, 2008, CELL, V132, P807, DOI 10.1016/j.cell.2007.12.041; Veltman DM, 2012, J CELL BIOL, V198, P501, DOI 10.1083/jcb.201205058; Iglesias PA, 2012, CURR OPIN CELL BIOL, V24, P245, DOI 10.1016/j.ceb.2011.11.009; Itoh T, 2006, BBA-MOL CELL BIOL L, V1761, P897, DOI 10.1016/j.bbalip.2006.06.015; Shimada A, 2007, CELL, V129, P761, DOI 10.1016/j.cell.2007.03.040; Guerrier S, 2009, CELL, V138, P990, DOI 10.1016/j.cell.2009.06.047; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Houk AR, 2012, CELL, V148, P175, DOI 10.1016/j.cell.2011.10.050; Giannone G, 2007, CELL, V128, P561, DOI 10.1016/j.cell.2006.12.039; Soderling SH, 2002, NAT CELL BIOL, V4, P970, DOI 10.1038/ncb886; Gauthier NC, 2012, TRENDS CELL BIOL, V22, P527, DOI 10.1016/j.tcb.2012.07.005; Ho HYH, 2004, CELL, V118, P203, DOI 10.1016/j.cell.2004.06.027; Diz-Munoz A, 2013, TRENDS CELL BIOL, V23, P47, DOI 10.1016/j.tcb.2012.09.006; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Hao JJ, 2009, J CELL BIOL, V184, P451, DOI 10.1083/jcb.200807047; Gauthier NC, 2011, P NATL ACAD SCI USA, V108, P14467, DOI 10.1073/pnas.1105845108; Raucher D, 2000, CELL, V100, P221, DOI 10.1016/S0092-8674(00)81560-3; Takano K, 2008, EMBO J, V27, P2817, DOI 10.1038/emboj.2008.216; Padrick SB, 2008, MOL CELL, V32, P426, DOI 10.1016/j.molcel.2008.10.012; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Graziano BR, 2014, CURR OPIN CELL BIOL, V30, P60, DOI 10.1016/j.ceb.2014.06.007; Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005; Bhatia VK, 2009, EMBO J, V28, P3303, DOI 10.1038/emboj.2009.261; Morlot S, 2012, CELL, V151, P619, DOI 10.1016/j.cell.2012.09.017; Yamazaki D, 2013, MOL BIOL CELL, V24, P3393, DOI 10.1091/mbc.E13-04-0178; Huang CH, 2013, NAT CELL BIOL, V15, P1307, DOI 10.1038/ncb2859; Giannone G, 2004, CELL, V116, P431, DOI 10.1016/S0092-8674(04)00058-3; Malet-Engra G, 2013, CANCER RES, V73, P3412, DOI 10.1158/0008-5472.CAN-12-3564; Rolland Y, 2014, DEV CELL, V30, P553, DOI 10.1016/j.devcel.2014.08.006; Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091; Raucher D, 2000, J CELL BIOL, V148, P127, DOI 10.1083/jcb.148.1.127; Lieber AD, 2013, CURR BIOL, V23, P1409, DOI 10.1016/j.cub.2013.05.063; Batchelder EL, 2011, P NATL ACAD SCI USA, V108, P11429, DOI 10.1073/pnas.1010481108; Chander H, 2013, ONCOGENE, V32, P3080, DOI 10.1038/onc.2012.317; Diz-Munoz A., 2010, PLOS BIOL; Fujita H, 2002, J BIOL CHEM, V277, P45428, DOI 10.1074/jbc.M208090200; Hu JH, 2011, J BIOL CHEM, V286, P2261, DOI 10.1074/jbc.M110.157974; Itoh T, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000393; Jilkine A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001121; Neilson MP, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000618; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Truesdell P, 2014, ONCOGENE; Tsujita K, 2013, J CELL SCI, V126, P2267, DOI 10.1242/jcs.122515; Ueno T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002033; Weiner OD, 2007, PLOS BIOL, V5, P2053, DOI 10.1371/journal.pbio.0050221; Wu M, 2010, NAT CELL BIOL, V12, P902, DOI 10.1038/ncb2094; Wu M, 2013, P NATL ACAD SCI USA, V110, P1339, DOI 10.1073/pnas.1221538110	48	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					749	+		10.1038/ncb3162		17	Cell Biology	Cell Biology	CJ1XD	WOS:000355277500007		
J	Houlard, M; Godwin, J; Metson, J; Lee, J; Hirano, T; Nasmyth, K				Houlard, Martin; Godwin, Jonathan; Metson, Jean; Lee, Jibak; Hirano, Tatsuya; Nasmyth, Kim			Condensin confers the longitudinal rigidity of chromosomes	NATURE CELL BIOLOGY			English	Article							MITOTIC CHROMOSOME; CHROMATID SEGREGATION; STRUCTURAL INTEGRITY; SISTER CHROMATIDS; TOPOISOMERASE-II; MOUSE OOCYTES; PROTEIN; MITOSIS; CELLS; ARCHITECTURE	In addition to inter-chromatid cohesion, mitotic and meiotic chromatids must have three physical properties: compaction into 'threads' roughly co-linear with their DNA sequence, intra-chromatid cohesion determining their rigidity, and a mechanism to promote sister chromatid disentanglement. A fundamental issue in chromosome biology is whether a single molecular process accounts for all three features. There is universal agreement that a pair of Smc-kleisin complexes called condensin I and II facilitate sister chromatid disentanglement, but whether they also confer thread formation or longitudinal rigidity is either controversial or has never been directly addressed respectively. We show here that condensin II (beta-kleisin) has an essential role in all three processes during meiosis I in mouse oocytes and that its function overlaps with that of condensin I (gamma-kleisin), which is otherwise redundant. Pre-assembled meiotic bivalents unravel when condensin is inactivated by TEV cleavage, proving that it actually holds chromatin fibres together.	[Houlard, Martin; Godwin, Jonathan; Metson, Jean; Nasmyth, Kim] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Lee, Jibak] Kobe Univ, Grad Sch Agr Sci, Lab Dev Biotechnol, Nada Ku, Kobe, Hyogo 6578501, Japan; [Hirano, Tatsuya] RIKEN, Chromosome Dynam Lab, Wako, Saitama 3510198, Japan	Nasmyth, K (reprint author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	kim.nasmyth@bioch.ox.ac.uk	Hirano, Tatsuya/F-6008-2011		Wellcome Trust [091859/Z/10/Z]; ERC [294401]; MRC [84673]	We thank Micron microscopy facility and especially I. Dobbie for his technical support; all the staff of the BSB facility; B. Novak and all the members of the K.N. laboratory for discussions and comments on the manuscript. This work was supported by the Wellcome Trust (Grant Ref 091859/Z/10/Z), ERC grant (Proposal No 294401) and MRC (Grant ID 84673).	Almagro S, 2004, J BIOL CHEM, V279, P5118, DOI 10.1074/jbc.M307221200; Sutani T, 1999, GENE DEV, V13, P2271, DOI 10.1101/gad.13.17.2271; Burmann F, 2013, NAT STRUCT MOL BIOL, V20, P371, DOI 10.1038/nsmb.2488; Lee J, 2011, MOL BIOL CELL, V22, P3465, DOI 10.1091/mbc.E11-05-0423; Hirano T, 1997, CELL, V89, P511, DOI 10.1016/S0092-8674(00)80233-0; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Renshaw MJ, 2010, DEV CELL, V19, P232, DOI 10.1016/j.devcel.2010.07.013; Oliveira RA, 2010, NAT CELL BIOL, V12, P185, DOI 10.1038/ncb2018; Nasmyth K, 2002, SCIENCE, V297, P559, DOI 10.1126/science.1074757; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Oliveira RA, 2005, MOL CELL BIOL, V25, P8971, DOI 10.1128/MCB.25.20.8971-8984.2005; Sironi L, 2001, EMBO J, V20, P6371, DOI 10.1093/emboj/20.22.6371; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Nicklas RB, 1997, SCIENCE, V275, P632, DOI 10.1126/science.275.5300.632; Hagstrom KA, 2002, GENE DEV, V16, P729, DOI 10.1101/gad.968302; Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475; Schleiffer A, 2003, MOL CELL, V11, P571, DOI 10.1016/S1097-2765(03)00108-4; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Ribeiro SA, 2009, MOL BIOL CELL, V20, P2371, DOI 10.1091/mbc.E08-11-1127; Rattani A, 2013, ELIFE, V2, DOI 10.7554/eLife.01133; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Kitajima TS, 2011, CELL, V146, P568, DOI 10.1016/j.cell.2011.07.031; Lan ZJ, 2004, BIOL REPROD, V71, P1469, DOI 10.1095/biolreprod.104.031757; Poirier M, 2000, MOL BIOL CELL, V11, P269; Poirier MG, 2003, CURR TOP DEV BIOL, V55, P75, DOI 10.1016/S0070-2153(03)01002-0; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Charbin A, 2014, NUCLEIC ACIDS RES, V42, P340, DOI 10.1093/nar/gkt882; Steffensen S, 2001, CURR BIOL, V11, P295, DOI 10.1016/S0960-9822(01)00096-3; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; SAKA Y, 1994, EMBO J, V13, P4938; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Miyanari Y, 2013, NAT STRUCT MOL BIOL, V20, P1321, DOI 10.1038/nsmb.2680; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; Bhat MA, 1996, CELL, V87, P1103, DOI 10.1016/S0092-8674(00)81804-8; CREMER T, 1988, EXP CELL RES, V176, P199, DOI 10.1016/0014-4827(88)90325-4; Cuylen Sara, 2013, Dev Cell, V27, P469, DOI 10.1016/j.devcel.2013.10.018; Flemming W., 1881, ARCH MIKROSK ANAT, V18, P151, DOI 10.1007/BF02952594; Fujiwara T, 2013, MOL BIOL CELL, V24, P2515, DOI 10.1091/mbc.E13-04-0208; Lavoie BD, 2000, MOL BIOL CELL, V11, P1293; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Nagy A., 2003, MANIPULATING MOUSE E; STRUNNIKOV AV, 1995, GENE DEV, V9, P587, DOI 10.1101/gad.9.5.587; Tachibana-Konwalski K, 2010, GENE DEV, V24, P2505, DOI 10.1101/gad.605910	44	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1465-7392	1476-4679		NAT CELL BIOL	Nat. Cell Biol.	JUN	2015	17	6					771	+		10.1038/ncb3167		19	Cell Biology	Cell Biology	CJ1XD	WOS:000355277500009		
J	Mifsud, B; Tavares-Cadete, F; Young, AN; Sugar, R; Schoenfelder, S; Ferreira, L; Wingett, SW; Andrews, S; Grey, W; Ewels, PA; Herman, B; Happe, S; Higgs, A; LeProust, E; Follows, GA; Fraser, P; Luscombe, NM; Osborne, CS				Mifsud, Borbala; Tavares-Cadete, Filipe; Young, Alice N.; Sugar, Robert; Schoenfelder, Stefan; Ferreira, Lauren; Wingett, Steven W.; Andrews, Simon; Grey, William; Ewels, Philip A.; Herman, Bram; Happe, Scott; Higgs, Andy; LeProust, Emily; Follows, George A.; Fraser, Peter; Luscombe, Nicholas M.; Osborne, Cameron S.			Mapping long-range promoter contacts in human cells with high-resolution capture Hi-C	NATURE GENETICS			English	Article							INFLAMMATORY-BOWEL-DISEASE; CHROMATIN INTERACTIONS; HUMAN GENOME; TRANSCRIPTION; ENHANCER; GENES; CHROMOSOME; LANDSCAPE; PROTEIN; CTCF	Transcriptional control in large genomes often requires looping interactions between distal DNA elements, such as enhancers and target promoters. Current chromosome conformation capture techniques do not offer sufficiently high resolution to interrogate these regulatory interactions on a genomic scale. Here we use Capture Hi-C (CHi-C), an adapted genome conformation assay, to examine the long-range interactions of almost 22,000 promoters in 2 human blood cell types. We identify over 1.6 million shared and cell type restricted interactions spanning hundreds of kilobases between promoters and distal loci. Transcriptionally active genes contact enhancer-like elements, whereas transcriptionally inactive genes interact with previously uncharacterized elements marked by repressive features that may act as long-range silencers. Finally, we show that interacting loci are enriched for disease-associated SNPs, suggesting how distal mutations may disrupt the regulation of relevant genes. This study provides new insights and accessible tools to dissect the regulatory interactions that underlie normal and aberrant gene regulation.	[Mifsud, Borbala; Sugar, Robert; Luscombe, Nicholas M.] Francis Crick Inst, London, England; [Mifsud, Borbala; Luscombe, Nicholas M.] UCL, UCL Genet Inst, London, England; [Young, Alice N.; Schoenfelder, Stefan; Ferreira, Lauren; Ewels, Philip A.; Fraser, Peter; Osborne, Cameron S.] Babraham Inst, Nucl Dynam Programme, Cambridge, England; [Wingett, Steven W.; Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge, England; [Grey, William; Osborne, Cameron S.] Kings Coll London, Sch Med, Dept Med & Mol Genet, London, England; [Herman, Bram; Happe, Scott; Higgs, Andy; LeProust, Emily] Agilent Technol, Diagnost & Genom Div, Santa Clara, CA USA; [Follows, George A.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Dept Haematol, Cambridge, England; [Luscombe, Nicholas M.] Okinawa Inst Sci & Technol, Okinawa, Japan	Osborne, CS (reprint author), Babraham Inst, Nucl Dynam Programme, Cambridge, England.	nicholas.luscombe@ucl.ac.uk; cameron.osborne@kcl.ac.uk	Tavares-Cadete, Filipe/G-4962-2015; 	Tavares-Cadete, Filipe/0000-0002-3782-7170; Fraser, Peter/0000-0002-0041-1227; Mifsud, Borbala/0000-0003-3429-3094	Leukaemia and Lymphoma Research Fellowship; Framework Programme 7 Epigenesys Network of Excellence; Cancer Research UK; UCL; OIST; Wellcome Trust	We thank E. Darbo for assistance in data analysis and K. Tabbada for sequencing. This work was supported by a Leukaemia and Lymphoma Research Fellowship (C.S.O.), the Framework Programme 7 Epigenesys Network of Excellence (B.M., N.M.L.), Cancer Research UK (B.M., F.T.-C., N.M.L.), UCL (B.M., N.M.L.), OIST (F.T.-C., N.M.L.) and the Wellcome Trust (N.M.L.).	Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Jin FL, 2013, NATURE, V503, P290, DOI 10.1038/nature12644; Gnirke A, 2009, NAT BIOTECHNOL, V27, P182, DOI 10.1038/nbt.1523; Hughes JR, 2014, NAT GENET, V46, P205, DOI 10.1038/ng.2871; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Dekker J, 2013, NAT REV GENET, V14, P390, DOI 10.1038/nrg3454; Giresi PG, 2007, GENOME RES, V17, P877, DOI 10.1101/gr.5533506; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Tan-Wong SM, 2012, SCIENCE, V338, P671, DOI 10.1126/science.1224350; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Pauler FM, 2009, GENOME RES, V19, P221, DOI 10.1101/gr.080861.108; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Ma WX, 2015, NAT METHODS, V12, P71, DOI [10.1038/nmeth.3205, 10.1038/NMETH.3205]; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Thompson M, 2003, SCIENCE, V302, P1399, DOI 10.1126/science.1089814; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; De Luca A, 2003, BIOCHEM J, V369, P477, DOI 10.1042/BJ20020057; Dryden NH, 2014, GENOME RES, V24, P1854, DOI 10.1101/gr.175034.114; Huang W., 2009, NAT PROTOC, V4, P44, DOI DOI 10.1038/NPR0T.2008.211; Mink S, 1997, MOL CELL BIOL, V17, P6609; Nautiyal J, 2013, TRENDS ENDOCRIN MET, V24, P451, DOI 10.1016/j.tem.2013.05.001; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Yano K, 2000, GENOMICS, V65, P75, DOI 10.1006/geno.2000.6140; Yochum GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018966	36	10	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					598	606		10.1038/ng.3286		9	Genetics & Heredity	Genetics & Heredity	CJ3LW	WOS:000355386500010		
J	Wong, VK; Baker, S; Pickard, DJ; Parkhill, J; Page, AJ; Feasey, NA; Kingsley, RA; Thomson, NR; Keanel, JA; Weill, FX; Edwards, DJ; Hawkey, J; Harris, SR; Mather, AE; Cain, AK; Hadfield, J; Hart, PJ; Thieu, NTV; Klemm, EJ; Glinos, DA; Breiman, RF; Watson, CH; Kariuki, S; Gordon, MA; Heyderman, RS; Okoro, C; Jacobs, J; Lunguya, O; Edmunds, WJ; Msefula, C; Chabalgoity, JA; Kama, M; Jenkins, K; Dutta, S; Marks, F; Campos, J; Thompson, C; Obaro, S; MacLennan, CA; Dolecek, C; Keddy, KH; Smith, AM; Parry, CM; Karkey, A; Mulholland, EK; Campbell, JI; Dongol, S; Basnyat, B; Dufour, M; Bandaranayake, D; Naseri, TT; Singh, SP; Hatta, M; Newton, P; Onsare, RS; Isaia, L; Dance, D; Davong, V; Thwaites, G; Wijedoru, L; Crump, JA; De Pinna, E; Nair, S; Nilles, EJ; Thanh, DP; Turner, P; Soeng, S; Valcanis, M; Powling, J; Dimovski, K; Hogg, G; Farrar, J; Holt, KE; Dougan, G				Wong, Vanessa K.; Baker, Stephen; Pickard, Derek J.; Parkhill, Julian; Page, Andrew J.; Feasey, Nicholas A.; Kingsley, Robert A.; Thomson, Nicholas R.; Keanel, Jacqueline A.; Weill, Francois-Xavier; Edwards, David J.; Hawkey, Jane; Harris, Simon R.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Hart, Peter J.; Nga Tran Vu Thieu; Klemm, Elizabeth J.; Glinos, Dafni A.; Breiman, Robert F.; Watson, Conall H.; Kariuki, Samuel; Gordon, Melita A.; Heyderman, Robert S.; Okoro, Chinyere; Jacobs, Jan; Lunguya, Octavie; Edmunds, W. John; Msefula, Chisorno; Chabalgoity, Jose A.; Kama, Mike; Jenkins, Kylie; Dutta, Shanta; Marks, Florian; Campos, Josefina; Thompson, Corinne; Obaro, Stephen; MacLennan, Calman A.; Dolecek, Christiane; Keddy, Karen H.; Smith, Anthony M.; Parry, Christopher M.; Karkey, Abhilasha; Mulholland, E. Kim; Campbell, James I.; Dongol, Sabina; Basnyat, Buddha; Dufour, Muriel; Bandaranayake, Don; Naseri, Take Toleafoa; Singh, Shalini Pravin; Hatta, Mochammad; Newton, Paul; Onsare, Robert S.; Isaia, Lupeoletalalei; Dance, David; Davong, Viengmon; Thwaites, Guy; Wijedoru, Lalith; Crump, John A.; De Pinna, Elizabeth; Nair, Satheesh; Nilles, Eric J.; Duy Pham Thanh; Turner, Paul; Soeng, Sona; Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff; Farrar, Jeremy; Holt, Kathryn E.; Dougan, Gordon			Phylogeographical analysis of the dominant multidrug-resistant H58 clade of Salmonella Typhi identifies inter- and intracontinental transmission events	NATURE GENETICS			English	Article							ENTERICA SEROVAR TYPHI; ANTIBIOTIC-RESISTANCE; INTERACTIVE TREE; INCHI1 PLASMIDS; FEVER; MUTATIONS; EVOLUTION; ANNOTATION; POPULATION; PARATYPHI	The emergence of multidrug-resistant (MDR) typhoid is a major global health threat affecting many countries where the disease is endemic. Here whole-genome sequence analysis of 1,832 Salmonella enterica serovar Typhi (S. Typhi) identifies a single dominant MDR lineage, H58, that has emerged and spread throughout Asia and Africa over the last 30 years. Our analysis identifies numerous transmissions of H58, including multiple transfers from Asia to Africa and an ongoing, unrecognized MDR epidemic within Africa itself. Notably, our analysis indicates that H58 lineages are displacing antibiotic-sensitive isolates, transforming the global population structure of this pathogen. H58 isolates can harbor a complex MDR element residing either on transmissible IncHI1 plasmids or within multiple chromosomal integration sites. We also identify new mutations that define the H58 lineage. This phylogeographical analysis provides a framework to facilitate global management of MDR typhoid and is applicable to similar MDR lineages emerging in other bacterial species.	[Wong, Vanessa K.; Pickard, Derek J.; Page, Andrew J.; Kingsley, Robert A.; Keanel, Jacqueline A.; Mather, Alison E.; Cain, Amy K.; Hadfield, James; Klemm, Elizabeth J.; Glinos, Dafni A.; Okoro, Chinyere; MacLennan, Calman A.; Dougan, Gordon] Wellcome Trust Sanger Inst, Hinxton, England; [Wong, Vanessa K.] Univ Cambridge, Hosp Natl Hlth Serv NHS Fdn Trust, Addenbrookes Hosp, Dept Microbiol, Cambridge, England; [Baker, Stephen; Nga Tran Vu Thieu; Thompson, Corinne; Thwaites, Guy] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Baker, Stephen; Thompson, Corinne; Dolecek, Christiane; Newton, Paul; Dance, David; Thwaites, Guy; Turner, Paul; Farrar, Jeremy] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med & Global Hlth, Oxford, England; [Baker, Stephen; Thomson, Nicholas R.; Mulholland, E. Kim] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England; [Feasey, Nicholas A.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kingsley, Robert A.] Inst Food Res, Norwich, Norfolk, England; [Weill, Francois-Xavier] Inst Pasteur, Unite Bacteries Pathogenes Enter, Paris, France; [Edwards, David J.; Hawkey, Jane] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Melbourne, Vic, Australia; [Hawkey, Jane] Univ Melbourne, Fac Vet & Agr Sci, Melbourne, Vic, Australia; [MacLennan, Calman A.] Univ Birmingham, Coll Med & Dent Sci, Sch Immun & Infect, Inst Biomed Res, Birmingham, W Midlands, England; [Breiman, Robert F.; Kariuki, Samuel] Kenya Med Res Inst KEMRI, Nairobi, Kenya; [Breiman, Robert F.] Ctr Dis Control & Prevent, Atlanta, GA USA; [Breiman, Robert F.] Emory Global Hlth Inst, Atlanta, GA USA; [Watson, Conall H.; Edmunds, W. John] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, Ctr Math Modelling Infect Dis, London WC1, England; [Gordon, Melita A.] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Heyderman, Robert S.] Univ Malawi, Coll Med, Malawi Liverpool Wellcome Trust Clin Res Program, Blantyre, Malawi; [Jacobs, Jan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Jacobs, Jan] Univ Leuven, Katholieke Univ KU Leuven, Dept Microbiol & Immunol, Leuven, Belgium; [Lunguya, Octavie] Natl Inst Biomed Res, Kinshasa, DEM REP CONGO; [Lunguya, Octavie] Univ Hosp Kinshasa, Kinshasa, DEM REP CONGO; [Msefula, Chisorno] Univ Malawi, Coll Med, Dept Microbiol, Blantyre, Malawi; [Chabalgoity, Jose A.] Inst Higiene, Facultad Medicina, Dept Desarrollo Biotecnol, Montevideo, Uruguay; [Kama, Mike] Minist Hlth, Suva, Fiji; [Jenkins, Kylie] Fiji Hlth Sector Support Program, Suva, Fiji; [Dutta, Shanta] Natl Inst Cholera & Enter Dis, Kolkata, India; [Marks, Florian] Int Vaccine Inst, Dept Epidemiol, Seoul, South Korea; [Campos, Josefina] Carlos G Malbran Inst, ANLIS, Enteropathogen Div, Buenos Aires, DF, Argentina; [Obaro, Stephen] Univ Nebraska, Med Ctr, Div Pediat Infect Dis, Omaha, NE 68182 USA; [Obaro, Stephen] Univ Abuja, Teaching Hosp, Abuja, Nigeria; [Obaro, Stephen] Bingham Univ, Karu, Nigeria; [MacLennan, Calman A.] Novartis Vaccines Inst Global Hlth, Siena, Italy; [Keddy, Karen H.; Smith, Anthony M.] Univ Witwatersrand, Ctr Enter Dis, Natl Inst Communicable Dis, Div Natl Hlth Lab Serv, Johannesburg, South Africa; [Parry, Christopher M.] London Sch Hyg & Trop Med, Dept Clin Res, London WC1, England; [Parry, Christopher M.] Nagasaki Univ, Grad Sch Trop Med & Global Hlth, Nagasaki 852, Japan; [Dongol, Sabina; Basnyat, Buddha] Univ Oxford, Clin Res Unit, Wellcome Trust Major Overseas Programme, Patan Acad Hlth Sci, Kathmandu, Nepal; [Mulholland, E. Kim] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Dufour, Muriel] Inst Environm Sci & Res Ltd ESR, Enter & Leptospira Reference Lab, Porirua, New Zealand; [Bandaranayake, Don] Inst Environm Sci & Res, Natl Ctr Biosecur & Infect Dis, Porirua, New Zealand; [Singh, Shalini Pravin] WHO, Ctr Communicable Dis Control, Natl Influenza Ctr, Suva, Fiji; [Hatta, Mochammad] Hasanuddin Univ, Dept Microbiol, Makassar, Indonesia; [Newton, Paul; Dance, David; Davong, Viengmon] Mahosot Hosp, Microbiol Lab, Lao Oxford Mahosot Wellcome Trust Res Unit, Viangchan, Laos; [Wijedoru, Lalith; Turner, Paul] Mahidol Univ, Fac Trop Med, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [Wijedoru, Lalith] Chelsea & Westminster Hosp, Paediat Emergency Med, London, England; [Crump, John A.] Univ Otago, Ctr Int Hlth & Otago Int Hlth Res Network, Dunedin Sch Med, Dunedin, New Zealand; [De Pinna, Elizabeth; Nair, Satheesh] Publ Hlth England, Salmonella Reference Serv, London, England; [Nilles, Eric J.] WHO, Div Pacific Tech Support, Emerging Dis Surveillance & Response, Suva, Fiji; [Turner, Paul; Soeng, Sona] Angkor Hosp Children, Cambodia Oxford Med Res Unit, Siem Reap, Cambodia; [Valcanis, Mary; Powling, Joan; Dimovski, Karolina; Hogg, Geoff] Univ Melbourne, Microbiol Diagnost Unit, Dept Microbiol & Immunol, Doherty Inst Infect & Immun,Publ Hlth Lab, Melbourne, Vic, Australia	Wong, VK (reprint author), Wellcome Trust Sanger Inst, Hinxton, England.	vw1@sanger.ac.uk	MacLennan, Calman/L-9343-2014; Parkhill, Julian/G-4703-2011; Holt, Kathryn/A-8108-2012; 	MacLennan, Calman/0000-0001-9694-0846; Parkhill, Julian/0000-0002-7069-5958; Holt, Kathryn/0000-0003-3949-2471; Dance, David/0000-0001-9189-7244; Hawkey, Jane/0000-0001-9661-5293; Farrar, Jeremy/0000-0002-2700-623X; Thwaites, Guy/0000-0002-2858-2087	Wellcome Trust; Wellcome Trust award [098051]; Wellcome Trust research fellowship [WT092152MA]; Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme [101113/Z/13/Z]; Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme; Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant); European Society for Paediatric Infectious Diseases; University of Oxford-Li Ka Shing Global Health Foundation; Wellcome Trust [089275/H/091Z]; National Health and Medical Research Council of Australia [1061409]; Victorian Life Sciences Computation Initiative (VLSCI) [VR0082]; Clinical Research Fellowship from GlaxoSmithKline; UK Medical Research Council PhD studentship; Institut Pasteur; Institut de Veille Sanitaire; French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence) [ANR-10-LABX-62-IBEID]; UK Medical Research Council [MR/J003999/1, G1100100/1]; Society in Science; Branco Weiss Fellowship; antibiotic resistance surveillance project in the Democratic Republic of the Congo; Belgian Directorate General of Development Cooperation [2.01]; Institute of Tropical Medicine (Antwerp, Belgium) [2.01]; Bill and Melinda Gates Foundation; US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program [R01 TW009237]; UK Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J010367/1]; UK BBSRC Zoonoses in Emerging Livestock Systems awards [BB/L017679, BB/L018926, BB/L018845]; US National Institutes of Health grant [R01 AI099525-02]; Royal Society [100087/Z/12/Z]; National Institute of Allergy and Infectious Diseases of the US National Institutes of Health [R01 AI097493]	This work was supported by the Wellcome Trust. We would like to thank the members of the Pathogen Informatics Team and the core sequencing teams at the Wellcome Trust Sanger Institute (Cambridge, UK). We are grateful to D. Harris for his superb work in managing the sequence data. We also thank L. Fabre for her excellent technical assistance.; This work was supported by a number of organizations. The authors affiliated with the Wellcome Trust Sanger Institute were funded by Wellcome Trust award 098051; N.A.F. was supported by Wellcome Trust research fellowship WT092152MA. N.A.F., R.S.H. and this work were supported by a strategic award from the Wellcome Trust for the Malawi-Liverpool Wellcome Trust Clinical Research Programme (101113/Z/13/Z). C.M.P. was funded by the Wellcome Trust Mahidol University Oxford Tropical Medicine Research Programme, supported by the Wellcome Trust (Major Overseas Programmes-Thailand Unit Core Grant), the European Society for Paediatric Infectious Diseases and the University of Oxford-Li Ka Shing Global Health Foundation. D.D., P.N. and V.D. were supported by the Wellcome Trust (core grant 089275/H/091Z). K.E.H. was supported by the National Health and Medical Research Council of Australia (fellowship 1061409) and the Victorian Life Sciences Computation Initiative (VLSCI; grant VR0082). C.A.M. was supported by a Clinical Research Fellowship from GlaxoSmithKline, and P.J.H. was supported by a UK Medical Research Council PhD studentship. This work forms part of a European Union Framework Programme 7 Marie Curie Actions Industry Academia Partnerships and Pathways (LAPP) Consortium Programme, entitled GENDRIVAX (Genome-Driven Vaccine Development for Bacterial Infections), involving the Wellcome Trust Sanger Institute, KEMRI Nairobi and the Novartis Vaccines Institute for Global Health. The authors affiliated with the Institut Pasteur were funded by the Institut Pasteur, the Institut de Veille Sanitaire and the French government 'Investissement d'Avenir' program (Integrative Biology of Emerging Infectious Diseases Laboratory of Excellence, grant ANR-10-LABX-62-IBEID). C.H.W. was supported by the UK Medical Research Council (MR/J003999/1). CO. was supported by Society in Science and the Branco Weiss Fellowship, administered by ETH Zurich. A.K.C. was supported by the UK Medical Research Council (G1100100/1). J.J. was supported by the antibiotic resistance surveillance project in the Democratic Republic of the Congo, funded by project 2.01 of the Third Framework Agreement between the Belgian Directorate General of Development Cooperation and the Institute of Tropical Medicine (Antwerp, Belgium). F.M. was supported by a research grant from the Bill and Melinda Gates Foundation. The findings and conclusions contained within this publication are those of the authors and do not necessarily reflect positions or policies of the Bill and Melinda Gates Foundation. J.A. Crump was supported by the joint US National Institutes of Health-National Science Foundation Ecology and Evolution of Infectious Disease program (R01 TW009237), the UK Biotechnology and Biological Sciences Research Council (BBSRC; BB/J010367/1) and UK BBSRC Zoonoses in Emerging Livestock Systems awards BB/L017679, BB/L018926 and BB/L018845. S.K. was supported by US National Institutes of Health grant R01 AI099525-02. S.B. is a Sir Henry Dale Fellow, jointly funded by the Wellcome Trust and the Royal Society (100087/Z/12/Z). S.O. was supported by the National Institute of Allergy and Infectious Diseases of the US National Institutes of Health (R01 AI097493). The content is solely the responsibility of the authors and does not necessarily represent the official views of the US National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. C.D.; was supported by the University of Oxford-Li Ka Shing Global Health Foundation.	ANDERSON ES, 1975, J HYG-CAMBRIDGE, V74, P289; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Lutterloh E, 2012, CLIN INFECT DIS, V54, P1100, DOI 10.1093/cid/cis012; Crump JA, 2010, CLIN INFECT DIS, V50, P241, DOI 10.1086/649541; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Kidgell C, 2002, INFECT GENET EVOL, V2, P39, DOI 10.1016/S1567-1348(02)00089-8; Holt KE, 2012, NAT GENET, V44, P1056, DOI 10.1038/ng.2369; Mirza SH, 1996, J MED MICROBIOL, V44, P317; Menezes GA, 2012, CLIN MICROBIOL INFEC, V18, P239, DOI 10.1111/j.1469-0691.2011.03546.x; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Kariuki S, 2010, J CLIN MICROBIOL, V48, P2171, DOI 10.1128/JCM.01983-09; Bhutta ZA, 2006, BRIT MED J, V333, P78, DOI 10.1136/bmj.333.7558.78; Marvig RL, 2012, ANTIMICROB AGENTS CH, V56, P4519, DOI 10.1128/AAC.00630-12; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI 10.1093/nar/gkr201; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Baker S, 2008, J CLIN MICROBIOL, V46, P1741, DOI 10.1128/JCM.02249-07; Phoba MF, 2012, EMERG INFECT DIS, V18, P1692, DOI 10.3201/eid1810.120525; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Hensel M, 1997, MOL MICROBIOL, V24, P155, DOI 10.1046/j.1365-2958.1997.3271699.x; Haanpera M, 2005, ANTIMICROB AGENTS CH, V49, P457, DOI 10.1128/AAC.49.1.457-460.2005; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Connor BA, 2005, LANCET INFECT DIS, V5, P623, DOI 10.1016/S1473-3099(05)70239-5; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; Lawhon SD, 2003, MOL MICROBIOL, V48, P1633, DOI 10.1046/j.1365-2958.2003.03535.x; [Anonymous], 2013, ELIFE, V2; Fraser A, 2007, VACCINE, V25, P7848, DOI 10.1016/j.vaccine.2007.08.027; Parry CM, 2002, NEW ENGL J MED, V347, P1770, DOI 10.1056/NEJMra020201; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Thomson N, 2004, J MOL BIOL, V339, P279, DOI 10.1016/j.jmb.2004.03.058; Eaves DJ, 2004, ANTIMICROB AGENTS CH, V48, P4012, DOI 10.1128/AAC.48.10.4012-4015.2004; Ashton PM, 2015, NAT BIOTECHNOL, V33, P296, DOI 10.1038/nbt.3103; Parkhill J, 2001, NATURE, V413, P848, DOI 10.1038/35101607; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Phan MD, 2009, ANTIMICROB AGENTS CH, V53, P716, DOI 10.1128/AAC.00645-08; Chau TT, 2007, ANTIMICROB AGENTS CH, V51, P4315, DOI 10.1128/AAC.00294-07; Wain J, 1997, CLIN INFECT DIS, V25, P1404, DOI 10.1086/516128; Roumagnac P, 2006, SCIENCE, V314, P1301, DOI 10.1126/science.1134933; Fu YX, 1999, NATURE, V401, P293; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Baker S, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110008; Baucheron S, 2005, ANTIMICROB AGENTS CH, V49, P862, DOI 10.1128/AAC.49.2.862-863.2005; BODHIDATTA L, 1987, REV INFECT DIS, V9, P841; Breiman RF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029119; Bwakura-Dangarembizi M, 2014, NEW ENGL J MED, V370, P41, DOI 10.1056/NEJMoa1214901; Casali N, 2014, NAT GENET, V46, P279, DOI 10.1038/ng.2878; Chiou CS, 2014, ANTIMICROB AGENTS CH, V58, P6501, DOI 10.1128/AAC.03608-14; Gomes C, 2013, MICROB DRUG RESIST, V19, P88, DOI 10.1089/mdr.2012.0036; Gupta SK, 2014, ANTIMICROB AGENTS CH, V58, P212, DOI 10.1128/AAC.01310-13; Hendriksen RS, 2015, J CLIN MICROBIOL, V53, P262, DOI 10.1128/JCM.02026-14; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001245; Holt KE, 2007, J BACTERIOL, V189, P4257, DOI 10.1128/JB.00232-07; Holt KE, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-36; Holt KE, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000929; Holt KE, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-144; Holt KE, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001490; Hooper D C, 1993, Drugs, V45 Suppl 3, P8; Inouye M, 2014, GENOME MED, V6, DOI 10.1186/s13073-014-0090-6; Keddy KH, 2010, EMERG INFECT DIS, V16, P879, DOI 10.3201/eid1605.091917; Khan MI, 2010, EXPERT REV VACCINES, V9, P485, DOI [10.1586/erv.10.43, 10.1586/ERV.10.43]; Le Hello S, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00395; Le TAH, 2007, J CLIN MICROBIOL, V45, P3485, DOI 10.1128/JCM.00948-07; Mogasale V, 2014, LANCET GLOB HEALTH, V2, pE570, DOI 10.1016/S2214-109X(14)70301-8; OLARTE J, 1973, ANTIMICROB AGENTS CH, V4, P597; Song YJ, 2010, J ANTIMICROB CHEMOTH, V65, P1631, DOI 10.1093/jac/dkq175; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	73	7	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1061-4036	1546-1718		NAT GENET	Nature Genet.	JUN	2015	47	6					632	639		10.1038/ng.3281		8	Genetics & Heredity	Genetics & Heredity	CJ3LW	WOS:000355386500014		
J	Tiwari, DK; Arai, Y; Yamanaka, M; Matsuda, T; Agetsuma, M; Nakano, M; Fujita, K; Nagai, T				Tiwari, Dhermendra K.; Arai, Yoshiyuki; Yamanaka, Masahito; Matsuda, Tomoki; Agetsuma, Masakazu; Nakano, Masahiro; Fujita, Katsumasa; Nagai, Takeharu			A fast-and positively photoswitchable fluorescent protein for ultralow-laser-power RESOLFT nanoscopy	NATURE METHODS			English	Article							ILLUMINATION MICROSCOPY; STIMULATED-EMISSION; RESOLUTION LIMIT; BARRIER; GFP; BREAKING; CELLS	Fluorescence nanoscopy has revolutionized our ability to visualize biological structures not resolvable by conventional microscopy. However, photodamage induced by intense light exposure has limited its use in live specimens. Here we describe Kohinoor, a fast-switching, positively photoswitchable fluorescent protein, and show that it has high photostability over many switching repeats. With Kohinoor, we achieved super-resolution imaging of live HeLa cells using biocompatible, ultralow laser intensity (0.004 J/cm(2)) in reversible saturable optical fluorescence transition (RESOLFT) nanoscopy.	[Tiwari, Dhermendra K.; Arai, Yoshiyuki; Matsuda, Tomoki; Agetsuma, Masakazu; Nakano, Masahiro; Nagai, Takeharu] Osaka Univ, Inst Sci & Ind Res, Osaka, Japan; [Yamanaka, Masahito; Fujita, Katsumasa] Osaka Univ, Dept Appl Phys, Osaka, Japan	Nagai, T (reprint author), Osaka Univ, Inst Sci & Ind Res, Osaka, Japan.	ng1@sanken.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23115003]; Cooperative Research Program of 'Network Joint Research Center for Materials and Devices'; postdoctoral fellowship from the Japan Society for the Promotion of Science;  [3306]	This work was supported by a grant-in-aid for Scientific Research on Innovative Areas, 'Spying minority in biological phenomena (no. 3306)', from the Ministry of Education, Culture, Sports, Science and Technology, Japan (no. 23115003) (to T.N.), Cooperative Research Program of 'Network Joint Research Center for Materials and Devices' (to K.F.) and a postdoctoral fellowship from the Japan Society for the Promotion of Science (to D.K.T.).	Andresen M, 2005, P NATL ACAD SCI USA, V102, P13070, DOI 10.1073/pnas.0502772102; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Grotjohann T, 2011, NATURE, V478, P204, DOI 10.1038/nature10497; Matsuda T, 2008, NAT METHODS, V5, P339, DOI [10.1038/nmeth.1193, 10.1038/NMETH.1193]; Kao YT, 2012, BIOMED OPT EXPRESS, V3, P1955, DOI 10.1364/BOE.3.001955; Andresen M, 2008, NAT BIOTECHNOL, V26, P1035, DOI 10.1038/nbt.1493; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Zhao HM, 1998, NAT BIOTECHNOL, V16, P258, DOI 10.1038/nbt0398-258; Hafi N, 2014, NAT METHODS, V11, P579, DOI [10.1038/nmeth.2919, 10.1038/NMETH.2919]; Tiwari DK, 2013, DEV GROWTH DIFFER, V55, P491, DOI 10.1111/dgd.12064; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; Brakemann T, 2011, NAT BIOTECHNOL, V29, P942, DOI 10.1038/nbt.1952; Tomosugi W, 2009, NAT METHODS, V6, P351, DOI [10.1038/nmeth.1317, 10.1038/NMETH.1317]; Schwentker MA, 2007, MICROSC RES TECHNIQ, V70, P269, DOI 10.1002/jemt.20443; PFENNIG N, 1986, J MICROBIOL METH, V4, P303, DOI 10.1016/0167-7012(86)90043-6; Chmyrov A, 2013, NAT METHODS, V10, P737, DOI 10.1038/nmeth.2556; Hofmann M, 2005, P NATL ACAD SCI USA, V102, P17565, DOI 10.1073/pnas.0506010102; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Wu YC, 2013, NAT BIOTECHNOL, V31, P1032, DOI 10.1038/nbt.2713; Hell SW, 2004, PHYS LETT A, V326, P140, DOI 10.1016/j.physleta.2004.03.082; Brakemann T, 2010, J BIOL CHEM, V285, P14603, DOI 10.1074/jbc.M109.086314; Chen BC, 2014, SCIENCE, V346, P439, DOI 10.1126/science.1257998; Gayda S, 2012, BIOPHYS J, V103, P2521, DOI 10.1016/j.bpj.2012.11.011; Grotjohann T, 2012, ELIFE, V1, DOI 10.7554/eLife.00248; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Stiel AC, 2007, BIOCHEM J, V402, P35, DOI 10.1042/BJ20061401	27	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2015	12	6					515	+		10.1038/nmeth.3362		7	Biochemical Research Methods	Biochemistry & Molecular Biology	CJ1MQ	WOS:000355248100018		
J	Tsugawa, H; Cajka, T; Kind, T; Ma, Y; Higgins, B; Ikeda, K; Kanazawa, M; VanderGheynst, J; Fiehn, O; Arita, M				Tsugawa, Hiroshi; Cajka, Tomas; Kind, Tobias; Ma, Yan; Higgins, Brendan; Ikeda, Kazutaka; Kanazawa, Mitsuhiro; VanderGheynst, Jean; Fiehn, Oliver; Arita, Masanori			MS-DIAL: data-independent MS/MS deconvolution for comprehensive metabolome analysis	NATURE METHODS			English	Article							MASS-SPECTROMETRY; CHLORELLA-MINUTISSIMA; IDENTIFICATION; TOOL; ACQUISITION; EXTRACTION; MRMPROBS; LIFE	Data-independent acquisition (DIA) in liquid chromatography (LC) coupled to tandem mass spectrometry (MS/MS) provides comprehensive untargeted acquisition of molecular data. We provide an open-source software pipeline, which we call MS-DIAL, for DIA-based identification and quantification of small molecules by mass spectral deconvolution. For a reversed-phase LC-MS/MS analysis of nine algal strains, MS-DIAL using an enriched LipidBlast library identified 1,023 lipid compounds, highlighting the chemotaxonomic relationships between the algal strains.	[Tsugawa, Hiroshi; Arita, Masanori] RIKEN Ctr Sustainable Resource Sci, Yokohama, Kanagawa, Japan; [Tsugawa, Hiroshi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka, Japan; [Cajka, Tomas; Kind, Tobias; Ma, Yan; Fiehn, Oliver] Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA; [Higgins, Brendan; VanderGheynst, Jean] Univ Calif Davis, Dept Biol & Agr Engn, Davis, CA 95616 USA; [Ikeda, Kazutaka] RIKEN Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Ikeda, Kazutaka] Japan Sci & Technol Agcy, Kawaguchi, Saitama, Japan; [Kanazawa, Mitsuhiro] Reifycs Inc, Minato Ku, Tokyo, Japan; [Fiehn, Oliver] King Abdulaziz Univ, Fac Sci, Dept Biochem, Jeddah 21413, Saudi Arabia; [Arita, Masanori] Natl Inst Genet, Mishima, Shizuoka 411, Japan	Fiehn, O (reprint author), Univ Calif Davis, Genome Ctr, Davis, CA 95616 USA.	ofiehn@ucdavis.edu; arita@nig.ac.jp	Cajka, Tomas/A-8914-2008		US National Science Foundation (NSF)-Japan Science and Technology Agency (JST) Strategic International Collaborative Research Program (SICORP); NSF [NSF MCB 113944]; National Institutes of Health (NIH) [P20 HL113452, U24 DK097154]; JST-Core Research for Evolutionary Science and Technology (JST-CREST); Database Integration Coordination Program by the National Bioscience Database Center (Japan);  [25871136]	This work was supported by the US National Science Foundation (NSF)-Japan Science and Technology Agency (JST) Strategic International Collaborative Research Program (SICORP) for Japan-United States metabolomics. We also thank the Lipid MAPS consortium for providing us the lipid SDF files; ChemAxon for a free research license for the Marvin and JChem cheminformatics tools; Z. Tietel and N. Nguyen (UC Davis) for assisting with the sample preparation of algal species; T. Bamba, Y. Izumi and T. Yamada (Osaka University) for suggestions and discussion of lipid annotation; D. Yukihira (Kyushu University) for discussion of retention time prediction; and A. Ogiwara (Reyfics Inc.) for development of the ABF file and for suggestions and discussion about MS-DIAL development. H.T. was also supported by Grant-in-Aid for Young Scientists (B) (Japan) 25871136. This study was also supported by the NSF (NSF MCB 113944), National Institutes of Health (NIH) (Grants P20 HL113452 and U24 DK097154), the JST-Core Research for Evolutionary Science and Technology (JST-CREST), and Database Integration Coordination Program by the National Bioscience Database Center (Japan).	Rost HL, 2014, NAT BIOTECHNOL, V32, P219, DOI 10.1038/nbt.2841; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Reiter L, 2011, NAT METHODS, V8, P430, DOI [10.1038/nmeth.1584, 10.1038/NMETH.1584]; GLADU PK, 1995, J PHYCOL, V31, P774, DOI 10.1111/j.0022-3646.1995.00774.x; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; GIROUD C, 1988, PLANT CELL PHYSIOL, V29, P587; Yap CW, 2011, J COMPUT CHEM, V32, P1466, DOI 10.1002/jcc.21707; Stein SE, 1999, J AM SOC MASS SPECTR, V10, P770, DOI 10.1016/S1044-0305(99)00047-1; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Tanadul OUM, 2014, BIOTECHNOL BIOENG, V111, P1323, DOI 10.1002/bit.25203; Egertson JD, 2013, NAT METHODS, V10, P744, DOI 10.1038/nmeth.2528; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Lommen A, 2009, ANAL CHEM, V81, P3079, DOI 10.1021/ac900036d; Fiehn O, 2005, LECT NOTES COMPUT SC, V3615, P224; Zhu XC, 2014, ANAL CHEM, V86, P1202, DOI 10.1021/ac403385y; Tsugawa H, 2013, ANAL CHEM, V85, P5191, DOI 10.1021/ac400515s; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Katajamaa M, 2006, BIOINFORMATICS, V22, P634, DOI 10.1093/bioinformatics/btk039; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; Nikolskiy I, 2013, ANAL CHEM, V85, P7713, DOI 10.1021/ac400751j; Creek DJ, 2014, METABOLOMICS, V10, P350, DOI 10.1007/s11306-014-0656-8; Sud M, 2007, NUCLEIC ACIDS RES, V35, pD527, DOI 10.1093/nar/gkl838; Kind T, 2012, J CHROMATOGR A, V1244, P139, DOI 10.1016/j.chroma.2012.04.074; Brand J.J., 2013, APPL PHYCOLOGY BIOTE, VSecond, DOI [10.1002/9781118567166.ch5, DOI 10.1002/9781118567166.CH5]; Cavalier-Smith T, 1998, BIOL REV, V73, P203, DOI 10.1017/S0006323198005167; Haigh WG, 1996, BBA-LIPID LIPID MET, V1299, P183, DOI 10.1016/0005-2760(95)00205-7; Higgins BT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096807; Lee Y, 2012, MOL CELL PROTEOMICS, V11, P973; Schymanski Emma L, 2013, Metabolites, V3, P412, DOI 10.3390/metabo3020412; Tsugawa H, 2014, BIOINFORMATICS, V30, P2379, DOI 10.1093/bioinformatics/btu203; Windig W, 1996, ANAL CHEM, V68, P3602, DOI 10.1021/ac960435y	33	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1548-7091	1548-7105		NAT METHODS	Nat. Methods	JUN	2015	12	6					523	+		10.1038/nmeth.3393		9	Biochemical Research Methods	Biochemistry & Molecular Biology	CJ1MQ	WOS:000355248100020		
J	Vohra, V; Kawashima, K; Kakara, T; Koganezawa, T; Osaka, I; Takimiya, K; Murata, H				Vohra, Varun; Kawashima, Kazuaki; Kakara, Takeshi; Koganezawa, Tomoyuki; Osaka, Itaru; Takimiya, Kazuo; Murata, Hideyuki			Efficient inverted polymer solar cells employing favourable molecular orientation	NATURE PHOTONICS			English	Article							POWER CONVERSION EFFICIENCY; LOW-BANDGAP POLYMER; FILL FACTORS; PERFORMANCE; COPOLYMERS; MORPHOLOGY; DESIGN; HETEROJUNCTIONS; TRANSISTOR	Improving the power conversion efficiency of polymer-based bulk-heterojunction solar cells is a critical issue. Here, we show that high efficiencies of similar to 10% can be obtained using the crystalline polymer PNTz4T in single-junction inverted cells with a thick active layer having a thickness of similar to 300 nm. The improved performance is probably due to the large population of polymer crystallites with a face-on orientation and the 'favourable' distribution of edge-on and face-on crystallites along the film thickness (revealed by in-depth studies of the blend films using grazing-incidence wide-angle X-ray diffraction), which results in a reduction in charge recombination and efficient charge transport. These results underscore the great promise of polymer solar cells and raise the hope of achieving even higher efficiencies by means of materials development and control of molecular ordering.	[Vohra, Varun; Murata, Hideyuki] JAIST, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Kawashima, Kazuaki; Osaka, Itaru; Takimiya, Kazuo] RIKEN, CEMS, Emergent Mol Funct Res Grp, Wako, Saitama 3510198, Japan; [Kawashima, Kazuaki; Kakara, Takeshi] Hiroshima Univ, Grad Sch Engn, Dept Appl Chem, Hiroshima 7398527, Japan; [Koganezawa, Tomoyuki] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Osaka, Itaru] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan	Vohra, V (reprint author), Univ Electrocommun, Grad Sch Informat & Engn, Dept Engn Sci, 1-5-1 Chofugaoka, Chofu, Tokyo 1828585, Japan.	varun.vohra@uec.ac.jp; itaru.osaka@riken.jp; takimiya@riken.jp; murata-h@jaist.ac.jp	Takimiya, Kazuo/A-5841-2010; Osaka, Itaru/B-3153-2010; Murata, Hideyuki/J-8453-2012	Takimiya, Kazuo/0000-0002-6001-1129; Murata, Hideyuki/0000-0001-8248-9652	Ministry of Education, Culture, Sports, Science and Technology (MEXT) [24685030, 23245041]; Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency; Nanotechnology Platform Program of MEXT	This research was supported by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) (nos. 24685030 and 23245041) and by Precursory Research for Embryonic Science and Technology from the Japan Science and Technology Agency. This work was partly supported by the Nanotechnology Platform Program of MEXT. Two-dimensional GIWAXD experiments were performed at SPring-8 with the approval of the Japan Synchrotron Radiation Research Institute (JASRI, proposal no. 2014A1530). The authors thank K. Tajima of CEMS, RIKEN, for helpful discussions regarding the fabrication of inverted cells and for the contact angle measurement, and K. Higashimine of the Center for Nano Materials and Technology, JAIST, for the EDS measurements. The authors thank Y. Hishikawa of the National Institute of Advanced Industrial Science and Technology (AIST) and H. Tobita of Japan Electrical Safety & Environment Technology Laboratories (JET) for technical discussions about the J-V measurements. The authors also thank Y. Hishikawa and A. Sasaki for measurement of the cell active area.	Ye L, 2014, CHEM MATER, V26, P3603, DOI 10.1021/cm501513n; Guo XG, 2013, NAT PHOTONICS, V7, P825, DOI 10.1038/NPHOTON.2013.207; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Price SC, 2011, J AM CHEM SOC, V133, P4625, DOI 10.1021/ja1112595; MATAKA S, 1991, B CHEM SOC JPN, V64, P68, DOI 10.1246/bcsj.64.68; Xu Z, 2009, ADV FUNCT MATER, V19, P1227, DOI 10.1002/adfm.200801286; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Osaka I, 2012, J AM CHEM SOC, V134, P3498, DOI 10.1021/ja210687r; Szarko JM, 2010, ADV MATER, V22, P5468, DOI 10.1002/adma.201002687; Liang YY, 2009, J AM CHEM SOC, V131, P7792, DOI 10.1021/ja901545q; Blouin N, 2008, J AM CHEM SOC, V130, P732, DOI 10.1021/ja0771989; Liang YY, 2009, J AM CHEM SOC, V131, P56, DOI 10.1021/ja808373p; Kline RJ, 2006, NAT MATER, V5, P222, DOI 10.1038/nmat1590; Stuart AC, 2013, J AM CHEM SOC, V135, P1806, DOI 10.1021/ja309289u; Osaka I, 2014, ADV MATER, V26, P331, DOI 10.1002/adma.201303059; Sirringhaus H, 1999, NATURE, V401, P685, DOI 10.1038/44359; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; Duong DT, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.205205; Guo XG, 2012, J AM CHEM SOC, V134, P18427, DOI 10.1021/ja3081583; Baker JL, 2010, LANGMUIR, V26, P9146, DOI 10.1021/la904840q; Facchetti A, 2011, CHEM MATER, V23, P733, DOI 10.1021/cm102419z; Park SH, 2009, NAT PHOTONICS, V3, P297, DOI 10.1038/NPHOTON.2009.69; Muhlbacher D, 2006, ADV MATER, V18, P2884, DOI 10.1002/adma.200600160; Boudreault PLT, 2011, CHEM MATER, V23, P456, DOI 10.1021/cm1021855; Wang M, 2011, J AM CHEM SOC, V133, P9638, DOI 10.1021/ja201131h; Beaujuge PM, 2011, J AM CHEM SOC, V133, P20009, DOI 10.1021/ja2073643; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Li WW, 2013, ADV MATER, V25, P3182, DOI 10.1002/adma.201300017; Peet J, 2007, NAT MATER, V6, P497, DOI 10.1038/nmat1928; Umeda T, 2009, J APPL PHYS, V105, DOI 10.1063/1.3072669; Osaka I, 2013, J AM CHEM SOC, V135, P8834, DOI 10.1021/ja404064m; Peet J, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3544940; Shrotriya V, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2335377; Rivnay J, 2012, CHEM REV, V112, P5488, DOI 10.1021/cr3001109; You JB, 2013, ADV MATER, V25, P3973, DOI 10.1002/adma.201300964; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Brabec C., 2008, ORGANIC PHOTOVOLTAIC; Liao SH, 2014, SCI REP-UK, V4, DOI 10.1038/srep06813; Liu YH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6293; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411	40	22	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-4885	1749-4893		NAT PHOTONICS	Nat. Photonics	JUN	2015	9	6					403	+		10.1038/NPHOTON.2015.84		7	Optics; Physics, Applied	Optics; Physics	CJ1GR	WOS:000355232400015		
J	Yasuno, F; Kazui, H; Yamamoto, A; Morita, N; Kajimoto, K; Ihara, M; Taguchi, A; Matsuoka, K; Kosaka, J; Tanaka, T; Kudo, T; Takeda, M; Nagatsuka, K; Iida, H; Kishimoto, T				Yasuno, Fumihiko; Kazui, Hiroaki; Yamamoto, Akihide; Morita, Naomi; Kajimoto, Katsufumi; Ihara, Masafumi; Taguchi, Akihiko; Matsuoka, Kiwamu; Kosaka, Jun; Tanaka, Toshihisa; Kudo, Takashi; Takeda, Masatoshi; Nagatsuka, Kazuyuki; Iida, Hidehiro; Kishimoto, Toshifumi			Resting-state synchrony between the retrosplenial cortex and anterior medial cortical structures relates to memory complaints in subjective cognitive impairment	NEUROBIOLOGY OF AGING			English	Article						Subjective cognitive impairment (SCI); Resting-state functional MRI (fMRI); Diffusion tensor imaging (DTI); Amyloid imaging; Self-referential processing; Cortical midline structures	PITTSBURGH-COMPOUND-B; POSITRON-EMISSION-TOMOGRAPHY; DEFAULT MODE NETWORK; ALZHEIMERS-DISEASE; CINGULATE CORTEX; SELF; PET; PREVALENCE; MONKEY; BRAIN	Subjective cognitive impairment (SCI) is a clinical state characterized by subjective cognitive deficits without cognitive impairment. To test the hypothesis that this state might involve dysfunction of self-referential processing mediated by cortical midline structures, we investigated abnormalities of functional connectivity in these structures in individuals with SCI using resting-state functional magnetic resonance imaging. We performed functional connectivity analysis for 23 individuals with SCI and 30 individuals without SCI. To reveal the pathophysiological basis of the functional connectivity change, we performed magnetic resonance-diffusion tensor imaging. Positron emission tomography-amyloid imaging was conducted in 13 SCI and 15 nonSCI subjects. Individuals with SCI showed reduced functional connectivity in cortical midline structures. Reduction in white matter connections was related to reduced functional connectivity, but we found no amyloid deposition in individuals with SCI. The results do not necessarily contradict the possibility that SCI indicates initial cognitive decrements, but imply that reduced functional connectivity in cortical midline structures contributes to overestimation of the experience of forgetfulness. (C) 2015 Elsevier Inc. All rights reserved.	[Yasuno, Fumihiko; Matsuoka, Kiwamu; Kosaka, Jun; Kishimoto, Toshifumi] Nara Med Univ, Dept Psychiat, Kashihara, Nara 6348522, Japan; [Yasuno, Fumihiko; Yamamoto, Akihide] Natl Cerebral & Cardiovasc Ctr, Dept Investigat Radiol, Suita, Osaka, Japan; [Kazui, Hiroaki; Tanaka, Toshihisa; Takeda, Masatoshi] Osaka Univ, Sch Med, Dept Neuropsychiat, Suita, Osaka 565, Japan; [Morita, Naomi; Iida, Hidehiro] Natl Cerebral & Cardiovasc Ctr, Dept Radiol, Suita, Osaka, Japan; [Kajimoto, Katsufumi; Ihara, Masafumi; Taguchi, Akihiko; Nagatsuka, Kazuyuki] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka, Japan; [Taguchi, Akihiko] Inst Biomed Res & Innovat, Dept Regenerat Med Res, Kobe, Hyogo, Japan; [Kudo, Takashi] Osaka Univ, Hlth Care Ctr, Dept Psychiat, Suita, Osaka, Japan	Yasuno, F (reprint author), Nara Med Univ, Dept Psychiat, 840 Shijocho, Kashihara, Nara 6348522, Japan.	ejm86rp@yahoo.co.jp		Ihara, Masafumi/0000-0002-7102-4048	Japan Society for the Promotion of Science [24591740, 24591708]; Health and Labor Sciences Research Grants; Research on Dementia [H25-01]	This research was supported by Grants-in-Aid for Scientific Research (C) 24591740 and 24591708 from the Japan Society for the Promotion of Science, and by the Health and Labor Sciences Research Grants, Research on Dementia (H25-01).	Babiloni C, 2010, NEUROBIOL AGING, V31, P1787, DOI 10.1016/j.neurobiolaging.2008.09.020; Yasuno F, 2002, NEUROIMAGE, V16, P577, DOI 10.1006/nimg.2002.1120; Rowe CC, 2010, NEUROBIOL AGING, V31, P1275, DOI 10.1016/j.neurobiolaging.2010.04.007; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; McGuire PK, 1996, BRAIN, V119, P907, DOI 10.1093/brain/119.3.907; Roberts JL, 2009, DEMENT GERIATR COGN, V28, P95, DOI 10.1159/000234911; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Visser PJ, 2009, LANCET NEUROL, V8, P619, DOI 10.1016/S1474-4422(09)70139-5; Reisberg B, 2008, ALZHEIMERS DEMENT, V4, pS98, DOI 10.1016/j.jalz.2007.11.017; Perrotin A, 2012, ARCH NEUROL-CHICAGO, V69, P223, DOI 10.1001/archneurol.2011.666; Price JC, 2005, J CEREBR BLOOD F MET, V25, P1528, DOI 10.1038/sj.jcbfm.9600146; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Slavin MJ, 2010, AM J GERIAT PSYCHIAT, V18, P701, DOI 10.1097/JGP.0b013e3181df49fb; Burgess N, 2001, PHILOS T R SOC B, V356, P1493, DOI 10.1098/rstb.2001.0948; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Vann SD, 2009, NAT REV NEUROSCI, V10, P792, DOI 10.1038/nrn2733; Paus T, 2001, NAT REV NEUROSCI, V2, P417, DOI 10.1038/35077500; Innis RB, 2007, J CEREBR BLOOD F MET, V27, P1533, DOI 10.1038/sj.jcbfm.9600493; Waldorff FB, 2012, INT J GERIATR PSYCH, V27, P1180, DOI 10.1002/gps.3765; Zysset S, 2002, NEUROIMAGE, V15, P983, DOI 10.1006/nimg.2001.1008; Sperling RA, 2010, NEUROMOL MED, V12, P27, DOI 10.1007/s12017-009-8109-7; Reisberg B, 2008, INT PSYCHOGERIATR, V20, P1, DOI 10.1017/S1041610207006412; Amariglio RE, 2012, NEUROPSYCHOLOGIA, V50, P2880, DOI 10.1016/j.neuropsychologia.2012.08.011; SCHELTENS P, 1993, J NEUROL SCI, V114, P7, DOI 10.1016/0022-510X(93)90041-V; Lopresti BJ, 2005, J NUCL MED, V46, P1959; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; Kobayashi Y, 2003, J COMP NEUROL, V466, P48, DOI 10.1002/cne.10883; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Kim DH, 2002, MAGNET RESON MED, V48, P715, DOI 10.1002/mrm.10267; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Logan J, 1996, J CEREBR BLOOD F MET, V16, P834; Stewart R, 2011, BRIT J PSYCHIAT, V198, P199, DOI 10.1192/bjp.bp.110.078683; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; Kobayashi Y, 2007, J COMP NEUROL, V502, P810, DOI 10.1002/cne.21346; Jungwirth S, 2004, J AM GERIATR SOC, V52, P263, DOI 10.1111/j.1532-5415.2004.52066.x; Dunn CJ, 2014, NEUROIMAGE-CLIN, V4, P473, DOI 10.1016/j.nicl.2014.02.010; Friston K, 1995, HUMAN BRAIN MAPPING, V2, P165, DOI DOI 10.1002/HBM.460030303; Johnson Keith A, 2013, Alzheimers Dement, V9, pe106, DOI 10.1016/j.jalz.2013.06.001; Juncos-Rabadan O, 2012, DEMENT GERIATR COGN, V33, P226, DOI 10.1159/000338607; Kazui Hiroaki, 2003, No To Shinkei, V55, P317; Kazui H, 2006, J GERIATR PSYCH NEUR, V19, P3, DOI 10.1177/0891988705277543; Matsuoka K., 2014, INT J GERIATR PSYCHI; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571; WILSON B, 1989, J CLIN EXP NEUROPSYC, V11, P855, DOI 10.1080/01688638908400940; Yasuno F, 2014, PSYCHIAT RES-NEUROIM, V223, P9, DOI 10.1016/j.pscychresns.2014.04.009	48	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0197-4580	1558-1497		NEUROBIOL AGING	Neurobiol. Aging	JUN	2015	36	6					2145	2152		10.1016/j.neurobiolaging.2015.03.006		8	Geriatrics & Gerontology; Neurosciences	Geriatrics & Gerontology; Neurosciences & Neurology	CJ3JG	WOS:000355378600016		
J	Nishibe, M; Urban, ETR; Barbay, S; Nudo, RJ				Nishibe, Mariko; Urban, Edward T. R.; Barbay, Scott; Nudo, Randolph J.			Rehabilitative Training Promotes Rapid Motor Recovery but Delayed Motor Map Reorganization in a Rat Cortical Ischemic Infarct Model	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						cerebral cortex; neuronal plasticity; stroke; rats; Long-Evans; rehabilitation	CORTEX STROKE; BRAIN-INJURY; FUNCTIONAL RECOVERY; ADULT-RATS; COMPENSATION; LESIONS; DAMAGE; PLASTICITY; MECHANISMS; FORELIMB	Background. In preclinical stroke models, improvement in motor performance is associated with reorganization of cortical motor maps. However, the temporal relationship between performance gains and map plasticity is not clear. Objective. This study was designed to assess the effects of rehabilitative training on the temporal dynamics of behavioral and neurophysiological endpoints in a rat model of focal cortical infarct. Methods. Eight days after an ischemic infarct in primary motor cortex, adult rats received either rehabilitative training or were allowed to recover spontaneously. Motor performance and movement quality of the paretic forelimb was assessed on a skilled reach task. Intracortical microstimulation mapping procedures were conducted to assess the topography of spared forelimb representations either at the end of training (post-lesion day 18) or at the end of a 3-week follow-up period (post-lesion day 38). Results. Rats receiving rehabilitative training demonstrated more rapid improvement in motor performance and movement quality during the training period that persisted through the follow-up period. Motor maps in both groups were unusually small on post-lesion day 18. On post-lesion day 38, forelimb motor maps in the rehabilitative training group were significantly enlarged compared with the no-rehab group, and within the range of normal maps. Conclusions. Postinfarct rehabilitative training rapidly improves motor performance and movement quality after an ischemic infarct in motor cortex. However, training-induced motor improvements are not reflected in spared motor maps until substantially later, suggesting that early motor training after stroke can help shape the evolving poststroke neural network.	[Nishibe, Mariko] Osaka Univ, Osaka, Japan; [Urban, Edward T. R.; Barbay, Scott; Nudo, Randolph J.] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Nudo, RJ (reprint author), Univ Kansas, Med Ctr, Landon Ctr Aging, MS 1005,3901 Rainbow Blvd, Kansas City, KS 66160 USA.	rnudo@kumc.edu			NIH [R37 NS030853]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was funded by NIH R37 NS030853 to RJN.	Alaverdashvili M, 2008, EUR J NEUROSCI, V28, P311, DOI 10.1111/j.1460-9568.2008.06315.x; Kitago T, 2013, NEUROREHAB NEURAL RE, V27, P99, DOI 10.1177/1545968312452631; Gharbawie OA, 2006, NEUROSCIENCE, V137, P1107, DOI 10.1016/j.neuroscience.2005.10.043; Alaverdashvili M, 2013, NEUROSCI BIOBEHAV R, V37, P950, DOI 10.1016/j.neubiorev.2013.03.026; Eisner-Janowicz I, 2008, J NEUROPHYSIOL, V100, P1498, DOI 10.1152/jn.90447.2008; Brown CE, 2009, J NEUROSCI, V29, P1719, DOI 10.1523/JNEUROSCI.4249-08.2009; Whishaw IQ, 2008, BEHAV BRAIN RES, V192, P124, DOI 10.1016/j.bbr.2007.12.026; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Cirstea MC, 2000, BRAIN, V123, P940, DOI 10.1093/brain/123.5.940; Alaverdashvili M, 2008, BEHAV BRAIN RES, V188, P281, DOI 10.1016/j.bbr.2007.11.007; Urban ETR, 2012, MOL CELL BIOCHEM, V369, P267, DOI 10.1007/s11010-012-1390-z; NUDO RJ, 1990, SOMATOSENS MOT RES, V7, P463; Alaverdashvili M, 2010, NEUROSCIENCE, V167, P21, DOI 10.1016/j.neuroscience.2010.02.001; Clarkson AN, 2010, NATURE, V468, P305, DOI 10.1038/nature09511; McNeal DW, 2010, J COMP NEUROL, V518, P586, DOI 10.1002/cne.22218; Klein A, 2012, NEUROSCI BIOBEHAV R, V36, P1030, DOI 10.1016/j.neubiorev.2011.12.010; Lum PS, 2009, TOP STROKE REHABIL, V16, P237, DOI 10.1310/tsr1604-237; Carmichael ST, 2006, ANN NEUROL, V59, P735, DOI 10.1002/ana.20845; Metz GA, 2005, BEHAV BRAIN RES, V162, P71, DOI 10.1016/j.bbr.2005.03.002; Dancause N, 2005, J NEUROSCI, V25, P10167, DOI 10.1523/JNEUROSCI.3256-05.2005; Witte OW, 1997, ADV NEUROL, V73, P207; Carmichael ST, 2003, NEUROSCIENTIST, V9, P64, DOI 10.1177/1073858402239592; STROEMER RP, 1995, STROKE, V26, P2135; Dancause N, 2006, J NEUROPHYSIOL, V96, P3506, DOI 10.1152/jn.00792.2006; Maldonado MA, 2008, NEUROREHAB NEURAL RE, V22, P250, DOI 10.1177/1545968307308551; Nudo RJ, 2006, CURR OPIN NEUROBIOL, V16, P638, DOI 10.1016/j.conb.2006.10.004; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; Dijkhuizen RM, 2003, J NEUROSCI, V23, P510; Kleim JA, 2004, J NEUROSCI, V24, P628, DOI 10.1523/JNEUROSCI.3440-03.2004; Whishaw IQ, 2000, NEUROPHARMACOLOGY, V39, P788, DOI 10.1016/S0028-3908(99)00259-2; Clarkson AN, 2011, J NEUROSCI, V31, P3766, DOI 10.1523/JNEUROSCI.5780-10.2011; Gauthier LV, 2008, STROKE, V39, P1520, DOI 10.1161/STROKEAHA.107.502229; Moon SK, 2009, EXP NEUROL, V218, P145, DOI 10.1016/j.expneurol.2009.04.021; Kleim JA, 1998, J NEUROPHYSIOL, V80, P3321; Frost SB, 2003, J NEUROPHYSIOL, V89, P3205, DOI 10.1152/jn.01143.2002; Levin MF, 2009, NEUROREHAB NEURAL RE, V23, P313, DOI 10.1177/1545968308328727; Roby-Brami A, 2003, ACTA NEUROL SCAND, V107, P369, DOI 10.1034/j.1600-0404.2003.00021.x; Hsu JE, 2006, EXP NEUROL, V201, P479, DOI 10.1016/j.expneurol.2006.05.003; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Carmichael ST, 2004, STROKE, V35, P758, DOI 10.1161/01.STR.0000117235.11156.55; Jablonka JA, 2010, NEUROSCIENCE, V165, P90, DOI 10.1016/j.neuroscience.2009.09.074; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Knieling M, 2009, NEUROSCIENCE, V163, P759, DOI 10.1016/j.neuroscience.2009.07.004; Neumann-Haefelin T, 1998, NEUROSCIENCE, V87, P871, DOI 10.1016/S0306-4522(98)00124-9; Nudo R.J., 2007, P373; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Ward NS, 2006, ARCH PHYS MED REHAB, V87, pS30, DOI 10.1016/j.apmr.2006.08.334; Whishaw IQ, 1990, BEHAV BRAIN RES, V1, P49; WHISHAW IQ, 1991, BEHAV BRAIN RES, V42, P77, DOI 10.1016/S0166-4328(05)80042-7; Wittenberg GF, 2010, NEUROBIOL DIS, V37, P252, DOI 10.1016/j.nbd.2009.09.007	50	3	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	JUN	2015	29	5					472	482		10.1177/1545968314543499		11	Clinical Neurology; Rehabilitation	Neurosciences & Neurology; Rehabilitation	CJ3WI	WOS:000355414600009		
J	Watanabe, Y; Morishita, K; Nakasuji, T; Ando, M; Tanigawa, H				Watanabe, Y.; Morishita, K.; Nakasuji, T.; Ando, M.; Tanigawa, H.			Helium effects on microstructural change in RAFM steel under irradiation: Reaction rate theory modeling	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Ferritic alloy; Helium effects; Defect clusters; Nucleation; Reaction rate theory	COMPUTER-SIMULATION; FE; CLUSTERS; GROWTH; METALS	Reaction rate theory analysis has been conducted to investigate helium effects on the formation kinetics of interstitial type dislocation loops (I-loops) and helium bubbles in reduced-activation-ferritic/martensitic steel during irradiation, by focusing on the nucleation and growth processes of the defect clusters. The rate theory model employs the size and chemical composition dependence of thermal dissociation of point defects from defect clusters. In the calculations, the temperature and the production rate of Frenkel pairs are fixed to be T = 723 K and P-v = 10(-6) dpa/s, respectively. And then, only the production rate of helium atoms was changed into the following three cases: P-He = 0, 10(-7) and 10(-5) appm He/s. The calculation results show that helium effect on I-loop formation quite differs from that on bubble formation. As to I-loops, the loop formation hardly depends on the existence of helium, where the number density of I-loops is almost the same for the three cases of PH,. This is because helium atoms trapped in vacancies are easily emitted into the matrix due to the recombination between the vacancies and SIAs, which induces no pronounced increase or decrease of vacancies and SlAs in the matrix, leading to no remarkable impact on the I-loop nucleation. On the other hand, the bubble formation depends much on the existence of helium, in which the number density of bubbles for P-He = 10(-7) and 10(-5) appm He/s is much higher than that for PHe = 0. This is because helium atoms trapped in a bubble increase the vacancy binding energy, and suppress the vacancy dissociation from the bubble, resulting in a promotion of the bubble nucleation. And then, the helium effect on the promotion of bubble nucleation is very strong, even the number of helium atoms in a bubble is not so large. (C) 2014 Elsevier B.V. All rights reserved.	[Watanabe, Y.; Ando, M.; Tanigawa, H.] Japan Atom Energy Agcy, Aomori 0393212, Japan; [Morishita, K.] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 6110011, Japan; [Nakasuji, T.] Kyoto Univ, Grad Sch Energy Sci, Uji, Kyoto 6110011, Japan	Watanabe, Y (reprint author), Japan Atom Energy Agcy, Aomori 0393212, Japan.	watanabe.yoshiyuki32@jaea.go.jp			Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy, Kyoto University [ZE26B-25]	This work was supported by the "Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy, Kyoto University (ZE26B-25)".	Morishita K, 2003, J NUCL MATER, V323, P243, DOI 10.1016/j.jnucmat.2003.08.019; Zinkle SJ, 2013, FUSION ENG DES, V88, P472, DOI 10.1016/j.fusengdes.2013.02.081; Hashimoto N, 2013, J NUCL MATER, V442, pS796, DOI 10.1016/j.jnucmat.2012.11.047; Morishita K, 2006, J NUCL MATER, V353, P52, DOI 10.1016/j.jnucmat.2006.03.007; Cohen S. D., 1996, Computers in Physics, V10; Kuramoto E, 2000, J NUCL MATER, V283, P778, DOI 10.1016/S0022-3115(00)00361-5; KURAMOTO E, 1994, J NUCL MATER, V212, P175, DOI 10.1016/0022-3115(94)90051-5; Morishita K, 2007, NUCL INSTRUM METH B, V255, P41, DOI 10.1016/j.nimb.2006.11.036; Singh BN, 1997, J NUCL MATER, V251, P107, DOI 10.1016/S0022-3115(97)00244-4; Wakai E, 2002, J NUCL MATER, V307, P203, DOI 10.1016/S0022-3115(02)01261-8	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUN 1	2015	352						115	120		10.1016/j.nimb.2014.12.031		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CI8WU	WOS:000355053200026		
J	Yoshiie, T; Sato, K; Xu, Q; Nagai, Y				Yoshiie, T.; Sato, K.; Xu, Q.; Nagai, Y.			Reaction kinetic analysis of reactor surveillance data	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION B-BEAM INTERACTIONS WITH MATERIALS AND ATOMS			English	Article						Rate equation; A533B; Surveillance data; Precipitates; Voids	PRESSURE-VESSEL STEELS; AB-INITIO CALCULATIONS; EVOLUTION; ALLOYS; PRECIPITATION; IRON; FE; CU	In reactor pressure vessel surveillance data, it was found that the concentration of matrix defects was very low even after nearly 40 years of operation, though a large number of precipitates existed. In this paper, defect structures obtained from surveillance data of A533B (high Cu concentration) were simulated using reaction kinetic analysis with 11 rate equations. The coefficients used in the equations were quite different from those obtained by fitting a Fe-0.6 wt%Cu alloy irradiated by the Kyoto University Reactor. The difference was mainly caused by alloying elements in A533B, and the effect of alloying elements was extracted. The same code was applied to low-Cu A533B irradiated with high irradiation damage rate, and the formation of voids was correctly simulated. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshiie, T.; Sato, K.; Xu, Q.] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Nagai, Y.] Tohoku Univ, Inst Mat Res, Oarai Ctr, Oarai, Ibaraki 3111313, Japan	Yoshiie, T (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	yoshiie@rri.kyoto-u.ac.jp	Nagai, Yasuyoshi/A-8995-2011		Tohoku University by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT)	This work includes the results of "Research and development on degradation prediction of structural materials in nuclear reactors based on microstructural damage mechanisms" entrusted to the Tohoku University by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (MEXT).	Meslin E, 2013, ACTA MATER, V61, P6246, DOI 10.1016/j.actamat.2013.07.008; KIRITANI M, 1975, J PHYS SOC JPN, V38, P1677, DOI 10.1143/JPSJ.38.1677; Yoshiie T, 2008, J NUCL MATER, V377, P132, DOI 10.1016/j.jnucmat.2008.02.059; Odette GR, 2001, JOM-J MIN MET MAT S, V53, P18, DOI 10.1007/s11837-001-0081-0; [Anonymous], 2011, HEAR OP AG TECHN EV; Eason E. D., 2007, ORNLTM2006530; Malerba L, 2010, J NUCL MATER, V406, P7, DOI 10.1016/j.jnucmat.2010.05.016; Messina L, 2013, NUCL INSTRUM METH B, V303, P28, DOI 10.1016/j.nimb.2013.01.049; Miller M.K., 2001, MAT RES SOC S P, V650; Nagai Y, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2159091; Soneda N, 2010, J ENG GAS TURB POWER, V132, DOI 10.1115/1.4001056; Soneda N., 2013, CRIEPI RES REPORTS; Takeuchi T, 2010, J NUCL MATER, V402, P93, DOI 10.1016/j.jnucmat.2010.04.008; Vincent E, 2006, J NUCL MATER, V359, P227, DOI 10.1016/j.jnucmat.2006.08.022; Watanabe H, 2013, J NUCL MATER, V439, P268, DOI 10.1016/j.jnucmat.2012.08.029; YOSHIDA N, 1973, J PHYS SOC JPN, V35, P1418, DOI 10.1143/JPSJ.35.1418; Yoshiie T, 2013, NUCL INSTRUM METH B, V303, P37, DOI 10.1016/j.nimb.2012.11.032	17	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-583X	1872-9584		NUCL INSTRUM METH B	Nucl. Instrum. Methods Phys. Res. Sect. B-Beam Interact. Mater. Atoms	JUN 1	2015	352						125	129		10.1016/j.nimb.2015.01.028		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Atomic, Molecular & Chemical; Physics, Nuclear	Instruments & Instrumentation; Nuclear Science & Technology; Physics	CI8WU	WOS:000355053200028		
J	Huang, C; Tomata, Y; Kakizaki, M; Sugawara, Y; Hozawa, A; Momma, H; Tsuji, I; Nagatomi, R				Huang, C.; Tomata, Y.; Kakizaki, M.; Sugawara, Y.; Hozawa, A.; Momma, H.; Tsuji, I.; Nagatomi, R.			High circulating adiponectin levels predict decreased muscle strength among older adults aged 70 years and over: A prospective cohort study	NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES			English	Article						Adipokine; Sarcopenia; Physical function; Aging	SERUM ADIPONECTIN; HEART-FAILURE; PERFORMANCE; SARCOPENIA; MORTALITY; COMMUNITY; IMPACT; MASS	Background and aims: Population-based researches indicate that circulating adiponectin is inversely associated with muscle strength. However, interpretation of the findings has been limited by the use of a cross-sectional design. This study aimed to examine the prospective relationship between baseline circulating adiponectin concentration and change in muscular function-related physical performance in older adults. Methods and results: A 1-year prospective cohort study of Japanese community-dwelling elderly was conducted between 2002 and 2003. Four hundred thirty-four older persons participated in the measurements of physical function, including leg extension power, functional reach, timed up-and-go test, and 10-m maximum walking speed, at baseline and follow-up. After adjustment for potential covariates, higher serum adiponectin concentration was found to be significantly associated with poorer physical performance at baseline (leg extension power [watt], P < 0.001; functional reach [cm], P < 0.001; log timed up-and-go test, P = 0.007; log 10-m maximum walking speed, P < 0.001). The results of the prospective analysis by analysis of covariance indicated that the elderly with higher serum adiponectin concentrations (tertiles) at baseline tended to have a decreased performance in leg extension power (means [95% confidence interval]: lowest, -105 [-125, -85.7]; middle, -117 [-135, -97.8]; highest, -140 [-160, -120], watt, P for trend = 0.021) and timed up-and-go test (lowest, -0.08 [-0.28, -0.12]; middle, -0.10 [-0.29, 0.10]; highest, 0.28 [0.07, 0.48], s, P for trend = 0.019), but not two other functioning. Conclusion: High circulating adiponectin concentration may be an indicator of decreased physical performance, especially muscle strength, in older adults. (C) 2015 Elsevier B.V. All rights reserved.	[Huang, C.; Momma, H.; Nagatomi, R.] Tohoku Univ, Div Biomed Engn Hlth & Welf, Grad Sch Biomed Engn, Sendai, Miyagi 9808575, Japan; [Tomata, Y.; Kakizaki, M.; Sugawara, Y.; Tsuji, I.] Tohoku Univ, Dept Publ Hlth & Forens Med, Grad Sch Med, Sendai, Miyagi 9808575, Japan; [Hozawa, A.] Tohoku Univ, Tohoku Med Megabank Org, Dept Prevent Med & Epidemiol, Sendai, Miyagi 9808575, Japan	Huang, C (reprint author), Tohoku Univ, Div Biomed Engn Hlth & Welf, Grad Sch Biomed Engn, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan.	hcongman@yahoo.com; nagatomi@med.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [21689018]; Health Sciences Research Grants for Health Service from the Ministry of Health, Labor, and Welfare, Japan [H24-Choju-Ippan-005]; Japan Arteriosclerosis Prevention Fund; Center of Innovation Program from Japan Science and Technology Agency, JST	We are grateful to the study participants who consented in providing the data and the staff from the Tsurugaya Project. This work was supported by Grant-in-Aid for Young Scientists (A; 21689018) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; and Health Sciences Research Grants for Health Service (H24-Choju-Ippan-005) from the Ministry of Health, Labor, and Welfare, Japan; Japan Arteriosclerosis Prevention Fund. This study was also partially supported by a the Center of Innovation Program from Japan Science and Technology Agency, JST.	Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; BURKE WJ, 1992, J AM GERIATR SOC, V40, P1227; Loncar G, 2013, EUR J INTERN MED, V24, P818, DOI 10.1016/j.ejim.2013.09.011; Landi F, 2013, AGE AGEING, V42, P203, DOI 10.1093/ageing/afs194; Clark DJ, 2013, J GERONTOL A-BIOL, V68, P1419, DOI 10.1093/gerona/glt036; Verdijk LB, 2010, J AM GERIATR SOC, V58, P2069, DOI 10.1111/j.1532-5415.2010.03150.x; Choi KM, 2004, CLIN ENDOCRINOL, V61, P75, DOI 10.1111/j.1365-2265.2004.02063.x; Yoon HI, 2012, CHEST, V142, P893, DOI 10.1378/chest.11-2173; Ranheim T, 2004, ACTA OBSTET GYN SCAN, V83, P341, DOI 10.1111/j.0001-6349.2004.00413.x; EVANS WJ, 1995, J GERONTOL A-BIOL, V50, P5; Wannamethee SG, 2011, EUR J CARDIOV PREV R, V18, P65, DOI 10.1097/HJR.0b013e32833b09d9; Kistorp C, 2005, CIRCULATION, V112, P1756, DOI 10.1161/CIRCULATIONAHA.104.530972; Nishimura A, 2006, CLIN CHIM ACTA, V371, P163, DOI 10.1016/j.cca.2006.03.008; Bucci L, 2013, BIOGERONTOLOGY, V14, P261, DOI 10.1007/s10522-013-9428-5; DUNCAN PW, 1990, J GERONTOL, V45, pM192; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hozawa A, 2012, J GERONTOL A-BIOL, V67, P530, DOI 10.1093/gerona/glr191; Huang C, 2014, NUTR METAB CARDIOVAS, V24, P42, DOI 10.1016/j.numecd.2013.03.006; Ingelsson E, 2009, J CLIN ENDOCR METAB, V94, P953, DOI 10.1210/jc.2008-1772; Ito M, 1992, JPN J SPORTS SCI, P742; Kizer JR, 2010, J GERONTOL A-BIOL, V65, P1208, DOI 10.1093/gerona/glq122; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Martinez-Gomez D, 2012, NUTR METAB CARDIOVAS, V22, P252, DOI 10.1016/j.numecd.2010.07.010; Nagasaki H, 1995, AGING-CLIN EXP RES, V7, P451; Niino N., 1991, CLIN GERONTOL, V10, P85; Norman K, 2005, CLIN NUTR, V24, P143, DOI 10.1016/j.clnu.2004.08.007; Okuno S, 2012, OSTEOPOROSIS INT, V23, P2027, DOI 10.1007/s00198-011-1789-5; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; Tsai JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056250; World Health Organization (WHO), 1995, PHYS STAT US INT ANT; Yang GA, 2011, GERIATR GERONTOL INT, V11, P157, DOI 10.1111/j.1447-0594.2010.00651.x	32	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0939-4753	1590-3729		NUTR METAB CARDIOVAS	Nutr. Metab. Carbiovasc. Dis.	JUN	2015	25	6					594	601		10.1016/j.numecd.2015.03.010		8	Cardiac & Cardiovascular Systems; Endocrinology & Metabolism; Nutrition & Dietetics	Cardiovascular System & Cardiology; Endocrinology & Metabolism; Nutrition & Dietetics	CJ0GL	WOS:000355153700012		
J	Maruyama, K; Nishioka, S; Miyoshi, N; Higuchi, K; Mori, H; Tanno, S; Tomooka, K; Eguchi, E; Furukawa, S; Saito, I; Sakurai, S; Nishida, W; Osawa, H; Tanigawa, T				Maruyama, Koutatsu; Nishioka, Shinji; Miyoshi, Noriko; Higuchi, Kana; Mori, Hiromi; Tanno, Sakurako; Tomooka, Kiyohide; Eguchi, Eri; Furukawa, Shinya; Saito, Isao; Sakurai, Susumu; Nishida, Wataru; Osawa, Haruhiko; Tanigawa, Takeshi			The impact of masticatory ability as evaluated by salivary flow rates on obesity in japanese: The Toon health study	OBESITY			English	Article							BODY-MASS-INDEX; EATING FAST LEADS; WAIST CIRCUMFERENCE; PERIODONTAL STATUS; DIABETES-MELLITUS; WOMEN; MEN; ASSOCIATION; ADULTS; RISK	ObjectiveThis study examined the associations of masticatory ability evaluated by chewing-gum-stimulated salivary flow rate with anthropometric indices among a general Japanese population. MethodsIn total, 921 Japanese men and women aged 30-79 years participated in this cross-sectional study. Saliva production was stimulated by 5 min of gum chewing, then collected; salivary flow rate was calculated as g/min. Overweight, abdominal obesity in terms of waist circumference (WC), and waist-hip ratio (WHR), and elevated skinfold thickness statuses were determined. ResultsThe multivariable odds ratio and 95% confidence intervals of overweight, abdominal obesity (WC, WHR), and elevated skinfold thickness status for highest vs. lowest quartile of salivary flow rate were 0.59 (0.37-0.95, P for trend=0.02), 0.65 (0.43-0.98, P=0.03), 0.54 (0.35-0.83, P<0.01), and 0.61 (0.39-0.96, P<0.01), respectively. The linear trends of multivariable-adjusted means of BMI, WC, WHR, and skinfold thickness according to quartiles of salivary flow rate did not vary after stratification by overweight status. ConclusionsHigher stimulated salivary flow rate, a surrogate marker for mastication ability, was associated with lower prevalence of overweight, abdominal obesity (whether WC- or WHR-defined), and elevated skinfold thickness among the general Japanese population.	[Maruyama, Koutatsu] Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Ehime, Japan; [Nishioka, Shinji; Higuchi, Kana; Tomooka, Kiyohide; Saito, Isao] Ehime Univ, Grad Sch Med, Dept Basic Nursing & Hlth Sci, Toon, Ehime, Japan; [Miyoshi, Noriko; Mori, Hiromi; Furukawa, Shinya] Ehime Univ, Grad Sch Med, Dept Publ Hlth, Toon, Ehime, Japan; [Tanno, Sakurako] Ehime Univ Hosp, Ctr Sleep Med, Toon, Ehime, Japan; [Eguchi, Eri] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Publ Hlth, Okayama, Japan; [Sakurai, Susumu] Tenri Hlth Care Univ, Fac Hlth Care, Dept Clin Lab Sci, Tenri, Nara, Japan; [Nishida, Wataru] Nishida Wataru Diabet Clin, Matsuyama, Ehime, Japan; [Osawa, Haruhiko] Ehime Univ, Grad Sch Med, Dept Mol & Genet Med, Toon, Ehime, Japan; [Tanigawa, Takeshi] Juntendo Univ, Grad Sch Med, Dept Publ Hlth, Bunkyo Ku, Tokyo, Japan	Maruyama, K (reprint author), Ehime Univ, Grad Sch Med, Dept Basic Med Res & Educ, Toon, Ehime, Japan.	maruyama.kotatsu.mu@ehime-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [22390134, 25293142, 25860443, 25860441]; Health and Labor Sciences Research Grants from the Ministry of Health, Welfare, and Labor, Japan (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus) [201021038A]; 8020 Promotion Foundation	This study was supported in part by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology of Japan (Grants-in-Aid for Research B, no 22390134 in 2010-2012 and 25293142 from 2013, and Grant-in-Aid for Young Scientists B, no 25860443 and 25860441 from 2013), Health and Labor Sciences Research Grants from the Ministry of Health, Welfare, and Labor, Japan (Comprehensive Research on Life-Style Related Diseases including Cardiovascular Diseases and Diabetes Mellitus, no 201021038A in 2010-2012), and 8020 Promotion Foundation (in 2012).	Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Sasaki S, 2003, INT J OBESITY, V27, P1405, DOI 10.1038/sj.ijo.0802425; Ikebe K, 2011, ARCH ORAL BIOL, V56, P991, DOI 10.1016/j.archoralbio.2011.03.019; Ishikawa-Takata K, 2011, J EPIDEMIOL, V21, P114, DOI 10.2188/jea.JE20100079; Koh-Banerjee P, 2003, AM J CLIN NUTR, V78, P719; Dodds MWJ, 2005, J DENT, V33, P223, DOI 10.1016/j.jdent.2004.10.009; [Anonymous], 2011, WHO WHO WAIST CIRC W; Sakurai M, 2012, METABOLISM, V61, P1566, DOI 10.1016/j.metabol.2012.04.005; Flink H, 2008, COMMUNITY DENT ORAL, V36, P523, DOI [10.1111/j.1600-0528.2008.00432.x, 10.1111/j.1600-0528.2008.00440.x]; Modeer T, 2010, OBESITY, V18, P2367, DOI 10.1038/oby.2010.63; Ueno M, 2008, J ORAL REHABIL, V35, P337, DOI 10.1111/j.1365-2842.2008.01847.x; Mata AD, 2004, MOL CELL BIOCHEM, V261, P137, DOI 10.1023/B:MCBI.0000028748.40917.6f; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Li J, 2011, AM J CLIN NUTR, V94, P709, DOI 10.3945/ajcn.111.015164; Tabara Y, 2011, J HYPERTENS, V29, P1948, DOI 10.1097/HJH.0b013e32834abd06; Otsuka R, 2006, J EPIDEMIOL, V16, P117, DOI 10.2188/jea.16.117; Ekuni D, 2014, J CLIN PERIODONTOL, V41, P772, DOI 10.1111/jcpe.12273; Maruyama K, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a2002; Morita M, 2003, J ORAL REHABIL, V30, P260, DOI 10.1046/j.1365-2842.2003.01012.x; Murakami K, 2007, AM J CLIN NUTR, V86, P206; NAKAMURA T, 1986, Japanese Journal of Nutrition, V44, P69; N'gom Papa Ibrahima, 2002, J Prosthet Dent, V87, P667, DOI 10.1067/mpr.2002.123229; Ono Takahiro, 2003, Gerodontology, V20, P24, DOI 10.1111/j.1741-2358.2003.00024.x; Ostberg AL, 2012, BMC ORAL HEALTH, V12, DOI 10.1186/1472-6831-12-50; Otsuka R, 2008, PREV MED, V46, P154, DOI 10.1016/j.ypmed.2007.07.031; Takahashi K., 2001, Japanese Journal of Nutrition, V59, P221; Tanno S, 2014, SLEEP MED, V15, P1212, DOI 10.1016/j.sleep.2014.05.027; World Health Organization, 1997, OR HLTH SURV BAS MET	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1930-7381	1930-739X		OBESITY	Obesity	JUN	2015	23	6					1296	1302		10.1002/oby.21071		7	Endocrinology & Metabolism; Nutrition & Dietetics	Endocrinology & Metabolism; Nutrition & Dietetics	CJ0FG	WOS:000355150300023		
J	Ujiie, H; Kadota, K; Nitadori, J; Aerts, JG; Woo, KM; Sima, CS; Travis, WD; Jones, DR; Krug, LM; Adusumilli, PS				Ujiie, Hideki; Kadota, Kyuichi; Nitadori, Jun-ichi; Aerts, Joachim G.; Woo, Kaitlin M.; Sima, Camelia S.; Travis, William D.; Jones, David R.; Krug, Lee M.; Adusumilli, Prasad S.			The tumoral and stromal immune microenvironment in malignant pleural mesothelioma: A comprehensive analysis reveals prognostic immune markers	ONCOIMMUNOLOGY			English	Article						B lymphocyte; immune responses to cancer; pleural malignancy; tumor-infiltrating lymphocytes; T lymphocytes	I LUNG ADENOCARCINOMA; T-CELL RESPONSES; EXTRAPLEURAL PNEUMONECTOMY; BREAST-CANCER; B-CELLS; SURVIVAL; MACROPHAGES; RECURRENCE; OVEREXPRESSION; EXPRESSION	Antitumor immune responses against solid malignancies correlate with improved patient survival. We conducted a comprehensive investigation of immune responses in tumor and tumor-associated stroma in epithelioid malignant pleural mesothelioma with the goal of characterizing the tumor immune microenvironment and identifying prognostic immune markers. We investigated 8 types of tumor-infiltrating immune cells within the tumor nest and tumor-associated stroma, as well as tumor expression of 5 cytokine/chemokine receptors in 230 patients. According to univariate analyses, high densities of tumoral CD4- and CD20-expressing lymphocytes were associated with better outcomes. High expression of tumor interleukin-7 (IL-7) receptor was associated with worse outcomes. According to multivariate analyses, stage and tumoral CD20 detection were independently associated with survival. Analysis of single immune cell infiltration for CD163(+) tumor-associated macrophages did not correlate with survival. However, analysis of immunologically relevant cell combinations identified that: (1) high CD163(+) tumor-associated macrophages and low CD8(+) lymphocyte infiltration had worse prognosis than other groups and (2) low CD163(+) tumor associated macrophages and high CD20(+) lymphocyte infiltration had better prognosis than other groups. Multivariate analyses demonstrated that CD163/CD8 and CD163/CD20 were independent prognostic factors of survival. With a recent increase in immunotherapy investigations and clinical trials for malignant pleural mesothelioma patients, our observations that CD20(+) B lymphocytes and tumor-associated macrophages are prognostic markers provide important information about the tumor microenvironment of malignant pleural mesothelioma.	[Ujiie, Hideki; Kadota, Kyuichi; Nitadori, Jun-ichi; Jones, David R.; Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, New York, NY 10021 USA; [Ujiie, Hideki] Chiba Univ, Grad Sch Med, Dept Clin Mol Biol, Chiba, Japan; [Kadota, Kyuichi; Travis, William D.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Aerts, Joachim G.] Erasmus MC Canc Inst, Dept Pulm Med, Rotterdam, Netherlands; [Woo, Kaitlin M.; Sima, Camelia S.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY 10021 USA; [Krug, Lee M.] Mem Sloan Kettering Canc Ctr, Dept Med, Div Solid Tumor Oncol, Thorac Oncol Serv, New York, NY 10021 USA; [Adusumilli, Prasad S.] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA	Adusumilli, PS (reprint author), Mem Sloan Kettering Canc Ctr, Dept Surg, Thorac Serv, 1275 York Ave, New York, NY 10021 USA.	adusumip@mskcc.org			National Institutes of Health [R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P30 CA008748-48, P50 CA086438-13]; US Department of Defense [PR101053, LC110202]; Commonwealth Foundation for Cancer Research; Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center	This author's laboratory work is supported by grants from the National Institutes of Health (R21 CA164568-01A1, R21 CA164585-01A1, R01 CA136705-06, U54 CA137788, P30 CA008748-48, and P50 CA086438-13), the US Department of Defense (PR101053 and LC110202), and the Mr. William H. Goodwin and Mrs. Alice Goodwin, the Commonwealth Foundation for Cancer Research, and the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center.	Adusumilli PS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010162; Al-Rawi MAA, 2005, BRIT J SURG, V92, P305, DOI 10.1002/bjs.4832; Suzuki K, 2013, J CLIN ONCOL, V31, P490, DOI 10.1200/JCO.2012.45.2052; Flores RM, 2007, J THORAC ONCOL, V2, P957, DOI 10.1097/JTO.0b013e31815608d9; Yamada N, 2010, CANCER IMMUNOL IMMUN, V59, P1543, DOI 10.1007/s00262-010-0881-6; Kadota K, 2012, MODERN PATHOL, V25, P1117, DOI 10.1038/modpathol.2012.58; Rochman Y, 2009, NAT REV IMMUNOL, V9, P480, DOI 10.1038/nri2580; Kadota K, 2011, J THORAC ONCOL, V6, P896, DOI 10.1097/JTO.0b013e318211127a; Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Mahmoud SMA, 2012, BREAST CANCER RES TR, V132, P545, DOI 10.1007/s10549-011-1620-1; Baratelli F, 2005, J IMMUNOL, V175, P1483; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305; Chen C, 2013, EXP CELL RES, V319, P96, DOI 10.1016/j.yexcr.2012.09.006; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Krug LM, 2009, J CLIN ONCOL, V27, P3007, DOI 10.1200/JCO.2008.20.3943; Coughlin CM, 2004, BLOOD, V103, P2046, DOI 10.1182/blood-2003-07-2379; Servais EL, 2012, CLIN CANCER RES, V18, P2478, DOI 10.1158/1078-0432.CCR-11-2614; Ming J, 2009, EUR J CANCER, V45, P866, DOI 10.1016/j.ejca.2008.12.006; Yoshizawa A, 2010, CLIN CANCER RES, V16, P240, DOI 10.1158/1078-0432.CCR-09-0986; Izzi V, 2009, INT J ONCOL, V34, P543, DOI 10.3892/ijo_00000180; Flores RM, 2006, J THORAC ONCOL, V1, P289, DOI 10.1097/01243894-200605000-00004; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Zhang L, 2003, NEW ENGL J MED, V348, P203, DOI 10.1056/NEJMoa020177; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Kao SCH, 2011, J THORAC ONCOL, V6, P1923, DOI 10.1097/JTO.0b013e31822a3740; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Mazumdar M, 2000, STAT MED, V19, P113, DOI 10.1002/(SICI)1097-0258(20000115)19:1<113::AID-SIM245>3.3.CO;2-F; Anraku M, 2008, J THORAC CARDIOV SUR, V135, P823, DOI 10.1016/j.jtcvs.2007.10.026; Sica A, 2008, SEMIN CANCER BIOL, V18, P349, DOI 10.1016/j.semcancer.2008.03.004; Bograd AJ, 2011, CANCER IMMUNOL IMMUN, V60, P1509, DOI 10.1007/s00262-011-1103-6; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Brower V, 2012, J NATL CANCER I, V104, P649, DOI 10.1093/jnci/djs235; Edge SB, 2010, AJCC CANCER STAGING; HASSAN R, 2013, SCI TRANSL MED, V5, DOI DOI 10.1126/SCITRANSLMED.3006941; Kachala SS, 2014, CLIN CANCER RES, V20, P1020, DOI 10.1158/1078-0432.CCR-13-1862; Kadota K, 2013, ONCOIMMUNOLOGY, V2, DOI 10.4161/onci.24036; Milne K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006412; SCHULTZ KR, 1990, SCIENCE, V249, P921, DOI 10.1126/science.2118273; Suzuki K, 2011, CANCER IMMUNOL IMMUN, V60, P1721, DOI 10.1007/s00262-011-1073-8; Tewari N, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-436	44	1	1	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	2162-402X			ONCOIMMUNOLOGY	OncoImmunology	JUN	2015	4	6								10.1080/2162402X.2015.1009285		9	Oncology; Immunology	Oncology; Immunology	CJ0XK	WOS:000355203300020		
J	Atsumi, J; Hanami, T; Enokida, Y; Ogawa, H; Delobel, D; Mitani, Y; Kimura, Y; Soma, T; Tagami, M; Takase, Y; Ichihara, T; Takeyoshi, I; Usui, K; Hayashizaki, Y; Shimizu, K				Atsumi, Jun; Hanami, Takeshi; Enokida, Yasuaki; Ogawa, Hiroomi; Delobel, Diane; Mitani, Yasumasa; Kimura, Yasumasa; Soma, Takahiro; Tagami, Michihira; Takase, Yoshiaki; Ichihara, Tatsuo; Takeyoshi, Izumi; Usui, Kengo; Hayashizaki, Yoshihide; Shimizu, Kimibiro			Eprobe-mediated screening system for somatic mutations in the KRAS locus	ONCOLOGY REPORTS			English	Article						Eprobe; competing effect; Kristen rat sarcoma viral oncogene homolog; colorectal cancer	GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; METASTATIC COLORECTAL-CARCINOMA; SMART AMPLIFICATION PROCESS; MELTING CURVE ANALYSIS; RAS MUTATIONS; SENSITIVE DETECTION; THERAPY; SAMPLES; TISSUE	Activating mutations in the Kirsten rat sarcoma viral oncogene homolog (KRAS) loci are largely predictive of resistance to epidermal growth factor receptor (EGFR) therapy in colorectal cancer (CRC). A highly sensitive detection system for the KRAS gene mutations is urgently needed; however, conventional methods have issues with feasibility and cost performance. Here, we describe a novel detection system using a fluorescence 'Eprobe' capable of detecting low level KRAS gene mutations, via real-time PCR, with high sensitivity and simple usability. We designed our Eprobes to be complementary to wild-type (WT) KRAS or to the commonly mutated codons 12 and 13. The WT Eprobe binds strongly to the WT DNA template and suppresses amplification by blocking annealing of the primer during PCR. Eprobe-PCR with WT Eprobe shows high sensitivity (0.05-0.1% of plasmid DNA, 1% of genomic DNA) for the KRAS mutation by enrichment of the mutant type (MT) amplicon. Assay performance was compared to Sanger sequencing using 92 CRC samples. Discrepancies were analyzed by mutation genotyping via Eprobe-PCR with full match Eprobes for 7 prevalent mutations and the next generation sequencing (NGS). Significantly, the Eprobe system had a higher sensitivity for detecting KRAS mutations in CRC patient samples; these mutations could not be identified by Sanger sequencing. Thus, the Eprobe approach provides for highly sensitive and convenient mutation detection and should be useful for diagnostic applications.	[Atsumi, Jun; Enokida, Yasuaki; Ogawa, Hiroomi; Takase, Yoshiaki; Takeyoshi, Izumi; Shimizu, Kimibiro] Gunma Univ, Grad Sch Med, Dept Thorac, Maebashi, Gumma 371, Japan; [Atsumi, Jun; Enokida, Yasuaki; Ogawa, Hiroomi; Takase, Yoshiaki; Takeyoshi, Izumi; Shimizu, Kimibiro] Gunma Univ, Grad Sch Med, Dept Visceral Organ Surg, Maebashi, Gumma 371, Japan; [Hanami, Takeshi; Delobel, Diane; Mitani, Yasumasa; Kimura, Yasumasa; Soma, Takahiro; Tagami, Michihira; Ichihara, Tatsuo; Usui, Kengo] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa 2300045, Japan; [Mitani, Yasumasa; Kimura, Yasumasa; Ichihara, Tatsuo] KK DNAFORM, Tokyo, Japan; [Hayashizaki, Yoshihide] RIKEN Prevent Med & Diag Innovat Program, Yokohama, Kanagawa, Japan	Hanami, T (reprint author), RIKEN Ctr Life Sci Technol, Div Genom Technol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	thanami@riken.jp			RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); METI (Minister of Economy, Trade and Industry); Division of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government	We acknowledge Dr Matthias Harbers for his contributions to the manuscript preparation. This study was supported by i) research grants for RIKEN Omics Science Center from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to Y.H., ii) a research grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through RIKEN Preventive Medicine and Diagnosis Innovation Program to Y.H., iii) a Research Grant from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) to the RIKEN Center for Life Science Technologies, iv) FY2013 subsidy of expenses by METI (Minister of Economy, Trade and Industry) for measures for small business support, and v) a research grant and operational grant for the Division of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of the Japanese Government to K.S.	Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Oh JE, 2010, J MOL DIAGN, V12, P418, DOI 10.2353/jmoldx.2010.090146; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Miyamae Y, 2010, J MOL DIAGN, V12, P257, DOI 10.2353/jmoldx.2010.090105; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Tatsumi K, 2008, J MOL DIAGN, V10, P520, DOI 10.2353/jmoldx.2008.080024; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; Ikeda S, 2009, ANGEW CHEM INT EDIT, V48, P6480, DOI 10.1002/anie.200902000; Normanno N, 2009, NAT REV CLIN ONCOL, V6, P519, DOI 10.1038/nrclinonc.2009.111; Beau-Faller M, 2009, BRIT J CANCER, V100, P985, DOI 10.1038/sj.bjc.6604925; Bardelli A, 2010, J CLIN ONCOL, V28, P1254, DOI 10.1200/JCO.2009.24.6116; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Dono M, 2012, MOL MED, V18, P1519, DOI 10.2119/molmed.2012.00175; Lee S, 2012, VIRCHOWS ARCH, V460, P141, DOI 10.1007/s00428-011-1180-0; Mendelsohn J, 2006, SEMIN ONCOL, V33, P369, DOI 10.1053/j.seminoncol.2006.04.003; Arcila M, 2011, J MOL DIAGN, V13, P64, DOI 10.1016/j.jmoldx.2010.11.005; Dabritz J, 2005, BRIT J CANCER, V92, P405, DOI 10.1038/sj.bjc.6602319; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Araki T, 2010, J MOL DIAGN, V12, P118, DOI 10.2353/jmoldx.2010.090081; Aubin F, 2011, CURR ONCOL, V18, pE180; Blons H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068945; Cavallini A, 2010, ANTICANCER RES, V30, P5251; Chambers PA, 2013, HUM MUTAT, V34, P248, DOI 10.1002/humu.22207; de Castro DG, 2012, BRIT J CANCER, V107, P345, DOI 10.1038/bjc.2012.259; Hanami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070942; Kimura Y, 2012, BIOCHEMISTRY-US, V51, P6056, DOI 10.1021/bi300293d; Krypuy M, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-295; Lezhava A, 2010, HUM MUTAT, V31, P208, DOI 10.1002/humu.21177; Malapelle U, 2014, J CLIN PATHOL, V67, P1, DOI 10.1136/jclinpath-2013-201835; Tol J, 2010, J CELL MOL MED, V14, P2122, DOI 10.1111/j.1582-4934.2009.00788.x	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUN	2015	33	6					2719	2727		10.3892/or.2015.3883		9	Oncology	Oncology	CI8YX	WOS:000355058700009		
J	Kinoshita, R; Watanabe, M; Huang, P; Li, SA; Sakaguchi, M; Kumon, H; Futami, J				Kinoshita, Rie; Watanabe, Masami; Huang, Peng; Li, Shun-Ai; Sakaguchi, Masakiyo; Kumon, Hiromi; Futami, Junichiro			The cysteine-rich core domain of REIC/Dkk-3 is critical for its effect on monocyte differentiation and tumor regression	ONCOLOGY REPORTS			English	Article						REIC; monocyte; dendritic cell; anticancer immune; protein therapy	PROSTATE-CANCER CELLS; DENDRITIC CELLS; DOWN-REGULATION; ADENOVIRAL VECTOR; THERAPEUTIC AGENT; GM-CSF; GENE; OVEREXPRESSION; EXPRESSION; FAMILY	Reduced expression in immortalized cells (REIC)/Dickkopf (Dkk)-3 is a tumor-suppressor gene and has been studied as a promising therapeutic gene for cancer gene therapy. Intratumoral injection of an adenovirus vector carrying the human REIC/Dkk-3 gene (Ad-REIC) elicits cancer cell-specific apoptosis and anticancer immune responses. The cytokine-like effect of secretory REIC/Dkk-3 on the induction of dendritic cell (DC)-like cell differentiation from monocytes plays a role in systemic anticancer immunity. In the present study, we generated recombinant full-length and N-terminally truncated REIC/Dkk-3 to characterize the biological activity of the protein. During the purification procedure, we identified a 17 kDa cysteine-rich stable product (C17-REIC) showing limited degradation. Further analysis showed that the C17-REIC domain was sufficient for the induction of DC-like cell differentiation from monocytes. Concomitant with the differentiation of DCs, the REIC/Dkk-3 protein induced the phosphorylation of glycogen synthase kinase 3 beta (GSK-3 beta) and signal transducers and activators of transcription (STAT) at a level comparable to that of granulocyte/macrophage colony-stimulating factor. In a mouse model of subcutaneous renal adenocarcinoma, intraperitoneal injection of full-length and C17-REIC proteins exerted anticancer effects in parallel with the activation of immunocompetent cells such as DCs and cytotoxic T lymphocytes in peripheral blood. Taken together, our results indicate that the stable cysteine-rich core region of REIC/Dkk-3 is responsible for the induction of anticancer immune responses. Because REIC/Dkk-3 is a naturally circulating serum protein, the upregulation REIC/Dkk-3 protein expression could be a promising option for cancer therapy.	[Kinoshita, Rie; Futami, Junichiro] Okayama Univ, Dept Biotechnol, Div Chem & Biochem, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan; [Kinoshita, Rie; Huang, Peng; Li, Shun-Ai; Kumon, Hiromi] Okayama Univ, Innovat Ctr Okayama Nanobiotargeted Therapy, Okayama 7008530, Japan; [Watanabe, Masami] Okayama Univ Hosp, Ctr Innovat Clin Med, Okayama, Japan; [Watanabe, Masami; Kumon, Hiromi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama 7008530, Japan; [Sakaguchi, Masakiyo] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008530, Japan	Futami, J (reprint author), Okayama Univ, Dept Biotechnol, Div Chem & Biochem, Grad Sch Nat Sci & Technol, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	futamij@okayama-u.ac.jp			METI; Grant for Promotion of Science and Technology in Okayama Prefecture (by MEXT); Okayama University	The present study was supported by METI's FY2010 Supplementary Budget for Regional Innovation Creation R&D Programs 'Development of an intelligent injection system for nanobio-targeted therapy' and a Grant for Promotion of Science and Technology in Okayama Prefecture (by MEXT) 'Creation of nanobio-targeted therapy using REIC as a therapeutic gene for cancer'. We thank Ms. Tomoko Honjo (Okayama University) and Ms. Remi Sunami (Momotaro-Gene Inc.) for valuable assistance. Okayama University and Momotaro-Gene Inc. are applying for patents on the SGE systems. M.W., M.S., and H.K. are inventors of the patents. Okayama University and Momotaro-Gene Inc. are applying for patents on the Partial region polypeptide of the REIC/Dkk-3 protein. J.F., M.W. and H.K. are inventors of the patents. Momotaro-Gene Inc. holds the patents of Ad-REIC and REIC protein agents and develops the agents as a cancer therapeutic medicine. H.K., M.S. and M.W. own stock in Momotaro-Gene Inc. Okayama University and Momotaro-Gene Inc. are working together for the development of the Ad-REIC agent. Okayama University also received research funds for the joint research. H.K. is the chief science officer for Momotaro-Gene Inc.	Abarzua F, 2008, BIOCHEM BIOPH RES CO, V375, P614, DOI 10.1016/j.bbrc.2008.08.079; Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; van de Laar L, 2012, BLOOD, V119, P3383, DOI 10.1182/blood-2011-11-370130; Vilimek D, 2006, BIOCHEM CELL BIOL, V84, P20, DOI 10.1139/O05-154; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Alessandrini A, 2011, CELL IMMUNOL, V270, P114, DOI 10.1016/j.cellimm.2011.04.007; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Cheng ZH, 2011, NAT STRUCT MOL BIOL, V18, P1204, DOI 10.1038/nsmb.2139; Schuler G, 2003, CURR OPIN IMMUNOL, V15, P138, DOI 10.1016/S0952-7915(03)00015-3; Li L, 2002, J BIOL CHEM, V277, P5977, DOI 10.1074/jbc.M111131200; Laouar Y, 2003, IMMUNITY, V19, P903, DOI 10.1016/S1074-7613(03)00332-7; Luo J, 2009, CANCER LETT, V273, P194, DOI 10.1016/j.canlet.2008.05.045; Conti L, 2008, IMMUNOBIOLOGY, V213, P859, DOI 10.1016/j.imbio.2008.07.017; Krupnik VE, 1999, GENE, V238, P301, DOI 10.1016/S0378-1119(99)00365-0; Hirata T, 2012, INT J ONCOL, V41, P559, DOI 10.3892/ijo.2012.1503; Nestle FO, 2000, ONCOGENE, V19, P6673, DOI 10.1038/sj.onc.1204095; Zenzmaier C, 2008, EXP GERONTOL, V43, P867, DOI 10.1016/j.exger.2008.05.012; Tanimoto R, 2007, INT J MOL MED, V19, P363; Nakamura REI, 2010, GROWTH FACTORS, V28, P232, DOI 10.3109/08977191003738832; Zou GM, 2002, EUR CYTOKINE NETW, V13, P186; Fujii Y, 2014, ACTA MED OKAYAMA, V68, P63; Fujita K, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-71; Ochiai K, 2011, BIOCHEM BIOPH RES CO, V412, P391, DOI 10.1016/j.bbrc.2011.07.109; Sakaguchi M, 2009, J BIOL CHEM, V284, P14236, DOI 10.1074/jbc.M808002200; Sakaguchi M, 2014, MOL BIOTECHNOL, V56, P621, DOI 10.1007/s12033-014-9738-0; Shien K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087900; Tanimoto R, 2010, INT J CANCER, V126, P1562, DOI 10.1002/ijc.24764; Than SS, 2011, ONCOL REP, V25, P989, DOI 10.3892/or.2011.1149; Tormo AJ, 2013, JAK STAT, V2; Tsuji T, 2001, BIOCHEM BIOPH RES CO, V289, P257, DOI 10.1006/bbrc.2001.5972; Uchida D, 2014, J GASTROEN HEPATOL, V29, P973, DOI 10.1111/jgh.12501; Watanabe M, 2014, ONCOL REP, V31, P1089, DOI 10.3892/or.2013.2958; Watanabe M, 2009, INT J ONCOL, V34, P657, DOI 10.3892/ijo_00000191; Watanabe M, 2014, ONCOL LETT, V7, P595, DOI 10.3892/ol.2013.1777	35	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUN	2015	33	6					2908	2914		10.3892/or.2015.3885		7	Oncology	Oncology	CI8YX	WOS:000355058700031		
J	Wada, A; Ito, A; Iitsuka, H; Tsuneyama, K; Miyazono, T; Murakami, J; Shibahara, N; Sakurai, H; Saiki, I; Nakayama, T; Yoshie, O; Koizumi, K; Sugiyama, T				Wada, Akinori; Ito, Aya; Iitsuka, Hirofumi; Tsuneyama, Koichi; Miyazono, Takayoshi; Murakami, Jun; Shibahara, Naotoshi; Sakurai, Hiroaki; Saiki, Ikuo; Nakayama, Takashi; Yoshie, Osamu; Koizumi, Keiichi; Sugiyama, Toshiro			Role of chemokine CX3CL1 in progression of multiple myeloma via CX3CR1 in bone microenvironments	ONCOLOGY REPORTS			English	Article						chemokine CX3CL1; survival pathway; adhesion; osteoclast; multiple myeloma	DOWN-REGULATION; FRACTALKINE; EXPRESSION; SURVIVAL; CELLS; ADHESION; CANCER; CX(3)CR1; DISEASE; INHIBITION	Several chemokines/chemokine receptors such as CXCL12, CCL3, CXCR4 and CCR1 attract multiple myelomas to specific microenvironments. In the present study, we investigated whether the CX3CL1/CX3CR1 axis is involved in the interaction of the multiple myeloma cells with their microenvironment. The expression of CX3CR1 (also known as fractalkine) was detected in three of the seven human myeloma cell lines. CX3CL1-induced phosphorylation of Akt and ERK1/2 was detected in the CX3CR1-positive cell lines, but not in the CX3CR1-negative cell lines. In addition, CX3CL1-induced cell adhesion to fibronectin and vascular cell adhesion molecule-1 (VCAM-1) in the human myeloma RPMI-8226 cell line. We also investigated whether a relationship existed between myeloma cells and osteoclasts that may function via the CX3CL1/CX3CR1 axis. Conditioned medium from CX3CL1-stimulated RPMI-8226 cells drastically increased the osteoclast differentiation. Collectively, the results from the present study support the concept of the CX3CL1-mediated activation of the progression of the multiple myeloma via CX3CR1. Thus, CX3CR1 may represent a potential therapeutic target for the treatment of multiple myeloma in a bone microenvironment.	[Wada, Akinori; Miyazono, Takayoshi; Murakami, Jun; Sugiyama, Toshiro] Toyama Univ, Dept Gastroenterol & Hematol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Wada, Akinori; Ito, Aya; Iitsuka, Hirofumi; Shibahara, Naotoshi; Koizumi, Keiichi] Toyama Univ, Div Kampo Diagnost, Inst Nat Med, Toyama 9300194, Japan; [Tsuneyama, Koichi; Sakurai, Hiroaki] Toyama Univ, Dept Canc Cell Biol, Grad Sch Med & Pharmaceut Sci, Toyama 9300194, Japan; [Saiki, Ikuo] Toyama Univ, Div Pathogen Biochem, Inst Nat Med, Toyama 9300194, Japan; [Nakayama, Takashi] Kinki Univ, Sch Pharmaceut Sci, Div Chemotherapy, Osaka, Japan; [Yoshie, Osamu] Kinki Univ, Fac Med, Dept Microbiol, Osaka, Japan	Koizumi, K (reprint author), Toyama Univ, Div Kampo Diagnost, Inst Nat Med, 2630 Sugitani, Toyama 9300194, Japan.	kkoizumi@inm.u-toyama.ac.jp		Sakurai, Hiroaki/0000-0003-0657-9570	 [22501042]	We would like to thank Ms. Toyomi Kozawa and Mr. Yoshihiro Kuwabara for their technical assistance. The present study was supported by a Grant-in-Aid for Scientific Research (C) (no. 22501042).	Andreasson U, 2008, CANCER LETT, V259, P138, DOI 10.1016/j.canlet.2007.10.031; Shulby SA, 2004, CANCER RES, V64, P4693, DOI 10.1158/0008-5472.CAN-03-3437; Brenner H, 2008, BLOOD, V111, P2521, DOI 10.1182/blood-2007-08-104984; Kumar SK, 2008, BLOOD, V111, P2516, DOI 10.1182/blood-2007-10-116129; Baggiolini M, 1998, NATURE, V392, P565, DOI 10.1038/33340; Nakayama T, 2003, J IMMUNOL, V170, P1136; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Umehara H, 2004, ARTERIOSCL THROM VAS, V24, P34, DOI 10.1161/01.ATV.0000095360.62479.1F; Eychene A, 2008, NAT REV CANCER, V8, P683, DOI 10.1038/nrc2460; Nanki T, 2004, J IMMUNOL, V173, P7010; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Fong AM, 1998, J EXP MED, V188, P1413, DOI 10.1084/jem.188.8.1413; Kristinsson SY, 2007, J CLIN ONCOL, V25, P1993, DOI 10.1200/JCO.2006.09.0100; Saitoh Y, 2007, BIOCHEM BIOPH RES CO, V364, P417, DOI 10.1016/j.bbrc.2007.09.137; Koizumi K, 2009, J IMMUNOL, V183, P7825, DOI 10.4049/jimmunol.0803627; Imai T, 1997, CELL, V91, P521, DOI 10.1016/S0092-8674(00)80438-9; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Murphy G, 2008, RHEUMATOLOGY, V47, P1446, DOI 10.1093/rheumatology/ken197; Andre F, 2006, ANN ONCOL, V17, P945, DOI 10.1093/annonc/mdl053; Bazan JF, 1997, NATURE, V385, P640, DOI 10.1038/385640a0; Ferrer A, 2004, CANCER GENET CYTOGEN, V153, P69, DOI 10.1016/j.cancergencyto.2003.12.016; Kyle RA, 2003, BRIT J HAEMATOL, V121, P749; Kyle RA, 2004, NEW ENGL J MED, V351, P1860, DOI 10.1056/NEJMra041875; Marchesi F, 2008, CANCER RES, V68, P9060, DOI 10.1158/0008-5472.CAN-08-1810; Morito N, 2011, CANCER RES, V71, P339, DOI 10.1158/0008-5472.CAN-10-1057; Pistoia V, 2006, CURR DRUG TARGETS, V7, P81, DOI 10.2174/138945006775270187; Raffaghello L, 2009, SEMIN CANCER BIOL, V19, P97, DOI 10.1016/j.semcancer.2008.10.003; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; Trentin L, 2007, BRIT J HAEMATOL, V138, P594, DOI 10.1111/j.1365-2141.2007.06686.x	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUN	2015	33	6					2935	2939		10.3892/or.2015.3941		5	Oncology	Oncology	CI8YX	WOS:000355058700034		
J	Motoshima, T; Komohara, Y; Horlad, H; Takeuchi, A; Maeda, Y; Tanoue, K; Kawano, Y; Harada, M; Takeya, M; Eto, M				Motoshima, Takanobu; Komohara, Yoshihiro; Horlad, Hasita; Takeuchi, Ario; Maeda, Yoshehiro; Tanoue, Kenichiro; Kawano, Yoshiaki; Harada, Mamoru; Takeya, Motohiro; Eto, Masatoshi			Sorafenib enhances the antitumor effects of anti-CTLA-4 antibody in a murine cancer model by inhibiting myeloid-derived suppressor cells	ONCOLOGY REPORTS			English	Article						anti-CTLA-4 antibody; myeloid-derived suppressor cells; combination therapy; renal cell carcinoma	METASTATIC MELANOMA; JAPANESE PATIENTS; PROGNOSTIC-FACTORS; INTERFERON-ALPHA; TARGETED THERAPY; CARCINOMA; IPILIMUMAB; BLOCKADE; SURVIVAL; TRIAL	This antitumor effect of sorafenib is considered to be dependent not only on its direct cytotoxicity to cancer cells but also due to the inhibition of myeloid-derived suppressor cells (MDSCs). Recently, a novel antibody against cytotoxic T-lymphocyte antigen 4 (CTLA-4), which activates lymphocytes, is currently in clinical applications. The aim of the present study was to investigate the synergistic antitumor effects of anti-CTLA-4 antibody (Ab) and sorafenib in a murine cancer model. RENCA cells were subcutaneously inoculated into mice, which were randomly divided into 4 treatment groups: sorafenib plus anti-CTLA-4 Ab, sorafenib plus control Ab, vehicle plus anti-CTLA-4 Ab, and vehicle plus control Ab. Single therapy using anti-CTLA-4 Ab suppressed tumor growth, but no difference was noted when compared with the single therapy, group using sorafenib. Notably, the greatest decrease in tumor size was noted with sorafenib plus anti-CTLA-4 Ab (combination therapy), and the highest rate of tumor rejection was observed in the combination therapy group. The number of infiltrating CD4- or CD8-positive lymphocytes was strongly increased in the combination therapy group. These in vivo data indicate that sorafenib increased the immunostimulatory effect of anti-CTLA-4 Ab even when sorafenib was used at a low dose. An in vitro study using MDSCs and CD8(+) T cells showed that the inhibitory effect of MDSCs on CD8(+) T cells was significantly abrogated by the combined use of sorafenib and anti-CTLA-4 Ab. Sorafenib suppressed the expression of immunosuppressive factors in MDSCs. These data indicate that combination therapy of sorafenib and anti-CTLA-4 Ab may be effective in advanced kidney cancer patients.	[Motoshima, Takanobu; Maeda, Yoshehiro; Tanoue, Kenichiro; Kawano, Yoshiaki; Eto, Masatoshi] Kumamoto Univ, Dept Urol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Motoshima, Takanobu; Komohara, Yoshihiro; Horlad, Hasita; Takeya, Motohiro] Kumamoto Univ, Dept Cell Pathol, Grad Sch Med Sci, Kumamoto 8608556, Japan; [Takeuchi, Ario] Kyushu Univ, Dept Urol, Grad Sch Med Sci, Fukuoka, Japan; [Harada, Mamoru] Shimane Univ, Fac Med, Dept Immunol, Izumo, Shimane, Japan	Eto, M (reprint author), Kumamoto Univ, Dept Urol, Grad Sch Med Sci, Chuo Ku, Honjo 1-1-1, Kumamoto 8608556, Japan.	etom@kumamoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan; Graduate School of Medical Sciences, Kumamoto University, Japan; Ministry of Education, Science and Culture of Japan [26670703]	We thank Mr. Takenobu Nakagawa, Mr. Osamu Nakamura, Ms. Emi Kiyota and Ms. Yui Hayashida for their technical assistance. This study was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan. This study was supported in part by a scholarship for the Graduate School of Medical Sciences, Kumamoto University, Japan and by a grant from the Ministry of Education, Science and Culture of Japan (26670703) (to M.E.).	Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Small EJ, 2007, CLIN CANCER RES, V13, P1810, DOI 10.1158/1078-0432.CCR-06-2318; Postow MA, 2012, CLIN CANCER RES, V18, P1821, DOI 10.1158/1078-0432.CCR-12-0409; Bierie B, 2010, CYTOKINE GROWTH F R, V21, P49, DOI 10.1016/j.cytogfr.2009.11.008; Tanigawa G, 2011, JPN J CLIN ONCOL, V41, P1265, DOI 10.1093/jjco/hyr137; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Graziani G, 2012, PHARMACOL RES, V65, P9, DOI 10.1016/j.phrs.2011.09.002; Porembka MR, 2012, CANCER IMMUNOL IMMUN, V61, P1373, DOI 10.1007/s00262-011-1178-0; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Cao MD, 2011, LAB INVEST, V91, P598, DOI 10.1038/labinvest.2010.205; Takeuchi A, 2010, J UROLOGY, V184, P2549, DOI 10.1016/j.juro.2010.07.033; Hodi FS, 2003, P NATL ACAD SCI USA, V100, P4712, DOI 10.1073/pnas.0830997100; Fujita M, 2011, CANCER RES, V71, P2664, DOI 10.1158/0008-5472.CAN-10-3055; Patard JJ, 2011, EUR UROL, V60, P684, DOI 10.1016/j.eururo.2011.06.017; Horlad H, 2013, MOL NUTR FOOD RES, V57, P1046, DOI 10.1002/mnfr.201200610; Blansfield JA, 2005, J IMMUNOTHER, V28, P593, DOI 10.1097/01.cji.0000178913.41256.06; Patel PH, 2006, BRIT J CANCER, V94, P614, DOI 10.1038/sj.bjc.6602978; Motzer RJ, 2006, J CLIN ONCOL, V24, P5601, DOI 10.1200/JCO.2006.08.5415; Youn JI, 2010, EUR J IMMUNOL, V40, P2969, DOI 10.1002/eji.201040895; Naito S, 2011, BJU INT, V108, P1813, DOI 10.1111/j.1464-410X.2011.10281.x; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Yuasa T, 2012, BJU INT, V109, P1349, DOI 10.1111/j.1464-410X.2011.10534.x; Ascierto PA, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-196; Canil C, 2010, CUAJ-CAN UROL ASSOC, V4, P201; Ostrand-Rosenberg S, 2010, CANCER IMMUNOL IMMUN, V59, P1593, DOI 10.1007/s00262-010-0855-8; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Robert C, 2011, NEW ENGL J MED, V364, P2517, DOI 10.1056/NEJMoa1104621; Srivastava MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040677; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1021-335X	1791-2431		ONCOL REP	Oncol. Rep.	JUN	2015	33	6					2947	2953		10.3892/or.2015.3893		7	Oncology	Oncology	CI8YX	WOS:000355058700036		
J	Ueno, Y; Hiraoka, T; Miyazaki, M; Ito, M; Oshika, T				Ueno, Yuta; Hiraoka, Takahiro; Miyazaki, Maki; Ito, Mutsuko; Oshika, Tetsuro			Corneal Thickness Profile and Posterior Corneal Astigmatism in Normal Corneas	OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; ROTATING SCHEIMPFLUG CAMERA; TORIC INTRAOCULAR-LENS; IN-VIVO; JAPANESE POPULATION; KERATOMETRIC INDEX; CATARACT PATIENTS; AGE; PRESSURE; EYE	Purpose: To analyze the influence of corneal thickness profile on posterior corneal astigmatism (PA). Design: Prospective, observational study. Subjects: We included 418 normal subjects (213 men and 205 women) ranging in age from 6 to 93 years (49.0 +/- 23.4 years, mean +/- standard deviation) in this study. Methods: Anterior and posterior corneal topography were evaluated using 3-dimensional anterior segment optical coherence tomography. Pericentral corneal thickness (PCT) in each quadrant (superior, inferior, nasal, and temporal) was measured, and average PCT in the vertical (superior + inferior) and horizontal (nasal + temporal) directions was calculated. Posterior corneal astigmatism was calculated as (1) assumed PA based on the anterior corneal curvature measurement and the keratometric index and (2) actual PA derived from the direct measurement of posterior corneal curvature. Main Outcome Measures: Corneal thickness distribution and the difference between assumed and actual PA. Results: The PCT was significantly greater in the vertical (546.0 +/- 31.8 mu m) than in the horizontal direction (542.6 +/- 31.7 mu m) (P < 0.0001), and the difference between them was significantly correlated with subject age (r = 0.518, P < 0.0001). The difference between assumed and actual PA significantly correlated with the discrepancy between vertical and horizontal PCT (r = 0.819, P < 0.0001), as well as subject age (r = 0.533, P < 0.0001). Conclusions: Corneal thickness is greater in the vertical than in the horizontal direction, making the PA more against-the-rule pattern than calculated on the basis of the anterior corneal curvature measurement only. Such discrepancy is more prominent in older patients. (C) 2015 by the American Academy of Ophthalmology.	[Ueno, Yuta; Miyazaki, Maki] Univ Tsukuba Hosp, Dept Ophthalmol, Tsukuba, Ibaraki 3058576, Japan; [Hiraoka, Takahiro; Oshika, Tetsuro] Univ Tsukuba, Fac Med, Dept Ophthalmol, Tsukuba, Ibaraki 305, Japan; [Ito, Mutsuko] Ito Eye Clin, Tsukuba, Ibaraki, Japan	Ueno, Y (reprint author), Univ Tsukuba Hosp, Dept Ophthalmol, 2-1-1 Amakubo, Tsukuba, Ibaraki 3058576, Japan.	yu_ueno71@yahoo.co.jp					Ruhswurm I, 2000, J CATARACT REFR SURG, V26, P1022, DOI 10.1016/S0886-3350(00)00317-5; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Holland E, 2010, OPHTHALMOLOGY, V117, P2104, DOI 10.1016/j.ophtha.2010.07.033; Niederer RL, 2007, BRIT J OPHTHALMOL, V91, P1165, DOI 10.1136/bjo.2006.112656; Yun SH, 2004, OPT EXPRESS, V12, P2977, DOI 10.1364/OPEX.12.002977; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Yasuno Y, 2005, OPT EXPRESS, V13, P10652, DOI 10.1364/OPEX.13.010652; Nomura H, 2002, CURR EYE RES, V24, P81, DOI 10.1076/ceyr.24.2.81.8161; Mendicute J, 2008, J CATARACT REFR SURG, V34, P601, DOI 10.1016/j.jcrs.2007.11.033; Ueno Y, 2014, J REFRACT SURG, V30, P192, DOI 10.3928/1081597X-20140218-01; Jhanji V, 2013, CLIN EXP OPHTHALMOL, V41, P735, DOI 10.1111/ceo.12113; Nemesure B, 2003, ARCH OPHTHALMOL-CHIC, V121, P240; Khoramnia R, 2007, J CATARACT REFR SURG, V33, P830, DOI 10.1016/j.jcrs.2006.12.025; Huang JH, 2013, OPHTHALMOLOGY, V120, P1951, DOI 10.1016/j.ophtha.2013.02.022; Maeda N, 2010, EYE CONTACT LENS, V36, P254, DOI 10.1097/ICL.0b013e3181ef0dbb; Foster PJ, 1998, OPHTHALMOLOGY, V105, P969, DOI 10.1016/S0161-6420(98)96021-3; Szalai E, 2012, J CATARACT REFR SURG, V38, P485, DOI 10.1016/j.jcrs.2011.10.027; Fam HB, 2007, J CATARACT REFR SURG, V33, P686, DOI 10.1016/j.jcrs.2006.11.023; Germundsson J, 2013, INVEST OPHTH VIS SCI, V54, P6143, DOI 10.1167/iovs.13-12535; Holladay JT, 2009, J REFRACT SURG, V25, P862, DOI 10.3928/1081597X-20090917-07; Hwang YH, 2012, INVEST OPHTH VIS SCI, V53, P6851, DOI 10.1167/iovs.12-10173; Kamiya K, 2012, BRIT J OPHTHALMOL, V96, P267, DOI 10.1136/bjo.2011.202481; Li Y, 2010, J CATARACT REFR SURG, V36, P826, DOI 10.1016/j.jcrs.2009.11.016; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Suzuki S, 2005, OPHTHALMOLOGY, V112, P1327, DOI 10.1016/j.ophtha.2005.03.022; Wang DD, 2011, AM J OPHTHALMOL, V152, P454, DOI 10.1016/j.ajo.2011.03.005; Zheng YF, 2008, CORNEA, V27, P776, DOI 10.1097/ICO.0b013e31816f62d3	28	4	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JUN	2015	122	6					1072	1078		10.1016/j.ophtha.2015.01.021		7	Ophthalmology	Ophthalmology	CI9OJ	WOS:000355099200011		
J	Ikuno, Y; Ohno-Matsui, K; Wong, TY; Korobelnik, JF; Vitti, R; Li, T; Stemper, B; Asmus, F; Zeitz, O; Ishibashi, T				Ikuno, Yasushi; Ohno-Matsui, Kyoko; Wong, Tien Yin; Korobelnik, Jean-Francois; Vitti, Robert; Li, Tummy; Stemper, Brigitte; Asmus, Friedrich; Zeitz, Oliver; Ishibashi, Tatsuro		MYRROR Investigators	Intravitreal Aflibercept Injection in Patients with Myopic Choroidal Neovascularization The MYRROR Study	OPHTHALMOLOGY			English	Article							MACULAR EDEMA SECONDARY; VEGF TRAP-EYE; RANDOMIZED CLINICAL-TRIAL; PATHOLOGICAL MYOPIA; PREVALENCE; RANIBIZUMAB; VERTEPORFIN; BEVACIZUMAB; POPULATION; OUTCOMES	Purpose: To evaluate intravitreal aflibercept 2 mg in patients with myopic choroidal neovascularization (CNV). Design: An international, phase III, multicenter, randomized, double-masked, sham-controlled study. Participants: Patients aged >= 18 years with high myopia (<=- 6.0 diopters or axial length of >= 26.5 mm), active myopic CNV, and best-corrected visual acuity (BCVA) of 73-35 Early Treatment Diabetic Retinopathy Study letters in the study eye were included. Methods: Patients were randomized 3:1 to intravitreal aflibercept or sham. In the intravitreal aflibercept arm, patients received 1 injection at baseline. Additional injections were performed in case of CNV persistence or recurrence at monthly visits through week 44. In the sham arm, patients received sham injections through week 20. At week 24, after assessment of the primary efficacy end point, sham patients received a mandatory intravitreal aflibercept injection followed by intravitreal aflibercept (if disease persisted/recurred) or sham injection every 4 weeks. Main Outcome Measures: Mean change in BCVA from baseline to week 24. Results: A total of 122 patients were randomized to intravitreal aflibercept (n = 91) or sham (n = 31). Baseline demographics were similar across groups. At week 24, patients in the intravitreal aflibercept and sham groups gained 12.1 and lost 2 letters, respectively (P < 0.0001). By week 48, patients in the intravitreal aflibercept and sham/intravitreal aflibercept groups gained 13.5 and 3.9 letters. Patients in the intravitreal aflibercept group received 2 injections (median) in the first study quarter (week 0-8). Median number of injections in quarters 2 to 4 was 0. Patients in the "sham/intravitreal aflibercept" group received 2 and 1 (median) intravitreal aflibercept injections in quarters 3 and 4. Central retinal thickness improved in parallel with visual gains. Incidence of ocular adverse events was similar in both groups through week 48 (37.4% vs. 38.7); most were assessed by investigators as mild. No deaths occurred. Conclusions: Intravitreal aflibercept 2 mg was effective for treatment of myopic CNV with clinically important visual and anatomic benefits achieved with a limited number of injections given in the first 8 weeks of treatment. No new safety concerns occurred with treatment. Intravitreal aflibercept should be considered as a treatment option for myopic CNV. (C) 2015 by the American Academy of Ophthalmology.	[Ikuno, Yasushi] Osaka Univ, Sch Med, Dept Ophthalmol, Osaka, Japan; [Ohno-Matsui, Kyoko] Tokyo Med & Dent Univ, Dept Ophthalmol & Visual Sci, Tokyo, Japan; [Wong, Tien Yin] Natl Univ Singapore, Singapore Natl Eye Ctr, Duke NUS Grad Med Sch, Singapore Eye Res Inst, Singapore 117548, Singapore; [Korobelnik, Jean-Francois] CHU Bordeaux, Hop Pellegrin, Serv Ophtalmol, Bordeaux, France; [Korobelnik, Jean-Francois] Univ Bordeaux Segalen, Bordeaux, France; [Korobelnik, Jean-Francois] INSERM, ISPED, Ctr INSERM Epidemiol Biostat U897, Bordeaux, France; [Vitti, Robert] Regeneron Pharmaceut Inc, Tarrytown, NY 10591 USA; [Li, Tummy] Bayer HealthCare Pharmaceut, Beijing, Peoples R China; [Stemper, Brigitte] Bayer HealthCare Pharmaceut, Berlin, Germany; [Stemper, Brigitte] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Asmus, Friedrich] Univ Tubingen Hosp, Dept Neurodegenerat, Ctr Neurol, Tubingen, Germany; [Asmus, Friedrich] Hertie Inst Clin Brain Res, Tubingen, Germany; [Zeitz, Oliver] Univ Klinikum Hamburg Eppendorf, Klin & Poliklin Augenheilkunde, Hamburg, Germany; [Ishibashi, Tatsuro] Kyushu Univ, Dept Ophthalmol, Fukuoka 812, Japan	Ishibashi, T (reprint author), Kyushu Univ, Dept Ophthalmol, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ishi@eye.med.kyushu-u.ac.jp			Bayer HealthCare Pharmaceuticals	The MYRROR study was funded by Bayer HealthCare Pharmaceuticals.	Tufail A, 2013, OPHTHALMOLOGY, V120, P1944, DOI 10.1016/j.ophtha.2013.06.010; Brown DM, 2013, AM J OPHTHALMOL, V155, P429, DOI 10.1016/j.ajo.2012.09.026; Iwase A, 2006, OPHTHALMOLOGY, V113, P1354, DOI 10.1016/j.ophtha.2006.04.022; Cohen SY, 1996, OPHTHALMOLOGY, V103, P1241; McCarty CA, 1997, J REFRACT SURG, V13, P229; Vitale S, 2009, ARCH OPHTHALMOL-CHIC, V127, P1632, DOI 10.1001/archophthalmol.2009.303; Neelam K, 2012, PROG RETIN EYE RES, V31, P495, DOI 10.1016/j.preteyeres.2012.04.001; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; Do DV, 2012, OPHTHALMOLOGY, V119, P1658, DOI 10.1016/j.ophtha.2012.02.010; Boyer D, 2012, OPHTHALMOLOGY, V119, P1024, DOI 10.1016/j.ophtha.2012.01.042; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Wolf S, 2014, OPHTHALMOLOGY, V121, P682, DOI 10.1016/j.ophtha.2013.10.023; Yoshida T, 2003, OPHTHALMOLOGY, V110, P1297, DOI 10.1016/S0161-6420(03)00461-5; Asakuma T, 2012, OPHTHALMOLOGY, V119, P1760, DOI 10.1016/j.ophtha.2012.02.034; Holz FG, 2013, BRIT J OPHTHALMOL, V97, P278, DOI 10.1136/bjophthalmol-2012-301504; Nakanishi H, 2011, EYE, V25, P375, DOI 10.1038/eye.2010.226; Ikuno Y, 2010, AM J OPHTHALMOL, V149, P140, DOI 10.1016/j.ajo.2009.08.008; Tufail A, 2013, EYE, V27, P709, DOI 10.1038/eye.2013.8; Blinder KJ, 2003, OPHTHALMOLOGY, V110, P667, DOI 10.1016/S0161-6420(02)01998-X; Korobelnik JF, 2014, OPHTHALMOLOGY, V121, P2247, DOI 10.1016/j.ophtha.2014.05.006; Korobelnik JF, 2013, OPHTHALMOLOGY, V121, P202; Ohno-Matsui Kyoko, 2004, Curr Opin Ophthalmol, V15, P197, DOI 10.1097/01.icu.0000120709.35941.e9; PECE A, 1994, INT OPHTHALMOL, V18, P339; Rashid R, 2014, PATHOLOGIC MYOPIA, P187; Schmidt-Erfurth U, 2013, OPHTHALMOLOGY, V121, P193; Arnold J, 2001, OPHTHALMOLOGY, V108, P841; Wakabayashi T, 2009, AM J OPHTHALMOL, V148, P591, DOI 10.1016/j.ajo.2009.05.026	27	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JUN	2015	122	6					1220	1227		10.1016/j.ophtha.2015.01.025		8	Ophthalmology	Ophthalmology	CI9OJ	WOS:000355099200028		
J	Uji, A; Yoshimura, N				Uji, Akihito; Yoshimura, Nagahisa			Application of Extended Field Imaging to Optical Coherence Tomography	OPHTHALMOLOGY			English	Editorial Material									[Uji, Akihito; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, Kyoto 6068507, Japan	Uji, A (reprint author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Sakyo Ku, 54 Shogoin Kawahara Cho, Kyoto 6068507, Japan.	akihito1@kuhp.kyoto-u.ac.jp					Akagi T, 2013, AM J OPHTHALMOL, V155, P927, DOI 10.1016/j.ajo.2012.12.014; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Drexler W, 2001, NAT MED, V7, P502, DOI 10.1038/86589; Klein T, 2011, OPT EXPRESS, V19, P3044, DOI 10.1364/OE.19.003044; Hangai M, 2007, OPHTHALMOLOGY, V114, P763, DOI 10.1016/j.ophtha.2006.07.055	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0161-6420	1549-4713		OPHTHALMOLOGY	Ophthalmology	JUN	2015	122	6					1272	+				5	Ophthalmology	Ophthalmology	CI9OJ	WOS:000355099200036		
J	Katsuragawa, D; Numai, T				Katsuragawa, Daiya; Numai, Takahiro			Simulation of a ridge-type semiconductor laser with selective double-sided anti-guiding and partially undoped cladding layers	OPTICAL AND QUANTUM ELECTRONICS			English	Article						Semiconductor laser; Kink; Horizontal transverse mode	HORIZONTAL TRANSVERSE-MODES; LOW BEAM DIVERGENCE; POWER; DIODES; IMPROVEMENT	A ridge-type semiconductor laser with selective double-sided anti-guiding and partially undoped cladding layers is proposed, and lasing characteristics are simulated. With increases in the height and width of the selective double-sided anti-guiding layers, both kink-level and threshold current increase. With an increase in the thickness of the partially undoped cladding layers, the kink-level increases. There is an optimum value for the thickness of the partially undoped cladding layers to minimize the threshold current with maintaining kink-free operation. The lowest threshold current for kink-free operation is 46.1 mA, which is much lower than the previous lowest value of 57.0 mA.	[Katsuragawa, Daiya; Numai, Takahiro] Ritsumeikan Univ, Grad Sch Sci & Engn, Kusatsu, Shiga 5258577, Japan	Numai, T (reprint author), Ritsumeikan Univ, Grad Sch Sci & Engn, 1-1-1 Noji Higashi, Kusatsu, Shiga 5258577, Japan.	numai@se.ritsumei.ac.jp			Japan Society for Science [24560429]	This research was partially supported by the Japan Society for Science, Grant-in-Aid for Scientific Research (C) 24560429, 2014.	Wenzel H, 2008, IEEE PHOTONIC TECH L, V20, P214, DOI 10.1109/LPT.2007.913328; Buda M, 2003, IEEE PHOTONIC TECH L, V15, P1686, DOI 10.1109/LPT.2003.819756; Harder C.S., 1997, P OPT FIB COMM C 97, P350, DOI 10.1109/OFC.1997.719955; Katsuragawa D., 2013, PIERS 2013 STOCKH ST; Lim JJ, 2007, IET OPTOELECTRON, V1, P259, DOI 10.1049/iet-opt:20070036; Liu Y, 2005, IEEE J QUANTUM ELECT, V41, P15, DOI 10.1109/JQE.2004.839239; Michael S., 2005, P 31 IEEE PHOT SPEC, P719; Numai T., 2004, FUNDAMENTALS SEMICON; Qiu BC, 2005, IEEE J QUANTUM ELECT, V41, P1124, DOI 10.1109/JQE.2005.853359; SCHEMMANN MFC, 1995, APPL PHYS LETT, V66, P920, DOI 10.1063/1.113597; Shomura N, 2008, IEEE J QUANTUM ELECT, V44, P819, DOI 10.1109/JQE.2008.924817; Takada H, 2009, IEEE J QUANTUM ELECT, V45, P917, DOI 10.1109/JQE.2009.2016439; Yuda M, 2004, IEEE J QUANTUM ELECT, V40, P1203, DOI [10.1109/JQE.2004.833218, 10.1109/jqe.2004.833218]	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0306-8919	1572-817X		OPT QUANT ELECTRON	Opt. Quantum Electron.	JUN	2015	47	6			SI		1381	1387		10.1007/s11082-014-0084-z		7	Engineering, Electrical & Electronic; Optics	Engineering; Optics	CJ4GX	WOS:000355444000013		
J	Satoh, T				Satoh, Takao			THE JOHNSON-MORITA THEORY FOR THE RING OF FRICKE CHARACTERS OF FREE GROUPS	PACIFIC JOURNAL OF MATHEMATICS			English	Article						ring of Fricke characters; automorphism group of free groups; IA-automorphism group; Andreadakis-Johnson filtration; Johnson homomorphisms	MAPPING CLASS GROUP; TORELLI GROUP; AUTOMORPHISM GROUP; HOMOMORPHISMS	For a free group F-n of rank n, we consider the ring X-Q(F-n) of SL(2,C)-characters of F-n generated by all Fricke characters tr x for x is an element of F-n. Its ideal J generated by tr x - 2 for all x is an element of F-n is Aut F-n-invariant. We denote by epsilon(n)(1) the subgroup of the automorphism group Aut F-n of F-n consisting of all automorphisms which act on J / J(2) trivially. The group epsilon(n)(1) is regarded as a Fricke character analogue of the IA-automorphism group of F-n and the Torelli subgroup of the mapping class group of a surface. In our previous work, we constructed a homomorphism eta(1) from epsilon(n)(1) into Hom(Q) (J / J(2), J(2) / J(3)) as a Fricke character analogue of the first Johnson homomorphisms of the mapping class group and Aut F-n. In this paper, according to Morita's work for the extension of the first Johnson homomorphism of the mapping class group, we extend eta(1) to Aut F-n as a crossed homomorphism. We see that the obtained crossed homomorphism eta is not null cohomologous. We also compute the images of Nielsen's generators of Aut F-n by eta.	Tokyo Univ Sci, Fac Sci Div 3, Dept Math, Shinjuku Ku, Tokyo 1628601, Japan	Satoh, T (reprint author), Tokyo Univ Sci, Fac Sci Div 3, Dept Math, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	takao@rs.tus.ac.jp			JSPS	The author would like to thank the referee for the careful reading and helpful comments for the original paper. The author is supported by Grant-in-Aid for Young Scientists (B) by JSPS.	ANDREADA.S, 1965, P LOND MATH SOC, V15, P239; JOHNSON D, 1985, TOPOLOGY, V24, P127, DOI 10.1016/0040-9383(85)90050-3; WHITTEMO.A, 1973, P AM MATH SOC, V40, P383, DOI 10.2307/2039378; MAGNUS W, 1980, MATH Z, V170, P91, DOI 10.1007/BF01214715; Nielsen J, 1924, MATH ANN, V91, P169, DOI 10.1007/BF01556078; JOHNSON D, 1985, TOPOLOGY, V24, P113, DOI 10.1016/0040-9383(85)90049-7; Cartan H., 1999, HOMOLOGICAL ALGEBRA; Day MB, 2013, J TOPOL ANAL, V5, P57, DOI 10.1142/S1793525313500027; Fricke R., 1897, VORLESUNGEN THEORIE; Hain R, 1997, J AM MATH SOC, V10, P597, DOI 10.1090/S0894-0347-97-00235-X; Hatakenaka E., 2014, ARXIV12061500; Hatakenaka E., 2015, J COMMUT AL IN PRESS; HOROWITZ RD, 1972, COMMUN PUR APPL MATH, V25, P635, DOI 10.1002/cpa.3160250602; JOHNSON D, 1983, ANN MATH, V118, P423, DOI 10.2307/2006977; JOHNSON D, 1980, MATH ANN, V249, P225, DOI 10.1007/BF01363897; Kawazumi N., 2006, ARXIVMATGT0505497; Maclachlan C., 2003, GRADUATE TEXTS MATH, V219; MORITA S, 1993, DUKE MATH J, V70, P699, DOI 10.1215/S0012-7094-93-07017-2; MORITA S, 1993, INVENT MATH, V111, P197, DOI 10.1007/BF01231286; Satoh T, 2013, J PURE APPL ALGEBRA, V217, P137, DOI 10.1016/j.jpaa.2012.06.017; Satoh T, 2009, T AM MATH SOC, V361, P2085; Satoh T., 2013, HDB TEICHMULLER THEO, VV; Vogt H., 1889, ANN SCI ECOLE NORM S, p[6, 3]	23	0	0	PACIFIC JOURNAL MATHEMATICS	BERKELEY	PO BOX 4163, BERKELEY, CA 94704-0163 USA	0030-8730			PAC J MATH	Pac. J. Math.	JUN	2015	275	2					443	461		10.2140/pjm.2015.275.443		19	Mathematics	Mathematics	CJ2LR	WOS:000355316800007		
J	Kawada, T				Kawada, Tomoyuki			Sleep in children with atopic dermatitis	PEDIATRIC ALLERGY AND IMMUNOLOGY			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 113, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 113, Japan.	kawada@nms.ac.jp					Chang YS, 2014, PEDIATRICS, V134, pE397, DOI 10.1542/peds.2014-0376; Wootton CI, 2012, BRIT J DERMATOL, V167, P1131, DOI 10.1111/j.1365-2133.2012.11184.x; Ersser SJ, 2014, COCHRANE DB SYST REV, V1; Gustafson CJ, 2014, SKIN RES TECHNOL, V20, P510, DOI 10.1111/srt.12147; Honaker SM, 2014, PAEDIATR RESPIR REV, V15, P333, DOI 10.1016/j.prrv.2014.04.011; Kawada T, 2010, CLIN EXP DERMATOL, V35, P193, DOI 10.1111/j.1365-2230.2009.03214.x; Rolinck-Werninghaus C, 2015, PEDIAT ALLERGY IMMUN, DOI [10.1111/pai.12338, DOI 10.1111/PAI.12338]	7	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0905-6157	1399-3038		PEDIAT ALLERG IMM-UK	Pediatr. Allergy Immunol.	JUN	2015	26	4					384	385		10.1111/pai.12363		2	Allergy; Immunology; Pediatrics	Allergy; Immunology; Pediatrics	CJ0FC	WOS:000355149800014		
J	Hamal, DB; Higuchi, M; Higuchi, K				Hamal, Dipendra Bahadur; Higuchi, Masahiko; Higuchi, Katsuhiko			Calculation of magnetic oscillations via the magnetic-field-containing relativistic tight-binding approximation method: Revisiting the de Haas-van Alphen effect	PHYSICAL REVIEW B			English	Article							DENSITY-FUNCTIONAL THEORY; SINGLE-PARTICLE EQUATION; DIAMAGNETIC METALS; SUSCEPTIBILITY; DEPENDENCE; BREAKDOWN	The magnetic-field-containing relativistic tight-binding approximation (MFRTB) method [Phys. Rev. B 91, 075122 (2015)] is the first-principles calculation method for electronic structures of materials immersed in the magnetic field. In this paper, the MFRTB method is applied to the simple cubic lattice immersed in the magnetic field. The total energy and magnetization oscillate with the inverse of the magnitude of the magnetic field, which means that the de Haas-van Alphen oscillation is revisited directly through the MFRTB method. It is shown that the conventional Lifshitz-Kosevich (LK) formula is a good approximation to the results of the MFRTB method in the experimentally available magnetic field. Furthermore, the additional oscillation peaks of the magnetization are found especially in the high magnetic field, which cannot be explained by the LK formula.	[Hamal, Dipendra Bahadur; Higuchi, Katsuhiko] Hiroshima Univ, Grad Sch Adv Sci Matter, Higashihiroshima 7398527, Japan; [Higuchi, Masahiko] Shinshu Univ, Dept Phys, Fac Sci, Matsumoto, Nagano 3908621, Japan	Hamal, DB (reprint author), Hiroshima Univ, Grad Sch Adv Sci Matter, Higashihiroshima 7398527, Japan.				Japan Society for the Promotion of Science [26400354, 26400397]	This work was partially supported by Grant-in-Aid for Scientific Research (Grants No. 26400354 and No. 26400397) of Japan Society for the Promotion of Science.	VIGNALE G, 1988, PHYS REV B, V37, P10685, DOI 10.1103/PhysRevB.37.10685; SLATER JC, 1954, PHYS REV, V94, P1498, DOI 10.1103/PhysRev.94.1498; Landau L, 1930, Z PHYS, V64, P629, DOI 10.1007/BF01397213; de Haas WJ, 1930, P K AKAD WET-AMSTERD, V33, P1106; ONSAGER L, 1952, PHILOS MAG, V43, P1006; VIGNALE G, 1987, PHYS REV LETT, V59, P2360, DOI 10.1103/PhysRevLett.59.2360; HOFSTADTER DR, 1976, PHYS REV B, V14, P2239, DOI 10.1103/PhysRevB.14.2239; Ashcroft N. W., 1976, SOLID STATE PHYS; Baba S, 2011, J PHYS SOC JPN, V80, DOI 10.1143/JPSJ.80.094601; Bradley C. J., 1972, MATH THEORY SYMMETRY; de Haas WJ, 1930, P K AKAD WET-AMSTERD, V33, P680; de Haas WJ, 1932, P K AKAD WET-AMSTERD, V35, P454; Gat O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.186801; Goto T, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.044602; Gvozdikov VM, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.155436; Han SY, 2000, PHYS REV LETT, V85, P1500, DOI 10.1103/PhysRevLett.85.1500; Harrison W. A., 2004, ELEMENTARY ELECT STR; Higuchi K, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195122; Higuchi K, 2015, PHYS REV B, V91, DOI 10.1103/PhysRevB.91.075122; Higuchi M, 1997, J PHYS SOC JPN, V66, P149, DOI 10.1143/JPSJ.66.149; Higuchi M, 1998, J PHYS SOC JPN, V67, P2037, DOI 10.1143/JPSJ.67.2037; Higuchi M, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.195114; Higuchi M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.042505; Kishigi K, 2014, PHYS REV B, V90, DOI 10.1103/PhysRevB.90.085427; Kittel C., 2005, INTRO SOLID STATE PH, V8th; Kubler J., 2000, THEORY ITINERANT ELE; Lifshits I.M., 1955, Zhurnal Eksperimental'noi i Teoreticheskoi Fiziki, V29; MACHIDA K, 1995, PHYS REV B, V51, P8946, DOI 10.1103/PhysRevB.51.8946; Marder M. P., 2000, CONDENS MATTER PHYS; Mitsumoto K, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.034702; Norman M. R., 1993, HDB PHYS CHEM RARE E, V17; Okabe K, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.124604; Onuki Y., 1995, HDB PHYS CHEM RARE E, V20; Sandhu PS, 1997, PHYS REV B, V56, P11566, DOI 10.1103/PhysRevB.56.11566; Shoenberg D., 1984, MAGNETIC OSCILLATION; Singleton J., 2001, BAND THEORY ELECT PR; Taut M, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.165304; Xu WH, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.241102	38	0	0	AMER PHYSICAL SOC	COLLEGE PK	ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA	1098-0121	1550-235X		PHYS REV B	Phys. Rev. B	JUN 1	2015	91	24							245101	10.1103/PhysRevB.91.245101		9	Physics, Condensed Matter	Physics	CJ3VF	WOS:000355411600001		
J	Nebuya, S; Koike, T; Imai, H; Iwashita, Y; Brown, BH; Soma, K				Nebuya, Satoru; Koike, Tomotaka; Imai, Hiroshi; Iwashita, Yoshiaki; Brown, Brian H.; Soma, Kazui			Feasibility of using 'lung density' values estimated from EIT images for clinical diagnosis of lung abnormalities in mechanically ventilated ICU patients	PHYSIOLOGICAL MEASUREMENT			English	Article						impedance; tomography; absolute lung resistivity; lung density; CT value	ELECTRICAL-IMPEDANCE TOMOGRAPHY; INJURY; TISSUE; VOLUME	This paper reports on the results of a study which compares lung density values obtained from electrical impedance tomography (EIT), clinical diagnosis and CT values (HU) within a region of interest in the lung. The purpose was to assess the clinical use of lung density estimation using EIT data. In 11 patients supported by a mechanical ventilator, the consistency of regional lung density measurements as estimated by EIT was validated to assess the feasibility of its use in intensive care medicine. There were significant differences in regional lung densities recorded in the supine position between normal lungs and diseased lungs associated with pneumonia, atelectasis and pleural effusion (normal; 240 +/- 71.7 kg m(-3), pneumonia; 306 +/- 38.6 kg m(-3), atelectasis; 497 +/- 130 kg m(-3), pleural effusion; 467 +/- 113 kg m(-3): Steel-Dwass test, p < 0.05). In addition, in order to compare lung density with CT image pixels, the image resolution of CT images, which was originally 512 x 512 pixels, was changed to 16 x 16 pixels to match that of the EIT images. The results of CT and EIT images from five patients in an intensive care unit showed a correlation coefficient of 0.66 +/- 0.13 between the CT values (HU) and the lung density values (kg m(-3)) obtained from EIT. These results indicate that it may be possible to obtain a quantitative value for regional lung density using EIT.	[Nebuya, Satoru] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan; [Koike, Tomotaka] Kitasato Univ Hosp, Crit Care Ctr, Sagamihara, Kanagawa, Japan; [Imai, Hiroshi; Iwashita, Yoshiaki] Mie Univ Hosp, Emergency & Crit Care Ctr, Tsu, Mie, Japan; [Brown, Brian H.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England; [Soma, Kazui] Kitasato Univ, Dept Med, Sagamihara, Kanagawa, Japan	Nebuya, S (reprint author), Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa, Japan.	nebuya@kitasato-u.ac.jp					Bikker IG, 2009, INTENS CARE MED, V35, P1362, DOI 10.1007/s00134-009-1512-6; Blaser D, 2014, PHYSIOL MEAS, V35, P975, DOI 10.1088/0967-3334/35/6/975; Costa ELV, 2009, INTENS CARE MED, V35, P1132, DOI 10.1007/s00134-009-1447-y; Arad M, 2009, PHYSIOL MEAS, V30, P421, DOI 10.1088/0967-3334/30/4/006; Wilson AJ, 2001, PHYSIOL MEAS, V22, P49, DOI 10.1088/0967-3334/22/1/307; Metherall P, 1996, NATURE, V380, P509, DOI 10.1038/380509a0; Grasso S, 2009, AM J RESP CRIT CARE, V180, P415, DOI 10.1164/rccm.200901-0156OC; Brown BH, 2002, MED BIOL ENG COMPUT, V40, P388, DOI 10.1007/BF02345070; Nebuya S, 2011, PHYSIOL MEAS, V32, P1953, DOI 10.1088/0967-3334/32/12/006; Victorino JA, 2004, AM J RESP CRIT CARE, V169, P791, DOI 10.1164/rccm.200301-133OC; Adler A, 2012, PHYSIOL MEAS, V33, P679, DOI 10.1088/0967-3334/33/5/679; Frank JA, 2006, CHEST, V130, P1906, DOI 10.1378/chest.130.6.1906; Zhao ZQ, 2009, INTENS CARE MED, V35, P1900, DOI 10.1007/s00134-009-1589-y; Frank JA, 2003, CRIT CARE, V7, P233, DOI 10.1186/cc1829; Boyd E, 1962, GROWTH INCLUDING REP, P346; Grychtol B, 2010, PHYSIOL MEAS, V31, pS31, DOI 10.1088/0967-3334/31/8/S03; Nopp P, 1997, MED BIOL ENG COMPUT, V35, P695, DOI 10.1007/BF02510980; Ricard J D, 2003, Eur Respir J Suppl, V42, p2s; Rouby Jean-Jacques, 2003, Crit Care Med, V31, pS285, DOI 10.1097/01.CCM.0000057905.74813.BC; Schaefer MS, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-51; van der Burg PS, 2014, EUR J PEDIATR, V173, P1715, DOI 10.1007/s00431-014-2399-y	21	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0967-3334	1361-6579		PHYSIOL MEAS	Physiol. Meas.	JUN	2015	36	6					1261	1271		10.1088/0967-3334/36/6/1261		11	Biophysics; Engineering, Biomedical; Physiology	Biophysics; Engineering; Physiology	CJ0FS	WOS:000355151800014		
J	Doi, K; Ogata, F; Eto, H; Kato, H; Kuno, S; Kinoshita, K; Kanayama, K; Feng, J; Manabe, I; Yoshimura, K				Doi, Kentaro; Ogata, Fusa; Eto, Hitomi; Kato, Harunosuke; Kuno, Shinichiro; Kinoshita, Kahori; Kanayama, Koji; Feng, Jingwei; Manabe, Ichiro; Yoshimura, Kotaro			Differential Contributions of Graft-Derived and Host-Derived Cells in Tissue Regeneration/Remodeling after Fat Grafting	PLASTIC AND RECONSTRUCTIVE SURGERY			English	Article							MESENCHYMAL STEM-CELLS; ADIPOSE STROMAL CELLS; IN-VIVO; GROWTH-FACTOR; MURINE; ADIPOCYTES; ACTIVATION; DEATH; VITRO	Background: Recent research indicates that the adipose tissue of nonvascularized grafts is completely remodeled within 3 months, although origins of next-generation cells are unclear. Methods: Inguinal fat pads of green fluorescent protein mice and wild-type mice were cross-transplanted beneath the scalp. At 1, 2, 4, and 12 weeks after transplantation, grafted fat was harvested, weighed, and analyzed through immunohistochemistry, whole-mount staining, and flow cytometry of cell isolates. Bone marrow of green fluorescent protein mice was transplanted to wild-type mice (after irradiation). Eight weeks later, these mice also received fat grafts, which were analyzed as well. Results: The majority of host-derived cells detected during remodeling of grafted fat were macrophages (> 90 percent at the early stage; 60 percent at 12 weeks). Cell origins were analyzed at 12 weeks (i.e., when completely regenerated). At this point, mature adipocytes were largely derived from adipose-derived stem/stromal cells of grafts. Although vascular wall constituents were chiefly graft derived, vascular endothelial cells originated equally from graft and host bone marrow. Adipose-derived stem/stromal cells of regenerated fat were an admixture of grafted, host nonbone marrow, and host bone marrow cells. Conclusions: The above findings underscore the importance of adipose stem/stromal cells in the grafted fat for adipocyte regeneration. Host bone marrow and local tissues contributed substantially to capillary networks and provided new adipose-derived stem/stromal cells. An appreciation of mechanisms that are operant in this setting stands to improve clinical outcomes of fat grafting and cell-based therapies.	Univ Tokyo Grad Sch Med, Dept Plast Surg, Tokyo, Japan; Univ Tokyo Grad Sch Med, Dept Cardiol, Tokyo, Japan	Yoshimura, K (reprint author), Univ Tokyo Sch Med, Dept Plast Surg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kotaro-yoshimura@umin.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [B3-24390398]	This study was supported by the Japanese Ministry of Education, Culture, Sports, Science, and Technology (Grant-in-Aid for Scientific Research B3-24390398). The authors greatly appreciate the substantial contributions to this study by Drs. Kazuhide Mineda and Takanobu Mashiko. They also thank Ayako Sato for technical assistance.	Seo MJ, 2005, BIOCHEM BIOPH RES CO, V328, P258, DOI 10.1016/j.bbrc.2004.12.158; Tomiyama K, 2008, STEM CELLS, V26, P330, DOI 10.1634/stemcells.2007-0567; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Hausman GJ, 2006, J CLIN INVEST, V116, P3103, DOI 10.1172/JCI30666; Lee YH, 2013, CELL METAB, V18, P355, DOI 10.1016/j.cmet.2013.08.003; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI285510; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Suga H, 2009, STEM CELLS, V27, P238, DOI 10.1634/stemcells.2008-0261; Suga H, 2010, PLAST RECONSTR SURG, V126, P1911, DOI 10.1097/PRS.0b013e3181f4468b; Safford KM, 2002, BIOCHEM BIOPH RES CO, V294, P371, DOI 10.1016/S0006-291X(02)00469-2; Yanez R, 2006, STEM CELLS, V24, P2582, DOI 10.1634/stemcells.2006-0228; Mineda K, 2014, PLAST RECONSTR SURG, V133, P1064, DOI 10.1097/PRS.0000000000000097; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Stillaert F, 2007, TISSUE ENG, V13, P2291, DOI 10.1089/ten.2006.0382; Safford KM, 2004, EXP NEUROL, V187, P319, DOI 10.1016/j.expneurol.2004.01.027; Casteilla Louis, 2011, World J Stem Cells, V3, P25, DOI 10.4252/wjsc.v3.i4.25; DiMarino A. M., 2013, FRONTIERS IMMUNOLOGY, V4, P1; Eto H, 2013, STEM CELLS DEV, V22, P985, DOI 10.1089/scd.2012.0442; Gil-Ortega M, 2013, STEM CELLS, V31, P1309, DOI 10.1002/stem.1375; Gimble JM, 2010, STEM CELL RES THER, V1, P1; Kato H, 2010, TISSUE ENG PT A, V16, P2029, DOI 10.1089/ten.TEA.2009.0551; Kato H, 2014, PLAST RECONSTR SURG, V133, p303E, DOI 10.1097/PRS.0000000000000066; Lagaaij EL, 2001, LANCET, V357, P33, DOI 10.1016/S0140-6736(00)03569-8; Tholpady SS, 2003, ANAT REC PART A, V272A, P398, DOI 10.1002/ar.a.10039	24	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0032-1052	1529-4242		PLAST RECONSTR SURG	Plast. Reconstr. Surg.	JUN	2015	135	6					1607	1617		10.1097/PRS.0000000000001292		11	Surgery	Surgery	CJ1EM	WOS:000355225000049		
J	Li, CT; Zhang, M; Qin, JX; Zhang, Y; Qiu, JH				Li, Cheng-tao; Zhang, Min; Qin, Jia-xiang; Zhang, Yi; Qiu, Jian-hui			Study on molecular modeling and the difference of PC lipase-catalyzed degradation of poly (butylene succinate) copolymers modified by linear monomers	POLYMER DEGRADATION AND STABILITY			English	Article						Enzymatic degradation; PBS copolyesters; Pseudomonas cepacia lipase; Molecular docking	FORCE-FIELD; ENZYMATIC DEGRADATION; POLY(EPSILON-CAPROLACTONE); ESTERIFICATION; BIODEGRADATION; DYNAMICS; SOLVENT; CEPACIA	The enzymatic degradation of poly (butylene succinate-co-hexane succinate) (PBS-co-HS), poly (butylene succinate-co-butylene adipate) (PBS-co-BA), and poly(butylene succinate) (PBS) was conducted for the purpose of gaining more underlying information about the degradation rules and differences in organic solvents. Among various hydrolytic enzymes, the lipase from Pseudomonas cepacia (PC) was chosen for these studies. The rules for enzymatic degradation were investigated by molecular weight variation and MALDI-TOF-MS analysis of the degradation products. In addition, the mechanism of the combination between substrate and enzyme was studied by molecular docking. The results indicated that PBS-based copolymers exhibited obvious degradation in chloroform. Compared to PBS-co-BA, PBS-co-HS exhibited a higher degradation rate after 60 h of enzymatic degradation. In particular, a maximum degradation of approximately 85% was observed for PBS-co-10%HS. The enzymatic degradation of PBS-based copolymers produced not only linear segments but also cyclic oligomers. Furthermore, PBS-co-HS produced more oligomers than PBS-co-BA. According to the molecular docking results, the free energy of binding between PC lipase and substrate in chloroform was in the order of HSH > BAB > BSB. That is, the docking of substrate containing HS in the active site of PC lipase was more stable than for any other substrate. (C) 2015 Elsevier Ltd. All rights reserved.	[Li, Cheng-tao; Zhang, Min; Qin, Jia-xiang; Zhang, Yi] Shaanxi Univ Sci & Technol, Minist Educ, Key Lab Auxiliary Chem & Technol Chem Ind, Xian 710021, Peoples R China; [Qiu, Jian-hui] Akita Prefecture Univ, Akita 0150055, Japan	Li, CT (reprint author), Shaanxi Univ Sci & Technol, Minist Educ, Key Lab Auxiliary Chem & Technol Chem Ind, Xian 710021, Peoples R China.	lct515@163.com			Research Fund for the Doctoral Program of Higher Education of China [20126125110001]; scientific research fund of Shaanxi University of science and the innovation team fund of Shaanxi University of Science and Technology [TD10-01]	Financial support for this work was provided by the Research Fund for the Doctoral Program of Higher Education of China (20126125110001), scientific research fund of Shaanxi University of science and the innovation team fund of Shaanxi University of Science and Technology (TD10-01).	BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Kukreja N, 2008, PHARMACOL RES, V57, P171, DOI [10.1016/j.phrs.2008.01.012, 10.1016/.i.phrs.2008.01.012]; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Villeneuve P, 2000, J MOL CATAL B-ENZYM, V9, P113, DOI 10.1016/S1381-1177(99)00107-1; Tian HY, 2012, PROG POLYM SCI, V37, P237, DOI 10.1016/j.progpolymsci.2011.06.004; Venugopal J, 2005, TISSUE ENG, V11, P847, DOI 10.1089/ten.2005.11.847; Zhang M, 2010, CHEM J CHINESE U, V31, P612; Luic M, 2008, J PHYS CHEM B, V112, P4876, DOI 10.1021/jp077717u; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Yuriev E, 2013, J MOL RECOGNIT, V26, P215, DOI 10.1002/jmr.2266; Artham T, 2009, ENZYME MICROB TECHNO, V48, P71; Carbone LA, 2009, MACROMOL RAPID COMM, V30, P1021; Chang QL, 1999, ENZYME MICROB TECH, V25, P290, DOI 10.1016/S0141-0229(99)00072-1; Hiroshi U, 1996, MACROMOLECULES, V28, p7046 ~7050; Pastorino L, 2004, ENZYME MICROB TECH, V35, P321, DOI 10.1016/j.enzmictec.2004.05.005; Shiro K, 2000, BIOMACROMOLECULES, V1, P3; Sivalingam G, 2003, POLYM DEGRAD STABIL, V79, P413, DOI 10.1016/S0141-3910(02)00357-9; Sivalingam G, 2003, CHEM ENG SCI, V58, P2911, DOI 10.1016/S0009-2509(03)00155-6; Sivalingam G, 2004, J APPL POLYM SCI, V91, P2391, DOI 10.1002/app.13394; [张敏 Zhang Min], 2012, [塑料, Plastics], V41, P5	23	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0141-3910	1873-2321		POLYM DEGRAD STABIL	Polym. Degrad. Stabil.	JUN	2015	116						75	80		10.1016/j.polymdegradstab.2015.03.017		6	Polymer Science	Polymer Science	CJ2XU	WOS:000355348800008		
J	Chernozhukov, V; Chetverikov, D; Kato, K				Chernozhukov, Victor; Chetverikov, Denis; Kato, Kengo			Comparison and anti-concentration bounds for maxima of Gaussian random vectors	PROBABILITY THEORY AND RELATED FIELDS			English	Article						Slepian inequality; Anti-concentration; Levy concentration function; Maximum of Gaussian random vector; Conditional multiplier central limit theorem	INEQUALITIES	Slepian and Sudakov-Fernique type inequalities, which compare expectations of maxima of Gaussian random vectors under certain restrictions on the covariance matrices, play an important role in probability theory, especially in empirical process and extreme value theories. Here we give explicit comparisons of expectations of smooth functions and distribution functions of maxima of Gaussian random vectors without any restriction on the covariance matrices. We also establish an anti-concentration inequality for the maximum of a Gaussian random vector, which derives a useful upper bound on the L,vy concentration function for the Gaussian maximum. The bound is dimension-free and applies to vectors with arbitrary covariance matrices. This anti-concentration inequality plays a crucial role in establishing bounds on the Kolmogorov distance between maxima of Gaussian random vectors. These results have immediate applications in mathematical statistics. As an example of application, we establish a conditional multiplier central limit theorem for maxima of sums of independent random vectors where the dimension of the vectors is possibly much larger than the sample size.	[Chernozhukov, Victor] MIT, Dept Econ, Cambridge, MA 02142 USA; [Chernozhukov, Victor] MIT, Ctr Operat Res, Cambridge, MA 02142 USA; [Chetverikov, Denis] Univ Calif Los Angeles, Dept Econ, Los Angeles, CA 90095 USA; [Kato, Kengo] Univ Tokyo, Grad Sch Econ, Bunkyo Ku, Tokyo 1130033, Japan	Kato, K (reprint author), Univ Tokyo, Grad Sch Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	vchern@mit.edu; chetverikov@econ.ucla.edu; kkato@e.u-tokyo.ac.jp			National Science Foundation; Japan Society for the Promotion of Science [2730179, 25780152]	V. Chernozhukov and D. Chetverikov are supported by a National Science Foundation grant. K. Kato is supported by the Grant-in-Aid for Young Scientists (B) (22730179, 25780152), the Japan Society for the Promotion of Science. We would like to thank the Editors and an anonymous referee for their careful review.	Rudelson M, 2009, COMMUN PUR APPL MATH, V62, P1707; SLEPIAN D, 1962, BELL SYST TECH J, V41, P463; Bentkus V, 2003, J STAT PLAN INFER, V113, P385, DOI 10.1016/S0378-3758(02)00094-0; Candes E, 2007, ANN STAT, V35, P2313, DOI 10.1214/009053606000001523; Li WBV, 2002, PROBAB THEORY REL, V122, P494, DOI 10.1007/s004400100176; Li WV, 2001, HANDB STAT, V19, P533, DOI 10.1016/S0169-7161(01)19019-X; BALL K, 1993, DISCRETE COMPUT GEOM, V10, P411, DOI 10.1007/BF02573986; Borell C., 1975, INVENT MATH, V30, P205; Buhlmann P, 2011, SPRINGER SER STAT, P1, DOI 10.1007/978-3-642-20192-9; Chatterjee S., 2005, ARXIVMATH0510424; Chen LHY, 2011, PROBAB APPL SER, P1, DOI 10.1007/978-3-642-15007-4; Chernozhukov V., 2013, ARXIV13037152; Chernozhukov V, 2013, ANN STAT, V41, P2786, DOI 10.1214/13-AOS1161; Dudley R. M., 1999, UNIFORM CENTRAL LIMI; GORDON Y, 1985, ISRAEL J MATH, V50, P265, DOI 10.1007/BF02759761; Klivans AR, 2008, ANN IEEE SYMP FOUND, P541, DOI 10.1109/FOCS.2008.64; Leadbetter M. R., 1983, EXTREMES RELATED PRO; Ledoux M., 1991, PROBABILITY BANACH S; Ledoux M., 2001, CONCENTRATION MEASUR; Nazarov F, 2003, LECT NOTES MATH, V1807, P169; Nourdin I, 2009, ELECTRON J PROBAB, V14, P2287; Panchenko D., 2013, SHERRINGTON KIRKPATR; Rudelson M, 2008, ADV MATH, V218, P600, DOI 10.1016/j.aim.2008.01.010; STEIN CM, 1981, ANN STAT, V9, P1135, DOI 10.1214/aos/1176345632; Sudakov V.N., 1978, J SOVIET MATH, V9, P9, DOI 10.1007/BF01086099; Talagrand M., 2003, SPIN GLASSES CHALLEN; Taylor J., 2007, RANDOM FIELDS GEOMET; van der Vaart A. W., 1996, WEAK CONVERGENCE EMP; Vershynin R., 2007, C P PHEN HIGH DIM SA; Yan LQ, 2009, J THEOR PROBAB, V22, P827, DOI 10.1007/s10959-009-0248-0; YLVISAKE.D, 1968, ANN MATH STAT, V39, P261, DOI 10.1214/aoms/1177698528; Ylvisaker D, 1965, ANN STAT, V36, P1043	32	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0178-8051	1432-2064		PROBAB THEORY REL	Probab. Theory Relat. Field	JUN	2015	162	1-2					47	70		10.1007/s00440-014-0565-9		24	Statistics & Probability	Mathematics	CJ0QO	WOS:000355182400002		
J	Schepaschenko, D; See, L; Lesiv, M; McCallum, I; Fritz, S; Salk, C; Moltchanova, E; Perger, C; Shchepashchenko, M; Shvidenko, A; Kovalevskyi, S; Gilitukha, D; Albrecht, F; Kraxner, F; Bun, A; Maksyutov, S; Sokolov, A; Durauer, M; Obersteiner, M; Karminov, V; Ontikov, P				Schepaschenko, Dmitry; See, Linda; Lesiv, Myroslava; McCallum, Ian; Fritz, Steffen; Salk, Carl; Moltchanova, Elena; Perger, Christoph; Shchepashchenko, Maria; Shvidenko, Anatoly; Kovalevskyi, Sergii; Gilitukha, Dmytro; Albrecht, Franziska; Kraxner, Florian; Bun, Andriy; Maksyutov, Shamil; Sokolov, Alexander; Duerauer, Martina; Obersteiner, Michael; Karminov, Viktor; Ontikov, Petr			Development of a global hybrid forest mask through the synergy of remote sensing, crowdsourcing and FAO statistics	REMOTE SENSING OF ENVIRONMENT			English	Article						Forest cover; Geographically weighted regression; Crowdsourcing	GEOGRAPHICALLY-WEIGHTED REGRESSION; LAND-COVER; ACCURACY; DATASETS; MODELS; SERIES; SCALE	A number of global and regional maps of forest extent are available, but when compared spatially, there are large areas of disagreement. Moreover, there is currently no global forest map that is consistent with forest statistics from FAO (Food and Agriculture Organization of the United Nations). By combining these diverse data sources into a single forest cover product, it is possible to produce a global forest map that is more accurate than the individual input layers and to produce a map that is consistent with FAO statistics. In this paper we applied geographically weighted regression (GWR) to integrate eight different forest products into three global hybrid forest cover maps at a 1 km resolution for the reference year 2000. Input products included global land cover and forest maps at varying resolutions from 30 m to 1 km, mosaics of regional land use/land cover products where available, and the MODIS Vegetation Continuous Fields product. The GWR was trained using crowdsourced data collected via the Geo-Wiki platform and the hybrid maps were then validated using an independent dataset collected via the same system. Three different hybrid maps were produced: two consistent with FAO statistics, one at the country and one at the regional level, and a "best guess" forest cover map that is independent of FAO. Independent validation showed that the "best guess" hybrid product had the best overall accuracy of 93% when compared with the individual input datasets. The global hybrid forest cover maps are available at http://biomass.geo-wild.org. (C) 2015 Elsevier Inc. All rights reserved.	[Schepaschenko, Dmitry; See, Linda; Lesiv, Myroslava; McCallum, Ian; Fritz, Steffen; Salk, Carl; Perger, Christoph; Shvidenko, Anatoly; Albrecht, Franziska; Kraxner, Florian; Duerauer, Martina; Obersteiner, Michael] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Schepaschenko, Dmitry; Karminov, Viktor; Ontikov, Petr] Moscow State Forest Univ, Mytishchi 141005, Russia; [Lesiv, Myroslava] Polish Acad Sci, Syst Res Inst, PL-01447 Warsaw, Poland; [Lesiv, Myroslava] Lviv Polytech Natl Univ, UA-79000 Lvov, Ukraine; [Salk, Carl] Swedish Agr Univ, Southern Swedish Forest Res Ctr, SE-23053 Alnarp, Sweden; [Moltchanova, Elena] Univ Canterbury, Sch Math & Stat, Christchurch 8140, New Zealand; [Shchepashchenko, Maria] Russian Inst Continuous Educ Forestry, Pushchino 141200, Moscow Reg, Russia; [Kovalevskyi, Sergii; Gilitukha, Dmytro] Natl Univ Life & Environm Sci Ukraine, UA-03041 Kiev, Ukraine; [Bun, Andriy] Delft Univ Technol, NL-2628 CN Delft, Netherlands; [Maksyutov, Shamil] Natl Inst Environm Studies, Ctr Global Environm Res, Tsukuba, Ibaraki 3058506, Japan; [Sokolov, Alexander; Ontikov, Petr] Cent Forest Inventory Enterprise ZentrLesProekt, Ivanteyevka 141280, Moscow Reg, Russia	Schepaschenko, D (reprint author), Int Inst Appl Syst Anal, Schlosspl 1, A-2361 Laxenburg, Austria.	schepd@iiasa.ac.at; see@iiasa.ac.at; myroslava.lesiv@gmail.com; mccallum@iiasa.ac.at; fritz@iiasa.ac.at; carlsalk@gmail.com; moltchan@iiasa.ac.at; pergerch@iiasa.ac.at; mariaschep@gmail.com; shvidenk@iiasa.ac.at; kovalevskyis.s@gmail.com; dmitriy.nau@gmail.com; franziska.k.albrecht@gmail.com; kraxner@iiasa.ac.at; andr.bun@gmail.com; shamil@nies.go.jp; sokolov_a66@mail.ru; duerauer@iiasa.ac.at; oberstei@iiasa.ac.at; vnk57@yandex.ru; opv86@mail.ru	Maksyutov, Shamil/G-6494-2011	Maksyutov, Shamil/0000-0002-1200-9577	EC [283080, 612755, 603719, 627481]; ESA; International Climate Initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU), Germany; National Institute for Environmental Studies, Japan; Foundation for Polish Science	This study has been partly supported by the EC-funded 7th Framework Programme Projects GEOCARBON (283080), AGRICISTRADE (612755), SIGMA (603719), SIFCAS - FP7-PEOPLE-2013-IIF (627481); the GLOBBIOMASS project supported by ESA; the REDD-PAC project supported by the International Climate Initiative of the Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU), Germany; the NEFCA project supported by the National Institute for Environmental Studies, Japan; and the Foundation for Polish Science under International PhD Projects in Intelligent Computing (Innovative Economy Operational Programme 2007-2013 and European Regional Development Fund).	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Wang Q, 2005, GLOBAL ECOL BIOGEOGR, V14, P379, DOI 10.1111/j.1466-822x.2005.00153.x; Herold M, 2008, REMOTE SENS ENVIRON, V112, P2538, DOI 10.1016/j.rse.2007.11.013; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Hansen MC, 2013, SCIENCE, V342, P850, DOI 10.1126/science.1244693; Jung M, 2006, REMOTE SENS ENVIRON, V101, P534, DOI 10.1016/j.rse.2006.01.020; Fritz S, 2012, ENVIRON MODELL SOFTW, V31, P110, DOI 10.1016/j.envsoft.2011.11.015; Gong P, 2013, INT J REMOTE SENS, V34, P2607, DOI 10.1080/01431161.2012.748992; Liu CR, 2011, ECOGRAPHY, V34, P232, DOI 10.1111/j.1600-0587.2010.06354.x; Santoro M, 2011, REMOTE SENS ENVIRON, V115, P490, DOI 10.1016/j.rse.2010.09.018; Potapov P, 2011, REMOTE SENS ENVIRON, V115, P548, DOI 10.1016/j.rse.2010.10.001; Brunsdon C, 2001, INT J CLIMATOL, V21, P455, DOI 10.1002/joc.614; Comber A, 2013, INT J APPL EARTH OBS, V23, P37, DOI 10.1016/j.jag.2012.11.002; Verhegghen A, 2012, BIOGEOSCIENCES, V9, P5061, DOI 10.5194/bg-9-5061-2012; McCallum I, 2006, INT J APPL EARTH OBS, V8, P246, DOI 10.1016/j.jag.2005.12.002; Comber A, 2012, REMOTE SENS ENVIRON, V127, P237, DOI 10.1016/j.rse.2012.09.005; Pan YD, 2011, SCIENCE, V333, P988, DOI 10.1126/science.1201609; Nelson GC, 2014, P NATL ACAD SCI USA, V111, P3274, DOI 10.1073/pnas.1222465110; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P431, DOI 10.1111/1467-9884.00145; Zhao YY, 2014, INT J REMOTE SENS, V35, P4795, DOI 10.1080/01431161.2014.930202; Sexton JO, 2013, INT J DIGIT EARTH, V6, P427, DOI 10.1080/17538947.2013.786146; Foody GM, 2010, REMOTE SENS ENVIRON, V114, P2271, DOI 10.1016/j.rse.2010.05.003; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fritz S, 2009, REMOTE SENS-BASEL, V1, P345, DOI 10.3390/rs1030345; Fritz S, 2013, ENVIRON SCI TECHNOL, V47, P1688, DOI 10.1021/es303141h; Brunsdon C, 1998, J ROY STAT SOC D-STA, V47, P471, DOI 10.1111/1467-9884.00148; Comber AJ, 2013, REMOTE SENS LETT, V4, P373, DOI 10.1080/2150704X.2012.736694; Defourny P, 2006, P ISPRS COMM 7 MIDT; DiMiceli C.M., 2011, ANN GLOBAL AUTOMATED; FAO, 2010, 163 FAO, P378; FAO (Food and Agriculture Organization of the United Nations), 2010, 144E FAO; Fotheringham A. S., 2002, GEOGRAPHICALLY WEIGH; Fritz S, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL046213; Fritz S., 2011, GEOPHYS RES LETT, V38, pn/a; INPE, 2014, PROJ PRODES MON FLOR; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; Iwao K., 2011, Journal of Geographic Information System, V3, P160; Kempeneers P., 2012, PAN EUROPEAN FOREST; Kindermann G., 2006, CARBON BALANCE MANAG, V1; Le Quere C, 2013, EARTH SYST SCI DATA, V6, P689, DOI [10.5194/essdd-6-689-2013, DOI 10.5194/ESSDD-6-689-2013]; Lesiv M., 2013, P 8 INT SCI TECHN C, P6; Leung Y, 2000, ENVIRON PLANN A, V32, P9, DOI 10.1068/a3162; Olofsson P., 2012, REMOTE SENS ENVIRON, V129, P122; Pampel F. C., 2000, LOGISTIC REGRESSION; Ramankutty N, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB002952; Schepaschenko D., 2011, Journal of Land Use Science, V6, P245, DOI 10.1080/1747423X.2010.511681; Seebach L, 2012, ENVIRON SCI POLICY, V22, P13, DOI 10.1016/j.envsci.2012.04.010; Shvidenko A., 2005, MILLENIUM ECOSYSTEM, V1, P587; Song Xiao-qi, 2013, Instrument Techniques and Sensor; Tateishi R., 2008, INT ARCH PHOTOGRA B7, VXXXVII, P1369; Vancutsem C, 2013, REMOTE SENS-BASEL, V5, P19, DOI 10.3390/rs5010019; Wheeler D., 2010, HDB APPL SPATIAL ANA, P461, DOI DOI 10.1007/978-3-642-03647-7_22	53	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	JUN 1	2015	162						208	220		10.1016/j.rse.2015.02.011		13	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	CI8WI	WOS:000355052000016		
J	Buchwitz, M; Reuter, M; Schneising, O; Boesch, H; Guerlet, S; Dils, B; Aben, I; Armante, R; Bergamaschi, P; Blumenstock, T; Bovensmann, H; Brunner, D; Buchmann, B; Burrows, JP; Butz, A; Chedin, A; Chevallier, F; Crevoisier, CD; Deutscher, NM; Frankenberg, C; Hase, F; Hasekamp, OP; Heymann, J; Kaminski, T; Laeng, A; Lichtenberg, G; De Maziere, M; Noel, S; Notholt, J; Orphal, J; Popp, C; Parker, R; Scholze, M; Sussmann, R; Stiller, GP; Warneke, T; Zehner, C; Bril, A; Crisp, D; Griffith, DWT; Kuze, A; O'Dell, C; Oshchepkov, S; Sherlock, V; Suto, H; Wennberg, P; Wunch, D; Yokota, T; Yoshida, Y				Buchwitz, M.; Reuter, M.; Schneising, O.; Boesch, H.; Guerlet, S.; Dils, B.; Aben, I.; Armante, R.; Bergamaschi, P.; Blumenstock, T.; Bovensmann, H.; Brunner, D.; Buchmann, B.; Burrows, J. P.; Butz, A.; Chedin, A.; Chevallier, F.; Crevoisier, C. D.; Deutscher, N. M.; Frankenberg, C.; Hase, F.; Hasekamp, O. P.; Heymann, J.; Kaminski, T.; Laeng, A.; Lichtenberg, G.; De Maziere, M.; Noel, S.; Notholt, J.; Orphal, J.; Popp, C.; Parker, R.; Scholze, M.; Sussmann, R.; Stiller, G. P.; Warneke, T.; Zehner, C.; Bril, A.; Crisp, D.; Griffith, D. W. T.; Kuze, A.; O'Dell, C.; Oshchepkov, S.; Sherlock, V.; Suto, H.; Wennberg, P.; Wunch, D.; Yokota, T.; Yoshida, Y.			The Greenhouse Gas Climate Change Initiative (GHG-CCI): Comparison and quality assessment of near-surface-sensitive satellite-derived CO2 and CH4 global data sets	REMOTE SENSING OF ENVIRONMENT			English	Article						SCIAMACHY; GOSAT; Greenhouse gases; Carbon dioxide; Methane; Climate change	COLUMN OBSERVING NETWORK; HYPERSPECTRAL INFRARED OBSERVATIONS; ATMOSPHERIC CO2; RETRIEVAL ALGORITHM; CARBON-DIOXIDE; METHANE EMISSIONS; SOLAR OCCULTATION; THIN CLOUDS; 1ST YEAR; PART 1	The GHG-CCI project is one of several projects of the European Space Agency's (ESA) Climate Change Initiative (CCI). The goal of the CCI is to generate and deliver data sets of various satellite-derived Essential Climate Variables (ECVs) in line with GCOS (Global Climate Observing System) requirements. The "ECV Greenhouse Gases" (ECV GHG) is the global distribution of important climate relevant gases - atmospheric CO2 and CH4 - with a quality sufficient to obtain information on regional CO2 and CH4 sources and sinks. Two satellite instruments deliver the main input data for GHG-CCI: SCIAMACHY/ENVISAT and TANSO-FTS/GOSAT. The first order priority goal of GHG-CCI is the further development of retrieval algorithms for near-surface-sensitive column-averaged dry air mole fractions of CO2 and CH4, denoted XCO2 and XCH4, to meet the demanding user requirements. GHG-CCI focuses on four core data products: XCO2 from SCIAMACHY and TANSO and XCH4 from the same two sensors. For each of the four core data products at least two candidate retrieval algorithms have been independently further developed and the corresponding data products have been quality-assessed and inter-compared. This activity is referred to as "Round Robin" (RR) activity within the CCI. The main goal of the RR was to identify for each of the four core products which algorithms should be used to generate the Climate Research Data Package (CRDP). The CRDP will essentially be the first version of the ECV GHG. This manuscript gives an overview of the GHG-CCI RR and related activities. This comprises the establishment of the user requirements, the improvement of the candidate retrieval algorithms and comparisons with ground-based observations and models. The manuscript summarizes the final RR algorithm selection decision and its justification. Comparison with ground-based Total Carbon Column Observing Network (TCCON) data indicates that the "breakthrough" single measurement precision requirement has been met for SCIAMACHY and TANSO XCO2 (<3 ppm) and TANSO XCH4 (<17 ppb). The achieved relative accuracy for XCH4 is 3-15 ppb for SCIAMACHY and 2-8 ppb for TANSO depending on algorithm and time period. Meeting the 0.5 ppm systematic error requirement for XCO2 remains a challenge: approximately 1 ppm has been achieved at the validation sites but also larger differences have been found in regions remote from TCCON. More research is needed to identify the causes for the observed differences. In this context GHG-CCI suggests taking advantage of the ensemble of existing data products, for example, via the EnseMble Median Algorithm (EMMA). (C) 2013 Elsevier Inc All rights reserved.	[Buchwitz, M.; Reuter, M.; Schneising, O.; Bovensmann, H.; Burrows, J. P.; Deutscher, N. M.; Heymann, J.; Noel, S.; Notholt, J.; Warneke, T.] Univ Bremen, Inst Environm Phys IUP, D-28334 Bremen, Germany; [Boesch, H.] Univ Leicester, Leicester, Leics, England; [Guerlet, S.; Aben, I.; Hasekamp, O. P.] SRON Netherlands Inst Space Res, Utrecht, Netherlands; [Dils, B.; De Maziere, M.] Belgian Inst Space Aeron BIRA, Brussels, Belgium; [Lichtenberg, G.] Deutsch Zentrum Luft & Raumfahrt DLR, Oberpfaffenhofen, Germany; [Armante, R.; Chedin, A.; Crevoisier, C. D.] Meteorol Dynam Lab, Palaiseau, France; [Blumenstock, T.; Butz, A.; Hase, F.; Laeng, A.; Orphal, J.; Sussmann, R.; Stiller, G. P.] Karlsruhe Inst Technol, D-76021 Karlsruhe, Germany; [Blumenstock, T.; Butz, A.; Hase, F.; Laeng, A.; Orphal, J.; Sussmann, R.; Stiller, G. P.] Karlsruhe Inst Technol, Garmisch Partenkirchen, Germany; [Brunner, D.; Buchmann, B.; Popp, C.] Swiss Fed Labs Mat Sci & Technol Empa, Dubendorf, Switzerland; [Chevallier, F.] Lab Sci Climat & Environm, Gif Sur Yvette, France; [Bergamaschi, P.] European Commiss Joint Res Ctr EC JRC, Inst Environm & Sustainabil, Air & Climate Unit, Ispra, Italy; [Frankenberg, C.; Crisp, D.] Jet Prop Lab, Pasadena, CA USA; [Kaminski, T.; Scholze, M.] FastOpt GmbH, Hamburg, Germany; [Scholze, M.] Univ Bristol, Bristol, Avon, England; [Zehner, C.] European Space Agcy, ESRIN, Frascati, Italy; [Bril, A.; Oshchepkov, S.; Yokota, T.; Yoshida, Y.] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Deutscher, N. M.; Griffith, D. W. T.] Univ Wollongong, Wollongong, NSW, Australia; [Kuze, A.; Suto, H.] Japan Aerosp Explorat Agcy JAXA, Tsukuba, Ibaraki, Japan; [O'Dell, C.] Colorado State Univ, Ft Collins, CO 80523 USA; [Sherlock, V.] Natl Inst Water & Atmospher Res NIWA, Lauder, New Zealand; [Wennberg, P.; Wunch, D.] CALTECH, Pasadena, CA 91125 USA	Buchwitz, M (reprint author), Univ Bremen, Inst Environm Phys IUP, FB1,Otto Hahn Allee 1, D-28334 Bremen, Germany.	Michael.Buchwitz@iup.physik.uni-bremen.de	Boesch, Hartmut/G-6021-2012; Deutscher, Nicholas/E-3683-2015; Brunner, Dominik/A-1255-2009	Deutscher, Nicholas/0000-0002-2906-2577; Brunner, Dominik/0000-0002-4007-6902	ESA/ESRIN (GHG-CCI); EU (MACC-II) [283576]; DLR (SADOS); State of Bremen; University of Bremen; NASA [NNX11AG01G, NAG5-12247, NNG05-GD07G]; NASA Orbiting Carbon Observatory Program; DOE ARM program; Australian Research Council [DP0879468, LP0562346]; EU project IMECC; EU project GEOmon; Senate of Bremen	This work was primarily funded by ESA/ESRIN (GHG-CCI) but also received funding from EU FP7 (grant agreement No. 283576, MACC-II), DLR (SADOS), and the State and the University of Bremen. We thank the members of the GOSAT Project (JAM, NIES, and Ministry of the Environment (MoE), Japan) for providing GOSAT Level 1B and Level 2 data products (GOSAT RA1 PI project CONSCIGO). The ACOS v2.9 data were produced by the ACOS/OCO-2 project at the Jet Propulsion Laboratory, California Institute of Technology, and obtained from the ACOS/OCO-2 data archive maintained at the NASA Goddard Earth Science Data and Information Services Center. We thank NOAA for making available the CarbonTracker CO<INF>2</INF> fields. We also thank TCCON and related funding organizations (NASA grants NNX11AG01G, NAG5-12247, NNG05-GD07G, NASA Orbiting Carbon Observatory Program, DOE ARM program, the Australian Research Council, DP0879468 and LP0562346, the EU projects IMECC and GEOmon, the Senate of Bremen). Last but not least we would like to thank the two referees for helpful comments.	von Clarmann T, 2009, ATMOS MEAS TECH, V2, P159; Reuter M, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015047; Chevallier F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL024229; Oshchepkov S, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2008JD010061; Heymann J, 2012, ATMOS MEAS TECH, V5, P2375, DOI 10.5194/amt-5-2375-2012; Bloom AA, 2010, SCIENCE, V327, P322, DOI 10.1126/science.1175176; Chevallier F, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007375; Deutscher NM, 2010, ATMOS MEAS TECH, V3, P947, DOI 10.5194/amt-3-947-2010; Wofsy SC, 2011, PHILOS T R SOC A, V369, P2073, DOI 10.1098/rsta.2010.0313; Crisp D, 2012, ATMOS MEAS TECH, V5, P687, DOI 10.5194/amt-5-687-2012; Buchwitz M, 2005, ATMOS CHEM PHYS, V5, P941; Sussmann R, 2013, ATMOS MEAS TECH, V6, P397, DOI 10.5194/amt-6-397-2013; Frankenberg C, 2005, SCIENCE, V308, P1010, DOI 10.1126/science.1106644; O'Dell CW, 2012, ATMOS MEAS TECH, V5, P99, DOI 10.5194/amt-5-99-2012; Kaminski T, 2012, BIOGEOSCIENCES, V9, P3173, DOI 10.5194/bg-9-3173-2012; Buchwitz M, 2000, J GEOPHYS RES-ATMOS, V105, P15231, DOI 10.1029/2000JD900191; Reuter M, 2010, ATMOS MEAS TECH, V3, P209; Dlugokencky EJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL039780; Frankenberg C, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD014849; Wunch D, 2010, ATMOS MEAS TECH, V3, P1351, DOI 10.5194/amt-3-1351-2010; Crevoisier C, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020141; Simpson IJ, 2012, NATURE, V488, P490, DOI 10.1038/nature11342; Bril A, 2007, APPL OPTICS, V46, P2460, DOI 10.1364/AO.46.002460; Crevoisier C, 2009, ATMOS CHEM PHYS, V9, P4797; Parker R, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047871; Butz A, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL047888; Meirink JF, 2006, ATMOS CHEM PHYS, V6, P1275; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Boesch H, 2011, REMOTE SENS-BASEL, V3, P270, DOI 10.3390/rs3020270; Reuter M, 2013, ATMOS CHEM PHYS, V13, P1771, DOI 10.5194/acp-13-1771-2013; Crisp D, 2004, ADV SPACE RES-SERIES, V34, P700, DOI 10.1016/j.asr.2003.08.062; Buchwitz M, 2007, ATMOS CHEM PHYS, V7, P4249; Schneising O, 2009, ATMOS CHEM PHYS, V9, P443; Wecht KJ, 2012, ATMOS CHEM PHYS, V12, P1823, DOI 10.5194/acp-12-1823-2012; Wunch D, 2011, PHILOS T R SOC A, V369, P2087, DOI 10.1098/rsta.2010.0240; Butz A, 2012, REMOTE SENS ENVIRON, V120, P267, DOI 10.1016/j.rse.2011.05.030; Stephens BB, 2007, SCIENCE, V316, P1732, DOI 10.1126/science.1137004; Wunch D, 2011, ATMOS CHEM PHYS, V11, P12317, DOI 10.5194/acp-11-12317-2011; Yoshida Y, 2011, ATMOS MEAS TECH, V4, P717, DOI 10.5194/amt-4-717-2011; Kuze A, 2009, APPL OPTICS, V48, P6716, DOI 10.1364/AO.48.006716; Schepers D, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017549; Bovensmann H, 2010, ATMOS MEAS TECH, V3, P781, DOI 10.5194/amt-3-781-2010; Bergamaschi P, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012287; Buchwitz M., 2011, TECHNICAL REPORT, P45; Buchwitz M., 2011, TECHNICAL REPORT, P15; Buchwitz M., 2011, ALGORITHM INTERCOMPA, P192; Buchwitz M., 2012, ALGORITHM SELECTION; Buchwitz M., 2012, ALGORITHM INTERCOMPA; Canadell JG, 2010, CURR OPIN ENV SUST, V2, P301, DOI 10.1016/j.cosust.2010.08.003; Cogan AJ, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD018087; Crevoisier C, 2009, ATMOS CHEM PHYS, V9, P6337; Dils B., 2013, ATMOSPHERIC MEASUREM, V6, P8679; Foucher PY, 2009, ATMOS CHEM PHYS, V9, P2873, DOI 10.5194/acp-9-2873-2009; GCOS (Global Climate Observing System), 2006, GLOB CLIM OBS SYST, V107; Geibel MC, 2012, ATMOS CHEM PHYS, V12, P8763, DOI 10.5194/acp-12-8763-2012; Heymann J, 2012, ATMOS MEAS TECH, V5, P1935, DOI 10.5194/amt-5-1935-2012; Kaminski T, 2010, TELLUS B, V62, P784, DOI 10.1111/j.1600-0889.2010.00483.x; Messerschmidt J., 2012, ATMOSPHERIC CHEM PHY, V11, P10765; Noel S, 2011, ATMOS MEAS TECH, V4, P2567, DOI 10.5194/amt-4-2567-2011; Notholt J., PRODUCT VALIDATION A; Oshchepkov S, 2011, J GEOPHYS RES-ATMOS, V116, DOI 10.1029/2010JD015352; Oshchepkov S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2009JD012116; Oshchepkov S, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2012JD017505; Peters W., P NATL ACAD SCI PNAS, V104, P18925; Reuter M., 2012, TECHNICAL REPORT, P486; Reuter M, 2012, ATMOS MEAS TECH, V5, P1349, DOI 10.5194/amt-5-1349-2012; RIGBY M, 2008, GEOPHYS RES LETT, V35; Rodgers C.D., 2000, INVERSE METHODS ATMO; Schneising O, 2008, ATMOS CHEM PHYS, V8, P3827; Schneising O, 2012, ATMOS CHEM PHYS, V12, P1527, DOI 10.5194/acp-12-1527-2012; Schneising O., 2011, ATMOSPHERIC CHEM PHY, V11, P2881; Solomon S., 2007, CLIMATE CHANGE, P235, DOI DOI 10.1038/NCLIMATE1258	72	12	12	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0034-4257	1879-0704		REMOTE SENS ENVIRON	Remote Sens. Environ.	JUN 1	2015	162						344	362		10.1016/j.rse.2013.04.024		19	Environmental Sciences; Remote Sensing; Imaging Science & Photographic Technology	Environmental Sciences & Ecology; Remote Sensing; Imaging Science & Photographic Technology	CI8WI	WOS:000355052000024		
J	Hirohashi, N; La Spina, FA; Romarowski, A; Buffone, MG				Hirohashi, Noritaka; La Spina, Florenza A.; Romarowski, Ana; Buffone, Mariano G.			Redistribution of the intra-acrosomal EGFP before acrosomal exocytosis in mouse spermatozoa	REPRODUCTION			English	Article							MAMMALIAN SPERM; ZONA-PELLUCIDA; FERTILIZATION; PROGESTERONE; VITRO; BEGIN; VIVO; PH	Mammalian spermatozoa must undergo complex physiological and morphological alterations within the female reproductive tract before they become fertilization competent. Two important alterations are capacitation and the acrosome reaction (AR), by which spermatozoa become capable of penetrating the zona pellucida (ZP) of the oocyte. Although various biochemical stimulants have been reported to induce the AR, the true physiological inducer in vivo remains to be identified. Previously, it has been reported that most fertilizing spermatozoa undergo the AR before contacting the ZP and that only a small fraction of in vitro-capacitated spermatozoa can penetrate the ZP. Therefore, it is important to identify which capacitating spermatozoa undergo the AR in response to potential AR inducers such as progesterone. Here we show that spermatozoa undergo a dynamic rearrangement of the acrosome during in vitro capacitation. This involves the rapid movement of an artificially introduced soluble component of the acrosome, enhanced green fluorescent protein (EGFP), from the acrosomal cap region to the equatorial segment (EQ) of the sperm head. Spermatozoa exhibiting the EQ pattern were more sensitive to progesterone than were those without it. We suggest that spermatozoa that are ready to undergo acrosomal exocytosis can be detected by real-time EGFP imaging. This offers a promising new method for identifying where spermatozoa undergo the AR in the female reproductive tract in vivo.	[Hirohashi, Noritaka] Shimane Univ, Educ & Res Ctr Biol Resources, Oki Marine Biol Stn, Oki, Shimane 6850024, Japan; [Hirohashi, Noritaka] Ochanomizu Univ, Dept Biol Sci, Tokyo 1128610, Japan; [La Spina, Florenza A.; Romarowski, Ana; Buffone, Mariano G.] Consejo Nacl Invest Cient & Tecn, Natl Res Council Argentina, Inst Biol & Med Expt IBYME, RA-1033 Buenos Aires, DF, Argentina	Hirohashi, N (reprint author), Shimane Univ, Educ & Res Ctr Biol Resources, Oki Marine Biol Stn, 194 Kamo, Oki, Shimane 6850024, Japan.	hiro@life.shimane-u.ac.jp; mgbuffone@ibyme.conicet.gov.ar			National Institutes of Health [RO1TW008662]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010-2426, 2012-1175]; Japanese Society for Promotion of Science (JSPS) [FY2011]	This work was supported by the National Institutes of Health (grant number RO1TW008662), the Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010-2426 and 2012-1175), and the Japanese Society for Promotion of Science (JSPS) (FY2011).	Inoue N, 2011, P NATL ACAD SCI USA, V108, P20008, DOI 10.1073/pnas.1116965108; Buffone MG, 2009, J CELL PHYSIOL, V220, P611, DOI 10.1002/jcp.21781; STOCK CE, 1989, J REPROD FERTIL, V86, P723; ROLDAN ERS, 1994, SCIENCE, V266, P1578, DOI 10.1126/science.7985030; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105; Buffone MG, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.114.117911; Zanetti N, 2009, BIOL REPROD, V81, P396, DOI 10.1095/biolreprod.109.076166; AUSTIN CR, 1951, AUST J SCI RES SER B, V4, P581; Ho K, 2009, REPROD FERT DEVELOP, V21, P345, DOI 10.1071/RD08183; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Miki K, 2013, CURR BIOL, V23, P443, DOI 10.1016/j.cub.2013.02.007; CHANG MC, 1951, NATURE, V168, P697, DOI 10.1038/168697b0; Yanagimachi R, 2011, BIOL REPROD, V85, P4, DOI 10.1095/biolreprod.111.092601; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; Bedford JM, 2011, P NATL ACAD SCI USA, V108, P4703, DOI 10.1073/pnas.1102296108; Buffone MG, 2009, J CELL SCI, V122, P3153, DOI 10.1242/jcs.052977; Chang H, 2012, BIOL REPROD, V86, P1; Hirohashi Noritaka, 2011, Commun Integr Biol, V4, P471, DOI 10.4161/cib.4.4.15636; Kaneko T, 2001, BIOL REPROD, V65, P544, DOI 10.1095/biolreprod65.2.544; KUZAN FB, 1984, FERTIL STERIL, V41, P766; Muro Yuko, 2012, Biol Reprod, V86, P1, DOI 10.1095/biolreprod.111.095877; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; PARINAUD J, 1992, FERTIL STERIL, V58, P599; STEWARTSAVAGE J, 1988, GAMETE RES, V21, P1, DOI 10.1002/mrd.1120210102; Wassarman PM, 2001, CELLS TISSUES ORGANS, V168, P36, DOI 10.1159/000016804; YANAGIMA.R, 1966, J REPROD FERTIL, V11, P359; YANAGIMACHI R, 1976, J REPROD FERTIL, V46, P49	28	2	2	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	1470-1626			REPRODUCTION	Reproduction	JUN	2015	149	6					657	663		10.1530/REP-15-0017		7	Developmental Biology; Reproductive Biology	Developmental Biology; Reproductive Biology	CJ2AB	WOS:000355285300015		
J	Nishikiori, H; Teshima, K; Fujii, T				Nishikiori, Hiromasa; Teshima, Katsuya; Fujii, Tsuneo			Photoinduced electron transfer in rhodamine B-containing amorphous titania gels	RESEARCH ON CHEMICAL INTERMEDIATES			English	Article						Rhodamine B; Photoinduced electron transfer; Photocurrent; Amorphous gel; Titania	SENSITIZED SOLAR-CELLS; PHOTOCATALYTIC DEGRADATION; THERMAL-STABILITY; DYE; FILMS; TIO2; SILICA; LIGHT; 6G; PHOTODEGRADATION	Amorphous titania gel films containing the dye rhodamine B (RhB) were prepared by a sol-gel method, without heating. The RhB existed in the films as the RhB cation, which was transformed into the rhodamine 110 (Rh110) cation; its xanthene skeleton then decomposed during irradiation with visible light. This process was induced by electron transfer from the RhB cation to the titania gel matrix, because formation of the RhB radical on loss of an electron caused sequential dissociation of the N-ethyl groups. During irradiation with visible light a photocurrent was observed in electrodes coated with the RhB-containing titania gel and immersed in an I-2-LiI electrolyte. This photocurrent resulted from electron injection from the LUMO level of the dye into conduction band-like states of the titania gel. Because of its effective electron supply the electrolyte inhibited dissociation of the N-ethyl groups of RhB.	[Nishikiori, Hiromasa; Teshima, Katsuya] Shinshu Univ, Dept Environm Sci & Technol, Fac Engn, Nagano 3808553, Japan; [Fujii, Tsuneo] Nagano Prefectural Inst Technol, Ueda, Nagano 3861211, Japan	Nishikiori, H (reprint author), Shinshu Univ, Dept Environm Sci & Technol, Fac Engn, 4-17-1 Wakasato, Nagano 3808553, Japan.	nishiki@shinshu-u.ac.jp			JSPS KAKENHI [24550153]	This work was supported by JSPS KAKENHI grant number 24550153.	Anderson R, 1998, J NON-CRYST SOLIDS, V232, P72, DOI 10.1016/S0022-3093(98)00373-1; DISLICH H, 1971, ANGEW CHEM INT EDIT, V10, P363, DOI 10.1002/anie.197103631; AVNIR D, 1984, J PHYS CHEM-US, V88, P5956, DOI 10.1021/j150668a042; Asbury JB, 2003, J PHYS CHEM B, V107, P7376, DOI 10.1021/jp034148r; BRINKER CJ, 1991, THIN SOLID FILMS, V201, P97, DOI 10.1016/0040-6090(91)90158-T; Qu P, 1998, J MOL CATAL A-CHEM, V129, P257, DOI 10.1016/S1381-1169(97)00185-4; Mountjoy G, 2003, J SOL-GEL SCI TECHN, V26, P161, DOI 10.1023/A:1020774310142; Wang Q, 2008, LANGMUIR, V24, P7338, DOI 10.1021/la800313s; NAZEERUDDIN MK, 1993, J AM CHEM SOC, V115, P6382, DOI 10.1021/ja00067a063; Chatterjee D, 2005, J PHOTOCH PHOTOBIO C, V6, P186, DOI 10.1016/j.jphotochemrev.2005.09.001; RAMETTE RW, 1956, J AM CHEM SOC, V78, P4872, DOI 10.1021/ja01600a017; Chen F, 2003, INT J PHOTOENERGY, V5, P209, DOI 10.1155/S1110662X03000345; Gratzel M, 2003, J PHOTOCH PHOTOBIO C, V4, P145, DOI 10.1016/S1389-5567(03)00026-1; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Du LC, 2010, J PHYS CHEM C, V114, P8135, DOI 10.1021/jp911418g; HAGFELDT A, 1995, CHEM REV, V95, P49, DOI 10.1021/cr00033a003; WATANABE T, 1977, J PHYS CHEM-US, V81, P1845, DOI 10.1021/j100534a012; Zhuang JD, 2010, LANGMUIR, V26, P9686, DOI 10.1021/la100302m; ARBELOA IL, 1981, CHEM PHYS LETT, V79, P347, DOI 10.1016/0009-2614(81)80219-9; AUSTIN JM, 1986, J PHYS CHEM-US, V90, P1839, DOI 10.1021/j100400a021; Benko G, 2002, J AM CHEM SOC, V124, P489, DOI 10.1021/ja016561n; Brinker C. J., 1991, J CERAM SOC JPN, V99, P862; Brinker C.J., 1990, SOL GEL SCI PHYS CHE; CHAN MS, 1980, SOL ENERGY, V24, P561, DOI 10.1016/0038-092X(80)90355-2; Chang PH, 2008, LANGMUIR, V24, P11921, DOI 10.1021/la802213v; DISLICH H, 1983, J NON-CRYST SOLIDS, V57, P371, DOI 10.1016/0022-3093(83)90425-8; FUJII T, 1990, J PHOTOCH PHOTOBIO A, V54, P231, DOI 10.1016/1010-6030(90)85036-V; Fujishima A., 2000, J PHOTOCH PHOTOBIO C, V1, P1, DOI DOI 10.1016/S1389-5567(00)00002-2; KEMNITZ K, 1983, CHEM PHYS LETT, V101, P337, DOI 10.1016/0009-2614(83)87489-2; Khader MA, 2008, OPT LASER TECHNOL, V40, P445, DOI 10.1016/j.optlastec.2007.07.008; Maeda M., 1984, LASER DYES PROPERTIE; NARANG U, 1993, APPL SPECTROSC, V47, P229, DOI 10.1366/0003702934048253; NEGISHI N, 1994, LANGMUIR, V10, P1772, DOI 10.1021/la00018a025; Nishikiori H, 2006, J PHOTOCH PHOTOBIO A, V179, P125, DOI 10.1016/j.jphotochem.2005.08.010; Nishikiori H, 2011, J PHYS CHEM C, V115, P2880, DOI 10.1021/jp109958z; Nishikiori H, 2001, J SOL-GEL SCI TECHN, V20, P95, DOI 10.1023/A:1008732818526; Nishikiori H, 2012, RSC ADV, V2, P4258, DOI 10.1039/c2ra00495j; Nishikiori H, 2012, J PHYS CHEM C, V116, P4848, DOI 10.1021/jp2094388; REISFELD R, 1988, CHEM PHYS LETT, V147, P142, DOI 10.1016/0009-2614(88)85073-5; Yu JS, 2001, J ELECTROANAL CHEM, V504, P89, DOI 10.1016/S0022-0728(00)00514-3; Zi GL, 2012, RES CHEM INTERMEDIAT, V38, P2383, DOI 10.1007/s11164-012-0554-5	41	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0922-6168	1568-5675		RES CHEM INTERMEDIAT	Res. Chem. Intermed.	JUN	2015	41	6					3803	3816		10.1007/s11164-013-1490-8		14	Chemistry, Multidisciplinary	Chemistry	CJ0FD	WOS:000355149900041		
J	Sato, A; Kayama, H; Shojima, K; Matsumoto, S; Koyama, H; Minami, Y; Nojima, S; Morii, E; Honda, H; Takeda, K; Kikuchi, A				Sato, Akira; Kayama, Hisako; Shojima, Kensaku; Matsumoto, Shinji; Koyama, Hirofumi; Minami, Yasuhiro; Nojima, Satoshi; Morii, Eiichi; Honda, Hiroaki; Takeda, Kiyoshi; Kikuchi, Akira			The Wnt5a-Ror2 axis promotes the signaling circuit between interleukin-12 and interferon-gamma in colitis	SCIENTIFIC REPORTS			English	Article							DENDRITIC CELLS; BETA-CATENIN; MICROBIAL STIMULATION; ADAPTIVE IMMUNITY; SMALL-INTESTINE; AXON GUIDANCE; T-CELLS; RECEPTOR; WNT; RESPONSES	Wnt5a, which regulates various cellular functions in Wnt signaling, is involved in inflammatory responses, however the mechanism is not well understood. We examined the role of Wnt5a signaling in intestinal immunity using conditional knockout mice for Wnt5a and its receptor Ror2. Removing Wnt5a or Ror2 in adult mice suppressed dextran sodium sulfate (DSS)-induced colitis. It also attenuated the DSS-dependent increase in inflammatory cytokine production and decreased interferon-gamma (IFN-gamma)-producing CD4(+) Th-1 cell numbers in the colon. Wnt5a was highly expressed in stromal fibroblasts in ulcerative lesions in the DSS-treated mice and inflammatory bowel disease patients. Dendritic cells (DCs) isolated from the colon of Wnt5a and Ror2 deficient mice reduced the ability to differentiate naive CD4(+) T cells to IFN-gamma-producing CD4(+) Th1 cells. In vitro experiments demonstrated that the Wnt5a-Ror2 signaling axis augmented the DCs priming effect of IFN-gamma, leading to enhanced lipopolysaccharide (LPS)-induced interleukin (IL)-12 expression. Taken together, these results suggest that Wnt5a promotes IFN-gamma signaling, leading to IL-12 expression in DCs, and thereby inducing Th1 differentiation in colitis.	[Sato, Akira; Shojima, Kensaku; Matsumoto, Shinji; Koyama, Hirofumi; Kikuchi, Akira] Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, Suita, Osaka 5650871, Japan; [Kayama, Hisako; Takeda, Kiyoshi] Osaka Univ, Grad Sch Med, Dept Microbiol & Immunol, Suita, Osaka 5650871, Japan; [Nojima, Satoshi; Morii, Eiichi] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan; [Honda, Hiroaki] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Dis Model, Minami Ku, Hiroshima 7348553, Japan; [Minami, Yasuhiro] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Chuoh Ku, Kobe, Hyogo 6500017, Japan	Kikuchi, A (reprint author), Osaka Univ, Grad Sch Med, Dept Mol Biol & Biochem, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	akikuchi@molbiobc.med.osaka-u.ac.jp			Scientific Research on Innovative Areas [23112004];  [21249017];  [25250018];  [24590378]	We thank Dr. J. Takeda and the RIKEN BioResource Center in Japan for providing us with KY1.1 ES cells and B6-Tg(CAG-FLPe)36 mice (RBRC01834). We are grateful to Drs. T. Harada, Y. Kudo, M. Yamamoto, M. Murakami, M. Ohshima, and N. Oue for technical assistance. We thank Dr. Y. Hori for preparing human inflammatory bowel disease (IBD) samples. We also thank Dr. R. Nishinakamura, M. Nishita, and all of our laboratory members for helpful discussions. This work was supported by awards from Grants-in-Aid for Scientific Research to A.K. (2009-2011; No. 21249017 and 2013-2014; No. 25250018) and A.S. (2012-2014; No. 24590378) and an award from Scientific Research on Innovative Areas to A.K. (2011-2014; No. 23112004).	Qiao Y, 2013, IMMUNITY, V39, P454, DOI 10.1016/j.immuni.2013.08.009; Ma XJ, 1997, J BIOL CHEM, V272, P10389; Kim J, 2010, J IMMUNOL, V185, P1274, DOI 10.4049/jimmunol.1000181; Koboziev I, 2010, ANN NY ACAD SCI, V1207, pE86, DOI 10.1111/j.1749-6632.2010.05711.x; Takeuchi S, 2000, GENES CELLS, V5, P71, DOI 10.1046/j.1365-2443.2000.00300.x; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; Oderup C, 2013, J IMMUNOL, V190, P6126, DOI 10.4049/jimmunol.1203002; Blumenthal A, 2006, BLOOD, V108, P965, DOI 10.1182/blood-2005-12-5046; Kayama H, 2012, P NATL ACAD SCI USA, V109, P5010, DOI 10.1073/pnas.1114931109; Fujimoto K, 2011, J IMMUNOL, V186, P6287, DOI 10.4049/jimmunol.1004036; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Bekiaris V, 2014, IMMUNOL REV, V260, P86, DOI 10.1111/imr.12194; Kayama H, 2008, J BIOL CHEM, V283, P12468, DOI 10.1074/jbc.M709965200; Kayama H, 2012, INT IMMUNOL, V24, P673, DOI 10.1093/intimm/dxs094; Garrett WS, 2010, CELL, V140, P859, DOI 10.1016/j.cell.2010.01.023; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522; Lin SD, 2010, J CELL BIOL, V190, P263, DOI 10.1083/jcb.200912128; HAYES MP, 1995, BLOOD, V86, P646; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Manicassamy S, 2010, SCIENCE, V329, P849, DOI 10.1126/science.1188510; Maeda K, 2012, NAT MED, V18, P405, DOI 10.1038/nm.2653; Kikuchi A, 2012, ACTA PHYSIOL, V204, P17, DOI 10.1111/j.1748-1716.2011.02294.x; Sakane H, 2012, J CELL SCI, V125, P449, DOI 10.1242/jcs.091876; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Chen YP, 2002, P NATL ACAD SCI USA, V99, P14338, DOI 10.1073/pnas.212290499; Atarashi K, 2008, NATURE, V455, P808, DOI 10.1038/nature07240; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Sugimura R, 2012, CELL, V150, P351, DOI 10.1016/j.cell.2012.05.041; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Hu XY, 2009, IMMUNITY, V31, P539, DOI 10.1016/j.immuni.2009.09.002; Stark GR, 2007, CYTOKINE GROWTH F R, V18, P419, DOI 10.1016/j.cytogfr.2007.06.013; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; Ueda Y, 2010, INT IMMUNOL, V22, P953, DOI 10.1093/intimm/dxq449; Krajina T, 2003, EUR J IMMUNOL, V33, P1073, DOI 10.1002/eji.200323518; Sato A, 2010, EMBO J, V29, P41, DOI 10.1038/emboj.2009.322; Nishita M, 2010, TRENDS CELL BIOL, V20, P346, DOI 10.1016/j.tcb.2010.03.001; Liang HL, 2007, J EXP MED, V204, P3077, DOI 10.1084/jem.20062692; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Christman MA, 2008, AM J PHYSIOL-HEART C, V294, pH2864, DOI 10.1152/ajpheart.00982.2007; Gujral TS, 2014, CELL, V159, P844, DOI 10.1016/j.cell.2014.10.032; Karlis J, 2004, INFLAMM BOWEL DIS, V10, P834, DOI 10.1097/00054725-200411000-00018; Kayama H, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000514; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kusu T, 2013, J IMMUNOL, V190, P774, DOI 10.4049/jimmunol.1103067; Naskar D, 2014, J IMMUNOL, V192, P4386, DOI 10.4049/jimmunol.1302817; Niess Jan Hendrik, 2010, Gut Microbes, V1, P396, DOI 10.4161/gmic.1.6.13939; Shojima K, 2015, SCI REP-UK, V5, DOI 10.1038/srep08042; Valencia J, 2014, IMMUNOL LETT, V162, P188, DOI 10.1016/j.imlet.2014.08.015; Yu CH, 2014, EUR J IMMUNOL, V44, P1480, DOI 10.1002/eji.201343959	53	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUN 1	2015	5								10536	10.1038/srep10536		16	Multidisciplinary Sciences	Science & Technology - Other Topics	CJ6IX	WOS:000355598600001		
J	Wang, QP; Jiang, Y; Zhang, JQ; Kawaharada, K; Li, L; Wang, DJ; Ao, JP				Wang, Qingpeng; Jiang, Ying; Zhang, Jiaqi; Kawaharada, Kazuya; Li, Liuan; Wang, Dejun; Ao, Jin-Ping			Effects of recess process and surface treatment on the threshold voltage of GaN MOSFETs fabricated on a AlGaN/GaN heterostructure	SEMICONDUCTOR SCIENCE AND TECHNOLOGY			English	Article						GaN MOSFET; recess gate; etching damage; enhancement mode	ETCHING-INDUCED DAMAGE	GaN MOSFETs on a AlGaN/GaN heterostructure with a recess gate were fabricated. The charges near the SiO2/GaN interface of the GaN MOSFETs with different etching conditions were evaluated. It was found that stronger bombardment damage in the dry process will bring more charges near the interface and finally make the threshold voltage of the device negative. Nitrogen plasma treatment and ammonia water (NH4OH) treatment were investigated to recover or remove the damaged layer in order to achieve an enhancement-mode (E-mode) device with positive threshold voltage on the dry-recessed semi-insulating (SI) GaN surface. The influence of these treatments on the interface state density was also characterized using the Terman method by using the GaN MOS capacitor. An E-mode GaN MOSFET with a maximum field-effect mobility of 148.1 cm(2) V-1 s(-1) and a MOS capacitor with an interface state density of 3 x 10(11) cm(-2) eV(-1) were realized by the NH4OH treatment.	[Wang, Qingpeng; Jiang, Ying; Zhang, Jiaqi; Kawaharada, Kazuya; Li, Liuan; Ao, Jin-Ping] Univ Tokushima, Inst Sci & Technol, Tokushima 7708506, Japan; [Wang, Qingpeng; Jiang, Ying; Zhang, Jiaqi; Wang, Dejun] Dalian Univ Technol, Sch Elect Sci & Technol, Dalian 116024, Peoples R China	Wang, QP (reprint author), Univ Tokushima, Inst Sci & Technol, 2-1 Minami Josanjima, Tokushima 7708506, Japan.	jpao@ee.tokushima-u.ac.jp			State Scholarship Fund of China Scholarship Council	The authors Q Wang and Y Jiang are supported by a scholarship under the State Scholarship Fund of China Scholarship Council.	Ao JP, 2003, IEEE ELECTR DEVICE L, V24, P500, DOI 10.1109/LED.2003.815158; Ao JP, 2008, IEICE T ELECTRON, VE91C, P1004, DOI 10.1093/ietele/e91-c.7.1004; Christou A, 2008, IEEE T DEVICE MAT RE, V8, P239, DOI 10.1109/TDMR.2008.925989; Kevin M, 2005, IEEE T ELECTRON DEV, V52, P6; Lee JM, 2004, J VAC SCI TECHNOL B, V22, P479, DOI 10.1116/1.1645880; Milligan J., 2007, RAD C 2007 IEEE APR, P960; Narita T, 2011, PHYS STATUS SOLIDI A, V208, P1541, DOI 10.1002/pssa.201000952; Niiyama Y, 2009, CISC 2009 ANN IEEE, V1-4; Ping AT, 1998, J ELECTRON MATER, V27, P261, DOI 10.1007/s11664-998-0397-4; Sze S M, 2007, PHYS SEMICONDUCTOR D, V3rd, P303; Wang Q., 2013, POWERTECH POWERTECH, P1; Wang QP, 2014, IEEE T ELECTRON DEV, V61, P498, DOI 10.1109/TED.2013.2296094; Wang QP, 2014, SOLID STATE ELECTRON, V99, P59, DOI 10.1016/j.sse.2014.05.004	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0268-1242	1361-6641		SEMICOND SCI TECH	Semicond. Sci. Technol.	JUN	2015	30	6							065004	10.1088/0268-1242/30/6/065004		6	Engineering, Electrical & Electronic; Materials Science, Multidisciplinary; Physics, Condensed Matter	Engineering; Materials Science; Physics	CJ1HT	WOS:000355235400010		
J	Kawada, T				Kawada, Tomoyuki			Characteristics of patients with hypersomnia by actigraphy	SLEEP MEDICINE			English	Letter									Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.	kawada@nms.ac.jp					American Academy of Sleep Medicine, 2014, INT CLASS SLEEP DIS; Heier MS, 2007, SLEEP, V30, P969; Meltzer LJ, 2012, SLEEP, V35, P159, DOI 10.5665/sleep.1608; Filardi M, 2015, SLEEP MED, V16, P126, DOI 10.1016/j.sleep.2014.08.017	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1389-9457	1878-5506		SLEEP MED	Sleep Med.	JUN	2015	16	6					807	807		10.1016/j.sleep.2015.02.520		1	Clinical Neurology	Neurosciences & Neurology	CJ0BG	WOS:000355136200022		
J	Kurokochi, H; Toyama, K				Kurokochi, Hiroyuki; Toyama, Keisuke			Invasive Tree Species Robinia pseudoacacia: A Potential Biomass Resource in Nagano Prefecture, Japan	SMALL-SCALE FORESTRY			English	Article						Black locust; Fast-growing tree; Naturally-regenerated forest; Nonnative species; Stem analysis	WOODY BIOMASS; FOREST SUCCESSION; RIPARIAN FORESTS; PLANTATIONS; BIOLOGY; RIVER	The introduced tree species, Robinia pseudoacacia (black locust), has spread extensively in many countries. Because of its active regeneration and rapid initial growth, R. pseudoacacia has not been successfully eradicated despite many efforts. To manage this species, developing information on the growth of R. pseudoacacia as a biomass resource is desirable, and this will motivate logging and could contribute to the extermination or sustainable use of this species. In the present study, the stand volume and growth of R. pseudoacacia forests in riverbeds along the Chikumagawa River in Nagano Prefecture in Japan were examined by tree ring and stem analyses. Seven plots were established in R. pseudoacacia riparian forests of varying ages, and 611 measurements of diameter at breast height and 386 measurements of tree height were made. Stand volumes, which were estimated using equations of stem volume curve based on the results of stem analysis of 47 sample trees, were almost the same as or higher than those of native broadleaf forests in Japan. Stand volumes continued to increase for more than 20 years. Current annual increments of four plots (aged 13-22 years) indicated that it could take < 5 years after regeneration for the annual increment of R. pseudoacacia forests to reach a maximum level. Growth of R. pseudoacacia was comparable to or faster than native broadleaved species in Japan, showing the possibility of short rotation harvesting.	[Kurokochi, Hiroyuki] Univ Tokyo, Asian Nat Environm Sci Ctr, Lab Forest Mol Ecol, Tokyo 1880002, Japan; [Toyama, Keisuke] Univ Tokyo Chiba Forest, Grad Sch Agr & Life Sci, Chiba 2995503, Japan	Kurokochi, H (reprint author), Univ Tokyo, Asian Nat Environm Sci Ctr, Lab Forest Mol Ecol, 1-1-8 Midori Cho, Tokyo 1880002, Japan.	kurokochi@anesc.u-tokyo.ac.jp; toyama@uf.a.u-tokyo.ac.jp			Japan Society for the Promotion of Science [6167]; University of Tokyo	We thank the staff of the Chikumagawa River Office, Ministry of Land, Infrastructure, Transport and Tourism of Japan for invaluable assistance in providing study sites and materials, and members of the Laboratory of Forest Botany, the University of Tokyo, for assistance and support in the field and laboratory. This study was supported in part by a Grant-in-Aid for Young Scientists from the Japan Society for the Promotion of Science (No. 6167) to HK.	Annighofer P, 2012, EUR J FOREST RES, V131, P1619, DOI 10.1007/s10342-012-0629-2; Kleinbauer I, 2010, BIOL CONSERV, V143, P382, DOI 10.1016/j.biocon.2009.10.024; Sakai AK, 2001, ANNU REV ECOL SYST, V32, P305, DOI 10.1146/annurev.ecolsys.32.081501.114037; Von Holle B, 2006, BIODIVERS CONSERV, V15, P2197, DOI 10.1007/s10531-004-6906-8; Aravanopoulos FA, 2010, BIOMASS BIOENERG, V34, P1531, DOI 10.1016/j.biombioe.2010.06.012; Vermeij GJ, 1996, BIOL CONSERV, V78, P3, DOI 10.1016/0006-3207(96)00013-4; Gruenewald H, 2007, ECOL ENG, V29, P319, DOI 10.1016/j.ecoleng.2006.09.012; Castro-Diez P, 2009, BIOL INVASIONS, V11, P1973, DOI 10.1007/s10530-008-9374-3; Kurokochi Hiroyuki, 2014, Journal of Ecology and Environment, V37, P21, DOI 10.5141/ecoenv.2014.003; Association of Japanese Agricultural Scientific Societies, 2008, RISK MAN EFF US NONN; Bohm C, 2011, ANN FOR RES, V54, P215; Boehm C., 2011, Journal of Forest Science (Prague), V57, P303; BORING LR, 1984, J ECOL, V72, P749, DOI 10.2307/2259529; Elliott KJ, 1998, AM MIDL NAT, V140, P219, DOI 10.1674/0003-0031(1998)140[0219:CIVSAD]2.0.CO;2; Hattori S, 2006, PUBLICLY OFFERED TRE; Hayao U, 1961, YIELD TABLE IMPORTAN; Iliev Nasko, 2005, Journal of Korean Forestry Society, V94, P291; Keresztesi B, 1983, FOR ECOL MANAG, V58, P144; Kurokochi H, 2012, FOR GENET TREE BREED, V1, P13; Kurokochi H, 2010, PLANT ECOL, V210, P31, DOI 10.1007/s11258-010-9735-8; Kurokochi H, 2012, JPN J FOREST ENV, V54, P101; Maekawa M, 1997, LANDSCAPE URBAN PLAN, V37, P37, DOI 10.1016/S0169-2046(96)00368-4; Ministry of Land Infrastructure Transport and Tourism, 2008, RIV ENV DAT; Papanastasis VP, 1998, FOREST ECOL MANAG, V110, P283, DOI 10.1016/S0378-1127(98)00293-X; Pimentel D, 2002, BIOL INVASIONS; Redel Karoly, 2002, Journal of Forestry Research (Harbin), V13, P260, DOI 10.1007/BF02860087; Redei K, 2012, SE EUR FOREST, V2, P101; Sakio H, 2009, ECOLOGY ROBINIA PSEU; Sakio H., 2003, Journal of the Japanese Forestry Society, V85, P355; Uehara K, 1959, ENCY TREES ILLUSTRAT; Vasilopoulos G, 2007, BOT HELV, V117, P125, DOI 10.1007/s00035-007-0796-9; Yamada K., 2007, Japanese Journal of Conservation Ecology, V12, P94; Yamada S, 1967, EXAMPLE ANAL TREES	33	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1873-7617	1873-7854		SMALL-SCALE FOR	Small-Scale For.	JUN	2015	14	2					205	215		10.1007/s11842-014-9282-6		11	Forestry	Forestry	CJ0FL	WOS:000355151100005		
J	Nower, N; Liu, Y; Unoki, M				Nower, Naushin; Liu, Yang; Unoki, Masashi			Restoration scheme of instantaneous amplitude and phase using Kalman filter with efficient linear prediction for speech enhancement	SPEECH COMMUNICATION			English	Article						Speech enhancement; Instantaneous amplitude and phase; Kalman filter; Gammatone filterbank; Linear prediction	HIDDEN MARKOV-MODELS; SPECTRAL SUBTRACTION; FREQUENCY-DOMAIN; NOISE; INTELLIGIBILITY; PERCEPTION; ESTIMATOR; ENVELOPE	This paper proposes a restoration scheme for the instantaneous amplitudes and phases in sub-bands by using a Kalman filter with linear prediction (LP). A few important studies have already proved that the phase spectrum in the short-time Fourier transform plays an important role in speech enhancement. Thus, the proposed scheme concentrates on simultaneously restoring both instantaneous amplitudes and phases. The Kalman filter, which is an optimal estimator in this scheme, is used for both instantaneous amplitudes and phases in the sub-band representation to remove the effect of noise. We found that the effectiveness of the Kalman filter depended on accurate estimates of LP coefficients. We propose an effective LP training phase to derive gender and content independent LP coefficients as central processing for Kalman filtering. We carried out objective and subjective tests under various noisy conditions to evaluate the effectiveness of the proposed scheme and compared it with typical methods. The signal to error ratio (SER), perceptual evaluation of speech quality (PESQ), and SNR loss were used as objective measures in these simulations. The mean preference score was used in subjective evaluations. The results revealed that the proposed scheme could effectively improve these objective and subjective measures more than those with typical methods. (C) 2015 Elsevier B.V. All rights reserved.	[Nower, Naushin; Liu, Yang; Unoki, Masashi] JAIST, Sch Informat Sci, Nomi, Ishikawa 9231292, Japan	Nower, N (reprint author), JAIST, Sch Informat Sci, 1-1 Asahidai, Nomi, Ishikawa 9231292, Japan.	naushin@jaist.ac.jp; yangliu@jaist.ac.jp; unoki@jaist.ac.jp			Japan Society for the Promotion of Science - Japan; Strategic Information and Communications R & D Promotion Program of the Ministry of Internal Affairs and Communications (MK), Japan [SCOPE: 131205001]	This work was supported by an A3 foresight program made available by the Japan Society for the Promotion of Science - Japan. It was also partially supported by the Strategic Information and Communications R & D Promotion Program (SCOPE: 131205001) of the Ministry of Internal Affairs and Communications (MK), Japan.	EPHRAIM Y, 1984, IEEE T ACOUST SPEECH, V32, P1109, DOI 10.1109/TASSP.1984.1164453; Moore BCJ, 2008, JARO-J ASSOC RES OTO, V9, P399, DOI 10.1007/s10162-008-0143-x; Hu Y, 2008, IEEE T AUDIO SPEECH, V16, P229, DOI 10.1109/TASL.2007.911054; Ma JF, 2011, SPEECH COMMUN, V53, P340, DOI 10.1016/j.specom.2010.10.005; Veisi H, 2013, SPEECH COMMUN, V55, P205, DOI 10.1016/j.specom.2012.08.005; Mohammadiha N, 2013, IEEE T AUDIO SPEECH, V21, P2140, DOI 10.1109/TASL.2013.2270369; Paliwal K, 2011, SPEECH COMMUN, V53, P465, DOI 10.1016/j.specom.2010.12.003; Loizou PC, 2011, IEEE T AUDIO SPEECH, V19, P47, DOI 10.1109/TASL.2010.2045180; Paliwal KK, 2005, SPEECH COMMUN, V45, P153, DOI 10.1016/j.specom.2004.08.001; BOLL SF, 1979, IEEE T ACOUST SPEECH, V27, P113, DOI 10.1109/TASSP.1979.1163209; Zhao DY, 2007, IEEE T AUDIO SPEECH, V15, P882, DOI 10.1109/TASL.2006.885256; Paliwal KK, 1993, IEEE T SPEECH AUDI P, V1, P3, DOI 10.1109/89.221363; Scalart P, 1996, INT CONF ACOUST SPEE, P629, DOI 10.1109/ICASSP.1996.543199; Cipra T., 1991, TRABAJOS ESTADISTICA, V6, P111, DOI 10.1007/BF02873526; DRULLMAN R, 1995, J ACOUST SOC AM, V97, P585, DOI 10.1121/1.413112; Ephraim Y., 1992, SIGNAL PROCESSING IE, V40, P725, DOI DOI 10.1109/78.127947; EPHRAIM Y, 1989, IEEE T ACOUST SPEECH, V37, P1846, DOI 10.1109/29.45532; Fardkhaleghi P., 2010, 5 IEEE INT S TEL IST, P895; Ji Ming, 2011, IEEE Transactions on Audio, Speech and Language Processing, V19, DOI 10.1109/TASL.2010.2064312; Kleinschmidt T, 2011, COMPUT SPEECH LANG, V25, P585, DOI 10.1016/j.csl.2010.09.001; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Nishikawa T, 2003, IEICE T FUND ELECTR, VE86A, P846; Nower N., 2014, P IEEE INT C AC SPEE, P4666; Paliwal K, 2012, SPEECH COMMUN, V54, P282, DOI 10.1016/j.specom.2011.09.003; Roux J.L., 2008, P STAT PERC AUD SAPA, P23; Ruofei Chen, 2012, IEEE Transactions on Audio, Speech and Language Processing, V20, DOI 10.1109/TASL.2011.2177821; Satorra A, 2001, PSYCHOMETRIKA, V66, P507, DOI 10.1007/BF02296192; Sawada H, 2013, IEEE T AUDIO SPEECH, V21, P971, DOI 10.1109/TASL.2013.2239990; Shannon B.J., 2006, P INTERSPEECH 2006 I, P1427; So S, 2011, SPEECH COMMUN, V53, P818, DOI 10.1016/j.specom.2011.02.001; Sriram S., 2007, IEEE T AUDIO SPEECH, V15, P441; Swaminathan J, 2010, THESIS PURDUE U; Swaminathan J, 2012, J NEUROSCI, V32, P1747, DOI 10.1523/JNEUROSCI.4493-11.2012; Unoki M., 1999, SPEECH COMMUN, V27, P279; WANG DL, 1982, IEEE T ACOUST SPEECH, V30, P679, DOI 10.1109/TASSP.1982.1163920; Zhang Y, 2013, SPEECH COMMUN, V55, P509, DOI 10.1016/j.specom.2012.09.005	36	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-6393	1872-7182		SPEECH COMMUN	Speech Commun.	JUN	2015	70						13	27		10.1016/j.specom.2015.02.006		15	Acoustics; Computer Science, Interdisciplinary Applications	Acoustics; Computer Science	CI8SC	WOS:000355041000002		
J	Yamada, K; Aota, Y; Higashi, T; Ishida, K; Nimura, T; Saito, T				Yamada, Katsutaka; Aota, Yoichi; Higashi, Takayuki; Ishida, Ko; Nimura, Takanori; Saito, Tomoyuki			Accuracies in Measuring Spinopelvic Parameters in Full-Spine Lateral Standing Radiograph	SPINE			English	Article						pelvic incidence; pelvic tilt; sacral slope; lumbar lordosis; sagittal vertical axis; reliability; computed tomography; full-spine lateral standing radiograph; pelvis lateral standing radiograph; interclass correlation coefficient; intraobserver reliability; interobserver reliability	PEDICLE SUBTRACTION OSTEOTOMY; SAGITTAL ALIGNMENT; PELVIC INCIDENCE; INTEROBSERVER RELIABILITY; DEFORMITY; KEY; CLASSIFICATION; VALIDATION; POSITION; BALANCE	Study Design. Prospective comparative study of measuring pelvic incidence (PI) among standing radiographs of whole spine and pelvis and computed tomographic (CT) scans in a cohort of patients. Objective. To analyze accuracies in measuring PI and other spinopelvic parameters. Summary of Background Data. Previous reports indicated relatively low agreement in measuring PI even among experienced spinal surgeons; intra- and inter-rater reliability in manually measuring PI were 0.69 (0.62-0.74) and 0.41 (0.36-0.45), respectively; the mean interclass correlation coefficient value of manually measuring PI was 0.881. No study compared PI on standing radiographs with that measured on CT scans. Methods. A total of 120 consecutive patients with spinal disease (38 patients had history of hip arthroplasty) who admitted to our hospital from April 2012 for 6 months were enrolled. Subjects had obtained full-spine lateral standing radiograph, standing radiograph of pelvis, and CT scans. Pelvic incidence on full-spine lateral standing radiograph and that on pelvis lateral standing radiograph were measured manually by 2 experienced spinal surgeons. Intra-and interobserver reliability of the measurements were analyzed by using interclass correlation coefficient. On CT scans, PI was measured using 3-dimensional CT scan software (CT-PI). PI among 3 different imaging modalities was evaluated using correlation coefficients. Results. In whole-spine radiographs, the intra- and interobserver agreement rates with measurements in PI (0.84 and 0.79, respectively) and sacral slope (0.87 and 0.83, respectively) were lower than those in pelvic tilt (0.98 and 0.96, respectively) and PI-lumbar lordosis (0.97 and 0.97, respectively). The correlation coefficient between P-PI and CT-PI was higher (0.95) than that between FS-PI and CT-PI (0.81) and between FS-PI and P-PI (0.85). Conclusion. The reliability of measuring PI is comparatively lower than that of other spinopelvic parameters, and the variability of PI measurement is mainly due to difficulty of precisely identifying sacral endplate.	[Yamada, Katsutaka; Aota, Yoichi; Higashi, Takayuki; Ishida, Ko; Nimura, Takanori; Saito, Tomoyuki] Yokohama City Univ, Dept Orthopaed Surg, Yokohama, Kanagawa 2360004, Japan	Yamada, K (reprint author), Yokohama City Univ, Dept Orthopaed Surg, Kanazawa Ku, Fukuura 3-9, Yokohama, Kanagawa 2360004, Japan.	katsutaka@af.em-net.ne.jp					Schwab F, 2006, SPINE, V31, pE959, DOI 10.1097/01.brs.0000248126.96737.0f; Vialle R, 2006, EUR SPINE J, V15, P1449, DOI 10.1007/s00586-006-0096-x; Smith JS, 2012, SPINE, V37, P845, DOI 10.1097/BRS.0b013e31823b0892; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037//0033-2909.86.2.420; Boulay C, 2006, EUR SPINE J, V15, P415, DOI 10.1007/s00586-005-0984-5; Rose PS, 2009, SPINE, V34, P785, DOI 10.1097/BRS.0b013e31819d0c86; Schwab F, 2009, SPINE, V34, P1828, DOI 10.1097/BRS.0b013e3181a13c08; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lafage V, 2009, SPINE, V34, pE599, DOI 10.1097/BRS.0b013e3181aad219; Lafage V, 2008, SPINE, V33, P1572, DOI 10.1097/BRS.0b013e31817886a2; Kim CH, 2012, J NEUROSURG-SPINE, V16, P154, DOI 10.3171/2011.10.SPINE11367; BRUNNER C, 1991, SPINE, V16, P1111, DOI 10.1097/00007632-199109000-00017; Legaye J, 2007, EUR SPINE J, V16, P219, DOI 10.1007/s00586-006-0090-3; Donner A, 2002, J ROY STAT SOC D-STA, V51, P367, DOI 10.1111/1467-9884.00324; Vialle R, 2005, J BONE JOINT SURG AM, V87A, P260, DOI 10.2106/JBJS.D.02043; Schwab F, 2010, SPINE, V35, P2224, DOI 10.1097/BRS.0b013e3181ee6bd4; Dimar JR, 2008, EUR SPINE J, V17, P1373, DOI 10.1007/s00586-008-0755-1; Lafage V, 2011, SPINE, V36, P1037, DOI 10.1097/BRS.0b013e3181eb9469; Legaye J, 1998, Eur Spine J, V7, P99, DOI 10.1007/s005860050038; Roussouly P, 2005, SPINE, V30, P346, DOI 10.1097/01.brs.0000152379.54463.65; Schwab F, 2012, SPINE, V37, P1077, DOI 10.1097/BRS.0b013e31823e15e2	21	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	JUN 1	2015	40	11					E640	E646		10.1097/BRS.0000000000000904		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CJ3IV	WOS:000355377500005		
J	Kanno, H; Ozawa, H; Koizumi, Y; Morozumi, N; Aizawa, T; Ishii, Y; Itoi, E				Kanno, Haruo; Ozawa, Hiroshi; Koizumi, Yutaka; Morozumi, Naoki; Aizawa, Toshimi; Ishii, Yushin; Itoi, Eiji			Changes in lumbar spondylolisthesis on axial-loaded MRI: do they reproduce the positional changes in the degree of olisthesis observed on X-ray images in the standing position?	SPINE JOURNAL			English	Article						Degenerative spondylolisthesis; Lumbar spine; Axial loading; Magnetic resonance imaging; Spinal canal stenosis; Olisthesis	SPINAL STENOSIS; COMPUTED-TOMOGRAPHY; DEGENERATIVE SPONDYLOLISTHESIS; OSTEOPOROTIC FRACTURES; DISC HEIGHT; COMPRESSION; RADIOGRAPHY; INSTABILITY; DISORDERS; SYMPTOMS	BACKGROUND CONTEXT: Axial-loaded magnetic resonance imaging (MRI) can partially simulate the lumbar spine in patients in a standing position and potentially provides additional imaging findings that cannot be obtained with conventional MRI in the clinical assessment of patients with degenerative lumbar disease. Previous studies have shown that axial-loaded MRI demonstrates a significant reduction in the size of the dural sac compared with conventional MRI. However, there has been no study to compare the degree of olisthesis among conventional MRI, axial-loaded MRI, and upright X-ray imaging in patients with degenerative spondylolisthesis (DS). PURPOSE: The purpose of the study is to determine whether axial-loaded MRI can demonstrate similar positional changes in lumbar olisthesis as those detected on upright lateral X-ray in patients with DS. STUDY DESIGN: This is an imaging cohort study. PATIENT SAMPLE: A total of 43 consecutive patients with DS exhibiting olisthesis of 3 mm or more on X-ray images in the standing position were prospectively evaluated in this study. OUTCOME MEASURES: The degree of olisthesis, intraclass correlation coefficient (ICC), and percentage of patients exhibiting olisthesis of 3 mm or more on MRI. METHODS: The degree of olisthesis was measured on conventional MRI, axial-loaded MRI, and lateral X-ray imaging performed in the upright position. The degree of olisthesis was compared among the three imaging techniques. The ICC values for the measurements of olisthesis between X-ray studies and conventional and axial-loaded MRI were calculated and compared. The percentage of patients exhibiting olisthesis of 3 mm or more was compared between conventional MRI and axial-loaded MRI. RESULTS: The degree of olisthesis on axial-loaded MRI (5.962.5 mm) was significantly greater than that observed on conventional MRI (4.4 +/- 2.4 mm) (p<.05) although the degrees on conventional and axial-loaded MRI were significantly smaller than that on upright X-ray images (7.1 +/- 2.8 mm) (p<.05). The ICC between axial-loaded MRI and X-ray imaging (0.75, 95% confidence interval: 0.58-0.85) was considerably greater than that observed between conventional MRI and X-ray imaging (0.40, 95% confidence interval: 0.11-0.62). The percentage of patients exhibiting olisthesis of 3 mm or more was significantly higher on axial-loaded MRI (91%) than on conventional MRI (63%) (p<.01). CONCLUSIONS: Axial-loaded MRI demonstrates a significantly larger degree of olisthesis than conventional MRI. In addition, the degree of olisthesis on axial-loaded MRI was found to be more strongly correlated with that observed on X-ray studies in the upright position. Furthermore, the use of axial-loaded MRI significantly reduced the misdiagnosis of olisthesis of 3 mm or more that was detected on X-ray imaging. These results suggest that axial-loaded MRI may be superior to identify the olisthesis of the lumbar spine and show the degrees of olisthesis correlated to those detected on upright X-ray imaging. Further studies should be needed to clarify the actual value of these findings on axial-loaded MRI and provide the evidence to support its clinical significance in the assessment of patients with DS. (C) 2015 Elsevier Inc. All rights reserved.	[Kanno, Haruo; Ozawa, Hiroshi; Aizawa, Toshimi; Itoi, Eiji] Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Koizumi, Yutaka; Morozumi, Naoki; Ishii, Yushin] Sendai Nishitaga Natl Hosp, Dept Orthopaed Surg, Taihaku Ku, Sendai, Miyagi, Japan	Kanno, H (reprint author), Tohoku Univ, Grad Sch Med, Dept Orthopaed Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kanno-h@isis.ocn.ne.jp					Kimura S, 2001, SPINE, V26, P2596, DOI 10.1097/00007632-200112010-00014; Yone K, 1999, J SPINAL DISORD, V12, P40; Hansson T, 2009, EUR SPINE J, V18, P679, DOI 10.1007/s00586-009-0919-7; Jayakumar P, 2006, SPINE, V31, pE298, DOI 10.1097/01.brs.0000216602.98524.07; Willen J, 2001, SPINE, V26, P2607, DOI 10.1097/00007632-200112010-00016; Danielson B, 2001, SPINE, V26, P2601, DOI 10.1097/00007632-200112010-00015; Ghogawala Z, 2004, J NEUROSURG-SPINE, V1, P267, DOI 10.3171/spi.2004.1.3.0267; Lohman CM, 2006, SPINE, V31, P1834, DOI 10.1097/01.brs.0000227370.65573.ac; Irwin ZN, 2005, SPINE, V30, P2208, DOI 10.1097/01.brs.0000181057.60012.08; Suzuki H, 2010, SPINE, V35, pE344, DOI 10.1097/BRS.0b013e3181c91121; VERBIEST H, 1954, J BONE JOINT SURG BR, V36, P230; Vogt MT, 1998, SPINE, V23, P2640, DOI 10.1097/00007632-199812010-00020; BLAND JM, 1986, LANCET, V1, P307; Brantigan John W, 2003, Spine J, V3, P186, DOI 10.1016/S1529-9430(02)00536-3; Danielson BI, 1998, ACTA RADIOL, V39, P604; Detwiler PW, 1997, NEUROSURG FOCUS, V3, pe4; Detwiler PW, 1997, NEUROSURG FOCUS, V3, P1; FRIBERG O, 1987, SPINE, V12, P119, DOI 10.1097/00007632-198703000-00007; Hioki A, 2011, J SPINAL DISORD TECH, V24, P93, DOI 10.1097/BSD.0b013e3181dd611f; Hioki A, 2010, SPINE, V35, P995, DOI 10.1097/BRS.0b013e3181bb8188; Hiwatashi A, 2004, AM J NEURORADIOL, V25, P170; Kanno H, 2012, SPINE, V37, pE985, DOI 10.1097/BRS.0b013e31821038f2; Kanno H, 2012, SPINE, V37, P207, DOI 10.1097/BRS.0b013e3182134e73; Knaub Mark A, 2005, Instr Course Lect, V54, P313; Li G, 2009, EUR SPINE J, V18, P577, DOI 10.1007/s00586-008-0877-5; LOWE RW, 1976, CLIN ORTHOP RELAT R, P80; Madsen R, 2008, SPINE, V33, P61, DOI 10.1097/BRS.0b013e31815e395f; MESCHAN I, 1946, RADIOLOGY, V47, P249; Ozawa H, 2012, AM J NEURORADIOL, V33, P1191, DOI 10.3174/ajnr.A2920; Perneros G, 2009, SPINE J, V9, P486, DOI 10.1016/j.spinee.2009.03.001; Sakai Y, 2008, SPINE, V33, P581, DOI 10.1097/BRS.0b013e318166e051; Sato K, 1997, SPINE, V22, P1898, DOI 10.1097/00007632-199708150-00018; Sengupta DK, 2005, SPINE, V30, pS71, DOI 10.1097/01.brs.0000155579.88537.8e; Vogt MT, 1999, SPINE, V24, P2536, DOI 10.1097/00007632-199912010-00016; Wang Y, 2011, SPINE, V36, P1236, DOI 10.1097/BRS.0b013e3181ecf283; Wessberg P, 2006, SPINE, V31, P3039, DOI 10.1097/01.brs.0000249513.91050.80; White A.A, 1990, CLIN BIOMECHANICS SP; Willen J, 2008, SPINE, V33, pE109, DOI 10.1097/BRS.0b013e318163f9ab; Willen J, 1997, SPINE, V22, P2968, DOI 10.1097/00007632-199712150-00021	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1255	1262		10.1016/j.spinee.2015.02.016		8	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700024		
J	Viehofer, AF; Shinohara, Y; Sprecher, CM; Boszczyk, BM; Buettner, A; Benjamin, M; Milz, S				Viehoefer, Arnd F.; Shinohara, Yasushi; Sprecher, Christoph M.; Boszczyk, Bronek M.; Buettner, Andreas; Benjamin, Mike; Milz, Stefan			The molecular composition of the extracellular matrix of the human iliolumbar ligament	SPINE JOURNAL			English	Article						Insertion; Enthesis; Attachment; Type II collagen; Lumbosacral junction	LOW-BACK-PAIN; MONOCLONAL-ANTIBODIES; LUMBOSACRAL JUNCTION; CONNECTIVE-TISSUE; COLLAGEN; FIBROCARTILAGE; ENTHESES; STABILITY; LUMICAN; TENDONS	BACKGROUND CONTEXT: The human iliolumbar ligament connects the transverse process of L5 to the iliac crest and contributes to lumbosacral stability and has been associated with low back pain. However, different opinions exist regarding the functional relevance of the ligament. PURPOSE: In the present study, we analyze the regional molecular composition of the ligament extracellular matrix. STUDY DESIGN: Special attention is given to the attachment sites, to determine whether the ligament is subjected to a certain mechanical environment. METHODS: Iliolumbar ligament samples, extending from one enthesis to the other, were removed from 11 cadavers and fixed in methanol. Cryosections were immunolabeled with a panel of antibodies directed against collagens, glycosaminoglycans, proteoglycans, matrix proteins, and neurofilament. RESULTS: The mid-substance of the ligament labeled for all the molecules normally found in dense fibrous connective tissue including types I, III, and VI collagen, versican, dermatan -, chondroitin 4 -, and keratan sulfate. However, both entheses were fibrocartilaginous and labeled for type II collagen, aggrecan, and chondroitin 6-sulfate. A common feature was fat between the fiber bundles near the entheses. Occasionally this fat contained nerve fibers. CONCLUSIONS: The existence of fibrocartilaginous entheses suggests that the insertion sites of the ligament are subject to both tensile and compressive loading-probably because of insertional angle changes between ligament and bone during loading. Our findings support the suggestion that the iliolumbar ligament might play an important role in the stabilization of the lumbosacral junction. (C) 2015 Elsevier Inc. All rights reserved.	[Viehoefer, Arnd F.; Shinohara, Yasushi; Sprecher, Christoph M.; Milz, Stefan] AO Fdn, AO Res Inst, CH-7270 Davos, Switzerland; [Shinohara, Yasushi] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6348522, Japan; [Boszczyk, Bronek M.] Nottingham Univ Hosp NHS Trust, Ctr Spinal Studies & Surg, Nottingham NG7 2UH, England; [Buettner, Andreas] Univ Rostock, Inst Legal Med, DE-18055 Rostock, Germany; [Benjamin, Mike] Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales; [Milz, Stefan] Univ Munich, Anatom Anstalt, DE-80336 Munich, Germany	Milz, S (reprint author), Univ Munich, Anatom Anstalt, Pettenkoferstr 1, DE-80336 Munich, Germany.	stefan.milz@med.uni-muenchen.de	Milz, Stefan/J-8218-2012	Milz, Stefan/0000-0002-3859-2107	NICHD	All antibodies obtained from the Developmental Studies Hybridoma Bank were developed under the auspices of the NICHD and maintained by the University of Iowa, Department of Biology, Iowa City, IA 52242.	Adamczyk C, 2008, J ANAT, V212, P645, DOI 10.1111/j.1469-7580.2008.00887.x; CATERSON B, 1985, FED PROC, V44, P386; HOLMDAHL R, 1986, ARTHRITIS RHEUM, V29, P400, DOI 10.1002/art.1780290314; Ezura Y, 2000, J CELL BIOL, V151, P779, DOI 10.1083/jcb.151.4.779; Rucco V, 1996, AM J PHYS MED REHAB, V75, P451, DOI 10.1097/00002060-199611000-00010; Frey H, 2013, FEBS J, V280, P2165, DOI 10.1111/febs.12145; Snijders CJ, 2004, CLIN BIOMECH, V19, P323, DOI 10.1016/j.clinbiomech.2004.01.006; Brezillon S, 2013, FEBS J, V280, P2369, DOI 10.1111/febs.12210; MAYNE R, 1988, CLIN BIOCHEM, V21, P111, DOI 10.1016/S0009-9120(88)80098-5; REIS ND, 1985, INJURY, V16, P421, DOI 10.1016/0020-1383(85)90063-4; LEONG JCY, 1987, SPINE, V12, P669, DOI 10.1097/00007632-198709000-00005; EVANS EJ, 1990, J ANAT, V171, P155; Onnerfjord P, 2012, J BIOL CHEM, V287, P18913, DOI 10.1074/jbc.M111.298968; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; YAMAMOTO I, 1990, SPINE, V15, P1138, DOI 10.1097/00007632-199011010-00010; Benjamin M, 2006, J ANAT, V208, P471, DOI 10.1111/j.1469-7580.2006.00540.x; Hammer N, 2010, ANN ANAT, V192, P162, DOI 10.1016/j.aanat.2010.02.003; Hayashida Y, 2006, P NATL ACAD SCI USA, V103, P13333, DOI 10.1073/pnas.0605441103; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Milz S, 2005, ADV ANAT EMBRYOL CEL, V178, P1; ASHER R, 1991, J NEUROSCI RES, V28, P410, DOI 10.1002/jnr.490280314; Benjamin M, 2004, ANN RHEUM DIS, V63, P1549, DOI 10.1136/ard.2003.019182; Bock CE, 1849, HDB ANATOMIE MENSCHE, P132; Boszczyk AA, 2003, J RHEUMATOL, V30, P1420; Boszczyk BM, 2003, J NEUROSURG, V99, P27, DOI 10.3171/spi.2003.99.1.0027; BROUDEUR P, 1982, REV RHUM, V49, P693; Broudeur P, 1981, LYON MED, V17, P4708; CALABRO A, 1992, ARCH BIOCHEM BIOPHYS, V298, P349, DOI 10.1016/0003-9861(92)90421-R; CASHMAN B, 1986, BRIT J RHEUMATOL, V25, P228; Chatuparisute P, 2012, APPL IMMUNOHISTO M M, V20, P318, DOI 10.1097/PAI.0b013e31822a8fb3; CHOW DHK, 1989, SPINE, V14, P611, DOI 10.1097/00007632-198906000-00013; COLLEE G, 1990, BRIT J RHEUMATOL, V29, P354; Fick R, 1904, HDB ANATOMIE MECHANI, P111; Fujiwara A, 2000, CLIN ORTHOP RELAT R, P167; Hartmann R, 1881, HDB ANATOMIE MENSCHE, P157; Henle J, 1871, HDB SYSTEMATISCHEN A, P116; HESSLE H, 1984, J BIOL CHEM, V259, P3955; HIRSCHBERG GG, 1979, ARCH PHYS MED REHAB, V60, P415; Jozsa L, 1997, HUMAN TENDONS ANATOM; Kiter E, 2010, SPINE, V35, pE101, DOI 10.1097/BRS.0b013e3181ae561d; Malinowski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050709; Milz S, 2008, SCAND J MED SCI SPOR, V18, P16, DOI 10.1111/j.1600-0838.2007.00644.x; Olsen Bjorn Reino, 1993, P32; Pel JJM, 2008, J BIOMECH, V41, P1878, DOI 10.1016/j.jbiomech.2008.04.002; Pool-Goudzwaard A, 2003, CLIN BIOMECH, V18, P99, DOI 10.1016/S0268-0033(02)00179-1; Pool-Goudzwaard AL, 2001, J ANAT, V199, P457, DOI 10.1046/j.1469-7580.2001.19940457.x; Sims JA, 1996, MED HYPOTHESES, V46, P511, DOI 10.1016/S0306-9877(96)90123-1; Snijders CJ, 2008, MANUAL THER, V13, P325, DOI 10.1016/j.math.2007.03.001; Waldeyer W, 1899, TOPOGRAPHISCH ANATOM, P28	49	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1325	1331		10.1016/j.spinee.2013.07.483		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700033		
J	Ohtori, S; Inoue, G; Miyagi, M; Takahashi, K				Ohtori, Seiji; Inoue, Gen; Miyagi, Masayuki; Takahashi, Kazuhisa			Pathomechanisms of discogenic low back pain in humans and animal models	SPINE JOURNAL			English	Article						Intervertebral disc; Pain; Sensory nerve; Inflammation; Hypermobility; Psychosocial factors	INTERVERTEBRAL DISC DEGENERATION; NERVE GROWTH-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; PRODUCE MATRIX METALLOPROTEINASES; POSTERIOR LONGITUDINAL LIGAMENT; ROOT GANGLION NEURONS; NECROSIS-FACTOR-ALPHA; ISSLS PRIZE WINNER; SPINAL DURA MATER; LUMBAR SPINE	BACKGROUND CONTEXT: Although explored in humans and animal models, the pathomechanisms of discogenic low back pain (LBP) remain unknown. PURPOSE: The aim of this study was to review the literature about the pathomechanisms of discogenic LBP. METHODS: Animal models of discogenic pain and specimens from degenerated human intervertebral discs (IVDs) have provided clues about the pathomechanisms of discogenic LBP. Painful discs are characterized by a confluence of innervation, inflammation, and mechanical hypermobility. These three possible mechanisms are discussed in this review. RESULTS: Animal models and specimens from humans have revealed sensory innervation of lumbar IVDs and sensory nerve ingrowth into the inner layer of IVDs. Cytokines such as tumor necrosis factor-alpha and interleukins induce this ingrowth. Nerve growth factor has also been recently identified as an inducer of ingrowth. Finally, disc degeneration induces several collagenases; their action results in hypermobility and pain. CONCLUSIONS: To treat discogenic LBP, it is important to prevent sensitization of sensory nerve fibers innervating the IVD, to suppress pathogenic increases of cytokines, and to decrease disc hypermobility. (C) 2015 Elsevier Inc. All rights reserved.	[Ohtori, Seiji; Inoue, Gen; Takahashi, Kazuhisa] Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Chiba 2608670, Japan; [Miyagi, Masayuki] Kitasato Univ, Sch Med, Dept Orthopaed Surg, Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Ohtori, S (reprint author), Chiba Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	sohtori@faculty.chiba-u.jp					LYONS G, 1981, BIOCHIM BIOPHYS ACTA, V673, P443, DOI 10.1016/0304-4165(81)90476-1; TROUT JJ, 1982, ANAT REC, V204, P307, DOI 10.1002/ar.1092040403; Matsudaira K, 2012, SPINE, V37, P1324, DOI 10.1097/BRS.0b013e3182498382; Cohen SP, 2007, ANESTHESIOLOGY, V107, P99, DOI 10.1097/01.anes.0000267518.20363.0d; Hadjipavlou AG, 2008, J BONE JOINT SURG BR, V90B, P1261, DOI 10.1302/0301-620X.90B10.20910; Punt IM, 2009, BIOMATERIALS, V30, P2079, DOI 10.1016/j.biomaterials.2008.12.071; Takada T, 2004, SPINE, V29, P1089, DOI 10.1097/00007632-200405150-00007; Roberts S, 1995, SPINE, V20, P2645, DOI 10.1097/00007632-199512150-00005; Lotz JC, 2006, J BONE JOINT SURG AM, V88A, P76, DOI 10.2106/JBJS.E.01448; MARCHAND F, 1990, SPINE, V15, P402, DOI 10.1097/00007632-199005000-00011; Murata Y, 2004, SPINE, V29, P2235, DOI 10.1097/01.brs.0000142223.30453.e5; EUSEBIO EB, 1990, DIS COLON RECTUM, V33, P770, DOI 10.1007/BF02052324; Aihara T, 2005, J BONE JOINT SURG BR, V87B, P687, DOI 10.1302/0301-620X.87B5.15727; TROUT JJ, 1982, TISSUE CELL, V14, P359, DOI 10.1016/0040-8166(82)90033-7; Adams MA, 2000, SPINE, V25, P1625, DOI 10.1097/00007632-200007010-00005; Goupille P, 1998, SPINE, V23, P1612, DOI 10.1097/00007632-199807150-00021; Zhao FD, 2005, SPINE, V30, P2621, DOI 10.1097/01.brs.0000188203.71182.c0; Kang JD, 1997, SPINE, V22, P1065, DOI 10.1097/00007632-199705150-00003; MCCARTHY PW, 1991, SPINE, V16, P653, DOI 10.1097/00007632-199106000-00010; PEARCE RH, 1987, J ORTHOPAED RES, V5, P198, DOI 10.1002/jor.1100050206; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Suseki K, 1998, J BONE JOINT SURG BR, V80B, P737, DOI 10.1302/0301-620X.80B4.8239; Handa T, 1997, SPINE, V22, P1085, DOI 10.1097/00007632-199705150-00006; ADAMS MA, 1986, J BONE JOINT SURG BR, V68, P36; THOMPSON JP, 1990, SPINE, V15, P411, DOI 10.1097/00007632-199005000-00012; Battie MC, 1995, SPINE, V20, P2601, DOI 10.1097/00007632-199512150-00001; MILLER JM, 1988, SYST BOT, V13, P173, DOI 10.1097/00007632-198802000-00008; Hall AM, 2011, PAIN, V152, P1044, DOI 10.1016/j.pain.2011.01.014; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2198; Ambalavanar R, 2003, J COMP NEUROL, V460, P167, DOI 10.1002/cne.10655; Noponen-Hietala N, 2005, PAIN, V114, P186, DOI 10.1016/j.pain.2004.12.015; MIMURA M, 1994, SPINE, V19, P1371; Ohtori S, 2001, SPINE, V26, P946, DOI 10.1097/00007632-200104150-00020; Truchon M, 2001, DISABIL REHABIL, V23, P758, DOI 10.1080/09638280110061744; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; LIANG M, 1982, ARCH INTERN MED, V142, P1108, DOI 10.1001/archinte.142.6.1108; Anderson DG, 2002, SPINE, V27, P1291, DOI 10.1097/00007632-200206150-00009; Carreon LY, 2008, SPINE J, V8, P747, DOI 10.1016/j.spinee.2007.06.013; FRYMOYER JW, 1984, J BONE JOINT SURG AM, V66A, P1048; Phillips FM, 2002, J BONE JOINT SURG BR, V84B, P289, DOI 10.1302/0301-620X.84B2.11937; MacLean JL, 2004, J ORTHOP RES, V22, P1193, DOI 10.1016/j.orthres.2004.04.004; Ozawa T, 2006, SPINE, V31, P2418, DOI 10.1097/01.brs.0000239159.74211.9c; Coppes MH, 1997, SPINE, V22, P2342, DOI 10.1097/00007632-199710150-00005; LIPSON SJ, 1981, ARTHRITIS RHEUM, V24, P12; Yoshida M, 2005, SPINE, V30, P55; [Anonymous], 1982, CLIN ORTHOPAEDICS; Battie MC, 2006, J BONE JOINT SURG AM, V88A, P3, DOI 10.2106/JBJS.E.01313; DePalma MJ, 2011, PAIN MED, V12, P224, DOI 10.1111/j.1526-4637.2010.01045.x; Nerlich AG, 1997, SPINE, V22, P2781, DOI 10.1097/00007632-199712150-00001; BOGDUK N, 1981, J ANAT, V132, P39; Lotz JC, 1998, SPINE, V23, P2493, DOI 10.1097/00007632-199812010-00004; AHMED M, 1993, SPINE, V18, P268, DOI 10.1097/00007632-199302000-00016; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Schultz IZ, 2004, PAIN, V107, P77, DOI 10.1016/j.pain.2003.09.019; BOGDUK N, 1983, SPINE, V8, P286, DOI 10.1097/00007632-198304000-00009; Burke JG, 2002, SPINE, V27, P1402, DOI 10.1097/00007632-200207010-00006; Freemont AJ, 1997, LANCET, V350, P178, DOI 10.1016/S0140-6736(97)02135-1; ASHTON IK, 1994, ACTA ORTHOP SCAND, V65, P635, DOI 10.3109/17453679408994620; Kanayama M, 2009, J NEUROSURG-SPINE, V11, P501, DOI 10.3171/2009.5.SPINE08675; Walsh AJL, 2004, J BIOMECH, V37, P329, DOI 10.1016/S0021-9290(03)00290-2; Freemont AJ, 2002, J PATHOL, V197, P286, DOI 10.1002/path.1108; Roughley PJ, 2004, SPINE, V29, P2691, DOI 10.1097/01.brs.0000146101.53784.b1; Rousseau MAA, 2007, SPINE, V32, P17, DOI 10.1097/01.brs.0000251013.07656.45; Kang JD, 1996, SPINE, V21, P271, DOI 10.1097/00007632-199602010-00003; Sztrolovics R, 1997, BIOCHEM J, V326, P235; Miyagi M, 2011, SPINE, V36, P2260, DOI 10.1097/BRS.0b013e31820e68c7; Peng BG, 2010, PAIN, V149, P124, DOI 10.1016/j.pain.2010.01.021; Zhao CQ, 2007, AGEING RES REV, V6, P247, DOI 10.1016/j.arr.2007.08.001; Melloh M, 2009, INT ORTHOP, V33, P301, DOI 10.1007/s00264-008-0707-8; Aoki Y, 2006, SPINE, V31, pE774, DOI 10.1097/01.brs.0000238681.71537.41; Ariga K, 2001, SPINE, V26, P2666, DOI 10.1097/00007632-200112150-00007; Bennett DL, 1996, NEUROSCI LETT, V206, P33, DOI 10.1016/0304-3940(96)12418-6; BUCKWALTER JA, 1995, SPINE, V20, P1307; Burton AK, 1996, J SPINAL DISORD, V9, P418; Chen JD, 2008, EUR J PAIN, V12, P798, DOI 10.1016/j.ejpain.2007.12.001; Ching CTS, 2003, CLIN BIOMECH, V18, P182, DOI 10.1016/S0268-0033(02)00188-2; Davis KG, 2002, SPINE, V27, P2645, DOI 10.1097/00007632-200212010-00003; Derby R, 2005, J NEUROSURG-SPINE, V3, P255, DOI 10.3171/spi.2005.3.4.0255; EDGAR MA, 1976, CLIN ORTHOP RELAT R, P35; EDGAR MA, 1966, J NEUROL NEUROSUR PS, V29, P530, DOI 10.1136/jnnp.29.6.530; FUJITA K, 1993, SPINE, V18, P1766, DOI 10.1097/00007632-199310000-00009; GROEN GJ, 1990, AM J ANAT, V188, P282, DOI 10.1002/aja.1001880307; Haefeli M, 2006, SPINE, V31, P1522, DOI 10.1097/01.brs.0000222032.52336.8e; HIRSCH CARL, 1963, ACTA ORTHOPAED SCAND, V33, P1, DOI 10.3109/17453676308999829; Holm S, 1993, Acta Orthop Scand Suppl, V251, P13; Horii M, 2011, SPINE, V36, pE80, DOI 10.1097/BRS.0b013e3181d4be3c; Hsieh AH, 2003, SPINE, V28, P1781, DOI 10.1097/01.BRS.0000083282.82244.F3; Hyodo H, 2005, EUR SPINE J, V14, P573, DOI 10.1007/s00586-004-0844-8; Inkinen RI, 1998, J RHEUMATOL, V25, P506; Inoue G, 2006, SPINE, V31, P1433, DOI 10.1097/01.brs.0000219946.25103.db; JACKSON HC, 1966, J BONE JOINT SURG AM, VA 48, P1272; Johnstone B, 1995, SPINE, V20, P2781; KANG JD, 1995, SPINE, V20, P2373, DOI 10.1097/00007632-199511001-00001; Kasra M, 2003, J ORTHOPAED RES, V21, P597, DOI 10.1016/S0736-0266(03)00027-5; KIMMEL DL, 1961, NEUROLOGY, V11, P800; KOJIMA Y, 1990, J ANAT, V169, P237; Koshi T, 2010, EUR SPINE J, V19, P593, DOI 10.1007/s00586-009-1237-9; LEE CK, 1988, SPINE, V13, P375, DOI 10.1097/00007632-198803000-00029; Lotz JC, 2008, EUR SPINE J, V17, P1149, DOI 10.1007/s00586-008-0721-y; Luschka H., 1850, NERVEN MENSCHLICHEN; MALINSKY JII, 1959, ACTA ANAT, V38, P96; Miyagi M, 2012, SPINE, V37, P1810, DOI 10.1097/BRS.0b013e31824ffac6; Miyauchi A, 2008, SPINE, V33, P687, DOI 10.1097/BRS.0b013e3181669548; Murphey F, 1968, Clin Neurosurg, V15, P343; NACHEMSON A, 1960, Acta Orthop Scand Suppl, V43, P1; Nachemson A, 2004, LUMBAR SPINE, P3; NACHEMSON A L, 1979, Spine, V4, P1, DOI 10.1097/00007632-197901000-00001; Nakamura S, 1996, J BONE JOINT SURG BR, V78B, P606; Neidlinger-Wilke C, 2006, EUR SPINE J S15, V15, P372, DOI 10.1007/s00586-006-0112-1; Niosi Christina A, 2004, Spine J, V4, p202S, DOI 10.1016/j.spinee.2004.07.013; ODonnell JL, 1996, SPINE, V21, P1653, DOI 10.1097/00007632-199607150-00007; Ohtori S, 1999, SPINE, V24, P2295, DOI 10.1097/00007632-199911150-00002; Ohtori S, 2010, J ORTHOP SCI, V15, P731, DOI 10.1007/s00776-010-1538-1; Oikawa Y, 2012, SPINE, V37, P114, DOI 10.1097/BRS.0b013e318210e6b5; Ono A, 1998, J SPINAL DISORD, V11, P253; Orita S, 2010, J ORTHOP RES, V28, P1614, DOI 10.1002/jor.21170; Orita S, 2013, SPINE J, V13, P284, DOI 10.1016/j.spinee.2013.01.020; Ozawa T, 2003, NEUROSCI LETT, V344, P65, DOI 10.1016/S0304-3940(03)00416-6; Palmer EI, 2004, J ORTHOPAED RES, V22, P164, DOI 10.1016/S0736-0266(02)00161-X; Palmgren T, 1999, SPINE, V24, P2075, DOI 10.1097/00007632-199910150-00002; PEDERSEN HE, 1956, J BONE JOINT SURG AM, V38, P377; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Rand NS, 2001, J SPINAL DISORD, V14, P339, DOI 10.1097/00002517-200108000-00010; Roofe PG, 1940, ARCH NEURO PSYCHIATR, V44, P100; Sasaki M, 2001, SPINE, V26, P463, DOI 10.1097/00007632-200103010-00008; SCHWARZER AC, 1995, SPINE, V20, P1878, DOI 10.1097/00007632-199509000-00007; Seki S, 2005, NAT GENET, V37, P607, DOI 10.1038/ng1557; Shinohara H, 1970, J JPN ORTHOP ASSOC, V44, P553; Singh K, 2005, SPINE J, V5, P267; SKELTON AM, 1995, FAM PRACT, V12, P44, DOI 10.1093/fampra/12.1.44; Sobajima Satoshi, 2005, Spine J, V5, P14, DOI 10.1016/j.spinee.2004.05.251; Sugiura A, 2008, SPINE, V33, P2047, DOI 10.1097/BRS.0b013e31817f8d58; Takahashi H, 1996, SPINE, V21, P218, DOI 10.1097/00007632-199601150-00011; TAKAHASHI Y, 1993, NEUROSCI LETT, V161, P1, DOI 10.1016/0304-3940(93)90125-5; Tanaka N, 2001, Spine J, V1, P47, DOI 10.1016/S1529-9430(01)00006-7; Tobinick EL, 2003, SWISS MED WKLY, V133, P170; Ulrich JA, 2007, SPINE, V32, P2812, DOI 10.1097/BRS.0b013e31815b9850; Urban J.P., 1998, SPINE, V13, P179; Urquhart DM, 2013, CLIN J PAIN, V29, P1015, DOI 10.1097/AJP.0b013e31827ff0c0; WIBERG GUNNAR, 1949, ACTA ORTHOPAED SCAND, V19, P211; Yamauchi K, 2009, SPINE, V34, P2263, DOI 10.1097/BRS.0b013e3181a5521d; YOSHIZAWA H, 1980, J PATHOL, V132, P95, DOI 10.1002/path.1711320202; Yukawa Y, 1997, SPINE, V22, P1736, DOI 10.1097/00007632-199708010-00010	146	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1347	1355		10.1016/j.spinee.2013.07.490		9	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700036		
J	Sakai, D; Nishimura, K; Tanaka, M; Nakajima, D; Grad, S; Alini, M; Kawada, H; Ando, K; Mochida, J				Sakai, Daisuke; Nishimura, Kazuhiro; Tanaka, Masahiro; Nakajima, Daisuke; Grad, Sibylle; Alini, Mauro; Kawada, Hiroshi; Ando, Kiyoshi; Mochida, Joji			Migration of bone marrow-derived cells for endogenous repair in a new tail-looping disc degeneration model in the mouse: a pilot study	SPINE JOURNAL			English	Article						Bone marrow-derived cells; Stem cells; Intervertebral disc; Disc degeneration; Bone marrow chimera; Spinal deformity; Mouse model	COLONY-STIMULATING FACTOR; INTERVERTEBRAL DISC; NUCLEUS PULPOSUS; STEM/PROGENITOR CELLS; STEM-CELLS; LUMBAR; MICE; MYOFIBROBLASTS; CONTRIBUTES; INFARCTION	BACKGROUND CONTEXT: Mobilization and homing of bone marrow-derived cells (BMCs) play a pivotal role in healing and regeneration of various tissues. However, the cellular response of BMCs in avascular tissue such as the intervertebral disc (IVD) has not been studied in detail. One of the main obstacles to this is a lack of a suitable mouse disc degeneration model. PURPOSE: The purpose of this study was to establish a reproducible disc degeneration mouse model suitable for analyzing the cellular response of the disc microenvironment and to determine whether BMCs are recruited into the IVD. STUDY DESIGN: An experimental animal study of disc degeneration investigating the potential of BMCs in an endogenous repair of the IVD. METHODS: We transplanted whole bone marrow cells from mice ubiquitously expressing enhanced green fluorescent protein into lethally irradiated mice. Intervertebral disc degeneration was induced through uneven loading by creating a loop in the tail of these mice. The vertebral bone-disc-vertebral bone units were harvested, and BMCs were identified by immunohistochemistry. RESULTS: A new disc degeneration model was established in the mouse. Applying this model in the bone marrow chimeric mice increased the number of BMCs in the peripheral bone marrow and vascular canals in the endplate, and some were found in the IVD. The migration of BMCs was related to the severity of IVD degeneration. CONCLUSIONS: Although providing a new disc degeneration model in mice, the present study provides evidence to suggest that although BMCs are recruited during disc degeneration, only a limited number of BMCs migrate to the IVD, presumably because of its avascular nature. This fact provides important elements for developing new treatments as many growth factors and compounds are being tested, both in investigational levels and clinical trials to nourish resident endogenous cells during the degenerative process. (C) 2015 The Authors. Published by Elsevier Inc.	[Sakai, Daisuke; Nishimura, Kazuhiro; Tanaka, Masahiro; Nakajima, Daisuke; Mochida, Joji] Tokai Univ, Sch Med, Surg Sci, Dept Orthopaed Surg, Isehara, Kanagawa 2591143, Japan; [Sakai, Daisuke; Tanaka, Masahiro; Nakajima, Daisuke; Kawada, Hiroshi; Ando, Kiyoshi; Mochida, Joji] Tokai Univ, Sch Med, Res Ctr Regenerat Med, Isehara, Kanagawa 2591143, Japan; [Sakai, Daisuke; Grad, Sibylle; Alini, Mauro] AO Spine Res Network, Dubendorf, Switzerland; [Grad, Sibylle; Alini, Mauro] AO Res Inst Davos, Musculoskeletal Regenerat Program, CH-7270 Davos, Switzerland	Sakai, D (reprint author), Tokai Univ, Sch Med, Surg Sci, Dept Orthopaed Surg, 143 Shimokasuya, Isehara, Kanagawa 2591143, Japan.	daisakai@is.icc.u-tokai.ac.jp					Mitsiadis TA, 2007, EXP CELL RES, V313, P3377, DOI 10.1016/j.yexcr.2007.07.027; Yang F, 2009, J PATHOL, V218, P113, DOI 10.1002/path.2519; Wu YJ, 2010, STEM CELLS, V28, P905, DOI 10.1002/stem.420; Nishimura K, 1998, SPINE, V23, P1531, DOI 10.1097/00007632-199807150-00006; Kawamoto T, 2000, HISTOCHEM CELL BIOL, V113, P331; Li CY, 2009, J HEPATOL, V50, P1174, DOI 10.1016/j.jhep.2009.01.028; Chen FM, 2011, BIOMATERIALS, V32, P3189, DOI 10.1016/j.biomaterials.2010.12.032; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Gruber HE, 2005, SPINE, V30, P2593, DOI 10.1097/01.brs.0000187877.30149.83; de Schepper EIT, 2010, SPINE, V35, P531, DOI 10.1097/BRS.0b013e3181aa5b33; Rajasekaran S, 2010, SPINE, V35, P1930, DOI 10.1097/BRS.0b013e3181e9a156; Fujita J, 2007, STEM CELLS, V25, P2750, DOI 10.1634/stemcells.2007-0275; Bussolati B, 2009, CURR STEM CELL RES T, V4, P2, DOI 10.2174/157488809787169129; Barbosa FL, 2010, EXP EYE RES, V91, P92, DOI 10.1016/j.exer.2010.04.007; Janssen WJ, 2010, J IMMUNOL METHODS, V357, P1, DOI 10.1016/j.jim.2010.03.013; Bae WC, 2011, ORTHOP CLIN N AM, V42, P585, DOI 10.1016/j.ocl.2011.07.004; Chou D, 2011, SPINE, V36, P43; Court C, 2001, Spine J, V1, P239, DOI 10.1016/S1529-9430(01)00056-0; Dahia CL, 2009, SPINE, V34, P447, DOI 10.1097/BRS.0b013e3181990c64; Direkze NC, 2003, STEM CELLS, V21, P514, DOI 10.1634/stemcells.21-5-514; HASSLER O, 1969, ACTA ORTHOP SCAND, V40, P765; HOLM S, 1981, CONNECT TISSUE RES, V8, P101, DOI 10.3109/03008208109152130; Kawada H, 2006, CIRCULATION, V113, P701, DOI 10.1161/CIRCULATIONAHA.105.563668; Nomura T, 2001, CLIN ORTHOP RELAT R, P94; O'Connell GD, 2007, SPINE, V32, P328, DOI 10.1097/01.brs.0000253961.40910.c1; Osada T, 2010, J NEUROSURG-SPINE, V13, P516, DOI 10.3171/2010.4.SPINE09973; Sakai D, 2008, EUR SPINE J, V17, pS452, DOI 10.1007/s00586-008-0743-5; Sarver JJ, 2005, J ORTHOP RES, V23, P150, DOI 10.1016/j.orthres.2004.04.010	28	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1356	1365		10.1016/j.spinee.2013.07.491		10	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700037		
J	Morimoto, T; Kaito, T; Matsuo, Y; Sugiura, T; Kashii, M; Makino, T; Iwasaki, M; Yoshikawa, H				Morimoto, Tokimitsu; Kaito, Takashi; Matsuo, Yohei; Sugiura, Tsuyoshi; Kashii, Masafumi; Makino, Takahiro; Iwasaki, Motoki; Yoshikawa, Hideki			The bone morphogenetic protein-2/7 heterodimer is a stronger inducer of bone regeneration than the individual homodimers in a rat spinal fusion model	SPINE JOURNAL			English	Article						Bone morphogenetic protein; BMP heterodimer; BMP homodimer; Cytokine therapy; Spinal fusion; Bone regeneration	PARATHYROID-HORMONE 1-34; ANTERIOR CERVICAL-SPINE; VIVO GENE-THERAPY; ACTIVITY IN-VITRO; OSTEOGENIC PROTEIN-1; ARTHRODESIS MODEL; BINDING PEPTIDE; RODENT MODEL; RECEPTORS; ENHANCEMENT	BACKGROUND CONTEXT: Bone morphogenetic proteins (BMPs) are a group of dimeric growth factors that belong to the transforming growth factor super family and are capable of eliciting new bone formation. Previous studies have suggested that the coexpression of two different BMP genes in a cell can result in the production of BMP heterodimers that are more potent than homodimers. However, because of the difficulty in optimizing the level of BMP gene expression, the coexpression of two different BMP genes also produces BMP homodimers as a by-product. These homodimers could, in theory, interact with the heterodimers. PURPOSE: To elucidate the effects of a BMP-2/7 heterodimer, which were investigated in depth using purified BMP-2/7 heterodimers, BMP-2 homodimers, and BMP-7 homodimers in a rat spinal fusion model. METHODS: Bilateral posterolateral fusion at L4-L5 was performed in four different groups: control group animals were implanted with collagen carriers alone; BMP-7 group animals with collagen carriers+1 mu g of BMP-7 homodimer; BMP-2 group animals with collagen carriers+1 mu g of BMP-2 homodimer; and BMP-2/7 group animals with collagen carriers+1 mu g of the BMP-2/7 heterodimer. The following assessments were performed: bone microstructural analysis of the fusion mass and tissue volume (TV) with microcomputed tomography (micro-CT); fusion assessment with manual palpation testing and three-dimensional CT images; and bone histomorphometrical analysis of the fusion mass. RESULTS: The fusion scores, as determined by radiography, and the TV of the newly formed bone, as determined by micro-CT, were significantly higher in the BMP-2/7 heterodimer group than the other groups (p<.0001). The microstructural indices of the newly formed bone did not differ between the groups. Moreover, histologic analysis of the fused spines revealed that the formation of the trabecular bone bridging the transverse process was the highest in this group. CONCLUSIONS: This study demonstrated that BMP-2/7 heterodimer is a stronger inducer of bone regeneration than BMP-2 or -7 homodimers. The use of a purified BMP-2/7 heterodimer may represent an efficient alternative to the current clinical use of BMP-2 or -7 homodimers. Further studies as to the side effects of BMP-2/7 heterodimer are required. (C) 2015 Elsevier Inc. All rights reserved.	[Morimoto, Tokimitsu; Kaito, Takashi; Kashii, Masafumi; Makino, Takahiro; Iwasaki, Motoki; Yoshikawa, Hideki] Osaka Univ, Grad Sch Med, Dept Orthoped Surg, Suita, Osaka 5650871, Japan; [Matsuo, Yohei; Sugiura, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Orthoped Biomat Sci, Suita, Osaka 5650871, Japan	Kaito, T (reprint author), Osaka Univ, Grad Sch Med, Dept Orthoped Surg, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	takashikaito@ort.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [25861313]	Author disclosures: TM: Nothing to disclose. TK: Grant: Japan Society for the Promotion of Science (No. 25861313, D, Paid directly to institution). YM: Nothing to disclose. TS: Nothing to disclose. MK: Nothing to disclose. TM: Nothing to disclose. MI: Nothing to disclose. HY: Nothing to disclose.	Ackerman SJ, 2002, SPINE S1, V27, P94; Alanay A, 2008, SPINE, V33, P1709, DOI 10.1097/BRS.0b013e31817e9dfd; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Shields LBE, 2006, SPINE, V31, P542, DOI 10.1097/01.brs.0000201424.27509.72; Miyazaki M, 2008, SPINE, V33, P863, DOI 10.1097/BRS.0b013e31816b45c3; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; HAZAMA M, 1995, BIOCHEM BIOPH RES CO, V209, P859, DOI 10.1006/bbrc.1995.1578; Smucker JD, 2006, SPINE, V31, P2813, DOI 10.1097/01.brs.0000245863.52371.c2; Abe Y, 2007, BONE, V41, P775, DOI 10.1016/j.bone.2007.06.025; AONO A, 1995, BIOCHEM BIOPH RES CO, V210, P670, DOI 10.1006/bbrc.1995.1712; Horiki M, 2004, J CELL BIOL, V165, P433, DOI 10.1083/jcb.200311015; Koh JT, 2008, J DENT RES, V87, P845; Taghavi CE, 2010, SPINE, V35, P2049, DOI 10.1097/BRS.0b013e3181cc0220; Nishitoh H, 1996, J BIOL CHEM, V271, P21345; Cahill KS, 2009, JAMA-J AM MED ASSOC, V302, P58, DOI 10.1001/jama.2009.956; WANG EA, 1990, P NATL ACAD SCI USA, V87, P2220, DOI 10.1073/pnas.87.6.2220; Isaacs MJ, 2010, MOL ENDOCRINOL, V24, P1469, DOI 10.1210/me.2009-0496; Zhu W, 2006, BONE, V39, P61, DOI 10.1016/j.bone.2005.12.018; Montgomery SR, 2014, J BONE MINER RES, V29, P1872, DOI 10.1002/jbmr.2213; Hsu WK, 2011, J ORTHOP RES, V29, P1812, DOI 10.1002/jor.21454; Kaito T, 2013, J BONE JOINT SURG AM, V95A, P1612, DOI 10.2106/JBJS.L.01396; Ming N, 2012, SPINE, V37, P1275, DOI 10.1097/BRS.0b013e31824ac089; Israel DI, 1996, GROWTH FACTORS, V13, P291, DOI 10.3109/08977199609003229; Moazzaz P, 2005, SPINE, V30, P1706, DOI 10.1097/01.brs.0000172230.01655.55; Sun P, 2012, DENT MATER J, V31, P239, DOI 10.4012/dmj.2011-191; Zhu W, 2004, J BONE MINER RES, V19, P2021, DOI 10.1359/JBMR.040821; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Nohe A, 2004, CELL SIGNAL, V16, P291, DOI 10.1016/j.cellsig.2003.08.011; YAMASHITA H, 1995, J CELL BIOL, V130, P217, DOI 10.1083/jcb.130.1.217; Lu J, 2008, SPINE, V33, P242, DOI 10.1097/BRS.0b013e318162451b; Charan Jaykaran, 2013, J Pharmacol Pharmacother, V4, P303, DOI 10.4103/0976-500X.119726; Miyazaki M, 2009, SPINE J, V9, P22, DOI 10.1016/j.spinee.2008.08.009; Morimoto T, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.01097; Salamon ML, 2003, J SPINAL DISORD TECH, V16, P90; STEINMANN JC, 1992, CLIN ORTHOP RELAT R, P80; Valera E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011167; Wang JC, 2003, J BONE JOINT SURG AM, V85A, P905; ZDEBLICK TA, 1993, SPINE, V18, P983, DOI 10.1097/00007632-199306150-00006	39	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1379	1390		10.1016/j.spinee.2015.02.034		12	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700039		
J	Inokuchi, R; Ohshima, K; Yamamoto, M; Fukuda, T; Nakamura, K				Inokuchi, Ryota; Ohshima, Kazuma; Yamamoto, Miyuki; Fukuda, Tatsuma; Nakamura, Kensuke			Crowned dens syndrome	SPINE JOURNAL			English	Editorial Material							DEPOSITION DISEASE		[Inokuchi, Ryota; Ohshima, Kazuma; Yamamoto, Miyuki; Fukuda, Tatsuma; Nakamura, Kensuke] Hitachi Gen Hosp, Dept Emergency & Crit Care Med, Hitachi, Ibaraki 3170077, Japan; [Inokuchi, Ryota; Ohshima, Kazuma; Yamamoto, Miyuki; Fukuda, Tatsuma; Nakamura, Kensuke] Tokyo Univ Hosp, Dept Emergency & Crit Care Med, Bunkyo Ku, Tokyo 1138655, Japan; [Inokuchi, Ryota] JR Gen Hosp, Dept Emergency & Crit Care Med, Sibuya Ku, Tokyo 1518528, Japan	Inokuchi, R (reprint author), Hitachi Gen Hosp, Dept Emergency & Crit Care Med, 2-1-1 Jonancho, Hitachi, Ibaraki 3170077, Japan.						Scutellari PN, 2007, RADIOL MED, V112, P195, DOI 10.1007/s11547-007-0135-7; Salaffi F, 2008, CLIN EXP RHEUMATOL, V26, P1040; Goto S, 2007, J BONE JOINT SURG AM, V89A, P2732, DOI 10.2106/JBJS.F01322; Matsumura M, 2012, NEW ENGL J MED, V367, pE34, DOI 10.1056/NEJMicm1100764; Baysal T, 2000, EUR RADIOL, V10, P1003, DOI 10.1007/s003300051052; Ferrone C, 2011, Reumatismo, V63, P246, DOI 10.4081/reumatismo.2011.246; Koyfman Anna, 2014, Neuroradiol J, V27, P495, DOI 10.15274/NRJ-2014-10056; Lee Gwang Soo, 2014, Korean J Spine, V11, P15, DOI 10.14245/kjs.2014.11.1.15	8	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1499	1500		10.1016/j.spinee.2015.03.022		2	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700059		
J	Kawada, T				Kawada, Tomoyuki			Screening method for major depressive disorders by questionnaire survey in patients with chronic spinal pain	SPINE JOURNAL			English	Letter							ADOLESCENTS		Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, Tokyo 1138602, Japan	Kawada, T (reprint author), Nippon Med Sch, Dept Hyg & Publ Hlth, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138602, Japan.						Richardson LP, 2010, PEDIATRICS, V126, P1117, DOI 10.1542/peds.2010-0852; Allgaier AK, 2012, DEPRESS ANXIETY, V29, P906, DOI 10.1002/da.21971; Choi Y, 2014, SPINE J, V14, P1175, DOI 10.1016/j.spinee.2013.10.037; HANLEY JA, 1983, RADIOLOGY, V148, P839; Whitney Kriscinda A, 2010, J Support Oncol, V8, P219, DOI 10.1016/j.suponc.2010.09.025	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					1509	1510		10.1016/j.spinee.2015.03.029		3	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700064		
J	Miyakoshi, N; Kobayashi, A; Hongo, M; Shimada, Y				Miyakoshi, Naohisa; Kobayashi, Akira; Hongo, Michio; Shimada, Yoichi			Sacral rib: an uncommon congenital anomaly	SPINE JOURNAL			English	Article						Congenital anomaly; Pelvic rib; Sacral rib; Supernumerary rib	PELVIC RIB	BACKGROUND CONTEXT: Sacral rib represents an uncommon pathology in which rib-like structures arise from the sacrum. Supernumerary ribs may occur at any level of the spine, but supernumerary ribs in the sacrococcygeal area are extremely rare. PURPOSE: To present the case of a patient with sacral rib and to discuss this entity with reference to the literature. STUDY DESIGN: A case report and literature review. METHODS: A 17-year-old girl presented with low back pain and discomfort in bilateral gluteal regions. Radiographs and computed tomography (CT) of the pelvis showed a smooth-surfaced, rodlike bony structure attaching to the sacrum on the left side. The appearance was consistent with sacral rib. The sacrum was hypoplastic and deviated to the right. Magnetic resonance imaging (MRI) showed insertion of the gluteus maximus (GM) onto the coccyx only on the right side. The sacral rib existed beneath the left GM muscle and received a partial insertion from the left GM muscle. No ligamentous continuation between the sacral rib and coccyx was observed. RESULTS: Conservative treatment relieved symptoms, so no surgical intervention was performed. CONCLUSIONS: Sacral rib is a rare congenital anomaly for which surgical intervention is usually unnecessary. However, appropriate workups with CT and/or MRI should be considered for women, because sacral rib may cause complications during childbirth. In the literature, sacral/coccygeal rib is sometimes called "pelvic rib.'' However, sacral/coccygeal rib should be distinguished from pelvic rib, because pelvic rib originating from the ilium is considered to represent a different entity. (C) 2015 Elsevier Inc. All rights reserved.	[Miyakoshi, Naohisa; Hongo, Michio; Shimada, Yoichi] Akita Univ, Grad Sch Med, Dept Orthoped Surg, Akita 0108543, Japan; [Kobayashi, Akira] Honobono En Long Term Care Hlth Facil, Showa Okubo, Katagami 0181401, Japan	Miyakoshi, N (reprint author), Akita Univ, Grad Sch Med, Dept Orthoped Surg, 1-1-1 Hondo, Akita 0108543, Japan.	miyakosh@doc.med.akita-u.ac.jp					Chin Kingsley R, 2010, Spine J, V10, pe1, DOI 10.1016/j.spinee.2010.02.018; DUNAWAY CL, 1983, SKELETAL RADIOL, V9, P212; HELIGMAN D, 1987, ORTHOPEDICS, V10, P1439; KAUSHAL SP, 1977, INT SURG, V62, P37; LAME EL, 1977, SKELETAL RADIOL, V2, P47; Maegele Marc, 2009, J Med Case Rep, V3, P139, DOI 10.1186/1752-1947-3-139; MARES AJ, 1981, Z KINDERCHIR, V34, P72; PAIS MJ, 1978, AM J ROENTGENOL, V131, P164; Rashid M, 2008, ACTA ORTHOP BELG, V74, P429; Shah JR, 2006, ACTA RADIOL, V47, P862, DOI 10.1080/02841850600820960; SULLIVAN D, 1974, RADIOLOGY, V110, P355; VANDERSLICE R, 1992, SPINE, V17, P1264	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					E35	E38		10.1016/j.spinee.2013.08.055		4	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700006		
J	Shigematsu, H; Koizumi, M; Matsumori, H; Iwata, E; Kura, T; Okuda, A; Ueda, Y; Tanaka, Y				Shigematsu, Hideki; Koizumi, Munehisa; Matsumori, Hiroaki; Iwata, Eiichiro; Kura, Tomohiko; Okuda, Akinori; Ueda, Yurito; Tanaka, Yasuhito			Revision surgery after cervical laminoplasty: report of five cases and literature review	SPINE JOURNAL			English	Article						Laminoplasty; Revision surgery; Lamina closure; Adjacent degeneration; Cervical spine; Myelopathy; Radiculopathy	OPEN-DOOR LAMINOPLASTY; POSTERIOR LONGITUDINAL LIGAMENT; ADJACENT SEGMENT DISEASE; TERM-FOLLOW-UP; STENOTIC MYELOPATHY; OSSIFICATION; CLOSURE; AREA	BACKGROUND CONTEXT: Revision surgery after laminoplasty is rarely performed, and there are few reports of this procedure in the English literature. PURPOSE: To evaluate the reasons why patients underwent revision surgery after laminoplasty and to discuss methods of preventing the need for revision surgery. A literature review with a comparative analysis between previous reports and present cases was also performed. STUDY DESIGN: Case report and literature review. PATIENT SAMPLE: Five patients who underwent revision surgery after laminoplasty. OUTCOME MEASURES: Diagnosis was based on the preoperative computed tomography and magnetic resonance imaging findings. Neurologic findings were evaluated using the Japanese Orthopedic Association score. METHODS: A total of 237 patients who underwent cervical laminoplasty for cervical spondylotic myelopathy from 1990 to 2010 were reviewed. Patients with ossification of the posterior longitudinal ligament, renal dialysis, infection, tumor, or rheumatoid arthritis were excluded. Five patients who underwent revision surgery for symptoms of recurrent myelopathy or radiculopathy were identified, and the clinical courses and radiological findings of these patients were retrospectively reviewed. RESULTS: The average interval from the initial surgery to revision surgery was 15.0 (range 9-19) years. The patients were four men and one woman with an average age at the time of the initial operation of 49.8 (range 34-65) years. Four patients developed symptoms of recurrent myelopathy after their initial surgery, for the following reasons: adjacent segment canal stenosis, restenosis after inadequate opening of the lamina with degenerative changes, and trauma after inadequate opening of the lamina. One patient developed new radiculopathy symptoms because of foraminal stenosis secondary to osteoarthritis at the Luschka and zygapophyseal joints. All patients experienced resolution of their symptoms after revision surgery. CONCLUSIONS: Revision surgery after laminoplasty is rare. Inadequate opening of the lamina is one of the important reasons for needing revision surgery. Degenerative changes after laminoplasty may also result in a need for revision surgery. Surgeons should be aware of the degenerative changes that can cause neurologic deterioration after laminoplasty. (C) 2015 Elsevier Inc. All rights reserved.	[Shigematsu, Hideki; Koizumi, Munehisa; Matsumori, Hiroaki; Iwata, Eiichiro; Kura, Tomohiko; Okuda, Akinori; Tanaka, Yasuhito] Nara Med Univ, Dept Orthopaed Surg, Kashihara, Nara 6348522, Japan; [Ueda, Yurito] Kashiba Asahigaoka Hosp, Dept Orthopaed Surg, Kashiba, Nara 839, Japan	Shigematsu, H (reprint author), Nara Med Univ, Dept Orthopaed Surg, 840 Shijyocho, Kashihara, Nara 6348522, Japan.	shideki@naramed-u.ac.jp					Matsumoto M, 2008, J NEUROSURG-SPINE, V9, P530, DOI 10.3171/SPI.2008.4.08176; Wang HQ, 2011, SPINE J, V11, P832, DOI 10.1016/j.spinee.2011.07.026; Yang SC, 2007, J SPINAL DISORD TECH, V20, P492, DOI 10.1097/BSD.0b013e318033e844; OBrien MF, 1996, SPINE, V21, P474, DOI 10.1097/00007632-199602150-00012; [Anonymous], 1999, CLIN ORTHOPAEDICS, DOI 10.1097/00003086-199902000-00005; Nassr A, 2012, SPINE, V37, P174, DOI 10.1097/BRS.0b013e318219cfe9; Sakaura H, 2011, EUR SPINE J, V20, P928, DOI 10.1007/s00586-011-1690-0; Chen HC, 2008, J SPINAL DISORD TECH, V21, P387, DOI 10.1097/BSD.0b013e318157c699; Chiba K, 2006, SPINE, V31, P2998, DOI 10.1097/01.brs.0000250307.78987.6b; Hori T, 2007, SPINE, V32, pE551, DOI 10.1097/BRS.0b013e31814614f3; Komura S, 2011, ARCH ORTHOP TRAUM SU, V131, P1177, DOI 10.1007/s00402-010-1248-3; Lee JY, 2007, J SPINAL DISORD TECH, V20, P33, DOI 10.1097/01.bsd.0000211229.81930.80; Liu G, 2009, SPINE, V34, P2760, DOI 10.1097/BRS.0b013e3181b11ee1; SATOMI K, 1994, SPINE, V19, P507, DOI 10.1097/00007632-199403000-00003; Seichi A, 2001, SPINE, V26, P479, DOI 10.1097/00007632-200103010-00010; Steinmetz MP, 2006, SPINE J S, V6, p274S; Takagi Hiroshi, 2002, J Orthop Sci, V7, P495, DOI 10.1007/s007760200086; Wada K, 2014, J ORTHOP SCI, V19, P511, DOI 10.1007/s00776-012-0299-4; Wang MY, 2003, NEUROSURGERY, V53, P770, DOI 10.1227/01.NEU.0000080176.51519.87; Wang MY, 2003, NEUROSURGERY, V53, P772	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					E7	E13		10.1016/j.spinee.2013.11.048		7	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700002		
J	Tarukado, K; Ikuta, K; Fukutoku, Y; Tono, O; Doi, T				Tarukado, Kiyoshi; Ikuta, Ko; Fukutoku, Yoshiaki; Tono, Osamu; Doi, Toshio			Spontaneous regression of posterior epidural migrated lumbar disc fragments: case series	SPINE JOURNAL			English	Article						Posterior epidural migrated lumbar disc fragments; Conservative treatment; Spontaneous lesion regression	CAUDA-EQUINA SYNDROME; HERNIATED NUCLEUS PULPOSUS; COMPRESSION; TUMOR	BACKGROUND CONTEXT: Posterior epidural migrated lumbar disc fragments is an extremely rare disorder. Surgical treatment was performed in all reported cases. To the best of our knowledge, there are no reported cases of the use of conservative treatment for posterior epidural migrated lumbar disc fragments. PURPOSE: To report the possibility of a spontaneous regression of posterior epidural migrated lumbar disc fragments. STUDY DESIGN: Case series. METHODS: Four patients with posterior epidural migrated lumbar disc fragments were treated at Karatsu Red Cross Hospital between April 2008 and August 2010. Spontaneous regression of the posterior epidural migrated lumbar disc fragments with relief of symptoms was observed on magnetic resonance imaging (MRI) in three cases. Another patient underwent surgical treatment. The present and previously reported cases of posterior epidural migrated lumbar disc fragments were analyzed with respect to patient age, imaging features on MRI, the level of the lesion, clinical symptoms, treatment, and outcomes. RESULTS: Conservative treatment was successful, and spontaneous lesion regression was seen on MRI with symptom relief in three cases. CONCLUSIONS: Although posterior epidural migrated lumbar disc fragment cases are generally treated surgically, the condition can regress spontaneously over time, as do sequestrated disc fragments. Spontaneous regression of lumbar disc herniations is a widely accepted observation at present. Posterior epidural migrated lumbar disc fragments fall under the sequestrated type of disc herniation. In fact, the course of treatment for posterior epidural migrated lumbar disc fragments should be determined based on the symptoms and examination findings, as in cases of ordinary herniation. However, providing early surgical treatment is important if the patient has acute cauda equina syndrome or the neurologic symptoms worsen over time. (C) 2015 Elsevier Inc. All rights reserved.	[Tarukado, Kiyoshi; Ikuta, Ko; Fukutoku, Yoshiaki] Karatsu Red Cross Hosp, Dept Orthoped Surg, Karatsu, Saga 8748588, Japan; [Tarukado, Kiyoshi; Tono, Osamu; Doi, Toshio] Kyushu Univ, Beppu Hosp, Dept Orthoped Surg, Tsurumi Beppu, Oita 8740838, Japan	Tarukado, K (reprint author), Kyushu Univ, Beppu Hosp, Dept Orthoped Surg, 4546 Tsurumihara, Tsurumi Beppu, Oita 8740838, Japan.	kt99059@hotmail.com					Komori H, 1996, SPINE, V21, P225, DOI 10.1097/00007632-199601150-00013; Dosoglu M, 2001, EUR SPINE J, V10, P348, DOI 10.1007/s005860100300; Akhaddar A, 2011, J NEUROSURG-SPINE, V15, P117, DOI 10.3171/2011.3.SPINE10832; HIRABAYASHI S, 1990, SPINE, V15, P1231, DOI 10.1097/00007632-199011010-00026; Haro H, 1996, SPINE, V21, P1647, DOI 10.1097/00007632-199607150-00006; Kim JS, 2010, J KOREAN NEUROSURG S, V47, P217, DOI 10.3340/jkns.2010.47.3.217; Sengoz A, 2011, J NEUROSURG-SPINE, V14, P313, DOI 10.3171/2010.11.SPINE10142; Bonaroti EA, 1998, SPINE, V23, P378, DOI 10.1097/00007632-199802010-00018; Chen CY, 2006, AM J NEURORADIOL, V27, P1592; Derincek A, 2009, ACTA ORTHOP BELG, V75, P423; El Asri AC, 2008, SURG NEUROL, V70, P668, DOI 10.1016/j.surneu.2007.06.034; enel A, 2003, TURK NEUROSURG, V13, P115; Eysel P, 2001, ARCH ORTHOP TRAUM SU, V121, P238, DOI 10.1007/s004020000213; Hodges S D, 1999, J South Orthop Assoc, V8, P222; Kim JH, 2004, J KOREAN NEUROSURG S, V35, P442; Kim Myoung Soo, 2003, [Journal of Korean Neurosurgical Society, 대한신경외과학회지], V33, P297; Kuzeyli K, 2003, SPINE, V28, P64; Lakshmanan Palaniappan, 2006, Spine J, V6, P583, DOI 10.1016/j.spinee.2005.09.009; LICHTOR T, 1989, SURG NEUROL, V32, P311, DOI 10.1016/0090-3019(89)90236-X; Lisai P, 2000, J ORTHOP TRAUMATOL, V2, P103; LOMBARDI V, 1973, J NEUROSURG, V39, P642, DOI 10.3171/jns.1973.39.5.0642; LUTZ JD, 1990, AM J NEURORADIOL, V11, P610; Neugroschl C, 1999, NEURORADIOLOGY, V41, P630; Nievas MNCY, 2009, J NEUROSURG-SPINE, V11, P42, DOI 10.3171/2009.3.SPINE08161; Robe P, 1999, J NEUROSURG, V90, P264, DOI 10.3171/spi.1999.90.2.0264; SAKAS DE, 1995, NEURORADIOLOGY, V37, P192; Saruhashi Y, 1999, J SPINAL DISORD, V12, P307; SEKERCI Z, 1992, NEUROSURG REV, V15, P311; Sen O, 2001, TURK NEUROSURG, V11, P108; Tatli M, 2005, BRIT J NEUROSURG, V19, P257, DOI 10.1080/02688690500208593; Teufack SG, 2010, J SPINAL CORD MED, V33, P268; Walsh AJ, 2004, EUR J ORTHOP SURG TR, V14, P30, DOI 10.1007/s00590-003-0124-z	32	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1529-9430	1878-1632		SPINE J	Spine Journal	JUN 1	2015	15	6					E57	E62		10.1016/j.spinee.2013.07.430		6	Clinical Neurology; Orthopedics	Neurosciences & Neurology; Orthopedics	CI6NF	WOS:000354875700010		
J	Toyoda, K; Koga, M; Hayakawa, M; Yamagami, H				Toyoda, Kazunori; Koga, Masatoshi; Hayakawa, Mikito; Yamagami, Hiroshi			Acute Reperfusion Therapy and Stroke Care in Asia After Successful Endovascular Trials	STROKE			English	Article						anticoagulants; Asia; cerebral hemorrhage; intracranial atherosclerosis; stroke; thrombectomy; thrombolysis, therapeutic	ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; FREE-RADICAL SCAVENGER; ATRIAL-FIBRILLATION; 0.6 MG/KG; SAFE IMPLEMENTATION; ARTERY OCCLUSION; RANDOMIZED-TRIAL; RISK-FACTORS; ALTEPLASE	The current status of and prospects for acute stroke care in Asia in the situation where both intravenous thrombolysis and endovascular therapies have been recognized as established strategies for acute stroke are reviewed. Of 15 million people annually having stroke worldwide, approximate to 9 million are Asians. The burdens of both ischemic and hemorrhagic strokes are severe in Asia. The unique features of stroke in Asia include susceptibility to intracranial atherosclerosis, high prevalence of intracerebral hemorrhage, effects of dietary and lifestyle habits, and several disorders with genetic causes. These features affect acute stroke care, such as the dosage of alteplase for thrombolysis and consideration of bleeding complications during antithrombotic therapy. Acute endovascular thrombectomy, as well as intravenous thrombolysis, is relatively prevalent in East Asia, but most of the other Asian countries need to develop their human resources and fundamental medical infrastructure for stroke care. A limitation of endovascular therapy in East Asia is the high prevalence of intracranial atherosclerosis that can cause recanalization failure and require additional angioplasty or permanent stent insertion although intracranial stenting is not an established strategy. Multinational collaboration on stroke research among Asian countries is infrequent. Asians should collaborate to perform their own thrombolytic and endovascular trials and seek the optimal strategy for stroke care specific to Asia.	[Toyoda, Kazunori; Hayakawa, Mikito] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Koga, Masatoshi] Natl Cerebral & Cardiovasc Ctr, Div Stroke Care Unit, Suita, Osaka 5658565, Japan; [Yamagami, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Osaka 5658565, Japan	Toyoda, K (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	toyoda@ncvc.go.jp	Toyoda, Kazunori/J-3828-2015	Toyoda, Kazunori/0000-0002-8346-9845	Intramural Research Fund for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center [H23-4-3]	This review article was supported, in part, by an Intramural Research Fund (H23-4-3) for Cardiovascular Diseases of the National Cerebral and Cardiovascular Center.	Aiyagari V, 2015, J STROKE CEREBROVASC, V24, P290, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.002; Alurkar A, 2013, STROKE, V44, P2000, DOI 10.1161/STROKEAHA.113.001446; Qureshi AI, 2011, NEUROCRIT CARE, V15, P559, DOI 10.1007/s12028-011-9538-3; Wang YJ, 2013, NEW ENGL J MED, V369, P11, DOI 10.1056/NEJMoa1215340; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Toyoda K, 2004, J NEUROL SCI, V221, P11, DOI 10.1016/j.jns.2004.03.002; Anderson CS, 2013, NEW ENGL J MED, V368, P2355, DOI 10.1056/NEJMoa1214609; Mehta RH, 2014, STROKE, V45, P2263, DOI 10.1161/STROKEAHA.114.005019; Uchiyama S, 2009, J STROKE CEREBROVASC, V18, P482, DOI 10.1016/j.jstrokecerebrovasdis.2009.07.010; Krishnamurthi RV, 2013, LANCET GLOB HEALTH, V1, pE259, DOI [10.1016/S2214-109X(13)70089-5, 10.1016/S0140-6736(13)61953-4]; Wong KSL, 2013, CIRCULATION, V128, P1656, DOI 10.1161/CIRCULATIONAHA.113.003187; Shen AYJ, 2007, J AM COLL CARDIOL, V50, P309, DOI 10.1016/j.jacc.2007.01.098; Gascou G, 2014, AM J NEURORADIOL, V35, P734, DOI 10.3174/ajnr.A3746; Kang DW, 2012, STROKE, V43, P3278, DOI 10.1161/STROKEAHA.112.675926; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Nakagawara J, 2010, STROKE, V41, P1984, DOI 10.1161/STROKEAHA.110.589606; Holmstedt CA, 2013, LANCET NEUROL, V12, P1106, DOI 10.1016/S1474-4422(13)70195-9; Wahlgren N, 2007, LANCET, V369, P275, DOI 10.1016/S0140-6736(07)60149-4; Bae YJ, 2014, AM J NEURORADIOL, V35, P149, DOI 10.3174/ajnr.A3562; Toyoda K, 2008, STROKE, V39, P1740, DOI 10.1161/STROKEAHA.107.504993; Kuroda S, 2008, LANCET NEUROL, V7, P1056, DOI 10.1016/S1474-4422(08)70240-0; Goto S, 2014, AM HEART J, V168, P303, DOI 10.1016/j.ahj.2014.06.005; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; Zhu LF, 2012, STROKE, V43, P787, DOI 10.1161/STROKEAHA.110.612986; Sato S, 2010, CEREBROVASC DIS, V29, P170, DOI 10.1159/000262314; Wong KSL, 2014, STROKE, V45, P1739, DOI 10.1161/STROKEAHA.113.002968; Masuda EM, 2004, J VASC SURG, V40, P24, DOI 10.1016/j.jvs.2004.02.035; Zaidat OO, 2015, JAMA-J AM MED ASSOC, V313, P1240, DOI 10.1001/jama.2015.1693; Yamaguchi T, 2006, STROKE, V37, P1810, DOI 10.1161/01.STR.0000227191.01792e3; Jiang WJ, 2011, STROKE, V42, P1971, DOI 10.1161/STROKEAHA.110.595926; Mozaffarian D, 2014, NEW ENGL J MED, V371, P624, DOI 10.1056/NEJMoa1304127; Shin YS, 2013, NEUROSURGERY, V72, P596, DOI 10.1227/NEU.0b013e3182846e09; Ma H, 2012, INT J STROKE, V7, P74, DOI 10.1111/j.1747-4949.2011.00730.x; Minematsu K, 2013, J STROKE CEREBROVASC, V22, P571, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.001; Asplund K, 2012, STROKE, V43, P830, DOI 10.1161/STROKEAHA.111.637249; Fukutake T, 2011, J STROKE CEREBROVASC, V20, P85, DOI 10.1016/j.jstrokecerebrovasdis.2010.11.008; Hori M, 2013, STROKE, V44, P1891, DOI 10.1161/STROKEAHA.113.000990; Liu LP, 2014, CNS NEUROSCI THER, V20, P483, DOI 10.1111/cns.12281; Xu AD, 2013, CNS NEUROSCI THER, V19, P543, DOI 10.1111/cns.12126; Aoki Junya, 2013, Cerebrovasc Dis Extra, V3, P35, DOI 10.1159/000348552; Bang Oh Young, 2014, J Stroke, V16, P27, DOI 10.5853/jos.2014.16.1.27; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Goyal M, 2015, NEW ENGL J MED, V372, P1019, DOI 10.1056/NEJMoa1414905; Derdeyn CP, 2014, LANCET, V383, P333, DOI 10.1016/S0140-6736(13)62038-3; Joint Working Group from the Japan Stroke Society Japan Neurosurgical Society and Japanese Society for Neuroendovascular Therapy, 2014, JPN J STROKE, V36, P151; Kim BJ, 2015, J STROKE, V17, P38, DOI 10.5853/jos.2015.17.1.38; Kim Tae Kwon, 2012, J Cerebrovasc Endovasc Neurosurg, V14, P203, DOI 10.7461/jcen.2012.14.3.203; Kimura K, 2012, J NEUROL SCI, V313, P132, DOI 10.1016/j.jns.2011.09.006; Koga M, 2014, INT J STROKE, V9, P1117, DOI 10.1111/ijs.12360; Jung KH, 2012, CIRC-CARDIOVASC QUAL, V5, P327, DOI 10.1161/CIRCOUTCOMES.111.963736; Matias-Guiu JA, 2014, J NEUROINTERV SURG, V6, pE11, DOI 10.1136/neurintsurg-2012-010395; Miyawaki S, 2013, STROKE, V44, P2894, DOI 10.1161/STROKEAHA.113.002477; Pandian Jeyaraj Durai, 2013, J Stroke, V15, P128, DOI 10.5853/jos.2013.15.3.128; Powles J, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003733; Ramaiah SS, 2013, CEREBROVASC DIS, V36, P161, DOI 10.1159/000354162; Rha JH, 2014, INT J STROKE, V9, P93, DOI 10.1111/j.1747-4949.2012.00895.x; Robert Asirvatham Alwin, 2014, Pan Afr Med J, V17, P14, DOI 10.11604/pamj.2014.17.14.3015; Song D, J STROKE IN PRESS; Suwanwela NC, 2014, J STROKE, V16, P1, DOI 10.5853/jos.2014.16.1.1; MARLER JR, 1995, NEW ENGL J MED, V333, P1581; Toyoda K, 2009, STROKE, V40, P3591, DOI 10.1161/STROKEAHA.109.562991; Toyoda K, 2015, INT J STROKE, V10, P253, DOI 10.1111/ijs.12420; Toyoda K, 2015, INT J STROKE; Toyoda K, 2009, DRUGS, V69, P633, DOI 10.2165/00003495-200969060-00001; Wasay M, 2014, NAT REV NEUROL, V10, P135, DOI 10.1038/nrneurol.2014.13; Yamaguchi T, 1995, THROMBOLYTIC THERAPY IN ACUTE ISCHEMIC STROKE III, P223; Yamamoto S, 2014, NEUROL MED-CHIR, V54, P113, DOI 10.2176/nmc.oa2012-0348; Yoshimura S, 2014, J STROKE CEREBROVASC, V23, P1183, DOI 10.1016/j.jstrokecerebrovasdis.2013.10.014	69	3	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUN	2015	46	6					1474	1481		10.1161/STROKEAHA.115.008781		8	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CI7KI	WOS:000354941800024		
J	Yukami, T; Yagita, Y; Sugiyama, Y; Oyama, N; Watanabe, A; Sasaki, T; Sakaguchi, M; Mochizuki, H; Kitagawa, K				Yukami, Toshiro; Yagita, Yoshiki; Sugiyama, Yukio; Oyama, Naoki; Watanabe, Akihiro; Sasaki, Tsutomu; Sakaguchi, Manabu; Mochizuki, Hideki; Kitagawa, Kazuo			Chronic Elevation of Tumor Necrosis Factor-alpha Mediates the Impairment of Leptomeningeal Arteriogenesis in db/db Mice	STROKE			English	Article						animal models; collateral circulation; diabetes mellitus; tumor necrosis factor-alpha	CAROTID-ARTERY OCCLUSION; COLLATERAL GROWTH; LASER SPECKLE; ADAPTIVE ARTERIOGENESIS; VESSEL DEVELOPMENT; STROKE; RABBIT; ANGIOGENESIS; MECHANISMS	Background and Purpose-Leptomeningeal collateral growth is a key factor that defines the severity of ischemic stroke. Patients with stroke generally have vascular risk factors, such as diabetes mellitus; however, consensus is lacking on how diabetes mellitus affects leptomeningeal arteriogenesis. We investigate the influence of diabetes mellitus on the leptomeningeal arteriogenesis. Methods-We measured the vessel diameter of the leptomeningeal anastomoses 14 days after the common carotid artery occlusion in db/db, db/+, and streptozotocin-induced hyperglycemic mice. In another set of these mice, we measured the infarct volume attributed to subsequent middle cerebral artery occlusion 14 days after the common carotid artery occlusion. Mac-2-positive cells on the dorsal brain surface and the mRNA expression of several macrophage-related factors in the cerebral cortex were examined. Finally, we tested whether the leptomeningeal arteriogenesis could be restored by pharmaceutical intervention in the db/db mice. Results-Cerebral hypoperfusion led to significant ipsilateral leptomeningeal collateral growth in db/+ mice and streptozotocin-induced hyperglycemic mice. The collateral growth contributed to reduced infarct volume. In contrast, leptomeningeal arteriogenesis was impaired in the db/db mice. The number of Mac-2-positive cells was increased and tumor necrosis factor-a mRNA expression was induced after common carotid artery occlusion in the db/+ mice. However, these responses were not observed in the db/db mice. Administration of the tumor necrosis factor-a inhibitor etanercept before common carotid artery occlusion restored the hypoperfusion-induced leptomeningeal collateral growth in db/db mice. Conclusions-These results indicate that leptomeningeal arteriogenesis is impaired in db/db mice and that suppression of the tumor necrosis factor-a response to hypoperfusion is the major contributing factor.	[Yukami, Toshiro; Sugiyama, Yukio; Oyama, Naoki; Watanabe, Akihiro; Sasaki, Tsutomu; Sakaguchi, Manabu; Mochizuki, Hideki] Osaka Univ, Grad Sch Med, Dept Neurol, Suita, Osaka 5650871, Japan; [Yagita, Yoshiki] Kawasaki Med Univ, Dept Stroke Med, Kurashiki, Okayama, Japan; [Kitagawa, Kazuo] Tokyo Womens Med Univ, Dept Neurol, Tokyo, Japan	Yukami, T (reprint author), Osaka Univ, Grad Sch Med, Dept Neurol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	yukami@neurol.med.osaka-u.ac.jp			Ministry of Education, Science, and Culture in Japan [23390234]	This study was supported by a Grant-in-Aid B (23390234) from the Ministry of Education, Science, and Culture in Japan.	Chen JL, 2011, STROKE, V42, P445, DOI 10.1161/STROKEAHA.110.596486; Lima FO, 2010, STROKE, V41, P2316, DOI 10.1161/STROKEAHA.110.592303; Tirziu D, 2012, CIRCULATION, V126, P2589, DOI 10.1161/CIRCULATIONAHA.112.119321; Waltenberger J, 2001, CARDIOVASC RES, V49, P554, DOI 10.1016/S0008-6363(00)00228-5; Grundmann S, 2005, AM J PHYSIOL-HEART C, V289, pH1497, DOI 10.1152/ajpheart.00959.2004; Bergmann CE, 2006, J LEUKOCYTE BIOL, V80, P59, DOI 10.1189/jlb.0206087; Gao X, 2007, CIRCULATION, V115, P245, DOI 10.1161/CIRCULATIONHA.106.650671; Sugiyama Y, 2014, NEUROSCI LETT, V564, P16, DOI 10.1016/j.neulet.2014.01.053; Ruiter MS, 2010, CLIN SCI, V119, P225, DOI 10.1042/CS20100082; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Luo Y, 2010, ARTERIOSCL THROM VAS, V30, P1307, DOI 10.1161/ATVBAHA.110.204222; Li WG, 2010, DIABETES, V59, P228, DOI 10.2337/db09-0902; Maki T, 2011, STROKE, V42, P1122, DOI 10.1161/STROKEAHA.110.603399; Sugiyama Y, 2011, STROKE, V42, P770, DOI 10.1161/STROKEAHA.110.597799; Kitagawa K, 2005, STROKE, V36, P2270, DOI 10.1161/01.STR.0000181075.77897.0e; Ayata C, 2004, J CEREBR BLOOD F MET, V24, P744, DOI 10.1097/01.WCB.0000122745.72175.D5; Abaci A, 1999, CIRCULATION, V99, P2239; Omura-Matsuoka E, 2011, J NEUROSCI RES, V89, P108, DOI 10.1002/jnr.22522; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Arras M, 1998, J CLIN INVEST, V101, P40, DOI 10.1172/JCI119877; Todo K, 2008, STROKE, V39, P1875, DOI 10.1161/STROKEAHA.107.503433; Forrester KR, 2002, MED BIOL ENG COMPUT, V40, P687, DOI 10.1007/BF02345307; Kernan WN, 2014, STROKE, V45, P2160, DOI 10.1161/STR.0000000000000024; Dunn AK, 2001, J CEREBR BLOOD F MET, V21, P195; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Shuaib A, 2011, LANCET NEUROL, V10, P909, DOI 10.1016/S1474-4422(11)70195-8; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; COYLE P, 1984, ANAT REC, V210, P357, DOI 10.1002/ar.1092100211; Fung E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00353; Hoefer IE, 2002, CIRCULATION, V105, P1639, DOI 10.1161/01.CIR.0000014987.32865.8E; HOTAMISLIGIL GS, 1994, J CLIN INVEST, V94, P1543, DOI 10.1172/JCI117495; Prakash R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056264	33	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUN	2015	46	6					1657	+		10.1161/STROKEAHA.114.008062		19	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CI7KI	WOS:000354941800051		
J	Shimada, K; Furukawa, H; Wada, K; Korai, M; Wei, Y; Tada, Y; Kuwabara, A; Shikata, F; Kitazato, KT; Nagahiro, S; Lawton, MT; Hashimoto, T				Shimada, Kenji; Furukawa, Hajime; Wada, Kosuke; Korai, Masaaki; Wei, Yuan; Tada, Yoshiteru; Kuwabara, Atsushi; Shikata, Fumiaki; Kitazato, Keiko T.; Nagahiro, Shinji; Lawton, Michael T.; Hashimoto, Tomoki			Protective Role of Peroxisome Proliferator-Activated Receptor-gamma in the Development of Intracranial Aneurysm Rupture	STROKE			English	Article						inflammation; intracranial aneurysm; subarachnoid hemorrhage	PPAR-GAMMA; DECREASING INCIDENCE; CEREBRAL ANEURYSMS; AORTIC-ANEURYSMS; PROMISING AGENT; DEFICIENT MICE; MACROPHAGES; ASPIRIN; CELLS; HYPERTENSION	Background and Purpose-Inflammation is emerging as a key component of the pathophysiology of intracranial aneurysms. Peroxisome proliferator-activated receptor-gamma (PPAR gamma) is a nuclear hormone receptor of which activation modulates various aspects of inflammation. Methods-Using a mouse model of intracranial aneurysm, we examined the potential roles of PPAR gamma in the development of rupture of intracranial aneurysm. Results-A PPAR gamma agonist, pioglitazone, significantly reduced the incidence of ruptured aneurysms and the rupture rate without affecting the total incidence aneurysm (unruptured aneurysms and ruptured aneurysms). PPAR gamma antagonist (GW9662) abolished the protective effect of pioglitazone. The protective effect of pioglitazone was absent in mice lacking macrophage PPAR gamma. Pioglitazone treatment reduced the mRNA levels of inflammatory cytokines (monocyte chemoattractant factor-1, interleukin-1, and interleukin-6) that are primarily produced by macrophages in the cerebral arteries. Pioglitazone treatment reduced the infiltration of M1 macrophage into the cerebral arteries and the macrophage M1/M2 ratio. Depletion of macrophages significantly reduced the rupture rate. Conclusions-Our data showed that the activation of macrophage PPAR gamma protects against the development of aneurysmal rupture. PPAR gamma in inflammatory cells may be a potential therapeutic target for the prevention of aneurysmal rupture.	[Shimada, Kenji; Furukawa, Hajime; Wada, Kosuke; Korai, Masaaki; Wei, Yuan; Kuwabara, Atsushi; Shikata, Fumiaki; Hashimoto, Tomoki] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94110 USA; [Lawton, Michael T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94110 USA; [Shimada, Kenji; Korai, Masaaki; Tada, Yoshiteru; Kitazato, Keiko T.; Nagahiro, Shinji] Univ Tokushima, Sch Med, Dept Neurosurg, Tokushima 770, Japan	Hashimoto, T (reprint author), Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, 1001 Potrero Ave,3C-38, San Francisco, CA 94110 USA.	hashimot@anesthesia.ucsf.edu			National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS055876, R01NS082280]; Brain Aneurysm Foundation Shirley Dudek Demmer Chair of Research; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science	This study was supported by R01NS055876 (T. Hashimoto) and R01NS082280 (T. Hashimoto) from the National Institutes of Health/National Institute of Neurological Disorders and Stroke and the Brain Aneurysm Foundation Shirley Dudek Demmer Chair of Research (K. Shimada). This work was supported by a Grant-in-Aid for the Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation from the Japan Society for the Promotion of Science (S. Nagahiro).	Nuki Y, 2009, J CEREBR BLOOD F MET, V29, P495, DOI 10.1038/jcbfm.2008.136; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; Hasan DM, 2011, STROKE, V42, P3156, DOI 10.1161/STROKEAHA.111.619411; Qu AJ, 2012, ARTERIOSCL THROM VAS, V32, P65, DOI 10.1161/ATVBAHA.111.239137; Tada Y, 2014, STROKE, V45, P579, DOI 10.1161/STROKEAHA.113.003072; Tobiasova Z, 2011, CIRCULATION, V124, P196, DOI 10.1161/CIRCULATIONAHA.110.015396; Faraci FM, 2011, AM J PHYSIOL-HEART C, V300, pH1566, DOI 10.1152/ajpheart.01310.2010; Tada Y, 2014, HYPERTENSION, V63, P1339, DOI 10.1161/HYPERTENSIONAHA.114.03300; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Jiang CY, 1998, NATURE, V391, P82; Bederson JB, 2000, STROKE, V31, P2742; Wiebers D, 2003, LANCET, V362, P103, DOI 10.1016/S0140-6736(03)13860-3; Welch JS, 2003, P NATL ACAD SCI USA, V100, P6712, DOI 10.1073/pnas.1031789100; Nuki Y, 2009, HYPERTENSION, V54, P1337, DOI 10.1161/HYPERTENSIONAHA.109.138297; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Jones A, 2009, CIRCULATION, V119, P3125, DOI 10.1161/CIRCULATIONAHA.109.852467; Chalouhi N, 2013, STROKE, V44, P3613, DOI 10.1161/STROKEAHA.113.002390; Wada K, 2014, TRANSL STROKE RES, V5, P248, DOI 10.1007/s12975-013-0296-8; Aoki T, 2012, NEUROSURGERY, V70, P1534, DOI 10.1227/NEU.0b013e318246a390; Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Baxter BT, 2004, AM J SURG, V188, P628, DOI 10.1016/j.amjsurg.2004.08.034; Chyatte D, 1997, STROKE, V28, P799; Dragomir E, 2006, VASC PHARMACOL, V44, P440, DOI 10.1016/j.vph.2006.02.006; Hasan D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-222; Hosaka K, 2014, J NEUROINTERV SURG, V6, P474, DOI 10.1136/neurintsurg-2013-010788; Kanematsu Y, 2011, STROKE, V42, P173, DOI 10.1161/STROKEAHA.110.590976; Kinouchi T, 2012, STROKE, V43, P478, DOI 10.1161/STROKEAHA.111.618926; Makino H, 2012, STROKE, V43, P2450, DOI 10.1161/STROKEAHA.112.659821; Nakaoka H, 2014, STROKE, V45, P2239, DOI 10.1161/STROKEAHA.114.005851; Schievink WI, 1997, NEW ENGL J MED, V336, P28, DOI 10.1056/NEJM199701023360106; Sugawara Akira, 2012, Curr Mol Pharmacol, V5, P248; Tymianski M, 2011, STROKE, V42, P3003, DOI 10.1161/STROKEAHA.111.626762	33	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUN	2015	46	6					1664	+		10.1161/STROKEAHA.114.007722		12	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CI7KI	WOS:000354941800052		
J	Feigin, VL; Krishnamurthi, R; Bhattacharjee, R; Parmar, P; Theadom, A; Hussein, T; Purohit, M; Hume, P; Abbott, M; Rush, E; Kasabov, N; Crezee, I; Frielick, S; Barker-Collo, S; Barber, PA; Arroll, B; Poulton, R; Ratnasabathy, Y; Tobias, M; Cabral, N; Martins, SCO; Furtado, LETA; Lindsay, P; Saposnik, G; Giroud, M; Bejot, Y; Hacke, W; Mehndiratta, MM; Pandian, JD; Gupta, S; Padma, V; Mandal, DK; Kokubo, Y; Ibrahim, NM; Sahathevan, R; Fu, H; Wang, WZ; Liu, L; Hou, ZG; Goncalves, AF; Correia, M; Varakin, Y; Kravchenko, M; Piradov, M; Saadah, M; Thrift, AG; Cadilhac, D; Davis, S; Donnan, G; Lopez, AD; Hankey, GJ; Maujean, A; Kendall, E; Brainin, M; Abd-Allah, F; Bornstein, NM; Caso, V; Marquez-Romero, JM; Akinyemi, RO; Bin Dhim, NF; Norrving, B; Sindi, S; Kivipelto, M; Mendis, S; Ikram, MA; Hofman, A; Mirza, SS; Rothwell, PM; Sandercock, P; Shakir, R; Sacco, RL; Culebras, A; Roth, GA; Moradi-Lakeh, M; Murray, C; Narayan, V; Mensah, GA; Wiebers, D; Moran, AE				Feigin, Valery L.; Krishnamurthi, Rita; Bhattacharjee, Rohit; Parmar, Priya; Theadom, Alice; Hussein, Tasleem; Purohit, Mitali; Hume, Patria; Abbott, Max; Rush, Elaine; Kasabov, Nikola; Crezee, Ineke; Frielick, Stanley; Barker-Collo, Suzanne; Barber, P. Alan; Arroll, Bruce; Poulton, Richie; Ratnasabathy, Yogini; Tobias, Martin; Cabral, Norberto; Martins, Sheila C. O.; Furtado, Luis E. T. A.; Lindsay, Patrice; Saposnik, Gustavo; Giroud, Maurice; Bejot, Yannick; Hacke, Werner; Mehndiratta, Man Mohan; Pandian, Jeyaraj Durai; Gupta, Sanjeev; Padma, Vasantha; Mandal, Dipes Kumar; Kokubo, Yoshihiro; Ibrahim, Norlinah Mohamed; Sahathevan, Ramesh; Fu, Hua; Wang, Wenzhi; Liu, Liping; Hou, Zeng-Guang; Goncalves, Antonio Freire; Correia, Manuel; Varakin, Yury; Kravchenko, Michael; Piradov, Michael; Saadah, Mohammed; Thrift, Amanda G.; Cadilhac, Dominique; Davis, Stephen; Donnan, Geoffrey; Lopez, Alan D.; Hankey, Graeme J.; Maujean, Annick; Kendall, Elizabeth; Brainin, Michael; Abd-Allah, Foad; Bornstein, Natan M.; Caso, Valeria; Manuel Marquez-Romero, Juan; Akinyemi, Rufus O.; Bin Dhim, Nasser F.; Norrving, Bo; Sindi, Shireen; Kivipelto, Miia; Mendis, Shanthi; Ikram, M. Arfan; Hofman, Albert; Mirza, Saira Saeed; Rothwell, Peter M.; Sandercock, Peter; Shakir, Raad; Sacco, Ralph L.; Culebras, Antonio; Roth, Gregory A.; Moradi-Lakeh, Maziar; Murray, Christopher; Narayan, Venkat; Mensah, George A.; Wiebers, David; Moran, Andrew E.		RIBURST Study Collaboration Writin	New Strategy to Reduce the Global Burden of Stroke	STROKE			English	Review						prevention and control; stroke	RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; RISK-FACTORS; SMARTPHONE APPLICATION; SYSTEMATIC ANALYSIS; NONCOMMUNICABLE DISEASES; PRIMARY PREVENTION; PUBLIC AWARENESS; ISCHEMIC-STROKE; 21 REGIONS		[Feigin, Valery L.; Krishnamurthi, Rita; Bhattacharjee, Rohit; Parmar, Priya; Theadom, Alice] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Sch Publ Hlth & Psychosocial Studies, Auckland 1142, New Zealand; [Hume, Patria; Abbott, Max; Rush, Elaine] Auckland Univ Technol, Fac Hlth & Environm Sci, Auckland 1142, New Zealand; [Hussein, Tasleem] Auckland Univ Technol, Informat Technol, Auckland 1142, New Zealand; [Purohit, Mitali] Auckland Univ Technol, Res & Innovat Off, Auckland 1142, New Zealand; [Kasabov, Nikola] Auckland Univ Technol, Knowledge Engn & Discovery Res Inst, Auckland 1142, New Zealand; [Crezee, Ineke] Auckland Univ Technol, Translat & Interpreting Dept, Auckland 1142, New Zealand; [Frielick, Stanley] Auckland Univ Technol, Ctr Learing & Teaching, Auckland 1142, New Zealand; [Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland 1, New Zealand; [Barber, P. Alan] Univ Auckland, Dept Neurol, Auckland 1, New Zealand; [Arroll, Bruce] Univ Auckland, Sch Publ Hlth, Auckland 1, New Zealand; [Poulton, Richie] Univ Otago, Dept Prevent & Social Med, Dunedin, New Zealand; [Ratnasabathy, Yogini] Older People Care, Waitemata DHB, Auckland, New Zealand; [Tobias, Martin] Minist Hlth, Hlth Intelligence, Wellington, New Zealand; [Cabral, Norberto] Univ Regiao Joinville, Joinville Stroke Register, Joinville, Brazil; [Martins, Sheila C. O.] Hosp Clin Porto Alegre, Hosp Moinhos Vento, Minist Hlth, Porto Alegre, RS, Brazil; [Furtado, Luis E. T. A.] Univ Fed Ceara, Dept Neurol, Sobral Ceara, Brazil; [Lindsay, Patrice] Stroke Fdn Canada, Ottawa, ON, Canada; [Saposnik, Gustavo] Univ Toronto, Dept Med & Hlth Policy, Management & Evaluat, Toronto, ON, Canada; [Giroud, Maurice; Bejot, Yannick] Univ Burgundy, Univ Hosp & Med Sch Dijon, Dijon Stroke Registry, EA4184, Dijon, France; [Hacke, Werner] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Mehndiratta, Man Mohan] Janakpuri Super Special Hosp, New Delhi, India; [Pandian, Jeyaraj Durai] Christian Med Coll & Hosp, Dept Neurol, Ludhiana, Punjab, India; [Gupta, Sanjeev] Banarsidas Chandiwala Inst Physiotherapy, New Delhi, India; [Padma, Vasantha] All India Inst Med Sci, New Delhi, India; [Mandal, Dipes Kumar] Stroke Fdn Bengal, Kolkata, W Bengal, India; [Kokubo, Yoshihiro] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Osaka, Japan; [Ibrahim, Norlinah Mohamed; Sahathevan, Ramesh] UKM Med Ctr, Kuala Lumpur, Malaysia; [Fu, Hua] Fudan Univ, Sch Publ Hlth, Shanghai 200433, Peoples R China; [Wang, Wenzhi] Beijing Neurosurg Inst, Beijing, Peoples R China; [Liu, Liping] Capital Med Univ, Beijing, Peoples R China; [Hou, Zeng-Guang] Inst Automat, Beijing, Peoples R China; [Goncalves, Antonio Freire] Univ Hosp Coimbra, Coimbra, Portugal; [Correia, Manuel] Hosp Santo Antoni, Serv Neurol, Oporto, Portugal; [Varakin, Yury; Kravchenko, Michael; Piradov, Michael] Res Ctr Neurol, Moscow, Russia; [Saadah, Mohammed] Univ Emirates, Abu Dhabi, U Arab Emirates; [Thrift, Amanda G.; Cadilhac, Dominique] Monash Univ, Dept Med, Clayton, Vic, Australia; [Davis, Stephen] Univ Melbourne, Royal Melbourne Hosp, Parkville, Vic 3052, Australia; [Donnan, Geoffrey] Univ Melbourne, Florey Inst Neurosci & Mental Hlth, Parkville, Vic 3052, Australia; [Lopez, Alan D.] Univ Melbourne, Publ Hlth, Parkville, Vic 3052, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia; [Brainin, Michael] Danube Univ, Ctr Clin Neurosci, Vienna, Austria; [Abd-Allah, Foad] Cairo Univ, Cairo, Egypt; [Bornstein, Natan M.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Caso, Valeria] Stroke Unit, Perugia, Italy; [Manuel Marquez-Romero, Juan] IMSS Aguascalientes, HGZ 2, Aguascalientes, Mexico; [Akinyemi, Rufus O.] Fed Med Ctr Abeokuta, Abeokuta, Nigeria; [Bin Dhim, Nasser F.] Saudi Elect Univ, Hlth Informat Dept, Riyadh, Saudi Arabia; [Norrving, Bo] Lund Univ, Dept Neurol, Lund, Sweden; [Sindi, Shireen] Karolinska Inst, Dept Epidemiol, Stockholm, Sweden; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Ctr Alzheimer Res, Stockholm, Sweden; [Mendis, Shanthi] WHO, Noncommun Dis, CH-1211 Geneva, Switzerland; [Ikram, M. Arfan; Hofman, Albert; Mirza, Saira Saeed] Erasmus Univ, Med Ctr, Rotterdam, Netherlands; [Rothwell, Peter M.] Univ Oxford, Nuffield Dept Neurosci, Oxford, England; [Sandercock, Peter] Western Gen Hosp, Edinburgh EH4 2XU, Midlothian, Scotland; [Shakir, Raad] Imperial Coll NHS Trust, Dept Neurol, London, England; [Sacco, Ralph L.] Univ Miami, Miller Sch Med, Dept Neurol, Coral Gables, FL 33124 USA; [Culebras, Antonio] SUNY Upstate Med Univ, Dept Neurol, Syracuse, NY 13210 USA; [Roth, Gregory A.] Univ Washington, Dept Med, Div Cardiol, Seattle, WA 98195 USA; [Roth, Gregory A.; Moradi-Lakeh, Maziar; Murray, Christopher] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Narayan, Venkat] Emory Univ, Atlanta, GA 30322 USA; [Mensah, George A.] NHLBI, Ctr Translat Res & Implementat Sci, NIH, Bethesda, MD 20892 USA; [Wiebers, David] Mayo Clin, Dept Neurol, Rochester, MN USA; [Moran, Andrew E.] Columbia Univ, Med Ctr, Div Gen Med, New York, NY 10027 USA	Feigin, VL (reprint author), Auckland Univ Technol, Fac Hlth & Environm Sci, Sch Publ Hlth & Psychosocial Studies, Natl Inst Stroke & Appl Neurosci, AUT North Shore Campus,AA254,90 Akoranga Dr, Auckland 1142, New Zealand.	valery.feigin@aut.ac.nz	Hankey, Graeme /H-4968-2014; Kravchenko, Mikhail/B-2596-2012; 	Hankey, Graeme /0000-0002-6044-7328; Piradov, Michael/0000-0002-6338-0392; Theadom, Alice/0000-0003-0351-6216; BinDhim, Nasser F/0000-0001-8117-1044	Auckland University of Technology, Research and Innovation Office, Faculty of Health and Environmental Sciences, Centre for Learning and Teaching; Kiwi Innovation Network Limited, Waikato Mail Centre, Hamilton, New Zealand; Auckland University of Technology Enterprises Ltd at Auckland University of Technology, Auckland, New Zealand	This study was supported by Auckland University of Technology, Research and Innovation Office, Faculty of Health and Environmental Sciences, Centre for Learning and Teaching and Auckland University of Technology Enterprises Ltd at Auckland University of Technology, Auckland 1142, New Zealand and Kiwi Innovation Network Limited, Waikato Mail Centre, Hamilton, New Zealand.	Alkadry Mohamad G, 2010, J Health Hum Serv Adm, V33, P63; Anchala R, 2014, J HYPERTENS, V32, P1170, DOI 10.1097/HJH.0000000000000146; ROSE G, 1981, BRIT MED J, V282, P1847; Dalton ARH, 2013, EUR J PREV CARDIOL, V20, P142, DOI 10.1177/1741826711428797; Buller DB, 2014, TELEMED E-HEALTH, V20, P206, DOI 10.1089/tmj.2013.0169; DAGOSTINO RB, 1994, STROKE, V25, P40; Roberts JL, 2009, DEMENT GERIATR COGN, V28, P95, DOI 10.1159/000234911; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Cooney MT, 2010, CIRCULATION, V122, P300, DOI 10.1161/CIRCULATIONAHA.109.852756; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Abd-Allah F, 2014, INT J STROKE, V9, P1105, DOI 10.1111/ijs.12313; Brindle P, 2003, BRIT MED J, V327, P1267, DOI 10.1136/bmj.327.7426.1267; Ellis-Hill C, 2009, DISABIL REHABIL, V31, P61, DOI 10.1080/09638280701775289; Li X, 2011, PSYCHOGERIATRICS, V11, P83, DOI 10.1111/j.1479-8301.2010.00349.x; [Anonymous], PREV CARD DIS POCK G; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Jones SP, 2010, AGE AGEING, V39, P11, DOI 10.1093/ageing/afp196; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Strong K, 2007, LANCET NEUROL, V6, P182, DOI 10.1016/S1474-4422(07)70031-5; Akinyemi RO, 2014, J AM GERIATR SOC, V62, P1460, DOI 10.1111/jgs.12940; Mendis S, 2010, PROG CARDIOVASC DIS, V53, P10, DOI 10.1016/j.pcad.2010.01.001; Bray JE, 2011, STROKE, V42, P2154, DOI 10.1161/STROKEAHA.110.612036; Sacco RL, 2013, LANCET, V382, pE4, DOI 10.1016/S0140-6736(11)61477-3; Beratarrechea A, 2014, TELEMED E-HEALTH, V20, P75, DOI 10.1089/tmj.2012.0328; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Kasabov N, 2014, NEUROCOMPUTING, V134, P269, DOI 10.1016/j.neucom.2013.09.049; Alberti KGMM, 2013, NAT REV ENDOCRINOL, V9, P258, DOI 10.1038/nrendo.2013.54; Arab F, 2013, LECT NOTES COMPUT SC, V8120, P547; BinDhim NF, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005371; Brouillette RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065925; Cappuccio FP, 2004, INT J EPIDEMIOL, V33, P387, DOI 10.1093/ije/dyh091; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Feigin VL, 2014, INT J STROKE, V9, P624, DOI 10.1111/ijs.12300; Feigin VL, 2013, LANCET, V382, P1; Feigin VL, 2014, STROKE RISKOMETER AP; Goff DC, 2014, CIRCULATION, V129, pS49, DOI 10.1161/01.cir.0000437741.48606.98; Goldstein LB, 2011, STROKE, V42, P517, DOI 10.1161/STR.0b013e3181fcb238; Hickey Anne, 2009, BMC Geriatr, V9, P35, DOI 10.1186/1471-2318-9-35; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Jansen J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004812; Kargman DE, 1999, NEUROEPIDEMIOLOGY, V18, P174, DOI 10.1159/000026209; Ke L, 2015, AM J HYPERTENS, V28, P159, DOI 10.1093/ajh/hpu121; Kim YS, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-2; Leung Rock, 2012, ACM Transactions on Accessible Computing, V4, DOI 10.1145/2399193.2399195; Licskai CJ, 2013, CAN RESPIR J, V20, P301; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Ly KH, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-62; Matthaei S, 2007, INT J CLIN PRACT, V61, P31, DOI 10.1111/j.1742-1241.2007.01611.x; Mendis S., GLOBAL STATUS REPORT; Miura Katsuyuki, 2011, EPMA J, V2, P59, DOI 10.1007/s13167-011-0069-y; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; Parmar P, 2015, INT J STROKE, V10, P231, DOI 10.1111/ijs.12411; Powles J, 2010, EUR J PUBLIC HEALTH, V20, P103, DOI 10.1093/eurpub/ckp067; Puska P, 2002, PUBLIC HLTH MED, V4, P5; Boden-Albala B, 2013, STROKE, V44, pS48, DOI 10.1161/STROKEAHA.111.000396; Record NB, 2015, JAMA-J AM MED ASSOC, V313, P147, DOI 10.1001/jama.2014.16969; Ryan Tony, 2010, Br J Community Nurs, V15, P381; World Health Organization, 2012, GLOB ACT PLAN CONTR, P1; World Health Organization (WHO), 2003, ADHERENCE LONG TERM	60	5	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0039-2499	1524-4628		STROKE	Stroke	JUN	2015	46	6					1740	+		10.1161/STROKEAHA.115.008222		10	Clinical Neurology; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CI7KI	WOS:000354941800066		
J	Yamaguchi, S; Iwasa, Y				Yamaguchi, Sachi; Iwasa, Yoh			Phenotype adjustment promotes adaptive evolution in a game without conflict	THEORETICAL POPULATION BIOLOGY			English	Article						Lifelong pair; Sex allocation; Phenotypic plasticity	SPONGE-ASSOCIATED SHRIMP; JAPONICA KUBO CRUSTACEA; GENETIC ASSIMILATION; LIFE-HISTORY; SEXUAL SYSTEMS; PLASTICITY; SPONGICOLIDAE; BARNACLES; DECAPODA; HERMAPHRODITISM	Organisms may adjust their phenotypes in response to social and physical environments. Such phenotypic plasticity is known to help or retard adaptive evolution. Here, we study the evolutionary outcomes of adaptive phenotypic plasticity in an evolutionary game involving two players who have no conflicts of interest. A possible example is the growth and sex allocation of a lifelong pair of shrimps entrapped in the body of a sponge. We consider random pair forrnation, the limitation of total resources for growth, and the needs of male investment to fertilize eggs laid by the partner. We compare the following three different evolutionary dynamics: (1) No adjustment: each individual develops a phenotype specified by its own genotype; (2) One-player adjustment: the phenotype of the first player is specified by its own genotype, and the second player chooses the phenotype that maximizes its own fitness; (3) Two-player adjustment: the first player exhibits an initial phenotype specified by its own genotype, the second player chooses a phenotype given that of the first player, and finally, the first player readjusts its phenotype given that of the second player. We demonstrate that both one-player and two-player adjustments evolve to achieve maximum fitness. In contrast, the dynamics without adjustment fails in some cases to evolve outcomes with the highest fitness. For an intermediate range of male cost, the evolution of no adjustment realizes two hermaphrodites with equal size, whereas the one-player and two-player adjustments realize a small male and a large female. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaguchi, Sachi] Kanagawa Univ, Fac Engn, Dept Informat Syst Creat, Yokohama, Kanagawa 2218686, Japan; [Iwasa, Yoh] Kyushu Univ, Fac Sci, Dept Biol, Fukuoka 8128581, Japan	Yamaguchi, S (reprint author), Kanagawa Univ, Fac Engn, Dept Informat Syst Creat, Yokohama, Kanagawa 2218686, Japan.	sachi.dwarfmale@gmail.com			Sasakawa Scientific Research Grant [26-503];  [24370011]	This work was supported in part by a Grant-in-Aid for Basic Scientific Research (B) (No. 24370011) to Y.I. and a Sasakawa Scientific Research Grant (26-503) to S.Y.	Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; TOMLINSON J, 1966, J THEOR BIOL, V11, P54, DOI 10.1016/0022-5193(66)90038-5; Ancel LW, 2000, THEOR POPUL BIOL, V58, P307, DOI 10.1006/tpbi.2000.1484; Jarne P, 2006, EVOLUTION, V60, P1816; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; Pigliucci M, 2003, EVOLUTION, V57, P1455; JARNE P, 1993, ANNU REV ECOL SYST, V24, P441, DOI 10.1146/annurev.es.24.110193.002301; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825; TAYLOR PD, 1978, MATH BIOSCI, V40, P145, DOI 10.1016/0025-5564(78)90077-9; Pacheco JM, 2009, P ROY SOC B-BIOL SCI, V276, P315, DOI 10.1098/rspb.2008.1126; CHARNOV EL, 1979, AM NAT, V113, P715, DOI 10.1086/283428; COSMIDES LM, 1981, J THEOR BIOL, V89, P83; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Arbilly M, 2011, THEOR POPUL BIOL, V80, P244, DOI 10.1016/j.tpb.2011.09.001; Baldwin J. M., 1896, AM NAT, V30, P441, DOI DOI 10.1086/276408; Bauer RT, 2006, INTEGR COMP BIOL, V46, P430, DOI 10.1093/icb/icj036; Chapman R., 2003, TRENDS ECOL EVOL, V18, P41; Charnov E., 1987, BARNACLE BIOL CRUSTA, V5, P89; CHARNOV E L, 1982; Houston A.I., 1985, P471; Houston A. I., 2005, TRENDS ECOL EVOL, V20, P32; JOHNSON VR, 1977, ANIM BEHAV, V25, P418, DOI 10.1016/0003-3472(77)90017-3; Koeller Peter, 2000, Journal of Northwest Atlantic Fishery Science, V27, P107, DOI 10.2960/J.v27.a10; Munday PL, 2006, BIOL LETTERS, V2, P355, DOI 10.1098/rsbl.2006.0488; Nowak MA, 2006, EVOLUTIONARY DYNAMIC; Saito T, 2001, ZOOL SCI, V18, P567, DOI 10.2108/zsj.18.567; Saito T, 2002, J NAT HIST, V36, P819, DOI 10.1080/00222930010026382; Saito T, 2001, J MAR BIOL ASSOC UK, V81, P789, DOI 10.1017/S002531540100460X; Scheiner S. M., 2012, ECOL EVOL, V2, P5751; Skyrm B., 2002, PHILOS SCI, V68, P407; Weibull J. W., 1995, EVOLUTIONARY GAME TH; WERDING B, 1990, CRUSTACEANA, V58, P88, DOI 10.1163/156854090X00804; Yamaguchi S, 2008, J THEOR BIOL, V253, P61, DOI 10.1016/j.jtbi.2008.01.025; Yamaguchi S, 2013, J THEOR BIOL, V320, P1, DOI 10.1016/j.jtbi.2012.12.001; Yamaguchi S, 2012, INTEGR COMP BIOL, V52, P356, DOI 10.1093/icb/ics046	36	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0040-5809	1096-0325		THEOR POPUL BIOL	Theor. Popul. Biol.	JUN	2015	102						16	25		10.1016/j.tpb.2015.03.004		10	Ecology; Evolutionary Biology; Genetics & Heredity	Environmental Sciences & Ecology; Evolutionary Biology; Genetics & Heredity	CJ1JK	WOS:000355239700003		
J	Sharma, AM; Araki, T; Kumar, A; Ikeda, N; Lavra, F; Rajan, J; Saba, L; Nicolaides, A; Laird, J; Shafique, S; Suri, JS				Sharma, Aditya M.; Araki, Tadashi; Kumar, Asheed; Ikeda, Nobutaka; Lavra, Francesco; Rajan, Jeny; Saba, Luca; Nicolaides, Andrew; Laird, John; Shafique, Shoaib; Suri, Jasjit S.			Automated Carotid Artery Lumen Measurement Utilizing Ultrasound	VASCULAR MEDICINE			English	Meeting Abstract									[Sharma, Aditya M.] Univ Virginia, Charlottesville, VA 22901 USA; [Araki, Tadashi] Toho Univ, Ohashi Med Ctr, Tokyo, Japan; [Kumar, Asheed; Rajan, Jeny] Natl Inst Technol, Mangaluru, Karnataka, India; [Ikeda, Nobutaka] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Lavra, Francesco; Saba, Luca] Univ Cagliari, Cagliari, Italy; [Nicolaides, Andrew] Vasc Screening & Diagnost Ctr, London, England; [Laird, John] UC Davis Vasc Ctr, Davis, CA USA; [Shafique, Shoaib] CorVasc Vasc Lab, Indianapolis, IN USA; [Suri, Jasjit S.] AtheroPoint, Roseville, CA USA								0	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1358-863X	1477-0377		VASC MED	Vasc. Med.	JUN	2015	20	3				Poster 25	293	294				2	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CJ2SE	WOS:000355334000047		
J	Osaki, H; Sasaki, A; Nomiyama, K; Sekiguchi, H; Tomioka, K; Takehara, T				Osaki, Hideki; Sasaki, Atsuko; Nomiyama, Koji; Sekiguchi, Hiroyuki; Tomioka, Keisuke; Takehara, Toshiaki			Isolation and characterization of two mitoviruses and a putative alphapartitivirus from Fusarium spp.	VIRUS GENES			English	Article						Double-stranded RNA; Fusarium; Mitovirus; Mulberry twig blight; Partitivirus; Potato dry rot	DOUBLE-STRANDED-RNA; PLANT-PATHOGENIC FUNGUS; OPHIOSTOMA-NOVO-ULMI; RHIZOCTONIA-SOLANI; BOTRYTIS-CINEREA; MOLECULAR CHARACTERIZATION; GENOME CHARACTERIZATION; ROSELLINIA-NECATRIX; HYPOVIRULENT STRAIN; VIRUSES	The filamentous fungus Fusarium spp. includes several important plant pathogens. We attempted to reveal presence of double-stranded (ds) RNAs in the genus. Thirty-seven Fusarium spp. at the MAFF collection were analyzed. In the strains of Fusarium coeruleum, Fusarium globosum and Fusarium solani f. sp. pisi, single dsRNA bands were detected. The strains of F. coeruleum and F. solani f. sp. pisi cause potato dry rot and mulberry twig blight, respectively. Sequence analyses revealed that dsRNAs in F. coeruleum and F. globosum consisted of 2423 and 2414 bp, respectively. Using the fungal mitochondrial translation table, the positive strands of these cDNAs were found to contain single open reading frames with the potential to encode a protein of putative 757 and 717 amino acids (molecular mass 88.5 and 84.0 kDa, respectively), similar to RNA-dependent RNA polymerases of members of the genus Mitovirus. These dsRNAs in F. coeruleum and F. globosum were assigned to the genus Mitovirus (family Narnaviridae), and these two mitoviruses were designated as Fusarium coeruleum mitovirus 1 and Fusarium globosum mitovirus 1. On the other hand, a positive strand of cDNA (1950 bp) from dsRNA in F. solani f. sp. pisi contained an ORF potentially encoding a putative RdRp of 608 amino acids (72.0 kDa). The putative RdRp was shown to be related to those of members of the genus of Alphapartitivirus (family Partitiviridae). We coined the name Fusarium solani partitivirus 2 for dsRNA in F. solani f. sp. pisi.	[Osaki, Hideki; Nomiyama, Koji; Sekiguchi, Hiroyuki; Tomioka, Keisuke; Takehara, Toshiaki] NARO Western Reg Agr Res Ctr, Fukuyama, Hiroshima 7218514, Japan; [Sasaki, Atsuko] NARO Inst Fruit Tree Sci, Tsukuba, Ibaraki 3058605, Japan	Osaki, H (reprint author), NARO Western Reg Agr Res Ctr, 6-12-1 Nishifukatsu, Fukuyama, Hiroshima 7218514, Japan.	hideki@affrc.go.jp					C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Ghabrial SA, 1998, VIRUS GENES, V16, P119, DOI 10.1023/A:1007966229595; OSAWA S, 1992, MICROBIOL REV, V56, P229; Nibert ML, 2014, VIRUS RES, V188, P128, DOI 10.1016/j.virusres.2014.04.007; Chiba S, 2009, J VIROL, V83, P12801, DOI 10.1128/JVI.01830-09; Rocha O, 2005, FOOD ADDIT CONTAM A, V22, P369, DOI 10.1080/02652030500058403; Wu MD, 2007, PHYTOPATHOLOGY, V97, P1590, DOI 10.1094/PHYTO-97-12-1590; Paquin B, 1997, CURR GENET, V31, P380, DOI 10.1007/s002940050220; Ghabrial SA, 2009, ANNU REV PHYTOPATHOL, V47, P353, DOI 10.1146/annurev-phyto-080508-081932; McCabe PM, 1999, TRENDS MICROBIOL, V7, P377, DOI 10.1016/S0966-842X(99)01568-1; ARAKI T, 1975, Annals of the Phytopathological Society of Japan, V41, P123; BRASIER CM, 1983, NATURE, V305, P220, DOI 10.1038/305220a0; Buck KW, 1998, MOLECULAR VARIABILITY OF FUNGAL PATHOGENS, P53; Buck KW, 1996, ADV VIRUS RES, V47, P159, DOI 10.1016/S0065-3527(08)60736-8; Chu YM, 2002, APPL ENVIRON MICROB, V68, P2529, DOI 10.1128/AEM.68.5.2529-2534.2002; Compel P, 1999, VIRUS GENES, V18, P49, DOI 10.1023/A:1008069318838; Deng F, 2003, PHYTOPATHOLOGY, V93, P1407, DOI 10.1094/PHYTO.2003.93.11.1407; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Hillman BI, 2011, VIRUS TAXONOMY CLASS, P1055; Hong YG, 1999, VIROLOGY, V258, P118, DOI 10.1006/viro.1999.9691; Howitt RLJ, 2001, J GEN VIROL, V82, P67; Huang SH, 1996, P NATL ACAD SCI USA, V93, P12541, DOI 10.1073/pnas.93.22.12541; Isogai Masamichi, 1998, Annals of the Phytopathological Society of Japan, V64, P244; Jian JH, 1997, MOL PLANT MICROBE IN, V10, P1002, DOI 10.1094/MPMI.1997.10.8.1002; LAKSHMAN DK, 1994, PHYTOPATHOLOGY, V84, P633, DOI 10.1094/Phyto-84-633; Lakshman DK, 1998, P NATL ACAD SCI USA, V95, P6425, DOI 10.1073/pnas.95.11.6425; Martinez-Alvarez P, 2014, ARCH VIROL, V159, P2153, DOI 10.1007/s00705-014-2012-8; Moses LM, 2010, MYCOPATHOLOGIA, V170, P237, DOI 10.1007/s11046-010-9318-1; Nirenberg Helgard I., 1997, Mycoscience, V38, P329, DOI 10.1007/BF02464091; Nogawa M, 1996, BIOSCI BIOTECH BIOCH, V60, P784; Osaki H, 2005, VIRUS RES, V107, P39, DOI 10.1016/j.virusres.2004.06.010; POLASHOCK JJ, 1994, P NATL ACAD SCI USA, V91, P8680, DOI 10.1073/pnas.91.18.8680; Potgieter CA, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-220; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasaki A, 2005, ARCH VIROL, V150, P1069, DOI 10.1007/s00705-005-0494-0; SHIRATA A, 1979, Bulletin of the Sericultural Experiment Station (Tokyo), V27, P807; Smart CD, 1999, VIROLOGY, V265, P66, DOI 10.1006/viro.1999.0039; Turner RL, 1999, VIROLOGY, V253, P115, DOI 10.1006/viro.1998.9495; Wu MD, 2010, VIROLOGY, V406, P117, DOI 10.1016/j.virol.2010.07.010; Xiao XQ, 2014, J VIROL, V88, P10120, DOI 10.1128/JVI.01036-14; Xie JT, 2012, VIROLOGY, V428, P77, DOI 10.1016/j.virol.2012.03.015; Yaegashi H, 2013, FEMS MICROBIOL ECOL, V83, P49, DOI 10.1111/j.1574-6941.2012.01454.x	42	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0920-8569	1572-994X		VIRUS GENES	Virus Genes	JUN	2015	50	3					466	473		10.1007/s11262-015-1182-0		8	Genetics & Heredity; Virology	Genetics & Heredity; Virology	CJ1GW	WOS:000355233000014		
J	Adaniya, C; Nishikawa, A				Adaniya, Chieko; Nishikawa, Akio			Formation of a New Limb Bud at the Boundary Between a Transplanted Limb Bud and the Tail Surface of Xenopus Tadpoles	ZOOLOGICAL SCIENCE			English	Article						limb bud; presumptive limb girdle; epithelial-mesenchymal interaction; Xenopus laevis; amphibian metamorphosis; extra limb	SUPERNUMERARY REGENERATION; NOTOPHTHALMUS-VIRIDESCENS; AMBYSTOMA-MEXICANUM; PROXIMODISTAL AXIS; ACTS DOWNSTREAM; INSECT LEGS; LAEVIS; EXPRESSION; FORELIMB; FROG	Through transplantation experiments with Xenopus laevis tadpoles, we found a new morphogenetic phenomenon consisting of limb bud formation at the boundary between transplanted whole limb buds and the tail surface. This phenomenon occurs without limb-limb stump interaction and has a number of unique features: (1) Only one extra limb bud was formed per transplant and the new limb and the transplanted limb were bilaterally symmetrical, forming a pair of limb girdles. (2) Extra new limb bud formation occurred not only at the tail but also at other non-limb regions, including abdominal and head surfaces. (3) Successful limb formation required the presence of basal 1/4 region (presumptive limb girdle) of a limb bud explant. (4) New limb formation was host-stage-dependent: before metamorphosis, limb bud formation ratio was high (> 90%), but as the host tadpole entered metamorphosis, this potential declined and morphological abnormalities of new limbs increased. (5) Cell lineage analysis showed that epidermis of the new limb bud always contained many (about 60%) host-derived cells, while new limb cartilage cells were completely graft-derived. These results suggest that heterotopic new limb formation occurs through interaction between graft mesenchyme and host epidermis. Thus, the present study has clarified the two important aspects of limb ontogeny: the importance of presumptive limb girdle for the limb bud initiation and the relationship between limb bud formation potential and metamorphic tissue remodeling. The present experimental system may help to improve our understanding of epithelial-mesenchymal interaction during limb bud initiation and subsequent limb cell differentiation during metamorphosis.	[Adaniya, Chieko; Nishikawa, Akio] Shimane Univ, Fac Life & Environm Sci, Dept Biol Sci, Matsue, Shimane, Japan	Nishikawa, A (reprint author), Shimane Univ, Fac Life & Environm Sci, Dept Biol Sci, 1060 Nishikawatsu, Matsue, Shimane, Japan.	akio@life.shimane-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors thank Dr. S. Tochinai (Hokkaido University) for his kindly giving of adult frogs of X. laevis (J strain) and X. borealis.	Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; MUNEOKA K, 1986, J EXP ZOOL, V240, P47, DOI 10.1002/jez.1402400107; CAMPBELL G, 1995, DEVELOPMENT, V121, P619; FRENCH V, 1976, SCIENCE, V193, P969, DOI 10.1126/science.948762; TSCHUMI PA, 1957, J ANAT, V91, P149; Christen B, 2012, DEVELOPMENT, V139, P2557, DOI 10.1242/dev.078774; Yokoyama H, 2000, DEV BIOL, V219, P18, DOI 10.1006/dbio.1999.9587; DENT JN, 1962, J MORPHOL, V110, P61, DOI 10.1002/jmor.1051100105; Jones TEM, 2013, J ANAT, V223, P474, DOI 10.1111/joa.12098; COHN MJ, 1995, CELL, V80, P739, DOI 10.1016/0092-8674(95)90352-6; TICKLE C, 1975, NATURE, V254, P199, DOI 10.1038/254199a0; Ohuchi H, 1997, DEVELOPMENT, V124, P2235; Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096; Mercader N, 2006, DEVELOPMENT, V133, P2805, DOI 10.1242/dev.02455; McEwan J, 2011, DEV DYNAM, V240, P1259, DOI 10.1002/dvdy.22555; Waxman JS, 2008, DEV CELL, V15, P923, DOI 10.1016/j.devcel.2008.09.009; Zhao XL, 2009, CURR BIOL, V19, P1050, DOI 10.1016/j.cub.2009.04.059; Mito T, 2002, MECH DEVELOP, V114, P27, DOI 10.1016/S0925-4773(02)00052-7; Balinsky BI, 1937, ROUX ARCH DEV BIOL, V136, P221; Balinsky BI, 1925, ROUX ARCH DEV BIOL, V105, P718; BALINSKY BI, 1956, P NATL ACAD SCI USA, V42, P781, DOI 10.1073/pnas.42.10.781; BOHN H, 1972, J EMBRYOL EXP MORPH, V28, P185; BRYANT SV, 1976, DEV BIOL, V50, P212, DOI 10.1016/0012-1606(76)90079-8; BRYANT SV, 1977, J EXP ZOOL, V202, P1, DOI 10.1002/jez.1402020102; MADEN M, 1981, J EMBRYOL EXP MORPH, V63, P243; MADEN M, 1993, DEV BIOL, V159, P379, DOI 10.1006/dbio.1993.1249; MADEN M, 1980, J EMBRYOL EXP MORPH, V57, P177; MEINHARDT H, 1983, J EMBRYOL EXP MORPH, V76, P115; Miller L, 1996, METAMORPHOSIS POSTEM, P599, DOI 10.1016/B978-012283245-1/50019-1; MOHANTYHEJMADI P, 1992, NATURE, V355, P352, DOI 10.1038/355352a0; Neto A, 2012, DEVELOPMENT, V139, P301, DOI 10.1242/dev.074856; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NISHIKAWA A, 1992, DEV BIOL, V151, P145, DOI 10.1016/0012-1606(92)90222-3; Niwa N, 1997, ZOOL SCI, V14, P115, DOI 10.2108/zsj.14.115; SAUNDERS JW, 1958, J EXP ZOOL, V137, P39, DOI 10.1002/jez.1401370104; Shimizu-Nishikawa K, 2003, DEV DYNAM, V227, P563, DOI 10.1002/dvdy.10345; TANK PW, 1978, DEV BIOL, V62, P143, DOI 10.1016/0012-1606(78)90097-0; THIEBAUD CH, 1983, DEV BIOL, V98, P245, DOI 10.1016/0012-1606(83)90353-6	38	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					223	232		10.2108/zs1400262		10	Zoology	Zoology	CI9SS	WOS:000355110700002		
J	Iwata, M; Taira, W; Hiyama, A; Otaki, JM				Iwata, Masaki; Taira, Wataru; Hiyama, Atsuki; Otaki, Joji M.			The Lycaenid Central Symmetry System: Color Pattern Analysis of the Pale Grass Blue Butterfly Zizeeria maha	ZOOLOGICAL SCIENCE			English	Article						central symmetry system; color pattern determination; induction model; long-range signal; lycaenid butterfly; nymphalid groundplan; pattern element; Zizeeria maha	FUKUSHIMA NUCLEAR ACCIDENT; BIOLOGICAL IMPACTS; EYESPOT DEVELOPMENT; WINGS; LEPIDOPTERA; NYMPHALIDAE; EVOLUTION; MODEL	The nymphalid groundplan has been proposed to explain diverse butterfly wing color patterns. In this model, each symmetry system is composed of a core element and a pair of paracore elements. The development of this elemental configuration has been explained by the induction model for positional information. However, the diversity of color patterns in other butterfly families in relation to the nymphalid groundplan has not been thoroughly examined. Here, we examined aberrant color pattern phenotypes of a lycaenid butterfly, Zizeeria maha, from mutagenesis and plasticity studies as well as from field surveys. In several mutants, the third and fourth spot arrays were coordinately positioned much closer to the discal spot in comparison to the normal phenotype. In temperature-shock types, the third and fourth array spots were elongated inwardly or outwardly from their normal positions. In field-caught spontaneous mutants, small black spots were located adjacent to normal black spots. Analysis of these aberrant phenotypes indicated that the spots belonging to the third and fourth arrays are synchronously changeable in position and shape around the discal spot. Thus, these arrays constitute paracore elements of the central symmetry system of the lycaenid butterflies, and the discal spot comprises the core element. These aberrant phenotypes can be explained by the black-inducing signals that propagate from the prospective discal spot, as predicted by the induction model. These results suggest the existence of long-range developmental signals that cover a large area of a wing not only in nymphalid butterflies, but also in lycaenid butterflies.	[Iwata, Masaki; Taira, Wataru; Hiyama, Atsuki; Otaki, Joji M.] Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, Nishihara, Okinawa 9030213, Japan	Otaki, JM (reprint author), Univ Ryukyus, Fac Sci, Dept Chem Biol & Marine Sci, BCPH Unit Mol Physiol, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	otaki@sci.u-ryukyu.ac.jp			University of the Ryukyus, Okinawa, Japan	The authors thank Tadashi Kudo of the Tsugaru Insect Club for supplying the figures for the inward and outward types. We also thank the members of the BCPH Unit of Molecular Physiology for discussion. This work was partly supported by the Hub Project from the University of the Ryukyus, Okinawa, Japan.	[Anonymous], 1924, P ZOOL SOC LOND; Hiyama A, 2012, SCI REP-UK, V2, DOI 10.1038/srep00570; Nijhout HF, 2001, J EXP ZOOL, V291, P213, DOI 10.1002/jez.1099; BRAKEFIELD PM, 1995, DEV BIOL, V168, P98, DOI 10.1006/dbio.1995.1064; Buckley J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-382; French V, 1995, DEV BIOL, V116, P103; Hiyama A, 2010, ENTOMOL SCI, V13, P293, DOI 10.1111/j.1479-8298.2010.00387.x; Hiyama A, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-168; Hiyama Atsuki, 2012, Frontiers in Genetics, V3, P15, DOI 10.3389/fgene.2012.00015; Iwata M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02379; Iwata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089500; Kusaba K, 2009, J INSECT PHYSIOL, V55, P174, DOI 10.1016/j.jinsphys.2008.11.006; Martin A, 2014, DEV BIOL, V395, P367, DOI 10.1016/j.ydbio.2014.08.031; Nijhout H. F., 1991, DEV EVOLUTION BUTTER; NIJHOUT HF, 1980, DEV BIOL, V80, P267, DOI 10.1016/0012-1606(80)90403-0; NIJHOUT HF, 1985, J EMBRYOL EXP MORPH, V86, P191; NIJHOUT HF, 1984, J EMBRYOL EXP MORPH, V81, P287; NIJHOUT HF, 1988, DEVELOPMENT, V102, P377; Nohara C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/s12862-014-0193-0; Nohara C, 2014, SCI REP-UK, V4, DOI 10.1038/srep04946; Otaki Joji M., 2003, Transactions of the Lepidopterological Society of Japan, V54, P197; Otaki JM, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-17; Otaki JM, 2004, DEV GROWTH DIFFER, V46, P1; Otaki JM, 1998, J INSECT PHYSIOL, V44, P1181, DOI 10.1016/S0022-1910(98)00083-3; Otaki JM, 2012, ZOOL SCI, V29, P568, DOI 10.2108/zsj.29.568; Otaki JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-252; Otaki JM, 2005, ZOOL SCI, V22, P21, DOI 10.2108/zsj.22.21; Otaki JM, 2011, ZOOL SCI, V28, P817, DOI 10.2108/zsj.28.817; Otaki JM, 2011, SCI REP-UK, V1, DOI 10.1038/srep00111; Otaki JM, 2011, ZOOL SCI, V28, P403, DOI 10.2108/zsj.28.403; Otaki JM, 2008, J INSECT PHYSIOL, V54, P1099, DOI 10.1016/j.jinsphys.2008.05.006; Scott JA, 1986, BUTTERFLIES N AM; SUFFERT FRITZ, 1927, BIOL ZENTRALBL, V47, P385; Taira W, 2014, J HERED, V105, P710, DOI 10.1093/jhered/esu013; Taira W, 2015, ZOOL SCI, V32, P38, DOI 10.2108/zs140058	35	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					233	239		10.2108/zs140249		7	Zoology	Zoology	CI9SS	WOS:000355110700003		
J	Tominaga, A; Matsui, M; Eto, K; Ota, H				Tominaga, Atsushi; Matsui, Masafumi; Eto, Koshiro; Ota, Hidetoshi			Phylogeny and Differentiation of Wide-ranging Ryukyu Kajika Frog Buergeria japonica (Amphibia: Rhacophoridae): Geographic Genetic Pattern Not Simply Explained by Vicariance Through Strait Formation	ZOOLOGICAL SCIENCE			English	Article						insular amphibia; phylogeography; Ryukyu; Taiwan; mitochondrial DNA	MITOCHONDRIAL-DNA; TAXONOMIC RELATIONSHIPS; ECHINOTRITON-ANDERSONI; COASTAL AREA; BROWN FROGS; GENUS RANA; ANURA; ARCHIPELAGO; JAPAN; PHYLOGEOGRAPHY	To investigate geographic genetic structures and taxonomic relationships among isolated populations of Buergeria japonica, occurring very widely in various habitats of the Ryukyu Archipelago and Taiwan, we conducted phylogenetic and demographic analyses among individuals from various localities, representing their entire distributional ranges. Buergeria japonica is genetically greatly differentiated and comprises three major clades (the Southern Taiwan [ST] clade, the Northern Taiwan + Southern Ryukyu [NT/SR] clade, and the Central + Northern Ryukyu [CR/NR] clade), each of which seems to represent independent species. The first divergence in the species is estimated to have occurred in the middle to late Miocene in areas of current Taiwan, then eastern periphery of the Asian continent. Split of the ST and the remaining clades, and subsequent divergence between the NT/SR and the CR/NR clades in the latter, indicate consecutive south to north vicariant diversifications. However, these vicariances are not always associated with formation of significant barriers such as deep straits. Less but still prominently diverged subclades (the Amami + Tokara [AM/TK] and the Okinawa [ON] subclades) in the CR/NR clade were recognized in spite of the absence of an intervening deep strait. Contrariwise, individuals from Amami and Tokara Groups formed the AM/TK subclade in spite of the presence of the intervening Tokara Gap (a long-standing deep tectonic strait). Furthermore, in the AM/TK subclade, low but definite genetic divergence was found between the Northern Amami + Tokara (NAM/TK) lineage and the Southern Amami (SAM) lineage. Estimated divergence time and gene flow rate within the NAM/TK lineage indicate that this species reached northern Tokara from the south by overseas dispersal over the Tokara Gap long after its formation, but not by more recent artificial transportation. This overseas dispersal would have been facilitated by its more frequent occurrence around coastal habitats than other frogs.	[Tominaga, Atsushi] Univ Ryukyus, Fac Educ, Dept Nat Sci, Nishihara, Okinawa 9030213, Japan; [Matsui, Masafumi; Eto, Koshiro] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Eto, Koshiro] Kyoto Univ Museum, Sakyo Ku, Kyoto 6068501, Japan; [Ota, Hidetoshi] Univ Hyogo, Inst Nat & Environm Sci, Sanda, Hyogo 6691546, Japan; [Ota, Hidetoshi] Museum Nat & Human Act, Sanda, Hyogo 6691546, Japan	Tominaga, A (reprint author), Univ Ryukyus, Fac Educ, Dept Nat Sci, Senbaru 1, Nishihara, Okinawa 9030213, Japan.	tominaga@edu.u-ryukyu.ac.jp					Kakehashi R, 2013, GENES GENET SYST, V88, P59; Matsui M, 2005, MOL PHYLOGENET EVOL, V37, P733, DOI 10.1016/j.ympev.2005.04.030; Tanabe AS, 2011, MOL ECOL RESOUR, V11, P914, DOI 10.1111/j.1755-0998.2011.03021.x; HUELSENBECK JP, 1993, SYST BIOL, V42, P247, DOI 10.2307/2992463; Haramura T, 2007, J ETHOL, V25, P3, DOI 10.1007/s10164-006-0197-3; Leache AD, 2002, SYSTEMATIC BIOL, V51, P44, DOI 10.1080/106351502753475871; Haramura T, 2011, J HERPETOL, V45, P432; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Lin HD, 2012, MOL PHYLOGENET EVOL, V62, P251, DOI 10.1016/j.ympev.2011.09.022; Vos RA, 2003, SYST BIOL, V52, P368, DOI 10.1080/10635150390196993; Komaki S, 2014, GENES GENET SYST, V89, P35; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Vences M, 2013, MOL PHYLOGENET EVOL, V68, P657, DOI 10.1016/j.ympev.2013.04.014; Haramura T, 2008, COPEIA, P64, DOI 10.1643/CH-06-091; Ota H, 1998, RES POPUL ECOL, V40, P189, DOI 10.1007/BF02763404; Babik W, 2004, MOL ECOL, V13, P1469, DOI 10.1111/j.1365-294X.2004.02157.x; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Fei L, 2012, COLORED ATLAS CHINES, P619; Fouquet A, 2009, CONSERV GENET, V11, P907; Fu JZ, 2000, BIOL J LINN SOC, V71, P203, DOI 10.1006/bijl.1999.0431; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Haramura T, 2004, CURR HERPETOL, V23, P8; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HAYASHI T, 1988, ZOOL SCI, V5, P1121; Hedges S. Blair, 1993, Herpetological Monographs, V7, P27, DOI 10.2307/1466949; Honda M, 2012, MOL PHYLOGENET EVOL, V65, P642, DOI 10.1016/j.ympev.2012.07.019; Hramura T, 2007, ZOOL SCI, V24, P820; Inger RF, 2001, J BIOGEOGR, V28, P863, DOI 10.1046/j.1365-2699.2001.00580.x; Jang-Liaw NH, 2008, ZOOL SCI, V25, P68, DOI 10.2108/zsj.25.68; Jobb G, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-18; Kimura M, 2003, FLORA FAUNA INLAND W; Kimura M, 1996, J GEOGR, V105, P259; Kizaki K, 1980, NATURAL HIST RYUKYUS; Kurabayashi A, 2012, GENES GENET SYST, V87, P39; Maeda N, 1999, FROGS TOADS JAPAN; Matsui Masafumi, 2011, Current Herpetology, V30, P111; Matsui M, 2005, ZOOL SCI, V22, P489, DOI 10.2108/zsj.22.489; Nguyen T. T., 2014, CURR HERPETOL, V34, P101; NISHIOKA M, 1987, Scientific Report of the Laboratory for Amphibian Biology Hiroshima University, V9, P53; Nishizawa T, 2011, MOL PHYLOGENET EVOL, V59, P139, DOI 10.1016/j.ympev.2011.01.015; Osozawa S, 2011, INT GEOL REV, V54, P1; Ota H., 2000, TROPICS, V10, P51; Rambaut A., 2007, TRACER V1 4, V4; Tanabe AS, 2008, PHYLOGEARS VERSION 1; Tominaga A, 2013, MOL PHYLOGENET EVOL, V66, P654, DOI 10.1016/j.ympev.2012.10.015; Tominaga A, 2006, MOL PHYLOGENET EVOL, V38, P677, DOI 10.1016/j.ympev.2005.10.014; Tominaga A, 2010, MOL PHYLOGENET EVOL, V54, P910, DOI 10.1016/j.ympev.2009.11.002; Tominaga A, 2014, ZOOL SCI, V31, P64, DOI 10.2108/zsj.31.64; Tsutsui WM, 2009, COMPANION JAPANESE H	51	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					240	247		10.2108/zs140227		8	Zoology	Zoology	CI9SS	WOS:000355110700004		
J	Cornette, R; Gusev, O; Nakahara, Y; Shimura, S; Kikawada, T; Okuda, T				Cornette, Richard; Gusev, Oleg; Nakahara, Yuichi; Shimura, Sachiko; Kikawada, Takahiro; Okuda, Takashi			Chironomid Midges (Diptera, Chironomidae) Show Extremely Small Genome Sizes	ZOOLOGICAL SCIENCE			English	Article						genome size; C-value; insects; chironomids; ecological adaptation	POLYPEDILUM-VANDERPLANKI; ANTARCTIC MIDGE; THUMMI-THUMMI; DNA-CONTENT; DEHYDRATION; ANHYDROBIOSIS; INSECTS; TOLERANCE; PROTEINS; TEMPERATURES	Chironomid midges (Diptera; Chironomidae) are found in various environments from the high Arctic to the Antarctic, including temperate and tropical regions. In many freshwater habitats, members of this family are among the most abundant invertebrates. In the present study, the genome sizes of 25 chironomid species were determined by flow cytometry and the resulting C-values ranged from 0.07 to 0.20 pg DNA (i.e. from about 68 to 195 Mbp). These genome sizes were uniformly very small and included, to our knowledge, the smallest genome sizes recorded to date among insects. Small proportion of transposable elements and short intron sizes were suggested to contribute to the reduction of genome sizes in chironomids. We discuss about the possible developmental and physiological advantages of having a small genome size and about putative implications for the ecological success of the family Chironomidae.	[Cornette, Richard; Nakahara, Yuichi; Shimura, Sachiko; Kikawada, Takahiro; Okuda, Takashi] Natl Inst Agrobiol Sci, Anhydrobiosis Res Grp, Tsukuba, Ibaraki 3058634, Japan; [Gusev, Oleg; Kikawada, Takahiro] Kazan Fed Univ, Inst Fundamental Biol & Med, Kazan 420008, Russia	Okuda, T (reprint author), Natl Inst Agrobiol Sci, Anhydrobiosis Res Grp, 1-2 Owashi, Tsukuba, Ibaraki 3058634, Japan.	oku@affrc.go.jp	Gusev, Oleg/D-9383-2011; Kikawada, Takahiro/A-1289-2010	Kikawada, Takahiro/0000-0002-2329-9282	NIAS; KAKENHI of the Ministry of Education, Culture, Sports, Science and Technology of Japan [23780055, 23128512]; Russian Science Foundation [N 14-44-00022]	We are grateful to Prof. Koichiro Kawai for providing us some chironomid species and to Mr. Tadashi Kobayashi for species determination. P. tonnoiri samples were collected in Australia under regulation 17 (license number: SF007249) and D. melanogaster strains were kindly provided by the Drosophila Genetic Resource Center in Kyoto Institute of Technology. We extend our gratitude to the Federal Ministry of Environment of Nigeria for permitting research on P. vanderplanki. This work was supported by NIAS and grants-in-aid for the scientific research (KAKENHI No 23780055 & 23128512) of the Ministry of Education, Culture, Sports, Science and Technology of Japan, and partially by Russian Science Foundation grant N 14-44-00022.	ABRAHAMS.S, 1973, NATURE, V245, P460, DOI 10.1038/245460a0; Adams A, 1985, ANTENNA, V8, P58; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; Hankeln T, 1998, J MOL EVOL, V46, P589, DOI 10.1007/PL00006339; HINTON HE, 1960, J INSECT PHYSIOL, V5, P286, DOI 10.1016/0022-1910(60)90011-1; Watanabe M, 2002, J EXP BIOL, V205, P2799; Franca MB, 2007, COMP BIOCHEM PHYS A, V146, P621, DOI 10.1016/j.cbpa.2006.02.030; DANKS HV, 1971, CAN ENTOMOL, V103, P1875; FERRARI JA, 1989, EVOLUTION, V43, P895, DOI 10.2307/2409317; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Rinehart JP, 2006, P NATL ACAD SCI USA, V103, P14223, DOI 10.1073/pnas.0606840103; Johnston JS, 1999, AM J BOT, V86, P609, DOI 10.2307/2656569; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; GARLAND T, 1994, PHYSIOL ZOOL, V67, P797; Gregory TR, 2002, GENETICA, V115, P131, DOI 10.1023/A:1016032400147; Gill SS, 2010, PLANT PHYSIOL BIOCH, V48, P909, DOI 10.1016/j.plaphy.2010.08.016; Cranston PS, 2012, SYST ENTOMOL, V37, P172, DOI 10.1111/j.1365-3113.2011.00603.x; Sakurai M, 2008, P NATL ACAD SCI USA, V105, P5093, DOI 10.1073/pnas.0706197105; Kikawada T, 2006, BIOCHEM BIOPH RES CO, V348, P56, DOI 10.1016/j.bbrc.2006.07.003; Lee RE, 2006, J EXP BIOL, V209, P399, DOI 10.1242/jeb.02001; PINDER LCV, 1986, ANNU REV ENTOMOL, V31, P1; Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006; Bennett Michael D., 2005, P89, DOI 10.1016/B978-012301463-4/50004-8; KOHSHIMA S, 1984, NATURE, V310, P225, DOI 10.1038/310225a0; Yeates DK, 1999, ANNU REV ENTOMOL, V44, P397, DOI 10.1146/annurev.ento.44.1.397; Ardila-Garcia AM, 2009, J ZOOL, V278, P163, DOI 10.1111/j.1469-7998.2009.00557.x; BENNETT MD, 1982, ENVIRON EXP BOT, V22, P307, DOI 10.1016/0098-8472(82)90023-5; Cornette R, 2010, J BIOL CHEM, V285, P35889, DOI 10.1074/jbc.M110.150623; Cornette R, 2011, IUBMB LIFE, V63, P419, DOI 10.1002/iub.463; Cranston P.S., 1995, P1; Doi H, 2004, REP RES ED CTR INLAN, V2, P25; Frouz J, 2003, EUR J ENTOMOL, V100, P459; Gambi MC, 1997, J MAR BIOL ASSOC UK, V77, P1045; Gregory TR, 2014, ANIMAL GENOME SIZE D; Gregory TR, 2003, CAN J ZOOL, V81, P1399, DOI 10.1139/Z03-126; Gregory T. Ryan, 2005, P3; Gusev O, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5784; Gusev O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014008; HINTON HE, 1951, P ZOOL SOC LOND, V121, P371; HINTON HE, 1960, NATURE, V188, P336, DOI 10.1038/188336a0; Johnston JS, 2004, INSECT MOL BIOL, V13, P581, DOI 10.1111/j.0962-1075.2004.00514.x; JONES RE, 1975, J ENTOMOL SER A, V49, P111; Kaiser TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032092; Kelley JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5611; MA RZ, 1992, J INSECT PHYSIOL, V38, P161, DOI 10.1016/0022-1910(92)90064-K; Madden C. P., 1995, Chironomids: from genes to ecosystems., P89; Petitpierre E, 1996, INT J INSECT MORPHOL, V25, P115, DOI 10.1016/0020-7322(95)00024-0; RASCH EM, 1971, CHROMOSOMA, V33, P1, DOI 10.1007/BF00326379; RUF HH, 1994, METHOD ENZYMOL, V231, P95; Saether OA, 2000, SYST ENTOMOL, V25, P393, DOI 10.1046/j.1365-3113.2000.00111.x; Schmidt-Ott U, 2009, DEV GENES EVOL, V219, P207, DOI 10.1007/s00427-009-0281-0; SUNOSE T, 1982, RES POPUL ECOL, V24, P70, DOI 10.1007/BF02515590; Takagi S, 2005, HYDROBIOLOGIA, V548, P153, DOI 10.1007/s10750-005-5196-9; Worland MR, 2010, PHYSIOL ENTOMOL, V35, P140, DOI 10.1111/j.1365-3032.2010.00722.x; Yeates David K., 2005, P14	55	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					248	254		10.2108/zs140166		7	Zoology	Zoology	CI9SS	WOS:000355110700005		
J	Yasumoto, Y; Takatsuki, S				Yasumoto, Yui; Takatsuki, Seiki			The Japanese Marten Favors Actinidia arguta, a Forest Edge Liane as a Directed Seed Disperser	ZOOLOGICAL SCIENCE			English	Article						directed seed dispersal; food habits; forest edge; Japanese marten; seed disperser	CARNIVOROUS MAMMALS; FOOD-HABITS; FRUGIVORY; PREFERENCES; MELAMPUS; AGENTS; FOINA	This study demonstrates the potential of the Japanese marten (Martes melampus) to serve as a directed seed disperser of Actinidia arguta, a representative forest edge liane. Fecal compositions of the Japanese marten in a western part of Tokyo, Japan were analyzed by the point-frame method. It fed on fruits in autumn (73.1%) and winter (63.0%), and the seeds of A. arguta were most frequently eaten (47.4%). Although the vegetation in the study area was dominated by forest (95.5%), seeds found in the marten feces were dominated by those of forest edge plants (92.1%), suggesting a strong selective bias, both habitat and food, toward these species. The density of marten feces was also higher at forest edges than forest interiors. A. arguta plants were more abundant at forest edges than within the forest at Afan Wood, Nagano Prefecture. These results suggest that the Japanese marten selectively uses forest edges as a location for feeding and defecation and thus functions as a directed seed disperser of A. arguta.	[Yasumoto, Yui; Takatsuki, Seiki] Azabu Univ, Sch Vet Med, Chuo Ku, Sagamihara, Kanagawa 229859, Japan	Takatsuki, S (reprint author), Azabu Univ, Sch Vet Med, Chuo Ku, 1-17-71 Fuchinobe, Sagamihara, Kanagawa 229859, Japan.	takatuki@azabu-u.ac.jp			Azabu University	Dr. Y. Tsuji at Primate Research Institute, Kyoto University introduced us to the Bonbori Valley and advised us to collect fecal samples of the Japanese marten. Y. Kishimoto at Wildlife Management Office advised us to utilize the ArcGIS system. The C. W. Nichol Afan Woodland Trust permitted us to study Actinidia aguta and provided facilities. This research was supported by a research project grant awarded by the Azabu University.	HOWE HF, 1982, ANNU REV ECOL SYST, V13, P201, DOI 10.1146/annurev.es.13.110182.001221; Wenny DG, 2001, EVOL ECOL RES, V3, P51; JANSON CH, 1983, SCIENCE, V219, P187, DOI 10.1126/science.219.4581.187; Peredo A, 2013, BASIC APPL ECOL, V14, P378, DOI 10.1016/j.baae.2013.05.003; WILLSON MF, 1993, OIKOS, V67, P159, DOI 10.2307/3545106; REID N, 1989, ECOLOGY, V70, P137, DOI 10.2307/1938420; GAUTIERHION A, 1985, OECOLOGIA, V65, P324, DOI 10.1007/BF00378906; BUSTAMANTE RO, 1992, ACTA OECOL, V13, P203; Schaumann F, 2002, FLORA, V197, P370, DOI 10.1078/0367-2530-00053; HERRERA CM, 1989, OIKOS, V55, P250, DOI 10.2307/3565429; Arai A, 2003, HONYURUI KAGAKU, V43, P19; Asahi M, 1971, B MUKOGAWA WOMENS U, V19, P1; CHAMRAD ALBERT D., 1964, J WILDL MAGMT, V28, P473, DOI 10.2307/3798199; Gonzalez-Varo JP, 2013, J ANIM ECOL, V82, P562, DOI 10.1111/1365-2656.12024; Herrera Carlos M., 2002, P185; Hickey JR, 1999, OIKOS, V87, P499, DOI 10.2307/3546814; Ishikawa S, 1994, SEEDS FRUITS JAPAN; Koike S, 2003, WILDL CONS JPN, V8, P19; Kusui H, 1995, WILDL KII PENINSULA, V3, P15; Kusui H, 1999, SEED DISPERSAL EVOLU, P37; Nakamura T, 2001, WILDLIFE CONSERVATIO, V6, P15; Nakashima Y, 2010, OECOLOGIA, V164, P721, DOI 10.1007/s00442-010-1714-1; Nakayama S, 2000, SEEDS WILD PLANTS JA; Oi Toru, 2012, Honyurui Kagaku, V52, P1; Otani T, 2002, ECOL RES, V17, P29, DOI 10.1046/j.1440-1703.2002.00460.x; Rico-Guzman Encarnacion, 2012, Galemys, V24, P25; Sakamoto Y, 2006, RES REP U FOREST IWA, V37, P17; Sakamoto Y, ZOOL SCI IN PRESS; Satake Y, 1989, WILD FLOWERS JAPAN W; STEWART DRM, 1967, J APPL ECOL, V4, P83, DOI 10.2307/2401411; Takatsuki Seiki, 2012, Honyurui Kagaku, V52, P167; Tsuji Y, 2014, ACTA THERIOL, V59, P479, DOI 10.1007/s13364-014-0181-1; Tsuji Y, 2004, ECOL RES, V19, P381, DOI 10.1111/j.1440-1703.2004.00648.x; Tsuji Y, 2011, MAMM BIOL, V76, P628, DOI 10.1016/j.mambio.2011.01.002; Ueuma Y, 2005, RES REPORTS HAKUSAN, V32, P31; Wenny DG, 2000, ECOL MONOGR, V70, P331, DOI 10.1890/0012-9615(2000)070[0331:SDSPAS]2.0.CO;2; Yamagishi M, 1990, B TOKYO U FOR, V83, P9; Yamamoto S, 2000, J FOREST RES, V5, P223, DOI [10.1007/BF02767114, DOI 10.1007/BF02767114]; Yamamoto Y, 1994, NATURAL ENV SCI RES, V7, P45; Zhou YB, 2008, J TROP ECOL, V24, P219, DOI 10.1017/S0266467408004793	40	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					255	259		10.2108/zs140241		5	Zoology	Zoology	CI9SS	WOS:000355110700006		
J	Oka, S; Miyamoto, K; Matsuzaki, S; Sato, T				Oka, Shin-ichiro; Miyamoto, Kei; Matsuzaki, Shohei; Sato, Taku			Growth of the Coconut Crab, Birgus latro, at its Northernmost Range Estimated from Mark-Recapture Using Individual Identification Based on Carapace Grooving Patterns	ZOOLOGICAL SCIENCE			English	Article						robber crab; northern limit; photo matching; recapture; GROTAG	ANOMURA COENOBITIDAE; LOBSTERS; ISLAND	Although populations of the coconut crab, Birgus latro, have declined in the tropical Indo-Pacific region, insufficient knowledge exists for the management of this species. We investigated the growth of the northernmost coconut crab population, located at Ocean Expo Park, Okinawa, southern Japan, using a mark-recapture method based on the identification of individual carapace grooving patterns. Of the 485 crabs photographed (264 males, 221 females; 14.3-68.8 mm thoracic length [ThL]), 64 males and 62 females were recaptured (recapture rate 26%). The liberty period ranged from two to 2384 days. The annual data indicated that most crabs molted during winter, except for juveniles and crabs near the maximum size. Using the GROTAG program, the asymptotic ThL (L-infinity) was estimated as 80.72 and 49.89 mm for males and females, respectively. The Brody growth coefficient (K) was 0.063 for both sexes. The growth curves from these parameters showed that males grew larger than females because of a difference in growth speed. Longevity was estimated at approximately 50 years for both sexes. The growth data obtained in the present study, which are the most precise gathered for the coconut crab to date, can be compared with the results of studies performed in other regions.	[Oka, Shin-ichiro; Miyamoto, Kei; Matsuzaki, Shohei] Okinawa Churashima Fdn, Okinawa 9050206, Japan; [Sato, Taku] Fisheries Res Agcy, Seikai Natl Fisheries Res Inst, Res Ctr Subtrop Fisheries, Okinawa 9070451, Japan	Oka, S (reprint author), Okinawa Churashima Fdn, 888 Ishikawa, Okinawa 9050206, Japan.	sh-oka@okichura.jp					FLETCHER WJ, 1990, J EXP MAR BIOL ECOL, V141, P63, DOI 10.1016/0022-0981(90)90158-9; Kilada R, 2012, CAN J FISH AQUAT SCI, V69, P1728, DOI 10.1139/cjfas-2012-0254; Drew MM, 2010, ZOOL ANZ, V249, P45, DOI 10.1016/j.jcz.2010.03.001; Simpfendorfer CA, 2000, FISH B-NOAA, V98, P811; Sato T, 2013, AQUAT BIOL, V19, P143, DOI 10.3354/ab00517; Drew MM, 2013, AQUAT BIOL, V19, P129, DOI 10.3354/ab00523; Drew MM, 2012, CRUSTACEANA, V85, P89, DOI 10.1163/156854012X623656; Fletcher WJ, 1993, NEARSHORE MARINE RES, P643; Fletcher WJ, 1991, AUSTR CTR INT AGR RE, V8, P35; Francis R.I.C.C., 1988, New Zealand Journal of Marine and Freshwater Research, V22, P42; Hartnoll R.G., 1982, P111; OKA S, 2013, CRUSTAC RES     1220, P17; Oka Shin-ichiro, 2014, Biological Magazine Okinawa, V52, P11; Sato T, 2010, MAR ECOL PROG SER, V402, P171, DOI 10.3354/meps08369; Stewart J, 2000, MAR BIOL, V136, P921, DOI 10.1007/s002270000272	15	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					260	265		10.2108/zs150008		6	Zoology	Zoology	CI9SS	WOS:000355110700007		
J	Kukita, S; Gouda, M; Ikeda, S; Ishibashi, S; Furuya, T; Nakamura, K				Kukita, Sayuri; Gouda, Mika; Ikeda, Sakiko; Ishibashi, Sakiko; Furuya, Tatsunori; Nakamura, Keiji			Effects of Photoperiod and Temperature on Growth and Development in Clouded Salamander (Hynobius nebulosus) Larvae	ZOOLOGICAL SCIENCE			English	Article						Hynobius nebulosus; phenotypic plasticity; body size; metamorphosis; growth rate; developmental period; photoperiod; temperature	AMPHIBIAN METAMORPHOSIS; ADAPTIVE SIGNIFICANCE; FOOD LEVEL; EGG SIZE; PHENOTYPIC PLASTICITY; AMBYSTOMA-TALPOIDEUM; SCAPHIOPUS-COUCHII; RANA-TEMPORARIA; COMMON FROG; TADPOLES	Day length is one of the most important factors that organisms use to predict seasonal changes in their environment. Several amphibians regulate their growth and development in response to photoperiod. However, many studies have not focused on the ecological effects of the photoperiodic response on growth and development because they use tropical animals, animals from a commercial source or from unknown localities, or extreme light regimens for experiments. In the present study, we examined the effects of photoperiod on growth and development in the clouded salamander (Hynobius nebulosus) by raising larvae under different photoperiods and at different temperatures in the laboratory. The average larval period under a long-day photoperiod of L16:D8 was longer than that under L12:D12 at 15 degrees C or 20 degrees C, although the difference between the photoperiods was only significant for 15 degrees C. Juveniles weighed more at metamorphosis under L16:D8 than those under L12:D12, irrespective of temperature, suggesting that a longer developmental period results in a heavier body weight. The head width of juveniles did not differ for different photoperiods at either temperature. However, the growth rate of the head width under L12:D12 was faster than that under L16:D8 at 15 degrees C. Long day length appears to produce larger H. nebulosus juveniles in a relatively stable aquatic environment with a low population density. Thus, development may be accelerated when the day length becomes shorter as winter approaches, and larvae may have increased the growth rate of their head widths to compensate for the shorter growing period under shorter day lengths.	[Kukita, Sayuri; Gouda, Mika; Ikeda, Sakiko; Ishibashi, Sakiko] Okayama Univ Sci, Fac Informat, Dept Biosphere Geosphere Syst Sci, Okayama 7000005, Japan; [Furuya, Tatsunori] Tsuguro Satoyama Nat Field, Maniwa 7000513, Japan; [Nakamura, Keiji] Okayama Univ Sci, Fac Biosphere Geosphere Sci, Dept Biosphere Geosphere Sci, Okayama 7000005, Japan	Nakamura, K (reprint author), Okayama Univ Sci, Fac Biosphere Geosphere Sci, Dept Biosphere Geosphere Sci, Okayama 7000005, Japan.	nakamura@big.ous.ac.jp					Rose CS, 2005, TRENDS ECOL EVOL, V20, P129, DOI 10.1016/j.tree.2005.01.005; SEMLITSCH RD, 1988, ECOLOGY, V69, P184, DOI 10.2307/1943173; Doughty P, 2003, AUST J ZOOL, V51, P271, DOI 10.1071/ZO02075; PARICHY DM, 1992, OECOLOGIA, V91, P579, DOI 10.1007/BF00650334; HENSLEY FR, 1993, ECOLOGY, V74, P2405, DOI 10.2307/1939591; SMITH DC, 1987, ECOLOGY, V68, P344, DOI 10.2307/1939265; Marshall DJ, 2007, OIKOS, V116, P1957, DOI 10.1111/j.2007.0030-1299.16203.x; Bradshaw WE, 2007, ANNU REV ECOL EVOL S, V38, P1, DOI 10.1146/annurev.ecolsys.37.091305.110115; NEWMAN RA, 1987, OECOLOGIA, V71, P301, DOI 10.1007/BF00377299; Uller T, 2008, TRENDS ECOL EVOL, V23, P432, DOI 10.1016/j.tree.2008.04.005; Newman RA, 1998, OECOLOGIA, V115, P9, DOI 10.1007/s004420050485; WILBUR HM, 1973, SCIENCE, V182, P1305, DOI 10.1126/science.182.4119.1305; NEWMAN RA, 1994, ECOLOGY, V75, P1085, DOI 10.2307/1939432; Rossiter MC, 1996, ANNU REV ECOL SYST, V27, P451, DOI 10.1146/annurev.ecolsys.27.1.451; Mousseau TA, 1998, TRENDS ECOL EVOL, V13, P403, DOI 10.1016/S0169-5347(98)01472-4; NEWMAN RA, 1989, ECOLOGY, V70, P1775, DOI 10.2307/1938111; Bernardo J, 1996, AM ZOOL, V36, P216; Reinhold K, 2002, J HERED, V93, P400, DOI 10.1093/jhered/93.6.400; Denver RJ, 1998, ECOLOGY, V79, P1859, DOI 10.1890/0012-9658(1998)079[1859:APIAMR]2.0.CO;2; Benard MF, 2004, ANNU REV ECOL EVOL S, V35, P651, DOI 10.1146/annurev.ecolsys.35.021004.112426; SEMLITSCH RD, 1985, OECOLOGIA, V65, P305, DOI 10.1007/BF00378903; Lind MI, 2008, P R SOC B, V275, P1073, DOI 10.1098/rspb.2007.1737; SEMLITSCH RD, 1988, COPEIA, P978; Atkinson D., 1996, ANIMALS TEMPERATURE, P183, DOI 10.1017/CBO9780511721854.009; ATKINSON D, 1994, ADV ECOL RES, V25, P1, DOI 10.1016/S0065-2504(08)60212-3; Beck CW, 1997, OECOLOGIA, V112, P187, DOI 10.1007/s004420050299; BERVEN KA, 1988, OECOLOGIA, V75, P67, DOI 10.1007/BF00378815; Buchanan Bryant W., 2006, P192; COLLINS JP, 1983, AM ZOOL, V23, P77; CUMMINS CP, 1986, J ANIM ECOL, V55, P303, DOI 10.2307/4710; Danks HV, 1987, INSECT DORMANCY ECOL; Gotthard K, 1999, OIKOS, V84, P453, DOI 10.2307/3546424; Gotthard K, 2001, EXPTL BIOL REV, P287; Gotthard K, 2008, BIOSCIENCE, V58, P222, DOI 10.1641/B580308; KAPLAN RH, 1985, COPEIA, P1028; KUSANO T, 1985, COPEIA, P472, DOI 10.2307/1444861; Laurila A, 2001, OIKOS, V95, P451, DOI 10.1034/j.1600-0706.2001.950310.x; Musolin DL, 2003, ECOL ENTOMOL, V28, P694, DOI 10.1111/j.1365-2311.2003.00559.x; Nishihara A, 1996, COPEIA, P478, DOI 10.2307/1446871; PFENNIG D, 1990, OECOLOGIA, V85, P101, DOI 10.1007/BF00317349; SEMLITSCH RD, 1982, ECOLOGY, V63, P905, DOI 10.2307/1937230; Shintani Y, 2010, ENTOMOL SCI, V13, P367, DOI 10.1111/j.1479-8298.2010.00403.x; Tauber MJ, 1986, SEASONAL ADAPTATIONS; WALLS SC, 1993, OECOLOGIA, V96, P162, DOI 10.1007/BF00317728; Weil Zachary M., 2010, P399; Wells K.D., 2007, ECOLOGY BEHAV AMPHIB; Yamada M, 2006, B OKAYAMA PREF NATUR, V14, P1	47	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					266	271		10.2108/zs140220		6	Zoology	Zoology	CI9SS	WOS:000355110700008		
J	Hirota, A; Takiya, Y; Sakamoto, J; Shiojiri, N; Suzuki, M; Tanaka, S; Okada, R				Hirota, Atsushi; Takiya, Yu; Sakamoto, Joe; Shiojiri, Nobuyoshi; Suzuki, Masakazu; Tanaka, Shigeyasu; Okada, Reiko			Molecular Cloning of cDNA Encoding an Aquaglyceroporin, AQP-h9, in the Japanese Tree Frog, Hyla japonica: Possible Roles of AQP-h9 in Freeze Tolerance	ZOOLOGICAL SCIENCE			English	Article						aquaporin; aquaglyceroporin; hibernation; freeze tolerance; Hyla japonica	WATER-CHANNEL; GENE-EXPRESSION; GRAY TREEFROG; GLYCEROL UPTAKE; AQUAPORINS; KIDNEY; LOCALIZATION; CHRYSOSCELIS; PROTEIN; ERYTHROCYTES	In order to study the freeze-tolerance mechanism in the Japanese tree frog, Hyla japonica, we cloned a cDNA encoding aquaporin (AQP) 9 from its liver. The predicted amino acid sequence of H. japonica AQP9 (AQP-h9) contained six putative transmembrane domains and two conserved Asn-Pro-Ala motifs, which are characteristic of AQPs. A swelling assay using Xenopus laevis oocytes injected with AQP-h9 cRNA showed that AQP-h9 facilitated water and glycerol permeation, confirming its property as an aquaglyceroporin. Subsequently, glycerol concentrations in serum and tissue extracts were compared among tree frogs that were hibernating, frozen, or thawed after freezing. Serum glycerol concentration of thawed frogs was significantly higher than that of hibernating frogs. Glycerol content in the liver did not change in the freezing experiment, whereas that in the skeletal muscle was elevated in thawed frogs as compared with hibernating or frozen frogs. Histological examination of the liver showed that erythrocytes aggregated in the sinusoids during hibernation and freezing, and immunoreactive AQP-h9 protein was detected over the erythrocytes. The AQP-h9 labeling was more intense in frozen frogs than in hibernating frogs, but nearly undetectable in thawed frogs. For the skeletal muscle, weak labels for AQP-h9 were observed in the cytoplasm of myocytes of hibernating frogs. AQP-h9 labeling was markedly enhanced by freezing and was decreased by thawing. These results indicate that glycerol may act as a cryoprotectant in H. japonica and that during hibernation, particularly during freezing, AQP-h9 may be involved in glycerol uptake in erythrocytes in the liver and in intracellular glycerol transport in the skeletal muscle cells.	[Hirota, Atsushi; Sakamoto, Joe; Shiojiri, Nobuyoshi; Suzuki, Masakazu; Tanaka, Shigeyasu; Okada, Reiko] Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Shizuoka 4228529, Japan; [Takiya, Yu; Shiojiri, Nobuyoshi; Suzuki, Masakazu; Tanaka, Shigeyasu; Okada, Reiko] Shizuoka Univ, Grad Sch Sci, Dept Biol, Shizuoka 4228529, Japan	Okada, R (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Integrated Biosci Sect, Shizuoka 4228529, Japan.	okada.reiko@shizuoka.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [20570055, 23370028, 26440165]	We express our sincere gratitude to Professor S. Kikuyama at Waseda University for his helpful comments and suggestion. We are very grateful to Dr. H. Mochida (Tanpaku Seisei Co.) for his generous technical assistance. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan to RO, MS, and ST (20570055; 23370028; 26440165).	Rojek A, 2008, ANNU REV PHYSIOL, V70, P301, DOI 10.1146/annurev.physiol.70.113006.100452; FUSHIMI K, 1993, NATURE, V361, P549, DOI 10.1038/361549a0; Ogushi Y, 2007, ENDOCRINOLOGY, V148, P5891, DOI 10.1210/en.2007-0613; Hansen M, 2002, J BIOL CHEM, V277, P4874, DOI 10.1074/jbc.M110683200; Ishibashi K, 1998, BIOCHEM BIOPH RES CO, V244, P268, DOI 10.1006/bbrc.1998.8252; Akabane G, 2007, AM J PHYSIOL-REG I, V292, pR2340, DOI 10.1152/ajpregu.00905.2006; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Kingsley PD, 2013, BLOOD, V121, pE5, DOI 10.1182/blood-2012-04-422394; Ishibashi K, 2011, AM J PHYSIOL-REG I, V300, pR566, DOI 10.1152/ajpregu.90464.2008; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Wakayama Y, 2004, CELL TISSUE RES, V316, P123, DOI 10.1007/s00441-004-0857-y; Virkki LV, 2002, J BIOL CHEM, V277, P40610, DOI 10.1074/jbc.M206157200; Wakayama Y, 2002, HISTOCHEM J, V34, P331, DOI 10.1023/A:1023382609541; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Tanii H, 2002, J MEMBRANE BIOL, V188, P43, DOI 10.1007/s00232-001-0172-4; Hasegawa T, 2003, ENDOCRINOLOGY, V144, P4087, DOI 10.1210/en.2003-0418; Shibata Y, 2014, AM J PHYSIOL-REG I, V307, pR44, DOI 10.1152/ajpregu.00186.2013; Zardoya R, 2005, BIOL CELL, V97, P397, DOI 10.1042/BC20040134; STOREY KB, 1984, J COMP PHYSIOL B, V155, P29, DOI 10.1007/BF00688788; ZHANG R, 1990, J BIOL CHEM, V265, P15375; Zimmerman SL, 2007, AM J PHYSIOL-REG I, V292, pR544, DOI 10.1152/ajpregu.00434.2006; Benga G, 2009, IUBMB LIFE, V61, P112, DOI 10.1002/iub.156; Suzuki M, 2010, J NEUROENDOCRINOL, V22, P407, DOI 10.1111/j.1365-2826.2010.01981.x; Liu YJ, 2007, P NATL ACAD SCI USA, V104, P12560, DOI 10.1073/pnas.0705313104; Pandey RN, 2010, COMP BIOCHEM PHYS A, V157, P86, DOI 10.1016/j.cbpa.2010.04.007; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Maeda N, 2012, MOL ASPECTS MED, V33, P665, DOI 10.1016/j.mam.2012.02.004; COSTANZO JP, 1992, COPEIA, P565; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Goldstein DL, 2010, J COMP PHYSIOL B, V180, P1257, DOI 10.1007/s00360-010-0496-4; Hillman SS, 2008, ECOLOGICAL ENV PHYSL; Inoue M, 2009, J MOL HISTOL, V40, P165, DOI 10.1007/s10735-009-9226-1; Layne JR, 2001, J EXP ZOOL, V290, P1, DOI 10.1002/jez.1030; LAYNE JR, 1989, J EXP ZOOL, V249, P133, DOI 10.1002/jez.1402490203; Mutyam V, 2011, J EXP ZOOL PART A, V315A, P424, DOI 10.1002/jez.689; Nakakura T, 2009, HISTOCHEM CELL BIOL, V131, P141, DOI 10.1007/s00418-008-0494-8; Nei M., 2000, MOL EVOLUTION PHYLOG; Saitoh Y, 2014, GEN ENDOCRINOLOGY, V155, P2166; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; SCHMID WD, 1982, SCIENCE, V215, P697, DOI 10.1126/science.7058335; Shibata Y, 2014, GEN COMP ENDOCRINOL; STOREY JM, 1985, CAN J ZOOL, V63, P49; Sugiura K, 2008, COMP BIOCHEM PHYS A, V151, P173, DOI 10.1016/j.cbpa.2008.06.014; TANAKA S, 1992, ENDOCRINOLOGY, V131, P779, DOI 10.1210/en.131.2.779	45	1	1	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					296	306		10.2108/zs140246		11	Zoology	Zoology	CI9SS	WOS:000355110700013		
J	Urata, M				Urata, Makoto			Molecular Identification of Ptychodera flava (Hemichordata: Enteropneusta): Reconsideration in Light of Nucleotide Polymorphism in the 18S Ribosomal RNA Gene	ZOOLOGICAL SCIENCE			English	Article						Ptychodera flava; Enteropneusta; Hemichordata; acorn worm; polymorphism; 18S; ITS; mit16S; mitCO1	ACORN WORMS; DEEP-SEA; PHYLOGENY; EVOLUTION; REGENERATION; INSIGHTS	Seven nuclear and mitochondrial DNA markers were examined in 12 specimens of Ptychodera flava, a model acorn worm used in molecular biology, collected in Japan from three local populations with different modes of living. A comparison of intraspecific results did not show genetically isolated populations despite the species' enclave habitats and asexual reproduction. Moreover, both the nuclear 18S ribosomal RNA gene and mitochondrial 16S ribosomal RNA gene sequences were identical to those from Moorea in French Polynesia, nearly 10,000 kilometers away from Japan. I also provide the first definitive information regarding polymorphisms in 18S ribosomal RNA gene, the external transcribed spacer (ETS), internal transcribed spacers (ITS), and mitochondrial cytochrome c oxidase subunit 1 (mtCO1) sequence in hemichordates using newly designed primer sets, and I show both high larval vagility and certain criteria for the molecular identification of this species.	Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Takehara Marine Sci Stn, Hiroshima 7250024, Japan	Urata, M (reprint author), Hiroshima Univ, Grad Sch Biosphere Sci, Setouchi Field Sci Ctr, Takehara Marine Sci Stn, 5-8-1 Minato Machi, Hiroshima 7250024, Japan.	urata@hiroshima-u.ac.jp					Perseke M, 2010, MOL PHYLOGENET EVOL, V56, P201, DOI 10.1016/j.ympev.2010.01.035; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Winchell CJ, 2002, MOL BIOL EVOL, V19, P762; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Freeman R, 2012, CURR BIOL, V22, P2053, DOI 10.1016/j.cub.2012.08.052; Giribet G, 2000, SYST BIOL, V49, P539, DOI 10.1080/10635159950127385; Humphreys T, 2010, ZOOL SCI, V27, P91, DOI 10.2108/zsj.27.91; Cameron CB, 2005, CAN J ZOOL, V83, P196, DOI 10.1139/Z04-190; Rychel AL, 2008, DEV DYNAM, V237, P3222, DOI 10.1002/dvdy.21747; Cameron CB, 2000, P NATL ACAD SCI USA, V97, P4469, DOI 10.1073/pnas.97.9.4469; Cannon JT, 2009, MOL PHYLOGENET EVOL, V52, P17, DOI 10.1016/j.ympev.2009.03.027; Osborn KJ, 2012, P ROY SOC B-BIOL SCI, V279, P1646, DOI 10.1098/rspb.2011.1916; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Bjornberg T. K. S., 1959, Boletim do Instituto Oceanografico Sao Paulo, V10, P1; Burdon-Jones C., 1998, Zoological Catalogue of Australia, V34, P1; Cannon JT, 2013, BIOL BULL-US, V225, P194; Hadfield M.G., 1975, P185; Hadfield M.G., 1978, P247; Holland ND, 2013, J MAR BIOL ASSOC UK, V93, P2197, DOI 10.1017/S0025315413000684; Horst CJ van der, 1939, KLASSEN ORDNUNGEN TI, V4, P1; Ikuta T, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-129; Miyamoto N, 2010, DEV GROWTH DIFFER, V52, P615, DOI 10.1111/j.1440-169X.2010.01197.x; Miyamoto Norio, 2008, Taxa, V25, P29; Nishikawa T, 1995, GUIDE SEASHORE ANIMA, VII, P494; NISHIKAWA T, 1977, Publications of the Seto Marine Biological Laboratory, V23, P393; SCHELTEMA R S, 1987, Biological Oceanography, V5, P85; Smith SE, 2003, CAN J ZOOL, V81, P133, DOI 10.1139/Z02-228; Trewavas E ., 1931, Scientific Reports Great Barrier Reef Expedition, V4, P39; van der Horst CJ, 1924, BIJDR DIERK, V23, P33; Willey A, 1897, Q J MICROSC SCI, V40, P165; Worsaae K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048529	31	0	0	ZOOLOGICAL SOC JAPAN	TOKYO	HONGO MT BUILDING 4F, HONGO 7-2-2, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0289-0003			ZOOL SCI	Zool. Sci.	JUN	2015	32	3					307	313		10.2108/zs140144		7	Zoology	Zoology	CI9SS	WOS:000355110700014		
J	Senda, K; Petrovic, M; Nakanishi, K				Senda, Kei; Petrovic, Mario; Nakanishi, Kei			Wrinkle generation in shear-enforced rectangular membrane	ACTA ASTRONAUTICA			English	Article						Membrane wrinkling; Bifurcation structure; FEM	FINITE-ELEMENT-ANALYSIS; NONLINEAR SHELL ANALYSIS; THIN MEMBRANES	The objective of this study is to clarify the wrinkle behavior of a flat rectangular membrane undergoing shear displacement. To achieve this goal, an equilibrium path tracking method using a finite element method is developed. This method includes a bifurcation path tracking analysis that searches for bifurcation solutions. This method establishes an image of the membrane behavior by calculating a series of successive equilibrium states before and after bifurcation buckling. Generally in experiments, flat rectangular membranes have shear displacement imposed on top or bottom edges, while the left and right sides have free boundaries. At large values of shear displacement, the wrinkles cover the entire membrane, but the free boundaries result in uneven shapes and distributions. Further increase in shear results in small wrinkles, referred to as collapsed sections, generated on existing wrinkles. As collapsed sections grow, new wrinkles are generated. However, the universality of this wrinkle generation mechanism may be affected by the free boundaries. By applying cyclic boundary conditions, effects of free boundaries, which include uneven wrinkle shape and distribution, can be eliminated. In addition, by changing the membrane aspect ratio, the effects of geometry are also evaluated. For all membranes, the wrinkle generation from collapsed sections is observed and its independence from free boundaries and aspect ratio is shown. By analyzing stress and displacement fields, the formation of collapsed sections is explained. In addition, for the cyclic boundary conditions, the change in aspect ratio results in almost the same bifurcation structure. Therefore, the wrinkle behavior evaluation in this study can be useful in predicting wrinkle behavior. (C) 2015 IAA. Published by Elsevier Ltd. All rights reserved.	[Senda, Kei; Petrovic, Mario; Nakanishi, Kei] Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Nishikyo Ku, Kyoto 6158530, Japan	Senda, K (reprint author), Kyoto Univ, Grad Sch Engn, Dept Aeronaut & Astronaut, Nishikyo Ku, Kyoto 6158530, Japan.	senda@kuaero.kyoto-u.ac.jp; mapetrov@live.com; keinakanishi5@gmail.com					Reddy BS, 1996, IEEE T IMAGE PROCESS, V5, P1266, DOI 10.1109/83.506761; Wang CG, 2009, INT J SOLIDS STRUCT, V46, P1516, DOI 10.1016/j.ijsolstr.2008.11.018; Bazant Z. P., 1991, STABILITY STRUCTURES; Chmielewsk A. B., 2001, GOSSAMER SPACECRAFT, P1; Endo A., 1976, POSTBUCKLING ANAL EL; Hoyle R., 2007, PATTERN FORMATION; Inoue S, 2009, PROGRESS IN SAFETY MANAGEMENT RESEARCH AND PRACTICE, P1; Leifer J, 2010, J SPACECRAFT ROCKETS, V47, P214, DOI 10.2514/1.45672; MILLER RK, 1985, COMPUT STRUCT, V20, P631, DOI 10.1016/0045-7949(85)90111-7; MILLER RK, 1982, AIAA J, V20, P1761, DOI 10.2514/3.8018; Miyazaki Y, 2006, INT J NUMER METH ENG, V66, P1179, DOI 10.1002/nme.1588; Senda K., 2006, P AIAA ATM FLIGHT ME, P1; Senda K., 2012, P AIAA GOSS SPAC FOR; Tessler A, 2005, J SPACECRAFT ROCKETS, V42, P287, DOI 10.2514/1.3915; Tessler A, 2007, J SPACECRAFT ROCKETS, V44, P582, DOI 10.2514/1.22913; Timoshenko S. P., 2010, THEORY ELASTIC STABI, V2nd; Wiggers P., 1988, COMPUT METHODS APPL, V70, P329; Wong Y.W., 2006, J MECH MATER STRUCT, V1, P1; Woo K, 2013, J SPACECRAFT ROCKETS, V50, P1024, DOI 10.2514/1.A32183; WRIGGERS P, 1988, COMPUT METHOD APPL M, V70, P329, DOI 10.1016/0045-7825(88)90024-2	20	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	JUN-JUL	2015	111						110	135		10.1016/j.actaastro.2015.02.022		26	Engineering, Aerospace	Engineering	CI2NY	WOS:000354585500011		
J	Boden, RC; Hein, AM; Kawaguchi, J				Boden, Ralf C.; Hein, Andreas M.; Kawaguchi, Junichiro			Target selection and mass estimation for manned NEO exploration using a baseline mission design	ACTA ASTRONAUTICA			English	Article						Asteroids; Near Earth Objects; Human space exploration; Manned missions; Mission design	SAMPLE RETURN MISSION; HAYABUSA	In recent years Near-Earth Objects (NEOs) have received an increased amount of interest as a target for human exploration. NEOs offer scientifically interesting targets, and at the same time function as a stepping stone for achieving future Mars missions. The aim of this research is to identify promising targets from the large number of known NEOs that qualify for a manned sample-return mission with a maximum duration of one year. By developing a baseline mission design and a mass estimation model, mission opportunities are evaluated based on on-orbit mass requirements, safety considerations, and the properties of the potential targets. A selection of promising NEOs is presented and the effects of mission requirements and restrictions are discussed. Regarding safety aspects, the use of free-return trajectories provides the lowest on-orbit mass, when compared to an alternative design that uses system redundancies to ensure return of the spacecraft to Earth. It is discovered that, although a number of targets are accessible within the analysed time frame, no NEO offers both easy access and high incentive for its exploration. Under the discussed aspects a first human exploration mission going beyond the vicinity of Earth will require a trade off between targets that provide easy access and those that are of scientific interest. This lack of optimal mission opportunities can be seen in the small number of only 4 NEOs that meet all requirements for a sample-return mission and remain below an on-orbit mass of 500 metric Tons (mT). All of them require a mass between 315 and 492 mT. Even less ideal, smaller asteroids that are better accessible require an on-orbit mass that exceeds the launch capability of future heavy lift vehicles (HLV) such as SLS by at least 30 mT. These mass requirements show that additional efforts are necessary to increase the number of available targets and reduce on-orbit mass requirements through advanced mission architectures. The need for on-orbit assembly also becomes apparent, as availability of a HLV alone does not provide sufficient payload capabilities for any manned mission targeting NEOs. (C) 2015 IAA. Published by Elsevier Ltd. All rights reserved.	[Boden, Ralf C.; Hein, Andreas M.] Tech Univ Munich, D-80290 Munich, Germany; [Kawaguchi, Junichiro] Japan Aerosp Explorat Agcy JAXA, Tokyo, Japan	Boden, RC (reprint author), Tech Univ Munich, D-80290 Munich, Germany.	boden.ralf@mytum.de; a.hein@tum.de; kawaguchi.junichiro@jaxa.jp					Agostinelli S, 2003, NUCL INSTRUM METH A, V506, P250, DOI 10.1016/S0168-9002(03)01368-8; Allison J, 2006, IEEE T NUCL SCI, V53, P270, DOI 10.1109/TNS.2006.869826; Tsuda Y, 2013, ACTA ASTRONAUT, V91, P356, DOI 10.1016/j.actaastro.2013.06.028; Chesley SR, 2002, ICARUS, V159, P423, DOI 10.1006/icar.2002.6910; Kawaguchi J, 2008, ACTA ASTRONAUT, V62, P639, DOI 10.1016/j.actaastro.2008.01.028; Warner BD, 2009, ICARUS, V202, P134, DOI 10.1016/j.icarus.2009.02.003; Barbee B., 2011, TECHNICAL REPORT; Berry R. L, 1970, AIAA 8 AER SCI M AM; Binzel R. P., 1989, ASTEROIDS, VII, P1139; Boden R. C., 2010, P 20 WORKSH JAXA AST, P221; Boden R. C., 2012, THESIS TU MUNCHEN; Boden R. C., 2013, THESIS TU MUNCHEN; Bowell E., 1989, ASTEROIDS, P524; Brophy J., 2012, ASTEROID RETRIEVAL F; Bryan C., 1969, LUNAR MODULE STRUCTU; Caporicci M., 2010, 61 INT ASTR C IAF; Chamberlin A., NEAR EARTH ASTEROID; Cohen M. M., 2009, AIAA SPACE 2009 C EX; Course F., 1969, APOLLO LUNAR SURFACE; Curtis H. D., 2005, ORBITAL MECH ENG STU; delaFuente H., 2000, AIAA SPAC INFL FOR; Desmars J., 2011, SF2A 2011; Drake B. G., 2009, HUMAN EXPLORATION MA; Elvis M, 2011, PLANET SPACE SCI, V59, P1408, DOI 10.1016/j.pss.2011.05.006; Hofstetter W., 2005, P 15 ANN INT S INT C; JAXA-International 'Manned Spacecraft Investigation Team, 2010, MANN SPAC SYST INT R; Korsmeyer DJ, 2008, ACTA ASTRONAUT, V63, P213, DOI 10.1016/j.actaastro.2007.12.014; Larson W., 2000, HUMAN SPACEFLIGHT MI; Lauretta D., 2012, 43 LUN PLAN I SCI C; Mainzer A, 2011, ASTROPHYS J, V743, DOI 10.1088/0004-637X/743/2/156; Maynard O. E., 1966, P AP LUN LAND MISS S, P11; McLaughlin R. J., 2001, TECHNICAL REPORT; Michel P, 2014, ACTA ASTRONAUT, V93, P530, DOI 10.1016/j.actaastro.2012.05.030; Orloff R. W., 1996, APOLLO NUMBERS; Pravec P., 2002, ASTEROIDS, VIII, P113; Shoemaker E. M., 1979, EARTH CROSSING ASTER, P253; Smith E., 1966, MANNED FLYBY MISSION, P61; Taylor J., 2006, DESCANSO DESIGN PERF, V12; Ueda M, 2011, PUBL ASTRON SOC JPN, V63, P947; Wagner S., 2009, IAC09D2 IOW STAT U; Wagner S., 2010, 10249 AAS, V10, P249; Walter U., 2007, ASTRONAUTICS; Wertz J. R., 1999, SPACE MISSION ANAL D; Wright M., 2002, BRIEF HIST LUNAR ROV; Yeomans D., NEAR EARTH OBJECT GR	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0094-5765	1879-2030		ACTA ASTRONAUT	Acta Astronaut.	JUN-JUL	2015	111						198	221		10.1016/j.actaastro.2015.02.018		24	Engineering, Aerospace	Engineering	CI2NY	WOS:000354585500017		
J	Yoshino, M; Kin, T; Ito, A; Saito, T; Nakagawa, D; Ino, K; Kamada, K; Mori, H; Kunimatsu, A; Nakatomi, H; Oyama, H; Saito, N				Yoshino, Masanori; Kin, Taichi; Ito, Akihiro; Saito, Toki; Nakagawa, Daichi; Ino, Kenji; Kamada, Kyousuke; Mori, Harushi; Kunimatsu, Akira; Nakatomi, Hirofumi; Oyama, Hiroshi; Saito, Nobuhito			Feasibility of diffusion tensor tractography for preoperative prediction of the location of the facial and vestibulocochlear nerves in relation to vestibular schwannoma	ACTA NEUROCHIRURGICA			English	Article						Diffusion tensor tractography; Facial nerve; Vestibulocochlear nerve; Vestibular schwannoma; Fractional anisotropy threshold	VISUALIZATION; PRESERVATION; SURGERY; HEARING	According to recent findings, diffusion tensor tractography (DTT) only allows prediction of facial nerve location in relation to vestibular schwannoma (VS) with high probability. However, previous studies have not mentioned why only the facial nerve was selectively visualized. Our previous report investigated the optimal conditions of DTT for normal facial and vestibulocochlear nerves. In the present study, we applied the optimal conditions of DTT to VS patients to assess the feasibility of DTT for the facial and vestibulocochlear nerves. We investigated 11 patients with VS who underwent tumor resection. Visualized tracts were compared with locations of the facial and cochlear nerves as identified by intraoperative electrophysiological monitoring. With the proposed method, visualized tracts corresponded to pathway area of the facial or cochlear nerves in nine of 11 patients (81.8 %); specifically, to the pathway area of the facial nerve in three of 11 patients (27.3 %), and to the pathway area of the cochlear nerve in six of 11 patients (54.5 %). We visualized facial or vestibulocochlear nerves in nine of 11 patients (81.8 %). For the first time, DTT proved able to visualize not only the facial nerve but also the vestibulocochlear nerve in VS patients. Despite our findings, good methods for distinguishing whether a visualized nerve tract represents facial nerve, vestibulocochlear nerve, or only noise remain unavailable. Close attention should therefore be paid to the interpretation of visualized fibers.	[Yoshino, Masanori; Kin, Taichi; Ito, Akihiro; Nakagawa, Daichi; Nakatomi, Hirofumi; Saito, Nobuhito] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Bunkyo Ku, Tokyo 1138655, Japan; [Saito, Toki; Oyama, Hiroshi] Univ Tokyo, Dept Clin Informat Engn, Bunkyo Ku, Tokyo 1138655, Japan; [Kamada, Kyousuke] Asahikawa Med Univ, Dept Neurosurg, Asahikawa, Hokkaido 0788510, Japan; [Ino, Kenji; Mori, Harushi; Kunimatsu, Akira] Univ Tokyo, Grad Sch Med, Dept Radiol, Bunkyo Ku, Tokyo 1138655, Japan	Yoshino, M (reprint author), Univ Tokyo, Grad Sch Med, Dept Neurosurg, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	ymasa-tky@umin.ac.jp			 [25670618]	This work was supported in part by Grant-in-Aid for Challenging Exploratory Research 25670618. We wish to thank Minoru Tanaka for suggesting this investigation.	HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146; Gerganov VM, 2011, J NEUROSURG, V115, P1087, DOI 10.3171/2011.7.JNS11495; Chen DQ, 2011, NEUROSURGERY, V68, P1077, DOI 10.1227/NEU.0b013e31820c6cbe; Samii M, 2006, J NEUROSURG, V105, P527, DOI 10.3171/jns.2006.105.4.527; Masutani Y, 2003, EUR J RADIOL, V46, P53, DOI 10.1016/S0720-048X(02)00328-5; Shigematsu Y, 1999, J COMPUT ASSIST TOMO, V23, P224, DOI 10.1097/00004728-199903000-00010; Nakai T, 2013, NEURORADIOLOGY, V55, P615, DOI 10.1007/s00234-013-1156-7; Mikami T, 2005, NEUROSURG REV, V28, P261, DOI 10.1007/s10143-005-0394-5; Taoka T, 2006, J MAGN RESON IMAGING, V24, P1005, DOI 10.1002/jmri.20725; GARDNER G, 1988, ANN OTO RHINOL LARYN, V97, P55; Roundy N, 2012, J NEUROSURG, V116, P697, DOI 10.3171/2011.12.JNS111404; Magnan J, 2013, NERVE MONITORING CER, P19; Nakatomi H, 2014, J NEUROSURG, V122, P24; Yoshino M, 2015, INT J COMPUT ASS RAD, V10, P383, DOI 10.1007/s11548-014-1129-2	14	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2015	157	6					939	946		10.1007/s00701-015-2411-y		8	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI4GL	WOS:000354706200008		
J	Takemoto, Y; Kawano, T; Nishi, T; Kuratsu, J				Takemoto, Yushin; Kawano, Takayuki; Nishi, Toru; Kuratsu, Junichi			Formation of a pseudoaneurysm in the chronic phase at the site of a ruptured dissecting anterior inferior cerebellar artery aneurysm	ACTA NEUROCHIRURGICA			English	Letter									[Takemoto, Yushin; Nishi, Toru] Saiseikai Kumamoto Hosp, Stroke Ctr, Dept Neurosurg, Kumamoto, Kumamoto, Japan; [Kawano, Takayuki; Kuratsu, Junichi] Kumamoto Univ, Sch Med, Dept Neurosurg, Chuo Ku, Kumamoto, Kumamoto 860, Japan	Kawano, T (reprint author), Kumamoto Univ, Sch Med, Dept Neurosurg, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 860, Japan.	tkawano-nsu@umin.net					Tatu L, 1996, NEUROLOGY, V47, P1125; Choi CH, 2006, ACTA NEUROCHIR, V148, P363, DOI 10.1007/s00701-005-0702-4; Ildan F, 1996, NEUROSURG REV, V19, P43, DOI 10.1007/BF00346609; Matsuyama T, 2002, NEUROL MED-CHIR, V42, P214, DOI 10.2176/nmc.42.214; Saito A, 2000, NEUROL SURG TOKYO, V28, P269	5	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JUN	2015	157	6					1045	1047		10.1007/s00701-015-2397-5		3	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI4GL	WOS:000354706200024		
J	Asakawa, K; Ishikawa, H				Asakawa, Ken; Ishikawa, Hitoshi			Why do melanopsin-containing retinal ganglion cells have the greatest sensitivity to blue light?	ACTA OPHTHALMOLOGICA			English	Letter									[Asakawa, Ken; Ishikawa, Hitoshi] Kitasato Univ, Dept Rehabil Orthopt & Visual Sci Course, Sch Allied Hlth Sci, Sagamihara, Kanagawa 2520373, Japan	Asakawa, K (reprint author), Kitasato Univ, Dept Rehabil Orthopt & Visual Sci Course, Sch Allied Hlth Sci, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520373, Japan.	asaken@kitasato-u.ac.jp					Kawasaki A, 2007, J NEURO-OPHTHALMOL, V27, P195; Wilhelm B, 2014, OPHTHAL PHYSL OPT, V34, P73, DOI 10.1111/opo.12094; Netto MV, 2004, J REFRACT SURG, V20, P337; Ishikawa H, 2012, JPN J OPHTHALMOL, V56, P181, DOI 10.1007/s10384-011-0116-1; Loewenfeld I.E., 1999, PUPIL ANATOMY PHYSL, V1	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	JUN	2015	93	4					E308	E309		10.1111/aos.12574		3	Ophthalmology	Ophthalmology	CI3GH	WOS:000354635300013		
J	Hayashi, K; Yoshida, M; Hirata, A; Yoshimura, K				Hayashi, Ken; Yoshida, Motoaki; Hirata, Akira; Yoshimura, Koichi			Short-term outcomes of combined implantation of diffractive multifocal intraocular lenses with different addition power	ACTA OPHTHALMOLOGICA			English	Article						binocular visual function; cataract surgery; diffractive multifocal intraocular lens; mix and match implantation; near addition power	CONTRAST SENSITIVITY; ACRYSOF RESTOR; BILATERAL IMPLANTATION; FUNCTIONAL OUTCOMES; VISUAL OUTCOMES; IOL; MULTICENTER; EXPERIENCE; ACUITY; MATCH	Purpose: To compare short-term binocular visual function between patients implanted with diffractive multifocal intraocular lenses (MIOLs) of different near addition powers in each eye or the same MIOLs bilaterally. Methods: Seventy patients scheduled for implantation of diffractive MIOLs were divided into two groups: (i) mix and match group, a MIOL with +3.0 dioptre (D) addition power implanted in the dominant eye (Alcon SN60D1) and a MIOL with +4.0D power implanted in the non-dominant eye (SN60D3) or (ii) same MIOL group, same MIOL (SN60D1) implanted bilaterally. At 3 months postoperatively, we examined binocular visual acuity (VA) at various distances, binocular contrast VA and that with a glare (glare VA), and near stereoacuity. Results: Mean binocular uncorrected (UNVA) or corrected near VA (CNVA) at 0.3 m was significantly better in the mix and match group than in the same MIOL group (p <= 0.0066). Binocular uncorrected and distance-corrected VA at other distances was similar. Binocular UNVA of 0.8 or better was achieved in 77.1% of patients in the mix and match group and 45.7% in the same MIOL group (p = 0.0144). Binocular contrast and glare VA, and stereoacuity did not significantly differ between groups. Spectacle independence and patient satisfaction with near vision were significantly better in the mix and match group (p <= 0.0195). Conclusion: Mix and match implantation of diffractive MIOLs with different addition power provides a better binocular VA curve and spectacle independence than bilateral implantation of the same MIOLs, without compromising contrast sensitivity and stereopsis.	[Hayashi, Ken; Yoshida, Motoaki; Hirata, Akira; Yoshimura, Koichi] Hayashi Eye Hosp, Fukuoka 8120011, Japan	Hayashi, K (reprint author), Hayashi Eye Hosp, Hakata Ku, 4-23-35 Hakataekimae, Fukuoka 8120011, Japan.	hayashi-ken@hayashi.or.jp		HAYASHI, KEN/0000-0002-7297-1477			Lin HT, 2012, INT J OPHTHALMOL-CHI, V5, P76, DOI 10.3980/j.issn.2222-3959.2012.01.16; Rabsilber TM, 2013, J CATARACT REFR SURG, V39, P350, DOI 10.1016/j.jcrs.2012.09.026; Petermeier K, 2011, J CATARACT REFR SURG, V37, P720, DOI 10.1016/j.jcrs.2010.11.027; Hayashi K, 2009, JPN J OPHTHALMOL, V53, P100, DOI 10.1007/s10384-008-0626-7; Maxwell WA, 2009, J CATARACT REFR SURG, V35, P2054, DOI 10.1016/j.jcrs.2009.06.041; Kohnen T, 2006, OPHTHALMOLOGY, V113, P578, DOI 10.1016/j.ophtha.2005.11.020; Lesieur G, 2012, J FR OPHTALMOL, V35, P338, DOI 10.1016/j.jfo.2011.09.012; Alio JL, 2012, OPHTHALMOLOGY, V119, P555, DOI 10.1016/j.ophtha.2011.08.036; Alfonso JF, 2010, J REFRACT SURG, V26, P471, DOI 10.3928/1081597X-20090728-04; Sheppard AL, 2013, J CATARACT REFR SURG, V39, P343, DOI 10.1016/j.jcrs.2012.09.017; Yoon SY, 2013, J CATARACT REFR SURG, V39, P1682, DOI 10.1016/j.jcrs.2013.04.043; de Vries NE, 2010, J CATARACT REFR SURG, V36, P1316, DOI 10.1016/j.jcrs.2010.01.036; Packer M, 2010, AM J OPHTHALMOL, V149, P577, DOI 10.1016/j.ajo.2009.10.022; Buckhurst PJ, 2012, INVEST OPHTH VIS SCI, V53, P3920, DOI 10.1167/iovs.11-9234; Hayashi K, 2009, J CATARACT REFR SURG, V35, P2070, DOI 10.1016/j.jcrs.2009.07.010; Chen WR, 2011, ACTA OPHTHALMOL, V89, P376, DOI 10.1111/j.1755-3768.2009.01702.x; Goes FJ, 2008, J REFRACT SURG, V24, P300; Gunenc U, 2008, J REFRACT SURG, V24, P233; Hayashi K, 2010, J REFRACT SURG, V27, P332; Isomura Y, 1980, J JPN OPHTHALMOL SOC, V84, P1619; Lacmanovic-Loncar V, 2008, ACTA CLIN CROAT, V47, P217; Lubiński Wojciech, 2011, Klin Oczna, V113, P209; Mojzis P, 2013, J CATARACT REFR SURG, V40, P60; Souza CE, 2006, AM J OPHTHALMOL, V141, P827, DOI 10.1016/j.ajo.2005.12.031; Van der Linden JW, 2014, ACTA OPHTHALMOL	25	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	JUN	2015	93	4					E287	E293		10.1111/aos.12591		7	Ophthalmology	Ophthalmology	CI3GH	WOS:000354635300008		
J	Inoue, M; Itoh, Y; Rii, T; Kita, Y; Hirota, K; Kunita, D; Hirakata, A				Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Kita, Yoshiyuki; Hirota, Kazunari; Kunita, Daisuke; Hirakata, Akito			Spontaneous resolution of peripapillary retinoschisis associated with glaucomatous optic neuropathy	ACTA OPHTHALMOLOGICA			English	Letter							MACULAR SCHISIS		[Inoue, Makoto; Itoh, Yuji; Rii, Tosho; Kita, Yoshiyuki; Hirota, Kazunari; Kunita, Daisuke; Hirakata, Akito] Kyorin Univ, Sch Med, Kyorin Eye Ctr, Mitaka, Tokyo 1818611, Japan; [Rii, Tosho] Shin Kong Wu Ho Su Mem Hosp, Dept Ophthalmol, Taipei, Taiwan	Inoue, M (reprint author), Kyorin Univ, Sch Med, Kyorin Eye Ctr, 6-20-2 Shinkawa, Mitaka, Tokyo 1818611, Japan.	inoue@eye-center.org					Hollander DA, 2005, ARCH OPHTHALMOL-CHIC, V123, P270, DOI 10.1001/archopht.123.2.270; Hwang YH, 2014, BRIT J OPHTHALMOL, V98, P669, DOI 10.1136/bjophthalmol-2013-303931; Kahook MY, 2007, AM J OPHTHALMOL, V143, P697, DOI 10.1016/j.ajo.2006.10.054; Zhao M, 2011, GRAEF ARCH CLIN EXP, V249, P1255, DOI 10.1007/s00417-011-1668-y; Zumbro DS, 2007, AM J OPHTHALMOL, V144, P70, DOI 10.1016/j.ajo.2007.03.027	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	JUN	2015	93	4					E317	E318		10.1111/aos.12568		2	Ophthalmology	Ophthalmology	CI3GH	WOS:000354635300020		
J	Tanihara, H; Inoue, T; Yamamoto, T; Kuwayama, Y; Abe, H; Suganami, H; Araie, M				Tanihara, Hidenobu; Inoue, Toshihiro; Yamamoto, Tetsuya; Kuwayama, Yasuaki; Abe, Haruki; Suganami, Hideki; Araie, Makoto		K-115 Clinical Study Grp	Intra-ocular pressure-lowering effects of a Rho kinase inhibitor, ripasudil (K-115), over 24 hours in primary open-angle glaucoma and ocular hypertension: a randomized, open-label, crossover study	ACTA OPHTHALMOLOGICA			English	Article						glaucoma; intra-ocular pressure; K-115; Rho kinase inhibitor; ripasudil	RETINAL GANGLION-CELLS; HUMOR OUTFLOW FACILITY; PROTEIN-KINASE; TRABECULAR MESHWORK; ACTIN CYTOSKELETON; ROCK INHIBITOR; OPTIC-NERVE; RABBIT EYES; Y-27632; TIMOLOL	Purpose: To investigate the intra-ocular pressure (IOP)-lowering effects of a selective Rho kinase inhibitor, ripasudil (K-115), over 24 hr in patients with primary open-angle glaucoma (POAG) or ocular hypertension (OHT). Methods: In this multicenter, prospective, randomized, open-label, 3-period, Latin-square crossover clinical study, 28 patients with POAG or OHT whose IOP level was 21 mmHg or higher were subdivided into three groups. Each patient was treated with placebo and ripasudil in concentrations of 0.2 and 0.4%, at 9: 00 and 21: 00 on day 1 through a total of 3 periods separated by washout periods. IOP was measured at 9: 00, 10: 00, 11: 00, 13: 00, 16: 00, 19: 00, 21: 00, 22: 00 and 23: 00 on day 1, and 1: 00, 4: 00, 7: 00 and 9: 00 on day 2 in sitting position using Goldmann applanation tonometer. Main outcome measure was the IOP reduction of placebo and ripasudil from baseline. Results: The mean IOP reduction was -5.2 mmHg for 0.2%, -6.4 mmHg for 0.4% and -2.0 mmHg for placebo at 2 hr after the first instillation. Also, the corresponding values were -6.8 mmHg for 0.2%, -7.3 mmHg for 0.4% and -4.1 mmHg for placebo at 2 hr after the second instillation. Statistically significant IOP reduction, compared with placebo, was found for both 0.2 and 0.4% from 1 through 7 hr after each instillation. In safety, conjunctival hyperaemia was observed in 22 patients (79%) for 0.2%, 27 patients (96%) for 0.4% and three patients (11%) for placebo. Conclusion: Ripasudil is a promising new topical medication to lower IOP for at least 7 hr after instillations in patients with POAG or OHT.	[Tanihara, Hidenobu; Inoue, Toshihiro] Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Kumamoto, Kumamoto 8608556, Japan; [Yamamoto, Tetsuya] Gifu Univ, Dept Ophthalmol, Grad Sch Med, Gifu, Japan; [Kuwayama, Yasuaki] Osaka Kosei Nenkin Hosp, Dept Ophthalmol, Osaka, Japan; [Abe, Haruki] Niigata Univ, Med & Dent Hosp, Div Ophthalmol & Visual Sci, Niigata, Japan; [Suganami, Hideki] Kowa Co Ltd, Nagoya, Aichi, Japan; [Araie, Makoto] Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Tokyo 113, Japan	Tanihara, H (reprint author), Kumamoto Univ, Dept Ophthalmol, Fac Life Sci, Chuo Ku, 1-1-1 Honjo, Kumamoto, Kumamoto 8608556, Japan.	tanihara@pearl.ocn.ne.jp			Kowa Company, Ltd, Nagoya, Japan; Kowa; MSD; Senju Pharmaceutical; Santen Pharmaceutical; Alcon Japan; Pfizer Japan; Bausch Lomb Japan; Otsuka Pharmaceutical; Topcon; Allergan Japan; Heidelberg Japan; Carl Zeiss Japan; Nitten Pharmaceutical; JFC	The work was sponsored by Kowa Company, Ltd, Nagoya, Japan. The sponsor participated in design of the study, conducting the study, data collection, data management, data analysis, review and approval of the manuscript of the study.; H.T. has received consulting fees from Kowa, and MSD, and board membership fees from Senju Pharmaceutical, Santen Pharmaceutical, Alcon Japan, and Pfizer Japan. T.I. has no financial interest. T.Y. has received consulting fees from Kowa, MSD and Otsuka Pharmaceutical, and board membership fees from Senju Pharmaceutical, Santen Pharmaceutical, Alcon Japan, and Pfizer Japan, and lecture fees from Alcon Japan, Kowa, MSD, Otsuka Pharmaceutical, Pfizer Japan, Santen Pharmaceutical, and Senju Pharmaceutical. Y.K. has received consulting fees from Kowa, MSD, and Bausch & Lomb Japan, and board membership fees from Senju Pharmaceutical, Santen Pharmaceutical, Alcon Japan, and Pfizer Japan, and lecture fees from Otsuka Pharmaceutical. H.A. has received consulting fees from Kowa, and board membership fees from Alcon Japan and Pfizer Japan. H.S. is an employee of Kowa. M.A. has received consulting fees from Kowa, MSD, Topcon, Allergan Japan, Bausch & Lomb Japan and Heidelberg Japan, and board membership fees from Senju Pharmaceutical, Santen Pharmaceutical, Alcon Japan, and Pfizer Japan and lecture fees from Carl Zeiss Japan, Otsuka Pharmaceutical, Nitten Pharmaceutical, JFC, Alcon Japan, Santen Pharmaceutical, and MSD and has patents with Topcon.	Agis Investigators, 2000, American Journal of Ophthalmology, V130, P429; Tokushige H, 2007, INVEST OPHTH VIS SCI, V48, P3216, DOI 10.1167/iovs.05-1617; Tian B, 2009, EXP EYE RES, V88, P713, DOI 10.1016/j.exer.2008.08.008; Stewart WC, 2008, OPHTHALMOLOGY, V115, P1117, DOI 10.1016/j.ophtha.2007.10.004; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Liu JHK, 2004, AM J OPHTHALMOL, V138, P389, DOI 10.1016/j.ajo.2004.04.022; Williams RD, 2011, AM J OPHTHALMOL, V152, P834, DOI 10.1016/j.ajo.2011.04.012; Tanihara H, 2013, JAMA OPHTHALMOL, V131, P1288, DOI 10.1001/jamaophthalmol.2013.323; Gulati V, 2012, ARCH OPHTHALMOL-CHIC, V130, P677, DOI 10.1001/archophthalmol.2011.2573; Asrani S, 2000, J GLAUCOMA, V9, P134; Honjo M, 2001, ARCH OPHTHALMOL-CHIC, V119, P1171; Tanihara H, 2008, ARCH OPHTHALMOL-CHIC, V126, P309, DOI 10.1001/archophthalmol.2007.76; Isobe T, 2014, CURR EYE RES, V39, P813, DOI 10.3109/02713683.2013.874444; Rao PV, 2001, INVEST OPHTH VIS SCI, V42, P1029; Hirata A, 2008, GRAEF ARCH CLIN EXP, V246, P51, DOI 10.1007/s00417-007-0666-6; Konstas AGP, 1997, ARCH OPHTHALMOL-CHIC, V115, P975; Kass MA, 2010, ARCH OPHTHALMOL-CHIC, V128, P276, DOI 10.1001/archophthalmol.2010.20; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Tanihara H, 2013, AM J OPHTHALMOL, V156, P731, DOI 10.1016/j.ajo.2013.05.016; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Honjo M, 2002, EXP EYE RES, V75, P135, DOI 10.1006/exer.2002.2009; Rao PV, 2005, EXP EYE RES, V80, P197, DOI 10.1016/j.exer.2004.08.029; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P1586, DOI 10.1167/iovs.02-0666; COAKES RL, 1978, ARCH OPHTHALMOL-CHIC, V96, P2045; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Liu JHK, 2003, INVEST OPHTH VIS SCI, V44, P4439, DOI 10.1167/iovs.03-0349; Honjo M, 2007, INVEST OPHTH VIS SCI, V48, P5549, DOI 10.1167/iovs.07-0878; Orzalesi N, 2000, INVEST OPHTH VIS SCI, V41, P2566; Epstein DL, 1999, INVEST OPHTH VIS SCI, V40, P74; Bagga H, 2009, CURR OPIN OPHTHALMOL, V20, P79, DOI 10.1097/ICU.0b013e32831eef4f; Tokushige H, 2011, CURR EYE RES, V36, P964, DOI 10.3109/02713683.2011.599106; Koga T, 2006, EXP EYE RES, V82, P362, DOI 10.1016/j.exer.2005.07.006; Grosheva I, 2006, EXP EYE RES, V82, P945, DOI 10.1016/j.exer.2006.01.006; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268; Konstas AGP, 1997, ARCH OPHTHALMOL-CHIC, V115, P182; Kopczynski CC, 2014, J OCUL PHARMACOL TH, V30, P85, DOI 10.1089/jop.2013.0197; LIPPA EA, 1992, ARCH OPHTHALMOL-CHIC, V110, P495; Liu JHK, 2009, OPHTHALMOLOGY, V116, P449, DOI 10.1016/j.ophtha.2008.09.054; MCCANNEL CA, 1992, GRAEF ARCH CLIN EXP, V230, P518, DOI 10.1007/BF00181771; Narumiya S, 1996, J BIOCHEM-TOKYO, V120, P215; Okka M, 2004, ARCH OPHTHALMOL-CHIC, V122, P1482, DOI 10.1001/archopht.122.10.1482; REISS GR, 1984, INVEST OPHTH VIS SCI, V25, P776; Sagawa H, 2007, EXP NEUROL, V205, P230, DOI 10.1016/j.expneurol.2007.02.002; Tian BH, 1998, ARCH OPHTHALMOL-CHIC, V116, P633	44	2	2	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1755-375X	1755-3768		ACTA OPHTHALMOL	Acta Ophthalmol.	JUN	2015	93	4					E254	E260		10.1111/aos.12599		7	Ophthalmology	Ophthalmology	CI3GH	WOS:000354635300003		
J	Yamashita, S				Yamashita, Shinji			East Asian Anthropology: A Japanese Perspective	AMERICAN ANTHROPOLOGIST			English	Editorial Material									Univ Tokyo, Tokyo 1138654, Japan	Yamashita, S (reprint author), Univ Tokyo, Tokyo 1138654, Japan.						King Thomas, 1993, ONE GOOD STORY ONE	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7294	1548-1433		AM ANTHROPOL	Am. Anthropol.	JUN	2015	117	2					376	377		10.1111/aman.12240		2	Anthropology	Anthropology	CI6NK	WOS:000354876400016		
J	Schmidt, R				Schmidt, Ryan			Native American DNA: Tribal Belonging and the False Promise of Genetic Science	AMERICAN ANTHROPOLOGIST			English	Book Review									[Schmidt, Ryan] Kitasato Univ, Tokyo, Japan	Schmidt, R (reprint author), Kitasato Univ, Tokyo, Japan.						TallBear K., 2013, NATIVE AM DNA TRIBAL	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0002-7294	1548-1433		AM ANTHROPOL	Am. Anthropol.	JUN	2015	117	2					445	446		10.1111/aman.12280		2	Anthropology	Anthropology	CI6NK	WOS:000354876400054		
J	Pelliccia, F; Parodi, G; Greco, C; Antoniucci, D; Brenner, R; Bossone, E; Cacciotti, L; Capucci, A; Citro, R; Delmas, C; Guerra, F; Ionescu, CN; Lairez, O; Larrauri-Reyes, M; Lee, PH; Mansencal, N; Marazzi, G; Mihos, CG; Morel, O; Nef, HM; Gil, IJN; Passaseo, I; Pineda, AM; Rosano, G; Santana, O; Schneck, F; Song, BG; Song, JK; Teh, AW; Ungprasert, P; Valbusa, A; Wahl, A; Yoshida, T; Gaudio, C; Kaski, JC				Pelliccia, Francesco; Parodi, Guido; Greco, Cesare; Antoniucci, David; Brenner, Roman; Bossone, Eduardo; Cacciotti, Luca; Capucci, Alessandro; Citro, Rodolfo; Delmas, Clement; Guerra, Federico; Ionescu, Costin N.; Lairez, Olivier; Larrauri-Reyes, Maiteder; Lee, Pil Hyung; Mansencal, Nicolas; Marazzi, Giuseppe; Mihos, Christos G.; Morel, Olivier; Nef, Holger M.; Nunez Gil, Ivan J.; Passaseo, Ilaria; Pineda, Andres M.; Rosano, Giuseppe; Santana, Orlando; Schneck, Franziska; Song, Bong Gun; Song, Jae-Kwan; Teh, Andrew W.; Ungprasert, Patompong; Valbusa, Alberto; Wahl, Andreas; Yoshida, Tetsuro; Gaudio, Carlo; Kaski, Juan Carlos			Comorbidities Frequency in Takotsubo Syndrome: An International Collaborative Systematic Review Including 1109 Patients	AMERICAN JOURNAL OF MEDICINE			English	Review						Acute left ventricular dysfunction; Apical ballooning syndrome; Cardiomyopathy; Takotsubo cardiomyopathy; Takotsubo syndrome	TAKO-TSUBO CARDIOMYOPATHY; APICAL BALLOONING SYNDROME; TERM-FOLLOW-UP; STRESS-INDUCED CARDIOMYOPATHY; CLINICAL CHARACTERISTICS; MYOCARDIAL-INFARCTION; WOMEN; METAANALYSES; POPULATION; STATEMENT	BACKGROUND: To identify predisposing factors that can result in the onset of takotsubo syndrome, we performed an international, collaborative systematic review focusing on clinical characteristics and comorbidities of patients with takotsubo syndrome. METHODS: We searched and reviewed cited references up to August 2013 to identify relevant studies. Corresponding authors of selected studies were contacted and asked to provide additional quantitative details. Data from each study were extracted by 2 independent reviewers. The cumulative prevalence of presenting features and comorbidities was assessed. Nineteen studies whose authors sent the requested information were included in the systematic review, with a total of 1109 patients (951 women; mean age, 59-76 years). Evaluation of risk factors showed that obesity was present in 17% of patients (range, 2%-48%), hypertension in 54% (range, 27%-83%), dyslipidemia in 32% (range, 7%-59%), diabetes in 17% (range, 4%-34%), and smoking in 22% (range, 6%-49%). Emotional stressors preceded takotsubo syndrome in 39% of patients and physical stressors in 35%. The most common comorbidities were psychological disorders (24%; range, 0-49%), pulmonary diseases (15%; range, 0-22%), and malignancies (10%; range, 4%-29%). Other common associated disorders were neurologic diseases (7%; range, 0-22%), chronic kidney disease (7%; range, 2%-27%), and thyroid diseases (6%; range, 0-37%). CONCLUSIONS: Patients with takotsubo syndrome have a relevant prevalence of cardiovascular risk factors and associated comorbidities. Such of associations needs to be evaluated in further studies. (C) 2015 Elsevier Inc. All rights reserved.	[Pelliccia, Francesco; Greco, Cesare; Gaudio, Carlo] Univ Roma La Sapienza, Dept Cardiovasc Sci, I-00179 Rome, Italy; [Parodi, Guido; Antoniucci, David] Careggi Hosp, Dept Heart & Vessels, Florence, Italy; [Brenner, Roman] Kantonsspital, Dept Cardiol, St Gallen, Switzerland; [Bossone, Eduardo; Citro, Rodolfo] Univ Hosp San Giovanni di Dio & Ruggi dAragona, Dept Cardiol, Salerno, Italy; [Cacciotti, Luca; Passaseo, Ilaria] Osped Vannini, Cardiol Unit, Rome, Italy; [Capucci, Alessandro; Guerra, Federico] Marche Polytech Univ, Cardiol & Arrhythmol Clin, Ancona, Italy; [Delmas, Clement; Lairez, Olivier] Rangueil Univ Hosp, Dept Cardiol, Toulouse, France; [Ionescu, Costin N.] Yale Univ, Cardiovasc Sect, New Haven, CT USA; [Larrauri-Reyes, Maiteder; Mihos, Christos G.; Pineda, Andres M.; Santana, Orlando] Mt Sinai Med Ctr, Dept Cardiol, Miami Beach, FL 33140 USA; [Lee, Pil Hyung; Song, Jae-Kwan] Univ Ulsan, Coll Med, Asan Med Ctr, Inst Heart, Seoul, South Korea; [Mansencal, Nicolas] Univ Versailles St Quentin, Ctr Reference Malad Cardiaques Hereditaires, Serv Cardiol, Hop Ambroise Pare, Boulogne, France; [Marazzi, Giuseppe; Rosano, Giuseppe] IRCCS San Raffaele Pisana, Rome, Italy; [Morel, Olivier] Pole Act Medicochirurg Cardiovasc, Strasbourg, France; [Nef, Holger M.; Schneck, Franziska] Univ Giessen, Dept Cardiol & Angiol, D-35390 Giessen, Germany; [Nunez Gil, Ivan J.] Hosp Clin San Carlos, Cardiovasc Inst, Madrid, Spain; [Rosano, Giuseppe; Kaski, Juan Carlos] Univ London, Cardiovasc & Cell Sci Res Inst, London, England; [Song, Bong Gun] Konkuk Univ Hosp, Cardiac & Vasc Ctr, Seoul, South Korea; [Teh, Andrew W.] Monash Univ, Eastern Hlth Clin Sch, Dept Cardiol, Clayton, Vic 3800, Australia; [Teh, Andrew W.] Austin Hosp, Dept Cardiol, Melbourne, Vic, Australia; [Ungprasert, Patompong] Mahidol Univ, Siriraj Hosp, Fac Med, Bangkok 10700, Thailand; [Valbusa, Alberto] Univ San Martino IST, IRCCS, Azienza Osped, Genoa, Italy; [Wahl, Andreas] Univ Hosp Bern, Cardiol, CH-3010 Bern, Switzerland; [Yoshida, Tetsuro] Onga Hosp, Onga Nakama Med Assoc, Dept Cardiovasc Med, Onga, Japan	Pelliccia, F (reprint author), Univ Roma La Sapienza, Dept Cardiovasc Sci, Via Tommaso Inghirami 85, I-00179 Rome, Italy.	f.pelliccia@mclink.it		Guerra, Federico/0000-0001-5394-1312			Ahmed Saeed, 2013, N Am J Med Sci, V5, P77, DOI 10.4103/1947-2714.107520; Amariles Pedro, 2011, Curr Clin Pharmacol, V6, P1; Jaguszewski M, 2014, EUR HEART J, V35, P999, DOI 10.1093/eurheartj/eht392; Eshtehardi P, 2009, INT J CARDIOL, V135, P370, DOI 10.1016/j.ijcard.2008.03.088; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; Parodi G, 2007, AM J CARDIOL, V99, P182, DOI 10.1016/j.amjcard.2006.07.080; Parodi G, 2011, CHEST, V139, P887, DOI 10.1378/chest.10-1041; Yoshida T, 2007, EUR HEART J, V28, P2598, DOI 10.1093/eurheartj/ehm401; Morel O, 2009, J CARD FAIL, V15, P206, DOI 10.1016/j.cardfail.2008.10.031; Patel SM, 2013, J CARD FAIL, V19, P306, DOI 10.1016/j.cardfail.2013.03.007; Rosano GMC, 2007, CLIMACTERIC, V10, P19, DOI 10.1080/13697130601114917; Ueyama T, 2008, ANN NY ACAD SCI, V1148, P479, DOI 10.1196/annals.1410.079; Olkin I, 1998, BIOMETRICS, V54, P317, DOI 10.2307/2534018; Martin EA, 2010, J AM COLL CARDIOL, V56, P1840, DOI 10.1016/j.jacc.2010.03.107; Pelliccia F, 2014, AM J MED, V127, P699, DOI 10.1016/j.amjmed.2014.04.004; Kurowski V, 2007, CHEST, V132, P809, DOI 10.1378/chest.07-0608; Burgdorf C, 2008, EUR J HEART FAIL, V10, P1015, DOI 10.1016/j.ejheart.2008.07.008; Prasad A, 2009, NAT REV CARDIOL, V6, P430, DOI 10.1038/nrcardio.2009.51; Gianni M, 2006, EUR HEART J, V27, P1523, DOI 10.1093/eurheartj/ehl032; Lee PH, 2010, J AM SOC ECHOCARDIOG, V23, P766, DOI 10.1016/j.echo.2010.05.002; Nascimento FO, 2011, CLINICS, V66, P1895, DOI 10.1590/S1807-59322011001100008; Pilgrim TM, 2008, INT J CARDIOL, V124, P283, DOI 10.1016/j.ijcard.2007.07.002; Swaab DF, 2005, AGEING RES REV, V4, P141, DOI 10.1016/j.arr.2005.03.003; Bybee KA, 2004, ANN INTERN MED, V141, P858; Brenner R, 2012, CLIN CARDIOL, V35, P340, DOI 10.1002/clc.21986; Burgdorf C, 2010, ANN INTERN MED, V152, P830, DOI 10.7326/0003-4819-152-12-201006150-00026; Cacciotti L, 2012, BMJ OPEN, V2, P5; Citro R, 2012, J AM GERIATR SOC, V60, P93, DOI 10.1111/j.1532-5415.2011.03730.x; Delmas C, 2013, CIRC J, V77, P175, DOI 10.1253/circj.CJ-12-0759; El-Sayed AM, 2012, AM J CARDIOL, V110, P1368, DOI 10.1016/j.amjcard.2012.06.041; GRECO C, 1988, LANCET, V2, P281; Guerra F, 2013, AM J CARDIOL, V112, P1720, DOI 10.1016/j.amjcard.2013.07.036; Ionescu CN, 2010, HEART LUNG CIRC, V19, P601, DOI 10.1016/j.hlc.2010.06.667; Lee YP, 2009, INT J CARDIOL, V133, P272, DOI 10.1016/j.ijcard.2007.11.039; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; Mansencal N, 2010, J AM COLL CARDIOL, V55, P500, DOI 10.1016/j.jacc.2009.08.062; Nef HM, 2009, EUR J HEART FAIL, V11, P758, DOI 10.1093/eurjhf/hfp076; Nunez-Gil IJ, 2012, REV ESP CARDIOL, V65, P996, DOI [10.1016/j.recesp.2012.04.016, 10.1016/j.rec.2012.04.010]; Pelliccia Francesco, 2013, COMORBIDITY FREQUENC; Rossor AM, 2001, THYROID, V17, P181; Schneider B, 2013, INT J CARDIOL, V166, P584, DOI 10.1016/j.ijcard.2011.11.027; Song BG, 2012, CLIN CARDIOL, V35, pE6, DOI 10.1002/clc.22053; Summers MR, 2010, J AM COLL CARDIOL, V55, P700, DOI 10.1016/j.jacc.2009.10.031; Suzuki H, 2013, CIRC J, V78, P256; Teh AW, 2010, HEART LUNG CIRC, V19, P63, DOI 10.1016/j.hlc.2009.10.002; Valbusa A, 2008, J CARDIOVASC MED, V9, P805, DOI 10.2459/JCM.0b013e3282f73264; Weihs Valerie, 2013, Eur Heart J Acute Cardiovasc Care, V2, P137, DOI 10.1177/2048872613483592; WHO, 2014, WORLD HLTH STAT 2014; Y-Hassan Shams, 2014, Cardiovasc Revasc Med, V15, P35, DOI 10.1016/j.carrev.2013.09.008	49	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0002-9343	1555-7162		AM J MED	Am. J. Med.	JUN	2015	128	6							654.e11	10.1016/j.amjmed.2015.01.016		9	Medicine, General & Internal	General & Internal Medicine	CI6NR	WOS:000354877200028		
J	Tsunoda, K; Kitano, N; Kai, Y; Uchida, K; Kuchiki, T; Okura, T; Nagamatsu, T				Tsunoda, Kenji; Kitano, Naruki; Kai, Yuko; Uchida, Ken; Kuchiki, Tsutomu; Okura, Tomohiro; Nagamatsu, Toshiya			Prospective Study of Physical Activity and Sleep in Middle-Aged and Older Adults	AMERICAN JOURNAL OF PREVENTIVE MEDICINE			English	Article							JAPANESE GENERAL-POPULATION; RANDOMIZED CONTROLLED-TRIAL; INSOMNIA; DURATION; QUALITY; EXERCISE; HEALTH; DISTURBANCES; COHORT; WOMEN	Introduction: Few prospective cohort studies have examined the association between physical activity (PA) and insomnia prevention, and the effective PA intensity remains unclear. This prospective study explores how PA intensity prevents incident short sleep duration and subjective insufficient sleep in middle-aged and older adults. Methods: A self-reported questionnaire gathered data on sleep and PA variables, including moderate low-intensity PA (MLPA); moderate high-intensity PA (MHPA); and vigorous-intensity PA (VPA), during health checkups conducted in Meiji Yasuda Shinjuku Medical Center in Tokyo. This study followed two cohorts from a 2008 baseline survey: (1) participants free of short sleep duration (n = 7,061) and (2) participants free of insufficient sleep (n = 7,385). They were divided into middle-aged (< 60 years; 45.7 [8.8] years for sleep duration and 45.5 [8.8] years for sleep sufficiency) and older adults (both groups aged 65.3 [4.7] years) and followed for a mean 3.4 years until 2013. Data were analyzed in 2014. Results: Engaging in MHPA (hazard ratio [HR] = 0.81, 95% CI = 0.67, 0.98) and VPA (HR = 0.83, 95% CI = 0.71, 0.97) had a significant preventive effect on incident subjective insufficient sleep among middle-aged adults. For older adults, only MLPA (HR = 0.58, 95% CI = 0.42, 0.81) had a significant preventive effect on incident insufficient sleep, and PA did not significantly affect incident short sleep duration. Conclusions: Middle-aged adults engaging in MHPA and VPA and older adults engaging in MLPA can effectively maintain sleep sufficiency. When providing an effective PA program to prevent insomnia, the intensity of PA should correspond to the participant's age. (C) 2015 American Journal of Preventive Medicine	[Tsunoda, Kenji; Kai, Yuko; Nagamatsu, Toshiya] Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, Hachioji, Tokyo 1920001, Japan; [Kitano, Naruki] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki, Japan; [Kitano, Naruki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan; [Uchida, Ken] Meiji Yasuda Life Fdn Hlth & Welf, Meiji Yasuda Shinjuku Med Ctr, Shinjuku Ku, Tokyo, Japan; [Kuchiki, Tsutomu] Meiji Yasuda Life Fdn Hlth & Welf, Meiji Yasuda Wellness Dev Off, Shinjuku Ku, Tokyo, Japan; [Okura, Tomohiro] Univ Tsukuba, Inst Hlth & Sport Sci, Tsukuba, Ibaraki, Japan	Tsunoda, K (reprint author), Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, 150 Tobuki, Hachioji, Tokyo 1920001, Japan.	tsunoda@my-zaidan.or.jp					Akerstedt T, 2002, J PSYCHOSOM RES, V53, P741, DOI 10.1016/S0022-3999(02)00333-1; Ancoli-Israel S, 2005, J AM GERIATR SOC, V53, pS264, DOI 10.1111/j.1532-5415.2005.53392.x; Kim K, 2000, SLEEP, V23, P41; Kessler RC, 2003, ARCH GEN PSYCHIAT, V60, P184, DOI 10.1001/archpsyc.60.2.184; Sanada K, 2007, EUR J APPL PHYSIOL, V99, P475, DOI 10.1007/s00421-006-0375-6; Virtanen M, 2009, SLEEP, V32, P737; Ohida T, 2001, SLEEP, V24, P333; Reid KJ, 2010, SLEEP MED, V11, P934, DOI 10.1016/j.sleep.2010.04.014; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Daley M, 2009, SLEEP, V32, P55; Ohayon MM, 2004, SLEEP, V27, P1255; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Tu XD, 2012, SLEEP MED, V13, P1138, DOI 10.1016/j.sleep.2012.06.014; King AC, 1997, JAMA-J AM MED ASSOC, V277, P32, DOI 10.1001/jama.277.1.32; Khalsa SBS, 2004, APPL PSYCHOPHYS BIOF, V29, P269, DOI 10.1007/s10484-004-0387-0; Youngstedt SD, 2002, AM J PHYSIOL-REG I, V282, pR259; Driver HS, 2000, SLEEP MED REV, V4, P387, DOI 10.1053/smrv.2000.0110; Unruh ML, 2008, J AM GERIATR SOC, V56, P1218, DOI 10.1111/j.1532-5415.2008.01755.x; King CR, 2008, JAMA-J AM MED ASSOC, V300, P2859, DOI 10.1001/jama.2008.867; Kubitz KA, 1996, SPORTS MED, V21, P277, DOI 10.2165/00007256-199621040-00004; Okajima I, 2012, J CLIN PSYCHIAT, V73, P377, DOI 10.4088/JCP.10m06286; Ainsworth BE, 2011, MED SCI SPORT EXER, V43, P1575, DOI 10.1249/MSS.0b013e31821ece12; Ursin R, 2005, SLEEP, V28, P1260; Gallicchio L, 2009, J SLEEP RES, V18, P148, DOI 10.1111/j.1365-2869.2008.00732.x; Taylor DJ, 2005, SLEEP, V28, P1457; Hung HC, 2013, OBESITY, V21, P486, DOI [10.1002/oby.20259, 10.1002/oby.2012.169]; Irwin MR, 2008, SLEEP, V31, P1001; Morgan K, 2003, J SLEEP RES, V12, P231, DOI 10.1046/j.1365-2869.2003.00355.x; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Amagai Y, 2004, J EPIDEMIOL, V14, P124, DOI 10.2188/jea.14.124; Hublin C, 2001, SLEEP, V24, P392; Doi Y, 2001, PSYCHIAT CLIN NEUROS, V55, P213, DOI 10.1046/j.1440-1819.2001.00830.x; Buman MP, 2010, SLEEP BIOL RHYTHMS, V4, P500; Cohen J., 1988, STAT POWER ANAL BEHA; Edwards BJ, 2009, BIOL RHYTHM RES, V40, P53, DOI 10.1080/09291010802067072; FORD DE, 1989, JAMA-J AM MED ASSOC, V262, P1479, DOI 10.1001/jama.262.11.1479; Inoue S, 2013, J AGING PHYS ACTIV, V21, P119; Statistics Bureau Ministry of Internal Affairs and Communications, 2011, POP 15 YEARS OLD AG; Tsushita K, 2014, STANDARD HLTH CHECKU; Uchiyama M, 2012, J JPN ASS PSYCHIAT H, V31, P1163; World Health Organization, 2010, GLOB REC PHYS ACT HL; Youngstedt SD, 2006, SLEEP BIOL RHYTHMS, V4, P215, DOI DOI 10.1111/J.1479-8425.2006.00235.X	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0749-3797	1873-2607		AM J PREV MED	Am. J. Prev. Med.	JUN	2015	48	6					662	673		10.1016/j.amepre.2014.12.006		12	Public, Environmental & Occupational Health; Medicine, General & Internal	Public, Environmental & Occupational Health; General & Internal Medicine	CI5EK	WOS:000354776000004		
J	Munakata, S; Tanaka, Y; Nezu, Y; Harada, Y; Yogo, T; Hara, Y; Tian, H; Matsuo, Y; Tagawa, M; Yodoi, J				Munakata, Shuntaro; Tanaka, Yoshikazu; Nezu, Yoshinori; Harada, Yasuji; Yogo, Takuya; Hara, Yasushi; Tian, Hai; Matsuo, Yoshiyuki; Tagawa, Masahiro; Yodoi, Junji			Induction of thioredoxin-1 in response to oxidative stress in dogs	AMERICAN JOURNAL OF VETERINARY RESEARCH			English	Article							LEUKEMIA-DERIVED FACTOR; POSSIBLE INVOLVEMENT; DNA-DAMAGE; LUNG; EXPRESSION; INJURY; OXYGEN	OBJECTIVE To determine whether thioredoxin (TRX)-1 can be used as a valid biomarker for oxidative stress in dogs. ANIMALS AND SAMPLES 10 Beagles and Madin-Darby canine kidney cells. PROCEDURES Madin-Darby canine kidney cells were used to verify antigen cross-reactivity between human and canine anti-TRX-antibodies. Dogs were assigned to receive 21% or 100% O-2 (5 dogs/group) via an artificial respirator during a 3-hour period of isoflurane anesthesia (starting at 0 hours). Blood and urine samples were collected before (baseline) and at 6, 12, 24, and 48 hours after commencement of inhalation anesthesia. Concentrations of TRX-1 and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in plasma and urine samples were analyzed; urine concentrations were reported as ratios against urine creatinine concentration. RESULTS Canine TRX-1 was recognized by monoclonal human anti-TRX-1 antibodies (clones of adult T-cell leukemia-derived factor [ADF]-11 and ADF21) by western blot analysis. Results of an ELISA indicated that plasma TRX-1 concentration and urine TRX-1-to-creatinine concentration ratio increased rapidly after the 3-hour period of hyperoxia with maximal peaks at 12 and 6 hours, respectively. Urine 8-OHdG-to-creatinine concentration ratio also increased significantly after hyperoxia induction. However, unlike the rapid increase in urine TRX-1-to-creatinine concentration ratio, maximal urine 8-OHdG-to-creatinine concentration ratio was attained at 48 hours after hyperoxia induction. These variables remained unchanged from baseline in the control group. CONCLUSIONS AND CLINICAL RELEVANCE Results indicated that human anti-TRX monoclonal antibodies cross-reacted with canine TRX, and plasma TRX-1 concentrations were rapidly increased in dogs following an oxidative stress challenge. Thus, TRX may be a valuable clinical biomarker for detecting oxidative stress more rapidly than 8-OHdG in dogs.	[Munakata, Shuntaro; Harada, Yasuji; Yogo, Takuya; Hara, Yasushi; Tagawa, Masahiro] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, Musashino, Tokyo 1800022, Japan; [Tanaka, Yoshikazu] Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Hyg, Musashino, Tokyo 1800022, Japan; [Nezu, Yoshinori] Nezu Vet Surg Support, Suginami Ku, Tokyo 1670034, Japan; [Tian, Hai; Yodoi, Junji] Adv Chem Technol Ctr Kyoto ACT Kyoto, JBPA Res Inst, Fushimi, Kyoto 6128374, Japan; [Tian, Hai; Yodoi, Junji] Redox Bio Sci Inc, Sakyo Ku, Kyoto 6068397, Japan; [Matsuo, Yoshiyuki; Yodoi, Junji] Kyoto Univ, Inst Virus Res, Dept Biol Responses, Lab Infect & Prevent,Sakyo Ku, Kyoto 6068507, Japan	Munakata, S (reprint author), Nippon Vet & Life Sci Univ, Fac Vet Med, Dept Vet Sci, Div Vet Surg, 1-7-1 Kyonan Cho, Musashino, Tokyo 1800022, Japan.	munazo@me.com			Nippon Veterinary and Life Science University	Supported in part by the Nippon Veterinary and Life Science University.	Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Callister ME, 2006, THORAX, V61, P521, DOI 10.1136/thx.2005.053041; Nakano M, 2003, FREE RADICAL BIO MED, V35, P826, DOI 10.1016/S0891-5849(03)00432-5; Kishimoto C, 2001, JPN CIRC J, V65, P491, DOI 10.1253/jcj.65.491; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Kaneko K, 2012, CLIN CHIM ACTA, V413, P1822, DOI 10.1016/j.cca.2012.07.009; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.biochem.54.1.237; Nakamura H, 1997, ANNU REV IMMUNOL, V15, P351, DOI 10.1146/annurev.immunol.15.1.351; Nakamura H, 1998, FREE RADICAL BIO MED, V24, P1176, DOI 10.1016/S0891-5849(97)00429-2; Tamura T, 1996, P NATL ACAD SCI USA, V93, P1006, DOI 10.1073/pnas.93.3.1006; Jikimoto T, 2002, MOL IMMUNOL, V38, P765, DOI 10.1016/S0161-5890(01)00113-4; TAGAYA Y, 1989, EMBO J, V8, P757; HALLIWELL B, 1991, FEBS LETT, V281, P9, DOI 10.1016/0014-5793(91)80347-6; Nakamura H, 2009, ADV DRUG DELIVER REV, V61, P303, DOI 10.1016/j.addr.2009.01.003; Sumida Y, 2000, J HEPATOL, V33, P616, DOI 10.1034/j.1600-0641.2000.033004616.x; Watanabe R, 2010, PHARMACOL THERAPEUT, V127, P261, DOI 10.1016/j.pharmthera.2010.04.004; Bendix I, 2012, BRAIN RES, V1484, P68, DOI 10.1016/j.brainres.2012.09.024; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, pL530; Fukunaga A, 2009, ANTIOXID REDOX SIGN, V11, P1227, DOI 10.1089/ARS.2008.2340; Hara T, 2007, ANTIOXID REDOX SIGN, V9, P1427, DOI 10.1089/ars.2007.1661; Kasai H., 2001, FOODS FOOD INGRED J, V194, P10; Kogaki H, 1996, J CLIN LAB ANAL, V10, P257, DOI 10.1002/(SICI)1098-2825(1996)10:5<257::AID-JCLA5>3.0.CO;2-5; Kondo N, 2004, J IMMUNOL, V172, P442; MURO K, 1995, SURG TODAY, V25, P626; Nakamura H, 1996, INT IMMUNOL, V8, P603, DOI 10.1093/intimm/8.4.603; Sanae N, 2005, TOKYO JIKEIKAI MED J, V120, P153; Sumida S, 1997, BIOCHEM MOL BIOL INT, V42, P601	27	0	0	AMER VETERINARY MEDICAL ASSOC	SCHAUMBURG	1931 N MEACHAM RD SUITE 100, SCHAUMBURG, IL 60173-4360 USA	0002-9645	1943-5681		AM J VET RES	Am. J. Vet. Res.	JUN	2015	76	6					554	560				7	Veterinary Sciences	Veterinary Sciences	CI7MM	WOS:000354947700019		
J	Tohyama, M; Miyata, S; Hattori, T; Shimizu, S; Matsuzaki, S				Tohyama, Masaya; Miyata, Shingo; Hattori, Tsuyoshi; Shimizu, Shoko; Matsuzaki, Shinsuke			Molecular basis of major psychiatric diseases such as schizophrenia and depression	ANATOMICAL SCIENCE INTERNATIONAL			English	Review						Schizophrenia; Depression; Neural development; Genes associated with major mental illnesses; DISC1; Dysbindin; PACAP; DBZ; FEZ1; Kendrin; Oligodendrocyte	CYCLASE-ACTIVATING POLYPEPTIDE; NEURITE OUTGROWTH; BIPOLAR DISORDER; SUSCEPTIBILITY GENE; MICE; DYSBINDIN; DISC1; BINDING; PROTEIN; ABNORMALITIES	Recently several potential susceptibility genes for major psychiatric disorders (schizophrenia and major depression) such as disrupted-in-schizophrenia 1(DISC1), dysbindin and pituitary adenylate cyclase-activating polypeptide (PACAP) have been reported. DISC1 is involved in neural development directly via adhesion molecules or via its binding partners of DISC1 such as elongation protein zeta-1 (FEZ1), DISC1-binding zinc-finger protein (DBZ) and kendrin. PACAP also regulates neural development via stathmin 1 or via regulation of the DISC1-DBZ binding. Dysbindin is also involved in neural development by regulating centrosomal microtubule network formation. All such molecules examined to date are involved in neural development. Thus, these findings provide new molecular insights into the mechanisms of neural development and neuropsychiatric disorders. On the other hand, in addition to neurons, both DISC and DBZ have been detected in oligodendrocytes and implicated in regulating oligodendrocyte differentiation. DISC1 inhibits the differentiation of oligodendrocyte precursor cells into oligodendrocytes, while DBZ has a positive regulatory role in oligodendrocyte differentiation. Evidence suggesting that disturbance of oligodendrocyte development causes major depression is also described.	[Tohyama, Masaya] Osaka Prefectural Hosp Org, Osaka 5588558, Japan; [Tohyama, Masaya; Miyata, Shingo; Shimizu, Shoko] Kinki Univ, Res Inst Tradit Asian Med, Div Mol Brain Sci, Osaka, Osaka 5898511, Japan; [Hattori, Tsuyoshi] Osaka Univ, Grad Sch Med, Dept Mol Neuropsychiat, Suita, Osaka 5650871, Japan; [Hattori, Tsuyoshi] Kanazawa Univ, Grad Sch Med Sci, Dept Neuroanat, Kanazawa, Ishikawa 9205111, Japan; [Matsuzaki, Shinsuke] Kanazawa Univ, Osaka Univ, United Grad Sch Child Dev, Dept Child Dev & Mol Brain Sci, Suita, Osaka 5650871, Japan; [Matsuzaki, Shinsuke] Hamamatsu Univ Sch Med, Suita, Osaka 5650871, Japan	Tohyama, M (reprint author), 3-1-56 Bandai Higashi,Sumiyoshiku, Osaka 5588558, Japan.	m.tohyama@opho.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labour and Welfare; Sakamoto Research Foundation of Psychiatric Diseases; Sumitomo Dainippon Pharma Co.	This work was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Ministry of Health, Labour and Welfare, the Sakamoto Research Foundation of Psychiatric Diseases, and Sumitomo Dainippon Pharma Co.	Anitha A, 2009, AM J MED GENET B, V150B, P967, DOI 10.1002/ajmg.b.30926; Hodgkinson CA, 2004, AM J HUM GENET, V75, P862, DOI 10.1086/425586; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Anitha A, 2008, BIOL PSYCHIAT, V63, P678, DOI 10.1016/j.biopsych.2007.07.010; Numakawa T, 2004, HUM MOL GENET, V13, P2699, DOI 10.1093/hmg/ddh280; Jaaro-Peled H, 2009, TRENDS NEUROSCI, V32, P485, DOI 10.1016/j.tins.2009.05.007; Ozeki Y, 2003, P NATL ACAD SCI USA, V100, P289, DOI 10.1073/pnas.0136913100; Yamada K, 2004, BIOL PSYCHIAT, V56, P683, DOI 10.1016/j.biopsych.2004.08.015; Shinoda T, 2007, J NEUROSCI, V27, P4, DOI 10.1523/JNEUROSCI.3825-06.2007; Nicot A, 2004, J NEUROSCI, V24, P8786, DOI 10.1523/JNEUROSCI.1910-04.2004; Hamidi M, 2004, BIOL PSYCHIAT, V55, P563, DOI 10.1016/j.biopsych.2003.11.006; Brandon NJ, 2004, MOL CELL NEUROSCI, V25, P42, DOI 10.1016/j.mcn.2003.09.009; Miyoshi K, 2003, MOL PSYCHIATR, V8, P685, DOI 10.1038/sj.mp.4001352; Aston C, 2005, MOL PSYCHIATR, V10, P309, DOI 10.1038/sj.mp.4001565; Taya S, 2007, J NEUROSCI, V27, P15, DOI 10.1523/JNEUROSCI.3826-06.2006; Koyama Y, 2013, J CHEM NEUROANAT, V53, P1, DOI 10.1016/j.jchemneu.2013.07.002; Cannon TD, 2005, ARCH GEN PSYCHIAT, V8, P685; Cardinaux JR, 1997, MOL BRAIN RES, V51, P220, DOI 10.1016/S0169-328X(97)00241-6; Feng YQ, 2008, SCHIZOPHR RES, V106, P218, DOI 10.1016/j.schres.2008.07.018; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P1335; Hashimoto R, 2007, MOL PSYCHIATR, V12, P1026, DOI 10.1038/sj.mp.4001982; Hattori S, 2008, BIOCHEM BIOPH RES CO, V373, P298, DOI 10.1016/j.bbrc.2008.06.016; Hattori T, 2014, PLOS ONE, V9; Hattori T, 2007, MOL PSYCHIATR, V12, P398, DOI 10.1038/sj.mp.4001945; Hattori T, 2010, MOL PSYCHIATR, V15, P1; Honda A, 2004, MOL BRAIN RES, V122, P89, DOI 10.1016/j.molbrainres.2003.11.020; Katayama T, 2009, PHARMACOGENOMICS, V10, P1967, DOI [10.2217/pgs.09.147, 10.2217/PGS.09.147]; Kubota K, 2009, BIOCHEM BIOPH RES CO, V379, P191, DOI 10.1016/j.bbrc.2008.12.017; Kumamoto N, 2006, BIOCHEM BIOPH RES CO, V345, P904, DOI 10.1016/j.bbrc.2006.04.163; Lacerda AL, 2005, J PSYCHIATR RES, V39, P47; Miyata S, 2015, BIOMED RES INT, DOI 10.1155/2015/492367; Miyata S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019859; Miyoshi K, 2004, BIOCHEM BIOPH RES CO, V317, P1195, DOI 10.1016/j.bbrc.2004.03.163; Okamoto M, 2015, J NEUROSCI IN PRESS; Okuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008773; Shimizu S, 2014, GLIA, V62, P709, DOI 10.1002/glia.22636; Shimizu S, 2008, BIOCHEM BIOPH RES CO, V377, P1051, DOI 10.1016/j.bbrc.2008.10.100; Straub Y, 2002, AM J HUM GENET, V71, P337; Wan S, 1995, NAT GENET, V10, P41; Yamada K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008596	40	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1447-6959	1447-073X		ANAT SCI INT	Anat. Sci. Int.	JUN	2015	90	3					137	143		10.1007/s12565-014-0269-3		7	Anatomy & Morphology; Developmental Biology	Anatomy & Morphology; Developmental Biology	CI5PP	WOS:000354810700001		
J	Kanao, M; Kanda, H; Huang, W; Liu, S; Yi, H; Candiotti, KA; Lubarsky, DA; Levitt, RC; Hao, SL				Kanao, Megumi; Kanda, Hirotsugu; Huang, Wan; Liu, Shue; Yi, Hyun; Candiotti, Keith A.; Lubarsky, David A.; Levitt, Roy C.; Hao, Shuanglin			Gene Transfer of Glutamic Acid Decarboxylase 67 by Herpes Simplex Virus Vectors Suppresses Neuropathic Pain Induced by Human Immunodeficiency Virus gp120 Combined with ddC in Rats	ANESTHESIA AND ANALGESIA			English	Article							ELEMENT-BINDING PROTEIN; PERIPHERAL-NERVE INJURY; DORSAL-HORN NEURONS; SPINAL-CORD-INJURY; REACTIVE OXYGEN; OXIDATIVE STRESS; GABAERGIC INHIBITION; SYNAPTIC PLASTICITY; INFLAMMATORY PAIN; MITOCHONDRIAL-DNA	BACKGROUND: Human immunodeficiency virus (HIV)-related painful sensory neuropathies primarily consist of the HIV infection-related distal sensory polyneuropathy and antiretroviral toxic neuropathies. Pharmacotherapy provides only partial relief of pain in patients with HIV/acquired immune deficiency syndrome because little is known about the exact neuropathological mechanisms for HIV-associated neuropathic pain (NP). Hypofunction of.-aminobutyric acid (GABA) GABAergic inhibitory mechanisms has been reported after peripheral nerve injury. In this study, we tested the hypothesis that HIV gp120 combined with antiretroviral therapy reduces spinal GABAergic inhibitory tone and that restoration of GABAergic inhibitory tone will reduce HIV-related NP in a rat model. METHODS: The application of recombinant HIV-1 envelope protein gp120 into the sciatic nerve plus systemic ddC (one antiretroviral drug) induced mechanical allodynia. The hind paws of rats were inoculated with replication-defective herpes simplex virus (HSV) vectors genetically encoding gad1 gene to express glutamic acid decarboxylase 67 (GAD67), an enzyme that catalyzes the decarboxylation of glutamate to GABA. Mechanical threshold was tested using von Frey filaments before and after treatments with the vectors. The expression of GAD67 in both the lumbar spinal cord and the L4-5 dorsal root ganglia was examined using western blots. The expression of mitochondrial superoxide in the spinal dorsal horn was examined using MitoSox imaging. The immunoreactivity of spinal GABA, pCREB, and pC/EBP beta was tested using immunohistochemistry. RESULTS: In the gp120 with ddC-induced neuropathic pain model, GAD67 expression mediated by the HSV vector caused an elevation of mechanical threshold that was apparent on day 3 after vector inoculation. The antiallodynic effect of the single HSV vector inoculation expressing GAD67 lasted >28 days. The area under the time-effect curves in the HSV vector expressing GAD67 was increased compared with that in the control vectors (P = 0.0005). Intrathecal GABA-A/B agonists elevated mechanical threshold in the pain model. The HSV vectors expressing GAD67 reversed the lowered GABA immunoreactivity in the spinal dorsal horn in the neuropathic rats. HSV vectors expressing GAD67 in the neuropathic rats reversed the increased signals of mitochondrial superoxide in the spinal dorsal horn. The vectors expressing GAD67 reversed the upregulated immunoreactivity expression of pCREB and pC/EBP beta in the spinal dorsal horn in rats exhibiting NP. CONCLUSIONS: Based on our results, we suggest that GAD67 mediated by HSV vectors acting through the suppression of mitochondrial reactive oxygen species and transcriptional factors in the spinal cord decreases pain in the HIV-related neuropathic pain model, providing preclinical evidence for gene therapy applications in patients with HIV-related pain states.	[Kanao, Megumi; Kanda, Hirotsugu; Huang, Wan; Liu, Shue; Yi, Hyun; Candiotti, Keith A.; Lubarsky, David A.; Levitt, Roy C.; Hao, Shuanglin] Univ Miami, Miller Sch Med, Dept Anesthesiol, Miami, FL 33136 USA; [Kanao, Megumi; Kanda, Hirotsugu] Asahikawa Med Univ, Dept Anesthesiol, Asahikawa, Hokkaido, Japan; [Levitt, Roy C.] Univ Miami, Miller Sch Med, Hussman Inst Human Genom, Miami, FL 33136 USA; [Levitt, Roy C.] Vet Affairs Med Ctr, Miami, FL 33125 USA	Hao, SL (reprint author), Univ Miami, Miller Sch Med, Dept Anesthesiol, 1550 NW 10th Ave,Fox Bldg,Rm 304C, Miami, FL 33136 USA.	shao@med.miami.edu			NIH [DA026734, DA025527, NS066792, DA34749, DE022903]	The study was supported by the NIH DA026734 (SH), DA025527 (SH), NS066792 (SH), and DA34749 (SH). RCL was supported by NIH DE022903. HK and MK were supported by Professor Hiroshi Iwasaki (Department of Anesthesiology, Asahikawa Medical University, Japan).	Fink DJ, 2011, ANN NEUROL, V70, P207, DOI 10.1002/ana.22446; Perl A, 2000, ANTIOXID REDOX SIGN, V2, P551, DOI 10.1089/15230860050192323; Lee I, 2007, PAIN, V133, P9, DOI 10.1016/j.pain.2007.01.035; Chandra J, 2000, FREE RADICAL BIO MED, V29, P323, DOI 10.1016/S0891-5849(00)00302-6; Hao SG, 2005, ANN NEUROL, V57, P914, DOI 10.1002/ana.20483; Herzberg U, 2001, J NEUROIMMUNOL, V116, P29, DOI 10.1016/S0165-5728(01)00288-0; Wallace VCJ, 2007, BRAIN, V130, P2688, DOI 10.1093/brain/awm195; Khalil Z, 1999, PAIN, V79, P31, DOI 10.1016/S0304-3959(98)00143-2; Hagiwara H, 2009, EUR J NEUROSCI, V30, P2379, DOI 10.1111/j.1460-9568.2009.07002.x; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Kim HK, 2004, PAIN, V111, P116, DOI 10.1016/j.pain.2004.06.008; Hao SL, 2011, NEUROPSYCHOPHARMACOL, V36, P664, DOI 10.1038/npp.2010.197; Liu J, 2004, MOL THER, V10, P57, DOI 10.1016/j.ymthe.2004.04.017; Apostolova N, 2011, TRENDS PHARMACOL SCI, V32, P715, DOI 10.1016/j.tips.2011.07.007; Verma S, 2005, CNS DRUGS, V19, P325, DOI 10.2165/00023210-200519040-00005; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Schifitto G, 2002, NEUROLOGY, V58, P1764; Sindrup SH, 1999, PAIN, V83, P389, DOI 10.1016/S0304-3959(99)00154-2; Salvemini D, 2011, FREE RADICAL BIO MED, V51, P951, DOI 10.1016/j.freeradbiomed.2011.01.026; Chattopadhyay M, 2011, EUR J PAIN, V15, P913, DOI 10.1016/j.ejpain.2011.03.007; Liu DX, 2004, J NEUROTRAUM, V21, P805, DOI 10.1089/0897715041269650; Kawasaki Y, 2004, J NEUROSCI, V24, P8310, DOI 10.1523/JNEUROSCI.2396-04.2004; Yowtak J, 2011, PAIN, V152, P844, DOI 10.1016/j.pain.2010.12.034; Baba H, 2003, MOL CELL NEUROSCI, V24, P818, DOI 10.1016/S1044-7431(03)00236-7; Moore KA, 2002, J NEUROSCI, V22, P6724; Mao YF, 2009, BRAIN RES, V1248, P68, DOI 10.1016/j.brainres.2008.10.073; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Hao SL, 2003, PAIN, V102, P135, DOI 10.1016/S0304-3959(02)00346-9; Mabuchi T, 2001, J NEUROSCI, V21, P9204; Gu XP, 2013, ONCOL REP, V30, P391, DOI 10.3892/or.2013.2437; Schwartz ES, 2009, J NEUROSCI, V29, P159, DOI 10.1523/JNEUROSCI.3792-08.2009; Huang W, 2014, GENE THER, V21, P328, DOI 10.1038/gt.2013.90; Miyazato M, 2009, GENE THER, V16, P660, DOI 10.1038/gt.2009.5; Wallace VCJ, 2007, PAIN, V133, P47, DOI 10.1016/j.pain.2007.02.015; Shafer SL, 2012, ANESTH ANALG, V114, P931, DOI 10.1213/ANE.0b013e31824a0b5b; Braz J, 2001, J NEUROSCI, V21, P7881; Glorioso JC, 2009, MOL THER, V17, P13, DOI 10.1038/mt.2008.213; Nestler EJ, 2002, NEUROBIOL LEARN MEM, V78, P637, DOI 10.1006/nlme.2002.4084; Zhang JW, 2004, J BIOL CHEM, V279, P4471, DOI 10.1074/jbc.M311327200; Malan TP, 2002, ANESTHESIOLOGY, V96, P1161, DOI 10.1097/00000542-200205000-00020; Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201; Tanaka K, 2001, PROG NEUROBIOL, V65, P173, DOI 10.1016/S0301-0082(01)00002-8; Mollace V, 2001, TRENDS NEUROSCI, V24, P411, DOI 10.1016/S0166-2236(00)01819-1; Gelain DP, 2006, CELL SIGNAL, V18, P1685, DOI 10.1016/j.cellsig.2006.01.008; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Kim HY, 2008, NEUROSCI LETT, V447, P87, DOI 10.1016/j.neulet.2008.09.041; Cornblath DR, 2006, CURR OPIN NEUROL, V19, P446, DOI 10.1097/01.wco.0000245366.59446.57; Crisp T, 2006, BEHAV BRAIN RES, V166, P159, DOI 10.1016/j.bbr.2005.07.006; Hao S, 2009, EUR J PAIN, V13, P380, DOI 10.1016/j.ejpain.2008.05.008; Fields J, 2011, J NEUROCHEM, V118, P93, DOI 10.1111/j.1471-4159.2011.07203.x; Schwartz ES, 2008, PAIN, V138, P514, DOI 10.1016/j.pain.2008.01.029; Huber R, 2012, CELL SIGNAL, V24, P1287, DOI 10.1016/j.cellsig.2012.02.007; Wilson SP, 1999, P NATL ACAD SCI USA, V96, P3211, DOI 10.1073/pnas.96.6.3211; Mao JR, 2002, J NEUROSCI, V22, P8312; Hao SL, 2013, CURR NEUROPHARMACOL, V11, P499, DOI 10.2174/1570159X11311050005; Hwang JH, 1997, PAIN, V70, P15; Huang W, 2014, ANESTH ANALG, V118, P671, DOI 10.1213/ANE.0000000000000079; Bai HP, 2014, J NEUROL SCI, V341, P68, DOI 10.1016/j.jns.2014.04.002; Descalzi G, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-90; Dorsey Susan G, 2006, AACN Clin Issues, V17, P30, DOI 10.1097/00044067-200601000-00004; El Jamali A, 2004, FASEB J, V18, P1096, DOI 10.1096/fj.03-1054fje; Gelman BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046178; Glorioso JC, 2004, ANNU REV MICROBIOL, V58, P253, DOI 10.1146/annurev.micro.58.030603.123709; Hao Shuanglin, 2007, Int Anesthesiol Clin, V45, P59, DOI 10.1097/AIA.0b013e318034199c; HAYTER AJ, 1986, J AM STAT ASSOC, V81, P1000; Jensen Troels S, 2007, Curr Opin Support Palliat Care, V1, P126, DOI 10.1097/SPC.0b013e3282eeb45f; Joseph EK, 2004, PAIN, V107, P147, DOI 10.1016/j.pain.2003.10.010; Kanda H, 2014, ANESTHESIOLOGY, V121, pA2225; Kim HY, 2011, J NEUROSCI, V31, P12982, DOI 10.1523/JNEUROSCI.3093-11.2011; Koutsilieri E, 1999, AIDS RES HUM RETROV, V15, P471, DOI 10.1089/088922299311222; Lewis W, 2001, LAB INVEST, V81, P777; Lewis W, 2006, AIDS, V20, P675, DOI 10.1097/01.aids.0000216367.23325.58; Manji H, 2000, CURR OPIN NEUROL, V13, P589, DOI 10.1097/00019052-200010000-00014; McArthur J H, 1998, J Assoc Nurses AIDS Care, V9, P84, DOI 10.1016/S1055-3290(98)80048-4; Shi YQ, 2012, J NEUROSCI, V32, P10833, DOI 10.1523/JNEUROSCI.5628-11.2012; Wang Y, 2013, GENE THER, V20, P742, DOI 10.1038/gt.2012.90; Yamaguchi T, 2002, EUR J BIOCHEM, V269, P2782, DOI 10.1046/j.1432-1033.2002.02954.x; Yowtak J, 2013, PAIN, V154, P2469, DOI 10.1016/j.pain.2013.07.024; Zheng WW, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-40	79	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-2999			ANESTH ANALG	Anesth. Analg.	JUN	2015	120	6					1394	1404		10.1213/ANE.0000000000000729		11	Anesthesiology	Anesthesiology	CI6JD	WOS:000354864100031		
J	Iida, R; Koketsu, Y				Iida, Ryosuke; Koketsu, Yuzo			Climatic factors associated with abortion occurrences in Japanese commercial pig herds	ANIMAL REPRODUCTION SCIENCE			English	Article						Abortion; Heat stress; Incidence rate; Culling; Reproductive failure	FEMALE PIGS; LITTER SIZE; SOWS; TEMPERATURE; PERFORMANCE; FARMS; IDENTIFICATION; THAILAND; INTERVAL; REMOVAL	Objectives were to determine climatic and production factors associated with abortions in commercial swine herds and to compare the reproductive performances and culling patterns between aborting and non-aborting females that were re-inseminated. There were 309,427 service records analyzed for 56,375 females entered into 100 herds. Climate data were obtained from 21 weather stations located close to the herds. Mean daily average temperatures (Tavg) for the 21-day pre-mating period for each female were combined with the female's reproductive data. Generalized linear model assessments were conducted for abortion risk per service. Abortion risk per service (+/- SE) was 0.7 +/- 0.06%, and mean value of Tavg (range) was 15.0 degrees C (-10.7 to 32.7 degrees C). Risk factors associated with an increased abortion risk per service were greater numbers of parities, delivering more stillbirth fetuses, greater mean Tavg for the 21-day pre-mating periods and re-servicing of females that did not get pregnant at the first servicing (P<0.05). Abortion risk per service for parities 1-5 increased by 0.1-0.3% when the Tavg increased from 20 to 30 degrees C (P<0.05), but there were no such associations for parities 0 and 6 or greater (P >= 0.37). Aborting re-serviced females had 0.4 fewer pigs born alive than non-aborting re-serviced females (P<0.05). Also, 64.6% of all aborting females were culled for reproductive failure, compared with only 23.4% of non-aborting females. In conclusion, producers should closely monitor females at greater risk of aborting and apply more advanced cooling systems. (C) 2015 Elsevier B.V. All rights reserved.	[Iida, Ryosuke; Koketsu, Yuzo] Meiji Univ, Sch Agr, Tama Ku, Kawasaki, Kanagawa 2148571, Japan	Iida, R (reprint author), Meiji Univ, Sch Agr, Tama Ku, Higashi Mita 1-1-1, Kawasaki, Kanagawa 2148571, Japan.	riid@shikon.meiji.ac.jp			Meiji University, Japan	The authors gratefully thank the swine producers for their cooperation in providing their valuable data for use in this study, and also the staff at Global Pig Farms, Inc. (Shibukawa, Gunma, Japan) for their technical assistance. We also thank Dr. I. McTaggart for his critical review of this manuscript. This work was supported by the Research Project Grant (Giken A 2012-2016) from Meiji University, Japan.	Almond GW, 2006, DIS SWINE, V9<SUP>th</SUP>, P113; Peel MC, 2007, HYDROL EARTH SYST SC, V11, P1633; Bertoldo MJ, 2012, REPROD FERT DEVELOP, V24, P822, DOI 10.1071/RD11249; Iida R, 2014, J ANIM SCI, V92, P4180, DOI [10.2527/jas.2014-7636, 10.2527/jas2014-7636]; NOBLET J, 1990, J ANIM SCI, V68, P562; Bloemhof S, 2013, J ANIM SCI, V91, P2667, DOI 10.2527/jas.2012-5902; Tummaruk P, 2004, J VET MED SCI, V66, P477, DOI 10.1292/jvms.66.477; Suriyasomboon A, 2006, THERIOGENOLOGY, V65, P606, DOI 10.1016/j.theriogenology.2005.06.005; Sasaki Y, 2007, THERIOGENOLOGY, V68, P123, DOI 10.1016/j.theriogenology.2007.04.021; Vargas AJ, 2009, PREV VET MED, V89, P75, DOI 10.1016/j.prevetmed.2009.02.001; Hoving LL, 2011, LIVEST SCI, V140, P124, DOI 10.1016/j.livsci.2011.02.019; Engblom L, 2007, LIVEST SCI, V106, P76, DOI 10.1016/j.livsci.2006.07.002; Bertoldo M, 2009, THERIOGENOLOGY, V72, P393, DOI 10.1016/j.theriogenology.2009.03.008; Dohoo I. R., 2009, VET EPIDEMIOLOGIC RE; Dominguez JC, 1996, VET REC, V139, P93; Iida R., 2014, P C RES WORK AN DIS; Japan Meteorological Agency, CLIM STAT JAP; Koketsu Y, 1997, THERIOGENOLOGY, V47, P1347, DOI 10.1016/S0093-691X(97)00127-1; Meredith MJ, 1995, ANIMAL BREEDING INFE, P278; Odehnalova S, 2008, CZECH J ANIM SCI, V53, P195; Rasbash I., 2012, USERS GUIDE MLWIN VE; STEVENSON JS, 1981, J ANIM SCI, V53, P177; Takai Y, 2007, THERIOGENOLOGY, V68, P87, DOI 10.1016/j.theriogenology.2007.02.014; Torremorrell M, 2007, CURRENT THERAPY LARG, V2nd, P794, DOI 10.1016/B978-072169323-1.50109-4; Tummaruk P, 2010, PREV VET MED, V96, P194, DOI 10.1016/j.prevetmed.2010.06.003	25	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0378-4320	1873-2232		ANIM REPROD SCI	Anim. Reprod. Sci.	JUN	2015	157						78	86		10.1016/j.anireprosci.2015.03.018		9	Agriculture, Dairy & Animal Science; Reproductive Biology	Agriculture; Reproductive Biology	CI8PF	WOS:000355033500011		
J	Michal, M; Kazakov, DV; Hadravsky, L; Kinkor, Z; Kuroda, N; Michal, M				Michal, Michael; Kazakov, Dmitry V.; Hadravsky, Ladislav; Kinkor, Zdenek; Kuroda, Naoto; Michal, Michal			High-grade myxoinflammatory fibroblastic sarcoma: a report of 23 cases	ANNALS OF DIAGNOSTIC PATHOLOGY			English	Article						High-grade myxoinflammatory fibroblastic sarcoma; Undifferentiated sarcoma; Pleomorphic hyalinizing angiectatic tumor; Chondrosarcoma; Soft tissues	HYALINIZING ANGIECTATIC TUMOR; HEMOSIDEROTIC FIBROLIPOMATOUS TUMOR; INFLAMMATORY MYXOHYALINE TUMOR; POTENTIAL DIAGNOSTIC PITFALL; OF-THE-LITERATURE; SOFT PARTS; CYCLIN D1; MYXOFIBROSARCOMA; LIPOSARCOMA; EXPRESSION	We describe 23 cases of high-grade myxoinflammatory fibroblastic sarcoma (MIFS). The patients were 15 women and 8 men, with the age ranging at the time of diagnosis from 39 to 93 years (mean, 64.3 years; median, 66 years). Follow-up was available for 18 patients, of whom 9 developed metastatic disease; 7 of these died. Most tumors showed a predilection for the soft tissues of the extremities, with 14 cases involving the lower limb and 5 the upper extremity. However, in both sites, the acral parts were affected in only 1 case each. Of the 4 remaining tumors, 2 were found in axilla, 1 was found in sacral area, and 1 developed in the scar on the breast, 14 years after previous excision of a mammary carcinoma and subsequent local irradiation. The tumor size ranged from 13 cm to as much as 30 cm in the largest dimension with a mean size of 8.3 cm. Histologically, the tumors were characterized by occurrence of 3 types of characteristic cells, including (1) lipoblast-like cells with an ample, distended, mucin-filled cytoplasm compartmentalized by a variable number of intracytoplasmic septa, thus remotely resembling soccer balls; (2) large, polygonal, bizarre ganglion-like cells similar to those seen in the Hodgkin disease, also called Reed-Sternberg-like cells. Within an ample, deeply eosinophilic cytoplasm, there was an oval nucleus with vesicular chromatin and a large, inclusion-like nucleolus. Binucleated, multinucleated, or more pleomorphic forms of these cells were also present; (3) cells with emperipolesis of variable sizes, ranging from very inconspicuous neoplastic cells containing only one to a few engulfed cells to conspicuous large ones having many inflammatory cells, usually polymorphonuclear leukocytes admixed with various numbers of some lymphoid cells, within the cytoplasm. Quite often, we found elements that combined the histologic features of all the above 3 characteristic tumor cell types. In 2 tumors, we found an additional undifferentiated spindle cell sarcoma component, whereas in another tumor, a chondrosarcomatous moiety was evident. For comparison, we studied 10 cases of pleomorphic hyalinizing angiectatic tumor (PHAT) of soft tissues. Based on the identification of morphological changes typical for MIFS within most of the cases of PHAT, we suggest that most cases of PHAT represent examples of MIFS merely having hyaline ectatic vessels. (C) 2015 Elsevier Inc. All rights reserved.	[Michal, Michael; Kazakov, Dmitry V.; Hadravsky, Ladislav; Kinkor, Zdenek; Kuroda, Naoto] Charles Univ Prague, Fac Med, Dept Pathol, Plzen 30460, Czech Republic; [Michal, Michael; Kazakov, Dmitry V.; Hadravsky, Ladislav; Kinkor, Zdenek; Kuroda, Naoto] Charles Univ Hosp Plzen, Plzen 30460, Czech Republic; [Michal, Michal] Red Cross Hosp Kochi, Kochi, Japan	Michal, M (reprint author), Charles Univ Prague, Fac Med, Dept Pathol, Alej Svobody 80, Plzen 30460, Czech Republic.	michael.michal@medima.cz					BOSCH F, 1994, BLOOD, V84, P2726; Lee CH, 2012, AM J SURG PATHOL, V36, P1562, DOI 10.1097/PAS.0b013e31825fa931; Hallor KH, 2009, J PATHOL, V217, P716, DOI 10.1002/path.2513; Chiu HY, 2012, J DERMATOL, V39, P422, DOI 10.1111/j.1346-8138.2011.01297.x; Michal M, 2006, AM J SURG PATHOL, V30, P721, DOI 10.1097/00000478-200606000-00007; Hassanein AM, 2008, J CUTAN PATHOL, V35, P186, DOI 10.1111/j.1600-0560.2007.00789.x; Montgomery EA, 1998, MODERN PATHOL, V11, P384; Hemminger JA, 2014, MODERN PATHOL, V27, P1238, DOI 10.1038/modpathol.2013.244; Capovilla M, 2006, AM J DERMATOPATH, V28, P276, DOI 10.1097/00000372-200606000-00053; Capovilla M, 2006, AM J DERMATOPATH, V28, P277; Carter JM, 2014, AM J SURG PATHOL, V38, P1182, DOI 10.1097/PAS.0000000000000212; de Vreeze Ronald S. A., 2011, Sarcoma, P638403, DOI 10.1155/2011/638403; Folpe AL, 2004, AM J SURG PATHOL, V28, P1417, DOI 10.1097/01.pas.0000141406.02581.fb; Illueca C, 2012, APPL IMMUNOHISTO M M, V20, P96, DOI 10.1097/PAI.0b013e31821a24ab; Kazakov DV, 2007, PATHOL INT, V57, P281, DOI 10.1111/j.1440-1827.2007.02094.x; Kinkor Z, 2002, PATHOL RES PRACT, V198, P639, DOI 10.1078/0344-0338-00315; Laskin WB, 2014, AM J SURG PATHOL, V38, P1, DOI 10.1097/PAS.0b013e31829f3d85; Laskin WB, 2015, AM J SURG PATHOL, V39, P197, DOI 10.1097/PAS.0000000000000299; Meis-Kindblom JM, 1998, AM J SURG PATHOL, V22, P911, DOI 10.1097/00000478-199808000-00001; Michal M, 1998, PATHOL RES PRACT, V194, P529; Mitsuhashi T, 2005, AM J DERMATOPATH, V27, P322, DOI 10.1097/01.dad.0000171605.48186.31; Oliva E, 2014, DIAGN HISTOPATHOL, V20, P376; Panoussopoulos D, 2004, INT J SURG PATHOL, V12, P79, DOI 10.1177/106689690401200115; Sakaki M, 2003, VIRCHOWS ARCH, V442, P25, DOI 10.1007/s00428-002-0723-9; Smith MEF, 1996, AM J SURG PATHOL, V20, P21, DOI 10.1097/00000478-199601000-00002; Solomon DA, 2013, AM J SURG PATHOL, V37, P1627, DOI 10.1097/PAS.0b013e31829ff078	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1092-9134	1532-8198		ANN DIAGN PATHOL	Ann. Diagn. Pathol.	JUN	2015	19	3					157	163		10.1016/j.anndiagpath.2015.03.012		7	Pathology	Pathology	CI8OT	WOS:000355032300013		
J	Higo, M; Isobe, K; Yamaguchi, M; Torigoe, Y				Higo, Masao; Isobe, Katsunori; Yamaguchi, Moe; Torigoe, Yoichi			Impact of a soil sampling strategy on the spatial distribution and diversity of arbuscular mycorrhizal communities at a small scale in two winter cover crop rotational systems	ANNALS OF MICROBIOLOGY			English	Article						Arbuscular mycorrhizal fungi; Agricultural management; AMF communities; Crop rotation; Soil sampling strategy	FUNGI COLONIZING ROOTS; UPLAND FIELD SOIL; MOLECULAR DIVERSITY; ANASTOMOSIS FORMATION; TEMPERATE GRASSLAND; SPORE DENSITY; PLANT-ROOTS; COLONIZATION; BIODIVERSITY; ABUNDANCE	It is vital to evaluate how soil sampling affects the spatial distribution and diversity of arbuscular mycorrhizal fungi (AMF) in agricultural ecosystems. Here, the impact of soil sampling on the spatial distribution and diversity of AMF in agricultural ecosystems was evaluated using field experiments. A molecular approach was taken to assess the spatial distribution of the AMF community from 1 m(2) plots from fields cropped with soybeans [Glycine max (L.) Merr.], in rotation with wheat (Triticum aestivum L.) and winter fallow. Phylogenetic analysis revealed 18 AMF phylotypes, including five Glomus, three Gigaspora, two each from Racocetra, Acaulospora, and Funneliformis and one each from Claroideoglomus, Rhizophagus, Diversispora, and Paraglomus at different sampling points in this study. Our results showed that the molecular diversity and composition of AMF communities in soil cropped with wheat, or left fallow did not change at scales of < 1 m(2). Canonical correspondence analysis (CCA) demonstrated that AMF communities by soil sampling point within each rotation were not significantly different. Thus, random soil sampling did not show any difference in AMF communities in soil under winter cover crop rotational systems, no matter where soil samples were collected from at a small scale (< 1 m(2)) in agricultural fields. Our results suggest that agricultural management can affect the diversity and composition of AMF communities more than soil sampling strategies.	[Higo, Masao; Isobe, Katsunori; Yamaguchi, Moe; Torigoe, Yoichi] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Higo, M (reprint author), Nihon Univ, Coll Bioresource Sci, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	higo.masao@nihon-u.ac.jp					Giovannetti M, 2001, NEW PHYTOL, V151, P717, DOI 10.1046/j.0028-646x.2001.00216.x; Lekberg Y, 2005, NEW PHYTOL, V168, P189, DOI 10.1111/j.1469-8137.2005.01490.x; Trouvelot S, 1999, MYCORRHIZA, V8, P203, DOI 10.1007/s005720050235; Daniell TJ, 2001, FEMS MICROBIOL ECOL, V36, P203, DOI 10.1016/S0168-6496(01)00134-9; Chifflot V, 2009, AGR ECOSYST ENVIRON, V131, P32, DOI 10.1016/j.agee.2008.11.010; Opik M, 2013, MYCORRHIZA, V23, P411, DOI 10.1007/s00572-013-0482-2; Gosling P, 2013, NEW PHYTOL, V198, P546, DOI 10.1111/nph.12169; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Higo M, 2014, BIOL FERT SOILS, V50, P913, DOI 10.1007/s00374-014-0912-0; Scheublin TR, 2004, APPL ENVIRON MICROB, V70, P6240, DOI 10.1128/AEM.70.10.6240-6246.2004; Holland TC, 2014, BIOL FERT SOILS, V50, P667, DOI 10.1007/s00374-013-0887-2; Mummey DL, 2008, FEMS MICROBIOL ECOL, V64, P260, DOI 10.1111/j.1574-6941.2008.00475.x; Opik M, 2009, NEW PHYTOL, V184, P424, DOI 10.1111/j.1469-8137.2009.02920.x; Renker C, 2006, MYCORRHIZA, V16, P525, DOI 10.1007/s00572-006-0067-4; Sikes BA, 2009, J ECOL, V97, P1274, DOI 10.1111/j.1365-2745.2009.01557.x; Murray TR, 2010, ECOLOGY, V91, P815, DOI 10.1890/09-0209.1; BIERMANN B, 1983, NEW PHYTOL, V95, P97, DOI 10.1111/j.1469-8137.1983.tb03472.x; Lumini E, 2010, ENVIRON MICROBIOL, V12, P2165, DOI 10.1111/j.1462-2920.2009.02099.x; Alguacil MM, 2008, ECOL APPL, V18, P527, DOI 10.1890/07-0521.1; Van Tuinen D, 1998, MOL ECOL, V7, P879, DOI 10.1046/j.1365-294x.1998.00410.x; Lekberg Y, 2012, J ECOL, V100, P151, DOI 10.1111/j.1365-2745.2011.01894.x; Giovannetti M, 1999, APPL ENVIRON MICROB, V65, P5571; Balestrini R, 2010, ENV MICROBIOL REP, V2, P594, DOI 10.1111/j.1758-2229.2010.00160.x; Oehl F, 2003, APPL ENVIRON MICROB, V69, P2816, DOI 10.1128/AEM.69.5.2816-2824.2003; Gollotte A, 2004, MYCORRHIZA, V14, P111, DOI 10.1007/s00572-003-0244-7; AN ZQ, 1993, MYCORRHIZA, V3, P171, DOI 10.1007/BF00203611; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Borriello R, 2012, BIOL FERT SOILS, V48, P911, DOI 10.1007/s00374-012-0683-4; Brito I, 2012, SOIL USE MANAGE, V28, P202, DOI 10.1111/j.1475-2743.2012.00404.x; Davison J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041938; Higo M, 2011, ANN MICROBIOL, V61, P383, DOI 10.1007/s13213-010-0142-0; Higo M, 2013, BIOL FERT SOILS, V49, P1085, DOI 10.1007/s00374-013-0807-5; Higo M, 2010, PLANT PROD SCI, V13, P74, DOI 10.1626/pps.13.74; Isobe K, 2007, PLANT PROD SCI, V10, P122, DOI 10.1626/pps.10.122; Isobe K, 2011, ADV MICROBIOL, V1, P13; Isobe K, 2008, PLANT PROD SCI, V11, P171, DOI 10.1626/pps.11.171; Jie WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072898; Thorup-Kristensen K, 2012, EUR J AGRON, V37, P66, DOI 10.1016/j.eja.2011.11.004; Piotrowski JS, 2004, NEW PHYTOL, V164, P365, DOI 10.1111/j.1469-8137.2004.01181.x; Sasvari Z, 2011, BIOL FERT SOILS, V47, P167, DOI 10.1007/s00374-010-0519-z; Smith SE, 2008, MYCORRHIZAL SYMBIOSIS, 3RD EDITION, P13, DOI 10.1016/B978-012370526-6.50003-9; Tsuji H, 2002, ROOT RES, V2, P43; Vandenkoornhuyse P, 2003, MOL ECOL, V12, P3085, DOI 10.1046/j.1365-294X.2003.01967.x; Vandenkoornhuyse P, 2002, MOL ECOL, V11, P1555, DOI 10.1046/j.1365-294X.2002.01538.x; Wolfe BE, 2007, MYCORRHIZA, V17, P175, DOI 10.1007/s00572-006-0089-y	45	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1590-4261	1869-2044		ANN MICROBIOL	Ann. Microbiol.	JUN	2015	65	2					985	993		10.1007/s13213-014-0942-8		9	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI4MR	WOS:000354724300039		
J	Hanaoka, Y; Yumoto, I				Hanaoka, Yoshiko; Yumoto, Isao			Manipulation of culture conditions for extensive extracellular catalase production by Exiguobacterium oxidotolerans T-2-2(T)	ANNALS OF MICROBIOLOGY			English	Article						Exiguobacterium oxidotolerans; Catalase; Extracellular production; Aeration; Low rotation rate	FACULTATIVELY PSYCHROPHILIC BACTERIUM; PURIFICATION; GROWTH; NOV.	A hydrogen peroxide (H2O2)-resistant bacterium, Exiguobacterium oxidotolerans T-2-2(T), secretes extracellular catalase. A low shaking frequency (60 rpm) was employed following the observation that a higher amount of extracellular catalase was produced under this condition compared with the previous shaking frequency (120 rpm). The cell concentration reached approximately 4.5 x 10(6) cells mL(-1), at which the initiation of extracellular catalase production was triggered, while the production of the extracellular catalase was largely dependent on that of the intracellular catalase. The best initial aeration condition for extracellular catalase production was 7.5 mg O L-1, which is 95 % of that of the air-saturated state measured under the low shaking frequency. In addition, although the total productivity of catalase was unchanged, introduction of aminolevulinic acid and Tween 60 promoted extracellular production. The extracellular and intracellular catalase productivities were 16,000 and 6,000 U mL(-1) of spent culture medium, respectively.	[Hanaoka, Yoshiko; Yumoto, Isao] Hokkaido Univ, Grad Sch Agr, Lab Environm Microbiol, Kita Ku, Sapporo, Hokkaido 0608589, Japan; [Hanaoka, Yoshiko; Yumoto, Isao] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, Sapporo, Hokkaido 0628517, Japan	Yumoto, I (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Toyohira Ku, 2-17-2-1 Tsukisamu Higashi, Sapporo, Hokkaido 0628517, Japan.	i.yumoto@aist.go.jp					Biswa P, 2013, FEMS MICROBIOL LETT, V343, P34, DOI 10.1111/1574-6968.12123; HILDEBRANDT AG, 1975, ARCH BIOCHEM BIOPHYS, V171, P385, DOI 10.1016/0003-9861(75)90047-8; Yumoto I, 2004, INT J SYST EVOL MICR, V54, P2013, DOI 10.1099/ijs.0.63129-0; Yumoto I, 2000, J BACTERIOL, V182, P1903, DOI 10.1128/JB.182.7.1903-1909.2000; Visick KL, 1998, J BACTERIOL, V180, P2087; Bendtsen JD, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-58; Dumas E, 2008, APPL ENVIRON MICROB, V74, P7399, DOI 10.1128/AEM.00594-08; Hanaoka Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076862; Hara I, 2007, BIOCHEMISTRY-US, V46, P11, DOI 10.1021/bi061519w; Kimoto H, 2012, INT J MOL SCI, V13, P1733, DOI 10.3390/ijms13021733; Kimoto H, 2008, PROTEIN EXPRES PURIF, V59, P357, DOI 10.1016/j.pep.2008.03.016; NADLER K, 1970, PLANT PHYSIOL, V46, P240, DOI 10.1104/pp.46.2.240; Nakayama M, 2008, J BIOSCI BIOENG, V106, P554, DOI 10.1263/jbb.106.554; Raynaud C, 1998, MICROBIOL-UK, V144, P577; Shi XL, 2008, BIOTECHNOL LETT, V30, P181, DOI 10.1007/s10529-007-9510-7; Takebe F, 2007, J BIOSCI BIOENG, V104, P464, DOI 10.1263/jbb.104.464; Yumoto I, 1998, J FERMENT BIOENG, V85, P113, DOI 10.1016/S0922-338X(97)80364-9; Yumoto I, 2010, INT J SYST EVOL MICR, V60, P205, DOI 10.1099/ijs.0.010959-0; Yumoto I, 1999, APPL ENVIRON MICROB, V65, P67; Zhou B, 2004, BIOTECHNOL LETT, V15, P281	20	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1590-4261	1869-2044		ANN MICROBIOL	Ann. Microbiol.	JUN	2015	65	2					1183	1187		10.1007/s13213-014-0943-7		5	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI4MR	WOS:000354724300062		
J	Takeda, K; Sowa, Y; Nishino, K; Itoh, K; Fushiki, S				Takeda, Kohsuke; Sowa, Yoshihiro; Nishino, Kenichi; Itoh, Kyoko; Fushiki, Shinji			Adipose-Derived Stem Cells Promote Proliferation, Migration, and Tube Formation of Lymphatic Endothelial Cells In Vitro by Secreting Lymphangiogenic Factors	ANNALS OF PLASTIC SURGERY			English	Article						adipose-derived stem cells; lymphangiogenesis; lymphedema	MARROW STROMAL CELLS; VEGF-C; THERAPEUTIC LYMPHANGIOGENESIS; VESSEL FORMATION; HEREDITARY LYMPHEDEMA; REGENERATIVE CELLS; NERVE REGENERATION; TYROSINE KINASE; CXCL5 CYTOKINE; TISSUE	Adipose-derived stem cells (ADSCs) are a promising new therapeutic modality for several diseases and have been applied to various clinical fields because of their multidifferentiation potential and capacity for growth-factor secretion. Recently, 2 in vivo studies showed ADSCs to have potential applications in lymphedema therapy. However, it remains unclear whether ADSCs have direct effects on lymphatic endothelial cells (LECs). In this study, human LECs were treated with murine ADSC-derived conditioned media. Changes in LEC proliferation, migration, and tube formation were assessed by WST-8 assay, transwell chamber assay, and Matrigel-based tube formation assay, respectively, with recombinant human vascular endothelial growth factor-C used as a positive control. Additionally, the expression of several lymphangiogenic factors in ADSCs was examined by quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay. Factors secreted by ADSCs induced LEC proliferation, migration, and tube formation more potently than recombinant human vascular endothelial growth factor-C. We confirmed by quantitative reverse transcription-polymerase chain reaction and enzyme-linked immunosorbent assay that some of the lymphangiogenic factors of ADSCs were dramatically up-regulated under serum-starved conditions. These data indicate that ADSCs could directly contribute to lymph-angiogenesis via secretory factors in vitro and may thus provide a therapeutic modality for patients with lymphedema.	[Takeda, Kohsuke; Sowa, Yoshihiro; Nishino, Kenichi] Kyoto Prefectural Univ Med, Dept Surg, Div Plast & Reconstruct Surg, Grad Sch Med Sci, Kyoto 6028566, Japan; [Itoh, Kyoko; Fushiki, Shinji] Kyoto Prefectural Univ Med, Dept Pathol & Appl Neurobiol, Grad Sch Med Sci, Kyoto 6028566, Japan	Takeda, K (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Plast & Reconstruct Surg, Grad Sch Med Sci,Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	kt0315kt@koto.kpu-m.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23659834]	This study was supported by Grants-in-Aid for Challenging Exploratory Research (No. 23659834) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Koh KS, 2012, ANN PLAS SURG, V69, P331, DOI 10.1097/SAP.0b013e31826239f0; Tammela T, 2005, BLOOD, V105, P4642, DOI 10.1182/blood-2004-08-3327; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Xu JB, 2012, INT J CANCER, V130, P787, DOI 10.1002/ijc.26035; Houtgraaf JH, 2012, J AM COLL CARDIOL, V59, P539, DOI 10.1016/j.jacc.2011.09.065; Sadat S, 2007, BIOCHEM BIOPH RES CO, V363, P674, DOI 10.1016/j.bbrc.2007.09.058; Yahata Y, 2003, J BIOL CHEM, V278, P40026, DOI 10.1074/jbc.M301866200; Lee MJ, 2010, J PROTEOME RES, V9, P1754, DOI 10.1021/pr900898n; Lee EY, 2009, WOUND REPAIR REGEN, V17, P540, DOI 10.1111/j.1524-475X.2009.00499.x; Jeltsch M, 1997, SCIENCE, V276, P1423, DOI 10.1126/science.276.5317.1423; Moon KM, 2012, INT J MOL SCI, V13, P1239, DOI 10.3390/ijms13011239; Cui K, 2011, J SURG RES, V171, P143, DOI 10.1016/j.jss.2010.03.001; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Paupert J, 2011, MOL ASPECTS MED, V32, P146, DOI 10.1016/j.mam.2011.04.002; Spinella F, 2009, CANCER RES, V69, P2669, DOI 10.1158/0008-5472.CAN-08-1879; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Choi I, 2013, ANGIOGENESIS, V16, P29, DOI 10.1007/s10456-012-9297-6; Kajiya K, 2005, EMBO J, V24, P2885, DOI 10.1038/sj.emboj.7600763; Sowa Y, 2012, STEM CELLS DEV, V21, P1852, DOI 10.1089/scd.2011.0403; Shin JW, 2006, MOL BIOL CELL, V17, P576, DOI 10.1091/mbc.E05-04-0368; Hsiao STF, 2012, STEM CELLS DEV, V21, P2189, DOI 10.1089/scd.2011.0674; Nakao N, 2010, AM J PATHOL, V177, P547, DOI [10.2353/ajpath.2010.091042, 10.2353/ajpath.2010.09.1042]; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Yan A, 2011, FUTURE ONCOL, V7, P1457, DOI [10.2217/fon.11.121, 10.2217/FON.11.121]; Karkkainen MJ, 2001, P NATL ACAD SCI USA, V98, P12677, DOI 10.1073/pnas.221449198; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Koshima I, 2000, J RECONSTR MICROSURG, V16, P437; Irrthum A, 2000, AM J HUM GENET, V67, P295, DOI 10.1086/303019; Kondo K, 2009, ARTERIOSCL THROM VAS, V29, P61, DOI 10.1161/ATVBAHA.108.166496; Conrad C, 2009, CIRCULATION, V119, P281, DOI 10.1161/CIRCULATIONAHA.108.793208; Zhang XF, 2005, J CELL PHYSIOL, V202, P205, DOI 10.1002/jcp.20106; Kubo H, 2002, P NATL ACAD SCI USA, V99, P8868, DOI 10.1073/pnas.062040199; Kumai Y, 2009, LARYNGOSCOPE, V119, P799, DOI 10.1002/lary.20149; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; Koshima I, 2004, ANN PLAS SURG, V53, P261, DOI 10.1097/01.sap.0000120319.89926.07; Warren AG, 2007, ANN PLAS SURG, V59, P464, DOI 10.1097/01.sap.0000257149.42922.7e; Murakami M, 2008, ARTERIOSCL THROM VAS, V28, P658, DOI 10.1161/ATVBAHA.107.150433; Bjorndahl M, 2005, P NATL ACAD SCI USA, V102, P15593, DOI 10.1073/pnas.0507865102; FOLDI E, 1985, ANGIOLOGY, V36, P171, DOI 10.1177/000331978503600306; Szuba A, 2002, FASEB J, V16, P1985, DOI 10.1096/fj.02-0401fje; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Bhang SH, 2011, BIOMATERIALS, V32, P2734, DOI 10.1016/j.biomaterials.2010.12.035; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Hwang JH, 2011, BIOMATERIALS, V32, P4415, DOI 10.1016/j.biomaterials.2011.02.051; Makinen T, 2001, EMBO J, V20, P4762, DOI 10.1093/emboj/20.17.4762; Maldonado GEM, 2011, CYTOTHERAPY, V13, P1249, DOI 10.3109/14653249.2011.594791; Blasi Antonella, 2011, Vasc Cell, V3, P5, DOI 10.1186/2045-824X-3-5; Cooke JP, 2012, CIRCULATION, V125, P853, DOI 10.1161/CIRCULATIONAHA.111.083477; Hou CQ, 2008, JPN J CLIN ONCOL, V38, P670, DOI 10.1093/jjco/hyn090; Mandriota SJ, EMBO J, V20, P672; Mishima K, 2007, MOL BIOL CELL, V18, P1421, DOI 10.1091/mbc.E06-09-0780; Morisada T, 2005, BLOOD, V105, P4649, DOI 10.1182/blood-2004-08-3382; Ning HX, 2009, DIFFERENTIATION, V77, P172, DOI 10.1016/j.diff.2008.09.019; Yoshimura Kotaro, 2011, Regen Med, V6, P33, DOI 10.2217/rme.11.62; Zhang HY, 2011, J SEX MED, V8, P437, DOI 10.1111/j.1743-6109.2010.02128.x; Zhang HY, 2010, BIOCHEM BIOPH RES CO, V402, P560, DOI 10.1016/j.bbrc.2010.10.090; Zhou H, 2011, JPN J CLIN ONCOL, V41, P841, DOI 10.1093/jjco/hyr055	57	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-7043	1536-3708		ANN PLAS SURG	Ann. Plast. Surg.	JUN	2015	74	6					728	736		10.1097/SAP.0000000000000084		9	Surgery	Surgery	CI6RF	WOS:000354888000020		
J	Yamazaki, S				Yamazaki, Sakiko			A Survey of Companion-Animal Owners Affected by the East Japan Great Earthquake in Iwate and Fukushima Prefectures, Japan	ANTHROZOOS			English	Article						animal relief; disaster; pet attachment; pet-related support	EVACUATION FAILURE; RISK-FACTORS; PET OWNERS; DISASTER	The unprecedented East Japan Great Earthquake in March 2011 impacted many humans as well as animals. To date, only national surveys that do not necessarily focus on the heavily impacted areas have been administered, and there is a lack of data on the situation for companion animals and their owners in these areas. This survey was administered between June and November 2012 to pet owners in Iwate (n = 140) and Fukushima (n = 149) Prefectures in north-eastern Japan, areas heavily affected by the disaster. It explored the types of disaster preparations for pets engaged in by owners; the situation on evacuation with pets; the use of, and need for, pet-related support after the disaster; and the associations between pet attachment and disaster-related behaviors of pet owners. In total, 41.2% (n = 119) of all respondents were able to evacuate with their pets, and evacuation rates were especially low in Fukushima. With the exception of preparation of pet food and other supplies, less than 50% of respondents engaged in different types of pet-related disaster preparations. Especially in Fukushima, those who evacuated with their pets were better prepared compared with those who could not. The rate of utilization of support was also low, with less than 50% of respondents utilizing each type of support, regardless of pet-evacuation status and area. The need for support was generally higher during the initial phase (immediately after the disaster; 30-40%) compared with the current phase (20-30%). However, in Fukushima the difference between the initial and current phases was not significant for both those who evacuated with their pets and those who could not. Bivariate analyses indicated mixed results for the association between disaster-related behaviors and pet attachment. Implications for future disaster-prevention measures are discussed.	Humane Soc Int, Tokyo 2040023, Japan	Yamazaki, S (reprint author), Humane Soc Int, 3-4-25 Takeoka Kiyose Shi, Tokyo 2040023, Japan.	sakikoyamazaki@hotmail.com			Humane Society International	The author acknowledges the financial support of Humane Society International, without which the present study could not have been completed. The author also extends her appreciation to Save Animals in Iwate and CHEERS Co., Ltd. for supporting the administration of the survey.	Anicom Insurance Inc., 2009, 9 GATS 1 NICH BOS HI; Lowe SR, 2009, J TRAUMA STRESS, V22, P244, DOI 10.1002/jts.20403; Brackenridge S, 2012, ANTHROZOOS, V25, P229, DOI 10.2752/175303712X13316289505503; Heath SE, 2001, AM J EPIDEMIOL, V153, P659, DOI 10.1093/aje/153.7.659; [Anonymous], 2012, INU DAKEDE 4000 BIKI; [Anonymous], 2011, KEIKAIKUIKI PETTO HO; Fukushima Prefecture, 2013, FUKUSHIMA PREFECTURE; Hall Molly J, 2004, J Psychiatr Pract, V10, P368, DOI 10.1097/00131746-200411000-00005; Glassey S., 2011, AUSTR J DISASTER TRA, V2011-2, P49; Heath SE, 2001, J AM VET MED ASSOC, V218, P1905, DOI 10.2460/javma.2001.218.1905; Hesterberg UW, 2012, DISASTER PREV MANAG, V21, P37, DOI 10.1108/09653561211202692; Higuchi S., 2006, NIIGATAKEN CHUETSU J; Hudson LC, 2001, J AM VET MED ASSOC, V218, P354, DOI 10.2460/javma.2001.218.354; Hunt Melissa G., 2012, Animals, V2, P529, DOI 10.3390/ani2040529; Hyogoken Nanbu Jishin Dobutsu Kyuen Honbu Katsudo no Kiroku Henshu linkai, 1996, DAI JISHIN HISAI DOB; Irisoyama Inc, 2012, JISH PETT KANS CHOS; Irvine L., 2004, PROVIDING PETS DISAS; Irvine L, 2009, ANIM ETHIC, P1; Japan Animal Welfare Society, 2005, 4849 JAWS; Japan Animal Welfare Society, 2005, 12211995 JGS; Japan Association for Promoting Harmonization Between People and Pets, 2011, DAI 9 KAI INU KAINUS; Japan Pet Care Association, 2011, HIT DOB BOS KANG; Japan Pet Care Association, NIIG CHUETS HIS DOB; Japan Pet Food Association, 2010, HEIS 22 NEND ZENK NE; Kobe City Veterinary Medical Association, HANSH AW DAISH OK DO; Ministry of Health Labour and Welfare, 2011, TOD INU TOR YOB; Ministry of the Environment, 2011, ITS ISSH IT PETT DOB; Ministry of the Environment, SHIRY 4 SAIG OK DOB; Ministry of the Environment, 2012, CHUO KANK SHING DOB; National Police Agency, 2013, HEIS 23 NEN 2011 TOH; Niigata Veterinary Medical Association, CHUETS DAISH OK KATS; Niigataken Bosai Kaigi, 2010, NIIG CHIIK BOS KEIK; Pet & Family Small-Amount Short-Term Insurance Company, 2012, PETT BOS TAIS ISH; Shinjuku Ward Health Center Department of Risk Management & Tokyo Veterinary Medical Association Shinjuku Branch, 2008, IZA IUT SAIG KAR PET; Staats S, 1996, ANTHROZOOS, V9, P88; Statistics Bureau, 2011, KOK CHOS; Sugita H., 2003, JGSS KENKYU RONBUNSH, V2, P127; Thompson K., 2013, AUSTR J COMMUNICATIO, V40, P123	38	0	0	BLOOMSBURY PUBLISHING  PLC	LONDON	50 BEDFORD SQ, LONDON, WC1B 3DP, ENGLAND	0892-7936	1753-0377		ANTHROZOOS	Anthrozoos	JUN	2015	28	2					291	304		10.2752/089279315X14219211661895		14	Anthropology; Environmental Studies; Sociology; Veterinary Sciences	Anthropology; Environmental Sciences & Ecology; Sociology; Veterinary Sciences	CI8SD	WOS:000355041100008		
J	Yoon, J; Yasumoto-Hirose, M; Kasai, H				Yoon, Jaewoo; Yasumoto-Hirose, Mina; Kasai, Hiroaki			Aureisphaera galaxeae gen. nov., sp nov., a marine member of the family Flavobacteriaceae isolated from the hard coral Galaxea fascicularis	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Bacteroidetes; Flavobacteriaceae; Aureisphaera galaxeae gen. nov., sp nov.; Galaxea fascicularis; 16S rRNA gene; Polyphasic taxonomy	PERFORMANCE LIQUID-CHROMATOGRAPHY; EMENDED DESCRIPTION; AEQUORIVITA-CAPSOSIPHONIS; DEOXYRIBONUCLEIC-ACID; WATER; VITELLIBACTER; BACTEROIDES; BACTERIUM	A novel Gram-stain negative, spherical, non-motile, strictly aerobic, heterotrophic, yellow pigmented bacterium, designated strain 04OKA003-7(T) was isolated from the hard coral Galaxea fascicularis L. collected at Akajima, Okinawa, Japan. Phylogenetic analysis based on the 16S rRNA gene sequence revealed the novel isolate is affiliated with the family Flavobacteriaceae of the phylum Bacteroidetes and that it showed highest sequence similarity (92.9 %) to Vitellibacter aestuarii JC2436(T) and Aureitalea marina S1-66(T). The strain could be differentiated phenotypically from recognized members of the family Flavobacteriaceae. The major fatty acids of strain 04OKA003-7(T) were identified as iso-C15:0 and iso-C17:0 3-OH as defined by the MIDI system. The DNA G+C content was determined to be 41 mol%, the major respiratory quinone was identified as menaquinone 6 (MK-6) and a polar lipid profile was present consisting of phosphatidylethanolamine, two unidentified aminolipids and an unidentified lipid. From the distinct phylogenetic position and combination of genotypic and phenotypic characteristics, the strain is considered to represent a novel genus for which the name Aureisphaera galaxeae gen. nov., sp. nov. is proposed. The type strain of A. galaxeae is 04OKA003-7(T) (=KCTC 32993(T) = NBRC 110018(T)).	[Yoon, Jaewoo] Keimyung Univ, Coll Pharm, Daegu 704701, South Korea; [Yasumoto-Hirose, Mina] Marine Biotechnol Inst, Kamaishi, Iwate 0260001, Japan; [Kasai, Hiroaki] Kitasato Univ, Marine Biosci Kamaishi Res Lab, Ofunato, Iwate 0220101, Japan	Yoon, J (reprint author), Keimyung Univ, Coll Pharm, 1095 Dalgubeoldaero, Daegu 704701, South Korea.	jwyoon@kmu.ac.kr			SAMICK THK	The present research has been conducted by the Educational-Industrial Collaboration Research Grant of SAMICK THK in 2015.	FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Zeng YX, 2013, ANTON LEEUW INT J G, V103, P1309, DOI 10.1007/s10482-013-9912-6; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; O'Sullivan LA, 2006, INT J SYST EVOL MICR, V56, P169, DOI 10.1099/ijs.0.63941-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; MARMUR J, 1961, J MOL BIOL, V3, P208; Brettar I, 2004, INT J SYST EVOL MICR, V54, P2335, DOI 10.1099/ijs.0.63255-0; McCammon SA, 1998, INT J SYST BACTERIOL, V48, P1405; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; DITTMER JC, 1964, J LIPID RES, V5, P126; COLLINS MD, 1981, J APPL BACTERIOL, V51, P129, DOI 10.1111/j.1365-2672.1981.tb00916.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697; Liu JJ, 2013, INT J SYST EVOL MICR, V63, P3192, DOI 10.1099/ijs.0.049635-0; PERRY LB, 1973, J APPL BACTERIOL, V36, P227, DOI 10.1111/j.1365-2672.1973.tb04095.x; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Osinga R, 2011, MAR BIOTECHNOL, V13, P658, DOI 10.1007/s10126-011-9382-7; Nedashkovskaya OI, 2003, INT J SYST EVOL MICR, V53, P1281, DOI 10.1099/ijs.0.02302-0; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Park S, 2014, INT J SYST EVOL MICR, V64, P588, DOI 10.1099/ijs.0.056713-0; Atlas R. M., 1993, HDB MICROBIOLOGICAL; Collins C. H., 1984, MICROBIOLOGICAL METH; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Garrity G. M., 2001, BERGEYS MANUAL SYSTE, P119; HANSEN GH, 1991, J MICROBIOL METH, V13, P231; Khan ST, 2007, INT J SYST EVOL MICR, V57, P265, DOI 10.1099/ijs.0.64628-0; Kim Bong-Soo, 2010, Int J Syst Evol Microbiol, V60, P1989, DOI 10.1099/ijs.0.019034-0; Kimura M., 1983, NEUTRAL THEORY MOL E; Ludwig W, 2001, BERGEYS MANUAL SYSTE, V1, P49; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Park S, 2012, INT J SYST EVOL MICR, V62, P912, DOI 10.1099/ijs.0.031450-0; Park S, 2013, ANTON LEEUW INT J G, V104, P139, DOI 10.1007/s10482-013-9934-0; Park SC, 2009, INT J SYST EVOL MICR, V59, P724, DOI 10.1099/ijs.0.004119-0; Reichenbach H, 1989, BERGEYS MANUAL SYSTE, V3, P2015; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M., 1990, 101 MIDI; Worliczek HL, 2007, SYST APPL MICROBIOL, V30, P355, DOI 10.1016/j.syapm.2007.03.004	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	JUN	2015	107	6					1379	1386		10.1007/s10482-015-0432-4		8	Microbiology	Microbiology	CI2XW	WOS:000354612500002		
J	Yoon, J; Oku, N; Kasai, H				Yoon, Jaewoo; Oku, Naoya; Kasai, Hiroaki			Wenyingzhuangia gracilariae sp nov., a novel marine bacterium of the phylum Bacteroidetes isolated from the red alga Gracilaria vermiculophylla	ANTONIE VAN LEEUWENHOEK INTERNATIONAL JOURNAL OF GENERAL AND MOLECULAR MICROBIOLOGY			English	Article						Bacteroidetes; Flavobacteriaceae; Wenyingzhuangia gracilariae sp nov.; Rhodophyta; 16S rRNA gene; Polyphasic taxonomy	PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-SITU HYBRIDIZATION; FAMILY FLAVOBACTERIACEAE; DEOXYRIBONUCLEIC-ACID; COMMUNITY COMPOSITION; GEN. NOV.; DIVERSITY; SEA; SYSTEMATICS	A Gram-negative, strictly aerobic, beige-pigmented, non-motile, rod-shaped bacterial strain designated N5DB13-4(T) was isolated from the red alga Gracilaria vermiculophylla (Rhodophyta) collected at Sodegaura Beach, Chiba, Japan. Phylogenetic analyses based on the 16S rRNA gene sequence revealed that the novel isolate is affiliated with the family Flavobacteriaceae within the phylum Bacteroidetes and that it showed highest sequence similarity (97.3 %) to Wenyingzhuangia heitensis H-MN17(T). The hybridization values for DNA-DNA relatedness between the strains N5DB13-4(T) and W. heitensis H-MN17(T) were 34.1 +/- A 3.5 %, which is below the threshold accepted for the phylogenetic definition of a novel prokaryotic species. The DNA G+C content of strain N5DB13-4(T) was determined to be 31.8 mol%; MK-6 was identified as the major menaquinone; and the presence of iso-C15:0, iso-C15:0 3-OH and iso-C17:0 3-OH as the major (> 10 %) cellular fatty acids. A complex polar lipid profile was present consisting of phosphatidylethanolamine, two unidentified glycolipids and four unidentified lipids. From the distinct phylogenetic position and combination of genotypic and phenotypic characteristics, the strain is considered to represent a novel species of the genus Wenyingzhuangia for which the name Wenyingzhuangia gracilariae sp. nov. is proposed. The type strain of W. gracilariae sp. nov. is N5DB13-4(T) (=KCTC 42246 (T)=NBRC 110602(T)).	[Yoon, Jaewoo] Keimyung Univ, Coll Pharm, Daegu 704701, South Korea; [Oku, Naoya] Toyama Prefectural Univ, Biotechnol Res Ctr, Toyama 9390398, Japan; [Kasai, Hiroaki] Kitasato Univ, Marine Biosci Kamaishi Res Lab, Ofunato, Iwate 0220101, Japan	Yoon, J (reprint author), Keimyung Univ, Coll Pharm, 1095 Dalgubeoldaero, Daegu 704701, South Korea.	jwyoon@kmu.ac.kr			New Energy and Industrial Technology Development Organization (NEDO); Institute for Fermentation, Osaka, Japan	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO), and in part by a research grant (2009-2011) of the Institute for Fermentation, Osaka, Japan.	AKAGAWAMATSUSHITA M, 1992, INT J SYST BACTERIOL, V42, P621; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Kirchman DL, 2002, FEMS MICROBIOL ECOL, V39, P91, DOI 10.1111/j.1574-6941.2002.tb00910.x; MARMUR J, 1961, J MOL BIOL, V3, P208; Brettar I, 2004, INT J SYST EVOL MICR, V54, P2335, DOI 10.1099/ijs.0.63255-0; Cottrell MT, 2000, APPL ENVIRON MICROB, V66, P5116, DOI 10.1128/AEM.66.12.5116-5122.2000; Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721; Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI 10.1099/ijs.0.02136-0; DITTMER JC, 1964, J LIPID RES, V5, P126; O'Sullivan LA, 2002, APPL ENVIRON MICROB, V68, P201, DOI 10.1128/AEM.68.1.201-210.2002; COLLINS MD, 1981, J APPL BACTERIOL, V51, P129, DOI 10.1111/j.1365-2672.1981.tb00916.x; WEISBURG WG, 1991, J BACTERIOL, V173, P697; PERRY LB, 1973, J APPL BACTERIOL, V36, P227, DOI 10.1111/j.1365-2672.1973.tb04095.x; KOMAGATA K, 1987, METHOD MICROBIOL, V19, P161; Bowman JP, 1997, APPL ENVIRON MICROB, V63, P3068; DELONG EF, 1993, LIMNOL OCEANOGR, V38, P924; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BIANCHI A, 1995, MICROBIAL DIVERSITY AND ECOSYSTEM FUNCTION, P185; Collins C. H., 1984, MICROBIOLOGICAL METH; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.2307/2408678; Fernandes N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050854; HANSEN GH, 1991, J MICROBIOL METH, V13, P231; Kimura M., 1983, NEUTRAL THEORY MOL E; Liu Y, 2014, INT J SYST EVOL MICR, V64, P469, DOI 10.1099/ijs.0.055012-0; MESBAH M, 1989, INT J SYST BACTERIOL, V39, P159; MINNIKIN DE, 1984, J MICROBIOL METH, V2, P233, DOI 10.1016/0167-7012(84)90018-6; Miranda LN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058269; Nylund GM, 2010, FEMS MICROBIOL ECOL, V71, P84, DOI 10.1111/j.1574-6941.2009.00791.x; Pinhassi J, 2003, APPL ENVIRON MICROB, V69, P199, DOI 10.1128/AEM.69.1.199-211.2003; Reichenbach H, 1989, BERGEYS MANUAL SYSTE, V3, P2015; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Sasser M., 1990, 101 MIDI; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463; Worliczek HL, 2007, SYST APPL MICROBIOL, V30, P355, DOI 10.1016/j.syapm.2007.03.004; Yoon J, 2015, ANTON LEEUW INT J G, V107, P655, DOI 10.1007/s10482-014-0360-8	37	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0003-6072	1572-9699		ANTON LEEUW INT J G	Antonie Van Leeuwenhoek	JUN	2015	107	6					1607	1613		10.1007/s10482-015-0456-9		7	Microbiology	Microbiology	CI2XW	WOS:000354612500024		
J	Iida, T; Itakura, M; Anda, M; Sugawara, M; Isawa, T; Okubo, T; Sato, S; Chiba-Kakizaki, K; Minamisawa, K				Iida, Takayuki; Itakura, Manabu; Anda, Mizue; Sugawara, Masayuki; Isawa, Tsuyoshi; Okubo, Takashi; Sato, Shusei; Chiba-Kakizaki, Kaori; Minamisawa, Kiwamu			Symbiosis Island Shuffling with Abundant Insertion Sequences in the Genomes of Extra-Slow-Growing Strains of Soybean Bradyrhizobia	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							HIGH COPY NUMBERS; RS-ALPHA; JAPONICUM STRAINS; CARBON-DIOXIDE; SP-NOV; BACTERIA; ROOT; PLASMID; POPULATIONS; CHROMOSOME	Extra-slow-growing bradyrhizobia from root nodules of field-grown soybeans harbor abundant insertion sequences (ISs) and are termed highly reiterated sequence-possessing (HRS) strains. We analyzed the genome organization of HRS strains with the focus on IS distribution and symbiosis island structure. Using pulsed-field gel electrophoresis, we consistently detected several plasmids (0.07 to 0.4 Mb) in the HRS strains (NK5, NK6, USDA135, 2281, USDA123, and T2), whereas no plasmids were detected in the non-HRS strain USDA110. The chromosomes of the six HRS strains (9.7 to 10.7 Mb) were larger than that of USDA110 (9.1 Mb). Using MiSeq sequences of 6 HRS and 17 non-HRS strains mapped to the USDA110 genome, we found that the copy numbers of ISRj1, ISRj2, ISFK1, IS1632, ISB27, ISBj8, and IS1631 were markedly higher in HRS strains. Whole-genome sequencing showed that the HRS strain NK6 had four small plasmids (136 to 212 kb) and a large chromosome (9,780 kb). Strong colinearity was found between 7.4-Mb core regions of the NK6 and USDA110 chromosomes. USDA110 symbiosis islands corresponded mainly to five small regions (S1 to S5) within two variable regions, V1 (0.8 Mb) and V2 (1.6 Mb), of the NK6 chromosome. The USDA110 nif gene cluster (nifDKENXSBZHQW-fixBCX) was split into two regions, S2 and S3, where ISRj1-mediated rearrangement occurred between nifS and nifB. ISs were also scattered in NK6 core regions, and ISRj1 insertion often disrupted some genes important for survival and environmental responses. These results suggest that HRS strains of soybean bradyrhizobia were subjected to IS-mediated symbiosis island shuffling and core genome degradation.	[Iida, Takayuki; Itakura, Manabu; Anda, Mizue; Sugawara, Masayuki; Isawa, Tsuyoshi; Okubo, Takashi; Sato, Shusei; Chiba-Kakizaki, Kaori; Minamisawa, Kiwamu] Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan	Minamisawa, K (reprint author), Tohoku Univ, Grad Sch Life Sci, Sendai, Miyagi 980, Japan.	kiwamu@ige.tohoku.ac.jp	Sato, Shusei/A-3616-2015	Sato, Shusei/0000-0002-0293-5366	Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-Based Technology for Agricultural Improvement) [SFC-2003]; Ministry of Agriculture, Forestry, and Fisheries of Japan (Bio-Oriented Technology Research Advancement Institution [BRAIN]); Ministry of Education, Culture, Sports, Science and Technology of Japan [23248052, 26252065]	This study was supported by grants from the Ministry of Agriculture, Forestry, and Fisheries of Japan (Genomics-Based Technology for Agricultural Improvement SFC-2003 and the Bio-Oriented Technology Research Advancement Institution [BRAIN]) and by Grants-in-Aid for Scientific Research (A) 23248052 and 26252065 from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Sameshima R, 2003, FEMS MICROBIOL ECOL, V44, P191, DOI 10.1016/S0168-6496(03)00009-6; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; XU LM, 1995, INT J SYST BACTERIOL, V45, P706; Bigot S, 2005, EMBO J, V24, P3770, DOI 10.1038/sj.emboj.7600835; Okubo T, 2012, MICROBES ENVIRON, V27, P306, DOI 10.1264/jsme2.ME11321; Delamuta JRM, 2013, INT J SYST EVOL MICR, V63, P3342, DOI 10.1099/ijs.0.049130-0; Chin CS, 2013, NAT METHODS, V10, P563, DOI [10.1038/nmeth.2474, 10.1038/NMETH.2474]; Mahillon J, 1998, MICROBIOL MOL BIOL R, V62, P725; Okubo T, 2014, MICROBES ENVIRON, V29, P184, DOI 10.1264/jsme2.ME14011; van Berkum P, 2000, INT J SYST EVOL MICR, V50, P2165; Sugawara M, 2013, MICROBES ENVIRON, V28, P217, DOI 10.1264/jsme2.ME12190; CATANESE CA, 1989, J BACTERIOL, V171, P4531; Giraud E, 2007, SCIENCE, V316, P1307, DOI 10.1126/science.1139548; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Lobry JR, 1996, MOL BIOL EVOL, V13, P660; Kanbe M, 2007, J BACTERIOL, V189, P1083, DOI 10.1128/JB.01405-06; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Blakely GW, 2000, J BIOL CHEM, V275, P9930, DOI 10.1074/jbc.275.14.9930; Cevallos MA, 2008, PLASMID, V60, P19, DOI 10.1016/j.plasmid.2008.03.001; Chaudhuri RR, 2006, NUCLEIC ACIDS RES, V34, pD335, DOI 10.1093/nar/gkj140; Cytryn EJ, 2008, ISME J, V2, P158, DOI 10.1038/ismej.2007.105; Ikeda S, 2014, MICROBES ENVIRON, V29, P50, DOI 10.1264/jsme2.ME13110; Isawa T, 1999, APPL ENVIRON MICROB, V65, P3493; Itakura M, 2009, ISME J, V3, P326, DOI 10.1038/ismej.2008.88; Kaneko T, 2011, GENES-BASEL, V2, P763, DOI 10.3390/genes2040763; Kasai-Maita H, 2013, MICROBES ENVIRON, V28, P275, DOI 10.1264/jsme2.ME12201; Koren S, 2012, NAT BIOTECHNOL, V30, P692, DOI 10.1038/nbt.2280; Lee KB, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-271; Lozano L, 2010, APPL ENVIRON MICROB, V76, P6504, DOI 10.1128/AEM.01001-10; Menna P, 2011, INT J SYST EVOL MICR, V61, P3052, DOI 10.1099/ijs.0.028803-0; Minamisawa K, 1998, APPL ENVIRON MICROB, V64, P1845; Minamisawa K, 2002, MICROBES ENVIRON, V17, P82, DOI 10.1264/jsme2.2002.82; Ohtsubo Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-376; Okazaki K, 2014, MICROBES ENVIRON, V29, P220, DOI 10.1264/jsme2.ME13182; Okubo T, 2013, APPL ENVIRON MICROB, V79, P2542, DOI 10.1128/AEM.00009-13; Parker MA, 2012, MOL ECOL, V21, P1769, DOI 10.1111/j.1365-294X.2012.05497.x; Parker MA, 2015, MICROB ECOL, V69, P630, DOI 10.1007/s00248-014-0503-5; RODRIGUEZQUINONES F, 1992, APPL ENVIRON MICROB, V58, P1878; Sachs JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026370; Saeki Y, 2013, MICROBES ENVIRON, V28, P470, DOI 10.1264/jsme2.ME13079; Shiina Y, 2014, MICROBES ENVIRON, V29, P420, DOI 10.1264/jsme2.ME14130; Siguier P, 2014, FEMS MICROBIOL REV, V38, P865, DOI 10.1111/1574-6976.12067; Siqueira AF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-420; SOBRAL BWS, 1990, APPL ENVIRON MICROB, V56, P1949; Takeshima K, 2013, MICROBES ENVIRON, V28, P414, DOI 10.1264/jsme2.ME13057; Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189	48	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	12					4143	4154		10.1128/AEM.00741-15		12	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI6JC	WOS:000354864000024		
J	Watanabe, A; Hiraga, K; Suda, M; Yukawa, H; Inui, M				Watanabe, Akira; Hiraga, Kazumi; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki			Functional Characterization of Corynebacterium alkanolyticum beta-Xylosidase and Xyloside ABC Transporter in Corynebacterium glutamicum	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							OXYGEN-DEPRIVATION CONDITIONS; STREPTOMYCES-THERMOVIOLACEUS OPC-520; ESCHERICHIA-COLI; GEOBACILLUS-STEAROTHERMOPHILUS; CRYSTALLOGRAPHIC ANALYSIS; EXPRESSION; CELLOBIOSE; CRYSTALLIZATION; FERMENTATION; SEQUENCE	The Corynebacterium alkanolyticum xylEFGD gene cluster comprises the xylD gene that encodes an intracellular beta-xylosidase next to the xylEFG operon encoding a substrate-binding protein and two membrane permease proteins of a xyloside ABC transporter. Cloning of the cluster revealed a recombinant beta-xylosidase of moderately high activity (turnover for p-nitrophenyl-beta-D-xylopyranoside of 111 +/- 4 s(-1)), weak alpha-L-arabinofuranosidase activity (turnover for p-nitrophenyl-alpha-L-arabinofuranoside of 5 +/- 1 s(-1)), and high tolerance to product inhibition (K-i for xylose of 67.6 +/- 2.6 mM). Heterologous expression of the entire cluster under the control of the strong constitutive tac promoter in the Corynebacterium glutamicum xylose-fermenting strain X1 enabled the resultant strain X1EFGD to rapidly utilize not only xylooligosaccharides but also arabino-xylooligosaccharides. The ability to utilize arabino-xylooligosaccharides depended on cgR_2369, a gene encoding a multitask ATP-binding protein. Heterologous expression of the contiguous xylD gene in strain X1 led to strain X1D with 10-fold greater beta-xylosidase activity than strain X1EFGD, albeit with a total loss of arabino-xylooligosaccharide utilization ability and only half the ability to utilize xylooligosaccharides. The findings suggest some inherent ability of Corynebacterium glutamicum to take up xylooligosaccharides, an ability that is enhanced by in the presence of a functional xylEFG-encoded xyloside ABC transporter. The finding that xylEFG imparts nonnative ability to take up arabino-xylooligosaccharides should be useful in constructing industrial strains with efficient fermentation of arabinoxylan, a major component of lignocellulosic biomass hydrolysates.	[Watanabe, Akira; Hiraga, Kazumi; Suda, Masako; Yukawa, Hideaki; Inui, Masayuki] Res Inst Innovat Technol Earth, Kizugawa Shi, Kyoto, Japan; [Inui, Masayuki] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300101, Japan	Inui, M (reprint author), Res Inst Innovat Technol Earth, Kizugawa Shi, Kyoto, Japan.	mmg-lab@rite.or.jp					Shulami S, 2007, APPL ENVIRON MICROB, V73, P874, DOI 10.1128/AEM.02367-06; VERTES AA, 1993, RES MICROBIOL, V144, P181, DOI 10.1016/0923-2508(93)90043-2; Wang C, 2014, APPL BIOCHEM BIOTECH, V172, P340, DOI 10.1007/s12010-013-0539-x; Arai K, 2008, J CHROMATOGR B, V875, P358, DOI 10.1016/j.jchromb.2008.09.010; Aristidou A, 2000, CURR OPIN BIOTECH, V11, P187, DOI 10.1016/S0958-1669(00)00085-9; Sasaki M, 2008, APPL MICROBIOL BIOT, V81, P691, DOI 10.1007/s00253-008-1703-z; Shao WL, 2011, APPL ENVIRON MICROB, V77, P719, DOI 10.1128/AEM.01511-10; Yamamoto S, 2013, BIOTECHNOL BIOENG, V110, P2938, DOI 10.1002/bit.24961; Shin HD, 2010, APPL ENVIRON MICROB, V76, P8150, DOI 10.1128/AEM.00908-10; Pinphanichakarn P, 2004, WORLD J MICROB BIOT, V20, P727, DOI 10.1007/s11274-004-4513-1; Yamamoto S, 2012, APPL ENVIRON MICROB, V78, P4447, DOI 10.1128/AEM.07998-11; Kim YA, 2010, J MICROBIOL BIOTECHN, V20, P1711, DOI 10.4014/jmb.1010.10040; Gopinath V, 2011, APPL MICROBIOL BIOT, V92, P985, DOI 10.1007/s00253-011-3478-x; Kang MK, 2014, APPL MICROBIOL BIOT, V98, P5991, DOI 10.1007/s00253-014-5714-7; Inui M, 2004, J MOL MICROB BIOTECH, V7, P182, DOI 10.1159/000079827; Jojima T, 2010, APPL MICROBIOL BIOT, V87, P159, DOI 10.1007/s00253-010-2493-7; Hasegawa S, 2013, APPL ENVIRON MICROB, V79, P1250, DOI 10.1128/AEM.02806-12; Kawaguchi H, 2006, APPL ENVIRON MICROB, V72, P3418, DOI 10.1128/AEM.72.5.3418-3128.2006; Meiswinkel TM, 2013, MICROB BIOTECHNOL, V6, P131, DOI 10.1111/1751-7915.12001; Buschke N, 2013, BIOTECHNOL J, V8, P557, DOI 10.1002/biot.201200367; Dodd D, 2009, GCB BIOENERGY, V1, P2, DOI 10.1111/j.1757-1707.2009.01004.x; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Crosman JT, 2002, J AM OIL CHEM SOC, V79, P467, DOI 10.1007/s11746-002-0507-5; Czjzek M, 2004, ACTA CRYSTALLOGR D, V60, P1461, DOI 10.1107/S0907444904013320; Ferreira MJ, 2010, J BACTERIOL, V192, P5312, DOI 10.1128/JB.00832-10; Inui M, 2004, J MOL MICROB BIOTECH, V8, P243, DOI 10.1159/000086705; Jojima T, 2015, APPL MICROBIOL BIOT, V99, P1165, DOI 10.1007/s00253-014-6223-4; Morioka H, 2010, ACTA CRYSTALLOGR F, V66, P791, DOI 10.1107/S1744309110013400; NAKAO Y, 1973, AGR BIOL CHEM TOKYO, V37, P2399; Qian Y, 2003, APPL ENVIRON MICROB, V69, P5957, DOI 10.1128/AEM.69.10.5957-5967.2003; Radek A, 2014, J BIOTECHNOL, V192, P156, DOI 10.1016/j.jbiotec.2014.09.026; RILEY J, 1990, NUCLEIC ACIDS RES, V18, P2887, DOI 10.1093/nar/18.10.2887; Sambrook J., 1989, MOL CLONING LAB MANU; Schlosser A, 1997, J BACTERIOL, V179, P2092; Schlosser A, 1999, APPL ENVIRON MICROB, V65, P2636; Tsujibo H, 2004, J BACTERIOL, V186, P1029, DOI 10.1128/JB.186.4.1029-1037.2004; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; Yukawa H, 2007, MICROBIOL-SGM, V153, P1042, DOI 10.1099/mic.0.2006/003657-0	38	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	12					4173	4183		10.1128/AEM.00792-15		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI6JC	WOS:000354864000027		
J	Cui, YS; Suzuki, S; Omori, Y; Wong, SK; Ijichi, M; Kaneko, R; Kameyama, S; Tanimoto, H; Hamasaki, K				Cui, Yingshun; Suzuki, Shotaro; Omori, Yuko; Wong, Shu-Kuan; Ijichi, Minoru; Kaneko, Ryo; Kameyama, Sohiko; Tanimoto, Hiroshi; Hamasaki, Koji			Abundance and Distribution of Dimethylsulfoniopropionate Degradation Genes and the Corresponding Bacterial Community Structure at Dimethyl Sulfide Hot Spots in the Tropical and Subtropical Pacific Ocean	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Article							DISSOLVED DIMETHYLSULFONIOPROPIONATE; GAS DIMETHYLSULFIDE; DMSP DEGRADATION; MARINE-BACTERIA; SURFACE OCEAN; SULFUR CYCLE; LYASE; BACTERIOPLANKTON; PHYTOPLANKTON; DIVERSITY	Dimethylsulfoniopropionate (DMSP) is mainly produced by marine phytoplankton but is released into the microbial food web and degraded by marine bacteria to dimethyl sulfide (DMS) and other products. To reveal the abundance and distribution of bacterial DMSP degradation genes and the corresponding bacterial communities in relation to DMS and DMSP concentrations in seawater, we collected surface seawater samples from DMS hot spot sites during a cruise across the Pacific Ocean. We analyzed the genes encoding DMSP lyase (dddP) and DMSP demethylase (dmdA), which are responsible for the transformation of DMSP to DMS and DMSP assimilation, respectively. The averaged abundance (+/- standard deviation) of these DMSP degradation genes relative to that of the 16S rRNA genes was 33% +/- 12%. The abundances of these genes showed large spatial variations. dddP genes showed more variation in abundances than dmdA genes. Multidimensional analysis based on the abundances of DMSP degradation genes and environmental factors revealed that the distribution pattern of these genes was influenced by chlorophyll a concentrations and temperatures. dddP genes, dmdA subclade C/2 genes, and dmdA subclade D genes exhibited significant correlations with the marine Roseobacter clade, SAR11 subgroup Ib, and SAR11 subgroup Ia, respectively. SAR11 subgroups Ia and Ib, which possessed dmdA genes, were suggested to be the main potential DMSP consumers. The Roseobacter clade members possessing dddP genes in oligotrophic subtropical regions were possible DMS producers. These results suggest that DMSP degradation genes are abundant and widely distributed in the surface seawater and that the marine bacteria possessing these genes influence the degradation of DMSP and regulate the emissions of DMS in subtropical gyres of the Pacific Ocean.	[Cui, Yingshun; Suzuki, Shotaro; Wong, Shu-Kuan; Ijichi, Minoru; Kaneko, Ryo; Hamasaki, Koji] Univ Tokyo, Atmosphere & Ocean Res Inst, Div Marine Life Sci, Marine Microbiol,Dept Marine Ecosyst Dynam, Kashiwa, Chiba, Japan; [Omori, Yuko; Tanimoto, Hiroshi] Natl Inst Environm Studies, Ctr Global Environm Res, Ibaraki, Japan; [Kameyama, Sohiko] Hokkaido Univ, Fac Environm Earth Sci, Sapporo, Hokkaido, Japan	Cui, YS (reprint author), Univ Tokyo, Atmosphere & Ocean Res Inst, Div Marine Life Sci, Marine Microbiol,Dept Marine Ecosyst Dynam, Kashiwa, Chiba, Japan.	yscui415@aori.u-tokyo.ac.jp	Tanimoto, Hiroshi/E-6779-2010; Kameyama, Sohiko/D-5143-2015		Japan Society for the Promotion of Science (JSPS) Research Fellowship for Foreign Scientists [P 11389]; JSPS [21014005, 2301389, 24121004]	This research was supported by a Japan Society for the Promotion of Science (JSPS) Research Fellowship for Foreign Scientists (no. P 11389) to Y.C. and grants-in-aid (no. 21014005, 2301389, and 24121004) from JSPS to K.H.	ALLDREDGE AL, 1985, DEEP-SEA RES, V32, P1445, DOI 10.1016/0198-0149(85)90096-2; Kim M, 2011, J MICROBIOL METH, V84, P81, DOI 10.1016/j.mimet.2010.10.020; DUCKLOW HW, 1983, J PLANKTON RES, V5, P333, DOI 10.1093/plankt/5.3.333; LOVELOCK JE, 1972, NATURE, V237, P452, DOI 10.1038/237452a0; Stefels J, 2007, BIOGEOCHEMISTRY, V83, P245, DOI 10.1007/s10533-007-9091-5; Howard EC, 2008, ENVIRON MICROBIOL, V10, P2397, DOI 10.1111/j.1462-2920.2008.01665.x; Kameyama S, 2009, ANAL CHEM, V81, P9021, DOI 10.1021/ac901630h; Kiene RP, 1999, APPL ENVIRON MICROB, V65, P4549; Todd JD, 2007, SCIENCE, V315, P666, DOI 10.1126/science.1135370; Curson ARJ, 2011, ISME J, V5, P1191, DOI 10.1038/ismej.2010.203; CHARLSON RJ, 1987, NATURE, V326, P655, DOI 10.1038/326655a0; Malmstrom RR, 2004, APPL ENVIRON MICROB, V70, P4129, DOI 10.1128/AEM.70.7.4129-4135.2004; Todd JD, 2011, ENVIRON MICROBIOL, V13, P427, DOI 10.1111/j.1462-2920.2010.02348.x; Kiene RP, 2000, GEOCHIM COSMOCHIM AC, V64, P2797, DOI 10.1016/S0016-7037(00)00399-9; ANDREAE MO, 1990, MAR CHEM, V30, P1, DOI 10.1016/0304-4203(90)90059-L; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Biers EJ, 2009, APPL ENVIRON MICROB, V75, P2221, DOI 10.1128/AEM.02118-08; AZAM F, 1977, LIMNOL OCEANOGR, V22, P492; Vallina SM, 2007, SCIENCE, V315, P506, DOI 10.1126/science.1133680; Tripp HJ, 2008, NATURE, V452, P741, DOI 10.1038/nature06776; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Curson ARJ, 2011, NAT REV MICROBIOL, V9, P849, DOI 10.1038/nrmicro2653; Stefels J, 2000, J SEA RES, V43, P183, DOI 10.1016/S1385-1101(00)00030-7; Kiene RP, 2000, LIMNOL OCEANOGR, V45, P849; Curson ARJ, 2008, ENVIRON MICROBIOL, V10, P757, DOI 10.1111/j.1462-2920.2007.01499.x; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Yoch DC, 2002, APPL ENVIRON MICROB, V68, P5804, DOI 10.1128/AEM.68.12.5804-5815.2002; Todd JD, 2012, ISME J, V6, P223, DOI 10.1038/ismej.2011.79; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Howard EC, 2006, SCIENCE, V314, P649, DOI 10.1126/science.1130657; BELL THA, 2010, DUST DEEK MR DOR, P1, DOI DOI 10.1029/2009GB003617; Carl P, 2008, PERFORMANCEANALYTICS; Harrell FE, 2007, DESIGN PACKAGE R PAC; HODSON RE, 1981, MAR BIOL, V64, P43, DOI 10.1007/BF00394079; Howard EC, 2011, APPL ENVIRON MICROB, V77, P524, DOI 10.1128/AEM.01457-10; Kasamatsu N, 2004, CAN J FISH AQUAT SCI, V61, P736, DOI 10.1139/F04-072; KELLER MD, 1989, ACS SYM SER, V393, P167; Kindt R, 2014, BIODIVERSITYR PACKAG; Lana A, 2011, GLOBAL BIOGEOCHEM CY, V25, DOI 10.1029/2010GB003850; Lane D. J., 1991, NUCL ACID TECHNIQUES, V4, P115, DOI DOI 10.1002/JOBM.3620310616; Levine NM, 2012, ENVIRON MICROBIOL, V14, P1210, DOI 10.1111/j.1462-2920.2012.02700.x; Moran MA, 2012, ANNU REV MAR SCI, V4, P523, DOI 10.1146/annurev-marine-120710-100827; Oksanen J., 2007, VEGAN PACKAGE COMMUN; Peng MJ, 2012, CAN J MICROBIOL, V58, P523, DOI [10.1139/w2012-019, 10.1139/W2012-019]; Penven P, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2005JC002945; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; SIMON M, 1985, APPL ENVIRON MICROB, V49, P1254; Todd JD, 2009, ENVIRON MICROBIOL, V11, P1624, DOI 10.1111/j.1462-2920.2009.01919.x; Varaljay VA, 2010, APPL ENVIRON MICROB, V76, P609, DOI 10.1128/AEM.01258-09; Varaljay VA, 2012, APPL ENVIRON MICROB, V78, P2775, DOI 10.1128/AEM.07559-11	51	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	12					4184	4194		10.1128/AEM.03873-14		11	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI6JC	WOS:000354864000028		
J	Moriguchi, K; Edahiro, N; Yamamoto, S; Tanaka, K; Kurata, N; Suzuki, K				Moriguchi, Kazuki; Edahiro, Noritaka; Yamamoto, Shinji; Tanaka, Katsuyuki; Kurata, Nori; Suzuki, Katsunori			Transkingdom Genetic Transfer from Escherichia coli to Saccharomyces cerevisiae as a Simple Gene Introduction Tool (vol 79, pg 4393, 2013)	APPLIED AND ENVIRONMENTAL MICROBIOLOGY			English	Correction									[Moriguchi, Kazuki; Edahiro, Noritaka; Yamamoto, Shinji; Tanaka, Katsuyuki; Suzuki, Katsunori] Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima 724, Japan; [Kurata, Nori] Natl Inst Genet, Plant Genet, Mishima, Shizuoka 411, Japan	Moriguchi, K (reprint author), Hiroshima Univ, Dept Biol Sci, Grad Sch Sci, Higashihiroshima 724, Japan.						Moriguchi K, 2013, APPL ENVIRON MICROB, V79, P4393, DOI 10.1128/AEM.00770-13	1	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0099-2240	1098-5336		APPL ENVIRON MICROB	Appl. Environ. Microbiol.	JUN	2015	81	12					4231	4231		10.1128/AEM.01110-15		1	Biotechnology & Applied Microbiology; Microbiology	Biotechnology & Applied Microbiology; Microbiology	CI6JC	WOS:000354864000033		
J	Basti, L; Endo, M; Segawa, S; Shumway, SE; Tanaka, Y; Nagai, S				Basti, Leila; Endo, Makoto; Segawa, Susumu; Shumway, Sandra E.; Tanaka, Yuji; Nagai, Satoshi			Prevalence and intensity of pathologies induced by the toxic dinoflagellate, Heterocapsa circularisquama, in the Mediterranean mussel, Mytilus galloprovincialis	AQUATIC TOXICOLOGY			English	Article						Harmful algal blooms; Heterocapsa circularisquama; Mytilus galloprovincialis; Histolopathology; Mechanism; Cytotoxicity	RED-TIDE DINOFLAGELLATE; PHOTOSENSITIZING HEMOLYTIC TOXIN; SCALLOP NODIPECTEN-SUBNODOSUS; CLAM RUDITAPES-PHILIPPINARUM; PINCTADA-FUCATA-MARTENSII; HARMFUL ALGAL BLOOMS; PROROCENTRUM-MINIMUM; BIVALVE MOLLUSKS; GYMNODINIUM-CATENATUM; COCHLODINIUM-POLYKRIKOIDES	The harmful dinoflagellate, Heterocapsa circularisquama, has been causing mass mortalities of bivalve molluscs in Japan, at relatively low cell densities. Although several studies have been conducted to determine the toxicity mechanisms, the specific cause of death is still unclear. In a previous study, in our laboratory, it was shown that H. circularisquama (10(3) cells ml(-1)) caused extensive cytotoxicity in the gills of short-neck clams, Ruditapes philippinarum. In the present study, Mediterranean mussels, Mytilus galloprovincialis, were exposed to H. circularisquama at four cell densities (5, 50, 500, 10(3) cells ml(-1)), three temperatures (15, 20, and 25 degrees C), and three exposure durations (3, 24, and 48 h), and the pathologies in nine organs (gills, labial palps, mantle, hepatopancreas, stomach, intestines, exhalant siphon, adductor muscles, and foot) were assessed. Foot, adductor muscles, and exhalent siphons of mussels were not affected; however, 16 inflammatory (hemocytic infiltration and aggregation, diapedesis, hyperplasia, hypertrophy, edema, melanization, and firbrosis) and degenerative (thrombus, thrombosed edema, cilia matting and exfoliation, epithelial desquamation, atrophy, and necrosis) pathologies were identified in the gills, labial palps, mantle, hepatopancreas, stomach, and intestines. The total prevalence and total intensity of pathology in each individual mussel, and the prevalence and intensity of pathology in each organ increased significantly with increased cell density, exposure duration, and temperature. The prevalence of pathology was the highest in gills, followed by the prevalence in labial palps, mantle, stomach, and intestines. Pathology was least prevalent in the hepatopancreas. The intensity of pathology was the highest in the gills, followed by the labial palps and mantle, the stomach and intestines, and the hepatopancreas. This detailed quantitative histopathological study demonstrates that exposure to H. circularisquama induces a broad cytotoxic effect in six vital organs, even at low density (5 cells ml(-1)) and low temperature (15 degrees C), but not in muscular organs. Combining cell density, time, and duration of exposure, the organ most affected by the harmful alga was the gill, followed by the labial palps and mantle, the stomach and intestines, and the hepatopancreas. The results of this pathological analysis show that exposure to H. ciruclarisquama severely affects the gills, the labial palps, and mantle thereby interfering with particle clearance and sorting, cleansing, and respiration, but also affects the stomach, intestines, and hepatopancreas, altering the digestive processes and possibly detoxification pathways, if mussels are able to detoxify the toxins of H. circularisquarna. In the most severe cases, bivalves would most likely have died as a result of combined severe alterations of the vital functions, failure of tissue repair, and moderate to heavy hemorrhaging in both the external organs and the digestive organs concomitantly with light to moderate alterations in the detoxifying processes. (C) 2015 Elsevier B.V. All rights reserved.	[Basti, Leila; Nagai, Satoshi] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Metagen Res Grp, Kanazawa, Kanagawa 2368648, Japan; [Endo, Makoto] Tokyo Univ Marine Sci & Technol, Lab Fish Hlth Management, Minato, Tokyo 1088477, Japan; [Segawa, Susumu] Tokyo Univ Agr, Fac Bioind, Dept Aqua Biosci & Ind, Aquat Ecol Lab, Abashiri 0992493, Japan; [Shumway, Sandra E.] Univ Connecticut, Dept Marine Sci, Groton, CT 06340 USA; [Tanaka, Yuji] Tokyo Univ Marine Sci & Technol, Dept Ocean Sci, Lab Planktol, Minato, Tokyo 1088477, Japan	Basti, L (reprint author), Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Metagen Res Grp, 2-12-4 Fukuura, Kanazawa, Kanagawa 2368648, Japan.	leilabasti@affrc.go.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan; Tokyo University of Marine Science and Technology	We would like to thank the Pearl Research Laboratory of K. Mikimoto & Co. Ltd., for providing H. circularisquama. The research was funded by the Ministry of Education, Culture, Sports, Science and Technology, Japan, through a grant to Basti & Segawa, and from Tokyo University of Marine Science and Technology to Basti & Tanaka, under the young strategic researcher program.	Matsuyama Y, 1999, JARQ-JPN AGR RES Q, V33, P283; SHUMWAY SE, 1987, AQUAT TOXICOL, V10, P9, DOI 10.1016/0166-445X(87)90024-5; Hallegraeff GM, 2012, HARMFUL ALGAE, V14, P130, DOI 10.1016/j.hal.2011.10.018; Oda T, 2001, J PHYCOL, V37, P509, DOI 10.1046/j.1529-8817.2001.037004509.x; Hegaret H, 2010, MAR ENVIRON RES, V69, P337, DOI 10.1016/j.marenvres.2009.12.008; Anderson DM, 2002, ESTUARIES, V25, P704, DOI 10.1007/BF02804901; Hiraga Y, 2002, J NAT PROD, V65, P1494, DOI 10.1021/np0201265; Basti L, 2013, MAR BIOL, V160, P211, DOI 10.1007/s00227-012-2079-2; Landsberg JH, 2002, REV FISH SCI, V10, P113, DOI 10.1080/20026491051695; Gobler CJ, 2008, HARMFUL ALGAE, V7, P293, DOI 10.1016/j.hal.2007.12.006; Basti L, 2009, AQUACULTURE, V291, P41, DOI 10.1016/j.aquaculture.2009.02.029; Basti L, 2010, FISHERIES SCI, V76, P625, DOI 10.1007/s12562-010-0252-4; Basti L, 2011, J SHELLFISH RES, V30, P177, DOI 10.2983/035.030.0125; Basti L, 2011, J SHELLFISH RES, V30, P829, DOI 10.2983/035.030.0324; Bricelj VM, 2007, MAR ECOL PROG SER, V331, P147, DOI 10.3354/meps331147; Estrada N, 2007, COMP BIOCHEM PHYS C, V146, P502, DOI 10.1016/j.cbpc.2007.06.003; Estrada NA, 2007, MAR BIOL, V151, P1205, DOI 10.1007/s00227-006-0568-x; Fujimoto A, 2013, JARQ-JPN AGR RES Q, V47, P329; GAINEY L F JR, 1988, Journal of Shellfish Research, V7, P623; Galimany E, 2008, HARMFUL ALGAE, V7, P702, DOI 10.1016/j.hal.2008.02.006; Galimany E, 2008, HARMFUL ALGAE, V7, P630, DOI 10.1016/j.hal.2008.01.001; Hegaret H, 2005, HARMFUL ALGAE, V4, P201, DOI 10.1016/j.hal.2003.12.005; Hegaret H, 2005, HARMFUL ALGAE, V4, P187, DOI 10.1016/j.hal.2003.12.004; Hegaret H, 2007, J SHELLFISH RES, V26, P549, DOI 10.2983/0730-8000(2007)26[549:DFROFS]2.0.CO;2; Horiguchi Takeo, 1995, Phycological Research, V43, P129, DOI 10.1111/j.1440-1835.1995.tb00016.x; Japan Meteorological Agency, 2008, GLOB WARM PROJ, V7; Kim D, 2002, COMP BIOCHEM PHYS C, V132, P415, DOI 10.1016/S1532-0456(02)00093-5; Kim D, 2008, J BIOCHEM MOL TOXIC, V22, P158, DOI 10.1002/jbt.20216; Kondo S, 2012, NIPPON SUISAN GAKK, V78, P719, DOI 10.2331/suisan.78.719; Leverone JR, 2006, TOXICON, V48, P75, DOI 10.1016/j.toxicon.2006.04.012; Matsuyama Yukihiko, 2003, Bulletin of Fisheries Research Agency, V9, P13; Matsuyama Y, 2001, HARMFUL ALGAL BLOOMS, P411; Matsuyama Yukihiko, 1999, Bulletin of Plankton Society of Japan, V46, P157; Matsuyama Y, 1997, MAR ECOL PROG SER, V146, P73, DOI 10.3354/meps146073; Matsuyama Y., 1998, HARMFUL ALGAE, P422; Matsuyama Y, 2012, HARMFUL ALGAE, V14, P144, DOI 10.1016/j.hal.2011.10.019; Matsuyama Y., 1996, HARMFUL TOXIC ALGAL, P247; Matsuyama Yukihiko, 1997, Bulletin of Nansei National Fisheries Research Institute, V30, P189; Matsuyama Yukihiko, 2003, Bulletin of Fisheries Research Agency, V7, P24; Matsuyama Y, 1999, FISHERIES SCI, V65, P248; Miyazaki Y, 2005, AQUAT TOXICOL, V73, P382, DOI 10.1016/j.aquatox.2005.04.005; Nagai K, 1996, AQUACULTURE, V144, P149, DOI 10.1016/S0044-8486(96)01307-5; Nagai K, 2006, AQUACULTURE, V255, P395, DOI 10.1016/j.aquaculture.2005.12.018; Nagai S., 2010, GLOBAL WARMING IMPAC, P209; NIELSEN MV, 1991, MAR BIOL, V108, P263, DOI 10.1007/BF01344341; PARRY GD, 1989, MAR BIOL, V102, P25, DOI 10.1007/BF00391320; Imojen P, 2005, HARMFUL ALGAE, V4, P61, DOI 10.1016/j/hal.2003.11.002; Sato Y, 2002, AQUAT TOXICOL, V56, P191, DOI 10.1016/S0166-445X(01)00191-6; Sato Y, 2006, J METEOROL SOC JPN, V84, P295, DOI 10.2151/jmsj.84.295; SHUMWAY S E, 1990, Journal of the World Aquaculture Society, V21, P65, DOI 10.1111/j.1749-7345.1990.tb00529.x; Smolowitz R, 1997, AQUACULT INT, V5, P291, DOI 10.1023/A:1018355905598; Tran D, 2010, AQUACULTURE, V298, P338, DOI 10.1016/j.aquaculture.2009.10.030; UCHIDA T, 1995, MAR ECOL PROG SER, V118, P301, DOI 10.3354/meps118301; WIDDOWS J, 1979, J MAR BIOL ASSOC UK, V59, P522; Wikfors G.H., 1993, TOXIC PHYTOPLANKTON, P452; Yamasaki Y, 2011, J SEA RES, V65, P76, DOI 10.1016/j.seares.2010.07.006; Yamatogi T, 2005, NIPPON SUISAN GAKK, V71, P746, DOI 10.2331/suisan.71.746	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	JUN	2015	163						37	50		10.1016/j.aquatox.2015.03.012		14	Marine & Freshwater Biology; Toxicology	Marine & Freshwater Biology; Toxicology	CI8VX	WOS:000355050900004		
J	Bain, PA; Kumar, A; Ogino, Y; Iguchi, T				Bain, Peter A.; Kumar, Anu; Ogino, Yukiko; Iguchi, Taisen			Nortestosterone-derived synthetic progestogens do not activate the progestogen receptor of Murray-Darling rainbowfish (Melanotaenia fluviatilis) but are potent agonists of androgen receptors alpha and beta	AQUATIC TOXICOLOGY			English	Article						Fish; Progestins; Androgen receptors; Progestogen receptors; Endocrine disruption	STICKLEBACK GASTEROSTEUS-ACULEATUS; MULTIPLE HORMONAL ACTIVITIES; TANDEM MASS-SPECTROMETRY; WATER TREATMENT PLANTS; WASTE-WATER; ENVIRONMENTAL CONCENTRATIONS; PROGESTERONE-RECEPTOR; CALUX METHOD; NORGESTIMATE; BINDING	Synthetic progestogens derived from 19-nortestosterone can elicit a number of adverse effects in fish including decreased fecundity, altered hormone levels, disruption of normal breeding cycles, expression in females of male-specific biomarkers, development of male secondary sexual characteristics in females, and changes in the expression of steroidogenic genes. A recent in vitro study showed that a number of representatives from this class of progestins were potent agonists of fathead minnow androgen receptor (AR) and only weak agonists of progesterone receptor (PR) from the same species. This confirms that synthetic progestogens derived from 19-nortestosterone function as AR agonists in otomorphs, which express a single AR subtype. However, numerous perciformes are known to express two AR subtypes. We have recently shown that AR alpha and AR beta from Murray-Darling rainbowfish (Melanotaenia fluviatilis) respond differently to certain androgens and anti-androgens. The goal of the present study was to determine concentration-response profiles for selected progestins in transactivation assays driven by rainbowfish AR alpha, AR beta and PR in order to ascertain the relative potency of progestins against these receptors. As a means of confirming the expected activity of the progestins and reference compounds used in the study against human-derived receptors, we also established concentration-response relationships using transactivation assays driven by human PR and AR. We found that all five 19-nortestosterone-derived progestins tested were highly potent agonists of rainbowfish AR alpha, but that only four of the five progestins were potent agonists of rainbowfish AR beta, with norgestimate exhibiting only weak activity against rainbowfish AR beta The spironolactone-derived progestin, drospirenone, was not an agonist of rainbowfish AR alpha or AR beta but was a weak agonist of rainbowfish PR None of the 19-nortestosterone-progestins activated rainbowfish PR. These findings confirm that the majority of 19-nortestosterone-derived progestins are likely to elicit strong androgenic activity in teleosts, but that PR-mediated effects would be minimal. In species that express two AR subtypes similar to rainbowfish AR alpha and AR beta, biological processes mediated by a specific subtype may be affected differently by progestins such as norgestimate. (C) 2015 Elsevier B.V. All rights reserved.	[Bain, Peter A.; Kumar, Anu] CSIRO, Land & Water Flagship, Glen Osmond, SA 5064, Australia; [Ogino, Yukiko; Iguchi, Taisen] Natl Inst Basic Biol, Div Mol Environm Endocrinol, Okazaki, Aichi 4440867, Japan	Bain, PA (reprint author), CSIRO, Land & Water Flagship, PMB2, Glen Osmond, SA 5064, Australia.	peter.bain@csiro.au	Bain, Peter/A-9067-2013	Bain, Peter/0000-0002-0159-8417	CSIRO (Division of Land and Water Capability Development Theme project) [R-00325-14-012]; UK-Japan Research Collaboration Grants from the Ministry of the Environment (Japan); Japan Society for the Promotion of Science [23254003, 24370029]	This work was supported by funding from CSIRO (Division of Land and Water Capability Development Theme project R-00325-14-012), UK-Japan Research Collaboration Grants from the Ministry of the Environment (Japan), and Grants-in-Aid for Scientific Research (23254003, 24370029) from the Japan Society for the Promotion of Science.	ALTON KB, 1984, CONTRACEPTION, V29, P19, DOI 10.1016/0010-7824(84)90055-6; Martyniuk CJ, 2013, GEN COMP ENDOCR, V194, P264, DOI 10.1016/j.ygcen.2013.09.019; FUHRMANN U, 1995, CONTRACEPTION, V51, P45, DOI 10.1016/0010-7824(94)00003-F; Orlando EF, 2014, GEN COMP ENDOCR, V203, P241, DOI 10.1016/j.ygcen.2014.03.038; van der Burg B, 2010, REPROD TOXICOL, V30, P18, DOI 10.1016/j.reprotox.2010.04.012; Fan ZL, 2011, ENVIRON SCI TECHNOL, V45, P2725, DOI 10.1021/es103429c; Rand-Weaver M, 2013, ENVIRON SCI TECHNOL, V47, P11384, DOI 10.1021/es402065a; Zucchi S, 2012, ENVIRON SCI TECHNOL, V46, P5183, DOI 10.1021/es300231y; Liu S, 2012, J ENVIRON MONITOR, V14, P482, DOI 10.1039/c1em10783f; Van der Linden SC, 2008, ENVIRON SCI TECHNOL, V42, P5814, DOI 10.1021/es702897y; Ogino Y, 2009, ENDOCRINOLOGY, V150, P5415, DOI 10.1210/en.2009-0523; Sitruk-Ware R, 2004, MATURITAS, V47, P277, DOI 10.1016/j.maturitas.2004.01.001; Paulos P, 2010, AQUAT TOXICOL, V99, P256, DOI 10.1016/j.aquatox.2010.05.001; Svensson J, 2014, AQUAT TOXICOL, V147, P84, DOI 10.1016/j.aquatox.2013.12.013; Schindler AE, 2008, MATURITAS, V61, P171, DOI 10.1016/j.maturitas.2003.09.014; PHILLIPS A, 1987, CONTRACEPTION, V36, P181, DOI 10.1016/0010-7824(87)90013-8; Bain PA, 2015, GEN COMP ENDOCR, V212, P84, DOI 10.1016/j.ygcen.2015.01.024; Svensson J, 2013, ENVIRON SCI TECHNOL, V47, P2043, DOI 10.1021/es304305k; van der Linden SC, 2014, MUTAT RES-GEN TOX EN, V760, P23, DOI 10.1016/j.mrgentox.2013.09.009; Chang H, 2011, WATER RES, V45, P732, DOI 10.1016/j.watres.2010.08.046; PHILLIPS A, 1990, CONTRACEPTION, V41, P399, DOI 10.1016/0010-7824(90)90039-X; van der Burg B, 2010, REPROD TOXICOL, V30, P73, DOI 10.1016/j.reprotox.2010.04.007; Chen SX, 2010, BIOL REPROD, V82, P171, DOI 10.1095/biolreprod.109.077644; Runnalls TJ, 2013, ENVIRON SCI TECHNOL, V47, P2077, DOI 10.1021/es3048834; Sonneveld E, 2011, TOXICOL IN VITRO, V25, P545, DOI 10.1016/j.tiv.2010.11.018; Besse JP, 2009, ENVIRON POLLUT, V157, P3485, DOI 10.1016/j.envpol.2009.06.012; Sonneveld E, 2005, TOXICOL SCI, V83, P136, DOI 10.1093/toxsci/kfi005; Zeilinger J, 2009, ENVIRON TOXICOL CHEM, V28, P2663, DOI 10.1897/08-485.1; Al-Odaini NA, 2010, J CHROMATOGR A, V1217, P6791, DOI 10.1016/j.chroma.2010.08.033; Bain PA, 2014, ENVIRON TOXICOL CHEM, V33, P2297, DOI 10.1002/etc.2676; Douard V, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-336; Garcia-Becerra R, 2004, J STEROID BIOCHEM, V91, P21, DOI 10.1016/j.jsbmb.2004.02.003; KUHNZ W, 1995, CONTRACEPTION, V51, P131, DOI 10.1016/0010-7824(94)00019-S; MADDEN S, 1991, J STEROID BIOCHEM, V38, P497, DOI 10.1016/0960-0760(91)90338-6; Margiotta-Casaluci L, 2013, GEN COMP ENDOCR, V191, P202, DOI 10.1016/j.ygcen.2013.06.017	35	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-445X	1879-1514		AQUAT TOXICOL	Aquat. Toxicol.	JUN	2015	163						97	101		10.1016/j.aquatox.2015.03.021		5	Marine & Freshwater Biology; Toxicology	Marine & Freshwater Biology; Toxicology	CI8VX	WOS:000355050900010		
J	Makino, J; Nii, M; Kamiya, T; Hara, H; Adachi, T				Makino, Junya; Nii, Miyuki; Kamiya, Tetsuro; Hara, Hirokazu; Adachi, Tetsuo			Oxidized low-density lipoprotein accelerates the destabilization of extracellular-superoxide dismutase mRNA during foam cell formation	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						Extracellular-superoxide dismutase; Oxidized low-density lipoprotein; 3 '-Untranslated region; mRNA; Destabilization	SMOOTH-MUSCLE-CELLS; EC-SOD; OXIDATIVE STRESS; COBALT CHLORIDE; LDL OXIDATION; U937 CELLS; EXPRESSION; DISEASE; ATHEROSCLEROSIS; SP1	Extracellular-superoxide dismutase (EC-SOD) is one of the main anti-oxidative enzymes that protect cells against the damaging effects of superoxide. In the present study, we investigated the regulation of EC-SOD expression during the oxidized low density lipoprotein (oxLDL)-induced foam cell formation of THP-1-derived macrophages. The uptake of oxLDL into THP-1-derived macrophages was increased and EC-SOD expression was decreased in a time-dependent manner by oxLDL. Furthermore, EC-SOD suppression by oxLDL was mediated by the binding to scavenger receptors, especially CD36, from the results with siRNA experience. EC-SOD expression is known to be regulated by histone acetylation and binding of the transcription factor Sp1/3 to the EC-SOD promoter region in human cell lines. However, oxLDL did not affect these processes. On the other hand, the stability of EC-SOD mRNA was decreased by oxLDL. Moreover, oxLDL promoted destabilization of ectopically expressed mRNA from EC-SOD or chimeric Cu,Zn-SOD gene with the sequence corresponding to 3'UTR of EC-SOD mRNA, whereas oxLDL had no effect on ectopic mRNA produced from EC-SOD gene lacking the sequence. These results suggested that oxLDL decreased the expression of EC-SOD, which, in turn, accelerated the destabilization of EC-SOD mRNA, leading to weaker protection against oxidative stress and atherosclerosis. (C) 2015 Elsevier Inc. All rights reserved.	[Makino, Junya; Nii, Miyuki; Kamiya, Tetsuro; Hara, Hirokazu; Adachi, Tetsuo] Gifu Pharmaceut Univ, Dept Biomed Pharmaceut, Lab Clin Pharmaceut, Gifu 5011196, Japan	Kamiya, T (reprint author), Gifu Pharmaceut Univ, Dept Biomed Pharmaceut, Lab Clin Pharmaceut, 1-25-4 Daigaku Nishi, Gifu 5011196, Japan.	tekamiya@gifu-pu.ac.jp			Japan Society for the Promotion for Science [26460070]; Gifu Pharmaceutical University	This study was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion for Science (T.K.: No. 26460070) and a grant for the encouragement of young scientists from Gifu Pharmaceutical University (T.K.).	ADACHI T, 1989, J BIOL CHEM, V264, P8537; Adachi T, 2006, BIOL PHARM BULL, V29, P2095, DOI 10.1248/bpb.29.2095; EMILI A, 1994, MOL CELL BIOL, V14, P1582; Watanabe K, 2013, ATHEROSCLEROSIS, V227, P51, DOI 10.1016/j.atherosclerosis.2012.12.020; Li QH, 2001, CIRCULATION, V103, P1893; Wright E, 2006, INT J CLIN PRACT, V60, P308, DOI 10.1111/j.1368-5031.2006.00825.x; Lappalainen J, 2011, ATHEROSCLEROSIS, V214, P357, DOI 10.1016/j.atherosclerosis.2010.11.024; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Moore KJ, 2011, CELL, V145, P341, DOI 10.1016/j.cell.2011.04.005; Laukkanen MO, 2000, GENE, V254, P173, DOI 10.1016/S0378-1119(00)00272-9; MARKLUND SL, 1982, P NATL ACAD SCI-BIOL, V79, P7634, DOI 10.1073/pnas.79.24.7634; Kamiya T, 2008, FREE RADICAL RES, V42, P949, DOI 10.1080/10715760802566566; Kiyan Y, 2014, J MOL CELL CARDIOL, V66, P72, DOI 10.1016/j.yjmcc.2013.11.005; Hagmeister U, 2012, J DERMATOL SCI, V67, P44, DOI 10.1016/j.jdermsci.2012.03.001; Makino J, 2012, FREE RADICAL RES, V46, P637, DOI 10.3109/10715762.2012.664841; Kamiya T, 2010, REDOX REP, V15, P131, DOI 10.1179/174329210X12650506623483; Zelko IN, 2004, FREE RADICAL BIO MED, V37, P1256, DOI 10.1016/j.freeradbiomed.2004.06.022; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Kamiya T, 2011, J CELL BIOCHEM, V112, P244, DOI 10.1002/jcb.22917; Chavez-Sanchez L, 2014, HUM IMMUNOL, V75, P322, DOI 10.1016/j.humimm.2014.01.012; CHIANG CM, 1995, SCIENCE, V267, P531, DOI 10.1126/science.7824954; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heistad DD, 2006, ARTERIOSCL THROM VAS, V26, P689, DOI 10.1161/01.ATV.0000203525.62147.28; Itabe H, 2000, BBA-MOL CELL BIOL L, V1487, P233, DOI 10.1016/S1388-1981(00)00098-6; Jerome WG, 2008, MICROSC MICROANAL, V14, P138, DOI 10.1017/S1431927608080069; Kamiya T, 2013, FREE RADICAL BIO MED, V61, P197, DOI 10.1016/j.freeradbiomed.2013.04.013; Laurila JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005786; Lu Z, 2008, HYPERTENSION, V51, P19, DOI 10.1161/HYPERTENSIONAHA.107.098186; Michael D. T., 2013, BIOMACROMOLECULES, V14, P2499; Miller YI, 2003, CURR OPIN LIPIDOL, V14, P437, DOI 10.1097/01.mol.0000092631.86399.49; Mukai E, 2004, ATHEROSCLEROSIS, V176, P289, DOI 10.1016/j.athersclerosis.2004.03.028; Ookawara T, 1998, AM J PHYSIOL-CELL PH, V275, pC840; Osawa M, 2012, RNA, V18, P1957, DOI 10.1261/rna.035311.112; Rios FJO, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076893; Ross R, 1999, NEW ENGL J MED, V340, P115; Takatsu H, 2001, BIOCHEM BIOPH RES CO, V285, P84, DOI 10.1006/bbrc.2001.5114; VACHIER I, 1994, EUR RESPIR J, V7, P1585, DOI 10.1183/09031936.94.07091585; Wang JH, 2013, CELL PHYSIOL BIOCHEM, V32, P121, DOI 10.1159/000350130; Yamamoto M, 2002, ATHEROSCLEROSIS, V163, P223, DOI 10.1016/S0021-9150(02)00007-2; Zelko IN, 2008, AM J RESP CELL MOL, V39, P243, DOI 10.1165/rcmb.2007-0378OC; Zelko IN, 2003, BIOCHEM J, V369, P375, DOI 10.1042/BJ20021431	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	JUN 1	2015	575						54	60		10.1016/j.abb.2015.04.001		7	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CI8OI	WOS:000355031200007		
J	Ogawa, T; Kimura, A; Sakuyama, H; Tamoi, M; Ishikawa, T; Shigeoka, S				Ogawa, Takahisa; Kimura, Ayako; Sakuyama, Harumi; Tamoi, Masahiro; Ishikawa, Takahiro; Shigeoka, Shigeru			Characterization and physiological role of two types of chloroplastic fructose-1,6-bisphosphatases in Euglena gracilis	ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS			English	Article						Fructose-1,6-bisphosphatase; Photosynthesis; Euglena gracilis	HYDROGEN-PEROXIDE; MOLECULAR CHARACTERIZATION; RESISTANCE; ENZYME; ACTIVATION; BINDING; OVEREXPRESSION; PHOTOSYNTHESIS; THIOREDOXIN; SEQUENCES	The chloroplastic fructose-1,6-bisphosphatase (FBPase) is a late-limiting enzyme in the Calvin cycle. In the present study, we isolated and characterized the cDNAs encoding two types of chloroplastic FBPase isoforms (EgFBPaseI and II) from Euglena gracilis. The K-m values of recombinant EgFBPaseI and EgFBPaseII for fructose 1,6-bisphosphate (Fru 1,6-P-2) were 165 +/- 17 and 2200 +/- 200 mu M, respectively. The activity of EgFBPaseI was inhibited by 1 mM H2O2 and recovered when incubated with DTT. The activity of EgFBPaseII was resistant to concentrations of H2O2 up to 1 mM, which was distinct from those of EgFBPaseI and spinach chloroplastic FBPase. The suppression of EgFBPaseI gene expression by gene silencing markedly decreased photosynthetic activity and inhibited cell growth. The results of the present study clearly demonstrated that EgFBPaseI played a critical role in photosynthesis in Euglena chloroplasts. (C) 2015 Elsevier Inc. All rights reserved.	[Ogawa, Takahisa; Kimura, Ayako; Sakuyama, Harumi; Tamoi, Masahiro; Shigeoka, Shigeru] Kinki Univ, Fac Agr, Dept Adv Biosci, Nara 6318505, Japan; [Ogawa, Takahisa; Kimura, Ayako; Sakuyama, Harumi; Tamoi, Masahiro; Ishikawa, Takahiro; Shigeoka, Shigeru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Ishikawa, Takahiro] Shimane Univ, Fac Life & Environm Sci, Matsue, Shimane 6908504, Japan	Tamoi, M (reprint author), Kinki Univ, Fac Agr, Dept Adv Biosci, 3327-204 Nakamachi, Nara 6318505, Japan.	tamoi@nara.kindai.ac.jp					TESSIER LH, 1991, EMBO J, V10, P2621; KAISER WM, 1979, PLANTA, V145, P377, DOI 10.1007/BF00388364; TAKEDA T, 1995, PLANT CELL PHYSIOL, V36, P1089; Tamoi M, 1996, ARCH BIOCHEM BIOPHYS, V334, P27, DOI 10.1006/abbi.1996.0425; INUI H, 1982, FEBS LETT, V150, P89, DOI 10.1016/0014-5793(82)81310-0; Serrato AJ, 2009, PLANT CELL ENVIRON, V32, P811, DOI 10.1111/j.1365-3040.2009.01960.x; INUI H, 1984, EUR J BIOCHEM, V142, P121, DOI 10.1111/j.1432-1033.1984.tb08258.x; CHARDOT T, 1991, BIOCHEM J, V278, P787; Durnford DG, 2006, EUKARYOT CELL, V5, P2079, DOI 10.1128/EC.00222-06; Ishikawa T, 2010, BIOCHEM J, V426, P125, DOI 10.1042/BJ20091406; CRAMER M, 1952, ARCH MIKROBIOL, V17, P384, DOI 10.1007/BF00410835; Miyagawa Y, 2001, NAT BIOTECHNOL, V19, P965, DOI 10.1038/nbt1001-965; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Tamoi M, 1998, BBA-PROTEIN STRUCT M, V1383, P232, DOI 10.1016/S0167-4838(97)00208-2; Chueca A, 2002, PHOTOSYNTH RES, V74, P235, DOI 10.1023/A:1021243110495; CSEKE C, 1984, TRENDS BIOCHEM SCI, V9, P533, DOI 10.1016/0968-0004(84)90284-6; Hermoso R, 1996, PLANT MOL BIOL, V30, P455, DOI 10.1007/BF00049324; HUPPE HC, 1989, Z NATURFORSCH C, V44, P487; Kitaoka S., 1989, BIOL EUGLENA, VIV, P2; PLA A, 1981, BIOCHIM BIOPHYS ACTA, V636, P113, DOI 10.1016/0005-2728(81)90082-7; Reichert A, 2003, BBA-PROTEINS PROTEOM, V1645, P212, DOI 10.1016/S1570-9639(02)00539-3; Smillie R.M., 1968, BIOL EUGLENA, VII, P2; Tamoi M, 1996, BIOCHEM J, V316, P685; Tang GL, 2000, PROTEIN EXPRES PURIF, V19, P411, DOI 10.1006/prep.2000.1267; Wangensteen OS, 2001, BBA-PROTEIN STRUCT M, V1547, P156, DOI 10.1016/S0167-4838(01)00178-9	25	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0003-9861	1096-0384		ARCH BIOCHEM BIOPHYS	Arch. Biochem. Biophys.	JUN 1	2015	575						61	68		10.1016/j.abb.2015.04.002		8	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CI8OI	WOS:000355031200008		
J	Romanenko, LA; Tanaka, N; Svetashev, VI; Mikhailov, VV				Romanenko, Lyudmila A.; Tanaka, Naoto; Svetashev, Vassilii I.; Mikhailov, Valery V.			Pseudomonas glareae sp nov., a marine sediment-derived bacterium with antagonistic activity	ARCHIVES OF MICROBIOLOGY			English	Article						Pseudomonas glareae sp nov.; Marine; Shallow sediments	SEQUENCE-ANALYSIS; FATTY-ACID; STUTZERI; SEAWATER	An aerobic, Gram-negative, motile, rod-shaped bacterium designated KMM 9500(T) was isolated from a sediment sample collected from the Sea of Japan seashore. Comparative 16S rRNA gene sequence analysis affiliated strain KMM 9500(T) to the genus Pseudomonas as a distinct subline clustered with Pseudomonas marincola KMM 3042(T) and Pseudomonas segetis KCTC 12331(T) sharing the highest similarities of 98 and 97.9 %, respectively. Strain KMM 9500(T) was characterized by mainly possessing ubiquinone Q-9, and by the predominance of C-18:1 omega 7c, C-16:1 omega 7c, and C-16:0 followed by C-12:0 in its fatty acid profile. Polar lipids consisted of phosphatidylethanolamine, phosphatidylglycerol, diphosphatidylglycerol, an unknown aminophospholipid, and unknown phospholipids. Strain KMM 9500(T) was found to inhibit growth of Gram-negative and Gram-positive indicatory microorganisms. Based on the phylogenetic analysis and distinctive phenotypic characteristics, strain 9500(T) is concluded to represent a novel species of the genus Pseudomonas, for which the name Pseudomonas glareae sp. nov. is proposed. The type strain of the species is strain KMM 9500(T) (=NRIC 0939(T)).	[Romanenko, Lyudmila A.; Mikhailov, Valery V.] Russian Acad Sci, Far Eastern Branch, GB Elyakov Pacific Inst Bioorgan Chem, Vladivostok 690022, Russia; [Tanaka, Naoto] Tokyo Univ Agr, NODAI Culture Collect Ctr, Setagaya Ku, Tokyo 1568502, Japan; [Svetashev, Vassilii I.] Russian Acad Sci, Inst Marine Biol, Far Eastern Branch, Vladivostok 690041, Russia; [Mikhailov, Valery V.] Far Eastern Fed Univ, Vladivostok 690091, Russia	Romanenko, LA (reprint author), Russian Acad Sci, Far Eastern Branch, GB Elyakov Pacific Inst Bioorgan Chem, Prospect 100 Let Vladivostoku 159, Vladivostok 690022, Russia.	lro@piboc.dvo.ru			RSF "Biodiversity and biotechnological potential of marine bacteria and fungi" [14-14-00030]	This study was supported by a grant from the RSF "Biodiversity and biotechnological potential of marine bacteria and fungi" No. 14-14-00030.	Lee DH, 2010, INT J SYST EVOL MICR, V60, P2719, DOI 10.1099/ijs.0.018093-0; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846; Shida O, 1997, INT J SYST BACTERIOL, V47, P289; Romanenko LA, 2005, INT J SYST EVOL MICR, V55, P919, DOI 10.1099/ijs.0.63176-0; Yumoto I, 2001, INT J SYST EVOL MICR, V51, P349; Romanenko LA, 2008, MICROBIOL RES, V163, P633, DOI 10.1016/j.micres.2006.10.001; Pascual J, 2012, INT J SYST EVOL MICR, V62, P438, DOI 10.1099/ijs.0.029447-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; COLLINS MD, 1984, ARCH MICROBIOL, V137, P247, DOI 10.1007/BF00414552; Kim M, 2014, INT J SYST EVOL MICR, V64, P346, DOI 10.1099/ijs.0.059774-0; KING EO, 1954, J LAB CLIN MED, V44, P301; BAUMANN P, 1983, INT J SYST BACTERIOL, V33, P857; Bennasar A, 1996, INT J SYST BACTERIOL, V46, P200; FOLCH J, 1957, J BIOL CHEM, V226, P497; MITCHELL K, 1990, J GEN MICROBIOL, V136, P2035; Palleroni N. J., 1992, PROKARYOTES, VIII, P3071; Palleroni N. J., 1984, BERGEYS MANUAL SYSTE, V1, P141; Park YD, 2006, INT J SYST EVOL MICR, V56, P2593, DOI 10.1099/ijs.0.63792-0; RAINEY PB, 1994, INT J SYST BACTERIOL, V44, P54; Romanenko LA, 2008, INT J SYST EVOL MICR, V58, P706, DOI 10.1099/ijs.0.65406-0; Romanenko LA, 2013, INT J SYST EVOL MICR, V63, P261; Romanenko LA, 2005, J GEN APPL MICROBIOL, V51, P65, DOI 10.2323/jgam.51.65; ROSSELLOMORA RA, 1993, INT J SYST BACTERIOL, V43, P852; Sasser M., 1990, 101 MIDI; Smibert Robert M., 1994, P607; STACKEBRANDT E, 2006, MICROBIOL TODAY, V33, P153; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P1, DOI DOI 10.1002/0471250953.BI0203S00; WAYNE LG, 1987, INT J SYST BACTERIOL, V37, P463	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-8933	1432-072X		ARCH MICROBIOL	Arch. Microbiol.	JUN	2015	197	5					693	699		10.1007/s00203-015-1103-6		7	Microbiology	Microbiology	CI7MV	WOS:000354948600008		
J	Tomihara, T; Hashimoto, Y; Taniuchi, M; Shimada, N				Tomihara, Tomohiro; Hashimoto, Yusuke; Taniuchi, Masatoshi; Shimada, Nagakazu			Relationship between femoral tunnel location and graft bending angle in outside-in and transportal technique for ACL double bundle reconstruction in 3D-CT study	ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY			English	Article						Anterior cruciate ligament; Double bundle reconstruction; Graft bending angle; Computed tomography	ANTERIOR CRUCIATE LIGAMENT; KNEE FLEXION ANGLE; COMPUTED-TOMOGRAPHY; HAMSTRING TENDONS; FOLLOW-UP; ENLARGEMENT; LENGTH	In anterior cruciate ligament (ACL) reconstruction, sharp angulation of the graft at tunnel aperture increases local strain to the graft. The purpose of this study is to investigate the relationship between femoral tunnel location and femoral graft bending angle after ACL double bundle reconstruction (ACL-DBR) with two different drilling techniques. In ACL-DBR, femoral tunnel was created by two techniques; outside-in technique (26 patients, group A) and transportal technique (25 patients, group B). CT scan was taken at 1 week postoperatively. The position of femoral tunnel exit on the lateral femoral cortex, and intra-articular femoral and tibial tunnel aperture of the anteromedial bundle (AMB) and postero-lateral bundle (PLB) was measured using a rectangular frame on three-dimensional CT images. Femoral graft bending angle was measured using two-dimensional CT images. Femoral tunnel exits of AMB and PLB in group A were significantly anterior and proximal than those in group B (p < 0.05), while there was no significant difference in intra-articular femoral and tibial tunnel apertures between group A and B. A mean femoral graft bending angle of AMB was 80.3A degrees in group A and 69.2 degrees in group B, respectively (p < 0.05). A mean femoral graft bending angle of PLB was 66.3A degrees in group A and 64.6A degrees in group B, respectively. In both groups, a significant (p < 0.05) correlation (r < -0.4) was observed between the position of the femoral tunnel exit (anterior-posterior ratio from femoral anterior border line) and the femoral graft bending angle in AMB. Since the femoral tunnel exit in outside-in technique was located more anterior and proximal, femoral graft bending angle of AMB in outside-in technique was greater than that in transportal technique. Anterior position of the femoral tunnel exit in AMB increased femoral graft bending angle in outside-in and transportal techniques.	[Tomihara, Tomohiro; Taniuchi, Masatoshi; Shimada, Nagakazu] Shimada Hosp, Dept Orthopaed Surg, Habikino 5830875, Japan; [Hashimoto, Yusuke] Osaka City Univ, Dept Orthopaed Surg, Grad Sch Med, Abeno Ku, Osaka 5458585, Japan	Tomihara, T (reprint author), Shimada Hosp, Dept Orthopaed Surg, 100-1 Kashiyama, Habikino 5830875, Japan.	m2033754@med.osaka-cu.ac.jp					Alavekios D, 2014, ARTHROSCOPY, V30, P1468, DOI 10.1016/j.arthro.2014.05.031; Gadikota HR, 2012, AM J SPORT MED, V40, P882, DOI 10.1177/0363546511434276; Segawa H, 2001, KNEE SURG SPORT TR A, V9, P206, DOI 10.1007/s001670100201; Lubowitz JH, 2009, ARTHROSCOPY, V25, P95, DOI 10.1016/j.arthro.2008.10.012; Sasaki N, 2012, ARTHROSCOPY, V28, P1135, DOI 10.1016/j.arthro.2011.12.021; Edwards A, 2008, KNEE SURG SPORT TR A, V16, P29, DOI 10.1007/s00167-007-0410-0; Hwang DH, 2013, ARTHROSCOPY, V29, P83, DOI 10.1016/j.arthro.2012.07.007; Chhabra A, 2006, ARTHROSCOPY, V22, P1107, DOI 10.1016/j.arthro.2006.05.019; Webster KE, 2001, KNEE SURG SPORT TR A, V9, P86, DOI 10.1007/s001670100191; Lertwanich P, 2011, ARTHROSCOPY, V27, P391, DOI 10.1016/j.arthro.2010.08.018; Fink C, 2001, ARTHROSCOPY, V17, P138, DOI 10.1053/jars.2001.21509; Basdekis G, 2008, ARTHROSCOPY, V24, P459, DOI 10.1016/j.arthro.2007.10.012; Bernard M, 1997, Am J Knee Surg, V10, P14; Golish SR, 2007, ARTHROSCOPY, V23, P1187, DOI 10.1016/j.arthro.2007.06013; Hensler D, 2011, J BONE JOINT SURG AM, V93A, P2063, DOI 10.2106/JBJS.J.01705; Iwahashi T, 2010, ARTHROSCOPY, V26, pS13, DOI 10.1016/j.arthro.2010.01.023; Kim JG, 2012, ARTHROSCOPY, V28, P1682, DOI 10.1016/j.arthro.2012.05.884; Lubowitz JH, 2010, ARTHROSCOPY, V26, P1357, DOI 10.1016/j.arthro.2010.02.014; Nishimoto K, 2009, KNEE SURG SPORT TR A, V17, P270, DOI 10.1007/s00167-008-0680-1; Panni AS, 2001, KNEE SURG SPORT TR A, V9, P77, DOI 10.1007/s001670000171; Park JS, 2014, COMP FEMORAL TUNNEL, DOI [10.1016/j.arthro.2014.07.023, DOI 10.1016/J.ARTHRO.2014.07.023]; Schreiber VM, 2010, SPORTS MED ARTHROSC, V18, P27, DOI 10.1097/JSA.0b013e3181bf6634; Segawa H, 2005, ARTHROSCOPY, V21, P439, DOI 10.1016/j.arthro.2004.12.007; Shin YS, 2014, BONE JOINT J, V96B, P743, DOI 10.1302/0301-620X.96B6.33201; SMIGIELSKI R, 2014, KNEE SURG SPORT TR A, DOI DOI 10.1007/S00167-014-3146-7.EPUB; Steiner Mark E, 2009, J Knee Surg, V22, P171; Udagawa K, 2014, AM J SPORT MED, V42, P2219, DOI 10.1177/0363546514536872; Wang JH, 2012, KNEE SURG SPORT TR A, V20, P1584, DOI 10.1007/s00167-011-1781-9	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0936-8051	1434-3916		ARCH ORTHOP TRAUM SU	Arch. Orthop. Trauma Surg.	JUN	2015	135	6					839	846		10.1007/s00402-015-2226-6		8	Orthopedics; Surgery	Orthopedics; Surgery	CI4GP	WOS:000354706700012		
J	Takano, T; Takashina, M; Doki, T; Hohdatsu, T				Takano, Tomomi; Takashina, Midori; Doki, Tomoyoshi; Hohdatsu, Tsutomu			Detection of canine astrovirus in dogs with diarrhea in Japan	ARCHIVES OF VIROLOGY			English	Article						Canine astrovirus; Diarrhea	INFECTION; CHINA	Canine astrovirus (CAstV) is the causative agent of gastroenteritis in dogs. We collected rectal swabs from dogs with or without diarrhea symptoms in Japan and examined the feces for the presence of CAstV by RT-PCR with primers based on a conserved region of the ORF1b gene. The ORF1b gene of CAstV was not detected in the 42 dogs without clinical illness but was present in three pups out of the 31 dogs with diarrhea symptoms. Based on the full-length capsid protein, the CAstV KU-D4-12 strain that we detected in this study shared high homology with the novel virulent CAstV VM-2011 strain.	[Takano, Tomomi; Takashina, Midori; Doki, Tomoyoshi; Hohdatsu, Tsutomu] Kitasato Univ, Sch Vet Med, Lab Vet Infect Dis, Towada, Aomori 0348628, Japan	Hohdatsu, T (reprint author), Kitasato Univ, Sch Vet Med, Lab Vet Infect Dis, Towada, Aomori 0348628, Japan.	hohdatsu@vmas.kitasato-u.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology [26850185]	This work was in part supported by KAKENHI (Grants-in-Aid for Young Scientists (B), No. 26850185) from the Ministry of Education, Culture, Sports, Science and Technology.	Zhu AL, 2011, ARCH VIROL, V156, P1671, DOI 10.1007/s00705-011-1022-z; Martella V, 2009, J VIROL, V83, P11391, DOI 10.1128/JVI.01385-09; Martella V, 2011, J GEN VIROL, V92, P1880, DOI 10.1099/vir.0.029025-0; Chung JY, 2013, VIRUS GENES, V47, P559, DOI 10.1007/s11262-013-0953-8; Elschner M, 2002, J VET MED B, V49, P77, DOI 10.1046/j.1439-0450.2002.00510.x; Grellet A, 2012, VET MICROBIOL, V157, P214, DOI 10.1016/j.vetmic.2011.11.012; De Benedictis P, 2011, INFECT GENET EVOL, V11, P1529, DOI 10.1016/j.meegid.2011.07.024; Martella V, 2012, J CLIN MICROBIOL, V50, P1066, DOI 10.1128/JCM.05018-11; Walter JE, 2003, CURR OPIN INFECT DIS, V16, P247, DOI 10.1097/01.qco.0000073775.11390.60; Koci MD, 2002, AVIAN PATHOL, V31, P213, DOI 10.1080/03079450220136521; Bosch A., 2011, VIRUS TAXONOMY CLASS, P953; Erles K, 2009, VIRUS RES, V141, P21, DOI 10.1016/j.virusres.2008.12.009; Hu B, 2014, J GEN VIROL, V95, P2442, DOI 10.1099/vir.0.067686-0; Lau SK, 2013, GENOME ANNOUNC, P1, DOI [10.1128/genomeA.00708-13, DOI 10.1128/GENOMEA.00708-13]; Martella V, 2011, VET CLIN N AM-SMALL, V41, P1087, DOI 10.1016/j.cvsm.2011.09.001; Wunderli W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027483	16	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	JUN	2015	160	6					1549	1553		10.1007/s00705-015-2405-3		5	Virology	Virology	CH9WZ	WOS:000354388500018		
J	Brown, JK; Zerbini, FM; Navas-Castillo, J; Moriones, E; Ramos-Sobrinho, R; Silva, JCF; Fiallo-Olive, E; Briddon, RW; Hernandez-Zepeda, C; Idris, A; Malathi, VG; Martin, DP; Rivera-Bustamante, R; Ueda, S; Varsani, A				Brown, Judith K.; Zerbini, F. Murilo; Navas-Castillo, Jesus; Moriones, Enrique; Ramos-Sobrinho, Roberto; Silva, Jose C. F.; Fiallo-Olive, Elvira; Briddon, Rob W.; Hernandez-Zepeda, Cecilia; Idris, Ali; Malathi, V. G.; Martin, Darren P.; Rivera-Bustamante, Rafael; Ueda, Shigenori; Varsani, Arvind			Revision of Begomovirus taxonomy based on pairwise sequence comparisons	ARCHIVES OF VIROLOGY			English	Article						Geminiviridae; Nomenclature; Sequence Demarcation Tool; Single-stranded DNA virus; Species demarcation; Taxonomy; Whitefly-transmitted viruses	CLONED DNA COMPONENTS; NUCLEOTIDE-SEQUENCE; NEW-WORLD; FAMILY GEMINIVIRIDAE; VIRAL METAGENOMICS; GENETIC DIVERSITY; BEMISIA-TABACI; VIRUS; TOMATO; IDENTIFICATION	Viruses of the genus Begomovirus (family Geminiviridae) are emergent pathogens of crops throughout the tropical and subtropical regions of the world. By virtue of having a small DNA genome that is easily cloned, and due to the recent innovations in cloning and low-cost sequencing, there has been a dramatic increase in the number of available begomovirus genome sequences. Even so, most of the available sequences have been obtained from cultivated plants and are likely a small and phylogenetically unrepresentative sample of begomovirus diversity, a factor constraining taxonomic decisions such as the establishment of operationally useful species demarcation criteria. In addition, problems in assigning new viruses to established species have highlighted shortcomings in the previously recommended mechanism of species demarcation. Based on the analysis of 3,123 full-length begomovirus genome (or DNA-A component) sequences available in public databases as of December 2012, a set of revised guidelines for the classification and nomenclature of begomoviruses are proposed. The guidelines primarily consider a) genus-level biological characteristics and b) results obtained using a standardized classification tool, Sequence Demarcation Tool, which performs pairwise sequence alignments and identity calculations. These guidelines are consistent with the recently published recommendations for the genera Mastrevirus and Curtovirus of the family Geminiviridae. Genome-wide pairwise identities of 91 % and 94 % are proposed as the demarcation threshold for begomoviruses belonging to different species and strains, respectively. Procedures and guidelines are outlined for resolving conflicts that may arise when assigning species and strains to categories wherever the pairwise identity falls on or very near the demarcation threshold value.	[Brown, Judith K.] Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA; [Zerbini, F. Murilo; Navas-Castillo, Jesus; Ramos-Sobrinho, Roberto; Fiallo-Olive, Elvira] Univ Fed Vicosa, Dept Fitopatol, BIOAGRO, BR-36570900 Vicosa, MG, Brazil; [Zerbini, F. Murilo; Navas-Castillo, Jesus; Ramos-Sobrinho, Roberto; Silva, Jose C. F.; Fiallo-Olive, Elvira] Univ Fed Vicosa, Natl Res Inst Plant Pest Interact INCT IPP, BR-36570900 Vicosa, MG, Brazil; [Navas-Castillo, Jesus; Moriones, Enrique; Fiallo-Olive, Elvira] Univ Malaga, Consejo Super Invest Cient IHSM UMA CSIC, Inst Hortofruticultura Subtrop & Mediterranea, Malaga 29750, Spain; [Briddon, Rob W.] Natl Inst Biotechnol & Genet Engn, Faisalabad, Pakistan; [Hernandez-Zepeda, Cecilia] Ctr Invest Cient Yucatan, Unidad Ciencias Agua, Cancun, Quintana Roo, Mexico; [Idris, Ali] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Ctr Desert Agr, Thuwal 239556900, Saudi Arabia; [Malathi, V. G.] Tamil Nadu Agr Univ, Adjunct Fac, Dept Plant Pathol, Coimbatore 641003, Tamil Nadu, India; [Martin, Darren P.] Univ Cape Town, Inst Infect Dis & Mol Med, Computat Biol Grp, ZA-7925 Cape Town, South Africa; [Rivera-Bustamante, Rafael] Genet Ctr Invest Estudios Avanzados IPN Cinvestav, Dept Ingn Genet, Unidad Irapuato, Irapuato 36821, Gto, Mexico; [Ueda, Shigenori] Ctr Kyushu Okinawa Reg, Kurume Res Stn, Natl Agr Res, Kurume, Fukuoka 8398503, Japan; [Varsani, Arvind] Univ Cape Town, Electron Microscope Unit, ZA-7701 Cape Town, South Africa; [Varsani, Arvind] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Varsani, Arvind] Univ Florida, Emerging Pathogens Inst, Gainesville, FL 32611 USA; [Varsani, Arvind] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand	Brown, JK (reprint author), Univ Arizona, Sch Plant Sci, Tucson, AZ 85721 USA.	jbrown@ag.arizona.edu; zerbini@ufv.br	Navas-Castillo, Jesus/G-3894-2011; Zerbini, Francisco Murilo/N-7359-2013; Rivera-Bustamante, Rafael/B-4688-2009	Zerbini, Francisco Murilo/0000-0001-8617-0200; Rivera-Bustamante, Rafael/0000-0002-5114-2370	Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain [AGR-214]; FEDER-FSE; National Research Foundation of South Africa	The analysis described in this manuscript was part of the taxonomic proposal 2013.015a,bP, approved by the Executive Committee of the ICTV in July 2013 and ratified in March 2014. JKB and FMZ are past and current chairs, respectively, of the Geminiviridae Study Group of the ICTV. JNC, EM, RWB, CHZ, AI, VGM, DPM, RRB, SU and AV were members of the Geminiviridae SG during 2012-2014, when the work was performed. JNC and EM are members of the Research Group AGR-214, partially funded by Consejeria de Economia, Innovacion y Ciencia, Junta de Andalucia, Spain, cofinanced by FEDER-FSE. DPM and AV are supported by the National Research Foundation of South Africa.	Albuquerque LC, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-241; Inoue-Nagata AK, 2004, J VIROL METHODS, V116, P209, DOI 10.1016/j.jviromet.2003.11.015; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.ento.40.1.511; BROWN JK, 1992, PLANT DIS, V76, P220; Morra MR, 2000, PLANT CELL, V12, P2259, DOI 10.1105/tpc.12.11.2259; Krenz B, 2012, J VIROL, V86, P7715, DOI 10.1128/JVI.00943-12; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicrol163; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Varsani A, 2014, ARCH VIROL, V159, P1873, DOI 10.1007/s00705-014-1982-x; Haible D, 2006, J VIROL METHODS, V135, P9, DOI 10.1016/j.jviromet.2006.01.017; Shepherd DN, 2008, J VIROL METHODS, V149, P97, DOI 10.1016/j.jviromet.2007.12.014; Loconsole G, 2012, VIROLOGY, V432, P162, DOI 10.1016/j.virol.2012.06.005; Rosario K, 2012, ARCH VIROL, V157, P1851, DOI 10.1007/s00705-012-1391-y; Varsani A, 2014, ARCH VIROL, V159, P2193, DOI 10.1007/s00705-014-2050-2; Idris A, 2014, VIRUSES-BASEL, V6, P1219, DOI 10.3390/v6031219; GILBERTSON RL, 1993, PHYTOPATHOLOGY, V83, P709, DOI 10.1094/Phyto-83-709; PADIDAM M, 1995, J GEN VIROL, V76, P249, DOI 10.1099/0022-1317-76-2-249; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Bernardo P, 2013, VIRUS RES, V177, P35, DOI 10.1016/j.virusres.2013.07.006; Zhang W, 2001, VIROLOGY, V279, P471, DOI 10.1006/viro.2000.0739; Fauquet CM, 2008, ARCH VIROL, V153, P783, DOI 10.1007/s00705-008-0037-6; Sanchez-Campos S, 2013, VIRUS RES, V173, P286, DOI 10.1016/j.virusres.2013.02.002; Melgarejo TA, 2013, J VIROL, V87, P5397, DOI 10.1128/JVI.00234-13; Muhire B, 2013, ARCH VIROL, V158, P1411, DOI 10.1007/s00705-012-1601-7; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019050; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Brown J. K., 2012, VIRUS TAXONOMY, P351; Brown JK, 2007, APSNET FEATURE S JAN, DOI [10.1094/APSnetFeature-2007-0107, DOI 10.1094/APSNETFEATURE-2007-0107]; Brown Judith K., 2010, P31; Candresse T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102945; Costa AS, 1975, TROPICAL DIS LEGUMES, P171; Duffy S, 2007, APPL ENVIRON MICROB, V73, P7114, DOI 10.1128/AEM.01150-07; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; GILBERTSON RL, 1991, PLANT DIS, V75, P336; Gill Raymond J., 2010, P5; HAMILTON WDO, 1984, EMBO J, V3, P2197; HARRISON BD, 1985, ANNU REV PHYTOPATHOL, V23, P55, DOI 10.1146/annurev.py.23.090185.000415; Morales FJ, 2004, VIRUS RES, V100, P57, DOI 10.1016/j.virusres.2003.12.014; Muhire BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108277; NAKHLA MK, 1994, PLANT DIS, V78, P926; Owor BE, 2007, J VIROL METHODS, V140, P100, DOI 10.1016/j.jviromet.2006.11.004; STANLEY J, 1983, NATURE, V301, P260, DOI 10.1038/301260a0; Van Regenmortel MHV, 2013, ARCH VIROL, V158, P1115, DOI 10.1007/s00705-012-1583-5	43	5	5	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0304-8608	1432-8798		ARCH VIROL	Arch. Virol.	JUN	2015	160	6					1593	1619		10.1007/s00705-015-2398-y		27	Virology	Virology	CH9WZ	WOS:000354388500026		
J	Mizuno, T; Hayashi, H; Kusuhara, H				Mizuno, Tadahaya; Hayashi, Hisamitsu; Kusuhara, Hiroyuki			Cellular Cholesterol Accumulation Facilitates Ubiquitination and Lysosomal Degradation of Cell Surface-Resident ABCA1	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						ABCA1; atherosclerosis; LXR beta; protein degradation; ubiquitin	CASSETTE TRANSPORTER A1; TANGIER-DISEASE; RECEPTOR-BETA; IN-VIVO; APOA-I; EFFLUX; BINDING; PATHWAY; GENE; EXPRESSION	Objective-By excreting cellular cholesterol to apolipoprotein A-I, ATP-binding cassette transporter A1 (ABCA1) mediates the biogenesis of high-density lipoprotein in hepatocytes and prevents foam cell formation from macrophages. We recently showed that cell surface-resident ABCA1 (csABCA1) undergoes ubiquitination and later lysosomal degradation through the endosomal sorting complex required for transport system. Herein, we investigated the relevance of this degradation pathway to the turnover of csABCA1 in hypercholesterolemia. Approach and Results-Immunoprecipitation and cell surface-biotinylation studies with HepG2 cells and mouse peritoneal macrophages showed that the ubiquitination level and degradation of csABCA1 were facilitated by treatment with a liver X receptor (LXR) agonist and acetylated low-density lipoprotein. The effects of an LXR agonist and acetylated low-density lipoprotein on the degradation of csABCA1 were repressed completely by treatment with bafilomycin, an inhibitor of lysosomal degradation, and by depletion of tumor susceptibility gene 101, a major component of endosomal sorting complex required for transport-I. RNAi analysis indicated that LXR beta inhibited the accelerated lysosomal degradation of csABCA1 by the LXR agonist, regardless of its transcriptional activity. Cell surface coimmunoprecipitation with COS1 cells expressing extracellularly hemagglutinin-tagged ABCA1 showed that LXR beta interacted with csABCA1 and inhibited the ubiquitination of csABCA1. Immunoprecipitates with anti-ABCA1 antibodies from the liver plasma membranes showed less LXR beta and a higher ubiquitination level of ABCA1 in high-fat diet-fed mice than in normal chow-fed mice. Conclusions-Under conditions of high cellular cholesterol content, csABCA1 became susceptible to ubiquitination by dissociation of LXR beta from csABCA1, which facilitated the lysosomal degradation of csABCA1 through the endosomal sorting complex required for transport system.	[Mizuno, Tadahaya; Hayashi, Hisamitsu; Kusuhara, Hiroyuki] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Dept Pharm,Bunkyo Ku, Tokyo 1130033, Japan	Hayashi, H (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Mol Pharmacokinet, Dept Pharm,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hayapi@mol.f.u-tokyo.ac.jp			Program for Promotion of Fundamental Studies [21790146, 26460192]	This study was supported by the Program for Promotion of Fundamental Studies in Grant-in-Aid for Young Scientists (B; 21790146) and Grant-in-Aid for Scientific Research (C; 26460192) to H. Hayashi.	Aida K, 2014, MOL PHARMACOL, V85, P482, DOI 10.1124/mol.113.091090; Chen WG, 2005, J BIOL CHEM, V280, P29277, DOI 10.1074/jbc.M505566200; d'Azzo A, 2005, TRAFFIC, V6, P429, DOI 10.1111/j.1600-0854.2005.00294.x; Arakawa R, 2002, J BIOL CHEM, V277, P22426, DOI 10.1074/jbc.M202996200; Munehira Y, 2004, J BIOL CHEM, V279, P15091, DOI 10.1074/jbc.M313436200; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Brooks-Wilson A, 1999, NAT GENET, V22, P336; Raiborg C, 2009, NATURE, V458, P445, DOI 10.1038/nature07961; Bodzioch M, 1999, NAT GENET, V22, P347; Hayashi H, 2012, HEPATOLOGY, V55, P1889, DOI 10.1002/hep.25591; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; Hayashi H, 2009, MOL PHARMACOL, V75, P143, DOI 10.1124/mol.108.049288; Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI 10.1172/JCI200216001; Morello F, 2005, J CLIN INVEST, V115, P1913, DOI 10.1172/JCI24594; GLOMSET JA, 1968, J LIPID RES, V9, P155; Aiello RJ, 2002, ARTERIOSCL THROM VAS, V22, P630, DOI 10.1161/01.ATV.0000014804.35824.DA; Okuhira K, 2005, J BIOL CHEM, V280, P39653, DOI 10.1074/jbc.M5101870200; Wang N, 2000, J BIOL CHEM, V275, P33053, DOI 10.1074/jbc.M005438200; Michael DR, 2012, CURR ATHEROSCLER REP, V14, P284, DOI 10.1007/s11883-012-0239-y; Hayashi H, 2012, J HEPATOL, V56, P1136, DOI 10.1016/j.jhep.2011.11.021; Schwarz M, 1996, J BIOL CHEM, V271, P18024; Singaraja RR, 2001, J BIOL CHEM, V276, P33969, DOI 10.1074/jbc.M102503200; Rust S, 1999, NAT GENET, V22, P352, DOI 10.1038/11921; Mizuno E, 2005, MOL BIOL CELL, V16, P5163, DOI 10.1091/mbc.E05-06-0560; Azuma Y, 2009, BIOCHEM BIOPH RES CO, V382, P145, DOI 10.1016/j.bbrc.2009.02.161; Azuma Y, 2009, GENES CELLS, V14, P191, DOI 10.1111/j.1365-2443.2008.01261.x; Feng B, 2002, J BIOL CHEM, V277, P43271, DOI 10.1074/jbc.M207532200; Fu Y, 2013, CELL METAB, V18, P225, DOI 10.1016/j.cmet.2013.07.003; Ghoneim RH, 2015, BRIT J NUTR, V113, P507, DOI 10.1017/S0007114514003717; Hozoji M, 2008, J BIOL CHEM, V283, P30057, DOI 10.1074/jbc.M804599200; Lawn RM, 1999, J CLIN INVEST, V104, pR25, DOI 10.1172/JCI8119; Mizuno T, 2011, HEPATOLOGY, V54, P631, DOI 10.1002/hep.24387; Ohoka N, 2012, ARTERIOSCL THROM VAS, V32, P1005, DOI 10.1161/ATVBAHA.111.238360; Takahashi Y, 1999, P NATL ACAD SCI USA, V96, P11358, DOI 10.1073/pnas.96.20.11358; Tamehiro N, 2007, J BIOL CHEM, V282, P21090, DOI 10.1074/jbc.M701228200; Timmins JM, 2005, J CLIN INVEST, V115, P1333, DOI 10.1172/JCI200523915; Urbe S, 2005, ESSAYS BIOCHEM, V41, P81, DOI 10.1042/EB0410081; Van Eck M, 2006, ARTERIOSCL THROM VAS, V26, P929, DOI 10.1161/01.ATV.0000208364.22732.16; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang X, 2007, J CLIN INVEST, V117, P2216, DOI 10.1172/JC32057; Wang YT, 2005, J BIOL CHEM, V280, P35896, DOI 10.1074/jbc.M506210200; Yokoyama S, 2012, BBA-MOL CELL BIOL L, V1821, P547, DOI 10.1016/j.bbalip.2011.07.017	42	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JUN	2015	35	6					1347	1356		10.1161/ATVBAHA.114.305182		10	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI5SU	WOS:000354820600010		
J	Motomura, Y; Kanno, S; Asano, K; Tanaka, M; Hasegawa, Y; Katagiri, H; Saito, T; Hara, H; Nishio, H; Hara, T; Yamasaki, S				Motomura, Yoshitomo; Kanno, Shunsuke; Asano, Kenichi; Tanaka, Masato; Hasegawa, Yutaka; Katagiri, Hideki; Saito, Takashi; Hara, Hiromitsu; Nishio, Hisanori; Hara, Toshiro; Yamasaki, Sho			Identification of Pathogenic Cardiac CD11c(+) Macrophages in Nod1-Mediated Acute Coronary Arteritis	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						chemokines; endothelial cells; macrophages; mucocutaneous lymph node syndrome; vasculitis	CELL-ASSOCIATED ANTIGENS; IN-VIVO DEPLETION; KAWASAKI-DISEASE; DENDRITIC CELLS; BONE-MARROW; DIAMINOPIMELIC ACID; MONOCYTE EMIGRATION; INSULIN-RESISTANCE; MOUSE MODEL; T-CELLS	Objective-Nod1 is an intracellular pattern recognition receptor for bacterial peptidoglycan fragments. We previously reported that a synthetic Nod1 ligand, FK565, induced acute coronary arteritis in mice similar to that of Kawasaki disease. However, the molecular mechanisms underlying this characteristic inflammation have remained elusive. Approach and Results-We found that CD11c(+) MHC class II+ cells accumulated in the heart of FK565-treated mice before arteritis development. Morphological features and gene expression signatures of the cardiac CD11c(+) MHC class II+ cells suggested that this population is closely related to macrophages, and thus, we designated them cardiac CD11c(+) macrophages. Nod1 in nonhematopoietic cells, rather than hematopoietic cells, was required for the increase of cardiac CD11c(+) macrophages and arteritis development. Among nonhematopoietic cells, cardiac endothelial cells produced a large amount of chemokines in response to FK565. Endothelial cell-specific blockade of Nod1 signaling suppressed FK565-induced expression of these chemokines, accumulation of cardiac CD11c(+) macrophages, and subsequent coronary arteritis development. We also found that CCR2(+) Ly6C(hi) inflammatory monocytes in peripheral blood supplied precursors of cardiac CD11c(+) macrophages. CCR2-deficient mice or pertussis toxin-treated mice exhibited decreased numbers of cardiac CD11c(+) macrophages and reduced arteritis. Conclusions-These results suggest that Ly6C(hi) monocytes are recruited to FK565-activated endothelial cells to generate cardiac CD11c(+) macrophages, which play a pivotal role in the pathogenesis of acute coronary arteritis.	[Motomura, Yoshitomo; Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Res Ctr Infect Dis, Fukuoka 8128582, Japan; [Motomura, Yoshitomo; Kanno, Shunsuke; Nishio, Hisanori; Hara, Toshiro] Kyushu Univ, Dept Pediat, Grad Sch Med Sci, Fukuoka 8128582, Japan; [Asano, Kenichi] Tokyo Univ Pharm & Life Sci, Lab Immune Regulat, Sch Life Sci, Tokyo, Japan; [Hasegawa, Yutaka; Katagiri, Hideki] Tohoku Univ Grad Sch Med, Dept Metab & Diabet, Sendai, Miyagi, Japan; [Saito, Takashi] RIKEN Ctr Integrat Med Sci, Lab Cell Signaling, Yokohama, Kanagawa, Japan; [Saito, Takashi] Osaka Univ, Immunol Frontier Res Ctr, World Premier Int Res Ctr, Lab Cell Signaling, Osaka, Japan; [Hara, Hiromitsu] Saga Univ, Fac Med, Dept Biomol Sci, Saga 840, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Project Host Response, Chiba, Japan	Yamasaki, S (reprint author), Kyushu Univ, Med Inst Bioregulat, Div Mol Immunol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp			Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan	This work was supported by Health and Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare, Japan.	Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Rosenkranz ME, 2005, CIRCULATION, V112, P2966, DOI 10.1161/CIRCULATIONAHA.105.537530; Uehara A, 2005, CELL MICROBIOL, V7, P53, DOI 10.1111/j.1462-5822.2004.00433.x; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Ikeda K, 2010, CLIN EXP IMMUNOL, V160, P246, DOI 10.1111/j.1365-2249.2009.04073.x; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Tamoutounour S, 2012, EUR J IMMUNOL, V42, P3150, DOI 10.1002/eji.201242847; Schiffer L, 2008, J IMMUNOL, V180, P1938; Sung SSJ, 2006, J IMMUNOL, V176, P2161; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; KAWASAKI T, 1974, PEDIATRICS, V54, P271; Shi C, 2011, IMMUNITY, V34, P590, DOI 10.1016/j.immuni.2011.02.016; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Zammit DJ, 2005, IMMUNITY, V22, P561, DOI 10.1016/j.immuni.2005.03.005; Asano K, 2011, IMMUNITY, V34, P85, DOI 10.1016/j.immuni.2010.12.011; Burns JC, 2004, LANCET, V364, P533, DOI 10.1016/S0140-6736(04)16814-1; Philpott DJ, 2014, NAT REV IMMUNOL, V14, P9, DOI 10.1038/nri3565; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Saijo S, 2010, IMMUNITY, V32, P681, DOI 10.1016/j.immuni.2010.05.001; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Masumoto J, 2006, J EXP MED, V203, P203, DOI 10.1084/jem.20051229; Hasegawa Y, 2012, CIRCULATION, V125, P1122, DOI 10.1161/CIRCULATIONAHA.111.054346; Muller WA, 2003, TRENDS IMMUNOL, V24, P327, DOI 10.1016/S1471-4906(03)00117-0; Karasawa K, 2015, J AM SOC NEPHROL, V26, P896, DOI 10.1681/ASN.2014020195; Ishifune C, 2014, P NATL ACAD SCI USA, V111, P5986, DOI 10.1073/pnas.1401671111; Miyake Y, 2007, J CLIN INVEST, V117, P2268, DOI 10.1172/JCI31990; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; van Rijt LS, 2005, J EXP MED, V201, P981, DOI 10.1084/jem.20042311; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Leon B, 2007, IMMUNITY, V26, P519, DOI 10.1016/j.immuni.2007.01.017; LEHMAN TJA, 1985, ARTHRITIS RHEUM, V28, P652, DOI 10.1002/art.1780280609; Frazer J, 2012, NATURE, V484, P21, DOI 10.1038/484021a; FURUKAWA S, 1992, ARCH DIS CHILD, V67, P706; Ikeda K, 2008, PEDIATR RES, V63, P182; Kanno S, 2015, J IMMUNOL, V194, P773, DOI 10.4049/jimmunol.1302841; Lin IC, 2013, IMMUNOBIOLOGY, V218, P201, DOI 10.1016/j.imbio.2012.04.004; MURATA H, 1987, JPN J EXP MED, V57, P305; Nishio H, 2011, ARTERIOSCL THROM VAS, V31, P1093, DOI 10.1161/ATVBAHA.110.216325; Onouchi Y, 2009, PEDIATR RES, V65, p46R, DOI 10.1203/PDR.0b013e31819dba60; Terai M, 1999, J LEUKOCYTE BIOL, V65, P566	42	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JUN	2015	35	6					1423	1433		10.1161/ATVBAHA.114.304846		11	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI5SU	WOS:000354820600018		
J	Sawada, H; Hao, H; Naito, Y; Oboshi, M; Hirotani, S; Mitsuno, M; Miyamoto, Y; Hirota, S; Masuyama, T				Sawada, Hisashi; Hao, Hiroyuki; Naito, Yoshiro; Oboshi, Makiko; Hirotani, Shinichi; Mitsuno, Masataka; Miyamoto, Yuji; Hirota, Seiichi; Masuyama, Tohru			Aortic Iron Overload With Oxidative Stress and Inflammation in Human and Murine Abdominal Aortic Aneurysm	ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY			English	Article						aneurysm; inflammation; iron; oxidative stress	PERIPHERAL ARTERIAL-DISEASE; CHRONIC KIDNEY-DISEASE; SMOOTH-MUSCLE-CELLS; E-DEFICIENT MICE; ANGIOTENSIN-II; RENAL DAMAGE; RAT MODEL; METABOLISM; RESTRICTION; BIOMARKERS	Objective-Although iron is an essential element for maintaining physiological function, excess iron leads to tissue damage caused by oxidative stress and inflammation. Oxidative stress and inflammation play critical roles for the development of abdominal aortic aneurysm (AAA). However, it has not been investigated whether iron plays a role in AAA formation through oxidative stress and inflammation. We, therefore, examined whether iron is involved in the pathophysiology of AAA formation using human AAA walls and murine AAA models. Approach and Results-Human aortic walls were collected from 53 patients who underwent cardiovascular surgery (non-AAA=34; AAA=19). Murine AAA was induced by infusion of angiotensin II to apolipoprotein E knockout mice. Iron was accumulated in human and murine AAA walls compared with non-AAA walls. Immunohistochemistry showed that both 8-hydroxy-2'-deoxyguanosine and CD68-positive areas were increased in AAA walls compared with non-AAA walls. The extent of iron accumulated area positively correlated with that of 8-hydroxy-2'-deoxyguanosine expression area and macrophage infiltration area in human and murine AAA walls. We next investigated the effects of dietary iron restriction on AAA formation in mice. Iron restriction reduced the incidence of AAA formation with attenuation of oxidative stress and inflammation. Aortic expression of transferrin receptor 1, intracellular iron transport protein, was increased in human and murine AAA walls, and transferrin receptor 1-positive area was similar to areas where iron accumulated and F4/80 were positive. Conclusions-Iron is involved in the pathophysiology of AAA formation with oxidative stress and inflammation. Dietary iron restriction could be a new therapeutic strategy for AAA progression.	[Sawada, Hisashi; Naito, Yoshiro; Oboshi, Makiko; Hirotani, Shinichi; Masuyama, Tohru] Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, Nishinomiya, Hyogo 6638501, Japan; [Hao, Hiroyuki; Hirotani, Shinichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Mitsuno, Masataka; Miyamoto, Yuji] Hyogo Coll Med, Dept Cardiovasc Surg, Nishinomiya, Hyogo 6638501, Japan	Naito, Y (reprint author), Hyogo Coll Med, Dept Internal Med, Cardiovasc Div, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	ynaito@hyo-med.ac.jp			Hyogo College of Medicine; JSPS KAKENHI [26860590, 25460919, 24590435]	This study was supported by a Grant-in-Aid for Graduate Students 2012 (to Dr Sawada) and Researchers 2007 (to Dr Hao), Hyogo College of Medicine. This study was also supported by a Grant-in-Aid for Young Scientists (B; JSPS KAKENHI Grant No. 26860590 to Dr Sawada) and Scientific Research (C) (JSPS KAKENHI Grant No. 25460919 to Dr Naito and No. 24590435 to Dr Hao).	Andrews NC, 1999, NEW ENGL J MED, V341, P1986, DOI 10.1056/NEJM199912233412607; Gavrila D, 2005, ARTERIOSCL THROM VAS, V25, P1671, DOI 10.1161/01.ATV.0000172631.50972.0f; Hentze MW, 2004, CELL, V117, P285, DOI 10.1016/S0092-8674(04)00343-5; Wassef M, 2001, J VASC SURG, V34, P730, DOI 10.1067/mva.2001.116966; THOMPSON RW, 1995, J CLIN INVEST, V96, P318, DOI 10.1172/JCI118037; Yoshimura K, 2005, NAT MED, V11, P1330, DOI 10.1038/nm1335; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Michel JB, 2011, CARDIOVASC RES, V90, P18, DOI 10.1093/cvr/cvq337; Zacharski LR, 2008, J NATL CANCER I, V100, P996, DOI 10.1093/jnci/djn209; Saraff K, 2003, ARTERIOSCL THROM VAS, V23, P1621, DOI 10.1161/01.ATV.0000085631.76095.64; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P464, DOI 10.1038/nrcardio.2009.80; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Martinez-Pinna R, 2014, THROMB HAEMOSTASIS, V112, P87, DOI 10.1160/TH13-08-0721; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.000011013.72016.ea; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Zacharski LR, 2007, JAMA-J AM MED ASSOC, V297, P603, DOI 10.1001/jama.297.6.603; Cai H, 2000, CIRC RES, V87, P840; Nordon IM, 2011, NAT REV CARDIOL, V8, P92, DOI 10.1038/nrcardio.2010.180; Griendling KK, 2003, CIRCULATION, V108, P2034, DOI 10.1161/01.CIR.0000093661.90582.c4; Hellenthal FAMVI, 2009, NAT REV CARDIOL, V6, P543, DOI 10.1038/nrcardio.2009.102; Kaneko H, 2011, ATHEROSCLEROSIS, V217, P350, DOI 10.1016/j.atherosclerosis.2011.03.042; Hentze MW, 2010, CELL, V142, P24, DOI 10.1016/j.cell.2010.06.028; Lee TS, 1999, CIRCULATION, V99, P1222; Ishida M, 1998, CIRC RES, V82, P7; Davis V, 1998, ARTERIOSCL THROM VAS, V18, P1625; Scaccabarozzi A, 2000, BRIT J HAEMATOL, V110, P978, DOI 10.1046/j.1365-2141.2000.02280.x; Kintscher U, 2001, HYPERTENSION, V37, P587; Tsai SH, 2013, CARDIOVASC RES, V100, P501, DOI 10.1093/cvr/cvt230; Torsney E, 2012, ARTERIOSCL THROM VAS, V32, P2678, DOI 10.1161/ATVBAHA.112.00009; Iwasa M, 2002, HEPATO-GASTROENTEROL, V49, P529; Miller FJ, 2002, ARTERIOSCL THROM VAS, V22, P560, DOI 10.1161/01.ATV.0000013778.72404.30; Murasawa S, 1998, HYPERTENSION, V32, P668; Nairz M, 2015, IMMUNOBIOLOGY, V220, P280, DOI 10.1016/j.imbio.2014.09.010; Naito Y, 2012, J HYPERTENS, V30, P2192, DOI 10.1097/HJH.0b013e3283581a64; Naito Y, 2011, HYPERTENSION, V57, P497, DOI 10.1161/HYPERTENSIONAHA.110.159681; Naito Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075906; Naito Y, 2013, J HYPERTENS, V31, P1203, DOI 10.1097/HJH.0b013e328360381d; Parastatidis I, 2013, ARTERIOSCL THROM VAS, V33, P2389, DOI 10.1161/ATVBAHA.113.302175; Zacharski LR, 2011, AM HEART J, V162, DOI 10.1016/j.ahj.2011.08.013	40	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1079-5642	1524-4636		ARTERIOSCL THROM VAS	Arterioscler. Thromb. Vasc. Biol.	JUN	2015	35	6					1507	1514		10.1161/ATVBAHA.115.305586		8	Hematology; Peripheral Vascular Disease	Hematology; Cardiovascular System & Cardiology	CI5SU	WOS:000354820600027		
J	Ogino-Nishimura, E; Nakagawa, T; Sakamoto, T; Ito, J				Ogino-Nishimura, Eriko; Nakagawa, Takayuki; Sakamoto, Tatsunori; Ito, Juichi			Efficacy of three-dimensional endoscopy in endonasal surgery	AURIS NASUS LARYNX			English	Article; Proceedings Paper	2nd Meeting of the European-Academy-of-ORL-HNS and CE-ORL-HNS	APR 27-30, 2013	Nice, FRANCE	European Acad ORL HNS, CE ORL HNS		Three-dimensional endoscopy; Endoscopic sinus surgery; Skull base surgery; Education	SKULL BASE SURGERY; SINUS SURGERY; STEREOSCOPIC ENDOSCOPE; PITUITARY SURGERY; PERFORMANCE; SYSTEM	Objective: To examine the efficacy of a three-dimensional (3D) endoscope for endoscopic sinus and skull base surgery. Methods: The study design was a retrospective case series and qualitative research. The clinical efficacy of 3D endoscopes was examined on five cadavers. We performed conventional endoscopic sinus surgery (ESS) in five cases and hypophysectomy in two cases using a 3D endoscope. The educational advantages of the 3D endoscope were assessed using questionnaires given to the participants of cadaver dissection courses. Results: In the posterior portion of the nasal cavity, images captured via 3D endoscopy provided a superior perception of depth of information than those via two-dimensional (2D) endoscopy. All endonasal surgeries were completed in clinical settings using a 3D endoscope without perioperative complications. In terms of the operative time and amount of bleeding, the results of 3D endoscopic surgeries were not inferior to those of 20 endoscopic surgeries. Fatigue from 3D viewing through polarized glasses did not adversely affect performance of the surgery. Moreover, questionnaires for the evaluation of educational efficacy were completed by 73 surgeons. Of the respondents, 89% agreed that 3D endoscopy provided a better understanding of the surgical anatomy than did 2D endoscopy. As for the site where 3D endoscopy would be the most useful for understanding surgical anatomy, 40% of the respondents named the skull base; 29%, the posterior ethmoid sinuses; and 26%, the sphenoid sinus; and 9%, the ethmoid bulla and middle turbinate. Conclusion: The 3D endoscope contributes to a more precise anatomical understanding of the posterior structures of the sinuses and skull base and ensures a more precise operation of the instruments. Thus, 3D endoscopes will likely become a standard device for endonasal surgery in the near future. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ogino-Nishimura, Eriko; Nakagawa, Takayuki; Sakamoto, Tatsunori; Ito, Juichi] Kyoto Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Kyoto, Japan; [Ogino-Nishimura, Eriko] Kyoto Ear Nose & Throat Surgictr, Kyotanabe, Japan	Ogino-Nishimura, E (reprint author), Kyoto Ear Nose & Throat Surgictr, Yamatenishi 2-2-3, Kyoto 6100355, Japan.	ogino@hiroshiba.com	Sakamoto, Tatsunori/N-3046-2015	Sakamoto, Tatsunori/0000-0001-6669-7013			Snyderman CH, 2008, J SURG ONCOL, V97, P658, DOI 10.1002/jso.21020; Yamauchi Y, 2005, ST HEAL T, V111, P611; Govindaraj S, 2010, J LARYNGOL OTOL, V124, P242, DOI 10.1017/S0022215109991368; Kari E, 2012, INT FORUM ALLERGY RH, V2, P2, DOI 10.1002/alr.20036; Siedek V, 2013, EUR ARCH OTO-RHINO-L, V270, P141, DOI 10.1007/s00405-012-1973-z; Shah RN, 2011, AM J RHINOL ALLERGY, V25, P141, DOI 10.2500/ajra.2011.25.3593; Byrn JC, 2007, AM J SURG, V193, P519, DOI 10.1016/j.amjsurg.2006.06.042; Brown SM, 2008, OTOLARYNG HEAD NECK, V138, P400, DOI 10.1016/j.otohns.2007.12.007; Szold A, 2005, SURG ENDOSC, V19, P730, DOI 10.1007/s00464-004-8272-8; CATALANO MF, 1993, GASTROINTEST ENDOSC, V39, P23, DOI 10.1016/S0016-5107(93)70005-X; Manes RP, 2011, INT FORUM ALLERGY RH, V1, P191, DOI 10.1002/alr.20012; Tabaee A, 2009, NEUROSURGERY, V64, P288, DOI 10.1227/01.NEU.0000338069.51023.3C; Wasserzug O, 2010, SKULL BASE-INTERD AP, V20, P223, DOI 10.1055/s-0030-1247630	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					203	207		10.1016/j.anl.2014.10.004		5	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300004		
J	Hamada, M; Iida, M; Nota, J; Matsumoto, N; Sawada, S; Mukushita, N; Washizu, Y; Shimasaki, M; Doi, T				Hamada, Masashi; Iida, Masahiro; Nota, Jumpei; Matsumoto, Noboru; Sawada, Shoichi; Mukushita, Naoko; Washizu, Yozo; Shimasaki, Mutsumi; Doi, Tadafumi			Safety and efficacy of adenotonsillectomy for obstructive sleep apnea in infants, toddlers and preschool children	AURIS NASUS LARYNX			English	Article						Harmonic Scalpel; Portable monitoring device; Apnea-hypopnea index; Postoperative complication; Clinical pathway	APNEA/HYPOPNEA SYNDROME; TONSILLECTOMY; COMPLICATIONS; AGE; ADENOIDECTOMY; HYPERTROPHY; OUTCOMES; SCALPEL; YOUNGER	Objective: To investigate and compare the safety and efficacy of adenotonsillectomy (AT) on obstructive sleep apnea (OSA) in infants and toddlers (IT) with preschool children (PS), and charts of 147 children between the ages of 11 months and 6 years were reviewed. Methods: Harmonic Scalpel (HS) was introduced into AT to reduce the operative duration and intraoperative hemorrhage. Preoperative and postoperative apnea-hypopnea indices (AHI) values obtained by the type 3 portable monitoring device, and the change achieved by AT were statistically compared between IT group (N = 50) and PS group (N = 97). The mean operative duration, the mean amount of intraoperative hemorrhage, the incidence of postoperative hemorrhage, the frequency of abnormal postoperative chest X-ray findings, and the length of hospital stay were also compared between the two groups. All statistical analyses were conducted using either the Student's t test or Fischer's exact test, and p-values <0.05 were considered statistically significant. Results: In the IT group, the mean preoperative AHI value was 13.5 +/- 7.1 and decreased to 4.7 +/- 3.4 postoperatively. In the PS group, the mean AHI value changed from 16.0 +/- 10.2 to 4.4 +/- 2.4. There were statistically significant differences between the preoperative and postoperative AHI values in both the IT and PS groups, but there were no statistically significant differences between the IT and PS groups. The mean operative durations in the IT group for tonsillectomy and adenoidectomy were 12.8 +/- 6.7 min and 19.5 +/- 8.1 min, respectively. The corresponding values in the PS group were 14.5 +/- 6.6 min and 22.9 +/- 9.7 min, respectively. The mean tonsillectomy durations were comparable, but the adenoidectomy duration was statistically shorter in the IT group. In the IT group, the mean amounts of intraoperative hemorrhage during tonsillectomy and during adenoidectomy were 6.0 +/- 5.1 and 18.9 +/- 10.6 g, respectively. The corresponding values in the PS group were 6.4 +/- 5.4 g and 26.2 +/- 13.4 g, respectively. The mean tonsillectomy blood loss was comparable between the groups but was statistically less during adenoidectomy in the IT group. There were no statistical differences between the two groups in the incidence of postoperative hemorrhage and of abnormal findings in the postoperative chest X-ray, and in the length of hospital stay. Conclusion: AT in IT can be performed without major perioperative complications and should be considered the primary treatment of OSA from infancy to early childhood. Ultrasonic devices may contribute to increasing the safety of this surgical treatment. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Hamada, Masashi; Iida, Masahiro] Tokai Univ, Sch Med, Dept Otolaryngol, Isehara, Kanagawa 2591193, Japan; [Nota, Jumpei] Ehime Univ, Sch Med, Dept Otolaryngol, Matsuyama, Ehime 790, Japan; [Hamada, Masashi; Nota, Jumpei; Matsumoto, Noboru; Sawada, Shoichi; Mukushita, Naoko; Washizu, Yozo] Kochi Med Sch, Dept Otolaiyngol, Kochi, Japan; [Shimasaki, Mutsumi; Doi, Tadafumi] Kochi Med Sch Hosp, Clin & Sleep Lab, Kochi, Japan	Hamada, M (reprint author), Tokai Univ, Sch Med, Dept Otolaryngol, 143 Shimokasuya, Isehara, Kanagawa 2591193, Japan.	mhamada@is.icc.u-tokai.ac.jp					Greenfeld M, 2003, INT J PEDIATR OTORHI, V67, P1055, DOI 10.1016/S0165-5876(03)00182-4; Gozal D, 2007, CURR OPIN PULM MED, V13, P505, DOI 10.1097/MCP.0b013e3282ef6880; Spencer DJ, 2012, ARCH OTOLARYNGOL, V138, P335, DOI 10.1001/archoto.2012.1; Marcus CL, 2002, PEDIATRICS, V109, P704; Kalantar N, 2006, INT J PEDIATR OTORHI, V70, P2103, DOI 10.1016/j.ijporl.2006.08.006; SUEN JS, 1995, ARCH OTOLARYNGOL, V121, P525; Don DM, 2009, INT J PEDIATR OTORHI, V73, P1025, DOI 10.1016/j.ijporl.2009.04.003; Friedman M, 2009, OTOLARYNG HEAD NECK, V140, P800, DOI 10.1016/j.otohns.2009.01.043; Tauman R, 2006, PAEDIATR RESPIR REV, V7, P247, DOI 10.1016/j.prrv.2006.08.003; Wilson YL, 2009, LARYNGOSCOPE, V119, P162, DOI 10.1002/lary.20024; Statham MM, 2006, ARCH OTOLARYNGOL, V132, P476, DOI 10.1001/archotol.132.5.476; Friedman M, 2002, OTOLARYNG HEAD NECK, V127, P13, DOI 10.1067/mhn.2002.126477; Brietzke SE, 2006, OTOLARYNG HEAD NECK, V134, P979, DOI 10.1016/j.otohns.2006.02.033; Lalakea ML, 1999, ARCH OTOLARYNGOL, V125, P749; Brigance JS, 2009, OTOLARYNG HEAD NECK, V140, P912, DOI 10.1016/j.otohns.2009.01.034; Cheng J, 2013, LARYNGOSCOPE, V123, P2281, DOI 10.1002/lary.23796; Hamada M, 2002, OTOLARYNGOL HEAD NEC, V74, P724; Hamada M, 2002, PRACTICA OTORHINOLAR, V95, P899; Hamada Masashi, 2012, Tokai J Exp Clin Med, V37, P66; Iber C, 2007, AASM MANUAL SCORING; Mitchell RB, 2005, OTOLARYNG HEAD NECK, V132, P681, DOI 10.1016/j.otohns.2004.12.010; Ochi K, 2000, LARYNGOSCOPE, V110, P1237, DOI 10.1097/00005537-200007000-00034; Parikh SR, 2006, OTOLARYNG HEAD NECK, V135, P684, DOI 10.1016/j.otohns.2006.05.003; Shine NP, 2006, ARCH OTOLARYNGOL, V132, P1123, DOI 10.1001/archotol.132.10.1123; Shintani T, 1998, INT J PEDIATR OTORHI, V44, P51, DOI 10.1016/S0165-5876(98)00047-0; Slovik Y, 2003, INT J PEDIATR OTORHI, V67, P847, DOI 10.1016/S0165-5876(03)00125-3; Wiatrak BJ, 2002, LARYNGOSCOPE, V112, P14	27	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					208	212		10.1016/j.anI.2014.12.005		5	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300005		
J	Murono, S; Hamaguchi, T; Yoshida, H; Nakanishi, Y; Tsuji, A; Endo, K; Kondo, S; Wakisaka, N; Yamada, M; Yoshizaki, T				Murono, Shigeyuki; Hamaguchi, Tsuyoshi; Yoshida, Hiroshi; Nakanishi, Yosuke; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yamada, Masahito; Yoshizaki, Tomokazu			Evaluation of dysphagia at the initial diagnosis of amyotrophic lateral sclerosis	AURIS NASUS LARYNX			English	Article						Amyotrophic lateral sclerosis; Dysphagia; Videofluoroscopy; Severity scale	SCALE	Objective: Dysphagia eventually occurs in amyotrophic lateral sclerosis (ALS). Swallowing in patients with ALS at their initial diagnosis was evaluated using videofluoroscopy (VF). Methods: Nineteen consecutive patients with ALS, 14 with bulbar symptoms, and 5 without them, underwent VF. Fourteen physiologic components, 6 oral and 8 pharyngeal components, were assessed during the examination. Results: Significantly poorer scores were observed in three of the 6 oral components and 3 of the 8 pharyngeal components in patients with bulbar symptoms. Furthermore, bolus transport from the oral cavity to pharynx, pharyngeal constriction, oral residue and pharyngeal residue were impaired in patients even without bulbar symptoms. On the other hand, pharyngoesophageal segment opening was preserved in patients even with bulbar symptoms. Bolus transport and initiation of pharyngeal swallow were correlated with the swallowing category of the ALS severity scale. Conclusion: Defining types of impairment in patients with or without bulbar symptoms is useful for evaluating dysphagia in this disease. Although VF showed impairment of oral and pharyngeal phases of swallowing, the oral phase affected the eating habit in ALS at the initial diagnosis. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Murono, Shigeyuki; Yoshida, Hiroshi; Nakanishi, Yosuke; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshizaki, Tomokazu] Kanazawa Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan; [Hamaguchi, Tsuyoshi; Yamada, Masahito] Kanazawa Univ, Sch Med, Dept Neurol, Kanazawa, Ishikawa 9208640, Japan	Murono, S (reprint author), Kanazawa Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	murono@med.kanazawa-u.ac.jp					Andersen PM, 2012, BUR J NEUROL, V19, P360; Fattori B, 2006, DYSPHAGIA, V21, P280, DOI 10.1007/s00455-006-9052-5; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Briani C, 1998, J NEUROL, V245, P211, DOI 10.1007/s004150050207; Ruoppolo G, 2013, ACTA NEUROL SCAND, V128, P397, DOI 10.1111/ane.12136; Kawai S, 2003, DYSPHAGIA, V18, P1, DOI 10.1007/s00547-002-0074-z; Rosenbek JC, 1996, DYSPHAGIA, V11, P93, DOI 10.1007/BF00417897; Kuhnlein P, 2008, NAT CLIN PRACT NEURO, V4, P366, DOI 10.1038/ncpneuro0853; Higo R, 2004, AURIS NASUS LARYNX, V31, P247, DOI 10.1016/j.anl.2004.05.009; HILLEL AD, 1989, NEUROEPIDEMIOLOGY, V8, P142, DOI 10.1159/000110176; Martin-Harris B, 2008, PHYS MED REHABIL CLI, V19, P769, DOI 10.1016/j.pmr.2008.06.004; Higo R, 2002, LARYNGOSCOPE, V112, P911, DOI 10.1097/00005537-200205000-00024; ROBBINS J, 1987, NEUROL CLIN, V5, P213	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					213	217		10.1016/j.anl.2014.10.012		5	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300006		
J	Murono, S; Nakanishi, Y; Tsuji, A; Endo, K; Kondo, S; Wakisaka, N; Yoshida, H; Yoshizaki, T				Murono, Shigeyuki; Nakanishi, Yosuke; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshida, Hiroshi; Yoshizaki, Tomokazu			Trends in the management of recurrent respiratory papillomatosis in Japan	AURIS NASUS LARYNX			English	Article						Respiratory papillomatosis; Therapy; Survey; Japan; Cidofovir	LARYNGEAL PAPILLOMATOSIS; BRITISH-ASSOCIATION; MEMBERS EXPERIENCE; CIDOFOVIR	Objective: Recurrent respiratory papillomatosis (RRP) has historically been and still continues to be a difficult disease to treat. The present study aimed to characterize current practices in the treatment of RRP in Japan. Methods: A questionnaire was posted to the Department of Otolaryngology of all 80 central university hospitals in Japan. Results: A total of 56 universities responded to the survey. Regarding the use of surgical instruments, a trend toward a preference for lasers (50 hospitals) rather than a microdebrider (16 hospitals) or cold instruments (20 hospitals) was observed. Among the 50 hospitals frequently performing laser surgery, a carbon dioxide (CO2) laser was most commonly used, followed by a potassium-titanyl-phosphate (ICTP) laser. The most favored adjuvant therapy was traditional Chinese medicine. Eight of the 56 university hospitals had an experience of using cidofovir, involving a total of 28 patients. Conclusion: The present study demonstrated the current trends in the management of RRP based on a questionnaire survey in a geographical area other than the US and UK for the first time. Treatment trends were generally similar in all three areas except for the least popular use of cidofovir in Japan. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Murono, Shigeyuki; Nakanishi, Yosuke; Tsuji, Akira; Endo, Kazuhira; Kondo, Satoru; Wakisaka, Naohiro; Yoshida, Hiroshi; Yoshizaki, Tomokazu] Kanazawa Univ, Dept Otolaryngol Head & Neck Surg, Kanazawa, Ishikawa 9208640, Japan	Murono, S (reprint author), Kanazawa Univ, Dept Otolaryngol Head & Neck Surg, 13-1 Takaramachi, Kanazawa, Ishikawa 9208640, Japan.	murono@med.kanazawa-u.ac.jp					Derkay CS, 2013, LARYNGOSCOPE, V123, P705, DOI 10.1002/lary.23673; Derkay CS, 2008, LARYNGOSCOPE, V118, P1236, DOI 10.1097/MLG.0b013e31816a7135; Venkatesan NN, 2012, OTOLARYNG CLIN N AM, V45, P671, DOI 10.1016/j.otc.2012.03.006; DERKAY CS, 1995, ARCH OTOLARYNGOL, V121, P1386; Zeitels SM, 2002, OTOLARYNG HEAD NECK, V126, P333, DOI 10.1067/mhn.2002.123546; Armstrong LR, 1999, ARCH OTOLARYNGOL, V125, P743; Chadha NK, 2007, OTOLARYNGOL HEAD NEC, V136, P836; CHO J-M, 1991, In Vivo (Attiki), V5, P389; DUGGAN MA, 1990, LARYNGOSCOPE, V100, P639; Lindman JP, 2005, ANN OTO RHINOL LARYN, V114, P499; Manickavasagam J, 2013, J LARYNGOL OTOL, V127, P917, DOI 10.1017/S0022215113001588; Okubo K, 2010, J ALTERN COMPLEM MED, V16, P427, DOI 10.1089/acm.2009.0314; Schraff S, 2004, ARCH OTOLARYNGOL, V130, P1039, DOI 10.1001/archotol.130.9.1039; Snoeck R, 1998, J MED VIROL, V54, P219, DOI 10.1002/(SICI)1096-9071(199803)54:3<219::AID-JMV13>3.0.CO;2-C; Tasca RA, 2006, INT J PEDIATR OTORHI, V70, P1183, DOI 10.1016/j.ijporl.2005.12.003	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					218	220		10.1016/j.anl.2014.10.006		3	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300007		
J	Ogawa, H; Fujimura, M; Ohkura, N; Makimura, K				Ogawa, Haruhiko; Fujimura, Masaki; Ohkura, Noriyuki; Makimura, Koichi			Effects of nebulized amphotericin B and budesonide inhalation for chronic cough-related laryngeal sensations	AURIS NASUS LARYNX			English	Article						A sensation of irritation in the throat; A sensation of mucus in the throat; Basidiomycetous fungi; Chronic cough; Fungus-associated chronic cough; Nebulized amphotericin B	REFRACTORY CHRONIC COUGH; CONTROLLED TRIAL; DOUBLE-BLIND; ASTHMA; GABAPENTIN; THROAT	Objective: To compare the acute effects of single nebulized amphotericin B and budesonide in treating cough-related laryngeal sensations in chronic cough patients, a randomized, single-blind, placebocontrolled, parallel-group trial was performed between two groups with positive and negative results of basidiomycetous (BM) fungi in their sputum culture. Methods: Forty patients presenting with chronic cough lasting 8 weeks or longer, whose sputum could be obtained, were recruited for this study. At the first visit, all patients underwent fungal culture sampling of sputum, capsaicin cough inhalation test, pulmonary function tests, and cough-related laryngeal sensation questionnaire (C-LSQ) consisting of 6 items with a severity scale of 0-5 for each item: (1) a sensation of irritation in the throat (SIT); (2) tickle in the throat; (3) throat clearing; (4) urge to cough; (5) a sensation of something stuck in the throat; and (6) a sensation of mucus in the throat (SMIT). The patients were randomly assigned to receive either nebulizer inhalation of 2.5 mg of amphotericin B (Group A) or nebulizer inhalation of 0.5 mg of budesonide (Group B). The efficacies of each therapy were estimated by the change in C-LSQ score. Results: There were significant differences in the delta score of item 1 (SIT) and item 2 in the BM-negative group and item 6 (SMIT) in the BM-positive group at 60 min after inhalation between Groups A and B (P < 0.05). Conclusion: The results of this study suggested that appropriate use of single inhalation of budesonide or amphotericin B, which would be selected based on the results of sputum culture, may lead to suppression of cough-related laryngeal sensations, such as SIT or SMIT. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Ogawa, Haruhiko] Ishikawa Ken Saiseikai Kanazawa Hosp, Div Pulm Med, Kanazawa, Ishikawa 9200353, Japan; [Fujimura, Masaki] Nanao Hosp, Natl Hosp Org, Resp Med, Nanao 9268531, Japan; [Ohkura, Noriyuki] Ishikawa Prefectural Cent Hosp, Resp Med, Kanazawa, Ishikawa, Japan; [Makimura, Koichi] Teikyo Univ, Grad Sch Med, Lab Space & Environm Med, Itabashi Ku, Tokyo 173, Japan; [Makimura, Koichi] Teikyo Univ, Grad Sch Med Technol, Itabashi Ku, Tokyo 173, Japan	Ogawa, H (reprint author), Ishikawa Ken Saiseikai Kanazawa Hosp, Div Pulm Med, Ni 13-6 Akatsuchi Machi, Kanazawa, Ishikawa 9200353, Japan.	saiseikh@po3.nsknet.or.jp; fujimura@nanao.hosp.go.jp; noriyukiohkura@gmail.com; makimura@med.teikyo-u.ac.jp					American Thoracic Society, 1987, AM REV RESPIR DIS, V136, P1285; Gibson PG, 2001, AM J RESP CRIT CARE, V163, P32; Vertigan AE, 2011, J VOICE, V25, P596, DOI 10.1016/j.jvoice.2010.07.009; ELLULMICALLEF R, 1983, BRIT J CLIN PHARMACO, V15, P419; IRWIN RS, 1990, AM REV RESPIR DIS, V141, P640; Ryan NM, 2012, LANCET, V380, P1583, DOI 10.1016/S0140-6736(12)60776-4; Chung KF, 2012, LANCET, V380, P1540, DOI 10.1016/S0140-6736(12)61070-8; Kuiper L, 2009, J AEROSOL MED PULM D, V22, P213, DOI 10.1089/jamp.2008.0715; Chen AH, 2013, RESPIROLOGY, V18, P47, DOI 10.1111/resp.12168; FUJIMURA M, 1992, EUR RESPIR J, V5, P291; Greenberg SD, 1996, SOUTH MED J, V59, P64; Helbling A, 2002, CHEM IMMUNOL, V81, P28; Ogawa H, 2014, ALLERGOL INT; Ogawa H, 2009, RESP MED, V103, P1492, DOI 10.1016/j.rmed.2009.04.016; Ogawa H, 2009, J ASTHMA, V46, P407, DOI 10.1080/02770900902846331; Ogawa H, 2013, RESPIROLOGY, V18, P1278, DOI 10.1111/resp.12166; Ogawa Haruhiko, 2011, Med Mycol J, V52, P205, DOI 10.3314/mmj.52.205; Ogawa H, 2013, RESPIROLOGY, V18, P732, DOI 10.1111/resp.12064; Ogawa H, 2014, PULM PHARMACOL THER, V27, P127, DOI 10.1016/j.pupt.2013.06.007; Ogawa Haruhiko, 2013, Cough, V9, P1, DOI 10.1186/1745-9974-9-1	20	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					221	225		10.1016/j.anl.2014.10.008		5	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300008		
J	Endo, K; Masatani, T; Tsuji, A; Kondo, S; Wakisaka, N; Murono, S; Yoshizaki, T				Endo, Kazuhira; Masatani, Tomomi; Tsuji, Akira; Kondo, Satoru; Wakisaka, Naohiro; Murono, Shigeyuki; Yoshizaki, Tomokazu			Thyroid dysfunction after intra-arterial chemotherapy for hypopharyngeal and laryngeal cancer	AURIS NASUS LARYNX			English	Article						Hypothyroidism; Radiation; Intra-arterial chemotherapy; Head and neck squamous cell carcinoma; Health-related quality of life	NECK-CANCER; ADVANCED HEAD; HYPOTHYROIDISM; RADIOTHERAPY; CARCINOMA	Objective: Hypothyroidism is a late side effect after curative radiotherapy in the head and neck region. Superselective intra-arterial chemotherapy (SSIAC), when combined with radiation (SSIAC-R), shows higher control potential for locally advanced head and neck cancers, which is attributable to a delivery of higher concentrations of chemotherapeutic agents. However, it could enhance damages in the normal tissues. Hypothyroidism is a late adverse effect after curative radiotherapy in the head and neck region. This study focuses on the toxic effect of treatment modality for thyroid function. Methods: A retrospective analysis was performed to examine patients' thyroid function after SSIAC-R for laryngeal and hypopharyngeal cancer. Results: Hypothyroidism was observed in 21 (77.8%) of 27 patients receiving SSIAC-R, 4 (33.3%) of 12 patients treated with radiation alone, and 7(41.1%) of 17 who underwent systemic chemoradiotherapy. The number of administered vessels significantly correlated with the incidence of developing hypothyroidism among SSIAC-R treated patients (P = 0.03). Conclusion: Concurrent setting of SSIAC with radiation significantly raises the possibility of hypothyroidism. Therefore, monitoring late complications of therapeutic procedures is essential during follow-up visits. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Endo, Kazuhira; Masatani, Tomomi; Tsuji, Akira; Kondo, Satoru; Wakisaka, Naohiro; Murono, Shigeyuki; Yoshizaki, Tomokazu] Kanazawa Univ, Div Otolaryngol, Grad Sch Med, Kanazawa, Ishikawa 9208640, Japan	Endo, K (reprint author), Kanazawa Univ, Div Otolaryngol, Grad Sch Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	endok@med.kanazawa-u.ac.jp					Boomsma MJ, 2011, RADIOTHER ONCOL, V99, P1, DOI 10.1016/j.radonc.2011.03.002; Mercado G, 2001, CANCER, V92, P2892, DOI 10.1002/1097-0142(20011201)92:11<2892::AID-CNCR10134>3.0.CO;2-T; Alterio D, 2007, INT J RADIAT ONCOL, V67, P144, DOI 10.1016/j.ijrobp.2006.08.051; ROBBINS KT, 1994, AM J SURG, V168, P419, DOI 10.1016/S0002-9610(05)80089-3; LIENING DA, 1990, OTOLARYNG HEAD NECK, V103, P10; National comprehensive cancer network, 2014, CLIN PRACT GUID ONC; PALMER BV, 1981, HEAD NECK SURG, V4, P13, DOI 10.1002/hed.2890040105; POSNER MR, 1984, LARYNGOSCOPE, V94, P451, DOI 10.1288/00005537-198404000-00002; Tell R, 1997, INT J RADIAT ONCOL, V39, P303, DOI 10.1016/S0360-3016(97)00117-X; Vaidya B, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a801; Vigario P, 2009, MED PRIN PRACT, V18, P317, DOI 10.1159/000215731; Yoshizaki T, 2007, ANN OTO RHINOL LARYN, V116, P754; Yoshizaki T, 2009, ANN OTO RHINOL LARYN, V118, P172	13	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					231	234		10.1016/j.anl.2014.12.002		4	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300010		
J	Akiyama, K; Karaki, M; Hoshikawaa, H; Mori, N				Akiyama, Kosuke; Karaki, Masayuki; Hoshikawaa, Hiroshi; Mori, Nozomu			Retrieval of ruptured medial rectus muscle with an endoscopic endonasal orbital approach. A case report and indication for surgical technique	AURIS NASUS LARYNX			English	Article						Medial rectus muscle; Endoscope; Blowout fracture; Endoscopic endonasal surgery		Introduction: Rupture of the extraocular muscle is extremely rare, and a traumatic event is especially uncommon. Although retrieval of an injured MRM is usually performed by an anterior approach by an ophthalmologist, missing muscles in the orbital retrobulbar space are sometimes difficult to identify. This is the first report to demonstrate direct muscle to muscle anastomosis by an endoscopic endonasal orbital approach by a single otolaryngologist. Case report: A 67-year-old man presented with left medial rectus muscle (MRM) rupture due to a traffic accident 4 months after injury. The MRM was completely ruptured, and the muscle was repaired by an endoscopic endonasal orbital approach. After surgery, his eye abduction was improved in the primary position, and adduction ability was markedly restored on right gaze without diplopia. Conclusions: Our endonasal endoscopic approach provides excellent access to the MRM in the orbital retrobulbar space and avoids a facial scar. We could suture both ends of the muscle together by an endonasal endoscopic approach and could obtain a good result without any complications. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Akiyama, Kosuke; Hoshikawaa, Hiroshi; Mori, Nozomu] Kagawa Univ, Fac Med, Dept Otolaryngol, Kagawa 7610793, Japan; [Karaki, Masayuki] Tanaka ENT Clin, Tyuou Ku, Kumamoto 8600803, Japan	Akiyama, K (reprint author), Kagawa Univ, Fac Med, Dept Otolaryngol, Miki Cho,Ikenobe 1750-1, Kagawa 7610793, Japan.	kakaka@med.kagawa-u.ac.jp					Karaki M, 2008, NEUROSURGERY, V63, P15, DOI 10.1227/01.NEU.0000315299.98345.D0; [Anonymous], 2008, NEUROSURGERY; Awad A H, 1997, J AAPOS, V1, P138, DOI 10.1016/S1091-8531(97)90054-9; BLOOM PA, 1993, J ROY SOC MED, V86, P112; Cherfan CG, 2011, CAN J OPHTHALMOL, V46, P501, DOI 10.1016/j.jcjo.2011.09.023; Farwell DG, 2007, OTOLARYNG CLIN N AM, V40, P319, DOI 10.1016/j.otc.2006.11.007; Huerva Valentín, 2008, Strabismus, V16, P33, DOI 10.1080/09273970701863529; Knapp P, 1978, S STRAB T NEW ORL AC, P301; Lenart TD, 2000, AM J OPHTHALMOL, V130, P645, DOI 10.1016/S0002-9394(00)00535-3; Ling R, 2001, J AAPOS, V5, P327, DOI 10.1067/mpa.2001.118217; McKeown CA, 1996, J PEDIATR OPHTHALMOL, V33, P225; Murray A D, 1998, J AAPOS, V2, P133, DOI 10.1016/S1091-8531(98)90003-9	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					241	244		10.1016/j.anl.2014.10.011		4	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300012		
J	Kubota, M; Kubo, K; Yasui, T; Matsumoto, N; Komune, S				Kubota, Marie; Kubo, Kazuhiko; Yasui, Tetsuro; Matsumoto, Nozomu; Komune, Shizuo			Development of conductive hearing loss due to posterior semicircular canal dehiscence	AURIS NASUS LARYNX			English	Article						Posterior semicircular canal dehiscence; Hearing loss; Hearing loss pattern transition; Surgical indication	INNER-EAR; JUGULAR BULB; OUTCOMES; VERTIGO; FOSSA	We herein report a case of posterior semicircular canal dehiscence (SCD) syndrome who had been audiologically followed up for eight years. The patient originally had sensorineural hearing loss. The audiogram had gradually transformed to pure conductive hearing loss. The posterior SCD was identified in CT scan. The reported case showed the possibility to distinguish the mechanism at play underlying the typical conductive hearing loss in SCD patients by tracing the transition of the hearing loss pattern. This information is of much help to predict the hearing outcomes if surgical intervention were chosen for the treatment. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Kubota, Marie; Kubo, Kazuhiko; Yasui, Tetsuro; Matsumoto, Nozomu; Komune, Shizuo] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 8128582, Japan	Kubota, M (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kubomari@virology.med.kyushu-u.ac.jp					Agrawal SK, 2008, OTOL NEUROTOL, V29, P363, DOI 10.1097/mao.0b013e3181616c9d; Sone M, 2012, INT J PEDIATR OTORHI, V76, P447, DOI 10.1016/j.ijporl.2011.12.007; Ward BK, 2012, OTOL NEUROTOL, V33, P1386, DOI 10.1097/MAO.0b013e318268d20d; Chien WW, 2011, CURR OPIN NEUROL, V24, P25, DOI 10.1097/WCO.0b013e328341ef88; Krombach GA, 2003, EUR RADIOL, V13, P1444, DOI 10.1007/s00330-003-1828-5; Merchant SN, 2008, OTOL NEUROTOL, V29, P282, DOI 10.1097/mao.0b013e318161ab24; Minor LB, 2003, OTOL NEUROTOL, V24, P270, DOI 10.1097/00129492-200303000-00023; Mikulec AA, 2006, LARYNGOSCOPE, V116, P375, DOI 10.1097/01.mlg.0000200358.93385.5c; Friedmann DR, 2010, LARYNGOSCOPE, V120, P365, DOI 10.1002/lary.20699; Gopen Q, 2010, OTOL NEUROTOL, V31, P339, DOI 10.1097/MAO.0b013e3181be65a4; Minor LB, 1998, ARCH OTOLARYNGOL, V124, P249; Chi FL, 2010, OTOL NEUROTOL, V31, P2, DOI 10.1097/MAO.0b013e3181bc35ce; Elmali M, 2013, EUR J RADIOL, V82, pE606, DOI 10.1016/j.ejrad.2013.06.022; WADIN K, 1986, Acta Radiologica Diagnosis, V27, P629; WADIN K, 1986, ACTA RADIOL, V27, P315	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					245	248		10.1016/j.anl.2014.10.014		4	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300013		
J	Maeda, Y; Kataoka, Y; Sugaya, A; Kariya, S; Kobayashi, K; Nishizaki, K				Maeda, Yukihide; Kataoka, Yuko; Sugaya, Akiko; Kariya, Shin; Kobayashi, Katsuhiro; Nishizaki, Kazunori			Steroid-dependent sensorineural hearing loss in a patient with Charcot-Marie-Tooth disease showing auditory neuropathy	AURIS NASUS LARYNX			English	Article						Sensorineural hearing loss; Steroid therapy; Auditory neuropathy; Hereditary sensorimotor neuropathy	GUINEA-PIG; MPZ GENE; DEXAMETHASONE; OTOTOXICITY; MUTATION	Charcot-Marie-Tooth disease (CMT) is the most common form of hereditary sensorimotor neuropathy and sometimes involves disorders of the peripheral auditory system. We present a case of steroid-dependent auditory neuropathy associated with CMT, in which the patient experienced 3 episodes of acute exacerbation of hearing loss and successful rescue of hearing by prednisolone. An 8-year-old boy was referred to the otolaryngology department at the University Hospital. He had been diagnosed with CMT type 1 (demyelinating type) at the Child Neurology Department and was suffering from mild hearing loss due to auditory neuropathy. An audiological diagnosis of auditory neuropathy was confirmed by auditory brainstem response and distortion-product otoacoustic emissions. At 9 years and 0 months old, 9 years and 2 months old, and 10 years and 0 months old, he had experienced acute exacerbations of hearing loss, each of which was successfully rescued by intravenous or oral prednisolone within 2 weeks. Steroid-responsive cases of CMT have been reported, but this is the first case report of steroid-responsive sensorineural hearing loss in CMT. The present case may have implications for the mechanisms of action of glucocorticoids in the treatment of sensorineural hearing loss. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Maeda, Yukihide; Kataoka, Yuko; Sugaya, Akiko; Kariya, Shin; Nishizaki, Kazunori] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Kobayashi, Katsuhiro] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Okayama, Japan	Maeda, Y (reprint author), Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan.	yamayuki@cc.okayama-u.ac.jp					Starr A, 2003, BRAIN, V126, P1604, DOI 10.1093/brain/awg156; DYCK PJ, 1982, MAYO CLIN PROC, V57, P239; Takemura K, 2004, HEARING RES, V196, P58, DOI 10.1016/j.heares.2004.06.003; Desarnaud F, 2000, BRAIN RES, V865, P12, DOI 10.1016/S0006-8993(00)02130-2; Rance G, 2012, BRAIN, V135, P1412, DOI 10.1093/brain/aws085; Li J, 2012, SEMIN NEUROL, V32, P204, DOI 10.1055/s-0032-1329198; Butinar D, 2008, CLIN NEUROPHYSIOL, V119, P367, DOI 10.1016/j.clinph.2007.10.004; Daldal A, 2002, OTOLARYNGOL HEAD NEC, V137, P747; Himeno C, 2002, HEARING RES, V167, P61, DOI 10.1016/S0378-5955(02)00345-3; Kabzinska D, 2007, AM J MED GENET A, V143A, P2196, DOI 10.1002/ajmg.a.31908; L'Heureux-Lebeau B, 2013, OTOL NEUROTOL, V34, pE105, DOI 10.1097/MAO.0b013e31828f47a8; Morawski K, 2009, OTOL NEUROTOL, V30, P851, DOI 10.1097/MAO.0b013e3181b12296; PARK YS, 1994, ANN OTO RHINOL LARYN, V103, P896; PAULI RM, 1984, CLIN GENET, V26, P383; Tabuchi K, 2006, OTOL NEUROTOL, V27, P1176, DOI 10.1097/01.mao.0000226313.82069.3f	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					249	253		10.1016/j.anl.2014.11.002		5	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300014		
J	Nakaya, M; Kida, W; Ito, A; Yoshihara, S; Fuchigami, T				Nakaya, Muneo; Kida, Wataru; Ito, Akiko; Yoshihara, Shintaro; Fuchigami, Teruhiko			Endoscopic transoral and transmaxillary excision of the infratemporal fossa hemangioma	AURIS NASUS LARYNX			English	Article						Endoscopic surgery; Hemangioma; Venous malformation; Infratemporal fossa		Hemangiomas in the infratemporal fossa (ITF) are extremely rare benign vascular tumors. For many tumors of the ITF, with the exception of some small hemangiomas, a lateral facial approach has often been required. Recently, however, there have been some reports that minimally invasive endoscopic surgery can be used in the ITF; this would reduce the risk of surgical complications. To date, there has been no report of a hemangioma of the ITF exceeding 6 cm being resected by the endoscopic approach without facial incisions. Here, however, we report two cases of ITF hemangiomas that were completely extracted endoscopically, using a transmaxillary and transoral approach, without facial incisions or surgical complications. (C) 2014 Elsevier Ireland Ltd. All rights reserved.	[Nakaya, Muneo; Kida, Wataru; Ito, Akiko; Yoshihara, Shintaro; Fuchigami, Teruhiko] Tokyo Metropolitan Tama Med Ctr, Dept Otolaryngol Head & Neck Surg, Fuchu, Tokyo 1838524, Japan	Nakaya, M (reprint author), Tokyo Metropolitan Tama Med Ctr, Dept Otolaryngol Head & Neck Surg, 2-8-29 Musashidai, Fuchu, Tokyo 1838524, Japan.	muneo@jcom.home.ne.jp					Theodosopoulos PV, 2010, NEUROSURGERY, V66, P196, DOI 10.1227/01.NEU.0000359224.75185.43; JANECKA IP, 1995, OTOLARYNG HEAD NECK, V112, P579, DOI 10.1177/019459989511200412; Edward DM, 2011, OP TECH OTOLARYNGOL, V22, P285; GRIME PD, 1991, INT J ORAL MAX SURG, V20, P291, DOI 10.1016/S0901-5027(05)80158-4; Isolan GR, 2007, SKULL BASE-INTERD AP, V17, P285, DOI 10.1055/s-2007-985193; Khalifa MA, 2008, INT J PEDIATR OTORHI, V72, P1855, DOI 10.1016/j.ijporl.2008.09.012; Kornfehl J, 1996, EUR ARCH OTO-RHINO-L, V253, P172, DOI 10.1007/BF00615116; Morsy SME, 2011, J LARYNGOL OTOL, V125, P701; Nakaya M, 2013, LARYNGOSCOPE, V123, P360, DOI 10.1002/lary.23402; SHAHEEN OH, 1982, J LARYNGOL OTOL, V96, P817, DOI 10.1017/S0022215100093166; Toriumi DM, 1989, ENT-EAR NOSE THROAT, V68; Williams H B, 1981, Adv Surg, V15, P317	12	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					258	262		10.1016/j.anl.2014.12.001		5	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300016		
J	Mori, M; Yabuki, K; Taguchi, T; Nishimura, G; Takahashi, M; Komatsu, M; Oridate, N				Mori, Makiko; Yabuki, Kenichiro; Taguchi, Takahide; Nishimura, Goshi; Takahashi, Masahiro; Komatsu, Masanori; Oridate, Nobuhiko			Long-term results of survival analysis after a 5-year follow-up: Efficacy of fluoro-2-deoxy-D-glucose positron emission tomography to evaluate responses to concurrent chemoradiotherapy for head and neck squamous cell carcinoma	AURIS NASUS LARYNX			English	Letter									[Mori, Makiko; Yabuki, Kenichiro; Taguchi, Takahide; Nishimura, Goshi; Takahashi, Masahiro; Komatsu, Masanori; Oridate, Nobuhiko] Yokohama City Univ, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Yokohama, Kanagawa 2360004, Japan	Oridate, N (reprint author), Yokohama City Univ, Sch Med, Dept Otorhinolaryngol & Head & Neck Surg, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	noridate@yokohama-cu.ac.jp					Mori M, 2011, AURIS NASUS LARYNX, V38, P724, DOI 10.1016/j.anl.2011.04.013	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0385-8146	1879-1476		AURIS NASUS LARYNX	Auris Nasus Larynx	JUN	2015	42	3					263	263		10.1016/j.anl.2015.02.014		1	Otorhinolaryngology	Otorhinolaryngology	CI8OJ	WOS:000355031300017		
J	Suzuki, S; Morimoto, S; Fujishiro, M; Kawasaki, M; Hayakawa, K; Miyashita, T; Ikeda, K; Miyazawa, K; Yanagida, M; Takamori, K; Ogawa, H; Sekigawa, I; Takasaki, Y				Suzuki, Satoshi; Morimoto, Shinji; Fujishiro, Maki; Kawasaki, Mikiko; Hayakawa, Kunihiro; Miyashita, Tomoko; Ikeda, Keigo; Miyazawa, Keiji; Yanagida, Mitsuaki; Takamori, Kenji; Ogawa, Hideoki; Sekigawa, Iwao; Takasaki, Yoshinari			Inhibition of the insulin-like growth factor system is a potential therapy for rheumatoid arthritis	AUTOIMMUNITY			English	Article						Anti-IGF-1R mAb; biologics; drug repositioning; insulin-like growth factor; rheumatoid arthritis	FACTOR-I RECEPTOR; BINDING-PROTEINS; JAK/STAT PATHWAY; SYNOVIAL-FLUID; ACTIVATION; EXPRESSION; ROLES; ALPHA	Objective: We have shown that connective tissue growth factor (CTGF) plays an important role in the pathogenesis of rheumatoid arthritis (RA). Insulin-like growth factor binding proteins (IGFBPs) are modules of CTGF. IGFBPs bind IGF-I and IGF-II. IGF-I plays a role in the regulation of immunity, bone metabolism and inflammation. Therefore, we investigated how the IGF system is associated with RA disease progression. Methods: Serum samples were collected from RA patients. IGF-I and IGFBP-3 production were evaluated by enzyme-linked immunosorbent assay, real-time RT-PCR and indirect immunofluorescence microscopy. Osteoclastogenesis was evaluated using tartrate-resistant acid phosphatase staining, a bone resorption assay and osteoclast-specific enzyme production. Angiogenesis was examined by a tube formation assay using human umbilical vein endothelial cells. Results: The serum concentrations of IGFBP-3 in RA patients were greater than those in normal controls. IGF-I and IGFBP-3 were produced primarily by macrophages in the RA synovium. Furthermore, tumor necrosis factor-a could induce aberrant IGF-I and IGFBP-3 production in synovial fibroblasts. IGF-I and IGFBP-3 promoted the induction of osteoclast generation and morphological changes, in combination with M-colony stimulating factor and the receptor activator of NF-kappa B ligand. In addition, IGF-I and IGFBP-3 induced angiogenesis, as determined by the tube formation assay. These effects were neutralized by anti-IGF-IR monoclonal antibody (mAb). Conclusions: These results indicate that aberrant IGF-I and IGFBP-3 production plays a role in abnormal osteoclastic activation and angiogenesis in RA. This work supports future clinical exploration of anti-IGF-IR mAb in drug repositioning as a new treatment for RA.	[Suzuki, Satoshi; Morimoto, Shinji; Fujishiro, Maki; Kawasaki, Mikiko; Hayakawa, Kunihiro; Miyashita, Tomoko; Ikeda, Keigo; Yanagida, Mitsuaki; Takamori, Kenji; Ogawa, Hideoki; Sekigawa, Iwao] Juntendo Univ, Grad Sch Med, Inst Environm & Gender Specif Med, Urayasu, Chiba 2790021, Japan; [Suzuki, Satoshi; Miyashita, Tomoko; Takasaki, Yoshinari] Juntendo Univ, Sch Med, Dept Internal Med & Rheumatol, Tokyo 113, Japan; [Morimoto, Shinji; Ikeda, Keigo; Sekigawa, Iwao] Juntendo Univ, Urayasu Hosp, Dept Internal Med & Rheumatol, Urayasu, Chiba 2790021, Japan; [Miyazawa, Keiji] Kissei Pharmaceut Co Ltd, Cent Res Labs, Azumino, Ngano, Japan	Morimoto, S (reprint author), Juntendo Univ, Urayasu Hosp, Dept Internal Med & Rheumatol, 2-1-1 Tomioka, Urayasu, Chiba 2790021, Japan.	morimoto@juntendo.ac.jp			Institute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine	This work was supported by grants from The Institute for Environment and Gender-Specific Medicine, Juntendo University Graduate School of Medicine.	Kawai M, 2012, ENDOCRIN METAB CLIN, V41, P323, DOI 10.1016/j.ecl.2012.04.013; KOCH AE, 1994, J IMMUNOL, V152, P4149; Walsh DA, 1998, AM J PATHOL, V152, P691; Gual P, 1998, ENDOCRINOLOGY, V139, P884, DOI 10.1210/en.139.3.884; Matsumoto T, 1996, J CLIN ENDOCR METAB, V81, P150, DOI 10.1210/jc.81.1.150; van der Heijde D, 2013, ARTHRITIS RHEUM-US, V65, P559, DOI 10.1002/art.37816; Paleolog EM, 2009, INT J EXP PATHOL, V90, P249, DOI 10.1111/j.1365-2613.2009.00640.x; FOURNIER T, 1995, J IMMUNOL, V155, P2123; Giustina A, 2008, ENDOCR REV, V29, P535, DOI 10.1210/er.2007-0036; Takahashi T, 1999, CIRC RES, V85, P884; Rajaram S, 1997, ENDOCR REV, V18, P801, DOI 10.1210/er.18.6.801; Takigawa M, 2003, J CELL PHYSIOL, V194, P256, DOI 10.1002/jcp.10206; La Cava A, 2004, J MOL MED-JMM, V82, P4, DOI 10.1007/s00109-003-0492-1; Collett-Solberg PF, 2000, ENDOCRINE, V12, P121, DOI 10.1385/ENDO:12:2:121; Feldmann M, 1996, CELL, V85, P307, DOI 10.1016/S0092-8674(00)81109-5; Seccareccia E, 2012, GROWTH HORM IGF RES, V22, P193, DOI 10.1016/j.ghir.2012.09.003; Zong CS, 2000, J BIOL CHEM, V275, P15099, DOI 10.1074/jbc.M000089200; Kisseleva T, 2002, GENE, V285, P1, DOI 10.1016/S0378-1119(02)00398-0; Himpe E, 2009, BIOFACTORS, V35, P76, DOI 10.1002/biof.20; Haruta K, 2012, INFLAMM RES, V61, P551, DOI 10.1007/s00011-012-0444-8; Yadav A, 2005, J BIOL CHEM, V280, P31830, DOI 10.1074/jbc.M501316200; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Ebong S, 2004, INVEST OPHTH VIS SCI, V45, P872, DOI 10.1167/iovs.03-0311; Fernihough JK, 1996, ARTHRITIS RHEUM, V39, P1556, DOI 10.1002/art.1780390916; Itoh Y, 2007, J IMMUNOL, V178, P3059; LEROITH D, 1995, ENDOCR REV, V16, P143; LUNDOLES.K, 1970, ARTHRITIS RHEUM, V13, P769, DOI 10.1002/art.1780130606; MOCHIZUKI H, 1992, ENDOCRINOLOGY, V131, P1075, DOI 10.1210/en.131.3.1075; Nakao K, 2005, BONE, V36, P884, DOI 10.1016/j.bone.2004.10.015; Neidel J, 2001, CLIN EXP RHEUMATOL, V19, P81; Nozawa K, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2863; Nozawa K, 2013, ARTHRITIS RHEUM-US, V65, P1477, DOI 10.1002/art.37902; ROONEY M, 1988, ARTHRITIS RHEUM, V31, P956, DOI 10.1002/art.1780310803; Salvi R, 2000, ARTHRITIS RES, V2, P504, DOI 10.1186/ar132; SEMBLE EL, 1985, J RHEUMATOL, V12, P237; Ueland T, 2005, EUR J ENDOCRINOL, V152, P327, DOI 10.1530/eje.1.01874	36	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0891-6934	1607-842X		AUTOIMMUNITY	Autoimmunity	JUN	2015	48	4					251	258		10.3109/08916934.2014.976631		8	Immunology	Immunology	CI5LP	WOS:000354798100008		
J	Ebihara, S; Date, F; Dong, YP; Ono, M				Ebihara, Shin; Date, Fumiko; Dong, Yupeng; Ono, Masao			Interleukin-17 is a critical target for the treatment of ankylosing enthesitis and psoriasis-like dermatitis in mice	AUTOIMMUNITY			English	Article						Animal model; ankylosing spondylitis; deep Koebner phenomenon; interleukin-17; psoriasis; psoriatic arthritis	ANTI-INTERLEUKIN-17A MONOCLONAL-ANTIBODY; UNFOLDED PROTEIN RESPONSE; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; CONTROLLED-TRIAL; TRANSGENIC RATS; IL-17 RECEPTOR; MOUSE MODEL; MAST-CELLS; DBA/1 MICE	Ankylosis is a major pathological manifestation of spondyloarthropathy. The aim of this study was to evaluate the effects of anti-IL-17 therapy on spontaneous ankylosing enthesitis in mice. In this study, we used male DBA/1 mice as a spontaneous ankylosis model. Serum IL-17 concentrations were determined using enzyme-linked immunosorbent assay. Male DBA/1 mice from different litters were mixed and caged together preceding the treatment at 10 weeks (wk) of age (prophylaxis) or 21 wk of age (intervention). Treatment with anti-IL-17 antibodies or saline was initiated after caging in groups of mice and administered weekly. The onset of tarsal ankylosis was assessed by ankle swelling and histopathological examination. Pathological changes and mRNA expression levels were assessed in joints and ears obtained at the experimental end-point. We found that circulating IL-17 increased with the onset of ankylosis in male DBA/1 mice, coinciding with the onset of dermatitis. The symptoms of dermatitis corresponded to the pathological characteristics of psoriasis: acanthosis with mild hyperkeratosis, scaling, epidermal microabscess formation and augmented expression of K16, S100A8 and S100A9. Prophylactic administration of anti-IL-17 antibodies significantly prevented the development of both ankylosis and dermatitis in male DBA/1 mice caged together. On the other hand, administration of anti-IL-17 antibodies after disease onset had a lesser but significant effect on ankylosis progression but did not affect dermatitis progression. In conclusion, IL-17 is a key mediator in the pathogenic process of tarsal ankylosis and psoriasis-like dermatitis in male DBA/1 mice caged together. Thus, IL-17 is a potential therapeutic target in ankylosing enthesitis and psoriasis in humans.	[Ebihara, Shin; Date, Fumiko; Dong, Yupeng; Ono, Masao] Tohoku Univ, Grad Sch Med, Dept Pathol, Sendai, Miyagi 9808575, Japan; [Ono, Masao] Natl Hosp Org, Mito Med Ctr, Higashi ibaraki, Japan	Ebihara, S (reprint author), Tohoku Univ, Grad Sch Med, Dept Pathol, Aoba Ku, 2-1 Seiryo, Sendai, Miyagi 9808575, Japan.	ebihara@med.tohoku.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [23659198]	This study was supported by grants-in-aid for scientific research from the Ministry of Education, Science, Sports and Culture of Japan to MO (No 23659198). The authors declare that they have no competing interests.	Mease PJ, 2000, LANCET, V356, P385, DOI 10.1016/S0140-6736(00)02530-7; Wendling D, 2007, JOINT BONE SPINE, V74, P304, DOI 10.1016/j.jbspin.2006.11.005; Charles P, 1999, J IMMUNOL, V163, P1521; Kenna TJ, 2012, ARTHRITIS RHEUM-US, V64, P1420, DOI 10.1002/art.33507; Smith E, 2008, J IMMUNOL, V181, P1357; Ritchlin C, 2007, NAT CLIN PRACT RHEUM, V3, P698, DOI 10.1038/ncprheum0670; Algood HMS, 2009, J IMMUNOL, V183, P5837, DOI 10.4049/jimmunol.0901206; Ballow M, 2011, J ALLERGY CLIN IMMUN, V127, P315, DOI 10.1016/j.jaci.2010.10.030; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; McGonagle D, 2011, ANN RHEUM DIS, V70, pI71, DOI 10.1136/ard.2010.144097; Turner MJ, 2007, ARTHRITIS RHEUM, V56, P215, DOI 10.1002/art.22295; Delay ML, 2009, ARTHRITIS RHEUM, V60, P2633, DOI 10.1002/art.24763; Ma HL, 2008, J CLIN INVEST, V118, P597, DOI 10.1172/JCI33263; Shen H, 2009, ARTHRITIS RHEUM, V60, P1647, DOI 10.1002/art.24568; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Raychaudhuri SP, 2012, MOL CELL BIOCHEM, V359, P419, DOI 10.1007/s11010-011-1036-6; Wilson NJ, 2007, NAT IMMUNOL, V8, P950, DOI 10.1038/ni1497; Iwakura Y, 2011, IMMUNITY, V34, P149, DOI 10.1016/j.immuni.2011.02.012; Lories RJU, 2004, ANN RHEUM DIS, V63, P595, DOI 10.1136/ard.2003.013599; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Davis JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325; Crellin NK, 2010, J EXP MED, V207, P281, DOI 10.1084/jem.20091509; LEIGH IM, 1995, BRIT J DERMATOL, V133, P501, DOI 10.1111/j.1365-2133.1995.tb02696.x; Braun J, 2002, LANCET, V359, P1187, DOI 10.1016/S0140-6736(02)08215-6; Baeten D, 2013, LANCET, V382, P1705, DOI 10.1016/S0140-6736(13)61134-4; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Papp KA, 2013, BRIT J DERMATOL, V168, P412, DOI 10.1111/bjd.12110; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Lories RJU, 2007, ARTHRITIS RHEUM, V56, P489, DOI 10.1002/art.22372; Pattison E, 2008, ANN RHEUM DIS, V67, P672, DOI 10.1136/ard.2007.073932; Corthay A, 2000, ARTHRITIS RHEUM, V43, P844, DOI 10.1002/1529-0131(200004)43:4<844::AID-ANR15>3.0.CO;2-B; Jandus C, 2008, ARTHRITIS RHEUM, V58, P2307, DOI 10.1002/art.23655; Eckert RL, 2004, J INVEST DERMATOL, V123, P23, DOI 10.1111/j.0022-202X.2004.22719.x; Appel H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3370; Bowes J, 2010, DISCOV MED, V52, P177; FitzGerald O, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2580; McInnes IB, 2014, ANN RHEUM DIS, V73, P349, DOI 10.1136/annrheumdis-2012-202646; Oishi H, 2005, ARTHRITIS RHEUM, V52, P959, DOI 10.1002/art.20956; Res PCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014108; Semprini S, 2002, HUM GENET, V111, P310, DOI 10.1007/s00439-002-0812-5; STANKLER L, 1969, BRIT J DERMATOL, V81, P534, DOI 10.1111/j.1365-2133.1969.tb16029.x; Van den Bosch F, 2000, ANN RHEUM DIS, V59, P428, DOI 10.1136/ard.59.6.428; Vegvari A, 2009, JOINT BONE SPINE, V76, P623, DOI 10.1016/j.jbspin.2009.02.006	43	2	2	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0891-6934	1607-842X		AUTOIMMUNITY	Autoimmunity	JUN	2015	48	4					259	266		10.3109/08916934.2014.976630		8	Immunology	Immunology	CI5LP	WOS:000354798100009		
J	Kashima, K; Ogawa, T; Sakurai, T				Kashima, Kenji; Ogawa, Toshiyuki; Sakurai, Tatsunari			Selective pattern formation control: Spatial spectrum consensus and Turing instability approach	AUTOMATICA			English	Article						Pattern generation; Synchronization; Pitchfork bifurcation; Instability; Nonlinearity; Chemical variables control	OSCILLATORS	Autonomous pattern formation phenomena are ubiquitous throughout nature. The goal of this paper is to show the possibility to effectively generate various desired spatial patterns by guiding such phenomena suitably. To this end, we employ a reaction-diffusion system as a mathematical model, and formulate and solve a novel pattern formation control problem. First, we describe the control objective in terms of spatial spectrum consensus, which enables utilize recent advances on networked control system theory. Next, the effectiveness of the proposed control law is evaluated theoretically by exploiting the center manifold theorem, and also numerically by simulation. The Turing instabilities play a crucial role throughout the paper. (C) 2015 Elsevier Ltd. All rights reserved.	[Kashima, Kenji] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Ogawa, Toshiyuki] Meiji Univ, Grad Sch Adv Study Math Sci, Nakano Ku, Tokyo 101, Japan; [Sakurai, Tatsunari] Chiba Univ, Dept Phys, Grad Sch Sci, Chiba 260, Japan	Kashima, K (reprint author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	kashima@amp.i.kyoto-u.ac.jp; togw@meiji.ac.jp; tatsunari@chiba-u.jp			Aihara Innovative Mathematical Modeling Project; Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"; JSPS KAKENHI [25400390, 25103008]; JSPS Core-to-Core Program "Nonequilibrium dynamics of soft matter and information"	This research was partially supported by the Aihara Innovative Mathematical Modeling Project, the Japan Society for the Promotion of Science (JSPS) through the "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)", initiated by the Council for Science and Technology Policy (CSTP). The authors express their gratitude to Prof. Jun-ichi Imura of Tokyo Institute of Technology for his fruitful comment. TS was supported by JSPS KAKENHI Grant Numbers 25400390, 25103008, and by the JSPS Core-to-Core Program "Nonequilibrium dynamics of soft matter and information".	Steur E, 2009, PHYSICA D, V238, P2119, DOI 10.1016/j.physd.2009.08.007; Mikhailov AS, 2006, PHYS REP, V425, P79, DOI 10.1016/j.physrep.2005.11.003; Arcak M, 2011, AUTOMATICA, V47, P1219, DOI 10.1016/j.automatica.2011.01.010; Fax JA, 2004, IEEE T AUTOMAT CONTR, V49, P1465, DOI 10.1109/TAC.2004.834433; CAHN JW, 1958, J CHEM PHYS, V28, P258, DOI 10.1063/1.1744102; CROSS MC, 1993, REV MOD PHYS, V65, P851, DOI 10.1103/RevModPhys.65.851; Stan GB, 2007, IEEE T AUTOMAT CONTR, V52, P256, DOI 10.1109/TAC.2006.890471; CAGINALP G, 1986, PHYS REV B, V33, P7792, DOI 10.1103/PhysRevB.33.7792; Camazine S., 2003, SELF ORG BIOL SYSTEM; Carr J, 1981, APPL CTR MANIFOLD TH; Curtain R., 1995, INTRO INFINITE DIMEN; Godsil C. D., 2001, ALGEBRAIC GRAPH THEO; HENRY D., 1981, GEOMETRIC THEORY SEM; HIRSCH MW, 1977, INVARIANT MANIFOLDS; Hsia J., 2011, AM CONTR C ACC 2011, P2284; Kashima K., 2013, AM CONTR C, P3765; Khalil H.K., 2002, NONLINEAR SYSTEMS; Krstic M, 2008, ADV DES CONTROL, P1; Kuznetsov YA, 2004, ELEMENTS APPL BIFURC; Mesbahi M, 2010, GRAPH THEORETIC METHODS IN MULTIAGENT NETWORKS, P1; Morton K.W., 2005, NUMERICAL SOLUTION P; Murray J.D., 2003, MATH BIOL; Seneta E, 2006, SPRINGER SER STAT, P1, DOI 10.1007/0-387-32792-4; Shafi SY, 2013, AUTOMATICA, V49, P3613, DOI 10.1016/j.automatica.2013.09.011; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-1098	1873-2836		AUTOMATICA	Automatica	JUN	2015	56						25	35		10.1016/j.automatica.2015.03.019		11	Automation & Control Systems; Engineering, Electrical & Electronic	Automation & Control Systems; Engineering	CI8UK	WOS:000355047000004		
J	Boussac, A; Rutherford, AW; Sugiura, M				Boussac, Alain; Rutherford, A. William; Sugiura, Miwa			Electron transfer pathways from the S-2-states to the S-3-states either after a Ca2+/Sr2+ or a Cl-/I- exchange in Photosystem II from	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article						Photosystem II; Oxygen evolution; Mn4CaO5 cluster; Spin state; EPR	OXYGEN-EVOLVING COMPLEX; PHOTOSYNTHETIC WATER OXIDATION; NEAR-INFRARED LIGHT; O BOND FORMATION; CYANOBACTERIUM SYNECHOCOCCUS-ELONGATUS; LIQUID-HELIUM TEMPERATURES; THERMOSYNECHOCOCCUS-ELONGATUS; S-2 STATE; MANGANESE COMPLEX; PROTON RELEASE	The site for water oxidation in Photosystem II (PSII) goes through five sequential oxidation states (S-0 to S-4) before O-2 is evolved. It consists of a Mn4CaO5-cluster close to a redox-active tyrosine residue (Y-z). Cl is also required for enzyme activity. By using EPR spectroscopy it has been shown that both Ca2+/Sr2+ exchange and Cl-/I- exchange perturb the proportions of centers showing high (S = 5/2) and low spin (S = 1/2) forms of the Systate. The S-3-state was also found to be heterogeneous with: i) a S = 3 form that is detectable by EPR and not sensitive to near-infrared light; and ii) a form that is not EPR visible but in which Mn photochemistry occurs resulting in the formation of a (S2Yz)' split EPR signal upon near-infrared illumination. In Sr/Cl-PSII, the high spin (S = 5/2) form of S-2 shows a marked heterogeneity with a g = 4.3 form generated at low temperature that converts to a relaxed form at g = 4.9 at higher temperatures. The high spin g = 4.9 form can then progress to the EPR detectable form of S-3 at temperatures as low as 180 K whereas the low spin (S = 1/2) S-2-state can only advance to the S-3 state at temperatures >= 235 K. Both of the two S-2 configurations and the two S-3 configurations are each shown to be in equilibrium at >= 235K but not at 198 K. Since both S-2 configurations are formed at 198 K, they likely arise from two specific populations of Si. The existence of heterogeneous populations in Si, Sy and S-3 states may be related to the structural flexibility associated with the positioning of the oxygen O-5 within the cluster highlighted in computational approaches and which has been linked to substrate exchange. These data are discussed in the context of recent in silico studies of the electron transfer pathways between the S-2-state(s) and the S-3-state(s).	[Boussac, Alain] CEA Saclay, CNRS UMR 9198, I2BC, F-91191 Gif Sur Yvette, France; [Rutherford, A. William] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England; [Sugiura, Miwa] Ehime Univ, Proteosci Res Ctr, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa] Ehime Univ, Grad Sch Sci & Technol, Dept Chem, Matsuyama, Ehime 7908577, Japan; [Sugiura, Miwa] Japan Sci & Technol Agcy JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Boussac, A (reprint author), CEA Saclay, CNRS UMR 9198, I2BC, F-91191 Gif Sur Yvette, France.	alain.boussac@cea.fr			French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; CEA/DSV "Bioenergie" program [LOC1041OXYDO]; Royal Society; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/K002627/1]; JST-PRESTO program [4018]; Ministry of Education, Science, Sports, Culture and Technology [21612007]	AB was supported in part by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01 and the CEA/DSV "Bioenergie" program LOC1041OXYDO. AWR is a recipient of a Wolfson Merit Award from the Royal Society and is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) grant BB/K002627/1. MS was supported by JST-PRESTO program (4018 for M.S.) and Grant-in-Aid for scientific research from the Ministry of Education, Science, Sports, Culture and Technology (21612007 for M.S.).	Renger G, 2011, J PHOTOCH PHOTOBIO B, V104, P35, DOI 10.1016/j.jphotobiol.2011.01.023; RAPPAPORT F, 1991, BIOCHEMISTRY-US, V30, P10004, DOI 10.1021/bi00105a027; Pokhrel R, 2014, PHYS CHEM CHEM PHYS, V16, P11812, DOI 10.1039/c4cp00493k; Su JH, 2007, BIOCHEMISTRY-US, V46, P10703, DOI 10.1021/bi7004174; Boussac A, 2012, BBA-BIOENERGETICS, V1817, P802, DOI 10.1016/j.bbabio.2012.02.031; Dau H, 2012, CURR OPIN CHEM BIOL, V16, P3, DOI 10.1016/j.cbpa.2012.02.011; Noguchi T, 2015, BBA-BIOENERGETICS, V1847, P35, DOI 10.1016/j.bbabio.2014.06.009; Cox N, 2011, J AM CHEM SOC, V133, P3635, DOI 10.1021/ja110145v; Bao H, 2013, PHOTOSYNTH RES, V116, P215, DOI 10.1007/s11120-013-9907-1; Siegbahn PEM, 2006, CHEM-EUR J, V12, P9217, DOI 10.1002/chem.200600774; Britt RD, 2004, BBA-BIOENERGETICS, V1655, P158, DOI 10.1016/j.bbabio.2003.11.009; Narzi D, 2014, P NATL ACAD SCI USA, V111, P8723, DOI 10.1073/pnas.1401719111; Krewald V, 2015, CHEM SCI, V6, P1676, DOI 10.1039/c4sc03720k; Bovi D, 2013, ANGEW CHEM INT EDIT, V52, P11744, DOI 10.1002/anie.201306667; Blomberg MRA, 2014, CHEM REV, V114, P3601, DOI 10.1021/cr400388t; Ishida N, 2008, J BIOL CHEM, V283, P13330, DOI 10.1074/jbc.M710583200; Boussac A, 2005, PLANT CELL PHYSIOL, V46, P837, DOI 10.1093/pcp/pci088; Kawakami K, 2009, P NATL ACAD SCI USA, V106, P8567, DOI 10.1073/pnas.0812797106; Glockner C, 2013, J BIOL CHEM, V288, P22607, DOI 10.1074/jbc.M113.476622; Kulik LV, 2007, J AM CHEM SOC, V129, P13421, DOI 10.1021/ja071487f; Siegbahn PEM, 2011, J PHOTOCH PHOTOBIO B, V104, P94, DOI 10.1016/j.jphotobiol.2011.01.014; Cox N, 2013, ACCOUNTS CHEM RES, V46, P1588, DOI 10.1021/ar3003249; KOK B, 1970, PHOTOCHEM PHOTOBIOL, V11, P457, DOI 10.1111/j.1751-1097.1970.tb06017.x; Pantazis DA, 2012, ANGEW CHEM INT EDIT, V51, P9935, DOI 10.1002/anie.201204705; CASEY JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P21, DOI 10.1016/0005-2728(84)90075-6; Isobe H, 2012, DALTON T, V41, P13727, DOI 10.1039/c2dt31420g; Ames W, 2011, J AM CHEM SOC, V133, P19743, DOI 10.1021/ja2041805; DISMUKES GC, 1981, P NATL ACAD SCI-BIOL, V78, P274, DOI 10.1073/pnas.78.1.274; Klauss A, 2012, P NATL ACAD SCI USA, V109, P16035, DOI 10.1073/pnas.1206266109; Siegbahn PEM, 2012, PHYS CHEM CHEM PHYS, V14, P4849, DOI 10.1039/c2cp00034b; Cox N, 2013, BBA-BIOENERGETICS, V1827, P1020, DOI 10.1016/j.bbabio.2013.01.013; Yamaguchi K, 2013, INT J QUANTUM CHEM, V113, P525, DOI 10.1002/qua.24117; Havelius KGV, 2010, APPL MAGN RESON, V37, P151, DOI 10.1007/s00723-009-0045-z; STYRING S, 1987, BIOCHEMISTRY-US, V26, P2401, DOI 10.1021/bi00383a001; Petrouleas V, 2005, BIOCHEMISTRY-US, V44, P6723, DOI 10.1021/bi0503201; Boussac A, 2004, J BIOL CHEM, V279, P22809, DOI 10.1074/jbc.M401677200; Umena Y, 2011, NATURE, V473, P55, DOI 10.1038/nature09913; Pal R, 2013, BIOCHEMISTRY-US, V52, P7703, DOI 10.1021/bi401214v; Siegbahn PEM, 2013, BBA-BIOENERGETICS, V1827, P1003, DOI 10.1016/j.bbabio.2012.10.006; Cox N, 2014, SCIENCE, V345, P804, DOI 10.1126/science.1254910; Saito K, 2011, BIOCHEMISTRY-US, V50, P9836, DOI 10.1021/bi201366j; Boussac A, 2000, BBA-BIOENERGETICS, V1457, P145, DOI 10.1016/S0005-2728(00)00073-6; Klauss A, 2015, J PHYS CHEM B, V119, P2677, DOI 10.1021/jp509069p; Horner O, 1998, J AM CHEM SOC, V120, P7924, DOI 10.1021/ja981330a; DEPAULA JC, 1985, BIOCHEMISTRY-US, V24, P8114, DOI 10.1021/bi00348a042; Guskov A, 2009, NAT STRUCT MOL BIOL, V16, P334, DOI 10.1038/nsmb.1559; Faller P, 2003, P NATL ACAD SCI USA, V100, P8732, DOI 10.1073/pnas.1530926100; Boussac A, 2013, J PHYS CHEM B, V117, P3308, DOI 10.1021/jp400337j; Boussac A, 2008, PHILOS T R SOC B, V363, P1203, DOI 10.1098/rstb.2007.2216; Diner BA, 2002, ANNU REV PLANT BIOL, V53, P551, DOI 10.1146/annurev.arplant.53.100301.135238; ZIMMERMANN JL, 1984, BIOCHIM BIOPHYS ACTA, V767, P160, DOI 10.1016/0005-2728(84)90091-4; Retegan M, 2014, PHYS CHEM CHEM PHYS, V16, P11901, DOI 10.1039/c4cp00696h; Boussac A, 2009, J AM CHEM SOC, V131, P5050, DOI 10.1021/ja900680t; Yano J, 2014, CHEM REV, V114, P4175, DOI 10.1021/cr4004874; Saito K, 2014, BBA-BIOENERGETICS, V1837, P159, DOI 10.1016/j.bbabio.2013.09.013; Nilsson H, 2014, BBA-BIOENERGETICS, V1837, P1257, DOI 10.1016/j.bbabio.2014.04.001; Boussac A, 1996, BBA-BIOENERGETICS, V1277, P253, DOI 10.1016/S0005-2728(96)00107-7; Boussac A, 2011, BBA-BIOENERGETICS, V1807, P119, DOI 10.1016/j.bbabio.2010.10.004; Boussac A, 1998, BIOCHEMISTRY-US, V37, P8995, DOI 10.1021/bi980195b; Boussac A, 1998, BIOCHEMISTRY-US, V37, P4001, DOI 10.1021/bi9728710; Boussac A, 2000, BIOCHEMISTRY-US, V39, P13788, DOI 10.1021/bi001159r; BOUSSAC A, 1988, BIOCHEMISTRY-US, V27, P3476, DOI 10.1021/bi00409a052; Boussac A, 1996, BIOCHEMISTRY-US, V35, P6984, DOI 10.1021/bi960636w; Chrysina M, 2010, BBA-BIOENERGETICS, V1797, P487, DOI 10.1016/j.bbabio.2010.01.008; CORRIE AR, 1991, BIOCHIM BIOPHYS ACTA, V1057, P384, DOI 10.1016/S0005-2728(05)80152-5; Dau H, 2007, PHOTOSYNTH RES, V92, P327, DOI 10.1007/s11120-007-9141-9; Debus RJ, 2015, BBA-BIOENERGETICS, V1847, P19, DOI 10.1016/j.bbabio.2014.07.007; Fufezan C, 2005, BIOCHEMISTRY-US, V44, P12780, DOI 10.1021/bi051000k; Ioannidis N, 2002, BIOCHEMISTRY-US, V41, P9589, DOI 10.1021/bi0159940; Isobe H, 2014, PHYS CHEM CHEM PHYS, V16, P11911, DOI 10.1039/c4cp00282b; Joliot P., 1975, BIOENERG PHOTOSYNTH, P387; Junge W, 2002, PHILOS T ROY SOC B, V357, P1407, DOI 10.1098/rstb.2002.1137; Koua F.H.M., 2013, P NATL ACAD SCI USA, V110, P3389; Koulougliotis D, 2003, BIOCHEMISTRY-US, V42, P3045, DOI 10.1021/bi027051o; Meinke C, 2000, BIOCHEMISTRY-US, V39, P7033, DOI 10.1021/bi9924258; Nilsson H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5305; Robertazzi A, 2014, BBA-BIOENERGETICS, V1837, P1389, DOI 10.1016/j.bbabio.2014.07.008; Saito K, 2013, P NATL ACAD SCI USA, V110, P7690, DOI 10.1073/pnas.1300817110; Sanakis Y., 2008, 14 INT C PHOT, P479; Sanakis Y, 2001, J AM CHEM SOC, V123, P10766, DOI 10.1021/ja016418u; Sedoud A, 2011, BIOCHEMISTRY-US, V50, P6012, DOI 10.1021/bi200313p; Siegbahn PEM, 2009, ACCOUNTS CHEM RES, V42, P1871, DOI 10.1021/ar900117k; Sjoholm J, 2010, BIOCHEMISTRY-US, V49, P9800, DOI 10.1021/bi101364t; STYRING S, 1988, BIOCHIM BIOPHYS ACTA, V933, P378, DOI 10.1016/0005-2728(88)90046-1; Sugiura M, 1999, PLANT CELL PHYSIOL, V40, P1219; Sugiura M, 2008, BBA-BIOENERGETICS, V1777, P331, DOI 10.1016/j.bbabio.2008.01.007; Sugiura M, 2014, BBA-BIOENERGETICS, V1837, P1922, DOI 10.1016/j.bbabio.2014.08.008; Suzuki H, 2009, J AM CHEM SOC, V131, P7849, DOI 10.1021/ja901696m	88	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	JUN-JUL	2015	1847	6-7					576	586		10.1016/j.bbabio.2015.03.006		11	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CI8XL	WOS:000355054900009		
J	Sun, ZY; Wang, T; Tan, L; Tang, YQ; Kida, K				Sun, Zhao-Yong; Wang, Ting; Tan, Li; Tang, Yue-Qin; Kida, Kenji			Development of a more efficient process for production of fuel ethanol from bamboo	BIOPROCESS AND BIOSYSTEMS ENGINEERING			English	Article						Bamboo; Concentrated sulfuric acid saccharification; Continuous ethanol fermentation; Fuel ethanol; Nutrient salt; Xylitol fermentation	SACCHAROMYCES-CEREVISIAE STRAIN; SULFURIC-ACID HYDROLYSIS; FLOCCULATING YEAST; XYLITOL PRODUCTION; ENZYMATIC SACCHARIFICATION; XYLOSE FERMENTATION; CANDIDA-TROPICALIS; PRETREATMENT; BIOMASS; AERATION	A process for production of fuel ethanol from bamboo treated with concentrated sulfuric acid has been previously proposed. To improve efficiency of the process, we tested saccharification with 70 weight% (wt%) sulfuric acid, acid-sugar separation by ion exclusion, addition of nutrients to the ethanol fermentation, and bioconversion of xylose to xylitol. A high efficiency of both sugar recovery (82.5 %) and acid recovery (97.5 %) was achieved in the saccharification process and in the continuous acid-sugar separation using a modified anion exchange resin, respectively. Reduction of the amount of mineral salts added to the saccharified liquid after acid-sugar separation did not negatively affect performance of the continuous ethanol fermentation. The ethanol yield and productivity were 93.7 % and 6 g/l h, respectively, at 35 A degrees C and pH 4.0. And the ethanol yield and productivity were almost the same even at pH 3.5. Moreover, the xylose remaining in the fermented mash was efficiently converted to xylitol in batch fermentation by Candida tropicalis strain 2.1776. These results demonstrate a more efficient process for the production of fuel ethanol from bamboo.	[Sun, Zhao-Yong; Wang, Ting; Tang, Yue-Qin; Kida, Kenji] Sichuan Univ, Coll Architecture & Environm, Chengdu 610065, Sichuan, Peoples R China; [Tan, Li; Kida, Kenji] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto 8608555, Japan	Kida, K (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, 2-39-1 Kurokami, Kumamoto 8608555, Japan.	szy198306@hotmail.com; kida@gpo.kumamoto-u.ac.jp			Ministry of the Environment of Japan	The authors thank Prof. Akinori Jyo at Kumamoto University for supplying the modified anion exchange resin, DOWEX 1 x 4 SS. This work was supported financially by the Ministry of the Environment of Japan.	Cheng KK, 2009, BIOCHEM ENG J, V43, P203, DOI 10.1016/j.bej.2008.09.012; Sun Y, 2010, J AGR FOOD CHEM, V58, P2253, DOI 10.1021/jf903731s; Zhang XY, 2007, INT BIODETER BIODEGR, V60, P159, DOI 10.1016/j.ibiod.2007.02.003; Ping Y, 2013, BIOCHEM ENG J, V75, P86, DOI 10.1016/j.bej.2013.03.022; Scurlock JMO, 2000, BIOMASS BIOENERG, V19, P229, DOI 10.1016/S0961-9534(00)00038-6; Tang Y, 2006, PROCESS BIOCHEM, V41, P909, DOI 10.1016/j.procbio.2005.09.008; KOTTER P, 1993, APPL MICROBIOL BIOT, V38, P776; Prakash G, 2011, BIORESOURCE TECHNOL, V102, P3304, DOI 10.1016/j.biortech.2010.10.074; KIDA K, 1992, J FERMENT BIOENG, V74, P169, DOI 10.1016/0922-338X(92)90078-9; Yamashita Y, 2010, CARBOHYD POLYM, V79, P914, DOI 10.1016/j.carbpol.2009.10.017; Sun ZY, 2013, BIORESOURCE TECHNOL, V128, P87, DOI 10.1016/j.biortech.2012.10.082; Sathitsuksanoh N, 2010, BIORESOURCE TECHNOL, V101, P4926, DOI 10.1016/j.biortech.2009.09.081; Cai Z, 2011, BIOTECHNOL J, V7, P34; Huang CF, 2011, BIORESOURCE TECHNOL, V102, P3322, DOI 10.1016/j.biortech.2010.10.111; Japanese Industrial Standards Committee, 1986, K01021986 JIS; Kadam KL, 1997, APPL MICROBIOL BIOT, V47, P625; KIDA K, 1989, J FERMENT BIOENG, V68, P107, DOI 10.1016/0922-338X(89)90057-3; KIDA K, 1991, J FERMENT BIOENG, V71, P340, DOI 10.1016/0922-338X(91)90347-J; KIDA K, 1993, J FERMENT BIOENG, V75, P213, DOI 10.1016/0922-338X(93)90118-R; Ko CH, 2008, J CHEM TECHNOL BIOT, V83, P534, DOI 10.1002/jctb.1828; Li YC, 2014, BIOTECHNOL LETT, V36, P2011, DOI 10.1007/s10529-014-1581-7; Liu ZS, 2012, BIORESOURCE TECHNOL, V119, P224, DOI 10.1016/j.biortech.2012.05.107; Matsuura H, 2014, J ION EXCH, V25, P81; Miller S, 2007, CHEM ENG COMMUN, V194, P85, DOI 10.1080/00986440600586545; Perry JH, 1942, CHEM ENG HDB, V3rd; Saka S, 2001, BIOMASS ENERGY ENV, P61; Shimokawa T, 2009, BIORESOURCE TECHNOL, V100, P6651, DOI 10.1016/j.biortech.2009.06.100; Sluiter A, 2008, NRELTP51042618; Sluiter A., 2005, NRELTP51042622; Sun ZY, 2011, BIORESOURCE TECHNOL, V102, P10929, DOI 10.1016/j.biortech.2011.09.071; Tomitaka M, 2013, J BIOSCI BIOENG, V116, P706, DOI 10.1016/j.jbiosc.2013.05.027; Walther T, 2001, BIORESOURCE TECHNOL, V76, P213, DOI 10.1016/S0960-8524(00)00113-9	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1615-7591	1615-7605		BIOPROC BIOSYST ENG	Bioprocess. Biosyst. Eng.	JUN	2015	38	6					1033	1043		10.1007/s00449-014-1345-8		11	Biotechnology & Applied Microbiology; Engineering, Chemical	Biotechnology & Applied Microbiology; Engineering	CI0EJ	WOS:000354408700004		
J	Yamaguchi, R; Yamamoto, T; Sakamoto, A; Ishimaru, Y; Narahara, S; Sugiuchi, H; Hirose, E; Yamaguchi, Y				Yamaguchi, Rui; Yamamoto, Takatoshi; Sakamoto, Arisa; Ishimaru, Yasuji; Narahara, Shinji; Sugiuchi, Hiroyuki; Hirose, Eiji; Yamaguchi, Yasuo			Mechanism of interleukin-13 production by granulocyte-macrophage colony-stimulating factor-dependent macrophages via protease-activated receptor-2	BLOOD CELLS MOLECULES AND DISEASES			English	Article						Extracellular signal-regulated kinase; Granulocyte-macrophage colony-stimulating factor; Interleukin-13; Neutrophil elastase; Protease-activated receptor-2	SIGNAL-REGULATED KINASE; CYTOKINE PRODUCTION; MAP KINASE; T-CELLS; PATHWAY; P38; INHIBITION; ERK1/2; PHOSPHORYLATION; LYMPHOCYTES	Background: Granulocyte-macrophage colony-stimulating factor (GM-CSF) promotes classically activated M1 macrophages. GM-CSF upregulates protease-activated receptor-2 (PAR-2) protein expression and activation of PAR-2 by human neutrophil elastase (HNE) regulates cytokine production. Aim: This study investigated the mechanism of PAR-2-mediated interleukin (IL)-13 production by GM-CSF-dependent macrophages stimulated with HNE. Methods: Adherent macrophages were obtained from primary cultures of human mononuclear cells. After stimulation with HNE to activate the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERIC) signaling pathway, IL-13 mRNA and protein levels were assessed by the reverse transcriptase-polymerase chain reaction and enzyme-linked immunosorbent assay, respectively. Results: PAR-2 protein was detected in GM-CSF-dependent macrophages by Western blotting. Unexpectedly, PD98059 (an ERK1 inhibitor) increased IL-13 production, even at higher concentrations. Interestingly, U0126 (an ERK1/2 inhibitor) reduced IL-13 production in a concentration-dependent manner. Neither SB203580 (a p38alpha/p38beta inhibitor) nor BIRB796 (a p38gamma/p38delta inhibitor) affected IL-13 production, while TMB-8 (a calcium chelator) diminished IL-13 production. Discussion: Stimulation with HNE promoted the production of IL-13 (a Th2 cytokine) by GM-CSF-dependent M1 macrophages. PAR-2-mediated IL-13 production may be dependent on the Ca2+/ERK2 signaling pathway. (C) 2015 Elsevier Inc. All rights reserved.	[Yamaguchi, Rui; Yamamoto, Takatoshi; Sakamoto, Arisa; Ishimaru, Yasuji; Narahara, Shinji; Sugiuchi, Hiroyuki; Hirose, Eiji; Yamaguchi, Yasuo] Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kumamoto 8615598, Japan; [Yamaguchi, Rui] Kumamoto Univ, Sch Med, Grad Sch Med Sci, Kumamoto 860, Japan	Yamaguchi, Y (reprint author), Kumamoto Hlth Sci Univ, Grad Sch Med Sci, Kita Ku, Izumi Machi 325, Kumamoto 8615598, Japan.	yamaguti@kumamoto-hsu.ac.jp			Kumamoto Health Science University special fellowship [27-A-01]	This study was supported by Kumamoto Health Science University special fellowship grant No. 27-A-01.	Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770; Cohen P, 1997, TRENDS CELL BIOL, V7, P353, DOI 10.1016/S0962-8924(97)01105-7; DeFea KA, 2000, J CELL BIOL, V148, P1267, DOI 10.1083/jcb.148.6.1267; Gordeeva AV, 2003, BIOCHEMISTRY-MOSCOW+, V68, P1077, DOI 10.1023/A:1026398310003; Adachi K, 2011, P NATL ACAD SCI USA, V108, P1549, DOI 10.1073/pnas.1017340108; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Verreck FAW, 2004, P NATL ACAD SCI USA, V101, P4560, DOI 10.1073/pnas.0400983101; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Fischer AM, 2005, IMMUNITY, V23, P431, DOI 10.1016/j.immuni.2005.08.013; Kumar S, 1997, BIOCHEM BIOPH RES CO, V235, P533, DOI 10.1006/bbrc.1997.6849; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Scott G, 2003, J INVEST DERMATOL, V121, P529, DOI 10.1046/j.1523-1747.2003.12427.x; Kuma Y, 2005, J BIOL CHEM, V280, P19472, DOI 10.1074/jbc.M414221200; Aoki M, 2015, BLOOD CELL MOL DIS, V54, P353, DOI 10.1016/j.bcmd.2015.01.007; Banfi C, 2009, J THROMB HAEMOST, V7, P206, DOI 10.1111/j.1538-7836.2008.03204.x; Belham CL, 1996, BIOCHEM J, V320, P939; Bhagatte Y, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.84; Cerioni L, 2003, FEBS LETT, V547, P92, DOI 10.1016/S0014-5793(03)00675-6; Driesbaugh K.H., 2015, J BIOL CHEM, V2015, P3529; Dutra-Oliveira A, 2012, BIOCHEM BIOPH RES CO, V421, P221, DOI 10.1016/j.bbrc.2012.03.140; Egerton M, 1996, EUR J IMMUNOL, V26, P2279, DOI 10.1002/eji.1830261002; Hawkins BJ, 2007, MOL CELL BIOL, V27, P7582, DOI 10.1128/MCB.00493-07; Jorritsma PJ, 2003, J IMMUNOL, V170, P2427; Kim SK, 2006, DRUG METAB DISPOS, V34, P683, DOI 10.1124/dmd.105.007666; KOHNO S, 1993, MICROBIOL IMMUNOL, V37, P207; Li YY, 2010, CHINESE MED J-PEKING, V123, P1715, DOI 10.3760/cma.j.issn.0366-6999.2010.13.019; Li ZS, 2010, FEBS LETT, V584, P2291, DOI 10.1016/j.febslet.2010.03.040; Lim SY, 2006, BRIT J PHARMACOL, V149, P591, DOI 10.1038/sj.bjp.0706905; Pahl A, 2002, BRIT J PHARMACOL, V135, P1915, DOI 10.1038/sj.bjp.0704656; Rharass T, 2014, J BIOL CHEM, V289, P27937, DOI 10.1074/jbc.M114.573519; Scicchitano MS, 2008, BLOOD CELL MOL DIS, V40, P370, DOI 10.1016/j.bcmd.2007.10.009; Son Y, 2011, J SIGNAL TRANSDUCT, V2011, P1, DOI DOI 10.1155/2011/792639; STRIETER RM, 1989, AM J RESP CELL MOL, V1, P57; Vantaggiato Chiara, 2006, J Biol, V5, P14	34	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1079-9796	1096-0961		BLOOD CELL MOL DIS	Blood Cells Mol. Dis.	JUN	2015	55	1					21	26		10.1016/j.bcmd.2015.03.006		6	Hematology	Hematology	CI6ZN	WOS:000354912800005		
J	Kobayashi, K; Yorifuji, T; Yamakawa, M; Oka, M; Inoue, S; Yoshinaga, H; Doi, H				Kobayashi, Katsuhiro; Yorifuji, Takashi; Yamakawa, Michiyo; Oka, Makio; Inoue, Sachiko; Yoshinaga, Harumi; Doi, Hiroyuki			Poor toddler-age sleep schedules predict school-age behavioral disorders in a longitudinal survey	BRAIN & DEVELOPMENT			English	Article						Sleep habits; Behavioral disorders; Children; ADHD; Survey	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHILDREN; DIFFICULTIES; ASSOCIATIONS; PREVALENCE; CHILDHOOD; DURATION; BEDTIME	Objective: Behavioral problems are often associated with poor sleep habits in children. We investigated whether undesirable toddler-age sleep schedules may be related to school-age behavioral problems. Methods: We analyzed the data of a nationwide longitudinal survey with available results from 2001 to 2011. The participants were 41,890 children. The predictors were waking time and bedtime at 2 years of age, and the outcomes were assessed by determining the presence or absence of three attention problems and four aggressiveness problems at 8 years of age. In logistic regression models with adjustments for confounding factors, we estimated odds ratios (ORs) and confidence intervals (CIs) for the association between toddler sleep schedules and behavior during primary-school age years. Results: The outcomes of attention problems and aggressiveness problems were observed in 1.7% and 1.2% of children, respectively, at 8 years of age. The OR of an irregular or late morning waking time at 2 years of age with the outcome of aggressiveness problems was 1.52 (95% CI, 1.04-2.22) in comparison to an early waking time. The OR of an irregular or late bedtime with attention problems was 1.62 (95% CI, 1.12-2.36), and the OR of an irregular or late bedtime with aggressiveness problems was 1.81 (95% CI, 1.19-2.77) in comparison to an early bedtime. Conclusion: Poor toddler-age sleep schedules were found to predict behavioral problems during primary-school age years. Thus, good and regular sleep habits appear to be important for young children's healthy development. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kobayashi, Katsuhiro; Oka, Makio; Yoshinaga, Harumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Okayama 7008558, Japan; [Kobayashi, Katsuhiro; Oka, Makio; Yoshinaga, Harumi] Okayama Univ Hosp, Okayama 7008558, Japan; [Yorifuji, Takashi; Yamakawa, Michiyo] Okayama Univ, Grad Sch Environm & Life Sci, Dept Human Ecol, Okayama 7008558, Japan; [Inoue, Sachiko; Doi, Hiroyuki] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Epidemiol, Okayama 7008558, Japan; [Inoue, Sachiko] Okayama Psychiat Med Ctr, Dept Child & Adolescent Psychiat, Okayama, Japan	Kobayashi, K (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Child Neurol, Kita Ku, 5-1 Shikatacho,2 Chome, Okayama 7008558, Japan.	k_koba@md.okayama-u.ac.jp			Ministry of Health, Labour and Welfare, Japan [24-7]; Ministry of Education, Culture, Sports, Science, and Technology, Japan [24591513, 2379066203, 24510033]; Health and Labour Sciences Research Grants on Health Research on Children, Youth and Families, Japan [H24-Jisedai-Ippan-004]; Japan Epilepsy Research Foundation	Kobayashi was supported by a Research Grant for Nervous and Mental Disorders from the Ministry of Health, Labour and Welfare, Japan (24-7) and by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 24591513). Yorifuji and Yamakawa were supported by Health and Labour Sciences Research Grants on Health Research on Children, Youth and Families, Japan (No. H24-Jisedai-Ippan-004). Yorifuji was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 2379066203). Yoshinaga was supported in part by the Japan Epilepsy Research Foundation. Doi was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (No. 24510033).	Beebe DW, 2011, PEDIATR CLIN N AM, V58, P649, DOI 10.1016/j.pcl.2011.03.002; Gregory AM, 2002, J AM ACAD CHILD PSY, V41, DOI 10.1097/00004583-200208000-00015; Komada Y, 2011, TOHOKU J EXP MED, V224, P127, DOI 10.1620/tjem.224.127; Castellanos FX, 2012, TRENDS COGN SCI, V16, P17, DOI 10.1016/j.tics.2011.11.007; Gregory AM, 2004, J AM ACAD CHILD PSY, V43, P744, DOI 10.1097/01.chi/0000122798.47863.a5; Willcutt E, 2012, NEUROTHERAPEUTICS, V9, P490, DOI 10.1007/s13311-012-0135-8; Faraone SV, 2010, PSYCHIAT CLIN N AM, V33, P159, DOI 10.1016/j.psc.2009.12.004; Smedje H, 2001, EUR CHILD ADOLES PSY, V10, P1; Sadeh A, 2002, CHILD DEV, V73, P405, DOI 10.1111/1467-8624.00414; Paavonen EJ, 2009, PEDIATRICS, V123, pE857, DOI 10.1542/peds.2008-2164; Department of Statistics and Information, 2001, 1 LONG SURV BAB 21 C; El-Sheikh M, 2010, CHILD DEV, V81, P870, DOI 10.1111/j.1467-8624.2010.01439.x; Gregory AM, 2008, ARCH PEDIAT ADOL MED, V162, P330, DOI 10.1001/archpedi.162.4.330; Itani T, 2001, PSYCHIAT NEUROLOGIA, V41, P243; Kelly Y, 2013, PEDIATRICS, V132, pE1184, DOI 10.1542/peds.2013-1906; Kohyama J, 2009, BRAIN DEV-JPN, V31, P255, DOI 10.1016/j.braindev.2008.07.006; Mindell JA, 2011, SLEEP MED, V12, P203, DOI 10.1016/j.sleep.2011.01.003; Paavonen EJ, 2009, EUR CHILD ADOLES PSY, V18, P747, DOI 10.1007/s00787-009-0033-8; Gau SSF, 2006, J SLEEP RES, V15, P403; Thunstrom M, 2002, ACTA PAEDIATR, V91, P584, DOI 10.1080/080352502753711731; Turnbull K, 2013, SLEEP, V36, P1077, DOI 10.5665/sleep.2814	21	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	JUN	2015	37	6					572	578		10.1016/j.braindev.2014.10.004		7	Clinical Neurology	Neurosciences & Neurology	CI8VN	WOS:000355049900003		
J	Batnini, S; Uno, A				Batnini, Soulef; Uno, Akira			Investigation of basic cognitive predictors of reading and spelling abilities in Tunisian third-grade primary school children	BRAIN & DEVELOPMENT			English	Article						Arabic orthography; Phonological processing; Automatization; Visual cognition; Receptive vocabulary; Reading and spelling	DOUBLE-DEFICIT HYPOTHESIS; NATIVE ARABIC READERS; DEVELOPMENTAL DYSLEXIA; ABSTRACT WORDS; ORTHOGRAPHIC CONSISTENCY; LEARNING-DISABILITIES; VOCABULARY; CONCRETE; CONTEXT; SENTENCES	Background: This study investigated first the main cognitive abilities; phonological processing, visual cognition, automatization and receptive vocabulary in predicting reading and spelling abilities in Arabic. Second, we compared good/poor readers and spellers to detect the characteristics of cognitive predictors which contribute to identifying reading and spelling difficulties in Arabic speaking children. Methods: A sample of 116 Tunisian third-grade children was tested on their abilities to read and spell, phonological processing, visual cognition, automatization and receptive vocabulary. Results: For reading, phonological processing and automatization uniquely predicted Arabic word reading and paragraph reading abilities. Automatization uniquely predicted Arabic non-word reading ability. For spelling, phonological processing was a unique predictor for Arabic word spelling ability. Furthermore, poor readers had significantly lower scores on the phonological processing test and slower reading times on the automatization test as compared with good readers. Additionally, poor spellers showed lower scores on the phonological processing test as compared with good spellers. Visual cognitive processing and receptive vocabulary were not significant cognitive predictors of Arabic reading and spelling abilities for Tunisian third grade children in this study. Conclusions: Our results are consistent with previous studies in alphabetic orthographies and demonstrate that phonological processing and automatization are the best cognitive predictors in detecting early literacy problems. We suggest including phonological processing and automatization tasks in screening tests and in intervention programs may help Tunisian children with poor literacy skills overcome reading and spelling difficulties in Arabic. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Batnini, Soulef; Uno, Akira] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 2058577, Japan; [Uno, Akira] LD Dyslexia Ctr, Chiba, Japan	Batnini, S (reprint author), Univ Tsukuba, Adv BDG D217, 1-1-1 Tenohdai, Tsukuba, Ibaraki 2058577, Japan.	batninisoulef@yahoo.co.uk					AbuRabia S, 1996, J PSYCHOLINGUIST RES, V25, P629, DOI 10.1007/BF01712413; Abu-Rabia S., 2002, J RES READ, V25, P299, DOI DOI 10.1111/1467-9817.00177; Abu-Rabia S., 2003, READ WRIT, V16, P423, DOI DOI 10.1023/A:1024237415143; Abu-Rabia S., 1995, READING PSYCHOL, V16, P1; Puolakanaho A, 2007, J CHILD PSYCHOL PSYC, V48, P923, DOI 10.1111/j.1469-7610.2007.01763.x; Ehri LC, 2001, READ RES QUART, V36, P250, DOI 10.1598/RRQ.36.3.2; Landerl K, 2008, J EDUC PSYCHOL, V100, P150, DOI 10.1037/0022-0663.100.1.150; Bishop DVM, 2004, PSYCHOL BULL, V130, P858, DOI 10.1037/0033-2909.130.6.858; Savage R, 2005, BRAIN LANG, V93, P152, DOI 10.1016/j.bandl.2004.09.005; Burani C, 2002, BRAIN LANG, V81, P568, DOI 10.1006/brln.2001.2548; Holmes VM, 1998, J MEM LANG, V39, P264, DOI 10.1006/jmla.1998.2583; Wolf M, 1999, J EDUC PSYCHOL, V91, P415, DOI 10.1037//0022-0663.91.3.415; Gathercole SE, 2000, BRIT J EDUC PSYCHOL, V70, P177, DOI 10.1348/000709900158047; Ho CSH, 2002, DEV PSYCHOL, V38, P543, DOI 10.1037//0012-1649.38.4.543; DENCKLA MB, 1976, NEUROPSYCHOLOGIA, V14, P471, DOI 10.1016/0028-3932(76)90075-0; Patel TK, 2004, J EDUC PSYCHOL, V96, P785, DOI 10.1037/0022-0663.96.4.785; AbuRabia S, 1997, J PSYCHOLINGUIST RES, V26, P465, DOI 10.1023/A:1025034220924; Wimmer H, 2000, J EDUC PSYCHOL, V92, P668, DOI 10.1037//0022-0663.92.4.668; Ouellette GP, 2006, J EDUC PSYCHOL, V98, P554, DOI 10.1037/0022-0663.98.3.554; Blachowicz CLZ, 2006, READ RES QUART, V41, P524, DOI 10.1598/RRQ.41.4.5; Juhasz BJ, 2003, J EXP PSYCHOL LEARN, V29, P1312, DOI 10.1037/0278-7393.29.6.1312; Biemiller A., 1999, LANGUAGE READING SUC; BLEASDALE FA, 1987, J EXP PSYCHOL LEARN, V13, P582, DOI 10.1037/0278-7393.13.4.582; Compton D L, 2001, Dyslexia, V7, P125, DOI 10.1002/dys.198; CORNWALL A, 1992, J LEARN DISABIL, V25, P532; Corwin J, 1993, TCN, V7, P21; Fawcett AJ, 2008, DYSLEXIA ROLE CEREBE, P13; Foorman B. R., 1997, LEARNING DISABILITIE, V8, P63; FRITH U, 1978, VISIBLE LANG, V12, P43; Frith U., 1985, SURFACE DYSLEXIA, V32, P301; Furnes B, 2010, DYSLEXIA, V16, P119, DOI 10.1002/dys.401; Kaneko M, 2004, ONSEI GENGO IGAKU, V45, P30; Katzir T, 2012, LEARN INDIVID DIFFER, V22, P673, DOI 10.1016/j.lindif.2012.07.002; Kunisue K, 2007, INT J PEDIATR OTORHI, V71, P1671, DOI 10.1016/j.ijport.2007.06.015; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; LENNOX C, 1993, APPL PSYCHOLINGUIST, V14, P473, DOI 10.1017/S0142716400010705; Lyytinen P, 2004, APPL PSYCHOLINGUIST, V25, P397, DOI 10.1017/S0142716404001183; Mann V., 2002, READING WRITING INTE, V15, P653, DOI DOI 10.1023/A:1020984704781; Meyler A, 1998, READ WRIT, V10, P519, DOI 10.1023/A:1007915517339; Paivio A., 1971, IMAGERY VERBAL PROCE; PAIVIO A, 1966, CAN J PSYCHOLOGY, V20, P378, DOI 10.1037/h0082953; Raven JC, 1976, COLOURED PROGR MATRI; Richek MA, 2005, READ TEACH, V58, P414, DOI 10.1598/RT.58.5.1; SCHWANENFLUGEL PJ, 1989, READ RES QUART, V24, P114, DOI 10.2307/748013; Snowling M, 1987, DYSLEXIA COGNITIVE D; Snowling M, 2001, INT ENCY SOCIAL BEHA; SNOWLING M, 1981, BRIT J PSYCHOL, V72, P83; Strauss E, 2006, COMPENDIUM NEUROPSYC; Thorndike R. L., 1986, STANFORD BINET INTEL; Uno A, 2002, SCTAW STANDARDIZED T; VELLUTINO FR, 1985, J EXP CHILD PSYCHOL, V39, P363, DOI 10.1016/0022-0965(85)90046-3; WATTENMAKER WD, 1987, J EXP PSYCHOL LEARN, V13, P140, DOI 10.1037//0278-7393.13.1.140; Witkin HA, 1971, MANUAL EMBEDDED FIGU; WOLF M, 1992, BRAIN LANG, V42, P219, DOI 10.1016/0093-934X(92)90099-Z; Wolf M, 1991, LEARN INDIVID DIFFER, V3, P205, DOI 10.1016/1041-6080(91)90008-O	55	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	JUN	2015	37	6					579	591		10.1016/j.braindev.2014.09.010		13	Clinical Neurology	Neurosciences & Neurology	CI8VN	WOS:000355049900004		
J	Kashiwagi, M; Tanabe, T; Ooba, C; Masuda, M; Shigehara, S; Murata, S; Ashida, A; Shirasu, A; Inoue, K; Okasora, K; Tamai, H				Kashiwagi, Mitsuru; Tanabe, Takuya; Ooba, Chizu; Masuda, Midori; Shigehara, Seiji; Murata, Shinya; Ashida, Atsuko; Shirasu, Akihiko; Inoue, Keisuke; Okasora, Keisuke; Tamai, Hiroshi			Differential diagnosis of delirious behavior in children with influenza	BRAIN & DEVELOPMENT			English	Article						Delirious behavior; Encephalopathy; Differential diagnosis; Disturbance of consciousness; Seizure; Age; Influenza; Reversible splenial lesion during febrile illness	REVERSIBLE SPLENIAL LESION; CLINICALLY MILD ENCEPHALITIS/ENCEPHALOPATHY; ENCEPHALOPATHY; ENCEPHALITIS; DIFFUSION; SPECTRUM	Delirious behavior (DB) in children infected with influenza virus is an important symptom associated with encephalopathy. As children with influenza-associated DB with encephalopathy may require therapy whereas children with influenza-associated DB without encephalopathy do not, distinguishing between these conditions is essential. To clarify these differences and identify the most common features of acute encephalopathy, we retrospectively reviewed the clinical course, laboratory data, magnetic resonance imaging (MRI) and electroencephalography (EEG) findings, therapy, and prognosis of 48 children with influenza exhibiting DB. Of the 48 children, 37 and 11 were diagnosed with influenza A and B, respectively. Moreover, 40 were diagnosed with DB without encephalopathy (DBNE group) and 8, with DB with encephalopathy (DBE group). Reversible splenial lesion (RESLE) was detected in 7 patients in the DBNE group, mild encephalitis/encephalopathy with a reversible splenial lesion (MERS) in 2 patients, and a mild form of acute encephalopathy with biphasic seizures and late reduced diffusion in 1 patient in the DBE group. Serum sodium levels <136 mEq/L were observed in 28 cases. Disturbance of consciousness was observed in 25 cases, seizure in 20, and slow waves on EEG in 22. Methylprednisolone pulse therapy was administered in 8 cases. No cases of neurological sequelae were observed. Although most of the clinico-radiological features of the DBNE and DBE groups did not differ substantially, marked differences were observed in the age at onset, initial neurological symptoms, duration of DB, rate of seizure, and slowing of background activity on EEG. These differences should be considered when distinguishing between DBNE and DBE in children. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Kashiwagi, Mitsuru; Ooba, Chizu; Masuda, Midori; Shigehara, Seiji; Murata, Shinya; Ashida, Atsuko; Shirasu, Akihiko; Inoue, Keisuke; Okasora, Keisuke] Hirakata City Hosp, Dept Pediat, Hirakata, Osaka 5731013, Japan; [Tanabe, Takuya] Tanabe Childrens Clin, Dept Child Neurol, Kashihara, Nara, Japan; [Tamai, Hiroshi] Osaka Med Coll, Dept Pediat, Osaka, Japan	Kashiwagi, M (reprint author), Hirakata City Hosp, Dept Pediat, 2-14-1 Kinnya Honnmachi, Hirakata, Osaka 5731013, Japan.	dbs003@art.osaka-med.ac.jp					Kashiwagi M, 2014, BRAIN DEV-JPN, V36, P330, DOI 10.1016/j.braindev.2013.05.007; Romano J, 1944, ARCH NEURO PSYCHIATR, V51, P356; Tada H, 2004, NEUROLOGY, V63, P1854; Takanashi J, 2006, AM J NEURORADIOL, V27, P836; Morandi A, 2012, CRIT CARE MED, V40, P2182, DOI 10.1097/CCM.0b013e318250acdc; Takanashi J, 2010, J NEUROL SCI, V292, P24, DOI 10.1016/j.jns.2010.02.013; Takanashi J, 2006, NEUROLOGY, V66, P1304, DOI 10.1212/01.wnl.0000210487.36667.a5; ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; Ekstrand JJ, 2012, SEMIN PEDIATR NEUROL, V19, P96, DOI 10.1016/j.spen.2012.02.004; Hemingway S, 2009, DIS NERVOUS SYSTEM C, P383; Hoshino A, 2011, BRAIN DEV, V34, P337; Kashiwagi Mitsuru, 2003, No To Hattatsu, V35, P310; Kawashima H, 2012, J MED VIROL, V84, P1151, DOI 10.1002/jmv.23317; KENNEDY CR, 1987, ARCH DIS CHILD, V62, P1156; KOPONEN H, 1989, J NEUROL NEUROSUR PS, V52, P980, DOI 10.1136/jnnp.52.8.980; Lockman LA, 1994, PEDIAT NEUROLOGY PRI, P183; Mitaki S, 2012, J NEUROL SCI, V317, P154, DOI 10.1016/j.jns.2012.02.020; Okumura A, 2005, BRAIN DEV-JPN, V27, P271, DOI 10.1016/j.brainres.2004.07.005; Okumura A, 2012, BRAIN DEV-JPN, V34, P13, DOI 10.1016/j.braindev.2011.01.004; Okumura A, 2009, BRAIN DEV-JPN, V31, P594, DOI 10.1016/j.braindev.2008.09.002; Posner JB, 2007, PLUM POSNERS DIAGNOS; Research Committee on the Clarification of Etiology and Establishment of Therapeutic and Preventive Measures of Influenza Encephalopathy, 2005, GUID INFL ENC, P1; Sakuma H, 2010, PEDIATR NEUROL, V43, P167, DOI 10.1016/j.pediatrneurol.2010.04.012; Sivertsen B, 1996, ACTA NEUROL SCAND, V93, P156; Takanashi J, 2009, BRAIN DEV-JPN, V31, P521, DOI 10.1016/j.braindev.2009.02.012; Takanashi J, 2009, BRAIN DEV-JPN, V31, P423, DOI 10.1016/j.braindev.2008.07.013; Turkel SB, 2003, PSYCHOSOMATICS, V44, P126, DOI 10.1176/appi.psy.44.2.126; Wada T, 2009, MICROBIOL IMMUNOL, V53, P83, DOI 10.1111/j.1348-0421.2008.00100.x; Yokota S, 2007, NIHON SYOUNIKAGAKKAI, V111, P1545	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	JUN	2015	37	6					618	624		10.1016/j.braindev.2014.09.003		7	Clinical Neurology	Neurosciences & Neurology	CI8VN	WOS:000355049900008		
J	Fukasawa, T; Kubota, T; Negoro, T; Saitoh, M; Mizuguchi, M; Ihara, Y; Ishii, A; Hirose, S				Fukasawa, Tatsuya; Kubota, Tetsuo; Negoro, Tamiko; Saitoh, Makiko; Mizuguchi, Masashi; Ihara, Yukiko; Ishii, Atsushi; Hirose, Shinichi			A case of recurrent encephalopathy with SCN2A missense mutation	BRAIN & DEVELOPMENT			English	Article						SCN2A; Mutation; Encephalopathy	GENE	Voltage-gated sodium channels regulate neuronal excitability, as well as survival and the patterning of neuronal connectivity during development. Mutations in SCN2A, which encodes the Na+ channel Na(v)1.2, cause epilepsy syndromes and predispose children to acute encephalopathy. Here, we report the case of a young male with recurrent acute encephalopathy who carried a novel missense mutation in the SCN2A gene. He was born by normal delivery and developed repetitive apneic episodes at 2 days of age. Diffusion-weighted imaging revealed high-intensity areas in diffuse subcortical white matter, bilateral thalami, and basal nuclei. His symptoms improved gradually without any specific treatment, but he exhibited a motor milestone delay after the episode. At the age of 10 months, he developed acute cerebellopathy associated with a respiratory syncytial viral infection. He received high-dose intravenous gammaglobulin and methylprednisolone pulse therapy and seemed to have no obvious sequelae after the episode. He then developed severe diffuse encephalopathy associated with gastroenteritis at the age of 14 months. He received high-dose intravenous gammaglobulin and methylprednisolone pulse therapy but was left with severe neurological sequelae. PCR-based analysis revealed a novel de novo missense mutation, c.4979T>G (p.Leu1660Trp), in the SCN2A gene. This case suggests that SCN2A mutations might predispose children to repetitive encephalopathy with variable clinical and imaging findings. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Fukasawa, Tatsuya; Kubota, Tetsuo; Negoro, Tamiko] Anjo Kosei Hosp, Dept Pediat, Anjo Shi, Aichi 4468602, Japan; [Saitoh, Makiko; Mizuguchi, Masashi] Univ Tokyo, Grad Sch Med, Dept Dev Med Sci, Tokyo 1138654, Japan; [Ihara, Yukiko; Ishii, Atsushi; Hirose, Shinichi] Fukuoka Univ, Sch Med, Dept Pediat, Fukuoka 81401, Japan	Fukasawa, T (reprint author), Anjo Kosei Hosp, Dept Pediat, 28 Higashihirokute Anjo Cho, Anjo Shi, Aichi 4468602, Japan.	fukasawa@kosei.anjo.aichi.jp			Japan Society for the Promotion of Science (JSPS) [23791201, 24249060, 25670481]; Ministry of Education, Culture, Sports, Science and Technology (MEXT) [221S0002, 25129708]; MEXT-supported Program for the Strategic Research Foundation at Private Universities; Ministry of Health, Labor and Welfare [H26-Nanji-Ippan-49, H26-Nanji-Ippan-51]; NCNP [24-7]; Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University; Mitsubishi Foundation; Takeda Scientific Foundation; Kobayashi Magobei Foundation; Japan Epilepsy Research Foundation; Kiyokun Foundation	We are indebted to all members of the study family for their helpful cooperation. Ms. Minako Yonetani and Akiyo Hamachi for their technical assistance. This work was supported by a Grant-in-Aid for Young Scientists (B) (23791201 to A.I.), Grant-in-Aid for Scientific Research (A) (24249060 to S.H.), Grant-in-Aid for Challenging Exploratory Research (25670481 to S.H.), Bilateral Joint Research Projects (S.H.) from Japan Society for the Promotion of Science (JSPS), Grants for Scientific Research on Innovative Areas (221S0002 and 25129708 to A.I and S.H.) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), MEXT-supported Program for the Strategic Research Foundation at Private Universities 2013-2017 (S.H.), a Grant-in-aid for the Research on Measures for Intractable Diseases (No. H26-Nanji-Ippan-49 and 51 to S.H.) from the Ministry of Health, Labor and Welfare, Intramural Research Grant (24-7) for Neurological and Psychiatric Disorders of NCNP (S.H.), the Joint Usage/Research Program of Medical Research Institute, Tokyo Medical and Dental University (S.H.), Grants from The Mitsubishi Foundation (S.H.) and Takeda Scientific Foundation (S.H.), Grants from the Kobayashi Magobei Foundation (A.I.), the Japan Epilepsy Research Foundation Grant (to A.I.) and Kiyokun Foundation (S.H.).	Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009; Shinohara M, 2013, NEUROLOGY, V80, P1571, DOI 10.1212/WNL.0b013e31828f18d8; Saitoh M, 2012, EPILEPSIA, V53, P558, DOI 10.1111/j.1528-1167.2011.03402.x; Hidaka F, 2006, CLIN IMMUNOL, V119, P188, DOI 10.1016/j.clim.2006.01.005; Liao YX, 2010, BRAIN, V133, P1403, DOI 10.1093/brain/awq057; Lossin C, 2009, BRAIN DEV-JPN, V31, P114, DOI 10.1016/j.braindev.2008.07.011; Shi XY, 2012, BRAIN DEV-JPN, V34, P541, DOI 10.1016/j.braindev.2011.09.016; Kobayashi K, 2012, EPILEPSY RES, V102, P109, DOI 10.1016/j.eplepsyres.2012.04.016; Kubota M, 2012, BRAIN DEV-JPN, V34, P20, DOI 10.1016/j.braindev.2010.12.012; Yamakawa K, 2009, BRAIN DEV-JPN, V31, P401, DOI 10.1016/j.braindev.2008.11.015	10	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	JUN	2015	37	6					631	634		10.1016/j.braindev.2014.10.001		4	Clinical Neurology	Neurosciences & Neurology	CI8VN	WOS:000355049900010		
J	Takano, K; Tsuyusaki, Y; Sato, M; Takagi, M; Anzai, R; Okuda, M; Iai, M; Yamashita, S; Okabe, T; Aida, N; Tsurusaki, Y; Saitsu, H; Matsumoto, N; Osaka, H				Takano, Kyoko; Tsuyusaki, Yu; Sato, Mutsumi; Takagi, Mariko; Anzai, Rie; Okuda, Mitsuko; Iai, Mizue; Yamashita, Sumimasa; Okabe, Tetsuhiko; Aida, Noriko; Tsurusaki, Yoshinori; Saitsu, Hirotomo; Matsumoto, Naomichi; Osaka, Hitoshi			A Japanese girl with an early-infantile onset vanishing white matter disease resembling Cree leukoencephalopathy	BRAIN & DEVELOPMENT			English	Article						Vanishing white matter disease (VWM); Cree leukoencephalopathy; Eukaryotic translation initiation factor 2B; eIF2B epsilon; EIF2B5	EIF2B-RELATED DISORDERS; IDENTIFICATION; MUTATIONS	Vanishing white matter disease (VWM)/childhood ataxia with central hypomyelination (CACH) is an autosomal recessive leukoencephalopathy caused by mutations in one of five genes, EIF2B1-5, encoding the 5 subunits of eukaryotic translation initiation factor 2B (eIF2B). The classical phenotype is characterized by early childhood onset and chronic progressive neurological deterioration with cerebellar ataxia, spasticity, optic atrophy and epilepsy. However, the onset of disease varies from antenatal period to adulthood. Cree leukoencephalopathy (CLE) is a severe variant of VWM and caused by a homozygous mutation (R195H) in the EIF2B5 gene. The patient reported in this study developed lethargy, vomiting and seizure 3 days after an oral poliovirus vaccination at the age of 4 months. She presented with rapid neurological deterioration within a month of onset. Brain MRI showed abnormal white matter intensity. Whole-exome sequencing identified two heterozygous mutations in the EIF2B5 gene: a known mutation, c.584G>A (R195H, which is homozygous in CLE), and a novel mutation, c.1223T>C (I408T, which resides in the "I-patch"). Mutations in the "I-patch" encoded region of eIF2B epsilon may be related to an early-infantile onset phenotype. This patient exhibits an early-infantile onset and progressive disease course resembling CLE, suggesting a severe functional disruption of eIF2B epsilon caused by R195H as well as by I408T mutations. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Takano, Kyoko; Tsuyusaki, Yu; Sato, Mutsumi; Takagi, Mariko; Anzai, Rie; Okuda, Mitsuko; Iai, Mizue; Yamashita, Sumimasa; Osaka, Hitoshi] Kanagawa Childrens Med Ctr, Div Neurol, Yokohama, Kanagawa, Japan; [Takano, Kyoko] Shinshu Univ, Sch Med, Dept Med Genet, Matsumoto, Nagano 3908621, Japan; [Okabe, Tetsuhiko; Aida, Noriko] Kanagawa Childrens Med Ctr, Dept Radiol, Yokohama, Kanagawa, Japan; [Tsurusaki, Yoshinori; Saitsu, Hirotomo; Matsumoto, Naomichi] Yokohama City Univ, Grad Sch Med, Human Genet, Yokohama, Kanagawa 232, Japan; [Osaka, Hitoshi] Jichi Med Sch, Dept Pediat, Shimotsuke, Japan	Takano, K (reprint author), Shinshu Univ, Sch Med, Dept Med Genet, 3-1-1 Asahi, Matsumoto, Nagano 3908621, Japan.	k_takano@shinshu-u.ac.jp					van der Lei HD, 2012, NEUROPEDIATRICS, V43, P22, DOI 10.1055/s-0032-1307456; Scheper GC, 2006, TRENDS MOL MED, V12, P159, DOI 10.1016/j.molmed.2006.02.006; Saitsu H, 2013, NAT GENET, V45, P445, DOI 10.1038/ng.2562; Wu Y, 2009, J HUM GENET, V54, P74, DOI 10.1038/jhg.2008.10; van der Knaap MS, 2003, AM J HUM GENET, V73, P1199, DOI 10.1086/379524; Fogli A, 2004, NEUROLOGY, V62, P1509; Fogli A, 2002, ANN NEUROL, V52, P506, DOI 10.1002/ana.10339; Harder S, 2010, AM J NEURORADIOL, V31, P1418, DOI 10.3174/ajnr.A2108; Horzinski L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008318; van der Knapp MS, 2006, LANCET NEUROL, V5, P413, DOI 10.1016/S1474-4422(06)70440-9; Wang XM, 2012, J BIOL CHEM, V287, P8263, DOI 10.1074/jbc.M111.331553	11	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	JUN	2015	37	6					638	642		10.1016/j.braindev.2014.10.002		5	Clinical Neurology	Neurosciences & Neurology	CI8VN	WOS:000355049900012		
J	Rebour, R; Delporte, L; Revol, P; Arsenault, L; Mizuno, K; Broussolle, E; Luaute, J; Rossetti, Y				Rebour, Remi; Delporte, Ludovic; Revol, Patrice; Arsenault, Lisette; Mizuno, Katsuhiro; Broussolle, Emmanuel; Luaute, Jacques; Rossetti, Yves			Dopa-Responsive Dystonia and gait analysis: A case study of levodopa therapeutic effects	BRAIN & DEVELOPMENT			English	Article						Dopa-Responsive Dystonia; Levodopa; Gait; Balance; Posture; Centre of Mass		Introduction: Patients suffering Dopa-Responsive Dystonia present dystonia, abnormal postural balance and gait impairment. Treatment with levodopa typically improves these three symptoms. The present study provides an extensive analysis of gait and posture in a patient with Dopa-Responsive Dystonia, prior to and during levodopa therapy. Method: The patient was assessed with the Unified Dystonia Rating Scale, underwent motion analysis with an optoelectronic system and postural analysis with force plates. Results: This study provides a detailed quantification of gait parameters in a Dopa-Responsive Dystonia patient. Prior to treatment, mean walking speed was severely reduced, gait cadence and step length were decreased and stride width was increased. Right lower limb and pelvis showed kinematic defects, trunk and Centre of Mass were backwards. During levodopa therapy, the walking speed was doubled, gait cadence and step length were increased and stride width was reduced. Nearly all kinematic parameters of lower limbs were significantly improved. The patient's Centre of Mass during gait and Centre of pressure in static position both shifted forward. Conclusion: Levodopa dramatically decreased dystonia and improved spatio-temporal, kinematic and posture parameters. Our main pathophysiological hypothesis is that trunk tilt and its consequences on the Centre of Mass position have a pivotal influence on gait and balance, explaining both the initial impairments and the therapeutic effects. Gait analysis proves to be an effective tool to understand the pathophysiology of this patient, the therapeutic effects and mild residual gait defects in order to plan further rehabilitation strategy for this DRD patient. We propose that it will also prove to be useful for the exploration of other dystonic patients. (C) 2014 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.	[Rebour, Remi; Delporte, Ludovic; Revol, Patrice; Arsenault, Lisette; Luaute, Jacques; Rossetti, Yves] Hop Pierre Wertheimer, Hosp Civils Lyon, F-69500 Bron, France; [Rebour, Remi; Delporte, Ludovic; Revol, Patrice; Arsenault, Lisette; Luaute, Jacques; Rossetti, Yves] Hop Henry Gabrielle, St Genis Laval, France; [Rebour, Remi; Luaute, Jacques; Rossetti, Yves] Hop Pierre Wertheimer, Hosp Civils Lyon, Serv Neuroreeducat, F-69500 Bron, France; [Revol, Patrice; Mizuno, Katsuhiro; Luaute, Jacques; Rossetti, Yves] Univ Lyon 1, CNRS, INSERM, ImpAct,Ctr Rech Neurosci Lyon, Bron, France; [Mizuno, Katsuhiro] Keio Univ, Sch Med, Dept Rehabil Med, Tokyo, Japan; [Broussolle, Emmanuel] Hop Pierre Wertheimer, Hosp Civils Lyon, Serv Neurol C, F-69500 Bron, France; [Broussolle, Emmanuel] Univ Lyon, CNRS, Ctr Neurosci Cognit, UMR 5229, Lyon, France	Rebour, R (reprint author), Hop Pierre Wertheimer, Hosp Civils Lyon, Plateforme Movement & Handicap,59 Blvd Pinel, F-69500 Bron, France.	remi.rebour@chu-lyon.fr; yves.rossetti@inserm.fr			Hospices Civils de Lyon - France (programme Thematique Prioritaire: Handicap); Inserm - France	This work was supported by Grants from Hospices Civils de Lyon - France (programme Thematique Prioritaire: Handicap) and Inserm - France.	Comella CL, 2003, MOVEMENT DISORD, V18, P303, DOI 10.1002/mds.10377; Saha D, 2008, GAIT POSTURE, V27, P653, DOI 10.1016/j.gaitpost.2007.08.009; Detrembleur C, 2000, GAIT POSTURE, V12, P243, DOI 10.1016/S0966-6362(00)00081-3; Tilikete C, 2001, CURR BIOL, V11, P524, DOI 10.1016/S0960-9822(01)00151-8; Nardone A, 2009, GAIT POSTURE, V30, P5, DOI 10.1016/j.gaitpost.2009.02.006; Bloem BR, 1999, EXP BRAIN RES, V124, P481, DOI 10.1007/s002210050644; Segawa M, 2011, BRAIN DEV-JPN, V33, P195, DOI 10.1016/j.braindev.2010.10.015; Cheyette BNR, 2008, PEDIATR NEUROL, V38, P273, DOI 10.1016/j.pediatrneurol.2007.12.005; DRILLIS R, 1964, Artif Limbs, V8, P44; NYGAARD TG, 1991, NEUROLOGY, V41, P174; Segawa M., 2009, ENCY NEUROSCIENCE, P525; Segawa M, 2000, BRAIN DEV-JPN, V22, pS65; Talvik I, 2010, BRAIN DEV-JPN, V32, P428, DOI 10.1016/j.braindev.2009.04.007	13	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0387-7604	1872-7131		BRAIN DEV-JPN	Brain Dev.	JUN	2015	37	6					643	650		10.1016/j.braindev.2014.09.005		8	Clinical Neurology	Neurosciences & Neurology	CI8VN	WOS:000355049900013		
J	Ohta, S; Najima, Y; Imamura, J				Ohta, Soichi; Najima, Yuho; Imamura, Jun			Dasatinib-induced gastric antral vascular ectasia in a patient with acute lymphoblastic leukaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Article									[Ohta, Soichi; Najima, Yuho] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Haematol, Tokyo, Japan; [Imamura, Jun] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Hepatol, Tokyo, Japan	Ohta, S (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Haematol, Tokyo, Japan.	yuhonajima@gmail.com						0	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	JUN	2015	169	5					612	612		10.1111/bjh.13407		1	Hematology	Hematology	CI1FY	WOS:000354489800003		
J	Ishida, T; Jo, T; Takemoto, S; Suzushima, H; Uozumi, K; Yamamoto, K; Uike, N; Saburi, Y; Nosaka, K; Utsunomiya, A; Tobinai, K; Fujiwara, H; Ishitsuka, K; Yoshida, S; Taira, N; Moriuchi, Y; Imada, K; Miyamoto, T; Akinaga, S; Tomonaga, M; Ueda, R				Ishida, Takashi; Jo, Tatsuro; Takemoto, Shigeki; Suzushima, Hitoshi; Uozumi, Kimiharu; Yamamoto, Kazuhito; Uike, Naokuni; Saburi, Yoshio; Nosaka, Kisato; Utsunomiya, Atae; Tobinai, Kensei; Fujiwara, Hiroshi; Ishitsuka, Kenji; Yoshida, Shinichiro; Taira, Naoya; Moriuchi, Yukiyoshi; Imada, Kazunori; Miyamoto, Toshihiro; Akinaga, Shiro; Tomonaga, Masao; Ueda, Ryuzo			Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						adult T-cell leukaemia-lymphoma; CCR4; mogamulizumab; randomized phase II study; antibody therapy	MONOCLONAL-ANTIBODY KW-0761; LEUKEMIA/LYMPHOMA; TRANSPLANTATION; EXPRESSION; CCR4; ASSOCIATION; RECEPTOR	This multicentre, randomized, phase II study was conducted to examine whether the addition of mogamulizumab, a humanized anti-CC chemokine receptor 4 antibody, to mLSG15, a dose-intensified chemotherapy, further increases efficacy without compromising safety of patients with newly diagnosed aggressive adult T-cell leukaemia-lymphoma (ATL). Patients were assigned 1:1 to receive mLSG15 plus mogamulizumab or mLSG15 alone. The primary endpoint was the complete response rate (%CR); secondary endpoints included the overall response rate (ORR) and safety. The %CR and ORR in the mLSG15-plus-mogamulizumab arm (n=29) were 52% [95% confidence interval (CI), 33-71%] and 86%, respectively; the corresponding values in the mLSG15 arm (n=24) were 33% (95% CI, 16-55%) and 75%, respectively. Grade3 treatment-emergent adverse events, including anaemia, thrombocytopenia, lymphopenia, leucopenia and decreased appetite, were observed more frequently (10% difference) in the mLSG15-plus-mogamulizumab arm. Several adverse events, including skin disorders, cytomegalovirus infection, pyrexia, hyperglycaemia and interstitial lung disease, were observed only in the mLSG15-plus-mogamulizumab arm. Although the combination strategy showed a potentially less favourable safety profile, a higher %CR was achieved, providing the basis for further investigation of this novel treatment for newly diagnosed aggressive ATL. This study was registered at ClinicalTrials.gov, identifier: NCT01173887.	[Ishida, Takashi] Nagoya City Univ, Grad Sch Med Sci, Dept Haematol & Oncol, Nagoya, Aichi 4678601, Japan; [Jo, Tatsuro; Tomonaga, Masao] Japanese Red Cross Nagasaki Genbaku Hosp, Dept Haematol, Nagasaki, Japan; [Takemoto, Shigeki] Natl Hosp Org Kumamoto Med Ctr, Dept Haematol, Kumamoto, Japan; [Takemoto, Shigeki] Natl Hosp Org Kumamoto Med Ctr, Inst Clin Res, Kumamoto, Japan; [Suzushima, Hitoshi] Kumamoto Shinto Gen Hosp, Dept Haematol, Kumamoto, Japan; [Uozumi, Kimiharu] Kagoshima Univ Hosp, Dept Haematol & Immunol, Kagoshima, Japan; [Yamamoto, Kazuhito] Aichi Canc Ctr Hosp, Dept Haematol & Cell Therapy, Nagoya, Aichi 464, Japan; [Uike, Naokuni] Natl Hosp Org Kyushu Canc Ctr, Dept Haematol, Fukuoka, Japan; [Saburi, Yoshio] Oita Prefectural Hosp, Dept Haematol, Oita, Japan; [Nosaka, Kisato] Kumamoto Univ Hosp, Ctr Canc, Kumamoto, Japan; [Utsunomiya, Atae] Imamura Bun In Hosp, Dept Haematol, Kagoshima, Japan; [Tobinai, Kensei] Natl Canc Ctr, Dept Haematol, Tokyo, Japan; [Fujiwara, Hiroshi] Ehime Univ, Grad Sch Med, Dept Bioregulatory Med, Toon, Japan; [Ishitsuka, Kenji] Fukuoka Univ, Dept Internal Med, Div Med Oncol Haematol & Infect Dis, Fukuoka 81401, Japan; [Yoshida, Shinichiro] Natl Hosp Org Nagasaki Med Ctr, Dept Haematol, Ohmura, Japan; [Taira, Naoya] Heartlife Hosp, Dept Internal Med, Okinawa, Japan; [Moriuchi, Yukiyoshi] Sasebo City Gen Hosp, Dept Haematol, Sasebo, Japan; [Imada, Kazunori] Kokura Mem Hosp, Dept Haematol, Kitakyushu, Fukuoka, Japan; [Miyamoto, Toshihiro] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan; [Akinaga, Shiro] Kyowa Hakko Kirin Co Ltd, Tokyo, Japan; [Ueda, Ryuzo] Aichi Med Univ, Sch Med, Dept Tumour Immunol, Nagoya, Aichi, Japan	Ishida, T (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Haematol & Oncol, Mizuho Ku, 1 Kawasumi, Nagoya, Aichi 4678601, Japan.	itakashi@med.nagoya-cu.ac.jp			Kyowa Hakko Kirin	We thank all the patients and their families who participated in this clinical trial. We also thank all the nurses, clinical research coordinators, review committees and medical experts who were involved in this study; a complete membership list appears in Appendix 1. We are also grateful to Masatoshi Sugiura, Noboru Takizawa, and Kouichi Kawamura (Kyowa Hakko Kirin) for their help with data management. This study was supported by Kyowa Hakko Kirin.	SIMON R, 1985, CANCER TREAT REP, V69, P1375; Ishida T, 2003, CLIN CANCER RES, V9, P3625; Ishida T, 2011, CANCER SCI, V102, P44, DOI 10.1111/j.1349-7006.2010.01767.x; Jacobs JFM, 2012, LANCET ONCOL, V13, pE32, DOI 10.1016/S1470-2045(11)70155-3; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Ogura M, 2014, J CLIN ONCOL, V32, P1157, DOI 10.1200/JCO.2013.52.0924; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Nakagawa M, 2009, CLIN CANCER RES, V15, P30, DOI 10.1158/1078-0432.CCR-08-1808; Yamada Y, 2001, BRIT J HAEMATOL, V113, P375, DOI 10.1046/j.1365-2141.2001.02737.x; Tsukasaki K, 2009, J CLIN ONCOL, V27, P453, DOI 10.1200/JCO.2008.18.2428; Tsukasaki K, 2007, J CLIN ONCOL, V25, P5458, DOI 10.1200/JCO.2007.11.9958; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Ishii T, 2010, CLIN CANCER RES, V16, P1520, DOI 10.1158/1078-0432.CCR-09-2697; Ishida T, 2012, J CLIN ONCOL, V30, P837, DOI 10.1200/JCO.2011.37.3472; Ishida T, 2004, CLIN CANCER RES, V10, P5494, DOI 10.1158/1078-0432.CCR-04-0371; Yano H, 2007, INT J CANCER, V120, P2052, DOI 10.1002/ijc.22536; WALDMANN TA, 1984, J CLIN INVEST, V73, P1711, DOI 10.1172/JCI111379; UCHIYAMA T, 1977, BLOOD, V50, P481; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; SHIMOYAMA M, 1991, BRIT J HAEMATOL, V79, P428, DOI 10.1111/j.1365-2141.1991.tb08051.x; Ishida T, 2012, BLOOD, V120, P1734, DOI 10.1182/blood-2012-03-414490; Hishizawa M, 2010, BLOOD, V116, P1369, DOI 10.1182/blood-2009-10-247510; Yoshie O, 2002, BLOOD, V99, P1505, DOI 10.1182/blood.V99.5.1505; Matsuoka M, 2007, NAT REV CANCER, V7, P270, DOI 10.1038/nrc2111; Yamamoto K, 2010, J CLIN ONCOL, V28, P1591, DOI 10.1200/JCO.2009.25.3575; Ishida T, 2013, CANCER SCI, V104, P647, DOI 10.1111/cas.12116; Chihara D, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.57; Iwanaga M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00322; Michels-van Amelsfort JMR, 2011, EXPERT REV CLIN IMMU, V7, P499, DOI [10.1586/eci.11.28, 10.1586/ECI.11.28]; Ogata M, 2011, J MED VIROL, V83, P702, DOI 10.1002/jmv.22013	30	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	JUN	2015	169	5					672	682		10.1111/bjh.13338		11	Hematology	Hematology	CI1FY	WOS:000354489800008		
J	Oshikawa, G; Kakihana, K; Saito, M; Aoki, J; Najima, Y; Kobayashi, T; Doki, N; Sakamaki, H; Ohashi, K				Oshikawa, Gaku; Kakihana, Kazuhiko; Saito, Makoto; Aoki, Jun; Najima, Yuho; Kobayashi, Takeshi; Doki, Noriko; Sakamaki, Hisashi; Ohashi, Kazuteru			Post-transplant maintenance therapy with azacitidine and gemtuzumab ozogamicin for high-risk acute myeloid leukaemia	BRITISH JOURNAL OF HAEMATOLOGY			English	Letter						acute myeloid leukaemia; allogeneic haematopoietic stem cell transplantation; azacitidine; gemtuzumab ozogamicin; maintenance therapy	CELL TRANSPLANTATION		[Oshikawa, Gaku; Kakihana, Kazuhiko; Aoki, Jun; Najima, Yuho; Kobayashi, Takeshi; Doki, Noriko; Sakamaki, Hisashi; Ohashi, Kazuteru] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Haematol, Tokyo, Japan; [Saito, Makoto] Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Clin Res Support, Tokyo, Japan	Oshikawa, G (reprint author), Komagome Hosp, Tokyo Metropolitan Canc & Infect Dis Ctr, Div Haematol, Tokyo, Japan.	kakihana@cick.jp					Mielcarek M, 2007, BIOL BLOOD MARROW TR, V13, P1160, DOI 10.1016/j.bbmt.2007.06.007; PINTO A, 1984, BLOOD, V64, P922; Sanchez-Abarca LI, 2010, BLOOD, V115, P107, DOI 10.1182/blood-2009-03-210393; Nand S, 2013, BLOOD, V122, P3432, DOI 10.1182/blood-2013-06-506592; Choi J, 2010, BLOOD, V116, P129, DOI 10.1182/blood-2009-12-257253; Schmid C, 2012, BLOOD, V119, P1599, DOI 10.1182/blood-2011-08-375840; Linenberger ML, 2001, BLOOD, V98, P988, DOI 10.1182/blood.V98.4.988; Balaian L, 2006, LEUKEMIA, V20, P2093, DOI 10.1038/sj.leu.2404437; desLima M., 2010, CANCER, V116, P5420; Watanabe K., 2014, LEUKEMIA LYMPHOMA, DOI [10.3109/10428194.2014.964701, DOI 10.3109/10428194.2014.964701]	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	JUN	2015	169	5					756	759		10.1111/bjh.13248		4	Hematology	Hematology	CI1FY	WOS:000354489800019		
J	Hikichi, T; Kitamei, H; Shioya, S				Hikichi, Taiichi; Kitamei, Hirokuni; Shioya, Shoko			Prognostic factors of 2-year outcomes of ranibizumab therapy for polypoidal choroidal vasculopathy	BRITISH JOURNAL OF OPHTHALMOLOGY			English	Article							OPTICAL COHERENCE TOMOGRAPHY; INTRAVITREAL RANIBIZUMAB; MACULAR DEGENERATION; VASCULAR HYPERPERMEABILITY; FUNDUS AUTOFLUORESCENCE; PHOTODYNAMIC THERAPY; INJECTIONS; THICKNESS	Purpose To determine predictors of 2-year outcomes after three, monthly, intravitreal ranibizumab (IVR) injections followed by as-needed injections for treatment-naive polypoidal choroidal vasculopathy (PCV). Methods This trial included 85 Japanese patients with symptomatic treatment-naive PCV who received one 0.5 mg IVR injection monthly for 3 months followed by as-needed retreatments. PCV with subfoveal leakage on fluorescein angiography with or without actual choroidal neovascularisation were included. Analyses evaluated independent baseline predictors of better and improved visual acuity (VA) and need for fewer reinjections 2 years after the first injection. Results After the three monthly injections, 1.3 +/- 1.4 and 1.5 +/- 2.0 (mean +/- SD) as-needed injections were administered during years 1 and 2, respectively. The baseline logarithm of the minimum angle of resolution, VA (0.60 +/- 0.49) improved significantly (p= 0.001) (0.41 +/- 0.47) 2 years after the first injection. Younger patients' eyes with a better baseline VA and no cluster of grapelike polypoidal lesions were significant independent predictors of better VA 2 years after treatment. No baseline factors predicted fewer ranibizumab reinjections during 2 years. At 2 years, resolution of polypoidal lesions 1 month after the three monthly injections did not affect VA and number of reinjections during 2 years. Conclusions Patient age, baseline VA and clusters of grape-like polypoidal lesions predicted VA outcomes 2 years after treatment with IVR for PCV.	[Hikichi, Taiichi; Kitamei, Hirokuni; Shioya, Shoko] Ohtsuka Eye Hosp, Dept Ophthalmol, Sapporo, Hokkaido 0010016, Japan	Hikichi, T (reprint author), Ohtsuka Eye Hosp, Kita Ku, Kita 16 Nishi 4, Sapporo, Hokkaido 0010016, Japan.	taiichi-hikichi@hokkaido.med.or.jp			Novartis Pharma Japan; Bayer Japan; Santen Pharmaceutical Co.; Ohtsuka Pharmaceutical Co.; Senjyu Pharmaceutical Co.	TH received lecture fees from Novartis Pharma Japan, Bayer Japan, Santen Pharmaceutical Co., Ohtsuka Pharmaceutical Co. and Senjyu Pharmaceutical Co. HK received lecture fee from Novartis Pharma Japan. SS received lecture fees from Novartis Pharma Japan.	Koizumi H, 2013, AM J OPHTHALMOL, V155, P305, DOI 10.1016/j.ajo.2012.07.018; Yuzawa M, 2005, BRIT J OPHTHALMOL, V89, P602, DOI 10.1136/bjo.2004.049296; Koh AHC, 2013, RETINA-J RET VIT DIS, V33, P686, DOI 10.1097/IAE.0b013e3182852446; Saito M, 2013, GRAEF ARCH CLIN EXP, V251, P2099, DOI 10.1007/s00417-013-2323-6; Yannuzzi LA, 1999, ARCH OPHTHALMOL-CHIC, V117, P1503; Bessho H, 2011, RETINA-J RET VIT DIS, V31, P1598, DOI 10.1097/IAE.0b013e31820d3f28; Sasahara M, 2006, AM J OPHTHALMOL, V142, P601, DOI 10.1016/j.ajo.2006.05.051; Jirarattanasopa P, 2012, INVEST OPHTH VIS SCI, V53, P3663, DOI 10.1167/iovs.12-9619; Saito M, 2011, RETINA-J RET VIT DIS, V31, P1589, DOI 10.1097/IAE.0b013e31820f4b21; Koizumi H, 2011, BRIT J OPHTHALMOL, V95, P1555, DOI 10.1136/bjophthalmol-2011-300285; Grunwald JE, 2014, OPHTHALMOLOGY, V121, P150, DOI 10.1016/j.ophtha.2013.08.015; Yamazaki T, 2012, OPHTHALMOLOGY, V119, P1621, DOI 10.1016/j.ophtha.2012.02.022; Yamashiro K, 2012, AM J OPHTHALMOL, V154, P125, DOI 10.1016/j.ajo.2012.01.010; Lalwani Geeta A, 2009, Am J Ophthalmol, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Uyama M, 2002, AM J OPHTHALMOL, V133, P639, DOI 10.1016/S0002-9394(02)01404-6; Cho HJ, 2012, EYE, V26, P426, DOI 10.1038/eye.2011.324; Lai TYY, 2011, RETINA-J RET VIT DIS, V31, P1581, DOI 10.1097/IAE.0b013e31820d3f3f; Cheng CK, 2011, RETINA-J RET VIT DIS, V31, P846, DOI 10.1097/IAE.0b013e3181f84fdf; Fung AE, 2007, AM J OPHTHALMOL, V143, P566, DOI 10.1016/j.ajo.2007.01.028; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831; Hikichi T, 2013, BRIT J OPHTHALMOL, V97, P617, DOI 10.1136/bjophthalmol-2012-302652; Channa R, 2015, AM J OPHTHALMOL, V159, P9, DOI 10.1016/j.ajo.2014.09.012; Hikichi T, 2013, RETINA, V33, P1945; Ijiri S, 2014, GRAEFES ARCH CLIN EX; Inoue M, 2014, RETINA-J RET VIT DIS, V34, P2178, DOI 10.1097/IAE.0000000000000229; Kang HM, 2013, AM J OPHTHALMOL, V156, P652, DOI 10.1016/j.ajo.2013.05.038; Koh E, 2012, RETINA, V32, P1453; Lam BL, 2013, INVEST OPHTH VIS SCI, V54, P193, DOI 10.1167/iovs.12-10542; Lee YH, 2011, RETINA, V31, P1827; Ohishi A, 2014, OPHTHALMOLOGY, V121, P1151; Ojima Y, 2009, RETINA-J RET VIT DIS, V29, P52, DOI 10.1097/IAE.0b013e3181884fbf; Ueno C, 2012, RETINA-J RET VIT DIS, V32, P2006, DOI 10.1097/IAE.0b013e31825c1c31; Yamagishi T, 2012, OPHTHALMOLOGY, V119, P1650, DOI 10.1016/j.ophtha.2012.02.016; Yamagishi T, 2014, BRIT J OPHTHALMOL, V98, P780, DOI 10.1136/bjophthalmol-2013-303739; YANNUZZI LA, 1990, RETINA-J RET VIT DIS, V10, P1, DOI 10.1097/00006982-199001010-00001	35	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0007-1161	1468-2079		BRIT J OPHTHALMOL	Br. J. Ophthalmol.	JUN	2015	99	6					817	822		10.1136/bjophthalmol-2014-305606		6	Ophthalmology	Ophthalmology	CI7NO	WOS:000354950600019		
J	Ono, S; Imai, R; Ida, Y; Shibata, D; Komiya, T; Matsumura, H				Ono, Sayaka; Imai, Ryutro; Ida, Yukiko; Shibata, Dai; Komiya, Takako; Matsumura, Hajime			Increased wound pH as an indicator of local wound infection in second degree burns	BURNS			English	Article						pH; Wound infection; Colonization; Second degree burns; Staphylococcus		Wound pH affects a number of important factors in wound healing. It is known that the pH of the skin surface of healthy adults and children is 4.2-5.6 and that it decreases with the lapse of epithelialization. We measured the pH of the exudates from second degree burns in 26 cases. Among these, local burn wound infection developed in 6 cases. The causative organisms were Staphylococcus aureus in 2 cases and Staphylococcus epidermidis in 4 cases. The maximum pH value measured was 10.0 and the minimum was 5.0 for all samples. There were no differences in the initial measurements of pH between the non-infected cases and the local-infected cases. In Cases of local infection, the pH rose prior to the onset of clinical signs of local burn infection. By consecutive measurement of pH, early detection of local wound infection can be achieved and this is very beneficial in clinical practice. Moreover, measurement is very easy and results are available immediately. In conclusion, consecutive pH measurement of exudates is considered to be a useful indicator in the treatment of second degree burns. (C) 2014 Elsevier Ltd and ISBI. All rights reserved.	[Ono, Sayaka; Imai, Ryutro; Ida, Yukiko; Shibata, Dai; Komiya, Takako; Matsumura, Hajime] Tokyo Med Univ, Dept Plast & Reconstruct Surg, Tokyo 1600023, Japan	Matsumura, H (reprint author), Tokyo Med Univ, Dept Plast & Reconstruct Surg, Shinjuku Ku, 6-7-1 Nishishinjuku, Tokyo 1600023, Japan.	hmatsu-tki@umin.ac.jp					Hachem JP, 2005, J INVEST DERMATOL, V125, P510, DOI 10.1111/j.0022-202X.2005.23838.x; Rashaan ZM, 2014, WOUND REPAIR REGEN, V22, P473, DOI 10.1111/wrr.12196; Ganong WF, 2001, REV MED PHYSL, V20th; LEVEEN HH, 1973, ANN SURG, V178, P745, DOI 10.1097/00000658-197312000-00011; Lund C, 1999, J Obstet Gynecol Neonatal Nurs, V28, P241; Molan P C, 2004, J Wound Care, V13, P353; PILLSBURY DM, 1952, J INVEST DERMATOL, V18, P173; Solomon E, 1990, HUMAN ANATOMY PHYSL; Stacy M, 2000, BIOCH MEASUREMENTS T, P99; Tabuse H, 1990, ANTIBIOT CHEMOTHER, V6, P121; Thomas J, 2011, INT WOUND J, V9, P428; Tsukada K, 1992, WOUNDS, V4, P16	12	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0305-4179	1879-1409		BURNS	Burns	JUN	2015	41	4					820	824		10.1016/j.burns.2014.10.023		5	Critical Care Medicine; Dermatology; Surgery	General & Internal Medicine; Dermatology; Surgery	CI8MZ	WOS:000355027700022		
J	Nishinou, T				Nishinou, Takeo			Toric Degenerations, Tropical Curve, and Gromov-Witten Invariants of Fano Manifolds	CANADIAN JOURNAL OF MATHEMATICS-JOURNAL CANADIEN DE MATHEMATIQUES			English	Article						Fano varieties; Gromov-Witten invariants; tropical curves	VARIETIES; SURFACE; MODULI	In this paper, we give a tropical method for computing Gromov-Witten type invariants of Fano manifolds of special type. This method applies to those Fano manifolds that admit toric degenerations to toric Fano varieties with singularities allowing small resolutions. Examples include (generalized) flag manifolds of type A and some moduli space of rank two bundles on a genus two curve.	Tohoku Univ, Dept Math, Sendai, Miyagi 980, Japan	Nishinou, T (reprint author), Tohoku Univ, Dept Math, Sendai, Miyagi 980, Japan.	nishinou@math.tohoku.ac.jp			 [19740034]	Research supported by Grant-in-Aid for Young Scientists (No. 19740034).	GROMOV M, 1985, INVENT MATH, V82, P307, DOI 10.1007/BF01388806; Kogan M, 2005, ADV MATH, V193, P1, DOI 10.1016/j.aim.2004.03.017; Nishinou T, 2010, ADV MATH, V224, P648, DOI 10.1016/j.aim.2009.12.012; GOLDMAN WM, 1986, INVENT MATH, V85, P263, DOI 10.1007/BF01389091; Cho CH, 2006, ASIAN J MATH, V10, P773; Nishinou T, 2006, DUKE MATH J, V135, P1, DOI 10.1215/S0012-7094-06-13511-1; Cox D. A., 1999, MATH SURVEYS MONOGRA, V68; JEFFREY LC, 1992, COMMUN MATH PHYS, V150, P593, DOI 10.1007/BF02096964; McDuff D., 2012, AM MATH SOC C PUBLIC, V52; Mikhalkin G, 2005, J AM MATH SOC, V18, P313, DOI 10.1090/S0894-0347-05-00477-7; NARASIMH.MS, 1969, ANN MATH, V89, P14, DOI 10.2307/1970807; Newstead P. E., 1968, TOPOLOGY, V7, P205, DOI 10.1016/0040-9383(68)90001-3; Nishinou T, 2012, AM J MATH, V134, P1423; Nishinou T., CORRES THEOREMS TROP; Ruan W.-D., 2002, J SYMPLECT GEOM, V1, P435	15	0	0	CANADIAN MATHEMATICAL SOC	OTTAWA	209-1725 ST LAURENT BLVD, OTTAWA, ONTARIO K1G 3V4, CANADA	0008-414X	1496-4279		CAN J MATH	Can. J. Math.-J. Can. Math.	JUN	2015	67	3					667	695		10.4153/CJM-2014-006-3		29	Mathematics	Mathematics	CI6XP	WOS:000354907800008		
J	Aoyama, T; Katayama, Y; Murakawa, M; Atsumi, Y; Yamaoku, K; Kanazawa, A; Higuchi, A; Shiozawa, M; Kobayashi, S; Ueno, M; Morimoto, M; Yamamoto, N; Oshima, T; Yoshikawa, T; Rino, Y; Masuda, M; Morinaga, S				Aoyama, Toru; Katayama, Yusuke; Murakawa, Masaaki; Atsumi, Yosuke; Yamaoku, Koichiro; Kanazawa, Amane; Higuchi, Akio; Shiozawa, Manabu; Kobayashi, Satoshi; Ueno, Makoto; Morimoto, Manabu; Yamamoto, Naoto; Oshima, Takashi; Yoshikawa, Takaki; Rino, Yasushi; Masuda, Munetaka; Morinaga, Soichiro			Safety and feasibility of S-1 adjuvant chemotherapy for pancreatic cancer in elderly patients	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Pancreatic cancer; Elderly patient; Adjuvant chemotherapy	RANDOMIZED CONTROLLED-TRIAL; HEAD RESECTION; PANCREATICODUODENECTOMY; GEMCITABINE; 5-FLUOROURACIL; MORTALITY; FISTULA; RISK; ACID	The safety and feasibility of administering S-1 adjuvant chemotherapy for pancreatic cancer has not yet been fully evaluated in elderly patients. This retrospective study selected patients who underwent curative surgery for pancreatic cancer, were diagnosed with stage II disease or lower or stage III disease with combined resection of the celiac artery, and received adjuvant S-1 at our institution. The patients were categorized into two groups: non-elderly patients (< 70 years of age: group A) and elderly patients (> 70 years of age: group B). The toxicity and S-1 continuation rates were compared between the two groups. A total of 76 patients were evaluated in the present study. There were no grade 4 toxicities. The incidences of grade 3 hematological and non-hematological toxicities were < 5 % in both groups, and the differences were not significantly different. The continuation rate at 6 months was 60.5 % in group A and 72.7 % in group B, which was also not significantly different. These results suggest that S-1 adjuvant chemotherapy for pancreatic cancer is safe and feasible, regardless of the age of the patient, especially for elderly patients who may be candidates for clinical trials.	[Aoyama, Toru; Katayama, Yusuke; Murakawa, Masaaki; Atsumi, Yosuke; Yamaoku, Koichiro; Kanazawa, Amane; Higuchi, Akio; Shiozawa, Manabu; Morinaga, Soichiro] Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, Yokohama, Kanagawa 2418515, Japan; [Kobayashi, Satoshi; Ueno, Makoto; Morimoto, Manabu] Kanagawa Canc Ctr, Dept Hepatobiliary & Pancreat Oncol, Yokohama, Kanagawa 2418515, Japan; [Yamamoto, Naoto; Oshima, Takashi; Yoshikawa, Takaki; Rino, Yasushi; Masuda, Munetaka] Yokohama City Univ, Dept Surg, Yokohama, Kanagawa 232, Japan	Aoyama, T (reprint author), Kanagawa Canc Ctr, Dept Gastrointestinal Surg, Asahi Ku, 2-3-2 Nakao, Yokohama, Kanagawa 2418515, Japan.	aoyamat@kcch.jp			Kanagawa Prefectural Hospitals Cancer Fund; Yokohama Foundation for Advancement of Medical Science	This work was supported in part by the Kanagawa Prefectural Hospitals Cancer Fund and Yokohama Foundation for Advancement of Medical Science.	Tsushima T, 2010, GASTRIC CANCER, V13, P245, DOI 10.1007/s10120-010-0566-z; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Maeda A, 2008, JPN J CLIN ONCOL, V38, P227, DOI 10.1093/jjco/hym178; Yeo CJ, 2002, ANN SURG, V236, P355, DOI 10.1097/01.SLA.0000027272.08464.0B; Kawai M, 2006, ANN SURG, V244, P1, DOI 10.1097/01.sla.0000218077.14035.a6; Neoptolemos JP, 2010, JAMA-J AM MED ASSOC, V304, P1073, DOI 10.1001/jama.2010.1275; Hariharan D, 2008, HPB, V10, P58, DOI 10.1080/13651820701883148; Buchler MW, 2000, BRIT J SURG, V87, P883, DOI 10.1046/j.1365-2168.2000.01465.x; Neoptolemos JP, 2004, NEW ENGL J MED, V350, P1200, DOI 10.1056/NEJMoa032295; Oettle H, 2007, JAMA-J AM MED ASSOC, V297, P267, DOI 10.1001/jama.297.3.267; Povoski SP, 1999, ANN SURG, V230, P131, DOI 10.1097/00000658-199908000-00001; Aoyama T, 2014, CANCER CHEMOTH PHARM, V74, P1235, DOI 10.1007/s00280-014-2601-y; Bonadonna G, 1981, NEW ENGL J MED, V304, P101; Hirata K, 1999, CLIN CANCER RES, V5, P2000; Munoz-Bongrand N, 2004, J AM COLL SURGEONS, V199, P198, DOI 10.1016/j.jamcollsurg.2004.03.015; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; Sobin LH, TNM CLASSIFICATION M, V6th; TATSUMI K, 1987, JPN J CANCER RES, V78, P748; Uesaka K, 2013, GASTR CANC S	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1115	1120		10.1007/s00280-015-2736-5		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000002		
J	Kitazono, S; Fujiwara, Y; Nakamichi, S; Mizugaki, H; Nokihara, H; Yamamoto, N; Yamada, Y; Inukai, E; Nakamura, O; Tamura, T				Kitazono, Satoru; Fujiwara, Yutaka; Nakamichi, Shinji; Mizugaki, Hidenori; Nokihara, Hiroshi; Yamamoto, Noboru; Yamada, Yasuhide; Inukai, Eri; Nakamura, Osamu; Tamura, Tomohide			A phase I study of resminostat in Japanese patients with advanced solid tumors	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Resminostat; Histone deacetylase; Phase I; Solid tumor	HISTONE DEACETYLASE INHIBITORS; T-CELL LYMPHOMA; HDAC INHIBITORS; VORINOSTAT; EXPRESSION; CANCER; AGENTS	This study was performed to evaluate the safety and determine the recommended dose (RD) of resminostat monotherapy, an oral histone deacetylase (HDAC) inhibitor, in Japanese patients with advanced solid tumors. Resminostat was administered to patients with advanced solid tumors on a 14-day cycle consisting of once-daily administration on days 1-5. The dose was initiated at 400 mg and increased to 600 mg and then 800 mg. Treatment with resminostat was continued until disease progression or discontinuation for any other reason. Dose-limiting toxicities (DLTs) were assessed according to the adverse drug reactions occurring in the first cycle. Secondary objectives included the pharmacokinetics, pharmacodynamics, and efficacy. A total of 12 patients were enrolled in the study and received resminostat. No DLTs were reported in any patient. The maximum tolerated dose was not reached. Frequently reported grade 3/4 adverse drug reactions were as follows: lymphocytopenia (33.3 %), thrombocytopenia (25.0 %), neutropenia (16.7 %), and leukocytopenia (16.7 %). Pharmacokinetic analysis revealed that there was no accumulation of the drug over the 5-day administration period and no significant difference in pharmacokinetic parameters between the single dose and multiple doses. Measurement of acetylated H4 histone protein levels in peripheral blood mononuclear cells demonstrated that resminostat inhibited HDAC activity at all the doses assessed. No patients had a complete or partial response, whereas three patients had stable disease. Resminostat was safely administered to Japanese patients with advanced solid tumors. The RD of resminostat monotherapy in Japanese patients was estimated to be 800 mg.	[Kitazono, Satoru; Fujiwara, Yutaka; Nakamichi, Shinji; Mizugaki, Hidenori; Nokihara, Hiroshi; Yamamoto, Noboru; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo 1040045, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Dept Gastrointestinal Oncol, Chuo Ku, Tokyo 1040045, Japan; [Inukai, Eri; Nakamura, Osamu] Yakult Honsha Co Ltd, Pharmaceut Res & Dev Dept, Chuo Ku, Tokyo 1040061, Japan	Fujiwara, Y (reprint author), Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	yutakafu@ncc.go.jp			Yakult Honsha Co., Ltd.	We thank the participating patients and their families, as well as the investigators, research nurses, study coordinators, and operation staff. This study was sponsored by Yakult Honsha Co., Ltd.	Finnin MS, 1999, NATURE, V401, P188; Shah MH, 2006, CLIN CANCER RES, V12, P3997, DOI 10.1158/1078-0432.CCR-05-2689; Mann BS, 2007, ONCOLOGIST, V12, P1247, DOI 10.1634/theoncologist.12-10-1247; Richon VM, 2000, P NATL ACAD SCI USA, V97, P10014, DOI 10.1073/pnas.180316197; Piekarz RL, 2009, J CLIN ONCOL, V27, P5410, DOI 10.1200/JCO.2008.21.6150; Brunetto AT, 2013, CLIN CANCER RES, V19, P5494, DOI 10.1158/1078-0432.CCR-13-0735; Kristeleit R, 2005, CLIN LUNG CANCER, V7, pS19, DOI 10.3816/CLC.2005.s.004; Lane AA, 2009, J CLIN ONCOL, V27, P5459, DOI 10.1200/JCO.2009.22.1291; Piekarz RL, 2011, BLOOD, V117, P5827, DOI 10.1182/blood-2010-10-312603; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Mann BS, 2007, CLIN CANCER RES, V13, P2318, DOI 10.1158/1078-0432.CCR-06-2672; Glaser KB, 2003, MOL CANCER THER, V2, P151; Falkenberg KJ, 2014, NAT REV DRUG DISCOV, V13, P673, DOI 10.1038/nrd4360; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Arts GJ, 2003, GENOME RES, V13, P2325, DOI 10.1101/gr.1332603; Mandl-Weber S, 2010, BRIT J HAEMATOL, V149, P518, DOI 10.1111/j.1365-2141.2010.08124.x; Marsoni S, 2008, EPIGENETICS-US, V3, P164; Molife R, 2007, CLIN CANCER RES, V13, P1068, DOI 10.1158/1078-0432.CCR-06-1715; Pohlman B, 2009, BLOOD, V114, P379; Tan JH, 2010, J HEMATOL ONCOL, V3, DOI 10.1186/1756-8722-3-5; Ververis Katherine, 2013, Biologics, V7, P47, DOI 10.2147/BTT.S29965	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1155	1161		10.1007/s00280-015-2741-8		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000006		
J	Yamamoto, D; Iwase, S; Tsubota, Y; Ariyoshi, K; Kawaguchi, T; Miyaji, T; Sueoka, N; Yamamoto, C; Teramoto, S; Odagiri, H; Kitamura, K; Nagumo, Y; Yamaguchi, T				Yamamoto, D.; Iwase, S.; Tsubota, Y.; Ariyoshi, K.; Kawaguchi, T.; Miyaji, T.; Sueoka, N.; Yamamoto, C.; Teramoto, S.; Odagiri, H.; Kitamura, K.; Nagumo, Y.; Yamaguchi, T.			Randomized study of orally administered fluorinated pyrimidines (capecitabine versus S-1) in women with metastatic or recurrent breast cancer: Japan Breast Cancer Research Network 05 Trial	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						S-1; Capecitabine; Metastatic breast cancer; Recurrent breast cancer; Clinical trial	MULTICENTER PHASE-II; GASTRIC-CANCER; EFFICACY; FLUOROPYRIMIDINE; 5-FLUOROURACIL; THERAPY; TUMORS	Capecitabine and S-1 are orally administered fluorinated pyrimidines with high-level activity against metastatic breast cancer (MBC). This randomized, multicenter, phase II study compared the activities and safeties of the oral fluoropyrimidines, capecitabine and S-1, in breast cancer patients. Patients with MBC were randomly assigned to receive capecitabine 825 g/m(2) twice daily on days 1-21 every 4 weeks or S-1 40-60 mg twice daily, according to body surface area, on days 1-28 every 6 weeks. The primary endpoint was progression-free survival (PFS). A total of 142 patients were enrolled and randomized to either capecitabine (N = 73) or S-1 (N = 69). Median PFS (progression-free survival) was 1.2 years for capecitabine and 1.3 years for S-1, with a hazard ratio (S-1/capecitabine) of 0.85 (95 % confidence interval [CI] 0.52-1.38) (P = 0.48 by log-rank). The confirmed objective response rates were 24.0 % for capecitabine and 23.1 % for S-1 (P = 0.938). The most common treatment-related adverse events were grade 1-2 in intensity. Thrombocytopenia (S-1: 9.2 %, capecitabine: 1.4 %; P = 0.040) and nausea (S-1: 26.2 %, capecitabine: 14.1 %; P = 0.079) were more frequent in the S-1 group, while hand-foot syndrome occurred more often in the capecitabine group (S-1: 10.8 %, capecitabine: 25.4 %; P = 0.029). The results of the current study demonstrate that both S-1 and capecitabine are effective and well-tolerated treatments in patients with MBC, while their adverse events were different. They are both convenient, orally administered drugs, making them attractive agents for use in outpatient treatment.	[Yamamoto, D.; Tsubota, Y.; Sueoka, N.] Kansai Med Univ, Dept Surg, Osaka, Japan; [Iwase, S.; Ariyoshi, K.] Univ Tokyo, Inst Med Sci, Dept Palliat Med, Tokyo 1138655, Japan; [Kawaguchi, T.] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Pract Pharm, Tokyo, Japan; [Miyaji, T.; Yamaguchi, T.] Univ Tokyo, Grad Sch Med, Dept Clin Trial Data Management, Bunkyo Ku, Tokyo 1138655, Japan; [Yamamoto, D.; Yamamoto, C.] Seiko Hosp, Dept Internal Med, Neyagawa, Osaka, Japan; [Teramoto, S.] Kyushu Cent Hosp, Dept Breast Surg, Fukuoka, Japan; [Odagiri, H.] Hirosaki Natl Hosp, Dept Surg, Hirosaki, Aomori, Japan; [Kitamura, K.] Nagumo Clin, Breast Unit, Fukuoka, Japan; [Nagumo, Y.] Nagumo Clin, Breast Unit, Tokyo, Japan; [Yamaguchi, T.] Tohoku Univ, Grad Sch Med, Div Biostat, Sendai, Miyagi 980, Japan	Miyaji, T (reprint author), Univ Tokyo, Grad Sch Med, Dept Clin Trial Data Management, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	tmiyaji@m.u-tokyo.ac.jp					Burzykowski T, 2008, J CLIN ONCOL, V26, P1987, DOI 10.1200/JCO.2007.10.8407; Haller DG, 2008, J CLIN ONCOL, V26, P2118, DOI 10.1200/JCO.2007.15.2090; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; O'Shaughnessy JA, 2001, ANN ONCOL, V12, P1247, DOI 10.1023/A:1012281104865; Miwa M, 1998, EUR J CANCER, V34, P1274, DOI 10.1016/S0959-8049(98)00058-6; Reichardt P, 2003, ANN ONCOL, V14, P1227, DOI 10.1093/annonc/mdg346; Yamamoto D, 2008, CANCER CHEMOTH PHARM, V61, P509, DOI 10.1007/s00280-007-0497-5; Walko CM, 2005, CLIN THER, V27, P23, DOI 10.1016/j.clinthera.2005.01.005; Lee JL, 2008, BRIT J CANCER, V99, P584, DOI 10.1038/sj.bjc.6604536; Asgari MM, 1999, J CUTAN PATHOL, V26, P287, DOI 10.1111/j.1600-0560.1999.tb01846.x; Blum JL, 2001, CANCER, V92, P1759, DOI 10.1002/1097-0142(20011001)92:7<1759::AID-CNCR1691>3.0.CO;2-A; Fumoleau P, 2004, EUR J CANCER, V40, P536, DOI 10.1016/j.ejca.2003.11.007; Ito Y, 2009, BREAST CANCER-TOKYO, V16, P126, DOI 10.1007/s12282-008-0073-9; Kawaguchi Takashi, 2009, Cases J, V2, P9081, DOI 10.1186/1757-1626-2-9081; Koukourakis GV, 2008, MOLECULES, V13, P1897, DOI 10.3390/molecules13081897; Nukatsuka M, 2004, INT J ONCOL, V25, P1531; Saek Toshiaki, 2004, Breast Cancer, V11, P194, DOI 10.1007/BF02968301; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Shien T, 2008, JPN J CLIN ONCOL, V38, P172, DOI 10.1093/jjco/hyn001; Shin HR, 2010, CANCER SCI, V101, P1241, DOI 10.1111/j.1349-7006.2010.01519.x; Yamamoto D, 2010, BREAST CARE, V5, P415, DOI 10.1159/000322660; Yamamoto D, 2010, ANTICANCER RES, V30, P3827	22	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1183	1189		10.1007/s00280-015-2738-3		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000009		
J	Nakano, K; Ando, H; Kurokawa, S; Hosohata, K; Ushijima, K; Takada, M; Tateishi, M; Yonezawa, A; Masuda, S; Matsubara, K; Inui, K; Morita, T; Fujimura, A				Nakano, Kazuhiko; Ando, Hitoshi; Kurokawa, Shinsuke; Hosohata, Keiko; Ushijima, Kentarou; Takada, Makoto; Tateishi, Masato; Yonezawa, Atsushi; Masuda, Satohiro; Matsubara, Kazuo; Inui, Ken-ichi; Morita, Tatsuo; Fujimura, Akio			Association of decreased mRNA expression of multidrug and toxin extrusion protein 1 in peripheral blood cells with the development of flutamide-induced liver injury	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Flutamide; Liver injury; Multidrug and toxin extrusion protein 1; Prostate cancer; Solute carrier family 47; Member 1	MAXIMUM ANDROGEN BLOCKADE; ADVANCED PROSTATE-CANCER; TRANSPORTER PROTEIN; GENETIC-VARIATION; 1 MATE1; HEPATOTOXICITY; METFORMIN; ANTIANDROGENS; CARCINOMA; THERAPY	The anti-prostate cancer drug flutamide occasionally causes hepatotoxicity, and predictive biomarkers of flutamide-induced liver injury (FILI) are needed to improve safety of this drug. The aim of this prospective study was to identify such a biomarker by analyzing peripheral blood samples from patients before flutamide therapy. Blood samples were obtained from 52 patients with prostate cancer before flutamide therapy. FILI was defined as treatment-related elevation of the serum concentration of aspartate or alanine aminotransferase to more than twice the upper limit of the reference range. The patients were monitored for at least 6 months regarding FILI. Microarray and quantitative real-time PCR analyses were conducted to compare gene expression profiles between the groups with and without FILI. Seventeen patients developed FILI. Microarray analysis of the training set in 15 patients detected 11 annotated genes showing > twofold expression changes between the groups (p < 0.005). Quantitative PCR analysis of both the training set and validation set confirmed that mRNA levels of multidrug and toxin extrusion protein 1 (MATE1 or SLC47A1, encoded by 1 of the 11 genes) were significantly lower in patients with FILI. A small experiment on mice (three per group) showed that Mate1 knockout mice had an elevated serum concentration of 4-nitro-3-(trifluoromethyl)phenylamine, a major metabolite of flutamide, 2 h after administration of the drug, suggesting that Mate1 could affect the pharmacokinetics of flutamide. The MATE1 mRNA level in peripheral blood is a possible negative predictive biomarker of FILI.	[Nakano, Kazuhiko; Kurokawa, Shinsuke; Morita, Tatsuo] Jichi Med Univ, Dept Urol, Shimotsuke, Tochigi 3290498, Japan; [Ando, Hitoshi; Hosohata, Keiko; Ushijima, Kentarou; Fujimura, Akio] Jichi Med Univ, Div Clin Pharmacol, Dept Pharmacol, Shimotsuke, Tochigi 3290498, Japan; [Takada, Makoto; Tateishi, Masato] Nagasaki Int Univ, Fac Pharmaceut Sci, Div Biopharmaceut, Nagasaki, Japan; [Yonezawa, Atsushi; Masuda, Satohiro; Matsubara, Kazuo] Kyoto Univ, Kyoto Univ Hosp, Dept Clin Pharmacol & Therapeut, Kyoto, Japan; [Inui, Ken-ichi] Kyoto Pharmaceut Univ, Kyoto 607, Japan	Fujimura, A (reprint author), Jichi Med Univ, Div Clin Pharmacol, Dept Pharmacol, Yakushiji 3311-1, Shimotsuke, Tochigi 3290498, Japan.	akiofuji@jichi.ac.jp	Masuda, Satohiro/E-6691-2010	Masuda, Satohiro/0000-0002-3589-5989	Ministry of Health, Labor, and Welfare of Japan [H20-BIO-G-003]	We are grateful to Mrs. Hisae Shiokawa and Dr. Hidetoshi Tsuda for technical assistance and to Dr. Kenji Komatsu, Dr. Takeshi Koshimizu, Dr. Shinsuke Natsui, Dr. Kazumi Suzuki, Dr. Masayuki Yuzawa, and Dr. Minoru Kobayashi for collecting patients' data. We also thank all the participants for their cooperation. This work was supported by a grant from the Ministry of Health, Labor, and Welfare of Japan (H20-BIO-G-003).	Aizawa Y, 2003, MOL CELL BIOCHEM, V252, P149, DOI 10.1023/A:1025560513308; Suzuki H, 2008, J UROLOGY, V180, P921, DOI 10.1016/j.juro.2008.05.045; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; Tanihara Y, 2007, BIOCHEM PHARMACOL, V74, P359, DOI 10.1016/j.bcp.2007.04.010; Toyama K, 2012, BRIT J PHARMACOL, V166, P1183, DOI 10.1111/j.1476-5381.2012.01853.x; Dalesio O, 2000, LANCET, V355, P1491; Devouassoux G, 2008, ALLERGY, V63, P125, DOI 10.1111/j.1398-9995.2007.01558.x; Kajiwara M, 2009, J HUM GENET, V54, P40, DOI 10.1038/jhg.2008.1; Otsuka M, 2005, P NATL ACAD SCI USA, V102, P17923, DOI 10.1073/pnas.0506483102; Osculati A, 2006, LANCET, V367, P1140, DOI 10.1016/S0140-6736(06)68498-5; Thole Z, 2004, UROL INT, V73, P289, DOI 10.1159/000081585; Wysowski DK, 1996, J UROLOGY, V155, P209, DOI 10.1016/S0022-5347(01)66596-0; Becker MSL, 2009, DIABETES, V58, P745, DOI 10.2337/db08-1028; Yonezawa A, 2011, BRIT J PHARMACOL, V164, P1817, DOI 10.1111/j.1476-5381.2011.01394.x; Tsuda M, 2009, MOL PHARMACOL, V75, P1280, DOI 10.1124/mol.109.056242; Cetin M, 1999, HUM EXP TOXICOL, V18, P137, DOI 10.1191/096032799678839806; Ha Choi Ji, 2009, Pharmacogenet Genomics, V19, P770, DOI 10.1097/FPC.0b013e328330eeca; Huang T, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-44; Kojima S, 2004, J UROLOGY, V171, P679, DOI 10.1097/01.ju.0000106190.32540.6c; Matsuoka H, 2012, ONCOL REP, V27, P1393, DOI 10.3892/or.2012.1660; Ozono S, 2002, PROSTATE CANCER P D, V5, P128, DOI 10.1038/sj.pcan.4500564; Uetrecht J, 2002, DRUG METAB REV, V34, P651, DOI 10.1081/DMR-120005667; Wada T, 1999, Hinyokika Kiyo, V45, P521	23	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1191	1197		10.1007/s00280-015-2743-6		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000010		
J	Kawamura, T; Hata, A; Takeshita, J; Fujita, S; Hayashi, M; Tomii, K; Katakami, N				Kawamura, Takahisa; Hata, Akito; Takeshita, Jumpei; Fujita, Shiro; Hayashi, Michio; Tomii, Keisuke; Katakami, Nobuyuki			High-dose erlotinib for refractory leptomeningeal metastases after failure of standard-dose EGFR-TKIs	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Non-small cell lung cancer; EGFR-TKI; Leptomeningeal metastases; High-dose erlotinib	CELL LUNG-CANCER; GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITORS; BRAIN METASTASES; INTRAVENTRICULAR CHEMOTHERAPY; GOOD RESPONSE; PHASE-II; GEFITINIB; RESISTANCE; MUTATION	After initial response to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), approximately one-third of patients develop central nervous system (CNS) metastases, including leptomeningeal metastases (LM). To achieve longer survival, control of CNS metastases is important, but therapeutic options are limited for LM after failure of standard-dose EGFR-TKIs. We retrospectively evaluated the efficacy and safety of high-dose erlotinib in EGFR-mutant non-small cell lung cancer (NSCLC) patients with refractory LM after failure of standard-dose EGFR-TKIs. Survivals from diagnosis of LM to death were compared in patients with or without high-dose erlotinib. Between January 2007 and April 2013, we identified 35 patients with EGFR-mutant NSCLC, complicated with LM, and 12 underwent high-dose erlotinib, while the other 23 received only standard-dose EGFR-TKIs. In patients receiving high-dose erlotinib, magnetic resonance imaging response was confirmed in 3 (30 %) of 10 evaluable patients. Median time to CNS progression was 2.3 months (95 % confidence interval [CI] 1.8-5.5 months). Performance status and neurological symptoms improved in 4 (33 %) of 12 and 6 (50 %) of 12 patients, respectively. No severe adverse events (a parts per thousand yengrade 3) associated with high-dose erlotinib were observed. Median survival time from diagnosis of LM in patients with high-dose erlotinib was 6.2 months (95 % CI 2.5-8.5 months), and in those without 5.9 months (95 % CI 1.3-7.8 months) (p = 0.94). High-dose erlotinib suggested its efficacy and safety in some patients with refractory LM. It represents a potential therapeutic option against LM after failure of standard-dose EGFR-TKIs, especially to palliate LM-related neurological symptoms.	[Kawamura, Takahisa; Hayashi, Michio; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Hata, Akito; Takeshita, Jumpei; Fujita, Shiro; Katakami, Nobuyuki] Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan	Hata, A (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	a-hata@fbri.org					Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Katayama T, 2009, J THORAC ONCOL, V4, P1415, DOI 10.1097/JTO.0b013e3181b62572; Chamberlain MC, 1997, J NEUROSURG, V87, P694, DOI 10.3171/jns.1997.87.5.0694; Nagai Y, 2005, CANCER RES, V65, P7276, DOI 10.1158/0008-5472.CAN-05-0331; Morris PG, 2012, J THORAC ONCOL, V7, P382, DOI 10.1097/JTO.0b013e3182398e4f; Welsh JW, 2013, J CLIN ONCOL, V31, P895, DOI 10.1200/JCO.2011.40.1174; Asahina H, 2010, ONCOLOGY-BASEL, V79, P423, DOI 10.1159/000326488; Clarke JL, 2010, J NEURO-ONCOL, V99, P283, DOI 10.1007/s11060-010-0128-6; Lee E, 2013, J THORAC ONCOL, V8, P1069, DOI 10.1097/JTO.0b013e318294c8e8; Hata A, 2011, J THORAC ONCOL, V6, P653, DOI 10.1097/JTO.0b013e3181d899bb; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kuiper JL, 2013, LUNG CANCER, V80, P102, DOI 10.1016/j.lungcan.2012.12.024; Langer CJ, 2005, J CLIN ONCOL, V23, P6207, DOI 10.1200/JCO.2005.03.145; Jamal-Hanjani M, 2012, CLIN CANCER RES, V18, P938, DOI 10.1158/1078-0432.CCR-11-2529; Gwak HS, 2013, J THORAC ONCOL, V8, P599, DOI 10.1097/JTO.0b013e318287c943; Togashi Y, 2012, CANCER CHEMOTH PHARM, V70, P399, DOI 10.1007/s00280-012-1929-4; Omuro AMP, 2005, CANCER, V103, P2344, DOI 10.1002/cncr.21033; Herbst RS, 2011, LANCET, V377, P1846, DOI 10.1016/S0140-6736(11)60545-X; Yi HG, 2009, LUNG CANCER, V65, P80, DOI 10.1016/j.lungcan.2008.10.016; Heon S, 2010, CLIN CANCER RES, V16, P5873, DOI 10.1158/1078-0432.CCR-10-1588; Grossman SA, 1999, CANCER TREAT REV, V25, P103, DOI 10.1053/ctrv.1999.0119; Sundstrom JT, 1998, ANN MED, V30, P296, DOI 10.3109/07853899809005858; Milton DI, 2006, CANCER, V107, P1034, DOI 10.1002/cncr.22088; Jackman DM, 2006, J CLIN ONCOL, V24, P4517, DOI 10.1200/JCO.2006.06.6126; Grommes C, 2011, NEURO-ONCOLOGY, V13, P1364, DOI 10.1093/neuonc/nor121; Dhruva N, 2009, J CLIN ONCOL, V27, pE31, DOI 10.1200/JCO.2008.21.0963; Heon S, 2012, J CLIN ONCOL S, V30; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1261	1266		10.1007/s00280-015-2759-y		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000018		
J	Hata, A; Katakami, N; Fujita, S; Nanjo, S; Takeshita, J; Tanaka, K; Kaneda, T; Nishiyama, A; Nishimura, T; Nakagawa, A; Otsuka, K; Morita, S; Urata, Y; Negoro, S				Hata, Akito; Katakami, Nobuyuki; Fujita, Shiro; Nanjo, Shigeki; Takeshita, Jumpei; Tanaka, Kosuke; Kaneda, Toshihiko; Nishiyama, Akihiro; Nishimura, Takashi; Nakagawa, Atsushi; Otsuka, Kojiro; Morita, Satoshi; Urata, Yoshiko; Negoro, Shunichi			A phase II study of pemetrexed monotherapy in chemo-na < ve Eastern Cooperative Oncology Group performance status 2 patients with EGFR wild-type or unknown advanced non-squamous non-small cell lung cancer (HANSHIN Oncology Group 002)	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Pemetrexed; Eastern Cooperative Oncology Group performance status 2; Epidermal growth factor receptor gene wild-type; Non-squamous non-small cell lung cancer	PACLITAXEL POLIGLUMEX CT-2103; SINGLE-AGENT; COMBINATION CHEMOTHERAPY; TRIAL; CARBOPLATIN; GEMCITABINE; MUTATIONS; GEFITINIB; EFFICACY; PPX	The aim of our study was to investigate the efficacy and safety of pemetrexed monotherapy in chemo-na < ve Eastern Cooperative Oncology Group (ECOG) performance status (PS) 2 patients with epidermal growth factor receptor (EGFR) wild-type or unknown advanced non-squamous non-small cell lung cancer (NSCLC). Pemetrexed was administered at 500 mg/m(2) triweekly until progression with supplementations in chemo-na < ve ECOG PS 2 patients with EGFR wild-type or unknown advanced non-squamous NSCLC. Between September 2009 and April 2013, twenty-eight patients were enrolled. Median age was 75 (range 59-89). Nineteen (68 %) of 28 were ever smoker, and 18 (64 %) had pulmonary emphysema. Sixteen (57 %) had comorbidities such as hypertension, heart disease, and/or diabetes. In 26 eligible patients, the overall response rate, disease control rate, median PFS, and median overall survival were 11.5, 53.8 %, 3.0 [95 % confidence interval (CI) 1.9-5.7] months and 9.5 (95 % CI 3.3-12.5) months, respectively. Median administered course number was 3 (range 1-14). Median duration of PS maintenance a parts per thousand currency sign2 was 4.9 (95 % CI 1.3-9.7) months. Common (a parts per thousand yen10 %) grade 3/4 toxicities included 7 (27 %) neutropenia, 7 (27 %) leukopenia, 4 (15 %) fatigue, and 3 (12 %) thrombocytopenia. Febrile neutropenia and interstitial lung disease were not observed. There were no treatment-related deaths. Pemetrexed monotherapy demonstrated moderate efficacy and good safety in chemo-na < ve PS 2 patients with EGFR wild-type or unknown non-squamous NSCLC. It can be a therapeutic option in "frail" PS 2 non-squamous NSCLC patients without the indication of combination regimens, if the patient is EGFR wild-type.	[Hata, Akito; Katakami, Nobuyuki; Fujita, Shiro; Nanjo, Shigeki; Takeshita, Jumpei; Tanaka, Kosuke] Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Kaneda, Toshihiko] Kobe City Med Ctr, West Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Nishiyama, Akihiro] Kurashiki Cent Hosp, Dept Resp Med, Kurashiki, Okayama, Japan; [Nishimura, Takashi] Kyoto Katsura Hosp, Dept Resp Med, Kyoto, Japan; [Nakagawa, Atsushi; Otsuka, Kojiro] Kobe City Med Ctr, Gen Hosp, Dept Resp Med, Kobe, Hyogo, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Kyoto, Japan; [Urata, Yoshiko; Negoro, Shunichi] Hyogo Canc Ctr, Dept Thorac Oncol, Akashi, Hyogo, Japan	Hata, A (reprint author), Inst Biomed Res & Innovat, Div Integrated Oncol, Chuo Ku, 2-2 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	a-hata@fbri.org			Foundation for Biomedical Research and Innovation	This study was supported by Foundation for Biomedical Research and Innovation.	Inoue A, 2009, J CLIN ONCOL, V27, P1394, DOI 10.1200/JCO.2008.18.7658; O'Brien MER, 2008, J THORAC ONCOL, V3, P728, DOI 10.1097/JTO.0b013e31817c6b68; Lilenbaum RC, 2005, J CLIN ONCOL, V23, P190, DOI 10.1200/JCO.2005.07.172; Peters S, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds226; Scagliotti G, 2009, ONCOLOGIST, V14, P253, DOI 10.1634/theoncologist.2008-0232; Zukin M, 2013, J CLIN ONCOL, V31, P2849, DOI 10.1200/JCO.2012.48.1911; Kawaguchi T, 2010, J THORAC ONCOL, V5, P620, DOI 10.1097/JTO.0b013e3181d2dcd9; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Langer CJ, 2008, J THORAC ONCOL, V3, P623, DOI 10.1097/JTO.0b013e3181753b4b; Lilenbaum R, 2008, J CLIN ONCOL, V26, P863, DOI 10.1200/JCO.2007.13.2720; Langer C, 2007, J CLIN ONCOL, V25, P418, DOI 10.1200/JCO.2005.04.9452; Lilenbaum R, 2009, J THORAC ONCOL, V4, P869, DOI 10.1097/JTO.0b013e3181a9a020; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Lilenbaum RC, 2008, J THORAC ONCOL, V3, P125, DOI 10.1097/JTO.0b013e3181622c17; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Ohe Y, 2008, CLIN CANCER RES, V14, P4206, DOI [10.1158/1078-0432.CCR-07-5143, 10.1168/1078-0432.CCR-07-5143]; Saito H, 2012, AM J CLIN ONCOL-CANC, V35, P58, DOI 10.1097/COC.0b013e318201a0f3; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Kosmidis PA, 2007, J THORAC ONCOL, V2, P135; The National Comprehensive Cancer Network, 2015, NCCN CLIN PRACT GUID	21	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1267	1272		10.1007/s00280-015-2755-2		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000019		
J	Kato, T; Uehara, K; Maeda, A; Sakamoto, E; Hiramatsu, K; Takeuchi, E; Goto, H; Tojima, Y; Yatsuya, H; Nagino, M				Kato, Takehiro; Uehara, Keisuke; Maeda, Atsuyuki; Sakamoto, Eiji; Hiramatsu, Kazuhiro; Takeuchi, Eiji; Goto, Hidenari; Tojima, Yuichiro; Yatsuya, Hiroshi; Nagino, Masato		Nagoya Surgical Oncology Grp	Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial	CANCER CHEMOTHERAPY AND PHARMACOLOGY			English	Article						Colorectal cancer; Liver metastasis; Adjuvant chemotherapy; S-1; Survival	LONG-TERM SURVIVAL; ACTS-CC TRIAL; COLON-CANCER; HEPATIC RESECTION; PERIOPERATIVE CHEMOTHERAPY; STAGE-II; SURGERY; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN	We previously showed that S-1 after curative resection of colorectal liver metastasis had acceptable toxicity and a high rate of completion of therapy in a prospective phase II trial. We here reported the primary endpoint of disease-free survival (DFS). Between October 2008 and August 2010, 60 patients were eligible for this study and received S-1 for 28 days followed by a 2-week rest period. Treatment was started within 8 weeks after surgery and repeated for eight cycles. Median follow-up was 41 months. Among 60 patients, 45 had solitary metastasis, and the median maximum tumor diameter was 2.6 cm. The 3-year DFS and overall survival were 47.4 and 80.0 %, respectively. Recurrences developed in 31 patients, with the remnant liver the most common site (19 patients). Multivariate analysis showed that positive lymph node metastasis around the primary site (p = 0.013) and early liver metastasis (synchronous disease or metachronous disease within 12 months) (p = 0.041) were independent poor prognostic factors for DFS. Patients having both risk factors had a significantly worse DFS than those without these risk factors (p < 0.001). Early liver metastasis was an independent indicator of early recurrence within 1 year. S-1 after curative liver resection yielded promising survival in patients with a low tumor burden. Outcome in patients having both positive lymph node metastasis around the primary site and early liver metastasis was much worse than in patients without these conditions; therefore, they might warrant more aggressive therapy.	[Kato, Takehiro; Uehara, Keisuke; Nagino, Masato] Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, Nagoya, Aichi 4668550, Japan; [Maeda, Atsuyuki] Ogaki Municipal Hosp, Dept Surg, Gifu, Japan; [Sakamoto, Eiji] Nagoya Daini Red Cross Hosp, Dept Surg, Nagoya, Aichi, Japan; [Hiramatsu, Kazuhiro] Toyohashi Municipal Hosp, Dept Surg, Toyohashi, Aichi, Japan; [Takeuchi, Eiji] Japanese Red Cross Nagoya Daiichi Hosp, Dept Surg, Nagoya, Aichi, Japan; [Goto, Hidenari] Anjo Kosei Hosp, Dept Surg, Anjo, Aichi, Japan; [Tojima, Yuichiro] Chukyo Hosp, Dept Surg, Nagoya, Aichi, Japan; [Yatsuya, Hiroshi] Fujita Hlth Univ, Sch Med, Dept Publ Hlth, Toyoake, Aichi, Japan	Uehara, K (reprint author), Nagoya Univ, Grad Sch Med, Div Surg Oncol,Dept Surg, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kuehara@med.nagoya-u.ac.jp					Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T., 2013, CURR COLORECTAL CANC, V9, P261; Nordlinger B, 2013, LANCET ONCOL, V14, P1208, DOI 10.1016/S1470-2045(13)70447-9; Choti MA, 2002, ANN SURG, V235, P759, DOI 10.1097/00000658-200206000-00002; Hamaguchi T, 2011, CANCER CHEMOTH PHARM, V67, P587, DOI 10.1007/s00280-010-1358-1; Kanemitsu Y, 2009, JPN J CLIN ONCOL, V39, P406, DOI 10.1093/jjco/hyp035; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Portier G, 2006, J CLIN ONCOL, V24, P4976, DOI 10.1200/JCO.2006.06.8353; Adam R, 2004, ANN SURG, V240, P644, DOI 10.1097/01.sla.0000141198.92114.16; Adam R, 2010, ANN SURG, V252, P774, DOI 10.1097/SLA.0b013e3181fcf3e3; Nordlinger B, 2008, LANCET, V371, P1007, DOI 10.1016/S0140-6736(08)60455-9; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Tsuchiya T, 2014, CANCER CHEMOTH PHARM, V73, P1253, DOI 10.1007/s00280-014-2461-5; Rees M, 2008, ANN SURG, V247, P125, DOI 10.1097/SLA.0b013e31815aa2c2; Nordlinger B, 2009, ANN ONCOL, V20, P985, DOI 10.1093/annonc/mdn735; Pawlik TM, 2005, ANN SURG, V241, P715, DOI 10.1097/01.sla.0000160703.75808.7d; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Mochizuki I, 2012, BRIT J CANCER, V106, P1268, DOI 10.1038/bjc.2012.86; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Kobayashi A, 2014, J CLIN ONCOL S, V32, p5s; Kondo K, 2013, ANN ONCOL, V23, p9s; Kunieda K, 2012, J CLIN ONCOL S, V30; National Comprehensive Cancer Network, 2012, NCCN CLIN PRACT GUID, V2; Sakuramoto S, 2007, NEW ENGL J MED, V357, P1810, DOI 10.1056/NEJMoa072252; Sobin LH, 2010, TNM CLASSIFICATION M; Uehara K, 2013, ANN SURG ONCOL, V20, P475, DOI 10.1245/s10434-012-2665-z; Ueno H, 2000, ANN SURG, V231, P59, DOI 10.1097/00000658-200001000-00009; Yoshida M, 2014, ANN ONCOL, V25, P1743, DOI 10.1093/annonc/mdu232	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0344-5704	1432-0843		CANCER CHEMOTH PHARM	Cancer Chemother. Pharmacol.	JUN	2015	75	6					1281	1288		10.1007/s00280-015-2752-5		8	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI7MZ	WOS:000354949000021		
J	Fukushima, N; Ishii, S; Tsujiuchi, T; Kagawa, N; Katoh, K				Fukushima, Nobuyuki; Ishii, Shoichi; Tsujiuchi, Toshifumi; Kagawa, Nao; Katoh, Kazutaka			Comparative analyses of lysophosphatidic acid receptor-mediated signaling	CELLULAR AND MOLECULAR LIFE SCIENCES			English	Review						Phylogenetic tree; Evolution; Lpar; ATX; LIPH; LIPI; Lipase	PROTEIN-COUPLED RECEPTOR; CENTRAL-NERVOUS-SYSTEM; LPA-PRODUCING ENZYME; EDG FAMILY; LYSOPHOSPHOLIPID RECEPTORS; MAXIMUM-LIKELIHOOD; NEUROPATHIC PAIN; GENE FAMILY; EXPRESSION; AUTOTAXIN	Lysophosphatidic acid (LPA) is a bioactive lipid mediator that activates G protein-coupled LPA receptors to exert fundamental cellular functions. Six LPA receptor genes have been identified in vertebrates and are classified into two subfamilies, the endothelial differentiation genes (edg) and the non-edg family. Studies using genetically engineered mice, frogs, and zebrafish have demonstrated that LPA receptor-mediated signaling has biological, developmental, and pathophysiological functions. Computational analyses have also identified several amino acids (aa) critical for LPA recognition by human LPA receptors. This review focuses on the evolutionary aspects of LPA receptor-mediated signaling by comparing the aa sequences of vertebrate LPA receptors and LPA-producing enzymes; it also summarizes the LPA receptor-dependent effects commonly observed in mouse, frog, and fish.	[Fukushima, Nobuyuki; Ishii, Shoichi] Kinki Univ, Dept Life Sci, Div Mol Neurobiol, Higashiosaka, Osaka 5778502, Japan; [Tsujiuchi, Toshifumi] Kinki Univ, Dept Life Sci, Div Canc Biol & Bioinformat, Higashiosaka, Osaka 5778502, Japan; [Kagawa, Nao] Kinki Univ, Dept Life Sci, Div Anim Genet, Higashiosaka, Osaka 5778502, Japan; [Katoh, Kazutaka] Osaka Univ, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan; [Katoh, Kazutaka] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo, Japan	Fukushima, N (reprint author), Kinki Univ, Dept Life Sci, Div Mol Neurobiol, Higashiosaka, Osaka 5778502, Japan.	nfukushima@life.kindai.ac.jp; katoh@ifrec.osaka-u.ac.jp		Katoh, Kazutaka/0000-0003-4133-8393	Ministry of Education, Culture, Sports, Science and Technology, Japan	This work was supported by a Grant-in-Aid for Scientific Research on Innovative Areas (to NF) and Platform for Drug Discovery, Informatics, and Structural Life Science (to KK), from the Ministry of Education, Culture, Sports, Science and Technology, Japan. We thank Dr. D. Standley for reading of the manuscript.	Aikawa S, 2014, J BIOCH, V157, P81; Valentine WJ, 2008, J BIOL CHEM, V283, P12175, DOI 10.1074/jbc.M708847200; Ochiai S, 2013, EUR J PHARMACOL, V715, P15, DOI 10.1016/j.ejphar.2013.06.029; Zhang GF, 1999, GENE, V227, P89, DOI 10.1016/S0378-1119(98)00589-7; Inoue A, 2011, EMBO J, V30, P4248, DOI 10.1038/emboj.2011.296; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Hesse M, 2012, MOL BIOL REP, V39, P761, DOI 10.1007/s11033-011-0796-0; Leblanc R, 2015, EXP CELL RES, V333, P183, DOI 10.1016/j.yexcr.2014.11.010; Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Hausmann Jens, 2013, Advances in Biological Regulation, V53, P112, DOI 10.1016/j.jbior.2012.09.010; Geach TJ, 2014, DEVELOPMENT, V141, P940, DOI 10.1242/dev.104901; Bandoh K, 2000, FEBS LETT, V478, P159, DOI 10.1016/S0014-5793(00)01827-5; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Herr KJ, 2011, P NATL ACAD SCI USA, V108, P15444, DOI 10.1073/pnas.1106129108; Whelan S, 2001, MOL BIOL EVOL, V18, P691; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; An SZ, 1998, J BIOL CHEM, V273, P7906, DOI 10.1074/jbc.273.14.7906; Fukushima N, 1998, P NATL ACAD SCI USA, V95, P6151, DOI 10.1073/pnas.95.11.6151; Ye XQ, 2008, BIOL REPROD, V79, P328, DOI 10.1095/biolreprod.108.068783; Lai SL, 2012, DEVELOPMENT, V139, P4439, DOI 10.1242/dev.081745; Choi JW, 2010, ANNU REV PHARMACOL, V50, P157, DOI 10.1146/annurev.pharmtox.010909.105753; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Choi JW, 2013, BBA-MOL CELL BIOL L, V1831, P20, DOI 10.1016/j.bbalip.2012.07.015; Zhao PW, 2013, LIFE SCI, V92, P453, DOI 10.1016/j.lfs.2012.06.039; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Trimbuch T, 2009, CELL, V138, P1222, DOI 10.1016/j.cell.2009.06.050; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Yanagida K, 2011, J BIOCHEM, V150, P223, DOI 10.1093/jb/mvr087; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Regard JB, 2008, CELL, V135, P561, DOI 10.1016/j.cell.2008.08.040; Willier S, 2013, BIOL CELL, V105, P317, DOI 10.1111/boc.201300011; Nakanaga K, 2010, J BIOCHEM, V148, P13, DOI 10.1093/jb/mvq052; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Contos JJA, 2000, GENOMICS, V64, P155, DOI 10.1006/geno.2000.6122; Contos JJA, 2000, MOL PHARMACOL, V58, P1188; Contos JJA, 2001, GENE, V267, P243, DOI 10.1016/S0378-1119(01)00410-3; Felsenstein J, 2004, INFERRING PHYLOGENIE; Fukushima N, 2001, ANNU REV PHARMACOL, V41, P507, DOI 10.1146/annurev.pharmtox.41.1.507; Fukushima N, 2013, LYSOPHOSPHOLIPID REC, P399; Furuta D, 2012, MOL CELL NEUROSCI, V50, P21, DOI 10.1016/j.mcn.2012.03.006; Holmes RS, 2012, BIO-TECHNOL, V2, P263; Ishii S, 2009, PROSTAG OTH LIPID M, V89, P57, DOI 10.1016/j.prostaglandins.2009.06.001; Kimura M, 1985, NEUTRAL THEORY MOL E; Kimura Y, 2001, J BIOL CHEM, V276, P15208, DOI 10.1074/jbc.M011588200; KUMA K, 1995, MOL BIOL EVOL, V12, P123; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee MJ, 1998, SCIENCE, V279, P1552, DOI 10.1126/science.279.5356.1552; Lee SJ, 2008, FASEB J, V22, P3706, DOI 10.1096/fj.08-106088; Li G, 2009, J MOL GRAPH MODEL, V28, P70, DOI 10.1016/j.jmgm.2009.04.004; Lin ME, 2012, J BIOL CHEM, V287, P17608, DOI 10.1074/jbc.M111.330183; Masse K, 2010, INT J DEV BIOL, V54, P1361, DOI 10.1387/ijdb.103068km; Morimoto Y, 2014, GENE, V551, P189, DOI 10.1016/j.gene.2014.08.056; Raza SI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104756; Seki Y, 2014, BIOCHEM BIOPH RES CO, V443, P1141, DOI 10.1016/j.bbrc.2013.12.106; Shano S, 2008, BBA-MOL CELL RES, V1783, P748, DOI 10.1016/j.bbamcr.2007.11.013; Sumida H, 2010, BLOOD, V116, P5060, DOI 10.1182/blood-2010-03-272443; SUTCLIFFE JG, 1988, ANNU REV NEUROSCI, V11, P157, DOI 10.1146/annurev.neuro.11.1.157; Tsujiuchi T, 2014, HISTOL HISTOPATHOL, V29, P313; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Varsano T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049227; Williams JR, 2009, J BIOL CHEM, V284, P17304, DOI 10.1074/jbc.M109.003194; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhao J, 2014, CELL SIGNAL, V26, P2406, DOI 10.1016/j.cellsig.2014.07.005	74	1	1	SPRINGER BASEL AG	BASEL	PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND	1420-682X	1420-9071		CELL MOL LIFE SCI	Cell. Mol. Life Sci.	JUN	2015	72	12					2377	2394		10.1007/s00018-015-1872-8		18	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CI6PS	WOS:000354883500009		
J	Potthast, A; Radosta, S; Saake, B; Lebioda, S; Heinze, T; Henniges, U; Isogai, A; Koschella, A; Kosma, P; Rosenau, T; Schiehser, S; Sixta, H; Strlic, M; Strobin, G; Vorwerg, W; Wetzel, H				Potthast, Antje; Radosta, Sylvia; Saake, Bodo; Lebioda, Sascha; Heinze, Thomas; Henniges, Ute; Isogai, Akira; Koschella, Andreas; Kosma, Paul; Rosenau, Thomas; Schiehser, Sonja; Sixta, Herbert; Strlic, Matija; Strobin, Grazyna; Vorwerg, Waltraud; Wetzel, Hendrik			Comparison testing of methods for gel permeation chromatography of cellulose: coming closer to a standard protocol	CELLULOSE			English	Article						Round robin; Calibration; Carbanilation; Dimethylacetamide lithium chloride (DMAc/LiC1); Multi-angle laser light scattering (MALLS); Refractive index	SIZE-EXCLUSION CHROMATOGRAPHY; MOLECULAR-MASS DISTRIBUTION; SEC-MALLS ANALYSIS; N,N-DIMETHYLACETAMIDE/LITHIUM CHLORIDE; LITHIUM-CHLORIDE; LIGHT-SCATTERING; IONIC LIQUIDS; KRAFT PULP; DISSOLUTION; PULLULAN	A round robin on GPC of a wide range of different pulp samples was conducted among leading groups in cellulose analysis. The aim was to survey the status quo of the methods available to date. The pulp samples covered not only fully-bleached dissolving pulps but also bleached paper pulps and one un-bleached sample. The methods applied were current state-of-the-art GPC with RI, MALLS, and viscosimetry detectors. Different dissolution protocols were compared as well. Following from the obtained results, more standardized protocols were proposed for approaches with different equipment (RI or MALLS/RI) and solvent systems (direct dissolution or derivatization). Major influencing factors, such as derivatization compared to direct solution, calibration versus light scattering and in-between lab variation, were discussed.	[Potthast, Antje; Henniges, Ute; Rosenau, Thomas; Schiehser, Sonja] Univ Nat Resources & Life Sci, Dept Chem, Div Chem Renewable Resources, A-3430 Tulln, Austria; [Radosta, Sylvia; Vorwerg, Waltraud; Wetzel, Hendrik] Fraunhofer Inst Appl Polymer Res IAP, D-14476 Potsdam, Germany; [Saake, Bodo; Lebioda, Sascha] Univ Hamburg, Dept Wood Sci, D-21031 Hamburg, Germany; [Heinze, Thomas; Koschella, Andreas] Univ Jena, Kompetenzzentrum Polysaccharidforsch, D-07743 Jena, Germany; [Isogai, Akira] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Kosma, Paul] Univ Nat Resources & Life Sci, Dept Chem, Div Organ Chem, A-1190 Vienna, Austria; [Sixta, Herbert] Aalto Univ, Vuorimiehentie, Dept Forest Prod Technol, Espoo 02150, Finland; [Strlic, Matija] UCL, Bartlett Sch Grad Studies, London WC1E 6BT, England; [Strobin, Grazyna] Inst Biopolymers & Chem Fibres, PL-90570 Lodz, Poland	Potthast, A (reprint author), Univ Nat Resources & Life Sci, Dept Chem, Div Chem Renewable Resources, Konrad Lorenz Str 24, A-3430 Tulln, Austria.	antje.potthast@boku.ac.at	Sixta, Herbert/A-8071-2013; Strlic, Matija/C-1579-2008				Schelosky N, 1999, PAPIER, V53, P728; SINNER M, 1978, J CHROMATOGR, V156, P197, DOI 10.1016/S0021-9673(00)83140-4; Berggren R, 2003, J APPL POLYM SCI, V88, P1170, DOI 10.1002/app.11767; Burchard W, 1999, ADV POLYM SCI, V143, P113; Bikova T, 2002, CARBOHYD POLYM, V48, P23, DOI 10.1016/S0144-8617(01)00207-7; MCCORMICK CL, 1979, J POLYM SCI POL LETT, V17, P479, DOI 10.1002/pol.1979.130170801; El Seoud OA, 2007, BIOMACROMOLECULES, V8, P2629, DOI 10.1021/bm070062i; Fukaya Y, 2011, CHEM COMMUN, V47, P1994, DOI 10.1039/c0cc05307d; Henniges U, 2011, BIOMACROMOLECULES, V12, P871, DOI 10.1021/bm101555q; Mourey TH, 2004, INT J POLYM ANAL CH, V9, P97, DOI 10.1080/10236660490890510; Strlic M, 2002, J CHROMATOGR A, V964, P47, DOI 10.1016/S0021-9673(02)00591-5; Zhang C, 2014, J PHYS CHEM B, V118, P9507, DOI 10.1021/jp506013c; Rosenau T, 2014, CELLULOSE, V21, P2271, DOI 10.1007/s10570-014-0289-0; DAWSEY TR, 1990, J MACROMOL SCI R M C, VC30, P405; Wang H, 2012, CHEM SOC REV, V41, P1519, DOI 10.1039/c2cs15311d; Roder T, 1999, POLYMER, V40, P4143, DOI 10.1016/S0032-3861(98)00674-0; MCCORMICK CL, 1985, MACROMOLECULES, V18, P2394, DOI 10.1021/ma00154a010; Hasani M, 2013, CARBOHYD POLYM, V98, P1565, DOI 10.1016/j.carbpol.2013.07.001; Sjoholm E, 2000, CARBOHYD POLYM, V41, P153, DOI 10.1016/S0144-8617(99)00080-6; Willfor S, 2009, IND CROP PROD, V29, P571, DOI 10.1016/j.indcrop.2008.11.003; Christensen BE, 2001, CARBOHYD POLYM, V45, P11, DOI 10.1016/S0144-8617(00)00237-X; Morgenstern B, 1999, POLYMER, V40, P1299, DOI 10.1016/S0032-3861(98)00267-5; Arndt KF, 1996, US patent, Patent No. [4,059,457, 4059457]; Barth H. G., 1999, SIZE EXCLUSION CHROM; Barth H. G., 1998, ANAL CHEM, V70, P251, DOI 10.1021/a1980015t; CAROLAN G, 1983, CARBOHYD RES, V114, P237, DOI 10.1016/0008-6215(83)88190-7; CATLEY BJ, 1986, CARBOHYD RES, V153, P79, DOI 10.1016/S0008-6215(00)90197-6; Chrapava S, 2003, PHYS CHEM CHEM PHYS, V5, P1842, DOI 10.1039/b212665f; Dupont AL, 2004, CARBOHYD POLYM, V58, P233, DOI 10.1016/j.carbpol.2004.07.016; Engel P, 2012, BIOTECHNOL BIOFUELS, V5, P8; Gallot-Grubisic Z, 1967, J POLYM SCI, V5, P753; Ganster J, 1999, POLYM HDB, P135; Hall DM, 1973, J APPL POLYM SCI, V17, P3729; Henniges U, 2011, CURR CHROMATOGR, V1, P52; Henniges U, 2007, CELLULOSE, V14, P497, DOI 10.1007/s10570-007-9130-3; Kes M, 2013, J CHROMATOGR A, V1281, P32, DOI 10.1016/j.chroma.2013.01.038; Klemm D., 1998, COMPREHENSIVE CELLUL; Kuroda K, 2013, ANAL METHODS-UK, V5, P3172, DOI 10.1039/c3ay40182k; Leathers TD, 2004, BIOPOLYMERS, V6; McCormick C. L., 1982, MACROMOLECULAR SOLUT, P101; MORGENSTERN B, 1993, ACTA POLYM, V44, P100, DOI 10.1002/actp.1993.010440208; Morgenstern B, 2001, THESIS DRESDEN U TEC; Morgenstern B, 1996, TRENDS POLYM SCI, V4, P87; Mori S, 1998, INT J POLYM ANAL CH, V4, P531, DOI 10.1080/10236669808009733; Podzimek S., 2011, LIGHT SCATTERING SIZ; Potthast A, 2002, POLYMER, V44, P7; Qiu H, 2012, HDB IONIC LIQUIDS PR, P325; Rohrling J, 2002, BIOMACROMOLECULES, V3, P959, DOI 10.1021/bm020029q; Rosenau T, 2001, HOLZFORSCHUNG, V55, P661, DOI 10.1515/HF.2001.107; Siller M, 2014, CELLULOSE, V21, P3291, DOI 10.1007/s10570-014-0356-6; Stol R, 2002, ANAL CHEM, V74, P2314, DOI 10.1021/ac0111309; Strlic M, 2003, J BIOCHEM BIOPH METH, V56, P265, DOI 10.1016/S0165-022X(03)00064-2; TAGUCHI R, 1973, AGR BIOL CHEM TOKYO, V37, P1583; TERBOJEVICH M, 1995, J APPL POLYM SCI, V55, P1663, DOI 10.1002/app.1995.070551206; TIMPA JD, 1991, J AGR FOOD CHEM, V39, P270, DOI 10.1021/jf00002a010; Turbak AF, 1981, US Patent, Patent No. [4,302,252, 4302252, US 4302252 (A)-1981-11-24]; TURBAK AF, 1980, CHEMTECH, V10, P51; WESTERMARK U, 1994, HOLZFORSCHUNG, V48, P146, DOI 10.1515/hfsg.1994.48.s1.146; Yanagisawa M, 2005, BIOMACROMOLECULES, V6, P1258, DOI 10.1021/bm0493686m; Yanagisawa M, 2005, CELLULOSE, V12, P151, DOI 10.1007/s10570-004-0866-8; Yanagisawa M, 2004, CELLULOSE, V11, P169, DOI 10.1023/B:CELL.0000025388.92043.ec	61	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0969-0239	1572-882X		CELLULOSE	Cellulose	JUN	2015	22	3					1591	1613		10.1007/s10570-015-0586-2		23	Materials Science, Paper & Wood; Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CH7CK	WOS:000354193000011		
J	Toyama, K; Soyama, M; Tanaka, S; Iji, M				Toyama, Kiyohiko; Soyama, Makoto; Tanaka, Shukichi; Iji, Masatoshi			Development of cardanol-bonded cellulose thermoplastics: high productivity achieved in two-step heterogeneous process	CELLULOSE			English	Article						Bioplastic; Cellulose; Cardanol; Heterogeneous process; Energy reduction; Solvent reduction	NUT SHELL LIQUID; CASHEW; ACETATE; ESTERS	We developed a heterogeneous process with low energy consumption to synthesize novel high-strength and heat-resistant cellulose-based bioplastics: cellulose esters bonded with a short chain component (acetic acid) and a long one (3-pentadecylphenoxy acetic acid; PAA), which is a derivative of cardanol, extracted from cashew nut shells. Although we recently showed that PAA-bonded cellulose acetates (cardanol-bonded cellulose resins) exhibit highly practical properties for durable products, they were synthesized in a homogeneous process, which requires large quantities of poor solvents to isolate the resins. In the developed two-step heterogeneous process, the cardanol-bonded cellulose resins are produced without poor solvents. In the first step, cellulose is esterified with limited amounts of the long and short chain components using a selected reaction solvent and catalyst. The resultant intermediate products are adequately swollen in the solvent then efficiently recovered by filtration. In the second step, the short chain component is additionally bonded to attain good thermoplasticity of the final products, which are readily recovered only by distilling a solvent and the remaining short chain component. The solvent usage was reduced by approximately 90 % compared with a homogeneous process, which leads to a large reduction in energy. The produced cardanol-bonded cellulose resins exhibited higher thermoplasticity, elastic modulus, water resistivity, and close heat resistivity compared to that of a homogeneous process. Furthermore, the mechanical and thermal characteristics of the resins were greatly improved by adding a specific polyester, polybutylene succinate adipate, and glass fiber, reaching high-level target properties for durable products.	[Toyama, Kiyohiko; Soyama, Makoto; Tanaka, Shukichi; Iji, Masatoshi] NEC Corp Ltd, Smart Energy Res Labs, Tsukuba, Ibaraki 3058501, Japan	Toyama, K (reprint author), NEC Corp Ltd, Smart Energy Res Labs, 34 Miyukigaoka, Tsukuba, Ibaraki 3058501, Japan.	k-toyama@bq.jp.nec.com			Japan Science and Technology Agency's Advanced Low Carbon Technology Research and Development Program (ALCA).	The authors are grateful to Ms. Toshie Miyamoto and Dr. Fumi Tanabe for their support in the experiments. The work was supported by the Japan Science and Technology Agency's Advanced Low Carbon Technology Research and Development Program (ALCA).	Edgar KJ, 2001, PROG POLYM SCI, V26, P1605, DOI 10.1016/S0079-6700(01)00027-2; Freire CSR, 2006, CELL CHEM TECHNOL, V40, P691; Iji M, 2011, POLYM J, V43, P738, DOI 10.1038/pj.2011.57; Iji M, 2013, CELLULOSE, V20, P559, DOI 10.1007/s10570-012-9832-z; Kumar PP, 2002, J AGR FOOD CHEM, V50, P4705, DOI 10.1021/jf020224w; Sealey JE, 1996, J POLYM SCI POL PHYS, V34, P1613, DOI 10.1002/(SICI)1099-0488(19960715)34:9<1613::AID-POLB10>3.0.CO;2-A; Tanaka S, 2013, J APPL POLYM SCI, V130, P1578, DOI [10.1002/APP.39313, 10.1002/app.39313]; Roy D, 2009, CHEM SOC REV, V38, P2046, DOI 10.1039/b808639g; Yan CH, 2009, BIOMACROMOLECULES, V10, P2013, DOI 10.1021/bm900447u; Teramoto Y, 2004, BIOMACROMOLECULES, V5, P407, DOI 10.1021/bm034453i; Serizawa S, 2006, J APPL POLYM SCI, V100, P618, DOI 10.1002/app.23377; Matsumura H, 2000, J APPL POLYM SCI, V78, P2242, DOI 10.1002/1097-4628(20001220)78:13<2242::AID-APP20>3.0.CO;2-5; Teramoto Y, 2003, POLYMER, V44, P2701, DOI 10.1016/S0032-3861(03)00190-3; Lubi MC, 2000, DES MONOMERS POLYM, V3, P123, DOI 10.1163/156855500300142834; Bogan RT, 1985, ENCY POLYM SCI ENG, V3, P158; Edgar KJ, 1998, ACS S SERIES, V688; Enomoto-Rogers Y, 2009, BIOMACROMOLECULES, V10, P2110, DOI 10.1021/bm900229g; Hwan-Man P, 2004, BIOMACROMOLECULES, V5, P2281; Li Shen, 2010, Biofuels, Bioproducts and Biorefining, V4, DOI 10.1002/bbb.189; NIE L, 1994, J APPL POLYM SCI, V54, P601, DOI 10.1002/app.1994.070540511; Soyama M, 2014, POLYM PREPR JPN, V63, P3683; Tanaka S, 2014, 21 ANN M CELL SOC JA, pK18; TEZUKA Y, 1995, CARBOHYD RES, V273, P83, DOI 10.1016/0008-6215(95)00107-5; Toyama K, 2014, 248 ACS NAT M; Toyama K, 2014, POLYM PREPR JPN, V63, P3681; Yoshioka M, 1999, CELLULOSE, V6, P193, DOI 10.1023/A:1009221730934; Zepnik S, 2010, BIOPLASTIC MAGAZINE, V5, P44	27	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0969-0239	1572-882X		CELLULOSE	Cellulose	JUN	2015	22	3					1625	1639		10.1007/s10570-015-0601-7		15	Materials Science, Paper & Wood; Materials Science, Textiles; Polymer Science	Materials Science; Polymer Science	CH7CK	WOS:000354193000013		
J	Tanaka, M				Tanaka, Masahiko			The Dendritic Differentiation of Purkinje Neurons: Unsolved Mystery in Formation of Unique Dendrites	CEREBELLUM			English	Article							CELL DENDRITES; SELF-AVOIDANCE; GRANULE CELLS; MORPHOGENESIS; CEREBELLUM; DYNAMICS; MORPHOLOGY; GROWTH	Purkinje neurons play a central role in cerebellar functions. For Purkinje neurons to play such a role, the unique morphology of their dendrites is important. Purkinje neurons have the most elaborate dendritic trees among neurons in the brain (Fig. 1). They extend long proximal dendrites towards the pial surface. These dendrites branch extensively to form numerous synapses with parallel fibers, axons of granule cells. Purkinje dendrites are formed in a plane that is oriented perpendicular to the long axis of the cerebellum. Such unique dendritic trees differentiate over several postnatal weeks in rodents [1]. To date, many studies have investigated the cellular and molecular mechanisms of the dendritic differentiation of Purkinje neurons [2, 3]. Although those studies identified a number of molecules involved in Purkinje dendrite differentiation, several important aspects concerning differentiation of the unique dendrites remain unclear. This editorial highlights these aspects of the dendritic differentiation of Purkinje neurons (Fig. 2).	Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biophys, Nagoya, Aichi 4678603, Japan	Tanaka, M (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cellular Biophys, Nagoya, Aichi 4678603, Japan.	mtanaka@phar.nagoya-cu.ac.jp					Altman J., 1997, DEV CEREBELLAR SYSTE; Tanaka M, 2009, NEUROCHEM RES, V34, P2078, DOI 10.1007/s11064-009-0073-y; Tanaka M, 2003, J NEUROSCI, V23, P2804; Ohashi R, 2014, DEV NEUROBIOL, V74, P467, DOI 10.1002/dneu.22139; Fujishima K, 2012, DEVELOPMENT, V139, P3442, DOI 10.1242/dev.081315; Gibson DA, 2014, NEURON, V81, P1040, DOI 10.1016/j.neuron.2014.01.009; Lefebvre JL, 2012, NATURE, V488, P517, DOI 10.1038/nature11305; Kessels MM, 2011, EUR J CELL BIOL, V90, P926, DOI 10.1016/j.ejcb.2010.08.011; Miyazaki T, 2004, J NEUROSCI, V24, P1734, DOI 10.1523/JNEUROSCI.4208-03.2004; Haag N, 2012, J NEUROSCI, V32, P17842, DOI 10.1523/JNEUROSCI.0843-12.2012; ARMENGOL JA, 1991, DEV BRAIN RES, V64, P95, DOI 10.1016/0165-3806(91)90213-3; HENDELMAN WJ, 1980, J COMP NEUROL, V193, P1063, DOI 10.1002/cne.901930417; Hisatsune C, 2006, J NEUROSCI, V26, P10916, DOI 10.1523/JNEUROSCI.3269-06.2006; Kaneko M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020108; Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002; Lohmann C, 2005, CELL CALCIUM, V37, P403, DOI 10.1016/j.ceca.2005.01.008; Lordkipanidze T, 2005, GLIA, V51, P229, DOI 10.1002/glia.20200; Petrinovic MM, 2013, P NATL ACAD SCI USA, V110, P1083, DOI 10.1073/pnas.1214255110; Tanaka M, 2006, NEUROSCIENCE, V141, P663, DOI 10.1016/j.neuroscience.2006.04.044	19	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	JUN	2015	14	3					227	230		10.1007/s12311-014-0585-0		4	Neurosciences	Neurosciences & Neurology	CI8AL	WOS:000354989700001		
J	Shih, EK; Sekerkova, G; Ohtsuki, G; Aldinger, KA; Chizhikov, VV; Hansel, C; Mugnaini, E; Millen, KJ				Shih, Evelyn K.; Sekerkova, Gabriella; Ohtsuki, Gen; Aldinger, Kimberly A.; Chizhikov, Victor V.; Hansel, Christian; Mugnaini, Enrico; Millen, Kathleen J.			The Spontaneous Ataxic Mouse Mutant Tippy is Characterized by a Novel Purkinje Cell Morphogenesis and Degeneration Phenotype	CEREBELLUM			English	Article						Cerebellum; Climbing fibers; Dendritogenesis; Purkinje cell degeneration; Spinogenesis	GLUTAMATE-RECEPTOR DELTA-2; CEREBELLAR CORTEX; MULTIPLE INNERVATION; CLIMBING FIBERS; RAT CEREBELLUM; SYNAPTIC CURRENTS; AXON DEGENERATION; MATURE CEREBELLUM; MICE; STAGGERER	This study represents the first detailed analysis of the spontaneous neurological mouse mutant, tippy, uncovering its unique cerebellar phenotype. Homozygous tippy mutant mice are small, ataxic, and die around weaning. Although the cerebellum shows grossly normal foliation, tippy mutants display a complex cerebellar Purkinje cell phenotype consisting of abnormal dendritic branching with immature spine features and patchy, non-apoptotic cell death that is associated with widespread dystrophy and degeneration of the Purkinje cell axons throughout the white matter, the cerebellar nuclei, and the vestibular nuclei. Moderate anatomical abnormalities of climbing fiber innervation of tippy mutant Purkinje cells were not associated with changes in climbing fiber-EPSC amplitudes. However, decreased ESPC amplitudes were observed in response to parallel fiber stimulation and correlated well with anatomical evidence for patchy dark cell degeneration of Purkinje cell dendrites in the molecular layer. The data suggest that the Purkinje neurons are a primary target of the tippy mutation. Furthermore, we hypothesize that the Purkinje cell axonal pathology together with disruptions in the balance of climbing fiber and parallel fiber-Purkinje cell input in the cerebellar cortex underlie the ataxic phenotype in these mice. The constellation of Purkinje cell dendritic malformation and degeneration phenotypes in tippy mutants is unique and has not been reported in any other neurologic mutant. Fine mapping of the tippy mutation to a 2.1 MB region of distal chromosome 9, which does not encompass any gene previously implicated in cerebellar development or neuronal degeneration, confirms that the tippy mutation identifies novel biology and gene function.	[Shih, Evelyn K.] Childrens Hosp Philadelphia, Div Neurol, Philadelphia, PA 19104 USA; [Sekerkova, Gabriella] Northwestern Univ, Dept Physiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ohtsuki, Gen] Kyushu Univ, Grad Sch Med Sci, Dept Mol Physiol, Higashi Ku, Fukuoka 8128582, Japan; [Aldinger, Kimberly A.; Millen, Kathleen J.] Seattle Childrens Res Inst, Ctr Integrat Brain Res, Seattle, WA 98101 USA; [Chizhikov, Victor V.] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, Memphis, TN 38163 USA; [Hansel, Christian] Univ Chicago, Dept Neurobiol, Chicago, IL 60637 USA; [Mugnaini, Enrico] Northwestern Univ, Feinberg Sch Med, Dept Cellular & Mol Biol, Chicago, IL 60611 USA; [Mugnaini, Enrico] Northwestern Univ, Hugh Knowles Ctr, Chicago, IL 60611 USA; [Millen, Kathleen J.] Univ Washington, Dept Pediat, Seattle, WA 98101 USA	Millen, KJ (reprint author), Seattle Childrens Res Inst, Ctr Integrat Brain Res, 1900 Ninth Ave Mailstop JMB-10, Seattle, WA 98101 USA.	kathleen.millen@seattlechildrens.org			NIH [R03NS065382, R01NS050386, R01 NS072441, R01 NS09904, T32 GM007281]; NRSA [F31NS061436-01]; NWO-ALW [817.02.013]; Brain Research Foundation	We thank M. Rose Rogers, Nicholas Trojanowski, and Paul Wakenight for their invaluable technical assistance. This work was supported by NIH grants R03NS065382 (KJM), R01NS050386 and R01 NS072441 (KJM), R01 NS09904 (EM), T32 GM007281 (EKS), NRSA F31NS061436-01 (EKS), with additional funding from NWO-ALW 817.02.013 (CH) and the Brain Research Foundation (KJM).	MULLEN RJ, 1976, P NATL ACAD SCI USA, V73, P208, DOI 10.1073/pnas.73.1.208; Kaja S, 2011, NEUROSCIENCE, V175, P281, DOI 10.1016/j.neuroscience.2010.11.010; Gudbjartsson DF, 2005, NAT GENET, V37, P1015, DOI 10.1038/ng1005-1015; Grusser-Cornehls U, 2001, PROG NEUROBIOL, V63, P489, DOI 10.1016/S0301-0082(00)00024-1; SOTELO C, 1979, BRAIN RES, V175, P11, DOI 10.1016/0006-8993(79)90511-0; LANDIS DMD, 1978, J COMP NEUROL, V179, P831, DOI 10.1002/cne.901790408; Eskelinen EL, 2009, BBA-MOL CELL RES, V1793, P664, DOI 10.1016/j.bbamcr.2008.07.014; SIDMAN RL, 1962, SCIENCE, V137, P610, DOI 10.1126/science.137.3530.610; Chizhikov VV, 2007, J NEUROSCI, V27, P9780, DOI 10.1523/JNEUROSCI.5586-06.2007; Sarna JR, 2003, PROG NEUROBIOL, V70, P473, DOI 10.1016/S0301-0082(03)00114-X; Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576; Coleman M, 2005, NAT REV NEUROSCI, V6, P889, DOI 10.1038/nrn1788; Yang DS, 2008, AM J PATHOL, V173, P665, DOI 10.2353/ajpath.2008.071176; Saxena S, 2007, PROG NEUROBIOL, V83, P174, DOI 10.1016/j.pneurobio.2007.07.007; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; MARIANI J, 1982, J NEUROBIOL, V13, P119, DOI 10.1002/neu.480130204; PERKEL DJ, 1990, P ROY SOC B-BIOL SCI, V241, P116, DOI 10.1098/rspb.1990.0074; Faust PL, 2003, J COMP NEUROL, V461, P394, DOI 10.1002/cne.10699; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Chizhikov VV, 2004, DEVELOPMENT, V131, P2693, DOI 10.1242/dev.01139; Matsubayashi Y, 2008, J NEUROSCI METH, V174, P71, DOI 10.1016/j.jneumeth.2008.07.003; Fischer LR, 2007, NEURODEGENER DIS, V4, P431, DOI 10.1159/000107704; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Barclay J, 2001, J NEUROSCI, V21, P6095; SOTELO C, 1974, BRAIN RES, V67, P519, DOI 10.1016/0006-8993(74)90499-5; Hering H, 2001, NAT REV NEUROSCI, V2, P880, DOI 10.1038/35104061; Cesa R, 2009, NEUROSCIENCE, V162, P624, DOI 10.1016/j.neuroscience.2009.02.061; Hashimoto K, 2009, NEUROSCIENCE, V162, P601, DOI 10.1016/j.neuroscience.2008.12.037; Meisler MH, 1997, ANN MED, V29, P569, DOI 10.3109/07853899709007484; Wishart TM, 2006, J NEUROPATH EXP NEUR, V65, P733, DOI 10.1097/01.jnen.0000228202.35163.c4; KONNERTH A, 1990, P NATL ACAD SCI USA, V87, P2662, DOI 10.1073/pnas.87.7.2662; MUGNAINI E, 1987, ARCH ITAL BIOL, V126, P41; LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197; Cesa R, 2003, J NEUROSCI, V23, P2363; Cesa R, 2005, EUR J NEUROSCI, V22, P579, DOI 10.1111/j.1460-9568.2005.04244.x; CREPEL F, 1981, DEV BRAIN RES, V1, P59, DOI 10.1016/0165-3806(81)90094-8; CREPEL F, 1982, TRENDS NEUROSCI, V5, P266, DOI 10.1016/0166-2236(82)90168-0; Doulazmi M, 2001, DEV BRAIN RES, V127, P165, DOI 10.1016/S0165-3806(01)00131-6; Fisher LR, 2004, EXP NEUROL, V185, P20534; HERRUP K, 1983, DEV BRAIN RES, V11, P267, DOI 10.1016/0165-3806(83)90225-0; Hirano T, 2006, MOL NEUROBIOL, V33, P1, DOI 10.1385/MN:33:1:001; Ichikawa R, 2002, J NEUROSCI, V22, P8487; Ideraabdullah FY, 2007, BIOL REPROD, V76, P286, DOI 10.1095/biolreprod.106.056739; Ivannikov MV, 2010, CELL CALCIUM, V47, P507, DOI 10.1016/j.ceca.2010.04.004; Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002; Landsend AS, 1997, J NEUROSCI, V17, P834; Lane P. W., 1995, Mouse Genome, V93, P158; Larramendi E M, 1967, Brain Res, V5, P15; Morando L, 2001, P NATL ACAD SCI USA, V98, P9954, DOI 10.1073/pnas.171098398; Ohtsuki G, 2008, EUR J NEUROSCI, V28, P2393, DOI 10.1111/j.1460-9568.2008.06539.x; Ohtsuki G, 2009, FRONT CELL NEUROSCI, V3, DOI 10.3389/neuro.03.004.2009; Palay SL, 1974, CEREBELLAR CORTEX; PFENNING.K, 1969, BRAIN RES, V12, P10, DOI 10.1016/0006-8993(69)90051-1; RAKIC P, 1973, J COMP NEUROL, V152, P133, DOI 10.1002/cne.901520203; Resibois A, 2004, ACTA NEUROPATHOL, V107, P553, DOI 10.1007/s00401-004-0846-y; Rossi F, 1995, PROG NEUROBIOL, V47, P341, DOI 10.1016/0301-0082(95)00027-5; ROSSI F, 1991, J COMP NEUROL, V308, P536, DOI 10.1002/cne.903080404; Scelfo B, 2005, EUR J NEUROSCI, V21, P971, DOI 10.1111/j.1460-9568.2005.03933.x; Sekerkova G, 2007, NEUROSCIENCE, V145, P116, DOI 10.1016/j.neuroscience.2006.11.061; SIDMAN RL, 1965, SCIENCE, V150, P513, DOI 10.1126/science.150.3695.513; SOTELO C, 1975, BRAIN RES, V94, P19, DOI 10.1016/0006-8993(75)90874-4; SOTELO C, 1973, BRAIN RES, V62, P345, DOI 10.1016/0006-8993(73)90695-1; Takayama C, 1996, DEV BRAIN RES, V92, P147, DOI 10.1016/0165-3806(95)00212-X; WOODWARD DJ, 1974, J NEUROBIOL, V5, P283, DOI 10.1002/neu.480050402	64	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1473-4222	1473-4230		CEREBELLUM	Cerebellum	JUN	2015	14	3					292	307		10.1007/s12311-014-0640-x		16	Neurosciences	Neurosciences & Neurology	CI8AL	WOS:000354989700007		
J	Messina, G; Celauro, E; Atterrato, MT; Giordano, E; Iwashita, S; Dimitri, P				Messina, Giovanni; Celauro, Emanuele; Atterrato, Maria Teresa; Giordano, Ennio; Iwashita, Shintaro; Dimitri, Patrizio			The Bucentaur (BCNT) protein family: a long-neglected class of essential proteins required for chromatin/chromosome organization and function	CHROMOSOMA			English	Review						Bucentaur (BCNT); YETI; ATP-dependent chromatin remodeling complexes; H2A variant; Epigenetics	CHROMATIN REMODELING COMPLEX; DROSOPHILA-MELANOGASTER; HISTONE H2AZ; NUCLEAR-LOCALIZATION; REPETITIVE SEQUENCE; GENE; DNA; HETEROCHROMATIN; EXPRESSION; TIP60	The evolutionarily conserved Bucentaur (BCNT) protein superfamily was identified about two decades ago in bovines, but its biological role has long remained largely unknown. Sparse studies in the literature suggest that BCNT proteins perform important functions during development. Only recently, a functional analysis of the Drosophila BCNT ortholog, called YETI, has provided evidence that it is essential for proper fly development and plays roles in chromatin organization. Here, we introduce the BCNT proteins and comprehensively review data that contribute to clarify their function and mechanistic clues on how they may control development in multicellular organisms.	[Messina, Giovanni; Celauro, Emanuele; Atterrato, Maria Teresa; Dimitri, Patrizio] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Messina, Giovanni; Celauro, Emanuele; Atterrato, Maria Teresa; Dimitri, Patrizio] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Giordano, Ennio] Univ Naples Federico II, Dipartimento Biol, Naples, Italy; [Iwashita, Shintaro] Iwaki Meisei Univ, Fac Pharm, Iwaki, Fukushima 970, Japan	Dimitri, P (reprint author), Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	patrizio.dimitri@gmail.com		Celauro, Emanuele/0000-0002-0781-5873; Messina, Giovanni/0000-0002-7597-4972	Istituto Pasteur-Fondazione Cenci-Bolognetti; Fondazione Roma - Terzo Settore	The research of PD laboratory was supported by grants from Istituto Pasteur-Fondazione Cenci-Bolognetti and Fondazione Roma - Terzo Settore. The authors thank Dr. Si-Young Song, Master Kentaro Nakashima, and Dr. Yoshiko Ohno-Iwashita for the helpful discussion, and for Professor Tomoyasu Inoue for advice in preparing Fig. 7.	Adam J, 2013, ONCOGENE, V33, P2547, DOI DOI 10.1038/0NC.2013.222); ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Baldi S, 2013, CHROMOSOMA, V122, P245, DOI 10.1007/s00412-013-0409-x; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Moustakas A, 2001, J CELL SCI, V114, P4359; Havugimana PC, 2012, CELL, V150, P1068, DOI 10.1016/j.cell.2012.08.011; van Attikum H, 2005, NAT REV MOL CELL BIO, V6, P757, DOI 10.1038/nrm1737; Inman GJ, 2002, J BIOL CHEM, V277, P51008, DOI 10.1074/jbc.M208532200; Wu ML, 2008, J CLIN INVEST, V118, P2076, DOI 10.1172/JCI33715; Luk E, 2007, MOL CELL, V25, P357, DOI 10.1016/j.molcel.2006.12.015; Riggi N, 2007, CANCER LETT, V254, P1, DOI 10.1016/j.canlet.2006.12.009; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Fog CK, 2012, BIOESSAYS, V34, P50, DOI 10.1002/bies.201100107; Kusch T, 2004, SCIENCE, V306, P2084, DOI 10.1126/science.1103455; Couthouis J, 2012, HUM MOL GENET, V21, P2899, DOI 10.1093/hmg/dds116; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Gertow K, 2012, CIRC-CARDIOVASC GENE, V5, P656, DOI 10.1161/CIRCGENETICS.112.963660; Avvakumov N, 2011, MOL CELL, V41, P502, DOI 10.1016/j.molcel.2011.02.013; Fuxreiter M, 2008, NAT CHEM BIOL, V4, P728, DOI 10.1038/nchembio.127; Bickmore WA, 2003, HUM MOL GENET, V2, P207; Bustos-Valenzuela Juan C, 2011, BMC Res Notes, V4, P370, DOI 10.1186/1756-0500-4-370; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Codlin S, 2013, EMBO C FISS YEAST PO; Corradini N, 2003, CHROMOSOMA, V112, P26, DOI 10.1007/s00412-003-0241-9; Dastidar RG, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-30; Diekwisch TGH, 2002, J HISTOCHEM CYTOCHEM, V50, P583; Diekwisch TGH, 1999, GENE, V235, P19, DOI 10.1016/S0378-1119(99)00220-6; Dimitri P, 2003, GENETICA, V117, P209, DOI 10.1023/A:1022996112742; Harmacek L, 2014, DEV NEUROBIOL, V74, P483, DOI 10.1002/dneu.22142; Ishida T, 2007, NUCL ACIDS RES, V35; Iwashita S, 2011, BUCENTAUR BENT GENE, P383, DOI [10.5772/22351., DOI 10.5772/22351]; Iwashita S, 1999, BBA-GEN SUBJECTS, V1427, P408, DOI 10.1016/S0304-4165(99)00049-5; Iwashita S, 2014, 87 ANN M JAP BIOCH S; Iwashita S, 2003, MOL BIOL EVOL, V20, P1556, DOI 10.1093/molbev/msg168; Iwashita S, 2009, GENE, V435, P88, DOI 10.1016/j.gene.2009.01.012; Iwashita S, 2013, 86 ANN M JAP BIOCH S; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Leach BI, 2013, STRUCTURE, V21, P176, DOI 10.1016/j.str.2012.11.011; Leach TJ, 2000, J BIOL CHEM, V275, P23267, DOI 10.1074/jbc.M910206199; Makeyev AV, 2011, CLEFT PALATE-CRAN J, V48, P109, DOI 10.1597/09-093; March-Diaz R, 2009, MOL PLANT, V2, P565, DOI 10.1093/mp/ssp019; Messina G, 2014, J CELL SCI, V127, P2577, DOI 10.1242/jcs.150243; Morillo-Huesca M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012143; Nobukuni T, 1997, J BIOL CHEM, V272, P2801; Ryu HW, 2014, J PROTEOMICS, V102, P137, DOI 10.1016/j.jprot.2014.03.016; Tayal N, 2014, MOL BIOSYST, V10, P1469, DOI 10.1039/c3mb70539k; Tea JS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-5; Thisse B, 2004, FAST RELEASED CLONES; Wisniewski TP, 2003, BIOL CELL, V95, P595, DOI 10.1016/j.biolcel.2003.10.004; Wu WH, 2009, J BIOL CHEM, V284, P6200, DOI 10.1074/jbc.M808830200	57	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0009-5915	1432-0886		CHROMOSOMA	Chromosoma	JUN	2015	124	2					153	162		10.1007/s00412-014-0503-8		10	Biochemistry & Molecular Biology; Genetics & Heredity	Biochemistry & Molecular Biology; Genetics & Heredity	CJ0EG	WOS:000355146500003		
J	Yamagami, Y; Tozuka, T				Yamagami, Yoko; Tozuka, Tomoki			Interdecadal changes of the Indian Ocean subtropical dipole mode	CLIMATE DYNAMICS			English	Article							SEA-SURFACE TEMPERATURE; MIXED-LAYER DEPTH; SOUTHERN-HEMISPHERE; ATMOSPHERIC CIRCULATION; ANNULAR MODE; COUPLED GCM; VARIABILITY; ATLANTIC; SUMMER; EVENTS	Using observational data and outputs from an ocean general circulation model, the interdecadal changes in the Indian Ocean subtropical dipole (IOSD) are investigated for the first time. It is found that the frequency of the IOSD has become higher because of a decreasing trend in the mixed layer depth (MLD) over the southwestern pole in January and February. Positive (negative) sea surface temperature (SST) anomalies associated with the IOSD are generated when the mixed layer becomes anomalously shallow (deep). The thinner mixed layer in the recent decade amplifies this effect and even weak atmospheric forcing may trigger the IOSD. From a diagnosis of the Monin-Obukhov depth, it is shown that an increasing trend of surface heat flux, which is due to the decrease of wind speed (increase of specific humidity near the sea surface) associated with the poleward shift of westerly jet in January (the strengthening of Mascarene high in February), causes the decreasing trend of the MLD. On the other hand, the smaller amplitude in the recent decades is because the IOSD starts to develop in December, but the deeper mixed layer in December in the recent decade provides an unfavorable condition for its development. In addition, the shallower mixed layer in January and February may also amplify the negative feedback processes that damp the SST anomalies. Since no interdecadal changes in interannual variability of atmospheric forcing corresponding to that in the IOSD are observed, the interdecadal trend in the MLD is essential for that of the IOSD.	[Yamagami, Yoko; Tozuka, Tomoki] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, Tokyo 1130033, Japan	Yamagami, Y (reprint author), Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	yamagami@eps.s.u-tokyo.ac.jp	Tozuka, Tomoki/A-1805-2009				Reason CJC, 2001, GEOPHYS RES LETT, V28, P2225, DOI 10.1029/2000GL012735; ALLAN RJ, 1995, J CLIMATE, V8, P1853, DOI 10.1175/1520-0442(1995)008<1853:MVITCS>2.0.CO;2; Behera SK, 2001, GEOPHYS RES LETT, V28, P327, DOI 10.1029/2000GL011451; Kushner PJ, 2001, J CLIMATE, V14, P2238, DOI 10.1175/1520-0442(2001)014<0001:SHACRT>2.0.CO;2; Zheng XT, 2013, J CLIMATE, V26, P6067, DOI 10.1175/JCLI-D-12-00638.1; Nan S, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018381; Morioka Y, 2013, CLIM DYNAM, V41, P1955, DOI 10.1007/s00382-012-1584-9; Chiodi AM, 2007, J CLIMATE, V20, P4835, DOI 10.1175/JCLI4271.1; Chang P, 2006, J CLIMATE, V19, P5122, DOI 10.1175/JCLI3903.1; Rayner NA, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002670; Hermes JC, 2005, J CLIMATE, V18, P2864, DOI 10.1175/JCLI3422.1; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Tozuka T, 2007, J CLIMATE, V20, P2881, DOI 10.1175/JCLI4168.1; Tozuka T, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005547; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Terray P, 2011, CLIM DYNAM, V36, P2171, DOI 10.1007/s00382-010-0825-z; Yin JH, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023684; Terray P, 2003, CLIM DYNAM, V21, P593, DOI 10.1007/s00382-003-0354-0; Sallee JB, 2010, NAT GEOSCI, V3, P273, DOI [10.1038/ngeo812, 10.1038/NGEO812]; Fauchereau N, 2003, INT J CLIMATOL, V23, P663, DOI 10.1002/joc.905; Tozuka T, 2014, GEOPHYS RES LETT, V41, P2447, DOI 10.1002/2014GL059624; Thompson DWJ, 2000, J CLIMATE, V13, P1000, DOI 10.1175/1520-0442(2000)013<1000:AMITEC>2.0.CO;2; Fischer AS, 2005, J CLIMATE, V18, P3428, DOI 10.1175/JCLI3478.1; PAULSON CA, 1977, J PHYS OCEANOGR, V7, P952, DOI 10.1175/1520-0485(1977)007<0952:IMITUO>2.0.CO;2; Torrence C, 1998, B AM METEOROL SOC, V79, P61, DOI 10.1175/1520-0477(1998)079<0061:APGTWA>2.0.CO;2; Cai WJ, 2013, NAT GEOSCI, V6, P999, DOI 10.1038/NGEO2009; Suzuki R, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001974; Yamagata T, 2004, GEOPHYS MONOGR SER, V147, P189; McPhaden MJ, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051826; Zheng XT, 2010, J CLIMATE, V23, P1240, DOI 10.1175/2009JCLI3326.1; Morioka Y, 2012, J CLIMATE, V25, P4029, DOI 10.1175/JCLI-D-11-00396.1; QIU B, 1993, J PHYS OCEANOGR, V23, P2027, DOI 10.1175/1520-0485(1993)023<2027:UOHBIT>2.0.CO;2; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; Kataoka T, 2012, CLIM DYNAM, V39, P1385, DOI 10.1007/s00382-011-1271-2; KRAUS EB, 1967, TELLUS, V19, P98; Levitus S, 1994, WORLD OCEAN ATLAS 19, V3, P99; Levitus S., 1994, NOAA ATLAS NESDIS, V4, P117; Morioka Y, 2010, CLIM DYNAM, V35, P1075, DOI 10.1007/s00382-010-0843-x; Pacanowski RC, 1999, MOM 3 MANUAL, P680; Reason CJC, 1998, METEOROL ATMOS PHYS, V69, P49, DOI 10.1007/BF01025183; Reason CJC, 1996, J CLIMATE, V9, P97, DOI 10.1175/1520-0442(1996)009<0097:DROTOC>2.0.CO;2; Yuan CX, 2014, CLIM DYNAM, V42, P1291, DOI 10.1007/s00382-013-1704-1	42	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0930-7575	1432-0894		CLIM DYNAM	Clim. Dyn.	JUN	2015	44	11-12					3057	3066		10.1007/s00382-014-2202-9		10	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CI4GH	WOS:000354705700009		
J	Tanaka, S; Iwamoto, M; Kimura, K; Matsunami, N; Morishima, H; Yoshidome, K; Nomura, T; Morimoto, T; Yamamoto, D; Tsubota, Y; Kobayashi, T; Uchiyamal, K				Tanaka, Satoru; Iwamoto, Mitsuhiko; Kimura, Kosei; Matsunami, Nobuki; Morishima, Hirotaka; Yoshidome, Katsuhide; Nomura, Takashi; Morimoto, Takashi; Yamamoto, Daigo; Tsubota, Yu; Kobayashi, Toshihiro; Uchiyamal, Kazuhisa			Phase II Study of Neoadjuvant Anthracycline-Based Regimens Combined With Nanoparticle Albumin-Bound Paclitaxel and Trastuzumab for Human Epidermal Growth Factor Receptor 2-Positive Operable Breast Cancer	CLINICAL BREAST CANCER			English	Article						Human epidermal growth factor receptor 2; Nanoparticle albumin-bound paclitaxel; Neoadjuvant chemotherapy; Pathologic complete response; Trastuzumab	PLUS TRASTUZUMAB; OPEN-LABEL; RANDOMIZED-TRIAL; CHEMOTHERAPY; THERAPY; MULTICENTER; EPIRUBICIN; PERTUZUMAB; SURVIVAL; SAFETY	We treated patients with operable human epidermal growth factor receptor 2-positive breast cancer with neoadjuvant anthracycline regimens followed by nanoparticle albumin-bound paclitaxel plus trastuzumab. Of the 44 patients, 49% achieved a pathologic complete response (pCR). The pCR rate was 36% and 71% in the patients with estrogen receptor-positive and -negative cancer, respectively. Neoadjuvant therapy using this combination appears to be effective and safe. Introduction: Neoadjuvant chemotherapy plus trastuzumab results in a 30% to 50% pathologic complete response (pCR) rate in human epidermal growth factor receptor 2 (HER2)-positive breast cancer and has been associated with improved therapeutic outcomes. Thus, the pCR rate can be useful in evaluating novel agents in this patient population. Nanoparticle albumin-bound (nab)-paclitaxel (PTX) can reduce the toxicity of PTX while maintaining its efficacy. The present study evaluated the activity and safety of nab-PTX as a neoadjuvant treatment of HER2 breast cancer. Patients and Methods: We treated patients with stage I to IIIA breast cancer using neoadjuvant epirubicin/cyclophosphamide (EC) or 5-fluorouracil/epirubicin/cyclophosphamide every 3 weeks (q3w) for 4 cycles, followed by nab-PTX (260 mg/m(2)) plus trastuzumab q3w for 4 cycles. The primary endpoint was the pCR rate. The secondary endpoints included the clinical response rate, disease-free survival, pathologic response rate (defined as pCR or minimal residual invasive disease only in the breast), breast-conserving surgery rate, and safety. Results: Forty-six patients were enrolled. One patient met the exclusion criteria because of the coexistence of another malignant disease; therefore, we evaluated 45 patients in the entire study. One patient experienced rapid disease progression during EC therapy, leaving 44 patients evaluable for nab-PTX treatment. Of the 45 patients, 49% achieved a pCR. The pCR rate was 36% and 71% in those with estrogen receptor-positive and -negative cancer, respectively. Of all the study treatments, the most frequent reason for delay or dose reduction was hematologic toxicity; only 1 patient required a dose reduction for nab-PTX because of peripheral neuropathy. Conclusion: Neoadjuvant therapy using this combination appears to be effective and safe.	[Tanaka, Satoru; Iwamoto, Mitsuhiko; Kimura, Kosei; Uchiyamal, Kazuhisa] Osaka Med Coll Hosp, Dept Breast & Endocrine Surg, Takatsuki, Osaka 5698686, Japan; [Matsunami, Nobuki; Morishima, Hirotaka] Osaka Rosai Hosp, Dept Breast Surg, Osaka, Japan; [Yoshidome, Katsuhide] Osaka Police Hosp, Dept Breast Surg, Osaka, Japan; [Nomura, Takashi; Morimoto, Takashi] Yao Municipal Hosp, Dept Breast Surg, Osaka, Japan; [Yamamoto, Daigo; Tsubota, Yu] Kansai Med Univ, Takii Hosp, Dept Breast Surg, Osaka, Japan; [Kobayashi, Toshihiro] Takatsuki Red Cross Hosp, Dept Breast Surg, Osaka, Japan	Tanaka, S (reprint author), Osaka Med Coll Hosp, Dept Breast & Endocrine Surg, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	sur112@poh.osaka-med.ac.jp					Ibrahim NK, 2002, CLIN CANCER RES, V8, P1038; Schneeweiss A, 2013, ANN ONCOL, V24, P2278, DOI 10.1093/annonc/mdt182; Kaufmann M, 2003, J CLIN ONCOL, V21, P2600, DOI 10.1200/JCO.2003.01.136; Gradishar WJ, 2005, J CLIN ONCOL, V23, P7794, DOI 10.1200/JCO.2005.04.937; Pierga JY, 2010, BREAST CANCER RES TR, V122, P429, DOI 10.1007/s10549-010-0939-3; Robidoux A, 2010, CLIN BREAST CANCER, V10, P81, DOI [10.3816/CBC.2010.n.011, 10.3816/CBC.2010.011]; von Minckwitz G, 2012, J CLIN ONCOL, V30, P1796, DOI 10.1200/JCO.2011.38.8595; Buchholz TA, 2008, J CLIN ONCOL, V26, P791, DOI 10.1200/JCO.2007.15.0326; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Valachis A, 2011, BREAST, V20, P485, DOI 10.1016/j.breast.2011.06.009; Untch M, 2011, J CLIN ONCOL, V29, P3351, DOI 10.1200/JCO.2010.31.4930; Buzdar AU, 2005, J CLIN ONCOL, V23, P3676, DOI 10.1200/JCO.2005.07.032; Buzdar AU, 2013, LANCET ONCOL, V14, P1317, DOI 10.1016/S1470-2045(13)70502-3; Buzdar AU, 2007, CLIN CANCER RES, V13, P228, DOI 10.1158/1078-0432.CCR-06-1345; Ismael G, 2012, LANCET ONCOL, V13, P869, DOI 10.1016/S1470-2045(12)70329-7; Anton A, 2011, ANN ONCOL, V22, P74, DOI 10.1093/annonc/mdq317; Burstein HJ, 2003, J CLIN ONCOL, V21, P46, DOI 10.1200/JCO.2003.03.124; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Mariani G, 2009, NAT CLIN PRACT ONCOL, V6, P93, DOI 10.1038/ncponc1298; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Tolaney SM, 2013, CANCER RES, V73, DOI 10.1158/0008-5472.SABCS13-S1-04	24	0	0	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	JUN	2015	15	3					191	196		10.1016/j.clbc.2014.12.003		6	Oncology	Oncology	CI6YM	WOS:000354910100004		
J	Yanai, A; Inoue, N; Yagi, T; Nishimukai, A; Miyagawa, Y; Murase, K; Imamura, M; Enomoto, Y; Takatsuka, Y; Watanabe, T; Hirota, S; Sasa, M; Katagiri, T; Miyoshi, Y				Yanai, Ayako; Inoue, Natsuko; Yagi, Tomoko; Nishimukai, Arisa; Miyagawa, Yoshimasa; Murase, Keiko; Imamura, Michiko; Enomoto, Yukie; Takatsuka, Yuichi; Watanabe, Takahiro; Hirota, Seiichi; Sasa, Mitsunori; Katagiri, Toyomasa; Miyoshi, Yasuo			Activation of mTOR/S6K But Not MAPK Pathways Might Be Associated With High Ki-67, ER+, and HER2(-) Breast Cancer	CLINICAL BREAST CANCER			English	Article						Akt; Breast Cancer; Ki67; PI3K; S6 kinase	ESTROGEN-RECEPTOR-ALPHA; MOLECULAR PORTRAITS; PROTEIN-KINASE; TUMORS; RESISTANCE; PTEN	We determined the activation of the phosphoinositide 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways in 108 cases of estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancer with high and low Ki-67 expression. The expression levels of Ki-67, p53, phosphorylated MAPK (pMAPK), and protein S6 (pS6; downstream molecule of PI3K/Akt/mammalian target of rapamycin/S6 kinase pathway) were determined immunohistochemically. pS6 positivity, but not pMAPK positivity, was significantly associated with the high Ki-67 expression subset. Background: Evaluation of luminal A and luminal B characteristics of estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is considered important. Although the phosphoinositide 3 kinase (PI3K) and mitogen-activated protein kinase (MAPK) signaling pathways are thought to be involved in the luminal B subtype, the details of their contribution to breast cancer remain unclear. Materials and Methods: We determined the activation of these pathways (phosphorylated MAPK [pMAPK] and protein S6 [pS6; a downstream molecule of PI3K/Akt/mammalian target of rapamycin (mTOR)/S6 kinase (S6K)]) in 108 ER+, HER2(-) breast cancer cases with high and low Ki-67 expression. The ER, progesterone receptor (PgR), Ki-67, p53 expression levels were also determined immunohistochemically. The cutoff value for Ki-67 was set at 15%. Results: A significantly greater percentage of cancer cases with high Ki-67 expression showed pS6 positivity than did those with low Ki-67 expression (53.2% vs. 19.7%; P = .0003). No significant differences were found between the cases with high and low expression levels were detected for p53 (23.4% vs. 11.5%; P = .12) or pMAPK (36.2% vs. 34.4%; P = .85) positivity. Multivariate analysis showed that pS6 positivity (odds ratio 5.16, 95% confidence interval 1.95-13.63; P = .0009), nuclear grade 2 and 3, and low PgR expression (<= 20%) were independently associated with the high Ki-67 subset. Conclusion: From our findings, we have concluded that the pS6 expression level is associated with the characteristics of breast cancer with high Ki-67 expression. Because these associations were observed, irrespective of menopausal status, the biologic difference seems to be less affected by estrogen signaling than by activation of S6 protein, especially in terms of proliferation. Our findings have also indicated that targeting the mTOR/S6K pathway might be a useful strategy for the treatment of ER+/HER2(-) breast cancer with high Ki-67 expression.	[Yanai, Ayako; Inoue, Natsuko; Yagi, Tomoko; Nishimukai, Arisa; Miyagawa, Yoshimasa; Murase, Keiko; Imamura, Michiko; Enomoto, Yukie; Takatsuka, Yuichi; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo 6638501, Japan; [Watanabe, Takahiro; Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Sasa, Mitsunori] Tokushima Breast Care Clin, Tokushima, Tokushima, Japan; [Katagiri, Toyomasa] Univ Tokushima, Inst Genome Res, Div Genome Med, Tokushima, Tokushima, Japan	Miyoshi, Y (reprint author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	ymiyoshi@hyo-med.ac.jp			Hyogo College of Medicine	The present study was supported by the grant of Hyogo College of Medicine.	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Gori S, 2009, ANN ONCOL, V20, P648, DOI 10.1093/annonc/mdn681; Creighton CJ, 2006, CANCER RES, V66, P3903, DOI 10.1158/0008-5472.CAN-05-4363; Sun CH, 2011, HISTOPATHOLOGY, V58, P1054, DOI 10.1111/j.1365-2559.2011.03856.x; Yamnik RL, 2009, J BIOL CHEM, V284, P6361, DOI 10.1074/jbc.M807532200; Dillon RL, 2007, ONCOGENE, V26, P1338, DOI 10.1038/sj.onc.1210202; Yamashita H, 2009, CANCER SCI, V100, P2028, DOI 10.1111/j.1349-7006.2009.01274.x; Generali D, 2009, J CLIN ONCOL, V27, P227, DOI 10.1200/JCO.2007.13.7083; Beelen K, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3598; Creighton CJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2594; Kim EK, 2011, BREAST CANCER RES TR, V126, P93, DOI 10.1007/s10549-010-1315-z; Linderholm BK, 2011, BREAST CANCER RES TR, V125, P457, DOI 10.1007/s10549-010-1252-x; Millar EKA, 2011, BRIT J CANCER, V105, P272, DOI 10.1038/bjc.2011.228; Murase K, 2014, BREAST CANCER-TOKYO, V21, P52, DOI 10.1007/s12282-012-0348-z; Sakamoto Goi, 2005, Breast Cancer, V12 Suppl, pS1; Song CH, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2557; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412	19	1	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	JUN	2015	15	3					197	203		10.1016/j.clbc.2014.12.002		7	Oncology	Oncology	CI6YM	WOS:000354910100005		
J	Nishimukai, A; Yagi, T; Yanai, A; Miyagawa, Y; Enomoto, Y; Murase, K; Imamura, M; Takatsuka, Y; Sakita, I; Hatada, T; Miyoshi, Y				Nishimukai, Arisa; Yagi, Tomoko; Yanai, Ayako; Miyagawa, Yoshimasa; Enomoto, Yukie; Murase, Keiko; Imamura, Michiko; Takatsuka, Yuichi; Sakita, Isao; Hatada, Takuya; Miyoshi, Yasuo			High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast Cancer	CLINICAL BREAST CANCER			English	Article						Breast cancer; Ki-67; Postmenopausal; Progesterone receptor; Prognostic factor	CENTRALLY REVIEWED EXPRESSION; PREDICTIVE-VALUE; MAMMARY-GLAND; TAMOXIFEN; SUBTYPES; THERAPY; CELLS; TRIAL	We examined the prognostic significance of progesterone receptor (PgR) expression in immunohistochemical-based luminal subtypes defined by Ki-67 expression, taking menopausal status into consideration. The study included 327 surgically removed estrogen receptor-positive and human epidermal growth factor receptor 2-negative breast cancers. High Ki-67 expression (> 15%) and low PgR expression (<= 20%) were significant independent factors resulting in worse distant relapse-free survival. This association was observed in postmenopausal women but not in premenopausal women. Background: Accurate classification of luminal A and luminal B characteristics of estrogen receptor (ER)-positive and human epidermal growth factor receptor 2 (HER2)-negative breast cancer is considered clinically important for determining effective adjuvant treatment. Although Ki-67 expression has been identified as an essential constituent for this classification, the role of progesterone receptor (PgR) expression has yet to be fully elucidated. Because PgR expression is influenced by the estrogen milieu, we examined the prognostic significance of PgR expression in immunohistochemical (IHC)-based luminal subtypes defined by Ki-67 expression, taking menopausal status into consideration. Materials and Methods: We examined 327 surgically removed ER+ and HER2(-) breast cancer specimens. ER, PgR, and Ki67 expression was determined IHC for semiquantitative measurement. We used 1%, 20%,, and 15% as the cutoff value for ER, PgR, and Ki-67, respectively. Results: Breast cancer with low PgR (<= 20%) expression was significantly associated with postmenopausal status, a large tumor size, and low ER expression. The low PgR expression subset had significantly worse distant relapse-free survival (DRFS) than the high PgR expression I subset (P = .0067). This association was observed consistently in postmenopausal women but not in the premenopausal women. Multivariate analysis demonstrated that high Ki-67 expression (hazard ratio [HR], 3.80; 95% confidence interval [CI], 1.57-10.58; P = .003) and low PgR expression (HR, 2.54; 95% CI, 1.08-6.40; P = .038) were significant independent factors affecting DRFS. Conclusion: Low PgR expression was independently associated with a poorer prognosis for ER+ and HER2(-) breast cancer. Determination of PgR expression combined with that of Ki-67 could thus improve the accuracy of IHC-based classification of luminal A and luminal B breast cancer, especially for postmenopausal women.	[Nishimukai, Arisa; Yagi, Tomoko; Yanai, Ayako; Miyagawa, Yoshimasa; Enomoto, Yukie; Murase, Keiko; Imamura, Michiko; Takatsuka, Yuichi; Miyoshi, Yasuo] Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Nishinomiya, Hyogo 6638501, Japan; [Sakita, Isao] Sakita Clin, Nishinomiya, Hyogo, Japan; [Hatada, Takuya] Uminosato Clin, Minamiawaji, Hyogo, Japan	Miyoshi, Y (reprint author), Hyogo Coll Med, Dept Surg, Div Breast & Endocrine, Mukogawa Cho 1-1, Nishinomiya, Hyogo 6638501, Japan.	ymiyoshi@hyo-med.ac.jp			Hyogo College of Medicine	The present study was supported by the grant of Hyogo College of Medicine.	Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Cheang MCU, 2009, J NATL CANCER I, V101, P736, DOI 10.1093/jnci/djp082; Conneely OM, 2003, J MAMMARY GLAND BIOL, V8, P205, DOI 10.1023/A:1025952924864; Creighton CJ, 2009, BREAST CANCER RES TR, V114, P287, DOI 10.1007/s10549-008-0017-2; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Dowsett M, 2008, J CLIN ONCOL, V26, P1059, DOI 10.1200/JCO.2007.12.9437; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Prat A, 2012, NAT REV CLIN ONCOL, V9, P48, DOI 10.1038/nrclinonc.2011.178; Joshi PA, 2010, NATURE, V465, P803, DOI 10.1038/nature09091; Viale G, 2007, J CLIN ONCOL, V25, P3846, DOI 10.1200/JCO.2007.11.9453; Purdie CA, 2014, BRIT J CANCER, V110, P565, DOI 10.1038/bjc.2013.756; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; HORWITZ KB, 1978, J BIOL CHEM, V253, P2223; Viale G, 2008, J CLIN ONCOL, V26, P1404, DOI 10.1200/JCO.2007.10.6393; Carroll JS, 2013, P 36 SAN ANT BREAST; Chatterton RT, 2002, CANCER LETT, V188, P47, DOI 10.1016/S0304-3835(02)00461-5; Cui XJ, 2003, MOL ENDOCRINOL, V17, P575, DOI 10.1210/me.2002-0318; Kougioumtzi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098404; Sakamoto Goi, 2005, Breast Cancer, V12 Suppl, pS1	24	0	1	CIG MEDIA GROUP, LP	DALLAS	3500 MAPLE AVENUE, STE 750, DALLAS, TX 75219-3931 USA	1526-8209	1938-0666		CLIN BREAST CANCER	Clin. Breast Cancer	JUN	2015	15	3					204	211		10.1016/j.clbc.2014.12.007		8	Oncology	Oncology	CI6YM	WOS:000354910100006		
J	Hayashi, T; Kawakami, H; Osanai, M; Ishiwatari, H; Naruse, H; Hisai, H; Yanagawa, N; Kaneto, H; Koizumi, K; Sakurai, T; Sonoda, T				Hayashi, Tsuyoshi; Kawakami, Hiroshi; Osanai, Manabu; Ishiwatari, Hirotoshi; Naruse, Hirohito; Hisai, Hiroyuki; Yanagawa, Nobuyuki; Kaneto, Hiroyuki; Koizumi, Kazuya; Sakurai, Tamaki; Sonoda, Tomoko			No Benefit of Endoscopic Sphincterotomy Before Biliary Placement of Self-Expandable Metal Stents for Unresectable Pancreatic Cancer	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Endoscopic Sphincterotomy; Self-Expandable Metallic Stent; Adverse Event; Pancreas; Distal Biliary Stricture	COMMON BILE-DUCT; RANDOMIZED-TRIAL; DIAGNOSTIC-CRITERIA; SEVERITY ASSESSMENT; TOKYO GUIDELINES; NITINOL STENTS; COVERED METAL; OBSTRUCTION; MULTICENTER; MANAGEMENT	BACKGROUND & AIMS: Endoscopic sphincterotomy (ES) is performed routinely before self-expandable metallic stents (SEMS) are placed in malignant distal biliary strictures to prevent postprocedural pancreatitis. However, it is not clear whether ES actually prevents pancreatitis or affects other adverse events (AEs). We conducted a noninferiority trial to examine the necessity of ES before SEMS placement. METHODS: Two hundred patients with distal biliary strictures caused by unresectable pancreatic cancer were assigned randomly to groups that received ES or did not receive ES (non-ES) before SEMS placement, at 25 hospitals in Hokkaido, Japan, from August 2010 through November 2012. The primary outcome was early AEs (<= 30 d) specifically related to the presence or absence of ES (pancreatitis, bleeding, or perforation). Secondary outcomes measured included the effect of ES omission on time to SEMS dysfunction and patient survival times. RESULTS: The proportions of patients with early AEs were 9.2% in the non-ES group and 10.4% in the ES group (a difference of 1.2%, noninferior). The median times to SEMS dysfunction was longer than 594 days in the non-ES group and 541 days in the ES group (P = .88). The median overall survival times were 202 in the ES group vs 255 days in the non-ES group; P = .20). CONCLUSIONS: ES before SEMS does not affect the incidence of AEs, SEMS patency, or patient survival times. Our data provide no evidence for a benefit of ES to patients undergoing SEMS placement for a biliary stricture caused by pancreatic cancer.	[Hayashi, Tsuyoshi; Ishiwatari, Hirotoshi] Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Sapporo, Hokkaido 0608543, Japan; [Sonoda, Tomoko] Sapporo Med Univ, Sch Med, Dept Publ Hlth, Sapporo, Hokkaido 0608543, Japan; [Kawakami, Hiroshi] Hokkaido Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Sapporo, Hokkaido, Japan; [Osanai, Manabu] Teine Keijinkai Hosp, Ctr Gastroenterol, Sapporo, Hokkaido, Japan; [Naruse, Hirohito] Hakodate Municipal Hosp, Dept Gastroenterol, Hakodate, Hokkaido, Japan; [Hisai, Hiroyuki] Japan Red Cross Date Gen Hosp, Dept Gastroenterol, Date, Japan; [Yanagawa, Nobuyuki] Asahikawa Kosei Gen Hosp, Dept Gastroenterol, Asahikawa, Hokkaido, Japan; [Kaneto, Hiroyuki] Muroran City Gen Hosp, Dept Gastroenterol, Muroran, Hokkaido, Japan; [Koizumi, Kazuya] Asahikawa Med Univ, Dept Med, Div Gastroenterol & Hematol Oncol, Asahikawa, Hokkaido, Japan; [Sakurai, Tamaki] Steel Mem Muroran Hosp, Dept Gastroenterol, Muroran, Hokkaido, Japan	Hayashi, T (reprint author), Sapporo Med Univ, Sch Med, Dept Med Oncol & Hematol, Chuo Ku, South 1,West 16, Sapporo, Hokkaido 0608543, Japan.	thayashi69@sapmed.ac.jp			Japanese Foundation for Research and Promotion of Endoscopy	Tsuyoshi Hayashi is supported in part by a grant from The Japanese Foundation for Research and Promotion of Endoscopy.	COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Telford JJ, 2010, GASTROINTEST ENDOSC, V72, P907, DOI 10.1016/j.gie.2010.08.021; Aadam AA, 2012, GASTROINTEST ENDOSC, V76, P67, DOI 10.1016/j.gie.2012.02.041; Isayama H, 2012, GASTROINTEST ENDOSC, V76, P84, DOI 10.1016/j.gie.2012.02.039; Kawakami H, 2012, GASTROINTEST ENDOSC, V75, P362, DOI 10.1016/j.gie.2011.10.012; Soderlund C, 2006, GASTROINTEST ENDOSC, V63, P986, DOI 10.1016/j.gie.2005.11.052; Isayama H, 2011, DIGEST ENDOSC, V23, P310, DOI 10.1111/j.1443-1661.2011.01124.x; Kawakubo K, 2012, SURG ENDOSC, V26, P771, DOI 10.1007/s00464-011-1950-4; Wada K, 2007, J HEPATO-BILIARY-PAN, V14, P52, DOI 10.1007/s00534-006-1156-7; Tsuchiya T, 2011, DIGEST DIS SCI, V56, P1889, DOI 10.1007/s10620-011-1581-6; DAVIDS PHP, 1992, LANCET, V340, P1488, DOI 10.1016/0140-6736(92)92752-2; Kullman E, 2010, GASTROINTEST ENDOSC, V72, P915, DOI 10.1016/j.gie.2010.07.036; Isayama H, 2004, GUT, V53, P729, DOI 10.1136/gut.2003.018945; KNYRIM K, 1993, ENDOSCOPY, V25, P207, DOI 10.1055/s-2007-1010294; Hirota M, 2007, J HEPATO-BILIARY-PAN, V14, P78, DOI 10.1007/s00534-006-1159-4; Sofuni A, 2007, CLIN GASTROENTEROL H, V5, P1339, DOI 10.1016/j.cgh.2007.07.008; Artifon ELA, 2008, J CLIN GASTROENTEROL, V42, P815, DOI 10.1097/MCG.0b013e31803dcd8a; Costamagna G, 2011, ENDOSCOPY, V43, P317, DOI 10.1055/s-0030-1256294; Dumonceau Jean-Marc, 2014, Endoscopy, V46, P799, DOI 10.1055/s-0034-1377875; Isayama H, 2010, SURG ENDOSC, V24, P131, DOI 10.1007/s00464-009-0537-9; Michelle A, 2012, GASTROINTEST ENDOSC, V75, P467; Porta Miquel, 2005, Clin Transl Oncol, V7, P189, DOI 10.1007/BF02712816; Tarnasky PR, 1997, GASTROINTEST ENDOSC, V45, P46, DOI 10.1016/S0016-5107(97)70301-8; Ung KA, 2013, SCAND J GASTROENTERO, V48, P459, DOI 10.3109/00365521.2012.758766	24	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	JUN	2015	13	6					1151	+		10.1016/j.cgh.2015.01.008		10	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI5TZ	WOS:000354824000026		
J	Pinato, DJ; Arizumi, T; Allara, E; Jang, JW; Smirne, C; Kim, YW; Kudo, M; Pirisi, M; Sharma, R				Pinato, David J.; Arizumi, Tadaaki; Allara, Elias; Jang, Jeong Won; Smirne, Carlo; Kim, Young Woon; Kudo, Masatoshi; Pirisi, Mario; Sharma, Rohini			Validation of the Hepatoma Arterial Embolization Prognostic Score in European and Asian Populations and Proposed Modification	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Article						Outcome; Liver Cancer; Therapy; Hepatic; AUROC	UNRESECTABLE HEPATOCELLULAR-CARCINOMA; RANDOMIZED CONTROLLED TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; SURVIVAL; ART	BACKGROUND & AIMS: Transarterial chemoembolization (TACE) is used to treat hepatocellular carcinoma (HCC), but it is a challenge to predict patient survival. The hepatic arterial embolization prognostic (HAP) score has been shown to predict which patients will have shorter survival times and should not undergo TACE. We aimed to validate this scoring system in a prospective study of patients in Europe and Asia. METHODS: We evaluated the prognostic accuracy of the HAP score in estimating overall survival (OS) of 126 patients with HCC who received TACE in the United Kingdom or Italy (training set) from 2001 through 2013. We also analyzed data from 723 patients treated in Korea and Japan (validation set), including 79 with newly diagnosed HCC, who underwent TACE in Korea or Japan from 2004 through 2013. Response to TACE was determined based on computed tomography analysis. OS was calculated from the time of the first TACE until death or the last follow-up evaluation. RESULTS: OS was associated with hypoalbuminemia, a-fetoprotein level greater than 400 ng/mL, and tumor size greater than 7 cm at diagnosis (P<.01), but not a bilirubin level greater than 17 umol/L (P>.05), in both data sets. The lack of association between OS and bilirubin level was confirmed using receiver operating characteristic analysis. We developed a modified version of the HAP score, based on the level of albumin and a-fetoprotein and tumor size, which predicted OS with increased accuracy in the training and validation cohorts. CONCLUSIONS: In a multicenter validation study, we developed a modified version of the HAP that predicts survival of patients with HCC treated with TACE in Europe and Asia. This system might be used to identify patients with HCC most likely to benefit from TACE in clinical practice.	[Pinato, David J.; Sharma, Rohini] Univ London Imperial Coll Sci Technol & Med, Div Expt Med, London W12 0HS, England; [Arizumi, Tadaaki; Kudo, Masatoshi] Kinki Univ, Sch Med, Dept Gastroenterol & Hepatol, Osaka, Osaka 589, Japan; [Allara, Elias] Univ Turin, Sch Publ Hlth, Turin, Italy; [Jang, Jeong Won; Kim, Young Woon] Catholic Univ Korea, Seoul St Marys Hosp, Dept Internal Med, Seoul, South Korea; [Pirisi, Mario] Univ Piemonte Orientale, Dept Translat Med, Novara, Italy; [Smirne, Carlo; Pirisi, Mario] Univ Piemonte Orientale, Interdisciplinary Res Ctr Autoimmune Dis, Novara, Italy	Sharma, R (reprint author), Univ London Imperial Coll Sci Technol & Med, Hammersmith Campus,Du Cane Rd, London W12 0HS, England.	r.sharma@imperial.ac.uk					Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Cabibbo G, 2011, ALIMENT PHARM THER, V34, P196, DOI 10.1111/j.1365-2036.2011.04694.x; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Pinato DJ, 2012, J HEPATOL, V57, P1013, DOI 10.1016/j.jhep.2012.06.022; Sieghart W, 2013, HEPATOLOGY, V57, P2261, DOI 10.1002/hep.26256; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Kadalayil L, 2013, ANN ONCOL, V24, P2565, DOI 10.1093/annonc/mdt247; Camma C, 2008, ALIMENT PHARM THER, V28, P62, DOI 10.1111/j.1365-2036.2008.03692.x; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	JUN	2015	13	6					1204	+		10.1016/j.cgh.2014.11.037		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI5TZ	WOS:000354824000035		
J	Inoue, H; Katsurahara, M; Takei, Y				Inoue, Hiroyuki; Katsurahara, Masaki; Takei, Yoshiyuki			Intraductal Papillary Mucinous Neoplasm Presenting as Hemosuccus Pancreaticus	CLINICAL GASTROENTEROLOGY AND HEPATOLOGY			English	Editorial Material							CARCINOMA		[Inoue, Hiroyuki; Takei, Yoshiyuki] Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie, Japan; [Katsurahara, Masaki] Mie Univ, Grad Sch Med, Dept Endoscop Med, Tsu, Mie, Japan	Inoue, H (reprint author), Mie Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Tsu, Mie, Japan.						Inoue H, 2012, ENDOSCOPY, V44, pE336, DOI 10.1055/s-0032-1309863; Kapoor Sorabh, 2004, JOP, V5, P373; Kurland J, 2007, GASTROINTEST ENDOSC, V66, P1241, DOI 10.1016/j.gie.2007.04.025; Shan YS, 2000, PANCREAS, V20, P416, DOI 10.1097/00006676-200005000-00015; Shinzeki M, 2010, SURG TODAY, V40, P470, DOI 10.1007/s00595-009-4079-5	5	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1542-3565	1542-7714		CLIN GASTROENTEROL H	Clin. Gastroenterol. Hepatol.	JUN	2015	13	6					E57	E58		10.1016/j.cgh.2014.12.013		2	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI5TZ	WOS:000354824000005		
J	Hoshikawa, H; Mori, T; Yamamoto, Y; Kishino, T; Fukumura, T; Samukawa, Y; Mori, N; Nishiyama, Y				Hoshikawa, Hiroshi; Mori, Terushige; Yamamoto, Yuka; Kishino, Takehito; Fukumura, Takashi; Samukawa, Yasushi; Mori, Nozomu; Nishiyama, Yoshihiro			Prognostic Value Comparison Between F-18-FLT PET/CT and F-18-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Head and Neck Cancer	CLINICAL NUCLEAR MEDICINE			English	Article						F-18-FLT PET/CT; F-18-FDG PET/CT; metabolic tumor volume; total lesion proliferation; prognosis	POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; STANDARDIZED UPTAKE VALUE; TOTAL LESION GLYCOLYSIS; TUMOR VOLUME; EARLY RESPONSE; RADIATION-THERAPY; PREDICTIVE-VALUE; LUNG-CANCER; RADIOTHERAPY	Purpose: The present study compared the potential of pretreatment 3'-deoxy-3'-[F-18]-fluorothymidine (F-18-FLT) uptake parameters and those of F-18-FDG to predict the clinical outcome of head and neck squamous cell carcinoma treated with chemoradiotherapy. Methods: A total 53 patients undergoing pretreatment F-18-FLT PET/CTand F-18-FDG PET/CT from May 2006 to April 2013 were evaluated. The SUVmax, metabolic tumor volume (MTV), total lesion glycolysis, and total lesion proliferation (TLP) were determined semiquantitatively. Associations between clinical factors and PET/CT parameters and prognostic value were analyzed. Results: In univariate analyses, F-18-FLT SUVmax, MTV, TLP, F-18-FDG MTV, and total lesion glycolysis correlated with locoregional control (P = 0.02, P = 0.0007, P = 0.0001, P = 0.007, and P = 0.013, respectively). Clinical T stage, F-18-FLT SUVmax, MTV, TLP, and F-18-FDG SUVmax correlated with overall survival (P = 0.012, P = 0.0057, P = 0.0018, P = 0.0012, and P = 0.047, respectively). On multivariate analyses, F-18-FLT TLP was an independent factor for locoregional control (P = 0.002; hazards ratio [HR], 5.13; 95% confidence interval [CI], 1.81-14.54), as were F-18-FLT SUVmax and MTV for overall survival (P = 0.021; HR, 3.47; 95% CI, 1.2-10.01 and P = 0.029; HR, 3.17; 95% CI, 1.12-8.95). Conclusions: Pretreatment F-18-FLT PET/CT volume-based metabolic parameters are superior prognostic predictors to those of F-18-FDG PET/CT. F-18-FLT SUVmax and MTV can provide important prognostic information for patients with head and neck squamous cell carcinomas administered with chemoradiotherapy.	[Hoshikawa, Hiroshi; Mori, Terushige; Kishino, Takehito; Fukumura, Takashi; Samukawa, Yasushi; Mori, Nozomu] Kagawa Univ, Fac Med, Dept Otolaryngol, Miki, Kagawa, Japan; [Yamamoto, Yuka; Nishiyama, Yoshihiro] Kagawa Univ, Fac Med, Dept Radiol, Miki, Kagawa, Japan	Hoshikawa, H (reprint author), Kagawa Univ, Fac Med, Dept Otolaryngol, 1750-1 Ikenobe, Miki, Kagawa, Japan.	hiro@med.kagawa-u.ac.jp					Tylski P, 2010, J NUCL MED, V51, P268, DOI 10.2967/jnumed.109.066241; Pio BS, 2006, MOL IMAGING BIOL, V8, P36, DOI 10.1007/s11307-005-0029-9; Herrmann K, 2007, CLIN CANCER RES, V13, P3552, DOI 10.1158/1078-0432.CCR-06-3025; Menda Y, 2009, J NUCL MED, V50, P1028, DOI 10.2967/jnumed.108.058495; Wong RJ, 2002, J CLIN ONCOL, V20, P4199, DOI 10.1200/JCO.2002.02.590; Denis F, 2004, J CLIN ONCOL, V22, P69, DOI 10.1200/JCO.2004.08.021; Francis DL, 2003, GUT, V52, P1602, DOI 10.1136/gut.52.11.1602; Kim JJ, 2005, NAT REV CANCER, V5, P516, DOI 10.1038/nrc1650; Kenny L, 2007, EUR J NUCL MED MOL I, V34, P1339, DOI 10.1007/s00259-007-0379-4; Troost EGC, 2010, J NUCL MED, V51, P66, DOI 10.2967/jnumed.108.061499; Moon SH, 2013, HEAD NECK-J SCI SPEC, V35, P15, DOI 10.1002/hed.22904; Strauss LG, 1996, EUR J NUCL MED, V23, P1409, DOI 10.1007/BF01367602; Picchio M, 2014, EUR J NUCL MED MOL I, V41, P21, DOI 10.1007/s00259-013-2528-2; Herrmann K, 2011, J NUCL MED, V52, P690, DOI 10.2967/jnumed.110.084566; Schinagl DAX, 2011, EUR J NUCL MED MOL I, V38, P1449, DOI 10.1007/s00259-011-1789-x; Kishino T, 2012, J NUCL MED, V53, P1521, DOI 10.2967/jnumed.111.099200; Roedl JB, 2008, RADIOTHER ONCOL, V89, P278, DOI 10.1016/j.radonc.2008.06.014; Hoeben BAW, 2013, J NUCL MED, V54, P532, DOI 10.2967/jnumed.112.105999; Buck AK, 2002, CANCER RES, V62, P3331; Chu KP, 2012, INT J RADIAT ONCOL, V83, P1521, DOI 10.1016/j.ijrobp.2011.10.022; Abd El-Hafez YG, 2013, ORAL ONCOL, V49, P261, DOI 10.1016/j.oraloncology.2012.09.005; Rasey JS, 2002, J NUCL MED, V43, P1210; Soto DE, 2008, RADIOTHER ONCOL, V89, P13, DOI 10.1016/j.radonc.2008.05.021; Yamamoto Y, 2007, EUR J NUCL MED MOL I, V34, P1610, DOI 10.1007/s00259-007-0449-7; Allal AS, 2002, J CLIN ONCOL, V20, P1398, DOI 10.1200/JCO.20.5.1398; Inubushi M, 2013, ANN NUCL MED, V27, P1, DOI 10.1007/s12149-012-0652-x; Lee JA, 2010, RADIOTHER ONCOL, V96, P302, DOI 10.1016/j.radonc.2010.07.003; Minn H, 1997, J NUCL MED, V38, P1907; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; van Westreenen HL, 2005, J NUCL MED, V46, P400; Troost EGC, 2010, J NUCL MED, V51, P866, DOI 10.2967/jnumed.109.069310; La TH, 2009, INT J RADIAT ONCOL, V74, P1335, DOI 10.1016/j.ijrobp.2008.10.060; Mileshkin L, 2011, CLIN CANCER RES, V17, P3304, DOI 10.1158/1078-0432.CCR-10-2763; Gulec SA, 2011, EUR J NUCL MED MOL I, V38, P1289, DOI 10.1007/s00259-011-1758-4; Chung MK, 2009, CLIN CANCER RES, V15, P5861, DOI 10.1158/1078-0432.CCR-08-3290; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Hoshikawa H, 2013, ANN NUCL MED, V27, P363, DOI 10.1007/s12149-013-0694-8; Kahraman D, 2012, CLIN NUCL MED, V37, P1058, DOI 10.1097/RLU.0b013e3182639747; Lim R, 2012, J NUCL MED, V53, P1506	39	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0363-9762	1536-0229		CLIN NUCL MED	Clin. Nucl. Med.	JUN	2015	40	6					464	468				5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI6PN	WOS:000354883000016		
J	Kondo, Y; Nakajima, K; Kato, M; Ohrui, H; Takahashi, Y				Kondo, Yukishige; Nakajima, Kazuya; Kato, Masakatsu; Ohrui, Hidetaka; Takahashi, Yutaka			Golden organic crystals of an azobenzene derivative containing two ester bonds	COLORATION TECHNOLOGY			English	Article							POLYACETYLENE; POLYMER	Recently we found while we were synthesising a cationic surfactant that a synthetic intermediate, 4,4-bis{1-[2-(N,N-dimethylamino)]ethoxy}azobenzene, produced gold-coloured crystals [Matsumoto etal., J. Oleo Sci., 59, (2010) 151]. Here we describe how an azobenzene derivative, bis[4-(ethoxycarbonylmethoxy)phenyl]diazene, also forms gold-coloured crystals after recrystallisation from a mixture of acetone and water. The profile of the specular reflectance as a function of wavelength for the crystals is very similar to that for metallic gold plate, indicating that the crystals have a golden colour. The maximum specular reflectance of the crystals is 16%. Atomic force microscopy observation shows that the crystals have flat surfaces. X-ray diffraction measurements demonstrate the presence of a periodic structure in the crystals, which indicates that monolayers (lamellar structure) consisting of azobenzene molecules with a thickness of 1.42nm are stacked in the crystals. The gold-coloured crystals are tolerant of ultraviolet light irradiation. The gold-coloured crystals may be useful as a substitute for conventional metallic pigments in specific coating applications.	[Kondo, Yukishige; Nakajima, Kazuya; Kato, Masakatsu; Ohrui, Hidetaka; Takahashi, Yutaka] Tokyo Univ Sci, Dept Ind Chem, Fac Engn, Shinjuku Ku, Tokyo 1628601, Japan	Kondo, Y (reprint author), Tokyo Univ Sci, Dept Ind Chem, Fac Engn, Shinjuku Ku, 1-3 Kagurazaka, Tokyo 1628601, Japan.	ykondo@rs.tus.ac.jp					Kijima M, 1999, SYNTHETIC MET, V101, P59, DOI 10.1016/S0379-6779(98)01124-2; Shin JY, 1999, LANGMUIR, V15, P4404, DOI 10.1021/la981477f; Matsumoto A, 2010, J OLEO SCI, V59, P151, DOI 10.5650/jos.59.151; FISCHER E, 1955, J CHEM PHYS, V23, P1367, DOI 10.1063/1.1742302; KANATZIDIS MG, 1989, J AM CHEM SOC, V111, P4139, DOI 10.1021/ja00193a078; Kondo Y, 2014, LANGMUIR, V30, P4422, DOI 10.1021/la500035h; Niu L, 2007, J MACROMOL SCI A, V44, P1245, DOI 10.1080/10601320701606679; SHIRAKAWA H, 1977, J CHEM SOC CHEM COMM, P578, DOI 10.1039/c39770000578; Takahashi Y, 2014, LANGMUIR, V30, P41, DOI 10.1021/la4034782	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1472-3581	1478-4408		COLOR TECHNOL	Color. Technol.	JUN	2015	131	3					255	258		10.1111/cote.12151		4	Chemistry, Applied; Engineering, Chemical; Materials Science, Textiles	Chemistry; Engineering; Materials Science	CI4RA	WOS:000354738800010		
J	Ferreira, DR; Vasilyev, E				Ferreira, Diogo R.; Vasilyev, Evgeniy			Using logical decision trees to discover the cause of process delays from event logs	COMPUTERS IN INDUSTRY			English	Article						Process mining; Performance analysis; Logical decision trees; Regression trees; Root cause analysis	BUSINESS PROCESSES; MANAGEMENT; FRAMEWORK; PROM	In real-world business processes it is often difficult to explain why some process instances take longer than usual to complete. With process mining techniques, it is possible to do an a posteriori analysis of a large number of process instances and detect the occurrence of delays, but discovering the actual cause of such delays is a different problem. For example, it may be the case that when a certain activity is performed or a certain user (or combination of users) participates in the process, the process suffers a delay. In this work, we show that it is possible to retrieve possible causes of delay based on the information recorded in an event log. The approach consists in translating the event log into a logical representation, and then applying decision tree induction to classify process instances according to duration. Besides splitting those instances into several subsets, each path in the tree yields a rule that explains why a given subset has an average duration that is higher or lower than other subsets of instances. The approach is applied in two case studies involving real-world event logs, where it succeeds in discovering meaningful causes of delay, some of which having been pointed out by domain experts. (C) 2015 Elsevier B.V. All rights reserved.	[Ferreira, Diogo R.] Univ Lisbon, Inst Super Tecn, P-1699 Lisbon, Portugal; [Vasilyev, Evgeniy] GREE Inc, Tokyo, Japan	Ferreira, DR (reprint author), Inst Super Tecn, Campus Taguspk,Ave Prof Dr Cavaco Silva, P-2744016 Porto Salvo, Portugal.	diogo.ferreira@tecnico.ulisboa.pt; vasiliev.evgeni@gmail.com					de Leoni M, 2014, LECT NOTES COMPUT SC, V8659, P250; Mans RS, 2008, HEALTHINF 2008: PROCEEDINGS OF THE FIRST INTERNATIONAL CONFERENCE ON HEALTH INFORMATICS, VOL 1, P118; Grigori D, 2004, COMPUT IND, V53, P321, DOI 10.1016/j.compind.2003.10.007; Wielemaker J, 2012, THEOR PRACT LOG PROG, V12, P67, DOI 10.1017/S1471068411000494; de Medeiros AKA, 2007, DATA MIN KNOWL DISC, V14, P245, DOI 10.1007/s10618-006-0061-7; van der Aalst WMP, 2002, LECT NOTES COMPUT SC, V2360, P1; Suriadi S, 2013, LECT NOTES BUS INF P, V132, P174; van der Aalst WMP, 2004, COMPUT IND, V53, P231, DOI 10.1016/j.compind.2003.10.001; Ferreira HM, 2006, INT J COOP INF SYST, V15, P485, DOI 10.1142/S0218843006001463; Chesani F, 2009, LECT NOTES COMPUT SC, V5460, P278; Wen LJ, 2009, J INTELL INF SYST, V32, P163, DOI 10.1007/s10844-007-0052-1; van der Aalst W, 2004, IEEE T KNOWL DATA EN, V16, P1128, DOI 10.1109/TKDE.2004.47; Blockeel H, 1998, ARTIF INTELL, V101, P285, DOI 10.1016/S0004-3702(98)00034-4; Rozinat A, 2009, INFORM SYST, V34, P305, DOI 10.1016/j.is.2008.09.002; Pesic M, 2007, 11TH IEEE INTERNATIONAL ENTERPRISE DISTRIBUTED OBJECT COMPUTING CONFERENCE, PROCEEDINGS, P287, DOI 10.1109/EDOC.2007.14; Rozinat A, 2006, LECT NOTES COMPUT SC, V4102, P420; van Dongen BF, 2005, LECT NOTES COMPUT SC, V3536, P444; van der Aalst WMP, 2007, INFORM SYST, V32, P713, DOI 10.1016/j.is.2006.05.003; Blockeel H., 1998, P 15 INT C MACH LEAR, P55; Blockeel H., 1998, THESIS KU LEUVEN BEL; Breiman L., 1984, CLASSIFICATION REGRE; Cover T. M., 2006, ELEMENTS INFORM THEO; GELFAND SB, 1991, IEEE T PATTERN ANAL, V13, P163, DOI 10.1109/34.67645; Goedertier S, 2008, LECT NOTES COMPUT SC, V4928, P42; Hornix P., 2007, THESIS EINDHOVEN U T; Lavrac N., 1994, INDUCTIVE LOGIC PROG; Mans R.S., 2011, THESIS EINDHOVEN U T; Muggleton S., 1991, New Generation Computing, V8; Pesic M, 2006, LECT NOTES COMPUT SC, V4103, P169; Quinlan J. R., 1986, Machine Learning, V1, DOI 10.1023/A:1022643204877; Quinlan J. R., 1993, C4 5 PROGRAMS MACHIN; Quinlan J.R., 1988, TOWARDS AUTOMATED LO, V1, P305; Raedt L.D., 1995, LECT NOTES ARTIF INT, V997, P80; Rokach L., 2008, DATA MINING DECISION; van Bon J., 2005, FDN IT SERVICE MANAG; van der Aalst WMP, 2011, PROCESS MINING: DISCOVERY, CONFORMANCE AND ENHANCEMENT OF BUSINESS PROCESSES, P1, DOI 10.1007/978-3-642-19345-3; Van Der Aalst W. M. P., 2005, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V14, DOI 10.1007/s10606-005-9005-9; van Dongen B., 2013, CEUR WORKSH PROCEEDI, V1052; van der Aalst WMP, 2004, LECT NOTES COMPUT SC, V3080, P244; Weijters A.J.M.M., 2006, 166 WP EINDH U TECHN	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-3615	1872-6194		COMPUT IND	Comput. Ind.	JUN	2015	70						194	207		10.1016/j.compind.2015.02.009		14	Computer Science, Interdisciplinary Applications	Computer Science	CI2ND	WOS:000354583400016		
J	Matsumoto, Y; Dogru, M; Shimazaki, J; Tsubota, K				Matsumoto, Yukihiro; Dogru, Murat; Shimazaki, Jun; Tsubota, Kazuo			Novel Corneal Piggyback Technique for Consecutive Intraocular Lens Implantation and Penetrating Keratoplasty Surgery	CORNEA			English	Article; Proceedings Paper	Annual Meeting of the American-Society-of-Cataract-and-Refractive-Surgery (ASCRS)	APR 19-23, 2013	San Francisco, CA	Amer Soc Cataract & Refract Surg		piggyback technique; corneal transplantation; intraocular lens implantation	AUTOMATED ENDOTHELIAL KERATOPLASTY	Purpose: To report a novel "piggyback" penetrating keratoplasty technique performed in a patient with severe keratoconus. Methods: A 43-year-old man underwent cataract surgery and a new "piggyback" penetrating keratoplasty (PKP) technique in his right eye, as he suffered from severe keratoconus and mature cataract due to severe atopic dermatitis. Under general anesthesia, phacoemulsification and aspiration (PEA), intraocular lens (IOL) implantation, and "piggyback" PKP while avoiding open-sky surgery was performed to prevent serious complications including IOL and vitreous prolapse. This PKP technique had been completed as a totally closed surgery. Results: One year after "piggyback" PKP and cataract surgery, the grafted cornea remained clear and IOL was also well positioned. Best-corrected visual acuity improved from hand motions to 30/100. Conclusions: A novel "piggyback" PKP technique was successfully performed in a patient with severe keratoconus. The new "piggyback" corneal transplantation technique may become an indispensable tool for transplant surgeons who want to improve surgical safety and predictability.	[Matsumoto, Yukihiro; Dogru, Murat; Tsubota, Kazuo] Keio Univ, Sch Med, Dept Ophthalmol, Tokyo 1608582, Japan; [Dogru, Murat; Shimazaki, Jun] Ichikawa Gen Hosp, Tokyo Dent Coll, Dept Ophthalmol, Chiba, Japan	Dogru, M (reprint author), Keio Univ, Sch Med, Dept Ophthalmol, Shinjuku Ku, Shinanomachi 35, Tokyo 1608582, Japan.	muratodooru2012@yahoo.com					Price MO, 2010, OPHTHALMOLOGY, V117, P438, DOI 10.1016/j.ophtha.2009.07.036; Melles GRJ, 2006, CORNEA, V25, P987; Gorovoy MS, 2006, CORNEA, V25, P886, DOI 10.1097/01.ico.0000214224.90743.01; Price FW, 2005, J REFRACT SURG, V21, P339; Arslan OS, 2014, CORNEA, V33, P994, DOI 10.1097/ICO.0000000000000186; Chen W, 2013, CORNEA, V32, P1291, DOI 10.1097/ICO.0b013e31829954c5; López-Plandolit S, 2008, Arch Soc Esp Oftalmol, V83, P231; Mehta JS, 2008, ARCH OPHTHALMOL-CHIC, V126, P1383, DOI 10.1001/archopht.126.10.1383; Payne J W, 1980, Trans Am Ophthalmol Soc, V78, P983; Polack F M, 1985, Cornea, V4, P137	10	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0277-3740	1536-4798		CORNEA	Cornea	JUN	2015	34	6					713	716				4	Ophthalmology	Ophthalmology	CH8VB	WOS:000354313100025		
J	Sasabuchi, Y; Yasunaga, H; Matsui, H; Lefor, AK; Horiguchi, H; Fushimi, K; Sanui, M				Sasabuchi, Yusuke; Yasunaga, Hideo; Matsui, Hiroki; Lefor, Alan K.; Horiguchi, Hiromasa; Fushimi, Kiyohide; Sanui, Masamitsu			The Volume-Outcome Relationship in Critically Ill Patients in Relation to the ICU-to-Hospital Bed Ratio	CRITICAL CARE MEDICINE			English	Article						bed capacity; hospital volume; intensive care unit; mortality	INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; RETROSPECTIVE COHORT; SEVERE SEPSIS; MORTALITY; MULTICENTER; SERVICES	Objectives: A volume-outcome relationship in ICU patients has been suggested in recent studies. However, it is unclear whether the ICU-to-hospital bed ratio affects the volume-outcome relationship. The aim of this study is to investigate the relationship between hospital volume and in-hospital mortality of adult ICU patients in relation to the ratio of ICU beds to regular hospital beds. Design: Retrospective cohort study. Setting: Four hundred seventy-seven Japanese hospitals from 2007 to 2012 in the Japanese Diagnosis Procedure Combination database. Patients: A total of 596,143 patients discharged from acute care hospitals. Interventions: None. Measurements and Main Results: We analyzed data from 596,143 ICU patients from 2007 through 2012 using a nationwide administrative database. Patients were categorized into nine subgroups (the tertiles of hospital volume of ICU patients combined with the tertiles of ICU-to-hospital bed ratio). Multivariable logistic regression analyses were performed to examine the concurrent effects of hospital volume of ICU patients and ICU-to-hospital bed ratio on in-hospital mortality, with adjustment for patient and hospital characteristics. Higher hospital volume of ICU patients and a higher ICU-to-hospital bed ratio were independently associated with lower mortality. When patients were stratified by ICU-to-hospital bed ratio categories, in-hospital mortality was significantly lower in the high-volume subgroup (odds ratio, 0.74; 95% CI, 0.58-0.93) compared with the low-volume subgroup in hospitals with a high ICU-to-hospital bed ratio. However, these relationships were not significant in hospitals with low ICU-to-hospital bed ratios (odds ratio, 0.94; 95% CI, 0.59-1.50) or in hospitals with intermediate ICU-to-hospital bed ratios (odds ratio, 0.80; 95% CI, 0.71-1.08). Conclusions: An inverse relationship between hospital volume of ICU patients and mortality was seen only when the ICU-to-hospital bed ratio was sufficiently high. Regionalization and increasing the number of ICU beds in referral centers may improve patient outcomes.	[Sasabuchi, Yusuke; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Sasabuchi, Yusuke; Sanui, Masamitsu] Jichi Med Univ, Saitama Med Ctr, Dept Anesthesiol & Crit Care Med, Saitama, Japan; [Lefor, Alan K.] Jichi Med Univ, Dept Surg, Mibu, Tochigi, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Dept Hlth Policy & Informat, Grad Sch Med, Tokyo, Japan	Sasabuchi, Y (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	sasabuchi-tky@umin.ac.jp		Lefor, Alan/0000-0001-6673-5630; Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant) [H26-Policy-011]; Japanese Government	Supported, in part, by a grant from the Ministry of Health, Labour and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).; Drs. Sasabuchi, Yasunaga, Matsui, Lefor, Horiguchi, and Fushimi's institutions received grant support from the Japanese Government. Dr. Sanui has disclosed that he does not have any potential conflicts of interest.	Abbenbroek B, 2014, AUST CRIT CARE, V27, P157, DOI 10.1016/j.aucc.2014.02.001; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; SINGER DE, 1983, NEW ENGL J MED, V309, P1155, DOI 10.1056/NEJM198311103091905; Glance LG, 2006, CRIT CARE MED, V34, P1925, DOI 10.1097/01.CCM.0000226415.93237.84; Vincent JL, 1998, CRIT CARE MED, V26, P1793; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Penoyer DA, 2010, CRIT CARE MED, V38, P1521, DOI 10.1097/CCM.0b013e3181e47888; Kahn JM, 2006, NEW ENGL J MED, V355, P41, DOI 10.1056/NEJMsa053993; Desquilbet L, 2010, STAT MED, V29, P1037, DOI 10.1002/sim.3841; Durairaj L, 2005, CHEST, V128, P1682, DOI 10.1378/chest.128.3.1682; Kahn JM, 2008, AM J RESP CRIT CARE, V177, P285, DOI 10.1164/rccm.200708-1214OC; Wunsch H, 2008, CRIT CARE MED, V36, P2787, DOI 10.1097/CCM.0b013e318186aec8; Evans TW, 2011, CHEST, V140, P1618, DOI 10.1378/chest.11-0957; Tarnow-Mordi WO, 2000, LANCET, V356, P185, DOI 10.1016/S0140-6736(00)02478-8; Lecuyer L, 2008, EUR RESPIR J, V32, P748, DOI 10.1183/09031936.00142907; Goldfrad C, 2000, LANCET, V355, P1138, DOI 10.1016/S0140-6736(00)02062-6; Cooke CR, 2012, CRIT CARE MED, V40, P2569, DOI 10.1097/CCM.0b013e3182591eee; Kim MM, 2010, ARCH INTERN MED, V170, P369, DOI 10.1001/archinternmed.2009.521; Darmon M, 2011, EUR RESPIR J, V37, P364, DOI 10.1183/09031936.00195209; Ewart GW, 2004, CHEST, V125, P1518, DOI 10.1378/chest.125.4.1518; Gopal S, 2011, MINERVA ANESTESIOL, V77, P26; Hill AD, 2007, J CRIT CARE, V22, P290, DOI 10.1016/j.jcrc.2007.06.002; Iapichino G, 2004, INTENS CARE MED, V30, P290, DOI 10.1007/s00134-003-2113-4; Kanhere MH, 2012, INTENS CARE MED, V38, P741, DOI 10.1007/s00134-012-2519-y; Laupland KB, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-321; Metnitz B, 2009, WIEN KLIN WOCHENSCHR, V121, P34, DOI 10.1007/s00508-008-1019-0; Moran JL, 2012, CRIT CARE MED, V40, P800, DOI 10.1097/CCM.0b013e318236f2af; Needham DM, 2006, CRIT CARE MED, V34, P2349, DOI 10.1097/01.CCM.0000233858.85802.5C; Peelen L, 2007, CRIT CARE, V11, DOI 10.1186/cc5727; Reinikainen M, 2010, INTENS CARE MED, V36, P673, DOI 10.1007/s00134-009-1688-9; Shahin J, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e3394; STRAUSS MJ, 1986, JAMA-J AM MED ASSOC, V255, P1143, DOI 10.1001/jama.255.9.1143; Umegaki T, 2010, CRIT CARE RESUSC, V12, P96; Vaara ST, 2012, ACTA ANAESTH SCAND, V56, P1175, DOI 10.1111/j.1399-6576.2012.02747.x; Wunsch H, 2008, CRIT CARE MED, V36, pe1	35	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	JUN	2015	43	6					1239	1245		10.1097/CCM.0000000000000943		7	Critical Care Medicine	General & Internal Medicine	CI4LL	WOS:000354720300033		
J	Iwamuro, M; Hanayama, Y; Otsuka, F; Okada, H				Iwamuro, Masaya; Hanayama, Yoshihisa; Otsuka, Fumio; Okada, Hiroyuki			Gastric pseudopolyposis formed after recovery from gastric gangrene	DIGESTIVE AND LIVER DISEASE			English	Editorial Material									[Iwamuro, Masaya; Hanayama, Yoshihisa; Otsuka, Fumio] Okayama Univ, Dept Gen Med, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Iwamuro, Masaya] Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan; [Okada, Hiroyuki] Okayama Univ Hosp, Dept Endoscopy, Okayama, Japan	Iwamuro, M (reprint author), Okayama Univ, Dept Gastroenterol & Hepatol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008558, Japan.	iwamuromasaya@yahoo.co.jp					BERRY GJ, 1991, HUM PATHOL, V22, P59, DOI 10.1016/0046-8177(91)90062-T	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1590-8658	1878-3562		DIGEST LIVER DIS	Dig. Liver Dis.	JUN	2015	47	6					E9	E9		10.1016/j.dld.2014.12.016		1	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI6MY	WOS:000354875000001		
J	Hayakawa, K				Hayakawa, Kazuhiko			THE ASYMPTOTIC PROPERTIES OF THE SYSTEM GMM ESTIMATOR IN DYNAMIC PANEL DATA MODELS WHEN BOTH N AND T ARE LARGE	ECONOMETRIC THEORY			English	Article							INSTRUMENTAL-VARIABLE ESTIMATION; MAXIMUM-LIKELIHOOD-ESTIMATION; SHORT-TIME PERIODS; EFFICIENT ESTIMATION; COMPONENTS MODELS; MOMENT CONDITIONS; DISTRIBUTIONS; INFERENCE; BIAS; DEPENDENCE	In this paper, we derive the asymptotic properties of the system generalized method of moments (GMM) estimator in dynamic panel data models with individual and time effects when both N and T, the dimensions of cross-section and time series, are large. Specifically, we show that the two-step system GMM estimator is consistent when a suboptimal weighting matrix where off-diagonal blocks are set to zero is used. Such consistency results theoretically support the use of the system GMM estimator in large N and T contexts even though it was originally developed for large N and small T panels. Simulation results indicate that the large N and large T asymptotic results approximate the finite sample behavior reasonably well unless persistency of data is strong and/or the variance ratio of individual effects to the disturbances is large.	[Hayakawa, Kazuhiko] Hiroshima Univ, Higashihiroshima, Hiroshima 7398525, Japan	Hayakawa, K (reprint author), Hiroshima Univ, Dept Econ, 1-2-1 Kagamiyama, Higashihiroshima, Hiroshima 7398525, Japan.	kazuhaya@hiroshima-u.ac.jp	Hayakawa, Kazuhiko/B-2448-2013		JSPS Fellowship; JSPS [KAKENHI 20830056, 22730178]	This paper is a revision of the second chapter of my Ph.D. thesis submitted to Hitotsubashi University. I am deeply grateful to my advisers Taku Yamamoto and Eiji Kurozumi for their guidance and suggestions. I also acknowledge Guido Kuersteiner (co-editor), two anonymous referees, Katsuto Tanaka, In Choi, Ryo Okui, Hiroaki Chigira, and the participants of the European Meeting of Econometric Society in Milan, a research seminar at HKUST, and the Kansai Econometrics Conference for their helpful comments. Part of this paper was written while the author is visiting University of Cambridge as a JSPS Postdoctoral Fellow for Research Abroad. I acknowledge the financial support from the JSPS Fellowship and the Grant-in-Aid for Scientific Research (KAKENHI 20830056, 22730178) provided by the JSPS. However, all remaining errors are my own. Address correspondence to Kazuhiko Hayakawa, Department of Economics, Hiroshima University, 1-2-1 Kagamiyama, Higashi-Hiroshima, Hiroshima, 739-8525, Japan; e-mail: kazuhaya@hiroshima-u.ac.jp.	Hahn J, 2007, J ECONOMETRICS, V140, P574, DOI 10.1016/j.jeconom.2006.07.005; Dollar D, 2002, J ECON GROWTH, V7, P195, DOI 10.1023/A:1020139631000; Hayakawa K, 2007, ECON LETT, V95, P32, DOI 10.1016/j.econlet.2006.09.011; Sarafidis V, 2009, ECONOMET J, V12, P62, DOI 10.1111/j.1368-423X.2008.00260.x; NICKELL S, 1981, ECONOMETRICA, V49, P1417, DOI 10.2307/1911408; Beck T, 2000, J FINANC ECON, V58, P261, DOI 10.1016/S0304-405X(00)00072-6; ARELLANO M, 1991, REV ECON STUD, V58, P277, DOI 10.2307/2297968; Phillips PCB, 2007, J ECONOMETRICS, V137, P162, DOI 10.1016/j.jeconom.2006.03.009; Hsiao C, 2002, J ECONOMETRICS, V109, P107, DOI 10.1016/S0304-4076(01)00143-9; BHARGAVA A, 1983, ECONOMETRICA, V51, P1635, DOI 10.2307/1912110; Hahn JY, 2002, ECONOMETRICA, V70, P1639, DOI 10.1111/1468-0262.00344; Hayakawa K, 2009, ECONOMET THEOR, V25, P873, DOI 10.1017/S0266466609090707; Han C, 2014, ECONOMET THEOR, V30, P201, DOI 10.1017/S0266466613000170; Breusch T, 1999, J ECONOMETRICS, V91, P89, DOI 10.1016/S0304-4076(98)00050-5; Alvarez J, 2003, ECONOMETRICA, V71, P1121, DOI 10.1111/1468-0262.00441; Blundell R, 1998, J ECONOMETRICS, V87, P115, DOI 10.1016/S0304-4076(98)00009-8; HOLTZEAKIN D, 1988, ECONOMETRICA, V56, P1371, DOI 10.2307/1913103; Han C, 2010, ECONOMET THEOR, V26, P119, DOI 10.1017/S026646660909063X; AHN SC, 1995, J ECONOMETRICS, V68, P5, DOI 10.1016/0304-4076(94)01641-C; Bun MJG, 2010, ECONOMET J, V13, P95, DOI 10.1111/j.1368-423X.2009.00299.x; Phillips PCB, 1999, ECONOMETRICA, V67, P1057, DOI 10.1111/1468-0262.00070; Ahn SC, 1997, J ECONOMETRICS, V76, P309, DOI 10.1016/0304-4076(95)01793-3; Sarafidis V, 2009, J ECONOMETRICS, V148, P149, DOI 10.1016/j.jeconom.2008.10.006; MORIMUNE K, 1983, ECONOMETRICA, V51, P821, DOI 10.2307/1912160; Alonso-Borrego C, 1999, J BUS ECON STAT, V17, P36, DOI 10.2307/1392237; BEKKER PA, 1994, ECONOMETRICA, V62, P657, DOI 10.2307/2951662; Yu JH, 2008, J ECONOMETRICS, V146, P118, DOI 10.1016/j.jeconom.2008.08.002; Arellano M., 2003, PANEL DATA ECONOMETR; ARELLANO M, 1995, J ECONOMETRICS, V68, P29, DOI 10.1016/0304-4076(94)01642-D; Blundell R., 2000, ECONOMET REV, V19, P321, DOI DOI 10.1080/07474930008800475.ACCESSED; Bond S, 2005, ECONOMET REV, V24, P1, DOI 10.1081/ETC-200049126; Bond S., 2001, 2001W21 U OXF NUFF C; Bun MJG, 2006, J ECONOMETRICS, V132, P409, DOI 10.1016/j.jeconom.2005.02.006; Elhorst JP, 2005, GEOGR ANAL, V37, P85, DOI 10.1111/j.1538-4632.2005.00577.x; Elhorst JP, 2010, REG SCI URBAN ECON, V40, P272, DOI 10.1016/j.regsciurbeco.2010.03.003; Hahn J, 2006, ECONOMET THEOR, V22, P499, DOI 10.1017/S0266466606060245; Hayakawa K, 2010, J ECONOMETRICS, V159, P202, DOI 10.1016/j.jeconom.2010.06.002; Hayakawa K., 2012, CAMBRIDGE WORKING PA, V1224; Hayakawa K., 2012, J JAPAN STAT SOC, V42, P109; Hayakawa K., 2013, BEHAV GMM ESTI UNPUB; Hayakawa K, 2009, J ECONOMETRICS, V153, P133, DOI 10.1016/j.jeconom.2009.04.008; Hsiao C, 2008, J STAT PLAN INFER, V138, P2698, DOI 10.1016/j.jspi.2008.03.009; Kruiniger H, 2009, ECONOMET THEOR, V25, P1348, DOI 10.1017/S0266466608090531; KUNITOMO N, 1980, J AM STAT ASSOC, V75, P693; Moon H.R., 2010, DYNAMIC LINEAR UNPUB; Robertson D., 2010, 4 ESTIMATION P UNPUB; Sarafidis V., 2010, INSTRUMENTAL V UNPUB; Satchachai P, 2008, ECON LETT, V99, P252, DOI 10.1016/j.econlet.2007.06.036; Su L., 2007, QML ESTIMATION UNPUB; Sul D., 2003, ECONOMET J, V6, P217, DOI DOI 10.1111/1368-423X.00108; Wansbeek T., 1983, STAT PROBABIL LETT, V1, P213, DOI 10.1016/0167-7152(83)90033-0; WANSBEEK T, 1982, COMMUN STAT A-THEOR, V11, P2105, DOI 10.1080/03610928208828373	52	0	0	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0266-4666	1469-4360		ECONOMET THEOR	Economet. Theory	JUN	2015	31	3					647	667		10.1017/S0266466614000449		21	Economics; Mathematics, Interdisciplinary Applications; Social Sciences, Mathematical Methods; Statistics & Probability	Business & Economics; Mathematics; Mathematical Methods In Social Sciences	CI5UY	WOS:000354826500010		
J	Nakata, A; Murayama, H; Fukuda, K; Yamane, T; Arai, H; Hirai, T; Uchimoto, Y; Yamaki, J; Ogumi, Z				Nakata, Akiyoshi; Murayama, Haruno; Fukuda, Katsutoshi; Yamane, Tomokazu; Arai, Hajime; Hirai, Toshiro; Uchimoto, Yoshiharu; Yamaki, Jun-ichi; Ogumi, Zempachi			Transformation of Leaf-like Zinc Dendrite in Oxidation and Reduction Cycle	ELECTROCHIMICA ACTA			English	Article						zinc; dendrite; rechargeable battery; CT; in-situ XRD	ELECTROCHEMICAL-BEHAVIOR; BATTERIES; ELECTRODEPOSITION; GROWTH; OSCILLATION; ANODES	Zinc is a promising negative electrode material for aqueous battery systems whereas it shows insufficient rechargeability for use in secondary batteries. It has been reported that leaf-like dendrite deposits are often the origin of cell-failure, however, their nature and behavior on discharge (oxidation) - charge (reduction) cycling have been only poorly understood. Here we investigate the transformation of the leaflike zinc dendrites using ex-situ scanning electron microscopy, X-ray computational tomography and in-situ X-ray diffraction. It is shown that the leaf-like zinc dendrites obtained under diffusion-limited conditions are nearly completely dissolved at a low oxidation current density of 1 mA cm(-2) and cause re-evolution of the zinc dendrites. Oxidation at a high current density of 10 mA cm(-2) leads to the formation of leaf-like zinc oxide residual products that result in particulate zinc deposits in the following reduction process, enabling good rechargeability. The reaction behavior of this oxide residue is detailed and discussed for the development of long-life zinc electrodes. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakata, Akiyoshi; Murayama, Haruno; Fukuda, Katsutoshi; Yamane, Tomokazu; Arai, Hajime; Hirai, Toshiro; Yamaki, Jun-ichi; Ogumi, Zempachi] Kyoto Univ, Off Soc Acad Collaborat Innovat, Uji, Kyoto 6110011, Japan; [Uchimoto, Yoshiharu] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Nakata, A (reprint author), Kyoto Univ, Off Soc Acad Collaborat Innovat, Uji, Kyoto 6110011, Japan.	nakata@saci.kyoto-u.ac.jp			RISING project of NEDO in Japan	This work was financially supported by the RISING project of NEDO in Japan. The synchrotron radiation experiments were performed with the approval of the Japan Synchrotron Radiation Research Institute (JASRI) (Proposal Nos. 2012A1027 and 2012A7602). The authors thank Y. Miyamoto for her contributions to sample preparation and electrochemical evaluation.	DIGGLE JW, 1969, J ELECTROCHEM SOC, V116, P1503, DOI 10.1149/1.2411588; MATSUSHITA M, 1984, PHYS REV LETT, V53, P286, DOI 10.1103/PhysRevLett.53.286; Deiss E, 2002, ELECTROCHIM ACTA, V47, P3995, DOI 10.1016/S0013-4686(02)00316-X; Lee CW, 2006, J POWER SOURCES, V160, P1436, DOI 10.1016/j.jpowsour.2006.02.019; MCLARNON FR, 1991, J ELECTROCHEM SOC, V138, P645, DOI 10.1149/1.2085653; Zhu JL, 1998, J POWER SOURCES, V72, P231, DOI 10.1016/S0378-7753(97)02705-5; Beck F, 2000, ELECTROCHIM ACTA, V45, P2467, DOI 10.1016/S0013-4686(00)00344-3; Wang JM, 2001, J POWER SOURCES, V102, P139, DOI 10.1016/S0378-7753(01)00789-3; Zhu JL, 1998, J POWER SOURCES, V73, P266, DOI 10.1016/S0378-7753(98)00010-X; BASS K, 1991, J POWER SOURCES, V35, P333, DOI 10.1016/0378-7753(91)80117-G; MCBREEN J, 1984, J ELECTROANAL CHEM, V168, P415, DOI 10.1016/0368-1874(84)87113-0; Lee CW, 2006, J POWER SOURCES, V159, P1474, DOI 10.1016/j.jpowsour.2005.11.074; Ghavami RK, 2006, J POWER SOURCES, V162, P893, DOI 10.1016/j.jpowsour.2005.07.010; ARGOUL F, 1993, J ELECTROANAL CHEM, V359, P81, DOI 10.1016/0022-0728(93)80401-3; Chouvy C.D., 1991, J ELECTROCHEM SOC, V138, P2538; Fukami K, 2005, J ELECTROCHEM SOC, V152, pC493, DOI 10.1149/1.1932829; Karpinski AP, 1999, J POWER SOURCES, V80, P53, DOI 10.1016/S0378-7753(99)00164-0; MCBREEN J, 1994, J POWER SOURCES, V51, P37, DOI 10.1016/0378-7753(94)01954-1; Pierre J.S., 1987, J ELECTROCHEM SOC, V134, P1689; Sato Y., 1971, J ELECTROCHEM SOC, V118, P1270; WANG M, 1992, PHYS REV A, V45, P2493, DOI 10.1103/PhysRevA.45.2493	21	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	JUN 1	2015	166						82	87		10.1016/j.electacta.2015.03.076		6	Electrochemistry	Electrochemistry	CH4XH	WOS:000354036200011		
J	Goto, T; Hyodo, T; Ueda, T; Kamada, K; Kaneyasu, K; Shimizu, Y				Goto, Toshiyuki; Hyodo, Takeo; Ueda, Taro; Kamada, Kai; Kaneyasu, Kazunari; Shimizu, Yasuhiro			CO-sensing Properties of Potentiometric Gas Sensors Using an Anion-conducting Polymer Electrolyte and Au-loaded Metal Oxide Electrodes	ELECTROCHIMICA ACTA			English	Article						Gas sensor; Anion-conducting polymer; Carbon monoxide; Gold nanoparticle; Metal oxide	CARBON-MONOXIDE SENSOR; FUEL-CELL APPLICATION; ROOM-TEMPERATURE; AU/ZNO CATALYSTS; OXIDATION; PERFORMANCE; STABILITY; MECHANISM; MEMBRANE; ZIRCONIA	CO-sensing properties of potentiometric gas sensors using an anion-conducting polymer (ACP) as an electrolyte and metal oxides loaded with and without Au as electrodes (EC(MO) or EC(nAu/MO(Tm)), respectively, MO: metal oxide (In2O3, ZnO or Co3O4), n: the loading amount of Au, 0.5 similar to 2.0 wt%, T: heat-treatment temperature, m: heat-treatment atmosphere, air or H-2) have been investigated in wet synthetic air (57% RH) at 30 degrees C. In addition, H-2-sensing properties of these sensors have also been investigated in the same gaseous conditions, to evaluate their CO selectivity against H-2. All of the EC(MO) sensors showed relatively small changes in electromotive force (EMF), i.e. responses, to both CO and H-2, but the Au loading to In2O3 and ZnO drastically improved the magnitude of CO response of the EC(In2O3) and EC(ZnO) sensors, respectively. The EC(2.0Au/In2O3(400air)) sensor showed larger CO response, faster CO response speed, excellent CO selectivity against H-2 and better long-term stability than those of the EC (2.0Au/ZnO(400air)) sensor. The influence of moisture on the CO response of the EC(2.0Au/In2O3(400air)) sensor was almost negligible in the humidity range of 40 similar to 100% RH. The magnitude of CO response of the EC(2.0Au/In2O3(400air)) sensor in wet synthetic air showed a good linear relationship with CO concentration, but the CO response was largely affected by the concentration of O-2. These results indicate that the EMF of the EC(2.0Au/In2O3(400air)) sensor is probably determined by the mixed potential resulting from CO oxidation and O-2 reduction. The heat-treatment conditions of the 2.0 wt% Au-loaded In2O3 powder largely affected the CO-sensing properties of the EC(2.0Au/In2O3(Tm)) sensors. Among these sensors heat-treated in various conditions, the as-fabricated EC(2.0Au/In2O3(250H(2))) sensor showed the most excellent CO selectivity against H-2 in their concentration range of 10 similar to 3000 ppm. (C) 2015 Elsevier Ltd. All rights reserved.	[Goto, Toshiyuki; Hyodo, Takeo; Ueda, Taro; Kamada, Kai; Shimizu, Yasuhiro] Nagasaki Univ, Grad Sch Engn, Nagasaki 8528521, Japan; [Kaneyasu, Kazunari] Figaro Engn Inc, Mino, Osaka 5628505, Japan	Shimizu, Y (reprint author), Nagasaki Univ, Grad Sch Engn, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	shimizu@nagasaki-u.ac.jp					Ren XM, 2014, ACS APPL MATER INTER, V6, P13330, DOI 10.1021/am503870g; Hu QH, 2014, PHYS STATUS SOLIDI A, V211, P2729, DOI 10.1002/pssa.201431392; YAN HQ, 1994, SENSOR ACTUAT B-CHEM, V17, P165, DOI 10.1016/0925-4005(94)87045-4; Li NW, 2013, J AM CHEM SOC, V135, P10124, DOI 10.1021/ja403671u; SING KSW, 1982, PURE APPL CHEM, V54, P2201, DOI 10.1351/pac198254112201; Kah JCY, 2008, GOLD BULL, V41, P23; Seo DW, 2012, ELECTROCHIM ACTA, V86, P360, DOI 10.1016/j.electacta.2012.04.065; Date M, 2002, CATAL TODAY, V72, P89, DOI 10.1016/S0920-5861(01)00481-3; MIURA N, 1990, SOLID STATE IONICS, V40-1, P452, DOI 10.1016/0167-2738(90)90377-4; Stoica D, 2008, J PHYS CHEM B, V112, P12338, DOI 10.1021/jp804787x; Hjiri M, 2014, MAT SCI SEMICON PROC, V27, P319, DOI 10.1016/j.mssp.2014.07.009; Miura N, 1998, SENSOR ACTUAT B-CHEM, V47, P84, DOI 10.1016/S0925-4005(98)00053-7; vanderWal PD, 1996, SENSOR ACTUAT B-CHEM, V35, P119, DOI 10.1016/S0925-4005(97)80040-8; Wang GY, 2003, APPL CATAL A-GEN, V239, P1, DOI 10.1016/S0926-860X(02)00098-4; Sorita R, 1997, SENSOR ACTUAT B-CHEM, V40, P29, DOI 10.1016/S0925-4005(97)80195-5; Stegmeier S, 2009, PROCEDIA CHEM, V1, P236, DOI 10.1016/j.proche.2009.07.059; Matsumoto K, 2011, ADV FUNCT MATER, V21, P1089, DOI 10.1002/adfm.201001806; Gutierrez LF, 2011, CATALYSTS, V1, P97, DOI 10.3390/catal1010097; Li XH, 2013, J MEMBRANE SCI, V436, P202, DOI 10.1016/j.memsci.2013.02.041; Su J, 2013, INORG CHEM, V52, P5924, DOI 10.1021/ic400109j; HARUTA M, 1993, J CATAL, V144, P175, DOI 10.1006/jcat.1993.1322; Cao YC, 2012, J POWER SOURCES, V201, P226, DOI 10.1016/j.jpowsour.2011.10.113; GAO Y, 1993, J APPL ELECTROCHEM, V23, P1102, DOI 10.1007/BF00625582; Goto T, 2012, ECS TRANSACTIONS, V50, P267, DOI 10.1149/05012.0267ecst; Goto T., 2013, CHEM SENSORS, V29, P94; Hyodo T., 2012, REPORTS FACULTY ENG, V42, P42; Hyodo T, 2012, ELECTROCHIM ACTA, V82, P19, DOI 10.1016/j.electacta.2012.03.142; Kim IJ, 2005, SENSOR ACTUAT B-CHEM, V107, P825, DOI 10.1016/j.snb.2004.12.036; Manoukian M., 2011, U.S. Patent, Patent No. [2011/0005928, 20110005928]; Miura N., 1983, P INT M CHEM SENSORS, P233; MIURA N, 1982, DENKI KAGAKU, V50, P858; O'Neil MJ, 2006, MERCK INDEX; Ohkuma N., 1998, J SURF SCI SOC JPN, V9-6, P42; Rodriguez-Gonzalez V, 2009, J PHYS CHEM C, V113, P8911, DOI 10.1021/jp8099797; Stegmeier S, 2011, SENSOR ACTUAT B-CHEM, V154, P270, DOI 10.1016/j.snb.2010.01.022; Takeda H., 2013, CHEM SENSORS, V29, P82; Takeda H, 2015, ELECTROCHIM ACTA, V155, P8, DOI 10.1016/j.electacta.2014.12.168; Wallgren K, 2001, ELECTROCHIM ACTA, V46, P1523, DOI 10.1016/S0013-4686(00)00748-9; Wang GY, 2002, REACT KINET CATAL L, V75, P343, DOI 10.1023/A:1015263332467; Yu JH, 2002, J ELECTROCERAM, V8, P249, DOI 10.1023/A:1020810503321	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	JUN 1	2015	166						232	243		10.1016/j.electacta.2015.03.045		12	Electrochemistry	Electrochemistry	CH4XH	WOS:000354036200031		
J	Kim, B; Ma, S; Jhong, HRM; Kenis, PJA				Kim, Byoungsu; Ma, Sichao; Jhong, Huei-Ru Molly; Kenis, Paul J. A.			Influence of dilute feed and pH on electrochemical reduction of CO2 to CO on Ag in a continuous flow electrolyzer	ELECTROCHIMICA ACTA			English	Article						Carbon dioxide; Electrochemical reduction; Dilute feed; Carbon monoxide; Electrolyte pH	GAS-DIFFUSION ELECTRODES; CARBON-DIOXIDE; METAL-ELECTRODES; PERFORMANCE; TEMPERATURE; CONVERSION; CATALYSTS; FORMATE; DESIGN; CELLS	Electrochemical conversion of CO2 to useful chemical intermediates may be a promising strategy to help reduce CO2 emissions, while utilizing otherwise wasted excess renewable energy. Here we explore the effect of diluted CO2 streams (10-100% by volume using N-2 as diluting inert gas) on the product selectivity and on the CO/CO2 conversion ratio for the electrochemical reduction of CO2 into CO, specifically using a gas diffusion electrode loaded with Ag catalyst in a continuous flow electrolyzer. When using diluted CO2 feeds for the electrolyzer, we still observed high Faradaic efficiencies for CO (>80%), high conversion ratios (up to 32% per pass), and partial current densities for CO of 29 mA/cm(2) when operating the cell at 3.0 V. Most notably, we observed that the decrease in partial current density for CO was less than 45% when switching from a 100% CO2 feed to a 10% CO2 feed. Also, we studied the effect of pH and the interplay between pH and the diluted CO2 feed. We observed higher levels of CO formation as well as a higher Faradaic efficiency for CO when using an alkaline electrolyte, compared to when using a neutral or acidic electrolyte. However, the effect of CO2 concentration in the feed is more significant than the effect of pH on electrochemical reduction of CO2 to CO. (C) 2015 Elsevier Ltd. All rights reserved.	[Kim, Byoungsu; Jhong, Huei-Ru Molly; Kenis, Paul J. A.] Univ Illinois, Dept Chem & Biomol Engn, Urbana, IL 61801 USA; [Ma, Sichao] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Kim, Byoungsu; Ma, Sichao; Jhong, Huei-Ru Molly; Kenis, Paul J. A.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka 812, Japan	Kenis, PJA (reprint author), Univ Illinois, Dept Chem & Biomol Engn, 600 South Mathews Ave, Urbana, IL 61801 USA.	kenis@illinois.edu			Department of Energy [DE-SC0004453]; National Science Foundation [CTS 05-47617]; International Institute of Carbon Neutral Energy Research (WPI-I2CNER) - World Premier International Research Center Initiative (WPI), MEXT, Japan	We gratefully acknowledge financial support from the Department of Energy through an STTR grant to Dioxide Materials and UIUC (DE-SC0004453), the National Science Foundation (CTS 05-47617), and the International Institute of Carbon Neutral Energy Research (WPI-I2CNER), sponsored by the World Premier International Research Center Initiative (WPI), MEXT, Japan.	Rosen BA, 2011, SCIENCE, V334, P643, DOI 10.1126/science.1209786; Ma SC, 2014, CHEMSUSCHEM, V7, P866, DOI 10.1002/cssc.201300934; Cole EB, 2010, J AM CHEM SOC, V132, P11539, DOI 10.1021/ja1023496; Lu Y, 2006, CATAL TODAY, V115, P263, DOI 10.1016/j.cattod.2006.02.056; Jhong HR, 2013, ADV ENERGY MATER, V3, P589, DOI 10.1002/aenm.201200759; Dry ME, 2002, CATAL TODAY, V71, P227, DOI 10.1016/S0920-5861(01)00453-9; Agarwal AS, 2011, CHEMSUSCHEM, V4, P1301, DOI 10.1002/cssc.201100220; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; MAHMOOD MN, 1987, J APPL ELECTROCHEM, V17, P1223, DOI 10.1007/BF01023606; Chen YH, 2012, J AM CHEM SOC, V134, P19969, DOI 10.1021/ja309317u; Oh Y, 2013, CHEM SOC REV, V42, P2253, DOI 10.1039/c2cs35276a; Thorson MR, 2013, J ELECTROCHEM SOC, V160, pF69, DOI 10.1149/2.052301jes; Kumar B, 2012, ANNU REV PHYS CHEM, V63, P541, DOI 10.1146/annurev-physchem-032511-143759; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Yang LH, 2013, DALTON T, V42, P11186, DOI 10.1039/c3dt50337b; NODA H, 1995, B CHEM SOC JPN, V68, P1889, DOI 10.1246/bcsj.68.1889; D'Alessandro DM, 2010, ANGEW CHEM INT EDIT, V49, P6058, DOI 10.1002/anie.201000431; Appel AM, 2013, CHEM REV, V113, P6621, DOI 10.1021/cr300463y; Park S, 2012, ENERG ENVIRON SCI, V5, P9331, DOI 10.1039/c2ee22554a; COOK RL, 1990, J ELECTROCHEM SOC, V137, P607, DOI 10.1149/1.2086515; Wu JJ, 2013, J ELECTROCHEM SOC, V160, pF953, DOI 10.1149/2.030309jes; Centi G, 2009, CATAL TODAY, V148, P191, DOI 10.1016/j.cattod.2009.07.075; Dufek EJ, 2012, ELECTROCHEM SOLID ST, V15, pB48, DOI 10.1149/2.010204esl; Jhong HR, 2013, CURR OPIN CHEM ENG, V2, P191, DOI 10.1016/j.coche.2013.03.005; Delacourt C, 2008, J ELECTROCHEM SOC, V155, pB42, DOI 10.1149/1.2801871; HORI Y, 1994, ELECTROCHIM ACTA, V39, P1833, DOI 10.1016/0013-4686(94)85172-7; Hori Y, 2008, MOD ASP ELECTROCHEM, P89; Tornow CE, 2012, J AM CHEM SOC, V134, P19520, DOI 10.1021/ja308217w; Bidrawn F, 2008, ELECTROCHEM SOLID ST, V11, pB167, DOI 10.1149/1.2943664; Jiang Y, 2003, J ELECTROCHEM SOC, V150, pA942, DOI 10.1149/1.1579480; KOMATSU S, 1995, ELECTROCHIM ACTA, V40, P745, DOI 10.1016/0013-4686(94)00325-U; KYRIACOU GZ, 1993, J APPL ELECTROCHEM, V23, P483; Li H, 2006, J APPL ELECTROCHEM, V36, P1105, DOI 10.1007/s10800-006-9194-z; Qu JP, 2005, ELECTROCHIM ACTA, V50, P3576, DOI 10.1016/j.electacta.2004.11.061; Taylor P., 2010, ENERGY TECHNOLOGY PE; Whipple DT, 2010, ELECTROCHEM SOLID ST, V13, pD109, DOI 10.1149/1.3456590	36	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-4686	1873-3859		ELECTROCHIM ACTA	Electrochim. Acta	JUN 1	2015	166						271	276		10.1016/j.electacta.2015.03.064		6	Electrochemistry	Electrochemistry	CH4XH	WOS:000354036200035		
J	Hosseini, R; Takemura, A; Hosseini, A				Hosseini, Reza; Takemura, Akimichi; Hosseini, Alireza			Non-linear time-varying stochastic models for agroclimate risk assessment	ENVIRONMENTAL AND ECOLOGICAL STATISTICS			English	Article						Frost; Minimum temperature; Non-linear; Risk assessment; Time-varying; Weather derivative	SERIES; IDENTIFICATION	This work develops a model for minimum temperature in order to assess the weather related risk in agriculture industry. Non-linear autoregressive models with time-varying coefficients and volatility with various seasonal components and lags are compared in an appropriate model-selection algorithm using AIC. The optimal model is a time-varying autoregressive model which includes non-linear and seasonally-varying autoregressive terms as well as time-varying volatility. These models are then used to simulate future weather from which the probabilities of appropriate complex hazard events are estimated.	[Hosseini, Reza] IBM Res Collaboratory, Singapore 486048, Singapore; [Takemura, Akimichi] Univ Tokyo, Dept Math Informat, Grad Sch Informat Sci & Technol, Bunkyo Ku, Tokyo 1138656, Japan; [Hosseini, Alireza] Univ Yazd, Dept Ind Engn, Yazd 74189195, Iran	Hosseini, R (reprint author), IBM Res Collaboratory, 9 Changi Business Pk 1, Singapore 486048, Singapore.	reza1317@gmail.com; takemura@stat.t.u-tokyo.ac.jp; alirezahosseini65@gmail.com			Japanese Society for Promotion of Science	The first author was supported by research grants from the Japanese Society for Promotion of Science.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Anderson PL, 1999, STOCH PROC APPL, V83, P149, DOI 10.1016/S0304-4149(99)00027-7; Finley AO, 2008, J AGR BIOL ENVIR ST, V13, P60, DOI 10.1198/108571108X273160; Wang XZ, 2006, DATA MIN KNOWL DISC, V13, P335, DOI 10.1007/s10618-005-0039-x; JONES RH, 1967, BIOMETRIKA, V54, P403, DOI 10.2307/2335032; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; De Livera AM, 2011, J AM STAT ASSOC, V106, P1513, DOI 10.1198/jasa.2011.tm09771; Benth FE, 2007, QUANT FINANC, V7, P553, DOI 10.1080/14697680601155334; Brockwell P.J., 1991, TIME SERIES THEORY M; Gladyshev EG, 1961, SOV MATH, V2, P351; Hastie T., 2009, ELEMENTS STAT LEARNI; Hosseini A., 2012, Journal of Nuts, V3, P45; Hosseini R, 2011, ENVIRON ECOL STAT, V18, P795, DOI 10.1007/s10651-010-0169-1; Hosseini R, 2012, J AGR BIOL ENVIR ST, V17, P283, DOI 10.1007/s13253-012-0090-1; Kedem B, 2002, WILEY SERIES PROBABI; Richards T. J., 2004, American Journal of Agricultural Economics, V86, P1005, DOI 10.1111/j.0002-9092.2004.00649.x; Tesfaye YG, 2006, WATER RESOUR RES, V42, DOI 10.1029/2004WR003772; Tong H., 1990, NONLINEAR TIME SERIE; TROUTMAN BM, 1979, BIOMETRIKA, V66, P219	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1352-8505	1573-3009		ENVIRON ECOL STAT	Environ. Ecol. Stat.	JUN	2015	22	2					227	246		10.1007/s10651-014-0295-2		20	Environmental Sciences; Mathematics, Interdisciplinary Applications; Statistics & Probability	Environmental Sciences & Ecology; Mathematics	CI2ZW	WOS:000354618100002		
J	Ukisu, Y				Ukisu, Yuji			Complete catalytic debromination of polybrominated diphenyl ethers over a silica-supported palladium nanoparticle catalyst	ENVIRONMENTAL CHEMISTRY LETTERS			English	Article						Brominated flame retardants; Decabromodiphenyl ether; Polybrominated dibenzofurans; Catalytic dehalogenation; Palladium catalyst; Alkaline 2-propanol; PBDE	BROMINATED FLAME RETARDANTS; HYDROGEN-TRANSFER HYDRODECHLORINATION; DECABROMODIPHENYL ETHER; DIBENZOFURANS; ENVIRONMENT; REDUCTION; PATHWAYS; PRODUCTS; RELEASE; DIOXINS	Polybrominated diphenyl ethers (PBDE) are widely used as brominated flame retardants, and the release of PBDE into the environment is of great concern. Here, the catalytic debromination of PBDE was achieved with a silica-supported Pd nanoparticle catalyst in a solution of 2-propanol/methanol 99/1 v/v containing dissolved NaOH. Results show that decabromodiphenyl ether (deca-BDE) was completely debrominated at 45 A degrees C into two bromine-free products, diphenyl ether (55 %) and dibenzofuran (45 %), according to gas chromatography-mass spectrometry analysis. This finding indicates that the catalytic reaction included not only substitution of a bromine atom by a hydrogen atom but also a cyclization arising from a C-C bond formation at the ortho positions of the diphenyl ether moiety. Results further show that 2,2',4,4'-tetrabromodiphenyl ether, having two bromines in ortho positions, was converted to diphenyl ether (90 %) and dibenzofuran (10 %). 4,4'-Dibromodiphenyl ether, having no ortho bromines, yielded only diphenyl ether. This study is the first showing the complete catalytic debromination of deca-BDE to bromine-free products under mild conditions.	Natl Inst Adv Ind Sci & Technol, AIST Tsukuba West, Tsukuba, Ibaraki 3058569, Japan	Ukisu, Y (reprint author), Natl Inst Adv Ind Sci & Technol, AIST Tsukuba West, 16-1 Onogawa, Tsukuba, Ibaraki 3058569, Japan.	y-ukisu@aist.go.jp			National Institute of Advanced Industrial Science and Technology (AIST), Japan	The author gratefully acknowledges financial support from the National Institute of Advanced Industrial Science and Technology (AIST), Japan.	Law RJ, 2014, ENVIRON INT, V65, P147, DOI 10.1016/j.envint.2014.01.006; Sun CY, 2012, CHEMOSPHERE, V89, P420, DOI 10.1016/j.chemosphere.2012.05.076; Hagberg J, 2006, ENVIRON INT, V32, P851, DOI 10.1016/j.envint.2006.04.001; Shih YH, 2009, J HAZARD MATER, V165, P34, DOI 10.1016/j.jhazmat.2008.09.103; WATANABE I, 1987, B ENVIRON CONTAM TOX, V39, P953; BUSER HR, 1986, ENVIRON SCI TECHNOL, V20, P404, DOI 10.1021/es00146a015; de Wit CA, 2002, CHEMOSPHERE, V46, P583, DOI 10.1016/S0045-6535(01)00225-9; Lei M, 2014, CHEM ENG J, V241, P207, DOI 10.1016/j.cej.2013.12.032; Yu K, 2012, ENVIRON SCI TECHNOL, V46, P8969, DOI 10.1021/es300516e; Lu M, 2013, BIORESOURCE TECHNOL, V149, P8, DOI 10.1016/j.biortech.2013.09.040; Keum YS, 2005, ENVIRON SCI TECHNOL, V39, P2280, DOI 10.1021/es048846g; Weber R, 2003, ENVIRON INT, V29, P699, DOI 10.1016/S0160-4120(03)00118-1; Bezares-Cruz J, 2004, ENVIRON SCI TECHNOL, V38, P4149, DOI 10.1021/es0498608o; Bonin PML, 2005, CHEMOSPHERE, V58, P961, DOI 10.1016/j.chemosphere.2004.09.099; Alaee M, 2003, ENVIRON INT, V29, P683, DOI 10.1016/S0160-4120(03)00121-1; Shih YH, 2010, CHEMOSPHERE, V78, P1200, DOI 10.1016/j.chemosphere.2009.12.061; Ukisu Y, 1997, J MOL CATAL A-CHEM, V125, P135, DOI 10.1016/S1381-1169(97)00092-7; Ren M, 2011, ENVIRON POLLUT, V159, P1375, DOI 10.1016/j.envpol.2011.01.004; Ebert J, 2003, ENVIRON INT, V29, P711, DOI 10.1016/S0160-4120(03)00117-X; Watanabe I, 2003, ENVIRON INT, V29, P665, DOI 10.1016/S0160-4120(03)00123-5; Huang AZ, 2013, ENVIRON SCI TECHNOL, V47, P518, DOI 10.1021/es302935e; Chou HL, 2013, INT BIODETER BIODEGR, V85, P671, DOI 10.1016/j.ibiod.2013.05.006; Guan GQ, 2010, J CHEM ENG DATA, V55, P5294, DOI 10.1021/je100316k; Nose K, 2007, CHEMOSPHERE, V68, P120, DOI 10.1016/j.chemosphere.2006.12.030; Peverly AA, 2013, J ELECTROANAL CHEM, V704, P227, DOI 10.1016/j.jelechem.2013.07.002; Ukisu Y, 2006, REACT KINET CATAL L, V89, P341, DOI 10.1007/s11144-006-0146-8; Ukisu Y, 2010, REACT KINET MECH CAT, V100, P93, DOI 10.1007/s11144-010-0176-0; Ukisu Y, 2008, APPL CATAL A-GEN, V349, P229, DOI 10.1016/j.apcata.2008.07.040; Ukisu Y, 2012, REACT KINET MECH CAT, V107, P277, DOI 10.1007/s11144-012-0489-2; Ukisu Y, 2003, APPL CATAL B-ENVIRON, V40, P141, DOI 10.1016/S0926-3373(02)00148-0	30	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1610-3653	1610-3661		ENVIRON CHEM LETT	Environ. Chem. Lett.	JUN	2015	13	2					211	216		10.1007/s10311-015-0499-1		6	Chemistry, Multidisciplinary; Engineering, Environmental; Environmental Sciences	Chemistry; Engineering; Environmental Sciences & Ecology	CI4LW	WOS:000354721700008		
J	Cao, YJ; Tang, CY; Song, XF; Liu, CM				Cao, Yingjie; Tang, Changyuan; Song, Xianfang; Liu, Changming			Major ion chemistry, chemical weathering and CO2 consumption in the Songhua River basin, Northeast China	ENVIRONMENTAL EARTH SCIENCES			English	Article						The Songhua River; Major ion chemistry; Long-term trends; Chemical weathering; CO2 consumption	CHANGJIANG YANGTZE-RIVER; ELEMENT CHEMISTRY; WATER CHEMISTRY; AMAZON RIVER; GEOCHEMISTRY; TIME	A detailed analysis of the major ion chemistry, chemical weathering and CO2 consumption was conducted in the Songhua River basin, which is the largest basin with a draining area of 557 thousand km(2) in Northeast China. The dataset used in this study included major ion concentrations came from 56 hydrological stations from the year of 1962 to 1984. The median of the total dissolved solid concentration of the Songhua River was 104.8 mg/L, about two times higher than the global average (65.0 mg/L), but lower than that of other Chinese Rivers. Prevalent ions were Na+, Ca2+ and HCO3 (-), and the average Ca2+/Na+ and Mg2+/Na+ molar ratios were 0.70 and 0.42, which were close to silicate weathering end-member. Long-term trend analysis by seasonal MK test showed that from 1962 to 1984, Ca2+, Na+ + K+ and HCO3 (-) were significantly increasing, and the increasing rates calculated by linear fit slopes for Ca2+, Na+ + K+ and HCO3 (-) ions were 0.22, 0.63 and 2.35 mg/year, respectively. An inverse model showed that the dissolved loads primarily came from rock weathering (91.5 %), including silicate weathering (66.4 %) and a small portion from carbonates (16.1 %) and evaporites (9.0 %). Other origins consisted of anthropogenic inputs (5.3 %) and atmospheric inputs (3.2 %). Average silicate and carbonate weathering rates were estimated as 4.03 and 1.76 t km(-2) year(-1), and CO2 consumption rates of silicates and carbonates were 17.1 x 104 and 1.85 x 104 mol km(-2) year(-1), respectively. These results are consistent with the lithologies of the study area, which mainly consisted of silicate rocks.	[Cao, Yingjie; Tang, Changyuan] Sun Yat Sen Univ, Sch Environm Sci & Engn, Guangzhou 510275, Guangdong, Peoples R China; [Cao, Yingjie; Tang, Changyuan] Chiba Univ, Fac Hort, Grad Sch Hort, Matsudo, Chiba 2718510, Japan; [Song, Xianfang; Liu, Changming] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Key Lab Water Cycle & Related Land Surface Proc, Beijing 100101, Peoples R China	Tang, CY (reprint author), Chiba Univ, Fac Hort, Grad Sch Hort, Matsudo, Chiba 2718510, Japan.	tangchangyuan@gmail.com			Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences [KZCX2-YW-Q06-1]	This work was funded by the Main Direction Program of Knowledge Innovation of Chinese Academy of Sciences: Study on water cycle, water resource carrying capacity and optimization configuration (No. KZCX2-YW-Q06-1). The authors wish to thank Dr. Long Di for the suggestions to this paper.	Chen JS, 2002, CHEM GEOL, V187, P231, DOI 10.1016/S0009-2541(02)00032-3; ZHANG J, 1995, J HYDROL, V168, P173, DOI 10.1016/0022-1694(94)02635-O; EDMOND JM, 1992, SCIENCE, V258, P1594, DOI 10.1126/science.258.5088.1594; RAYMO ME, 1992, NATURE, V359, P117, DOI 10.1038/359117a0; GIBBS RJ, 1970, SCIENCE, V170, P1088, DOI 10.1126/science.170.3962.1088; Gaillardet J, 1997, CHEM GEOL, V142, P141, DOI 10.1016/S0009-2541(97)00074-0; STALLARD RF, 1981, J GEOPHYS RES-OC ATM, V86, P9844, DOI 10.1029/JC086iC10p09844; HIRSCH RM, 1984, WATER RESOUR RES, V20, P727, DOI 10.1029/WR020i006p00727; WALKER JCG, 1981, J GEOPHYS RES-OC ATM, V86, P9776, DOI 10.1029/JC086iC10p09776; BERNER RA, 1983, AM J SCI, V283, P641; GORDEEV VV, 1993, MAR CHEM, V43, P33, DOI 10.1016/0304-4203(93)90214-9; Zhang LA, 2011, APPL GEOCHEM, V26, P293, DOI 10.1016/j.apgeochem.2010.12.002; Gaillardet J, 1999, CHEM GEOL, V159, P3, DOI 10.1016/S0009-2541(99)00031-5; Xu ZF, 2010, APPL GEOCHEM, V25, P1603, DOI 10.1016/j.apgeochem.2010.08.012; GIBBS RJ, 1972, GEOCHIM COSMOCHIM AC, V36, P1061, DOI 10.1016/0016-7037(72)90021-X; Li SY, 2009, CHEM GEOL, V264, P89, DOI 10.1016/j.chemgeo.2009.02.021; Wu WH, 2008, CHEM GEOL, V249, P307, DOI 10.1016/j.chemgeo.2008.01.025; Appelo C.A.J., 2005, GEOCHEMISTRY GROUNDW; BERNER RA, 1991, AM J SCI, V291, P339; Li Yi, 2010, Atmospheric Research, V96, DOI 10.1016/j.atmosres.2009.12.011; Meybeck M., 1989, PALAEOGEOGR PALAEOCL, V75, P283, DOI 10.1016/0031-0182(89)90191-0; NEGREL P, 1993, EARTH PLANET SC LETT, V120, P59, DOI 10.1016/0012-821X(93)90023-3; Ollivier P, 2010, GEOCHIM COSMOCHIM AC, V74, P907, DOI 10.1016/j.gca.2009.10.037; Ran XB, 2010, HYDROL PROCESS, V24, P2481, DOI 10.1002/hyp.7684; Song X., 2010, SCI SOIL WATER CONSE, V8, P46; Zhang SR, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000493	26	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	JUN	2015	73	11					7505	7516		10.1007/s12665-014-3921-2		12	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CI4IQ	WOS:000354712300060		
J	Huang, Y; Yu, M; Xu, Q; Sawada, K; Moriguchi, S; Yashima, A; Liu, CW; Xue, L				Huang, Yu; Yu, Miao; Xu, Qiang; Sawada, Kazuhide; Moriguchi, Shuji; Yashima, Atsushi; Liu, Chengwei; Xue, Long			InSAR-derived digital elevation models for terrain change analysis of earthquake-triggered flow-like landslides based on ALOS/PALSAR imagery	ENVIRONMENTAL EARTH SCIENCES			English	Article						Flow-like landslide; DEM; InSAR; ALOS/PALSAR; Earthquake; Hazard assessment	5.12 WENCHUAN EARTHQUAKE; SAR INTERFEROMETRY; CHINA; SICHUAN; AREA; GPS	Earthquakes can directly trigger multiple simultaneous slope failures in mountainous regions. Among these slope failures, flow-like landslides with high velocities and long run-outs can result in damage that is more destructive than other types of landslides. Timely and accurate recognition of the locations and magnitudes of flow-like landslides is essential for post-disaster relief. Synthetic aperture radar (SAR) sensors are suitable for deformation monitoring because of their capability to operate at day or night and in all weather conditions. Interferometric synthetic aperture radar (InSAR) is an advanced technique that extracts three-dimensional terrain and changes information from the radar images at a regional scale. The focus of this study is the Donghekou landslide-debris flow that was triggered by the 2008 Wenchuan earthquake. ALOS/PALSAR remote satellite images were interpreted by InSAR to generate digital surface elevation models. A comparison of data from a typical InSAR configuration with field survey data proves that the former is an effective method for rapidly detecting flow-like landslides in a mountainous area. The comparison also shows that the accuracy of the results is closely related to the correlation between the satellite radar images used, and further that the study accuracy would improve with the inclusion of better correlation. In this way, representations of pre- and post-landslide terrains could be generated for use in numerical simulations. The InSAR method has particular significance for areas without terrain data prior to slope failure, and can provide basic data for landslide hazard assessments.	[Huang, Yu; Yu, Miao; Liu, Chengwei; Xue, Long] Tongji Univ, Coll Civil Engn, Dept Geotech Engn, Shanghai 200092, Peoples R China; [Huang, Yu] Tongji Univ, Minist Educ, Key Lab Geotech & Underground Engn, Shanghai 200092, Peoples R China; [Xu, Qiang] Chengdu Univ Technol, State Key Lab Geohazard Prevent & Geoenvironm Pro, Chengdu 610059, Peoples R China; [Sawada, Kazuhide; Yashima, Atsushi] Gifu Univ, Dept Civil Engn, Gifu 5011193, Japan; [Moriguchi, Shuji] Tohoku Univ, Int Res Inst Disaster Sci, Sendai, Miyagi 9808579, Japan	Huang, Y (reprint author), Tongji Univ, Coll Civil Engn, Dept Geotech Engn, Shanghai 200092, Peoples R China.	yhuang@tongji.edu.cn	Huang, Yu/K-8849-2012	Huang, Yu/0000-0002-9935-7717	National Natural Science Foundation of China; Japan Society for the Promotion of Science under China-Japan Scientific Cooperation Program [41211140042]; National Key Technologies R&D Program of China [2012BAJ11B04]; National Science Fund for Distinguished Young Scholars of China [41225011]; Chang Jiang Scholars Program of China	This work was supported by the National Natural Science Foundation of China and the Japan Society for the Promotion of Science under the China-Japan Scientific Cooperation Program (Grant No. 41211140042), the National Key Technologies R&D Program of China (Grant No. 2012BAJ11B04), the National Science Fund for Distinguished Young Scholars of China (Grant No. 41225011) and the Chang Jiang Scholars Program of China. The ALOS PALSAR data in this work are copyrighted by JAXA/METI.	Abdikan S, 2014, ENVIRON EARTH SCI, V71, P4081, DOI 10.1007/s12665-013-2793-1; Gong JH, 2010, LANDSLIDES, V7, P181, DOI 10.1007/s10346-010-0201-4; Hungr O, 2001, ENVIRON ENG GEOSCI, V7, P221; Yin YP, 2010, LANDSLIDES, V7, P359, DOI 10.1007/s10346-010-0225-9; Strozzi T, 2005, LANDSLIDES, V2, P193, DOI 10.1007/s10346-005-0003-2; Liu P, 2013, INT J APPL EARTH OBS, V21, P253, DOI 10.1016/j.jag.2011.10.010; Wang FW, 2009, LANDSLIDES, V6, P47, DOI 10.1007/s10346-009-0141-z; Dai FC, 2011, J ASIAN EARTH SCI, V40, P883, DOI 10.1016/j.jseaes.2010.04.010; Zhao CY, 2012, REMOTE SENS ENVIRON, V124, P348, DOI 10.1016/j.rse.2012.05.025; Huang RQ, 2009, SCI CHINA SER E, V52, P810, DOI 10.1007/s11431-009-0117-1; Zhou JW, 2013, J ASIAN EARTH SCI, V76, P70, DOI 10.1016/j.jseaes.2013.08.007; Yin YP, 2009, LANDSLIDES, V6, P139, DOI 10.1007/s10346-009-0148-5; Catani F, 2005, LANDSLIDES, V2, P329, DOI 10.1007/s10346-005-0021-0; Chang DS, 2011, LANDSLIDES, V8, P321, DOI 10.1007/s10346-011-0256-x; Crosta GB, 2005, ENG GEOL, V79, P185, DOI 10.1016/j.enggeo.2005.01.014; Evans SG, 2009, ENG GEOL, V109, P195, DOI 10.1016/j.enggeo.2009.08.007; Dong SC, 2014, ENVIRON EARTH SCI, V72, P677, DOI 10.1007/s12665-013-2990-y; Greif V, 2012, ENVIRON EARTH SCI, V66, P1585, DOI 10.1007/s12665-011-0951-x; Gupta M, 2014, ENVIRON EARTH SCI, V71, P2875, DOI 10.1007/s12665-013-2664-9; Huang Y, 2012, LANDSLIDES, V9, P275, DOI 10.1007/s10346-011-0285-5; Huang Y, 2014, ENG GEOL, V168, P86, DOI 10.1016/j.enggeo.2013.10.022; Pardo JM, 2013, ENVIRON EARTH SCI, V70, P1957, DOI 10.1007/s12665-013-2710-7; Peyret M, 2008, ENG GEOL, V100, P131, DOI 10.1016/j.enggeo.2008.02.013; [任馨 REN Xin], 2008, [水利水电技术, Water Resources and Hydropower Engineering], V39, P27; Shimada M., 2008, EOS T AGU, V89, P277, DOI DOI 10.1029/2008EO310002; Singh LP, 2005, LANDSLIDES, V2, P221, DOI 10.1007/s10346-005-0059-z; Sun P, 2011, J MT SCI-ENGL, V8, P140, DOI 10.1007/s11629-011-2112-9; Wang GJ, 2013, ENVIRON EARTH SCI, V69, P2763, DOI 10.1007/s12665-012-2097-x; Zhang DX, 2013, LANDSLIDES, V10, P231, DOI 10.1007/s10346-012-0378-9; Zhou JM, 2014, ENVIRON EARTH SCI, V71, P3581, DOI 10.1007/s12665-013-2749-5	30	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1866-6280	1866-6299		ENVIRON EARTH SCI	Environ. Earth Sci.	JUN	2015	73	11					7661	7668		10.1007/s12665-014-3939-5		8	Environmental Sciences; Geosciences, Multidisciplinary; Water Resources	Environmental Sciences & Ecology; Geology; Water Resources	CI4IQ	WOS:000354712300072		
J	Satoh, A				Satoh, Akira			Sedimentation Behavior of Dispersions Composed of Large and Small Charged Colloidal Particles: Development of New Technology to Improve the Visibility of Small Lakes and Ponds	ENVIRONMENTAL ENGINEERING SCIENCE			English	Article						lake; particle suspension; charged spherical particle; sedimentation; pond; visibility	ACTIVATED CARBONS; SUSPENSIONS; ELECTROCOAGULATION; SPECTROSCOPY; WATER	In this study, we treat the dirty (small) and the adsorbing (large) particles, which are both of approximately micron-order or smaller, as charged and oppositely charged spheres and investigate the behavior of these particles under the gravity field by means of Brownian dynamics simulations. We have here mainly discussed the dependence of the adsorption rate on the particle diameter ratio, the volumetric fraction of large particles, and the input amount of large particles. Large particles adsorb much more small particles, per large particle, but the total number of small particles adsorbed by the large particles more significantly increases for large particles with smaller diameter if the same input amount of adsorbing agents (large particles) is used. This is because large particles with small diameter more actively perform random motion and move more extensively to adsorb small particles, although the surface area of large particles increases with decreasing diameter, leading to more opportunity to contact small particles. Hence, it is seen that putting numerous adsorbing particles with smaller diameter into water is more effective for removing suspended substances or dirty particles. Even if the input amount of large particles is increased, an adsorption performance cannot significantly be improved because the number of inefficient large particles that do not contribute to the adsorption performance increases. From these results, we understand that an optimal input amount of adsorption agents, from a commercial point of view, should be determined by various factors in the application of the adsorption technique to actual situations.	Akita Prefecture Univ, Fac Syst Sci & Technol, Yuri Honjo 0150055, Japan	Satoh, A (reprint author), Akita Prefecture Univ, Fac Syst Sci & Technol, Yuri Honjo 0150055, Japan.	asatoh@akita-pu.ac.jp					Adachi Y., 2003, SOID COLLOID SCI; Adachi Y, 1999, T AGR ENG SOC JAPAN, V67, P593; Wotton RS, 2002, HYDROBIOLOGIA, V469, P193, DOI 10.1023/A:1015503005899; PETSEV DN, 1993, COLLOID SURFACE A, V81, P65, DOI 10.1016/0927-7757(93)80235-7; HOGG R, 1966, T FARADAY SOC, V62, P1638, DOI 10.1039/tf9666201638; Schroth BK, 1997, CLAY CLAY MINER, V45, P85, DOI 10.1346/CCMN.1997.0450110; Vasudevan S, 2012, ENVIRON ENG SCI, V29, P563, DOI 10.1089/ees.2010.0429; BUSCALL R, 1990, COLLOID SURFACE, V43, P33, DOI 10.1016/0166-6622(90)80002-L; BARKER GC, 1990, COLLOID SURFACE, V43, P55, DOI 10.1016/0166-6622(90)80003-M; Barrera-Diaz C, 2008, ENVIRON ENG SCI, V25, P529, DOI 10.1089/ees.2007.0106; CLARK CJ, 1984, CLAY CLAY MINER, V32, P291, DOI 10.1346/CCMN.1984.0320407; Gauden PA, 2006, J COLLOID INTERF SCI, V300, P453, DOI 10.1016/j.jcis.2006.04.017; Ismadji S, 2001, CARBON, V39, P1237, DOI 10.1016/S0008-6223(00)00252-9; Iwata S., 1995, SOIL WATER INTERACTI; Kitagawa Y, 2001, SCIENCE, V11, P329; Kitahara F., 1972, ELECT INTERFACIAL PH; Kitahara F., 1994, FUNDAMENTALS INTERFA; Knapik HG, 2014, ENVIRON ENG SCI, V31, P653, DOI 10.1089/ees.2014.0064; NOVICH BE, 1984, CLAY CLAY MINER, V32, P400, DOI 10.1346/CCMN.1984.0320508; Okai T., 2007, ANN REPORT KAGAWA PR, V6, P29; Satoh A, 2009, J COLLOID INTERF SCI, V338, P236, DOI 10.1016/j.jcis.2009.06.030; Satoh A., 2003, INTRO MOL MICROSIMUL; Satoh A., 2010, INTRO PRACTICE MOL S; Tachibana T., 1981, COLLOID CHEM ITS NEW; Takami Y, 2000, J MINING MAT PROCESS, V116, P789; The Cray Science Society, 1987, CRAY HDB; Vissers JPC, 1997, COLLOID SURFACE A, V126, P33, DOI 10.1016/S0927-7757(96)03896-4; WEDLOCK DJ, 1990, COLLOID SURFACE, V43, P67, DOI 10.1016/0166-6622(90)80004-N	28	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1092-8758	1557-9018		ENVIRON ENG SCI	Environ. Eng. Sci.	JUN 1	2015	32	6					528	538		10.1089/ees.2014.0493		11	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CI9YG	WOS:000355126100009		
J	Tazib, T; Kobayashi, Y; Koyama, H; Matsui, T				Tazib, Tanveer; Kobayashi, Yuriko; Koyama, Hiroyuki; Matsui, Tsutomu			QTL analyses for anther length and dehiscence at flowering as traits for the tolerance of extreme temperatures in rice (Oryza sativa L.)	EUPHYTICA			English	Article						Apical dehiscence length; Basal dehiscence length; High-temperature stress; QTL analysis; Rice (Oryza sativa L.)	COLD TOLERANCE; FLORAL CHARACTERS; BASAL DEHISCENCE; HUMID CONDITION; POLLINATION; STERILITY; PLANTS; IDENTIFICATION; VARIETIES; STAGE	Quantitative trait loci (QTLs) for anther length (AL), length of the dehiscence that forms at the apex of the anther [apical dehiscence length (ADL)] and at the base of the anther [basal dehiscence length (BDL)], and the percentage of longitudinal dehiscence (LD) in rice (Oryza sativa L.) were analyzed using data from two consecutive years (2009 and 2010). Backcross inbred lines (BILs) derived from backcrossing of the rice cultivars (Nipponbare x Kasalath) x Nipponbare (95 lines) were used in both years for the detection of the QTLs. Each phenotype was significantly correlated between the 2 years, though its heritability was low. The anther dehiscence is strongly under control from both the environmental and genetic factors. Four major QTLs (alpha < 0.05) were detected for AL, three for ADL, four for BDL, and one for LD, using composite interval mapping. These QTLs explained 47-42, 32-25 and 36-28 % of the phenotypic variation in total for AL, ADL and BDL in BILs in 2009-2010, respectively, and for LD, 25 % in 2010. The phenotypic effects of the QTLs were examined using 54 chromosome segment substitution lines (CSSLs) derived from Nipponbare x Kasalath. Four of the detected QTLs had significant effects in CSSLs with Kasalath-type segments at marker positions linked with the QTLs, and the CSSLs can, therefore, be donors for breeding rice with high-temperature tolerance.	[Tazib, Tanveer; Matsui, Tsutomu] Gifu Univ, Fac Appl Biol Sci, Lab Crop Prod Sci, Gifu 5011193, Japan; [Kobayashi, Yuriko; Koyama, Hiroyuki] Gifu Univ, Fac Appl Biol Sci, Lab Plant Cell Technol, Gifu 5011193, Japan	Matsui, T (reprint author), Gifu Univ, Fac Appl Biol Sci, Lab Crop Prod Sci, 1-1 Yanagido, Gifu 5011193, Japan.	matsuit@gifu-u.ac.jp			Ministry of Agriculture, Forestry and Fisheries, Japan	Part of this work was financially supported by the Ministry of Agriculture, Forestry and Fisheries, Japan, through a research project entitled "Development of technologies for mitigation and adaptation to climate change in agriculture, forestry and fisheries". We thank the National Institute of Agrobiological Sciences (http://www.nias.affrc.go.jp/index_e.html) for providing the rice seeds. We thank Shouta Yamada for his technical assistance.	Miura K, 2011, TRENDS PLANT SCI, V16, P319, DOI 10.1016/j.tplants.2011.02.009; Saito K, 2004, THEOR APPL GENET, V109, P515, DOI 10.1007/s00122-004-1667-z; Saito K, 2001, THEOR APPL GENET, V103, P862, DOI 10.1007/s001220100661; SATAKE T, 1978, JPN J CROP SCI, V47, P6; Asins MJ, 2002, PLANT BREEDING, V121, P281, DOI 10.1046/j.1439-0523.2002.730285.x; Matsui T, 2005, PLANT PROD SCI, V8, P109, DOI 10.1626/pps.8.109; Ye CR, 2012, PLANT BREEDING, V131, P33, DOI 10.1111/j.1439-0523.2011.01924.x; Shah F, 2011, J AGR SCI, V149, P545, DOI 10.1017/S0021859611000360; Matsui T, 2001, PLANT PROD SCI, V4, P90; Chase K, 1997, THEOR APPL GENET, V94, P724, DOI 10.1007/s001220050471; Hashimoto K, 1961, B HOKKAIDO STUDY M B, V2, P11; HORIE T, 1992, AGR SYST, V40, P211, DOI 10.1016/0308-521X(92)90022-G; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Matsui Tsutomu, 2000, Plant Production Science, V3, P430; Matsui T, 2003, ANN BOT-LONDON, V91, P473, DOI 10.1093/aob/mcg045; Matsui T, 1999, ANN BOT-LONDON, V84, P501, DOI 10.1006/anbo.1999.0943; Matsui T, 2005, PHYTON-ANN REI BOT A, V45, P401; Matsui T, 2009, GAMMA FIELD S, V48, P43; Osada A., 1973, Proceedings of the Crop Science Society of Japan, V42, P103; Shimazaki Y, 1964, RES B HOKKAIDO NATL, V83, P1; Song XJ, 2008, RICE, V1, P135, DOI 10.1007/s12284-008-9018-3; SUZUKI S, 1981, JPN J BREED, V31, P57; SUZUKI S, 1982, JPN J BREED, V32, P9; Tanno H, 1999, JPN J CROP SCI, V68, P508; Tian XH, 2010, PLANT PROD SCI, V13, P243, DOI 10.1626/pps.13.243; Uchijima T, 1976, J AGROMETEOROL, V31, P199; Wang S, 2012, WINDOWS QTL CARTOGRA; Xiao YingHui, 2011, Rice Science, V18, P204; Zhang YS, 2011, PLANT BREEDING, V130, P185, DOI 10.1111/j.1439-0523.2010.01807.x; Zhao L, 2010, AGR ECOSYST ENVIRON, V139, P110, DOI 10.1016/j.agee.2010.07.006	30	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0014-2336	1573-5060		EUPHYTICA	Euphytica	JUN	2015	203	3					629	642		10.1007/s10681-014-1291-1		14	Agronomy; Plant Sciences; Horticulture	Agriculture; Plant Sciences	CI5SM	WOS:000354819700013		
J	Merkonidis, C; Grosse, F; Ninh, T; Hummel, C; Haehner, A; Hummel, T				Merkonidis, Christos; Grosse, Franz; Ninh, Timomi; Hummel, Cornelia; Haehner, Antje; Hummel, Thomas			Characteristics of chemosensory disorders-results from a survey	EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY			English	Article						Smell; Taste; Chemosensory characteristics	ADOPTED COPING STRATEGIES; QUALITY-OF-LIFE; OLFACTORY DYSFUNCTION; CHRONIC RHINOSINUSITIS; SMELL IDENTIFICATION; ALLERGIC RHINITIS; ODOR MEMORY; FOOD-INTAKE; TASTE; SENSITIVITY	This survey was undertaken to investigate the nature of chemosensory dysfunction in relation to the underlying cause, severity, and course of the disease and to elucidate their clinical significance. A total of 269 patients (116 men and 149 women) with chemosensory disorders participated in the survey. Approximately 89 % had olfactory loss, either alone or in combination with taste loss and 2 % had gustatory loss alone; 7.4 % had chemosensory distortions. Dysosmia was significantly higher in those on more than four medicines per day (p < 0.02). Most patients (51.6 %) reported sudden onset of symptoms. Self-reported etiologies included: flu/infection (39.4 %), medication intake (13 %), sinusitis (12 %), operation (10.7 %), head-trauma (9.3 %), and not-specified (12.7 %). The most frequent complaint was diminished pleasure from eating followed by a decrease in general quality of life (QoL). Patients with gradual onset of symptoms or long-standing disease complained the least (p < 0.005). Of all etiologies, patients with SND complained the most (p < 0.04). Overall, 18.6 % ate more and 7.3 % ate less, 7.5 % changed their food preferences, and 19 % reported weight gain and 15.8 % weight loss. Haptic feedback was considered more important than visual appeal and acoustic feedback of food. Older patients however valued visual appeal more. When asked directly, 63 % reported having experienced household-mishaps, 58.1 % problems with social communication, 56.8 % reported having changed their sexual behavior and 35.9 % suffered depression. 60.4 % did not cope well with the changes in their lives. Women reported more problems than men, particularly relating to interpersonal communication (64.5 vs. 57.6 %) and mood (47.9 vs. 40.9 %). Women also had more frequent spontaneous recollections of smells (p < 0.02). Chemosensory disorders have a significant impact on QoL. Reduced pleasure from eating is the predominant complaint of patients seeking medical attention. The steeper the onset of symptoms, the worse the ability to cope with changes in daily life. Older patients value the visual appeal, whereas younger patients value the haptic feedback of foods.	[Merkonidis, Christos; Grosse, Franz; Hummel, Cornelia; Haehner, Antje; Hummel, Thomas] Tech Univ Dresden, Interdisciplinary Ctr Smell & Taste, Dept Otorhinolaryngol, D-01307 Dresden, Germany; [Merkonidis, Christos] Ipswich Hosp NHS Trust, Ear Nose & Throat Dept, Ipswich, Suffolk, England; [Ninh, Timomi] Hyogo Coll Med, Dept Otolaryngol, Nishinomiya, Hyogo 6638501, Japan	Hummel, T (reprint author), Tech Univ Dresden, Interdisciplinary Ctr Smell & Taste, Dept Otorhinolaryngol, Fetscherstr 74, D-01307 Dresden, Germany.	thummel@mail.zih.tu-dresden.de					Stuck BA, 2003, ALLERGY, V58, P1195, DOI 10.1034/j.1398-9995.2003.00162.x; Hummel T, 2005, ACTA OTO-LARYNGOL, V125, P116, DOI 10.1080/00016480410022787; Murphy C, 2002, JAMA-J AM MED ASSOC, V288, P2307, DOI 10.1001/jama.288.18.2307; Doty RL, 2004, OTOLARYNG CLIN N AM, V37, P1229, DOI 10.1016/j.otc.2004.05.002; Peveler R, 2002, BRIT MED J, V325, P149, DOI 10.1136/bmj.325.7356.149; Gutman M, 2004, OTOLARYNG HEAD NECK, V130, P545, DOI 10.1016/j.otohns.2004.02.007; Landis BN, 2003, CHEM SENSES, V28, P691, DOI 10.1093/chemse/bjg061; CABANAC M, 1971, SCIENCE, V173, P1103, DOI 10.1126/science.173.4002.1103; Silvestre FJ, 2012, MED ORAL PATOL ORAL, V17, pE1, DOI 10.4317/medoral.17219; Aschenbrenner K, 2008, J PSYCHIATR RES, V43, P129, DOI 10.1016/j.jpsychires.2008.03.003; Nordin S, 2008, CURR OPIN ALLERGY CL, V8, P10, DOI 10.1097/ACI.0b013e3282f3f473; Landis BN, 2009, RHINOLOGY, V47, P454, DOI 10.4193/Rhin08.174; DUNCAN HJ, 1995, ARCH OTOLARYNGOL, V121, P1183; Ship JA, 1996, J GERONTOL A-BIOL, V51, pM86; VANSTRIEN T, 1986, INT J EAT DISORDER, V5, P295, DOI 10.1002/1098-108X(198602)5:2<295::AID-EAT2260050209>3.0.CO;2-T; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Klimek L, 1997, J ALLERGY CLIN IMMUN, V100, P158, DOI 10.1016/S0091-6749(97)70218-5; Wolfensberger M, 2002, CHEM SENSES, V27, P617, DOI 10.1093/chemse/27.7.617; Bramerson A, 2004, LARYNGOSCOPE, V114, P733; Verhagen JV, 2004, J NEUROPHYSIOL, V92, P1685, DOI 10.1152/jn.00321.2004; Nederkoorn C, 2004, APPETITE, V42, P125, DOI 10.1016/j.appet.2003.11.001; Havermans RC, 2010, CHEM SENSES, V35, P735, DOI 10.1093/chemse/bjq074; Rolls ET, 2007, P NUTR SOC, V66, P96, DOI 10.1017/S0029665107005332; Nordin S, 2011, ACTA OTO-LARYNGOL, V131, P826, DOI 10.3109/00016489.2010.539625; Miwa T, 2001, ARCH OTOLARYNGOL, V127, P497; Seo HS, 2009, APPETITE, V53, P314, DOI 10.1016/j.appet.2009.07.010; DEEMS DA, 1991, ARCH OTOLARYNGOL, V117, P519; Frasnelli J, 2005, EUR ARCH OTO-RHINO-L, V262, P231, DOI 10.1007/s00405-004-0796-y; Houser SM, 2008, LARYNGOSCOPE, V118, P1521, DOI 10.1097/MLG.0b013e31817d01b8; Jansen A, 1998, BEHAV RES THER, V36, P257, DOI 10.1016/S0005-7967(98)00055-2; Frasnelli J, 2006, NEUROSCIENCE, V142, P541, DOI 10.1016/j.neuroscience.2006.06.005; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635; Hoffman HJ, 1998, ANN NY ACAD SCI, V855, P716, DOI 10.1111/j.1749-6632.1998.tb10650.x; NORDIN S, 1995, J GERONTOL B-PSYCHOL, V50, pP187; Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Tepper BJ, 2008, ANNU REV NUTR, V28, P367, DOI 10.1146/annurev.nutr.28.061807.155458; Landis BN, 2010, J NEUROL, V257, P1303, DOI 10.1007/s00415-010-5513-8; FRANZOI SL, 1987, PERS SOC PSYCHOL B, V13, P19, DOI 10.1177/0146167287131002; Blomqvist EH, 2004, RHINOLOGY, V42, P189; Busch MA, 2013, BUNDESGESUNDHEITSBLA, V5; DOTY RL, 1989, OTOLARYNG CLIN N AM, V22, P397; Flohr ELR, 2014, NEUROSCIENCE, V268, P118, DOI 10.1016/j.neuroscience.2014.03.018; Gudziol V, 2009, J SEX MED, V6, P1924, DOI 10.1111/j.1743-6109.2009.01266.x; HENDRIKS A P J, 1988, Rhinology (Utrecht), V26, P229; Herz RS, 1997, HUM NATURE-INT BIOS, V8, P275, DOI 10.1007/BF02912495; Hoffman Howard J, 2009, Ann N Y Acad Sci, V1170, P514, DOI 10.1111/j.1749-6632.2009.04597.x; Hufnagl B, 2003, CHEM SENSES, V28, pE27; Keller Andreas, 2013, BMC Ear Nose Throat Disord, V13, P8, DOI 10.1186/1472-6815-13-8; Koster EP, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00064; Krause HF, 2003, OTOLARYNG HEAD NECK, V128, P14, DOI 10.1067/mhn.2003.3; Levy LM, 1999, J COMPUT ASSIST TOMO, V23, P487, DOI 10.1097/00004728-199907000-00001; Litvack JR, 2009, AMJ RHINOL ALLERGY, V23, P139, DOI 10.2500/ajra.2009.23.3286; Litvack JR, 2008, LARYNGOSCOPE, V118, P2225, DOI 10.1097/MLG.0b013e318184e216; Morgan CD, 1997, EVOKED POTENTIAL, V104, P351, DOI 10.1016/S0168-5597(97)00020-8; NEWMAN LJ, 1994, JAMA-J AM MED ASSOC, V271, P363, DOI 10.1001/jama.271.5.363; PELIKAN Z, 1990, J ALLERGY CLIN IMMUN, V86, P484, DOI 10.1016/S0091-6749(05)80203-9; ROLLS ET, 1989, EUR J NEUROSCI, V1, P53, DOI 10.1111/j.1460-9568.1989.tb00774.x; Seiden AM, 2004, OTOLARYNG CLIN N AM, V37, P1159, DOI 10.1016/j.otc.2004.06.007; SHIP JA, 1993, J GERONTOL, V48, pM26; Shu CH, 2009, AMJ RHINOL ALLERGY, V23, P413, DOI 10.2500/ajra.2009.23.3343; Silvestre F-J, 2008, ANNU REV NUTR, V28, P367; Smith D. V., 2003, Handbook of olfaction and gustation, P731; Tennen H, 1991, SMELL TASTE HLTH DIS, P787; Welge-Lussen A, 2014, PRACTICAL GUIDE CLIN, P49; Welge-Lussen A, 2011, J NEUROL, V258, P386, DOI 10.1007/s00415-010-5763-5; WYSOCKI CJ, 1989, ANN NY ACAD SCI, V561, P12, DOI 10.1111/j.1749-6632.1989.tb20966.x; YOUNGENTOB SL, 1986, AM J OTOLARYNG, V7, P187, DOI 10.1016/S0196-0709(86)80005-9	68	3	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0937-4477	1434-4726		EUR ARCH OTO-RHINO-L	Eur. Arch. Oto-Rhino-Laryn.	JUN	2015	272	6					1403	1416		10.1007/s00405-014-3210-4		14	Otorhinolaryngology	Otorhinolaryngology	CI3BZ	WOS:000354623800011		
J	Matsumoto, K; Hasegawa, T; Kamei, T; Koyanagi, J; Takahashi, T; Akimoto, M; Sugibayashi, K				Matsumoto, Kaori; Hasegawa, Tetsuya; Kamei, Tomoyo; Koyanagi, Junichi; Takahashi, Tamiko; Akimoto, Masayuki; Sugibayashi, Kenji			Reductive metabolism of nabumetone by human liver microsomal and cytosolic fractions: exploratory prediction using inhibitors and substrates as marker probes	EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Nabumetone; Carbonyl reductase; Aldoketo reductase; 11 beta-Hydroxysteroid dehydrogenase; In vitro metabolism	PERFORMANCE LIQUID-CHROMATOGRAPHY; IN-VITRO CHARACTERIZATION; ACTIVE METABOLITE; 4-METHYLNITROSAMINO-1-(3-PYRIDYL)-1-BUTANONE NNK; 6-METHOXY-2-NAPHTHYLACETIC ACID; DIHYDRODIOL DEHYDROGENASES; CARBONYL REDUCTION; RHEUMATIC DISEASES; ENZYMES; PURIFICATION	The metabolic reduction of nabumetone was examined by inhibition and correlation studies using human liver microsomes and cytosol. This reduction was observed in both fractions, with the V (max) values for reduction activity being approximately fourfold higher, and the V (max) /K (m) values approximately three-fold higher, in the microsomes than in the cytosol. The reduction of nabumetone was inhibited by 18 beta-glycyrrhetinic acid, an 11 beta-hydroxysteroid dehydrogenase (11 beta-HSD) inhibitor, in the microsomal fraction. The reduction activity was also inhibited by quercetin and menadione [carbonyl reductase (CBR) inhibitors], and by phenolphthalein and medroxyprogesterone acetate [potent inhibitors of aldo-keto reductase (AKR) 1C1, 1C2 and 1C4] in the cytosol. A good correlation (r (2) = 0.93) was observed between the reduction of nabumetone and of cortisone, as a marker of 11 beta-HSD activity, in the microsomal fractions. There was also an excellent relationship between reduction of nabumetone and of the AKR1C substrates, acetohexamide, and ethacrynic acid (r (2) = 0.92 and 0.93, respectively), in the cytosol fractions. However, a poor correlation was observed between the formation of 4-(6-methoxy-2-naphthyl)-butan-2-ol (MNBO) from nabumetone and CBR activity (with 4-benzoyl pyridine reduction as a CBR substrate) in the cytosol fractions (r (2) = 0.24). These findings indicate that nabumetone may be metabolized by 11 beta-HSD in human liver microsomes, and primarily by AKR1C4 in human liver cytosol, although multiple enzymes in the AKR1C subfamily may be involved. It cannot be completely denied that CBR is involved to some extent in the formation of MNBO from nabumetone in the cytosol fraction.	[Matsumoto, Kaori; Hasegawa, Tetsuya; Kamei, Tomoyo; Koyanagi, Junichi; Takahashi, Tamiko; Akimoto, Masayuki] Josai Int Univ, Fac Pharmaceut Sci, Togane, Chiba 2838555, Japan; [Sugibayashi, Kenji] Josai Univ, Fac Pharmaceut Sci, Sakado, Saitama 3500295, Japan	Akimoto, M (reprint author), Josai Int Univ, Fac Pharmaceut Sci, 1 Gumyo, Togane, Chiba 2838555, Japan.	makimoto@jiu.ac.jp					Mikami E, 2000, J PHARMACEUT BIOMED, V23, P917, DOI 10.1016/S0731-7085(00)00365-4; Diederich S, 2000, EUR J ENDOCRINOL, V142, P200, DOI 10.1530/eje.0.1420200; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; Lee SK, 2008, ARCH PHARM RES, V31, P764, DOI 10.1007/s12272-001-1224-3; Turpeinen M, 2009, DRUG METAB DISPOS, V37, P1017, DOI 10.1124/dmd.108.025700; Steckelbroeck S, 2006, J PHARMACOL EXP THER, V316, P1300, DOI 10.1124/jpet.105.091587; KENDALL MJ, 1989, EUR J CLIN PHARMACOL, V36, P299, DOI 10.1007/BF00558163; Barski OA, 2008, DRUG METAB REV, V40, P553, DOI 10.1080/03602530802431439 ; Atalla A, 2000, XENOBIOTICA, V30, P755; Atalla A, 2001, CHEM-BIOL INTERACT, V130, P737, DOI 10.1016/S0009-2797(00)00304-5; Penning TM, 2000, BIOCHEM J, V351, P67, DOI 10.1042/0264-6021:3510067; Skarydova L, 2013, XENOBIOTICA, V43, P346, DOI 10.3109/00498254.2012.720048; OHARA H, 1995, BIOCHEM PHARMACOL, V50, P221, DOI 10.1016/0006-2952(95)00124-I; Blech S, 2010, DRUG METAB DISPOS, V38, P667, DOI 10.1124/dmd.109.031476; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Davies N M, 1997, Clin Pharmacokinet, V33, P404; DEYASHIKI Y, 1992, BIOCHEM J, V282, P741; FRIEDEL HA, 1988, DRUGS, V35, P504; FRIEDEL HA, 1993, DRUGS, V45, P131, DOI 10.2165/00003495-199345010-00009; Grothusen A, 1996, ARCH TOXICOL, V71, P64, DOI 10.1007/s002040050359; HADDOCK RE, 1984, XENOBIOTICA, V14, P327; HARA A, 1990, J BIOCHEM-TOKYO, V108, P250; Higaki Y, 2003, CHEM-BIOL INTERACT, V143, P503, DOI 10.1016/S0009-2797(02)00206-5; Imamura Y, 2004, J APPL TOXICOL, V24, P437, DOI 10.1002/jat.996; Kobylinska K, 2003, J PHARMACEUT BIOMED, V32, P323, DOI 10.1016/S0731-7085(03)00078-5; MANGAN FR, 1987, AM J MED, V83, P6, DOI 10.1016/0002-9343(87)90585-7; Maser E, 2003, CHEM-BIOL INTERACT, V143, P435, DOI 10.1016/S0009-2797(02)00180-1; Maser E, 2000, CANC LETT, V148, P134; Matsumoto K, 2011, 131 ANN M PHARM SOC, VIV, P219; Matsumoto K, 2011, BIOL PHARM BULL, V34, P734; NAKAYAMA T, 1985, BIOCHEM PHARMACOL, V34, P107, DOI 10.1016/0006-2952(85)90108-X; Nobilis M, 2003, J PHARMACEUT BIOMED, V32, P641, DOI 10.1016/S0731-7085(03)00171-7; Piwowarska J, 2009, PHARMACOL REP, V61, P604; Tani N, 2005, XENOBIOTICA, V35, P1121, DOI 10.1080/00498250500342746; Tong Z, 2010, DRUG METAB DISPOS, V38, P801, DOI 10.1124/dmd.110.032169; Tsuchiya S, 1988, XENOBIO METAB DISPOS, V3, P67	36	1	1	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0378-7966	2107-0180		EUR J DRUG METAB PH	Eur. J. Drug Metabol. Pharmacokinet.	JUN	2015	40	2					127	135		10.1007/s13318-014-0190-0		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH7KN	WOS:000354215200002		
J	Kawase, A; Ito, A; Yamada, A; Iwaki, M				Kawase, Atsushi; Ito, Ayami; Yamada, Ayano; Iwaki, Masahiro			Age-related changes in mRNA levels of hepatic transporters, cytochrome P450 and UDP-glucuronosyltransferase in female rats	EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Cytochrome P450; Transporter; Aging; Liver	CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; METABOLIZING ENZYME GENE; GROWTH-HORMONE; ACTIVATED RECEPTOR; GENDER-DIFFERENCES; INDUCED ARTHRITIS; ENHANCER MODULE; P-GLYCOPROTEIN; DWARF RATS	Hepatic transporters and metabolic enzymes affect drug pharmacokinetics. Limited information exists on the alteration in mRNA levels of hepatic transporters and metabolic enzymes with aging. We examined the effects of aging on the mRNA levels of representative hepatic drug transporters and metabolic enzymes by analyzing their levels in 10-, 30- and 50-week-old male and female rats. Levels of mRNA of drug transporters including multidrug resistance protein (Mdr)1a, multidrug resistance-associated protein (Mrp)2, breast cancer resistance protein (Bcrp) and organic anion-transporting polypeptide (Oatp)1a1, and the metabolic enzymes cytochrome P450 (CYP)3A1, CYP3A2 and UDP-glucuronosyltransferase (UGT)1A1 were analyzed using real-time reverse transcriptase polymerase chain reaction. The mRNA levels of transporters in male rats did not decrease with age, while the mRNA levels of Bcrp and Oatp1a1 in female rats decreased with age. The mRNA levels of CYP3A1 and CYP3A2 in male rats were higher than those in female rats. The mRNA levels of metabolic enzymes decreased with age in female but not male rats. In particular, the mRNA levels of UGT1A1 in 10-week-old female rats were higher than those in male rats. mRNA expression of hepatic transporters and metabolic enzymes are more susceptible to aging in female than male rats. The age-related decreases in the mRNA levels of Bcrp, Oatp1a1, CYP3A1 and CYP3A2 in female rats may affect the metabolism and transport of substrates. This study showed that aging affected the mRNA expression of hepatic transporters and metabolic enzymes in rats.	[Kawase, Atsushi; Ito, Ayami; Yamada, Ayano; Iwaki, Masahiro] Kinki Univ, Sch Pharm, Dept Pharm, Higashi Osaka 5778502, Japan	Iwaki, M (reprint author), Kinki Univ, Sch Pharm, Dept Pharm, 3-4-1 Kowakae, Higashi Osaka 5778502, Japan.	kawase@phar.kindai.ac.jp; iwaki@phar.kindai.ac.jp					Szatmari I, 2006, J BIOL CHEM, V281, P23812, DOI 10.1074/jbc.M604890200; Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638; Sugatani J, 2004, BIOCHEM PHARMACOL, V67, P989, DOI 10.1016/j.bcp.2003.11.002; Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019; Sugatani J, 2001, HEPATOLOGY, V33, P1232, DOI 10.1053/jhep.2001.24172; Yueh MF, 2003, J BIOL CHEM, V278, P15001, DOI 10.1074/jbc.M300645200; Gandhi M, 2004, ANNU REV PHARMACOL, V44, P499, DOI 10.1146/annurev.pharmtox.44.101802.121453; Kast HR, 2002, J BIOL CHEM, V277, P2908, DOI 10.1074/jbc.M109326200; Osabe M, 2008, DRUG METAB DISPOS, V36, P294, DOI 10.1124/dmd.107.017731; Schwartz JB, 2007, CLIN PHARMACOL THER, V82, P87, DOI 10.1038/sj.clpt.6100226; Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Jiang ZW, 2006, PHARMACOGENET GENOM, V16, P359, DOI 10.1097/01.fpc.0000204994.99429.46; Pampori NA, 1999, ENDOCRINOLOGY, V140, P1245, DOI 10.1210/en.140.3.1245; Thomas RP, 2002, J GASTROINTEST SURG, V6, P445, DOI 10.1016/S1091-255X(01)00010-5; Tanaka Y, 2005, BIOCHEM BIOPH RES CO, V326, P181, DOI 10.1016/j.bbrc.2004.11.012; MORSELLI PL, 1980, CLIN PHARMACOKINET, V5, P485; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; STEWART CF, 1987, CLIN PHARMACY, V6, P548; Buckley DB, 2009, DRUG METAB DISPOS, V37, P834, DOI 10.1124/dmd.108.024224; Rost D, 2005, EUR J CLIN INVEST, V35, P635, DOI 10.1111/j.1365-2362.2005.01556.x; Imai Y, 2005, CANCER RES, V65, P596; SHAPIRO BH, 1995, INT J BIOCHEM CELL B, V27, P9, DOI 10.1016/1357-2725(94)00056-5; Cheng XG, 2005, DRUG METAB DISPOS, V33, P1276, DOI 10.1124/dmd.105.003988; Takeuchi T, 2004, BIOCHEM BIOPH RES CO, V325, P549, DOI 10.1016/j.bbrc.2004.10.073; BURCHELL B, 1989, PHARMACOL THERAPEUT, V43, P261, DOI 10.1016/0163-7258(89)90122-8; BURCHELL B, 1994, HEPATOLOGY, V20, P1622, DOI 10.1002/hep.1840200636; Chen GF, 1997, J PHARMACOL EXP THER, V283, P1486; DUTTON GJ, 1978, ANNU REV PHARMACOL, V18, P17, DOI 10.1146/annurev.pa.18.040178.000313; Kawase A, 2007, DRUG METAB DISPOS, V35, P256, DOI 10.1124/dmd.106.011536; Kawase A, 2008, DRUG METAB PHARMACOK, V23, P196, DOI 10.2133/dmpk.23.196; Komura H, 2005, J PHARM SCI-US, V94, P397, DOI 10.1002/jpa.20255; Lee C, 2006, DRUG METAB DISPOS, V34, P1530, DOI 10.1124/dmd.106.009936; Lee JS, 2008, TOXICOL SCI, V106, P263, DOI 10.1093/toxsci/kfn144; LEGRAVEREND C, 1992, FASEB J, V6, P711; Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P1019; MINERS JO, 1991, PHARMACOL THERAPEUT, V51, P347, DOI 10.1016/0163-7258(91)90065-T; MORGAN ET, 1985, J BIOL CHEM, V260, P1895; Mori K, 2007, TOXICOL PATHOL, V35, P242, DOI 10.1080/01926230601156286; Kim SK, 2007, PHARMACOL THERAPEUT, V113, P88, DOI 10.1016/j.pharmthera.2006.07.004; SHIMADA M, 1995, J PHARMACOL EXP THER, V275, P972; Suzuki T, 2006, LIFE SCI, V79, P455, DOI 10.1016/j.lfs.2006.01.024; Timsit YE, 2000, TOXICOL APPL PHARM, V163, P105, DOI 10.1006/taap.1999.8862; Uno S, 2007, DRUG METAB PHARMACOK, V22, P313, DOI 10.2133/dmpk.22.313; Uno S, 2008, XENOBIOTICA, V38, P482, DOI 10.1080/00498250801935982 ; Yun KU, 2010, ARCH TOXICOL, V84, P939, DOI 10.1007/s00204-010-0520-1	46	0	0	SPRINGER FRANCE	PARIS	22 RUE DE PALESTRO, PARIS, 75002, FRANCE	0378-7966	2107-0180		EUR J DRUG METAB PH	Eur. J. Drug Metabol. Pharmacokinet.	JUN	2015	40	2					239	244		10.1007/s13318-014-0208-7		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH7KN	WOS:000354215200012		
J	Harada, R; Okamura, N; Furumoto, S; Furukawa, K; Ishiki, A; Tomita, N; Hiraoka, K; Watanuki, S; Shidahara, M; Miyake, M; Ishikawa, Y; Matsuda, R; Inami, A; Yoshikawa, T; Tago, T; Funaki, Y; Iwata, R; Tashiro, M; Yanai, K; Arai, H; Kudo, Y				Harada, Ryuichi; Okamura, Nobuyuki; Furumoto, Shozo; Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Ishikawa, Yoichi; Matsuda, Rin; Inami, Akie; Yoshikawa, Takeo; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Tashiro, Manabu; Yanai, Kazuhiko; Arai, Hiroyuki; Kudo, Yukitsuka			[F-18]THK-5117 PET for assessing neurofibrillary pathology in Alzheimer's disease	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						[F-18]THK-5117; Alzheimer's disease; Tau; Neurofibrillary tangles; PET; Imaging	POSITRON-EMISSION-TOMOGRAPHY; MILD COGNITIVE IMPAIRMENT; BETA-AMYLOID PLAQUES; PHF-TAU RADIOLIGAND; BINDING CHARACTERISTICS; CEREBROSPINAL-FLUID; SENILE PLAQUES; PROTEIN-TAU; TANGLES; DERIVATIVES	Purpose Visualization of the spatial distribution of neurofibrillary tangles would help in the diagnosis, prevention and treatment of dementia. The purpose of the study was to evaluate the clinical utility of [F-18]THK-5117 as a highly selective tau imaging radiotracer. Methods We initially evaluated in vitro binding of [H-3]THK-5117 in post-mortem brain tissues from patients with Alzheimer's disease (AD). In clinical PET studies, [F-18]THK-5117 retention in eight patients with AD was compared with that in six healthy elderly controls. Ten subjects underwent an additional [C-11]PiB PET scan within 2 weeks. Results In post-mortem brain samples, THK-5117 bound selectively to neurofibrillary deposits, which differed from the binding target of PiB. In clinical PET studies, [F-18]THK-5117 binding in the temporal lobe clearly distinguished patients with AD from healthy elderly subjects. Compared with [C-11]PiB, [F-18]THK-5117 retention was higher in the medial temporal cortex. Conclusion These findings suggest that [F-18]THK-5117 provides regional information on neurofibrillary pathology in living subjects.	[Harada, Ryuichi; Okamura, Nobuyuki; Kudo, Yukitsuka] Tohoku Univ, Inst Dev Aging & Canc, Div Neuroimaging, Sendai, Miyagi 9808575, Japan; [Okamura, Nobuyuki; Yoshikawa, Takeo; Yanai, Kazuhiko] Tohoku Univ, Sch Med, Dept Pharmacol, Aoba Ku, Sendai, Miyagi 9808575, Japan; [Furumoto, Shozo] Tohoku Univ, Frontier Res Inst Interdisciplinary Sci, Sendai, Miyagi 9808578, Japan; [Furumoto, Shozo; Ishikawa, Yoichi; Tago, Tetsuro; Funaki, Yoshihito; Iwata, Ren; Kudo, Yukitsuka] Tohoku Univ, Div Radiopharmaceut Chem, Ctr Cyclotron & Radioisotope, Sendai, Miyagi 9808578, Japan; [Furukawa, Katsutoshi; Ishiki, Aiko; Tomita, Naoki; Arai, Hiroyuki] Tohoku Univ, Inst Dev Aging & Canc, Dept Geriatr & Gerontol, Sendai, Miyagi 9808575, Japan; [Hiraoka, Kotaro; Watanuki, Shoichi; Shidahara, Miho; Miyake, Masayasu; Matsuda, Rin; Inami, Akie; Tashiro, Manabu] Tohoku Univ, Div Cyclotron Nucl Med, Ctr Cyclotron & Radioisotope, Sendai, Miyagi 9808578, Japan; [Shidahara, Miho] Tohoku Univ, Sch Med, Div Med Phys, Sendai, Miyagi 9808575, Japan	Okamura, N (reprint author), Tohoku Univ, Inst Dev Aging & Canc, Div Neuroimaging, Sendai, Miyagi 9808575, Japan.	nookamura@med.tohoku.ac.jp			GE Healthcare; SEI (Sumitomo Electric Industries, Ltd.) Group CSR Foundation; Industrial Technology Research Grant Program of the NEDO in Japan [09E51025a]; Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan [23390297, 26117003]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	This study was supported by the research fund from GE Healthcare, the SEI (Sumitomo Electric Industries, Ltd.) Group CSR Foundation, the Industrial Technology Research Grant Program of the NEDO in Japan (09E51025a), Health and Labor Sciences Research Grants from the Ministry of Health, Labor, and Welfare of Japan, a Grant-in-Aid for Scientific Research (B) (23390297), a Grant-in-Aid for Scientific Research on Innovative Areas (26117003) and "Japan Advanced Molecular Imaging Program (J-AMP)" of the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan.	Agdeppa ED, 2001, J NEUROSCI, V21, part. no.; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Chien DT, 2013, J ALZHEIMERS DIS, V34, P457, DOI 10.3233/JAD-122059; Gotz J, 2012, BRIT J PHARMACOL, V165, P1246, DOI 10.1111/j.1476-5381.2011.01713.x; Okamura N, 2013, J NUCL MED, V54, P1420, DOI 10.2967/jnumed.112.117341; Xia CF, 2013, ALZHEIMERS DEMENT, V9, P666, DOI 10.1016/j.jalz.2012.11.008; Whitwell JL, 2008, NEUROLOGY, V71, P743, DOI 10.1212/01.wnl.0000324924.91351.7d; Okamura N, 2005, J NEUROSCI, V25, P10857, DOI 10.1523/JNEUROSCI.1738-05.2005; Villemagne VL, 2014, EUR J NUCL MED MOL I, V41, P816, DOI 10.1007/s00259-013-2681-7; Jack CR, 2013, NEURON, V80, P1347, DOI 10.1016/j.neuron.2013.12.003; ARAI H, 1995, ANN NEUROL, V38, P649, DOI 10.1002/ana.410380414; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Fodero-Tavoletti MT, 2011, BRAIN, V134, P1089, DOI 10.1093/brain/awr038; Itoh N, 2001, ANN NEUROL, V50, P150, DOI 10.1002/ana.1054; Vandenberghe R, 2010, ANN NEUROL, V68, P319, DOI 10.1002/ana.22068; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; Verdurand M, 2008, NUCL MED COMMUN, V29, P920, DOI 10.1097/MNM.0b013e328304e0e1; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Maruyama M, 2013, NEURON, V79, P1094, DOI 10.1016/j.neuron.2013.07.037; Chien DT, 2014, J ALZHEIMERS DIS, V38, P171, DOI 10.3233/JAD-130098; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631; Herholz K, 2011, LANCET NEUROL, V10, P667, DOI 10.1016/S1474-4422(11)70123-5; GomezIsla T, 1997, ANN NEUROL, V41, P17, DOI 10.1002/ana.410410106; Harada R, 2013, EUR J NUCL MED MOL I, V40, P125, DOI 10.1007/s00259-012-2261-2; Small GW, 2006, NEW ENGL J MED, V355, P2652, DOI 10.1056/NEJMoa054625; Shoghi-Jadid K, 2002, AM J GERIAT PSYCHIAT, V10, P24, DOI 10.1176/appi.ajgp.10.1.24; Wischik CM, 2014, BIOCHEM PHARMACOL, V88, P529, DOI 10.1016/j.bcp.2013.12.008; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; BIERER LM, 1995, ARCH NEUROL-CHICAGO, V52, P81; Cummings Jeffrey L, 2011, Alzheimers Dement, V7, pe13, DOI 10.1016/j.jalz.2010.06.004; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; HOF PR, 1992, ARCH NEUROL-CHICAGO, V49, P946; KITAMOTO T, 1987, LAB INVEST, V57, P230; Kuzuhara S, 1989, No To Shinkei, V41, P465; MULLERGARTNER HW, 1992, J CEREBR BLOOD F MET, V12, P571; Murayama H, 1999, AM J PATHOL, V155, P877, DOI 10.1016/S0002-9440(10)65187-5; Okamura N, 2014, BRAIN, V137, P1762, DOI 10.1093/brain/awu064; Takashima A, 2010, CURR ALZHEIMER RES, V7, P665, DOI 10.2174/156720510793611600; WILCOCK GK, 1982, J NEUROL SCI, V56, P343, DOI 10.1016/0022-510X(82)90155-1	42	7	7	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	JUN	2015	42	7					1052	1061		10.1007/s00259-015-3035-4		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH7BH	WOS:000354190100008		
J	Kobayashi, K; Hirata, K; Yamaguchi, S; Manabe, O; Terasaka, S; Kobayashi, H; Shiga, T; Hattori, N; Tanaka, S; Kuge, Y; Tamaki, N				Kobayashi, Kentaro; Hirata, Kenji; Yamaguchi, Shigeru; Manabe, Osamu; Terasaka, Shunsuke; Kobayashi, Hiroyuki; Shiga, Tohru; Hattori, Naoya; Tanaka, Shinya; Kuge, Yuji; Tamaki, Nagara			Prognostic value of volume-based measurements on C-11-methionine PET in glioma patients	EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING			English	Article						Glioma; C-11-methionine; Positron emission tomography; Volume-based parameters	POSITRON-EMISSION-TOMOGRAPHY; TOTAL LESION GLYCOLYSIS; METABOLIC TUMOR VOLUME; LOW-GRADE GLIOMAS; BRAIN-TUMORS; GLIOBLASTOMA-MULTIFORME; F-18-FDG PET/CT; SURVIVAL; CANCER; METHIONINE	Purpose C-11-methionine (MET) PET is an established diagnostic tool for glioma. Studies have suggested that MET uptake intensity in the tumor is a useful index for predicting patient outcome. Because MET uptake is known to reflect tumor expansion more accurately than MRI, we aimed to elucidate the association between volume-based tumor measurements and patient prognosis. Methods The study population comprised 52 patients with newly diagnosed glioma who underwent PET scanning 20 min after injection of 370 MBq MET. The tumor was contoured using a threshold of 1.3 times the activity of the contralateral normal cortex. Metabolic tumor volume (MTV) was defined as the total volume within the boundary. Total lesion methionine uptake (TLMU) was defined as MTV times the mean standardized uptake value (SUVmean) within the boundary. The tumor-to-normal ratio (TNR), calculated as the maximum standardized uptake value (SUVmax) divided by the contralateral reference value, was also recorded. All patients underwent surgery (biopsy or tumor resection) targeting the tissue with high MET uptake. The Kaplan-Meier method was used to estimate the predictive value of each measurement. Results Grade II tumor was diagnosed in 12 patients (3 diffuse astrocytoma, 2 oligodendroglioma, and 7 oligoastrocytoma), grade III in 18 patients (8 anaplastic astrocytoma, 6 anaplastic oligodendroglioma, and 4 anaplastic oligoastrocytoma), and grade IV in 22 patients (all glioblastoma). TNR, MTV and TLMU were 3.1 +/- 1.2, 51.6 +/- 49.9 ml and 147.7 +/- 153.3 ml, respectively. None of the three measurements was able to categorize the glioma patients in terms of survival when all patients were analyzed. However, when only patients with astrocytic tumor (N = 33) were analyzed (i.e., when those with oligodendroglial components were excluded), MTV and TLMU successfully predicted patient outcome with higher values associated with a poorer prognosis (P < 0.05 and P < 0.01, respectively), while the predictive ability of TNR did not reach statistical significance (P = NS). Conclusion MTV and TLMU may be useful for predicting outcome in patients with astrocytic tumor.	[Kobayashi, Kentaro; Hirata, Kenji; Manabe, Osamu; Shiga, Tohru; Tamaki, Nagara] Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Yamaguchi, Shigeru; Terasaka, Shunsuke; Kobayashi, Hiroyuki] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0608638, Japan; [Hattori, Naoya] Hokkaido Univ, Grad Sch Med, Dept Mol Imaging, Sapporo, Hokkaido 0608638, Japan; [Tanaka, Shinya] Hokkaido Univ, Grad Sch Med, Dept Canc Pathol, Sapporo, Hokkaido 0608638, Japan; [Hirata, Kenji] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Kuge, Yuji] Hokkaido Univ, Cent Inst Isotope Sci, Sapporo, Hokkaido 0608638, Japan	Hirata, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Nucl Med, Kita Ku, Kita 15,Nishi 7, Sapporo, Hokkaido 0608638, Japan.	k.kobayashi@med.hokudai.ac.jp; khirata@med.hokudai.ac.jp	Yamaguchi, Shigeru/G-5419-2012	Yamaguchi, Shigeru/0000-0003-3710-5888	Translational Research Network Program of Ministry of Education, Culture, Sports, Science and Technology; SNMMI Wagner-Torizuka Fellowship; Hokkaido University HIROKO's Fund for Academic Exchange Bayer Best Research Award of the Japan Radiological Society	Translational Research Network Program of Ministry of Education, Culture, Sports, Science and Technology (2014); SNMMI Wagner-Torizuka Fellowship (2013/2015); Hokkaido University HIROKO's Fund for Academic Exchange (2012) Bayer Best Research Award of the Japan Radiological Society (2014).	Chen HHW, 2012, RADIOLOGY, V264, P559, DOI 10.1148/radiol.12111148; Nariai T, 2005, J NEUROSURG, V103, P498, DOI 10.3171/jns.2005.103.3.0498; Pirotte B, 2006, J NEUROSURG, V104, P238, DOI 10.3171/jns.2006.104.2.238; Cairncross JG, 1998, J NATL CANCER I, V90, P1473, DOI 10.1093/jnci/90.19.1473; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Fonti R, 2012, J NUCL MED, V53, P1829, DOI 10.2967/jnumed.112.106500; Galldiks N, 2010, EUR J NUCL MED MOL I, V37, P84, DOI 10.1007/s00259-009-1219-5; Arbizu J, 2012, EUR J NUCL MED MOL I, V39, P771, DOI 10.1007/s00259-011-2049-9; Lacroix M, 2001, J NEUROSURG, V95, P190, DOI 10.3171/jns.2001.95.2.0190; Becherer A, 2003, EUR J NUCL MED MOL I, V30, P1561, DOI 10.1007/s00259-003-1259-1; Bading JR, 1996, NUCL MED BIOL, V23, P779, DOI 10.1016/0969-8051(96)00073-X; Liao SS, 2013, CLIN NUCL MED, V38, P715, DOI 10.1097/RLU.0b013e31829f57fa; Behin A, 2003, LANCET, V361, P323, DOI 10.1016/S0140-6736(03)12328-8; Rigau V, 2011, BRAIN PATHOL, V21, P633, DOI 10.1111/j.1750-3639.2011.00491.x; Ryu IS, 2013, J NUCL MED, V54, P1032, DOI 10.2967/jnumed.112.116053; Kaschten B, 1998, J NUCL MED, V39, P778; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Brandes AA, 2006, J CLIN ONCOL, V24, P4746, DOI 10.1200/JCO.2006.06.3891; Glaudemans AWJM, 2013, EUR J NUCL MED MOL I, V40, P615, DOI 10.1007/s00259-012-2295-5; Singhal T, 2012, J NUCL MED, V53, P1709, DOI 10.2967/jnumed.111.102533; Terakawa Y, 2008, J NUCL MED, V49, P694, DOI 10.2967/jnumed.107.048082; Erdem-Eraslan L, 2013, J CLIN ONCOL, V31, P328, DOI 10.1200/JCO.2012.44.1444; Kim S, 2005, EUR J NUCL MED MOL I, V32, P52, DOI 10.1007/s00259-004-1598-6; Kidd EA, 2013, INT J RADIAT ONCOL, V85, P116, DOI 10.1016/j.ijrobp.2012.02.056; Grosu AL, 2005, INT J RADIAT ONCOL, V63, P64, DOI 10.1016/j.ijrobp.2005.01.045; Galldiks N, 2012, MOL IMAGING, V11, P516, DOI 10.2310/7290.2012.00022; Ribom D, 2001, CANCER, V92, P1541, DOI 10.1002/1097-0142(20010915)92:6<1541::AID-CNCR1480>3.0.CO;2-D; Tanaka Y, 2009, J NEUROSURG, V110, P163, DOI 10.3171/2008.4.17569; Chu KP, 2012, INT J RADIAT ONCOL, V83, P1521, DOI 10.1016/j.ijrobp.2011.10.022; Miwa K, 2004, J NEUROL NEUROSUR PS, V75, P1457, DOI 10.1136/jnnp.2003.028480; Chung JK, 2002, EUR J NUCL MED MOL I, V29, P176, DOI 10.1007/s00259-001-0690-4; Boellaard R, 2004, J NUCL MED, V45, P1519; Kato T, 2008, AM J NEURORADIOL, V29, P1867, DOI 10.3174/ajnr.A1242; Okamoto S, 2011, ANN NUCL MED, V25, P213, DOI 10.1007/s12149-010-0450-2; Singhal T, 2008, MOL IMAGING BIOL, V10, P1, DOI 10.1007/s11307-007-0115-2; Smits A, 2008, EUR J NUCL MED MOL I, V35, P65, DOI 10.1007/s00259-007-0531-1; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Miyazaki M, 2014, NEUROPATHOLOGY, V34, P268, DOI 10.1111/neup.12091; Salvati M, 2009, J NEURO-ONCOL, V94, P129, DOI 10.1007/s11060-009-9815-6; Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005; Hirata K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105682; ISSELBAC.KJ, 1972, P NATL ACAD SCI USA, V69, P585, DOI 10.1073/pnas.69.3.585; Jansen NL, 2015, J NUCL MED, V56, P9, DOI 10.2967/jnumed.114.144675; Kawai N, 2011, EUR J NUCL MED MOL I, V38, P441, DOI 10.1007/s00259-010-1645-4; Manabe O, 2015, EUR J NUCL MED MOL I, V42, P896, DOI 10.1007/s00259-015-2996-7; Lee IH, 2009, INT J RADIAT ONCOL, V73, P479, DOI 10.1016/j.ijrobp.2008.04.050; Stummer W, 2008, NEUROSURGERY, V62, P564, DOI [10.1227/01.neu.0000317304.31579.17, 10.1227/01.NEU.0000297118.47076.5F]; Stupp R, 2014, ANN ONCOL, V25, P93, DOI 10.1093/annonc/mdu050; Suchorska B, 2015, NEUROLOGY, V84, P710, DOI 10.1212/WNL.0000000000001262; Yamaguchi S, 2011, J NEURO-ONCOL, V101, P335, DOI 10.1007/s11060-010-0262-1; Yoshikawa K, 2006, J NEURO-ONCOL, V78, P91, DOI 10.1007/s11060-005-9064-2	51	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1619-7070	1619-7089		EUR J NUCL MED MOL I	Eur. J. Nucl. Med. Mol. Imaging	JUN	2015	42	7					1071	1080		10.1007/s00259-015-3046-1		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CH7BH	WOS:000354190100010		
J	Ichinoseki-Sekine, N; Kakigi, R; Miura, S; Naito, H				Ichinoseki-Sekine, Noriko; Kakigi, Ryo; Miura, Susumu; Naito, Hisashi			Whey peptide ingestion suppresses body fat accumulation in senescence-accelerated mouse prone 6 (SAMP6)	EUROPEAN JOURNAL OF NUTRITION			English	Article						Whey peptide hydrolysate; Adipose tissue; Fatty acid oxidation; Skeletal muscle; Mouse	SKELETAL-MUSCLE; ADIPOSE-TISSUE; WISTAR RATS; RED MEAT; PROTEINS; EXERCISE; HEALTH; METABOLISM; DISEASE; LIVER	Body weight in young growing and young adult animals was reduced by a high dietary density of whey protein concentrate; however, it is unclear whether dietary proteins similarly affect body weight in aging animals. Here, we examined whether whey protein or whey peptide ingestion suppressed body fat accumulation and affected protein expression and phosphorylation in skeletal muscle in aging mice. Twenty-six male senescence-accelerated mouse prone 6 (SAMP6) mice were assigned randomly to three dietary treatment groups: 18.7 % casein control (CON), 18.7 % whey protein (WPR), and 18.7 % whey peptide (WPE). After 28 weeks of treatment, skeletal tissues were dissected and weighed for analysis. Western blotting was performed to examine the expression of AMP-activated protein kinase (AMPK), acetyl-CoA carboxylase (ACC), and adipose triglyceride lipase (ATGL) in quadriceps muscles. Body (CON: 47.6 +/- A 2.2 g, WPR: 48.2 +/- A 2.7 g, WPE: 38.3 +/- A 2.0 g) and relative white adipose tissue (CON: 38.5 +/- A 3.5 mg/g, WPR: 43.8 +/- A 4.0 mg/g, WPE: 21.1 +/- A 4.4 mg/g) weights were lower in the WPE group compared with the other two groups (p < 0.05), and no significant differences were observed between the CON and WPR groups. The relative weights of tibialis anterior muscle (CON: 1.04 +/- A 0.04 mg/g, WPR: 0.97 +/- A 0.03 mg/g, 1.23 +/- A 0.05 mg/g) and gastrocnemius muscle (CON: 3.02 +/- A 0.12 mg/g, WPR: 2.92 +/- A 0.15 mg/g, WPE: 3.65 +/- A 0.18 mg/g) were higher in the WPE group compared with the other groups (p < 0.05). The phosphorylation of AMPK (WPR: 1.03 +/- A 0.11, WPE: 1.36 +/- A 0.12; fold change from control) and ACC (WPR: 1.08 +/- A 0.07, WPE: 1.18 +/- A 0.05; fold change from control) in WPE was higher than in CON (p < 0.05). There were no significant differences in the expression levels of ATGL among the three groups. These data suggest that a normal (or moderate excess) dietary density of whey peptide attenuates body fat accumulation via upregulation of fatty acid oxidation in skeletal muscle in aging mice.	[Ichinoseki-Sekine, Noriko; Naito, Hisashi] Juntendo Univ, Grad Sch Hlth & Sports Sci, Chiba 2701695, Japan; [Kakigi, Ryo] Juntendo Univ, Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Miura, Susumu] Megmilk Snow Brand Co Ltd, Shinjuku Ku, Tokyo 1608575, Japan	Naito, H (reprint author), Juntendo Univ, Grad Sch Hlth & Sports Sci, 1-1 Hiragagakuendai, Chiba 2701695, Japan.	hnaitou@juntendo.ac.jp	Naito, Hisashi/F-5655-2011		Megmilk Snow Brand Co., Ltd.	The authors have read the journal's policy and declare the following conflicts: SM is an employee of Megmilk Snow Brand Co., Ltd, Japan and HN received a research fund from Megmilk Snow Brand Co., Ltd. The sponsor had no control over the study design, decision to publish, or preparation of the manuscript. There are no patents, products in development, or marketed products to declare.	REEVES PG, 1993, J NUTR, V123, P1939; Park H, 2002, J BIOL CHEM, V277, P32571, DOI 10.1074/jbc.M201692200; Calbet JAL, 2004, EUR J NUTR, V43, P127, DOI 10.1007/s00394-004-0448-4; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747; Pennings B, 2011, AM J CLIN NUTR, V93, P997, DOI 10.3945/ajcn.110.008102; ROGERS P, 1980, BRIT J NUTR, V43, P83, DOI 10.1079/BJN19800066; Ha E, 2003, J NUTR BIOCHEM, V14, P251, DOI 10.1016/S0955-2863(03)00030-5; Wolfe RR, 2006, AM J CLIN NUTR, V84, P475; Lopaschuk GD, 2010, PHYSIOL REV, V90, P207, DOI 10.1152/physrev.00015.2009; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Boirie Y, 1997, P NATL ACAD SCI USA, V94, P14930, DOI 10.1073/pnas.94.26.14930; Short KR, 2004, AM J PHYSIOL-ENDOC M, V286, pE92, DOI 10.1152/ajpendo.00366.2003; Belobrajdic DP, 2004, J NUTR, V134, P1454; Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x; Abu-Elheiga L, 2001, SCIENCE, V291, P2613, DOI 10.1126/science.1056843; Candow DG, 2005, J GERONTOL A-BIOL, V60, P148; Belobrajdic DP, 2003, CANCER LETT, V198, P43, DOI 10.1016/S0304-3835(03)00307-0; Chen H, 2006, TISSUE CELL, V38, P325, DOI 10.1016/j.tice.2006.08.001; Dangin M, 2002, J NUTR, V132, p3228S; Griffiths RD, 1996, NUTRITION, V12, P456, DOI 10.1016/S0899-9007(96)00141-4; Hirofuji C, 2000, NEUROREPORT, V11, P823, DOI 10.1097/00001756-200003200-00033; Kakigi R, 2011, J PHYSIOL SCI, V61, P131, DOI 10.1007/s12576-010-0130-y; Morifuji M, 2005, NUTRITION, V21, P1052, DOI 10.1016/j.nut.2005.01.010; MOUGHAN PJ, 1991, J PEDIATR GASTR NUTR, V12, P253, DOI 10.1097/00005176-199102000-00019; Niimi K, 2009, COMPARATIVE MED, V59, P431; Sakuma K, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/204164; Short K R, 2000, Curr Opin Clin Nutr Metab Care, V3, P39, DOI 10.1097/00075197-200001000-00007; SUGIURA T, 1990, BIOMED RES-TOKYO, V11, P87	29	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1436-6207	1436-6215		EUR J NUTR	Eur. J. Nutr.	JUN	2015	54	4					551	556		10.1007/s00394-014-0736-6		6	Nutrition & Dietetics	Nutrition & Dietetics	CI4KG	WOS:000354716500006		
J	Yazawa, S				Yazawa, Shujiro			toward a new construction of the theory of inequality	EUROPEAN POLITICAL SCIENCE			English	Editorial Material									[Yazawa, Shujiro] Seijo Univ, Setagaya Ku, Tokyo 1578511, Japan; [Yazawa, Shujiro] Hitotsubashi Univ, Kunitachi, Tokyo 1868601, Japan	Yazawa, S (reprint author), Seijo Univ, Setagaya Ku, 6-1-20 Seijo, Tokyo 1578511, Japan.	syazawa@seijo.ac.jp					Kawamoto T., 1995, ADVENTURE CONT ETHIC; Negri A., 2013, SPINOZA OUT TIME POL; SEN A, 1990, NEW YORK REV BOOKS, V37, P49	3	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	1680-4333	1682-0983		EUR POLIT SCI	Eur. Polit. Sci.	JUN	2015	14	2					190	192		10.1057/eps.2014.49		3	Political Science	Government & Law	CI5VW	WOS:000354828900018		
J	Tennakoon, AH; Izawa, T; Wijesundera, KK; Katou-Ichikawa, C; Tanaka, M; Golbar, HM; Kuwamura, M; Yamate, J				Tennakoon, Anusha H.; Izawa, Takeshi; Wijesundera, Kavindra K.; Katou-Ichikawa, Chisa; Tanaka, Miyuu; Golbar, Hossain M.; Kuwamura, Mitsuru; Yamate, Jyoji			Analysis of glial fibrillary acidic protein (GFAP)-expressing ductular cells in a rat liver cirrhosis model induced by repeated injections of thioacetamide (TAA)	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						Cirrhosis; Ductular reaction; Glial fibrillary acidic protein; Hepatic progenitor cells; Rat liver; Thioacetamide	HEPATIC STELLATE CELLS; GROWTH-FACTOR-BETA; EPITHELIAL-MESENCHYMAL TRANSITION; HEPATOCELLULAR-CARCINOMA; PROGENITOR CELLS; STEM-CELLS; CADHERIN EXPRESSION; MURINE MODEL; OVAL CELLS; FIBROSIS	Glial fibrillary acidic protein (GFAP), a type III intermediate filament protein, is expressed in hepatic stellate cells (HSCs), the principal fibrogenic cell type in the liver. Further, GFAP could be a marker for hepatic progenitor cells (HPCs). In this study, the participation of GFAP-expressing cells in HPC expansion/ductular reaction was investigated in a rat model of liver cirrhosis. Six-week-old male F344 rats were injected intraperitoneally with thioacetamide (100 mg/kg BW, twice a week) and examined at post-first injection weeks 5, 10, 15,20 and 25. Fibrosis-related proliferation of ductular cells was observed as demonstrated by CK19 immunostaining. Some of these cells were stained with GFAP. No co-staining was observed between CK19 and alpha-smooth muscle actin (alpha-SMA; myofibroblast marker). There were proliferating ductular cells stained with alpha-fetoprotein or beta-catenin; the ductular reaction was related to increased expression of hepatocarcinogenesis-related factors (Wnt2, Wnt4 and glypican-3). These results for the first time show the participation of GFAP-positive HPCs in ductular reaction in a chemically induced rodent model. Though the ductular cells were chaperoned by myofibroblasts, they show no direct evidence for epithelial to mesenchymal transition. These findings shed new light in understanding the roles of GFAP-expressing HPCs in liver cirrhosis and provide further evidence of interaction between newly-formed bile ductules and HSCs, suggesting that both cells could be in the common lineage of HPCs. (C) 2015 Elsevier Inc. All rights reserved.	[Tennakoon, Anusha H.; Izawa, Takeshi; Wijesundera, Kavindra K.; Katou-Ichikawa, Chisa; Tanaka, Miyuu; Golbar, Hossain M.; Kuwamura, Mitsuru; Yamate, Jyoji] Osaka Prefecture Univ, Lab Vte Pathol, Grad Sch Life & Environm Sci, Div Vet Sci, Izumisano City, Osaka 5988531, Japan	Yamate, J (reprint author), Osaka Prefecture Univ, Vet Sci, Grad Sch Life & Environm Sci, 1-58 Rinku Ourai Kita, Izumisano City, Osaka 5988531, Japan.	yamate@vet.osakafu-u.ac.jp			JSPS KAKENHI [26292152, 26850184]	This work was supported in part by JSPS KAKENHI Grant Number 26292152 to Jyoji Yamate and 26850184 to Takeshi Izawa.	Valdes F, 2002, MOL CANCER RES, V1, P68; Tennakoon AH, 2013, EXP TOXICOL PATHOL, V65, P1159, DOI 10.1016/j.etp.2013.05.008; Inagawa S, 2002, CLIN CANCER RES, V8, P450; Apte U, 2008, HEPATOLOGY, V47, P288, DOI 10.1002/hep.21973; Strazzabosco M, 2012, J HEPATOL, V56, P1159, DOI 10.1016/j.jhep.2011.09.022; Ankoma-Sey V, 1999, NEWS PHYSIOL SCI, V14, P149; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Guzman G, 2005, MODERN PATHOL, V18, P1498, DOI 10.1038/modpathol.3800458; Lim YS, 2007, HISTOCHEM CELL BIOL, V127, P149, DOI 10.1007/s00418-006-0233-y; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Sell S, 2008, J CLIN ONCOL, V26, P2800, DOI 10.1200/JCO.2007.15.5945; Schmelzer E, 2006, STEM CELLS, V24, P1852, DOI 10.1634/stemcells.2006-0036; Yovchev MI, 2008, HEPATOLOGY, V47, P636, DOI 10.1002/hep.22047; Paku S, 2001, AM J PATHOL, V158, P1313, DOI 10.1016/S0002-9440(10)64082-5; Napoli J, 1997, HEPATOLOGY, V26, P624, DOI 10.1002/hep.510260314; Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436; Omenetti A, 2008, J CLIN INVEST, V118, P3331, DOI 10.1172/JCI35875; Van Hul NKM, 2009, HEPATOLOGY, V49, P1625, DOI 10.1002/hep.22820; Clouston AD, 2005, HEPATOLOGY, V41, P809, DOI 10.1002/hep.20650; Gaudio E, 2009, DIGEST LIVER DIS, V41, P455, DOI 10.1016/j.dld.2009.03.009; Sell S, 1998, HEPATOLOGY, V27, P317, DOI 10.1002/hep.510270202; Liu H, 2010, WORLD J GASTROENTERO, V16, P4410, DOI 10.3748/wjg.v16.i35.4410; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; Yang L, 2008, STEM CELLS, V26, P2104, DOI 10.1634/stemcells.2008-0115; Fleig SV, 2007, LAB INVEST, V87, P1227, DOI 10.1038/labinvest.3700689; Thompson MD, 2007, HEPATOLOGY, V45, P1298, DOI 10.1002/hep.21651; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Xia JL, 2006, AM J PATHOL, V168, P1500, DOI 10.2353/ajpath.2006.050747; Capurro MI, 2005, CANCER RES, V65, P6245, DOI 10.1158/0008-5472.CAN-04-4244; Michalopoulos GK, 2011, INT J BIOCHEM CELL B, V43, P173, DOI 10.1016/j.biocel.2009.09.014; Polakis P, 2000, GENE DEV, V14, P1837; Eleazar JA, 2004, J HEPATOL, V41, P983, DOI 10.1016/j.jhep.2004.08.017; Benvegnu L, 2004, GUT, V53, P744, DOI 10.1136/gut.2003.020263; Choi SS, 2009, HEPATOLOGY, V50, P2007, DOI 10.1002/hep.23196; Gravdal K, 2007, CLIN CANCER RES, V13, P7003, DOI 10.1158/1078-0432.CCR-07-1263; Hwang S, 2012, CELL BIOL INT, V36, P279, DOI 10.1042/CBI20110325; Dowman JK, 2014, AM J PATHOL, V184, P1550, DOI 10.1016/j.ajpath.2014.01.034; Egyed-Zsigmond I, 2010, ROM J MORPHOL EMBRYO, V51, P265; Gribilas G, 2009, DIGEST DIS SCI, V54, P2367, DOI 10.1007/s10620-008-0623-1; Grozdanov PN, 2006, LAB INVEST, V86, P1272, DOI 10.1038/labinvest.3700479; Knight B, 2007, J HEPATOL, V46, P134, DOI 10.1016/j.jhep.2006.08.015; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Roskams T, 2006, J HEPATOL, V45, P1, DOI 10.1016/j.jhep.2006.05.002; Schmitt-Graeff A, 2006, HUM PATHOL, V37, P1200, DOI 10.1016/j.humpath.2006.04.017; Ueberham E, 2007, J MOL HISTOL, V38, P359, DOI 10.1007/s10735-007-9098-1; Ueberham Elke, 2010, Comp Hepatol, V9, P8, DOI 10.1186/1476-5926-9-8; Wang P, 2009, LIVER INT, V29, P575, DOI 10.1111/j.1478-3231.2009.01992.x; Wee A, 2006, APPL IMMUNOHISTO M M, V14, P266, DOI 10.1097/00129039-200609000-00003; Wood MJ, 2014, HEPATOLOGY, V59, P848, DOI 10.1002/hep.26706; Yuzugullu H, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-90	50	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	JUN	2015	98	3					476	485		10.1016/j.yexmp.2015.03.010		10	Pathology	Pathology	CI6YE	WOS:000354909300022		
J	Harima, M; Arumugam, S; Wen, J; Pitchaimani, V; Karuppagounder, V; Afrin, MR; Sreedhar, R; Miyashita, S; Nomoto, M; Ueno, K; Nakamura, M; Watanabe, K				Harima, Meilei; Arumugam, Somasundaram; Wen, Juan; Pitchaimani, Vigneshwaran; Karuppagounder, Vengadeshprabhu; Afrin, Mst. Rejina; Sreedhar, Remya; Miyashita, Shizuka; Nomoto, Mayumi; Ueno, Kazuyuki; Nakamura, Masahiko; Watanabe, Kenichi			Effect of carvedilol against myocardial injury due to ischemia-reperfusion of the brain in rats	EXPERIMENTAL AND MOLECULAR PATHOLOGY			English	Article						Carvedilol; Cardiac injury; Ischemia-reperfusion; Brain; Apoptosis	OXIDATIVE STRESS; INTRACRANIAL-PRESSURE; APOPTOSIS; PROTECTS; DAMAGE; ANTIOXIDANT; INVOLVEMENT; DYSFUNCTION; EXPRESSION; INFARCTION	We have previously reported the mechanism behind the myocardial injury and the activation of autonomic nervous system during the ischemia-reperfusion (IR) of the rat brain. This study was planned to investigate the effect of carvedilol, a (beta-blacker, in improving the myocardial injury caused by IR of the rat brain. We have used a whole cerebral IR model in rats by clamping both the right and left common carotid arteries. Rats were divided into five groups; Sham surgery group (Group-Sham), carvedilol treatment before ischemia group (Group-Is + C), vehicle control group (Group-Is + V), carvedilol treatment before reperfusion group (Group-Re + C) and the vehicle control group (Group-Re + V). We have measured the blood pressure and heart rate via a catheter, myocardial tissue (beta 1-adrenaline receptor (beta 1-AR) levels, phosphor-p38 mitogen-activated protein kinase (p-p38 MAPK) signaling factor, malondialdehyde (MDA), and apoptosis (TUNEL assay and expression of caspase-7 protein). The results indicated that the increased expressions of beta 1-AR, p-p38 MAPK, caspase-7, apoptotic cells and MDA level in the myocardial tissue due to brain ischemia-reperfusion were significantly reduced by carvedilol treatment. From these observations we can suggest that, with the advantage of its antioxidant and beta blocking action, carvedilol had played the improvement of myocardial injury in ischemia-reperfusion of the brain. (C) 2015 Elsevier Inc. All rights reserved.	[Harima, Meilei; Arumugam, Somasundaram; Wen, Juan; Pitchaimani, Vigneshwaran; Karuppagounder, Vengadeshprabhu; Afrin, Mst. Rejina; Sreedhar, Remya; Miyashita, Shizuka; Nomoto, Mayumi; Watanabe, Kenichi] Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Akiha Ku, Niigata 9568603, Japan; [Ueno, Kazuyuki] Niigata Univ Pharm & Appl Life Sci, Dept Pharmaceut Sci, Akiha Ku, Niigata 9568603, Japan; [Nakamura, Masahiko] Yamanashi Prefectural Cent Hosp, Dept Cardiol, Kofu, Yamanashi, Japan	Watanabe, K (reprint author), Niigata Univ Pharm & Appl Life Sci, Dept Clin Pharmacol, Akiha Ku, 265-1 Higashijima, Niigata 9568603, Japan.	watanabe@nupals.ac.jp			Yujin Memorial Grant, Ministry of Education, Culture, Sports, Science and Technology, Japan [23602012]; Promotion and Mutual Aid Corporation for Private Schools, Japan [26460239]	This research was supported by a Yujin Memorial Grant, Ministry of Education, Culture, Sports, Science and Technology, Japan (23602012), and by a grant from the Promotion and Mutual Aid Corporation for Private Schools, Japan (26460239).	Zhang YE, 2011, RESUSCITATION, V82, P1081, DOI 10.1016/j.resuscitation.2011.01.034; Min JY, 2009, STROKE, V40, P2560, DOI 10.1161/STROKEAHA.108.536086; SHIVALKAR B, 1993, CIRCULATION, V87, P230; Arumugam S, 2012, TOXICOLOGY, V291, P139, DOI 10.1016/j.tox.2011.11.008; Communal C, 1999, CIRCULATION, V100, P2210; Arumugam S, 2012, J CELL MOL MED, V16, P2176, DOI 10.1111/j.1582-4934.2012.01526.x; Parlaktas BS, 2014, INT BRAZ J UROL, V40, P109, DOI 10.1590/S1677-5538.IBJU.2014.01.16; Ichikawa H, 2002, BIOL PHARM BULL, V25, P898, DOI 10.1248/bpb.25.898; Hakucho A, 2014, HEPATOL RES, V44, P560, DOI 10.1111/hepr.12143; Armstead WM, 2010, AM J PHYSIOL-HEART C, V299, pH76, DOI 10.1152/ajpheart.00185.2010; Arozal W., 2011, ISRN PHARM; DAVIS AM, 1993, TEX HEART I J, V20, P158; Du QX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113048; Hassan F, 2012, J PHARMACOL EXP THER, V343, P62, DOI 10.1124/jpet.112.196915; Liu QW, 2013, INDIAN J PHARMACOL, V45, P458, DOI 10.4103/0253-7613.117729; Mashaly Hazem Antar, 2008, Cleve Clin J Med, V75 Suppl 2, pS26; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Sahu BD, 2014, CHEM-BIOL INTERACT, V223, P69, DOI 10.1016/j.cbi.2014.09.009; SHANLIN RJ, 1988, J AM COLL CARDIOL, V12, P727; Suzuki H., 2014, NEUROIMAGE C, V105C, P84; WHITE M, 1995, CIRCULATION, V92, P2183; Xu CQ, 2014, J MOL CELL CARDIOL, V75, P111, DOI 10.1016/j.yjmcc.2014.07.009	22	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4800	1096-0945		EXP MOL PATHOL	Exp. Mol. Pathol.	JUN	2015	98	3					558	562		10.1016/j.yexmp.2015.04.001		5	Pathology	Pathology	CI6YE	WOS:000354909300033		
J	Tsubokawa, D; Ishiwata, K; Goso, Y; Yokoyama, T; Kanuka, H; Ishihara, K; Nakamura, T; Tsuji, N				Tsubokawa, Daigo; Ishiwata, Kenji; Goso, Yukinobu; Yokoyama, Takuya; Kanuka, Hirotaka; Ishihara, Kazuhiko; Nakamura, Takeshi; Tsuji, Naotoshi			Induction of Sd(a)-sialomucin and sulfated H-sulfomucin in mouse small intestinal mucosa by infection with parasitic helminth	EXPERIMENTAL PARASITOLOGY			English	Article						Goblet cell mucin; Mucosa; Helminth; Heligmosomoides polygyrus; Nippostrongylus brasiliensis; Vampirolepis nana	REPUBLIC-OF-KOREA; NIPPOSTRONGYLUS-BRASILIENSIS; MONOCLONAL-ANTIBODY; GLYCOSYLATION ALTERATIONS; CARBOHYDRATE MOIETY; MUCINS; RAT; MICE; METACERCARIAE; EXPRESSION	Mucin is a major component of mucus on gastrointestinal mucosa. Mucin alteration in the host is considered to be the principal event for expulsion of intestinal helminths. However, it is unclear what mucin alterations are induced by various helminth infections. In this study, the alterations of mouse small intestinal mucin after infection with two nematodes, Nippostrongylus brasiliensis and Heligmosomoides polygyrus, which parasitize the jejunal epithelium, and a cestode, Vampirolepis nana, which parasitizes the ileal epithelium, were examined biochemically and histologically using two anti-mucin monoclonal antibodies (mAbs), HCM31 and PGM34, which recognize Sd(a) antigen, NeuAc alpha 2-3(GalNAc beta 1-4)Gal beta 1-4GlcNAc beta-, and sulphated H type 2 antigen, Fuc alpha 1-2Gal beta 1-4GlcNAc(6SO(3)H)beta-, respectively. The goblet cell mucins that reacted with HCM31 increased conspicuously on the jejunal mucosa concurrently with expulsion of N. brasiliensis. Increased levels of HCM31-reactive mucins were observed in the jejunal mucosa after H. polygyrus infection, despite the ongoing parasitism. Goblet cell mucins that reacted with PGM34 increased on the ileal mucosa during V. nana parasitism. Small intestinal goblet cells reacting with the two mAbs were not observed in non-infected mice, although sialomucins and sulfomucins were abundantly present. Additionally, the number of ileal goblet cells that reacted with the two mAbs was increased at the time of expulsion of heterophyid trematode. These results indicate that the type of specific acidic mucins expressed after infection varies among species of intestinal helminth, and, furthermore, that the relationship with worm expulsion is also different. (C) 2015 Elsevier Inc. All rights reserved.	[Tsubokawa, Daigo; Nakamura, Takeshi; Tsuji, Naotoshi] Kitasato Univ, Sch Med, Dept Parasitol, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Ishiwata, Kenji; Yokoyama, Takuya; Kanuka, Hirotaka] Jikei Univ, Sch Med, Dept Trop Med, Minato Ku, Tokyo 1058461, Japan; [Goso, Yukinobu] Kitasato Univ, Sch Med, Dept Biochem, Minami Ku, Sagamihara, Kanagawa 2520374, Japan; [Ishihara, Kazuhiko] Kitasato Jr Coll Hlth & Hyg Sci, Minamiuonuma, Niigata 9497241, Japan	Tsuji, N (reprint author), Kitasato Univ, Sch Med, Dept Parasitol, Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	tsujin@med.kitasato-u.ac.jp			Kitasato University Integrative Research Program of the Graduate School of Medical Sciences	We would like to express our sincere appreciation to Dr. M. Kurihara (Kanagawa Institute of Technology) and Dr. T. Chimuro (Kanto Chemical Co. Inc.) for kindly providing us with anti-mucin mAbs. We also thank Ms. S. Sugawara and Ms. F. Mikami for their valuable technical assistance. This work was supported in part by grants from the Kitasato University Integrative Research Program of the Graduate School of Medical Sciences (to D.T.).	Hicks SJ, 2000, PARASITOL TODAY, V16, P476, DOI 10.1016/S0169-4758(00)01773-7; Dekker J, 2002, TRENDS BIOCHEM SCI, V27, P126, DOI 10.1016/S0968-0004(01)02052-7; ISHIKAWA N, 1993, IMMUNOLOGY, V78, P303; Robbe C, 2004, BIOCHEM J, V384, P307, DOI 10.1042/BJ20040605; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Hollingsworth MA, 2004, NAT REV CANCER, V4, P45, DOI 10.1038/nrc1251; Holmen JM, 2002, GLYCOCONJUGATE J, V19, P67, DOI 10.1023/A:1022589015687; JOURDIAN GW, 1971, J BIOL CHEM, V246, P430; Theodoropoulos G, 2001, TRENDS PARASITOL, V17, P130, DOI 10.1016/S1471-4922(00)01775-X; Soga K, 2008, PARASITOL RES, V103, P1427, DOI 10.1007/s00436-008-1152-8; Sohn WM, 2009, KOREAN J PARASITOL, V47, pS103, DOI 10.3347/kjp.2009.47.S.S103; Hasnain SZ, 2013, INT J BIOCHEM CELL B, V45, P364, DOI 10.1016/j.biocel.2012.10.011; AZUUMI Y, 1980, GUT, V21, P533, DOI 10.1136/gut.21.6.533; Escande F, 2004, BBA-GENE STRUCT EXPR, V1676, P240, DOI 10.1016/j.bbaexp.2004.01.001; Guk SM, 2005, J PARASITOL, V91, P12, DOI 10.1645/GE-367R; Larsson JMH, 2013, AM J PHYSIOL-GASTR L, V305, pG357, DOI 10.1152/ajpgi.00048.2013; Ikezawa T, 2004, J GASTROENTEROL, V39, P113, DOI 10.1007/s00535-003-1261-1; Ikezawa T, 2002, BIOMED RES-TOKYO, V23, P63; ISHIHARA K, 1993, HYBRIDOMA, V12, P609, DOI 10.1089/hyb.1993.12.609; Ishiwata K, 2010, J IMMUNOL, V184, P2086, DOI 10.4049/jimmunol.0804051; Iwai T, 2009, J GASTROENTEROL, V44, P277, DOI 10.1007/s00535-009-0007-0; Karlsson NG, 2000, BIOCHEM J, V350, P805, DOI 10.1042/0264-6021:3500805; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Li MH, 2013, PARASITOL RES, V112, P1647, DOI 10.1007/s00436-013-3320-8; MALAGOLINI N, 1989, CANCER RES, V49, P6466; Matsuzawa K, 2008, PARASITOL INT, V57, P512, DOI 10.1016/j.parint.2008.06.001; Nishiyama K, 2014, BIOSCI BIOTECH BIOCH, V78, P1444, DOI 10.1080/09168451.2014.918491; OTA H, 1991, HISTOCHEM J, V23, P22, DOI 10.1007/BF01886504; Saegusa Y, 2008, SCAND J GASTROENTERO, V43, P59, DOI 10.1080/00365520701579662; Tsubokawa D, 2012, FEBS OPEN BIO, V2, P223, DOI 10.1016/j.fob.2012.07.006; Tsubokawa D, 2007, FEBS J, V274, P1833, DOI 10.1111/j.1742-4658.2007.05731.x; Tsubokawa D, 2009, EXP PARASITOL, V123, P319, DOI 10.1016/j.exppara.2009.08.008; WATANABE N, 1988, P NATL ACAD SCI USA, V85, P4460, DOI 10.1073/pnas.85.12.4460; WATANABE N, 1994, PARASITE IMMUNOL, V16, P137, DOI 10.1111/j.1365-3024.1994.tb00333.x; Watanabe N, 2003, INT ARCH ALLERGY IMM, V131, P11, DOI 10.1159/000070475	35	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	JUN	2015	153						165	173		10.1016/j.exppara.2015.03.008		9	Parasitology	Parasitology	CI4XA	WOS:000354756000023		
J	Hayakawa, EH; Tokumasu, F; Usukura, J; Matsuoka, H; Tsuboi, T; Wellems, TE				Hayakawa, Eri H.; Tokumasu, Fuyuki; Usukura, Jiro; Matsuoka, Hiroyuki; Tsuboi, Takafumi; Wellems, Thomas E.			Imaging of the subsurface structures of "unroofed" Plasmodium falciparum-infected erythrocytes	EXPERIMENTAL PARASITOLOGY			English	Article						Malaria parasite; Maurer's clefts; Cytoskeleton; Electron microscopy; Freeze etching	RED-BLOOD-CELLS; VESICLE-MEDIATED TRAFFICKING; PLASMA-MEMBRANE INTERFACE; MAURERS CLEFT ORGANELLES; ETCH ELECTRON TOMOGRAPHY; ATOMIC-FORCE MICROSCOPY; PARASITE PROTEINS; MALARIA PARASITES; SURFACE-MEMBRANE; CYTOSKELETON	Intraerythrocytic stages of Plasmodium falciparum parasites modify the membranes of their host erythrocytes with numerous expressed proteins. They also install new membranous structures in the erythrocyte cytoplasm, including Maurer's clefts (MC) and a tubulovesicular network. These structures support molecular trafficking processes that are necessary for the growth and multiplication of P. falciparum intraerythrocytic stages. To study the morphology and organization of these modifications, we prepared samples of P. falciparum-infected erythrocytes by 'unroofing' techniques and examined them by transmission electron microscopy. Images of the 'unroofed' parasitized erythrocytes feature cytoskeleton alterations and the presence of new membranous structures generated by P. falciparum, including small vesicles and MC connected by extensions to the inner erythrocyte membrane. Non-parasitized erythrocytes showed no evidence of these structures or extensions. In further experiments, we observed a relative absence of MC and extensions after treatment of parasitized erythrocytes with aluminum tetrafluoride (AlF4-), an inhibitor of vesicle trafficking. The morphology and physical location of MC, extensions and small vesicles in unroofed specimens are consistent with the role of these structures in the trafficking of P. falciparum proteins to the surface of parasitized erythrocytes. (C) 2015 Elsevier Inc. All rights reserved.	[Hayakawa, Eri H.; Matsuoka, Hiroyuki] Jichi Med Univ, Dept Infect & Immun, Lab Med Zool & Parasitol, Shimotsuke, Tochigi 3290498, Japan; [Tokumasu, Fuyuki] Univ Tokyo, Grad Sch Med, Dept Lipid, Bunkyo Ku, Tokyo 1130033, Japan; [Usukura, Jiro] Nagoya Univ, EcoTopia Sci Inst, Div Integrated Project, Nagoya, Aichi 4648603, Japan; [Tsuboi, Takafumi] Ehime Univ, Proteo Sci Ctr, Div Malaria Res, Matsuyama, Ehime 7908577, Japan; [Wellems, Thomas E.] NIAID, Lab Malaria & Vector Res, NIH, Bethesda, MD 20892 USA	Hayakawa, EH (reprint author), Jichi Med Univ, Dept Infect & Immun, Lab Med Zool & Parasitol, Shimotsuke, Tochigi 3290498, Japan.	erihayakawa@jichi.ac.jp; TWELLEMS@niaid.nih.gov		Tokumasu, Fuyuki/0000-0003-2790-1071	NIAID, NIH; JSPS KAKENHI [24500992]; Ohyama Health Foundation Inc.	We thank Dr. Motomi Toni, Division of Molecular Parasitology, Proteo-Science Center, Ehime University, for discussions and advice on electron microscopy of the inner membrane structure of parasitized erythrocytes. We are grateful to Japanese Red Cross Society for supplying human erythrocytes. This research was supported in part by the Intramural Research Program of the NIAID, NIH. E.H.H. was partially supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research (C), grant number 24500992) and the Ohyama Health Foundation Inc..	ELMENDORF HG, 1994, J CELL BIOL, V124, P449, DOI 10.1083/jcb.124.4.449; Nguitragool W, 2011, CELL, V145, P665, DOI 10.1016/j.cell.2011.05.002; Cooke BM, 2006, J CELL BIOL, V172, P899, DOI 10.1083/jcb.200509122; Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x; Nagao E, 2000, J STRUCT BIOL, V130, P34, DOI 10.1006/jsbi.2000.4236; BENGTSSON T, 1990, P NATL ACAD SCI USA, V87, P2921, DOI 10.1073/pnas.87.8.2921; Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004; Glenister FK, 2002, BLOOD, V99, P1060, DOI 10.1182/blood.V99.3.1060; Swihart AH, 2001, J MICROSC-OXFORD, V204, P212, DOI 10.1046/j.1365-2818.2001.00960.x; Morone N, 2010, METHODS MOL BIOL, V657, P275, DOI 10.1007/978-1-60761-783-9_22; SCHMIDT JA, 1982, J CLIN INVEST, V70, P379, DOI 10.1172/JCI110627; Cyrklaff M, 2011, SCIENCE, V334, P1283, DOI 10.1126/science.1213775; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Bugnard E, 1998, J NEUROSCI METH, V82, P97, DOI 10.1016/S0165-0270(98)00043-0; CENTONZE VE, 1986, CELL MOTIL CYTOSKEL, V6, P376, DOI 10.1002/cm.970060404; Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x; Heuser J, 2000, TRAFFIC, V1, P545, DOI 10.1034/j.1600-0854.2000.010704.x; KOURY ST, 1987, CELL TISSUE RES, V249, P69, DOI 10.1007/BF00215420; Morone N, 2008, METHOD CELL BIOL, V88, P207, DOI 10.1016/S0091-679X(08)00412-3; Parker PD, 2004, BLOOD, V103, P2404, DOI 10.1182/blood-2003-08-2692; POUVELLE B, 1991, NATURE, V353, P73, DOI 10.1038/353073a0; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; SWAN JA, 1984, J CELL BIOL, V99, P2108, DOI 10.1083/jcb.99.6.2108; Taraschi TF, 2001, INT J PARASITOL, V31, P1381, DOI 10.1016/S0020-7519(01)00256-9; Taraschi TF, 2003, BLOOD, V102, P3420, DOI 10.1182/blood-2003-05-1448; Terasawa K, 2006, ARCH HISTOL CYTOL, V69, P329, DOI 10.1679/aohc.69.329; TILLACK TW, 1970, J CELL BIOL, V45, P649, DOI 10.1083/jcb.45.3.649; Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x; Tokumasu F, 2014, BIOL OPEN, V3, P529, DOI 10.1242/bio.20147732; Trelka DP, 2000, MOL BIOCHEM PARASIT, V106, P131, DOI 10.1016/S0166-6851(99)00207-8; TSUKITA S, 1981, J CELL BIOL, V90, P70, DOI 10.1083/jcb.90.1.70; Usukura J, 2012, J ELECTRON MICROSC, V61, P321, DOI 10.1093/jmicro/dfs055; WARD GE, 1993, J CELL SCI, V106, P237; Watanabe T, 2008, CELL STRUCT FUNCT, V33, P101, DOI 10.1247/csf.08006; Wickert H, 2003, EUR J CELL BIOL, V82, P271, DOI 10.1078/0171-9335-00319; Wickert H, 2007, TRENDS PARASITOL, V23, P502, DOI 10.1016/j.pt.2007.08.008	36	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4894	1090-2449		EXP PARASITOL	Exp. Parasitol.	JUN	2015	153						174	179		10.1016/j.exppara.2015.03.021		6	Parasitology	Parasitology	CI4XA	WOS:000354756000024		
J	Komatsu, S; Ichikawa, D; Miyamae, M; Kawaguchi, T; Morimura, R; Hirajima, S; Okajima, W; Ohashi, T; Imamura, T; Konishi, H; Shiozaki, A; Ikoma, H; Okamoto, K; Taniguchi, H; Otsuji, E				Komatsu, Shuhei; Ichikawa, Daisuke; Miyamae, Mahito; Kawaguchi, Tsutomu; Morimura, Ryo; Hirajima, Shoji; Okajima, Wataru; Ohashi, Takuma; Imamura, Taisuke; Konishi, Hirotaka; Shiozaki, Atsushi; Ikoma, Hisashi; Okamoto, Kazuma; Taniguchi, Hiroki; Otsuji, Eigo			Malignant potential in pancreatic neoplasm; new insights provided by circulating miR-223 in plasma	EXPERT OPINION ON BIOLOGICAL THERAPY			English	Article						biomarker; intraductal papillary mucinous neoplasm; liquid biopsy; microRNA; pancreatic cancer; pancreatic invasive ductal carcinoma; plasma; prognosis	SQUAMOUS-CELL CARCINOMA; PAPILLARY MUCINOUS NEOPLASM; DUCTAL CARCINOMA; GENE-EXPRESSION; CLINICAL IMPACT; HUMAN CANCERS; SMALL RNAS; FOLLOW-UP; MICRORNA; TUMOR	Background: Recent studies have identified that microRNAs are stably detectable in plasma/serum because of their binding to specific proteins or being packaged in secretory vesicles. Methods: We tested miR-223 as a candidate of novel plasma biomarker in pancreatic cancer (PCa) and intraductal papillary mucinous neoplasm (IPMN). Results: i) miR-223 expression was significantly higher in PCa tissues (p = 0.0069) than in normal tissues. ii) Plasma miR-223 levels were significantly higher in 71 PCa patients than 67 healthy volunteers (p < 0.0001). iii) Plasma miR-223 levels were significantly reduced in postoperative samples (p = 0.0297). iv) Plasma miR-223 levels tended to discriminate the malignant potential between benign IPMN and malignant IPMN (p = 0.0963), and the progressive extent of invasiveness between malignant IPMN and pancreatic invasive ductal carcinoma (PIDC) (p = 0.0004). Multivariate logistic regression analysis revealed that a low level of plasma miR-223 was an independent risk factor for PIDC (p = 0.0012, odds ratio 7.90 [95% CI: 2.06 - 41.2]). v) There was no significant correlation between plasma miR-223 levels and the number of any blood cell types in the peripheral blood. Conclusion: Plasma miR-223 might be a clinically useful biomarker for screening PCa, and predicting malignant potential of IPMN and the invasiveness of PCa.	[Komatsu, Shuhei; Ichikawa, Daisuke; Miyamae, Mahito; Kawaguchi, Tsutomu; Morimura, Ryo; Hirajima, Shoji; Okajima, Wataru; Ohashi, Takuma; Imamura, Taisuke; Konishi, Hirotaka; Shiozaki, Atsushi; Ikoma, Hisashi; Okamoto, Kazuma; Otsuji, Eigo] Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kamigyo Ku, Kyoto 602, Japan; [Taniguchi, Hiroki] Kyoto Second Red Cross Hosp, Dept Surg, Kamigyo Ku, Kyoto 6028026, Japan	Komatsu, S (reprint author), Kyoto Prefectural Univ Med, Dept Surg, Div Digest Surg, Kyoto 602, Japan.	skomatsu@koto.kpu-m.ac.jp					Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ozaka M, 2012, CANCER CHEMOTH PHARM, V69, P1197, DOI 10.1007/s00280-012-1822-1; Skog J, 2008, NAT CELL BIOL, V10, P1470, DOI 10.1038/ncb1800; Komatsu S, 2012, EXPERT OPIN BIOL TH, V12, pS53, DOI 10.1517/14712598.2012.681373; Kanno A, 2010, J GASTROENTEROL, V45, P952, DOI 10.1007/s00535-010-0238-0; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Li XH, 2011, MOL CANCER RES, V9, P824, DOI 10.1158/1541-7786.MCR-10-0529; Komatsu S, 2011, BRIT J CANCER, V105, P104, DOI 10.1038/bjc.2011.198; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Sultana A, 2008, BRIT J CANCER, V99, P6, DOI 10.1038/sj.bjc.6604436; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Konishi H, 2012, BRIT J CANCER, V106, P740, DOI 10.1038/bjc.2011.588; Kosaka N, 2010, CANCER SCI, V101, P2087, DOI 10.1111/j.1349-7006.2010.01650.x; Morimura R, 2011, BRIT J CANCER, V105, P1733, DOI 10.1038/bjc.2011.453; Hirajima S, 2013, BRIT J CANCER, V108, P1822, DOI 10.1038/bjc.2013.148; Benson EA, 2013, DRUG METAB DISPOS, V41, P1778, DOI 10.1124/dmd.113.052357; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Akobeng AK, 2007, ACTA PAEDIATR, V96, P644, DOI 10.1111/j.1651-2227.2006.00178.x; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Ichikawa D, 2012, GASTROENTEROLOGY, V142, P1074, DOI 10.1053/j.gastro.2012.03.008; Uehara H, 2008, GUT, V57, P1561, DOI 10.1136/gut.2007.145631; Hirata K, 2007, DIGEST SURG, V24, P137, DOI 10.1159/000102067; Kurashige J, 2012, BRIT J CANCER, V106, P182, DOI 10.1038/bjc.2011.509; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hasselmann DO, 2001, CLIN CHEM, V47, P1488; Vickers KC, 2011, NAT CELL BIOL, V13, P423, DOI 10.1038/ncb2210; Szafranska AE, 2007, ONCOGENE, V26, P4442, DOI 10.1038/sj.onc.1210228; Tsujiura M, 2010, BRIT J CANCER, V102, P1174, DOI 10.1038/sj.bjc.6605608; Zardo G, 2012, BLOOD, V119, P4034, DOI 10.1182/blood-2011-08-371344; Sobin LH, 2010, CANCER-AM CANCER SOC, V116, P5336, DOI 10.1002/cncr.25537; Bloomston M, 2007, JAMA-J AM MED ASSOC, V297, P1901, DOI 10.1001/jama.297.17.1901; Yamaguchi K, 2002, PANCREATOLOGY, V2, P484, DOI 10.1159/000064716; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Abue M, 2015, INT J ONCOL, V46, P539, DOI 10.3892/ijo.2014.2743; Rechavi O, 2009, GENE DEV, V23, P1971, DOI 10.1101/gad.1789609; Kawaguchi T, 2013, BRIT J CANCER, V108, P361, DOI 10.1038/bjc.2012.546; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; Tanno S, 2010, PANCREAS, V39, P36, DOI 10.1097/MPA.0b013e3181b91cd0; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Ingkakul T, 2010, ANN SURG, V251, P70, DOI 10.1097/SLA.0b013e3181c5ddc3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Heinemann V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-82; Komatsu S, 2014, BRIT J CANCER, V111, P1614, DOI 10.1038/bjc.2014.451; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Pritchard CC, 2011, CANC PREV RES, V5, P492; Wei YB, 2014, SCI REP-UK, V4, DOI 10.1038/srep07546	48	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1471-2598	1744-7682		EXPERT OPIN BIOL TH	Expert Opin. Biol. Ther.	JUN	2015	15	6					773	785		10.1517/14712598.2015.1029914		13	Biotechnology & Applied Microbiology; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Research & Experimental Medicine	CI5LF	WOS:000354797000003		
J	Yabe, D; Nishikino, R; Kaneko, M; Iwasaki, M; Seino, Y				Yabe, Daisuke; Nishikino, Rie; Kaneko, Makiko; Iwasaki, Masahiro; Seino, Yutaka			Short-term impacts of sodium/glucose co-transporter 2 inhibitors in Japanese clinical practice: considerations for their appropriate use to avoid serious adverse events	EXPERT OPINION ON DRUG SAFETY			English	Editorial Material						dehydration; hypoglycemia; serious adverse events; sodium/glucose co-transporter 2 inhibitors; urogenital infections	TYPE-2; MUSCLE; GLUCAGON	Sodium/glucose co-transporter 2 inhibitors (SGLT2i) represent a novel class of glucose-lowering agents that lower plasma glucose levels through pharmacological inhibition of glucose reuptake from the kidney, independent of insulin secretion and action. Clinical trials of SGLT2i demonstrated therapeutic benefits on glycemic control and bodyweight in individuals with type 2 diabetes, with few cases of serious adverse events (SAEs). However, a considerable number of SAEs were reported in patients receiving SGLT2i clinically in Japan during the first 3 months of their use. These included urogenital infections, hypoglycemia and dehydration. Unexpectedly, serious skin and subcutaneous disorders, mainly reported as generalized rash or skin eruption, were prominent in patients receiving SGLT2i, but with unknown mechanisms. There is also concern for potential SAEs associated with chronic SGLT2i administration, especially in the non-obese type 2 diabetes characterized by reduced insulin secretion often seen in East Asia. Chronic SAEs may include severe hypoglycemia due to depletion of hepatic glycogen storage, acceleration of diabetes-associated sarcopenia and ketosis/ketoacidosis. The current information on acute SAEs confirms the importance of caution in the appropriate use of SGLT2i. Furthermore, careful long-term observation of patients receiving SGLT2i is essential to avoid SAEs and for better clinical use of this drug class.	[Yabe, Daisuke; Seino, Yutaka] Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Fukushima Ku, Osaka 5530003, Japan; [Yabe, Daisuke; Iwasaki, Masahiro] Kansai Elect Power Hosp, Ctr Metab & Clin Nutr, Fukushima Ku, Osaka 5530003, Japan; [Yabe, Daisuke] Kobe Univ, Grad Sch Med, Dept Physiol & Cell Biol, Div Mol & Metab Med,Chuo ku, Kobe, Hyogo 6500047, Japan; [Nishikino, Rie; Iwasaki, Masahiro] Japan Med Data Ctr Co Ltd, Minato Ku, Tokyo 1050012, Japan	Seino, Y (reprint author), Kansai Elect Power Hosp, Ctr Diabet Endocrinol & Metab, Fukushima Ku, 2-1-7, Osaka 5530003, Japan.	ydaisuke-kyoto@umin.ac.jp; seino.yutaka@e2.kepco.co.jp					Dimitriadis G, 2011, DIABETES RES CLIN PR, V93, pS52, DOI 10.1016/S0168-8227(11)70014-6; Unger RH, 2012, J CLIN INVEST, V122, P4, DOI 10.1172/JCI60016; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Ramnanan CJ, 2011, DIABETES OBES METAB, V13, P118, DOI 10.1111/j.1463-1326.2011.01454.x; Vasilakou D, 2013, ANN INTERN MED, V159, P262, DOI 10.7326/0003-4819-159-4-201308200-00007; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Yabe D, 2014, J DIABETES INVEST, V5, P475, DOI 10.1111/jdi.12229; Hasan FM, 2014, DIABETES RES CLIN PR, V104, P297, DOI 10.1016/j.diabres.2014.02.014; Fujita Y, 2014, J DIABETES INVEST, V5, P265, DOI 10.1111/jdi.12214; Hoffman KB, 2014, DRUG SAFETY, V37, P283, DOI 10.1007/s40264-014-0150-2; Kalyani RR, 2014, LANCET DIABETES ENDO, V2, P819, DOI 10.1016/S2213-8587(14)70034-8; Tauchi K, 10 DEATHS REPORTED F; Yabe D, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0602-9; Yabe D, 2015, J DIABETES COMPLICAT, V29, P413, DOI 10.1016/j.jdiacomp.2014.12.010	15	3	3	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1474-0338	1744-764X		EXPERT OPIN DRUG SAF	Expert Opin. Drug Saf.	JUN	2015	14	6					795	800		10.1517/14740338.2015.1034105		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CI1YO	WOS:000354541400001		
J	Baek, JH; Jin, SM; Kaku, K; Jung, JA; Kim, JR; Ko, JW; Kim, MJ; Lee, SY; Huh, WS; Kim, JH				Baek, Jong-Ha; Jin, Sang-Man; Kaku, Kohei; Jung, Jin-Ah; Kim, Jung-Ryul; Ko, Jae-Wook; Kim, Min-Ji; Lee, Soo-Youn; Huh, Woo-seong; Kim, Jae Hyeon			Efficacy of mitiglinide and sitagliptin, alone or in combination, on postprandial excursion and glycemic variability assessed by continuous glucose monitoring: a post hoc analysis with single-day treatment	EXPERT OPINION ON PHARMACOTHERAPY			English	Review						continuous glucose monitoring; glycemic variability; mitiglinide; postprandial hyperglycemia; sitagliptin	DIPEPTIDYL-PEPTIDASE-IV; TYPE-2 DIABETES-MELLITUS; OXIDATIVE STRESS MARKERS; GLUCAGON-LIKE PEPTIDE-1; JAPANESE PATIENTS; INHIBITOR VILDAGLIPTIN; ISLET FUNCTION; DOUBLE-BLIND; DPP-IV; NATEGLINIDE	Objective: To compare the efficacy of mitiglinide and sitagliptin, alone or in combination, on postprandial excursion and glycemic variability assessed by continuous glucose monitoring (CGM) in a single-day treatment setting. Methods: This was a post hoc analysis of a randomized crossover study comparing the efficacy of sitagliptin, mitiglinide and the combination of these two drugs. Twenty-four hour CGM was performed before and after a single-day treatment with each drug alone or in combination. Results: Mean glucose levels were decreased in all groups. The average of three postprandial glucose excursions AUC (average of all three 4-h postprandial periods throughout the day) (AUCpp-average) decreased in the mitiglinide and combination treatment groups, but not in the sitagliptin group. The lowering effect on AUCpp-average was greater in patients given mitiglinide (-47 mg/dl, p < 0.001) or combination treatment (-66 mg/dl, p < 0.001) compared with sitagliptin alone (-18 mg/dl). The reduction in mean amplitude of glycemic excursion was greater with mitiglinide (-29.3 mg/dl, p < 0.001) and combination treatment (-28.3 mg/dl, p < 0.01) than with sitagliptin alone (-8.9 mg/dl). Conclusions: Mitiglinide or combination treatment resulted in lower glycemic variability and postprandial glucose excursion than sitagliptin alone; however, the results of this single-day pharmacodynamics study cannot be generalized to a clinical setting.	[Baek, Jong-Ha; Jin, Sang-Man; Huh, Woo-seong; Kim, Jae Hyeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Baek, Jong-Ha] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Sch Med, Dept Internal Med, Jinju, South Korea; [Kaku, Kohei] Kawasaki Med Univ, Dept Internal Med, Okayama, Japan; [Jung, Jin-Ah; Kim, Jung-Ryul; Ko, Jae-Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Clin Pharmacol & Therapeut, Seoul, South Korea; [Kim, Min-Ji] Samsung Biomed Res Inst, Dept Biostat Team, Seoul, South Korea; [Lee, Soo-Youn] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Lab Med & Genet, Seoul, South Korea; [Kim, Jae Hyeon] Samsung Biomed Res Inst, Seoul, South Korea	Kim, JH (reprint author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	wooseong.huh@samsung.com; jaehyeon@skku.edu	Lee, Soo Youn/F-4614-2014		JW Pharmaceutical Co., Ltd; Ministry of Health, Welfare and Family Affairs, Republic of Korea [A090001]; Kissei Pharmaceutical Co., Ltd.; Astellas; Boehringer Ingelheim; Daiichi-Sankyo; Dainippon-Sumitomo; MSD; Novartis; Novo Nordisk; Sanwa; Taisho; Takeda Pharmaceutical Co., Ltd.	This study was supported by JW Pharmaceutical Co., Ltd, and from the Korea Healthcare Technology R&D project, Ministry of Health, Welfare and Family Affairs, Republic of Korea (A090001). Article processing charges were funded by Kissei Pharmaceutical Co., Ltd. K Kaku has received research funding, consultancy fees and lecture fees from Astellas, Boehringer Ingelheim, Daiichi-Sankyo, Dainippon-Sumitomo, MSD, Novartis, Novo Nordisk, Sanwa, Taisho and Takeda Pharmaceutical Co., Ltd. The authors declare that there are no potential conflicts of interest relevant to this article. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Ahrén Bo, 2010, Diabetes Metab Syndr Obes, V3, P31; Ando K, 2014, EXPERT OPIN PHARMACO, V15, P2479, DOI 10.1517/14656566.2014.970531; Barbieri M, 2013, ATHEROSCLEROSIS, V227, P349, DOI 10.1016/j.atherosclerosis.2012.12.018; Vella A, 2007, DIABETES, V56, P1475, DOI 10.2337/db07-0136; Rizzo MR, 2012, DIABETES CARE, V35, P2076, DOI 10.2337/dc12-0199; Kodani N, 2013, CLIN DRUG INVEST, V33, P563, DOI 10.1007/s40261-013-0098-5; Nonaka K, 2008, DIABETES RES CLIN PR, V79, P291, DOI 10.1016/j.diabres.2007.08.021; Kohnert KD, 2009, DIABETES CARE, V32, P1058, DOI 10.2337/dc08-1956; Kim HS, 2013, DIABETES TECHNOL THE, V15, P810, DOI 10.1089/dia.2013.0038; Azuma K, 2008, J CLIN ENDOCR METAB, V93, P459, DOI 10.1210/jc.2007-1369; Herman GA, 2005, CLIN PHARMACOL THER, V78, P675, DOI 10.1016/j.clpt.2005.09.002; Mori Y, 2011, DIABETES TECHNOL THE, V13, P699, DOI 10.1089/dia.2011.0025; Rosenstock J, 2008, DIABETES CARE, V31, P30, DOI 10.2337/dc07-1616; Herman GA, 2006, J CLIN ENDOCR METAB, V91, P4612, DOI 10.1210/jc.2006-1009; Baghurst PA, 2011, DIABETES TECHNOL THE, V13, P296, DOI 10.1089/dia.2010.0090; Scott R, 2007, INT J CLIN PRACT, V61, P171, DOI 10.1111/j.1742-1241.2006.01246.x; Duffy NA, 2007, EUR J PHARMACOL, V568, P278, DOI 10.1016/j.ejphar.2007.05.010; Borch-Johnsen K, 1999, LANCET, V354, P617; Jung JA, 2013, ADV THER, V30, P1018, DOI 10.1007/s12325-013-0072-x; Kaku Kohei, 2014, Diabetes Ther, V5, P97, DOI 10.1007/s13300-014-0051-5; Kitahara Y, 2011, BIOL PHARM BULL, V34, P671; Li H, 2013, BIOMED REP, V1, P913; Lin SD, 2011, J DIABETES COMPLICAT, V25, P332, DOI 10.1016/j.jdiacomp.2011.06.004; Man CD, 2009, DIABETES CARE, V32, P14, DOI 10.2337/dc08-1512; Phillippe HM, 2013, EXPERT OPIN PHARMACO, V14, P2133, DOI 10.1517/14656566.2013.834048; Raskin P, 2003, DIABETES CARE, V26, P2063, DOI 10.2337/diacare.26.7.2063; Rosenstock J, 2004, DIABETES CARE, V27, P1265, DOI 10.2337/diacare.27.6.1265; Sha S, 2015, DIABETES OBES METAB, V17, P188, DOI 10.1111/dom.12418; Stein P, 2014, METABOLISM, V63, P1296, DOI 10.1016/j.metabol.2014.07.003; Suh S, 2014, DIABETES METAB, V40, P272, DOI 10.1016/j.diabet.2014.01.006; Yamazaki M, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-54; Zaccardi Francesco, 2008, J Diabetes Sci Technol, V2, P1061; Zhan Mei, 2012, J Evid Based Med, V5, P154, DOI 10.1111/j.1756-5391.2012.01189.x	33	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1465-6566	1744-7666		EXPERT OPIN PHARMACO	Expert Opin. Pharmacother.	JUN	2015	16	8					1127	1136		10.1517/14656566.2015.1035646		10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH7KI	WOS:000354214700002		
J	Uto, Y				Uto, Yoshikazu			1,2-Benzisoxazole compounds: a patent review (2009-2014)	EXPERT OPINION ON THERAPEUTIC PATENTS			English	Review						antipsychotics; benzisoxazole; bioisoster; CNS disease; kinase	MULTIRECEPTOR ATYPICAL ANTIPSYCHOTICS; ACTIVE INDOLE-DERIVATIVES; PIPERIDINE DERIVATIVES; BIOLOGICAL EVALUATION; PARTIAL AGONIST; INHIBITORS; DISCOVERY; SCHIZOPHRENIA; IDENTIFICATION; PALIPERIDONE	Introduction: Benzisoxazoles represent a class of heterocyclic compounds of great importance for the preparation of biologically active compounds. Benzisoxazoles are an important structure and some benzisoxazole-based medicines have been approved for human clinical use, including atypical antipsychotics (risperidone, paliperidone and iloperidone) and an anticonvulsant (zonisamide). Areas covered: This review puts emphasis on the recent progress in therapeutically attractive benzisoxazole derivatives especially 1,2-benzisoxazoles, which were published in the patent literature between 2009 and 2014. As for the class of medicines, the main focus is on atypical antipsychotics and potential therapeutic treatments for other CNS disorders. This review also covers the examples of benzisoxazole-based kinase inhibitors. Moreover, novel benzisoxazoles with significant therapeutic interest are also mentioned. Expert opinion: More recent examples of structural modification of existing drugs led to the discovery of some promising benzisoxazoles for antipsychotic use. The design of multi-target ligands is important for the manipulation of pharmacological properties and safety profiles for the use of antipsychotics. Benzisoxazoles have been widely used as pharmacophores in the search for novel drug candidates in a variety of therapeutic area. It is fair to assume that the wide and frequent use of benzisoxazoles in drug discovery and development will continue into the future.	[Uto, Yoshikazu] Daiichi Sankyo Co Ltd, Venture Sci Labs, Shinagawa Ku, Tokyo 1408710, Japan	Uto, Y (reprint author), Daiichi Sankyo Co Ltd, Venture Sci Labs, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	uto.yoshikazu.pw@daiichisankyo.co.jp					Abbott Laboratories, 2009, Indazoles, benzisoxazoles and benzisothiazoles as inhibitors of protein kinases, Patent No. [WO012312, 043453]; AbbVie Inc, 2013, Novel tricyclic compounds, Patent No. [US072470, 125853]; Actelion Pharmaceuticals Ltd, 2009, 2-Aza-bicyclo 3.3.0] octane derivatives, Patent No. [WO016564, 050334]; Actelion Pharmaceuticals Ltd, 2010, Thiazolidine compounds as orexin receptor antagonists, Patent No. [WO004507, 040634]; Actelion Pharmaceuticals Ltd, 2010, Oxazolidine compounds as orexin receptor antagonists, Patent No. [WO038200, 082918]; Actelion Pharmaceuticals Ltd, 2012, Patent No. [WO004722, 042450]; Adamed Ltd, 2013, Patent No. [WO001505, 034646]; Adamed Ltd., 2012, Patent No. [WO035123, 072147]; Aldexa Therapeutics Inc, 2014, Patent No. [WO116593, 201816]; Alkermes Inc, 2011, Prodrugs for the treatment of schizophrenia and bipolar disease, Patent No. [WO084850, 135083]; Almirall S. A., 2011, New 7-phenyl-[ 1,2,4] triazolo[ 4,3-a] pyridin-3(2H)-one derivatives, Patent No. [WO057757, 110433]; Roth BL, 2004, NAT REV DRUG DISCOV, V3, P353, DOI 10.1038/nrd1346; Jain M, 2003, J MED CHEM, V46, P5428, DOI 10.1021/jm020581y; Rautio J, 2008, NAT REV DRUG DISCOV, V7, P255, DOI 10.1038/nrd2468; Brodney MA, 2012, J MED CHEM, V55, P9240, DOI 10.1021/jm300953p; King GF, 2014, ACS CHEM NEUROSCI, V5, P749, DOI 10.1021/cn500171p; NUHRICH A, 1994, EUR J MED CHEM, V29, P75, DOI 10.1016/0223-5234(94)90129-5; UNO H, 1979, J MED CHEM, V22, P180, DOI 10.1021/jm00188a011; [Anonymous], 2010, Johnson & Johnson Web Site, Patent No. 031735; Kolaczkowski M, 2014, J MED CHEM, V57, P4543, DOI 10.1021/jm401895u; [Anonymous], 2011, ClinicalTrials. gov Web Site, Patent No. 0001215; Schwarzschild MA, 2006, TRENDS NEUROSCI, V29, P647, DOI 10.1016/j.tins.2006.09.004; Vermeir M, 2008, DRUG METAB DISPOS, V36, P769, DOI 10.1124/dmd.107.018275; [Anonymous], 2011, Pfizer Web Site, Patent No. 013212; [Anonymous], 2014, Iloperidone label information FDA Web Site, Patent No. 024048; [Anonymous], 2014, Paliperidone palmitate label information FDA Web Site, Patent No. 028655; Priya BS, 2005, BIOORGAN MED CHEM, V13, P2623, DOI 10.1016/j.bmc.2005.01.026; Keith JM, 2012, ACS MED CHEM LETT, V3, P823, DOI 10.1021/ml300186g; [Anonymous], 2014, AstraZeneca Web Site, Patent No. 012121; Takasu K, 2010, PAIN, V151, P87, DOI 10.1016/j.pain.2010.06.020; [Anonymous], 2014, Risperidone label information FDA Web Site, Patent No. [027500, WO 027500]; Kapur S, 2003, PROG NEURO-PSYCHOPH, V27, P1081, DOI 10.1016/j.pnpbp.2003.09.004; [Anonymous], 2010, ClinicalTrials. gov Web Site, Patent No. 002103; Hughes ZA, 2013, NEUROPHARMACOLOGY, V66, P202, DOI 10.1016/j.neuropharm.2012.04.007; Gao LJ, 2014, J MED CHEM, V57, P7624, DOI 10.1021/jm5007929; Chen Y, 2014, EUR J MED CHEM, V74, P427, DOI 10.1016/j.ejmech.2014.01.012; YEVICH JP, 1986, J MED CHEM, V29, P359, DOI 10.1021/jm00153a010; Ferraris D, 2008, J MED CHEM, V51, P3357, DOI 10.1021/jm800200u; STRUPCZEWSKI JT, 1985, J MED CHEM, V28, P761, DOI 10.1021/jm00383a012; [Anonymous], 2014, Paliperidone label information FDA Web Site, Patent No. 027710; Kothare SV, 2008, EXPERT OPIN DRUG MET, V4, P493, DOI 10.1517/17425255.4.4.493 ; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Carter NJ, 2012, DRUGS, V72, P1137, DOI 10.2165/11208640-000000000-00000; Chen Y, 2013, J MED CHEM, V56, P4671, DOI 10.1021/jm400408r; [Anonymous], 2014, ClinicalTrials.gov Web Site, Patent No. 012312; Lamani RS, 2009, EUR J MED CHEM, V44, P2828, DOI 10.1016/j.ejmech.2008.12.019; [Anonymous], 2011, ClinicalTrials. gov Web Site, Patent No. 003895; Ascendis Pharma A/S, 2014, [No title captured], Patent No. 001505; Ascendis Pharma A/S, 2013, High-loading water-soluble carrier-linked prodrugs for diagnosis and therapy, Patent No. [WO024047, 054634]; Ascendis Pharma A/S, 2013, Polymeric hyperbranched carrier-linked prodrugs for diagnosis and therapy, Patent No. [WO024048, 052899]; Ascendis Pharma A/S, 2011, Carrier linked paliperidone prodrugs, Patent No. [WO042450, 084850]; AstraZeneca, 2010, Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections, Patent No. [WO043893, 101774]; Bach P, 2007, EXPERT OPIN THER PAT, V17, P371, DOI 10.1517/13543776.17.4.371; Barcelo M, 2011, MEDCHEMCOMM, V2, P1194, DOI 10.1039/c1md00202c; Basarab GS, 2014, J MED CHEM, V57, P9078, DOI 10.1021/jm501174m; BioEnergenix, 2014, Heterocyclic compounds for the inhibition of PASK, Patent No. [WO066795, 124047]; Bobo WV, 2010, EXPERT REV NEUROTHER, V10, P1637, DOI [10.1586/ern.10.143, 10.1586/ERN.10.143]; Boehringer Ingelheim International Gmbh, 2014, Patent No. [WO082918, 130153]; Boehringer Ingelheim Pharma GmbH & Co. KG, 2009, Patent No. [WO050248, 103420983]; Boss C, 2014, EXPERT OPIN THER PAT, V24, P1367, DOI 10.1517/13543776.2014.978859; Bristol-Myers Squib Co, 2014, Phthalazinones and isoquinolinones as ROCK inhibitors, Patent No. [WO113620, 18941]; Bristol-Myers Squibb Co, 2013, Patent No. [WO049263, 102757426]; CalciMedica Inc., 2013, [No title captured], Patent No. 017071; CalciMedica Inc., 2012, Compounds that modulate intracellular calcium, Patent No. [WO027710, 062858]; Chen Y, 2012, ARCH PHARM, V345, P859, DOI 10.1002/ardp.201200023; China State Institute of Pharmaceutical Industry and Jiangsu Hengyi Pharmaceutical Co. Ltd, 2010, Aralkyl substituted piperidine or piperazine derivatives and their use for treating schizophrenia, Patent No. [WO012121, 043893]; China State Institute of Pharmaceutical Industry and Zhejiang Huahai Pharmaceutical Co. Ltd, 2011, N-(Naphthoxyalkyl) heteroaryl piperidine compound and preparation method and application thereof, Patent No. [CN102161658, 141809]; de Vicente J, 2014, BIOORG MED CHEM LETT, V24, P4969, DOI 10.1016/j.bmcl.2014.09.031; Deng HF, 2010, EXPERT OPIN DRUG DIS, V5, P961, DOI 10.1517/17460441.2010.513378; Domain Therapeutics SA, 2010, Patent No. [WO084425, 132774]; Domain Therapeutics SA Web Site, 2012, [No title captured], Patent No. 004722; Domain Therapeutics SA Web Site, 2014, [No title captured], Patent No. 016564; Eastwood P, 2011, BIOORG MED CHEM LETT, V21, P6253, DOI 10.1016/j.bmcl.2011.09.006; F. Hoffmann-La Roche AG, 2013, Patent No. [WO050334, 102161658]; F. Hoffmann-La Roche AG, 2013, Indazole compounds, compositions and methods of use, Patent No. [WO024011, 057757]; FDA Web Site, 2014, [No title captured], Patent No. 004507; Gilead Calistoga LLC, 2012, Atropisomers of PI3K-inhibiting compounds, Patent No. [WO040634, 084425]; Grimwood S, 2011, ALZHEIMERS DEMENT S, V7, pS653; Gualtieri F, 1999, CHEM HETEROCYCLIC 2, V49, P1, DOI 10.1002/9780470187364.ch1; Hoffmann F., 2010, Patent No. [WO034646, 072470]; Hoffmann F., 2010, Patent No. [WO031735, 064984]; Hoffmann F., 2011, Benzisoxazole analogs as glycogen synthase activators, Patent No. [WO057956, 111875]; Hoffmann F., 2008, Patent No. [WO052899, 103242219]; Hoffmann F., 2009, Patent No. [WO013212, 049263]; Institute of Medicinal Biotechnology, 2012, Patent No. [CN102757426, 140347]; Janssen Pharmaceutica NV, 2014, Patent No. [WO033167, 066795]; Janssen Pharmaceutica NV, 2013, Patent No. [WO085954, 136147]; Ji ZQ, 2012, BIOORG MED CHEM LETT, V22, P4528, DOI 10.1016/j.bmcl.2012.05.125; Jiangsu Nhwa Pharmaceutical Co. Ltd, 2010, Patent No. [WO072147, 130183]; Jiangsu Nhwa Pharmaceutical Co. Ltd., 2009, 2,6-Diketone-piperazin-(piperidine) derivative and application thereof, Patent No. [CN103242219, 143571]; Jiangsu Nhwa Pharmaceutical Co. Ltd and Huazhong University of Science and Technology, 2012, [1,3,4] Oxadiazole derivative and application thereof, Patent No. [WO130183, 6077843]; Kolaczkowski M, 2014, BRIT J PHARMACOL, V171, P973, DOI 10.1111/bph.12509; Leo Laboratories Ltd, 2014, Patent No. [WO001215, 033167]; Lera RM, 2014, J MED CHEM, V57, P3623; Merck Patent GmbH and Cancer Research Technology Ltd, 2013, Patent No. [WO110433, 146553]; Merck Sharp & Dohme Corp. & Mochida Pharmaceutical Co. Ltd, 2014, Patent No. [WO120346, 212930]; Merck Sharp & Dohme, 2013, Patent No. [WO062858, 113620]; Mitsubishi Tanabe Pharma Corp, 2009, Patent No. [WO125853, 40027]; Nicholas T, 2011, ALZHEIMERS DEMENT, V7, pS786; Nielsen RE, 2015, ACTA PSYCHIAT SCAND, V131, P185, DOI 10.1111/acps.12374; Nippon Chemiphar Co. Ltd, 2011, Patent No. [WO043453, 085954]; Organon N. V., 2011, 2-(1,2-Benzisoxazol-3-yl) benzylamine derivatives, Patent No. [WO003895, 038200]; Pfizer Inc, 2011, (R)-4-((4-((4-(tetrahydrofuran-3-yloxy) benzo[d] isoxazol-3-yloxy) methyl) piperidin-1-yl) methyl) tetrahydro-2H-pyran-4-ol, a partial agonist of 5-HT4 receptors, Patent No. [WO101774, 138488]; PIGINI M, 1975, EUR J MED CHEM, V10, P29; PIGINI M, 1975, EUR J MED CHEM, V10, P33; Respivert Ltd, 2014, Kinase inhibitors, Patent No. [WO033446, 050248]; Sawant-Basak A, 2013, J PHARM SCI-US, V102, P3277, DOI 10.1002/jps.23542; SHUTSKE GM, 1982, J MED CHEM, V25, P36, DOI 10.1021/jm00343a008; Signal Pharmaceuticals LLC, 2010, Aminotriazolopyridines and their use as kinase inhibitors, Patent No. [WO027500, 057956]; Sumitomo Dainippon Pharma, 2014, Patent No. [WO054634, 103183646]; Sumitomo Dainippon Pharma Web Site, 2014, [No title captured], Patent No. 024011; Sumitomo-Dainippon Pharma Co. Ltd, 2011, N-Acyl cyclic amine derivative or pharmaceutically acceptable salt thereof, Patent No. [WO111875, 159033]; Sumitomo-Dainippon Pharma Co. Ltd, 2011, A cycloalkane derivative, Patent No. [WO002103, 035123]; Takeda Pharmaceutical Company Ltd, 2009, Heterocyclic compounds and use thereof, Patent No. [WO028655, 062955]; Tianjin Institute of Pharmaceutical Research, 2013, Patent No. [CN103420983, 143404]; Tianjin International Joint Academy of Biotechnology and Medicine, 2013, Patent No. [CN103183646, 144545]; University of Massachusetts, 2011, Compounds for modulating TLR2, Patent No. [WO062955, 116593]; Uto Y, 2012, EXPERT OPIN THER PAT, V22, P701, DOI 10.1517/13543776.2012.681303; Wyeth LLC, 2010, Bisaryl alkynylamides as negative allosteric modulators of metabotropic glutamate receptor 5 (mGluR5), Patent No. [WO124047, 212976]; Xenon Pharmaceuticals Inc, 2013, Biaryl ether sulfonamides and their use as therapeutic agents, Patent No. [WO064984, 120346]; Xenon Pharmaceuticals Inc, 2014, [No title captured], Patent No. 024047; Zhou SH, 2010, ANTIVIR RES, V87, P295, DOI 10.1016/j.antiviral.2010.06.011	122	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1354-3776	1744-7674		EXPERT OPIN THER PAT	Expert Opin. Ther. Patents	JUN	2015	25	6					643	662		10.1517/13543776.2015.1027192		20	Chemistry, Medicinal; Pharmacology & Pharmacy	Pharmacology & Pharmacy	CI7NV	WOS:000354951400003		
J	Lee, S; Han, KH; Yabuki, E; Nakamura, Y; Kawakami, S; Shimada, K; Hayakawa, T; Onoue, H; Fukushima, M				Lee, Seulki; Han, Kyu-Ho; Yabuki, Erina; Nakamura, Yumi; Kawakami, Sakura; Shimada, Kenichiro; Hayakawa, Toru; Onoue, Hirotake; Fukushima, Michihiro			Dietary L-cysteine inhibits D-galactosamine-induced acute liver injury in rats	FOOD SCIENCE AND BIOTECHNOLOGY			English	Article						antioxidant; L-cysteine; rat; D-galactosamine; gluthathione	INDUCED OXIDATIVE STRESS; N-ACETYLCYSTEINE; MITOCHONDRIAL GLUTATHIONE; CARBON-TETRACHLORIDE; LIPID-PEROXIDATION; DAMAGE; ACID; ENZYME; HEPATOTOXICITY; ANTIOXIDANTS	The effects of l-cysteine (1 and 2%) on the antioxidative system were examined in rats with d-galactosamine (d-GalN)-induced injury. These rats showed increases in serum antioxidative enzyme and hepatic thiobarbituric acid reactive substances (TBARS) activities, with decreased hepatic/serum glutathione (GSH) levels and GSH-related enzyme activities. However, l-cysteine supplementation resulted in a decrease of hepatic TBARS levels, and increased catalase and serum GSH levels. The activities of serum enzymes in rats receiving 2% l-cysteine were significantly (p < 0.05) lower than in d-GalN-injected group rats, and similar to levels in control group rats without acute liver injury. In addition, 2% l-cysteine increased the glutathione reductase activity and decreased the serum TBARS level in liver injury group rats. Dietary l-cysteine, especially at a 2% level, exerts a hepatoprotective effect by alteration of the GSH level and antioxidative enzyme activities.	[Lee, Seulki; Han, Kyu-Ho; Fukushima, Michihiro] Iwate Univ, Dept Bioresources Sci, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan; [Han, Kyu-Ho; Yabuki, Erina; Nakamura, Yumi; Kawakami, Sakura; Shimada, Kenichiro; Fukushima, Michihiro] Obihiro Univ Agr & Vet Med, Dept Food Sci, Obihiro, Hokkaido 0808555, Japan; [Hayakawa, Toru] Obihiro Univ Agr & Vet Med, Dept Anim & Food Hyg, Obihiro, Hokkaido 0808555, Japan; [Onoue, Hirotake] Tomo Chem Co Ltd, Tokyo 1020082, Japan	Fukushima, M (reprint author), Iwate Univ, Dept Bioresources Sci, United Grad Sch Agr Sci, Morioka, Iwate 0208550, Japan.	fukushim@obihiro.ac.jp					Aebi H., 1974, METHOD ENZYMAT AN, P673; AlMustafa ZH, 1997, TOXICOLOGY, V121, P223, DOI 10.1016/S0300-483X(97)00069-3; Blouet C, 2007, FREE RADICAL BIO MED, V42, P1089, DOI 10.1016/j.freeradbiomed.2007.01.006; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Nandi D, 2005, TOXICOLOGY, V211, P26, DOI 10.1016/j.tox.2005.02.013; Shimoda H, 2008, J AGR FOOD CHEM, V56, P4444, DOI 10.1021/jf8002174; TATEISHI N, 1977, J NUTR, V107, P51; COHN VH, 1966, ANAL BIOCHEM, V14, P434, DOI 10.1016/0003-2697(66)90286-7; Chalasani N, 2004, AM J GASTROENTEROL, V99, P1497, DOI 10.1111/j.1572-0241.2004.30159.x; Bostwick DG, 2000, CANCER, V89, P123, DOI 10.1002/1097-0142(20000701)89:1<123::AID-CNCR17>3.0.CO;2-9; Han D, 1997, AM J PHYSIOL-REG I, V273, pR1771; Kim YG, 2003, LIFE SCI, V72, P1171, DOI 10.1016/S0024-3205(02)02366-4; BURGUNDER JM, 1989, EUR J CLIN PHARMACOL, V36, P127, DOI 10.1007/BF00609183; GEUBEL AP, 1991, GASTROENTEROLOGY, V100, P1701; Salmon AB, 2010, FREE RADICAL BIO MED, V48, P642, DOI 10.1016/j.freeradbiomed.2009.12.015; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Ohta Y, 2007, FREE RADICAL RES, V41, P135, DOI 10.1080/10715760600953842; Wong CK, 2003, ENVIRON TOXICOL PHAR, V14, P109, DOI 10.1016/S1382-6689(03)00045-0; Awe S, 2011, J TOXICOL ENV HLTH S, V3, P31; Choi Sang Hoon, 2011, [Journal of Food Hygiene and Safety, 한국식품위생안전성학회지], V26, P235; Coen M, 2009, J PROTEOME RES, V8, P5175, DOI 10.1021/pr9005266; Dilger RN, 2007, J NUTR, V137, P331; Thannickal VJ, 2000, AM J PHYSIOL-LUNG C, V279, pL1005; Forsberg L, 1999, HUM MUTAT, V13, P294, DOI 10.1002/(SICI)1098-1004(1999)13:4<294::AID-HUMU6>3.0.CO;2-5; HU HL, 1992, BIOL TRACE ELEM RES, V34, P19, DOI 10.1007/BF02783894; Lee S, 2013, BIOSCI BIOTECH BIOCH, V77, P1430, DOI 10.1271/bbb.130083; Lee SK, 2010, YAKHAK HOEJI, V54, P97; MARTINS EAL, 1991, MUTAT RES, V250, P95, DOI 10.1016/0027-5107(91)90166-L; MCMILLAN JM, 1992, TOXICOL APPL PHARM, V115, P234, DOI 10.1016/0041-008X(92)90328-P; MEREDITH MJ, 1983, BIOCHEM PHARMACOL, V32, P1383, DOI 10.1016/0006-2952(83)90451-3; National Research Council, GUIDE CARE USE LAB A; O'Donovan DJ, 2000, MOL GENET METAB, V71, P352, DOI 10.1006/mgme.2000.3063; Ohba K, 2005, BIOSCI BIOTECH BIOCH, V69, P1988, DOI 10.1271/bbb.69.1988; Patterson RA, 2003, ATHEROSCLEROSIS, V169, P87, DOI 10.1016/S0021-9150(03)00154-0; PRICE VF, 1989, TOXICOL APPL PHARM, V101, P356, DOI 10.1016/0041-008X(89)90283-4; Seckin S, 2008, J I FM, V71, P29; SIMON JB, 1985, CAN FAM PHYSICIAN, V31, P2155; TANAKA E, 1984, Journal of Toxicological Sciences, V9, P245; Tsutsui S, 1997, J VET MED SCI, V59, P785, DOI 10.1292/jvms.59.785; Vimal V, 2004, J ETHNOPHARMACOL, V90, P151, DOI 10.1016/j.jep.2003.09.027; WORTHING.DJ, 1974, EUR J BIOCHEM, V48, P167, DOI 10.1111/j.1432-1033.1974.tb03754.x; Youn SH, 2012, ENG LIFE SCI, V12, P514, DOI 10.1002/elsc.201200002	42	0	0	KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST	SEOUL	#605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-7708	2092-6456		FOOD SCI BIOTECHNOL	Food Sci. Biotechnol.	JUN	2015	24	3					1151	1157		10.1007/s10068-015-0147-3		7	Food Science & Technology	Food Science & Technology	CI6QR	WOS:000354886300047		
J	Nagasawa, S; Torimitsu, S; Chiba, F; Kubo, Y; Yajima, D; Iwase, H				Nagasawa, Sayaka; Torimitsu, Suguru; Chiba, Fumiko; Kubo, Yuko; Yajima, Daisuke; Iwase, Hirotaro			Donepezil distribution in postmortem cases and potential for redistribution	FORENSIC SCIENCE INTERNATIONAL			English	Article						Donepezil; Postmortem redistribution; Central blood; Peripheral blood; Liver; LC/MS/MS	ALZHEIMERS-DISEASE; DRUG REDISTRIBUTION; DOUBLE-BLIND; CHOLINESTERASE-INHIBITORS; ATRIOVENTRICULAR-BLOCK; FEMORAL BLOOD; OVERDOSE; POLYMORPHISM; BIOMARKERS; TOXICOLOGY	Donepezil (DPZ) is an acetylcholine-esterase inhibitor currently used as the frontline drug to treat Alzheimer's disease. The aim of this study was to investigate the possibility of postmortem redistribution (PMR) of DPZ, which could complicate the determination of cause of death in medico-legal cases. Additionally, metabolic enzyme DNA polymorphism, drug-drug interaction and the presence of lesions in metabolic and egestion organs were examined to eliminate the possibility of a high antemortem DPZ concentration. Subsequently, the average DPZ concentration of four sites of peripheral blood (right and left femoral artery and vein) was compared with central blood and liver DPZ concentrations in seven postmortem cases. DPZ concentrations ranged from 0.02 to 0.45 mu g/mL in the peripheral blood, 0.09-0.4 mg/mL in central blood, and from 1.2 to 6.7 mu g/kg in the liver. In most specimens, the concentrations were higher than the therapeutic range (approximately 0.030-0.075 mu g/mL). DPZ central blood to peripheral blood (C/P) ratios averaged 1.73 +/- 1.02 (+/- standard deviation) while liver to peripheral blood (L/P) ratios were higher and averaged 17.5 +/- 7.25. It is documented that a C/P ratio of less than (or about) 1.0 and an L/P ratio less than 5 are not indicative of PMR, whereas a C/P ratio exceeding 2 and L/P ratio exceeding 20 highlight a propensity for significant PMR. Our data suggest that DPZ exhibits a moderate degree of PMR. Additionally, a lowered pH was found in all blood specimens (<6-6.75 in the peripheral blood and <6-6.66 in the central blood). This postmortem reduction in blood pH may increase the ionic forms of DPZ, resulting in a high blood DPZ concentration. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Nagasawa, Sayaka; Torimitsu, Suguru; Chiba, Fumiko; Kubo, Yuko; Yajima, Daisuke; Iwase, Hirotaro] Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, Chiba 2608670, Japan; [Torimitsu, Suguru; Chiba, Fumiko; Iwase, Hirotaro] Univ Tokyo, Grad Sch Med, Dept Forens Med, Bunkyo Ku, Tokyo 1130033, Japan	Nagasawa, S (reprint author), Chiba Univ, Grad Sch Med, Dept Legal Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	nagasawa.s@chiba-u.jp					Amuah JE, 2010, PHARMACOEPIDEM DR S, V19, P670, DOI 10.1002/pds.1946; Varsaldi F, 2006, EUR J CLIN PHARMACOL, V62, P721, DOI 10.1007/s00228-006-0168-1; Hilberg T, 1999, J FORENSIC SCI, V44, P956; POUNDER DJ, 1990, FORENSIC SCI INT, V45, P253, DOI 10.1016/0379-0738(90)90182-X; Rogers SL, 1998, ARCH INTERN MED, V158, P1021, DOI 10.1001/archinte.158.9.1021; Rogers SL, 1998, NEUROLOGY, V50, P136; McIntyre IM, 2012, FORENSIC SCI INT, V223, P349, DOI 10.1016/j.forsciint.2012.10.020; Hiemke C, 2011, PHARMACOPSYCHIATRY, V44, P195, DOI 10.1055/s-0031-1286287; Drummer OH, 2004, FORENSIC SCI INT, V142, P101, DOI 10.1016/j.forsciint.2004.02.013; Shudo K, 2009, CURR ALZHEIMER RES, V6, P302; Zhong Y, 2013, AM J MED SCI, V345, P222, DOI 10.1097/MAJ.0b013e318255a8f9; Tanaka A, 2009, INTERNAL MED, V48, P1219, DOI 10.2169/internalmedicine.48.2181; Rosenbloom MH, 2010, ALZ DIS ASSOC DIS, V24, P209, DOI 10.1097/WAD.0b013e3181b7642b; Druid H, 1997, J FORENSIC SCI, V42, P79; Kumar A, 2015, PHARMACOL REP, V67, P195, DOI 10.1016/j.pharep.2014.09.004; McIntyre IM, 2012, J ANAL TOXICOL, V36, P177, DOI 10.1093/jat/bks011; Shepherd G, 1999, ANN PHARMACOTHER, V33, P812, DOI 10.1345/aph.18273; Pelissier-Alicot AL, 2003, J ANAL TOXICOL, V27, P533; Baselt R.C., 2014, DISPOSITION TOXIC DR, V10th, P706; Carracio T., 2009, CLIN TOXICOL, V47, P744; Cheewakriengkrai L, 2013, EXPERT OPIN PHARMACO, V14, P331, DOI 10.1517/14656566.2013.760543; Christensen D.D., 2012, POSTGRAD MED, V24, P10; Cook J., 2000, J CLIN PATHOL, V53, P282; Bentham P, 2004, LANCET, V363, P2105; Dalpe-Scott M, 1995, CAN SOC FORENSIC SCI, V28, P113; Eisai Company, 1999, AR DON HYDR TABL SUM; Flockhart DA, 2007, DRUG INTERACTIONS CY; Garlich FM, 2014, CLIN TOXICOL, V52, P291, DOI 10.3109/15563650.2014.900182; Greene YM, 1999, J CLIN PSYCHIAT, V60, P56; Hefner G., 2014, THER DRUG MONIT; Hijazi Z, 2014, HEART, V100, P1193, DOI 10.1136/heartjnl-2013-304872; Howes LG, 2014, DRUG SAFETY, V37, P391, DOI 10.1007/s40264-014-0161-z; Imbimbo BP, 2001, CNS DRUGS, V15, P375, DOI 10.2165/00023210-200115050-00004; Koeber R, 2012, J CHROMATOGR B, V881-82, P1, DOI 10.1016/j.jchromb.2011.10.027; Leikin JB, 2003, J TOXICOL-CLIN TOXIC, V41, P47, DOI 10.1081/CLT-120018270; Linnet K, 2011, J ANAL TOXICOL, V35, P227; Maqliulo L., 2011, EUR J CLIN PHARMACOL, V67, P47; Matsumoto Y., 2004, INT J NEUROPSYCHOPH, V7, P101; Mcintyre I. M., 2014, FORENSIC SCI MED PAT, V10, P91; McIntyre I.M., 2012, J FORENSIC RES, V3, P157, DOI DOI 10.4172/2157-7145.1000157; Michael G., 2011, FORENSIC SCI INT, V212, P247; Molino I., 2013, SCI WORLD J, V213; Moore KA, 1999, AM J FOREN MED PATH, V20, P98, DOI 10.1097/00000433-199903000-00023; Nicolson WB, 2014, HEART, V100, P1878, DOI 10.1136/heartjnl-2014-305672; Olazarán Javier, 2013, Dement Geriatr Cogn Dis Extra, V3, P48, DOI 10.1159/000345279; Pei ZQ, 2014, PEPTIDES, V55, P131, DOI 10.1016/j.peptides.2014.02.016; Pounder D.J., 1993, LEG MED, P161; PROUTY RW, 1990, J FORENSIC SCI, V35, P243; Sonali N, 2014, DEMENT GERIATR COGN, V37, P58, DOI 10.1159/000350050; Suleyman T, 2006, EMERG MED J, V23, P641, DOI 10.1136/emj.2006.036251; Takaya Y., 2009, J CARDIOL, V54, P507; Thornton SL, 2014, PEDIATR EMERG CARE, V30, P649, DOI 10.1097/PEC.0000000000000216; World Health Organization Alzheimer's Disease International, 2009, PUBL HLTH PRIOR; Yano Hidetaka, 2003, Rinsho Shinkeigaku, V43, P482; Yarema MC, 2005, CLIN TOXICOL, V43, P235, DOI 10.1081/CLT-200058950	55	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUN	2015	251						132	138		10.1016/j.forsciint.2015.04.006		7	Medicine, Legal	Legal Medicine	CH6DI	WOS:000354125900023		
J	Kakizaki, E; Yukawa, N				Kakizaki, Eiji; Yukawa, Nobuhiro			Simple protocol for extracting diatoms from lung tissues of suspected drowning cases within 3 h: First practical application	FORENSIC SCIENCE INTERNATIONAL			English	Article						Drowning; Diatom test; Enzymatic digestion; Tissue solubilization; Proteinase K; Hydrochloric acid	PLEURAL EFFUSION; FRESH-WATER; DIAGNOSIS; SEAWATER; VICTIMS; INDICATOR; BACTERIA; BLOOD	Conventional acid digestion of tissues for analyzing diatoms obtained from suspected drowning cases is time-consuming, laborious and potentially dangerous. We propose a new protocol for solubilizing lung tissue using only Qiagen Proteinase K, Qiagen Buffer ATL, and 5N hydrochloric acid that can accelerate and simplify diatom extraction from suspected drowning cases. The lower lobe of the right lung (1 g, inner region) and the upper lobe of the left lung (1 g, peripheral region) of ten immersed victims were digested in 15-mL conical centrifuge tubes containing 9 mL of Buffer ATL and 1 mL of 20 mg/mL Proteinase K solution at 56 degrees C for 15-60 min. The digest was washed with ultrapure water and then heated at 70 degrees C for 15 min in 5N hydrochloric acid. The acid residue was washed with ultrapure water followed by ethanol. The identification of 60-23,000 valves in 20 lung samples from the ten victims suggested that they had aspirated water before death. The proposed digestive protocol required only a low-speed centrifuge and a block incubator (or water bath) and diatoms could usually be extracted from lung samples within about 3 h. Informative results of lung diatom tests were very helpful to confirm drowning as a cause of death. Therefore, the proposed protocol can be useful as a simple minimal test to support or challenge a diagnosis of death by drowning when characteristic autopsy findings of drowning are obvious and the probability of drowning is very high, when characteristic autopsy findings of drowning are absent and the probability of drowning is very low, and when conventional diatom testing is not performed due to logistic, personnel or budgetary limitations. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kakizaki, Eiji; Yukawa, Nobuhiro] Miyazaki Univ, Fac Med, Dept Social Med, Div Legal Med, Kiyotake, Miyazaki 8891692, Japan	Kakizaki, E (reprint author), Miyazaki Univ, Fac Med, Dept Social Med, Div Legal Med, 5200 Kihara, Kiyotake, Miyazaki 8891692, Japan.	eijik@med.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293163]	We thank the staff at the Forensic Science Laboratory of Miyazaki Prefectural Police Headquarters for the GC/MS and alcohol analyses. We also thank Ms. Nahomi Takayama, Ms. Yuri Inoue, Ms. Ai Sonoda and Ms. Fumina Shimoda for technical assistance with the preliminary experiment, as well as Ms. Haruna Matsuda for technical assistance with forensic autopsies. We sincerely thank Dr. Tatsuo Shinohara, Shimizu Chuo Clinic in Miyazaki, for his kind donation to support our research. This study was supported by a Grant-in-Aid for Scientific Research (No. 25293163) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Lunetta P, 2005, FOREN PATHOL REV, V3, P3, DOI 10.1007/978-1-59259-910-3_1; Usumoto Y, 2009, J FORENSIC LEG MED, V16, P321, DOI 10.1016/j.jflm.2008.12.028; Ludes B, 1999, INT J LEGAL MED, V112, P163, DOI 10.1007/s004140050224; Piette MHA, 2006, FORENSIC SCI INT, V163, P1, DOI 10.1016/j.forsciint.2004.10.027; Kakizaki Eiji, 2009, Legal Medicine, V11, P91, DOI 10.1016/j.legalmed.2008.10.004; Kakizaki E, 2012, FORENSIC SCI INT, V220, P135, DOI 10.1016/j.forsciint.2012.02.010; LUDES B, 1994, INT J LEGAL MED, V107, P37, DOI 10.1007/BF01247273; Hurlimann J, 2000, INT J LEGAL MED, V114, P6, DOI 10.1007/s004149900122; Lunetta P, 2013, LEGAL MED-TOKYO, V15, P229, DOI 10.1016/j.legalmed.2013.03.002; Kakizaki E, 2008, FORENSIC SCI INT, V176, P236, DOI 10.1016/j.forsciint.2007.09.018; Kakizaki E, 2011, FORENSIC SCI INT, V204, P80, DOI 10.1016/j.forsciint.2010.05.006; Armstrong E. J., 2011, WATER RELATED DEATH, P1; AUER A, 1991, AM J FOREN MED PATH, V12, P213, DOI 10.1097/00000433-199109000-00009; Bortolotti F, 2011, MED SCI LAW, V51, pS7, DOI 10.1258/msl.2010.010057; Diaz-Palma PA, 2009, FORENSIC SCI INT, V184, P37, DOI 10.1016/j.forsciint.2008.11.015; DiGiancamillo A, 2011, LEGAL MED-TOKYO, V13, P268, DOI 10.1016/j.legalmed.2011.05.005; Di Giancamillo A, 2010, LEG MED, V12, P13, DOI 10.1016/j.legalmed.2009.09.007; DiMaio VJ, 2001, FORENSIC PATHOLOGY, V2nd, P399; Inoue Hiromasa, 2005, Legal Medicine, V7, P96, DOI 10.1016/j.legalmed.2004.09.002; Kakizaki E, 2010, LEGAL MED, V12, P195, DOI 10.1016/j.legalmed.2010.03.008; Matoba K, 2012, LEGAL MED-TOKYO, V14, P134, DOI 10.1016/j.legalmed.2012.01.008; PACHAR JV, 1993, MED SCI LAW, V33, P291; Pollanen MS, 1997, J FORENSIC SCI, V42, P281; Sambrook J., 2001, MOL CLONING, V1, P61; Saukko P, 2004, KNIGHTS FORENSIC PAT, P395; Seo Y, 2013, FORENSIC SCI INT, V232, P154, DOI 10.1016/j.forsciint.2013.07.016; Shkrum M. J., 2007, FORENSIC PATHOLOGY T, P243; Strauss W. M., 2001, CURR PROTOC MOL BIOL, V42, P221; Yajima D, 2013, FORENSIC SCI INT, V233, P167, DOI 10.1016/j.forsciint.2013.08.027; YOSHIOKA N, 1986, Research and Practice in Forensic Medicine, V29, P57; Yukawa N., 2013, ESSENTIALS AUTOPSY P, P1	31	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUN	2015	251						179	185		10.1016/j.forsciint.2015.03.025		7	Medicine, Legal	Legal Medicine	CH6DI	WOS:000354125900027		
J	Tsujikawa, K; Iwata, YT; Inoue, M; Higashibayashi, S; Inoue, H				Tsujikawa, Kenji; Iwata, Yuko T.; Inoue, Mika; Higashibayashi, Shuhei; Inoue, Hiroyuki			Comments on "Characterization of four new designer drugs, 5-chloro-NNEI, NNEI indazole analog, alpha-PHPP and alpha-POP, with 11 newly distributed designer drugs in illegal products"	FORENSIC SCIENCE INTERNATIONAL			English	Letter						3,4-Dichloromethylphenidate; Diastereomers; Gas chromatography-mass spectrometry; Thermal decomposition	METHYLPHENIDATE		[Tsujikawa, Kenji; Iwata, Yuko T.; Inoue, Hiroyuki] Natl Res Inst Police Sci, Kashiwa, Chiba 2770882, Japan; [Inoue, Mika; Higashibayashi, Shuhei] Natl Inst Nat Sci, Inst Mol Sci, Tsukuba, Ibaraki, Japan	Tsujikawa, K (reprint author), Natl Res Inst Police Sci, 6-3-1 Kashiwanoha, Kashiwa, Chiba 2770882, Japan.	tujikawa@nrips.go.jp					Davies H.M., 2012, PCT, Patent No. [WO 2012145234, 2012145234]; Davies HML, 2004, BIOORG MED CHEM LETT, V14, P1799, DOI 10.1016/j.bmcl.2003.12.097; Flamm B.L., 1975, BIOMED MASS SPECTROM, V2, P218; Kim DI, 2007, J MED CHEM, V50, P2718, DOI 10.1021/jm061354p; Uchiyama N, 2014, FORENSIC SCI INT, V243, P1, DOI 10.1016/j.forsciint.2014.03.013	5	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0379-0738	1872-6283		FORENSIC SCI INT	Forensic Sci.Int.	JUN	2015	251						E15	E17		10.1016/j.forsciint.2015.04.008		3	Medicine, Legal	Legal Medicine	CH6DI	WOS:000354125900003		
J	Chalabi-Dchar, M; Cassant-Sourdy, S; Duluc, C; Fanjul, M; Lulka, H; Samain, R; Roche, C; Breibach, F; Delisle, MB; Poupot, M; Dufresne, M; Shimaoka, T; Yonehara, S; Mathonnet, M; Pyronnet, S; Bousquet, C				Chalabi-Dchar, Mounira; Cassant-Sourdy, Stephanie; Duluc, Camille; Fanjul, Marjorie; Lulka, Hubert; Samain, Remi; Roche, Catherine; Breibach, Florence; Delisle, Marie-Bernadette; Poupot, Mary; Dufresne, Marlene; Shimaoka, Takeshi; Yonehara, Shin; Mathonnet, Muriel; Pyronnet, Stephane; Bousquet, Corinne			Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16	GASTROENTEROLOGY			English	Article						Tumor Suppressor; Signal Transduction; Oncogene; Mouse Model	INTRAEPITHELIAL NEOPLASIA; CELL PLASTICITY; CANCER; EXPRESSION; PATHWAY; ADENOCARCINOMA; IDENTIFICATION; TUMORIGENESIS; PROGRESSION; BINDING	BACKGROUND & AIMS: The KRAS gene is mutated in most pancreatic ductal adenocarcinomas (PDAC). Expression of this KRAS oncoprotein in mice is sufficient to initiate carcinogenesis but not progression to cancer. Activation of phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K) is required for KRAS for induction and maintenance of PDAC in mice. The somatostatin receptor subtype 2 (sst2) inhibits PI3K, but sst2 expression is lost during the development of human PDAC. We investigated the effects of sst2 loss during KRAS-induced PDAC development in mice. METHODS: We analyzed tumor growth in mice that expressed the oncogenic form of KRAS (KRAS(G12D)) in pancreatic precursor cells, as well as sst2+/- and sst2-/-, and in crossed KRAS(G12D); sst2+/- and KRAS(G12D); sst2-/- mice. Pancreatic tissues and acini were collected and assessed by histologic, immunoblot, immunohistochemical, and reverse-transcription polymerase chain reaction analyses. We also compared protein levels in paraffin-embedded PDAC samples from patients vs heathy pancreatic tissues from individuals without pancreatic cancer. RESULTS: In sst2+/- mice, PI3K was activated and signaled via AKT (PKB; protein kinase B); when these mice were crossed with KRAS(G12D) mice, premalignant lesions, tumors, and lymph node metastases developed more rapidly than in KRAS(G12D) mice. In crossed KRAS(G12D); sst2+/- mice, activation of PI3K signaling via AKT resulted in activation of nuclear factor-kappa B (NF-kappa B), which increased KRAS activity and its downstream pathways, promoting initiation and progression of neoplastic lesions. We found this activation loop to be mediated by PI3K-induced production of the chemokine CXCL16. Administration of a CXCL16-neutralizing antibody to KRAS(G12D) mice reduced activation of PI3K signaling to AKT and NF-kappa B, blocking carcinogenesis. Levels of CXCL16 and its receptor CXCR6 were significantly higher in PDAC tissues and surrounding acini than in healthy pancreatic tissues from mice or human beings. In addition, expression of sst2 was progressively lost, involving increased PI3K activity, in mouse lesions that expressed KRAS(G12D) and progressed to PDAC. CONCLUSIONS: Based on analyses of mice, loss of sst2 from pancreatic tissues activates PI3K signaling via AKT, leading to activation of NF-kappa B, amplification of oncogenic KRAS signaling, increased expression of CXCL16, and pancreatic tumor formation. CXCL16 might be a therapeutic target for PDAC.	[Chalabi-Dchar, Mounira; Cassant-Sourdy, Stephanie; Duluc, Camille; Fanjul, Marjorie; Lulka, Hubert; Samain, Remi; Poupot, Mary; Dufresne, Marlene; Pyronnet, Stephane; Bousquet, Corinne] Toulouse Univ, Canc Res Ctr Toulouse, INSERM UMR 1037, Equipe Labellisee Ligue Canc, Toulouse, France; [Chalabi-Dchar, Mounira; Cassant-Sourdy, Stephanie; Duluc, Camille; Fanjul, Marjorie; Lulka, Hubert; Samain, Remi; Poupot, Mary; Dufresne, Marlene; Pyronnet, Stephane; Bousquet, Corinne] Lab Excellence Toulouse Canc, Toulouse, France; [Roche, Catherine] Aix Marseille Univ, CNRS UMR7286, Neurobiol & Neurophysiol Res Ctr Marseille, Marseille, France; [Roche, Catherine] AP HM Concept, Mol Biol Lab, Marseille, France; [Breibach, Florence; Delisle, Marie-Bernadette] Toulouse Hosp, Dept Pathol, Toulouse, France; [Shimaoka, Takeshi] Univ Tokyo, Grad Sch Sci, Dept Mol Prevent Med, Tokyo 113, Japan; [Yonehara, Shin] Kyoto Univ, Grad Sch Biostudies, Lab Mol & Cellular Biol, Kyoto, Japan; [Mathonnet, Muriel] Univ Limoges, Med & Pharm Fac, EA Lab 3842, Limoges, France	Bousquet, C (reprint author), Canc Res Ctr Toulouse, INSERM UMR 1037, 0 Ave Hubert Curien,Oncopole Entree C,CS53717, F-31037 Toulouse 1, France.	corinne.bousquet@inserm.fr			Ligue Nationale Contre le Cancer; Labex Equipe Labellisee Ligue Contre le Cancer and Laboratoire d'Excellence Toulouse Cancer; Canceropole Grand Sud-Ouest [RMA04002BPA]; Fondation de France [2014 00047506]; French National Institute of Cancer [INCA_PLBIO13-134, R13132BP, 2013-102]; French Ministry of Research and Association de la Recherche Contre le Cancer; Association Fondation pour la Recherche Medicale	Supported by the Ligue Nationale Contre le Cancer, the Labex Equipe Labellisee Ligue Contre le Cancer and Laboratoire d'Excellence Toulouse Cancer, the Canceropole Grand Sud-Ouest (RMA04002BPA), the Fondation de France (2014 00047506) and the French National Institute of Cancer (INCA_PLBIO13-134, R13132BP, No2013-102). Also supported by a fellowship from the Ligue Nationale Contre le Cancer (M.C.-D), a fellowship from the French Ministry of Research and Association de la Recherche Contre le Cancer (C.D.), and by the Association Fondation pour la Recherche Medicale (R.S.).	Najib S, 2012, MOL CELL BIOL, V32, P1004, DOI 10.1128/MCB.06252-11; Ardito CM, 2012, CANCER CELL, V22, P304, DOI 10.1016/j.ccr.2012.07.024; Daniluk J, 2012, J CLIN INVEST, V122, P1519, DOI 10.1172/JCI59743; Pyronnet S, 2008, MOL CELL ENDOCRINOL, V286, P230, DOI 10.1016/j.mce.2008.02.002; Wente MN, 2008, INT J ONCOL, V33, P297, DOI 10.3892/ijo_00000009; Malka D, 2002, GUT, V51, P849, DOI 10.1136/gut.51.6.849; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Eser S, 2013, CANCER CELL, V23, P406, DOI 10.1016/j.ccr.2013.01.023; Laklai H, 2009, P NATL ACAD SCI USA, V106, P17769, DOI 10.1073/pnas.0908674106; di Magliano MP, 2013, GASTROENTEROLOGY, V144, P1220, DOI 10.1053/j.gastro.2013.01.071; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Baer R, 2014, GENE DEV, V28, P2621, DOI 10.1101/gad.249409.114; Guerra C, 2007, CANCER CELL, V11, P291, DOI 10.1016/j.ccr.2007.01.012; Borst O, 2012, CIRC RES, V111, P1297, DOI 10.1161/CIRCRESAHA.112.276444; Trotman LC, 2006, NATURE, V441, P523, DOI 10.1038/nature04809; Lesina M, 2011, CANCER CELL, V19, P456, DOI 10.1016/j.ccr.2011.03.009; Zhu LQ, 2007, AM J PATHOL, V171, P263, DOI 10.2353/ajpath.2007.061176; Bousquet C, 2006, EMBO J, V25, P3943, DOI 10.1038/sj.emboj.7601279; Buscail L, 1996, CANCER RES, V56, P1823; Carriere C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027725; Gaida MM, 2010, INT J MOL MED, V26, P281, DOI 10.3892/ijmm_00000463; Jung YH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2766; Laval S, 2014, ONCOGENE, V33, P1934, DOI 10.1038/onc.2013.146; Maitra A, 2012, CANCER CELL, V22, P701, DOI 10.1016/j.ccr.2012.11.015; Torrisani J, 2008, ENDOCRINOLOGY, V149, P3137, DOI 10.1210/en.2007-1525; Wehr A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112327; Wu CYC, 2014, GASTROENTEROLOGY, V147, P1405, DOI 10.1053/j.gastro.2014.08.032	27	1	2	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0016-5085	1528-0012		GASTROENTEROLOGY	Gastroenterology	JUN	2015	148	7					1452	1465		10.1053/j.gastro.2015.02.009		14	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI8IC	WOS:000355014700036		
J	Fukumoto, Y				Fukumoto, Yoshiyasu			Invariance of finiteness of K-area under surgery	GEOMETRIAE DEDICATA			English	Article						Scalar curvature; K-area; Vector bundle; Surgery		K-area is an invariant for Riemannian manifolds introduced by Gromov as an obstruction to the existence of positive scalar curvature. However in general it is difficult to determine whether K-area is finite or not in spite of its natural definition. In this paper, we study how the invariant changes under surgery.	Kyoto Univ, Dept Math, Fac Sci, Sakyo Ku, Kyoto 6068502, Japan	Fukumoto, Y (reprint author), Kyoto Univ, Dept Math, Fac Sci, Sakyo Ku, Kyoto 6068502, Japan.	fukumoto@math.kyoto-u.ac.jp					GROMOV M, 1980, ANN MATH, V111, P423, DOI 10.2307/1971103; Gromov M., 1996, POSITIVE CURVATURE M; Gromov M., 1983, I HAUTES ETUDES SCI, V58, P83; Hanke B., 2011, SPRINGER P MATH, P275; Listing M., 2010, ARXIV10073166	5	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	JUN	2015	176	1					175	183		10.1007/s10711-014-9962-6		9	Mathematics	Mathematics	CI3FI	WOS:000354632600007		
J	Kasahara, Y				Kasahara, Yasushi			On visualization of the linearity problem for mapping class groups of surfaces	GEOMETRIAE DEDICATA			English	Article						Mapping class group; Linear representation; Deformation space	BRAID-GROUPS	We derive two types of linearity conditions for mapping class groups of orientable surfaces: one for once-punctured surface, and the other for closed surface, respectively. For the once-punctured case, the condition is described in terms of the action of the mapping class group on the deformation space of linear representations of the fundamental group of the corresponding closed surface. For the closed case, the condition is described in terms of the vector space generated by the isotopy classes of essential simple closed curves on the corresponding surface. The latter condition also describes the linearity for the mapping class group of compact orientable surface with boundary, up to center.	Kochi Univ Technol, Dept Math, Kochi 7828502, Japan	Kasahara, Y (reprint author), Kochi Univ Technol, Dept Math, Kochi 7828502, Japan.	kasahara.yasushi@kochi-tech.ac.jp			Japan Society for Promotion of Sciences [23540102]	The author is grateful to Louis Funar and Makoto Sakuma for valuable discussions and comments. He is grateful to Masatoshi Sato for an enlightening conversation. He is grateful to the referee for helpful comments. The author was partially supported by the Grant-in-Aid for Scientific Research (C) (No. 23540102) from the Japan Society for Promotion of Sciences.	Andersen JE, 1997, P AM MATH SOC, V125, P1511, DOI 10.1090/S0002-9939-97-03788-X; Gervais S, 2001, TOPOLOGY, V40, P703, DOI 10.1016/S0040-9383(99)00079-8; Krammer D, 2002, ANN MATH, V155, P131, DOI 10.2307/3062152; Bigelow SJ, 2001, J AM MATH SOC, V14, P471, DOI 10.1090/S0894-0347-00-00361-1; Bigelow S.J., 2001, ALGEBR GEOM TOPOL, V1, P699, DOI 10.2140/agt.2001.1.699; Birman J., 1975, BRAIDS LINKS MAPPING; Brendle T.E., 2001, ALGEBR GEOM TOPOL, V1, P445, DOI 10.2140/agt.2001.1.445; Farb B, 2001, DUKE MATH J, V106, P581; Farb B., 2012, PRINCETON MATH SERIE, V49; FORMANEK E, 1992, J ALGEBRA, V149, P494, DOI 10.1016/0021-8693(92)90029-L; Franks J, 2013, P AM MATH SOC, V141, P2951; Goldman W.M, 2006, P S PURE MATH, V74, P189, DOI DOI 10.1090/PSPUM/074/2264541.MR2264541; Korkmaz M., 2011, ARXIV11083241; Korkmaz M., 2000, TURKISH J MATH, V24, P367; Korkmaz M., 2011, ARXIV11044816; Krammer D, 2000, INVENT MATH, V142, P451, DOI 10.1007/s002220000088; Paris L, 2000, J REINE ANGEW MATH, V521, P47	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	JUN	2015	176	1					295	304		10.1007/s10711-014-9968-0		10	Mathematics	Mathematics	CI3FI	WOS:000354632600013		
J	Watanabe, K				Watanabe, Kenta			The Clifford index of line bundles on a 2-elementary K3 surface given by a double cover of a Del Pezzo surface	GEOMETRIAE DEDICATA			English	Article						Clifford index; 2-Elementary K3 surface; Del Pezzo surface	CURVES	We call a K3 surface a 2-elementary K3 surface if the N,ron-Severi lattice satisfies the condition that is a 2-elementary group, where . In this paper, in the case where is a 2-elementary K3 surface given by a double cover of a smooth Del Pezzo surface of degree and is a base point free and big line bundle on , for any smooth curve in the linear system , we investigate line bundles on which compute the Clifford index of C.	Osaka Univ, Grad Sch Sci, Dept Math, Osaka 5600043, Japan	Watanabe, K (reprint author), Osaka Univ, Grad Sch Sci, Dept Math, Osaka 5600043, Japan.	goo314kenta@mail.goo.ne.jp			Japan Society for the Promotion Science [25400039]	The author would like to thank Professor Akira Ohbuchi and Professor Kazuhiro Konno for their detailed comments. The author is partially supported by Grant-in-Aid for Scientific Research (25400039), Japan Society for the Promotion Science.	Alexeev V., 2006, MSJ MEMORIES, V15; SAINTDONAT B, 1974, AM J MATH, V96, P602, DOI 10.2307/2373709; Demazure M., 1980, LECT NOTES MATH, V777; EISENBUD D, 1989, COMPOS MATH, V72, P173; GREEN M, 1987, INVENT MATH, V89, P357, DOI 10.1007/BF01389083; Johnsen T., 2004, LECT NOTES MATH, V1842; Knutsen AL, 2001, MANUSCRIPTA MATH, V104, P211, DOI 10.1007/s002290170040; Nikulin V.V., 1983, J SOVIET MATH, V22, P1401, DOI 10.1007/BF01094757; REID M, 1976, J LOND MATH SOC, V13, P454	9	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0046-5755	1572-9168		GEOMETRIAE DEDICATA	Geod. Dedic.	JUN	2015	176	1					329	343		10.1007/s10711-014-9971-5		15	Mathematics	Mathematics	CI3FI	WOS:000354632600016		
J	Imaizumi, F; Nishii, R; Murakami, W; Daimaru, H				Imaizumi, Fumitoshi; Nishii, Ryoko; Murakami, Wataru; Daimaru, Hiromu			Parallel retreat of rock slopes underlain by alternation of strata	GEOMORPHOLOGY			English	Article						Alternating layers; Erosion rate; Geometric model; Japan; Landslide; Parallel retreat	AKAISHI MOUNTAINS; COLORADO PLATEAU; SOIL PRODUCTION; MASS STRENGTH; CENTRAL JAPAN; RATES; EVOLUTION; ROCKSLIDE; EROSION; CLIFF	Characteristic landscapes (e.g., cuesta, cliff and overhang of caprock, or stepped terrain) formed by differential erosion can be found in areas composed of variable geology exhibiting different resistances to weathering. Parallel retreat of slopes, defined as recession of slopes without changes in their topography, is sometimes observed on slopes composed of multiple strata. However, the conditions needed for such parallel retreat have not yet been sufficiently clarified. In this study, we elucidated the conditions for parallel retreat of rock slopes composed of alternating layers using a geometric method. In addition, to evaluate whether various rock slopes fulfilled the conditions for parallel retreat, we analyzed topographic data obtained from periodic measurement of rock slopes in the Aka-kuzure landslide, central Japan. Our geometric analysis of the two-dimensional slopes indicates that dip angle, slope gradient, and erosion rate are the factors that determine parallel retreat conditions. However, dip angle does not significantly affect parallel retreat conditions in the case of steep back slopes (slope gradient > 40 degrees). In contrast, dip angle is an important factor when we consider the parallel retreat conditions in dip slopes and gentler back slopes (slope gradient < 40 degrees). Geology in the Aka-kuzure landslide is complex because of faulting, folding, and toppling, but spatial distribution of the erosion rate measured by airborne LiDAR scanning and terrestrial laser scanning (TLS) roughly fulfills parallel retreat conditions. The Aka-kuzure landslide is characterized by repetition of steep sandstone cliffs and gentle shale slopes that form a stepped topography. The inherent resistance of sandstone to weathering is greater than that of shale. However, the vertical erosion rate within the sandstone was higher than that within the shale, due to direct relationship between slope gradient and vertical erosion rate in the Aka-kuzure landslide. (C) 2015 Elsevier B.V. All rights reserved.	[Imaizumi, Fumitoshi] Shizuoka Univ, Grad Sch Agr, Suruga Ku, Shizuoka 4228529, Japan; [Nishii, Ryoko] Publ Works Res Inst, Tsukuba, Ibaraki 3058516, Japan; [Murakami, Wataru; Daimaru, Hiromu] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Imaizumi, F (reprint author), Shizuoka Univ, Grad Sch Agr, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	imaizumi@cii.shizuoka.ac.jp			JSPS KAKENHI Grant [24780141]; Research and Education Funding for the Japanese Alps Inter-Universities Cooperative Project, MEXT, Japan	This work was supported by JSPS KAKENHI Grant Number 24780141 and Research and Education Funding for the Japanese Alps Inter-Universities Cooperative Project, MEXT, Japan. The Ohigawa Chisan Center, Ministry of Agriculture, Forestry and Fisheries, kindly provided us with topographic data We appreciate the Tokushu Tokai Paper Co., Ltd., land owner around the Aka-kuzure landslide, for allowing us to access the site. Gratitude is also expressed to Yasuhiro Ogawa, Takashi Miyamae (Forestay and Forest Products Research Institute), Toru Endo, Akira Takinami, Yoshikazu Endo and Yusuke Ueji (Ikawa University Forest, University of Tsukuba) for their help.	ALEXANDROWICZ Z, 1989, Z GEOMORPHOL, V33, P275; ROBERTS RG, 1986, CAN J FOREST RES, V16, P1092, DOI 10.1139/x86-189; Hettema MHH, 1998, INT J ROCK MECH MIN, V35, P3, DOI 10.1016/S0148-9062(97)00318-5; Matsuoka N, 2001, EARTH-SCI REV, V55, P107, DOI 10.1016/S0012-8252(01)00057-5; Lin Z, 2004, GEOMORPHOLOGY, V63, P159, DOI 10.1016/j.geomorph.2004.03.012; Heimsath AM, 2001, EARTH SURF PROC LAND, V26, P531, DOI 10.1002/esp.209; Su J, 2006, PHOTOGRAMM ENG REM S, V72, P1265; Heimsath AM, 1997, NATURE, V388, P358, DOI 10.1038/41056; Imaizumi F, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026250; Turkington AV, 2005, GEOMORPHOLOGY, V67, P229, DOI 10.1016/j.geomorph.2004.09.028; Tsou CY, 2011, GEOMORPHOLOGY, V127, P166, DOI 10.1016/j.geomorph.2010.12.013; Antoniou AA, 2010, GEOMORPHOLOGY, V118, P152, DOI 10.1016/j.geomorph.2009.12.015; Ashraf MI, 2012, HYDROL PROCESS, V26, P1119, DOI 10.1002/hyp.8195; BRADLEY WC, 1963, GEOL SOC AM BULL, V74, P519, DOI 10.1130/0016-7606(1963)74[519:LEIMSO]2.0.CO;2; Chigira M., 2000, J NEPAL GEOL SOC, V22, P497; CHIGIRA M, 1994, ENG GEOL, V38, P221, DOI 10.1016/0013-7952(94)90039-6; Coleman S.M., 1981, QUATERNARY RES, V15, P250; DIBB TE, 1983, Q J ENG GEOL HYDROGE, V16, P149, DOI 10.1144/GSL.QJEG.1983.016.02.08; Hall K, 2004, EARTH SURF PROC LAND, V29, P43, DOI 10.1002/esp.1012; Hall K., 1993, Permafrost and Periglacial Processes, V4, P245, DOI 10.1002/ppp.3430040306; Ikeda H., 1993, B TSUKUBA U FOR, V9, P149; Imaizumi F., 2014, EARTH SURF PROCESS L; Imaizumi F, 2010, GEOMORPHOLOGY, V115, P32, DOI 10.1016/j.geomorph.2009.09.026; Kano K.-I., 1988, Modern Geology, V12; KANO K, 1991, TECTONOPHYSICS, V185, P375, DOI 10.1016/0040-1951(91)90455-2; Kano K., 1986, GEOSCIENCE REPORTS, V12, P89; KIRK RM, 1977, NEW ZEAL J GEOL GEOP, V20, P571; Lin CW, 2004, ENG GEOL, V71, P49, DOI 10.1016/S0013-7952(03)00125-X; Matsuoka N, 1999, GEOMORPHOLOGY, V28, P309, DOI 10.1016/S0169-555X(98)00116-0; MATSUOKA N, 1995, GEOMORPHOLOGY, V12, P323, DOI 10.1016/01695-55X9(50)0013U-; Mayback M, 1987, AM J SCI, V287, P401; MOON BP, 1983, GEOGR ANN A, V65, P135, DOI 10.2307/520727; MOTTERSHEAD DN, 1989, EARTH SURF PROCESSES, V14, P383, DOI 10.1002/esp.3290140504; Mutluturk M, 2004, INT J ROCK MECH MIN, V41, P237, DOI 10.1016/S1365-1609(03)00095-9; Nagai O., 2000, J JPN LANDSLIDE SOC, V37, P20; NICHOLAS RM, 1986, Z GEOMORPHOL, V30, P167; Nishii R, 2010, ENG GEOL, V115, P49, DOI 10.1016/j.enggeo.2010.06.014; Obanawa H, 2008, GEOMORPHOLOGY, V97, P697, DOI 10.1016/j.geomorph.2007.09.013; PENTECOST A, 1991, EARTH SURF PROCESSES, V16, P83, DOI 10.1002/esp.3290160109; Phillips JD, 2005, GEOMORPHOLOGY, V67, P255, DOI 10.1016/j.geomorph.2004.06.012; SCHMIDT KH, 1989, EARTH SURF PROCESSES, V14, P93, DOI 10.1002/esp.3290140202; SELBY MJ, 1982, EARTH SURF PROC LAND, V7, P489, DOI 10.1002/esp.3290070509; Sidle R.C., 2006, AM GEOPHYS UNION WAT, V18; Suzuki T, 2002, T JPN GEOMORPHOL UNI, V23, P159; Trustrum N., 1988, GEOMORPHOLOGY, V1, P143, DOI 10.1016/0169-555X(88)90012-8	45	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-555X	1872-695X		GEOMORPHOLOGY	Geomorphology	JUN 1	2015	238						27	36		10.1016/j.geomorph.2015.02.030		10	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CI8QE	WOS:000355036000003		
J	Ouchi, S				Ouchi, Shunji			Experimental landform development by rainfall erosion with uplift at various rates	GEOMORPHOLOGY			English	Article						Analog model experiment; Landform evolution; Threshold uplift rate; Fluvial erosion; Slope failures; Steady state	THRESHOLD HILLSLOPES; ROCK-UPLIFT; TOPOGRAPHY; TECTONICS; RELIEF; LANDSCAPES; INCISION	Four runs (1, 2, 3, and 4) of physical analog model experiments, in which a square (ca. 60 x 60 cm) column of a mixture of fine sand and kaolinite is slowly raised at different rates (ca. 5.1, 13, 0.5, 0.2 mm/h, respectively) under artificial rainfall of about 38 mm/h, were conducted to observe how experimental landforms develop in relation to these uplift rates. As a square mound gradually emerges from ground level, fluvial erosion starts at the mound edges and develops into valley systems. This process of fluvial erosion, expressed in a linear relationship between relief (maximum height-minimum height) and mean cell slope (mean value of the highest slope gradient in a 1 cm x 1 cm grid cell), dominates until relief reaches about 60 mm, around the time when slope failures (slumps) start to dominate. If fluvial erosion dominates throughout the run (relief stays below 60 mm), the uplift rate is considered to be below the lower threshold and landform development is in the "characteristic relief phase." In all four runs, relief increases above 60 mm and slumps become significant as hills grow, indicating that uplift rates in this series are above the lower threshold. In run 1, the uplift at a high rate overwhelmed erosion and a massive mountain-like topography formed despite the occurrence of large slumps. The uplift rate in run 1 is thus above the upper threshold and landform development is in the "mountain building phase." The mountain is likely to collapse when it grows higher than the limit of mountain growth determined by factors other than uplift rates. In runs 2, 3, and 4, after valley systems develop over the surface, hills grow with the occurrence of slumps and channel profiles seem to become stable at gradients corresponding to the uplift rates. As slopes grow steeper than a certain "critical gradient," which is possibly the angle of repose of dry mound-forming material, they become vulnerable to slumps. However, Slopes of material containing water and clay can grow steeper than this gradient in the absence of triggering events. The frequency distribution of cell slopes becomes bimodal, indicating the dominance of two types of slopes divided by the critical gradient, one below and another above. The former represents surfaces formed mainly by fluvial processes, and the latter surfaces formed by and/or waiting for slumps. Slumps reduce relief, but average height (zmean) does not fall unless sediments produced by slumps are carried away by fluvial processes. The combination of slope failure, fluvial processes, and uplift eventually works to keep zmean stable around a certain height depending on uplift rates, while relief repeats decrease and increase. The experimental landforms in runs 2, 3, and 4 seem to have achieved a certain steady state with uplift and erosion. The landform development in these runs is considered to be in the "steady-state phase," with uplift rates between the lower and upper thresholds. These observations and interpretations are surprisingly consistent with studies on real landforms and can be of value in interpreting their development. (C) 2015 Elsevier B.V. All rights reserved.	Chuo Univ, Coll Sci & Engn, Bunkyo Ku, Tokyo 1128551, Japan	Ouchi, S (reprint author), Chuo Univ, Coll Sci & Engn, Bunkyo Ku, 1-13-27 Kasuga, Tokyo 1128551, Japan.	souchi@kc.chuo-u.ac.jp			Chuo University; Ministry of Education, Culture, Sports, Science, and Technology, Japan [21501005, 26350405]	I gratefully acknowledge the support for this study of Chuo University and by a Grant-in-Aid for Scientific Research (No. 21501005 and No. 26350405) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. I express my special thanks to Dr. Ellen Wohl of Colorado State University and Dr. Claudio Vita-Finzi of Natural History Museum, London, for their reading and correcting the manuscript that largely helped to improve the writing. I also thank an anonymous reviewer and the editor for their appropriate comments and corrections on the manuscript. Finally, I would like to dedicate this article to the memory of my dear Professor Dr. Stanley A. Schumm, who passed away on 10 April 2011. I could not have continued studying geomorphology without meeting him in 1979 and without his instruction during the days in graduate school. I sincerely pray for the repose of his soul.	AHNERT F, 1970, AM J SCI, V268, P243; Burbank DW, 1996, NATURE, V379, P505, DOI 10.1038/379505a0; Lague D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001785; Montgomery DR, 2002, EARTH PLANET SC LETT, V201, P481, DOI 10.1016/S0012-821X(02)00725-2; Larsen IJ, 2012, NAT GEOSCI, V5, P468, DOI 10.1038/ngeo1479; Wobus C, 2006, GEOL SOC AM SPEC PAP, V398, P55, DOI 10.1130/2006.2398(04); Paola C, 2009, EARTH-SCI REV, V97, P1, DOI 10.1016/j.earscirev.2009.05.003; Kirby E, 2001, GEOLOGY, V29, P415, DOI 10.1130/0091-7613(2001)029<0415:QDRURV>2.0.CO;2; Roering JJ, 1999, WATER RESOUR RES, V35, P853, DOI 10.1029/1998WR900090; Bonnet S, 2003, GEOLOGY, V31, P123, DOI 10.1130/0091-7613(2003)031<0123:LRTCCI>2.0.CO;2; Montgomery DR, 2001, AM J SCI, V301, P432, DOI 10.2475/ajs.301.4-5.432; Kirby E, 2012, J STRUCT GEOL, V44, P54, DOI 10.1016/j.jsg.2012.07.009; Roering J, 2012, NAT GEOSCI, V5, P446, DOI 10.1038/ngeo1511; Willett SD, 2002, GEOLOGY, V30, P175, DOI 10.1130/0091-7613(2002)030<0175:OSSIMB>2.0.CO;2; Bonnet S, 2006, GEOL SOC SPEC PUBL, V253, P327, DOI 10.1144/GSL.SP.2006.253.01.17; Ouchi S, 2011, GEOMORPHOLOGY, V127, P88, DOI 10.1016/j.geomorph.2010.12.009; SCHMIDT KM, 1995, SCIENCE, V270, P617, DOI 10.1126/science.270.5236.617; Schumm SA, 1987, EXPT FLUVIAL GEOMORP; Schumm S.A., 1963, 454H US GEOL SURV PR, P1; Strahler NA, 1950, J GEOPHYS RES, P800; Strahler NA, 1950, J GEOPHYS RES, V248, P673; Turowski JM, 2006, J GEOPHYS RES-EARTH, V111, DOI 10.1029/2005JF000306	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0169-555X	1872-695X		GEOMORPHOLOGY	Geomorphology	JUN 1	2015	238						68	77		10.1016/j.geomorph.2015.03.001		10	Geography, Physical; Geosciences, Multidisciplinary	Physical Geography; Geology	CI8QE	WOS:000355036000007		
J	Wang, W; Liu, SW; Santosh, M; Zhang, LF; Bai, X; Zhao, Y; Zhang, SH; Guo, RR				Wang, Wei; Liu, Shuwen; Santosh, M.; Zhang, Lifei; Bai, Xiang; Zhao, Yue; Zhang, Shuanhong; Guo, Rongrong			1.23 Ga mafic dykes in the North China Craton and their implications for the reconstruction of the Columbia supercontinent	GONDWANA RESEARCH			English	Article						Mafic dykes; Geochronology; Mantle plume; Columbia-Rodinia transition; North China Craton	LARGE IGNEOUS PROVINCES; CONTINENTAL BREAK-UP; PB BADDELEYITE AGES; MANTLE PLUME; MESOPROTEROZOIC SUPERCONTINENT; HF ISOTOPES; LU-HF; GEOCHEMICAL CONSTRAINTS; GRANITOID GNEISSES; TECTONIC EVOLUTION	The Proterozoic world was shaped by the Paleo-Mesoproterozoic Columbia and Neoproterozoic Rodinia supercontinents. The North China Craton (NCC) is an integral component of Columbia supercontinent assembly, but the lack of rock records in the transitional period between Columbia and Rodinia in the late Mesoproterozoic (1.3-1.2 Ga) has resulted in its exclusion from models that trace the Columbia-Rodinia transition. The paleogeographic position of the NCC is also elusive, with India, Baltica, and Siberia as potential neighbors during the early evolution of Columbia. Here we report the discovery of a suite of similar to 1.23 Ga mafic dykes covering an area of similar to 0.6 x 10(6) km(2) of the NCC. These mafic rocks can be classified into both alkaline and subalkaline groups. The former group may have been derived from lower degrees of partial melting of a depleted asthenospheric mantle with limited involvement of a lithospheric mantle component, whereas the latter group can be modeled by higher degrees of partial melting of a subduction-modified enriched lithospheric mantle. Considering the large areal extent of the 123 Ga mafic dykes, and their dominantly OIB (Ocean Island Basalt)-like geochemical features, a Mesoproterozoic mantle plume regime is invoked for the NCC. Compiling information on global similar to 1.27-121 Ga mafic dykes, flood basalts and layered intrusions, we establish a Mesoproterozoic hotspot track, and consider the NCC to have been located between Laurentia and Baltica. Combined with recent paleomagnetic and geological data, we infer that the Laurentia-NCC-Baltica connection may have existed since the late Paleoproterozoic. We further propose that both plate tectonic (introversion or extroversion) and mantle plume regimes played vital roles during the supercontinent transition. (C) 2014 International Association for Gondwana Research. Published by Elsevier B.V. All rights reserved.	[Wang, Wei; Liu, Shuwen; Zhang, Lifei; Bai, Xiang; Guo, Rongrong] Peking Univ, Sch Earth & Space Sci, Key Lab Orogen Belts & Crustal Evolut, Minist Educ, Beijing 100871, Peoples R China; [Santosh, M.] China Univ Geosci, Sch Earth Sci & Resources, Beijing 100083, Peoples R China; [Santosh, M.] Kochi Univ, Fac Sci, Kochi 7808520, Japan; [Zhao, Yue; Zhang, Shuanhong] Chinese Acad Geol Sci, Inst Geomech, Beijing 100081, Peoples R China	Liu, SW (reprint author), Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China.	swliu@pku.edu.cn	Zhang, Shuan-Hong/G-6488-2010; Santosh, M/B-2563-2012		National Natural Science Foundation of China [41121062, 41272209, 41072143, 40872120]; China Geological Survey [1212011121070]	We thank Prof. Joseph G Meert, Associate Editor of Gondwana Research and Prof. Wenjiao Xiao and an anonymous referee for helpful comments on an earlier version of this paper. We also thank F. Ma for zircon U-Pb isotopic and trace element analyses, Z.C. Hu for zircon Lu-Hf isotopic analyses, and B. Yang, LB. Gu, and M. Liu for whole-rock major and trace element analyses. Funding for this research was provided by the National Natural Science Foundation of China (grants: 41121062, 41272209, 41072143 and 40872120) and the China Geological Survey (grant 1212011121070).	Zhao GC, 2002, EARTH-SCI REV, V59, P125, DOI 10.1016/S0012-8252(02)00073-9; Ernst RE, 2008, PRECAMBRIAN RES, V160, P159, DOI 10.1016/j.precamres.2007.04.019; Zhang SH, 2012, PRECAMBRIAN RES, V222, P339, DOI 10.1016/j.precamres.2011.06.003; Santosh M, 2007, GONDWANA RES, V11, P263, DOI 10.1016/j.gr.2006.10.009; Peng P, 2011, LITHOS, V127, P210, DOI 10.1016/j.lithos.2011.08.018; Kusky T, 2007, GONDWANA RES, V12, P4, DOI 10.1016/j.gr.2006.11.012; Wang XL, 2010, PRECAMBRIAN RES, V182, P204, DOI 10.1016/j.precamres.2010.08.007; Zhang SH, 2007, PRECAMBRIAN RES, V155, P287, DOI 10.1016/j.precamres.2007.02.008; Zhao GC, 2001, PRECAMBRIAN RES, V107, P45, DOI 10.1016/S0301-9268(00)00154-6; Meert JG, 2012, GONDWANA RES, V21, P987, DOI 10.1016/j.gr.2011.12.002; Wang W, 2012, PRECAMBRIAN RES, V222, P290, DOI 10.1016/j.precamres.2011.10.023; Liu SW, 2006, PRECAMBRIAN RES, V148, P205, DOI 10.1016/j.precamres.2006.04.003; Santosh M, 2012, PRECAMBRIAN RES, V222, P77, DOI 10.1016/j.precamres.2011.05.003; Wang W, 2015, GONDWANA RES, V27, P300, DOI 10.1016/j.gr.2013.10.004; Yang KF, 2011, TECTONOPHYSICS, V498, P1, DOI 10.1016/j.tecto.2010.11.015; [Anonymous], 2013, GEOSCI FRONT, DOI DOI 10.1016/j.gsf.2013.05.004; Shellnutt JG, 2012, INT J EARTH SCI, V101, P3, DOI 10.1007/s00531-010-0636-9; [Anonymous], 2001, GEOLOGICAL SOC AM SP; Soderlund U, 2005, CONTRIB MINERAL PETR, V150, P174, DOI 10.1007/s00410-005-0011-1; Wang W, 2013, LITHOS, V162, P175, DOI 10.1016/j.lithos.2013.01.005; Hoek JD, 1995, PRECAMBRIAN RES, V75, P121, DOI 10.1016/0301-9268(95)00033-X; Yoshida M, 2011, EARTH-SCI REV, V105, P1, DOI 10.1016/j.earscirev.2010.12.002; Gower CF, 2002, CAN J EARTH SCI, V39, P795, DOI 10.1139/E01-090; Andersen T, 2002, CHEM GEOL, V192, P59, DOI 10.1016/S0009-2541(02)00195-X; Nance RD, 2014, GONDWANA RES, V25, P4, DOI 10.1016/j.gr.2012.12.026; Guo JH, 2002, J METAMORPH GEOL, V20, P741, DOI 10.1046/j.1525-1314.2002.00401.x; Condie KC, 2002, GONDWANA RES, V5, P41, DOI 10.1016/S1342-937X(05)70886-8; Torsvik TH, 1996, EARTH-SCI REV, V40, P229, DOI 10.1016/0012-8252(96)00008-6; Wang W, 2011, GONDWANA RES, V20, P64, DOI 10.1016/j.gr.2011.02.012; Pearce JA, 2008, LITHOS, V100, P14, DOI 10.1016/j.lithos.2007.06.016; Guo RR, 2013, GONDWANA RES, V24, P664, DOI 10.1016/j.gr.2012.12.025; Liu SW, 2002, PRECAMBRIAN RES, V117, P41, DOI 10.1016/S0301-9268(02)00063-3; Yuan HL, 2004, GEOSTAND GEOANAL RES, V28, P353, DOI 10.1111/j.1751-908X.2004.tb00755.x; Lu SN, 2008, PRECAMBRIAN RES, V160, P77, DOI 10.1016/j.precamres.2007.04.017; Wilde SA, 2002, GONDWANA RES, V5, P85, DOI 10.1016/S1342-937X(05)70892-3; Wan YS, 2012, PRECAMBRIAN RES, V222, P265, DOI 10.1016/j.precamres.2011.05.001; FREY FA, 1978, EARTH PLANET SC LETT, V38, P129, DOI 10.1016/0012-821X(78)90130-9; Li XH, 2003, PRECAMBRIAN RES, V122, P45, DOI 10.1016/S0301-9268(02)00207-3; Donnadieu Y, 2004, NATURE, V428, P303, DOI 10.1038/nature02408; Liu SW, 2004, PRECAMBRIAN RES, V130, P229, DOI 10.1016/j.precamres.2003.12.001; Rogers JJW, 2002, GONDWANA RES, V5, P5, DOI 10.1016/S1342-937X(05)70883-2; Liu SW, 2005, J ASIAN EARTH SCI, V24, P643, DOI 10.1016/j.jseaes.2003.10.010; Regelous M, 2003, J PETROL, V44, P113, DOI 10.1093/petrology/44.1.113; Xu YG, 2001, LITHOS, V58, P145, DOI 10.1016/S0024-4937(01)00055-X; Liu SW, 2012, PRECAMBRIAN RES, V222, P173, DOI 10.1016/j.precamres.2011.07.006; Dalziel IWD, 2000, J GEOL, V108, P499, DOI 10.1086/314418; Zhai MG, 2013, GONDWANA RES, V24, P275, DOI 10.1016/j.gr.2013.02.007; Evans DAD, 2011, GEOLOGY, V39, P443, DOI 10.1130/G31654.1; Jourdan F, 2007, J PETROL, V48, P1043, DOI 10.1093/petrology/egm010; Li ZX, 2008, PRECAMBRIAN RES, V160, P179, DOI 10.1016/j.precamres.2007.04.021; HOFFMAN PF, 1991, SCIENCE, V252, P1409, DOI 10.1126/science.252.5011.1409; Miller RR, 1997, PRECAMBRIAN RES, V81, P67, DOI 10.1016/S0301-9268(96)00024-1; Griffin WL, 2000, GEOCHIM COSMOCHIM AC, V64, P133, DOI 10.1016/S0016-7037(99)00343-9; DePaolo DJ, 2000, CHEM GEOL, V169, P157, DOI 10.1016/S0009-2541(00)00261-8; Pirajno F, 2012, ORE GEOL REV, V48, P2, DOI 10.1016/j.oregeorev.2012.04.007; Ernst RE, 2013, PRECAMBRIAN RES, V230, P103, DOI 10.1016/j.precamres.2013.01.010; Fitzsimons ICW, 2000, GEOLOGY, V28, P879, DOI 10.1130/0091-7613(2000)028<0879:GABPIE>2.3.CO;2; Zhao GC, 2012, PRECAMBRIAN RES, V222, P55, DOI 10.1016/j.precamres.2012.09.016; Xiao WJ, 2010, GONDWANA RES, V18, P253, DOI 10.1016/j.gr.2010.01.007; Wang W, 2013, PRECAMBRIAN RES, V224, P184, DOI 10.1016/j.precamres.2012.09.019; Chen LW, 2013, PRECAMBRIAN RES, V228, P36, DOI 10.1016/j.precamres.2013.01.011; Zhao TP, 2009, LITHOS, V113, P673, DOI 10.1016/j.lithos.2009.07.002; BlichertToft J, 1997, EARTH PLANET SC LETT, V148, P243, DOI 10.1016/S0012-821X(97)00040-X; Zhao GC, 1999, GEOL MAG, V136, P223, DOI 10.1017/S001675689900254X; Liu DY, 2008, AM J SCI, V308, P200, DOI 10.2475/03.2008.02; Corfu F, 2003, REV MINERAL GEOCHEM, V53, P469, DOI 10.2113/0530469; Baragar WRA, 1996, J PETROL, V37, P317, DOI 10.1093/petrology/37.2.317; Zhao GC, 2009, GONDWANA RES, V16, P170, DOI 10.1016/j.gr.2009.02.004; Zhang SH, 2009, EARTH PLANET SC LETT, V288, P588, DOI 10.1016/j.epsl.2009.10.023; Bryan SE, 2008, EARTH-SCI REV, V86, P175, DOI 10.1016/j.earscirev.2007.08.008; Santosh M, 2010, PRECAMBRIAN RES, V178, P149, DOI 10.1016/j.precamres.2010.02.003; Guo JH, 2012, PRECAMBRIAN RES, V222, P124, DOI 10.1016/j.precamres.2011.07.020; Peng P, 2008, LITHOS, V101, P260, DOI 10.1016/j.lithos.2007.07.006; Condie KC, 1998, EARTH PLANET SC LETT, V163, P97, DOI 10.1016/S0012-821X(98)00178-2; Zhao GC, 2005, PRECAMBRIAN RES, V136, P177, DOI 10.1016/j.precamres.2004.10.002; Hu ZC, 2012, J ANAL ATOM SPECTROM, V27, P1391, DOI 10.1039/c2ja30078h; Pesonen LJ, 2003, TECTONOPHYSICS, V375, P289, DOI 10.1016/S0040-1951(03)00343-3; Bahat A.E., 2013, LITHOS, V174, P85; BENNETT VC, 2003, TREATISE GEOCHEMISTR, V2, P493, DOI DOI 10.1016/B0-08-043751-6/02013-2; Deng H, 2013, LITHOS, V175, P193, DOI 10.1016/j.lithos.2013.05.007; WINCHESTER JA, 1976, EARTH PLANET SC LETT, V28, P459, DOI 10.1016/0012-821X(76)90207-7; [高林志 GAO Linzhi], 2008, [地球学报, Acta Geoscientia Sinica], V29, P366; Hoffman F. P., 1989, GEOLOGY, V17, P135; [侯贵廷 Hou Guiting], 2005, [岩石矿物学杂志, Acta Petrologica et Mineralogica], V24, P179; Ludwig K. R., 2003, SPECIAL PUBLICATION, V4; Meert J.G., 2014, GEOSCIENCE FRONTIERS; Murphy JB, 2003, GEOLOGY, V31, P873, DOI 10.1130/G19668.1; [裴福萍 Pei Fuping], 2013, [吉林大学学报. 地球科学版, Journal of Jilin University. Earth Science Edition], V43, P110; Peng TP, 2013, PRECAMBRIAN RES, V235, P190, DOI 10.1016/j.precamres.2013.06.013; Pisarevsky SA, 2003, GEOPHYS J INT, V155, pF6, DOI 10.1046/j.1365-246X.2003.02074.x; ROMER RL, 1995, CAN J EARTH SCI, V32, P1401, DOI 10.1139/e95-113; Soderlund U, 2004, EARTH PLANET SC LETT, V219, P311, DOI 10.1016/S0012-821X(04)00012-3; Sun S. S., 1989, MAGMATISM OCEAN BASI, V42, P313, DOI DOI 10.1144/GSL.SP.1989.042.01.19; Taylor S., 1985, CONTINENTAL CRUST IT; Van Achterbergh E., 2001, SHORT COURSE SERIES, V29, P239	95	4	4	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1342-937X	1878-0571		GONDWANA RES	Gondwana Res.	JUN	2015	27	4					1407	1418		10.1016/j.gr.2014.02.002		12	Geosciences, Multidisciplinary	Geology	CI8LW	WOS:000355024800006		
J	Sakamoto, N; Kawamura, Y; Sato, N; Nimura, A; Matsuki, M; Yamauchi, A; Kanno, T; Tanabe, Y; Takeuchi, T; Natori, S; Saijo, Y; Aburano, T; Hasebe, N				Sakamoto, Naka; Kawamura, Yuichiro; Sato, Nobuyuki; Nimura, Asami; Matsuki, Motoki; Yamauchi, Atsushi; Kanno, Takayasu; Tanabe, Yasuko; Takeuchi, Toshiharu; Natori, Shunsuke; Saijo, Yasuaki; Aburano, Tamio; Hasebe, Naoyuki			Late gadolinium enhancement on cardiac magnetic resonance represents the depolarizing and repolarizing electrically damaged foci causing malignant ventricular arrhythmia in hypertrophic cardiomyopathy	HEART RHYTHM			English	Article						Cardiac magnetic resonance; Late gadolinium enhancement; Hypertrophic cardiomyopathy; Ventricular tachycardia	T-WAVE ALTERNANS; QUANTITATIVE-ANALYSIS; SUDDEN-DEATH; DISEASE; TACHYCARDIA; ACTIVATION; SUBSTRATE; FIBROSIS; ABLATION; EVENTS	BACKGROUND The presence of a myocardial scar detected by late gadolinium enhancement (LGE) on cardiac magnetic resonance (CMR) has been described as a predictor of all-cause mortality in hypertrophic cardiomyopathy (HCM). However, the detailed spatial relationship between LGE site and electrical abnormality is unclear in high-risk HCM with malignant arrhythmia. OBJECTIVE The purpose of this study was to elucidate the detailed relationship between the site on CMR imaging and the electrically damaged site, a potential origin of ventricular arrhythmias in patients with HCM. METHODS Fifty consecutive HCM patients underwent contrast-enhanced CMR. Of those patients, 18 patients with ventricular tachycardia underwent electrophysiology study including endocardial mapping of the left ventricle (LV). The LGE area was calculated at 12 different LV sites: anterior, lateral, posterior, and septal segments of the basal, middle, and apical portions. At each LV site, the bipolar electrogram, effective refractory period (ERP), and monophasic action potential were recorded. RESULTS LGE-positive segments demonstrated a significantly lower amplitude (4.0 +/- 2.8 mV vs 7.3 +/- 3.6 mV; P<.001), longer duration (54.7 +/- 17.8 vs 40.6 +/- 7.8 ms; P<.001), longer ERP (320 t 42 ms vs 284 +/- 37 ms; P=.001), and longer monophasic action potential duration measured at 900/, repolarization (321 +/- 19 ms vs 283 +/- 25 ms; P<.001) than did LGE-negative segments. The LGE area negatively correlated with the amplitude (r = 0.59; P<.001) and positively correlated with the duration (r = 0.64; P<.001), ERP (r = 0.44; P<.001), and action potential duration measured at 900/0 repolarization (r = 0.63; P<.001). All the observed VTs originated from LGE-positive segments. CONCLUSION The spatial distribution of LGE significantly correlates with depolarizing and repolarizing electrical damage in highrisk HCM with malignant ventricular arrhythmia.	[Sakamoto, Naka; Kawamura, Yuichiro; Sato, Nobuyuki; Nimura, Asami; Matsuki, Motoki; Yamauchi, Atsushi; Kanno, Takayasu; Tanabe, Yasuko; Takeuchi, Toshiharu; Hasebe, Naoyuki] Asahikawa Med Univ, Dept Cardiol, Asahikawa, Hokkaido 0788510, Japan; [Natori, Shunsuke] Furano Hosp, Dept Cardiol, Furano, Hokkaido, Japan; [Saijo, Yasuaki] Asahikawa Med Univ, Dept Hlth Sci, Div Community Med & Epidemiol, Asahikawa, Hokkaido, Japan; [Aburano, Tamio] Asahikawa Med Univ, Dept Radiol, Asahikawa, Hokkaido, Japan	Sato, N (reprint author), Asahikawa Med Univ, Dept Cardiol, Midorigaoka Higashi 2-1-1, Asahikawa, Hokkaido 0788510, Japan.	nsato@asahikawa-med.ac.jp					Adabag AS, 2008, J AM COLL CARDIOL, V51, P1369, DOI 10.1016/j.jacc.2007.11.071; DEBAKKER JMT, 1993, CIRCULATION, V88, P915; Moon JCC, 2004, J AM COLL CARDIOL, V43, P2260, DOI 10.1016/j.jacc.2004.03.035; Varnava AM, 2000, HEART, V84, P476, DOI 10.1136/heart.84.5.476; Soejima K, 2004, J AM COLL CARDIOL, V43, P1834, DOI 10.1016/j.jacc.2004.01.029; MARON BJ, 1981, CIRCULATION, V63, P882; Bruder O, 2010, J AM COLL CARDIOL, V56, P875, DOI 10.1016/j.jacc.2010.05.007; Hunold P, 2005, AM J ROENTGENOL, V184, P1420; Moon JCC, 2003, J AM COLL CARDIOL, V41, P1561, DOI 10.1016/S0735-1097(03)00189-X; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; Leonardi S, 2009, EUR HEART J, V30, P2003, DOI 10.1093/eurheartj/ehp152; Inada K, 2011, J CARDIOVASC ELECTR, V22, P41, DOI 10.1111/j.1540-8167.2010.01875.x; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Kallianos K, 2015, MAGN RESON IMAGING C, V23, P89, DOI 10.1016/j.mric.2014.09.004; Kuroda N, 2002, CIRC J, V66, P457, DOI 10.1253/circj.66.457; Maron Barry J., 2003, Journal of the American College of Cardiology, V42, P1687, DOI 10.1016/S0735-1097(03)00941-0; Puntmann VO, 2010, CIRC J, V74, P531, DOI 10.1253/circj.CJ-09-0723; Satoh H, 2014, WORLD J CARDIOL, V26, P585; SAUMAREZ RC, 1992, CIRCULATION, V86, P467; Saumarez RC, 2003, CIRCULATION, V107, P2595, DOI 10.1161/01.CIR.0000068342.96569.A1; Schumacher B, 2005, CIRCULATION, V112, P2096, DOI 10.1161/CIRCULATIONAHA.104.515643; Swynghedauw B, 2003, J MOL MED-JMM, V81, P336, DOI 10.1007/s00109-003-0437-8; TANAKA M, 1986, BRIT HEART J, V55, P575; Trzos E, 2011, ANN NONINVAS ELECTRO, V16, P276, DOI 10.1111/j.1542-474X.2011.00443.x	24	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	JUN	2015	12	6					1276	1284				9	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5TF	WOS:000354821900028		
J	Shimizu, W				Shimizu, Wataru			Where does heterogeneity exist in ventricular tachyarrhythmias?	HEART RHYTHM			English	Editorial Material							LONG-QT-SYNDROME; TORSADE-DE-POINTES; EARLY AFTERDEPOLARIZATIONS; CANINE VENTRICLE; CARDIAC MEMORY; ELECTRICAL HETEROGENEITY; LQT3 MODELS; M-CELLS; REPOLARIZATION; CONTRIBUTES		[Shimizu, Wataru] Nippon Med Sch, Dept Cardiovasc Med, Tokyo 1138603, Japan	Shimizu, W (reprint author), Nippon Med Sch, Grad Sch Med, Dept Cardiovasc Med, Bunkyo Ku, 1-1-5 Sendagi, Tokyo 1138603, Japan.	wshimizu@nms.ac.jp					Shimizu W, 2000, J AM COLL CARDIOL, V35, P778, DOI 10.1016/S0735-1097(99)00582-3; ROSENBAUM MB, 1982, AM J CARDIOL, V50, P213, DOI 10.1016/0002-9149(82)90169-2; SICOURI S, 1991, CIRC RES, V68, P1729; ANTZELEVITCH C, 1991, CIRC RES, V69, P1427; Shvilkin A, 1998, CIRCULATION, V97, P1810; Qi DT, 2015, HEART RHYTHM, V12, P1295, DOI 10.1016/j.hrthm.2015.02.013; ElSherif N, 1996, CIRC RES, V79, P474; BRACHMANN J, 1983, CIRCULATION, V68, P846; Callans D., 2009, CARDIAC ELECTROPHYSI, V5th, P669; COSTARDJACKLE A, 1989, CIRCULATION, V80, P1412; Kurita T, 1996, JPN CIRC J, V60, P189, DOI 10.1253/jcj.60.189; LIU DW, 1995, CIRC RES, V76, P351; Noda T, 2004, EUR HEART J, V25, P2149, DOI 10.1016/j.ehj.2004.08.020; SHIMIZU W, 1991, CIRCULATION, V84, P1915; Shimizu W, 1999, J ELECTROCARDIOL, V32, P177, DOI 10.1016/S0022-0736(99)90077-8; Shimizu W, 1997, CIRCULATION, V96, P2038; SURAWICZ B, 1989, J AM COLL CARDIOL, V14, P172; VOS MA, 1995, CIRCULATION, V91, P864; Zygmunt AC, 2000, AM J PHYSIOL-HEART C, V278, pH1671; Zygmunt AC, 2001, AM J PHYSIOL-HEART C, V281, pH689	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	JUN	2015	12	6					1304	1305		10.1016/j.hrthm.2015.02.034		2	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5TF	WOS:000354821900032		
J	Yamamoto, T; Shimano, M; Inden, Y; Takefuji, M; Yanagisawa, S; Yoshida, N; Tsuji, Y; Hirai, M; Murohara, T				Yamamoto, Toshihiko; Shimano, Masayuki; Inden, Yasuya; Takefuji, Mikito; Yanagisawa, Satoshi; Yoshida, Naoki; Tsuji, Yukiomi; Hirai, Makoto; Murohara, Toyoaki			Alogliptin, a dipeptidyl peptidase-4 inhibitor, regulates the atrial arrhythmogenic substrate in rabbits	HEART RHYTHM			English	Article						Atrial fibrillation; DPP-4 inhibitor; Atrial arrhythmogenic substrate; Atrial fibrosis; Atrial neovascularization	CONGESTIVE-HEART-FAILURE; FIBRILLATION SUBSTRATE; FIBROSIS; INFLAMMATION; DOGS; DYSFUNCTION; MECHANISMS; PROMOTION; OUTCOMES; MODEL	BACKGROUND Dipeptidyl peptidase-4 (DPP-4) inhibitors were recently reported to have cardioprotective effects via amelioration of ventricular function. However, the role of DPP-4 inhibition in atrial remodeling, especially of the arrhythmogenic substrate, remains unclear. OBJECTIVE We investigated the effects of a DPP-4 inhibitor, alogliptin, on atrial fibrillation (AF) in a rabbit model of heart failure caused by ventricular tachypacing (VIP). METHODS Rabbits subjected to VIP at 380 bpm for 1 or 3 weeks, with or without alogliptin treatment, were assessed using echocardiography, electrophysiology, histology, and immunobLotting and compared with nonpaced animals. RESULTS VIP rabbits exhibited increased duration of atrial burst pacing-induced AF, whereas administration of alogliptin shortened this duration by 730/o. The extent of atrial fibrosis after VIP was reduced by 39% in the alogliptin-treated group. VIP rabbits treated with alogliptin displayed a 1.6-fold increase in left atrial myocardial capillary density compared with nontreated rabbits. A 2-fold increase in endothelial nitric oxide synthase (eNOS) phosphorylation was observed in the Left atrium of alogliptin-treated rabbits compared with nontreated rabbits. Moreover, a nitric oxide synthase inhibitor (r-nitro-L-arginine methyl ester) blocked the beneficial effects of alogliptin on AF duration, fibrosis, and capillary density. CONCLUSION Alogliptin shortened the duration of AF caused by VIP-induced fibrotic atrial tissue by augmenting atrial angiogenesis and activating eNOS. Our findings suggest that DPP-4 inhibitors may be useful in the prevention of heart failure-induced AF.	[Yamamoto, Toshihiko; Shimano, Masayuki; Inden, Yasuya; Takefuji, Mikito; Yanagisawa, Satoshi; Yoshida, Naoki; Murohara, Toyoaki] Nagoya Univ, Grad Sch Med, Dept Cardiol, Nagoya, Aichi 4668550, Japan; [Shimano, Masayuki] Nagoya First Red Cross Hosp, Nagoya, Aichi, Japan; [Tsuji, Yukiomi] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 852, Japan; [Hirai, Makoto] Nagoya Univ, Grad Sch Hlth Sci, Nagoya, Aichi 4668550, Japan	Shimano, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Cardiol, Showa Ku, 65 Tsurumai, Nagoya, Aichi 4668550, Japan.	mshimano@med.nagoya-u.ac.jp	Murohara, Toyoaki/M-4958-2014; Yanagisawa, Satoshi/Q-1723-2015				Feng J, 2007, J MED CHEM, V50, P2297, DOI 10.1021/jm0701041; Wang TJ, 2003, CIRCULATION, V107, P2920, DOI 10.1161/01.CIR.0000072767.89944.6E; Kitamura K, 2011, AM J PHYSIOL-HEART C, V300, pH1814, DOI 10.1152/ajpheart.00771.2010; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Li DS, 2001, CIRCULATION, V104, P2608, DOI 10.1161/hc4601.099402; Christopher R, 2008, CLIN THER, V30, P513, DOI 10.1016/j.clinthera.2008.03.005; Ishii M, 2014, J BIOL CHEM, V289, P27235, DOI 10.1074/jbc.M114.557835; Kazakov A, 2013, CARDIOVASC RES, V100, P211, DOI 10.1093/cvr/cvt181; Burstein B, 2008, J AM COLL CARDIOL, V51, P802, DOI 10.1016/j.jacc.2007.09.064; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; GALLAGHER JJ, 1985, J AM COLL CARDIOL, V6, P1172; Du X, 2009, EUR HEART J, V30, P1128, DOI 10.1093/eurheartj/ehp055; Sauve M, 2010, DIABETES, V59, P1063, DOI 10.2337/db09-0955; Scirica BM, 2013, NEW ENGL J MED, V369, P1317, DOI 10.1056/NEJMoa1307684; Allessie M, 2002, CARDIOVASC RES, V54, P230, DOI 10.1016/S0008-6363(02)00258-4; Dobrian AD, 2011, AM J PHYSIOL-ENDOC M, V300, pE410, DOI 10.1152/ajpendo.00463.2010; Aksnes TA, 2008, AM J CARDIOL, V101, P634, DOI 10.1016/j.amjcard.2007.10.025; Kumagai K, 2004, CARDIOVASC RES, V62, P105, DOI 10.1016/j.cardiores.2004.01.018; Shah Z, 2011, VASC PHARMACOL, V55, P2, DOI 10.1016/j.vph.2011.03.001; Li DS, 1999, CIRCULATION, V100, P87; Shigeta T, 2012, CIRCULATION, V126, P1838, DOI 10.1161/CIRCULATIONAHA.112.096479; Shimano M, 2008, HEART RHYTHM, V5, P451, DOI 10.1016/j.hrthm.2007.12.010; Feng J, 2008, J MED CHEM, V51, P43571; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Mountantonakis SE, 2012, CIRC-HEART FAIL, V5, P191, DOI 10.1161/CIRCHEARTFAILURE.111.965681; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shimano M, 2010, J MOL CELL CARDIOL, V49, P210, DOI 10.1016/j.yjmcc.2010.02.021; Shinagawa K, 2002, CIRCULATION, V105, P2672, DOI 10.1161/01.CIR.0000016826.62813.F5; Sonia Z, 2013, BIOCHEM PHARMACOL, V85, P937; Tsuji Y, 2002, CIRCULATION, V106, P2012, DOI 10.1161/01.CIR.0000031160.86313.24	32	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1547-5271	1556-3871		HEART RHYTHM	Heart Rhythm	JUN	2015	12	6					1362	1369				8	Cardiac & Cardiovascular Systems	Cardiovascular System & Cardiology	CI5TF	WOS:000354821900040		
J	Kamada, T; Haruma, K; Ito, M; Inoue, K; Manabe, N; Matsumoto, H; Kusunoki, H; Hata, J; Yoshihara, M; Sumii, K; Akiyama, T; Tanaka, S; Shiotani, A; Graham, DY				Kamada, Tomoari; Haruma, Ken; Ito, Masanori; Inoue, Kazuhiko; Manabe, Noriaki; Matsumoto, Hiroshi; Kusunoki, Hiroaki; Hata, Jiro; Yoshihara, Masaharu; Sumii, Koji; Akiyama, Takashi; Tanaka, Shinji; Shiotani, Akiko; Graham, David Y.			Time Trends in Helicobacter pylori Infection and Atrophic Gastritis Over 40Years in Japan	HELICOBACTER			English	Article						Gastric atrophy; intestinal metaplasia; smoking; salt intake; Helicobacter pylori; gastric cancer	UNIDENTIFIED CURVED BACILLI; INTESTINAL METAPLASIA; DUODENAL-ULCER; REFLUX ESOPHAGITIS; GASTROINTESTINAL-DISEASES; VIRULENCE FACTORS; CANCER INCIDENCE; PEPTIC-ULCER; PREVALENCE; POPULATION	BackgroundHelicobacter pylori infection produces progressive mucosal damage that may eventually result in gastric cancer. We studied the changes that occurred in the presence and severity of atrophic gastritis and the prevalence of H.pylori infection that occurred coincident with improvements in economic and hygienic conditions in Japan since World War II. Materials and MethodsThe prevalence of H.pylori infection and histologic grades of gastric damage were retrospectively evaluated using gastric biopsy specimens obtained over a 40-year period. Gastric atrophy and intestinal metaplasia were scored using the updated Sydney classification system. ResultsThe prevalence of H.pylori and severity of atrophy were examined in 1381 patients including 289 patients examined in the 1970s (158 men; mean age, 44.9years), 787 in the 1990s (430 men; 44.2years), and 305 in the 2010s (163 men; 53.2years). Overall, the prevalence of H.pylori infection decreased significantly from 74.7% (1970s) to 53% (1990s) and 35.1% (2010s) (p<.01). The prevalence of atrophy in the antrum and corpus was significantly lower in the 2010s (33, 19%, respectively) compared to those evaluated in either the 1970s (98, 82%) (p<.001) or 1990s (80, 67%) (p<.001). The severity of atrophy and intestinal metaplasia also declined remarkably among those with H.pylori infection. ConclusionsThere has been a progressive and rapid decline in the prevalence of H.pylori infection as well a fall in the rate of progression of gastric atrophy among H.pylori-infected Japanese coincident with the westernization and improvements in economic and hygienic conditions in Japan since World War II.	[Kamada, Tomoari; Haruma, Ken; Matsumoto, Hiroshi; Shiotani, Akiko] Kawasaki Med Univ, Div Gastroenterol, Dept Internal Med, Kurashiki, Okayama 7010192, Japan; [Ito, Masanori] Hiroshima Univ, Dept Gastroenterol & Metab, Grad Sch Biomed Sci, Hiroshima, Japan; [Inoue, Kazuhiko; Kusunoki, Hiroaki] Kawasaki Med Univ, Dept Gen Med, Kurashiki, Okayama 7010192, Japan; [Manabe, Noriaki; Hata, Jiro] Kawasaki Med Univ, Div Endoscopy & Ultrasound, Dept Clin Pathol & Lab Med, Kurashiki, Okayama 7010192, Japan; [Yoshihara, Masaharu] Hiroshima Univ, Hlth Serv Ctr, Higashihiroshima 724, Japan; [Sumii, Koji] Saiseikai Hiroshima Hosp, Dept Internal Med, Hiroshima, Japan; [Akiyama, Takashi] Kawasaki Med Univ, Dept Pathol, Kurashiki, Okayama 7010192, Japan; [Tanaka, Shinji] Hiroshima Univ Hosp, Dept Endoscopy, Hiroshima, Japan; [Graham, David Y.] Michael E DeBakey VA Med Ctr, Dept Med, Houston, TX USA; [Graham, David Y.] Baylor Coll Med, Houston, TX 77030 USA	Kamada, T (reprint author), Kawasaki Med Univ, Div Gastroenterol, Dept Internal Med, Matsushima 577, Kurashiki, Okayama 7010192, Japan.	tkamada@med.kawasaki-m.ac.jp			Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service [R01 DK062813, DK56338]	Dr. Graham is supported in part by the Office of Research and Development Medical Research Service Department of Veterans Affairs, Public Health Service grants R01 DK062813 and DK56338 which funds the Texas Medical Center Digestive Diseases Center. The contents are solely the responsibility of the authors and do not necessarily represent the official views of the VA or NIH.	Shikata K, 2006, INT J CANCER, V119, P196, DOI 10.1002/ijc.21822; Tsai YC, 2013, ALIMENT PHARM THER, V37, P969, DOI 10.1111/apt.12291; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Matsunari O, 2012, J CLIN MICROBIOL, V50, P876, DOI 10.1128/JCM.05562-11; Shiota S, 2013, J DIGEST DIS, V14, P341, DOI 10.1111/1751-2980.12054; Valle J, 1996, SCAND J GASTROENTERO, V31, P546, DOI 10.3109/00365529609009126; MARSHALL BJ, 1984, LANCET, V1, P1311; Yang HB, 2009, AM J GASTROENTEROL, V104, P1642, DOI 10.1038/ajg.2009.172; Akamatsu T, 2011, J GASTROENTEROL, V46, P1353, DOI 10.1007/s00535-011-0450-6; Graham DY, 2014, WORLD J GASTROENTERO, V20, P5191, DOI 10.3748/wjg.v20.i18.5191; CORREA P, 1988, CANCER RES, V48, P3554; Marugame T, 2007, JPN J CLIN ONCOL, V37, P884, DOI 10.1093/jjco/hym112; Shiotani A, 2013, SEMIN CANCER BIOL, V23, P492, DOI 10.1016/j.semcancer.2013.07.004; Fujisawa T, 1999, AM J GASTROENTEROL, V94, P2094; Rugge M, 2011, WORLD J GASTROENTERO, V17, P4596, DOI 10.3748/wjg.v17.i41.4596; Furukawa N, 1999, J GASTROENTEROL, V34, P441, DOI 10.1007/s005350050293; Comfort MW, 1951, ANN INTERN MED, V36, P1331; Comfort MW, 1934, AM J SURG, V26, P447, DOI 10.1016/S0002-9610(34)90446-3; Correa P., 1995, Alimentary Pharmacology and Therapeutics, V9, P13; Fujiya K, 2014, DIGEST DIS SCI, V59, P631, DOI 10.1007/s10620-013-2961-x; GRAHAM DY, 1989, GASTROENTEROLOGY, V96, P615; Graham DY, 1997, GASTROENTEROLOGY, V113, P1983, DOI 10.1016/S0016-5085(97)70019-2; Haruma K, 1997, J CLIN GASTROENTEROL, V25, P583, DOI 10.1097/00004836-199712000-00006; IMAI T, 1983, CANCER, V52, P353, DOI 10.1002/1097-0142(19830715)52:2<353::AID-CNCR2820520229>3.0.CO;2-3; International Agency for Research on Cancer, 2012, BIOL AGENTS REV HU B, V100B, P385; International Agency for Research on Cancer, 1994, IARC MON EV CARC RIS, V61, P177; KEKKI M, 1984, SCAND J GASTROENTERO, V19, P382; KEKKI M, 1980, SCAND J GASTROENTERO, V15, P509; KEKKI M, 1990, GASTROEN CLIN BIOL, V14, P217; Kuipers EJ, 1996, NEW ENGL J MED, V334, P1018, DOI 10.1056/NEJM199604183341603; MARSHALL B J, 1984, Microbios Letters, V25, P83; Nakajima S, 2010, J GASTROEN HEPATOL, V25, pS99, DOI 10.1111/j.1440-1746.2009.06214.x; Nakamura M, 2002, DIGEST DIS SCI, V47, P675, DOI 10.1023/A:1017901110580; NOMURA A, 1982, J NATL CANCER I, V68, P401; Sahara S, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-223; Shinozaki K., 2010, Kawasaki Medical Journal, V36, P97; Shinozaki K, 2010, NUTR CANCER, V62, P1067, DOI 10.1080/01635581.2010.492086; SIPPONEN P, 1994, GUT, V35, P1167, DOI 10.1136/gut.35.9.1167; SIURALA M, 1972, BRIT MED J, V3, P530; SIURALA M, 1981, ANN CLIN RES, V13, P111; SIURALA M, 1966, Scandinavian Journal of Gastroenterology, V1, P40; Ueda J, 2014, HELICOBACTER, V19, P105, DOI 10.1111/hel.12110; VILLAKO K, 1981, ANN CLIN RES, V13, P114; WARREN JR, 1983, LANCET, V1, P1273	44	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1083-4389	1523-5378		HELICOBACTER	Helicobacter	JUN	2015	20	3					192	198		10.1111/hel.12193		7	Gastroenterology & Hepatology; Microbiology	Gastroenterology & Hepatology; Microbiology	CI1FL	WOS:000354488200005		
J	Kaneko, K; Kamimoto, K; Miyajima, A; Itoh, T				Kaneko, Kota; Kamimoto, Kenji; Miyajima, Atsushi; Itoh, Tohru			Adaptive remodeling of the biliary architecture underlies liver homeostasis	HEPATOLOGY			English	Article							PROGENITOR CELLS; STEM/PROGENITOR CELLS; EPITHELIAL-CELLS; PLASMID DNA; STEM-CELLS; HEPATOCYTES; REGENERATION; DISEASE; INJURY; MICE	Serving as the center for metabolism and detoxification, the liver is inherently susceptible to a wide variety of damage imposed by toxins or chemicals. Induction of cell populations with biliary epithelial phenotypes, which include progenitor-like cells and are referred to as liver progenitor cells, is often observed in histopathological examination of various liver diseases in both human patients and animal models and has been implicated in regeneration. However, the tissue dynamics underlying this phenomenon remains largely unclear. We have developed a simple imaging technique to reveal the global and fine-scale architecture of the biliary tract spreading in the mouse liver. Using this novel method, we show that the emergence and expansion of liver progenitor cells actually reflect structural transformation of the intrahepatic biliary tree in mouse liver injury models. The biliary branches expanded their area gradually and contiguously along with the course of chronic injury. Relevant regulatory signals known to be involved in liver progenitor cell regulation, including fibroblast growth factor 7 and tumor necrosis factor-like weak inducer of apoptosis, can modulate the dynamics of the biliary epithelium in different ways. Importantly, the structural transformations of the biliary tree were diverse and corresponded well with the parenchymal injury patterns. That is, when chronic hepatocyte damage was induced in the pericentral area, the biliary branches exhibited an extended structure from the periportal area with apparent tropism toward the distant injured area. Conclusion: The hepatobiliary system possesses a unique and unprecedented structural flexibility and can remodel dynamically and adaptively in response to various injury conditions; this type of tissue plasticity should constitute an essential component to maintain liver homeostasis. (Hepatology 2015;61:2056-2066)	[Kaneko, Kota; Kamimoto, Kenji; Miyajima, Atsushi; Itoh, Tohru] Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Tokyo 1130032, Japan	Itoh, T (reprint author), Univ Tokyo, Inst Mol & Cellular Biosci, Lab Cell Growth & Differentiat, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	itohru@iam.u-tokyo.ac.jp			National Institute of Child Health and Human Development	We thank Drs. Yuichiro Arima and Hiroki Kurihara for advice on ink injection and tissue clearing methods, Dr. Hinako M. Takase for pLIVE-Fgf7 and -Tweak constructs, and Dr. Tetsuya J. Kobayashi for comments on image data quantification. We also thank members of the Miyajima lab for helpful discussions and advice. The TROMA-III developed by Dr. Rolf Kemler was obtained from the Developmental Studies Hybridoma Bank developed under the auspices of the National Institute of Child Health and Human Development and maintained by The University of Iowa, Department of Biology, Iowa City, IA.	Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Jakubowski A, 2005, J CLIN INVEST, V115, P2330, DOI 10.1172/JCI23486; Roskams TA, 2004, HEPATOLOGY, V39, P1739, DOI 10.1002/hep.20130; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Furuyama K, 2011, NAT GENET, V43, P34, DOI 10.1038/ng.722; Wooddell CI, 2008, J GENE MED, V10, P551, DOI 10.1002/jgm.1179; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Itoh T, 2014, HEPATOLOGY, V59, P1617, DOI 10.1002/hep.26753; Espanol-Suner R, 2012, GASTROENTEROLOGY, V143, P1564, DOI 10.1053/j.gastro.2012.08.024; Lowes KN, 1999, AM J PATHOL, V154, P537, DOI 10.1016/S0002-9440(10)65299-6; Fausto N, 2004, HEPATOLOGY, V39, P1477, DOI 10.1002/hep.20214; Zhang GF, 1999, HUM GENE THER, V10, P1735, DOI 10.1089/10430349950017734; Sekiya S, 2012, J CLIN INVEST, V122, P3914, DOI 10.1172/JCI63065; Yanger K, 2013, GENE DEV, V27, P719, DOI 10.1101/gad.207803.112; Tarlow BD, 2014, HEPATOLOGY, V60, P278, DOI 10.1002/hep.27084; Sackett SD, 2009, HEPATOLOGY, V49, P920, DOI 10.1002/hep.22705; Isse K, 2013, HEPATOLOGY, V57, P1632, DOI 10.1002/hep.26131; Sekiya S, 2014, AM J PATHOL, V184, P1468, DOI 10.1016/j.ajpath.2014.01.005; Takase HM, 2013, GENE DEV, V27, P169, DOI 10.1101/gad.204776.112; Michalopoulos GK, 2014, AM J PATHOL, V184, P1263, DOI 10.1016/j.ajpath.2014.02.020; Schaub JR, 2014, CELL REP, V8, P933, DOI 10.1016/j.celrep.2014.07.003; Kordes C, 2013, J CLIN INVEST, V123, P1874, DOI 10.1172/JCI66027; Yanger K, 2014, CELL STEM CELL, V15, P340, DOI 10.1016/j.stem.2014.06.003; Cardinal M, 2009, WOUND REPAIR REGEN, V17, P173, DOI 10.1111/j.1524-475X.2009.00464.x; Choi TY, 2014, GASTROENTEROLOGY, V146, P776, DOI 10.1053/j.gastro.2013.10.019; Ernst TM, 2014, J MAGN RESON IMAGING, V40, P1355, DOI 10.1002/jmri.24475; Fernandez-Garrido S, 2014, NANOTECHNOLOGY, V25; He JB, 2014, GASTROENTEROLOGY, V146, P789, DOI 10.1053/j.gastro.2013.11.045; Miyajima A, 2014, CELL STEM CELL, V14, P561, DOI 10.1016/j.stem.2014.04.010; Rodrigo-Torres D, 2014, HEPATOLOGY, V60, P1367, DOI 10.1002/hep.27078; Sparks EE, 2011, DIS MODEL MECH, V4, P359, DOI 10.1242/dmm.005793; Tarlow BD, 2014, CELL STEM CELL, V15, P605, DOI 10.1016/j.stem.2014.09.008; Uchihara T, 2002, EXP NEUROL, V178, P124, DOI 10.1006/exnr.2002.8028; Wang YX, 2014, ACAD RADIOL, V21, P472, DOI 10.1016/j.acra.2013.12.012; Yeoh GCT, 2007, HEPATOLOGY, V45, P486, DOI 10.1002/hep.21535	35	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0270-9139	1527-3350		HEPATOLOGY	Hepatology	JUN	2015	61	6					2056	2066		10.1002/hep.27685		11	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CI5UG	WOS:000354824700031		
J	Sasayama, D; Hori, H; Nakamura, S; Yamamoto, N; Hattori, K; Teraishi, T; Ota, M; Kunugi, H				Sasayama, D.; Hori, H.; Nakamura, S.; Yamamoto, N.; Hattori, K.; Teraishi, T.; Ota, M.; Kunugi, H.			Increased Protein and mRNA Expression of Resistin After Dexamethasone Administration	HORMONE AND METABOLIC RESEARCH			English	Article						microarray analysis; gene expression; single nucleotide polymorphism	DEPRESSED-PATIENTS; ADIPONECTIN; GLUCOCORTICOIDS; CONFER; BLOOD	Synthetic glucocorticoids such as dexamethasone are widely used to treat a variety of inflammatory and autoimmune conditions, but they may induce adverse events including hyperglycemia. To shed light on the effect and action mechanism of dexamethasone, we examined the alterations of gene expression levels caused by dexamethasone. Microarray analysis was performed on whole blood collected from 24 physically healthy subjects at baseline and after dexamethasone administration. The expression levels of resistin mRNA were found to be significantly increased after the dexamethasone administration. In a separate sample of 12 subjects, we examined plasma resistin protein levels and found that they were increased after dexamethasone administration. Furthermore, the plasma mRNA and protein levels of resistin were significantly higher in individuals who carried the A allele of RETN single nucleotide polymorphism rs3219175 than in those who did not carry the allele. There was no significant interaction between the genotype and dexamethasone administration. No significant correlation was found between plasma levels of cortisol and resistin. Consistent with previous studies, the genotype of RETN rs3219175 was a strong determinant of resistin levels. The present study showed that oral administration of dexamethasone increases the protein and mRNA levels of resistin irrespective of the rs3219175 genotype.	[Sasayama, D.; Hori, H.; Yamamoto, N.; Hattori, K.; Teraishi, T.; Ota, M.; Kunugi, H.] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, Kodaira, Tokyo 1878502, Japan; [Sasayama, D.] Shinshu Univ, Sch Med, Dept Psychiat, Matsumoto, Nagano 390, Japan; [Nakamura, S.] DNA Chip Res Inc, Yokohama, Kanagawa, Japan	Sasayama, D (reprint author), Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Mental Disorder Res, 4-1-1 Ogawahigashi, Kodaira, Tokyo 1878502, Japan.	sasayama@shinshu-u.ac.jp			Health and Labor Sciences Research Grants; Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan; Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP	This study was supported by Health and Labor Sciences Research Grants, the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Understanding of molecular and environmental bases for brain health) and Intramural Research Grant for Neurological and Psychiatric Disorders of NCNP (H.K.).	Ahlstrom M, 2009, STEROIDS, V74, P277, DOI 10.1016/j.steroids.2008.12.002; Czock D, 2005, CLIN PHARMACOKINET, V44, P61, DOI 10.2165/00003088-200544010-00003; Tsiotra PC, 2013, BIOMED RES INT, DOI 10.1155/2013/487081; Tanaka N, 2013, MOD RHEUMATOL, V23, P8, DOI 10.1007/s10165-012-0623-z; McDonough AK, 2008, CURR OPIN RHEUMATOL, V20, P131, DOI 10.1097/BOR.0b013e3282f51031; Seo JB, 2003, MOL ENDOCRINOL, V17, P1522, DOI 10.1210/me.2003-0028; Tokuyama Y, 2007, METABOLISM, V56, P693, DOI 10.1016/j.metabol.2006.12.019; Rulcova A, 2013, PHARMACOL REP, V65, P1322; Menke A, 2012, NEUROPSYCHOPHARMACOL, V37, P1455, DOI 10.1038/npp.2011.331; Galon J, 2002, FASEB J, V16, P61, DOI 10.1096/fj.01-0245com; Kaser S, 2003, BIOCHEM BIOPH RES CO, V309, P286, DOI 10.1016/j.bbrc.2003.07.003; Cheng XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060213; Gertz EM, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-566; Lehrke M, 2004, PLOS MED, V1, P161, DOI 10.1371/journals.pmed.0010045; Lewandowski KC, 2006, CLIN ENDOCRINOL, V65, P551, DOI 10.1111/j.1365-2265.2006.02638.x; Onum H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009718; Raff H, 2006, ENDOCRINE, V29, P341, DOI 10.1385/ENDO:29:2:341; Sasayama D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054967; Sasayama D, 2014, J PSYCHIATR RES, V50, P79, DOI 10.1016/j.jpsychires.2013.12.002; Schuld A, 2001, PSYCHONEUROENDOCRINO, V26, P65, DOI 10.1016/S0306-4530(00)00039-1; Weber-Hamann B, 2007, J PSYCHIAT RES, V41, P344, DOI 10.1016/j.jpsychires.2006.01.002	21	1	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0018-5043	1439-4286		HORM METAB RES	Horm. Metab. Res.	JUN	2015	47	6					433	438		10.1055/s-0034-1383651		6	Endocrinology & Metabolism	Endocrinology & Metabolism	CI6OY	WOS:000354881200006		
J	Suzuki, H; Yamamoto, Y				Suzuki, Hiroo; Yamamoto, Yuji			Robustness to temporal constraint explains expertise in ball-over-net sports	HUMAN MOVEMENT SCIENCE			English	Article						Attractor; Fractal dimension; Fractal transition; Motor control; Table tennis	DYNAMICAL-SYSTEMS; FRACTAL TRANSITION; PHASE-TRANSITIONS; ATTRACTORS; MOVEMENTS; VARIABILITY; DIMENSION; INPUTS; NOISE	The present study investigated motor expertise in interpersonal competitive ball-over-net sports in terms of a dynamical system with temporal input. In a theoretical framework, the behavior of the system is characterized by a fractal-like structure according to switching input, which changes uniquely according to the duration of input and internal parameter of the system. We investigated periodic movements, in which the player executed a forehand or backhand stroke repeatedly, and continuous switching movements, in which the player continuously switched between two movement patterns corresponding to hitting the ball under two ball directions and with six temporal constraint conditions during a table tennis rally. In the periodic movement, we observed two limit-cycle attractors corresponding to each direction in the phase space independent of temporal constraint or skill level. Conversely, in the continuous switching movement, a transition in trajectories between the two limit-cycle attractors was observed in the phase space, and this transition was characterized by a fractal-like structure. The fractal-like structure moved closer to the random structure as temporal constraint increased independent of skill level. However, the temporal constraint condition closest to the random structure was higher for the advanced players than for the novices, indicating that robustness to the temporal constraint was higher for the advanced players than for the novices. Our results suggest that motor expertise in interpersonal competitive ball-over-net sports is more robust to temporal constraints with various inputs. (C) 2015 The Authors. Published by Elsevier B.V.	[Suzuki, Hiroo] Nagoya Univ, Grad Sch Educ & Human Dev, Chikusa Ku, Nagoya, Aichi 4640814, Japan; [Yamamoto, Yuji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Chikusa Ku, Nagoya, Aichi 4640814, Japan	Suzuki, H (reprint author), Nagoya Univ, Grad Sch Educ & Human Dev, Chikusa Ku, Nagoya, Aichi 4640814, Japan.	hiroo@htc.nagoya-u.ac.jp			JSPS KAKENHI [20240060, 24240085, 26882038]	We thank members of the DSA project for helpful suggestions. The work was supported by JSPS KAKENHI Grant Nos. 20240060, 24240085, and 26882038.	Abernethy B., 2004, ANTICIPATORY BEHAV E; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Elliott B, 2006, BRIT J SPORT MED, V40, P392, DOI 10.1136/bjsm.2005.023150; Argyris J, 1998, CHAOS SOLITON FRACT, V9, P343, DOI 10.1016/S0960-0779(97)00120-3; HAKEN H, 1985, BIOL CYBERN, V51, P347, DOI 10.1007/BF00336922; Gohara K, 1999, FRACTALS, V7, P205, DOI 10.1142/S0218348X99000220; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; Davids K, 2003, SPORTS MED, V33, P245, DOI 10.2165/00007256-200333040-00001; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Gohara K, 1999, FRACTALS, V7, P313, DOI 10.1142/S0218348X99000311; Yamamoto Y, 2000, HUM MOVEMENT SCI, V19, P341, DOI 10.1016/S0167-9457(00)00018-X; BUCHANAN JJ, 1993, EXP BRAIN RES, V94, P131; GRASSBERGER P, 1983, PHYS LETT A, V97, P224, DOI 10.1016/0375-9601(83)90752-1; HENON M, 1976, COMMUN MATH PHYS, V50, P69, DOI 10.1007/BF01608556; Hodges N. J., 2006, EXPERT PERFORMANCE S; KELSO JAS, 1984, AM J PHYSIOL, V246, P1000; Mandelbrot B, 1977, FRACTAL GEOMETRY NAT; Meinel K., 1960, BEWEGUNGSLEHRE; Nishikawa J, 2008, INT J BIFURCAT CHAOS, V18, P3665; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Strogatz S, 2001, NONLINEAR DYNAMICS C; Wada R, 2001, INT J BIFURCAT CHAOS, V11, P755, DOI 10.1142/S0218127401002602; Wickstrom R L, 1975, Exerc Sport Sci Rev, V3, P163; Winter D., 1990, BIOMECHANICS MOTOR C; YAMADA N, 1995, HUM MOVEMENT SCI, V14, P371, DOI 10.1016/0167-9457(95)00018-N; Yuza N., 1992, INTERNATIONAL JOURNA, V1, P79	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	JUN	2015	41						193	206		10.1016/j.humov.2015.02.009		14	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Neurosciences & Neurology; Psychology; Sport Sciences	CI8RH	WOS:000355038900016		
J	Yu, B; Yang, LQ; Ishii, H; Mukherjee, S				Yu, Bo; Yang, Liuqing; Ishii, Hiroyuki; Mukherjee, Sayandev			Dynamic TDD Support in Macrocell-Assisted Small Cell Architecture	IEEE JOURNAL ON SELECTED AREAS IN COMMUNICATIONS			English	Article						Dynamic TDD; small cell; interference coordination; stochastic geometry	WIRELESS NETWORKS; INTERFERENCE; SYSTEMS; LTE	Dynamic allocation of subframes to uplink (UL) or downlink (DL) in time division duplex (TDD), termed 'Dynamic TDD,' has been studied by the 3rd Generation Partnership Project (3GPP) since the Long Term Evolution (LTE) Release 11 time-frame. At the same time, 3GPP is also standardizing macrocell-assisted small cell heterogeneous architectures for inclusion in LTE Release 12 as a solution offering high data rate to user terminals (UEs) along with high system capacity through spatial reuse of spectrum. In this paper, we focus on a particular small cell architecture proposed by DOCOMO, known as the Phantom Cell architecture, which provides the option to support dynamic TDD. For an arbitrarily-located UE in a small cell network, we apply results from stochastic geometry to derive expressions for the distribution of DL signal to interference plus noise ratio (SINR) at an arbitrary UE and the distribution of UL SINR at its serving base station (BS). The analytical results are verified by system level simulations. These results can be used to study aspects of system design for small cells, and the sensitivity of SINR to the extent of synchronization across small cells employing dynamic TDD. In order to deal with the severe inter-cell interference (ICI) problem in dynamic TDD, we further propose a frequency domain interference coordination technique. Finally, system level simulations based on more realistic system models and assumptions are conducted to evaluate the performance of dynamic TDD systems and the proposed interference coordination technique.	[Yu, Bo; Yang, Liuqing] Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA; [Ishii, Hiroyuki] NTT DOCOMO Inc, Tokyo 1006150, Japan; [Mukherjee, Sayandev] DOCOMO Innovat Inc, Palo Alto, CA 94304 USA	Yu, B (reprint author), Colorado State Univ, Dept Elect & Comp Engn, Ft Collins, CO 80523 USA.	bo.yu@colostate.edu; lqyang@engr.colostate.edu; ishiihiro@nttdocomo.com; smukherjee@docomoinnovations.com	Yu, Bo/N-3380-2015				3GPP, 2010, 8642D43GPP TR, V3rd; 3GPP, 2010, 36814 3GPP TR; 3GPP, 2010, 36213 3GPP TS; Al-Rawi M, 2011, 2011 IEEE 22ND INTERNATIONAL SYMPOSIUM ON PERSONAL INDOOR AND MOBILE RADIO COMMUNICATIONS (PIMRC), P1590, DOI 10.1109/PIMRC.2011.6139772; [Anonymous], 2012, 36101 3GPP TS; Yu B, 2012, IEEE GLOBE WORK, P585; Andrews JG, 2011, IEEE T COMMUN, V59, P3122, DOI 10.1109/TCOMM.2011.100411.100541; Andrews JG, 2010, IEEE COMMUN MAG, V48, P156, DOI 10.1109/MCOM.2010.5621983; Omiyi P, 2007, IEEE T WIREL COMMUN, V6, P2721, DOI 10.1109/TWC.2007.05975; ElSawy H, 2013, IEEE COMMUN SURV TUT, V15, P996, DOI 10.1109/SURV.2013.052213.00000; Shen ZK, 2012, IEEE COMMUN MAG, V50, P51; Lee CH, 2012, IEEE T WIREL COMMUN, V11, P1392, DOI 10.1109/TWC.2012.021512.110131; Mukherjee S, 2012, IEEE J SEL AREA COMM, V30, P575, DOI 10.1109/JSAC.2012.120407; Foss SG, 1996, ADV APPL PROBAB, V28, P965, DOI 10.2307/1428159; Ishii H, 2012, IEEE GLOBE WORK, P624, DOI 10.1109/GLOCOMW.2012.6477646; Calka P., 2010, NEW PERSPECTIVES STO; CATT Ericsson ST-Ericsson, 2010, 3GPP TSG RAN M 51 KA, P51; Cisco, 2014, CISC VIS NETW IND GL; Dhillon H., 2012, P IEEE GLOB COMM C, P2179, DOI DOI 10.1109/GLOCOM.2012.6503438; ElBamby M. S., 2014, P 11 ISWCS BARC SPAI, P939; Gradshteyn I. S., 2000, TABLE INTEGRALS SERI; Haas H, 2001, IEEE J SEL AREA COMM, V19, P1831, DOI 10.1109/49.957300; ITU, 2008, ITURM2135; Kingman J. F. C., 1993, POISSON PROCESSES; Moller J., 2008, TESSELATIONS SCI VIR; Mukherjee S, 2014, ANALYTICAL MODELING OF HETEROGENEOUS CELLULAR NETWORKS: GEOMETRY, COVERAGE, AND CAPACITY, P1; NTT DOCOMO Inc, 2012, 3GPP WORKSH REL 12 O; Sohn I, 2009, IEEE T WIREL COMMUN, V8, P2990, DOI 10.1109/TWC.2009.080137; Voss F, 2009, IEEE J SEL AREA COMM, V27, P1047, DOI 10.1109/JSAC.2009.090903	29	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0733-8716	1558-0008		IEEE J SEL AREA COMM	IEEE J. Sel. Areas Commun.	JUN	2015	33	6					1201	1213		10.1109/JSAC.2015.2417013		13	Engineering, Electrical & Electronic; Telecommunications	Engineering; Telecommunications	CI7MJ	WOS:000354947400014		
J	Sun, A; Wu, ZS				Sun, An; Wu, Zhishen			Multimode Interference in Single Mode-Multimode FBG for Simultaneous Measurement of Strain and Bending	IEEE SENSORS JOURNAL			English	Article						Fiber optic sensors; fiber Bragg grating; strain measurement; bending measurement	FIBER BRAGG GRATINGS; OPTICAL-FIBER; SENSORS; TEMPERATURE; DEVICES	In this paper, a discriminating measurement of strain and bending based on single mode-multimode fiber Bragg grating (FBG) structure is investigated experimentally. Experimental results show that the reflected modes of single mode-multimode FBG exhibit different responses toward the bending of transmitting multimode fiber because of the effect of multimode interference, which can be used for ratiometrical detection of bending, meanwhile the wavelength of the reflected modes is immune from bending but sensitive to strain. Using the different responses of the reflected modes of single mode-multimode FBG to bending, strain and bending can be discriminated by measuring simultaneously the wavelength shift of FBG resonance and the reflected intensity ratio between different modes.	[Sun, An; Wu, Zhishen] Southeast Univ, Int Inst Urban Syst Engn, Nanjing 210018, Jiangsu, Peoples R China; [Wu, Zhishen] Ibaraki Univ, Dept Urban & Civil Engn, Hitachi, Ibaraki 3160034, Japan	Sun, A (reprint author), Southeast Univ, Int Inst Urban Syst Engn, Nanjing 210018, Jiangsu, Peoples R China.	ansun_iiuse@163.com; zswu@mx.ibaraki.ac.jp			National Natural Science Foundation of China [51308109]; Natural Science Foundation of Jiangsu Province [BK20130620]; National Key Technology Research and Development Program during the Twelfth Five-Year Plan Period [2011BAK02B03]	This work was supported in part by the National Natural Science Foundation of China under Grant 51308109, in part by the Natural Science Foundation of Jiangsu Province under Grant BK20130620, and in part by the National Key Technology Research and Development Program during the Twelfth Five-Year Plan Period under Grant 2011BAK02B03. The associate editor coordinating the review of this paper and approving it for publication was Dr. Anna G. Mignani.	Mizunami T, 2000, J LIGHTWAVE TECHNOL, V18, P230, DOI 10.1109/50.822797; Zhao W, 2000, SMART MATER STRUCT, V9, P212, DOI 10.1088/0964-1726/9/2/312; Djambova TV, 2000, JPN J APPL PHYS 1, V39, P1566, DOI 10.1143/JJAP.39.1566; SOLDANO LB, 1995, J LIGHTWAVE TECHNOL, V13, P615, DOI 10.1109/50.372474; Wang Q, 2008, J LIGHTWAVE TECHNOL, V26, P512, DOI 10.1109/JLT.2007.915205; Lim J, 2002, IEEE T INSTRUM MEAS, V51, P622, DOI 10.1109/TIM.2002.802253; Schermer RT, 2007, IEEE J QUANTUM ELECT, V43, P899, DOI 10.1109/JQE.2007.903364; Liu Y, 2005, OPT EXPRESS, V13, P8508, DOI 10.1364/OPEX.13.008508; Sun A, 2011, MICROW OPT TECHN LET, V53, P442, DOI 10.1002/mop.25688; WANSER KH, 1994, P SOC PHOTO-OPT INS, V2360, P265, DOI 10.1117/12.185051; Lu CG, 2006, J LIGHTWAVE TECHNOL, V24, P598, DOI 10.1109/JLT.2005.859841; Culshaw B, 1996, P IEEE, V84, P78, DOI 10.1109/5.476028; Hofmann P, 2012, J LIGHTWAVE TECHNOL, V30, P2289, DOI 10.1109/JLT.2012.2196406; Liu T., 2005, P SOC PHOTO-OPT INS, V5634, P54, DOI 10.1117/12.576055; Mafi A, 2011, OPT LETT, V36, P3596, DOI 10.1364/OL.36.003596; Marcuse D., 1991, THEORY DIELECTRIC OP, P251; Mizunami T., 1999, P IEEE OFS APR, V13, P216; Sang XZ, 2006, J OPTOELECTRON ADV M, V8, P1616; Sun A, 2012, IEEE PHOTONIC TECH L, V24, P413, DOI 10.1109/LPT.2011.2179931; Sun Y, 2003, OPT COMMUN, V223, P91, DOI 10.1016/S0030-4018(03)01636-5; Szkopek T, 2001, IEEE J SEL TOP QUANT, V7, P425, DOI 10.1109/2944.962266; Wan CF, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/494260; Wu Q, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/2/025203	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1530-437X	1558-1748		IEEE SENS J	IEEE Sens. J.	JUN	2015	15	6					3390	3394		10.1109/JSEN.2014.2383838		5	Engineering, Electrical & Electronic; Instruments & Instrumentation; Physics, Applied	Engineering; Instruments & Instrumentation; Physics	CI7OV	WOS:000354954500007		
J	Manabe, H; Fukumoto, M; Yagi, T				Manabe, Hiroyuki; Fukumoto, Masaaki; Yagi, Tohru			Direct Gaze Estimation Based on Nonlinearity of EOG	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Electrooculography (EOG); Gaze estimation; nonlinearity; saccade	SACCADIC EYE-MOVEMENTS; OCULAR ARTIFACTS; EEG RECORDINGS; SEPARATION; INTERFACE; REMOVAL	Electrooculography (EOG) is one of the measures used to estimate the direction of a person's gaze; however, conventional EOG techniques suffer from a drift issue which makes it difficult to extract an accurate absolute eye angle. The technique proposed here is based on the nonlinearity of the EOG and offers a practical solution to this problem. It estimates the absolute eye angles before and after a saccade, which cancels the offset due to the drift. Additionally, it does not require any effort from the user or any target, but instead uses only the difference of the EOGs. Experiments with five subjects confirm that the proposed technique can estimate the absolute eye angle with an error of less than 4.. They also show improvements are achieved with several options such as weighting and multiple saccades. The technique will contribute to practical EOG-based interaction systems.	[Manabe, Hiroyuki; Fukumoto, Masaaki] NTT DOCOMO, Res Labs, Yokosuka, Kanagawa 2398536, Japan; [Manabe, Hiroyuki; Yagi, Tohru] Tokyo Inst Technol, Tokyo 1528550, Japan	Manabe, H (reprint author), NTT DOCOMO, Res Labs, Yokosuka, Kanagawa 2398536, Japan.	manabehiroyuki@acm.org	Yagi, Tohru/I-1545-2015				Wallstrom GL, 2004, INT J PSYCHOPHYSIOL, V53, P105, DOI 10.1016/j.ijpsycho.2004.03.007; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Bulling A, 2011, IEEE T PATTERN ANAL, V33, P741, DOI 10.1109/TPAMI.2010.86; Henderson JM, 2003, TRENDS COGN SCI, V7, P498, DOI 10.1016/j.tics.2003.09.006; Joyce CA, 2004, PSYCHOPHYSIOLOGY, V41, P313, DOI 10.1046/j.1469-8986.2003.00141.x; Kumar D, 2002, P ANN INT IEEE EMBS, P64; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Jung TP, 2000, PSYCHOPHYSIOLOGY, V37, P163, DOI 10.1017/S0048577200980259; Marmor MF, 2011, DOC OPHTHALMOL, V122, P1, DOI 10.1007/s10633-011-9259-0; Moretti DV, 2003, INT J PSYCHOPHYSIOL, V47, P199, DOI 10.1016/S0167-8760(02)00153-8; Itakura N, 2010, BIOMED SIGNAL PROCES, V5, P142, DOI 10.1016/j.bspc.2009.12.002; Hutton SB, 2008, BRAIN COGNITION, V68, P327, DOI 10.1016/j.bandc.2008.08.021; BERG P, 1991, ELECTROEN CLIN NEURO, V79, P36, DOI 10.1016/0013-4694(91)90154-V; Berger S, 2012, PSYCHOL MARKET, V29, P411, DOI 10.1002/mar.20530; Bulling A., 2009, P 27 INT C HUM FACT, P3259, DOI 10.1145/1520340.1520468; Estrany B., 2008, P C PERV TECHN REL A; Goldberg J. H., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium; HAKKINEN V, 1993, ELECTROEN CLIN NEURO, V86, P294, DOI 10.1016/0013-4694(93)90111-8; Holland C, 2012, P S EYE TRACK RES AP, P277; Horng W.B., 2004, P IEEE INT C NETW SE, V1, P7; Ishiguro Y, 2012, IEEE INT SYM WRBL CO, P72, DOI 10.1109/ISWC.2012.32; Itsuki N., 1995, J JAPANESE OPHTHALMO, V99, P1012; Itsuki N., 2004, P INT C CONTR AUT RO, P947; Kelly JW, 2011, IEEE T BIO-MED ENG, V58, P598, DOI 10.1109/TBME.2010.2093932; Kierkels JJM, 2006, IEEE T BIO-MED ENG, V53, P246, DOI 10.1109/TBME.2005.862533; Manabe H., 2013, P IEEE C ENG MED BIO, P53; Manabe H., 2006, P C HUM FACT COMP SY, P1073; McAdams E, 2011, INTEGR CIRCUIT SYST, P31, DOI 10.1007/978-1-4419-6597-4_3; Ohno T., 2002, Proceedings ETRA 2002. Eye Tracking Research and Applications Symposium; Patmore D. W., 1998, P 3 INT ACM C ASS TE, P197, DOI 10.1145/274497.274533; Rapela J, 2012, IEEE ENG MED BIO, P3504, DOI 10.1109/EMBC.2012.6346721; Salvucci D., 2000, S EYE TRACK RES APPL, V469, P71, DOI DOI 10.1145/355017.355028; Sibert L.E., 2000, P SIGCHI C HUM FACT, P281, DOI 10.1145/332040.332445; Simini F., 2011, P 10 INT WORKSH BIOM, P1; Vigario RN, 1997, ELECTROEN CLIN NEURO, V103, P395, DOI 10.1016/S0013-4694(97)00042-8; Yagi T, 2006, IEEE SYS MAN CYBERN, P3222, DOI 10.1109/ICSMC.2006.384613; Yamagishi Kenji, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P2574	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	JUN	2015	62	6					1553	1562		10.1109/TBME.2015.2394409		10	Engineering, Biomedical	Engineering	CI7KY	WOS:000354943400011		
J	Ghandali, S; Alizadeh, B; Fujita, M; Navabi, Z				Ghandali, Samaneh; Alizadeh, Bijan; Fujita, Masahiro; Navabi, Zainalabedin			Automatic High-Level Data-Flow Synthesis and Optimization of Polynomial Datapaths Using Functional Decomposition	IEEE TRANSACTIONS ON COMPUTERS			English	Article						High-level synthesis; polynomial datapath; functional decomposition; modulo optimization; vanishing polynomial	FACTORIZATION; EXPRESSIONS; ELIMINATION; GENERATION; Z(M); CODE	This paper concentrates on high-level data-flow optimization and synthesis techniques for datapath intensive designs such as those in Digital Signal Processing (DSP), computer graphics and embedded systems applications, which are modeled as polynomial computations over Z(2n1) x Z(2n2) x ... x Z(2nd) to Z(2m). Our main contribution in this paper is proposing an optimization method based on functional decomposition of multivariate polynomial in the form of f(x) = g(x) o h(x) + f(0) = g(h(x)) + f(0) to obtain good building blocks, and vanishing polynomials over Z(2m) to add/delete redundancy to/from given polynomial functions to extract further common sub-expressions. Experimental results for combinational implementation of the designs have shown an average saving of 38.85 and 18.85 percent in the number of gates and critical path delay, respectively, compared with the state-of-the-art techniques. Regarding the comparison with our previous works, the area and delay are improved by 10.87 and 11.22 percent, respectively. Furthermore, experimental results of sequential implementations have shown an average saving of 39.26 and 34.70 percent in the area and the latency, respectively, compared with the state-of-the-art techniques.	[Ghandali, Samaneh; Alizadeh, Bijan; Navabi, Zainalabedin] Univ Tehran, Dept Elect & Comp Engn, Tehran 14399515, Iran; [Alizadeh, Bijan] Inst Res Fundamental Sci IPM, Sch Comp Sci, Tehran, Iran; [Fujita, Masahiro] Univ Tokyo, VLSI Design & Educ Ctr VDEC, Tokyo, Japan	Ghandali, S (reprint author), Univ Tehran, Dept Elect & Comp Engn, North Kargar Ave, Tehran 14399515, Iran.	s.ghandali@ut.ac.ir; b.alizadeh@ut.ac.ir; fujita@ee.t.u-tokyo.ac.jp; navabi@ut.ac.ir					AHO AV, 1977, J ACM, V24, P146, DOI 10.1145/321992.322001; Alizadeh B, 2010, IEEE T COMPUT AID D, V29, P1422, DOI 10.1109/TCAD.2010.2059271; Alizadeh Bijan, 2009, Proceedings of the 2009 IEEE/ACM International Conference on Computer-Aided Design (ICCAD 2009), DOI 10.1145/1687399.1687536; Alizadeh B., 2008, P 5 WORKSH CFV, P22; Sarbishei O, 2009, DES AUT CON, P931; von zur Gathen J, 2003, APPL ALGEBR ENG COMM, V14, P11, DOI 10.1007/s00200-003-0122-8; Kaltofen E, 2008, J SYMB COMPUT, V43, P359, DOI 10.1016/j.jsc.2007.11.005; CHEN ZB, 1995, DISCRETE MATH, V137, P137, DOI 10.1016/0012-365X(93)E0162-W; [Anonymous], 2014, GCC COMPILER; BREUER MA, 1969, COMMUN ACM, V12, P333, DOI 10.1145/363011.363153; Chen ZB, 1996, DISCRETE MATH, V162, P67, DOI 10.1016/0012-365X(95)00305-G; Cheng K. T., 1993, P EUR C DES AUT, P373; Coussy P., 2008, HIGH LEVEL SYNTHESIS; De Micheli G., 1994, SYNTHESIS OPTIMIZATI; Ghandali S., 2012, P 10 ACM IEEE C FORM, P65; Gopalakrishnan S, 2007, IEEE IC CAD, P143; Gopalakrishnan S, 2009, DES AUT TEST EUROPE, P1452; Guthaus M. R., 2001, Proceedings of the Fourth Annual IEEE International Workshop on Workload Characterization. WWC-4 (Cat. No.01EX538), DOI 10.1109/WWC.2001.990739; Haedicke F, 2010, ICCAD-IEEE ACM INT, P756, DOI 10.1109/ICCAD.2010.5654279; Hosangadi A., 2004, P ICCAD, P169; Hosangadi A, 2006, IEEE T COMPUT AID D, V25, P2012, DOI 10.1109/TCAD.2006.875712; KOZEN D, 1989, J SYMB COMPUT, V7, P445, DOI 10.1016/S0747-7171(89)80027-6; Krumm J., 2001, SAVITZKY GOLAY FILTE; Mathews V. J., 2000, POLYNOMIAL SIGNAL PR; Peymandoust A, 2003, IEEE T COMPUT AID D, V22, P1154, DOI 10.1109/TCAD.2003.816213; Smarandache F., 1980, ANALELE U TIMISOARA, V47, P79; Smith J., 1998, P INT C COMP AID DES, P678, DOI 10.1145/288548.289115; Smith J., 1999, P DES AUT TEST EUR, P217; Verma AK, 2006, DES AUT CON, P445; von zur Gathen J., 1999, P 2 WORKSH COMP ALG, P463; Von Zur Gathen J., 1990, Journal of Symbolic Computation, V9	31	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	JUN	2015	64	6					1579	1593		10.1109/TC.2014.2345395		15	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CI0GH	WOS:000354414500006		
J	Li, P; Guo, S; Hu, JK				Li, Peng; Guo, Song; Hu, Jiankun			Energy-Efficient Cooperative Communications for Multimedia Applications in Multi-Channel Wireless Networks	IEEE TRANSACTIONS ON COMPUTERS			English	Article						Energy efficiency; cooperative communication; multi-channel; optimization; online algorithm	FORWARD RELAY NETWORKS; RESOURCE-ALLOCATION; CELLULAR NETWORKS; POWER ALLOCATION; DIVERSITY; SELECTION	The dramatic growth of mobile multimedia communications imposes new requirements on quality-of-service and energy efficiency in wireless networks. In this paper, we study the energy-and spectrum-efficient cooperative communication (ESCC) problem by exploiting the benefits of cooperative communication (CC) for mobile multimedia applications in multi-channel wireless networks. In a static network, it is formulated as a mixed-integer nonlinear programming problem. To solve this problem, we use linearization and reformulation techniques to transform it into a mixed-integer linear programming problem that is solved by a branch-and-bound algorithm with enhanced performance. To deal with the problem in dynamic networks, we propose an online algorithm with low computational complexity and deployment overhead. Extensive simulations are conducted to show that the proposed algorithm can significantly improve the performance of energy efficiency in both static and dynamic networks.	[Li, Peng; Guo, Song] Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan; [Hu, Jiankun] Univ New S Wales, Sch Engn & Informat Technol, Sydney, NSW 2052, Australia	Li, P (reprint author), Univ Aizu, Sch Comp Sci & Engn, Aizu Wakamatsu, Fukushima, Japan.	pengli@u-aizu.ac.jp; sguo@u-aizu.ac.jp; J.Hu@adfa.edu.au					Asghari V, 2011, IEEE T VEH TECHNOL, V60, P2656, DOI 10.1109/TVT.2011.2136391; Zhao Y, 2007, IEEE T WIREL COMMUN, V6, P3114, DOI 10.1109/TWC.2007.06026; Fang WW, 2010, IEEE T CONSUM ELECTR, V56, P2185, DOI 10.1109/TCE.2010.5681089; He ZH, 2006, IEEE T CIRC SYST VID, V16, P590, DOI 10.1109/TCSVT.2006.873154; Pei YY, 2013, IEEE T WIREL COMMUN, V12, P3611, DOI 10.1109/TWC.2013.061713.121956; Luo CQ, 2013, IEEE J SEL AREA COMM, V31, P2442, DOI 10.1109/JSAC.2013.131129; Yang MJ, 2013, IEEE VEH TECHNOL MAG, V8, P31, DOI 10.1109/MVT.2012.2234052; Yu CH, 2011, IEEE T WIREL COMMUN, V10, P2752, DOI 10.1109/TWC.2011.060811.102120; Bisio I, 2012, IEEE COMMUN LETT, V16, P596, DOI 10.1109/LCOMM.2012.030912.111913; BISIO I, 2012, P IEEE GLOBECOM, P3311; BISIO I, 2013, P IEEE ICC, P4271; Bletsas A, 2006, IEEE J SEL AREA COMM, V24, P659, DOI 10.1109/JSAC.2005.862417; Bo Sun J. C., 2011, P INT C E BUS E GOV, P1; Gong X., 2008, P IEEE GLOBECOM, P1; Hajiaghayi M, 2011, IEEE INFOCOM SER, P76, DOI 10.1109/INFCOM.2011.5935298; Huang XG, 2011, 2011 IEEE WIRELESS COMMUNICATIONS AND NETWORKING CONFERENCE (WCNC), P1097; Ji W., 2010, P IEEE ICCT NOV, P938; Jiang C., 2012, P IEEE INFOCOM, P1934; Katsaggelos AK, 2005, IEEE WIREL COMMUN, V12, P24, DOI 10.1109/MWC.2005.1497855; Laneman JN, 2004, IEEE T INFORM THEORY, V50, P3062, DOI 10.1109/TIT.2004.838089; Li P, 2012, IEEE T VEH TECHNOL, V61, P2768, DOI 10.1109/TVT.2012.2195733; Li P., 2012, P IEEE ICC, P5097; Sharma S, 2011, IEEE ACM T NETWORK, V19, P879, DOI 10.1109/TNET.2010.2091148; Simic L., 2007, P PIMRC 07 ATH, P1; van der Meulen E. C., 1971, Advances in Applied Probability, V3; Wang XB, 2010, IEEE T BROADCAST, V56, P226, DOI 10.1109/TBC.2010.2047140; YANG D, 2011, P IEEE INT C COMM, V53, P1	27	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	0018-9340	1557-9956		IEEE T COMPUT	IEEE Trans. Comput.	JUN	2015	64	6					1670	1679		10.1109/TC.2014.2345397		10	Computer Science, Hardware & Architecture; Engineering, Electrical & Electronic	Computer Science; Engineering	CI0GH	WOS:000354414500013		
J	Takahashi, A; Kikuchi, S; Miyata, K; Binder, A				Takahashi, Akeshi; Kikuchi, Satoshi; Miyata, Kenji; Binder, Andreas			Asynchronous Torque of Line-Starting Permanent-Magnet Synchronous Motors	IEEE TRANSACTIONS ON ENERGY CONVERSION			English	Article						Line-starting; permanent-magnet (PM); torque separation; transient-state	PERFORMANCE ANALYSIS; AC MOTOR; EFFICIENCY; OPERATION; MACHINES	A modified theory and a proposed analytical approach clarified asynchronous torque characteristics of line-starting permanent-magnet (PM) motors, taking into consideration the mutual effect among the fields due to armature current, cage-bar current, and PMs. Theoretical and analyzed results revealed that cage torque had an oscillating component with slip frequency due to magnetic saturation. This component cannot be seen in the conventional theory. It was also found that the coupling effect between PM flux and cage-bar flux caused on magnet torque larger oscillation and more significant negative dc component, compared with the case in the conventional theory. The theoretical and analyzed results were validated on the basis of experimental approaches. Results are given for a two-pole prototype motor with P-N = 5 kW, n(N) = 3000 min(-1), V-N = 200 V, and Y-connection.	[Takahashi, Akeshi; Kikuchi, Satoshi; Miyata, Kenji] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191221, Japan; [Binder, Andreas] Tech Univ Darmstadt, Inst Elect Energy Convers, D-64283 Darmstadt, Germany	Takahashi, A (reprint author), Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191221, Japan.	akeshi.takahashi.hc@hitachi.com; satoshi.kikuchi.rq@hitachi.com; kenji.miyata.fv@hitachi.com; abinder@ew.tu-darmstadt.de					Almeida A. T., 2014, IEEE T IND APPL, V50, P1274; Ferreira FJTE, 2013, IEEE T ENERGY CONVER, V28, P523, DOI 10.1109/TEC.2013.2270084; RAHMAN MA, 1990, IEEE T ENERGY CONVER, V5, P211, DOI 10.1109/60.50833; Brandes J., 1989, THESIS HANNOVER U HA; CONSOLI A, 1986, IEEE T IND APPL, V22, P32, DOI 10.1109/TIA.1986.4504678; Debruyne C, 2014, IEEE T IND APPL, V50, P1034, DOI 10.1109/TIA.2013.2277593; HONSINGER VB, 1980, IEEE T POWER AP SYST, V99, P1503, DOI 10.1109/TPAS.1980.319574; IGLESIAS I, 1992, IEEE T ENERGY CONVER, V7, P768, DOI 10.1109/60.182661; ISHIZAKI A, 1986, IEEE T ENERGY CONVER, V1, P101; Kurihara K, 2004, IEEE T IND APPL, V40, P789, DOI 10.1109/TIA.2004.827476; MILLER TJE, 1985, IEEE T IND APPL, V21, P651, DOI 10.1109/TIA.1985.349722; OSHEBA SM, 1991, IEEE T ENERGY CONVER, V6, P83, DOI 10.1109/60.73793; OSTOVIC V, 1987, IEEE T IND APPL, V23, P836, DOI 10.1109/TIA.1987.4504992; OSTOVIC V, 1988, IEEE T IND APPL, V24, P308, DOI 10.1109/28.2871; Popescu M, 2005, IEEE T ENERGY CONVER, V20, P142, DOI 10.1109/TEC.2004.837307; Popescu M, 2003, IEEE T IND APPL, V39, P1021, DOI 10.1109/TIA.2003.813745; RAHMAN MA, 1994, IEEE T MAGN, V30, P3664, DOI 10.1109/20.312735; RICHTER E, 1985, IEEE T IND APPL, V21, P644, DOI 10.1109/TIA.1985.349721; Takahashi A., 2008, P INT C EL MACH PORT, P1; ZHOU P, 1994, IEEE T MAGN, V30, P1350, DOI 10.1109/20.305531	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8969	1558-0059		IEEE T ENERGY CONVER	IEEE Trans. Energy Convers.	JUN	2015	30	2					498	506		10.1109/TEC.2014.2361836		9	Energy & Fuels; Engineering, Electrical & Electronic	Energy & Fuels; Engineering	CI6JF	WOS:000354864300009		
J	Katayama, N; Kogoshi, S				Katayama, Noboru; Kogoshi, Sumio			Real-Time Electrochemical Impedance Diagnosis for Fuel Cells Using a DC-DC Converter	IEEE TRANSACTIONS ON ENERGY CONVERSION			English	Article						DC-DC converter; digital signal processor; electric double layer capacitor; electrochemical impedance analysis; fuel cell	FOURIER-TRANSFORM; SPECTROSCOPY; DEGRADATION; PERFORMANCE; DURABILITY; MECHANISMS	A multiport bidirectional dc-dc converter with a diagnosis function for fuel cells that employs electrochemical impedance analysis was developed. The proposed converter, which is connected to electric double layer capacitors, can freely adjust the fuel cell voltage without fluctuation of the load voltage. A signal that consists of multiple frequency sinusoidal waves is superimposed as a duty ratio signal of the chopper circuit connected to the fuel cell, which enables simultaneous impedance measurement for these frequencies. The voltage and current values of the fuel cell are acquired by a digital signal processor to conduct fast Fourier transform calculations that give voltage and current spectra. The fraction of the spectra yields the electrochemical impedance. Experiments were conducted to validate the proposed method using a polymer electrolyte membrane fuel cell. The sinusoidal waves in the imposed signal have multiple frequencies to reduce the measuring time. The impedance characteristics determined using the proposed method are in good agreement with those obtained with an electrochemical instrument. To demonstrate the proposed method, the Nyquist plots when the fuel cell current, the operation temperature, and the stoichiometric ratios were changed and produced using the proposed method.	[Katayama, Noboru; Kogoshi, Sumio] Tokyo Univ Sci, Dept Elect Engn, Chiba 2788510, Japan	Katayama, N (reprint author), Tokyo Univ Sci, Dept Elect Engn, Chiba 2788510, Japan.	katayama@rs.tus.ac.jp; kogoshi@ee.noda.tus.ac.jp			Japan Society for the Promotion of Science [25820109]	This work was supported by the Grant-in-Aid for Young Scientists (B) (No. 25820109) from the Japan Society for the Promotion of Science. Paper no. TEC-00476-2014	Narjiss A, 2008, INT POWER ELECT MOT, P734, DOI 10.1109/EPEPEMC.2008.4635354; Yuan XZ, 2007, INT J HYDROGEN ENERG, V32, P4365, DOI 10.1016/j.ijhydene.2007.05.036; Wu JF, 2008, J POWER SOURCES, V184, P104, DOI 10.1016/j.jpowsour.2008.06.006; Kong CS, 2002, J POWER SOURCES, V108, P185, DOI 10.1016/S0378-7753(02)00028-9; Kim J, 2013, IEEE T IND ELECTRON, V60, P5086, DOI 10.1109/TIE.2012.2226414; Schmittinger W, 2008, J POWER SOURCES, V180, P1, DOI 10.1016/j.jpowsour.2008.01.070; Andreasen SJ, 2009, FUEL CELLS, V9, P463, DOI 10.1002/fuce.200800137; Hinaje M, 2009, INT J HYDROGEN ENERG, V34, P2718, DOI 10.1016/j.ijhydene.2009.01.076; WILKINSON DP, 1994, J POWER SOURCES, V49, P117, DOI 10.1016/0378-7753(93)01803-P; Fouquet N, 2006, J POWER SOURCES, V159, P905, DOI 10.1016/j.jpowsour.2005.11.035; Huang WX, 2014, IEEE T IND ELECTRON, V61, P5987, DOI 10.1109/TIE.2014.2311389; OSAKA T, 1982, B CHEM SOC JPN, V55, P36, DOI 10.1246/bcsj.55.36; Ordonez M, 2010, IEEE T IND ELECTRON, V57, P1925, DOI 10.1109/TIE.2009.2028295; Brunetto C, 2009, ELECTR POW SYST RES, V79, P17, DOI 10.1016/j.epsr.2008.05.012; Ciureanu M, 2000, J NEW MAT ELECT SYST, V3, P107; Dhirde AM, 2010, IEEE T ENERGY CONVER, V25, P778, DOI 10.1109/TEC.2010.2049267; Franco AA, 2007, J ELECTROCHEM SOC, V154, pB712, DOI 10.1149/1.2731040; Hao LX, 2008, J POWER SOURCES, V177, P404, DOI 10.1016/j.jpowsour.2007.11.034; Li H, 2008, J POWER SOURCES, V178, P103, DOI 10.1016/j.jpowsour.2007.12.068; Katayama N, 2013, INT C POWER ELECT DR, P72, DOI 10.1109/PEDS.2013.6526991; Qu SG, 2010, J POWER SOURCES, V195, P6629, DOI 10.1016/j.jpowsour.2010.04.029; Rubio MA, 2008, J POWER SOURCES, V183, P118, DOI 10.1016/j.jpowsour.2008.05.011; Saleh FS, 2012, J ELECTROCHEM SOC, V159, pB546, DOI 10.1149/2.098205jes; SCHWARTZ DT, 1989, J ELECTROCHEM SOC, V136, P1755, DOI 10.1149/1.2097006; Springer TE, 1991, J ELECTROCHEM SOC, V138, P2234; Uno M, 2011, J POWER SOURCES, V196, P9884, DOI 10.1016/j.jpowsour.2011.08.030	26	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0885-8969	1558-0059		IEEE T ENERGY CONVER	IEEE Trans. Energy Convers.	JUN	2015	30	2					707	713		10.1109/TEC.2014.2376529		7	Energy & Fuels; Engineering, Electrical & Electronic	Energy & Fuels; Engineering	CI6JF	WOS:000354864300031		
J	Kuzuoka, S; Watanabe, S				Kuzuoka, Shigeaki; Watanabe, Shun			An Information-Spectrum Approach to Weak Variable-Length Source Coding With Side-Information	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						epsilon source coding; information-spectrum method; multiterminal source coding; one-shot coding theorem; side-information; Slepian-Wolf coding; weak variable-length coding	RATE-DISTORTION FUNCTION; GENERAL SOURCES; DATA-COMPRESSION; LINKED ENCODERS; WOLF; DECODER; THEOREMS	This paper studies variable-length (VL) source coding of general sources with side-information. Novel one-shot coding bounds for Slepian-Wolf (SW) coding, which give nonasymptotic tradeoff between the error probability and the codeword length of VL-SW coding, are established. One-shot results are applied to asymptotic analysis, and a general formula for the optimal coding rate achievable by weakly lossless VL-SW coding (i.e., VL-SW coding with vanishing error probability) is derived. Our general formula reveals how the encoder side-information and/or VL coding improve the optimal coding rate in the general setting. In addition, it is shown that if the encoder side-information is useless in weakly lossless VL coding then it is also useless even in the case where the error probability may be positive asymptotically.	[Kuzuoka, Shigeaki] Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan; [Watanabe, Shun] Tokyo Univ Agr & Technol, Dept Comp & Informat Sci, Tokyo 1848588, Japan	Kuzuoka, S (reprint author), Wakayama Univ, Fac Syst Engn, Wakayama 6408510, Japan.	kuzuoka@ieee.org; shunwata@cc.tuat.ac.jp			JSPS KAKENHI [26820145]	Manuscript received January 21, 2015; revised April 6, 2015; accepted April 11, 2015. Date of publication April 20, 2015; date of current version May 15, 2015. S. Kuzuoka was supported by JSPS KAKENHI under Grant 26820145. This paper was presented at the 2014 IEEE International Symposium on Information Theory.	Hayashi M, 2008, IEEE T INFORM THEORY, V54, P4619, DOI 10.1109/TIT.2008.928985; Alon N, 1996, IEEE T INFORM THEORY, V42, P1329, DOI 10.1109/18.532875; Tan VYF, 2014, IEEE T INFORM THEORY, V60, P881, DOI 10.1109/TIT.2013.2291231; SLEPIAN D, 1973, IEEE T INFORM THEORY, V19, P471, DOI 10.1109/TIT.1973.1055037; HAN TS, 1993, IEEE T INFORM THEORY, V39, P752, DOI 10.1109/18.256486; ELIAS P, 1975, IEEE T INFORM THEORY, V21, P194, DOI 10.1109/TIT.1975.1055349; COVER TM, 1975, IEEE T INFORM THEORY, V21, P226, DOI 10.1109/TIT.1975.1055356; WYNER AD, 1976, IEEE T INFORM THEORY, V22, P1, DOI 10.1109/TIT.1976.1055508; Watanabe S, 2015, IEEE T INFORM THEORY, V61, P1574, DOI 10.1109/TIT.2015.2400994; Billingsley P., 1968, CONVERGENCE PROBABIL; Chen J, 2008, IEEE ICC, P1426, DOI 10.1109/ICC.2008.276; Chen J., 2007, P 45 ANN ALL C SEP, P292; Cover T. M., 2006, ELEMENTS INFORM THEO; Han T. S., 2002, INFORM SPECTRUM METH; Han TS, 2000, IEEE T INFORM THEORY, V46, P1217; He DK, 2009, IEEE T INFORM THEORY, V55, P5607, DOI 10.1109/TIT.2009.2032803; Iwata K, 2002, IEICE T FUND ELECTR, VE85A, P1387; KIEFFER JC, 1980, INFORM CONTROL, V46, P93, DOI 10.1016/S0019-9958(80)90693-2; Kimura A, 2004, IEEE T INFORM THEORY, V50, P183, DOI 10.1109/TIT.2003.821968; Koga H, 2005, IEEE T INFORM THEORY, V51, P1546, DOI 10.1109/TIT.2005.844098; Korner J., 1981, INFORM THEORY CODING; Kostina V., 2014, VARIABLE LENGTH COMP; Koulgi P, 2003, IEEE T INFORM THEORY, V49, P99, DOI 10.1109/TIT.2002.806154; Kuzuoka S., 2014, INFORM SPECTRUM APPR; Kuzuoka S, 2012, 2012 INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY AND ITS APPLICATIONS (ISITA 2012), P155; MIYAKE S, 1995, IEICE T FUND ELECTR, VE78A, P1063; Muramatsu J., 1997, Proceeding. 1997 IEEE International Symposium on Information Theory (Cat. No.97CH36074), DOI 10.1109/ISIT.1997.613098; Nomura R., 2013, P IEEE INT S INF THE, P1974; Oohama Y, 1996, IEEE T INFORM THEORY, V42, P837, DOI 10.1109/18.490548; Verdu S., 2012, P 46 ANN C INF SCI S, P1; Weinberger N., 2014, LARGE DEVIATIONS ANA; Yang EH, 2001, IEEE T INFORM THEORY, V47, P2130; Yang EH, 2010, IEEE T INFORM THEORY, V56, P1808, DOI 10.1109/TIT.2010.2040867; Yang EH, 2008, IEEE T INFORM THEORY, V54, P5575, DOI 10.1109/TIT.2008.2006449; Yang ST, 2007, J ZHEJIANG UNIV-SC A, V8, P1263, DOI 10.1631/jzus.2007.A1263; Yonezawa H., 2002, P 25 S INF THEOR ITS, P263	36	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	JUN	2015	61	6					3559	3573		10.1109/TIT.2015.2424406		15	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CI7LA	WOS:000354943600037		
J	Muramatsu, J				Muramatsu, Jun			Variable-Length Lossy Source Code Using a Constrained-Random-Number Generator	IEEE TRANSACTIONS ON INFORMATION THEORY			English	Article						Balanced-coloring property; constrained-random-number generator; Gibbs sampling; rate-distortion theory; sparse matrix; sum-product algorithm; variable length lossy source code	LEMPEL-ZIV ALGORITHM; DATA-COMPRESSION; DISTORTION-COMPLEXITY; FIDELITY-CRITERION; UNIVERSAL DATABASE; MEMORYLESS SOURCES; CODING THEOREMS; GRAPH CODES; INFORMATION; CAPACITY	A variable-length lossy source code is introduced with a rate-distortion pair close to the rate-distortion function. Random numbers that satisfy a condition specified by a function and its value are used to construct a stochastic encoder. The proof of the theorem is based on the balanced-coloring property of an ensemble of functions. Since an ensemble of systematic sparse matrices has this property, we can construct a tractable code for a memoryless source. Some algorithms for implementing the code are introduced and compared by simulation.	NTT Corp, NTT Commun Sci Labs, Kyoto 6190237, Japan	Muramatsu, J (reprint author), NTT Corp, NTT Commun Sci Labs, Kyoto 6190237, Japan.	muramatsu.jun@lab.ntt.co.jp					Ahlswede R, 1998, IEEE T INFORM THEORY, V44, P225, DOI 10.1109/18.651026; Kschischang FR, 2001, IEEE T INFORM THEORY, V47, P498, DOI 10.1109/18.910572; CARTER JL, 1979, J COMPUT SYST SCI, V18, P143, DOI 10.1016/0022-0000(79)90044-8; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.2307/2334940; BLAHUT RE, 1972, IEEE T INFORM THEORY, V18, P460, DOI 10.1109/TIT.1972.1054855; VITERBI AJ, 1974, IEEE T INFORM THEORY, V20, P325, DOI 10.1109/TIT.1974.1055233; Muramatsu J, 2014, IEEE T INFORM THEORY, V60, P2667, DOI 10.1109/TIT.2014.2309140; Zamir R, 2002, IEEE T INFORM THEORY, V48, P1250, DOI 10.1109/TIT.2002.1003821; Korada SB, 2010, IEEE T INFORM THEORY, V56, P1751, DOI 10.1109/TIT.2010.2040961; COVER TM, 1975, IEEE T INFORM THEORY, V21, P226, DOI 10.1109/TIT.1975.1055356; Zamir R, 2001, IEEE T INFORM THEORY, V47, P99, DOI 10.1109/18.904515; Aji SM, 2000, IEEE T INFORM THEORY, V46, P325, DOI 10.1109/18.825794; SHANNON CE, 1948, AT&T TECH J, V27, P623; Berger T., 1971, RATE DISTORTION THEO; CSISZAR I, 1982, IEEE T INFORM THEORY, V28, P585, DOI 10.1109/TIT.1982.1056524; Csiszar I., 2011, INFORM THEORY CODING, V2nd; Dembo A, 2002, IEEE T INFORM THEORY, V48, P1590, DOI 10.1109/TIT.2002.1003841; FINAMORE WA, 1980, IEEE T INFORM THEORY, V26, P144, DOI 10.1109/TIT.1980.1056165; Gray R., 1984, ASSP MAG, V1, P4; Gupta A, 2009, IEEE T INFORM THEORY, V55, P1961, DOI 10.1109/TIT.2009.2016040; Han TS, 1997, IEEE T INFORM THEORY, V43, P1145; HASHIMOTO T, 1983, IEEE T INFORM THEORY, V29, P785, DOI 10.1109/TIT.1983.1056767; Honda J, 2014, IEEE T INFORM THEORY, V60, P762, DOI 10.1109/TIT.2013.2288335; Impagliazzo R., 1989, P 30 ANN IEEE S FDN, P248; Jalali S, 2012, IEEE T INFORM THEORY, V58, P2475, DOI 10.1109/TIT.2011.2178059; Kontoyiannis I, 1999, IEEE T INFORM THEORY, V45, P2293, DOI 10.1109/18.796370; Matsunaga Y, 2003, IEEE T INFORM THEORY, V49, P2225, DOI 10.1109/TIT.2003.815805; Miyake S, 2008, IEICE T FUND ELECTR, VE91A, P1488, DOI 10.1093/ietfec/e91-a.6.l488; Muramatsu J., 2013, P IEEE INT S INF THE, P2354; Muramatsu J, 2005, IEICE T FUND ELECTR, VE88A, P1063, DOI 10.1093/ietfec/e88-a.4.1063; Muramatsu J, 2010, IEEE T INFORM THEORY, V56, P2143, DOI 10.1109/TIT.2010.2043781; MURAMATSU J, 1994, IEICE T FUND ELECTR, VE77A, P1224; Muramatsu J, 1996, IEICE T FUND ELECTR, VE79A, P1456; MURAMATSU J, 1995, IEICE T FUND ELECTR, VE78A, P1057; Muramatsu J, 2011, 2011 IEEE INTERNATIONAL SYMPOSIUM ON INFORMATION THEORY PROCEEDINGS (ISIT), P613; Muramatsu J., 2010, CONSTRUCTION SLEPIAN; Murayama T, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.035105; Neuhoff DL, 1998, IEEE T INFORM THEORY, V44, P778, DOI 10.1109/18.661520; ORNSTEIN DS, 1990, ANN PROBAB, V18, P441, DOI 10.1214/aop/1176990840; Shannon C.E., 1959, IRE National Convention Record, V7; Takahashi H., 1974, PUBL RES I MATH SCI, V9, P721, DOI DOI 10.2977/PRIMS/1195192451; Wainwright MJ, 2009, IEEE T INFORM THEORY, V55, P1061, DOI 10.1109/TIT.2008.2009815; Yang EH, 1997, IEEE T INFORM THEORY, V43, P1465; Yang EH, 1996, IEEE T INFORM THEORY, V42, P239, DOI 10.1109/18.481794; Yang EH, 1998, IEEE T INFORM THEORY, V44, P47, DOI 10.1109/18.650987; Yassaee MH, 2014, IEEE T INFORM THEORY, V60, P6760, DOI 10.1109/TIT.2014.2351812; Zhang Z, 1996, IEEE T INFORM THEORY, V42, P803	47	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9448	1557-9654		IEEE T INFORM THEORY	IEEE Trans. Inf. Theory	JUN	2015	61	6					3574	3592		10.1109/TIT.2015.2428238		19	Computer Science, Information Systems; Engineering, Electrical & Electronic	Computer Science; Engineering	CI7LA	WOS:000354943600038		
J	Oe, T; Urano, C; Kaneko, NH; Eisaki, H; Yoshida, Y; Yamamoto, A; Takenaka, K				Oe, Takehiko; Urano, Chiharu; Kaneko, Nobu-hisa; Eisaki, Hiroshi; Yoshida, Yoshiyuki; Yamamoto, Atsuhi; Takenaka, Koshi			Antiperovskite Manganese Nitride Standard Resistor	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Aging rate; antiperovskite compound; dc resistance standard; Mn3Ag1-xCuxN; Seebeck coefficient; standard resistor; temperature coefficient of resistance (TCR); thermal electromotive force (EMF) against copper		The antiperovskite manganese nitride compound Mn3Ag1-xCuxN has a broad resistivity-temperature curve around room temperature that is comparable with the Manganin alloy. This curvature and the peak temperature can be adjusted by codoping with Cu and In or Fe. The drift rate of the resistance value was strongly affected by the condition of the four-terminal contact and the shape of the sample. Samples with spot-welded contacts show lower resistance drift rates than samples with Ag-paste contacts. The four-terminal-shaped sample has a drift rate that is 80 times lower than the normal cuboid-shaped sample. We confirmed that the Mn3AgN sample has a sufficiently low-thermal electromotive force against copper that is less than a few microvolts per kelvin. We expect that this antiperovskite compound could be used as a material for precision resistors and could improve the temperature coefficient of resistors for developing metrology standards.	[Oe, Takehiko; Urano, Chiharu; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan; [Oe, Takehiko] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4648601, Japan; [Eisaki, Hiroshi; Yoshida, Yoshiyuki] Natl Inst Adv Ind Sci & Technol, Elect & Photon Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Yamamoto, Atsuhi] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Takenaka, Koshi] Nagoya Univ, Dept Appl Phys, Nagoya, Aichi 4648601, Japan	Oe, T (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	t.oe@aist.go.jp	Takenaka, Koshi/J-9544-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan [22360291, 26286038]	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology of Japan under Grant 22360291 and Grant 26286038. The Associate Editor coordinating the review process was Dr. Regis Landim.	Takenaka K, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3541449; Takenaka K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2831715; Oe T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826611; Chi EO, 2001, SOLID STATE COMMUN, V120, P307, DOI 10.1016/S0038-1098(01)00395-7; Asano K, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2917472; Hadano M, 2012, J APPL PHYS, V111, DOI 10.1063/1.3673425; Lin JC, 2012, J APPL PHYS, V111, DOI 10.1063/1.4725471; Oe T., 2014, C PRECIS ELECTROMAGN, P692; Oe T, 2013, IEEE T INSTRUM MEAS, V62, P1450, DOI 10.1109/TIM.2012.2230794; Oe T., 2012, C PRECIS ELECTROMAGN, P364	10	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1446	1450		10.1109/TIM.2014.2381732		5	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300022		
J	Fukuyama, Y; Elmquist, RE; Huang, LI; Yang, YF; Liu, FH; Kaneko, NH				Fukuyama, Yasuhiro; Elmquist, Randolph E.; Huang, Lung-I; Yang, Yanfei; Liu, Fan-Hung; Kaneko, Nobu-hisa			Controlling the Fermi Level in a Single-Layer Graphene QHE Device for Resistance Standard	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Graphene; quantized Hall resistance (QHR); quantum Hall effect (QHE); quantum standard; resistance standard		The National Metrology Institute of Japan/National Institute of Advanced Industrial Science and Technology (NMIJ/AIST) and the National Institute of Standards and Technology (NIST) are collaborating on the development of graphene-based quantized Hall resistance devices. We formed graphene films on silicon carbide (0001) substrates and processed the samples into Hall bar devices using the NIST clean room facility. The electronic transport properties have been observed at the NIST and NMIJ/AIST. Hydrogen intercalation and photochemical gating were employed to control the Fermi level in the samples. For the first method, the Fermi level was observed to move across the Dirac point. For the latter technique, it moved closer to the Dirac point.	[Fukuyama, Yasuhiro; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Elmquist, Randolph E.; Huang, Lung-I; Yang, Yanfei] NIST, Gaithersburg, MD 20899 USA; [Liu, Fan-Hung] Natl Taiwan Univ, Inst Electroopt Engn, Taipei 10617, Taiwan	Fukuyama, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	y.fukuyama@aist.go.jp					Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Gusynin VP, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146801; Lara-Avila S, 2011, ADV MATER, V23, P878, DOI 10.1002/adma.201003993; Riedl C, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.246804; Elmquist R. E., 2012, P CPEM WASH DC US JU, P514; Fukuyama Y., 2014, P CPEM RIO DE JAN BR, P36	6	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1451	1454		10.1109/TIM.2015.2395512		4	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300023		
J	Domae, A; Abe, T; Kumagai, M; Zama, M; Oe, T; Kaneko, NH				Domae, Atsushi; Abe, Takayuki; Kumagai, Masaya; Zama, Matsuo; Oe, Takehiko; Kaneko, Nobu-hisa			Development and Evaluation of High-Stability Metal-Foil Resistor With a Resistance of 1 k Omega	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Drift rate; electrical resistance measurement; frequency dependence; measurement standards; phase-angle measurements; resistors; temperature dependence	CALIBRATION	Prototype models of a high-stability metal-foil resistor of 1 k Omega with a four-terminal-pair design were developed, and the key characteristics were evaluated. Two types of metalfoil resistors were fabricated: serial number (s/n) 1 is made from two resistor devices of 500 Omega and s/n 2 is made from three resistor devices of 333 Omega. To develop these resistor devices, a new resistor-device design was introduced. The s/n 1 resistor has the following key characteristics: drift rate: 0.010 (mu Omega/Omega)/year, first-order temperature coefficient at 23 degrees C: -0.165 (mu Omega/Omega)/degrees C, frequency dependence of the resistance (relative change in resistance normalized at 1 kHz): +/- 0.21 mu Omega/Omega in the frequency range from 400 Hz to 2 kHz, and time constant: -0.46 ns. The s/n 2 resistor has the following key characteristics: drift rate: -0.092 ( mu Omega/Omega)/year, first-order temperature coefficient at 23 degrees C: 0.096 (mu Omega/Omega)/degrees C, frequency dependence of the resistance (relative change in resistance normalized at 1 kHz): +/- 0.54 mu Omega/Omega in the frequency range from 400 Hz to 2 kHz, and time constant: 0.12 ns.	[Domae, Atsushi; Oe, Takehiko; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Abe, Takayuki] Japan Elect Meters Inspect Corp, Tokyo 1080023, Japan; [Kumagai, Masaya; Zama, Matsuo] Alpha Elect Corp, Tokyo 1010047, Japan	Domae, A (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	domae-atsushi@aist.go.jp; t-abe@jemic.go.jp; masaya.kumagai@alpha-elec.co.jp; matuo.zama@alpha-elec.co.jp; t.oe@aist.go.jp; nobuhisa.kaneko@aist.go.jp					Domae A, 2013, IEEE T INSTRUM MEAS, V62, P1776, DOI 10.1109/TIM.2013.2253973; Domae A., 2014, P CPEM RIO DE JAN BR, P100; Gibbings D.L.H., 1963, Proceedings of the Institution of Electrical Engineers, V110; Guildline Instruments Limited, GUILDL 7334 CAT; Kaneko N., 2012, NCSLI MEAS J MEAS SC, V7, P34; Kibble B. P., 1984, COAXIAL AC BRIDGES; Kon S, 2011, IEEE T INSTRUM MEAS, V60, P2286, DOI 10.1109/TIM.2010.2103414; Nakamura Y, 1997, METROLOGIA, V34, P353, DOI 10.1088/0026-1394/34/4/8; Nakamura Y., 2004, AIST B METROL, V3, P341; Pritchard B. J., 1990, CPEM '90 Digest. Conference on Precision Electromagnetic Measurements (Cat. No.90CH2822-5), DOI 10.1109/CPEM.1990.110027; Sakamoto Y, 2011, IEEE T INSTRUM MEAS, V60, P2544, DOI 10.1109/TIM.2011.2108613; Tinsley Precision Instruments, TINSL 5685 CAT; Zapf T. L., 1961, J RES NBS C ENG INST, V65C, P183	13	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1490	1495		10.1109/TIM.2015.2398955		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300030		
J	Zhang, LL; Azuma, Y; Kurokawa, A; Kuramoto, N; Fujii, K				Zhang, Lulu; Azuma, Yasushi; Kurokawa, Akira; Kuramoto, Naoki; Fujii, Kenichi			Surface Layer Analysis of Si Sphere by XRF and XPS	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Chemical analysis; silicon; surface contamination; thickness measurement; X-ray spectroscopy	MEAN FREE PATHS; ELASTIC-SCATTERING; ULTRATHIN SIO2; SILICON SPHERE; ELECTRON; ELEMENTS; CRYSTAL; PROJECT; AUGER	To reduce the uncertainty of the Avogadro constant for the new definition of the kilogram, the surface analysis of the Si sphere produced for the accurate determination of the Avogadro constant is indispensable. In this paper, we conducted the surface quantitative analyses to find out the metallic contaminations on a 1-kg natural Si sphere by X-ray fluorescence analysis. The X-ray photoelectron spectroscopy investigations were also carried out to estimate the thickness of the oxide layer and clarify the chemical binding state of the carbonaceous contamination layer on the surface of a dummy Si sphere.	[Zhang, Lulu; Azuma, Yasushi; Kurokawa, Akira; Kuramoto, Naoki; Fujii, Kenichi] Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058565, Japan; [Zhang, Lulu; Azuma, Yasushi; Kurokawa, Akira; Kuramoto, Naoki; Fujii, Kenichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Zhang, LL (reprint author), Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058565, Japan.	lulu.zhang@aist.go.jp					Andreas B, 2011, METROLOGIA, V48, pS1, DOI 10.1088/0026-1394/48/2/S01; TANUMA S, 1991, SURF INTERFACE ANAL, V17, P911, DOI 10.1002/sia.740171304; Cumpson PJ, 1997, SURF INTERFACE ANAL, V25, P430; Powell CJ, 1999, J PHYS CHEM REF DATA, V28, P19, DOI 10.1063/1.556035; Tanuma S, 2011, SURF INTERFACE ANAL, V43, P689, DOI 10.1002/sia.3522; Seah MP, 2002, SURF INTERFACE ANAL, V33, P640, DOI 10.1002/sia.1433; Nicolaus RA, 2013, IEEE T INSTRUM MEAS, V62, P1499, DOI 10.1109/TIM.2013.2242633; HOUK RS, 1980, ANAL CHEM, V52, P2283, DOI 10.1021/ac50064a012; Busch I, 2011, METROLOGIA, V48, pS62, DOI 10.1088/0026-1394/48/2/S10; CHAMBERS SA, 1992, SURF SCI REP, V16, P261, DOI 10.1016/0167-5729(92)90016-5; HAN ZL, 1991, SURF SCI, V258, P313, DOI 10.1016/0039-6028(91)90926-J; Kuramoto N, 2011, IEEE T INSTRUM MEAS, V60, P2615, DOI 10.1109/TIM.2010.2099272; Moriyama T., 2013, RIGAKU J, V29, P19; Picard A, 2009, METROLOGIA, V46, P1, DOI 10.1088/0026-1394/46/1/001; Seah M. P., 2008, 27 NPL AS; Seah MP, 2003, J VAC SCI TECHNOL A, V21, P345, DOI 10.1116/1.1535173; Zhang L., 2014, P CPEM AUG, P208	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1509	1513		10.1109/TIM.2015.2389352		5	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300033		
J	Kaneko, NH; Oe, T; Kim, WS; Chae, DH; Elmquist, R; Kraft, M				Kaneko, Nobu-hisa; Oe, Takehiko; Kim, Wan-Seop; Chae, Dong-Hun; Elmquist, Randolph; Kraft, Marlin			Transportation Effect and Basic Characteristics of Metal-Foil Resistors Examined in an International Trilateral Pilot Study	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						International comparison; quantum Hall effect; resistance standard; standard resistor; transportation effect		The transportation effect and other important characteristics of 100 Omega standard resistors of a new construction have been studied. For the transportation effect, four resistors have been transported by air between three national metrology institutes (NMIs): 1) the Korea Research Institute of Standards and Science; 2) the National Institute of Standards and Technology in the USA; and 3) the National Metrology Institute of Japan. Two of the resistors have been transported in hand-carried luggage and the other two by normal air freight. Resistance values as well as other characteristics have been carefully evaluated before and after the transportation to the NMIs. The measurements were done by means of their primary national standards based on the quantum Hall effect. No noticeable difference between the two transportation methods has been detected within a standard uncertainty of 0.01 mu Omega/Omega. Other characteristics, the drift rate: about 0.05 (mu Omega/Omega)/year or less, temperature coefficient: about 0.02 (mu Omega/Omega)/degrees C or less, and power coefficient: negligible, have also been reported. It is demonstrated that this excellent performance is suitable for utilization in NMIs and international comparisons.	[Kaneko, Nobu-hisa; Oe, Takehiko] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan; [Oe, Takehiko] Nagoya Univ, Dept Crystalline Mat Sci, Nagoya, Aichi 4668550, Japan; [Kim, Wan-Seop; Chae, Dong-Hun] Korea Res Inst Stand & Sci, Taejon 305340, South Korea; [Elmquist, Randolph; Kraft, Marlin] NIST, Quantum Measurement Div, Gaithersburg, MD 20899 USA	Kaneko, NH (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	nobuhisa.kaneko@aist.go.jp; t.oe@aist.go.jp; ws2kim@kriss.re.kr; dhchae@kriss.re.kr; randolph.elmquist@nist.gov; marlin.kraft@nist.gov					Alpha Electronics Corp, 2014, ULTR PRIM STAND RES; Jeckelmann B, 1997, PHYS REV B, V55, P13124, DOI 10.1103/PhysRevB.55.13124; HARVEY IK, 1972, REV SCI INSTRUM, V43, P1626, DOI 10.1063/1.1685508; Delahaye F, 1997, METROLOGIA, V34, P211, DOI 10.1088/0026-1394/34/3/2; Domae A, 2013, IEEE T INSTRUM MEAS, V62, P1776, DOI 10.1109/TIM.2013.2253973; Domae A., 2014, CPEM AUG, P100; Kaneko N., 2012, NCSLI MEAS J MEAS SC, V7, P34; Kaneko N.-H., 2014, CPEM AUG, P546; MACMARTI.MP, 1966, IEEE T INSTRUM MEAS, VIM15, P212, DOI 10.1109/TIM.1966.4313542; Sakamoto Y, 2011, IEEE T INSTRUM MEAS, V60, P2544, DOI 10.1109/TIM.2011.2108613; Schumacker B., 2007, METROLOGIA, V44, DOI DOI 10.1088/0026-1394/44/1A/01004	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1514	1519		10.1109/TIM.2015.2399013		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300034		
J	Mizushima, S; Kuramoto, N; Ueda, K; Fujii, K				Mizushima, Shigeki; Kuramoto, Naoki; Ueda, Kazunaga; Fujii, Kenichi			Mass Measurement of 1-kg Silicon Spheres for Determination of the Avogadro and Planck Constants	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Avogadro's constant; mass measurement; Planck's constant; silicon sphere	WATT BALANCE; KILOGRAM; STANDARDS; PROJECT; SI	For the accurate determination of the Avogadro and Planck constants by the X-ray crystal density method, the mass of 1-kg silicon spheres must be measured precisely. This paper describes the mass measurement method and the evaluation of its uncertainty at the National Metrology Institute of Japan (NMIJ). For the precise mass measurement, the amount of the physical adsorption of water vapor on the surface of the silicon spheres, which could be a relative amount of about 10(-8) of the total mass, was evaluated by comparison weighings both in nitrogen gas and in water vapor at a pressure of about 1200 Pa. In addition, we compare the results of seven 1-kg mass measurements conducted at the NMIJ and the International Bureau of Weights and Measures from 1996 to 2011 to confirm the reliability of our mass measurement.	[Mizushima, Shigeki; Kuramoto, Naoki; Ueda, Kazunaga; Fujii, Kenichi] Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Mizushima, Shigeki; Kuramoto, Naoki; Ueda, Kazunaga; Fujii, Kenichi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058563, Japan	Mizushima, S (reprint author), Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	s.mizushima@aist.go.jp; n.kuramoto@aist.go.jp; kazunaga-ueda@aist.go.jp; fujii.kenichi@aist.go.jp			Japan Society for the Promotion of Science [24360037]	This work was supported by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research under Grant 24360037. This work was conducted in the framework of unfunded participation in the European Metrology Research Programme. The Associate Editor coordinating the review process was Dr. Branislav Djokic.	Andreas B, 2011, METROLOGIA, V48, pS1, DOI 10.1088/0026-1394/48/2/S01; Picard A, 2011, METROLOGIA, V48, pS112, DOI 10.1088/0026-1394/48/2/S14; Sanchez CA, 2014, METROLOGIA, V51, pS5, DOI 10.1088/0026-1394/51/2/S5; Andreas B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030801; Milton MJT, 2014, METROLOGIA, V51, pR21, DOI 10.1088/0026-1394/51/3/R21; Busch I, 2011, METROLOGIA, V48, pS62, DOI 10.1088/0026-1394/48/2/S10; Schlamminger S, 2014, METROLOGIA, V51, pS15, DOI 10.1088/0026-1394/51/2/S15; Aupetit C., 2004, METROLOGIA S, V41, DOI 10.1088/0026-1394/41/1A/07002; Becerra Luis Omar, 2014, Metrologia, V51, DOI 10.1088/0026-1394/51/1A/07009; Consultative Committee for Mass and Related Quantities, 2013, STRAT 2014 2024; Consultative Committee for Mass and Related Quantities, 2013, P 14 M CCM, P36; Consultative Committee for Mass and Related Quantities, 2010, P 12 M CCM, P23; Consultative Committee for Units, 2005, P 17 M CCU, P16; General Conference on Weights and Measures, 2011, P 24 M CGPM, P532; GIRARD G, 1994, METROLOGIA, V31, P317, DOI 10.1088/0026-1394/31/4/007; International Bureau of Weights and Measures, 1993, UNPUB; International Committee for Weights and Measures, 2005, P 94 M CIPM, P233; MCCLELLA.AL, 1967, J COLLOID INTERF SCI, V23, P577, DOI 10.1016/0021-9797(67)90204-4; Mizushima S, 2004, METROLOGIA, V41, pS68, DOI 10.1088/0026-1394/41/2/S07; Mizushima S., 2014, P CPEM RIO DE JAN BR, P392; Mohr PJ, 2012, REV MOD PHYS, V84, P1527, DOI 10.1103/RevModPhys.84.1527; Picard A, 2004, METROLOGIA, V41, P333, DOI 10.1088/0026-1394/41/4/016; Picard A., 2008, METROLOGIA, V46, P1; Stenger J, 2012, METROLOGIA, V49, pL25, DOI 10.1088/0026-1394/49/6/L25	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1527	1532		10.1109/TIM.2015.2389351		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300036		
J	Yamada, T; Kon, S				Yamada, Tatsuji; Kon, Seitaro			Error and Uncertainty Estimations for A Passive-CC-Based AC Current Ratio Standard at High Audio Frequencies	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Calibration; current comparators (CCs); current transformers (CTs); error compensation; uncertainty	CURRENT COMPARATOR; SYSTEM	This paper describes a development framework for alternating current ratio standard working at high audio frequencies. To realize this, first, a calibration method for frequency-dependent balancing current generators (BCGs) producing error currents to balance current comparators (CCs) is proposed. Second, the BCG error correction is made not only for the current transformer (CT) calibration but also for the CC self-calibration. Third, practical capacitive error corrections are also proposed to be introduced for the CT and CC calibrations. Finally, in consideration of the BCG error, capacitive error, and compensated CC error, a proposed way of calculating CT error and estimating its uncertainty is described.	[Yamada, Tatsuji; Kon, Seitaro] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan	Yamada, T (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	yamada.79@aist.go.jp					[Anonymous], 2002, 600448 IEC; [Anonymous], 2004, 6185092 IEC; Kon S, 2011, IEEE T INSTRUM MEAS, V60, P2286, DOI 10.1109/TIM.2010.2103414; KUSTERS NL, 1964, IEEE T INSTRUM MEAS, VIM13, P107, DOI 10.1109/TIM.1964.4313383; Miljanic P.N., 1962, Transactions of the American Institute of Electrical Engineers, Part I (Communications and Electronics), V81; Moore W. J. M., 1988, IEE ELECT MEASUREMEN; Takahashi K., 2001, THESIS SAGA U SAGA; TAKAHASHI K, 1989, IEEE T INSTRUM MEAS, V38, P402, DOI 10.1109/19.192315; UCA International Users Group, 2004, 6185092 IEC UCA INT; Yamada T, 2012, IEEE T POWER DELIVER, V27, P1377, DOI 10.1109/TPWRD.2012.2189590; Yamada T., 2014, CPEM DIG AUG, P728	11	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1546	1552		10.1109/TIM.2015.2407511		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300039		
J	Amagai, Y; Fujiki, H; Shimizume, K; Kishino, K; Hidaka, S				Amagai, Yasutaka; Fujiki, Hiroyuki; Shimizume, Koji; Kishino, Kaname; Hidaka, Shigeru			Improvements in the Low-Frequency Characteristic and Sensitivity of a Thin-Film Multijunction Thermal Converter in Vacuum	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						AC-DC difference; electrical variable measurement; numerical analysis; thermal converter; thermal voltage converter	AC-DC TRANSFER; TRANSFER STANDARDS; PERFORMANCE; SIMULATION; CHIP	We have improved the ac-dc transfer differences and enhanced the sensitivity in our thin-film multijunction thermal converters (TFMJTCs) in vacuum. The ac-dc transfer differences of the TFMJTCs are less than 1 mu V/V down to 1 Hz and 10 mu V/V down to 0.2 Hz owing to the increased thermal time constant. The measured output voltage exceeds 120 mV at 10(-4) Pa owing to the reduction of heat conduction to the air. The sensitivity of the device, defined as the ratio of the output voltage to the input power, is 2.4 V/W, which is approximately three times larger than that measured at ambient pressure. Numerical simulations of the heat transfer of our TFMJTC explain the experimental results well.	[Amagai, Yasutaka; Fujiki, Hiroyuki] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan; [Shimizume, Koji; Kishino, Kaname; Hidaka, Shigeru] Nikkohm Co Ltd, Misawa 0330036, Japan	Amagai, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	y-amagai@aist.go.jp; h-fujiki@aist.go.jp; shimizume-k@nikkohm.co.jp; kishino-k@nikkohm.co.jp; hidaka@nikkohm.co.jp					Amaga Y, 2014, ELECTR ENG JPN, V188, P18, DOI 10.1002/eej.22524; Amagai Y., 2014, P C PREC EL MEAS CPE, P50; Escriba C, 2005, SENSOR ACTUAT A-PHYS, V120, P267, DOI 10.1016/j.sna.2004.11.027; MASTRANGELO CH, 1991, IEEE J SOLID-ST CIRC, V26, P1998, DOI 10.1109/4.104194; Avramov-Zamurovic S, 1998, IEEE T INSTRUM MEAS, V47, P87, DOI 10.1109/19.728796; Du CH, 2002, JPN J APPL PHYS 1, V41, P4340, DOI 10.1143/JJAP.41.4340; Fujiki H., 2014, P C PREC EL MEAS CPE, P48; Fujiki H, 2007, IEEE SENS J, V7, P1243, DOI 10.1109/JSEN.2007.897966; Fujiki H, 2011, IEEE T INSTRUM MEAS, V60, P2725, DOI 10.1109/TIM.2010.2103412; Hidaka S, 2013, IEEJ T ELECTR ELECTR, V8, P101, DOI 10.1002/tee.21797; INGLIS BD, 1992, METROLOGIA, V29, P191, DOI 10.1088/0026-1394/29/2/007; KINARD JR, 1995, IEEE T INSTRUM MEAS, V44, P383, DOI 10.1109/19.377859; KLONZ M, 1989, IEEE T INSTRUM MEAS, V38, P335, DOI 10.1109/19.192301; Klonz M, 2001, IEEE T INSTRUM MEAS, V50, P1490, DOI 10.1109/19.982933; Laiz H, 1999, IEEE T INSTRUM MEAS, V48, P1155, DOI 10.1109/19.816130; Laiz H, 2003, IEEE T INSTRUM MEAS, V52, P350, DOI 10.1109/TIM.2003.810037; Laiz H, 1999, MICROELECTR J, V30, P1155, DOI 10.1016/S0026-2692(99)00079-8; Lipe TE, 2013, J PHYS CONF SER, V450, DOI 10.1088/1742-6596/450/1/012036; Oldham NM, 1997, IEEE T INSTRUM MEAS, V46, P352, DOI 10.1109/19.571854; Sasaki H, 2010, IEEE T INSTRUM MEAS, V59, P2930, DOI 10.1109/TIM.2010.2047126; SASAKI H, 1993, IEEE T INSTRUM MEAS, V42, P603, DOI 10.1109/19.278635; Sasaki H, 2011, IEEJ T ELECTR ELECTR, V6, P293, DOI 10.1002/tee.20659; Swerlein R. L., 1997, PROGRAM LISTING DESC; Wunsch TF, 2001, IEEE T INSTRUM MEAS, V50, P330, DOI 10.1109/19.918134	24	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1570	1575		10.1109/TIM.2014.2385133		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300043		
J	Amagai, Y; Yamamoto, A; Akoshima, M; Fujiki, H; Kaneko, N				Amagai, Yasutaka; Yamamoto, Atsushi; Akoshima, Megumi; Fujiki, Hiroyuki; Kaneko, Nobu-hisa			AC/DC Transfer Technique for Measuring Thomson Coefficient: Toward Thermoelectric Metrology	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						AC-DC difference; electrical variable measurement; thermal converter; thermal variable measurement; thermoelectric energy conversion; thermoelectricity	JUNCTION THERMAL CONVERTERS; ABSOLUTE SCALE	We introduce an ac/dc transfer technique for measuring the Thomson coefficient of a metallic sample in high-temperature thermoelectric metrology. The Thomson coefficient is measured by applying equivalent dc and ac to a metallic wire configured similarly to a single-junction thermal converter that is widely used in ac/dc transfer devices. The use of ac/dc makes the expression of the Thomson coefficient simpler than in conventional methods. We describe the measurement principle, the design of the measurement setup, and the experimental results in detail. The experimental results agree closely with those obtained from using a conventional method.	[Amagai, Yasutaka; Akoshima, Megumi; Fujiki, Hiroyuki; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan; [Yamamoto, Atsushi] Natl Inst Adv Ind Sci & Technol, Energy Technol Res Inst, Tsukuba, Ibaraki 3058568, Japan	Amagai, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	y-amagai@aist.go.jp; a.yamamoto@aist.go.jp			Japan-U.S. Cooperation on Clean Energy Technologies through the Ministry of Economy, Trade and Industry; Japan Society for the Promotion of Science [25871194]	The work was supported in part by the Japan-U.S. Cooperation on Clean Energy Technologies through the Ministry of Economy, Trade and Industry and in part by the Japan Society for the Promotion of Science through the Grants-in-Aid for Scientific Research under Grant 25871194. The Associate Editor coordinating the review process was Dr. Lucas Di Lillo.	Amagai Y., 2014, CPEM DIG, P52; Amagai Y., 2014, P MAT RES SOC S, V1642, P1; [Anonymous], 2008, EV MEAS DAT GUID EXP; Martin J, 2010, J APPL PHYS, V108, DOI 10.1063/1.3503505; Bubanja V, 2000, J ENG MATH, V38, P33, DOI 10.1023/A:1004637514734; He C. Y., 1972, J PHYS CHEM REF DATA, V1, P279; HERMACH FL, 1952, J RES NAT BUR STAND, V48, P121, DOI 10.6028/jres.048.018; Hust I. G., 1975, THERMAL CONDUCTIVITY, P1; INGLIS BD, 1978, IEEE T INSTRUM MEAS, V27, P440, DOI 10.1109/TIM.1978.4314734; Nettleton H.R., 1916, Proceedings of the Physical Society of London, V29, DOI 10.1088/1478-7814/29/1/304; ROBERTS RB, 1981, PHILOS MAG B, V43, P1125, DOI 10.1080/01418638108222579; ROBERTS RB, 1977, NATURE, V265, P226, DOI 10.1038/265226a0; ROBERTS RB, 1977, PHILOS MAG, V36, P91, DOI 10.1080/00318087708244450; ROBERTS RB, 1985, PHILOS MAG B, V52, P1147, DOI 10.1080/13642818508238957; Sasaki H, 1999, IEEE T INSTRUM MEAS, V48, P408, DOI 10.1109/19.769612; UHER C, 1987, J APPL PHYS, V62, P4636, DOI 10.1063/1.339011; Widdis F.C., 1962, Proceedings of the Institution of Electrical Engineers. C. Institution Monographs, V109	17	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1576	1581		10.1109/TIM.2014.2381752		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300044		
J	Domae, A; Sakamoto, N; Kiryu, S; Kaneko, N				Domae, Atsushi; Sakamoto, Norihiko; Kiryu, Syogo; Kaneko, Nobu-hisa			Development of 7.75 Ratio Voltage Divider Toward a Precise Measurement of Decade Resistance Based on the AC Quantized Hall Resistance	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						AC quantized Hall resistance (QHR); ac resistance; bridge circuit; inductive voltage divider (IVD); voltage ratio	CALIBRATION; CAPACITANCE; RESISTORS; STANDARDS	At the National Metrology Institute of Japan, we are developing a transformer bridge circuit that can precisely compare the i = 2 plateau resistance in an ac quantized Hall resistance with a 100-k Omega resistance. In this paper, we propose a practical transformer voltage ratio of 7.75:1, which is the most important parameter for developing a transformer bridge circuit. Further, we describe the design of an inductive voltage divider (IVD) to realize the 7.75:1 ratio. We intend to use the proposed IVD as a reference standard for calibrating the voltage ratio of the transformer. The reference IVD was fabricated with the two-stage technique and calibrated by Thompson's method. The deviation from the nominal ratio of 7.75 was estimated to be -5.92x10(-6) for in-phase and -22.75x10(-6) for quadrature. The standard uncertainty of this calibration was estimated to be 0.63 x 10(-6) for in-phase and 6.28 x 10(-6) for quadrature.	[Domae, Atsushi; Sakamoto, Norihiko; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Kiryu, Syogo] Tokyo City Univ, Setagaya Ku, Tokyo 1580082, Japan	Domae, A (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	domae-atsushi@aist.go.jp					QUINN TJ, 1989, METROLOGIA, V26, P69, DOI 10.1088/0026-1394/26/1/006; Schurr J, 2009, METROLOGIA, V46, P619, DOI 10.1088/0026-1394/46/6/003; Chua SW, 1999, IEEE T INSTRUM MEAS, V48, P342; DELAHAYE F, 1993, IEEE T INSTRUM MEAS, V42, P287, DOI 10.1109/19.278566; Domae A., 2009, SOC SIGNAL PROCESS A, V12, P17; Domae A, 2011, IEEE T INSTRUM MEAS, V60, P2602, DOI 10.1109/TIM.2010.2101192; Domae A., 2014, CPEM C RIO DE JAN BR, P686; Eckardt H., 2001, CCEMK3 PHYS TECHN BU; Gibbings D.L.H., 1963, Proceedings of the Institution of Electrical Engineers, V110; Inglis AD, 2003, IEEE T INSTRUM MEAS, V52, P559, DOI 10.1109/TIM.2003.810454; Kibble B. P., 1984, COAXIAL AC BRIDGES; Kibble BP, 2008, METROLOGIA, V45, pL25, DOI 10.1088/0026-1394/45/5/N01; Kon S, 2011, IEEE T INSTRUM MEAS, V60, P2286, DOI 10.1109/TIM.2010.2103414; MELCHER J, 1993, IEEE T INSTRUM MEAS, V42, P292, DOI 10.1109/19.278568; Nakamura Y, 2001, IEEE T INSTRUM MEAS, V50, P290, DOI 10.1109/19.918124; Nakamura Y., 2005, AIST B METROL, V4, P45; THOMPSON AM, 1983, IEEE T INSTRUM MEAS, V32, P47, DOI 10.1109/TIM.1983.4315008; Witt TJ, 1998, REV SCI INSTRUM, V69, P2823, DOI 10.1063/1.1149062	18	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1588	1594		10.1109/TIM.2014.2383131		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300046		
J	Maruyama, M; Iwasa, A; Yamamori, H; Chen, SF; Urano, C; Kaneko, N				Maruyama, Michitaka; Iwasa, Akio; Yamamori, Hirotake; Chen, Shih-Fang; Urano, Chiharu; Kaneko, Nobu-hisa			Calibration System for Zener Voltage Standards Using a 10 V Programmable Josephson Voltage Standard at NMIJ	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Calibration; dc voltage; Josephson junction array; liquid helium; mechanical cooler; programmable Josephson voltage standard (PJVS); Zener voltage standard		We have developed a calibration system for the Zener voltage standards using a programmable Josephson voltage standard (PJVS) for liquid-helium consumption reduction and improvement in the calibration performance. The PJVS array is composed of 524 288 niobium nitride (NbN)-based overdamped Josephson junctions and is cooled by a 10-K compact cooler. To verify the validity of the system, indirect and direct comparisons of the PJVS system and our conventional Josephson voltage standard system have been carried out. As a result, an agreement within a relative expanded uncertainty of 8.4 x 10(-10) was obtained for a nominal voltage of 10 V. We also discuss the uncertainty sources in the calibration of the Zener voltage standards using our PJVS system.	[Maruyama, Michitaka; Iwasa, Akio; Urano, Chiharu; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058566, Japan; [Yamamori, Hirotake] Natl Inst Adv Ind Sci & Technol, Nanoelect Res Inst, Tsukuba, Ibaraki 3058566, Japan; [Chen, Shih-Fang] Ind Technol Res Inst, Ctr Measurement Stand, Hsinchu 31040, Taiwan	Maruyama, M (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058566, Japan.	m-maruyama@aist.go.jp					Burroughs CJ, 2011, IEEE T INSTRUM MEAS, V60, P2482, DOI 10.1109/TIM.2010.2101191; Benz SP, 1997, APPL PHYS LETT, V71, P1866, DOI 10.1063/1.120189; HAMILTON CA, 1995, IEEE T INSTRUM MEAS, V44, P223, DOI 10.1109/19.377816; Budovsky I, 2010, 2010 CONFERENCE ON PRECISION ELECTROMAGNETIC MEASUREMENTS CPEM, P50, DOI 10.1109/CPEM.2010.5543405; Granger G., 2014, P CPEM AUG, P530; Hamilton CA, 1997, IEEE T APPL SUPERCON, V7, P3756, DOI 10.1109/77.622234; Maruyama M., 2014, P CPEM AUG, P416; Maruyama M., 2014, P CPEM AUG, P260; Maruyama M., 2014, P CPEM AUG, P262; Murayama Y, 1997, IEEE T INSTRUM MEAS, V46, P233, DOI 10.1109/19.571820; Overney F, 2010, 2010 CONFERENCE ON PRECISION ELECTROMAGNETIC MEASUREMENTS CPEM, P215, DOI 10.1109/CPEM.2010.5544779; SAKAMOTO Y, 1991, IEEE T INSTRUM MEAS, V40, P337, DOI 10.1109/TIM.1990.1032953; Schulze H, 2000, SUPERCOND SCI TECH, V13, P1293, DOI 10.1088/0953-2048/13/9/301; Shoji A, 2003, IEEE T APPL SUPERCON, V13, P919, DOI 10.1109/TASC.2003.814082; Takahashi H., 2014, P INT SUP S ISS NOV; Williams J. M., 2012, P CPEM JUL, P676; Witt TJ, 2002, IEE P-SCI MEAS TECH, V149, P305, DOI 10.1049/ip-smt:20020640; Yamada T., 2009, SUPERCOND SCI TECH, V22; Yamada T, 2009, IEEE T INSTRUM MEAS, V58, P832, DOI 10.1109/TIM.2008.2008580; Yamamori H., 2008, SUPERCOND SCI TECH, V21	20	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1606	1612		10.1109/TIM.2015.2411998		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300049		
J	Maruyama, M; Takahashi, H; Katayama, K; Yonezawa, T; Kanai, T; Iwasa, A; Urano, C; Kiryu, S; Kaneko, N				Maruyama, Michitaka; Takahashi, Hikari; Katayama, Kenichi; Yonezawa, Takahito; Kanai, Takahiro; Iwasa, Akio; Urano, Chiharu; Kiryu, Shogo; Kaneko, Nobu-hisa			Evaluation of Linearity Characteristics in Digital Voltmeters Using a PJVS System With a 10-K Cooler	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						DC voltage; digital voltmeter (DVM); Josephson junction array; linearity; mechanical cooler; precision measurements; programmable Josephson voltage standard (PJVS)	JOSEPHSON; STANDARDS	We have evaluated the linearity of commercial digital voltmeters (DVMs) using a programmable Josephson voltage standard (PJVS) system. The PJVS system is composed of a 524 288-niobium nitride-based Josephson junction array that has the ability to generate arbitrary output voltages up to 17 V with a resolution of 12 bits. In our system, the junction array is operated in a 10-K compact cooler without a liquid-helium coolant. Up to now, we have succeeded in generating accurate dc voltage levels of up to approximately 13 V using this system. In this paper, we demonstrate our PJVS system as a tool for investigating the linearity characteristics of commercial DVMs, with an accuracy level of 0.1 mu V/V or better, and discuss the uncertainty sources in these measurements.	[Maruyama, Michitaka; Iwasa, Akio; Urano, Chiharu; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan; [Takahashi, Hikari; Kiryu, Shogo] Tokyo City Univ, Fac Engn, Tokyo 1588557, Japan; [Katayama, Kenichi; Yonezawa, Takahito; Kanai, Takahiro] ADC Corp, Saitama 3550812, Japan	Maruyama, M (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	m-maruyama@aist.go.jp					Burroughs CJ, 2011, IEEE T INSTRUM MEAS, V60, P2482, DOI 10.1109/TIM.2010.2101191; Muller F, 2013, IEEE T APPL SUPERCON, V23, DOI 10.1109/TASC.2012.2235895; HAMILTON CA, 1995, IEEE T INSTRUM MEAS, V44, P223, DOI 10.1109/19.377816; [Anonymous], 2008, 1002008 JCGM, V100, P2008; van den Brom HE, 2007, MEAS SCI TECHNOL, V18, P3316, DOI 10.1088/0957-0233/18/11/008; Chen S.-F., 2014, P CPEM AUG, P258; GIEM JI, 1991, IEEE T INSTRUM MEAS, V40, P329, DOI 10.1109/TIM.1990.1032951; GOEKE WC, 1989, HEWLETT-PACKARD J, V40, P22; Hamilton CA, 1997, IEEE T INSTRUM MEAS, V46, P224, DOI 10.1109/19.571818; Iwasa A., 2011, P NCSL INT WORKSH S; Maruyama M., 2014, P CPEM AUG, P260; Maruyama M., 2014, P CPEM AUG, P262; POPEL R, 1992, METROLOGIA, V29, P153, DOI 10.1088/0026-1394/29/2/005; Rufenacht A., 2014, IEEE EARLY ACCESS AR, VPP, P1; Yamada T., 2009, SUPERCOND SCI TECH, V22; Yamamori H., 2008, SUPERCOND SCI TECH, V21	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1613	1619		10.1109/TIM.2015.2418455		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300050		
J	Kuramoto, N; Azuma, Y; Inaba, H; Hong, FL; Fujii, K				Kuramoto, Naoki; Azuma, Yasushi; Inaba, Hajime; Hong, Feng-Lei; Fujii, Kenichi			Improvements to the Volume Measurement of Si-28 Spheres to Determine the Avogadro Constant	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Avogadro constant; diameter measurement; optical interferometer; silicon crystal; spectroscopic ellipsometer; volume measurement	KILOGRAM; INTERFEROMETER; SYSTEM; UNITS	In the determination of the Avogadro constant using the X-ray crystal density method with a Si-28-enriched crystal prepared by the International Avogadro Coordination (IAC) project, the volume measurement and surface analysis of Si-28 spheres play a crucial role. For accurate volume determination, an optical interferometer has been improved taking account of the geometrical shape of the optical components. Furthermore, a new spectroscopic ellipsometer with a sphere rotation system has been developed for accurate surface analysis. The optical interferometer and the ellipsometer have been used for the volume determination and surface analysis of the Si-28 spheres repolished by the IAC, respectively. On the basis of the preliminary uncertainty estimation, the relative standard uncertainty of the apparent volume measurement has been reduced from 4.4 x 10(-8) to 2.7 x 10(-8) by the improvement of the interferometer. The number of ellipsometric measurement points on the sphere surface has been increased from 20 to 7782 by the installation of the new ellipsometer, yielding more reliable information on the sphere surface. Details of the improvements and the preliminary results of the measurements of the Si-28 spheres are given.	[Kuramoto, Naoki; Azuma, Yasushi; Inaba, Hajime; Hong, Feng-Lei; Fujii, Kenichi] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan	Kuramoto, N (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	n.kuramoto@aist.go.jp; azuma.y@aist.go.jp; h.inaba@aist.go.jp; f.hong@aist.go.jp; fujii.kenichi@aist.go.jp			Japan Society for the Promotion Science [24360037]; European Metrology Research Programme	This work was supported in part by the Grant-in-Aid for Scientific Research (B) under Grant 24360037 through the Japan Society for the Promotion Science and in part by the European Metrology Research Programme. The Associate Editor coordinating the review process was Dr. Branislav Djokic.	Andreas B, 2012, METROLOGIA, V49, P479, DOI 10.1088/0026-1394/49/4/479; Andreas B, 2011, METROLOGIA, V48, pS1, DOI 10.1088/0026-1394/48/2/S01; Andreas B, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.030801; Bartl G, 2011, METROLOGIA, V48, pS96, DOI 10.1088/0026-1394/48/2/S12; Becker P, 2007, METROLOGIA, V44, P1, DOI 10.1088/0026-1394/44/1/001; Busch I, 2011, METROLOGIA, V48, pS62, DOI 10.1088/0026-1394/48/2/S10; Kuramoto N, 2011, METROLOGIA, V48, pS83, DOI 10.1088/0026-1394/48/2/S11; Inaba H, 2006, OPT EXPRESS, V14, P5223, DOI 10.1364/OE.14.005223; Bartl G., 2009, MEAS SCI TECHNOL, V20; Davis RS, 2011, PHILOS T R SOC A, V369, P3975, DOI 10.1098/rsta.2011.0181; Inaba H, 2009, IEEE T INSTRUM MEAS, V58, P1234, DOI 10.1109/TIM.2008.2008589; ISHIKAWA J, 1995, APPL OPTICS, V34, P6095, DOI 10.1364/AO.34.006095; Kuramoto N., 2014, CPEM DIG, P210; TAYLOR BN, 1991, IEEE T INSTRUM MEAS, V40, P86, DOI 10.1109/TIM.1990.1032889	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1650	1656		10.1109/TIM.2015.2401212		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300055		
J	Waseda, A; Fujimoto, H; Zhang, XW; Kuramoto, N; Fujii, K				Waseda, Atsushi; Fujimoto, Hiroyuki; Zhang, Xiao Wei; Kuramoto, Naoki; Fujii, Kenichi			Homogeneity Characterization of Lattice Spacing of Silicon Single Crystals	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Avogadro constant; impurity; lattice comparator; lattice spacing; silicon single crystal	COMPARATOR	The homogeneity of the lattice spacing of silicon single crystals was investigated by a self-referenced lattice comparator. Strain measurements were performed on single crystals from an Si-28 ingot (Avo28), which was used to determine the Avogadro constant. A swirl pattern was observed for sample 9.R1 cut from the tail side of the Avo28 ingot. The lattice spacing distribution of seed-side sample 4.R1 was smooth and homogeneous. The lattice spacing distribution was larger for the sample with higher impurities of carbon and oxygen.	[Waseda, Atsushi; Fujimoto, Hiroyuki; Kuramoto, Naoki; Fujii, Kenichi] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan; [Zhang, Xiao Wei] High Energy Accelerator Res Org, Photon Factory, Tsukuba, Ibaraki 3050801, Japan	Waseda, A (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	waseda.atsushi@aist.go.jp; h.fujimoto@aist.go.jp; xiaowei@post.kek.jp; n.kuramoto@aist.go.jp; fujii.kenichi@aist.go.jp			Japan Society for the Promotion of Science [24360037]; European Metrology Research Programme	This work was supported in part by the Japan Society for the Promotion of Science through the Grants-in Aid for Scientific Research under Grant 24360037 and in part by the European Metrology Research Programme. The Associate Editor coordinating the review process was Dr. Branislav Djokic.	Andreas B, 2011, METROLOGIA, V48, pS1, DOI 10.1088/0026-1394/48/2/S01; Fujimoto H, 2011, METROLOGIA, V48, pS55, DOI 10.1088/0026-1394/48/2/S09; Fujii K, 2005, IEEE T INSTRUM MEAS, V54, P854, DOI 10.1109/TIM.2004.843101; Nakayama K, 1997, IEEE T INSTRUM MEAS, V46, P580, DOI 10.1109/19.571922; Waseda A., 2014, P C PREC EL MEAS CPE, P400; Zhang XW, 2003, J APPL CRYSTALLOGR, V36, P188, DOI 10.1107/S0021889802021374	6	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1692	1695		10.1109/TIM.2014.2383091		4	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300061		
J	Nakamura, S; Pashkin, YA; Tsai, JS; Kaneko, N				Nakamura, Shuji; Pashkin, Yuri A.; Tsai, Jaw-Shen; Kaneko, Nobu-hisa			Single-Electron Pumping by Parallel SINIS Turnstiles for Quantum Current Standard	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Parallel operation; quantum current standard; single-electron transistor; SINIS turnstile; superconductor	PHASE-SLIP	As a step toward realizing the quantum current standard, single-electron pumping of parallel SINIS turnstiles was performed. Eleven SINIS turnstiles were fabricated on the same chip, and the number of operating SINIS turnstiles was increased one by one. As a result, 11 turnstiles were operated simultaneously up to 100 MHz, resulting in a pumped dc of 176.2 pA. We also did a linearity check toward parallelization. This paper for increasing the pumped current by parallelization will lead to practical use of stable and accurate dc sources with tiny values of the output current and the metrology triangle experiment for SI redefinition.	[Nakamura, Shuji; Kaneko, Nobu-hisa] Natl Inst Adv Ind Sci & Techonol, Tsukuba, Ibaraki 3058563, Japan; [Pashkin, Yuri A.] Univ Lancaster, Dept Phys, Lancaster LA1 4YB, England; [Tsai, Jaw-Shen] Inst Phys & Chem Res, Tsukuba, Ibaraki 3058501, Japan	Nakamura, S (reprint author), Natl Inst Adv Ind Sci & Techonol, Tsukuba, Ibaraki 3058563, Japan.	shuji.nakamura@aist.go.jp; nobuhisa.kaneko@aist.go.jp			U.K. Engineering and Physical Sciences Research Council; Royal Society; Wolfson Foundation;  [13307974]	This work was supported by the Grants-in-Aid for Scientific Research under Grant 13307974. The work of Y. A. Pashkin was supported in part by the U.K. Engineering and Physical Sciences Research Council, in part by the Royal Society, and in part by the Wolfson Foundation. The Associate Editor coordinating the review process was Dr. Regis Landim.	Kemppinen A, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3127229; Astafiev OV, 2012, NATURE, V484, P355, DOI 10.1038/nature10930; Pekola JP, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.026803; Pekola JR, 2008, NAT PHYS, V4, P120, DOI 10.1038/nphys808; Blumenthal MD, 2007, NAT PHYS, V3, P343, DOI 10.1038/nphys582; Keller MW, 1996, APPL PHYS LETT, V69, P1804, DOI 10.1063/1.117492; Mooij JE, 2006, NAT PHYS, V2, P169, DOI 10.1038/nphys234; Scherer H, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/12/124010; Averin DV, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.066801; Maisi VF, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/113057; Pekola JP, 2013, REV MOD PHYS, V85, P1421, DOI 10.1103/RevModPhys.85.1421; Benz SP, 2000, APPL PHYS LETT, V77, P1014, DOI 10.1063/1.1288597; Knowles HS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4730407; Nakamura S., 2014, P CPEM AUG, P660; Nakamura S., UNPUB; Ohshiro T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00501	16	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1696	1701		10.1109/TIM.2015.2418452		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300062		
J	Kato, Y; Horibe, M; Ameya, M; Kurokawa, S; Shimada, Y				Kato, Yuto; Horibe, Masahiro; Ameya, Michitaka; Kurokawa, Satoru; Shimada, Yozo			New Uncertainty Analysis for Permittivity Measurements Using the Transmission/Reflection Method	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						Network analyzer; permittivity measurement; S-parameter; transmission/reflection (T/R) method; uncertainty		We have developed a new algorithm for the uncertainty analysis of permittivity calculations of high-loss materials using the transmission/reflection (T/R) method. In the T/R method, several calculation procedures are performed to derive the permittivity. In our method, the permittivity is derived from measured S-parameters by solving an equation in which S-parameters are included in the form (S-21+S-12)+beta(S-11+S-22), where beta is a weighted factor to be optimized to minimize the uncertainty. We confirmed its efficacy by doing numerical calculations, as well as using actual measurement data for several materials obtained with a waveguide fixture. We also considered the effect of the type of calibration method used on a vector network analyzer on the permittivity uncertainty, and quantitatively clarified that it is essential to develop a highly accurate S-parameter measurement system to perform permittivity measurements using the T/R method accurately.	[Kato, Yuto; Horibe, Masahiro; Ameya, Michitaka; Kurokawa, Satoru; Shimada, Yozo] Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan	Kato, Y (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058563, Japan.	y-katou@aist.go.jp					Baker-Jarvis J., 1990, 1341 NAT I STAND TEC; BIPM IEC IFCC ISO IUPAC IUPAP OIML, 2008, 100 BIPM IEC IFCC IS; de Vreede J. P. M., 2003, 038 NAT PHYS LAB; EURAMET, 2007, EURAMETCG12; Kato Y., 2014, P EUR MICR C EUMC OC, P1174; Kato Y., 2014, P C PREC EL MEAS CPE, P186; Kim S., 2012, P 2012 C PREC EL MEA, P640; Rytting D., 1987, P HEWL PACK RF MICR, P35	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1748	1753		10.1109/TIM.2015.2401231		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300069		
J	Fujiki, H; Amagai, Y; Shimizume, K; Kishino, K; Hidaka, S				Fujiki, Hiroyuki; Amagai, Yasutaka; Shimizume, Koji; Kishino, Kaname; Hidaka, Shigeru			Fabrication of Thin Film Multijunction Thermal Converters With Improved Long-Term Stability	IEEE TRANSACTIONS ON INSTRUMENTATION AND MEASUREMENT			English	Article						AC voltage standard; ac-dc transfer difference; long-term stability; thermal converter; thermocouple; thin film	AC-DC TRANSFER; VOLTAGE MEASUREMENTS; TRANSFER STANDARDS; PERFORMANCE; ACCURACY	To increase the long-term stability of thin-film multijunction thermal converters (TFMJTCs) developed by the National Metrology Institute of Japan and Nikkohm Corporation Ltd., we prevented their degradation by improving the design and fabrication process. Judging from the Arrhenius model experiments, we successfully increased the lifetime of a renewed TFMJTC to more than 20 years by improving the deposition pattern of a Bi-Sb-Cu-based thin-film thermopile. We also evaluated the thermoelectric effect of the renewed TFMJTCs by the fast-reversed dc method. The low thermoelectric effect of less than 0.1 mu V/V has been realized, which is comparable with that of high-quality multijunction thermal converters previously produced by other national metrology institutes.	[Fujiki, Hiroyuki; Amagai, Yasutaka] Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan; [Fujiki, Hiroyuki; Amagai, Yasutaka] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Shimizume, Koji; Kishino, Kaname; Hidaka, Shigeru] Nikkohm Co Ltd, Misawa 0330036, Japan	Fujiki, H (reprint author), Natl Metrol Inst Japan, Tsukuba, Ibaraki 3058568, Japan.	h-fujiki@aist.go.jp; y-amagai@aist.go.jp; shimizume-k@nikkohm.co.jp; kishino-k@nikkohm.co.jp; hidaka@nikkohm.co.jp					Amaga Y, 2014, ELECTR ENG JPN, V188, P18, DOI 10.1002/eej.22524; Amagai Y., 2014, P C PREC EL MEAS CPE, P50; Amagai Y, 2013, IEEE T INSTRUM MEAS, V62, P1621, DOI 10.1109/TIM.2013.2245182; Benz SP, 1997, APPL PHYS LETT, V71, P1866, DOI 10.1063/1.120189; HAMILTON CA, 1995, IEEE T INSTRUM MEAS, V44, P223, DOI 10.1109/19.377816; Behr R, 2007, IEEE T INSTRUM MEAS, V56, P235, DOI 10.1109/TIM.2007.891076; Budovsky I, 2011, IEEE T INSTRUM MEAS, V60, P2439, DOI 10.1109/TIM.2011.2108554; Fujiki H., 2014, P C PREC EL MEAS CPE, P48; Fujiki H, 2007, IEEE SENS J, V7, P1243, DOI 10.1109/JSEN.2007.897966; Fujiki H, 2011, IEEE T INSTRUM MEAS, V60, P2725, DOI 10.1109/TIM.2010.2103412; HERMACH FL, 1952, J RES NAT BUR STAND, V48, P121, DOI 10.6028/jres.048.018; HERMACH FL, 1966, IEEE T INSTRUM MEAS, VIM15, P260, DOI 10.1109/TIM.1966.4313549; INGLIS BD, 1992, METROLOGIA, V29, P191, DOI 10.1088/0026-1394/29/2/007; KINARD JR, 1995, IEEE T INSTRUM MEAS, V44, P383, DOI 10.1109/19.377859; KLONZ M, 1989, IEEE T INSTRUM MEAS, V38, P335, DOI 10.1109/19.192301; KLONZ M, 1991, IEEE T INSTRUM MEAS, V40, P350, DOI 10.1109/TIM.1990.1032957; KLONZ M, 1987, IEEE T INSTRUM MEAS, V36, P320; Laiz H, 2003, IEEE T INSTRUM MEAS, V52, P350, DOI 10.1109/TIM.2003.810037; Lipe T. E., 2012, P 2012 C PREC EL MEA, P434; Rufenacht Alain, 2009, IEEE Transactions on Instrumentation and Measurement, V58, DOI 10.1109/TIM.2008.2008087; Sasaki H., 1999, 989 ETL; Sasaki H, 2011, IEEJ T ELECTR ELECTR, V6, P293, DOI 10.1002/tee.20659; Scarioni L, 2006, IEEE T INSTRUM MEAS, V55, P2281, DOI 10.1109/TIM.2006.884130	23	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9456	1557-9662		IEEE T INSTRUM MEAS	IEEE Trans. Instrum. Meas.	JUN	2015	64	6					1754	1759		10.1109/TIM.2015.2389371		6	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI0GO	WOS:000354415300070		
J	Saito, H; Shioda, S				Saito, Hiroshi; Shioda, Shigeo			Parameter Estimation Method for Time-Variant Target Object Using Randomly Deployed Sensors and Its Application to Participatory Sensing	IEEE TRANSACTIONS ON MOBILE COMPUTING			English	Article						Sensor network; estimation; time-variant target object; (adaptive) Kalman filter; ubiquitous network; integral geometry; geometric probability; software sensor (soft sensor); participatory sensing	NETWORKS	We propose a method for estimating the size, perimeter length, and location of a time-variant target object moving in a monitored area. This method uses only binary information from sensors of which locations are unknown, where the binary information includes whether each sensor has detected the target object or not. Analysis based on integral geometry provides the relationship between the number of sensors detecting the target object and the target object parameters to be estimated. Because this relationship is linear, a linear filter, such as the Kalman filter, is applicable to estimate parameters if we can assume that the dynamics of the parameters are linear. As a concrete example, the size, shape, and location of an active thunder area is estimated. The model discussed in this paper is applicable as a model of participatory sensing.	[Saito, Hiroshi] Nippon Telegraph & Tel Corp, Network Technol Labs, Musashino, Tokyo 1808585, Japan; [Shioda, Shigeo] Chiba Univ, Dept Engn, Chiba, Japan	Saito, H (reprint author), Nippon Telegraph & Tel Corp, Network Technol Labs, 3-9-11 Midori Cho, Musashino, Tokyo 1808585, Japan.	saito.hiroshi@lab.ntt.co.jp; shioda@faculty.chiba-u.jp					Anderson B. D., 1979, OPTIMAL FILTERING; Kwon S, 2009, IEEE ACM T NETWORK, V17, P857, DOI 10.1109/TNET.2008.2002222; Cook BW, 2006, P IEEE, V94, P1177, DOI 10.1109/JPROC.2006.873620; Akyildiz IF, 2002, IEEE COMMUN MAG, V40, P102, DOI 10.1109/MCOM.2002.1024422; Saito H, 2011, IEEE T SIGNAL PROCES, V59, P4971, DOI 10.1109/TSP.2011.2161476; Saito H, 2012, IEEE T MOBILE COMPUT, V11, P125, DOI 10.1109/TMC.2011.65; Choi W, 2005, IEEE INFOCOM SER, P1985; Cressie N., 1991, STAT SPATIAL DATA; Fang L, 2005, IEEE INFOCOM SER, P161; Fortuna L, 2007, ADV IND CONTROL, P1, DOI 10.1007/978-1-84628-480-9; Kahn J M, 1999, P 5 ANN ACM IEEE INT, P271, DOI DOI 10.1145/313451.313558; Lazos L, 2007, PROCEEDINGS OF THE SIXTH INTERNATIONAL SYMPOSIUM ON INFORMATION PROCESSING IN SENSOR NETWORKS, P519, DOI 10.1109/IPSN.2007.4379712; Lazos L., 2006, ACM T SENSOR NETWORK, V2, P325, DOI 10.1145/1167935.1167937; Lin B, 2007, COMPUT CHEM ENG, V31, P419, DOI 10.1016/j.compchemeng.2006.05.030; Liu B. L., 2004, Physica Status Solidi C, DOI 10.1002/pssc.200304020; Manohar P., 2006, P IEEE GLOB TEL C SA; Pottie GJ, 2000, COMMUN ACM, V43, P51, DOI 10.1145/332833.332838; Reddy S., 2010, P 8 INT C PERV COMP, P17; Saito H., 2010, P IEEE SENS NETW UB; Saito H., 2009, P DIGITAL MAPPING EL, P1; Saito H, 2011, IEICE T INF SYST, VE94D, P772, DOI 10.1587/transinf.E94.D.772; SAITO H, 2009, P IEEE C COMP COMM, P2901; Saito H, 2008, IEEE COMMUN MAG, V46, P112, DOI 10.1109/MCOM.2008.4689217; Santalo L. A., 2004, INTEGRAL GEOMETRY GE; SHAKKOTTAI S, 2003, P IEEE INFOCOM, P1073; Tian Di, 2002, P 1 ACM INT WORKSH W, P32; UMEHIRA M, 2007, P IEEE 65 VEH TECHN, P165; Ye F., 2003, P 23 INT C DISTR COM, P28; ZHANG F, 2012, P IEEE C COMP COMM, P2246	29	0	0	IEEE COMPUTER SOC	LOS ALAMITOS	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA	1536-1233	1558-0660		IEEE T MOBILE COMPUT	IEEE. Trans. Mob. Comput.	JUN	2015	14	6					1259	1271		10.1109/TMC.2014.2347037		13	Computer Science, Information Systems; Telecommunications	Computer Science; Telecommunications	CI0UY	WOS:000354455400012		
J	Ogita, T; Bergamo, P; Maurano, F; D'Arienzo, R; Mazzarella, G; Bozzella, G; Luongo, D; Sashihara, T; Suzuki, T; Tanabe, S; Rossi, M				Ogita, Tasuku; Bergamo, Paolo; Maurano, Francesco; D'Arienzo, Rossana; Mazzarella, Giuseppe; Bozzella, Giuseppina; Luongo, Diomira; Sashihara, Toshihiro; Suzuki, Takuya; Tanabe, Soichi; Rossi, Mauro			Modulatory activity of Lactobacillus rhamnosus OLL2838 in a mouse model of intestinal immunopathology	IMMUNOBIOLOGY			English	Article						Enteropathy; Gluten; Immunomodulation; Lactobacilli; Transgenic mice	LACTIC-ACID BACTERIA; DENDRITIC CELLS; NITRIC-OXIDE; COMMENSAL BACTERIA; OXIDATIVE STRESS; TRANSGENIC MICE; IMMUNE-SYSTEM; IN-VITRO; MACROPHAGES; MICROBIOTA	Gut microbiota and probiotic strains play an important role in oral tolerance by modulating regulatory and effector cell components of the immune system. We have previously described the ability of Lactobacilli to influence both the innate and adaptive immunity to wheat gluten, a food antigen, in mouse. In this study, we further explored the immunomodulatory mechanisms elicited in this model by testing three specific probiotic strains, namely L. rhamnosus OLL2838, B. infantis ATCC15697 and S. thermophilus Sfi39. In vitro analysis showed the all tested strains induced maturation of bone marrow derived dendritic cells (DCs). However, only L. rhamnosus induced appreciable levels of IL-10 and nitric oxide productions, whereas S. thermophilus essentially elicited IL-12 and TNF-alpha. The anti-inflammatory ability of OLL2838 was then tested in vivo by adopting mice that develop a gluten-specific enteropathy. This model is characterized by villus blunting, crypt hyperplasia, high levels of intestinal IFN-gamma, increased cell apoptosis in lamina propria, and reduced intestinal total glutathione (GSHtot) and glutathione S-transferase (GST) activity. We found that, following administration of OLL2838, GSHtot and GST activity were enhanced, whereas caspase-3 activity was reduced. On the contrary, this probiotic strain failed in recovering the normal histology and further increased intestinal IFN-gamma. Confocal microscopy revealed the inability of the probiotic strain to appropriately interact with enterocytes of the small intestine and with Peyer's patches in treated mice. In conclusion, these data highlighted the potential of L. rhamnosus OLL2838 to recover specific toxicity parameters induced by gluten in enteropathic mice through mechanisms that involve induction of low levels of reactive oxygen species (ROS). (C) 2015 Elsevier GmbH. All rights reserved.	[Ogita, Tasuku] Natl Agr & Food Res Org, Natl Food Res Inst Food Funct Div, Funct Food Factor Lab, Tsukuba, Ibaraki, Japan; [Bergamo, Paolo; Maurano, Francesco; D'Arienzo, Rossana; Mazzarella, Giuseppe; Bozzella, Giuseppina; Luongo, Diomira; Rossi, Mauro] CNR, Inst Food Sci, Avellino, Italy; [Sashihara, Toshihiro] Meiji Corp Ltd, Inst Food Sci, Odawara, Japan; [Suzuki, Takuya; Tanabe, Soichi] Hiroshima Univ, Grad Sch Biosphere Sci, Hiroshima, Japan	Rossi, M (reprint author), CNR, Ist Sci Alimentaz, Via Roma 64, I-83100 Avellino, Italy.	mrossi@isa.cnr.it		Bergamo, Paolo/0000-0002-1726-7911; Maurano, Francesco/0000-0002-6780-8325	CNR	The authors thank Ms. Loredana Arciuolo for excellent technical assistance with the management of the mouse colony. This work was funded by CNR grants under the Agreement of Scientific Cooperation CNR-JSPS 2010-11 and 2013 CNR ordinary grants.	Iliev ID, 2009, MUCOSAL IMMUNOL, V2, P340, DOI 10.1038/mi.2009.13; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Sanz Y, 2011, INT REV IMMUNOL, V30, P207, DOI 10.3109/08830185.2011.599084; Connelly L, 2001, J IMMUNOL, V166, P3873; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Rescigno M, 2014, CELL MICROBIOL, V16, P1004, DOI 10.1111/cmi.12301; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Ishii T, 2000, J BIOL CHEM, V275, P16023, DOI 10.1074/jbc.275.21.16023; Baumgart DC, 2007, LANCET, V369, P1627, DOI 10.1016/S0140-6736(07)60750-8; Singh N, 2014, IMMUNITY, V40, P128, DOI 10.1016/j.immuni.2013.12.007; Grangette C, 2005, P NATL ACAD SCI USA, V102, P10321, DOI 10.1073/pnas.0504084102; O'Mahony L, 2006, AM J PHYSIOL-GASTR L, V290, pG839, DOI 10.1152/ajpgi.00112.2005; Foligne B, 2007, WORLD J GASTROENTERO, V13, P236; Bergamo P, 2007, FREE RADICAL BIO MED, V43, P71, DOI 10.1016/j.freeradbiomed.2007.03.023; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Meyer AL, 2007, J HUM NUTR DIET, V20, P590, DOI 10.1111/j.1365-277X.2007.00807.x; Wink DA, 1998, FREE RADICAL BIO MED, V25, P434, DOI 10.1016/S0891-5849(98)00092-6; Granucci F, 2003, J IMMUNOL, V170, P5075; Rivollier A, 2012, J EXP MED, V209, P139, DOI 10.1084/jem.20101387; Borchers AT, 2009, J GASTROENTEROL, V44, P26, DOI 10.1007/s00535-008-2296-0; Tejada-Simon MV, 1999, J FOOD PROTECT, V62, P1435; D'Arienzo R, 2009, CYTOKINE, V48, P254, DOI 10.1016/j.cyto.2009.08.003; Miyauchi E, 2009, J DAIRY SCI, V92, P2400, DOI 10.3168/jds.2008-1698; Bergamo P, 2011, MOL NUTR FOOD RES, V55, pS248, DOI 10.1002/mnfr.201100295; Cheng S, 1996, EUR J IMMUNOGENET, V23, P15, DOI 10.1111/j.1744-313X.1996.tb00260.x; D'Arienzo R, 2008, IMMUNOL LETT, V119, P78, DOI 10.1016/j.imlet.2008.04.006; Foligne B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000313; Green L.C., 1982, BIOCHEMISTRY-US, V126, P131, DOI DOI 10.1016/0003-2697(82)90118-X; Hiramatsu Y, 2011, CYTOTECHNOLOGY, V63, P307, DOI 10.1007/s10616-011-9349-6; Khalil R, 2009, POL J MICROBIOL, V58, P49; Kumar A, 2007, EMBO J, V26, P4457, DOI 10.1038/sj.emboj.7601867; Luongo D, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-298; Luongo D, 2009, INT REV IMMUNOL, V28, P446, DOI 10.3109/08830180903236486; Matsumoto M, 2002, CURR MICROBIOL, V44, P212, DOI 10.1007/s00284-001-0087-4; Mazzarella G, 2014, AM J PHYSIOL-GASTR L, V307, pG302, DOI 10.1152/ajpgi.00002.2014	35	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	JUN	2015	220	6					701	710		10.1016/j.imbio.2015.01.004		10	Immunology	Immunology	CI8WX	WOS:000355053500001		
J	Kotaki, R; Wajima, S; Shiokawa, A; Hachimura, S				Kotaki, Ryutaro; Wajima, Shun-ichi; Shiokawa, Aya; Hachimura, Satoshi			Toll-like receptor 2 suppresses Toll-like receptor 9 responses in Peyer's patch dendritic cells	IMMUNOBIOLOGY			English	Article						Dendritic cells; Interleukin-12; Interleukin-23; Intestinal immunity; Peyer's patches; Toll-like receptors	INNATE IMMUNE DEFENSE; MYCOBACTERIUM-TUBERCULOSIS; LYMPHOID-TISSUES; BONE-MARROW; TLR SYNERGY; T-CELLS; IN-VIVO; INDUCTION; IL-12; TUMOR	In the intestine, immune responses to commensal microbes should be regulated precisely. This regulation is achieved partly by dendritic cells (DCs), which recognize microbes through Toll-like receptors (TLRs). Although TLR responses have been intensely studied, cross-talk between individual TLRs remains unclear. The present study shows that TLR2 suppressed TLR9-induced Il12b gene expression and subsequent interleukin (IL)-12 and IL-23 production in DCs from Peyer's patch, a lymphoid tissue in the small intestine. The DCs expressed Il12b gene and produced IL-12 and IL-23 in response to TLR9 stimulation, and these responses were suppressed when the DCs were stimulated simultaneously with TLR2. The suppression was also observed in the non-intestinal DCs, such as spleen DCs and bone marrow-derived DCs. Peyer's patch DCs expressed Il12b gene also in response to TLR7 or CD40 stimulation, but these responses were not suppressed by simultaneous TLR2 stimulation. In addition, TLR9-induced Tnf and Il6 gene expression was not suppressed by TLR2. Furthermore, the supernatant of TLR2-stimulated DCs could not suppress TLR9-induced Il12b gene expression. These results suggest that TLR2 suppress TLR9-induced responses selectively, and this suppression is not mediated by secretory factors. The suppressive TLR cross-talk might play a certain role in preventing excess inflammatory responses to commensal microbes in the intestine and may have implications for the therapeutic strategies for intestinal inflammatory diseases, autoimmune diseases and cancer. (C) 2015 Elsevier GmbH. All rights reserved.	[Kotaki, Ryutaro; Wajima, Shun-ichi; Shiokawa, Aya; Hachimura, Satoshi] Univ Tokyo, Ctr Food Safety, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan	Hachimura, S (reprint author), Univ Tokyo, Ctr Food Safety, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan.	ahachi@mail.ecc.u-tokyo.ac.jp			Japan Society for the Promotion of Science (JSPS) [23380073]	This work was supported by a Grant-in-Aid for Scientific Research (B) 23380073 from the Japan Society for the Promotion of Science (JSPS) to SH.	Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Simmons DP, 2010, J IMMUNOL, V185, P2405, DOI 10.4049/jimmunol.0904005; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Uhlig HH, 2006, IMMUNITY, V25, P309, DOI 10.1016/j.immuni.2006.05.017; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Chaudhry A, 2011, IMMUNITY, V34, P566, DOI 10.1016/j.immuni.2011.03.018; Becker C, 2003, J CLIN INVEST, V112, P693, DOI 10.1172/JC1200317464; Lelouard H, 2012, GASTROENTEROLOGY, V142, P592, DOI 10.1053/j.gastro.2011.11.039; Bode KA, 2009, J IMMUNOL, V182, P2176, DOI 10.4049/jimmunol.0802560; Tye H, 2012, CANCER CELL, V22, P466, DOI 10.1016/j.ccr.2012.08.010; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Liu B, 2011, GASTROENTEROLOGY, V141, P653, DOI 10.1053/j.gastro.2011.04.053; Neutra MR, 2001, NAT IMMUNOL, V2, P1004, DOI 10.1038/ni1101-1004; Manicassamy S, 2009, NAT MED, V15, P401, DOI 10.1038/nm.1925; Goriely S, 2008, NAT REV IMMUNOL, V8, P81, DOI 10.1038/nri2225; Sato A, 2003, J IMMUNOL, V171, P3684; Hue S, 2006, J EXP MED, V203, P2473, DOI 10.1084/jem.20061099; Negishi H, 2012, NAT IMMUNOL, V13, P659, DOI 10.1038/ni.2307; Yen D, 2006, J CLIN INVEST, V116, P1310, DOI 10.1172/JCI21404; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Hall JA, 2008, IMMUNITY, V29, P637, DOI 10.1016/j.immuni.2008.08.009; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Monteleone I, 2008, EUR J IMMUNOL, V38, P1533, DOI 10.1002/eji.200737909; Ouyang XS, 2007, BIOCHEM BIOPH RES CO, V354, P1045, DOI 10.1016/j.bbrc.2007.01.090; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Huber S, 2011, IMMUNITY, V34, P554, DOI 10.1016/j.immuni.2011.01.020; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Edwards AD, 2002, J IMMUNOL, V169, P3652; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Obata T, 2010, P NATL ACAD SCI USA, V107, P7419, DOI 10.1073/pnas.1001061107; Schulz O, 2013, TRENDS IMMUNOL, V34, P155, DOI 10.1016/j.it.2012.09.006; Vignali DAA, 2012, NAT IMMUNOL, V13, P722, DOI 10.1038/ni.2366; Davidson NJ, 1998, J IMMUNOL, V161, P3143; Makela SM, 2009, J LEUKOCYTE BIOL, V85, P664, DOI 10.1189/jlb.0808503; Krummen M, 2010, J LEUKOCYTE BIOL, V88, P189, DOI 10.1189/jlb.0408228; Liu YC, 2012, J IMMUNOL, V188, P1019, DOI 10.4049/jimmunol.1102181; Re F, 2004, J IMMUNOL, V173, P7548; Hirata N, 2008, MOL IMMUNOL, V45, P2734, DOI 10.1016/j.molimm.2008.02.010; Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457; Pompei L, 2007, J IMMUNOL, V178, P5192; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Huang B, 2007, CANCER RES, V67, P4346, DOI 10.1158/0008-5472.CAN-06-4067; Mitchell D, 2010, J INFECT DIS, V202, P318, DOI 10.1086/653499; Shcheblyakov DV, 2011, ACTA NATURAE, V3, P83; Wang S, 2011, J IMMUNOL, V187, P141, DOI 10.4049/jimmunol.1003740; Yang HZ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006520; Zhang CY, 2012, CELL MOL IMMUNOL, V9, P324, DOI 10.1038/cmi.2012.11	47	0	0	ELSEVIER GMBH, URBAN & FISCHER VERLAG	JENA	OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY	0171-2985			IMMUNOBIOLOGY	Immunobiology	JUN	2015	220	6					734	743		10.1016/j.imbio.2014.12.022		10	Immunology	Immunology	CI8WX	WOS:000355053500005		
J	Meyer-Rochow, VB				Meyer-Rochow, Victor Benno			Compound eyes of insects and crustaceans: Some examples that show there is still a lot of work left to be done	INSECT SCIENCE			English	Article						aging; miniaturization; photoreceptors; sexual dimorphism; vision	POSTEMBRYONIC PHOTORECEPTOR DEVELOPMENT; PETROLISTHES-ELONGATUS CRUSTACEA; SCREENING PIGMENT MIGRATION; CIRCULARLY-POLARIZED LIGHT; ORGYIA-ANTIQUA LEPIDOPTERA; RETINA-LAMINA PROJECTIONS; EARLY CAMBRIAN ARTHROPODS; LIGIA-EXOTICA CRUSTACEA; BEE MEGALOPTA-GENALIS; CARAUSIUS-MOROSUS-BR	Similarities and differences between the 2 main kinds of compound eye (apposition and superposition) are briefly explained before several promising topics for research on compound eyes are being introduced. Research on the embryology and molecular control of the development of the insect clear-zone eye with superposition optics is one of the suggestions, because almost all of the developmental work on insect eyes in the past has focused on eyes with apposition optics. Age- and habitat-related ultrastructural studies of the retinal organization are another suggestion and the deer cad Lipoptena cervi, which has an aerial phase during which it is winged followed by a several months long parasitic phase during which it is wingless, is mentioned as a candidate species. Sexual dimorphism expressing itself in many species as a difference in eye structure and function provides another promising field for compound eye researchers and so is a focus on compound eye miniaturization in very small insects, especially those that are aquatic and belong to species, in which clear-zone eyes are diagnostic or are tiny insects that are not aquatic, but belong to taxa like the Diptera for instance, in which open rather than closed rhabdoms are the rule. Structures like interommatidial hairs and glands as well as corneal microridges are yet another field that could yield interesting results and in the past has received insufficient consideration. Finally, the dearth of information on distance vision and depth perception is mentioned and a plea is made to examine the photic environment inside the foam shelters of spittle bugs, chrysales of pupae and other structures shielding insects and crustaceans.	[Meyer-Rochow, Victor Benno] Univ Oulu, Dept Biol, FIN-90014 Oulu, Finland; Hachijo Isl Geothermal Energy Museum, Nakanogo, Hachijojima, Tokyo 1001623, Japan	Meyer-Rochow, VB (reprint author), Oulu Univ, Dept Biol, POB 3000, FIN-90014 Oulu, Finland.	b.meyer-rochow@jacobs-university.de					Allee JP, 2006, J INSECT PHYSIOL, V52, P450, DOI 10.1016/j.jinsphys.2005.12.006; Bernath B, 2012, J INSECT PHYSIOL, V58, P1000, DOI 10.1016/j.jinsphys.2012.05.004; Muller CHG, 2003, ZOOMORPHOLOGY, V122, P191, DOI 10.1007/s00435-003-0085-0; Briscoe AD, 2008, J EXP BIOL, V211, P1805, DOI 10.1242/jeb.013045; Zeil J, 2006, J COMP PHYSIOL A, V192, P1, DOI 10.1007/s00359-005-0048-7; NOIROT C, 1974, ANNU REV ENTOMOL, V19, P61, DOI 10.1146/annurev.en.19.010174.000425; Keskinen E, 2004, ARTHROPOD STRUCT DEV, V33, P405, DOI 10.1016/j.asd.2004.05.010; Oakley TH, 2003, INTEGR COMP BIOL, V43, P522, DOI 10.1093/icb/43.4.522; Oakley TH, 2005, HYDROBIOLOGIA, V538, P179, DOI 10.1007/s10750-004-4961-5; Waloszek D, 2005, ARTHROPOD STRUCT DEV, V34, P189, DOI 10.1016/j.asd.2005.01.005; Bao RY, 2009, MOL BIOL EVOL, V26, P1273, DOI 10.1093/molbev/msp039; Oakley TH, 2002, P NATL ACAD SCI USA, V99, P1426, DOI 10.1073/pnas.032483599; Paulus HF, 2000, J ZOOL SYST EVOL RES, V38, P189, DOI 10.1046/j.1439-0469.2000.383152.x; Niven JE, 2008, J EXP BIOL, V211, P1792, DOI 10.1242/jeb.017574; BERNHARD CG, 1962, ACTA PHYSIOL SCAND, V56, P385, DOI 10.1111/j.1748-1716.1962.tb02515.x; Meyer-Rochow VB, 2001, ZOOL SCI, V18, P1175, DOI 10.2108/zsj.18.1175; HAARLOV N, 1964, OIKOS, V15, P93, DOI 10.2307/3564750; MEYERROCHOW VB, 1979, J INSECT PHYSIOL, V25, P601, DOI 10.1016/0022-1910(79)90076-3; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; MEYERROCHOW VB, 1994, J ROY SOC NEW ZEAL, V24, P423; Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X; MEYERROCHOW VB, 1982, PROC R SOC SER B-BIO, V215, P433, DOI 10.1098/rspb.1982.0052; WARRANT EJ, 1993, PROG NEUROBIOL, V40, P413, DOI 10.1016/0301-0082(93)90017-M; Frolov R, 2012, J NEUROSCI, V32, P16821, DOI 10.1523/JNEUROSCI.2612-12.2012; Stavenga DG, 2002, J COMP PHYSIOL A, V188, P337, DOI 10.1007/s00359-002-0307-9; MEYERROCHOW VB, 1990, EXP BIOL, V48, P329; HORRIDGE GA, 1970, PROC R SOC SER B-BIO, V175, P69, DOI 10.1098/rspb.1970.0012; Zelhof AC, 2006, NATURE, V443, P696, DOI 10.1038/nature05128; Warrant EJ, 2004, CURR BIOL, V14, P1309, DOI 10.1016/j.cub.2004.07.057; Hafner GS, 1998, CELL TISSUE RES, V293, P535, DOI 10.1007/s004410051146; TOH Y, 1982, J ULTRA MOL STRUCT R, V78, P40, DOI 10.1016/S0022-5320(82)80012-9; Chiou TH, 2008, CURR BIOL, V18, P429, DOI 10.1016/j.cub.2008.02.066; Bernath B, 2008, VISION RES, V48, P1449, DOI [10.1016/j.visres.2008.04.007, 10.1016/i.visres.2008.04.007]; Fischer S, 2011, VISUAL NEUROSCI, V28, P295, DOI 10.1017/S0952523810000192; Speiser DI, 2013, INTEGR COMP BIOL, V53, P78, DOI 10.1093/icb/ict025; Greiner B, 2004, CELL TISSUE RES, V316, P377, DOI 10.1007/s00441-004-0883-9; NILSSON DE, 1986, TISSUE CELL, V18, P509, DOI 10.1016/0040-8166(86)90017-0; MEYERROCHOW VB, 1975, CELL TISSUE RES, V162, P439; Paterson JR, 2011, NATURE, V480, P237, DOI 10.1038/nature10689; Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg; NILSSON DE, 1983, NATURE, V302, P818, DOI 10.1038/302818a0; Melzer RR, 1997, NATURWISSENSCHAFTEN, V84, P542, DOI 10.1007/s001140050442; Montell C, 2012, TRENDS NEUROSCI, V35, P356, DOI 10.1016/j.tins.2012.03.004; Meyer-Rochow VB, 2007, LUMINESCENCE, V22, P251, DOI 10.1002/bio.955; Harzsch S, 2006, ARTHROPOD STRUCT DEV, V35, P319, DOI 10.1016/j.asd.2006.08.009; Melzer RR, 2000, NATURWISSENSCHAFTEN, V87, P308, DOI 10.1007/s001140050727; Meyer-Rochow VB, 2007, J INSECT PHYSIOL, V53, P157, DOI 10.1016/j.jinsphys.2006.11.002; Harzsch S, 2007, ORG DIVERS EVOL, V7, P20, DOI 10.1016/j.ode.2006.02.004; Hafner GS, 2001, CELL TISSUE RES, V305, P147; Stavenga DG, 2006, P ROY SOC B-BIOL SCI, V273, P661, DOI 10.1098/rspb.2005.3369; Greiner B, 2007, J COMP PHYSIOL A, V193, P591, DOI 10.1007/s00359-007-0214-1; Blaho M, 2012, PHYSIOL BEHAV, V105, P1067, DOI 10.1016/j.physbeh.2011.11.020; Meyer-Rochow VB, 2008, INVERTEBR BIOL, V127, P201, DOI 10.1111/j.1744-7410.2008.00131.x; Autrum H, 1981, HDB SENSORY PHYSL, VVII/6c; Autrum H., 1981, HDB SENSORY PHYSL 6C, VVII, P1; Bernhard G. D., 1970, Z VERGL PHYSIOL, V67, P1; Bitsakos K, 2006, BIOL CYBERN, V95, P487, DOI 10.1007/s00422-006-0097-1; BOSE R, 1991, PARASITOL RES, V77, P723, DOI 10.1007/BF00928691; Brady P, 2010, AM NAT, V175, P614, DOI 10.1086/651593; BRAITENB.V, 1967, EXP BRAIN RES, V3, P271; BREMER S, 1993, ZOOMORPHOLOGY, V113, P205, DOI 10.1007/BF00394861; BUTLER L, 1970, J MORPHOL, V130, P103, DOI 10.1002/jmor.1051300110; Campbell K. S. W., 1975, J P ROYAL SOC NEW S, V108, P168; Clarkson E, 2006, ARTHROPOD STRUCT DEV, V35, P247, DOI 10.1016/j.asd.2006.08.002; Clarkson E.N.K., 1979, Palaeontology (Oxford), V22, P1; Dahl F., 1951, ARK ZOOL, V2, P535; Debaisieux P., 1944, CELLULE, V50, P9; Dewan R, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/1/016003; Dietrich W, 1909, Z WISS ZOOL ABT A, V92, P465; Dorlochter M, 1997, PROG NEUROBIOL, V53, P451, DOI 10.1016/S0301-0082(97)00046-4; DUELLI P, 1978, CELL TISSUE RES, V187, P417; Eguchi E., 1999, ATLAS ARTHROPOD RECE; EGUCHI E, 1986, ZOOL SCI, V3, P931; Ehnbom K., 1948, OPUSC ENTOMOL S, V8, P1; Eisenbeis G., 1985, ATLAS BIOL BODENARTH; ELOFSSON R, 1976, ZOOL SCR, V5, P97, DOI 10.1111/j.1463-6409.1976.tb00685.x; Exner S., 1891, PHYSL FACETTIRTEN AU; FAHRENBA.WH, 1969, Z ZELLFORSCH MIK ANA, V93, P451; FINCHAM AA, 1984, ZOOL J LINN SOC-LOND, V81, P89, DOI 10.1111/j.1096-3642.1984.tb01173.x; Fischer S, 2012, J MORPHOL, V273, P1064, DOI 10.1002/jmor.20045; Fischer S, 2014, ACTA ZOOL-STOCKHOLM, V95, P438, DOI 10.1111/azo.12041; Franceschini N, 1975, PHOTORECEPTOR OPTICS, P98; Frederiksen R, 2008, CURR BIOL, V18, P349, DOI 10.1016/j.cub.2008.01.057; Friedrich M, 2011, BRAIN BEHAV EVOLUT, V78, P199, DOI 10.1159/000329850; Friedrich M, 2003, INTEGR COMP BIOL, V43, P508, DOI 10.1093/icb/43.4.508; Gemne G, 1971, PHILOS T R SOC B, V261, P343; Gokan H., 1998, APPL ENTOMOL ZOOL, V33, P157; GOKAN N, 1984, Z MIKROSK ANAT FORSC, V98, P17; GOKAN N, 1979, APPL ENTOMOL ZOOL, V14, P12; Gokan Nobuo, 2000, Journal of Agricultural Science Tokyo Nogyo Daigaku, V45, P15; Gotz K. G., 1969, RENDICONTI SIF COURS, V43, P494; Grenacher H., 1880, ARCH MIKROSK ANAT, V18, P415, DOI 10.1007/BF02952607; Grenacher H., 1879, UNTERSUCHUNGEN SEHOR; Gullan P.J., 2000, INSECTS OUTLINE ENTO; GUO AK, 1980, SCI SINICA, V23, P1461; GUO AK, 1981, SCI SINICA, V24, P542; Gupta S, 2000, ENTOMOL FENNICA, V11, P89; HARIYAMA T, 1986, J EXP BIOL, V123, P1; Harzsch Steffen, 1995, Zoology (Jena), V99, P189; HASSENSTEIN B, 1956, Z NATURFORSCH PT B, V11, P513; Hesse R, 1901, Z WISS ZOOL ABT A, V70, P347; HONEGGER HW, 1979, J COMP PHYSIOL, V129, P247; Honkanen A, 2009, EUR J ENTOMOL, V106, P619; HORRIDGE G A, 1969, Tissue and Cell, V1, P425, DOI 10.1016/S0040-8166(69)80015-7; Horridge G. A., 1975, COMPOUND EYE VISION; Horridge G. A., 2008, WHAT DOES HONEYBEE S; HORRIDGE GA, 1972, PROC R SOC SER B-BIO, V182, P457, DOI 10.1098/rspb.1972.0088; HORRIDGE GA, 1969, PROC R SOC SER B-BIO, V171, P445, DOI 10.1098/rspb.1969.0005; HORRIDGE GA, 1968, NATURE, V218, P778, DOI 10.1038/218778a0; HORRIDGE GA, 1964, PROC R SOC SER B-BIO, V161, P216, DOI 10.1098/rspb.1964.0091; Horvath Gabor, 2004, POLARIZED LIGHT ANIM; Insausti TC, 2000, MEM I OSWALDO CRUZ, V95, P381, DOI 10.1590/S0074-02762000000300014; Karpilow JM, 1996, J NEUROBIOL, V31, P149, DOI 10.1002/(SICI)1097-4695(199610)31:2<149::AID-NEU2>3.3.CO;2-Y; Kashiwagi T., 1999, ACTA NEUROBIOLOGIAE, V60, P9; Keskinen E, 2002, BIOCELL, V26, P357; Kirchhoffer W., 1908, ARCH BIONTOLOGIE, V2, P237; Kirschfeld K., 1973, Fortschritte Zool, V21, P229; KOLB G, 1985, ZOOMORPHOLOGY, V105, P90, DOI 10.1007/BF00312143; Kristensen N. P., 2013, J MORPHOLOHGY, V275, P153; Land M. F., 2003, ANIMAL EYES; Land M. F., 1981, HDB SENSORY PHYSL, VVII, P471; Land MF, 2005, J COMP PHYSIOL A, V191, P639, DOI 10.1007/s00359-005-0616-x; Lau S. T. F., 2006, J ASIA-PAC ENTOMOL, V9, P19; Lau T. F. S., 2007, J ASIA-PAC ENTOMOL, V10, P1; Lau TF, 2007, EUR J ENTOMOL, V104, P459; Lau TF, 2007, EUR J ENTOMOL, V104, P247; Laughlin SB, 1975, PHOTORECEPTOR OPTICS, P237; Lee MSY, 2011, NATURE, V474, P631, DOI 10.1038/nature10097; LUNAU K, 1995, NATURWISSENSCHAFTEN, V82, P432, DOI 10.1007/s001140050213; Maas Andreas, 2003, Fossils and Strata, V49, P1; Mazokhin-Porshnyakov GA., 1969, INSECT VISION; MENZEL R, 1971, Z NATURFORSCH PT B, VB 26, P357; MENZI U, 1987, J COMP PHYSIOL A, V160, P11, DOI 10.1007/BF00613437; Meyer-Rochow V B, 2000, Int J Circumpolar Health, V59, P38; Meyer-Rochow V. Benno, 1999, P97; MEYERROC.VB, 1972, Z ZELLFORSCH MIK ANA, V133, P59, DOI 10.1007/BF00307068; MEYER-ROCHOW V B, 1971, Mikrokosmos, V60, P348; Meyer-Rochow Victor Benno, 2008, Entomologie Heute, V20, P193; Meyer-Rochow V.B., 1975, P299; MEYERROC.VB, 1973, PROC R SOC SER B-BIO, V183, P159, DOI 10.1098/rspb.1973.0011; Meyer-Rochow VB, 2009, BIOCELL, V33, P115; MEYERROCHOW VB, 1993, VISION RES, V33, P2645, DOI 10.1016/0042-6989(93)90223-J; Meyer-Rochow VB, 2004, VISION RES, V44, P2213, DOI 10.1016/j.visres.2004.04.009; Meyer-Rochow VB, 2003, APPL ENTOMOL ZOOL, V38, P281, DOI 10.1303/aez.2003.281; MEYERROCHOW VB, 1984, J NEUROCYTOL, V13, P935, DOI 10.1007/BF01148595; MEYERROCHOW VB, 1981, PROC R SOC SER B-BIO, V212, P93, DOI 10.1098/rspb.1981.0027; Meyer-Rochow VB, 2002, MICRON, V33, P23, DOI 10.1016/S0968-4328(00)00073-1; MEYERROCHOW VB, 1975, PROC R SOC SER B-BIO, V188, P1, DOI 10.1098/rspb.1975.0001; MEYERROCHOW VB, 1982, CELL TISSUE RES, V221, P625; MEYERROCHOW VB, 1979, PROC R SOC SER B-BIO, V206, P353, DOI 10.1098/rspb.1979.0110; MEYERROCHOW VP, 1991, B ZOOL, V58, P59; Miller W. H., 1979, HDB SENSORY PHYSL, VVII, P69; Mishra M, 2006, INVERTEBR REPROD DEV, V49, P213, DOI 10.1080/07924259.2006.9652209; Mishra M, 2006, INVERTEBR BIOL, V125, P265, DOI 10.1111/j.1744-7410.2006.00059.x; Mishra M, 2008, MICRON, V39, P471, DOI 10.1016/j.micron.2007.02.006; Mishra M, 2006, J ELECTRON MICROSC, V55, P289, DOI 10.1093/jmicro/dfl035; Mobbs P. G., 1985, NERVOUS SYSTEM STRUC, V5, P299; Mouissan B, 2010, INSECT BIOCHEM MOLEC, V40, P363; Muller CHG, 2007, ARTHROPOD STRUCT DEV, V36, P463, DOI 10.1016/j.asd.2007.09.002; Muller C.H.G., 2003, AFR INVERTEBR, V44, P185; Nilsson D.-E., 1989, P30; Niven JE, 2007, PLOS BIOL, V5, P828, DOI 10.1371/journal.pbio.0050116; PARKER G. H., 1890, B MUS COMP ZOOL HARV, V20, P1; Ready DF, 2002, RES PRO CEL, V37, P191; Riek E. F., 1970, INSECTS AUSTR, P224; SANDEMAN DC, 1974, J NEUROBIOL, V5, P475, DOI 10.1002/neu.480050602; Schlamp C. S, 1989, THESIS U W ONTARIO L, P1; Schneider F., 1952, Mitteilungen der Schweizerischen Entomologischen Gesellschaft, V25, P269; Schoenemann B., 2014, B GEOSCI, V89, P209; Schoenemann B, 2012, P ROY SOC B-BIOL SCI, V279, P1335, DOI 10.1098/rspb.2011.1888; SEITZ G, 1968, Z VERGL PHYSIOL, V59, P205; Serb JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012525; SHELTON PMJ, 1977, J EMBRYOL EXP MORPH, V39, P235; Snyder A. W., 1979, VISION INVERTEBRATES, VVII/6A, P225; Snyder A. W., 1975, PHOTORECEPTOR OPTICS; Spratford CM, 2013, DEVELOPMENT, V140, P1994, DOI 10.1242/dev.088963; Stavenga D. G., 1975, PHOTORECEPTOR OPTICS, P126; Stavenga D. G, 1989, FACETS VISION, P152; Stavenga D.G., 1989, FACETS VISION; SUCH J, 1975, CR ACAD SCI D NAT, V281, P67; Such J., 1969, CR HEBD ACAD SCI, V269, P356; SUCH J, 1978, INT J INSECT MORPHOL, V7, P165, DOI 10.1016/0020-7322(78)90015-6; Szczawinska W., 1891, ARCH BIOL, V10, P523; Tautz J., 2007, PHANOMEN HONIGBIENE; Terakita A, 1996, VISUAL NEUROSCI, V13, P539; THIELE H, 1971, Z MORPHOL TIERE, V69, P9, DOI 10.1007/BF00294386; Tomic N, 2011, PERSPECT BIOL MED, V54, P332, DOI 10.1353/pbm.2011.0034; TUURALA OSMO, 1954, ANN ACAD SCI FENNICAE SER A, V24, P1; TYRER NM, 1979, CELL TISSUE RES, V203, P79; van Hateren J.H., 1989, P74; WACHMANN E, 1979, ZOOMORPHOLOGIE, V92, P19, DOI 10.1007/BF00999833; WADA S, 1974, Z MORPHOL TIERE, V77, P87, DOI 10.1007/BF00374212; Warrant E, 1999, J EXP BIOL, V202, P497; Warrant E, 2006, INVERTEBRATE VISION, pXIX; WEYRAUTHER E, 1986, J COMP PHYSIOL A, V159, P55, DOI 10.1007/BF00612495; WEYRAUTHER E, 1989, J INSECT PHYSIOL, V35, P925, DOI 10.1016/0022-1910(89)90015-2; Wihlm M. W., 2013, CAN ENTOMOL, V144, P273; WOLKEN JJ, 1965, J CELL BIOL, V26, P968, DOI 10.1083/jcb.26.3.968; Yagi N., 1963, COMPOUND EYE LEPIDOP; Yang M., 2004, BIOCELL, V28, P1; ZACK S, 1981, J NEUROBIOL, V12, P55, DOI 10.1002/neu.480120105; ZEIL J, 1983, J COMP PHYSIOL, V150, P379	202	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1672-9609	1744-7917		INSECT SCI	Insect Sci.	JUN	2015	22	3					461	481		10.1111/1744-7917.12117		21	Entomology	Entomology	CI8EV	WOS:000355003400014		
J	Ishihara, S; Nishikawa, T; Tanaka, T; Tanaka, J; Kiyomatsu, T; Kawai, K; Hata, K; Nozawa, H; Kazama, S; Yamaguchi, H; Sunami, E; Kitayama, J; Sugihara, K; Watanabe, T				Ishihara, Soichiro; Nishikawa, Takeshi; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Kawai, Kazushige; Hata, Keisuke; Nozawa, Hioaki; Kazama, Shinsuke; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Sugihara, Kenichi; Watanabe, Toshiaki			Benefit of primary tumor resection in stage IV colorectal cancer with unresectable metastasis: a multicenter retrospective study using a propensity score analysis	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Colorectal cancer; Stage IV; Primary tumor resection; Propensity score analysis	SIDED COLON-CANCER; PROGNOSTIC IMPACT; SURGERY; COMORBIDITY; SURVIVAL; WOMEN; RISK	Retrospective studies have shown that primary tumor resection improves the prognosis of patients with colorectal cancer (CRC) with unresectable metastasis (mCRC). The aim of this study was to investigate the prognostic impact of primary tumor resection in various subgroups of mCRC patients. A total of 1982 patients with mCRC from January 1997 to December 2007 were retrospectively evaluated. The impact of primary tumor resection on cancer-specific survival (CSS) was analyzed using propensity score analysis to mitigate selection bias. Covariates in the models for propensity scores included treatment period, age, gender, tumor location, depth, lymph node metastasis, number of metastatic organs, and carcinoembryonic antigen (CEA) levels. Among the whole patient population, primary tumor resection significantly improved CSS [hazard ratio (HR) 0.46, 95 % confidence interval (CI) 0.32-0.66, p < 0.01]. However, primary tumor resection did not significantly improve CSS in the following subgroups: patients treated in the first 5 years of the study (HR 0.56, 95 % CI 0.28-1.13, p = 0.08), patients aged > 65 years (HR 0.72, 95 % CI 0.36-1.42, p = 0.31), female patients (HR 0.60, 95 % CI 0.31-1.17, p = 0.13), patients with right-sided colon cancer (HR 0.68, 95 % CI 0.39-1.20, p = 0.17), and patients without nodal involvement (HR 0.54, 95 % CI 0.25-1.17, p = 0.09). Our study suggests that primary tumor resection improves the survival of patients with mCRC. However, the prognostic benefit is different among patient subpopulations.	[Ishihara, Soichiro; Nishikawa, Takeshi; Tanaka, Toshiaki; Tanaka, Junichiro; Kiyomatsu, Tomomichi; Kawai, Kazushige; Hata, Keisuke; Nozawa, Hioaki; Kazama, Shinsuke; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138655, Japan; [Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Bunkyo Ku, Tokyo 1138519, Japan	Watanabe, T (reprint author), Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	toshwatanabe@yahoo.co.jp					Ahmed S, 2014, J GERIATR ONCOL, V5, P133, DOI 10.1016/j.jgo.2013.12.005; Janssen-Heijnen MLG, 2007, EUR J CANCER, V43, P2179, DOI 10.1016/j.ejca.2007.06.008; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Weiss JM, 2011, J CLIN ONCOL, V29, P4401, DOI 10.1200/JCO.2011.36.4414; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Zervoudakis A, 2011, J NATL CANCER I, V103, P826, DOI 10.1093/jnci/djr101; Ruo L, 2003, J AM COLL SURGEONS, V196, P722, DOI 10.1016/S1072-7515(03)00136-4; Azzoni C, 2007, INT J COLORECTAL DIS, V22, P115, DOI 10.1007/s00384-006-0093-x; Grothey A, 2008, J CLIN ONCOL, V26, P5326, DOI 10.1200/JCO.2008.16.3212; Stelzner S, 2005, J SURG ONCOL, V89, P211, DOI 10.1002/jso.20196; Nawa T, 2008, J GASTROEN HEPATOL, V23, P418, DOI 10.1111/j.1440-1746.2007.04923.x; Nitzkorski JR, 2012, ANN SURG ONCOL, V19, P379, DOI 10.1245/s10434-011-2028-1; Koo JH, 2008, AM J GASTROENTEROL, V103, P1488, DOI 10.1111/j.1572-0241.2007.01779.x; Simmonds P, 2000, LANCET, V356, P968, DOI 10.1016/S0140-6736(00)02713-6; Austin PC, 2013, STAT MED, V32, P2837, DOI 10.1002/sim.5705; Clendenen TV, 2009, CANCER EPIDEM BIOMAR, V18, P275, DOI 10.1158/1055-9965.EPI-08-0777; Gervaz P, 2004, J SURG ONCOL, V88, P261, DOI 10.1002/jso.20156; Gonsalves WI, 2012, J SURG ONCOL, V106, P486, DOI 10.1002/jso.23102; Hsu HH, 2006, CHINESE J PHYSIOL, V49, P110; Ishihara S, 2014, ANN SURG ONCOL, V21, P2949, DOI 10.1245/s10434-014-3719-1; Ishihara S, 2012, INT J COLORECTAL DIS, V27, P371, DOI 10.1007/s00384-011-1343-0; Ishihara S, 2014, INT J SURG, V12, P925, DOI 10.1016/j.ijsu.2014.07.270; Jess P, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002608; Lee WS, 2012, AM J SURG, V203, P715, DOI 10.1016/j.amjsurg.2011.05.015; Nitsche U, 2014, INT J COLORECTAL DIS, V29, P971, DOI 10.1007/s00384-014-1914-y; van Leersum NJ, 2013, INT J CANCER, V132, P2157, DOI 10.1002/ijc.27871; Verhoef C, 2011, EUR J CANCER, V47, pS61, DOI 10.1016/S0959-8049(11)70148-4	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JUN	2015	30	6					807	812		10.1007/s00384-015-2228-4		6	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CI4HI	WOS:000354708800009		
J	Kotake, K; Kobayashi, H; Asano, M; Ozawa, H; Sugihara, K				Kotake, Kenjiro; Kobayashi, Hirotoshi; Asano, Michio; Ozawa, Heita; Sugihara, Kenichi			Influence of extent of lymph node dissection on survival for patients with pT2 colon cancer	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						pT2 colon cancer; Lymph node metastasis; Lymph node dissection; Overall survival; Propensity score matching	T2 COLORECTAL-CANCER; TUMOR-CELLS; STAGE-II; T1; RESECTION; LIGATION; NUMBER; CARCINOMA; SURGERY; MICROMETASTASES	The optimal extent of lymph node dissection for early-stage colon cancer (CC) remains undefined. This study assessed the influence of the extent of lymph node dissection on overall survival (OS) in patients with pT2 CC. We retrospectively examined data from the multi-institutional registry system of the Japanese Society for Cancer of the Colon and Rectum and used a propensity score matching method to balance potential confounders of lymph node dissection. We extracted 463 matched pairs from 1433 patients who underwent major resections for pT2 CC between 1995 and 2004. Lymph node metastasis was found in 301 (21.0 %) of 1433 patients with pT2 CC. In this cohort, significant independent risk factors for lymph node metastasis were lymphatic invasion and venous invasion. Patients who underwent D3 or D2 lymph node dissection did not significantly differ in OS, either among the propensity score-matched cohort (estimated hazard ratio [HR] 0.85, 95 % confidence interval [CI] 0.536-1.346, P = 0.484) or in the cohort as a whole (HR 0.720, 95 % CI 0.492-1.052, P = 0.089). For patients with pT2 CC, D3 lymph node dissection did not add to OS. D2 lymph node dissection may be adequate for pT2 CC.	[Kotake, Kenjiro; Ozawa, Heita] Tochigi Canc Ctr, Dept Colorectal Surg, Utsunomiya, Tochigi 3200834, Japan; [Kobayashi, Hirotoshi; Sugihara, Kenichi] Tokyo Med & Dent Univ, Dept Surg Oncol, Grad Sch, Bunkyo Ku, Tokyo 1138519, Japan; [Asano, Michio] Asano Clin, Dept Surg, Hamamatsu, Shizuoka 4328061, Japan	Kotake, K (reprint author), Tochigi Canc Ctr, Dept Colorectal Surg, 4-9-13 Yohnan, Utsunomiya, Tochigi 3200834, Japan.	kkotake@tcc.pref.tochigi.lg.jp					Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Le Voyer TE, 2003, J CLIN ONCOL, V21, P2912, DOI 10.1200/JCO.2003.05.062; Baxter NN, 2005, J NATL CANCER I, V97, P219, DOI 10.1093/jnci/dji020; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Hida J, 2005, DIS COLON RECTUM, V48, P2232, DOI 10.1007/s10350-005-0161-2; Faerden AE, 2011, DIS COLON RECTUM, V54, P200, DOI 10.1007/DCR.0b013e3181fd4c7c; Watanabe T, 2012, INT J CLIN ONCOL, V17, P1, DOI 10.1007/s10147-011-0315-2; Swanson RS, 2003, ANN SURG ONCOL, V10, P65, DOI 10.1245/ASO.2003.03.058; Kotake K, 2012, JPN J CLIN ONCOL, V42, P29, DOI 10.1093/jjco/hyr164; Matsuda T, 2011, JPN J CLIN ONCOL, V41, P139, DOI 10.1093/jjco/hyq169; Bardakcioglu O, 2013, ANN SURG, V258, P270, DOI 10.1097/SLA.0b013e31828faa66; Joseph NE, 2003, ANN SURG ONCOL, V10, P213, DOI 10.1245/ASO.2003.03.059; Kajiwara Y, 2010, DIS COLON RECTUM, V53, P1393, DOI 10.1007/DCR.0b013e3181ec5f66; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Hashiguchi Y, 2011, BRIT J SURG, V98, P1171, DOI 10.1002/bjs.7518; Fang WL, 2005, HEPATO-GASTROENTEROL, V52, P1688; Huh JW, 2010, J GASTROINTEST SURG, V14, P1074, DOI 10.1007/s11605-010-1206-y; Rahbari NN, 2012, J CLIN ONCOL, V30, P60, DOI 10.1200/JCO.2011.36.9504; Maggard MA, 2009, DIGEST DIS SCI, V54, P640, DOI 10.1007/s10620-008-0373-0; Sondenaa K, 2014, INT J COLORECTAL DIS, V29, P419, DOI 10.1007/s00384-013-1818-2; Bhangu A, 2013, ANN SURG, V258, P569, DOI [DOI 10.1097/SLA.0B013E3182A4E85A, 10.1097/ SLA. 0b013e3182a4e85a]; Bhangu A, 2013, ANN SURG, V258, P563, DOI 10.1097/SLA.0b013e3182a4e85a; GRINNELL RS, 1965, SURG GYNECOL OBSTETR, V120, P1031; Japanese Society for Cancer of the Colon and Rectum, 1997, JAP CLASS COL CARC; Kijima S, 2014, WORLD J GASTROENTERO, V20, P16964, DOI 10.3748/wjg.v20.i45.16964; Kobayashi Y, 2009, DIS COLON RECTUM, V52, P942, DOI 10.1007/DCR.0b013e3181a4f85d; Kotake K, 2003, JAPAN DIS COLON RECT, V46, pS32; Kotake K, 2014, INT J COLORECTAL DIS, V29, P847, DOI 10.1007/s00384-014-1885-z; Lips DJ, 2011, BMC SURG, V11, DOI 10.1186/1471-2482-11-11; Nakafusa Y, 2004, HEPATO-GASTROENTEROL, V51, P722; National Comprehensive Cancer Network, 2015, CLIN PRACT GUID ONC; ROSI PA, 1962, SURG GYNECOL OBSTET, V114, P15; Slanetz CA, 1997, DIS COLON RECTUM, V40, P1205, DOI 10.1007/BF02055167; Stamos MJ, 2007, CLIN CANCER RES, V13, p6885S, DOI 10.1158/1078-0432.CCR-07-1150	34	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JUN	2015	30	6					813	820		10.1007/s00384-015-2194-x		8	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CI4HI	WOS:000354708800010		
J	Maeda, H; Okamoto, K; Namikawa, T; Akimori, T; Kamioka, N; Shiga, M; Dabanaka, K; Hanazaki, K; Kobayashi, M				Maeda, Hiromichi; Okamoto, Ken; Namikawa, Tsutomu; Akimori, Toyokazu; Kamioka, Norihito; Shiga, Mai; Dabanaka, Ken; Hanazaki, Kazuhiro; Kobayashi, Michiya			Rarity of late anastomotic leakage after low anterior resection of the rectum	INTERNATIONAL JOURNAL OF COLORECTAL DISEASE			English	Article						Rectal cancer; Anastomotic leakage; Low anterior resection; Complication	CANCER; SURGERY	Late anastomotic leakage is reported to account for half of all anastomotic leakages after low anterior resection of the rectum. An important clinical question is whether late and early anastomotic leakages are different entities. We retrospectively reviewed the medical records of patients who experienced anastomotic leakage after low anterior resection in two Japanese hospitals. The clinical characteristics were extracted and analyzed. During the study period, 179 patients underwent low anterior resection. A pelvic drainage tube was routinely utilized in all cases and was generally removed 4 to 6 days after the operation. Twenty-six patients had anastomotic leakage; the diagnosis was based on fecal contamination of the drainage in 24 cases. The median interval between operation and detection of anastomotic leakage was 3.5 days. Anastomotic leakage was diagnosed within 7 days of the operation in 25 cases and on postoperative day 20 (after hospital discharge) in one case. There was no instance of anastomotic leakage diagnosed more than 30 days after the operation. There was no relationship between clinical variables and days of leakage diagnosis. The rarity of late anastomotic leakage in our study, compared with previous studies, may relate to the relatively extended period of pelvic drainage tube usage in our institutes, which likely shortens the interval before leakage diagnosis. Our results suggest that late anastomotic leakage is a delayed symptom of subtle early anastomotic leakage rather than a separate entity.	[Maeda, Hiromichi; Okamoto, Ken; Kobayashi, Michiya] Kochi Med Sch Hosp, Canc Treatment Ctr, Nankoku, Kochi 7838505, Japan; [Okamoto, Ken; Kobayashi, Michiya] Kochi Univ, Kochi Med Sch, Dept Human Hlth & Med Sci, Kochi 780, Japan; [Namikawa, Tsutomu; Shiga, Mai; Dabanaka, Ken; Hanazaki, Kazuhiro] Kochi Univ, Kochi Med Sch, Depatment Surg, Kochi 780, Japan; [Akimori, Toyokazu; Kamioka, Norihito] Kochi Prefectural Hata Kenmin Hosp, Dept Surg, Kochi, Japan	Maeda, H (reprint author), Kochi Med Sch Hosp, Canc Treatment Ctr, Oko Cho, Nankoku, Kochi 7838505, Japan.	hmaeda@kochi-u.ac.jp					Fouda E, 2011, J GASTROINTEST SURG, V15, P137, DOI 10.1007/s11605-010-1364-y; Hyman N, 2007, ANN SURG, V245, P254, DOI 10.1097/01.sla.0000225083.27182.85; Rahbari NN, 2010, SURGERY, V147, P339, DOI 10.1016/j.surg.2009.10.012; Matthiessen P, 2007, ANN SURG, V246, P207, DOI 10.1097/SLA.0b013e3180603024; Snijders HS, 2012, EJSO-EUR J SURG ONC, V38, P1013, DOI 10.1016/j.ejso.2012.07.111; Floodeen H, 2013, COLORECTAL DIS, V15, P334, DOI 10.1111/j.1463-1318.2012.03195.x; Lowry A C, 2001, Colorectal Dis, V3, P272, DOI 10.1046/j.1463-1318.2001.00269.x; Morks AN, 2013, COLORECTAL DIS, V15, pE271, DOI 10.1111/codi.12167; Pasternak B, 2010, COLORECTAL DIS, V12, pE93, DOI 10.1111/j.1463-1318.2009.01908.x	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0179-1958	1432-1262		INT J COLORECTAL DIS	Int. J. Colorectal Dis.	JUN	2015	30	6					831	834		10.1007/s00384-015-2207-9		4	Gastroenterology & Hepatology; Surgery	Gastroenterology & Hepatology; Surgery	CI4HI	WOS:000354708800012		
J	Ohtsuka, T				Ohtsuka, Tsutomu			Different effect of oral cyclosporine therapy and oral antihistamine therapy on serum high-sensitivity C-reactive protein level and thymus and activation-regulated chemokine level in atopic dermatitis in older children and adulthood	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							ALLERGIC DISORDERS; DISEASE-ACTIVITY; TARC PRODUCTION; IN-VITRO; SEVERITY; CELLS; BEPOTASTINE; VIVO	BackgroundMany patients with atopic dermatitis (AD) are treated with oral cyclosporine or antihistamine therapy in clinical practice. ObjectiveTo evaluate the effectiveness of oral cyclosporine and antihistamine therapy on clinical and laboratory findings in patients with AD. Subjects and methodsTwenty-five patients with AD (male-female=11:14, age 16-42years old, mean 26.2years old) were treated with oral cyclosporine therapy. Twenty-three patients with AD (male-female=10:13, age 15-32years old, mean 24.2years old) were treated with oral antihistamine therapy. Laboratory findings including high-sensitivity C-reactive protein (CRP) and thymus and activation-regulated chemokine (TARC) were statistically studied. ResultsSerum TARC level after oral cyclosporine therapy (1013883pg/ml) was significantly decreased compared to before therapy (38194 +/- 4678pg/ml; P<0.02). Basophil counts in peripheral blood after the therapy (49.7 +/- 26.4x10(-3)cells/l) were more significantly increased than before therapy (41.1 +/- 16.7x10(-3)cells/l; P<0.05). Serum high-sensitivity CRP level after antihistamine therapy (0.09 +/- 0.08mg/ml) was significantly decreased compared to before therapy (0.13 +/- 0.12mg/ml; P<0.05). Basophil counts in peripheral blood after the therapy (33.4 +/- 16.2x10(-3)cells/l) were more significantly decreased than before therapy (41.5 +/- 23.3x10(-3)cells/l; P<0.01). ConclusionDifferent effects of oral cyclosporine therapy and oral antihistamine therapy to serum high-sensitivity CRP level, TARC level, and peripheral blood basophils in adult patients with AD were shown. A combination of these two therapies may be more effective for the treatment of AD in adults.	Int Univ Hlth & Welf Hosp, Dept Dermatol, Nasushiobara, Tochigi 3292763, Japan	Ohtsuka, T (reprint author), Int Univ Hlth & Welf Hosp, Dept Dermatol, 537-3 Iguchi, Nasushiobara, Tochigi 3292763, Japan.	tohtsuka@iuhw.ac.jp					Romagnani S, 1998, ALLERGY, V53, P12; Kakinuma T, 2001, J ALLERGY CLIN IMMUN, V107, P535, DOI 10.1067/mai.2001.113237; Ohtsuka T, 2010, INT J DERMATOL, V49, P579, DOI 10.1111/j.1365-4632.2010.04384.x; Ridker PM, 2001, CIRCULATION, V103, P1813; Oranje AP, 2007, BRIT J DERMATOL, V157, P645, DOI 10.1111/j.1365-2133.2007.08112.x; Campbell JJ, 1999, NATURE, V400, P776, DOI 10.1038/23495; [Anonymous], 1980, ACTA DERM-VENEREOL S; Kakinuma T, 2003, J ALLERGY CLIN IMMUN, V111, P592, DOI 10.1067/mai.2003.114; Vulcano M, 2001, EUR J IMMUNOL, V31, P812, DOI 10.1002/1521-4141(200103)31:3<812::AID-IMMU812>3.0.CO;2-L; Jahnz-Rozyk K, 2005, ALLERGY, V60, P685, DOI 10.1111/j.1398-9995.2005.00774.x; Charman C, 2003, J INVEST DERMATOL, V120, P932, DOI 10.1046/j.1523-1747.2003.12251.x; Shimada Y, 2004, J DERMATOL SCI, V34, P201, DOI 10.1016/j.jdermsci.2004.01.001; DirkJan H, 2004, J ALLERGY CLIN IMMUN, V113, P334; Frezzolini A, 2002, ALLERGY, V57, P815, DOI 10.1034/j.1398-9995.2002.23687.x; Furukawa H, 2004, J DERMATOL SCI, V35, P35, DOI 10.1016/j.jdermsci.2004.02.008; Gutgesell C, 2002, BRIT J DERMATOL, V147, P914, DOI 10.1046/j.1365-2133.2002.04938.x; Harper JI, 2001, DERMATOLOGY, V203, P3, DOI 10.1159/000051694; Kemp A, 2003, PEDIATR ALLERGY IMMU, V14, P74, DOI 10.1034/j.1399-3038.2003.00017.x; Kida T, 2010, EXP EYE RES, V91, P85, DOI 10.1016/j.exer.2010.04.006; Leung DYM, 2003, LANCET, V361, P151, DOI 10.1016/S0140-6736(03)12193-9; Leung TF, 2002, J ALLERGY CLIN IMMUN, V110, P404, DOI 10.1067/mai.2002.126378; Lyseng-Williamson KA, 2010, DRUGS, V70, P1579, DOI 10.2165/11205880-000000000-00000; MUNRO CS, 1994, BRIT J DERMATOL, V130, P376, DOI 10.1111/j.1365-2133.1994.tb02936.x; Ohtsuka T, 2010, J DERMATOL, V37, P801, DOI 10.1111/j.1346-8138.2010.00883.x; SCHULTZ LF, 2002, IMMUNOL ALLERGY CLIN, V22, P1; Song TW, 2006, CLIN EXP ALLERGY, V36, P346, DOI 10.1111/1365-2222.2006.02430.x; vansJoost T, 1994, BRIT J DERMATOL, V130, P634; Vestergaard C, 2001, J DERMATOL SCI, V26, P46, DOI 10.1016/S0923-1811(00)00160-2	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	JUN	2015	54	6					648	655		10.1111/ijd.12374		8	Dermatology	Dermatology	CJ0BA	WOS:000355135300025		
J	Takahashi, Y; Yoneda, M; Tanaka, M; Furuta, K; Isogai, Z				Takahashi, Yoshiko; Yoneda, Masahiko; Tanaka, Makiko; Furuta, Katsunori; Isogai, Zenzo			Ilium pressure ulcer with pathognomonic wound deformity: the "cliff phenomenon"	INTERNATIONAL JOURNAL OF DERMATOLOGY			English	Article							CLASSIFICATION		[Takahashi, Yoshiko; Yoneda, Masahiko] Aichi Prefectural Univ, Sch Nursing & Hlth, Dept Nursing & Hlth, Nagakute, Aichi, Japan; [Tanaka, Makiko] Yamaguchi Prefectural Univ, Grad Div Hlth & Welf, Dept Nursing & Human Nutr, Yamaguchi, Japan; [Furuta, Katsunori] Natl Ctr Geriatr & Gerontol, Dept Pharm, Obu, Aichi 4748511, Japan; [Furuta, Katsunori] Natl Ctr Geriatr & Gerontol, Dept Clin Res & Dev, Obu, Aichi 4748511, Japan; [Isogai, Zenzo] Natl Ctr Geriatr & Gerontol, Div Dermatol & Connect Tissue Med, Dept Adv Med, Obu, Aichi 4748511, Japan	Isogai, Z (reprint author), Natl Ctr Geriatr & Gerontol, Div Dermatol & Connect Tissue Med, Dept Adv Med, 35 Gengo,Morioka Cho, Obu, Aichi 4748511, Japan.	zenzo@ncgg.go.jp					Whitney J, 2006, WOUND REPAIR REGEN, V14, P663, DOI 10.1111/j.1524-475X.2006.00175.x; Mizokami F, 2012, INT WOULD J IN PRESS; Ohura T, 2006, WOUNDS, V18, P329; SHEA JD, 1975, CLIN ORTHOP RELAT R, P89	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0011-9059	1365-4632		INT J DERMATOL	Int. J. Dermatol.	JUN	2015	54	6					E197	E199		10.1111/ijd.12288		3	Dermatology	Dermatology	CJ0BA	WOS:000355135300001		
J	Yamane, K; Kondo, C; Kondo, D; Kawasaki, K				Yamane, Koji; Kondo, Chihiro; Kondo, Daichi; Kawasaki, Kiyoshi			Low compression ratio diesel engines fueled with biodiesel by using spark-induced compression ignition	INTERNATIONAL JOURNAL OF ENGINE RESEARCH			English	Article						Biodiesel; low compression ratio; diesel engines; combustion; spark		The objective of this study was to demonstrate a novel combustion system in which autoignition is induced by spark discharge into a pre-mixture formed during a long ignition delay time in a direct injection diesel engine with a low compression ratio. The effects of spark discharge on the autoignition process were investigated by changing the spark timing, injection timing, equivalence ratio and fuel amount. The fuel used was lauric acid methyl ester, a fatty acid methyl ester that is relatively volatile and exhibits higher ignition quality than standard diesel fuel. The results obtained with a single-cylinder common-rail direct injection diesel engine show that spark-induced compression ignition combustion was obtained with a volumetric efficiency of 34%. In this study, the autoignition timing was advanced by spark discharge and was controlled by the spark timing within 5 degrees crank angle. We also observed the spark-induced compression ignition combustion flame in a constant volume combustion vessel using direct high-speed photography and OH radical chemiluminescence spectroscopy by means of a combination of an optical band-pass filter, an image intensifier and a charge-coupled device camera. The results showed that spark-induced compression ignition occurs not by flame propagation due to spark ignition but by autoignition of a spray pre-mixture. It was also evident that autoignition is induced by transportation of OH radicals formed at the spark plug by the spray flow.	[Yamane, Koji; Kondo, Chihiro; Kondo, Daichi; Kawasaki, Kiyoshi] Univ Shiga Prefecture, Dept Mech Syst Engn, Hikone 5228533, Japan	Yamane, K (reprint author), Univ Shiga Prefecture, Dept Mech Syst Engn, Hikone 5228533, Japan.	yamane@mech.usp.ac.jp			JSPS KAKENHI [22560205]; Naoji Iwatani Foundation	This work was financially supported by JSPS KAKENHI Grant Number 22560205 and by The Naoji Iwatani Foundation in 2012.	Ando H, 2011, TRANS SOC AUTOMOT EN, V42, P397; Dhinagar S, 1992, 920545 SAE; Fritz S, 1987, 871674 SAE; Inagaki K, 2011, TRANS SOC AUTOMOT EN, V42, P219; Kawasaki K, 2010, TRANS SOC AUTOMOT EN, V41, P865; Kondo C, 2011, TRANS SOC AUTOMOT EN, V42, P1111; Koyama T, 2011, TRANS SOC AUTOMOT EN, V42, P747; Kuwahara K, 2011, TRANS SOC AUTOMOT EN, V42, P163; Miyamoto N, 1970, TRANS SOC AUTOMOT EN, V38, P623; Nagamine Y, 2010, P 21 S INT COMB ENG, P279; Persson H, 2007, 2007011856 SAE; Phatak R, 1983, 830588 SAE; Ward MAV, 1990, 13502 US ARM TANK AU	13	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	1468-0874	2041-3149		INT J ENGINE RES	Int. J. Engine Res.	JUN	2015	16	4					580	591		10.1177/1468087414542888		12	Thermodynamics; Engineering, Mechanical; Transportation Science & Technology	Thermodynamics; Engineering; Transportation	CH8ZC	WOS:000354324500006		
J	Tanaka, T; Terai, Y; Ono, YJ; Fujiwara, S; Tanaka, Y; Sasaki, H; Tsunetoh, S; Kanemura, M; Yamamoto, K; Yamada, T; Ohmichi, M				Tanaka, Tomohito; Terai, Yoshito; Ono, Yoshihiro J.; Fujiwara, Satoe; Tanaka, Yoshimichi; Sasaki, Hiroshi; Tsunetoh, Satoshi; Kanemura, Masanori; Yamamoto, Kazuhiro; Yamada, Takashi; Ohmichi, Masahide			Preoperative MRI and Intraoperative Frozen Section Diagnosis of Myometrial Invasion In Patients With Endometrial Cancer	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Endometrial cancer; Lymphadenectomy; MRI; Frozen section; Myometrial invasion	LYMPH-NODE METASTASIS; MAGNETIC-RESONANCE; SURGICAL-MANAGEMENT; CORPUS CANCER; LYMPHADENECTOMY; ADENOCARCINOMA; DISSEMINATION; CARCINOMA; GRADE; WOMEN	Objective: The rate of lymph node metastasis is extremely low in patients with low-risk endometrial cancer; lymphadenectomy may be unnecessary for these patients under an accurate preoperative diagnosis. The aim of this study was to evaluate the diagnostic accuracy of myometrial invasion (MI) on preoperative magnetic resonance imaging (MRI) and intraoperative frozen sections (FSs). Materials and Methods: Endometrial cancer was diagnosed in a total of 378 patients by preoperative endometrial curettage, preoperative magnetic resonance imaging MRI, and intraoperative FSs; the 378 patients underwent hysterectomy. The depth of MI was evaluated between the preoperative MRI, intraoperative FSs, and final paraffin sections (PSs). The histologic grade was also evaluated between preoperative endometrial curettage, intraoperative FSs, and final PSs. Results: The sensitivity, specificity, positive predictive value, and negative predictive value for deep MI (>= 50%) on MRI were 57.8%, 92.0%, 69.3%, and 87.5%, respectively, with a kappa value of 0.53. These figures on FSswere 66.7%, 97.9%, 90.9%, and 90.4%, with a kappa value of 0.71. When grade 3 endometrioid adenocarcinoma, serous carcinoma, clear cell carcinoma, and carcinosarcoma were considered high-grade tumors, the grade evaluation at the time of FSswas 70.2%, 99.0%, 96.1%, and 89.7%, with a kappa value of 0.75. In the patients with low-grade tumors, including grade 1 or 2 endometrioid adenocarcinoma on preoperative endometrial curettage, the rate of unexpected lymph node metastasis did not differ significantly between the patients who had a diagnosis of MI and lymph node metastasis by MRI and those with diagnosis of MI and histological grade by FSs (4.0% vs 2.6%; P > 0.05). Conclusions: Frozen sections had a higher agreement rate for MI than MRI; however, MRI is still considered an acceptable modality to guide preoperative decisions regarding lymphadenectomy especially in grade 1 or 2 endometrioid adenocarcinoma.	[Tanaka, Tomohito; Terai, Yoshito; Ono, Yoshihiro J.; Fujiwara, Satoe; Tanaka, Yoshimichi; Sasaki, Hiroshi; Tsunetoh, Satoshi; Kanemura, Masanori; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan; [Yamamoto, Kazuhiro] Osaka Med Coll, Dept Radiol, Takatsuki, Osaka 5698686, Japan; [Yamada, Takashi] Osaka Med Coll, Dept Pathol, Takatsuki, Osaka 5698686, Japan	Tanaka, T (reprint author), Osaka Med Coll, Dept Obstet & Gynecol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	gyn123@poh.osaka-med.ac.jp					Sanjuan A, 2006, INT J GYNECOL CANCER, V16, P385, DOI 10.1111/j.1525-1438.2006.00414.x; Lowery WJ, 2012, GYNECOL ONCOL, V126, P12, DOI 10.1016/j.ygyno.2012.05.003; BORONOW RC, 1984, OBSTET GYNECOL, V63, P825; Mariani A, 2000, AM J OBSTET GYNECOL, V182, P1506, DOI 10.1067/mob.2000.107335; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Stephan JM, 2014, GYNECOL ONCOL, V133, P499, DOI 10.1016/j.ygyno.2014.03.569; [Anonymous], 2012, NCCN CLIN PRACTICE G; Larson DM, 1996, OBSTET GYNECOL, V88, P394, DOI 10.1016/0029-7844(96)00161-5; Convery PA, 2011, GYNECOL ONCOL, V123, P65, DOI 10.1016/j.ygyno.2011.06.025; Kang S, 2013, GYNECOL ONCOL, V129, P33, DOI 10.1016/j.ygyno.2013.01.005; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Wu LM, 2013, EUR RADIOL, V23, P435, DOI 10.1007/s00330-012-2609-9; AlHilli MM, 2013, GYNECOL ONCOL, V128, P294, DOI 10.1016/j.ygyno.2012.10.009; Case AS, 2006, OBSTET GYNECOL, V108, P1375, DOI 10.1097/01.AOG.0000245444.14015.00; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Kumar S, 2012, GYNECOL ONCOL, V127, P525, DOI 10.1016/j.ygyno.2012.08.024; Panici PB, 2008, J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Chan JK, 2007, GYNECOL ONCOL, V106, P282, DOI 10.1016/j.ygyno.2007.05.033; Courtney-Brooks M, 2014, INT J GYNECOL CANCER, V24, P91, DOI 10.1097/IGC.0000000000000008; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Egle D, 2008, GYNECOL ONCOL, V110, P286, DOI 10.1016/j.ygyno.2008.05.007; Gallego JC, 2014, ABDOM IMAGING, V39, P1021, DOI 10.1007/s00261-014-0134-9; Hahn HS, 2013, INT J GYNECOL CANCER, V23, P1411, DOI 10.1097/IGC.0b013e3182a580d3; Hernandez E, 2006, OBSTET GYNECOL, V107, P952, DOI 10.1097/01.AOG.0000209463.53764.e7; Kisu I, 2013, ACTA OBSTET GYN SCAN, V92, P525, DOI 10.1111/aogs.12048	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	JUN	2015	25	5					879	883		10.1097/IGC.0000000000000470		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CI7ZT	WOS:000354987300020		
J	Hanawa, S; Mitsuhashi, A; Usui, H; Yamamoto, N; Watanabe-Nemoto, M; Nishikimi, K; Uehara, T; Tate, S; Uno, T; Shozu, M				Hanawa, Shinsuke; Mitsuhashi, Akira; Usui, Hirokazu; Yamamoto, Noriko; Watanabe-Nemoto, Miho; Nishikimi, Kyoko; Uehara, Takashi; Tate, Shinichi; Uno, Takashi; Shozu, Makio			Daily Low-Dose Cisplatin-Based Concurrent Chemoradiotherapy for the Treatment of Cervical Cancer in Patients 70 Years or Older	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Cervical cancer; Chemoradiotherapy; Elderly; Low-dose cisplatin	GYNECOLOGIC-ONCOLOGY-GROUP; CELL LUNG-CANCER; ELDERLY-PATIENTS; MULTIINSTITUTIONAL PHASE-2; CONCOMITANT CISPLATIN; RADIATION-THERAPY; RADIOTHERAPY; CARCINOMA; CHEMORADIATION; CHEMOTHERAPY	Objectives: It has been established that concurrent chemoradiotherapy (CCRT) is efficacious for cervical cancer, but adherence is unsatisfactory among elderly patients. To improve adherence, we have developed and initiated a daily low-dose cisplatin-based CCRT regimen. Here, we retrospectively evaluated the use of CCRT, especially for elderly patients. Methods: The study included a total of 53 patients who were 70 years or older, had stage IB-IVA cervical cancer, and were initially treated with daily CCRT. The daily CCRT comprised pelvic external beam radiotherapy (2 Gy/d x 25) with daily low-dose cisplatin (8.0 mg/m(2) per day) and either low-or high-dose-rate intracavitary brachytherapy. Results: The median age was 72 years (range, 70-85 years). The median follow-up duration was 32 months (range, 2-104 months). The 3-year overall survival rate was 79.0%. Daily cisplatin chemotherapy was successfully completed in 32 (60.4%) of the 53 patients. Grade 3 or 4 neutropenia was observed in 19 patients (36%). A late complication of grade 3 rectal hemorrhage occurred in 3 patients who received high-dose-rate brachytherapy. All primary tumors responded to daily CCRT; complete response was observed in 43 patients (91.5%) and partial response was observed in 4 patients (8.5%). Conclusions: Daily CCRT in patients 70 years and older had acceptable compliance and safety. Daily CCRT is suggested to be a good treatment option for elderly patients who have advanced cervical cancer and require concurrent cisplatin.	[Hanawa, Shinsuke; Mitsuhashi, Akira; Usui, Hirokazu; Yamamoto, Noriko; Nishikimi, Kyoko; Uehara, Takashi; Tate, Shinichi; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chuo Ku, Chiba 2608670, Japan; [Watanabe-Nemoto, Miho; Uno, Takashi] Chiba Univ, Grad Sch Med, Dept Radiol, Chuo Ku, Chiba 2608670, Japan	Mitsuhashi, A (reprint author), Chiba Univ, Grad Sch Med, Dept Reprod Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	antira@faculty.chiba-u.jp					Mitsuhashi A, 2013, INT J GYNECOL CANCER, V23, P1453, DOI 10.1097/IGC.0b013e3182559bda; Nugent EK, 2010, GYNECOL ONCOL, V116, P438, DOI 10.1016/j.ygyno.2009.09.045; Eifel PJ, 2004, J CLIN ONCOL, V22, P872, DOI 10.1200/JCO.2004.07.197; Goodheart M, 2008, INT J GYNECOL CANCER, V18, P95, DOI 10.1111/j.1525-1438.2007.00967.x; Rose PG, 1999, NEW ENGL J MED, V340, P1144, DOI 10.1056/NEJM199904153401502; [Anonymous], 2014, ACTA OBSTET GYNAECOL, V66, P995; Atagi S, 2012, LANCET ONCOL, V13, P671, DOI 10.1016/S1470-2045(12)70139-0; Keys HM, 1999, NEW ENGL J MED, V340, P1154, DOI 10.1056/NEJM199904153401503; Whitney CW, 1999, J CLIN ONCOL, V17, P1339; Hoebers FJP, 2007, RADIOTHER ONCOL, V85, P42, DOI 10.1016/j.radonc.2007.03.014; Kato S, 2013, INT J RADIAT ONCOL, V87, P100, DOI 10.1016/j.ijrobp.2013.04.053; Kato S, 2010, INT J RADIAT ONCOL, V77, P751, DOI 10.1016/j.ijrobp.2009.06.011; Kunos C, 2009, INT J GYNECOL CANCER, V19, P1258, DOI 10.1111/IGC.0b013e3181b33ace; Mitsuhashi A, 2005, GYNECOL ONCOL, V96, P194, DOI 10.1016/j.ygyno.2004.09.038; Morris M, 1999, NEW ENGL J MED, V340, P1137, DOI 10.1056/NEJM199904153401501; Nelson NJ, 2000, J NATL CANCER I, V92, P1968, DOI 10.1093/jnci/92.24.1968; SCHAAKEKONING C, 1992, NEW ENGL J MED, V326, P524, DOI 10.1056/NEJM199202203260805; Toita T, 2012, INT J GYNECOL CANCER, V22, P1420, DOI 10.1097/IGC.0b013e3182647265	18	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	JUN	2015	25	5					891	896		10.1097/IGC.0000000000000436		6	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CI7ZT	WOS:000354987300022		
J	Ryu, N; Ogawa, M; Matsui, H; Usui, H; Shozu, M				Ryu, Noriko; Ogawa, Masaki; Matsui, Hideo; Usui, Hirokazu; Shozu, Makio			The Clinical Characteristics and Early Detection of Postpartum Choriocarcinoma	INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER			English	Article						Postpartum choriocarcinoma; Intraplacental choriocarcinoma; Initial presenting symptoms; Prognosis	GESTATIONAL TROPHOBLASTIC TUMORS; INTRAPLACENTAL CHORIOCARCINOMA; COMBINATION CHEMOTHERAPY; TERM PLACENTA; ACTINOMYCIN-D; PREGNANCY	Objectives: This study aimed to identify the clinical and demographic characteristics and prognosis of patients with conditions diagnosed with postpartum choriocarcinoma based on the International Federation of Gynecology and Obstetrics 2000 prognosis scoring system or based on pathologically confirmed choriocarcinoma and to analyze the patients' clinical symptoms for early detection of this disease. Methods/Materials: Between January 1983 and August 2013, 24 consecutive women with postpartum choriocarcinoma were treated at 2 hospitals. Data on clinical and demographic characteristics, including initial presenting symptoms, type of antecedent pregnancy, fetal complications, and prognosis of these patients, were analyzed. According to the time interval between the previous delivery and the onset of disease, patients were divided into 2 groups: the short and long interval groups. Results: The most common symptom among the 24 patients with postpartum choriocarcinoma was irregular vaginal bleeding (14/24); in some cases, bleeding was caused by metastatic foci (7/24). Massive genital bleeding causing emergency hysterectomy and several obstetric complications, such as unknown severe fetal anemia and fetal growth retardation, was only observed in the short interval group. The overall primary remission rate was 91.7%. Conclusions: The most common symptom of patients with postpartum choriocarcinoma in the short and long interval groups was genital bleeding, and the overall prognosis may be improved by introduction of an appropriate chemotherapy regimen. Careful pathological examination of the placenta is needed in cases of fetomaternal hemorrhage, unknown fetal anemia, and abnormal obstetric events, including premature delivery, still birth, and infantile growth retardation, for the early detection of intraplacental choriocarcinoma.	[Ryu, Noriko; Ogawa, Masaki; Matsui, Hideo] Tokyo Womens Med Univ, Dept Obstet & Gynecol, Tokyo 1628666, Japan; [Usui, Hirokazu; Shozu, Makio] Chiba Univ, Grad Sch Med, Dept Reprod Med, Chiba, Japan	Matsui, H (reprint author), Tokyo Womens Med Univ, Dept Obstet & Gynecol, Shinnjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	matsui.hideo@twmu.ac.jp					Matsui H, 2005, GYNECOL ONCOL, V96, P616, DOI 10.1016/j.ygyno.2004.11.011; Liu JP, 2006, GYNECOL ONCOL, V103, P1147, DOI 10.1016/j.ygyno.2006.08.007; Sebire NJ, 2005, FETAL PEDIATR PATHOL, V24, P21, DOI 10.1080/15227950590961180; Bower M, 1997, J CLIN ONCOL, V15, P2636; Ma Y, 2008, INT J GYNECOL CANCER, V18, P1097, DOI 10.1111/j.1525-1438.2007.01132.x; BAGSHAWE KD, 1986, LANCET, V2, P673; Matsui H, 2000, GYNECOL ONCOL, V78, P28, DOI 10.1006/gyno.2000.5813; Arima T, 1995, CANCER GENET CYTOGEN, V85, P5, DOI 10.1016/0165-4608(95)00109-3; BERKOWITZ RS, 1984, GYNECOL ONCOL, V17, P52, DOI 10.1016/0090-8258(84)90059-3; Dobson LS, 1999, BRIT J CANCER, V79, P1531, DOI 10.1038/sj.bjc.6690244; DRISCOLL SG, 1963, OBSTET GYNECOL, V21, P96; FISHER RA, 1992, CANCER, V69, P839, DOI 10.1002/1097-0142(19920201)69:3<839::AID-CNCR2820690336>3.0.CO;2-E; Jacques SM, 1998, PEDIATR DEVEL PATHOL, V1, P380, DOI 10.1007/s100249900052; Matsui H, 2002, CANCER, V95, P1051, DOI 10.1002/cncr.10790; MILLER JM, 1979, OBSTET GYNECOL, V53, P207; Takai N, 2000, PATHOL INT, V50, P258, DOI 10.1046/j.1440-1827.2000.01036.x	16	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1048-891X	1525-1438		INT J GYNECOL CANCER	Int. J. Gynecol. Cancer	JUN	2015	25	5					926	930		10.1097/IGC.0000000000000184		5	Oncology; Obstetrics & Gynecology	Oncology; Obstetrics & Gynecology	CI7ZT	WOS:000354987300027		
J	Nakano, K				Nakano, Katsuyuki			Life-cycle assessment framework for adaptation planning to climate change: linking regional climate impact with product design	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Adaptation; Characterization; Climate change; Environmental management system (EMS); Hotspot analysis; ISO 14001; Life-cycle assessment (LCA); Resilience	ENVIRONMENTAL-MANAGEMENT SYSTEMS; LCA; VULNERABILITY	An organization has to consider the influence from an environmental change, such as climate change, to its business activities. Life-cycle assessment (LCA) evaluates an impact to the environment; however, there is no LCA method to evaluate an impact from the environment. This study aims to develop a method for evaluating a relative potential impact from climate change to a product system using an LCA framework and to support adaptation planning. This paper proposes LCA framework adaptation planning (LCA-AP) that can be applied to climate change. First, it identifies environmental drivers induced by climate change that impact human health and social assets. Second, an elementary flow from each environmental driver with potential impacts, such as freshwater use, is identified. Third, an activity requiring a large amount of the elementary flow is identified. The identified activity is a hotspot potentially impacted by climate change, and possible improvements are considered. LCA-AP is demonstrated by a case study of printing paper production. The current life-cycle impact assessment methods, such as water footprints and land use, evaluate impacts to the environment. In contrast, LCA-AP evaluates an impact from the environment, and the environmental mechanism is different. In LCA-AP, a practitioner has to calculate the impact for each country and has to do the same for the water footprint method. After hotspots are identified, the next step is to scrutinize an actual risk of climate change to a company's own product supply chain. Collaboration with a business partner may identify a risk and its countermeasure. Application of LCA-AP to climate change was proposed, and its effectiveness demonstrated through a case study. LCA-AP evaluates a relative potential impact from climate change to a product system in an LCA framework at the product design stage. Existing LCA databases and software can be used to implement LCA-AP. The author recommends expanding the method to other environmental impact categories and developing a way to prioritize impact categories through damage assessment and weighting.	Japan Environm Management Assoc Ind JEMAI, Chiyoda Ku, Tokyo 1010044, Japan	Nakano, K (reprint author), Japan Environm Management Assoc Ind JEMAI, Chiyoda Ku, 2-1,Kajicho 2 Chome, Tokyo 1010044, Japan.	nakano@jemai.or.jp		Nakano, Katsuyuki/0000-0001-5123-5510			Lewandowska A, 2014, INT J LIFE CYCLE ASS, V19, P1794, DOI 10.1007/s11367-014-0787-1; Ridoutt BG, 2010, GLOBAL ENVIRON CHANG, V20, P113, DOI 10.1016/j.gloenvcha.2009.08.003; Hillary R, 2004, J CLEAN PROD, V12, P561, DOI 10.1016/j.jclepo.2003.08.006; [Anonymous], 2006, 14040 ISO; [Anonymous], 2014, 14046 ISO; Pfister S, 2009, ENVIRON SCI TECHNOL, V43, P4098, DOI 10.1021/es802423e; Allison EH, 2009, FISH FISH, V10, P173, DOI 10.1111/j.1467-2979.2008.00310.x; Nakano K, 2011, J CLEAN PROD, V19, P1189, DOI 10.1016/j.jclepro.2011.03.007; Kikuchi Y, 2009, J IND ECOL, V13, P945, DOI 10.1111/j.1530-9290.2009.00180.x; Meyfroidt P, 2009, P NATL ACAD SCI USA, V106, P16139, DOI 10.1073/pnas.0904942106; Kikuchi Y, 2008, ENVIRON SCI TECHNOL, V42, P4527, DOI 10.1021/es7024164; Fussel HM, 2007, GLOBAL ENVIRON CHANG, V17, P155, DOI 10.1016/j.gloenvcha.2006.05.002; Zhang Y, 2010, ENVIRON SCI TECHNOL, V44, P2624, DOI 10.1021/es900548a; Canals LMI, 2007, J CLEAN PROD, V15, P1426, DOI 10.1016/j.jclepro.2006.05.005; Baan L, 2012, INT J LIFE CYCLE ASS, V18, P1216; Benoit Norris C., 2012, SUSTAINABILITY, V4, P1946; Boulay AM, 2015, INT J LIFE CYCLE ASS, V20, P139, DOI 10.1007/s11367-014-0814-2; Development Assistance Research Associates (DARA), 2012, CLIM VULN MON; Esty D.C., 2005, 2005 ENV SUSTAINABIL; Flemstrom K., 2004, RELATIONSHIPS LIFE C; Goedkoop M, 2012, RECIPE 2008 REPORT; Hellmann J, 2014, U NOTRE DAME GLOBAL; Henigan M, 2013, 207SC1 ISOTC; IPCC, 2014, CLIM CHANG 2014 IMP; Irving S, 2001, ENVIRON IMPACT ASSES, V21, P385; ISO, 2004, 14001 ISP; Itsubo N, 2012, JLCA NEWS ENGL ED, V13, P1; Kaly U, 2004, ENV VULNERABILITY IN; Kreft S., 2013, GLOBAL CLIMATE RISK; Lassaux S., 2012, INT J LIFE CYCLE ASS, V12, P118; LCA forum of Japan, 2013, JLCA DAT; Lewandowska A, 2012, INT J LIFE CYCLE ASS, V18, P472; Lewandowska A, 2011, INT J LIFE CYCLE ASS, V16, P247, DOI 10.1007/s11367-011-0252-3; Motoshita M, 2014, INT J LIFE CYCLE ASS, DOI [10.1007/s11367-014-0811-5, DOI 10.1007/S11367-014-0811-5]; New Earth, 2014, SOC HOTSP DAT; Norris CB, 2014, SUSTAINABILITY-BASEL, V6, P6973, DOI 10.3390/su6106973; PE international, 2014, GABI LCA DAT DOC; Rodríguez C., 2014, Proceedings of the 9th International Conference on Life Cycle Assessment in the Agri-Food Sector (LCA Food 2014), San Francisco, California, USA, 8-10 October, 2014, P1120; Tahara K, 2010, P 9 INT C EC TOK, P119; Van Oel PR, 2011, WATER RESOUR MANAG, V26, P733; Weidema B. P., 2013, ECOINVENT DATABASE O; Wheeler David, 2011, QUANTIFYING VULNERAB; Wiedmann TO, 2015, P NATL ACAD SCI USA, V112, P6271, DOI 10.1073/pnas.1220362110	43	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	JUN	2015	20	6					819	828		10.1007/s11367-015-0867-x		10	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CI7RS	WOS:000354962700009		
J	Martinez-Blanco, J; Inaba, A; Finkbeiner, M				Martinez-Blanco, Julia; Inaba, Atsushi; Finkbeiner, Matthias			Scoping organizational LCA-challenges and solutions	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Organization; Product LCA; Reporting flow; Reporting organization; Reporting unit; System boundary		Although the largely used life cycle assessment (LCA) was initially targeted for products, it can also be adapted to the organizational level. The resulting methodology is the so-called organizational LCA (O-LCA), introduced by ISO/TS 14072 and being developed by several initiatives. O-LCA's object of study is the organization and its value chain; it adopts a life cycle approach and assesses a multi-set of environmental impacts. This paper introduces the methodological framework of O-LCA to researchers and practitioners and focuses particularly on the scoping phase. Here, we discuss the solutions adopted for each identified challenge when accommodating product LCA to organizations. Those critical elements are analyzed and contrasted with main baseline initiatives: primarily product LCA standards and also Organisation Environmental Footprint and GHG Protocol. Additionally, small deviations from ISO/TS 14072 that are proposed by the authors are pointed out and explained. An example was made up to illustrate and support the explanations. O-LCA also follows a four-phase approach, including goal and scope definition, inventory, impact assessment, and interpretation. Although product and O-LCA are comparable, main differences are mostly at the scope level, which is very relevant for the subsequent phases of O-LCA. Function is the main basis for the definition of the unit of analysis in product LCA, while in O-LCA, are the organization and its portfolio, which is unique for each organization. The reporting organization should be described in terms of subject of study, sites that are to be partially or totally considered, and period when the organization is depicted. Finally, as in product LCA, the boundary of the studied system is defined that includes direct and indirect activities along the value chain of the organization. Most principles, requirements, and guidelines of product LCA apply for O-LCA, and the major identified differences are at the unit of analysis and boundary definition level. A cross-divergence that affects the perspective of the two methods is that O-LCA is not foreseen for comparative assertions intended to be disclosed to the public.	[Martinez-Blanco, Julia; Finkbeiner, Matthias] Tech Univ Berlin, Dept Environm Technol, Chair Sustainable Engn, D-10623 Berlin, Germany; [Inaba, Atsushi] Kogakuin Univ, Dept Environm & Energy Chem, Tokyo 1638677, Japan	Martinez-Blanco, J (reprint author), Tech Univ Berlin, Dept Environm Technol, Chair Sustainable Engn, D-10623 Berlin, Germany.	julia.martinezblanco@tu-berlin.de			UNEP/SETAC Life Cycle Initiative secretariat	The authors want to thank all the participants of the flagship project "LCA of organizations" of the UNEP/SETAC Life Cycle Initiative. Particularly, we want to acknowledge the support from the initiative's secretariat and the contribution of the working group to the project.	ADEME, 2010, BIL CARB CO LOC AUTH; [Anonymous], 2006, 14040 ISO; Suh S, 2004, ENVIRON SCI TECHNOL, V38, P657, DOI 10.1021/es0263745; [Anonymous], 2004, 14001 ISO; Huang YA, 2009, ENVIRON SCI TECHNOL, V43, P8509, DOI 10.1021/es901643a; Defra, 2013, ENV REP GUID INCL MA; Downie J, 2011, J CLEAN PROD, V56, P156; Draucker L, 2013, SETAC N AM 34 ANN M; European Commission, 2010, INT REF LIF CYCL DAT; European Commission, 2013, ORG ENV FOOTPR GUID; Finkbeiner M, 2014, BACKGR FUTUR PROSPEC, P85; Finkbeiner M, 2013, INT J LIFE CYCLE ASS, V19, P266; Finkbeiner M, 2013, J ENV ACCOUNT MANAG, V1, P55; Galatola M, 2014, INT J LIFE CYCLE ASS, V19, P1356, DOI 10.1007/s11367-014-0740-3; International Organization for Standardization (ISO), 2006, 14044 ISO; International Organization for Standardization (ISO), 2006, 140641 ISO; ISO, 2013, 14069 ISOTR; ISO, 2014, 14072 ISOTS; Makower J, 2014, STATE GREEN BUSINESS; Martinez-Blanco J, 2015, J LIFE CYCLE ASSESSM, V11, P1; Mila i Canals L, 2010, INT J LIFE CYCLE ASS, V16, P50; Pelletier N, 2013, INT J LIFE CYCLE ASS, V19, P387; UNEP/SETAC, 2015, GUID ORG LIF CYCL AS; WRI and WBCSD, 2011, CORP VAL CHAIN SCOP; WRI and WBCSD, 2004, GHG PROT CORP ACC RE	25	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	JUN	2015	20	6					829	841		10.1007/s11367-015-0883-x		13	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CI7RS	WOS:000354962700010		
J	Boulay, AM; Bayart, JB; Bulle, C; Franceschini, H; Motoshita, M; Munoz, I; Pfister, S; Margni, M				Boulay, Anne-Marie; Bayart, Jean-Baptiste; Bulle, Cecile; Franceschini, Helen; Motoshita, Masaharu; Munoz, Ivan; Pfister, Stephan; Margni, Manuele			Analysis of water use impact assessment methods (part B): applicability for water footprinting and decision making with a laundry case study	INTERNATIONAL JOURNAL OF LIFE CYCLE ASSESSMENT			English	Article						Water availability; Water degradation; Water footprint; Water scarcity; Water use impacts	HUMAN HEALTH; CONSUMPTION; LCA	The integration of different water impact assessment methods within a water footprinting concept is still ongoing, and a limited number of case studies have been published presenting a comprehensive study of all water-related impacts. Although industries are increasingly interested in assessing their water footprint beyond a simple inventory assessment, they often lack guidance regarding the applicability and interpretation of the different methods available. This paper aims to illustrate how different water-related methods can be applied within a water footprint study of a laundry detergent and discuss their applicability. The concept of water footprinting, as defined by the recently published ISO Standard (ISO 2014), is illustrated through the case study of a load of laundry using water availability and water degradation impact categories. At the midpoint, it covers scarcity, availability, and pollution indicators such as eutrophication, acidification, human, and eco-toxicity. At the endpoint, impacts on human health and ecosystems are covered for water deprivation and degradation. Sensitivity analyses are performed on the most sensitive modeling choices identified in part A of this paper. The applicability of the different methodologies and their interpretation within a water footprint concept for decision making is presented. The discussion covers general applicability issues such as inventory flow definition, data availability, regionalization, and inclusion of wastewater treatment systems. Method-specific discussion covers the use of interim ecotoxicity factors, the interaction of scarcity and availability assessments and the limits of such methods, and the geographic coverage and availability of impact assessment methods. Lastly, possible double counting, databases, software, data quality, and integration of a water footprint within a life cycle assessment (LCA) are discussed. This study has shown that water footprinting as proposed in the ISO standard can be applied to a laundry detergent product but with caveats. The science and the data availability are rapidly evolving, but the results obtained with present methods enable companies to map where in the life cycle and in the world impacts might occur.	[Boulay, Anne-Marie; Bulle, Cecile; Margni, Manuele] Ecole Polytech, CIRAIG, Montreal, PQ H3C 3A7, Canada; [Bayart, Jean-Baptiste] Quantis, Lausanne, Switzerland; [Franceschini, Helen; Munoz, Ivan] Unilever, Safety & Environm Assurance Ctr, Colworth, England; [Motoshita, Masaharu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan; [Pfister, Stephan] ETH, Inst Environm Engn, CH-8093 Zurich, Switzerland; [Motoshita, Masaharu] Tech Univ Berlin, Dept Environm Technol, D-10623 Berlin, Germany	Boulay, AM (reprint author), Ecole Polytech, CIRAIG, Montreal, PQ H3C 3A7, Canada.	anne-marie.boulay@polymtl.ca	Pfister, Stephan/B-1317-2011	Pfister, Stephan/0000-0001-8984-2041	International Chair in Life Cycle Assessment	The authors would like to thank Anna Kounina for her contribution in the original work of the case study and Samuel Vionnet for his support on the case study. We acknowledge the financial support of the industrial partners in the International Chair in Life Cycle Assessment (a research unit of CIRAIG): Arcelor Mittal, Bombardier, le Mouvement Desjardins, Hydro-Quebec, LVMH, Michelin, Nestle, RECYC-QUEBEC, RONA, SAQ, Solvay, Total, Umicore, and Veolia Environnement.	Bayart JB, 2010, INT J LIFE CYCLE ASS, V15, P439, DOI 10.1007/s11367-010-0172-7; [Anonymous], 2014, 14046 ISO; Pfister S, 2009, ENVIRON SCI TECHNOL, V43, P4098, DOI 10.1021/es802423e; Berger M, 2013, J IND ECOL, V17, P79, DOI 10.1111/j.1530-9290.2012.00495.x; Boulay AM, 2011, ENVIRON SCI TECHNOL, V45, P8948, DOI 10.1021/es1030883; Hanafiah MM, 2011, ENVIRON SCI TECHNOL, V45, P5272, DOI 10.1021/es1039634; Kounina A, 2013, INT J LIFE CYCLE ASS, V18, P707, DOI 10.1007/s11367-012-0519-3; Rosenbaum RK, 2008, INT J LIFE CYCLE ASS, V13, P532, DOI 10.1007/s11367-008-0038-4; Boulay AM, 2011, INT J LIFE CYCLE ASS, V16, P639, DOI 10.1007/s11367-011-0300-z; Pfister S, 2011, SCI TOTAL ENVIRON, V409, P4206, DOI 10.1016/j.scitotenv.2011.07.019; Jeswani HK, 2011, J CLEAN PROD, V19, P1288, DOI 10.1016/j.jclepro.2011.04.003; Jolliet O, 2003, INT J LIFE CYCLE ASS, V8, P324, DOI 10.1007/BF02978505; Australian and New Zealand Environmentent and Conservation Council and Agriculture and Resource Management Council of Australia and New Zealand, 2000, AUSTR NZ GUID FRESH; Bayart JB, 2014, INT J LIFE CYCLE ASS, V19, P1336, DOI 10.1007/s11367-014-0732-3; Berger M, 2012, ENVIRON SCI TECHNOL, V46, P4091, DOI 10.1021/es2040043; Boulay AM, 2015, INT J LIFE CYCLE ASS, V20, P139, DOI 10.1007/s11367-014-0814-2; Canadian Council of Ministers of the Environment, 2007, CAN ENV QUAL GUID; CIRAIG, 2012, WAT TOOL; CIRAIG, 2012, IMP WAT US LCA GOOGL; Department of Water Affairs Forestry, 2011, S AFR WAT QUAL GUID, V7; Detergent Ingredients Database, 2007, DID LIST 2007; Doka G, 2009, LIFE CYCLE INVENTORI; Eurostat, 2013, POP CONN WAST COLL T; Frischknecht R, 2004, ECOINVENT OVERVIEW M, P75; Frischknecht R, 2008, SWISS ECOLOGICAL SCA; Frischknecht R, 2007, ECOINVENT OVERVIEW M; GEMStat, 2009, UNEP GLOB ENV MON SY; Goedkoop M., 2012, RECIPE 2008 LIFE CYC; Growing Blue, 2012, WAT IMP IND TOOL; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2011, WATER FOOTPRINT ASSE; Hoof G, 2011, INT J LIFE CYCLE ASS, V16, P803; Mila I., 2009, INT J LIFE CYCLE ASS, V14, P28, DOI DOI 10.1007/511367-008-0030-Z; Ministry of Environmental Protection of the People's Republic of China, 2002, ENV QUAL STAND SURF; Motoshita M., 2010, INT J LIFE CYCLE ASS, V16, P65; Motoshita M, 2010, P 9 INT C ECOBALANCE, P3; Oceanographic Commission UNESCO's Intergovernmental (IOC), 2008, GLOB NEWS DAT; van Zelm R, 2011, ENVIRON SCI TECHNOL, V45, P629, DOI 10.1021/es102383v; Verones F, 2011, ENVIRON SCI TECHNOL, V45, P7608, DOI 10.1021/es202585y; Water Footprint Network, 2011, WATERSTAT; Wernet G, 2012, INT J LIFE CYCLE ASS, V17, P720, DOI 10.1007/s11367-012-0404-0	41	2	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0948-3349	1614-7502		INT J LIFE CYCLE ASS	Int. J. Life Cycle Assess.	JUN	2015	20	6					865	879		10.1007/s11367-015-0868-9		15	Engineering, Environmental; Environmental Sciences	Engineering; Environmental Sciences & Ecology	CI7RS	WOS:000354962700013		
J	Sakamoto, K; Yokogawa, T; Ueno, H; Oguchi, K; Kazuno, H; Ishida, K; Tanaka, N; Osada, A; Yamada, Y; Okabe, H; Matsuo, K				Sakamoto, Kazuki; Yokogawa, Tatsushi; Ueno, Hiroyuki; Oguchi, Kei; Kazuno, Hiromi; Ishida, Keiji; Tanaka, Nozomu; Osada, Akiko; Yamada, Yukari; Okabe, Hiroyuki; Matsuo, Kenichi			Crucial roles of thymidine kinase 1 and deoxyUTPase in incorporating the antineoplastic nucleosides trifluridine and 2 '-deoxy-5-fluorouridine into DNA	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						TAS-102; trifluridine; tipiracil hydrochloride; 5-fluorouracil	THYMIDYLATE SYNTHASE; COLORECTAL-CANCER; FLUORINATED PYRIMIDINES; LUNG-CANCER; CELL-CYCLE; INHIBITION; EXPRESSION; TAS-102; TRIFLUOROTHYMIDINE; MECHANISM	Trifluridine (FTD) and 2'-deoxy-5-fluorouridine (FdUrd), a derivative of 5-fluorouracil (5-FU), are antitumor agents that inhibit thymidylate synthase activity and their nucleotides are incorporated into DNA. However, it is evident that several differences occur in the underlying antitumor mechanisms associated with these nucleoside analogues. Recently, TAS-102 (composed of FTD and tipiracil hydrochloride, TPI) was shown to prolong the survival of patients with colorectal cancer who received a median of 2 prior therapies, including 5-FU. TAS-102 was recently approved for clinical use in Japan. These data suggest that the antitumor activities of TAS-102 and 5-FU proceed via different mechanisms. Thus, we analyzed their properties in terms of thymidine salvage pathway utilization, involving membrane transporters, a nucleoside kinase, a nucleotide-dephosphorylating enzyme, and DNA polymerase a. FTD incorporated into DNA with higher efficiency than FdUrd did. Both FTD and FdUrd were transported into cells by ENT1 and ENT2 and were phosphorylated by thymidine kinase 1, which showed a higher catalytic activity for FTD than for FdUrd. deoxyUTPase (DUT) did not recognize dTTP and FTD-triphosphate (F(3)dTTP), whereas deoxyuridine-triphosphate (dUTP) and FdUrd-triphosphate (FdUTP) were efficiently degraded by DUT. DNA polymerase a incorporated both F3dTTP and FdUTP into DNA at sites aligned with adenine on the opposite strand. FTD-treated cells showed differing nuclear morphologies compared to FdUrd-treated cells. These findings indicate that FTD and FdUrd are incorporated into DNA with different efficiencies due to differences in the substrate specificities of TK1 and DUT, causing abundant FTD incorporation into DNA.	[Sakamoto, Kazuki; Yokogawa, Tatsushi; Ueno, Hiroyuki; Oguchi, Kei; Kazuno, Hiromi; Ishida, Keiji; Tanaka, Nozomu; Osada, Akiko; Yamada, Yukari; Okabe, Hiroyuki; Matsuo, Kenichi] Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Drug Discovery & Dev 1, Tsukuba, Ibaraki 3002611, Japan	Sakamoto, K (reprint author), Taiho Pharmaceut Co Ltd, Discovery & Preclin Res Div, Drug Discovery & Dev 1, 3 Okubo, Tsukuba, Ibaraki 3002611, Japan.	ka-sakamoto@taiho.co.jp					Meyers M, 2001, CANCER RES, V61, P5193; Skevaki CL, 2011, DRUGS, V71, P331, DOI 10.2165/11585330-000000000-00000; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Ladner RD, 2000, CANCER RES, V60, P3493; BELT JA, 1988, J BIOL CHEM, V263, P13819; Aufderklamm S, 2012, CANCER LETT, V316, P6, DOI 10.1016/j.canlet.2011.10.025; HEIDELBERGER C, 1957, NATURE, V179, P663, DOI 10.1038/179663a0; Wilson PM, 2012, MOL CANCER THER, V11, P616, DOI 10.1158/1535-7163.MCT-11-0781; REYES P, 1965, MOL PHARMACOL, V1, P14; Temmink OH, 2004, NUCLEOS NUCLEOT NUCL, V23, P1491, DOI 10.1081/NCN-200027707; Temmink OH, 2010, MOL CANCER THER, V9, P1047, DOI 10.1158/1535-7163.MCT-09-0932; HEIDELBERGER C, 1964, J MED CHEM, V7, P1, DOI 10.1021/jm00331a001; SHERLEY JL, 1988, J BIOL CHEM, V263, P8350; Temmink OH, 2007, CANCER SCI, V98, P779, DOI 10.1111/j.1349-7006.2007.00477.x; Yoshino T, 2012, LANCET ONCOL, V13, P993, DOI 10.1016/S1470-2045(12)70345-5; ANSFIELD FJ, 1971, CANCER CHEMOTH REP 1, V55, P205; Temmink OH, 2005, ANTI-CANCER DRUG, V16, P285, DOI 10.1097/00001813-200503000-00007; Emura T, 2004, INT J MOL MED, V13, P249; Kobayashi D, 2003, J PHARMACOL EXP THER, V306, P703, DOI 10.1124/jpet.103.051300; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; ECKSTEIN JW, 1994, BIOCHEMISTRY-US, V33, P15086, DOI 10.1021/bi00254a018; Fukushima M, 2000, BIOCHEM PHARMACOL, V59, P1227, DOI 10.1016/S0006-2952(00)00253-7; Heidelberger C, 1965, Prog Nucleic Acid Res Mol Biol, V4, P1, DOI 10.1016/S0079-6603(08)60783-7; Johnston PG, 2003, J CLIN ONCOL, V21, P815, DOI 10.1200/JCO.2003.07.039; Leichman CG, 2001, CURR OPIN ONCOL, V13, P291, DOI 10.1097/00001622-200107000-00013; Muggia Franco M, 2009, Mol Cancer Ther, V8, P992, DOI 10.1158/1535-7163.MCT-08-0731; Nobili S, 2011, INT J CANCER, V128, P1935, DOI 10.1002/ijc.25514; Parsels LA, 1998, CANCER CHEMOTH PHARM, V42, P357, DOI 10.1007/s002800050829; Shintani M, 2010, ONCOL REP, V23, P1345, DOI 10.3892/or_00000770; Tanaka N, 2014, ONCOL REP, V32, P2319, DOI 10.3892/or.2014.3487; WEBER G, 1983, CANCER RES, V43, P3466; WILLIAMS MV, 1979, J BIOL CHEM, V254, P2897	33	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUN	2015	46	6					2327	2334		10.3892/ijo.2015.2974		8	Oncology	Oncology	CI3QK	WOS:000354662300005		
J	Yoshikawa, K; Noguchi, K; Nakano, Y; Yamamura, M; Takaoka, K; Hashimoto-Tamaoki, T; Kishimoto, H				Yoshikawa, Kyohei; Noguchi, Kazuma; Nakano, Yoshiro; Yamamura, Michiyo; Takaoka, Kazuki; Hashimoto-Tamaoki, Tomoko; Kishimoto, Hiromitsu			The Hippo pathway transcriptional co-activator, YAP, confers resistance to cisplatin in human oral squamous cell carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						oral squamous cell carcinoma; cisplatin; acquired resistance; Hippo pathway; Yes-associated protein	NECK-CANCER; TUMOR-SUPPRESSOR; ADVANCED HEAD; TAZ; PHARMACOLOGY; ATP7B; DRUGS; SENSITIVITY; REGULATORS; INFUSION	Cisplatin (CDDP) is widely used to treat oral squamous cell carcinoma (OSCC), however, many patients exhibit acquired drug resistance. Yes-associated protein (YAP) is a transcriptional co-activator of the Hippo pathway that regulates organ size and promotes cell proliferation. YAP overexpression correlates with epithelial-mesenchymal transition and nodal metastasis, resulting in anti-tubulin drug resistance. Whether YAP overexpression is the cause of CDDP resistance in cancer cells is unclear, therefore, we investigated the correlation between YAP expression and CDDP sensitivity. We established three CDDP-resistant cell lines (OSC-19-R, SCCKN-R and HSC-3-R) from the OSCC parental cell lines. We also examined the expression levels of ATP7B, GST-pi and ERCC1, which are strongly associated with CDDP resistance, and Hippo pathway-related proteins by western blotting. Using immunocytochemistry, we examined the cellular localization of YAP. Additionally, following knockdown of YAP using short interfering RNAs (siRNAs), we analyzed changes in sensitivity to CDDP. Compared with parental OSC-19 cells, OSC-19-R cells were obviously larger. Expression levels of YAP were not significantly different between OSC-19 and OSC-19-R. However, expression levels of phosphorylated YAP in OSC-19-R were decreased. We observed translocation of YAP from the cytoplasm to the nucleus in OSC-19-R cells. Knockdown of YAP using siRNAs revealed that sensitivity to CDDP was significantly increased. Translocation of YAP correlated with the acquisition of CDDP resistance. YAP could be a new therapeutic target for the treatment of patients with cancer that are resistant to CDDP.	[Yoshikawa, Kyohei; Noguchi, Kazuma; Yamamura, Michiyo; Takaoka, Kazuki; Kishimoto, Hiromitsu] Hyogo Coll Med, Dept Oral & Maxillofacial Surg, Nishinomiya, Hyogo 6638501, Japan; [Nakano, Yoshiro; Hashimoto-Tamaoki, Tomoko] Hyogo Coll Med, Dept Genet, Nishinomiya, Hyogo 6638501, Japan	Noguchi, K (reprint author), Hyogo Coll Med, Dept Oral & Maxillofacial Surg, 1-1 Mukogawa Cho, Nishinomiya, Hyogo 6638501, Japan.	knoguchi@hyo-med.ac.jp			 [25463123];  [26861760]	The authors thank Dr Keiko Wakai for preparation of the experiments and Ms. Takako Nanba for management of grants. This study was supported by Grants-in-Aid for JSPS KAKENHI (grant nos. 25463123 to K.N. and 26861760 to K.Y.).	Zhao YL, 2014, CANCER RES, V74, P4493, DOI 10.1158/0008-5472.CAN-13-2712; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; WEAVER A, 1984, AM J SURG, V148, P525, DOI 10.1016/0002-9610(84)90381-7; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Overgaard J, 2010, LANCET ONCOL, V11, P553, DOI 10.1016/S1470-2045(10)70072-3; Lai D, 2011, CANCER RES, V71, P2728, DOI 10.1158/0008-5472.CAN-10-2711; Safaei R, 2005, CRIT REV ONCOL HEMAT, V53, P13, DOI 10.1016/j.critervonc.2004.09.007; Yuan M, 2008, CELL DEATH DIFFER, V15, P1752, DOI 10.1038/cdd.2008.108; Frisch SM, 2013, J CELL SCI, V126, P21, DOI 10.1242/jcs.120907; Kawahara M, 2008, BLOOD, V112, P3856, DOI 10.1182/blood-2007-09-111773; Vidal M, 2006, CURR OPIN GENET DEV, V16, P10, DOI 10.1016/j.gde.2005.12.004; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Avruch J, 2011, BRIT J CANCER, V104, P24, DOI 10.1038/sj.bjc.6606011; Koberle B, 2010, BBA-REV CANCER, V1806, P172, DOI 10.1016/j.bbcan.2010.07.004; Roepman P, 2005, NAT GENET, V37, P182, DOI 10.1038/ng1502; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Samimi G, 2004, MOL PHARMACOL, V66, P25, DOI 10.1124/mol.66.1.25; Lai D, 2012, BIOSCIENCE REP, V32, P361, DOI 10.1042/BSR20110125; Yoshizawa K, 2007, ONCOL REP, V18, P987; Visser S, 2010, GENE, V449, P22, DOI 10.1016/j.gene.2009.09.008; Hall MD, 2008, ANNU REV PHARMACOL, V48, P495, DOI 10.1146/annurev.pharmtox.48.080907.180426; Katano K, 2003, MOL PHARMACOL, V64, P466, DOI 10.1124/mol.64.2.466; Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691; Sudol M, 2010, TRENDS BIOCHEM SCI, V35, P627, DOI 10.1016/j.tibs.2010.05.010; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; CAREY TE, 1993, ANTICANCER RES, V13, P2561; Solioz M, 1996, TRENDS BIOCHEM SCI, V21, P237; Culotta VC, 1999, ADV EXP MED BIOL, V448, P247; Ge L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027529; Guo XC, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-33; Haddad RI, 2008, NEW ENGL J MED, V359, P1143, DOI 10.1056/NEJMra0707975; Liu AM, 2012, BBA-REV CANCER, V1826, P357, DOI 10.1016/j.bbcan.2012.05.006; Lo Muzio L, 2005, HUM PATHOL, V36, P187, DOI 10.1016/j.humpath.2004.12.003; Nylander K, 2000, INT J CANCER, V87, P368, DOI 10.1002/1097-0215(20000801)87:3<368::AID-IJC9>3.3.CO;2-A; ROONEY M, 1985, CANCER, V55, P1123, DOI 10.1002/1097-0142(19850301)55:5<1123::AID-CNCR2820550530>3.0.CO;2-8; Yamamura M, 2013, INT J ONCOL, V42, P873, DOI 10.3892/ijo.2013.1761	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUN	2015	46	6					2364	2370		10.3892/ijo.2015.2948		7	Oncology	Oncology	CI3QK	WOS:000354662300009		
J	Nishikawa, H; Kita, R; Kimura, T; Endo, M; Ohara, Y; Sakamoto, A; Saito, S; Nishijima, N; Nasu, A; Komekado, H; Osaki, Y				Nishikawa, Hiroki; Kita, Ryuichi; Kimura, Toru; Endo, Masatsugu; Ohara, Yoshiaki; Sakamoto, Azusa; Saito, Sumio; Nishijima, Norihiro; Nasu, Akihiro; Komekado, Hideyuki; Osaki, Yukio			Proposal of the performance status combined Japan Integrated Staging system in hepatocellular carcinoma complicated with cirrhosis	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						hepatocellular carcinoma; liver cirrhosis; performance status; Japan Integrated Staging; predictability	CONSENSUS RECOMMENDATIONS; RADIOFREQUENCY ABLATION; CLIP SCORE; JIS SCORE; MANAGEMENT; PROGNOSIS; COHORT; CLASSIFICATION; VALIDATION	The present study examined the prognostic ability of our proposed performance status combined Japan Integrated Staging (PS-JIS) system in hepatocellular carcinoma (HCC) patients with liver cirrhosis (LC) comparing with other four prognostic systems including original JIS system, the Barcelona Clinic Liver Cancer classification system, TNM classification system and the Cancer of the Liver Italian Program (CLIP) scoring system. A total of 1,170 HCC patients complicated with LC were analysed. The disease was staged for all analysed patients by means of the five staging systems. The cumulative overall survival (OS) rate was calculated by Kaplan-Meier method and tested by log-rank test. We also examined prognostic factors associated with OS using univariate and multivariate analyses and compared the prognostic ability in each prognostic system using concordance index (c-index) at 1-, 3- and 5-year time-points. Overall significance in each prognostic system was P<0.001. In the multivariate analyses, tumor number, Child-Pugh classification, PS, initial treatment modality and several laboratory parameters were significant independent predictors linked to OS. For all cases, in each time-point, the c-index of PS-JIS system was the highest among five staging systems (0.847, 0.816 and 0.808, respectively), indicating that PS-JIS system has the best predictability among these staging systems. According to subgroup analyses stratified by initial treatment modality, in patients treated with surgical resection (n=205), CLIP scoring system had the highest c-index at every time-point, whereas in patients treated with percutaneous ablative therapies (n=632) at 3- and 5-year time-point and in those with transcatheter arterial therapies (n=281) at every time-point, the c-index of PS-JIS system was the highest. In conclusion, the proposed PS-JIS score can be a useful prognostic system for HCC patients complicated with liver cirrhosis.	[Nishikawa, Hiroki; Kita, Ryuichi; Kimura, Toru; Endo, Masatsugu; Ohara, Yoshiaki; Sakamoto, Azusa; Saito, Sumio; Nishijima, Norihiro; Nasu, Akihiro; Komekado, Hideyuki; Osaki, Yukio] Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Osaka 5430027, Japan	Nishikawa, H (reprint author), Osaka Red Cross Hosp, Dept Gastroenterol & Hepatol, Tennoji Ku, 5-30 Fudegasaki Cho, Osaka 5430027, Japan.	h-nishikawa@osaka-med.jrc.or.jp					Cillo U, 2006, J HEPATOL, V44, P723, DOI 10.1016/j.jhep.2005.12.015; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Cho YK, 2008, CANCER, V112, P352, DOI 10.1002/cncr.23185; Levy I, 2002, GUT, V50, P881, DOI 10.1136/gut.50.6.881; Kudo M, 2003, J GASTROENTEROL, V38, P207, DOI 10.1007/s005350300038; Kudo M, 2004, HEPATOLOGY, V40, P1396, DOI 10.1002/hep.20486; Kudo M, 2011, DIGEST DIS, V29, P339, DOI 10.1159/000327577; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933; [Anonymous], 1989, JPN J SURG, V19, P98; Marrero JA, 2005, HEPATOLOGY, V41, P707, DOI 10.1002/hep.20636; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; HANLEY JA, 1982, RADIOLOGY, V143, P29; Collette S, 2008, ANN ONCOL, V19, P1117, DOI 10.1093/annonc/mdn030; Poon D, 2009, LANCET ONCOL, V10, P1111, DOI 10.1016/S1470-2045(09)70241-4; Guglielmi A, 2008, AM J GASTROENTEROL, V103, P597, DOI 10.1111/j.1572-0241.2007.01604.x; Montano-Loza AJ, 2014, WORLD J GASTROENTERO, V20, P8061, DOI 10.3748/wjg.v20.i25.8061; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Huitzil-Melendez FD, 2010, J CLIN ONCOL, V28, P2889, DOI 10.1200/JCO.2009.25.9895; Park JW, 2013, LIVER INT, V33, P327, DOI 10.1111/liv.12083; Manghisi G, 1998, HEPATOLOGY, V28, P751; Cillo U, 2004, J HEPATOL, V40, P124, DOI 10.1016/j.jhep.2003.09.027; Gomaa AI, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090929; Hsu CY, 2013, HEPATOLOGY, V57, P112, DOI 10.1002/hep.25950; Kitai S, 2008, INTERVIROLOGY, V51, P86, DOI 10.1159/000122599; Osaki Y, 2015, HEPATOL RES, V45, P59, DOI 10.1111/hepr.12378; Takanishi Danny M Jr, 2007, Hawaii Med J, V66, P209; Yamasaki T, 2001, CANCER, V91, P1342, DOI 10.1002/1097-0142(20010401)91:7<1342::AID-CNCR1137>3.0.CO;2-0; Zhao Jianjun, 2014, Zhonghua Yi Xue Za Zhi, V94, P903	29	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUN	2015	46	6					2371	2379		10.3892/ijo.2015.2969		9	Oncology	Oncology	CI3QK	WOS:000354662300010		
J	Takenaka, M; Saito, M; Iwakawa, R; Yanaihara, N; Saito, M; Kato, M; Ichikawa, H; Shibata, T; Yokota, J; Okamoto, A; Kohno, T				Takenaka, Masataka; Saito, Motonobu; Iwakawa, Reika; Yanaihara, Nozomu; Saito, Misato; Kato, Mamoru; Ichikawa, Hitoshi; Shibata, Tatsuhiro; Yokota, Jun; Okamoto, Aikou; Kohno, Takashi			Profiling of actionable gene alterations in ovarian cancer by targeted deep sequencing	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						ovarian cancer; molecular targeted therapy; gene mutation; gene amplification; targeted deep sequencing	CLEAR-CELL CARCINOMA; SYNTHETIC-LETHAL INTERACTIONS; GYNECOLOGIC MALIGNANCIES; SEROUS CARCINOMA; PIK3CA MUTATIONS; BRAF MUTATIONS; THERAPY; KRAS; INHIBITORS; OVEREXPRESSION	To construct a profile of therapeutically actionable gene alterations in the major histological types of ovarian cancer, 72 Japanese patients with surgically resected ovarian cancers were selected from an original cohort consisting of 267 patients who had not received pre-treatment before surgery. Somatic mutations and copy number alterations at 740 hotspots in 46 cancer-related genes were detected by deep sequencing of genomic DNAs obtained from snap-frozen tumor tissues using a next generation sequencer. The alterations were verified by Sanger sequencing and quantitative genomic PCR. Mutations and/or copy number aberrations which will make tumors respond to molecular targeting drugs were detected in nine genes of 35/72 (48.6%) patients; PIK3CA (25.0%), KRAS (13.9%), ERBB2 (4.3%), PTEN (2.8%), RB1 (2.8%), CDKN2A (2.8%), AKT1 (1.4%), CTNNB1 (1.4%) and NRAS (1.4%). These mutations tended to occur in a mutually exclusive manner. Non-serous histological type tumors showed such actionable gene alterations frequently (32/47; 68.1%). Therefore, ovarian cancers, particularly of non-serous types, frequently carry gene aberrations that link to therapy using molecular targeting drugs.	[Takenaka, Masataka; Saito, Motonobu; Iwakawa, Reika; Yokota, Jun; Kohno, Takashi] Natl Canc Ctr, Div Genome Biol, Res Inst, Tokyo 1040045, Japan; [Kato, Mamoru; Shibata, Tatsuhiro] Natl Canc Ctr, Div Canc Genom, Res Inst, Tokyo 1040045, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Div Genet, Res Inst, Tokyo 1040045, Japan; [Takenaka, Masataka; Yanaihara, Nozomu; Saito, Misato; Okamoto, Aikou] Jikei Univ, Dept Obstet & Gynecol, Sch Med, Tokyo 1058471, Japan	Kohno, T (reprint author), Natl Canc Ctr, Div Genome Biol, Res Inst, Chuo Ku, Tsukiji 5-1-1, Tokyo 1040045, Japan.	tkkohno@ncc.go.jp			Ministry of Health, Labor, and Welfare for Research for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control and Promotion of Cancer Control Programs; Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University; Research Resident Fellowship from the Foundation for Promotion of Cancer Research for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control, Japan	This study was supported by Grants-in-Aid from the Ministry of Health, Labor, and Welfare for Research for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control and Promotion of Cancer Control Programs; and Extramural Collaborative Research Grant of Cancer Research Institute, Kanazawa University. M.T. and R.I. are awardees of the Research Resident Fellowship from the Foundation for Promotion of Cancer Research for the 3rd Term Comprehensive 10-Year Strategy for Cancer Control, Japan.	Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; Janku F, 2012, J CLIN ONCOL, V30, P777, DOI 10.1200/JCO.2011.36.1196; Janne PA, 2013, LANCET ONCOL, V14, P38, DOI 10.1016/S1470-2045(12)70489-8; Gordon GM, 2013, J CELL SCI, V126, P2004, DOI 10.1242/jcs.121301; Mayr D, 2006, GYNECOL ONCOL, V103, P883, DOI 10.1016/j.ygyno.2006.05.029; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Heintz APM, 2006, INT J GYNECOL OBSTET, V95, pS161, DOI 10.1016/S0020-7292(06)60033-7; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Yan M, 2014, CANCER TREAT REV, V40, P770, DOI 10.1016/j.ctrv.2014.02.008; Helming KC, 2014, NAT MED, V20, P251, DOI 10.1038/nm.3480; Chen JS, 2003, DRUG RESIST UPDATE, V6, P129, DOI 10.1016/S1368-7646(03)00040-2; Chan DA, 2011, NAT REV DRUG DISCOV, V10, P351, DOI 10.1038/nrd3374; Hutson TE, 2014, J CLIN ONCOL, V32, P760, DOI 10.1200/JCO.2013.50.3961; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Koshiyama M, 2014, CANCER BIOL THER, V15, P22, DOI 10.4161/cbt.26608; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Janku F, 2013, CANCER RES, V73, P276, DOI 10.1158/0008-5472.CAN-12-1726; Kurman RJ, 2011, HUM PATHOL, V42, P918, DOI 10.1016/j.humpath.2011.03.003; Singer G, 2003, J NATL CANCER I, V95, P484; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Yamamoto S, 2011, J PATHOL, V225, P189, DOI 10.1002/path.2940; Miller CR, 2014, GYNECOL ONCOL, V133, P128, DOI 10.1016/j.ygyno.2014.01.008; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Yamamoto S, 2012, VIRCHOWS ARCH, V460, P77, DOI 10.1007/s00428-011-1169-8; Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Sheppard KE, 2013, CLIN CANCER RES, V19, P5320, DOI 10.1158/1078-0432.CCR-13-0259; [Anonymous], 2013, AM CANC SOC CANC FAC; Haruta S, 2011, ONCOL REP, V26, P1347, DOI 10.3892/or.2011.1456; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bartholomeusz C, 2012, MOL CANCER THER, V11, P360, DOI 10.1158/1535-7163.MCT-11-0400; Gemignani ML, 2003, GYNECOL ONCOL, V90, P378, DOI 10.1016/S0090-8258(03)00264-6; Honig A, 2012, ANTICANCER RES, V32, P2035; Kalamanathan S, 2011, ANTICANCER RES, V31, P2661; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; McAlpine JN, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-433; Ross JS, 2010, BREAST DIS, V21, P378, DOI 10.1016/j.breastdis.2010.10.001; Tuefferd M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001138; Wiegand KC, 2011, NEW ENGL J MED, V363, P1532	39	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUN	2015	46	6					2389	2398		10.3892/ijo.2015.2951		10	Oncology	Oncology	CI3QK	WOS:000354662300012		
J	Fujita, K; Iwama, H; Saicamoto, T; Okura, R; Kobayashi, K; Takano, J; Katsura, A; Tatsuta, M; Maeda, E; Mimura, S; Nomura, T; Tani, J; Miyoshi, H; Morishita, A; Yoneyama, H; Yamana, Y; Himoto, T; Okano, K; Suzuki, Y; Niki, T; Hirashima, M; Masaki, T				Fujita, Koji; Iwama, Hisakazu; Saicamoto, Teppei; Okura, Ryoichi; Kobayashi, Kiyoyuki; Takano, Jitsuko; Katsura, Akiko; Tatsuta, Miwa; Maeda, Emiko; Mimura, Shima; Nomura, Takako; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Yamana, Yuka; Himoto, Takashi; Okano, Keiichi; Suzuki, Yasuyuki; Niki, Toshiro; Hirashima, Mitsuomi; Masaki, Tsutomu			Galectin-9 suppresses the growth of hepatocellular carcinoma via apoptosis in vitro and in vivo	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						hepatocellular carcinoma; galectin-9; apoptosis; miR-1246; DYRK1A	ANTIDIABETIC DRUG METFORMIN; CANCER; SORAFENIB; INHIBITION; EXPRESSION; RESISTANCE; IMMUNITY; PATHWAY; DISEASE; BCL-2	Galectin-9, a soluble beta-galactoside-binding animal lectin, evokes apoptosis in various human cancer cell lines. The galectin-9 antitumor effect against hepatocellular carcinoma (HCC) is, however, unknown. We investigated whether galectin-9 suppresses HCC growth in vitro and in vivo. We assessed the antitumor effect of galectin-9 on HCC cells by conducting WST-8 assay in vitro and xenograft model analysis in vivo. Galectin-9-induced apoptosis was evaluated by FACS and ELISA in vitro and by TUNEL stain in vivo. Cell cycle alteration was profiled by FACS. Caspases were profiled by colorimetry. MicroRNAs related to the galectin-9 antitumor effects were determined using microarrays, and their antitumor effect was confirmed in a transfection study in vitro. The expression levels of the target proteins of the miRNAs extracted above were analyzed by western blot analysis. To summarize the results, galectin-9 inhibited the growth of the HCC cell lines HLE and Li-7 in vitro and Li-7 in vivo inducing apoptosis. Cell cycle turnover was not arrested in HLE and Li-7 cells in vitro. miR-1246 was similarly extracted both in vitro and in vivo, which sensitized Li-7 cells to apoptosis when transfected into the cells. DYRK1A, a target protein of miR-1246 was downregulated in Li-7 cells. Caspase-9 was upregulated in Li-7 cells in vitro and in vivo. In conclusion, galectin-9 inhibited the growth of HCC cells by apoptosis, but not cell cycle arrest, in vitro and in vivo. miR-1246 mediated signals of galectin-9, possibly through miR-1246-DYRK1A-caspase-9 axis. Galectin-9 might be a candidate agent for HCC chemotherapy.	[Fujita, Koji; Saicamoto, Teppei; Okura, Ryoichi; Kobayashi, Kiyoyuki; Takano, Jitsuko; Katsura, Akiko; Tatsuta, Miwa; Maeda, Emiko; Mimura, Shima; Nomura, Takako; Tani, Joji; Miyoshi, Hisaaki; Morishita, Asahiro; Yoneyama, Hirohito; Yamana, Yuka; Himoto, Takashi; Masaki, Tsutomu] Kagawa Univ, Dept Gastroenterol & Neurol, Miki, Kagawa 761079, Japan; [Iwama, Hisakazu] Kagawa Univ, Life Sci Res Ctr, Miki, Kagawa 761079, Japan; [Okano, Keiichi; Suzuki, Yasuyuki] Kagawa Univ, Dept Gastroenterol Surg, Miki, Kagawa 761079, Japan; [Niki, Toshiro; Hirashima, Mitsuomi] Kagawa Univ, Dept Immunol & Immunopathol, Miki, Kagawa 761079, Japan	Masaki, T (reprint author), Kagawa Univ, Dept Gastroenterol, Sch Med, Ikenobe 1750-1, Miki, Kagawa 761079, Japan.	tmasaki@med.kagawa-u.ac.jp					Rao RV, 2004, CELL DEATH DIFFER, V11, P372, DOI 10.1038/sj.cdd.4401378; Kerr TA, 2011, TRANSL RES, V157, P241, DOI 10.1016/j.trsl.2011.01.008; Kato K, 2012, MOL CANCER THER, V11, P549, DOI 10.1158/1535-7163.MCT-11-0594; Bruix J, 2012, J HEPATOL, V57, P821, DOI 10.1016/j.jhep.2012.06.014; MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545; Kobayashi T, 2010, LEUKEMIA, V24, P843, DOI 10.1038/leu.2010.25; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Kushibiki T, 2013, INT J MOL SCI, V14, P13542, DOI 10.3390/ijms140713542; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Schutte B, 2004, EXP CELL RES, V297, P11, DOI 10.1016/j.yexcr.2004.02.019; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Wiersma VR, 2013, MED RES REV, V33, pE102, DOI 10.1002/med.20249; Meza-Junco J, 2012, CANCER TREAT REV, V38, P54, DOI 10.1016/j.ctrv.2011.05.002; Nishikawa T, 2006, J HEPATOL, V44, P1074, DOI 10.1016/j.jhep.2005.11.045; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Kashio Y, 2003, J IMMUNOL, V170, P3631; Li H, 2012, HEPATOLOGY, V56, P1342, DOI 10.1002/hep.25777; Bach D, 2013, J PHOTOCH PHOTOBIO B, V120, P74, DOI 10.1016/j.jphotobiol.2013.01.012; Nagahara K, 2008, J IMMUNOL, V181, P7660; Forner A, 2012, LANCET, V379, P1245, DOI 10.1016/S0140-6736(11)61347-0; Miyoshi H, 2014, INT J ONCOL, V45, P322, DOI 10.3892/ijo.2014.2419; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Kobayashi M, 2013, INT J ONCOL, V42, P517, DOI 10.3892/ijo.2012.1722; Callegari Elisa, 2013, Onco Targets Ther, V6, P1167, DOI 10.2147/OTT.S36161; Deng LF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-363; Fujihara Shintaro, 2013, Recent Pat Endocr Metab Immune Drug Discov, V7, P130; Kageshita T, 2002, INT J CANCER, V99, P809, DOI 10.1002/ijc.10436; Kuroda J, 2010, MOL CANCER RES, V8, P994, DOI 10.1158/1541-7786.MCR-10-0040; Matsumoto R, 1998, J BIOL CHEM, V273, P16976, DOI 10.1074/jbc.273.27.16976; Nishi N, 2005, FEBS LETT, V579, P2058, DOI 10.1016/j.febslet.2005.02.054; Nobumoto A, 2008, GLYCOBIOLOGY, V18, P735, DOI 10.1093/glycob/cwn062; Tamura T, 2002, J CONTROL RELEASE, V80, P295, DOI 10.1016/S0168-3659(02)00003-2; Wada J, 1997, J CLIN INVEST, V99, P2452, DOI 10.1172/JCI119429; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98; Zhang ZY, 2012, ASIAN PAC J CANCER P, V13, P2503, DOI 10.7314/APJCP.2012.13.6.2503	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUN	2015	46	6					2419	2430		10.3892/ijo.2015.2941		12	Oncology	Oncology	CI3QK	WOS:000354662300015		
J	Tanaka, Y; Kanda, M; Sugimoto, H; Shimizu, D; Sueoka, S; Takami, H; Ezaka, K; Hashimoto, R; Okamura, Y; Iwata, N; Tanaka, C; Yamada, S; Fujii, T; Nakayama, G; Koike, M; Nomoto, S; Fujiwara, M; Kodera, Y				Tanaka, Yuri; Kanda, Mitsuro; Sugimoto, Hiroyuki; Shimizu, Dai; Sueoka, Satoshi; Takami, Hideki; Ezaka, Kazuhiro; Hashimoto, Ryoji; Okamura, Yukiyasu; Iwata, Naoki; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Koike, Masahiko; Nomoto, Shuji; Fujiwara, Michitaka; Kodera, Yasuhiro			Translational implication of Kallmann syndrome-1 gene expression in hepatocellular carcinoma	INTERNATIONAL JOURNAL OF ONCOLOGY			English	Article						hepatocellular carcinoma; Kallmann syndrome-1; methylation; tumor suppressor; biomarker	FIBROBLAST-GROWTH-FACTOR; GASTRIC-CANCER; PROMOTER HYPERMETHYLATION; DECREASED EXPRESSION; FACTOR RECEPTOR-1; DOWN-REGULATION; ANOSMIN-1; METHYLATION; RECURRENCE; EZRIN	Accumulation of epigenetic alterations causes inactivation of tumor suppressors and contributes to the initiation and progression of hepatocellular carcinoma (HCC). Identification of methylated genes is necessary to improve our understanding of the pathogenesis of HCC and develop novel biomarkers and therapeutic targets. The Kallmann syndrome-1 (KAL1) gene encodes an extracellular matrix-related protein with diverse oncological functions. However, the function of KAL1 in HCC has not been examined. We investigated the methylation status of the KAL1 promoter region in HCC cell lines, and evaluated KAL1 mRNA levels and those of genes encoding potential interacting cell adhesion factors. KAL1 mRNA expression level was heterogeneous in nine HCC cell lines, and reactivation of KAL1 mRNA expression was observed in cells with promoter hypermethylation of KAL1 gene after demethylation. In addition, KAL1 mRNA levels inversely correlated with those of ezrin in all nine HCC cell lines. KAL1 expression levels in 144 pairs of surgically-resected tissues were determined and correlated to clinicopathological parameters. KAL1 mRNA level was independent of the background liver status, whereas HCC tissues showed significantly lower KAL1 mRNA levels than corresponding noncancerous liver tissues. Downregulation of KAL1 mRNA in HCC was significantly associated with malignant phenotype characteristics, including elevated tumor markers, larger tumor size, vascular invasion, and hypermethylation of KAL1 Patients with downregulation of KAL1 were more likely to have a shorter overall survival than other patients, and multivariate analysis identified downregulation of KAL1 as an independent prognostic factor (hazard ratio 2.04, 95% confidence interval 1.11-3.90, P=0.022). Our results indicated that KAL1 may act as a putative tumor suppressor in HCC and is inactivated by promoter hypermethylation. KAL1 may serve as a biomarker of malignant phenotype of HCC.	[Tanaka, Yuri; Kanda, Mitsuro; Sugimoto, Hiroyuki; Shimizu, Dai; Sueoka, Satoshi; Takami, Hideki; Ezaka, Kazuhiro; Hashimoto, Ryoji; Iwata, Naoki; Tanaka, Chie; Yamada, Suguru; Fujii, Tsutomu; Nakayama, Goro; Koike, Masahiko; Fujiwara, Michitaka; Kodera, Yasuhiro] Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Nagoya, Aichi 4668550, Japan; [Okamura, Yukiyasu] Shizuoka Canc Ctr, Dept Hepatobiliary Pancreat Surg, Shizuoka 4118777, Japan; [Nomoto, Shuji] Aichi Gakuin Univ, Dept Surg, Sch Dent, Chikusa Ku, Nagoya, Aichi 4648651, Japan	Kanda, M (reprint author), Nagoya Univ, Grad Sch Med, Dept Gastroenterol Surg Surg 2, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	m-kanda@med.nagoya-u.ac.jp					Kanda M, 2011, MOL CARCINOGEN, V50, P571, DOI 10.1002/mc.20735; Sawan C, 2008, MUTAT RES-FUND MOL M, V642, P1, DOI 10.1016/j.mrfmmm.2008.03.002; Kanda M, 2015, INT J ONCOL, V46, P641, DOI 10.3892/ijo.2014.2762; Kanda M, 2014, INT J ONCOL, V45, P2005, DOI 10.3892/ijo.2014.2637; Yam JWP, 2009, J GASTROEN HEPATOL, V24, P520, DOI 10.1111/j.1440-1746.2009.05813.x; Miki D, 2012, CANCER SCI, V103, P846, DOI 10.1111/j.1349-7006.2012.02242.x; Galuppo R, 2014, DIGEST DIS SCI, V59, P1688, DOI 10.1007/s10620-014-3058-x; Nomoto S, 2010, ANN SURG ONCOL, V17, P923, DOI 10.1245/s10434-009-0790-0; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Wang J, 2013, BIOCHEM BIOPH RES CO, V439, P47, DOI 10.1016/j.bbrc.2013.08.032; Kang YK, 2010, MOL CARCINOGEN, V49, P798, DOI 10.1002/mc.20653; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Kanda M, 2014, INT J ONCOL, V44, P44, DOI 10.3892/ijo.2013.2165; Chen Y, 2011, CANCER RES, V71, P1721, DOI 10.1158/0008-5472.CAN-09-4683; Hernandez-Gea V, 2013, GASTROENTEROLOGY, V144, P512, DOI 10.1053/j.gastro.2013.01.002; Kanda M, 2008, J SURG ONCOL, V98, P190, DOI 10.1002/jso.21095; Kanda M, 2014, J SURG ONCOL, V110, P136, DOI 10.1002/jso.23614; Khare S, 2013, WORLD J GASTROENTERO, V19, P5439, DOI 10.3748/wjg.v19.i33.5439; Choy CT, 2014, ENDOCR-RELAT CANCER, V21, P85, DOI 10.1530/ERC-13-0181; Di Schiavi E, 2013, CURR GENOMICS, V14, P2, DOI 10.2174/138920213804999174; El-Serag HB, 2011, NEW ENGL J MED, V365, P1118, DOI 10.1056/NEJMra1001683; Ghaffari A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0438-2; Giannelli G, 2014, GUT, V63, P1668, DOI 10.1136/gutjnl-2014-307323; GUIOLI S, 1992, NAT GENET, V1, P337, DOI 10.1038/ng0892-337; HARDELIN JP, 1992, P NATL ACAD SCI USA, V89, P8190, DOI 10.1073/pnas.89.17.8190; Huang XQ, 2006, CANCER RES, V66, P1481, DOI 10.1158/0008-5472.CAN-05-2412; Jian BX, 2009, CELL CYCLE, V8, P3770; Kanda M, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0066-9; Kanda M, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/s13046-014-0088-3; Kanda M, 2015, GASTRIC CANCER, V18, P288, DOI 10.1007/s10120-014-0372-0; Kawahara T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079654; Liu JN, 2015, J ORAL PATHOL MED, V44, P109, DOI 10.1111/jop.12206; Ogasawara S, 1996, HEPATOLOGY, V24, P198, DOI 10.1002/hep.510240132; Oya H, 2014, J GASTROENTEROL; Piao J, 2014, EXP MOL PATHOL, V98, P1; Shimizu D, 2014, ONCOL REP, V31, P1305, DOI 10.3892/or.2013.2939; Sobin L, 2009, INT UNION CANC TNM C; Soussi-Yanicostas N, 2002, CELL, V109, P217, DOI 10.1016/S0092-8674(02)00713-4; Takai Daiya, 2003, In Silico Biology, V3, P235; Takami H, 2013, J SURG ONCOL, V108, P557, DOI 10.1002/jso.23440; Gonzalez-Martinez D, 2004, J NEUROSCI, V24, P10384, DOI 10.1523/JNEUROSCI.3400-04.2004; Wu L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088913; Yamada S, 2014, ANN SURG ONCOL, V21, P436, DOI 10.1245/s10434-014-3575-z; Zheng SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065753	45	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1019-6439	1791-2423		INT J ONCOL	Int. J. Oncol.	JUN	2015	46	6					2546	2554		10.3892/ijo.2015.2965		9	Oncology	Oncology	CI3QK	WOS:000354662300028		
J	Alam, MA; Fukumizu, K				Alam, Md. Ashad; Fukumizu, Kenji			Higher-Order Regularized Kernel Canonical Correlation Analysis	INTERNATIONAL JOURNAL OF PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE			English	Article						Kernel CCA; kernel choice; higher-order regularization; cross-validation	REGRESSION; EXTRACTION	It is well known that the performance of kernel methods depends on the choice of appropriate kernels and associated parameters. While cross-validation (CV) is a useful method of kernel and parameter choice for supervised learning such as the support vector machines, there are no general well-founded methods for unsupervised kernel methods. This paper discusses CV for kernel canonical correlation analysis (KCCA), and proposes a new regularization approach for KCCA. As we demonstrate with Gaussian kernels, the CV errors for KCCA tend to decrease as the bandwidth parameter of the kernel decreases, which provides inappropriate features with all the data concentrated in a few points. This is caused by the ill-posedness of the KCCA with the CV. To solve this problem, we propose to use constraints on the fourth-order moments of canonical variables in addition to the variances. Experiments on synthesized and real-world data demonstrate that the proposed higher-order regularized KCCA can be applied effectively with the CV to find appropriate kernel and regularization parameters.	[Alam, Md. Ashad] Grad Univ Adv Studies, Inst Stat Math, Dept Stat Sci, Tachikawa, Tokyo 1908562, Japan; [Fukumizu, Kenji] Inst Stat Math, Dept Math Anal & Stat Inference, Tachikawa, Tokyo 1908562, Japan	Alam, MA (reprint author), Grad Univ Adv Studies, Inst Stat Math, Dept Stat Sci, 10-3 Midori Cho, Tachikawa, Tokyo 1908562, Japan.	ashad.hstu@gmail.com; fukumizu@ism.ac.jp			JSPS KAKENHI [22300098]; MEXT [25120012]	This work has been supported in part by JSPS KAKENHI (B) 22300098 and MEXT Grant-in-Aid for Scientific Research on Innovative Areas 25120012.	Akaho S., 2001, INT M PSYCH SOC TOK, P321; Alam M. A., 2011, TECHNICAL REPORT, V111, P47; Alam M. A., 2010, J MULTIMEDIA, V5, P3; STONE M, 1974, J R STAT SOC B, V36, P111; Huang SY, 2009, NEURAL COMPUT, V21, P3179, DOI 10.1162/neco.2009.02-08-706; Schuldt C, 2004, INT C PATT RECOG, P32, DOI 10.1109/ICPR.2004.1334462; Hardoon DR, 2004, NEURAL COMPUT, V16, P2639, DOI 10.1162/0899766042321814; ARONSZAJN N, 1950, T AM MATH SOC, V68, P337; Jiang B, 2008, J MACH LEARN RES, V9, P521; Alzate C, 2008, NEURAL NETWORKS, V21, P170, DOI 10.1016/j.neunet.2007.12.047; Danafar S, 2010, LECT NOTES ARTIF INT, V6321, P264, DOI 10.1007/978-3-642-15880-3_23; DIACONIS P, 1984, ANN STAT, V12, P793, DOI 10.1214/aos/1176346703; Arlot S, 2010, STAT SURV, V4, P40, DOI DOI 10.1214/09-SS054; Bach F.R., 2002, J MACHINE LEARNING R, V3, P1; BREIMAN L, 1985, J AM STAT ASSOC, V80, P580, DOI 10.2307/2288473; Filannino M., 2011, DBWORLD E MAIL CLASS; Frank A., 2010, UCI MACHINE LEARNING; Fukumizu K, 2007, J MACH LEARN RES, V8, P361; Gonzalez I., 2005, J STAT SOFTW, V23, P1; Gretton A., 2008, ADV NEURAL INFORM PR, V20, P585; Hardoon DR, 2009, MACH LEARN, V74, P23, DOI 10.1007/s10994-008-5085-3; Hoegaerts L, 2005, NEUROCOMPUTING, V63, P293, DOI 10.1016/j.neucom.2004.04.013; Huang SY, 2009, J STAT PLAN INFER, V139, P2162, DOI 10.1016/j.jspi.2008.10.011; Izenman AJ, 2008, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-78189-1_1; Johnson RA, 2007, APPL MULTIVARIATE ST; Kelley C. T., 1999, ITERATIVE METHODS OP; Lai P., 2000, Computing and Information Systems, V7; Mathworks Inc, 2005, MATL 7 0 REL 14 HELP; Melzer T, 2001, LECT NOTES COMPUT SC, V2130, P353; Otopal N, 2012, LINEAR ALGEBRA APPL, V437, P1, DOI 10.1016/j.laa.2012.02.014; Samarov D, 2011, ANN APPL STAT, V5, P2169, DOI 10.1214/11-AOAS472; Shawe-Taylor J., 2004, KERNEL METHODS PATTE; Smola A., 2002, LEARNING KERNELS; Suetani H, 2006, J PHYS A-MATH GEN, V39, P10723, DOI 10.1088/0305-4470/39/34/009; Suykens J. A., 2002, LEAST SQUARES SUPPOR; Van Gestel T., 2001, P INT C ART NEUR NET, V7, P381; Woen A. B., 2009, ANN APPL STAT, V3, P564; Yamanishi Y, 2003, BIOINFORMATICS, V19, pi323, DOI 10.1093/bioinformatics/btg1045	38	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-0014	1793-6381		INT J PATTERN RECOGN	Int. J. Pattern Recognit. Artif. Intell.	JUN	2015	29	4							1551005	10.1142/S0218001415510052		24	Computer Science, Artificial Intelligence	Computer Science	CI5UI	WOS:000354824900005		
J	Matsuki, S; Kusatake, K; Hein, KZ; Anraku, K; Morita, E				Matsuki, Shingo; Kusatake, Kenji; Hein, Kyaw Zaw; Anraku, Kuniaki; Morita, Eishin			Condylomata acuminata in the neovagina after male-to-female reassignment treated with CO2 laser and imiquimod	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						Transsexual; condylomata acuminata; genital warts; HPV; treatment; CO2 laser; imiquimod cream; gender reassignment surgery		Condylomata acuminata are frequently occurring genital warts, but little is known about clinical features of the genital warts in transsexuals and their incidence. We report a case of condylomata acuminata arising on the neourethral meatus and the transplanted skin of the neovagina in a male-to-female transsexual, which was successfully treated with CO2 laser irradiation followed by topical application of imiquimod cream on the residual warts. This is a first report of using imiquimod cream for condylomata acuminata arising on the neovagina in a male-to-female transsexual.	[Matsuki, Shingo; Kusatake, Kenji; Hein, Kyaw Zaw; Morita, Eishin] Shimane Univ, Fac Med, Dept Dermatol, Izumo, Shimane 6938501, Japan; [Anraku, Kuniaki] Matsue Red Cross Hosp, Dept Plast Surg, Matsue, Shimane, Japan	Matsuki, S (reprint author), Shimane Univ, Fac Med, Dept Dermatol, Enya Cho 89-1, Izumo, Shimane 6938501, Japan.	smatsuki@med.shimane-u.ac.jp					BUSCEMA J, 1987, OBSTET GYNECOL, V69, P528; Chisato T, 2014, ACTA DERM-VENEREOL, V94, P118; FIUMARA NJ, 1973, BRIT J VENER DIS, V49, P478; Liguori G, 2004, UROL INT, V73, P87, DOI 10.1159/000078811; Wasef W, 2005, INT J STD AIDS, V16, P388, DOI 10.1258/0956462053888871; Yang C, 2009, INT J STD AIDS, V20, P211, DOI 10.1258/ijsa.2008.008213	6	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	JUN	2015	26	7					509	511		10.1177/0956462414542476		3	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CI1YS	WOS:000354541800010		
J	Shiibashi, M; Yoshimoto, M; Shigeeda, T; Fujimura, S; Kato, S				Shiibashi, Miyo; Yoshimoto, Miwako; Shigeeda, Takashi; Fujimura, Shigeto; Kato, Satoshi			A case of proliferative diabetic retinopathy that regressed on human immunodeficiency virus treatment	INTERNATIONAL JOURNAL OF STD & AIDS			English	Article						Human immunodeficiency virus; HIV; AIDS; proliferative diabetic retinopathy; highly active antiretroviral therapy		We report the case of a patient with proliferative diabetic retinopathy, who was later found to have human immunodeficiency virus infection that progressed rapidly. However, we could not determine the clinical course after the onset of human immunodeficiency virus because the patient died shortly after it was detected. In this patient, the activity of proliferative diabetic retinopathy showed regression after treatment for human immunodeficiency virus was initiated.	[Shiibashi, Miyo; Shigeeda, Takashi; Fujimura, Shigeto; Kato, Satoshi] Univ Tokyo, Dept Ophthalmol & Visual Sci, Tokyo 1138655, Japan; [Yoshimoto, Miwako] Tokyo Teishin Hosp, Dept Ophthalmol, Tokyo, Japan	Kato, S (reprint author), Univ Tokyo, Dept Ophthalmol, Grad Sch Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	katou-s@ka2.so-net.ne.jp					ADAN A, 1990, AM J OPHTHALMOL, V109, P744; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366; GLASGOW BJ, 1994, AM J OPHTHALMOL, V118, P46; NEWSOME DA, 1984, AM J OPHTHALMOL, V98, P590; Takeda Norio, 2007, GANKI, V58, P23	5	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0956-4624	1758-1052		INT J STD AIDS	Int. J. STD AIDS	JUN	2015	26	7					516	517		10.1177/0956462414544161		2	Immunology; Infectious Diseases	Immunology; Infectious Diseases	CI1YS	WOS:000354541800012		
J	Ono, M; Miyauchi, S; Edzuki, Y; Saiki, K; Fukuda, H; Tonai, M; Magilvy, JK; Murashima, S				Ono, M.; Miyauchi, S.; Edzuki, Y.; Saiki, K.; Fukuda, H.; Tonai, M.; Magilvy, J. K.; Murashima, S.			Japanese nurse practitioner practice and outcomes in a nursing home	INTERNATIONAL NURSING REVIEW			English	Article						Ambulance Transfer; Hospitalization; Nurse Practitioner Role Development; Nursing Home Residents; Skilled Nursing Care		AimBy describing the practice of a Japanese nurse practitioner, this descriptive case study discusses role development and outcomes before and after the intervention. BackgroundOne of the first Japanese nurse practitioners intervened at a nursing home during the government-designated trial period for nurse practitioner practice. ConclusionBecause of the nurse practitioner's meticulous observation and timely care provision to the residents in collaboration with the physician and the other staff in the facility, comparative data showed improvement in daily health status management of every resident and decreased deterioration of residents' health conditions requiring ambulance transfer and hospitalization.	[Ono, M.; Miyauchi, S.; Murashima, S.] Oita Univ Nursing & Hlth Sci, Oita 8701201, Japan; [Edzuki, Y.] Oita Univ Nursing & Hlth Sci, Dept Specialized Nursing, Div Gen & Gerontol Nursing, Oita 8701201, Japan; [Miyauchi, S.] Oita Univ Nursing & Hlth Sci, Div Linguist, Oita 8701201, Japan; [Saiki, K.] Oita Univ Nursing & Hlth Sci, Div Hlth Informat & Biostat, Dept Human Sci, Oita 8701201, Japan; [Tonai, M.] Oita Univ Nursing & Hlth Sci, Div Nursing Assessment, Dept Basic Nursing Sci, Oita 8701201, Japan; [Fukuda, H.] Oita Univ Nursing & Hlth Sci, Ctr Nursing Educ Res & Collaborat, Oita 8701201, Japan; [Murashima, S.] Oita Univ Nursing & Hlth Sci, Board Directors, Oita 8701201, Japan; [Murashima, S.] Univ Tokyo, Dept Community Hlth Nursing, Tokyo, Japan; [Magilvy, J. K.] Univ Colorado, Coll Nursing, Aurora, CO USA	Miyauchi, S (reprint author), Oita Univ Nursing & Hlth Sci, Div Linguist, Dept Human Sci, 2944-9 Megusuno, Oita 8701201, Japan.	miyauchi@oita-nhs.ac.jp					Aiken LH, 2014, LANCET, V383, P1824, DOI 10.1016/S0140-6736(13)62631-8; Arbon P., 2008, J CLIN NURS, V18, P255; Bakerjian D, 2008, RES GERONTOL NURS, V1, P177, DOI 10.3928/00220124-20091301-01; Fukuda H., 2014, INT NURS REV, V61, P487; Kato Chikako, 2008, Nagoya J Med Sci, V70, P19; Klaasen Kathleen, 2009, Can Nurse, V105, P24; Mezey M, 2002, J GERONTOL A-BIOL, V57, pM438; Goldberg Sarah, 2014, Nurs Older People, V26, P20, DOI 10.7748/nop2014.04.26.4.20.e561; Thompson Jacqueline, 2014, Br J Nurs, V23, P252; Wagner LM, 2007, RES NURS HEALTH, V30, P131, DOI 10.1002/nur.20185	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-8132	1466-7657		INT NURS REV	Int. Nurs. Rev.	JUN	2015	62	2					275	279		10.1111/inr.12158		5	Nursing	Nursing	CI5SJ	WOS:000354819400017		
J	Yamanishi, T; Yasuda, K; Kaga, K; Fuse, M				Yamanishi, T.; Yasuda, K.; Kaga, K.; Fuse, M.			RANDOMIZED, DOUBLE-BLIND, SHAM-CONTROLLED EVALUATION OF THE EFFECT OF MAGNETIC STIMULATION IN PATIENTS WITH URODYNAMIC STRESS URINARY INCONTINENCE	INTERNATIONAL UROGYNECOLOGY JOURNAL			English	Meeting Abstract									[Yamanishi, T.; Kaga, K.; Fuse, M.] Dokkyo Med Univ, Urol Continence Ctr, Mibu, Tochigi, Japan; [Yasuda, K.] Dokkyo Med Univ, Koshigaya Hosp, Urol, Saitama, Japan							[Anonymous], 1999, NEUROUROL URODYN, V18, P505; [Anonymous], 2014, INT J UROL, V21, P395; [Anonymous], 2000, J UROL, V163, P456	3	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0937-3462	1433-3023		INT UROGYNECOL J	Int. Urogynecol. J.	JUN	2015	26			1		OP 115	S144	S145				2	Obstetrics & Gynecology; Urology & Nephrology	Obstetrics & Gynecology; Urology & Nephrology	CI3AF	WOS:000354619100116		
J	Sakiyama, M; Kawakubo, Y				Sakiyama, Masayuki; Kawakubo, Yo			Preventable frostbite due to cold pack	INTERNATIONAL WOUND JOURNAL			English	Letter									[Sakiyama, Masayuki] Natl Def Med Coll, Dept Dermatol, Tokorozawa, Saitama 359, Japan; [Sakiyama, Masayuki; Kawakubo, Yo] Self Def Forces Cent Hosp, Dept Dermatol, Tokyo, Japan	Sakiyama, M (reprint author), Natl Def Med Coll, Dept Dermatol, Tokorozawa, Saitama 359, Japan.	sakiyama@ndmc.ac.jp					Ahmad Z, 2013, INT WOUND J, V10, P480, DOI 10.1111/j.1742-481X.2012.00946.x; STEVENS DM, 1978, NEW ENGL J MED, V299, P1415; Yamamoto T, 1999, JPN J ORTHOPEDIC SPO, V18, P337	3	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-4801	1742-481X		INT WOUND J	Int. Wound J.	JUN	2015	12	3					366	366		10.1111/iwj.12105		1	Dermatology; Surgery	Dermatology; Surgery	CI1CA	WOS:000354476800026		
J	Nishio, M; Horiike, A; Nokihara, H; Horinouchi, H; Nakamichi, S; Wakui, H; Ohyanagi, F; Kudo, K; Yanagitani, N; Takahashi, S; Kuboki, Y; Yamamoto, N; Yamada, Y; Abe, M; Tahata, T; Tamura, T				Nishio, Makoto; Horiike, Atsushi; Nokihara, Hiroshi; Horinouchi, Hidehito; Nakamichi, Shinji; Wakui, Hiroshi; Ohyanagi, Fumiyoshi; Kudo, Keita; Yanagitani, Noriko; Takahashi, Shunji; Kuboki, Yasutoshi; Yamamoto, Noboru; Yamada, Yasuhide; Abe, Masaichi; Tahata, Takashi; Tamura, Tomohide			Phase I study of the anti-MET antibody onartuzumab in patients with solid tumors and MET-positive lung cancer	INVESTIGATIONAL NEW DRUGS			English	Article						MET; Onartuzumab; Japanese patients; Lung cancer; Phase I study; Solid tumors	TYROSINE KINASE INHIBITOR; GROWTH-FACTOR; JAPANESE PATIENTS; SCATTER FACTOR; ERLOTINIB; RECEPTOR; PROLIFERATION; AMPLIFICATION; ANGIOGENESIS; MALIGNANCIES	Onartuzumab is a monovalent, humanized, monoclonal antibody that showed significant survival benefits in combination with erlotinib in MET-positive non-small-cell lung cancer (NSCLC) in pre-specified subgroup analyses of a randomized phase II study. We conducted a two-stage, open-label, multicenter, phase I study of onartuzumab in Japanese patients. Stage 1 investigated the safety, tolerability, pharmacokinetics (PK), and recommended dose of onartuzumab in patients with solid tumors, and Stage 2 determined the safety, tolerability, and PK of onartuzumab plus erlotinib in patients with MET-positive NSCLC. Nine patients received onartuzumab monotherapy (4, 15, or 30 mg/kg on Day 1 of each 21-day cycle) in Stage 1, and six patients received onartuzumab (15 mg/kg) plus erlotinib (150 mg/day) in Stage 2. There were no dose-limiting toxicities in either stage. Serious adverse events (AEs) occurred in one patient in Stage 1 (convulsion), and two patients in Stage 2 (once case each of diarrhea, vomiting, and pulmonary embolism), but there were no grade 4 AEs or AEs leading to death. Onartuzumab PKs were linear in the dose range of 4 to 30 mg/kg, and were not affected by co-administration with erlotinib. PK parameters of onartuzumab were similar to those reported in non-Japanese patients. A partial response was observed in a patient with MET immunohistochemistry 3+ NSCLC without MET gene amplification. Based on these results, the recommended dose of onartuzumab in Japanese patients with solid tumors is 15 mg/kg every 21 days. The combination of onartuzumab with erlotinib is feasible in Japanese patients with MET-positive lung cancer.	[Nishio, Makoto; Horiike, Atsushi; Ohyanagi, Fumiyoshi; Kudo, Keita; Yanagitani, Noriko; Takahashi, Shunji; Kuboki, Yasutoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Koto Ku, Tokyo 1358550, Japan; [Nokihara, Hiroshi; Horinouchi, Hidehito; Nakamichi, Shinji; Wakui, Hiroshi; Yamamoto, Noboru; Yamada, Yasuhide; Tamura, Tomohide] Natl Canc Ctr, Tokyo, Japan; [Abe, Masaichi; Tahata, Takashi] Chugai Pharmaceut Co Ltd, Tokyo, Japan	Nishio, M (reprint author), Japanese Fdn Canc Res, Canc Inst Hosp, Dept Thorac Med Oncol, Koto Ku, 3-10-6 Ariake, Tokyo 1358550, Japan.	mnishio@jfcr.or.jp			National Cancer Center Research and Development Fund; Chugai; Taiho; Sanofi; Zenyaku; Novartis; Quintiles; BMS; Astellas	Makoto Nishio has received honoraria from Chugai, Pfizer and Eli Lilly. Hiroshi Nokihara has received honoraria from Sanofi, Eli Lilly and Boehringer Ingelheim. Hidehito Horinouchi has received research support from National Cancer Center Research and Development Fund and honoraria from Johnson & Johnson, Taiho and Eli Lilly. Shunji Takahashi has received research support from Chugai, Taiho, Sanofi, Zenyaku and Novartis and honoraria from Astrazeneka, Novartis, Astellas and Daiichisankyo. Noboru Yamamoto has received support from a project sponsor Quintiles, Chugai, BMS, Astellas, Novartis and Taiho. Yasuhide Yamada has received honoraria from Taiho and Chugai. Masaichi Abe and Takashi Tahata are employees of Chugai, and Takashi Tahata holds stock in Chugai. Tomohide Tamura has received honoraria from Chugai, Eli Lilly, Kyowa Kirin, Pfizer and Exelixis.	Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Dziadziuszko R, 2012, J THORAC ONCOL, V7, P340, DOI 10.1097/JTO.0b013e318240ca0d; Ichimura E, 1996, JPN J CANCER RES, V87, P1063; Masuya D, 2004, BRIT J CANCER, V90, P1555, DOI 10.1038/sj.bjc.6601718; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Koeppen H, 2014, J PATHOL, V232, P210, DOI 10.1002/path.4268; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Hidalgo M, 2001, J CLIN ONCOL, V19, P3267; Lutterbach B, 2007, CANCER RES, V67, P2081, DOI 10.1158/0008-5472.CAN-06-3495; Weimar IS, 1998, LEUKEMIA, V12, P1195, DOI 10.1038/sj.leu.2401080; Salgia R, 2014, CLIN CANCER RES, V20, P1666, DOI 10.1158/1078-0432.CCR-13-2070; Kubota K, 2008, J THORAC ONCOL, V3, P1439, DOI 10.1097/JTO.0b013e31818d6702; Schmidt NO, 1999, INT J CANCER, V84, P10, DOI 10.1002/(SICI)1097-0215(19990219)84:1<10::AID-IJC3>3.0.CO;2-L; Yamamoto N, 2008, CANCER CHEMOTH PHARM, V61, P489, DOI 10.1007/s00280-007-0494-8; Derksen PWB, 2003, LEUKEMIA, V17, P764, DOI 10.1038/sj.leu.2402875; Fazekas K., 2000, Clinical and Experimental Metastasis, V18, P639, DOI 10.1023/A:1013136303880; Penuel E, 2013, MOL CANCER THER, V12, P1122, DOI 10.1158/1535-7163.MCT-13-0015; Rosen E M, 1997, EXS, V79, P193	18	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					632	640		10.1007/s10637-015-0227-5		9	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100009		
J	Nakamichi, S; Nokihara, H; Yamamoto, N; Yamada, Y; Fujiwara, Y; Tamura, Y; Wakui, H; Honda, K; Mizugaki, H; Kitazono, S; Tanabe, Y; Asahina, H; Yamazaki, N; Suzuki, S; Matsuoka, M; Ogita, Y; Tamura, T				Nakamichi, Shinji; Nokihara, Hiroshi; Yamamoto, Noboru; Yamada, Yasuhide; Fujiwara, Yutaka; Tamura, Yosuke; Wakui, Hiroshi; Honda, Kazunori; Mizugaki, Hidenori; Kitazono, Satoru; Tanabe, Yuko; Asahina, Hajime; Yamazaki, Naoya; Suzuki, Shigenobu; Matsuoka, Mieko; Ogita, Yoshitaka; Tamura, Tomohide			Phase I and pharmacokinetics/pharmacodynamics study of the MEK inhibitor RO4987655 in Japanese patients with advanced solid tumors	INVESTIGATIONAL NEW DRUGS			English	Article						Phase I study; Dose escalation; MAPK pathway; MEK inhibitor; Japanease	DOSE-ESCALATION; ADVANCED CANCER; ADVANCED MALIGNANCIES; AZD6244 ARRY-142886; SIGNALING PATHWAYS; MUTATIONS; MELANOMA; SAFETY; TRIAL; BRAF	RO4987655 is an oral and selective inhibitor of MEK, a key enzyme of the mitogen-activated protein kinase (MAPK) signaling pathway. This phase I dose-escalation study of RO4987655 in Japanese patients with advanced solid tumors aimed to determine maximum tolerated dose (MTD) and to evaluate safety, pharmacokinetics (PK), pharmacodynamics (PD), and anti-tumor activity. Patients received a single dose of RO4987655 (1, 2, 4, 5, or 6.5 mg) followed by continuous once-daily dosing (1, 2, or 4 mg QD) or twice-daily dosing (4, 5, or 6.5 mg BID) in 28-day cycles. A 3 + 3 dose-escalation design was used. PD was evaluated by pERK inhibition in peripheral blood mononuclear cells (PBMCs). In dose-escalation, 25 patients were enrolled. After the MTD was determined, a further six patients were administered the MTD for further confirmation of safety. MTD was determined as 8 mg/day (4 mg BID) due to a total of four dose-limiting toxicities (DLTs) of grade 3 creatine phosphokinase (CPK) elevation (2 DLTs each in 10 mg/day and 13 mg/day). Most commonly related adverse events included dermatitis acneiform, CPK elevation, and eye disorders. Plasma concentration of RO4987655 appeared to increase in a dose-proportional manner with a plasma half-life of 4.32 to 21.1 h. Following multiple dose administration, a steady-state condition was reached by Cycle 1 Day 8. The inhibitory effects of RO4987655 on pERK in PBMCs increased in a dose-dependent manner. One esophageal cancer patient had confirmed partial response and seven patients showed progression-free survival for longer than 16 weeks. The MTD of RO4987655 for Japanese patients was determined as 8 mg/day (4 mg BID). RO4987655 was tolerated up to the MTD with a favorable PK/PD profile in Japanese patients with advanced solid tumors.	[Nakamichi, Shinji; Nokihara, Hiroshi; Yamamoto, Noboru; Fujiwara, Yutaka; Tamura, Yosuke; Wakui, Hiroshi; Honda, Kazunori; Mizugaki, Hidenori; Kitazono, Satoru; Tanabe, Yuko; Asahina, Hajime; Tamura, Tomohide] Natl Canc Ctr, Dept Thorac Oncol, Chuo Ku, Tokyo, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Dept Gastrointestinal Oncol, Chuo Ku, Tokyo, Japan; [Yamazaki, Naoya] Natl Canc Ctr, Dept Dermatol Oncol, Chuo Ku, Tokyo, Japan; [Suzuki, Shigenobu] Natl Canc Ctr, Dept Ophthalm Oncol, Chuo Ku, Tokyo, Japan; [Matsuoka, Mieko; Ogita, Yoshitaka] Chugai Pharmaceut Co Ltd, Clin Res Planning Dept, Chuo Ku, Tokyo, Japan	Tamura, T (reprint author), St Lukes Int Hosp, Thorac Ctr, Chuo Ku, 9-1 Akashi Cho, Tokyo, Japan.	ttamura@ncc.go.jp			Chugai Pharmaceutical Co., Ltd., Japan	The authors thank all the patients who participated in this study, their families, and staff at the National Cancer Center Hospital. This study was sponsored by Chugai Pharmaceutical Co., Ltd., Japan. Quality control of data, data analysis, and statistical analysis was performed at Chugai Pharmaceutical Co., Ltd. Writing assistance was funded by Chugai Pharmaceutical Co., Ltd.	Akinleye A, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-27; Ascierto PA, 2013, LANCET ONCOL, V14, P249, DOI 10.1016/S1470-2045(13)70024-X; BOS JL, 1989, CANCER RES, V49, P4682; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; LoRusso PM, 2005, J CLIN ONCOL, V23, P5281, DOI 10.1200/JCO.2005.14.415; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Garcia R, 2009, EMBO REP, V10, P278, DOI 10.1038/embor.2009.4; Weekes CD, 2013, CLIN CANCER RES, V19, P1232, DOI 10.1158/1078-0432.CCR-12-3529; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Carvajal RD, 2014, JAMA-J AM MED ASSOC, V311, P2397, DOI 10.1001/jama.2014.6096; Dutton SJ, 2014, LANCET ONCOL, V15, P894, DOI 10.1016/S1470-2045(14)70024-5; Isshiki Y, 2011, BIOORG MED CHEM LETT, V21, P1795, DOI 10.1016/j.bmcl.2011.01.062; Lee L, 2009, CLIN CANCER RES, V15, P7368, DOI 10.1158/1078-0432.CCR-09-1696; Martinez-Garcia M, 2012, CLIN CANCER RES, V18, P4806, DOI 10.1158/1078-0432.CCR-12-0742; Cohen RB, 2013, EUR J CANCER, V49, P1521, DOI 10.1016/j.ejca.2013.01.013; Adjei AA, 2008, J CLIN ONCOL, V26, P2139, DOI 10.1200/JCO.2007.14.4956; Banerji U, 2010, CLIN CANCER RES, V16, P1613, DOI 10.1158/1078-0432.CCR-09-2483; Huang WH, 2009, J OCUL PHARMACOL TH, V25, P519, DOI 10.1089/jop.2009.0060; Fecher LA, 2008, CURR OPIN ONCOL, V20, P183, DOI 10.1097/CCO.0b013e3282f5271c; Zimmer L, 2014, CLIN CANCER RES, V20, P4251, DOI 10.1158/1078-0432.CCR-14-0341; Renouf DJ, 2012, J CLIN ONCOL, V30, P3277, DOI 10.1200/JCO.2011.41.5851; Infante JR, 2012, LANCET ONCOL, V13, P773, DOI 10.1016/S1470-2045(12)70270-X; Honda K, 2013, CANCER CHEMOTH PHARM, V72, P577, DOI 10.1007/s00280-013-2228-4; Leijen S, 2012, CLIN CANCER RES, V18, P4794, DOI 10.1158/1078-0432.CCR-12-0868; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Ciuffini L, 2008, ONCOGENE, V27, P528, DOI 10.1038/sj.onc.1210665; Doi T, 2013, P 104 ANN M AM ASS C; Flaherty KT, 2012, NEW ENGL J MED, V367, P107, DOI 10.1056/NEJMoa1203421; Flaherty KT, 2012, NEW ENGL J MED, V367, P1694, DOI 10.1056/NEJMoa1210093; Lawlor MA, 2000, MOL CELL BIOL, V20, P3256, DOI 10.1128/MCB.20.9.3256-3265.2000; Moreno Garcia V, 2012, BRIT J CANCER, V107, P1797	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					641	651		10.1007/s10637-015-0229-3		11	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100010		
J	Kawazoe, A; Shitara, K; Fukuoka, S; Noguchi, M; Kuboki, Y; Bando, H; Okamoto, W; Kojima, T; Fuse, N; Yoshino, T; Ohtsu, A; Doi, T				Kawazoe, Akihito; Shitara, Kohei; Fukuoka, Shota; Noguchi, Masaaki; Kuboki, Yasutoshi; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Fuse, Nozomu; Yoshino, Takayuki; Ohtsu, Atsushi; Doi, Toshihiko			Clinical outcomes in 66 patients with advanced gastric cancer treated in phase I trials: the NCCHE experience	INVESTIGATIONAL NEW DRUGS			English	Article						Gastric cancer; Chemotherapy; Phase I trial; Clinical outcome	1ST-LINE THERAPY; PERSONALIZED MEDICINE; PROGNOSTIC-FACTORS; DOUBLE-BLIND; SURVIVAL; ADENOCARCINOMA; ONCOLOGY; SAFETY; FLUOROURACIL; MULTICENTER	Background Although patients with advanced gastric cancer (AGC) have a poor prognosis when conventional therapies fail, they are often candidates for phase I trials. However, there is no detailed report on clinical outcomes of patients with AGC treated in phase I trials. Methods We retrospectively reviewed the medical records of 66 consecutive patients with AGC enrolled in phase I trials between March 2008 and July 2014 at our institution in Japan. Results Median age was 66 years (range, 28-78 years) and median number of previous lines of conventional chemotherapy was 3 (range, 1-6). Five (8.6 %) and seven (12 %) patients showed objective response and stable disease > 3 months, respectively. Although the time to treatment failure (TTF) of the best phase I treatment was shorter than that of the last line of conventional chemotherapy (median 1.5 vs. 2.3 months; P = 0.002), TTF of the best phase I treatment was longer than that of the last line of treatment in 21 patients (32 %). Severe adverse events and grade 3 or higher toxicities were reported in eight (12 %) and 13 patients (20 %), respectively. No treatment-related death was observed. Median survival time from the start of phase I treatment was 7.5 months, and four deaths (6 %) within 30 days after last administration were observed. Conclusion Phase I trials of patients with AGC was acceptably feasible with some efficacy signal. Our results suggest that phase I trials might be one treatment option for patients with AGC when conventional therapies fail.	[Kawazoe, Akihito; Shitara, Kohei; Fukuoka, Shota; Noguchi, Masaaki; Kuboki, Yasutoshi; Bando, Hideaki; Okamoto, Wataru; Kojima, Takashi; Fuse, Nozomu; Yoshino, Takayuki; Ohtsu, Atsushi; Doi, Toshihiko] Natl Canc Ctr Hosp East NCCHE, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba 2778577, Japan	Shitara, K (reprint author), Natl Canc Ctr Hosp East NCCHE, Dept Gastroenterol & Gastrointestinal Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	kshitara@east.ncc.go.jp					Bachelot T, 2000, ANN ONCOL, V11, P151, DOI 10.1023/A:1008368319526; Jain RK, 2012, J CLIN ONCOL, V30, P2684, DOI 10.1200/JCO.2011.36.4752; Koizumi W, 2008, LANCET ONCOL, V9, P215, DOI [10.1016/S1470-2045(08)70035-4, 10.1016/S1470-204S(08)70035-4]; Gupta S, 2012, J NATL CANCER I, V104, P1860, DOI 10.1093/jnci/djs439; Agrawal M, 2003, JAMA-J AM MED ASSOC, V290, P1075, DOI 10.1001/jama.290.8.1075; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Boku N, 2009, LANCET ONCOL, V10, P1063, DOI 10.1016/S1470-2045(09)70259-1; Cassier PA, 2014, ANN ONCOL, V25, P1222, DOI 10.1093/annonc/mdu108; Kang YK, 2009, ANN ONCOL, V20, P666, DOI 10.1093/annonc/mdn717; ANDERSON JR, 1983, J CLIN ONCOL, V1, P710; Roberts TG, 2004, JAMA-J AM MED ASSOC, V292, P2130, DOI 10.1001/jama.292.17.2130; Hong DS, 2012, CLIN COLORECTAL CANC, V11, P297, DOI 10.1016/j.clcc.2012.02.001; Cunningham D, 2008, NEW ENGL J MED, V358, P36, DOI 10.1056/NEJMoa073149; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Fuchs CS, 2014, LANCET, V383, P31, DOI 10.1016/S0140-6736(13)61719-5; Garrido-Laguna I, 2010, CLIN CANCER RES, V16, P4031, DOI 10.1158/1078-0432.CCR-10-0672; Van Cutsem E, 2006, J CLIN ONCOL, V24, P4991, DOI 10.1200/JCO.2006.06.8429; Garraway LA, 2013, J CLIN ONCOL, V31, P1806, DOI 10.1200/JCO.2012.46.8934; Brahmer JR, 2012, NEW ENGL J MED, V366, P2455, DOI 10.1056/NEJMoa1200694; Horstmann E, 2005, NEW ENGL J MED, V352, P895, DOI 10.1056/NEJMsa042220; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Ajani JA, 2010, J CLIN ONCOL, V28, P1547, DOI 10.1200/JCO.2009.25.4706; Tsimberidou AM, 2012, CLIN CANCER RES, V18, P6373, DOI 10.1158/1078-0432.CCR-12-1627; Bang YJ, 2010, LANCET, V376, P687, DOI 10.1016/S0140-6736(10)61121-X; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Han C, 2003, BRIT J CANCER, V89, P1166, DOI 10.1038/sj.bjc.6601218; Khan K, 2014, GASTRIC CANCER, V17, P621, DOI 10.1007/s10120-013-0328-9; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Muro K, 2014, ANN ONCOL, V25, P1; Nagatsuma AK, 2014, GASTRIC CANCER, DOI [10.1007/s10120-014-0360-4, DOI 10.1007/S10120-014-0360-4]; Tsimberidou AM, 2009, J CLIN ENDOCR METAB, V94, P4423, DOI 10.1210/jc.2009-0743; Tsimberidou AM, 2014, CLIN CANCER RES, V20, P4827, DOI 10.1158/1078-0432.CCR-14-0603; Wilke H, 2014, LANCET ONCOL, V15, P1224, DOI 10.1016/S1470-2045(14)70420-6	35	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					664	670		10.1007/s10637-015-0231-9		7	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100012		
J	Omlin, A; Jones, RJ; van der Noll, R; Satoh, T; Niwakawa, M; Smith, SA; Graham, J; Ong, M; Finkelman, RD; Schellens, JHM; Zivi, A; Crespo, M; Riisnaes, R; Nava-Rodrigues, D; Malone, MD; Dive, C; Sloane, R; Moore, D; Alumkal, JJ; Dymond, A; Dickinson, PA; Ranson, M; Clack, G; de Bono, J; Elliott, T				Omlin, A.; Jones, R. J.; van der Noll, R.; Satoh, T.; Niwakawa, M.; Smith, S. A.; Graham, J.; Ong, M.; Finkelman, R. D.; Schellens, J. H. M.; Zivi, A.; Crespo, M.; Riisnaes, R.; Nava-Rodrigues, D.; Malone, M. D.; Dive, C.; Sloane, R.; Moore, D.; Alumkal, J. J.; Dymond, A.; Dickinson, P. A.; Ranson, M.; Clack, G.; de Bono, J.; Elliott, T.			AZD3514, an oral selective androgen receptor down-regulator in patients with castration-resistant prostate cancer - results of two parallel first-in-human phase I studies	INVESTIGATIONAL NEW DRUGS			English	Article						(5) Castration-resistant prostate cancer; Phase I; First-in-human; AZD3514; Selective androgen receptor down-regulator	SPLICE VARIANTS; INCREASED SURVIVAL; SMALL-MOLECULE; ABIRATERONE; ENZALUTAMIDE; CHEMOTHERAPY; TRIALS; DESIGN	Background AZD3514 is a first-in-class, orally bio-available, androgen-dependent and -independent androgen receptor inhibitor and selective androgen-receptor down-regulator (SARD). Methods In study 1 and 2, castration-resistant prostate cancer (CRPC) patients (pts) were initially recruited into a once daily (QD) oral schedule (A). In study 1, pharmacokinetic assessments led to twice daily (BID) dosing (schedule B) to increase exposure. Study 2 explored a once daily schedule. Results In study 1, 49 pts were treated with escalating doses of AZD3514 (A 35 pts, B 14 pts). Starting doses were 100 mg (A) and 1000 mg (B). The AZD3514 formulation was switched from capsules to tablets at 1000 mg QD. 2000 mg BID was considered non-tolerable due to grade (G) 2 toxicities (nausea [N], vomiting [V]). No adverse events (AEs) met the dose-limiting toxicity (DLT) definition. Thirteen pts received AZD3514 in study 2, with starting doses of 250 mg QD. The most frequent drug-related AEs were N: G1/2 in 55/70 pts (79 %); G3 in 1 pt (1.4 %); & V: G1/2 in 34/70 pts (49 %) & G3 in 1 pt (1.4 %). PSA declines (a parts per thousand yen50 %) were documented in 9/70 patients (13 %). Objective soft tissue responses per RECIST1.1 were observed in 4/24 (17 %) pts in study 1. Conclusion AZD3514 has moderate anti-tumour activity in pts with advanced CRPC but with significant levels of nausea and vomiting. However, anti-tumour activity as judged by significant PSA declines, objective responses and durable disease stabilisations, provides the rationale for future development of SARD compounds.	[Omlin, A.; Ong, M.; Zivi, A.; Crespo, M.; Riisnaes, R.; Nava-Rodrigues, D.; de Bono, J.] Royal Marsden NHS Fdn Trust, Prostate Targeted Therapy Grp, Sutton, Surrey, England; [Omlin, A.; Ong, M.; Zivi, A.; Crespo, M.; Riisnaes, R.; Nava-Rodrigues, D.; de Bono, J.] Royal Marsden NHS Fdn Trust, Drug Dev Unit, Sutton, Surrey, England; [Omlin, A.; Ong, M.; Zivi, A.; Crespo, M.; Riisnaes, R.; Nava-Rodrigues, D.; de Bono, J.] Inst Canc Res, Sutton, Surrey, England; [Jones, R. J.; Graham, J.] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland; [van der Noll, R.; Schellens, J. H. M.] Netherlands Canc Inst, Amsterdam, Netherlands; [Satoh, T.] Kitasato Univ, Sch Med, Dept Urol, Sagamihara, Kanagawa 228, Japan; [Niwakawa, M.] Shizuoka Canc Ctr Hosp, Div Urol, Shizuoka, Japan; [Smith, S. A.; Malone, M. D.; Dymond, A.; Dickinson, P. A.; Clack, G.] AstraZeneca, Macclesfield, Cheshire, England; [Finkelman, R. D.] AstraZeneca, Wilmington, DE USA; [Schellens, J. H. M.] UIPS, Utrecht, Netherlands; [Alumkal, J. J.] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA; [Ranson, M.; Elliott, T.] Christie NHS Fdn Trust, Manchester, Lancs, England; [Dive, C.; Sloane, R.; Moore, D.] Canc Res UK Manchester Inst, Manchester, Lancs, England	Elliott, T (reprint author), Christie NHS Fdn Trust, Manchester, Lancs, England.	Tony.Elliott@christie.nhs.uk	Elliott, Tony/M-1057-2015	Graham, John/0000-0003-3381-9787; Elliott, Tony/0000-0002-0715-9431	AstraZeneca	This trial was sponsored by AstraZeneca.	Bradbury RH, 2013, BIOORG MED CHEM LETT, V23, P1945, DOI 10.1016/j.bmcl.2013.02.056; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; Bianchini D, 2014, EUR J CANCER, V50, P78, DOI 10.1016/j.ejca.2013.08.020; Scher HI, 2012, NEW ENGL J MED, V367, P1187, DOI 10.1056/NEJMoa1207506; De Bono JS, 2011, NEW ENGL J MED, V364, P1995, DOI 10.1056/NEJMoa1014618; Loddick SA, 2013, MOL CANCER THER, V12, P1715, DOI 10.1158/1535-7163.MCT-12-1174; Cao B, 2014, ONCOTARGET, V5, P1646; Scher HI, 2008, J CLIN ONCOL, V26, P1148, DOI 10.1200/JCO.2007.12.4487; Myung JK, 2013, J CLIN INVEST, V123, P2948, DOI 10.1172/JCI66398; Attard G, 2009, CANCER CELL, V16, P458, DOI 10.1016/j.ccr.2009.11.006; Allard WJ, 2004, CLIN CANCER RES, V10, P6897, DOI 10.1158/1078-0432.CCR-04-0378; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Schrader AJ, 2014, EUR UROL, V65, P30, DOI 10.1016/j.eururo.2013.06.042; Loriot Y, 2013, ANN ONCOL, V24, P1807, DOI 10.1093/annonc/mdt136; Li YM, 2013, CANCER RES, V73, P483, DOI 10.1158/0008-5472.CAN-12-3630; Noonan KL, 2013, ANN ONCOL, V24, P1802, DOI 10.1093/annonc/mdt138; Mostaghel EA, 2011, CLIN CANCER RES, V17, P5913, DOI 10.1158/1078-0432.CCR-11-0728; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Antonarakis ES, 2014, J CLIN ONCOL, V32; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Balbas MD, 2013, ELIFE, V2, DOI 10.7554/eLife.00499; Beer TM, 2014, NEW ENGL J MED, DOI [10.1056/NEJMoa1405095, DOI 10.1056/NEJMOA1405095]; Dalal K, 2014, J BIOL CHEM, V289, P26417, DOI 10.1074/jbc.M114.553818; Skolnik JM, 2008, J CLIN ONCOL, V26, P190, DOI 10.1200/JCO.2007.12.7712; Taplin ME, 2014, ESMO C 2014 MADR; Yu ZT, 2014, FIXED POINT THEORY A, DOI 10.1186/1687-1812-2014-20	26	2	2	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					679	690		10.1007/s10637-015-0235-5		12	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100014		
J	Ogasawara, S; Chiba, T; Ooka, Y; Kanogawa, N; Saito, T; Motoyama, T; Suzuki, E; Tawada, A; Kanai, F; Yokosuka, O				Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Saito, Tomoko; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Kanai, Fumihiko; Yokosuka, Osamu			Sorafenib treatment in Child-Pugh A and B patients with advanced hepatocellular carcinoma: safety, efficacy and prognostic factors	INVESTIGATIONAL NEW DRUGS			English	Article						Hepatocellular carcinoma; Sorafenib; Child-Pugh B; Prognostic factor; Macrovascular invasion	PHASE-III TRIAL; ALPHA-FETOPROTEIN; LIVER-CIRRHOSIS; SURVIVAL; OUTCOMES; THERAPY	Background We aimed to evaluate the safety, efficacy and prognostic impact of baseline and early clinical markers in both Child-Pugh A and B patients with advanced hepatocellular carcinoma (HCC). Methods We prospectively studied 89 Japanese patients with HCC (Child-Pugh A, n = 59; Child-Pugh B, n = 30) who were started with sorafenib between May 2010 and July 2013. Results Frequency of sorafenib-related adverse events was almost similar between Child-Pugh score 5, 6, and 7 patients. The rate of liver dysfunction, including any grade encephalopathy, a parts per thousand yen grade 3 ascites, or a parts per thousand yen grade 3 bilirubin increased, in Child-Pugh score a parts per thousand yen8 group was significantly higher than that in the other groups. The median overall survival of Child-Pugh score 5, 6, 7 and a parts per thousand yen8 patients were 14.5, 11.1, 8.7 and 4.6 months, respectively. Patients in Child-Pugh score 6 had significantly longer OS than those in Child-Pugh score 7 (P = 0.049). Multivariate analysis identified macrovascular invasion (MVI), alpha-fetoprotein (AFP), Child-Pugh score and aspartate aminotransferase (AST) as baseline predictors of survival. However, extrahepatic metastasis (EHM) was not a significant prognostic factor. In addition, decrease in AFP level and development of hand-foot skin reaction within 4 weeks after sorafenib initiation were closely associated with favorable survival. Conclusion It is possible that not only Child-Pugh score 5 and 6 but also 7 patients are eligible for future clinical trials with sorafenib or similar drugs. Various survival predictors identified in this study might be considered as stratification factor. Although both MVI and EHM is a phenotype of advanced HCC, MVI should be discriminated from EHM because of the prognostic impact on survival in sorafenib-treated advanced HCC patients.	[Ogasawara, Sadahisa; Chiba, Tetsuhiro; Ooka, Yoshihiko; Kanogawa, Naoya; Saito, Tomoko; Motoyama, Tenyu; Suzuki, Eiichiro; Tawada, Akinobu; Kanai, Fumihiko; Yokosuka, Osamu] Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, Chiba 2608670, Japan	Chiba, T (reprint author), Chiba Univ, Grad Sch Med, Dept Gastroenterol & Nephrol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	techiba@faculty.chiba-u.jp			Bayer Yakuhin Co., Ltd.	This study was supported by a grant from Bayer Yakuhin Co., Ltd.	Abou-Alfa Ghassan K, 2011, Gastrointest Cancer Res, V4, P40; Cheng AL, 2013, J CLIN ONCOL, V31, P4067, DOI 10.1200/JCO.2012.45.8372; Kudo M, 2011, EUR J CANCER, V47, P2117, DOI 10.1016/j.ejca.2011.05.007; Pinter M, 2009, ONCOLOGIST, V14, P70, DOI 10.1634/theoncologist.2008-0191; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Pressiani T, 2013, ANN ONCOL, V24, P406, DOI 10.1093/annonc/mds343; Kim JE, 2011, CANCER CHEMOTH PHARM, V68, P1285, DOI 10.1007/s00280-011-1616-x; Omata M, 2010, HEPATOL INT, V4, P439, DOI 10.1007/s12072-010-9165-7; Kuzuya T, 2011, ONCOLOGY-BASEL, V81, P251, DOI 10.1159/000334454; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Personeni N, 2012, J HEPATOL, V57, P101, DOI 10.1016/j.jhep.2012.02.016; Ogasawara S, 2011, HEPATOL INT, V5, P850, DOI 10.1007/s12072-010-9249-4; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiu J, 2012, CANCER-AM CANCER SOC, V118, P5293, DOI 10.1002/cncr.27543; Johnson PJ, 2013, J CLIN ONCOL, V31, P3517, DOI 10.1200/JCO.2012.48.4410; D'Amico G, 2006, J HEPATOL, V44, P217, DOI 10.1016/j.jhep.2005.10.013; Reig M, 2014, J HEPATOL, V61, P318, DOI 10.1016/j.jhep.2014.03.030; Kim HY, 2013, J GASTROEN HEPATOL, V28, P1756, DOI 10.1111/jgh.12310; Yau T, 2011, ONCOLOGIST, V16, P1270, DOI 10.1634/theoncologist.2011-0105; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Lencioni R, 2014, INT J CLIN PRACT, V68, P609, DOI 10.1111/ijcp.12352; Otsuka T, 2012, HEPATOL RES, V42, P879, DOI 10.1111/j.1872-034X.2012.00991.x; Iavarone M, 2011, HEPATOLOGY, V54, P2055, DOI 10.1002/hep.24644; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Nakazawa T, 2013, EUR J GASTROEN HEPAT, V25, P683, DOI 10.1097/MEG.0b013e32835d913b; Cainap C, 2015, J CLIN ONCOL, V33, P172, DOI 10.1200/JCO.2013.54.3298; Cho JY, 2013, LIVER INT, V33, P950, DOI 10.1111/liv.12168; European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer, 2012, J HEPATOL, V56, P908, DOI DOI 10.1016/J.JHEP.2011.12.001; Kudo M, 2010, DIG DIS, V29, P339; Sohn W, 2014, J HEPATOL	30	2	3	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					729	739		10.1007/s10637-015-0237-3		11	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100019		
J	Yoshino, T; Komatsu, Y; Yamada, Y; Yamazaki, K; Tsuji, A; Ura, T; Grothey, A; Van Cutsem, E; Wagner, A; Cihon, F; Hamada, Y; Ohtsu, A				Yoshino, Takayuki; Komatsu, Yoshito; Yamada, Yasuhide; Yamazaki, Kentaro; Tsuji, Akihito; Ura, Takashi; Grothey, Axel; Van Cutsem, Eric; Wagner, Andrea; Cihon, Frank; Hamada, Yoko; Ohtsu, Atsushi			Randomized phase III trial of regorafenib in metastatic colorectal cancer: analysis of the CORRECT Japanese and non-Japanese subpopulations	INVESTIGATIONAL NEW DRUGS			English	Article						Regorafenib; Protein kinase inhibitors; Japanese; Colorectal cancer; Clinical trial; Phase III	CARCINOMA SUBGROUP ANALYSIS; BAY 73-4506; EFFICACY; REGIMEN; SAFETY; SCORES	Background In the international, phase III, randomized, double-blind CORRECT trial, regorafenib significantly prolonged overall survival (OS) versus placebo in patients with metastatic colorectal cancer (mCRC) that had progressed on all standard therapies. This post hoc analysis evaluated the efficacy and safety of regorafenib in Japanese and non-Japanese subpopulations in the CORRECT trial. Methods Patients were randomized 2 : 1 to regorafenib 160 mg once daily or placebo for weeks 1-3 of each 4-week cycle. The primary endpoint was OS. Outcomes were assessed using descriptive statistics. Results One hundred Japanese and 660 non-Japanese patients were randomized to regorafenib (n = 67 and n = 438) or placebo (n = 33 and n = 222). Regorafenib had a consistent OS benefit in the Japanese and non-Japanese subpopulations, with hazard ratios of 0.81 (95 % confidence interval [CI] 0.43-1.51) and 0.77 (95 % CI 0.62-0.94), respectively. Regorafenib-associated hand-foot skin reaction, hypertension, proteinuria, thrombocytopenia, and lipase elevations occurred more frequently in the Japanese subpopulation than in the non-Japanese subpopulation, but were generally manageable. Conclusion Regorafenib appears to have comparable efficacy in Japanese and non-Japanese subpopulations, with a manageable adverse-event profile, suggesting that this agent could potentially become a standard of care in patients with mCRC.	[Yoshino, Takayuki] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba 2778577, Japan; [Komatsu, Yoshito] Hokkaido Univ Hosp, Ctr Canc, Dept Canc Chemotherapy, Sapporo, Hokkaido 060, Japan; [Yamada, Yasuhide] Natl Canc Ctr, Gastrointestinal Oncol Div, Tokyo, Japan; [Yamazaki, Kentaro] Shizuoka Canc Ctr, Gastrointestinal Oncol, Nagaizumi, Shizuoka, Japan; [Tsuji, Akihito] Kochi Hlth Sci Ctr, Dept Med Oncol, Kochi, Japan; [Ura, Takashi] Aichi Canc Ctr Hosp, Dept Clin Oncol, Chikusa Ku, Nagoya, Aichi 464, Japan; [Grothey, Axel] Mayo Clin, Dept Oncol, Rochester, MN USA; [Van Cutsem, Eric] Univ Hosp, Digest Oncol, Leuven, Belgium; [Van Cutsem, Eric] Katholieke Univ Leuven, Leuven, Belgium; [Wagner, Andrea] Bayer Pharma AG, Global Clin Dev Oncol, Berlin, Germany; [Cihon, Frank] Bayer HealthCare Pharmaceut, Global Biostat, Whippany, NJ USA; [Hamada, Yoko] Bayer Yakuhin Ltd, Med Affairs Oncol & Hematol, Osaka, Japan; [Ohtsu, Atsushi] Natl Canc Ctr Hosp East, Exploratory Oncol Res & Clin Trial Ctr, Kashiwa, Chiba 2778577, Japan	Yoshino, T (reprint author), Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, 6-5-1 Kashiwanoha, Kashiwa, Chiba 2778577, Japan.	tyoshino@east.ncc.go.jp			Bayer HealthCare Pharmaceuticals, Leverkusen, Germany; Bayer Yakuhin Ltd.	The authors thank the patients, their families, and all of the investigators who participated in the trial. This work was supported by Bayer HealthCare Pharmaceuticals, Leverkusen, Germany. Bayer provided the study medication and collaborated with the investigators on protocol design, data collection, and interpretation. Editorial assistance in the preparation of this manuscript was provided by Succinct Medical Communications, with financial support from Bayer Yakuhin Ltd. The authors retained editorial control over the manuscript and the decision to publish.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Osoba D, 1998, J CLIN ONCOL, V16, P139; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864; Strumberg D, 2012, BRIT J CANCER, V106, P1722, DOI 10.1038/bjc.2012.153; Shirao K, 2004, J CLIN ONCOL, V22, P3466, DOI 10.1200/JCO.2004.05.017; Schmoll HJ, 2012, ANN ONCOL, V23, P2479, DOI 10.1093/annonc/mds236; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Ueda T, 2013, JPN J CLIN ONCOL, V43, P616, DOI 10.1093/jjco/hyt054; Mross K, 2012, CLIN CANCER RES, V18, P2658, DOI 10.1158/1078-0432.CCR-11-1900; Tsukamoto T, 2011, JPN J CLIN ONCOL, V41, P17, DOI 10.1093/jjco/hyq166; Bayer HealthCare, 2013, BAYERS STIV REG TABL; Bayer HealthCare, 2013, BAYERS STIV REG APPR; EuroQol Group, 1990, Health Policy, V16, P199; Foundation for Promotion of Cancer Research, 2013, CANC STAT JAP 2013; Globocan, 2013, COL CANC EST CANC IN; National Comprehensive Cancer Network Inc, 2014, NCCN CLIN PRACT GUID; Pickard AS, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-70; Sunakawa Y, 2013, INVEST NEW DRUGS, V32, P104; US Food and Drug Administration, 2012, ONCOLOGY WILLISTON P, V26, P896; Yoshino T, 2007, JPN J CLIN ONCOL, V37, P686, DOI 10.1093/jjco/hym091	20	1	1	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					740	750		10.1007/s10637-014-0154-x		11	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100020		
J	Miura, S; Kaira, K; Kaira, R; Akamatsu, H; Ono, A; Shukuya, T; Tsuya, A; Nakamura, Y; Kenmotsu, H; Naito, T; Murakami, H; Takahashi, T; Endo, M; Yamamoto, N				Miura, Satoru; Kaira, Kyoichi; Kaira, Rieko; Akamatsu, Hiroaki; Ono, Akira; Shukuya, Takehito; Tsuya, Asuka; Nakamura, Yukiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki; Endo, Masahiro; Yamamoto, Nobuyuki			The efficacy of amrubicin on central nervous system metastases originating from small-cell lung cancer: a case series of eight patients	INVESTIGATIONAL NEW DRUGS			English	Article						Small-cell lung cancer; Chemotherapy; Amrubicin; Central nervous system metastases	PHASE-III TRIAL; BRAIN METASTASES; CEREBROSPINAL-FLUID; 2ND-LINE TREATMENT; PROGNOSTIC-FACTORS; RADIATION-THERAPY; ONCOLOGY-GROUP; TOPOTECAN	Background Central nervous system (CNS) metastases caused by small-cell lung cancer (SCLC) are incurable and therefore fatal. Although such metastases are usually treated with chemotherapy or radiotherapy, their sensitivity to these treatment measures is unclear. Amrubicin appears to be a promising agent for relapsed SCLC, but its effectiveness in CNS metastases originating from SCLC is unknown. Methods Between April 2002 and December 2009, 110 SCLC patients with CNS metastasis were treated at Shizuoka Cancer Center. Of these, we retrospectively reviewed 8 consecutive cases with CNS metastases originating from relapsed SCLC that were treated with amrubicin as a second-line therapy. Results We recorded three sensitive relapses and five refractory cases. Amrubicin yielded a CNS response rate of 50 % (2 partial responses and 2 complete response; 95 % CI, 21.5-78.5 %) and the disease control rate for CNS lesions was 87.5 % (95 % CI, 52.9-97.8 %). All of the sensitive relapse patients achieved a partial response. The median time to progression for CNS metastases was 150.5 days (95 % CI, 9-171 days), and the median survival time from the start of amrubicin administration was 230.5 days (95 % CI, 89-619 days). We also report a dramatic improvement in one patient's radiological result of intramedullary spinal cord metastasis and alleviation of her symptoms following amrubicin monotherapy including this case series. Conclusions The results of this study suggest that amrubicin is active in patients with CNS metastases originating from SCLC.	[Miura, Satoru; Kaira, Kyoichi; Kaira, Rieko; Akamatsu, Hiroaki; Ono, Akira; Shukuya, Takehito; Tsuya, Asuka; Nakamura, Yukiko; Kenmotsu, Hirotsugu; Naito, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki; Yamamoto, Nobuyuki] Shizuoka Canc Ctr, Dept Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Dept Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Miura, Satoru] Niigata Univ, Med & Dent Hosp, Dept Resp Med, Chuo Ku, Niigata 9518510, Japan; [Kaira, Kyoichi] Gunma Univ Grad Med, Dept Oncol Clin Dev, Maebashi, Gunma 3718511, Japan; [Akamatsu, Hiroaki; Yamamoto, Nobuyuki] Wakayama Med Univ, Dept Internal Med 3, Wakayama 6418509, Japan	Kaira, K (reprint author), Shizuoka Canc Ctr, Dept Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	miusat1118@med.niigata-u.ac.jp; kkaira1970@yahoo.co.jp; rwatanabe9952@yahoo.co.jp; h-akamat@wakayama-med.ac.jp; a.ono@scchr.jp; tshukuya@juntendo.ac.jp; a-tsuya@hospital.city.osaka.jp; yu43-nakamura@city.yokohama.jp; h.kenmotsu@scchr.jp; t.naito@scchr.jp; ha.murakami@scchr.jp; t.takahashi@scchr.jp; m.endo@scchr.jp; nbyamamo@wakayama-med.ac.jp			Ministry of Health, Labor, and Welfare of Japan	This work was supported in part by a Grant-in-Aid for Cancer Research from the Ministry of Health, Labor, and Welfare of Japan. We appreciate Ms. Yuka Matsui for her technical assistance of manuscript submission.	O'Brien MER, 2006, J CLIN ONCOL, V24, P5441, DOI 10.1200/JCO.2006.06.5821; Inoue A, 2008, J CLIN ONCOL, V26, P5401, DOI 10.1200/JCO.2008.18.1974; BORGELT B, 1980, INT J RADIAT ONCOL, V6, P1; von Pawel J, 2014, J CLIN ONCOL, V32, P4012, DOI 10.1200/JCO.2013.54.5392; Lagerwaard FJ, 1999, INT J RADIAT ONCOL, V43, P795, DOI 10.1016/S0360-3016(98)00442-8; Wagner M, 2008, J THORAC ONCOL, V3, P677, DOI 10.1097/JTO.0b013e3181757a8b; Ettinger DS, 2010, J CLIN ONCOL, V28, P2598, DOI 10.1200/JCO.2009.26.7682; Murakami H, 2014, LUNG CANCER, V84, P67, DOI 10.1016/j.lungcan.2014.01.012; Onoda S, 2006, J CLIN ONCOL, V24, P5448, DOI 10.1200/JCO.2006.08.4145; Grossi F, 2001, CRIT REV ONCOL HEMAT, V37, P61, DOI 10.1016/S1040-8428(00)00098-6; Ardizzoni A, 1997, J CLIN ONCOL, V15, P2090; Baker SD, 1996, CANCER CHEMOTH PHARM, V37, P195; Castrucci WA, 2008, CANCER J, V14, P138, DOI 10.1097/PPO.0b013e318172d6e1; HIRSCH FR, 1983, CANCER, V51, P529, DOI 10.1002/1097-0142(19830201)51:3<529::AID-CNCR2820510327>3.0.CO;2-0; Jotte R, 2010, J CLIN ONCOL, V29, P287; Korfel A, 2002, EUR J CANCER, V38, P1724, DOI 10.1016/S0959-8049(02)00140-5; Mut M, 2005, J NEURO-ONCOL, V75, P43, DOI 10.1007/s11060-004-8097-2; PATCHELL RA, 1991, NEUROL CLIN, V9, P817; Saito EY, 2006, RADIAT ONCOL, V1, DOI 10.1186/1748-717X-1-20; SUNG C, 1994, CANCER RES, V54, P5118	20	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-6997	1573-0646		INVEST NEW DRUG	Invest. New Drugs	JUN	2015	33	3					755	760		10.1007/s10637-015-0233-7		6	Oncology; Pharmacology & Pharmacy	Oncology; Pharmacology & Pharmacy	CI3AZ	WOS:000354621100022		
J	Tamagawa, H				Tamagawa, Hirohisa			Membrane potential generation without ion transport	IONICS			English	Article						Membrane potential; Goldman-Hodgkin-Katz equation; Donnan theory; Ion adsorption	POISSON-BOLTZMANN EQUATION; DOUBLE-LAYER INTERACTION; POTENTIOMETRY; ADSORPTION; PARTICLES; ELECTRODE; PLATES	Current view about cell is that the cell is a watery solution coated with semi-permeable membrane and there exists nonzero potential, so-called membrane potential, across the semi-permeable cell membrane. Goldman-Hodgkin-Katz equation and Donnan theory are the fundamental existing theories for explaining the cause of membrane potential generation. However, the observations of membrane potential inexplicable by these existing theories have been repeatedly reported by a small number of researchers for more than the past half century. Hence, it is needless to say important to reconsider the membrane potential generation mechanism. Based on the experimental result shown in this paper, it was concluded that the existing theories were not genuinely right for the explanation of membrane potential generation. Adsorption theory is only a genuinely right theory instead. The adsorption theory describes that the adsorption of the mobile ions on the adsorption sites on the membrane generates the membrane potential. This work introduces the experimental observation inexplicable by Goldman-Hodgkin-Katz equation or Donnan theory but is in harmony with the adsorption theory.	Gifu Univ, Dept Mech Engn, Fac Engn, Gifu, Gifu 5011193, Japan	Tamagawa, H (reprint author), Gifu Univ, Dept Mech Engn, Fac Engn, 1-1 Yanagido, Gifu, Gifu 5011193, Japan.	tmgwhrhs@gifu-u.ac.jp			Ministry of Education, Science, Sports and Culture [26650032]	This research was conducted under the financial support of the Ministry of Education, Science, Sports and Culture, Grant-in-Aid for Challenging Exploratory Research, 26650032, 2014.	ANANDARAJAH A, 1994, J COLLOID INTERF SCI, V168, P111, DOI 10.1006/jcis.1994.1399; Borukhov I, 2000, ELECTROCHIM ACTA, V46, P221, DOI 10.1016/S0013-4686(00)00576-4; Alijo PHR, 2012, COLLOID SURFACE A, V412, P29, DOI 10.1016/j.colsurfa.2012.07.008; Basuray S, 2010, BIOMICROFLUIDICS, V4, DOI 10.1063/1.3294575; Chapot D, 2005, J COLLOID INTERF SCI, V285, P609, DOI 10.1016/j.jcis.2004.11.059; Cheng KL, 2002, MICROCHEM J, V72, P269, DOI 10.1016/S0026-265X(02)00092-9; Cheng KL, 1998, MICROCHEM J, V59, P457, DOI 10.1006/mchj.1998.1624; CHENG KL, 1990, MICROCHEM J, V42, P5, DOI 10.1016/0026-265X(90)90023-X; COLACICC.G, 1965, NATURE, V207, P936, DOI 10.1038/207936a0; COLACICC.G, 1965, NATURE, V207, P1045, DOI 10.1038/2071045a0; Hanai T, 1978, MAKU TO ION; HUANG CM, 1995, J ELECTROCHEM SOC, V142, pL175, DOI 10.1149/1.2050034; ISHIMA Y, 1981, BIOSYSTEMS, V13, P243, DOI 10.1016/0303-2647(81)90004-6; Ling G, 1991, REVOLUTION PHYSL LIV; Ling G, 2001, LIFE CELL BELOW CELL; Ling Gilbert N., 2011, Physiological Chemistry and Physics and Medical NMR, V41, P19; Matsumoto G, 1981, PHENOMENON SUBSTANCE; Mentre P, 2006, SAIBOU NO NAKANOMIZU; Miyakawa H, 2003, NYUURON SEIBUTSUBUTU; Plouraboue F, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041404; Polat M, 2010, J COLLOID INTERF SCI, V341, P178, DOI 10.1016/j.jcis.2009.09.008; Pollack G. H., 2001, CELLS GELS ENGINES L; Pollack G.H, 2013, 4 PHASE WATER SOLID; PRZYBYLSKI AT, 1985, BIOSYSTEMS, V17, P281, DOI 10.1016/0303-2647(85)90044-9; PRZYBYLSKI AT, 1982, NATURWISSENSCHAFTEN, V69, P561, DOI 10.1007/BF00396351; PRZYBYLSKI AT, 1984, APPL BIOCHEM BIOTECH, V10, P301, DOI 10.1007/BF02783764; Tamagawa Hirohisa, 2014, Membranes (Basel), V4, P257, DOI 10.3390/membranes4020257; Temsamani KR, 2001, SENSOR ACTUAT B-CHEM, V76, P551, DOI 10.1016/S0925-4005(01)00624-4; TEORELL T, 1959, J GEN PHYSIOL, V42, P831, DOI 10.1085/jgp.42.4.831; Trefalt G, 2013, J COLLOID INTERF SCI, V406, P111, DOI 10.1016/j.jcis.2013.05.071; YOSHIKAWA K, 1984, BIOPHYS CHEM, V20, P107, DOI 10.1016/0301-4622(84)80010-1; Yoshikawa K, 1984, BIOPHYS CHEM, V21, P33; Zhang JF, 2006, J COLLOID INTERF SCI, V300, P391, DOI 10.1016/j.jcis.2006.03.019	33	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0947-7047	1862-0760		IONICS	Ionics	JUN	2015	21	6					1631	1648		10.1007/s11581-014-1333-7		18	Chemistry, Physical; Electrochemistry; Physics, Condensed Matter	Chemistry; Electrochemistry; Physics	CI4JQ	WOS:000354714900016		
J	von Dassow, P; John, U; Ogata, H; Probert, I; Bendif, E; Kegel, JU; Audic, S; Wincker, P; Da Silva, C; Claverie, JM; Doney, S; Glover, DM; Flores, DM; Herrera, Y; Lescot, M; Garet-Delmas, MJ; de Vargas, C				von Dassow, Peter; John, Uwe; Ogata, Hiroyuki; Probert, Ian; Bendif, El Mahdi; Kegel, Jessica U.; Audic, Stephane; Wincker, Patrick; Da Silva, Corinne; Claverie, Jean-Michel; Doney, Scott; Glover, David M.; Mella Flores, Daniella; Herrera, Yeritza; Lescot, Magali; Garet-Delmas, Marie-Jose; de Vargas, Colomban			Life-cycle modification in open oceans accounts for genome variability in a cosmopolitan phytoplankton	ISME JOURNAL			English	Article							EMILIANIA-HUXLEYI PRYMNESIOPHYCEAE; CARBONATE CHEMISTRY; COCCOLITH FORMATION; FLOW-CYTOMETRY; EVOLUTION; CALCIFICATION; CHLAMYDOMONAS; HAPTOPHYTA; MEIOSIS; SEA	Emiliania huxleyi is the most abundant calcifying plankton in modern oceans with substantial intraspecific genome variability and a biphasic life cycle involving sexual alternation between calcified 2N and flagellated 1N cells. We show that high genome content variability in Emiliania relates to erosion of 1N-specific genes and loss of the ability to form flagellated cells. Analysis of 185 E. huxleyi strains isolated from world oceans suggests that loss of flagella occurred independently in lineages inhabiting oligotrophic open oceans over short evolutionary timescales. This environmentally linked physiogenomic change suggests life cycling is not advantageous in very large/diluted populations experiencing low biotic pressure and low ecological variability. Gene loss did not appear to reflect pressure for genome streamlining in oligotrophic oceans as previously observed in picoplankton. Life-cycle modifications might be common in plankton and cause major functional variability to be hidden from traditional taxonomic or molecular markers.	[von Dassow, Peter; Mella Flores, Daniella; Herrera, Yeritza] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Santiago 8331150, Chile; [von Dassow, Peter; Mella Flores, Daniella] Univ Paris 04, UPMC, CNRS,Stn Biol Roscoff, PUCCh,UACH,UMI Evolutionary Biol & Ecol Algae 361, Roscoff, France; [von Dassow, Peter] Inst Milenio Oceanog, Concepcion, Chile; [von Dassow, Peter; Audic, Stephane; Garet-Delmas, Marie-Jose; de Vargas, Colomban] CNRS, UMR 7144, Roscoff, France; [von Dassow, Peter; Audic, Stephane; Garet-Delmas, Marie-Jose; de Vargas, Colomban] UPMC, CNRS, EPEP, Stn Biol Roscoff, Roscoff, France; [John, Uwe; Kegel, Jessica U.] Alfred Wegener Inst Helmhotz Ctr Polar & Marine R, Bremerhaven, Germany; [Ogata, Hiroyuki] Kyoto Univ, Inst Chem Res, Kyoto 606, Japan; [Ogata, Hiroyuki; Claverie, Jean-Michel] Aix Marseille Univ, CNRS, Mediterranean Inst Microbiol FR 3479, Lab Informat Genom & Struct,UMR 7256, Marseille, France; [Probert, Ian] UMPC, CNRS, Roscoff Culture Collect, Stn Biol Roscoff,FR2424, Roscoff, France; [Bendif, El Mahdi] Marine Biol Assoc UK, Plymouth, Devon, England; [Wincker, Patrick; Da Silva, Corinne] CEA Genoscope, Evry, France; [Doney, Scott; Glover, David M.] Woods Hole Oceanog Inst, Dept Marine Chem & Geochem, Woods Hole, MA 02543 USA	von Dassow, P (reprint author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Alameda 340, Santiago 8331150, Chile.	pvondassow@bio.puc.cl	Doney, Scott/F-9247-2010; Kegel, Jessica/L-1726-2014	Doney, Scott/0000-0002-3683-2437; Claverie, jean-michel/0000-0003-1424-0315; Audic, Stephane/0000-0001-6193-4374; Kegel, Jessica/0000-0002-4740-9554	Marie Curie International Incoming Fellowship FUNSEXDEPHYND within the 7th European Community Framework Programme; FONDECYT [1110575, 312004]; French Agence Nationale de la Recherche/Investissements d'Avenir Grants POSEIDON; OCEANOMICS [ANR-11-BTBR-0008]; European ERA-net program BiodivERsA under the BioMarks project; NASA; NSF [NNX11AF55G, EF-0424599]; Genoscope sequencing initiative; PACES research program of the Alfred Wegener Helmholtz Institute Helmhotz Centre for Polar and Marine Research	This research was supported by a Marie Curie International Incoming Fellowship FUNSEXDEPHYND to PvD within the 7th European Community Framework Programme, FONDECYT Projects 1110575 (to PvD) and 312004 (to DM-F), the French Agence Nationale de la Recherche/Investissements d'Avenir Grants POSEIDON and OCEANOMICS (Grant No. ANR-11-BTBR-0008 to CdV and IP), the European ERA-net program BiodivERsA under the BioMarks project (to EMB), funding from NASA and NSF (Grants NNX11AF55G and EF-0424599 to DMG and SD), the Genoscope 2007-2008 sequencing initiative and the PACES research program of the Alfred Wegener Helmholtz Institute Helmhotz Centre for Polar and Marine Research. We are very grateful to Marco Groth for help with Illumina sequencing.	Carvalho-Santos Z, 2011, J CELL BIOL, V194, P165, DOI 10.1083/jcb.201011152; Mackinder L, 2011, ENVIRON MICROBIOL, V13, P3250, DOI 10.1111/j.1462-2920.2011.02561.x; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Flot JF, 2013, NATURE, V500, P453, DOI 10.1038/nature12326; Xu S, 2011, MOL BIOL EVOL, V28, P335, DOI 10.1093/molbev/msq199; Coelho SM, 2007, GENE, V406, P152, DOI 10.1016/j.gene.2007.07.025; Kaltz O, 2002, EVOLUTION, V56, P1743; Carpenter ML, 2012, J CELL SCI, V125, P2523, DOI 10.1242/jcs.103879; Hughes JS, 1999, AM NAT, V154, P306, DOI 10.1086/303241; Moore TS, 2012, REMOTE SENS ENVIRON, V117, P249, DOI 10.1016/j.rse.2011.10.001; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Ferris PJ, 2005, PLANT CELL, V17, P597, DOI 10.1105/tpc.104.028035; Langer G, 2009, BIOGEOSCIENCES, V6, P2637; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Becks L, 2010, NATURE, V468, P89, DOI 10.1038/nature09449; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Frada M, 2008, P NATL ACAD SCI USA, V105, P15944, DOI 10.1073/pnas.0807707105; Swan BK, 2013, P NATL ACAD SCI USA, V110, P11463, DOI 10.1073/pnas.1304246110; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Beaufort L, 2011, NATURE, V476, P80, DOI 10.1038/nature10295; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Boutet Emmanuel, 2007, V406, P89; Beaufort L, 2008, BIOGEOSCIENCES, V5, P1101; Lechner E, 2006, CURR OPIN PLANT BIOL, V9, P631, DOI 10.1016/j.pbi.2006.09.003; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Kamiya R, 2002, INT REV CYTOL, V219, P115; Figueroa RI, 2006, J PHYCOL, V42, P1028, DOI 10.1111/j.1529-8817.2006.00262.x; CORREA JA, 1991, J PHYCOL, V27, P448, DOI 10.1111/j.0022-3646.1991.00448.x; Peacock L, 2014, CURR BIOL, V24, P181, DOI 10.1016/j.cub.2013.11.044; Siokou-Frangou I, 2010, BIOGEOSCIENCES, V7, P1543, DOI 10.5194/bg-7-1543-2010; Raffi I, 2006, QUATERNARY SCI REV, V25, P3113, DOI 10.1016/j.quascirev.2006.07.007; Asai DJ, 2001, TRENDS CELL BIOL, V11, P196, DOI 10.1016/S0962-8924(01)01970-5; Becks L, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001317; Bendif E, 2014, J PHYCOL, V50, P140, DOI 10.1111/jpy.12147; Billard C, 2004, COCCOLITHOPHORES: FROM MOLECULAR PROCESSES TO GLOBAL IMPACT, P1; Brussaard CPD, 1996, AQUAT MICROB ECOL, V10, P105, DOI 10.3354/ame010105; Coolen MJL, 2011, SCIENCE, V333, P451, DOI 10.1126/science.1200072; Cros Lluisa, 2002, Scientia Marina, V66, P7; Forche A, 2008, PLOS BIOL, V6, P1084, DOI 10.1371/journal.pbio.0060110; Green JC, 1996, J MARINE SYST, V9, P33, DOI 10.1016/0924-7963(96)00014-0; Hagino K, 2004, GLOBAL ENV CHANGE OC, P121; Hagino K, 2011, J PHYCOL, V47, P1165; Houdan A, 2005, MAR ECOL PROG SER, V292, P139, DOI 10.3354/meps292139; Iglesias-Rodriguez MD, 2008, SCIENCE, V320, P336, DOI 10.1126/science.1154122; Kegel JU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080684; KLAVENES.D, 1971, ARCH MIKROBIOL, V75, P382, DOI 10.1007/BF00407700; Klaveness D., 1972, British phycol J, V7, P309; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; Renaud S, 2001, J PLANKTON RES, V23, P779, DOI 10.1093/plankt/23.8.779; Rokitta SD, 2011, J PHYCOL, V47, P829; Rokitta SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052212; Schurko AM, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-78; Silva A, 2013, ESTUAR COAST SHELF S, V118, P50, DOI 10.1016/j.ecss.2012.12.010; Uz BM, 2004, DEEP-SEA RES PT II, V51, P1001, DOI 10.1016/j.dsr2.2003.03.003; von Dassow P, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r114; von Dassow P, 2012, J PLANKTON RES, V34, P1011, DOI 10.1093/plankt/fbs061; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X	58	2	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1751-7362	1751-7370		ISME J	ISME J.	JUN	2015	9	6					1365	1377		10.1038/ismej.2014.221		13	Ecology; Microbiology	Environmental Sciences & Ecology; Microbiology	CI5HR	WOS:000354786700008		
J	Tobe, T; Ueda, K; Ando, M; Okamoto, Y; Kojima, N				Tobe, Takao; Ueda, Koji; Ando, Motozumi; Okamoto, Yoshinori; Kojima, Nakao			Thiol-mediated multiple mechanisms centered on selenodiglutathione determine selenium cytotoxicity against MCF-7 cancer cells	JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY			English	Article						Selenodiglutathione; Cancer chemotherapy; Glutathione; Thiol; Sulfur	OXIDATIVE DNA-DAMAGE; TOXICITY; GLUTATHIONE; METABOLISM; BLOOD; IDENTIFICATION; APOPTOSIS; COMPONENT; REDUCTASE; HUMANS	Selenium (Se) is an essential antioxidative micronutrient but can exert cancer-selective cytotoxicity if the nutritional levels are too high. Selenodiglutathione (GSSeSG) is a primary Se metabolite conjugated with two glutathione (GSH) moieties. GSSeSG has been suggested to be an important molecule for cytotoxicity. Here, we propose the underlying mechanisms for the potent cytotoxicity of GSSeSG: cellular intake; reductive metabolism; production of reactive oxygen species; oxidative damage to DNA; apoptosis induction. GSSeSG rather than selenite decreased cell viability and induced apoptosis accompanied by increases in intracellular Se contents. Therefore, GSSeSG-specific cytotoxicity may be ascribed to its preferable incorporation. Base oxidation and strand fragmentation in genomic DNA preceded cell death, suggesting that oxidative stress (including DNA damage) is crucial for GSSeSG cytotoxicity. Strand breaks of purified DNA were caused by the coexistence of GSSeSG and thiols (GSH, cysteine, homocysteine), but not the oxidized form or non-thiol reductants. This implies the important role of intracellular thiols in the mechanism of Se toxicity. GSH-assisted DNA strand breaks were inhibited by specific scavengers for hydrogen peroxide or hydroxyl radicals. The GSSeSG metabolite selenide induced some DNA strand breaks without GSH, whereas elemental Se did so only with GSH. These observations suggest involvement of Fenton-type reaction in the absence of transition metals and reactivation of inert elemental Se. Overall, our results suggest that chemical interactions between Se and the sulfur of thiols are crucial for the toxicity mechanisms of Se.	[Tobe, Takao; Ueda, Koji; Okamoto, Yoshinori; Kojima, Nakao] Meijo Univ, Fac Pharm, Tempaku Ku, Nagoya, Aichi 4688503, Japan; [Ando, Motozumi] Kobe Gakuin Univ, Fac Pharmaceut Sci, Chuo Ku, Kobe, Hyogo 6508586, Japan	Kojima, N (reprint author), Meijo Univ, Fac Pharm, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	kojiman@meijo-u.ac.jp			Research Institute of Meijo University to K. U.;  [23790161]	We are indebted to Dr. Kazuo Itoh and Dr. Yoshitaka Odo for the use of the ICP-MS. We would like to express gratitude to all the laboratory members who participated in this study for their technical support, especially Ms. Mai Takagi, Mr. Masayuki Hayashi, and Ms. Shino Matsuda for the data used in the present study. This work was supported by a Grant-in-Aid for Young Scientists (B) (Grant Number 23790161) and the Research Institute of Meijo University to K. U.	AMMAR EM, 1981, NEUROTOXICOLOGY, V2, P383; Ando M, 2011, J HEALTH SCI, V57, P72, DOI 10.1248/jhs.57.72; ROTRUCK JT, 1973, SCIENCE, V179, P588, DOI 10.1126/science.179.4073.588; Wastney ME, 2011, J NUTR, V141, P708, DOI [10.3945/jn.110.129049, 10.3945/jn.110129049]; Shiobara Y, 1998, TOXICOL APPL PHARM, V152, P309, DOI 10.1006/taap.1998.8537; CONE JE, 1976, P NATL ACAD SCI USA, V73, P2659, DOI 10.1073/pnas.73.8.2659; Olm E, 2009, P NATL ACAD SCI USA, V106, P11400, DOI 10.1073/pnas.0902204106; Rayman MP, 2008, BRIT J NUTR, V100, P254, DOI 10.1017/S0007114508939830; Finley JW, 2006, NUTR REV, V64, P146, DOI 10.1301/nr.2006.mar.146-151; Vinceti Marco, 2009, Reviews on Environmental Health, V24, P231; Brozmanova J, 2010, ARCH TOXICOL, V84, P919, DOI 10.1007/s00204-010-0595-8; Valdiglesias V, 2010, ARCH TOXICOL, V84, P337, DOI 10.1007/s00204-009-0505-0; Tarze A, 2007, J BIOL CHEM, V282, P8759, DOI 10.1074/jbc.M610078200; WANG L, 1994, NUCLEIC ACIDS RES, V22, P1774, DOI 10.1093/nar/22.9.1774; Pastore A, 2001, CLIN CHEM, V47, P1467; Seko Y, 1997, BIOMED ENVIRON SCI, V10, P333; Fairweather-Tait SJ, 2011, ANTIOXID REDOX SIGN, V14, P1337, DOI 10.1089/ars.2010.3275; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Fleming J, 2001, NUTR CANCER, V40, P42, DOI 10.1207/S15327914NC401_9; Gabel-Jensen C, 2006, ANAL BIOANAL CHEM, V384, P697, DOI 10.1007/s00216-005-0178-3; GANTHER HE, 1971, BIOCHEMISTRY-US, V10, P4089, DOI 10.1021/bi00798a013; Husbeck B, 2006, PROSTATE, V66, P218, DOI 10.1002/pros.20337; Jariwalla RJ, 2009, BRIT J NUTR, V101, P182, DOI 10.1017/S0007114508998305; Moustafa ME, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057389; Nakamuro K, 2000, J HEALTH SCI, V46, P418; Nishida H, 2010, CHEM PHARM BULL, V58, P957; Okamoto Y, 2008, CHEM RES TOXICOL, V21, P1120, DOI 10.1021/tx700428m; Park YC, 2004, BIOL TRACE ELEM RES, V98, P143, DOI 10.1385/BTER:98:2:143; Peyroche G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036343; Seko Y., 1989, SELENIUM BIOL MED, P70; Sun GX, 2010, ENVIRON SCI TECHNOL, V44, P6706, DOI 10.1021/es101843x; Vinceti M, 2001, Rev Environ Health, V16, P233; Weekley CM, 2014, J BIOL INORG CHEM, V19, P813, DOI 10.1007/s00775-014-1113-x; Whanger P, 1996, ANN CLIN LAB SCI, V26, P99; WU L, 1995, CARCINOGENESIS, V16, P1579, DOI 10.1093/carcin/16.7.1579	35	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0949-8257	1432-1327		J BIOL INORG CHEM	J. Biol. Inorg. Chem.	JUN	2015	20	4					687	694		10.1007/s00775-015-1254-6		8	Biochemistry & Molecular Biology; Chemistry, Inorganic & Nuclear	Biochemistry & Molecular Biology; Chemistry	CI4HK	WOS:000354709100007		
J	Nozoe, T; Goda, S; Selyanchyn, R; Wang, T; Nakazawa, K; Hirano, T; Matsui, H; Lee, SW				Nozoe, Takuma; Goda, Shigemi; Selyanchyn, Roman; Wang, Tao; Nakazawa, Kohji; Hirano, Takeshi; Matsui, Hidetaka; Lee, Seung-Woo			In vitro detection of small molecule metabolites excreted from cancer cells using a Tenax TA thin-film microextraction device	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Molecular cancer biomarkers; Cell culture; Thin-film microextraction; GC-MS	VOLATILE ORGANIC-COMPOUNDS; HUMAN LUNG-CANCER; EXHALED BREATH; UNMETABOLIZED VOCS; THERMAL-DESORPTION; BIOMARKERS; EXPOSURE; RELEASE; URINE; DIAGNOSIS	We developed a new device for the in vitro extraction of small molecule metabolites excreted from cancer cells. The extraction device, which was biocompatible and incubated with cancer cells, consists of a thin Tenax TA film deposited on the surface of a cylindrical aluminum rod. The Tenax TA solid phase was utilized for the direct extraction and preconcentration of the small molecule metabolites from a cell culture sample. The device fabrication and the metabolite extraction were optimized, tested, and validated using HeLa cell cultures. Comparison of metabolic profiles with the control measurement from the culture medium enabled detection of metabolites that were consumed or produced by the cell culture. Tentative identification and semi-quantitative investigation of the excreted metabolites were performed by GC-MS analysis. The proposed approach can be a valuable tool for the characterization of low-volatile cancer cell metabolites that are not covered by use of conventional methods based on headspace solid phase microextraction. (C) 2015 Elsevier B.V. All rights reserved.	[Nozoe, Takuma; Goda, Shigemi; Selyanchyn, Roman; Wang, Tao; Nakazawa, Kohji; Hirano, Takeshi; Lee, Seung-Woo] Univ Kitakyushu, Grad Sch Environm Engn, Kitakyushu, Fukuoka 8080135, Japan; [Selyanchyn, Roman] Kyushu Univ, WPI Int Inst Carbon Neutral Energy Res WPI I2 CNE, Fukuoka 8190395, Japan; [Matsui, Hidetaka] Shinkou Seiki Co Ltd, Fukuoka 8120054, Japan	Lee, SW (reprint author), Univ Kitakyushu, Grad Sch Environm Engn, 1-1 Hibikino, Kitakyushu, Fukuoka 8080135, Japan.	leesw@kitakyu-u.ac.jp			MEXT; Japan Society for the Promotion of Science [25293429]	This work was supported by MEXT via the 2nd Kitakyushu Knowledge-based Cluster Project. This work was supported by and a grant-in-aid for scientific research (B) (25293429) from the Japan Society for the Promotion of Science. Shinkou Seiki Co. Ltd. also supported us financially as a special research project. R. Selyanchyn acknowledges the fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Amann A, 2007, MINI-REV MED CHEM, V7, P115, DOI 10.2174/138955707779802606; Sponring A, 2010, CANCER BIOMARK, V7, P153, DOI 10.3233/CBM-2010-0182; Hakim M, 2012, CHEM REV, V112, P5949, DOI 10.1021/cr300174a; Phillips M, 2012, TUBERCULOSIS, V92, P314, DOI 10.1016/j.tube.2012.04.002; Hakim M, 2011, BRIT J CANCER, V104, P1649, DOI 10.1038/bjc.2011.128; Baltussen E, 1999, J MICROCOLUMN SEP, V11, P737, DOI 10.1002/(SICI)1520-667X(1999)11:10<737::AID-MCS7>3.0.CO;2-4; Filipiak W, 2010, CANCER EPIDEM BIOMAR, V19, P182, DOI 10.1158/1055-9965.EPI-09-0162; Chen X, 2007, CANCER, V110, P835, DOI 10.1002/cncr.22844; Phillips M, 2008, CLIN CHIM ACTA, V393, P76, DOI 10.1016/j.cca.2008.02.021; Dettmer K, 2002, ANAL BIOANAL CHEM, V373, P490, DOI 10.1007/s00216-002-1352-5; Wang YS, 2012, CANCER BIOMARK, V11, P129, DOI [10.3233/CBM-2012-00270, 10.3233/CBM-2012-0270]; Peng G, 2010, BRIT J CANCER, V103, P542, DOI 10.1038/sj.bjc.6605810; Waidyanatha S, 2001, CARCINOGENESIS, V22, P279, DOI 10.1093/carcin/22.2.279; Bruheim I, 2003, ANAL CHEM, V75, P1002, DOI 10.1021/ac026162q; [Anonymous], 2008, ADSORBENT RESINS TRA; Phillips M, 2010, J BREATH RES, V4, DOI 10.1088/1752-7155/4/2/026003; Sponring A, 2009, ANTICANCER RES, V29, P419; Barash O, 2012, NANOMED-NANOTECHNOL, V8, P580, DOI 10.1016/j.nano.2011.10.001; Filipiak W, 2008, CANCER CELL INT, V8, DOI 10.1186/1475-2867-8-17; Hanai Y, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-7; Janasik B, 2010, INT J OCCUP MED ENV, V23, P21, DOI 10.2478/v10001-010-0003-x; Matsumura K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008819; Mochalski P, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-72; Pawliszyn J., 2002, SAMPLING SAMPLE PREP; Selyanchyn R., 2013, DIAGNOSTICS, V3, P68; Selyanchyn R., 2009, CHROMATOGRAPHIA, V71, P317; Volden J, 2005, ANAL CHIM ACTA, V530, P263, DOI 10.1016/j.aca.2004.09.019; Wang BL, 2007, J OCCUP HEALTH, V49, P104, DOI 10.1539/joh.49.104; Zhang Z., 1994, ANAL CHEM, P66	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	JUN 1	2015	991						99	107		10.1016/j.jchromb.2015.04.016		9	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CI8MF	WOS:000355025700015		
J	Lin, SY; Chuang, SS; Jhuang, JY; Sakamoto, K; Takeuchi, K; Bahrami, A; Tsai, CC				Lin, Shih-Yao; Chuang, Shih-Sung; Jhuang, Jie-Yang; Sakamoto, Kana; Takeuchi, Kengo; Bahrami, Armita; Tsai, Chien-Chen			ALK positive large B-cell lymphoma with a massive neutrophilic infiltrate: report of a case mimicking epithelioid inflammatory myofibroblastic tumour	JOURNAL OF CLINICAL PATHOLOGY			English	Letter							FUSION		[Lin, Shih-Yao; Jhuang, Jie-Yang; Tsai, Chien-Chen] Far Eastern Mem Hosp, Dept Anat Pathol, New Taipei City 220, Taiwan; [Chuang, Shih-Sung] Taipei Med Univ, Dept Pathol, Tainan, Taiwan; [Chuang, Shih-Sung] Taipei Med Univ, Chi Mei Med Ctr, Tainan, Taiwan; [Sakamoto, Kana; Takeuchi, Kengo] Japanese Fdn Canc Res, Pathol Project Mol Targets Canc Inst, Canc Inst Hosp, Div Pathol, Tokyo, Japan; [Bahrami, Armita] St Jude Childrens Res Hosp, Dept Pathol, Memphis, TN 38105 USA	Tsai, CC (reprint author), Far Eastern Mem Hosp, Dept Anat Pathol, 21,Sec 2,Nanya S Rd, New Taipei City 220, Taiwan.	a0970295250@gmail.com					van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; Takeuchi K, 2011, HAEMATOL-HEMATOL J, V96, P464, DOI 10.3324/haematol.2010.033514; Gascoyne RD, 2003, BLOOD, V102, P2568, DOI 10.1182/blood-2003-03-0786; Onciu M, 2003, BLOOD, V102, P2642, DOI 10.1182/blood-2003-04-1095; Marino-Enriquez A, 2011, AM J SURG PATHOL, V35, P135, DOI 10.1097/PAS.0b013e318200cfd5; Beltran B, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-11; Swerdlow SH, 2008, WHO CLASSIFICATION T, P254	7	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0021-9746	1472-4146		J CLIN PATHOL	J. Clin. Pathol.	JUN	2015	68	6					496	498		10.1136/jclinpath-2014-202847		3	Pathology	Pathology	CI3NC	WOS:000354653500021		
J	Sanada, K; Mizuno, Y; Shindo, Y				Sanada, Kazuaki; Mizuno, Yuta; Shindo, Yasuhide			Damage progression and notched strength recovery of fiber-reinforced polymers encompassing self-healing of interfacial debonding	JOURNAL OF COMPOSITE MATERIALS			English	Article						Interface mechanics; polymer composites; notched tensile strength; damage progression; self-healing	COMPOSITES	This study examines the interfacial debonding behavior of self-healing fiber-reinforced polymers and the performance of repair of interfacial debonding. Self-healing is accomplished by incorporating a microencapsulated healing agent and a catalyst within a coating layer on the surface of the fiber strand. Single edge-notched tensile specimens of unidirectional fiber-reinforced polymers with coated fiber strands were prepared and tested. The healing efficiency was evaluated by the critical fracture loads of virgin and healed specimens. To investigate the release of the healing agent from microcapsules during interfacial debonding, an ultraviolet fluorescent dye was added to the healing agent, and post-fracture specimens were examined by an optical microscope under ultraviolet light. In addition to conducting experiments, finite-element analyses were performed using a three-dimensional model to predict the damage progression in single edge-notched tensile specimens.	[Sanada, Kazuaki; Mizuno, Yuta] Toyama Prefectural Univ, Dept Mech Syst Engn, Imizu, Toyama 9390398, Japan; [Shindo, Yasuhide] Tohoku Univ, Grad Sch Engn, Dept Mat Proc, Sendai, Miyagi 980, Japan	Sanada, K (reprint author), Toyama Prefectural Univ, 5180 Kurokawa, Imizu, Toyama 9390398, Japan.	sanada@pu-toyama.ac.jp					Sanada K, 2006, PLAST RUBBER COMPOS, V35, P67, DOI 10.1179/174328906X79914; Trask RS, 2007, J R SOC INTERFACE, V4, P363, DOI 10.1098/rsif.2006.0194; White SR, 2001, NATURE, V409, P794, DOI 10.1038/35057232; Blaiszik BJ, 2010, ADV FUNCT MATER, V20, P3547, DOI 10.1002/adfm.201000798; Kessler MR, 2003, COMPOS PART A-APPL S, V34, P743, DOI 10.1016/S1359-835X(03)00138-6; Kessler MR, 2001, COMPOS PART A-APPL S, V32, P683, DOI 10.1016/S1359-835X(00)00149-4; Patel AJ, 2010, COMPOS PART A-APPL S, V41, P360, DOI 10.1016/j.compositesa.2009.11.002; Williams G, 2007, COMPOS PART A-APPL S, V38, P1525, DOI 10.1016/j.compositesa.2007.01.013; Yuan YC, 2011, SMART MATER STRUCT, V20, DOI 10.1088/0964-1726/20/1/015024; Daniel IM, 2006, ENG MECH COMPOSITE M; GUILD FJ, 1994, J MATER SCI LETT, V13, P629, DOI 10.1007/BF00271216; Sanada K., 2008, J SOLID MECH MAT ENG, V2, P1517, DOI DOI 10.1299/JMMP.2.1517; Sanada K, 2008, OPEN MECH ENG J, V2, P97, DOI 10.2174/1874155X00802010097; Zhao LG, 2006, COMPOS SCI TECHNOL, V66, P36, DOI 10.1016/j.compscitech.2005.06.002	14	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	JUN	2015	49	14					1765	1776		10.1177/0021998314540193		12	Materials Science, Composites	Materials Science	CI6LP	WOS:000354871100008		
J	Chen, DD; Arakawa, K; Jiang, SY				Chen, Dingding; Arakawa, Kazuo; Jiang, Shiyi			Novel joints developed from partially un-moulded carbon-fibre-reinforced laminates	JOURNAL OF COMPOSITE MATERIALS			English	Article						Laminate; adhesive joints; strength; scanning electron microscopy; resin transfer moulding	LAP BONDED JOINTS; COMPOSITE-MATERIALS; FAILURE PREDICTION; SINGLE; ADHESIVE; STRENGTH; STRESS; CFRP	Two novel joints made from partially un-moulded carbon-fibre-reinforced plastic plates were designed to increase the strength of joints between carbon-fibre-reinforced plastic parts. In the partially un-moulded plate, a portion of the fabric stack was moulded with resin while the rest of the fabric stack remained dry. The plate was made using a manufacturing process developed from vacuum-assisted resin-transfer moulding. A new double-lap joint sandwiched a normal carbon-fibre-reinforced plastic plate between the dry fabric layers of a partially un-moulded plate. The other laminated joint overlapped the dry fabric layers of two partially un-moulded plates. Both joints were moulded by resin transfer. Tensile testing indicated that the two novel joints were more than twice as strong as a classical double-lap joint and half as strong as a normal, joint-free carbon-fibre-reinforced plastic plate. Additionally, the joints may potentially be made much stronger by modifying their shapes. In particular, the laminated joint may be made as strong as a normal carbon-fibre-reinforced plastic plate because its strength is determined by the fibre-matrix interface rather than the bondline strength, which is a key factor in determining the strength of a normal carbon-fibre-reinforced plastic plate.	[Chen, Dingding; Jiang, Shiyi] Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan; [Chen, Dingding] Natl Univ Def Technol, Coll Basic Educ Commanding Officers, Changsha, Hunan, Peoples R China; [Arakawa, Kazuo] Kyushu Univ, Appl Mech Res Inst, Fukuoka 8168580, Japan	Chen, DD (reprint author), Kyushu Univ, Interdisciplinary Grad Sch Engn Sci, Fukuoka 8168580, Japan.	dingding.mail@163.com	Kyushu, RIAM/F-4018-2015		Japan Society for the Promotion of Science [26630496]; Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University	This work was partly supported by a research grant from the Japan Society for the Promotion of Science (#26630496) and by the Collaborative Research Program of the Research Institute for Applied Mechanics, Kyushu University.	Al-Zubaidy H, 2012, COMPOS STRUCT, V94, P510, DOI 10.1016/j.compstruct.2011.08.018; Lobel T, 2013, COMPOS STRUCT, V106, P453, DOI 10.1016/j.compstruct.2013.06.020; Quaresimin M, 2006, INT J FATIGUE, V28, P1166, DOI 10.1016/j.ijfatigue.2006.02.005; O'Dwyer DJ, 2013, COMPOS SCI TECHNOL, V86, P61, DOI 10.1016/j.compscitech.2013.06.013; Feih S, 2005, INT J ADHES ADHES, V25, P47, DOI 10.1016/j.ijadhadh.2004.02.005; Zhao XL, 2007, ENG STRUCT, V29, P1808, DOI 10.1016/j.engstruct.2006.10-006; Wang ZY, 2009, COMPOS STRUCT, V89, P589, DOI 10.1016/j.compstruct.2008.11.002; Liu FR, 2013, COMPOS SCI TECHNOL, V83, P54, DOI 10.1016/j.compscitech.2013.04.018; da Silva LFM, 2007, INT J ADHES ADHES, V27, P227, DOI 10.1016/j.ijadhadh.2006.04.001; Fawzia S, 2006, COMPOS STRUCT, V75, P156, DOI 10.1016/j.compstruct.2006.04.038; Egan B, 2013, COMPOS PART A-APPL S, V53, P97, DOI 10.1016/j.compositesa.2013.05.006; Chen DD, 2012, J COMPOS MATER, V46, P3297, DOI 10.1177/0021998312437800; Choi I, 2013, COMPOS PART A-APPL S, V48, P1, DOI 10.1016/j.compositesa.2013.01.003; Dvorak GJ, 2001, COMPOS SCI TECHNOL, V61, P1123, DOI 10.1016/S0266-3538(01)00012-4; Fawzia S., 2005, ADV STEEL CONSTR, V1, P17; Greenhalgh ES, 2009, WOODHEAD PUBL MATER, P1; Jeong K-W, 2013, J COMPOS MATER, V48, P1417; Katnam KB, 2011, INT J ADHES ADHES, V31, P679, DOI 10.1016/j.ijadhadh.2011.06.013; Katnam KB, 2013, J ADHESION, V89, P486, DOI 10.1080/00218464.2013.759432; Kim HS, 2006, COMPOS PART A-APPL S, V37, P1708, DOI 10.1016/j.compositesa.2005.09.015; Kim KS, 2008, COMPOS STRUCT, V82, P513, DOI 10.1016/j.compstruct.2007.02.005; LEE DG, 1993, COMPOS STRUCT, V25, P313, DOI 10.1016/0263-8223(93)90178-S; Park SW, 2009, J ADHES SCI TECHNOL, V23, P619, DOI 10.1163/156856108X386959; Quaresimin M, 2006, COMPOS SCI TECHNOL, V66, P647, DOI 10.1016/j.compscitech.2005.07.036; Quaresimin M, 2006, COMPOS SCI TECHNOL, V66, P176, DOI 10.1016/j.compscitech.2005.04.026; Sun Z, 2012, COMPOS PART A-APPL S, V43, P2059, DOI 10.1016/j.compositesa.2012.06.002; Tang JH, 2013, COMPOS SCI TECHNOL, V86, P18, DOI 10.1016/j.compscitech.2013.06.018	27	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0021-9983	1530-793X		J COMPOS MATER	J. Compos Mater.	JUN	2015	49	14					1777	1786		10.1177/0021998314540195		10	Materials Science, Composites	Materials Science	CI6LP	WOS:000354871100009		
J	Dann, HM; Fredin, SM; Cotanch, KW; Grant, RJ; Kokko, C; Ji, P; Fujita, K				Dann, H. M.; Fredin, S. M.; Cotanch, K. W.; Grant, R. J.; Kokko, C.; Ji, P.; Fujita, K.			Effects of corn-based reduced-starch diets using alternative carbohydrate sources on performance of lactating Holstein cows	JOURNAL OF DAIRY SCIENCE			English	Article						feeding behavior; lactation; ruminal measures; starch	NEUTRAL DETERGENT FIBER; HIGH-MOISTURE CORN; PHYSICALLY EFFECTIVE FIBER; DAIRY-COWS; NUTRIENT DIGESTIBILITY; RUMINAL ACIDOSIS; MILK-PRODUCTION; PURINE DERIVATIVES; EXOGENOUS AMYLASE; FEED-INTAKE	Increases in grain prices have led to renewed interest in feeding reduced-starch diets to lactating dairy cows. An experiment was conducted to determine the effects of altering carbohydrate sources and reducing dietary starch on lactational performance, feeding behavior, and ruminal measures of Holstein dairy cows. Fifteen multiparous cows (6 ruminally cannulated) were blocked and assigned to 1 of 5 squares and used in a replicated 3 x 3 Latin square design with 21-d periods. Cows were fed 1 of 3 experimental diets: a control diet containing 20% brown midrib corn silage, 20% conventional corn silage, and 10% hay crop silage (CON); a reduced-starch high-forage diet containing 53% brown midrib corn silage and 10% hay crop silage (HFOR); and a reduced-starch diet containing the same forages as CON with partial replacement of corn meal by nonforage fiber sources (HNFFS). The CON diet contained (% of dry matter) 26.0% starch and 34.7% neutral detergent fiber (NDF), whereas the HFOR and HNFFS diets contained 21.4 or 21.3% starch and 38.3 or 38.0% NDF, respectively. Dry matter intake tended to be greater for cows fed the CON diet (28.2 kg/d) compared with those fed the HFOR diet (27.2 kg/d). Dry matter intake for cows fed the HNFFS diet was intermediate (27.7 kg/d). Milk yield was greater for cows fed the CON diet (51.6 kg/d) compared with those fed the HFOR diet (48.4 kg/d), but milk fat content tended to increase for cows fed the HFOR diet (3.98%) compared with those fed the CON diet (3.66%). Consequently, fat-corrected and solids-corrected milk yields were unaffected by dietary treatments. Total chewing, eating, and rumination times were similar across all dietary treatments. Rumination time per kilogram of DM was greatest for the HFOR diet, intermediate for the HNFFS diet, and least for the CON diet, whereas rumination time per kilogram of NDF was greatest for the CON diet and least for the HNFFS diet. Mean ruminal pH, NH3-N (mg/dL), and total volatile fatty acid concentrations (mM) were similar across all dietary treatments. Molar proportion of ruminal acetate (mol/100 mol) was increased for cows fed the HFOR diet compared with cows fed the CON diet. Microbial N yield measured by urinary purine derivatives was unaffected by dietary treatment. Reduced-starch diets containing greater amounts of high quality, highly digestible forage or nonforage fiber sources in place of corn meal resulted in similar fat-corrected or solids-corrected milk yield for high-producing dairy cows in the short term.	[Dann, H. M.; Fredin, S. M.; Cotanch, K. W.; Grant, R. J.; Kokko, C.; Ji, P.] William H Miner Agr Res Inst, Chazy, NY 12921 USA; [Fujita, K.] Zen Noh Natl Federat Agr Cooperat Associat, Tokyo 1006832, Japan	Dann, HM (reprint author), William H Miner Agr Res Inst, Chazy, NY 12921 USA.	Dann@whminer.com			Zen-Noh National Federation of Agricultural Cooperative Associations (Tokyo, Japan)	The authors thank the Zen-Noh National Federation of Agricultural Cooperative Associations (Tokyo, Japan) for funding the experiment and the research and farm staff of the William H. Miner Agricultural Research Institute (Chazy, NY) for care and feeding of the cows.	Akins MS, 2014, J DAIRY SCI, V97, P917, DOI 10.3168/jds.2013-6756; Allen MS, 1997, J DAIRY SCI, V80, P1447; [Anonymous], 2012, OFFICIAL METHODS ANA; FERGUSON JD, 1994, J DAIRY SCI, V77, P2695; TYRRELL HF, 1965, J DAIRY SCI, V48, P1215, DOI 10.3168/jds.S0022-0302(65)88430-2; Dann HM, 2008, J DAIRY SCI, V91, P663, DOI 10.3168/jds.2007-0521; SHOOK GE, 1993, VET CLIN N AM-FOOD A, V9, P563; Agle M, 2010, J DAIRY SCI, V93, P4211, DOI 10.3168/jds.2009-2977; Zebeli Q, 2012, J DAIRY SCI, V95, P1041, DOI 10.3168/jds.2011-4421; STERN MD, 1994, J DAIRY SCI, V77, P2762; Dohme F, 2008, J DAIRY SCI, V91, P3554, DOI 10.3168/jds.2008-1264; Allen MS, 2000, J DAIRY SCI, V83, P1598; Ferraretto LF, 2011, J DAIRY SCI, V94, P1490, DOI 10.3168/jds.2010-3736; Lammers BP, 1996, J DAIRY SCI, V79, P922; CHANEY AL, 1962, CLIN CHEM, V8, P130; Voelker JA, 2003, J DAIRY SCI, V86, P3562, DOI 10.3168/jds.S0022-0302(03)73961-7; Krause KM, 2006, ANIM FEED SCI TECH, V126, P215, DOI 10.1016/j.anifeedsci.2005.08.004; Weiss WP, 2011, J DAIRY SCI, V94, P2492, DOI 10.3168/jds.2010-3766; Penner GB, 2006, J DAIRY SCI, V89, P2132; Grant RJ, 1997, J DAIRY SCI, V80, P1438; RICHARDS CJ, 1995, ANIM FEED SCI TECH, V55, P35, DOI 10.1016/0377-8401(95)00790-T; Hall MB, 1999, J SCI FOOD AGR, V79, P2079, DOI 10.1002/(SICI)1097-0010(199912)79:15<2079::AID-JSFA502>3.3.CO;2-Q; Valadares RFD, 1999, J DAIRY SCI, V82, P2686; BAUER ML, 1995, J ANIM SCI, V73, P3445; BERNARD JK, 1991, J DAIRY SCI, V74, P991; Bradford BJ, 2012, J DAIRY SCI, V95, P4735, DOI 10.3168/jds.2012-5393; CHEN XB, 1990, BRIT J NUTR, V63, P131, DOI 10.1079/BJN19900098; Cotanch K., 2008, P CORN NUTR C FEED M, P77; Dann HM, 2014, J DAIRY SCI, V97, P7151, DOI 10.3168/jds.2014-8341; Fredin SM, 2015, J DAIRY SCI, V98, P554, DOI 10.3168/jds.2014-8592; Gencoglu H, 2010, J DAIRY SCI, V93, P723, DOI 10.3168/jds.2009-2673; Hall MB, 2009, J AOAC INT, V92, P42; KRISHNAMOORTHY U, 1982, J DAIRY SCI, V65, P217; Mertens D. R., 2002, DETERMINATION STARCH; Mertens DR, 1997, J DAIRY SCI, V80, P1463; NRC, 2001, NUTR REQ DAIR CATTL; Oba M, 2000, J DAIRY SCI, V83, P1350; Taylor CC, 2005, J DAIRY SCI, V88, P1425; USDA-NASS (National Agricultural Statistics Service), 2014, PRIC REC CORN MONTH; Van Soest P. J., 1970, AGR HDB, V379; VANSOEST PJ, 1991, J DAIRY SCI, V74, P3583; Voelker JA, 2003, J DAIRY SCI, V86, P3542, DOI 10.3168/jds.S0022-0302(03)73959-9	42	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0022-0302	1525-3198		J DAIRY SCI	J. Dairy Sci.	JUN	2015	98	6					4041	4054		10.3168/jds.2014-9078		14	Agriculture, Dairy & Animal Science; Food Science & Technology	Agriculture; Food Science & Technology	CI3GB	WOS:000354634600045		
J	Kanzaki, H; Shinohara, F; Itohiya-Kasuya, K; Ishikawa, M; Nakamura, Y				Kanzaki, H.; Shinohara, F.; Itohiya-Kasuya, K.; Ishikawa, M.; Nakamura, Y.			Nrf2 Activation Attenuates Both Orthodontic Tooth Movement and Relapse	JOURNAL OF DENTAL RESEARCH			English	Article						osteoclast; oxidative stress; reactive oxygen species (ROS); heme oxygenase-1 (HO-1); bone resorption; Kelch-like ECH-associated protein 1 (Keap1)	OSTEOCLAST DIFFERENTIATION; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; ALVEOLAR BONE; GENE-TRANSFER; EXPRESSION; TISSUE; IDENTIFICATION; RESORPTION; INDUCTION	During orthodontic tooth movement, osteoclasts resorb the alveolar bone at the compress side of periodontium. Reactive oxygen species (ROS) works as intracellular signaling molecules of RANKL during osteoclastogenesis, although ROS has cytotoxicity against cells such as lipid oxidation. To deal with oxidative stress, cells have a defense system that is scavenging ROS by augmented antioxidative stress enzymes via transcriptional regulation with nuclear factor E2-related factor 2 (Nrf2). Previously, we reported that augmented antioxidative stress enzymes by Nrf2-gene transfer inhibited bone destruction. In the present study, we examined the effects of Nrf2 activation on osteoclastogenesis and, thereby, orthodontic tooth movement and orthodontic relapse. Mouse macrophage cell line RAW264.7 cells were used as osteoclast progenitor cells and stimulated with recombinant RANKL (100 ng/mL) with or without Nrf2 activator sulforaphane (SFN) and epigallocatechin gallate (EGCG) or ROS scavenger catechin. Osteoclastogenesis, resorption activity, and osteoclast marker gene expression were examined. Intracellular ROS was analyzed by flow cytometry. Maxillary first molars of C57BL6 male mice were moved palatally with 0.012-inch NiTi wire (100-mN force); SFN or EGCG was injected into the palatal gingiva once a week; and phosphate buffered saline was injected on the contralateral side. Tooth movement was monitored using a stone model with precise impression, and the amount of the tooth movement was compared among groups. SFN and EGCG significantly, but catechin weakly, inhibited RANKL-mediated osteoclastogenesis in vitro. Western blot analysis revealed that SFN and EGCG augmented the nuclear translocation of Nrf2 and the expression of anti-oxidative stress enzymes such as HO-1, although catechin did not. SFN and EGCG significantly, but catechin weakly, attenuated the intracellular ROS. Finally, animal experiment revealed that both SFN and EGCG successfully inhibited the orthodontic tooth movement. Additionally, SFN inhibited the relapse. These results suggest that Nrf2 activation could be therapeutic target for the anchorage enforcement in orthodontic treatment and pharmacologic retention against relapse.	[Kanzaki, H.] Tohoku Univ Hosp, Maxillooral Disorders, Sendai, Miyagi, Japan; [Kanzaki, H.; Itohiya-Kasuya, K.; Ishikawa, M.; Nakamura, Y.] Tsurumi Univ, Sch Dent Med, Dept Orthodont, Yokohama, Kanagawa 2308501, Japan; [Shinohara, F.] Tohoku Univ, Grad Sch Dent, Oral Microbiol, Sendai, Miyagi 980, Japan	Kanzaki, H (reprint author), Tsurumi Univ, Sch Dent Med, Dept Orthodont, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	kanzaki-h@tsurumi-u.ac.jp			JSPS [23689081, 25670841]; Nestle Nutrition Council, Japan	This research was supported by the Grants-in-Aid for Scientific Research from JSPS (23689081 and 25670841) and the Nestle Nutrition Council, Japan. The authors acknowledge the Center of Research Instruments, Institute of Development, Aging and Cancer, Tohoku University, for generous permission to use the experimental instruments. Finally, the authors give their heartfelt appreciation to the experimental reagent companies and instrument companies for their various support in the rehabilitation from the damage caused by the Tohoku earthquake on March 11, 2011. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Hayashi R, 2013, FREE RADICAL BIO MED, V61, P333, DOI 10.1016/j.freeradbiomed.2013.04.008; Motohashi H, 2004, TRENDS MOL MED, V10, P549, DOI 10.1016/j.molmed.2004.09.003; Kanzaki H, 2004, J DENT RES, V83, P920; Kaipatur NR, 2013, AM J ORTHOD DENTOFAC, V144, P557, DOI 10.1016/j.ajodo.2013.06.015; Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; Karras JC, 2009, AM J ORTHOD DENTOFAC, V136, P843, DOI 10.1016/j.ajodo.2007.11.035; Kanzaki H, 2006, GENE THER, V13, P678, DOI 10.1038/sj.gt.3302707; Artaud-Macari E, 2013, ANTIOXID REDOX SIGN, V18, P66, DOI 10.1089/ars.2011.4240; Takeshita S, 2000, J BONE MINER RES, V15, P1477, DOI 10.1359/jbmr.2000.15.8.1477; Hyeon S, 2013, FREE RADICAL BIO MED, V65, P789, DOI 10.1016/j.freeradbiomed.2013.08.005; Carvalho RD, 2013, ARCH ORAL BIOL, V58, P50, DOI 10.1016/j.archoralbio.2012.04.020; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexer.2004.07.035; [Anonymous], 2002, MEPHAS ONLINE STAT A; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Kanzaki H, 2014, FREE RADICAL BIO MED, V77, P239, DOI 10.1016/j.freeradbiomed.2014.09.006; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; Braun S, 2002, MOL CELL BIOL, V22, P5492, DOI 10.1128/MCB.22.15.5492-5505.2002; HELFRICH MH, 1987, CELL TISSUE RES, V249, P125, DOI 10.1007/BF00215426; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Demirovic D, 2011, BIOGERONTOLOGY, V12, P437, DOI 10.1007/s10522-011-9326-7; Udagawa N, 1999, BONE, V25, P517, DOI 10.1016/S8756-3282(99)00210-0; BRUDVIK P, 1994, EUR J ORTHODONT, V16, P265; DAVIDOVITCH Z, 1988, DENT CLIN N AM, V32, P411; INAOKA T, 1995, BIOCHEM BIOPH RES CO, V206, P89, DOI 10.1006/bbrc.1995.1013; FACINO RM, 1994, ARZNEIMITTEL-FORSCH, V44-1, P592; Mönkkönen J, 1987, Toxicol Appl Pharmacol, V89, P287; STOREY E, 1973, AM J ORTHOD DENTOFAC, V63, P292, DOI 10.1016/0002-9416(73)90353-9; Vig GV, 2005, ORTHODONTICS CURRENT, P213; Wild AC, 1998, BIOCHEM J, V332, P373; Wu HP, 2009, J BONE MINER RES, V24, P871, DOI [10.1359/jbmr.081239, 10.1359/JBMR.081239]	32	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	JUN	2015	94	6					787	794		10.1177/0022034515577814		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI6JX	WOS:000354866300005		
J	Umeda, M; Terao, F; Miyazaki, K; Yoshizaki, K; Takahashi, I				Umeda, M.; Terao, F.; Miyazaki, K.; Yoshizaki, K.; Takahashi, I.			MicroRNA-200a Regulates the Development of Mandibular Condylar Cartilage	JOURNAL OF DENTAL RESEARCH			English	Article						proliferation; differentiation; chondrogenesis; type II collagen; Sox9; PCNA	CRANIAL NEURAL CREST; EXTRACELLULAR-MATRIX; NEONATAL MICE; DIFFERENTIATION; EXPRESSION; CHONDROGENESIS; COLLAGENS; TGFBR2; GROWTH; JOINT	Mandibular condylar cartilage (MCC) is classified as secondary cartilage, the histologic structure of which is unique from that of primary cartilage. MicroRNA (miRNA) is a small noncoding RNA that binds to the messenger RNA (mRNA) target to repress its translation and plays an important role in cell differentiation, proliferation, and death. Microarray analysis revealed that miR-200a was characteristically expressed during embryonic development. We hypothesized that miR-200a may be involved in regulating the formation of cartilage during MCC growth. We investigated the function of miR-200a by transfecting an inhibitor or mimic into MCC organ and cell cultures. A histologic examination revealed the localized inhibitory effects of the miR-200a mimic and widespread enhancing effects of the inhibitor on chondrocytic differentiation in the MCC organ culture system. An immunohistochemical examination and gene expression analysis demonstrated that the miR-200a inhibitor enhanced chondrogenesis, while the mimic had the opposite effect by enhancing cell proliferation. Quantitative reverse transcription polymerase chain reaction analysis revealed that miR-200a downregulated the gene expression of chondrocyte markers. Moreover, transfection of the miR-200a mimic into ATDC5 cells repressed the formation of the cartilaginous matrix. These results indicate that miR-200a contributed to chondrogenesis in developing MCC by controlling proliferation and differentiation in MCC cells.	[Umeda, M.] Kyushu Univ Hosp, Dept Orthodont, Fukuoka 812, Japan; [Terao, F.; Yoshizaki, K.; Takahashi, I.] Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped, Fukuoka 8128582, Japan; [Miyazaki, K.] Kyushu Univ, Grad Sch Dent, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped, Fukuoka 8128582, Japan	Takahashi, I (reprint author), Kyushu Univ, Fac Dent Sci, Div Oral Hlth Growth & Dev, Sect Orthodont & Dentofacial Orthoped,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	takahashi@dent.kyushu-u.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [22659376, 24390462, 24792293]	This study was supported by Grants-in Aid from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (No. 22659376, 24390462, and 24792293). We appreciate the technical support obtained from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. The authors declare no potential conflicts of interest with respect to the authorship and/or publication of this article.	Ali AM, 1996, J ORAL PATHOL MED, V25, P78, DOI 10.1111/j.1600-0714.1996.tb00197.x; Dunn W, 2009, ARTHRITIS RHEUM, V60, P2333, DOI 10.1002/art.24678; Dong SW, 2012, BIOCHEM BIOPH RES CO, V418, P587, DOI 10.1016/j.bbrc.2012.01.075; Hyun S, 2009, CELL, V139, P1096, DOI 10.1016/j.cell.2009.11.020; Kim D, 2010, J BIOL CHEM, V285, P26900, DOI 10.1074/jbc.M110.115105; Terao F, 2011, DEV BIOL, V350, P337, DOI 10.1016/j.ydbio.2010.11.029; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Miyaki S, 2010, GENE DEV, V24, P1173, DOI 10.1101/gad.1915510; SILBERMANN M, 1987, J ANAT, V151, P169; Zhong N, 2012, OSTEOARTHR CARTILAGE, V20, P593, DOI 10.1016/j.joca.2012.03.002; MILAM SB, 1991, J ORAL MAXIL SURG, V49, P381, DOI 10.1016/0278-2391(91)90376-W; EVANKO SP, 1993, ARCH BIOCHEM BIOPHYS, V307, P153, DOI 10.1006/abbi.1993.1574; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Soubani O, 2012, CARCINOGENESIS, V33, P1563, DOI 10.1093/carcin/bgs189; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; Bartel DP, 2004, NAT REV GENET, V5, P396, DOI 10.1038/nrg1328; Chai Y, 2000, DEVELOPMENT, V127, P1671; TROWELL OA, 1959, EXP CELL RES, V16, P118, DOI 10.1016/0014-4827(59)90201-0; Miyaki S, 2009, ARTHRITIS RHEUM, V60, P2723, DOI 10.1002/art.24745; Yang J, 2011, FEBS LETT, V585, P2992, DOI 10.1016/j.febslet.2011.08.013; Itoh T, 2009, J BIOL CHEM, V284, P19272, DOI 10.1074/jbc.M109.014001; Elson-Schwab I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013176; MIZOGUCHI I, 1993, ANAT EMBRYOL, V187, P9; MIZOGUCHI I, 1990, HISTOCHEMISTRY, V93, P593, DOI 10.1007/BF00272201; OKA K, 2008, DEV BIOL, V303, P303; Oka S, 2007, MECH DEVELOP, V124, P409, DOI 10.1016/j.mod.2007.02.003; SILBERMANN M, 1990, J ANAT, V170, P11; SOLURSH M, 1981, DEV BIOL, V86, P471, DOI 10.1016/0012-1606(81)90205-0; TAKAHASHI I, 1995, ANAT REC, V241, P328, DOI 10.1002/ar.1092410306; Terao F, 2007, INTERFACE ORAL HLTH, V2007, P179; Yamada S, 2002, J DENT RES, V81, P711	32	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0022-0345	1544-0591		J DENT RES	J. Dent. Res.	JUN	2015	94	6					795	802		10.1177/0022034515577411		8	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI6JX	WOS:000354866300006		
J	Min, JH; Inaba, D; Kwon, HK; Chung, JH; Kim, BI				Min, J. H.; Inaba, D.; Kwon, H. K.; Chung, J. H.; Kim, B. I.			Evaluation of penetration effect of resin infiltrant using optical coherence tomography	JOURNAL OF DENTISTRY			English	Article						Resin infiltrant (RI); Early caries lesion (EC); Optical coherence tomography (OCT); Confocal laser scanning microscopy (CLSM)	NATURAL CARIES LESIONS; IN-VITRO; SWEPT-SOURCE; FLUORESCENCE TECHNIQUES; TOOTH DEMINERALIZATION; CLINICAL MEASUREMENT; REFRACTIVE-INDEX; ENAMEL LESIONS; MINERAL LOSS; PS-OCT	Objective: The aims of this in vitro study were to investigate whether optical coherence tomography (OCT) could analyze infiltration of resin infiltrant (RI) into early dental caries (EC), and to confirm the correlation between the results of OCT and confocal laser scanning microscopy (CLSM) for evaluation of RI infiltration into EC. Methods: Sound bovine permanent teeth were used to produce sixty specimens by making two windows on the teeth. Each 20 specimens were demineralized for 20, 30, and 40 days, and the RI was treated on one of the windows. As a result, the images of the fifty-two specimens were taken by OCT and CLSM. The demineralized lesion depth (LDOCT and LDCLSM) and the infiltrated depth of RI into lesion (IDOCT and IDCLSM) obtained from the OCT and the CLSM were analyzed. The correlations between the LDOCT and the LDCLSM, and between the IDOCT and the IDCLSM, were analyzed by Pearson correlation and intra-class correlation. Also, Bland-Altman plot was constructed to assess the agreement between the IDOCT and the IDCLSM, and the IDOCT divided by refractive index of RI and the IDCLSM. Results: The Pearson correlation coefficient and intra-class correlation of 0.75 and 0.83 (95% CI: 0.71-0.91) respectively were confirmed between the LDOCT and the LDCLSM (p < 0.001), and 0.59 and 0.71 (95% CI: 0.50-0.84) respectively were observed between the IDOCT and the IDCLSM (p < 0.001). The lower bias was confirmed in Bland-Altman plot between adjusted IDOCT and the IDCLSM than between the IDOCT and the IDCLSM. Conclusion: The OCT was the promising quantitative evaluation method for RI penetrated into EC. Clinical significance: The OCT would be used as a nondestructive and real-time evaluation method for RI penetrated into EC on clinical procedure. (C) 2015 Elsevier Ltd. All rights reserved.	[Min, J. H.; Kwon, H. K.; Kim, B. I.] Yonsei Univ, Coll Dent, Oral Sci Res Inst, Dept Prevent Dent & Publ Oral Hlth,BK Plus Projec, Seoul 120749, South Korea; [Min, J. H.] Cheongju Univ, Coll Hlth Sci, Dept Dent Hyg, Cheongju, South Korea; [Inaba, D.] Iwate Med Univ, Sch Dent, Dept Prevent Dent, Morioka, Iwate 020, Japan; [Chung, J. H.] LG Elect Inc, Future IT R&D Lab, Seoul, South Korea	Kim, BI (reprint author), Yonsei Univ, Coll Dent, Dept Prevent Dent & Publ Oral Hlth, 50 Yonsei Ro, Seoul 120749, South Korea.	drkbi@yuhs.ac		Kim, Baek Il/0000-0001-8234-2327	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2062505]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2062505).	Amaechi Bennett T, 2004, Oral Health Prev Dent, V2, P377; Nakagawa H, 2013, J DENT, V41, P80, DOI 10.1016/j.jdent.2012.10.007; Paris S, 2007, J DENT RES, V86, P662; Meyer-Lueckel H, 2012, CARIES RES, V46, P544, DOI 10.1159/000341807; Pollock CL, 2011, CLIN REHABIL, V25, P693, DOI 10.1177/0269215510397394; Lynch RJM, 2007, CARIES RES, V41, P257, DOI 10.1159/000101914; Hariri I, 2013, CARIES RES, V47, P18, DOI 10.1159/000342416; Paris S, 2010, J DENT RES, V89, P823, DOI 10.1177/0022034510369289; Makishi P, 2011, J DENT, V39, P316, DOI 10.1016/j.jdent.2011.01.011; Paris S, 2009, MICROSC RES TECHNIQ, V72, P489, DOI 10.1002/jemt.20701; Monteiro GQM, 2011, DENT MATER, V27, pE213, DOI 10.1016/j.dental.2011.08.400; Wojtkowski M, 2002, OPT LETT, V27, P1415, DOI 10.1364/OL.27.001415; Hariri I, 2012, J DENT, V40, P387, DOI 10.1016/j.jdent.2012.01.017; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Meyer-Lueckel H, 2008, CARIES RES, V42, P117, DOI 10.1159/000118631; WHITE DJ, 1987, CARIES RES, V21, P228; Lee C, 2009, DENT MATER, V25, P721, DOI [10.1016/j.dental.2008.11.014, 10.1016/j.denta1.2008.11.014]; Le MH, 2010, LASER SURG MED, V42, P62, DOI 10.1002/lsm.20862; Choma MA, 2003, OPT EXPRESS, V11, P2183, DOI 10.1364/OE.11.002183; Paris S, 2010, CARIES RES, V44, P47, DOI 10.1159/000275917; Can AM, 2008, LASER SURG MED, V40, P342, DOI 10.1002/lsm.20633; Shimada Y, 2012, DENT MATER J, V31, P409, DOI 10.4012/dmj.2011-244; Koizumi H, 2008, AM J OPHTHALMOL, V145, P509, DOI 10.1016/j.ajo.2007.10.014; Ando M, 1997, CARIES RES, V31, P125; Braz AKS, 2011, DENT MATER, V27, pE60, DOI 10.1016/j.dental.2010.11.010; Leitgeb R, 2003, OPT EXPRESS, V11, P889, DOI 10.1364/OE.11.000889; Colston BW, 1998, APPL OPTICS, V37, P3582; Meyer-Lueckel H, 2008, J DENT RES, V87, P1112; Natsume Y, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3600448; Louie T, 2010, LASER SURG MED, V42, P738, DOI 10.1002/lsm.21013; Paris S, 2007, DENT MATER, V23, P742, DOI 10.1016/j.dental.2006.06.029; BLAND JM, 1986, LANCET, V1, P307; Lehtinen J, 2008, DENT MATER, V24, P1324, DOI 10.1016/j.dental.2008.02.012; Paris S, 2013, J Dent, V41 Suppl 5, pe28, DOI 10.1016/j.jdent.2013.04.003; Paris S, 2006, CARIES RES, V40, P124, DOI 10.1159/000091058; Paris S, 2013, J DENT, V41, P543, DOI 10.1016/j.jdent.2013.03.006; Stookey George K, 2005, Dent Clin North Am, V49, P753, DOI 10.1016/j.cden.2005.05.009; Stookey GK, 2005, DENT CLIN N AM, V49, pvi; Yim HK, 2014, J DENT, V42, P588, DOI 10.1016/j.jdent.2014.01.015	39	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0300-5712	1879-176X		J DENT	J. Dent.	JUN	2015	43	6					720	725		10.1016/j.jdent.2015.03.006		6	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CI6MK	WOS:000354873400012		
J	Takagi, S; Tokumitsu, H; Sanada, S				Takagi, Satoshi; Tokumitsu, Hideyuki; Sanada, Shigeru			Relationship Between the Contrast Effects of Raw Data Projection Images from Three-Dimensional Digital Subtraction Angiography and the Optimal Volume Rendering Parameters	JOURNAL OF DIGITAL IMAGING			English	Article						Two-dimensional (2D) digital subtraction angiography (DSA); Three-dimensional (3D) DSA; Volume rendering (VR); Rendering parameters; Contrast effect	CT ANGIOGRAPHY; INTRACRANIAL ANEURYSMS; ROTATIONAL ANGIOGRAPHY; COMPUTED-TOMOGRAPHY; FUSION; DSA	Volume rendering (VR) is a technique commonly used for the reconstruction of three-dimensional (3D) digital subtraction angiography (DSA) images, and the rendering parameters greatly affect the characteristics of the 3D image. This study aimed to test whether the optimal VR parameters for 3D DSA could be estimated from the contrast effects in rotational two-dimensional (2D) DSA images acquired using 3D DSA. Simulated blood vessels filled with various concentrations of contrast medium were scanned, and the 3D DSA data sets were reconstructed. The syngo AX vessel analysis software that was able to analyze 3D DSA VR image was used for objective measures. Raw data projection images of the 3D DSA data sets in which the mean diameter was calculated as a true value by the software at nine different thresholds for vessel segmentation were selected. In each image set, five images of all 133 rotational 2D DSA images were selected, and the contrast-enhanced area was extracted using a region-growing algorithm. Mean values and standard deviations of each contrast-enhanced area were calculated, and as the thresholds for vessel segmentation of the software increased by 500 every time, significant differences were observed in the mean values (P < 0.01). This optimal threshold can be applied to the window settings of the VR technique. Therefore, the optimal VR parameters for 3D DSA may be determined by analyzing the contrast effects of the raw data projection images, and user-dependent over- and underestimations of 3D DSA VR images also may be prevented.	[Takagi, Satoshi; Tokumitsu, Hideyuki] Natl Def Med Coll Hosp, Radiol Ctr, Tokorozawa, Saitama 3598513, Japan; [Sanada, Shigeru] Kanazawa Univ, Grad Sch Med Sci, Div Hlth Sci, Kanazawa, Ishikawa 9200942, Japan	Takagi, S (reprint author), Natl Def Med Coll Hosp, Radiol Ctr, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	rt.stakagi@gmail.com					Ide S, 2012, ACAD RADIOL, V19, P1345, DOI 10.1016/j.acra.2012.07.001; Leng LZ, 2013, WORLD NEUROSURG, V79, P504, DOI 10.1016/j.wneu.2011.09.008; Fishman EK, 2006, RADIOGRAPHICS, V26, P905, DOI 10.1148/rg.263055186; Serafin Z, 2012, NEURORADIOLOGY, V54, P1253, DOI 10.1007/s00234-012-1030-z; Golitz P, 2012, J NEUROSURG, V117, P29, DOI 10.3171/2012.3.JNS111895; Calhoun PS, 1999, RADIOGRAPHICS, V19, P745; Kucukay F, 2012, EUR J RADIOL, V81, P2794, DOI 10.1016/j.ejrad.2011.10.006; Lu L, 2012, RADIOLOGY, V262, P605, DOI 10.1148/radiol.11110486; Wong SC, 2012, ACAD RADIOL, V19, P701, DOI 10.1016/j.acra.2012.02.012; Luo B, 2011, STROKE, V42, P745, DOI 10.1161/STROKEAHA.110.593517; Sun G, 2012, ACAD RADIOL, V19, P281, DOI 10.1016/j.acra.2011.11.004; Lescher S, 2014, AM J NEURORADIOL, V35, P1942, DOI 10.3174/ajnr.A3981	12	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0897-1889	1618-727X		J DIGIT IMAGING	J. Digit. Imaging	JUN	2015	28	3					368	372		10.1007/s10278-014-9745-5		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI7NL	WOS:000354950200016		
J	Mori, S; Hirano, K; Nakano, M; Muramatsu, T; Tsukahara, R; Ito, Y; Ishimori, H				Mori, Shinsuke; Hirano, Keisuke; Nakano, Masatsugu; Muramatsu, Toshiya; Tsukahara, Reiko; Ito, Yoshiaki; Ishimori, Hiroshi			Intravascular Ultrasound Measurements After Drug-Eluting Stent Placement in Femoropopliteal Lesions: Determining Predictors of Restenosis	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						endovascular therapy; drug-eluting stent; superficial femoral artery; stenosis; intravascular ultrasound; restenosis	SUPERFICIAL FEMORAL-ARTERY; NITINOL STENT; SINGLE-ARM; FOLLOW-UP; ANGIOGRAPHIC RESTENOSIS; ENDOVASCULAR THERAPY; BALLOON ANGIOPLASTY; POPLITEAL ARTERIES; EUROPEAN-SOCIETY; SAPHENOUS-VEIN	Purpose: To investigate the relationship between postprocedure intravascular ultrasound (IVUS) findings and restenosis after placement of drug-eluting stents (DES) for femoropopliteal lesions. Methods: Between July 2012 and May 2013, DES were placed in 64 patients with 88 de novo femoropopliteal lesions. In 40 patients (mean age 74.29.4 years; 27 men), DES were placed in 50 lesions under IVUS guidance, and restenosis was monitored for 1 year. All patients were symptomatic (Rutherford 2-6), and 17 patients (43%) suffered from critical limb ischemia. IVUS findings after stenting were compared for patients with vs without restenosis, which was defined as a peak systolic velocity ratio >2.4 on duplex ultrasonography or >50% diameter stenosis on angiography. Results: Ten patients (14 lesions) developed restenosis, while 30 patients (36 lesions) did not. There were no significant differences in the frequency of diabetes or dialysis between the 2 groups. Female patients were predominant in the restenosis group (p<0.003). There were no significant differences of the percentage of TransAtlantic Inter-Society Consensus C/D lesions or stent edge dissection. Multivariate analysis indicated that cilostazol use [odds ratio (OR) 0.13; p=0.046], distal lumen cross-sectional area (CSA) (OR 0.86; p=0.035), and axial symmetry index (OR 0.60; p=0.045) were independent predictors of restenosis. Using receiver operator characteristic analysis, the best cutoff values of the distal lumen CSA and axial symmetry index for predicting restenosis were 17.1 cm(2) and 0.6, respectively. Conclusion: IVUS guidance of DES placement in femoropopliteal lesions can offer useful predictors of restenosis at 1 year. The utility of distal lumen CSA and the axial symmetry index in the prediction of restenosis after femoropopliteal DES placement should be confirmed in a larger cohort.	[Mori, Shinsuke; Hirano, Keisuke; Nakano, Masatsugu; Muramatsu, Toshiya; Tsukahara, Reiko; Ito, Yoshiaki; Ishimori, Hiroshi] Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Yokohama, Kanagawa 2300012, Japan	Mori, S (reprint author), Saiseikai Yokohama City Eastern Hosp, Dept Cardiol, Tsurumi Ku, 3-6-1 Shimosueyoshi, Yokohama, Kanagawa 2300012, Japan.	hello_morisun@yahoo.co.jp					AbuRahma AF, 1999, SURGERY, V126, P594, DOI 10.1067/msy.2099.99942; Iida O, 2013, CIRCULATION, V127, P2307, DOI 10.1161/CIRCULATIONAHA.112.000711; Witzenbichler B, 2014, CIRCULATION, V129, P463, DOI 10.1161/CIRCULATIONAHA.113.003942; Mintz GS, 2001, J AM COLL CARDIOL, V37, P1478, DOI 10.1016/S0735-1097(01)01175-5; Laird JR, 2010, CIRC-CARDIOVASC INTE, V3, P267, DOI 10.1161/CIRCINTERVENTIONS.109.903468; Hong MK, 2006, EUR HEART J, V27, P1305, DOI 10.1093/eurheartj/ehi882; Bosiers M, 2013, J CARDIOVASC SURG, V54, P115; Werk M, 2012, CIRC-CARDIOVASC INTE, V5, P831, DOI 10.1161/CIRCINTERVENTIONS.112.971630; Micari A, 2012, JACC-CARDIOVASC INTE, V5, P331, DOI 10.1016/j.jcin.2011.11.010; Doi H, 2009, JACC-CARDIOVASC INTE, V2, P1269, DOI 10.1016/j.jcin.2009.10.005; Krankenberg H, 2007, CIRCULATION, V116, P285, DOI 10.1161/CIRCULATIONAHA.107.689141; Bangalore S, 2012, CIRCULATION, V125, P2873, DOI 10.1161/CIRCULATIONAHA.112.097014; Soga Y, 2009, J AM COLL CARDIOL, V53, P48, DOI 10.1016/j.jacc.2008.09.020; RANKE C, 1992, ULTRASOUND MED BIOL, V18, P433, DOI 10.1016/0301-5629(92)90082-L; Miki K, 2013, CIRC J, V77, P1543, DOI 10.1253/circj.CJ-12-1182; Fitzgerald PJ, 2000, CIRCULATION, V102, P523; Zeller T, 2014, J ENDOVASC THER, V21, P359, DOI 10.1583/13-4630MR.1; Soga Y, 2010, J VASC SURG, V52, P608, DOI 10.1016/j.jvs.2010.03.050; Dake MD, 2011, CIRC-CARDIOVASC INTE, V4, P495, DOI 10.1161/CIRCINTERVENTIONS.111.962324; Hoffmann R, 1996, CIRCULATION, V94, P1247; Dake MD, 2013, J AM COLL CARDIOL, V61, P2417, DOI 10.1016/j.jacc.2013.03.034; Cheneau E, 2003, CIRCULATION, V108, P43, DOI 10.1161/01.CIR.0000078636.71728.40; Soga Y, 2011, J VASC SURG, V54, P1058, DOI 10.1016/j.jvs.2011.03.286; Tendera M, 2011, EUR HEART J, V32, P2851, DOI 10.1093/eurheartj/ehr211; Johnson WC, 2000, J VASC SURG, V32, P268, DOI 10.1067/mva.2000.106944; Dake MD, 2011, J ENDOVASC THER, V18, P613, DOI 10.1583/11-3560.1; Han RO, 2001, AM J CARDIOL, V88, P253, DOI 10.1016/S0002-9149(01)01636-8; Iida Osamu, 2014, J Endovasc Ther, V21, P485, DOI 10.1583/14-4721R.1; Klinkert P, 2003, J VASC SURG, V37, P149, DOI 10.1067/mva.2002.86; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Schillinger M, 2006, NEW ENGL J MED, V354, P1879, DOI 10.1056/NEJMoa051303; Schulte KL, 2012, J ENDOVASC THER, V19, P774, DOI 10.1583/JEVT-12-3861MR.1; Soga Yoshimitsu, 2011, Cardiovasc Interv Ther, V26, P38, DOI 10.1007/s12928-010-0032-1; Stabile E, 2012, J AM COLL CARDIOL, V60, P1739, DOI 10.1016/j.jacc.2012.07.033; Stefanini GG, 2013, NEW ENGL J MED, V368, P254, DOI 10.1056/NEJMra1210816; Suzuki K, 2011, CIRC J, V75, P939, DOI 10.1253/circj.CJ-10-1029; Takagi K, 2013, INT J CARDIOL, V168, P3791, DOI 10.1016/j.ijcard.2013.06.004; Tofigh A Mohammadi, 2007, Int J Surg, V5, P109	38	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	JUN	2015	22	3					341	349		10.1177/1526602815580308		9	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CI6KU	WOS:000354868700015		
J	Higashimori, A; Yokoi, Y				Higashimori, Akihiro; Yokoi, Yoshiaki			Use of Indigo Carmine Angiography to Qualitatively Assess Adequate Distal Perfusion After Endovascular Revascularization in Critical Limb Ischemia	JOURNAL OF ENDOVASCULAR THERAPY			English	Article						critical limb ischemia; ulcer; endovascular repair; occlusion; revascularization; balloon angioplasty; angiography; dye; indigo carmine	INDOCYANINE GREEN ANGIOGRAPHY; QUANTITATIVE-EVALUATION; POPLITEAL ARTERY; ANGIOPLASTY; THERAPY	Purpose: To report a novel technique to visualize the efficacy of revascularization in critical limb ischemia patients with ischemic foot ulcers. Technique: An 80-year-old man was admitted with nonhealing ulcers on his left second toe and lateral border of the foot owing to in-stent restenosis of the left popliteal artery. After dilation of the popliteal in-stent restenosis, below-the-knee angiography revealed that the anterior tibial artery (ATA) was occluded, the posterior tibial artery was hypoplastic, and the peroneal artery was enlarged, with 2 plantar arteries. To evaluate the foot circulation before performing additional procedures, a 4-F multipurpose catheter was advanced into the peroneal artery, and 5 mL of indigo carmine was injected. Immediately, the patient's second toe and lateral border ulcers were dyed blue. We concluded that sufficient blood flow had been obtained to the ulcerated area by balloon angioplasty alone, so the procedure was terminated. The ulcers completely healed at 1 month. Conclusion: Indigo carmine angiography provides visual information on foot perfusion, yielding new insights into microcirculation and helping to determine the effectiveness of treatment and procedure endpoint.	[Higashimori, Akihiro; Yokoi, Yoshiaki] Kishiwada Tokushukai Hosp, Dept Cardiol, Kishiwada, Osaka 5968522, Japan	Higashimori, A (reprint author), Kishiwada Tokushukai Hosp, Dept Cardiol, 4-27-1 Kamori, Kishiwada, Osaka 5968522, Japan.	akihiro.higashimori@tokushukai.jp					Iida O, 2010, CATHETER CARDIO INTE, V75, P830, DOI 10.1002/ccd.22319; Neville RF, 2009, ANN VASC SURG, V23, P367, DOI 10.1016/j.avsg.2008.08.022; Braun JD, 2013, J VASC SURG, V57, P1213, DOI 10.1016/j.jvs.2012.10.113; Feiring AJ, 2004, J AM COLL CARDIOL, V44, P2307, DOI 10.1016/j.jacc.2004.09.037; KOROGI Y, 1995, AM J ROENTGENOL, V165, P1269; KIM D, 1989, ANN SURG, V210, P776, DOI 10.1097/00000658-198912000-00014; Alexandrescu VA, 2008, J ENDOVASC THER, V15, P580, DOI 10.1583/08-2460.1; Igari K, 2013, EUR J VASC ENDOVASC, V46, P460, DOI 10.1016/j.ejvs.2013.07.016; Day CP, 2006, CLIN RADIOL, V61, P696, DOI 10.1016/j.crad.2006.03.014; Dorros G, 2001, CIRCULATION, V104, P2057, DOI 10.1161/hc4201.097943; Romiti M, 2008, J VASC SURG, V47, P975, DOI 10.1016/j.jvs.2008.01.005; Attinger CE, 2006, PLAST RECONSTR SURG, V117, P261; Gousse A E, 2000, Urology, V56, P508, DOI 10.1016/S0090-4295(00)00650-6; Kawarada O, 2014, CIRC-CARDIOVASC INTE, V7, P684, DOI 10.1161/CIRCINTERVENTIONS.113.001311; Kil SW, 2009, CARDIOVASC INTER RAD, V32, P233, DOI 10.1007/s00270-008-9460-z; Saito R, 2004, INT J UROL, V11, P171, DOI 10.1111/j.1442-2042.2003.00769.x; TAYLOR GI, 1987, BRIT J PLAST SURG, V40, P113, DOI 10.1016/0007-1226(87)90185-8; Terasaki H, 2013, ANN VASC SURG, V27, P1154, DOI 10.1016/j.avsg.2013.02.011; Utsunomiya M, 2012, J VASC SURG, V55, P113, DOI 10.1016/j.jvs.2011.08.001	19	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1526-6028	1545-1550		J ENDOVASC THER	J. Endovascular Ther.	JUN	2015	22	3					352	355		10.1177/1526602815582208		4	Surgery; Peripheral Vascular Disease	Surgery; Cardiovascular System & Cardiology	CI6KU	WOS:000354868700017		
J	Yoshiba, N; Yoshiba, K; Ohkura, N; Takei, E; Edanami, N; Oda, Y; Hosoya, A; Nakamura, H; Okiji, T				Yoshiba, Nagako; Yoshiba, Kunihiko; Ohkura, Naoto; Takei, Erika; Edanami, Naoki; Oda, Youhei; Hosoya, Akihiro; Nakamura, Hiroaki; Okiji, Takashi			Correlation between Fibrillin-1 Degradation and mRNA Downregulation and Myofibroblast Differentiation in Cultured Human Dental Pulp Tissue	JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY			English	Article						alpha-SMA; culture; fibrillin-1; human dental pulp; pSmad2; 3	SMOOTH-MUSCLE ACTIN; LATENT TGF-BETA; MATRIX METALLOPROTEINASES; MARFAN-SYNDROME; TRANSFORMING GROWTH-FACTOR-BETA-1; IN-VITRO; EXPRESSION; CELLS; COMPLEX; MICROFIBRILS	Myofibroblasts and extracellular matrix are important components in wound healing. Alpha-smooth muscle actin (-SMA) is a marker of myofibroblasts. Fibrillin-1 is a major constituent of microfibrils and an extracellular-regulator of TGF-1, an important cytokine in the transdifferentiation of resident fibroblasts into myofibroblasts. To study the correlation between changes in fibrillin-1 expression and myofibroblast differentiation, we examined alterations in fibrillin-1 and -SMA expression in organotypic cultures of dental pulp in vitro. Extracted healthy human teeth were cut to 1-mm-thick slices and cultured for 7 days. In intact dental pulp, fibrillin-1 was broadly distributed, and -SMA was observed in pericytes and vascular smooth muscle cells. After 7 days of culture, immunostaining for fibrillin-1 became faint concomitant with a downregulation in its mRNA levels. Furthermore, fibroblasts, odontoblasts and Schwann cells were immunoreactive for -SMA with a significant increase in -SMA mRNA expression. Double immunofluorescence staining was positive for pSmad2/3, central mediators of TGF- signaling, and -SMA. The administration of inhibitors for extracellular matrix proteases recovered fibrillin-1 immunostaining; moreover, fibroblasts lost their immunoreactivity for -SMA along with a downregulation in -SMA mRNA. These findings suggest that the expression of -SMA is TGF-1 dependent, and fibrillin-1 degradation and downregulation might be implicated in the differentiation of myofibroblasts in dental pulp wound healing.	[Yoshiba, Nagako; Yoshiba, Kunihiko; Ohkura, Naoto; Takei, Erika; Edanami, Naoki; Okiji, Takashi] Niigata Univ, Grad Sch Med & Dent Sci, Div Cariol Operat Dent & Endodont, Dept Oral Hlth Sci,Course Oral Life Sci, Niigata 9518514, Japan; [Oda, Youhei] Niigata Univ, Grad Sch Med & Dent Sci, Div Reconstruct Surg Oral & Maxillofacial Reg, Dept Oral Hlth Sci,Course Oral Life Sci, Niigata 9518514, Japan; [Hosoya, Akihiro; Nakamura, Hiroaki] Matsumoto Dent Univ, Dept Oral Histol, Inst Dent Sci, Nagano, Japan	Yoshiba, N (reprint author), Niigata Univ, Grad Sch Med & Dent Sci, Div Cariol Operat Dent & Endodont, Dept Oral Hlth Sci,Course Oral Life Sci,Chuo Ku, 2-5274 Gakkocho Dori, Niigata 9518514, Japan.	nagako@dent.niigata-u.ac.jp			Ministry of Education, Science, Sports and Culture, Japan [22592119, 25462952, 24592863]	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Science, Sports and Culture, Japan (no. 22592119, 25462952, and 24592863).	Carta L, 2009, J BIOL CHEM, V284, P5630, DOI 10.1074/jbc.M806962200; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Yoshiba K, 1996, J DENT RES, V75, P1590; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Ramirez F, 2004, PHYSIOL GENOMICS, V19, P151, DOI 10.1152/physiolgenomics.00092.2004; Hinz B, 2001, MOL BIOL CELL, V12, P2730; Chen XP, 2009, CELL ADHES MIGR, V3, P337, DOI 10.4161/cam.3.4.9338; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Buscemi L, 2011, CURR BIOL, V21, P2046, DOI 10.1016/j.cub.2011.11.037; Abdollah S, 1997, J BIOL CHEM, V272, P27678, DOI 10.1074/jbc.272.44.27678; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Bullard KM, 1999, ANN SURG, V230, P260, DOI 10.1097/00000658-199908000-00017; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Sloan AJ, 1999, ARCH ORAL BIOL, V44, P149, DOI 10.1016/S0003-9969(98)00106-X; Vaughan MB, 2000, EXP CELL RES, V257, P180, DOI 10.1006/excr.2000.4869; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Suda N, 2009, J EXP ZOOL PART B, V312B, P503, DOI 10.1002/jez.b.21278; Real C, 2005, INT J DEV BIOL, V49, P151, DOI 10.1387/ijdb.041940cr; Wisithphrom K, 2006, J ENDODONT, V32, P853, DOI 10.1016/j.joen.2006.03.017; Serini G, 1999, EXP CELL RES, V250, P273, DOI 10.1006/excr.1999.4543; Higashiyama R, 2011, J INVEST DERMATOL, V131, P529, DOI 10.1038/jid.2010.314; Chaponnier C, 2004, J PATHOL, V204, P386, DOI 10.1002/path.1635; Kinner B, 2002, EXP CELL RES, V278, P72, DOI 10.1006/excr.2002.5561; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Li P, 2007, J APPL PHYSIOL, V102, P390, DOI 10.1152/japplphysiol.00468.2006; Ashworth JL, 1999, BIOCHEM J, V340, P171, DOI 10.1042/0264-6021:3400171; Bolar N, 2012, CURR OPIN PEDIATR, V24, P498, DOI 10.1097/MOP.0b013e3283557d4c; De Coster PJ, 2004, PEDIATR DENT, V26, P535; He WX, 2004, ARCH ORAL BIOL, V49, P911, DOI 10.1016/j.archoralbio.2004.05.005; KIELTY CM, 1994, FEBS LETT, V351, P85, DOI 10.1016/0014-5793(94)00818-3; Lorena D, 2004, LAB INVEST, V84, P203, DOI 10.1038/labinvest.3700023; Magloire H, 1996, J DENT RES, V75, P1971; Palosaari H, 2003, EUR J ORAL SCI, V111, P117, DOI 10.1034/j.1600-0722.2003.00026.x; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1; Sloan Alastair J, 2012, Open Dent J, V6, P214, DOI 10.2174/1874210601206010214; Sloan A J, 2001, Adv Dent Res, V15, P63; Stark B, 2001, BRAIN RES, V913, P47, DOI 10.1016/S0006-8993(01)02757-3; Yoshiba N, 2012, HISTOCHEM CELL BIOL, V138, P583, DOI 10.1007/s00418-012-0978-4; Yoshiba N, 2013, JPN J CONSERV DENT, V56, P161; Yoshiba N, 2012, J ENDODONT, V38, P177, DOI 10.1016/j.joen.2011.09.016	43	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0022-1554	1551-5044		J HISTOCHEM CYTOCHEM	J. Histochem. Cytochem.	JUN	2015	63	6					438	448		10.1369/0022155415580622		11	Cell Biology	Cell Biology	CI8FZ	WOS:000355007000005		
J	Ueda, O; Tanaka, S; Nagasawa, Z; Hanaki, H; Shobuike, T; Miyamoto, H				Ueda, O.; Tanaka, S.; Nagasawa, Z.; Hanaki, H.; Shobuike, T.; Miyamoto, H.			Development of a novel matrix-assisted laser desorption/ionization time-of-flight mass spectrum (MALDI-TOF-MS)-based typing method to identify meticillin-resistant Staphylococcus aureus clones	JOURNAL OF HOSPITAL INFECTION			English	Article						Matrix-assisted laser desorption/ionization time-of-flight; Meticillin-resistant; Staphylococcus aureus; Typing; Pulsed-field gel electrophoresis; Phage open-reading frame typing	DESORPTION IONIZATION-TIME; ROUTINE IDENTIFICATION; RAPID IDENTIFICATION; SUBSPECIES LEVELS; SPECTROMETRY; BACTERIA; DIFFERENTIATION	Background: Mass spectrum analysis enables species-and subspecies-level identification, and can be used as an epidemiological tool in outbreak management. However, its reliability at clonal level has yet to be established. Aim: To establish a matrix-assisted laser desorption/ionization time-of-flight mass-spectrum-based method that enables bacterial clone identification with accuracy equivalent to pulsed-field gel-electrophoresis/phage open-reading frame typing (PFGE/POT). Methods: Meticillin-resistant Staphylococcus aureus (MRSA) was used in this study. Mass spectra were obtained from a standard strain of S. aureus (ATCC29213) and 57 clinically isolated strains, categorized according to POT. Peaks associated with MRSA clone identification (N = 67) were extracted. Based on this peak information, the feasibility of MRSA clone identification was examined by cluster analysis. Findings: In addition to the 58 strains used for peak extraction, mass spectrum analysis of 24 clinically isolated outbreak strains revealed that peak data could be used for successful identification of clones. These typing results were fully consistent with the PFGE and POT results. Conclusion: This novel method enables simple and rapid typing with accuracy equivalent to PFGE/POT. This method would be suited to rapid outbreak analysis, offering accurate information to combat infectious diseases. (C) 2015 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.	[Ueda, O.] Siemens Healthcare Diagnost KK, MM Business Unit, Microbiol Grp, Tokyo, Japan; [Tanaka, S.] Saga Univ Hosp, Dept Clin Lab, Saga, Japan; [Nagasawa, Z.] Int Univ Hlth & Welf, Sch Hlth Sci Fukuoka, Dept Med Technol & Sci, Fukuoka, Japan; [Hanaki, H.] Kitasato Univ, Res Ctr Antiinfect Drugs, Tokyo, Japan; [Ueda, O.; Shobuike, T.; Miyamoto, H.] Saga Univ, Fac Med, Dept Pathol & Microbiol, Saga 8498501, Japan	Miyamoto, H (reprint author), Saga Univ, Fac Med, Dept Pathol & Microbiol, Div Microbiol, 5-1-1 Nabeshima, Saga 8498501, Japan.	miyamoth@cc.saga-u.ac.jp					Seibold E, 2010, J CLIN MICROBIOL, V48, P1061, DOI 10.1128/JCM.01953-09; Saffert RT, 2011, J CLIN MICROBIOL, V49, P887, DOI 10.1128/JCM.01890-10; Alispahic M, 2010, J MED MICROBIOL, V59, P295, DOI 10.1099/jmm.0.016576-0; Harris SR, 2013, LANCET INFECT DIS, V13, P130, DOI 10.1016/S1473-3099(12)70268-2; Marko DC, 2012, J CLIN MICROBIOL, V50, P2034, DOI 10.1128/JCM.00330-12; Price JR, 2013, J HOSP INFECT, V83, P14, DOI 10.1016/j.jhin.2012.10.003; Cherkaoui A, 2010, J CLIN MICROBIOL, V48, P1169, DOI 10.1128/JCM.01881-09; Dubois D, 2010, J CLIN MICROBIOL, V48, P941, DOI 10.1128/JCM.00413-09; Diep BA, 2013, LANCET INFECT DIS, V13, P99, DOI 10.1016/S1473-3099(12)70276-1; Harris LG, 2010, INT J ARTIF ORGANS, V33, P568; Strommenger B, 2008, J CLIN MICROBIOL, V46, P574, DOI 10.1128/JCM.01599-07; Bizzini A, 2010, J CLIN MICROBIOL, V48, P1549, DOI 10.1128/JCM.01794-09; Saleeb PG, 2011, J CLIN MICROBIOL, V49, P1790, DOI 10.1128/JCM.02135-10; Verroken A, 2010, J CLIN MICROBIOL, V48, P4015, DOI 10.1128/JCM.01234-10; Wolters M, 2011, INT J MED MICROBIOL, V301, P64, DOI 10.1016/j.ijmm.2010.06.002; Healy M, 2005, J CLIN MICROBIOL, V43, P199, DOI 10.1128/JCM.43.1.199-207.2005; Seng P, 2009, CLIN INFECT DIS, V49, P543, DOI 10.1086/600885; Dieckmann R, 2008, APPL ENVIRON MICROB, V74, P7767, DOI 10.1128/AEM.01402-08; Bernardo K, 2002, PROTEOMICS, V2, P747, DOI 10.1002/1615-9861(200206)2:6<747::AID-PROT747>3.0.CO;2-V; Matsuyama Y, 2011, BIOCLINICA, V26, P51; Mellmann A, 2008, J CLIN MICROBIOL, V46, P1946, DOI 10.1128/JCM.00157-08; Moliner C, 2010, J MED MICROBIOL, V59, P273, DOI 10.1099/jmm.0.014100-0; Moriyama Hidehiko, 2012, Kansenshogaku Zasshi, V86, P115; Sato S, 2008, J MED TECHNOL, V57, P229; Suzuki M, 2011, CHEM TIMES, V3, P16; Uki N, 2013, CLIN PATHOL, V61, P224; Valerie EJ, 2000, J MED MICROBIOL, V49, P295; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967	28	2	2	W B SAUNDERS CO LTD	LONDON	32 JAMESTOWN RD, LONDON NW1 7BY, ENGLAND	0195-6701	1532-2939		J HOSP INFECT	J. Hosp. Infect.	JUN	2015	90	2					147	155		10.1016/j.jhin.2014.11.025		9	Infectious Diseases	Infectious Diseases	CI2KX	WOS:000354577600009		
J	Inoue, Y; Takahashi, M				Inoue, Yoshiyuki; Takahashi, Masafumi			Comment on "Radiation Exposure Induces Inflammasome Pathway Activation in Immune Cells"	JOURNAL OF IMMUNOLOGY			English	Letter									[Inoue, Yoshiyuki; Takahashi, Masafumi] Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, Shimotsuke, Tochigi 3290498, Japan	Takahashi, M (reprint author), Jichi Med Univ, Ctr Mol Med, Div Inflammat Res, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	masafumi2@jichi.ac.jp					Inoue Y, 2014, J IMMUNOL, V192, P4342, DOI 10.4049/jimmunol.1302039; Mizushina Y, 2015, J BIOL CHEM, V290, P5065, DOI 10.1074/jbc.M114.603217; Francois A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/123241; Stoecklein VM, 2015, J IMMUNOL, V194, P1178, DOI 10.4049/jimmunol.1303051	4	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUN 1	2015	194	11					5039	5039		10.4049/jimmunol.1500381		1	Immunology	Immunology	CI6WS	WOS:000354905300001		
J	Miki, H; Nakahashi-Oda, C; Sumida, T; Shibuya, A				Miki, Haruka; Nakahashi-Oda, Chigusa; Sumida, Takayuki; Shibuya, Akira			Involvement of CD300a Phosphatidylserine Immunoreceptor in Aluminum Salt Adjuvant-Induced Th2 Responses	JOURNAL OF IMMUNOLOGY			English	Article							IMMUNOGLOBULIN-LIKE RECEPTORS; INFLAMMATORY DENDRITIC CELLS; AIRWAY INFLAMMATION; INHIBITORY RECEPTOR; APOPTOTIC CELLS; LUNG-DISEASE; MAST-CELL; MAIR-I; IDENTIFICATION; DIFFERENTIATION	Aluminum salt (alum) has been widely used for vaccinations as an adjuvant. Alum not only enhances immunogenicity but also induces Th2 cell immune responses. However, the mechanisms of how alum enhances Th2 cell immune responses have been controversial. In an experimental allergic airway inflammation model, in which alum in conjunction with OVA Ag was i.p. injected for immunization, we found that apoptotic cells and inflammatory dendritic cells (iDC) expressing CD300a, an inhibitory immunoreceptor for phosphatidylserine (PS), significantly increased in number in the peritoneal cavity after the immunization. In contrast, apoptotic cells and iDCs were scarcely observed in the peritoneal cavity after injection of OVA alone. In CD300a-deficient mice, eosinophil infiltration in bronchoalveolar lavage fluid, serum IgE levels, and airway hyperreactivity were significantly decreased after immunization with alum plus OVA compared with wild-type mice. In vitro, iDCs purified from CD300a-deficient mice after the immunization induced significantly less IL-4 production from OT-II naive CD4(+) T cells after coculture with OVA Ag. CD300a expressed on iDCs bound PS on apoptotic cells in the peritoneal cavity after injection of OVA plus alum. Blocking CD300a interaction with PS by injection of a neutralizing anti-CD300a Ab resulted in inhibition of the development of allergic airway inflammation. These results suggest that CD300a is involved in alum-induced Th2 skewing.	[Miki, Haruka; Nakahashi-Oda, Chigusa; Shibuya, Akira] Univ Tsukuba, Fac Med, Dept Immunol, Tsukuba, Ibaraki 3058575, Japan; [Miki, Haruka; Sumida, Takayuki] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan; [Shibuya, Akira] Univ Tsukuba, Life Sci Ctr Tsukuba Adv Res Alliance, Tsukuba, Ibaraki 3058575, Japan; [Shibuya, Akira] Univ Tsukuba, Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Tsukuba, Ibaraki 3058575, Japan	Shibuya, A (reprint author), Univ Tsukuba, Inst Basic Med Sci, T1-1-1 Ten Nohdai, Tsukuba, Ibaraki 3058575, Japan.	ashibuya@md.tsukuba.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Yotsumoto K, 2003, J EXP MED, V198, P223, DOI 10.1084/jem.20021825; Knight DA, 2003, RESPIROLOGY, V8, P432, DOI 10.1046/j.1440-1843.2003.00493.x; Simhadri VR, 2012, BLOOD, V119, P2799, DOI 10.1182/blood-2011-08-372425; Serbina NV, 2008, ANNU REV IMMUNOL, V26, P421, DOI 10.1146/annurev.immunol.26.021607.090326; Phythian-Adams AT, 2010, J EXP MED, V207, P2089, DOI 10.1084/jem.20100734; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Nakahashi-Oda C, 2012, J EXP MED, V209, P1493, DOI 10.1084/jem.20120096; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Demento SL, 2009, VACCINE, V27, P3013, DOI 10.1016/j.vaccine.2009.03.034; Bachelet I, 2005, J IMMUNOL, V175, P7989; Karra L, 2009, CURR OPIN IMMUNOL, V21, P708, DOI 10.1016/j.coi.2009.09.010; Jankovic D, 2004, J IMMUNOL, V173, P2419; Marichal T, 2011, NAT MED, V17, P996, DOI 10.1038/nm.2403; Kool M, 2008, J EXP MED, V205, P869, DOI 10.1084/jem.20071087; Kumagai H, 2003, BIOCHEM BIOPH RES CO, V307, P719, DOI 10.1016/S0006-291X(03)01245-2; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Kuroda E, 2011, IMMUNITY, V34, P514, DOI 10.1016/j.immuni.2011.03.019; Bucchieri F, 2002, AM J RESP CELL MOL, V27, P179; Mori A, 2012, EUR J IMMUNOL, V42, P2709, DOI 10.1002/eji.201242372; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Munitz A, 2006, J ALLERGY CLIN IMMUN, V118, P1082, DOI 10.1016/j.jaci.2006.07.041; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Borrego F, 2013, BLOOD, V121, P1951, DOI 10.1182/blood-2012-09-435057; Goto N, 1997, VACCINE, V15, P1364, DOI 10.1016/S0264-410X(97)00054-6; Dominguez PM, 2010, IMMUNOL REV, V234, P90, DOI 10.1111/j.0105-2896.2009.00876.x; Flach TL, 2011, NAT MED, V17, P479, DOI 10.1038/nm.2306; Cantoni C, 1999, EUR J IMMUNOL, V29, P3148, DOI 10.1002/(SICI)1521-4141(199910)29:10<3148::AID-IMMU3148>3.0.CO;2-L; Hammad H, 2010, J EXP MED, V207, P2097, DOI 10.1084/jem.20101563; Nakahashi-Oda C, 2012, BIOCHEM BIOPH RES CO, V417, P646, DOI 10.1016/j.bbrc.2011.12.025; Marrack P, 2009, NAT REV IMMUNOL, V9, P287, DOI 10.1038/nri2510; Bachelet I, 2006, J ALLERGY CLIN IMMUN, V117, P1314, DOI 10.1016/j.jaci.2006.04.031; Chung DH, 2003, J IMMUNOL, V171, P6541; Clark GJ, 2000, TISSUE ANTIGENS, V55, P101, DOI 10.1034/j.1399-0039.2000.550201.x; Das J, 2001, NAT IMMUNOL, V2, P45, DOI 10.1038/83158; Doherty TA, 2009, AM J PHYSIOL-LUNG C, V296, pL229, DOI 10.1152/ajplung.90543.2008; Juncadella IJ, 2013, NATURE, V493, P547, DOI 10.1038/nature11714; McCubbrey AL, 2013, CHEST, V143, P1750, DOI 10.1378/chest.12-2413; Okoshi Y, 2005, INT IMMUNOL, V17, P65, DOI 10.1093/intimm/dxh187; Sabato V, 2014, J ALLERGY CLIN IMMUN, V134, P734, DOI 10.1016/j.jaci.2014.03.029; Shibuya Akira, 2009, Immune Netw, V9, P41, DOI 10.4110/in.2009.9.2.41	41	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUN 1	2015	194	11					5069	5076		10.4049/jimmunol.1402915		8	Immunology	Immunology	CI6WS	WOS:000354905300008		
J	Miyake, Y; Oh-hora, M; Yamasaki, S				Miyake, Yasunobu; Oh-hora, Masatsugu; Yamasaki, Sho			C-Type Lectin Receptor MCL Facilitates Mincle Expression and Signaling through Complex Formation	JOURNAL OF IMMUNOLOGY			English	Article							ACTIVATING RECEPTOR; PATHOGENIC FUNGUS; DENDRITIC CELLS; PROTECTIVE ROLE; CORD FACTOR; RECOGNITION; IDENTIFICATION; MALASSEZIA; PNEUMONIA; RESPONSES	C-type lectin receptors expressed in APCs are recently defined pattern recognition receptors that play a crucial role in immune responses against pathogen-associated molecular patterns. Among pathogen-associated molecular patterns, cord factor (trehalose-6,6'-dimycolate [TDM]) is the most potent immunostimulatory component of the mycobacterial cell wall. Two C-type lectin receptors, macrophage-inducible C-type lectin (Mincle) and macrophage C-type lectin (MCL), are required for immune responses against TDM. Previous studies indicate that MCL is required for TDM-induced Mincle expression. However, the mechanism by which MCL induces Mincle expression has not been fully understood. In this study, we demonstrate that MCL interacts with Mincle to promote its surface expression. After LPS or zymosan stimulation, MCL-deficient bone marrow-derived dendritic cells (BMDCs) had a lower level of Mincle protein expression, although mRNA expression was comparable with wild-type BMDCs. Meanwhile, BMDCs from MCL transgenic mice showed an enhanced level of Mincle expression on the cell surface. MCL was associated with Mincle through the stalk region and this region was necessary and sufficient for the enhancement of Mincle expression. This interaction appeared to be mediated by the hydrophobic repeat of MCL, as substitution of four hydrophobic residues within the stalk region with serine (MCL4S) abolished the function to enhance the surface expression of Mincle. MCL4S mutant failed to restore the defective TDM responses in MCL-deficient BMDCs. These results suggest that MCL positively regulates Mincle expression through protein-protein interaction via its stalk region, thereby magnifying Mincle-mediated signaling.	[Miyake, Yasunobu; Oh-hora, Masatsugu; Yamasaki, Sho] Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan; [Yamasaki, Sho] Chiba Univ, Med Mycol Res Ctr, Div Mol Immunol, Chiba 2608673, Japan	Yamasaki, S (reprint author), Kyushu Univ, Div Mol Immunol, Med Inst Bioregulat, Fukuoka 8128582, Japan.	yamasaki@bioreg.kyushu-u.ac.jp			Funding Program for Next Generation World-Leading Researchers; Japan Society for the Promotion of Science; Takeda Science Foundation	This work was supported by the Funding Program for Next Generation World-Leading Researchers (to S.Y.), a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (to S.Y. and Y.M.), and by a grant from the Takeda Science Foundation (to S.Y. and Y.M.).	Ishikawa E, 2009, J EXP MED, V206, P2879, DOI 10.1084/jem.20091750; Lobato-Pascual A, 2013, EUR J IMMUNOL, V43, P3167, DOI 10.1002/eji.201343752; NIWA H, 1991, GENE, V108, P193; Yamasaki S, 2008, NAT IMMUNOL, V9, P1179, DOI 10.1038/ni.1651; Hernanz-Falcon P, 2009, EUR J IMMUNOL, V39, P507, DOI 10.1002/eji.200838687; Zhao XQ, 2014, J BIOL CHEM, V289, P30052, DOI 10.1074/jbc.M114.588574; Behler F, 2012, J IMMUNOL, V189, P3121, DOI 10.4049/jimmunol.1201399; Arce I, 2004, EUR J IMMUNOL, V34, P210, DOI 10.1002/eji.200324230; Wells CA, 2008, J IMMUNOL, V180, P7404; Park SY, 1998, J CLIN INVEST, V102, P1229, DOI 10.1172/JCI3256; Furukawa A, 2013, P NATL ACAD SCI USA, V110, P17438, DOI 10.1073/pnas.1312649110; Flornes LM, 2004, IMMUNOGENETICS, V56, P506, DOI 10.1007/s00251-004-0714-x; Yamasaki S, 2009, P NATL ACAD SCI USA, V106, P1897, DOI 10.1073/pnas.0805177106; Killick KE, 2013, CELL MICROBIOL, V15, P1484, DOI 10.1111/cmi.12161; Figdor CG, 2002, NAT REV IMMUNOL, V2, P77, DOI 10.1038/nri723; Graham LM, 2012, J BIOL CHEM, V287, P25964, DOI 10.1074/jbc.M112.384164; Zhu LL, 2013, IMMUNITY, V39, P324, DOI 10.1016/j.immuni.2013.05.017; Takahara K, 2002, INT IMMUNOL, V14, P433, DOI 10.1093/intimm/14.5.433; Meyer-Wentrup F, 2007, J IMMUNOL, V178, P154; Ishikawa T, 2013, CELL HOST MICROBE, V13, P477, DOI 10.1016/j.chom.2013.03.008; Schoenen H, 2010, J IMMUNOL, V184, P2756, DOI 10.4049/jimmunol.0904013; BEAVIL AJ, 1992, P NATL ACAD SCI USA, V89, P753, DOI 10.1073/pnas.89.2.753; Cummings R.D., 2009, ESSENTIALS GLYCOBIOL, P403; Lee WB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002614; Matsumoto M, 1999, J Immunol, V163, P5039; Miyake Y, 2013, IMMUNITY, V38, P1050, DOI 10.1016/j.immuni.2013.03.010; Schoenen H, 2014, J IMMUNOL, V193, P3664, DOI 10.4049/jimmunol.1301593; Sharma A, 2014, J INFECT DIS, V209, P1837, DOI 10.1093/infdis/jit820; Steichen AL, 2013, J LEUKOCYTE BIOL, V94, P393, DOI 10.1189/jlb.1212622; Toyonaga K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088747; Zhang PN, 2001, J BIOL CHEM, V276, P19862, DOI 10.1074/jbc.M100597200	31	2	2	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUN 1	2015	194	11					5366	5374		10.4049/jimmunol.1402429		9	Immunology	Immunology	CI6WS	WOS:000354905300037		
J	Kimura, T; Endo, S; Inui, M; Saitoh, SI; Miyake, K; Takai, T				Kimura, Toshifumi; Endo, Shota; Inui, Masanori; Saitoh, Shin-Ichiroh; Miyake, Kensuke; Takai, Toshiyuki			Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses	JOURNAL OF IMMUNOLOGY			English	Article							TOLL-LIKE RECEPTORS; MYELIN-ASSOCIATED GLYCOPROTEIN; CYCLIC GMP-AMP; NEURITE OUTGROWTH; PIR-B; AXONAL REGENERATION; MESSENGER-RNA; CYTOSOLIC DNA; TRAFFICKING; MEMBRANE	TLRs are distributed in their characteristic cellular or subcellular compartments to efficiently recognize specific ligands and to initiate intracellular signaling. Whereas TLRs recognizing pathogen-associated lipids or proteins are localized to the cell surface, nucleic acid-sensing TLRs are expressed in endosomes and lysosomes. Several endoplasmic reticulum (ER)-resident proteins are known to regulate the trafficking of TLRs to the specific cellular compartments, thus playing important roles in the initiation of innate immune responses. In this study, we show that an ER-resident protein, Nogo-B (or RTN4-B), is necessary for immune responses triggered by nucleic acid-sensing TLRs, and that a newly identified Nogo-B-binding protein (glucosyltransferases, Rablike GTPase activators and myotubularins [GRAM] domain containing 4 [GRAMD4]) negatively regulates the responses. Production of inflammatory cytokines in vitro by macrophages stimulated with CpG-B oligonucleotides or polyinosinic: polycytidylic acid was attenuated in the absence of Nogo-B, which was also confirmed in serum samples from Nogo-deficient mice injected with polyinosinic: polycytidylic acid. Although a deficiency of Nogo-B did not change the incorporation or delivery of CpG to endosomes, the localization of TLR9 to endolysosomes was found to be impaired. We identified GRAMD4 as a downmodulator for TLR9 response with a Nogo-B binding ability in ER, because our knockdown and overexpression experiments indicated that GRAMD4 suppresses the TLR9 response and knockdown of Gramd4 strongly enhanced the response in the absence of Nogo-B. Our findings indicate a critical role of Nogo-B and GRAMD4 in trafficking of TLR9.	[Kimura, Toshifumi; Endo, Shota; Inui, Masanori; Takai, Toshiyuki] Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Saitoh, Shin-Ichiroh; Miyake, Kensuke] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Innate Immun, Tokyo 1088639, Japan	Takai, T (reprint author), Tohoku Univ, Dept Expt Immunol, Inst Dev Aging & Canc, 4-1 Seiryo, Sendai, Miyagi 9808575, Japan.	tostakai@idac.tohoku.ac.jp			Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Global Center of Excellence Program for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine	This work was supported by the Core Research for Evolutional Science and Technology Program of the Japan Science and Technology Agency (to T.T.), a grant-in-aid from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T.K. and T.T.), and by a grant from the Global Center of Excellence Program for Innovative Therapeutic Development Towards the Conquest of Signal Transduction Diseases with Network Medicine (to T.T.).	Atwal JK, 2008, SCIENCE, V322, P967, DOI 10.1126/science.1161151; Maeda A, 1999, ONCOGENE, V18, P2291, DOI 10.1038/sj.onc.1202552; Allan BB, 2000, SCIENCE, V289, P444, DOI 10.1126/science.289.5478.444; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; Nash M, 2009, MOL NEUROBIOL, V40, P224, DOI 10.1007/s12035-009-8083-y; Domeniconi M, 2002, NEURON, V35, P283, DOI 10.1016/S0896-6273(02)00770-5; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Chen MS, 2000, NATURE, V403, P434; Short B, 2005, BBA-MOL CELL RES, V1744, P383, DOI 10.1016/j.bbamcr.2005.02.001; Yu J, 2009, P NATL ACAD SCI USA, V106, P17511, DOI 10.1073/pnas.0907359106; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Wang YZ, 2007, BLOOD, V110, P962, DOI 10.1182/blood-2007-01-066027; Doerks T, 2000, TRENDS BIOCHEM SCI, V25, P483, DOI 10.1016/S0968-0004(00)01664-9; GrandPre T, 2000, NATURE, V403, P439; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Huber AB, 2002, J NEUROSCI, V22, P3553; Matsushita H, 2011, J BIOL CHEM, V286, P25739, DOI 10.1074/jbc.M110.157859; SCHINDLER U, 1994, MOL CELL BIOL, V14, P5820; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Yang YS, 2009, J NEUROSCI, V29, P13850, DOI 10.1523/JNEUROSCI.2312-09.2009; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Aggarwal Kunal, 2006, Briefings in Functional Genomics & Proteomics, V5, P112, DOI 10.1093/bfgp/ell018; Brinkmann MM, 2007, J CELL BIOL, V177, P265, DOI 10.1083/jcb.200612056; Fukui R, 2009, J EXP MED, V206, P1339, DOI 10.1084/jem.20082316; Oertle T, 2003, TRENDS CELL BIOL, V13, P187, DOI 10.1016/S0962-8924(03)00035-7; Avalos AM, 2013, J IMMUNOL, V190, P695, DOI 10.4049/jimmunol.1202342; Joset A, 2010, J CELL BIOL, V188, P271, DOI 10.1083/jcb.200906089; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Barton GM, 2009, NAT REV IMMUNOL, V9, P535, DOI 10.1038/nri2587; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Wang D, 2010, P NATL ACAD SCI USA, V107, P13806, DOI 10.1073/pnas.1009428107; Blander JM, 2012, IMMUNITY, V37, P947, DOI 10.1016/j.immuni.2012.11.009; Di Lorenzo A, 2011, BLOOD, V117, P2284, DOI 10.1182/blood-2010-04-281956; Goncalves JP, 2009, J R SOC INTERFACE, V6, P881, DOI 10.1098/rsif.2008.0407; Hayami K, 1997, J BIOL CHEM, V272, P7320; Ho LH, 1999, P NATL ACAD SCI USA, V96, P15086, DOI 10.1073/pnas.96.26.15086; John K, 2011, CELL DEATH DIFFER, V18, P874, DOI 10.1038/cdd.2010.153; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; Lee BL, 2013, ELIFE, V2, DOI 10.7554/eLife.00291; Lee HY, 2011, PLANT CELL, V23, P3374, DOI 10.1105/tpc.111.089656; Liu Y, 2008, J BIOL CHEM, V283, P6561, DOI 10.1074/jbc.M708096200; Oertle T, 2003, J MOL BIOL, V325, P299, DOI 10.1016/S0022-2836(02)01179-8; Onji M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2949; Stanelle J, 2005, CELL DEATH DIFFER, V12, P347, DOI 10.1038/sj.cdd.4401532; Takeshita F, 2004, SEMIN IMMUNOL, V16, P17, DOI 10.1016/j.smim.2003.10.009; Wakana Y, 2005, BIOCHEM BIOPH RES CO, V334, P1198, DOI 10.1016/j.bbrc.2005.07.012; Wright PL, 2010, J EXP MED, V207, P2595, DOI 10.1084/jem.20100786	56	0	0	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUN 1	2015	194	11					5426	5436		10.4049/jimmunol.1402006		11	Immunology	Immunology	CI6WS	WOS:000354905300043		
J	Narumi, K; Miyakawa, R; Ueda, R; Hashimoto, H; Yamamoto, Y; Yoshida, T; Aoki, K				Narumi, Kenta; Miyakawa, Reina; Ueda, Ryosuke; Hashimoto, Hisayoshi; Yamamoto, Yuki; Yoshida, Teruhiko; Aoki, Kazunori			Proinflammatory Proteins S100A8/S100A9 Activate NK Cells via Interaction with RAGE	JOURNAL OF IMMUNOLOGY			English	Article							GLYCATION END-PRODUCTS; CANCER; INFLAMMATION; NEUTROPHILS; EXPRESSION; RECEPTOR; INNATE; S100A9; METASTASIS; IMMUNITY	S100A8/A9, a proinflammatory protein, is upregulated in inflammatory diseases, and also has a tumor-promoting activity by the recruitment of myeloid cells and tumor cell invasion. However, whether the expression of S100A8/A9 in tumors predicts a good or poor prognosis is controversial in the clinical setting. In this study, to clarify the in vivo role of S100A8/A9 in the tumor micro-environment, we s.c. inoculated Pan02 cells stably expressing S100A8 and S100A9 proteins (Pan02-S100A8/A9) in syngeneic C57BL/6 mice. Unexpectedly, after small tumor nodules were once established, they rapidly disappeared. Flow cytometry showed that the number of NK cells in the tumors was increased, and an administration of anti-asialoGM1 Ab for NK cell depletion promoted the growth of Pan02-S100A8/A9 s.c. tumors. Although the S100A8/A9 proteins alone did not change the IFN-gamma expression of NK cells in vitro, a coculture with Pan02 cells, which express Rae-1, induced IFN-gamma production, and Pan02-S100A8/A9 cells further increased the number of IFN-gamma(+) NK cells, suggesting that S100A8/A9 enhanced the NK group 2D ligand-mediated intracellular activation pathway in NK cells. We then examined whether NK cell activation by S100A8/A9 was via their binding to receptor of advanced glycation end product (RAGE) by using the inhibitors. RAGE antagonistic peptide and anti-RAGE Ab inhibited the IFN-gamma production of NK cells induced by S100A8/A9 proteins, and an administration of FPS-ZM1, a RAGE inhibitor, significantly enhanced the in vivo growth of Pan02-S100A8/A9 tumors. We thus found a novel activation mechanism of NK cells via S100A8/A9-RAGE signaling, which may open a novel perspective on the in vivo interaction between inflammation and innate immunity.	[Narumi, Kenta; Miyakawa, Reina; Ueda, Ryosuke; Hashimoto, Hisayoshi; Yamamoto, Yuki; Aoki, Kazunori] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo 1040045, Japan; [Yoshida, Teruhiko] Natl Canc Ctr, Div Genet, Tokyo 1040045, Japan	Aoki, K (reprint author), Natl Canc Ctr, Div Mol & Cellular Med, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	kaoki@ncc.go.jp			Ministry of Health, Labour, and Welfare of Japan; National Cancer Center Research and Development Fund [23-A-38, 23-A-44, 26-A-11]	This work was supported in part by a Grant-in-Aid for Third Term Comprehensive 10-Year Strategy for Cancer Control from the Ministry of Health, Labour, and Welfare of Japan, grants-in-aid for research from the Ministry of Health, Labour, and Welfare of Japan, and by the National Cancer Center Research and Development Fund (23-A-38, 23-A-44, and 26-A-11).	Alves M, 2005, DIABETOLOGIA, V48, P2675, DOI 10.1007/s00125-005-0010-9; Kim WJ, 2011, MOL MED, V17, P478, DOI 10.2119/molmed.2010.00274; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Arumugam T, 2012, CLIN CANCER RES, V18, P4356, DOI 10.1158/1078-0432.CCR-12-0221; Mantovani A, 2011, NAT REV IMMUNOL, V11, P519, DOI 10.1038/nri3024; Pusterla T, 2013, HEPATOLOGY, V58, P363, DOI 10.1002/hep.26395; Mukhtar RA, 2012, ANN SURG ONCOL, V19, P3979, DOI 10.1245/s10434-012-2415-2; Dunn GP, 2002, NAT IMMUNOL, V3, P991, DOI 10.1038/ni1102-991; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; Chan CJ, 2014, CELL DEATH DIFFER, V21, P5, DOI 10.1038/cdd.2013.26; Lanier LL, 2008, NAT IMMUNOL, V9, P495, DOI 10.1038/ni1581; Kasahara M, 2012, IMMUNOGENETICS, V64, P855, DOI 10.1007/s00251-012-0638-9; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Hiratsuka S, 2008, NAT CELL BIOL, V10, P1349, DOI 10.1038/ncb1794; Ichikawa M, 2011, MOL CANCER RES, V9, P133, DOI 10.1158/1541-7786.MCR-10-0394; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Gregory AD, 2011, CANCER RES, V71, P2411, DOI 10.1158/0008-5472.CAN-10-2583; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Xie JL, 2013, CELL SIGNAL, V25, P2185, DOI 10.1016/j.cellsig.2013.06.013; Jin LY, 2012, GYNECOL ONCOL, V126, P140, DOI 10.1016/j.ygyno.2012.04.005; Costantini C, 2011, J LEUKOCYTE BIOL, V89, P221, DOI 10.1189/jlb.0510250; Srikrishna G, 2012, J INNATE IMMUN, V4, P31, DOI 10.1159/000330095; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Casanova-Acebes M, 2014, INT J HEMATOL, V99, P685, DOI 10.1007/s12185-014-1561-7; Choi JH, 2012, HISTOL HISTOPATHOL, V27, P1439; Fan B, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-316; Grebhardt S, 2012, INT J CANCER, V131, P2785, DOI 10.1002/ijc.27591; Khammanivong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069395; Marcais A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00450; Ohri CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021874; Spijkers-Hagelstein JAP, 2012, LEUKEMIA, V26, P1255, DOI 10.1038/leu.2011.388	34	1	1	AMER ASSOC IMMUNOLOGISTS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-1767	1550-6606		J IMMUNOL	J. Immunol.	JUN 1	2015	194	11					5539	5548		10.4049/jimmunol.1402301		10	Immunology	Immunology	CI6WS	WOS:000354905300054		
J	Ott, C; Mukherjee, R; Nakamura, Y				Ott, Christian; Mukherjee, Ranjan; Nakamura, Yoshihiko			A Hybrid System Framework for Unified Impedance and Admittance Control	JOURNAL OF INTELLIGENT & ROBOTIC SYSTEMS			English	Article						Impedance control; Admittance control; Hybrid control	FORCE CONTROL; CONTROLLED ROBOTS; MANIPULATION; IMPLEMENTATION; PERFORMANCE; STABILITY	Impedance Control and Admittance Control are two distinct implementations of the same control goal but their stability and performance characteristics are complementary. Impedance Control is better suited for dynamic interaction with stiff environments and Admittance Control is better suited for interaction with soft environments or operation in free space. In this paper, we use a hybrid systems framework to develop an entire family of controllers that have Impedance Control and Admittance Control at two ends of its spectrum; and intermediate controllers that have stability and performance characteristics that are an interpolation of those of Impedance Control and Admittance Control. The hybrid systems framework provides the scope for maintaining stability and achieving the best performance by choosing a specific controller for a given environment and by continuously changing the controller to adapt to a changing environment. The advantage of our approach is demonstrated with an extensive case study of a one-dimensional system and through experiments with the joint of a lightweight robotic arm.	[Ott, Christian] German Aerosp Ctr DLR eV, Inst Robot & Mech, D-82234 Wessling, Germany; [Mukherjee, Ranjan] Michigan State Univ, Dept Mech Engn, E Lansing, MI 48824 USA; [Nakamura, Yoshihiko] Univ Tokyo, Dept Mechanoinformat, Bunkyo Ku, Tokyo 113, Japan	Ott, C (reprint author), German Aerosp Ctr DLR eV, Inst Robot & Mech, Muenchenerstr 20, D-82234 Wessling, Germany.	christian.ott@dlr.de; mukherji@egr.msu.edu; nakamura@ynl.t.u-tokyo.ac.jp			Japanese-Ministry of Education, Culture, Sports, Science and Technology through the IRT Foundation; Aging Society; Japan-US Educational Commission (JUSEC) under the Fulbright Research Scholar Program	The theoretical development was done while the first two authors were visiting the Department of Mechano-Informatics, University of Tokyo. The first and third authors were supported by funds provided by the Japanese-Ministry of Education, Culture, Sports, Science and Technology through the IRT Foundation to Support Man and Aging Society. The second author gratefully acknowledges the support provided by the Japan-US Educational Commission (JUSEC) under the Fulbright Research Scholar Program. The first author would like to thank Jordi Artigas at DLR for his help in performing the experiments with the robot.	Aghili F., 2010, J DYN SYST MEAS CONT, V132; An C., 1987, IEEE T ROBOTIC AUTOM, p890 ; Kang SH, 2009, IEEE-ASME T MECH, V14, P282, DOI 10.1109/TMECH.2008.2005524; ANDERSON RJ, 1988, IEEE T ROBOTIC AUTOM, V4, P549, DOI 10.1109/56.20440; Valency T, 2003, J DYN SYST-T ASME, V125, P310, DOI 10.1115/1.1590685; PELLETIER M, 1994, IEEE INT CONF ROBOT, P1228; Liberzon D, 1999, IEEE CONTR SYST MAG, V19, P59, DOI 10.1109/37.793443; Brogliato B., 1999, NONSMOOTH MECH; CARIGNAN CR, 1994, IEEE INT CONF ROBOT, P1216; Cheng G., 2006, HUMANOIDS; Das T, 2009, IEEE T CONTR SYST T, V17, P242, DOI 10.1109/TCST.2008.924570; Eppinger SD, 1987, IEEE INT C ROB AUT, V4, P904; Ferretti G., 2000, IEEE INT C ROB AUT, P4027; Gantmacher F.R., 1959, THEORY MATRICES, V1, P239; HOGAN N, 1985, J DYN SYST-T ASME, V107, P8; HOGAN N, 1985, J DYN SYST-T ASME, V107, P17; HOGAN N, 1985, J DYN SYST-T ASME, V107, P1; Horn R. A., 1990, MATRIX ANAL; Lawrence D., 1988, ROB AUT 1988 P 1988, V2, P1185; Liu G.J., 1991, IEEE INT C ROB AUT S, P287; MASON MT, 1981, IEEE T SYST MAN CYB, V11, P418, DOI 10.1109/TSMC.1981.4308708; NEWMAN WS, 1992, J DYN SYST-T ASME, V114, P563, DOI 10.1115/1.2897725; Ott C, 2010, IEEE INT CONF ROBOT, P554, DOI 10.1109/ROBOT.2010.5509861; Ott C., 2006, IEEE RAS INT C HUM R, P276; Raibert M. H., 1981, T ASME, V102, P126; Roy J, 2002, IEEE T ROBOTIC AUTOM, V18, P121, DOI 10.1109/TRA.2002.999642; Salisbury J.K., 1980, P IEEE C DEC CONTR, P383; SERAJI H, 1994, IEEE INT CONF ROBOT, P2705; Siciliano B., 2008, HDB ROBOTICS; Slotine J.-J. E., 1987, IEEE T ROBOTIC AUTOM, P1392; Surdilovic D, 1996, IEEE INT CONF ROBOT, P629; LU WS, 1991, IEEE T ROBOTIC AUTOM, V7, P408, DOI 10.1109/70.88152	32	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0921-0296	1573-0409		J INTELL ROBOT SYST	J. Intell. Robot. Syst.	JUN	2015	78	3-4					359	375		10.1007/s10846-014-0082-1		17	Computer Science, Artificial Intelligence; Robotics	Computer Science; Robotics	CI1GC	WOS:000354490300002		
J	Chung, WY; Choi, BJ; Lim, SH; Matsuo, Y; Lennon, RJ; Gulati, R; Sandhu, GS; Holmes, DR; Rihal, CS; Lerman, A				Chung, Woo-Young; Choi, Byoung-Joo; Lim, Seong-Hoon; Matsuo, Yoshiki; Lennon, Ryan J.; Gulati, Rajiv; Sandhu, Gurpreet S.; Holmes, David R., Jr.; Rihal, Charanjit S.; Lerman, Amir			Three Dimensional Quantitative Coronary Angiography Can Detect Reliably Ischemic Coronary Lesions Based on Fractional Flow Reserve	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						Coronary Angiography; Myocardial Ischemia; Coronary Artery Disease	INTRAVASCULAR ULTRASOUND; ARTERY STENOSES; FOLLOW-UP; MULTIVESSEL EVALUATION; FUNCTIONAL SEVERITY; BLOOD-FLOW; INTERVENTION; RECONSTRUCTION; ANGIOPLASTY; DISEASE	Conventional coronary angiography (CAG) has limitations in evaluating lesions producing ischemia. Three dimensional quantitative coronary angiography (3D-QCA) shows reconstructed images of CAG using computer based algorithm, the Cardio-op B system (Paieon Medical, Rosh Ha'ayin, Israel). The aim of this study was to evaluate whether 3D-QCA can reliably predict ischemia assessed by myocardial fractional flow reserve (FFR) < 0.80. 3D-QCA images were reconstructed from CAG which also were evaluated with FFR to assess ischemia. Minimal luminal diameter (MLD), percent diameter stenosis (% DS), minimal luminal area (MLA), and percent area stenosis (% AS) were obtained. The results of 3D-QCA and FFR were compared. A total of 266 patients was enrolled for the present study. FFR for all lesions ranged from 0.57 to 1.00 (0.85 +/- 0.09). Measurement of MLD, % DS, MLA, and % AS all were significantly correlated with FFR (r = 0.569, 0609, 0.569, 0.670, respectively, all P < 0.001). In lesions with MLA < 4.0 mm(2), % AS of more than 65.5% had a 80% sensitivity and a 83% specificity to predict FFR < 0.80 (area under curve, AUC was 0.878). 3D-QCA can reliably predict coronary lesions producing ischemia and may be used to guide therapeutic approach for coronary artery disease.	[Chung, Woo-Young] Seoul Natl Univ, Coll Med, Dept Internal Med, Devis Cardiol,Boramae Med Ctr, Seoul 151, South Korea; [Choi, Byoung-Joo] Ajou Univ, Sch Med, Dept Cardiol, Suwon 441749, South Korea; [Lim, Seong-Hoon] Dankook Univ, Sch Med, Dept Internal Med, Div Cardiol, Cheonan, South Korea; [Matsuo, Yoshiki] Wakayama Med Univ, Div Cardiovasc Med, Wakayama, Japan; [Lennon, Ryan J.; Gulati, Rajiv; Sandhu, Gurpreet S.; Holmes, David R., Jr.; Rihal, Charanjit S.; Lerman, Amir] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA	Lerman, A (reprint author), 200 First St SW, Rochester, MN 55905 USA.	Lerman.Amir@mayo.edu					Agostoni P, 2008, AM J CARDIOL, V102, P272, DOI 10.1016/j.amjcard.2008.03.048; Tonino PAL, 2009, NEW ENGL J MED, V360, P213, DOI 10.1056/NEJMoa0807611; Hamilos M, 2009, CIRCULATION, V120, P1505, DOI 10.1161/CIRCULATIONAHA.109.850073; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; TOPOL EJ, 1995, CIRCULATION, V92, P2333; Legalery P, 2005, EUR HEART J, V26, P2623, DOI 10.1093/eurheartj/ehi484; Berger A, 2005, J AM COLL CARDIOL, V46, P438, DOI 10.1016/j.jacc.2005.04.041; Abizaid AS, 1999, CIRCULATION, V100, P256; PIJLS NHJ, 1993, CIRCULATION, V87, P1354; Gollapudi RR, 2007, CATHETER CARDIO INTE, V69, P479, DOI 10.1002/ccd.20955; Kang SJ, 2011, CIRC-CARDIOVASC INTE, V4, P65, DOI 10.1161/CIRCINTERVENTIONS.110.959148; Gibson CM, 1996, CIRCULATION, V93, P879; Yong ASC, 2011, EUR HEART J, V32, P345, DOI 10.1093/eurheartj/ehq259; PIJLS NHJ, 1995, CIRCULATION, V92, P3183; Tonino PAL, 2010, J AM COLL CARDIOL, V55, P2816, DOI 10.1016/j.jacc.2009.11.096; Pijls NHJ, 2010, J AM COLL CARDIOL, V56, P177, DOI 10.1016/j.jacc.2010.04.012; Briguori C, 2001, AM J CARDIOL, V87, P136, DOI 10.1016/S0002-9149(00)01304-7; Bech GJ, 2001, INT J CARDIOVASC INT, V4, P67; Dvir Danny, 2005, Int J Cardiovasc Intervent, V7, P141; GottsaunerWolf M, 1996, EUR HEART J, V17, P1167; Rittger H, 2009, EUROINTERVENTION, V5, P127; Rubinshtein R, 2012, CATHETER CARDIO INTE, V80, P304, DOI 10.1002/ccd.23425; Saad M, 2009, EUROINTERVENTION, V5, P573, DOI 10.4244/EIJV5I5A93; Schuurbiers JCH, 2009, CATHETER CARDIO INTE, V73, P620, DOI 10.1002/ccd.21872; Tu SX, 2010, CATHETER CARDIO INTE, V76, P291, DOI 10.1002/ccd.22502	26	0	0	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUN	2015	30	6					716	724		10.3346/jkms.2015.30.6.716		9	Medicine, General & Internal	General & Internal Medicine	CI7YE	WOS:000354982100010		
J	Koizumi, S; Kamisawa, T; Kuruma, S; Tabata, T; Chiba, K; Iwasaki, S; Kuwata, G; Fujiwara, T; Fujiwara, J; Arakawa, T; Koizumi, K; Momma, K				Koizumi, Satomi; Kamisawa, Terumi; Kuruma, Sawako; Tabata, Taku; Chiba, Kazuro; Iwasaki, Susumu; Kuwata, Go; Fujiwara, Takashi; Fujiwara, Junko; Arakawa, Takeo; Koizumi, Koichi; Momma, Kumiko			Organ Correlation in IgG4-Related Diseases	JOURNAL OF KOREAN MEDICAL SCIENCE			English	Article						IgG4; Pancreatitis; Cholangitis; Sclerosing	AUTOIMMUNE PANCREATITIS; DIAGNOSTIC-CRITERIA; RETROPERITONEAL FIBROSIS; SCLEROSING DISEASE; KIDNEY-DISEASE; LYMPHADENOPATHY	IgG4-related disease (IgG4-RD) is a potentially multiorgan disorder. In this study, clinical and serological features from 132 IgG4-RD patients were compared about organ correlations. Underlying pathologies comprised autoimmune pancreatitis (AIP) in 85 cases, IgG4-related sclerosing cholangitis (IgG4-SC) in 12, IgG4-related sialadenitis (IgG4-SIA) in 56, IgG4-related dacryoadenitis (IgG4-DAC) in 38, IgG4-related lymphadenopathy (IgG4-LYM) in 20, IgG4-related retroperitoneal fibrosis (IgG4-RF) in 19, IgG4-related kidney disease (IgG4-KD) in 6, IgG4-related pseudotumor (IgG4-PT) in 3. Sixty-five patients (49%) had multiple IgG4-RD (two affected organs in 36 patients, three in 19, four in 8, five in 1, and six in 1). Serum IgG4 levels were significantly higher with multiple lesions than with a single lesion (P < 0.001). The proportion of association with other IgG4-RD was 42% in AIP, the lowest of all IgG4-RDs. Serum IgG4 level was lower in AIP than in other IgG4-RDs. Frequently associated IgG4-RDs were SIA (25%) and DAC (12%) for AIP; AIP (75%) for IgG4-SC; DAC (57%), AIP (38%) and LYM (27%) for IgG4-SIA; AIP (26%) and LYM (26%) for IgG4-DAC; SIA (75%), DAC (50%) and AIP (45%) for IgG4-LYM; SIA (58%), AIP (42%) and LYM (32%) for IgG4-RF; AIP (100%) and SIA (67%) for IgG4-KID; and DAC (67%) and SIA (67%) for IgG4-PT. Most associated IgG4-RD lesions were diagnosed simultaneously, but IgG4-SIA and IgG4-DAC were sometimes identified before other lesions. About half of IgG4-RD patients had multiple IgG4-RD lesions, and some associations were seen between specific organs.	[Koizumi, Satomi; Kamisawa, Terumi; Kuruma, Sawako; Tabata, Taku; Chiba, Kazuro; Iwasaki, Susumu; Kuwata, Go; Fujiwara, Takashi; Fujiwara, Junko; Arakawa, Takeo; Koizumi, Koichi; Momma, Kumiko] Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Tokyo, Japan	Kamisawa, T (reprint author), Tokyo Metropolitan Komagome Hosp, Dept Internal Med, Bunkyo Ku, 3-18-22 Honkomagome, Tokyo, Japan.	kamisawa@cick.jp					Zen Y, 2009, AM J SURG PATHOL, V33, P1833; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Chiba K, 2013, INTERNAL MED, V52, P1545, DOI 10.2169/internalmedicine.52.0306; Kamisawa T, 2010, NAT REV GASTRO HEPAT, V7, P401, DOI 10.1038/nrgastro.2010.81; Ohara H, 2012, J HEPATO-BIL-PAN SCI, V19, P536, DOI 10.1007/s00534-012-0521-y; Saeki T, 2013, KIDNEY INT, V84, P826, DOI 10.1038/ki.2013.191; Kawano M, 2011, CLIN EXP NEPHROL, V15, P615, DOI 10.1007/s10157-011-0521-2; Hamano H, 2006, J GASTROENTEROL, V41, P1197, DOI 10.1007/s00535-006-1908-9; Sato Y, 2009, MODERN PATHOL, V22, P589, DOI 10.1038/modpathol.2009.17; Kamisawa T, 2003, J GASTROENTEROL, V38, P982, DOI 10.1007/s00535-003-1175-y; Kubota K, 2010, PANCREAS, V39, pE6, DOI 10.1097/MPA.0b013e3181bc119d; Zhang JJ, 2014, EUR J NUCL MED MOL I, V41, P1624, DOI 10.1007/s00259-014-2729-3; Moriyama M, 2013, CLIN ORAL INVEST, V17, P1995, DOI 10.1007/s00784-012-0905-z; Kanno A, 2012, PANCREAS, V41, P835, DOI 10.1097/MPA.0b013e3182480c99; Shimosegawa T, 2011, PANCREAS, V40, P352, DOI 10.1097/MPA.0b013e3182142fd2; Cheuk W, 2008, AM J SURG PATHOL, V32, P671, DOI 10.1097/PAS.0b013e318157c068; Deshpande V, 2012, NEW ENGL J MED, V6, P539; Kamisawa T, 2015, LANCET, V385, P1460, DOI 10.1016/S0140-6736(14)60720-0; Ohara H, 2005, PANCREAS, V31, P232, DOI 10.1097/01.mpa.0000175178.85786.1d; Okazaki Kazuichi, 2005, JOP, V6, P89; Ozaki Y, 2008, J GASTROENTEROL, V43, P144, DOI 10.1007/s00535-007-2132-y; Yamamoto M, 2006, MOD RHEUMATOL, V16, P335	22	0	0	KOREAN ACAD MEDICAL SCIENCES	SEOUL	302 75 DONG DU ICHON, DONG YONGSAN KU, SEOUL 140 031, SOUTH KOREA	1011-8934	1598-6357		J KOREAN MED SCI	J. Korean Med. Sci.	JUN	2015	30	6					743	748		10.3346/jkms.2015.30.6.743		6	Medicine, General & Internal	General & Internal Medicine	CI7YE	WOS:000354982100014		
J	Hara, Y; Ikoma, K; Kido, M; Sukenari, T; Arai, Y; Fujiwara, H; Kawata, M; Kubo, T				Hara, Yusuke; Ikoma, Kazuya; Kido, Masamitsu; Sukenari, Tsuyoshi; Arai, Yuji; Fujiwara, Hiroyoshi; Kawata, Mitsuhiro; Kubo, Toshikazu			Diffusion tensor imaging assesses triceps surae dysfunction after achilles tenotomy in rats	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						Achilles tendon; DTI; MRI; muscle function	HUMAN CALF MUSCLE; MAGNETIC-RESONANCE; SKELETAL-MUSCLE; TRACTOGRAPHY; ANISOTROPY; IMMOBILIZATION; ARCHITECTURE; CONTRACTION; RUPTURE; TENDON	PurposeTo elucidate the relationship of diffusion tensor imaging (DTI) with structural changes and muscle function in skeletal muscle. Materials and MethodsThe subjects were 21 12-week-old male rats. Achilles tenotomy was performed on the right legs. Proton density-weighted images and DTI (7.04T) of the triceps surae at 2 and 4 weeks posttenotomy were obtained. Eigenvalues () and fractional anisotropy (FA) were calculated from the muscle images. After imaging, histological specimens of the triceps surae were prepared. The long axis and cross-sectional area of the triceps surae were measured 2 and 4 weeks postoperatively. The strength of ankle plantar flexion was measured. Correlations of DTI parameters with morphological values and muscle strength were analyzed. Results(1) declined after tenotomy (P<0.01), and (2) and (3) declined at 4 weeks posttenotomy (P<0.01). FA increased at 4 weeks posttenotomy (P<0.01). Atrophy of the triceps surae was observed in the tissues images of the treatment group. The muscle belly significantly shortened postoperatively, and a decline in plantar flexion force was observed after tenotomy. Positive correlations were observed between (1) and muscle strength (r=0.89) and between (1) and the length of the long axis of the muscle belly (r=0.81). ConclusionDTI may serve as a marker of muscle function. J. Magn. Reson. Imaging 2015;41:1541-1548. (c) 2014 Wiley Periodicals, Inc.	[Hara, Yusuke; Ikoma, Kazuya; Kido, Masamitsu; Sukenari, Tsuyoshi; Arai, Yuji; Fujiwara, Hiroyoshi; Kubo, Toshikazu] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kyoto, Japan; [Kawata, Mitsuhiro] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Anat & Neurobiol, Kyoto, Japan	Ikoma, K (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Orthopaed, Kamigyo Ku, 465 Kajii Cho, Kyoto, Japan.	kazuya@koto.kpu-m.ac.jp					Aliev MK, 2004, MOL CELL BIOCHEM, V256, P257, DOI 10.1023/B:MCBI.0000009873.37245.54; Takagi T, 2009, NEUROIMAGE, V44, P884, DOI 10.1016/j.neuroimage.2008.09.022; Saotome T, 2006, MAGN RESON IMAGING, V24, P19, DOI 10.1016/j.mri.2005.09.009; BASSER PJ, 1994, BIOPHYS J, V66, P259; Zhang JY, 2008, EXP NEUROL, V212, P448, DOI 10.1016/j.expneurol.2008.04.033; Maganaris CN, 1998, J PHYSIOL-LONDON, V512, P603, DOI 10.1111/j.1469-7793.1998.603be.x; Okamoto Y, 2010, MAGN RESON MED SCI, V9, P1; Zaraiskaya T, 2006, J MAGN RESON IMAGING, V24, P402, DOI 10.1002/jmri.20651; Sinha U, 2002, J MAGN RESON IMAGING, V15, P87, DOI 10.1002/jmri.10035; Heemskerk AM, 2009, MAGN RESON MED, V61, P467, DOI 10.1002/mrm.21819; Bring D, 2010, SCAND J MED SCI SPOR, V20, P411, DOI 10.1111/j.1600-0838.2009.00954.x; BULLER AJ, 1965, J PHYSIOL-LONDON, V178, P326; Galban CJ, 2004, EUR J APPL PHYSIOL, V93, P253, DOI 10.1007/s00421-004-1186-2; Hatakenaka M, 2008, J MAGN RESON IMAGING, V27, P932, DOI 10.1002/jmri.21302; Hatakenaka Masamitsu, 2008, Magn Reson Med Sci, V7, P59, DOI 10.2463/mrms.7.59; JAKUBIECPUKA A, 1992, BIOCHEM J, V282, P237; JOZSA L, 1990, J BONE JOINT SURG BR, V72, P293; Kearney RS, 2012, PHYSIOTHERAPY, V98, P24, DOI 10.1016/j.physio.2011.04.349; Mamata H, 2004, NEUROCHEM INT, V45, P553, DOI 10.1016/j.neuint.2003.11.014; McMillan AB, 2011, J BIOMED BIOTECHNOL, V2011; Okamoto Y, 2012, J MED IMAG RADIAT ON, V56, P622, DOI 10.1111/j.1754-9485.2012.02450.x; Rasband WS, 1997, IMAGEJ; Saupe N, 2009, AM J ROENTGENOL, V92, P282; Schwenzer NF, 2009, NMR BIOMED, V22, P1047, DOI 10.1002/nbm.1409; Shorten PR, 2009, BIOPHYS J, V96, P4764, DOI 10.1016/j.bpj.2009.02.060; Sosnovik DE, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-47	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2015	41	6					1541	1548		10.1002/jmri.24707		8	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4QU	WOS:000354738100006		
J	Tsuji, K; Kishi, S; Tsuchida, T; Yamauchi, T; Ikegaya, S; Urasaki, Y; Fujiwara, Y; Ueda, T; Okazawa, H; Kimura, H				Tsuji, Kazunobu; Kishi, Shinji; Tsuchida, Tatsuro; Yamauchi, Takahiro; Ikegaya, Satoshi; Urasaki, Yoshimasa; Fujiwara, Yasuhiro; Ueda, Takanori; Okazawa, Hidehiko; Kimura, Hirohiko			Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						diffusion-weighted imaging; FDG-PET; CT; chemotherapy; malignant lymphoma	POSITRON-EMISSION-TOMOGRAPHY; NON-HODGKINS-LYMPHOMA; B-CELL LYMPHOMA; INTERNATIONAL WORKSHOP; INITIAL-EXPERIENCE; SUPPRESSION DWIBS; ONCOLOGY; INTERIM; F-18-FDG; SUPERIOR	BackgroundTo examine the utility of diffusion-weighted MRI (DW-MRI) for staging and early response to chemotherapy assessment in lymphoma patients as compared with fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT). MethodsTwenty-eight patients with histologically confirmed malignant lymphoma underwent both MRI and FDG-PET/CT before (pretreatment) and after two courses of chemotherapy (mid-treatment). Staging with MRI (DW-MRI alone and with T2-weighted images) and FDG-PET was compared visually, and the concordance rate (kappa value, ) was calculated. To evaluate early response to chemotherapy, patients were divided into two groups, lesion-positive (LP) and lesion-negative (LN), based on a proposed original criterion. Progression-free survival (PFS) was compared between the groups using the Kaplan-Meier method. ResultsThe stage diagnosed with DW-MRI alone and with FDG-PET/CT was concordant in 22 patients (=0.71; P<0.05), and by adding T2-weighted images, the number of concordant patients increased to 26 (=0.90; P<0.05). On mid-treatment imaging, 19 patients were diagnosed as LN from both modalities. PFS differed significantly between LP and LN on both DW-MRI (P=0.0013) and FDG-PET/CT (P=0.037). ConclusionDW-MRI is a promising tool for staging and evaluation of early response to chemotherapy in patients with lymphoma. J. Magn. Reson. Imaging 2015;41:1601-1607. (c) 2014 Wiley Periodicals, Inc.	[Tsuji, Kazunobu; Tsuchida, Tatsuro; Kimura, Hirohiko] Univ Fukui Hosp, Dept Radiol, Fukui, Japan; [Kishi, Shinji; Yamauchi, Takahiro; Ikegaya, Satoshi; Urasaki, Yoshimasa; Ueda, Takanori] Univ Fukui Hosp, Dept Hematol, Fukui, Japan; [Fujiwara, Yasuhiro] Univ Fukui Hosp, Div Radiol, Fukui, Japan; [Okazawa, Hidehiko] Univ Fukui, Biomed Imaging Res Ctr, Fukui 910, Japan	Tsuchida, T (reprint author), 23-3 Matsuokashimoaizuki, Eiheiji, Fukui 9101193, Japan.	tsucchy@u-fukui.ac.jp					Rohren EM, 2004, RADIOLOGY, V231, P305, DOI 10.1148/radiol.2312021185; Heusch P, 2013, EUR J RADIOL, V82, P870, DOI 10.1016/j.ejrad.2013.01.008; Koh DM, 2006, BRIT J RADIOL, V79, P633, DOI 10.1259/bjr/29739265; Juweid ME, 2007, J CLIN ONCOL, V25, P571, DOI 10.1200/JCO.2006.08.2305; Schoder H, 2005, J CLIN ONCOL, V23, P4643, DOI 10.1200/JCO.2005.12.072; Mikhaeel NG, 2005, ANN ONCOL, V16, P1514, DOI 10.1093/annonc/mdi272; Abdulqadhr G, 2011, ACTA RADIOL, V52, P173, DOI 10.1258/ar.2010.100246; Jerusalem G, 2001, ANN ONCOL, V12, P825, DOI 10.1023/A:1011169332265; Gallamini A, 2007, J CLIN ONCOL, V25, P3746, DOI 10.1200/JCO.2007.11.6525; Meignan M, 2009, LEUKEMIA LYMPHOMA, V50, P1257, DOI 10.1080/10428190903040048; Lin C, 2010, EUR RADIOL, V20, P2027, DOI 10.1007/s00330-010-1758-y; Wu XC, 2013, NMR BIOMED, V26, P1186, DOI 10.1002/nbm.2933; Kwee TC, 2008, EUR RADIOL, V18, P1937, DOI 10.1007/s00330-008-0968-z; Salamon J, 2014, EUR RADIOL, V24, P405, DOI 10.1007/s00330-013-3020-x; Komori T, 2007, ANN NUCL MED, V21, P209, DOI 10.1007/s12149-007-0010-6; Lin C, 2011, INVEST RADIOL, V46, P341, DOI 10.1097/RLI.0b013e3182087b03; Chen YB, 2012, MAGN RESON IMAGING, V30, P165, DOI 10.1016/j.mri.2011.09.019; Gallamini A, 2009, LEUKEMIA LYMPHOMA, V50, P1761, DOI 10.3109/10428190903308072; Juweid ME, 2005, J CLIN ONCOL, V23, P4652, DOI 10.1200/JCO.2005.01.891; DesPaepe K, 2013, CANC IMAGING, V13, P53; Even-Sapir E, 2003, EUR J NUCL MED MOL I, V30, pS65, DOI 10.1007/s00259-003-1164-7; Gu J, 2011, AM J ROENTGENOL, V197, pW384, DOI 10.2214/AJR.10.5692; LesRoux P. Y., 2011, EUROPEAN J NUCL MED, V38, P1064; Lin Chieh, 2007, Cancer Imaging, V7 Spec No A, pS88, DOI 10.1102/1470-7330.2007.9004; Lin C, 2010, Cancer Imaging, V10 Spec no A, pS172, DOI 10.1102/1470-7330.2010.9029; Schaefer JF, 2006, EUR RADIOL, V16, P2000, DOI 10.1007/s00330-006-0199-0; Stephane V, 2013, EUR J RADIOL, V82, P2011, DOI 10.1016/j.ejrad.2013.05.042; Takahara Taro, 2004, Radiat Med, V22, P275; Tsushima Y, 2007, ACAD RADIOL, V14, P643, DOI 10.1016/j.acra.2007.02.006; Wu XC, 2011, NMR BIOMED, V24, P1181, DOI 10.1002/nbm.1689	30	3	3	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2015	41	6					1601	1607		10.1002/jmri.24714		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4QU	WOS:000354738100012		
J	Noda, Y; Ito, K; Kanki, A; Tamada, T; Yamamoto, A; Kazuya, Y; Higaki, A				Noda, Yasufumi; Ito, Katsuyoshi; Kanki, Akihiko; Tamada, Tsutomu; Yamamoto, Akira; Kazuya, Yasokawa; Higaki, Atsushi			Measurement of renal cortical thickness using noncontrast-enhanced steady-state free precession MRI with spatially selective inversion recovery pulse: Association with renal function	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						corticomedullary differentiation; kidney; magnetic resonance imaging; cortical thickness; steady-state free precession (SSFP)	CHRONIC KIDNEY-DISEASE; CORTICOMEDULLARY DIFFERENTIATION; TAGGING PULSE; VENOUS FLOW; SSFP MRI; TIME; ANGIOGRAPHY; VOLUME; AGE	PurposeTo assess whether noncontrast-enhanced steady-state free precession (SSFP) magnetic resonance imaging (MRI) with a spatially selective inversion recovery (IR) pulse can improve the visibility of renal corticomedullary differentiation in patients showing renal dysfunction, and to investigate the correlation between renal cortical thickness and estimated glomerular filtration rate (eGFR). Materials and MethodsSixty-five patients with and without chronic kidney diseases (CKD) were investigated. Based on eGFR, patients were divided into three groups (Group 1, eGFR<60; Group 2, eGFR=60-90; and Group 3, eGFR>90). All patients underwent noncontrast-enhanced SSFP MRI with spatially selective IR pulses and minimal renal cortical thickness was measured. ResultsThe mean corticomedullary contrast ratio was significantly higher in SSFP images with optimal TI than in in-phase images in all three groups (P=0.001). Positive correlation was seen between the corticomedullary contrast ratio in SSFP images with optimal TI and eGFR (P=0.011, r=0.314). A significantly positive correlation was observed between minimal renal cortical thickness and eGFR (P<0.01, r=0.495). ConclusionNoncontrast-enhanced SSFP MRI with a spatially selective IR pulse using optimal TI can improve the visibility of renal corticomedullary differentiation even in patients with renal insufficiency. The decrease in renal cortical thickness measured using this technique correlated significantly with eGFR. J. Magn. Reson. Imaging 2015;41:1615-1621. (c) 2014 Wiley Periodicals, Inc.	[Noda, Yasufumi; Ito, Katsuyoshi; Kanki, Akihiko; Tamada, Tsutomu; Yamamoto, Akira; Kazuya, Yasokawa; Higaki, Atsushi] Kawasaki Med Univ, Dept Radiol, Kurashiki, Okayama 7010192, Japan	Noda, Y (reprint author), Kawasaki Med Univ, Dept Radiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	yasufumi@med.kawasaki-m.ac.jp					Garcia DM, 2005, MAGNET RESON MED, V54, P366, DOI 10.1002/mrm.20556; Mounier-Vehier C, 2002, KIDNEY INT, V61, P591, DOI 10.1046/j.1523-1755.2002.00167.x; Miyazaki M, 2008, RADIOLOGY, V248, P20, DOI 10.1148/radiol.2481071497; Perlman RL, 2005, AM J KIDNEY DIS, V45, P658, DOI 10.1053/j.ajkd.2004.12.021; Lee VS, 2007, J MAGN RESON IMAGING, V25, P790, DOI 10.1002/jmri.20878; Beland MD, 2010, AM J ROENTGENOL, V195, pW146, DOI 10.2214/AJR.09.4104; Muto NS, 2011, EUR J RADIOL, V78, P151, DOI 10.1016/j.ejrad.2009.10.005; BAUMGARTNER BR, 1989, INVEST RADIOL, V24, P884, DOI 10.1097/00004424-198911000-00008; BLUML S, 1993, MAGNET RESON MED, V30, P289, DOI 10.1002/mrm.1910300304; desBazelaire CM, 2004, RADIOLOGY, V230, P652; EDELMAN RR, 1989, RADIOLOGY, V171, P551; Evans N, 2004, PHYS THER, V84, P454; HRICAK H, 1983, RADIOLOGY, V146, P425; ISHIKAWA I, 1981, J COMPUT ASSIST TOMO, V5, P695, DOI 10.1097/00004728-198110000-00018; Ito K, 2002, AM J ROENTGENOL, V178, P343; Kanki A, 2013, J MAGN RESON IMAGING, V37, P1178, DOI 10.1002/jmri.23909; Karstoft K, 2007, J MAGN RESON IMAGING, V26, P1564, DOI 10.1002/jmri.21121; Kettritz U, 1996, JMRI-J MAGN RESON IM, V6, P136, DOI 10.1002/jmri.1880060125; LEUNG AWL, 1984, AM J ROENTGENOL, V143, P1215; MAROTTI M, 1987, MAGNET RESON MED, V5, P160, DOI 10.1002/mrm.1910050207; NISHIMURA DG, 1988, MAGNET RESON MED, V8, P96, DOI 10.1002/mrm.1910080112; Noda Y, 2014, J MAGN RESON IMAGING, V40, P79, DOI 10.1002/jmri.24332; Pietsch H, 2009, INVEST RADIOL, V44, P226, DOI 10.1097/RLI.0b013e3181998eb7; SEMELKA RC, 1994, RADIOLOGY, V190, P149; Silva Fred G., 2005, International Urology and Nephrology, V37, P185, DOI 10.1007/s11255-004-0873-6; Tsukuda T, 2005, J MAGN RESON IMAGING, V22, P527, DOI 10.1002/jmri.20419	26	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2015	41	6					1615	1621		10.1002/jmri.24719		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4QU	WOS:000354738100014		
J	Fukunaga, T; Fujii, S; Inoue, C; Kato, A; Chikumi, J; Kaminou, T; Ogawa, T				Fukunaga, Takeru; Fujii, Shinya; Inoue, Chie; Kato, Ayumi; Chikumi, Jun; Kaminou, Toshio; Ogawa, Toshihide			Accuracy of semiquantitative dynamic contrast-enhanced MRI for differentiating type II from type I endometrial carcinoma	JOURNAL OF MAGNETIC RESONANCE IMAGING			English	Article						endometrial carcinoma; magnetic resonance imaging; pelvis; dynamic contrast-enhanced imaging; sensitivity and specificity	PAPILLARY-SEROUS-CARCINOMA; MYOMETRIAL INVASION; TUMOR ANGIOGENESIS; CANCER; GRADE; MALIGNANCIES; PATTERNS; UTERUS; SPREAD; IMAGES	PurposeTo investigate type II endometrial carcinoma characterization using dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and evaluate the diagnostic accuracy of semiquantitative DCE-MRI in differentiating type II from type I tumors. Materials and MethodsSeventy-seven patients with endometrial carcinoma were retrospectively evaluated using 3T DCE-MRI. The maximum absolute enhancement of signal intensity (SImax), maximum relative enhancement (SIrel), wash-in rate (WIR), and the SImax/SI (piriformis) ratio were analyzed. To differentiate type I from type II tumors, optimal threshold criteria were established. The Mann-Whitney U-test was used for statistical comparison and receiver operating characteristic curve analysis was used to determine optimal cutoff values. ResultsThe SIrel (P<0.001), WIR (P<0.0001), and SImax/SI (piriformis) ratio (P<0.0001), but not SImax, differed significantly between type I and type II carcinomas. Cutoff values of SIrel 58.8, WIR 37.0, and SImax/SI (piriformis) ratio 1.55 had sensitivities of 93%, 93%, and 67%, specificities of 60%, 60%, and 79%, accuracies of 66%, 66%, and 67%, respectively, for predicting type II endometrial carcinoma. ConclusionEndometrial carcinoma with strong (high level) enhancement on DCE-MRI is suggestive of type II endometrial carcinoma. Semiquantitative evaluation of DCE-MRI may be useful for differentiating type II from type I tumors. J. Magn. Reson. Imaging 2015;41:1662-1668. (c) 2014 Wiley Periodicals, Inc.	[Fukunaga, Takeru; Fujii, Shinya; Inoue, Chie; Kato, Ayumi; Ogawa, Toshihide] Tottori Univ, Div Radiol, Dept Pathophysiol & Therapeut Sci, Fac Med, Yonago, Tottori 6838504, Japan; [Chikumi, Jun] Tottori Univ, Div Reprod Perinatal Med & Gynecol Oncol, Dept Surg, Fac Med, Yonago, Tottori 6838504, Japan; [Kaminou, Toshio] Natl Hosp Org Osaka Minami Med Ctr, Dept Radiol, Osaka, Japan	Fukunaga, T (reprint author), Tottori Univ, Div Radiol, Dept Pathophysiol & Therapeut Sci, 36-1 Nishi Cho, Yonago, Tottori 6838504, Japan.	taku_007a@med.tottori-u.ac.jp					Abulafia O, 1999, GYNECOL ONCOL, V72, P220, DOI 10.1006/gyno.1998.5152; Padhani AR, 2000, CLIN RADIOL, V55, P99, DOI 10.1053/crad.1999.0327; GOFF BA, 1994, GYNECOL ONCOL, V54, P264, DOI 10.1006/gyno.1994.1208; Jemal A, 2010, CA-CANCER J CLIN, V60, P277, DOI [10.3322/caac.20073, 10.1002/caac.20073]; YAMASHITA Y, 1993, RADIOLOGY, V186, P495; Hamilton CA, 2006, BRIT J CANCER, V94, P642, DOI 10.1038/sj.bjc.6603012; HRICAK H, 1991, RADIOLOGY, V181, P95; Doll A, 2008, J STEROID BIOCHEM, V108, P221, DOI 10.1016/j.jsbmb.2007.09.020; Frumovitz M, 2004, GYNECOL ONCOL, V95, P463, DOI 10.1016/j.ygyno.2004.07.016; Knopp MV, 1999, JMRI-J MAGN RESON IM, V10, P260, DOI 10.1002/(SICI)1522-2586(199909)10:3<260::AID-JMRI6>3.0.CO;2-7; SIRONI S, 1992, RADIOLOGY, V185, P207; Slomovitz BM, 2003, GYNECOL ONCOL, V91, P463, DOI 10.1016/j.ygyno.2003.08.018; Manfredi R, 2004, RADIOLOGY, V231, P372, DOI 10.1148/radiol.2312021184; Todo Y, 2010, LANCET, V375, P1165, DOI 10.1016/S0140-6736(09)62002-X; Matsubayashi R, 2000, RADIOLOGY, V217, P841; Dobrzycka B, 2013, GYNECOL ONCOL, V128, P454, DOI 10.1016/j.ygyno.2012.11.035; Rechichi G, 2011, AM J ROENTGENOL, V197, P256, DOI 10.2214/AJR.10.5584; Brasch RC, 2000, ACAD RADIOL, V7, P812, DOI 10.1016/S1076-6332(00)80630-3; BOKHMAN JV, 1983, GYNECOL ONCOL, V15, P10, DOI 10.1016/0090-8258(83)90111-7; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Hardesty LA, 2000, RADIOLOGY, V215, P45; HIRANO Y, 1992, RADIOGRAPHICS, V12, P243; Joja I, 1996, J COMPUT ASSIST TOMO, V20, P878, DOI 10.1097/00004728-199611000-00003; Kaneda S, 2011, ABDOM IMAGING, V36, P612, DOI 10.1007/s00261-011-9719-8; Kurman RJ, 1994, BLAUSTEINS PATHOLOGY, V4th, P439; Manfredi R, 2005, ABDOM IMAGING, V30, P626, DOI 10.1007/s00261-004-0298-9; Okadome M, 2014, J OBSTET GYNAECOL RE, V40, P1931, DOI 10.1111/jog.12436; Sohaib SA, 2010, SEMIN ULTRASOUND CT, V31, P377, DOI 10.1053/j.sult.2010.07.005; Su MY, 2003, J MAGN RESON IMAGING, V18, P467, DOI 10.1002/jmri.10380; TAKASHIMA S, 1993, RADIOLOGY, V189, P813; Tanaka YO, 2003, EUR RADIOL, V13, P2038, DOI 10.1007/s00330-002-1799-y; Tergas AI, 2012, GYNECOL ONCOL, V127, P316, DOI 10.1016/j.ygyno.2012.07.105; Thomassin-Naggara I, 2008, RADIOLOGY, V248, P148, DOI 10.1148/radiol.2481071120; VansRijswijk CS, 2004, RADIOLOGY, V233, P493	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1053-1807	1522-2586		J MAGN RESON IMAGING	J. Magn. Reson. Imaging	JUN	2015	41	6					1662	1668		10.1002/jmri.24730		7	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4QU	WOS:000354738100020		
J	Motoyasu, G; Yamazaki, H; Ohno, A; Soda, H; McLean, A				Motoyasu, Genjiro; Yamazaki, Hiroyuki; Ohno, Atsumi; Soda, Hiroshi; McLean, Alexander			Some Perspectives on Innovative Processing and Materials Development	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Review						cast wire; continuous casting; directional solidification; heated mold; single crystal	CONTINUOUS-CASTING PROCESS; ALUMINIDE DIFFUSION COATINGS; TIN EUTECTIC ALLOY; OCC PROCESS; INGOTS; WIRES; MICROSTRUCTURE; SOLIDIFICATION; SUPERALLOY; ZONE	Throughout a long and distinguished career, the research activities conducted by Professor Ravindran have been characterized by the quest to generate fundamental as well as practical knowledge through collaborative efforts involving academia and industry as a basis for development of innovative manufacturing routes and improvement in performance of existing products and processes based on near-net-shape casting technologies. In this paper, the generation, validation, and implementation of new knowledge is illustrated by the Ohno Continuous Casting process, a heated mold system that permits the production of net-shape or near-net-shape products with a high-quality surface, controlled solidification structure, and significantly enhanced properties.	[Motoyasu, Genjiro; Ohno, Atsumi] Chiba Inst Technol, Dept Mech Sci, Narashino, Chiba 275, Japan; [Yamazaki, Hiroyuki] Osaka Univ, Joining & Welding Res Inst, Osaka, Japan; [Yamazaki, Hiroyuki] Osaka Fuji Corp, Amagasaki, Hyogo, Japan; [Soda, Hiroshi; McLean, Alexander] Univ Toronto, Dept Mat Sci & Engn, Toronto, ON, Canada	Motoyasu, G (reprint author), Chiba Inst Technol, Dept Mech Sci, Narashino, Chiba 275, Japan.	genjiro.motoyasu@it-chiba.ac.jp					Sengupta S, 2005, J MATER SCI, V40, P2607, DOI 10.1007/s10853-005-2086-5; Elsawy A, 2005, MATER CORROS, V56, P669, DOI 10.1002/maco.200503870; Okayasu M, 2012, MAT SCI ENG A-STRUCT, V543, P185, DOI 10.1016/j.msea.2012.02.073; BOWER TF, 1967, T METALL SOC AIME, V239, P216; Elsawy A, 2006, CAN METALL QUART, V45, P59; Motegi T., 1995, KEIKINZOKU J JPN I L, V45, P339; Motoyasu G., 1987, IMONO, V59, P670; MOTOYASU G, 1987, J JPN I MET, V51, P935; Motoyasu G, 1999, J MATER SCI, V34, P3893, DOI 10.1023/A:1004674823296; Motoyasu G., 2004, P 66 WORLD FOUNDR C, V1, P385; Nakano K., 1987, P SOL PROC I MET LON, P413; OHNO A, 1971, T IRON STEEL I JPN, V11, P18; Ohno A., 1988, P INT S CAST NEAR NE, P177; OHNO A, 1986, JOM-J MIN MET MAT S, V38, P14; OHNO A, 1970, T IRON STEEL I JPN, V10, P13; Ohno A., 1990, P SPECIAL TECHNICAL, P161; Ohno A. E., 1987, SOLIDIFICATION SEPAR; Okayasu M, 2010, MAT SCI ENG A-STRUCT, V527, P3120, DOI 10.1016/j.msea.2010.01.071; Sawada K., 1988, SUMITOMO ELECT TECH, V27, P140; Sengupta S, 2002, J MATER SCI, V37, P1747, DOI 10.1023/A:1014969000741; Sengupta S, 2000, METALL MATER TRANS A, V31, P239, DOI 10.1007/s11661-000-0068-4; Sengupta S., 1998, THESIS U TORONTO TOR; Shimizu T., 1993, P INT S DEV APPL CER, P541; SODA H, 1995, J MATER SCI, V30, P5438, DOI 10.1007/BF00351555; Soda H, 1997, J MATER SCI, V32, P1841, DOI 10.1023/A:1018552722865; Soda H, 2005, INT J CAST METAL RES, V18, P163, DOI 10.1179/136404605225022973; Soda H., 1996, INT J CAST METAL RES, V9, P37; Soda H., 2001, P MERT C FLEM S SOL, P513; YAMAZAKI H, 1993, J JPN I MET, V57, P190; YAMAZAKI H, 1994, J JPN I MET, V58, P37; Yamazaki H., 1994, IMONO, V66, P751; Yoshie S., 2011, GUTHR HON S MONTR JU	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	JUN	2015	24	6			SI		2240	2249		10.1007/s11665-015-1513-2		10	Materials Science, Multidisciplinary	Materials Science	CI6SF	WOS:000354890800009		
J	Joy-A-Ka, S; Ogawa, Y; Akebono, H; Kato, M; Sugeta, A; Sun, YF; Fujii, H				Joy-A-Ka, Sutep; Ogawa, Yuki; Akebono, Hiroyuki; Kato, Masahiko; Sugeta, Atsushi; Sun, Yufeng; Fujii, Hidetoshi			Fatigue Damage Evaluation of Friction Stir Spot Welded Cross-Tension Joints Under Repeated Two-Step Force Amplitudes	JOURNAL OF MATERIALS ENGINEERING AND PERFORMANCE			English	Article						cumulative fatigue damage; friction stir spot welding; low carbon steel; plastic deformation; two-step force amplitudes	LAP-SHEAR SPECIMENS; HIGH-CARBON STEEL; MECHANICAL-PROPERTIES; BEHAVIOR; TOOL; MICROSTRUCTURES; SHEETS; COPPER	This paper investigates an approach to evaluate the fatigue damage of FSSW cross-tension specimens under two-step force amplitude conditions. In fatigue tests with repeated two-step force amplitude, the fatigue limit of the welded joint disappeared. However, the fatigue damage evaluation using the modified Miner's rule erred too much on the side of safety, as the modified Miner's rule tends to overestimate the damage by applied forces below the fatigue limit. Thus, it was determined that, within the testing conditions used in this study, the fatigue damage evaluation using Haibach's method yielded an accurate evaluation. In the case where significant plastic deformation caused by the applied force occurred near the welded zone, the cumulative fatigue damage value based on Miner's rule was often larger than unity. Therefore, it is important to consider a cumulative damage estimation that takes into account the effect of pre-strain from the high force amplitude.	[Joy-A-Ka, Sutep; Ogawa, Yuki; Akebono, Hiroyuki; Kato, Masahiko; Sugeta, Atsushi] Hiroshima Univ, Grad Sch Engn, Dept Mech Sci & Engn, Hiroshima 7398527, Japan; [Sun, Yufeng; Fujii, Hidetoshi] Osaka Univ, Joining & Welding Res Inst, Osaka 5670047, Japan	Joy-A-Ka, S (reprint author), Hiroshima Univ, Grad Sch Engn, Dept Mech Sci & Engn, 1-4-1 Kagamiyama, Hiroshima 7398527, Japan.	sutep@tistr.or.th; asugeta@hiroshima-u.ac.jp	Akebono, Hiroyuki/J-5890-2014				Cui L, 2007, SCRIPTA MATER, V56, P637, DOI 10.1016/j.scriptamat.2006.12.004; Tran VX, 2008, INT J FATIGUE, V30, P2175, DOI 10.1016/j.ijfatigue.2008.05.025; Su P, 2006, SCI TECHNOL WELD JOI, V11, P61, DOI 10.1179/174329306X77056; Ma ZY, 2008, METALL MATER TRANS A, V39A, P642, DOI 10.1007/s11661-007-9459-0; Lee WB, 2004, MATER LETT, V58, P1041, DOI 10.1016/j.matlet.2003.08.014; Sato YS, 2007, SCRIPTA MATER, V57, P557, DOI 10.1016/j.scriptamat.2007.04.050; Mishra RS, 2005, MAT SCI ENG R, V50, P1, DOI 10.1016/j.mser.2005.07.001; Park HS, 2004, MAT SCI ENG A-STRUCT, V371, P160, DOI 10.1016/j.msea.2003.11.030; Costa JD, 2012, INT J FATIGUE, V37, P8, DOI 10.1016/j.ijfatigue.2011.10.001; Khorrami MS, 2012, MAT SCI ENG A-STRUCT, V543, P243, DOI 10.1016/j.msea.2012.02.082; Chung YD, 2010, SCRIPTA MATER, V63, P223, DOI 10.1016/j.scriptamat.2010.03.060; Wang DA, 2007, J MATER PROCESS TECH, V186, P291, DOI 10.1016/j.jmatprotec.2006.12.045; Lin PC, 2008, INT J FATIGUE, V30, P74, DOI 10.1016/j.ijfatigue.2007.02.016; [Anonymous], 2004, JSMSSD604; Babu S., 2012, J MATER ENG PERFORM, V22, P71; Boronski Dariusz, 2015, Solid State Phenomena, V224, DOI 10.4028/www.scientific.net/SSP.224.27; Costa J. D., 2011, International Journal of Structural Integrity, V2, DOI 10.1108/17579861111135888; Feng Z., 2005, 2005011248 SAE INT; Fratini L, 2009, INT J ADV MANUF TECH, V43, P664, DOI 10.1007/s00170-008-1750-8; Fujii H, 2011, SCRIPTA MATER, V64, P657, DOI 10.1016/j.scriptamat.2010.12.014; Haibach E., 1971, P C FAT WELD STRUCT, P328; Jonckheere C., 2011, INT J ADV MANUF TECH, V62, P569; Joy-A-Ka S., 2013, P 9 INT C FRACT STRE; Joy-A-Ka S, 2013, PROCEEDINGS OF THE 1ST INTERNATIONAL JOINT SYMPOSIUM ON JOINING AND WELDING, P435; Pathak N., 2012, J MATER ENG PERFORM, V22, P131; Radaj D., 2006, STRUCTURAL STRESS ST, P366; Shiraly M, 2014, J MATER ENG PERFORM, V23, P413, DOI 10.1007/s11665-013-0768-8; Soltysiak R., 2010, J POLISH CIMAC, V5, P187; Sun YF, 2012, MATER DESIGN, V37, P384, DOI 10.1016/j.matdes.2012.01.027; Tanegashima R, 2013, INT J FATIGUE, V51, P121, DOI 10.1016/j.ijfatigue.2012.12.014; Tanegashima R, 2015, FATIGUE FRACT ENG M, V38, P870, DOI 10.1111/ffe.12258; Uematsu Y, 2010, PROCEDIA ENGINEER, V2, P193, DOI 10.1016/j.proeng.2010.03.021	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9495	1544-1024		J MATER ENG PERFORM	J. Mater. Eng. Perform.	JUN	2015	24	6			SI		2494	2502		10.1007/s11665-015-1534-x		9	Materials Science, Multidisciplinary	Materials Science	CI6SF	WOS:000354890800040		
J	Kawai, K; Arima, K; Morita, M; Shoji, S				Kawai, Kentaro; Arima, Kenta; Morita, Mizuho; Shoji, Shuichi			Microfluidic valve array control system integrating a fluid demultiplexer circuit	JOURNAL OF MICROMECHANICS AND MICROENGINEERING			English	Article						microvalve; pneumatic valve; hydraulic valve; fluid logic circuit; demultiplexer; valve control system	ACTUATED MICROVALVE	This paper proposes an efficient control method for the large-scale integration of microvalves in microfluidic systems. The proposed method can control 2(n) individual microvalves with 2n + 2 control lines (where n is an integer). The on-chip valves are closed by applying pressure to a control line, similar to conventional pneumatic microvalves. Another control line closes gate valves between the control line to the on-chip valves and the on-chip valves themselves, to preserve the state of the on-chip valves. The remaining control lines select an activated gate valve. While the addressed gate valve is selected by the other control lines, the corresponding on-chip valve is actuated by applying input pressure to the control line to the on-chip valves. Using this method would substantially reduce the number of world-to-chip connectors and off-chip valve controllers. Experiments conducted using a fabricated 2(8) microvalve array device, comprising 256 individual on-chip valves controlled with 18 (2 x 8 + 2) control lines, yielded switching speeds for the selected on-chip valve under 90 ms.	[Kawai, Kentaro; Shoji, Shuichi] Waseda Univ, Dept Nanosci & Nanoengn, Shinjuku Ku, Tokyo 1698555, Japan; [Kawai, Kentaro; Arima, Kenta; Morita, Mizuho] Osaka Univ, Dept Precis Sci & Technol, Suita, Osaka 5650871, Japan	Kawai, K (reprint author), Waseda Univ, Dept Nanosci & Nanoengn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	kawai@prec.eng.osaka-u.ac.jp			Japan Ministry of Education, Culture, Sports Science and Technology, Scientific Basic Research of Osaka University [07113700, 19206046, 24760207]	The fabrication process was partly performed at the Waseda University Nanotechnology Research Center (NTRC). This work is partly supported by the Japan Ministry of Education, Culture, Sports Science and Technology, Scientific Basic Research (A) No. 07113700, Grant-in-Aid for Global COE of Waseda University, Scientific Basic Research (A) No. 19206046, and Grant-in-Aid for Young Scientists (B) No. 24760207 of Osaka University.	Kim JH, 2004, MICROELECTRON ENG, V73-4, P864, DOI 10.1016/j.mee.2004.03.066; Chen ML, 2011, APPL PHYS A-MATER, V102, P667, DOI 10.1007/s00339-010-6103-4; SHOJI S, 1994, J MICROMECH MICROENG, V4, P157, DOI 10.1088/0960-1317/4/4/001; Li B, 2005, SENSOR ACTUAT A-PHYS, V117, P325, DOI 10.1016/j.sna.2004.06.029; Fazal I, 2007, J MICROMECH MICROENG, V17, P2366, DOI 10.1088/0960-1317/17/11/026; Wei J, 2012, SOFT MATTER, V8, P8050, DOI 10.1039/c2sm25474c; Liu RH, 2002, J MICROELECTROMECH S, V11, P45, DOI 10.1109/84.982862; Go JS, 2004, SENSOR ACTUAT A-PHYS, V114, P438, DOI 10.1016/j.sna.2003.12.028; Thorsen T, 2002, SCIENCE, V298, P580, DOI 10.1126/science.1076996; Wang HY, 2008, BIOSENS BIOELECTRON, V24, P613, DOI 10.1016/j.bios.2008.06.005; Chiu SH, 2009, LAB CHIP, V9, P1524, DOI 10.1039/b900139e; Bintoro JS, 2005, MICROELECTRON J, V36, P667, DOI 10.1016/j.mejo.2005.04.038; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Kawai K, 2007, P 11 INT C MIN SYST, P683; Kawai K, 2009, P TRANSD 09, P802; Kawai K, 2008, P 12 INT C MIN SYST, P32; Miyamoto K, 2012, SENSOR ACTUAT A-PHYS, V188, P133, DOI 10.1016/j.sna.2012.06.001; Park JY, 2006, J MICROMECH MICROENG, V16, P656, DOI 10.1088/0960-1317/16/3/022; Sato T, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.06FJ03; Shibata Y, 2009, P 13 INT C MIN SYST, P1488; Shuichi S, 2011, MICROFLUIDICS, V304, P1; Yang BZ, 2007, SENSOR ACTUAT A-PHYS, V134, P194, DOI 10.1016/j.sna.2006.07.017; Yasuda T, 2008, IEEJ T ELECTR ELECTR, V3, P290, DOI 10.1002/tee.20269; Yoshida K, 2010, SENSOR ACTUAT A-PHYS, V157, P290, DOI 10.1016/j.sna.2009.11.030	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0960-1317	1361-6439		J MICROMECH MICROENG	J. Micromech. Microeng.	JUN	2015	25	6							065016	10.1088/0960-1317/25/6/065016		7	Engineering, Electrical & Electronic; Nanoscience & Nanotechnology; Instruments & Instrumentation; Materials Science, Multidisciplinary; Mechanics	Engineering; Science & Technology - Other Topics; Instruments & Instrumentation; Materials Science; Mechanics	CI5NE	WOS:000354803000016		
J	Kazawa, K; Takeshita, Y; Yorioka, N; Moriyama, M				Kazawa, Kana; Takeshita, Yae; Yorioka, Noriaki; Moriyama, Michiko			Efficacy of a disease management program focused on acquisition of self-management skills in pre-dialysis patients with diabetic nephropathy: 24 months follow-up	JOURNAL OF NEPHROLOGY			English	Article						Diabetic nephropathy; Patient education; Self management; Disease management	RENAL REPLACEMENT THERAPY; QUALITY-OF-LIFE; MULTIFACTORIAL INTERVENTION; HEALTH; MORTALITY	Purpose We previously performed a preliminary 6-month controlled trial to examine the effect of a disease management education program on prolongation of the time to renal replacement therapy (RRT) and/or avoidance of RRT for patients with diabetic nephropathy. However, its duration was too short to follow the changes of renal function, so we performed the present study for 24 months. Methods This was a two-group comparative study. The intervention group received self-management education from disease management nurses and was supported by the nurses in cooperation with their primary physicians for 12 months. Then this group was followed for a further 12 months. The control group received standard care and was followed for 24 months. Results Of the 31 subjects enrolled in each group, 26 subjects in the intervention group and 27 subjects in the control group were analyzed after excluding drop-outs. During the study period, 0 and 2 subjects in the intervention and the control group started RRT, respectively. In the intervention group, renal function was maintained, while significant worsening was observed in the control group. Hemoglobin A1c (HbA1c) improved in the intervention group, but became significantly worse in the control group. In the intervention group, all process indicators of behavior modification increased significantly after intervention. Conclusion A well-designed disease management program might be useful for maintaining renal function and improving HbA1c in patients with diabetic nephropathy. It is considered that modification of patient behavior contributed to these results.	[Kazawa, Kana; Moriyama, Michiko] Hiroshima Univ, Inst Biomed & Hlth Sci, Div Nursing Sci, Minami Ku, Hiroshima 7348553, Japan; [Takeshita, Yae] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Div Nursing Sci, Minami Ku, Hiroshima 7348553, Japan; [Yorioka, Noriaki] Hiroshima Kidney Org, Aki Ku, Hiroshima 7360084, Japan	Kazawa, K (reprint author), Hiroshima Univ, Inst Biomed & Hlth Sci, Div Nursing Sci, Minami Ku, Kasumi 1-2-3, Hiroshima 7348553, Japan.	kanak1016@gmail.com					Alicic RZ, 2010, SEMIN DIALYSIS, V23, P140, DOI 10.1111/j.1525-139X.2010.00700.x; American Diabetes Association, 2003, DIABETES CARE S1, V26, P94; Wauters JP, 2004, NEPHROL DIAL TRANSPL, V19, P2341, DOI 10.1093/ndt/gfh387; Williams ME, 2010, SEMIN DIALYSIS, V23, P129, DOI 10.1111/j.1525-139X.2009.00698.x; Grace BS, 2012, NEPHROLOGY, V17, P76, DOI 10.1111/j.1440-1797.2011.01512.x; Mapes DL, 2003, KIDNEY INT, V64, P339, DOI 10.1046/j.1523-1755.2003.00072.x; Iseki K, 2005, NEPHROLOGY, V10, pS2, DOI 10.1111/j.1440-1797.2005.00447.x; Gaede P, 2003, NEW ENGL J MED, V348, P383; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037//0033-295X.84.2.191; Prochaska JO, 1997, AM J HEALTH PROMOT, V12, P38; Buren PNV, 2013, CURR DIABETES REV, V9, P62; Gaede P, 2008, NEW ENGL J MED, V358, P580, DOI 10.1056/NEJMoa0706245; Ginieri-Coccossis M, 2008, BMC NEPHROL, V9, DOI 10.1186/1471-2369-9-14; Gustafson D, 2012, J MED INTERNET RES, V14, P41, DOI 10.2196/jmir.1964; Howe RS, 2005, DIS MANAGEMENT CONTE, V1st, P1; Japan Diabetes Society, 2009, EV BAS PRACT GUID TR; Japanese Society of Nephrology, 2009, EV BAS PRACT GUID TR; Japanese Society of Nephrology, 2013, EV BAS PRACT GUID TR; Joss N, 2004, QJM-INT J MED, V97, P219, DOI 10.1093/qjmed/hch039; Kazawa K, 2013, J JPN ACAD NEPHROL N, V14, P92; Kazawa K, 2013, NEPHROL NURS J, V40, P141; Kim W, 1996, PSYCHOSOM MED, V36, P499; Locatelli F, 2004, J AM SOC NEPHROL, V15, pS25, DOI 10.1097/01.ASN.0000093239.32602.04; Ministry of Health Labour and Welfare Renal disease control committee, 2008, FUT REN DIS CONTR; Nakatani T, 2008, TRANPLANTATION NOW, V23, P143; Scottish Intercollegiate Guidelines Networks (SIGN), 2008, SIGN 103 DIAGN MAN C; Tazaki M, 2007, INTRO WHOQOL26	27	0	0	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	JUN	2015	28	3					329	338		10.1007/s40620-014-0144-2		10	Urology & Nephrology	Urology & Nephrology	CI6SW	WOS:000354892900009		
J	Hoshino, J; Suwabe, T; Hayami, N; Sumida, K; Mise, K; Kawada, M; Imafuku, A; Hiramatsu, R; Yamanouchi, M; Hasegawa, E; Sawa, N; Takei, R; Takaichi, K; Ubara, Y				Hoshino, Junichi; Suwabe, Tatsuya; Hayami, Noriko; Sumida, Keiichi; Mise, Koki; Kawada, Masahiro; Imafuku, Aya; Hiramatsu, Rikako; Yamanouchi, Masayuki; Hasegawa, Eiko; Sawa, Naoki; Takei, Ryoji; Takaichi, Kenmei; Ubara, Yoshifumi			Survival after arterial embolization therapy in patients with polycystic kidney and liver disease	JOURNAL OF NEPHROLOGY			English	Article						Autosomal dominant polycystic kidney disease (ADPKD); Hepatic transcatheter arterial embolization (hepatic TAE); Renal transcatheter arterial embolization (renal TAE); Polycystic liver disease (PLD); Survival; Cause of death	TREATMENT OPTIONS; CYSTS; PATHOPHYSIOLOGY; HEMODIALYSIS; CRITERIA; VOLUME; ADPKD; JAPAN	Background Transcatheter arterial embolization (TAE) has become a therapeutic option for symptomatic polycystic kidney disease (PKD) and polycystic liver disease (PLD). However, factors affecting survival with renal TAE remain unknown. Methods All symptomatic patients with severe PKD and/ or PLD who received renal and/or hepatic TAE at our center from October 1996 through March 2013 (n = 1,028) were followed until death. Their survival was compared with that of the general PKD population on dialysis in Japan. Factors affecting survival were analyzed using the Cox hazard model. Results After renal TAE, 5- and 10-year survival was, respectively, 0.78 (95 % confidence interval, 0.74-0.82) and 0.56 (0.49-0.63); with hepatic TAE, 0.69 (0.58-0.77) and 0.41 (0.22-0.60); and with dual TAE (renal and hepatic), 0.82 (0.72-0.88) and 0.45 (0.31-0.59). Survival after dialysis initiation was better among patients with renal TAE than among general PKD patients. Factors affecting survival after renal TAE were age [hazard ratio (HR) 3.02 (1.44-6.33) for every 10 years] and albumin [HR 0.70 (0.55-0.89) per 0.1 g/dl]. Kidney volume was not associated with patient death after TAE. The main causes of death among patients after renal TAE were similar to those of the general PKD population on dialysis whereas, after hepatic TAE, the main cause was cyst infection with liver failure (12.5 % with PLD and 5.9 % with PKD, p < 0.01). Conclusion Survival after renal TAE with severe PKD was better than for the general PKD population on dialysis, suggesting that renal TAE could overcome the disadvantage due to huge organ size.	[Hoshino, Junichi; Suwabe, Tatsuya; Hayami, Noriko; Sumida, Keiichi; Mise, Koki; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Takatsu Ku, Kawasaki, Kanagawa 2138587, Japan; [Hoshino, Junichi; Suwabe, Tatsuya; Hayami, Noriko; Sumida, Keiichi; Kawada, Masahiro; Imafuku, Aya; Hiramatsu, Rikako; Yamanouchi, Masayuki; Hasegawa, Eiko; Sawa, Naoki; Takaichi, Kenmei; Ubara, Yoshifumi] Toranomon Gen Hosp, Nephrol Ctr, Tokyo, Japan; [Takei, Ryoji] Touzan Hosp, Dept Radiol, Tokyo, Japan	Hoshino, J (reprint author), Toranomon Gen Hosp, Nephrol Ctr, Takatsu Ku, 1-3-1 Kajigaya, Kawasaki, Kanagawa 2138587, Japan.	hoshino@toranomon.gr.jp			Okinaka Memorial Institute; Toranomon Hospital; The Kidney Foundation, Japan [JKFB13-9]; Japanese Association of Dialysis Physicians (JADP Grant) [2013-11]	This work was supported by JH's research Grants from the Okinaka Memorial Institute, Toranomon Hospital, and The Kidney Foundation, Japan (JKFB13-9), by TS's Grant from the Japanese Association of Dialysis Physicians (JADP Grant 2013-11), and by YU's grant from the Okinaka Memorial Institute.	Abu-Wasel B, 2013, WORLD J GASTROENTERO, V19, P5775, DOI 10.3748/wjg.v19.i35.5775; Bae KT, 2006, CLIN J AM SOC NEPHRO, V1, P64, DOI 10.2215/CJN.00080605; DAVIES F, 1991, Q J MED, V79, P477; Park HC, 2009, J KOREAN MED SCI, V24, P57, DOI 10.3346/jkms.2009.24.1.57; Higashihara E, 1998, NEPHRON, V80, P421, DOI 10.1159/000045214; Ubara Y, 2002, AM J KIDNEY DIS, V39, P571, DOI 10.1053/ajkd.2002.31407; Hoshino J, 2014, AM J KIDNEY DIS, V63, P937, DOI 10.1053/j.ajkd.2014.01.422; Temmerman F, 2011, ALIMENT PHARM THER, V34, P702, DOI 10.1111/j.1365-2036.2011.04783.x; Higashihara E, 2012, CLIN EXP NEPHROL, V16, P622, DOI 10.1007/s10157-012-0611-9; Grantham JJ, 2006, NEW ENGL J MED, V354, P2122, DOI 10.1056/NEJMoa054341; Torres VE, 2012, NEW ENGL J MED, V367, P2407, DOI 10.1056/NEJMoa1205511; Nakai S, 2012, THER APHER DIAL, V16, P11, DOI 10.1111/j.1744-9987.2011.01050.x; Sherstha R, 1997, HEPATOLOGY, V26, P1282; Torres VE, 2007, AM J KIDNEY DIS, V49, P725, DOI 10.1053/j.ajkd.2007.04.009; Pei Y, 2009, J AM SOC NEPHROL, V20, P205, DOI 10.1681/ASN.2008050507; Drenth JPH, 2010, HEPATOLOGY, V52, P2223, DOI 10.1002/hep.24036; Takei R, 2007, AM J KIDNEY DIS, V49, P744, DOI 10.1053/j.ajkd.2007.03.018; Kistler AD, 2009, KIDNEY INT, V75, P235, DOI 10.1038/ki.2008.558; MILUTINOVIC J, 1980, AM J MED, V68, P741, DOI 10.1016/0002-9343(80)90266-1; Torres VE, 2009, KIDNEY INT, V76, P149, DOI 10.1038/ki.2009.128; FICK GM, 1995, J AM SOC NEPHROL, V5, P2048; Bistritz L, 2005, AM J GASTROENTEROL, V100, P2212, DOI 10.1111/j.1572-0241.2005.50258.x; Patient_Registration_Committee, 2011, OV REG DIAL TREATM J; Suwabe T, 2012, CLIN EXP NEPHROL, V16, P892, DOI 10.1007/s10157-012-0650-2; Ubara Y, 2004, AM J KIDNEY DIS, V43, P733, DOI 10.1053/j.ajkd.2003.12.035; Ubara Y, 1999, AM J KIDNEY DIS, V34, P926, DOI 10.1016/S0272-6386(99)70052-1	26	0	0	WICHTIG EDITORE	MILAN	72/74 VIA FRIULI, 20135 MILAN, ITALY	1121-8428	1724-6059		J NEPHROL	J. Nephrol.	JUN	2015	28	3					369	377		10.1007/s40620-014-0138-0		9	Urology & Nephrology	Urology & Nephrology	CI6SW	WOS:000354892900013		
J	Ohmae, S; Takahashi, T; Lu, XF; Nishimori, Y; Kodaka, Y; Takashima, I; Kitazawa, S				Ohmae, Shogo; Takahashi, Toshimitsu; Lu, Xiaofeng; Nishimori, Yasunori; Kodaka, Yasushi; Takashima, Ichiro; Kitazawa, Shigeru			Decoding the timing and target locations of saccadic eye movements from neuronal activity in macaque oculomotor areas	JOURNAL OF NEURAL ENGINEERING			English	Article						brain-machine interface; timing based BMI; frontal eye field; supplementary eye field; monkey	DELAYED VISUAL FEEDBACK; PREFRONTAL CORTEX; CORTICAL CONTROL; NEURAL CONTROL; MOTOR CORTEX; FIELD; TIME; MICROSTIMULATION; IMPLANTATION; PERFORMANCE	Objective. The control of movement timing has been a significant challenge for brain-machine interfaces (BMIs). As a first step toward developing a timing-based BMI, we aimed to decode movement timing and target locations in a visually guided saccadic eye movement task using the activity of neurons in the primate frontal eye field (FEF) and supplementary eye field (SEF). Approach. For this purpose, we developed a template-matching method that could recruit a variety of neurons in these areas. Main results. As a result, we were able to achieve a favorable estimation of saccade onset: for example, data from 20 randomly sampled FEF neurons or 40 SEF neurons achieved a median estimation error of similar to 10 ms with an interquartile range less than 50 ms (+/- similar to 25 ms). In the best case, seven simultaneously recorded SEF neurons using a multielectrode array achieved a comparable accuracy (10 +/- 30 ms). The method was significantly better than a heuristic method that used only a group of movement cells with sharp discharges at the onset of saccades. The estimation of target location was less accurate but still favorable, especially when we estimated target location at a timing of 200 ms after the onset of saccade: the method was able to discriminate 16 targets with an accuracy of 90%, which differed not only in their directions (eight directions) but also in amplitude (10/20 degrees) when we used data from 61 randomly sampled FEF neurons. Significance. The results show that the timing, amplitude and direction of saccades can be decoded from neuronal activity in the FEF and SEF and further suggest that timing-based BMIs can be developed by decoding timing information using the template-matching method.	[Ohmae, Shogo; Takahashi, Toshimitsu; Lu, Xiaofeng; Kitazawa, Shigeru] Juntendo Univ, Grad Sch Med, Dept Neurophysiol, Tokyo 1138421, Japan; [Ohmae, Shogo] Hokkaido Univ, Sch Med, Dept Physiol, Sapporo, Hokkaido 0608638, Japan; [Takahashi, Toshimitsu; Kitazawa, Shigeru] Osaka Univ, Grad Sch Frontier Biosci, Dynam Brain Network Lab, Osaka 5650871, Japan; [Takahashi, Toshimitsu; Kitazawa, Shigeru] Osaka Univ, Grad Sch Med, Dept Brain Physiol, Osaka 5650871, Japan; [Takahashi, Toshimitsu; Nishimori, Yasunori; Kodaka, Yasushi; Takashima, Ichiro; Kitazawa, Shigeru] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki, Japan; [Lu, Xiaofeng] Vet Adm Med Ctr, Minneapolis, MN 55417 USA; [Lu, Xiaofeng] Univ Minnesota, Dept Neurol, Minneapolis, MN 55414 USA	Ohmae, S (reprint author), Univ Penn, Dept Psychol, 3815 Walnut St, Philadelphia, PA 19104 USA.	sohmae@sas.upenn.edu; kitazawa@fbs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18500247, 21240029, 25119002]; Japan Society for the Promotion of Science	We are grateful to Hidetoshi Takada and Haruyo Kimizuka for technical assistance and Keiko Ohmae for editing illustrations. We thank Dr Yusuke Uchida for his contribution in recording data from SEF. This work was supported by the Grants-in-Aid for Scientific Research to XL (18500247) and to SK (21240029 and 25119002) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. SO was supported by the Research Fellowship for doctoral studies from the Japan Society for the Promotion of Science.	Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Nicolelis MAL, 2001, NATURE, V409, P403, DOI 10.1038/35053191; Schwartz AB, 2006, NEURON, V52, P205, DOI 10.1016/j.neuron.2006.09.019; Schafer RJ, 2011, SCIENCE, V332, P1568, DOI 10.1126/science.1199892; Taylor DM, 2002, SCIENCE, V296, P1829, DOI 10.1126/science.1070291; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Lu XF, 2002, NEURON, V34, P317, DOI 10.1016/S0896-6273(02)00657-8; Suner S, 2005, IEEE T NEUR SYS REH, V13, P524, DOI 10.1109/TNSRE.2005.857687; Serruya MD, 2002, NATURE, V416, P141, DOI 10.1038/416141a; Yanagisawa T, 2011, J NEUROSURG, V114, P1715, DOI 10.3171/2011.1.JNS101421; Heinzle J, 2007, J NEUROSCI, V27, P9341, DOI 10.1523/JNEUROSCI.0974-07.2007; Opris I, 2005, J COGNITIVE NEUROSCI, V17, P893, DOI 10.1162/0898929054021120; Stuphorn V, 2006, NAT NEUROSCI, V9, P925, DOI 10.1038/nn1714; SchlagRey M, 1997, NATURE, V390, P398, DOI 10.1038/37114; Marescaux J, 2002, ANN SURG, V235, P487, DOI 10.1097/00000658-200204000-00005; Tanaka M, 1998, J NEUROPHYSIOL, V80, P28; Chapin JK, 1999, NAT NEUROSCI, V2, P664, DOI 10.1038/10223; Wessberg J, 2000, NATURE, V408, P361; Chen LL, 1997, J NEUROPHYSIOL, V78, P1166; CHEN LL, 1995, J NEUROPHYSIOL, V73, P1122; BRUCE CJ, 1985, J NEUROPHYSIOL, V53, P603; Hanes DP, 1996, SCIENCE, V274, P427, DOI 10.1126/science.274.5286.427; OLSON CR, 1995, SCIENCE, V269, P985, DOI 10.1126/science.7638625; Carmena Jose M, 2003, PLoS Biol, V1, pE42; Fujisaki W, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00061; Graf ABA, 2014, ELIFE, V3, DOI 10.7554/eLife.02813; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Lebedev MA, 2008, J NEUROPHYSIOL, V99, P166, DOI 10.1152/jn.00734.2007; Lu XF, 1998, J NEUROPHYSIOL, V79, P2245; Ohmae S, 2008, EXP BRAIN RES, V184, P593, DOI 10.1007/s00221-007-1234-3; Opris I, 2001, EXP BRAIN RES, V138, P1, DOI 10.1007/s002210100686; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Quiroga RQ, 2006, J NEUROSCI, V26, P3615, DOI 10.1523/JNEUROSCI.3468-05.2006; ROBINSON DA, 1963, IEEE T BIO-MED ENG, VBM10, P137, DOI 10.1109/TBMEL.1963.4322822; Salinas E, 1994, J Comput Neurosci, V1, P89, DOI 10.1007/BF00962720; Scherberger H, 2003, J NEUROSCI METH, V130, P1, DOI 10.1016/S0165-0270(03)00190-0; SCHLAG J, 1987, J NEUROPHYSIOL, V57, P179; SMITH WM, 1960, SCIENCE, V132, P1013, DOI 10.1126/science.132.3433.1013; Uchida Y, 2007, J NEUROSCI, V27, P13750, DOI 10.1523/JNEUROSCI.2693-07.2007; Willett FR, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026011	41	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	JUN	2015	12	3							036014	10.1088/1741-2560/12/3/036014		21	Engineering, Biomedical; Neurosciences	Engineering; Neurosciences & Neurology	CI8DI	WOS:000354998600015		
J	Yin, XX; Xu, BL; Jiang, CH; Fu, YF; Wang, ZD; Li, HY; Shi, G				Yin, Xuxian; Xu, Baolei; Jiang, Changhao; Fu, Yunfa; Wang, Zhidong; Li, Hongyi; Shi, Gang			A hybrid BCI based on EEG and fNIRS signals improves the performance of decoding motor imagery of both force and speed of hand clenching	JOURNAL OF NEURAL ENGINEERING			English	Article						EEG-fNIRS; hand clenching force and speed; motor imagery; joint mutual information (JMI); extreme learning machines (ELMs)	NEAR-INFRARED SPECTROSCOPY; BRAIN-COMPUTER-INTERFACE; EXTREME LEARNING-MACHINE; THEORETIC FEATURE-SELECTION; OPTICAL PATHLENGTH; MENTAL TASKS; CLASSIFICATION; COMMUNICATION; RECOGNITION; MOVEMENTS	Objective. In order to increase the number of states classified by a brain-computer interface (BCI), we utilized a motor imagery task where subjects imagined both force and speed of hand clenching. Approach. The BCI utilized simultaneously recorded electroencephalographic (EEG) and functional near-infrared spectroscopy (fNIRS) signals. The time-phase-frequency feature was extracted from EEG, whereas the HbD [the difference of oxy-hemoglobin (HbO) and deoxyhemoglobin (Hb)] feature was used to improve the classification accuracy of fNIRS. The EEG and fNIRS features were combined and optimized using the joint mutual information (JMI) feature selection criterion; then the extracted features were classified with the extreme learning machines (ELMs). Main results. In this study, the averaged classification accuracy of EEG signals achieved by the time-phase-frequency feature improved by 7%, to 18%, more than the single-type feature, and improved by 15% more than common spatial pattern (CSP) feature. The HbD feature of fNIRS signals improved the accuracy by 1%, to 4%, more than Hb, HbO, or HbT (total hemoglobin). The EEG-fNIRS feature for decoding motor imagery of both force and speed of hand clenching achieved an accuracy of 89% +/- 2%, and improved the accuracy by 1% to 5% more than the sole EEG or fNIRS feature. Significance. Our novel motor imagery paradigm improves BCI performance by increasing the number of extracted commands. Both the time-phase-frequency and the HbD feature improve the classification accuracy of EEG and fNIRS signals, respectively, and the hybrid EEG-fNIRS technique achieves a higher decoding accuracy for two-class motor imagery, which may provide the framework for future multi-modal online BCI systems.	[Yin, Xuxian; Xu, Baolei; Wang, Zhidong; Li, Hongyi; Shi, Gang] Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China; [Yin, Xuxian] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Jiang, Changhao] Capital Inst Phys Educ, Key Lab Motor & Brain imaging, Beijing 100088, Peoples R China; [Fu, Yunfa] Kunming Univ Sci & Technol, Sch Automat & Informat Engn, Kunming 650500, Peoples R China; [Wang, Zhidong] Chiba Inst Technol, Dept Adv Robot, Chiba 2750016, Japan; [Li, Hongyi] Northeastern Univ, Sch Mech Engn & Automat, Shenyang 110004, Peoples R China	Yin, XX (reprint author), Chinese Acad Sci, Shenyang Inst Automat, State Key Lab Robot, Shenyang 110016, Peoples R China.	blxu@sina.cn			National Natural Science Foundation (NNSF) of China [61203368, 81470084, 61463024]; National High Technology Research and Development Program of China (863 Program) [2012AA02A605]	This work is supported by the National Natural Science Foundation (NNSF) of China under Grant Nos. 61203368, 81470084, and 61463024, and by the National High Technology Research and Development Program of China (863 Program) under Grant No. 2012AA02A605.	Brown G, 2012, J MACH LEARN RES, V13, P27; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; De Massari D, 2013, BRAIN, V136, P1989, DOI 10.1093/brain/awt102; Tachtsidis I, 2009, ADV EXP MED BIOL, V645, P307, DOI 10.1007/978-0-387-85998-9_46; Ortiz-Rosario A, 2013, REV NEUROSCIENCE, V24, P537, DOI 10.1515/revneuro-2013-0032; McFarland DJ, 1997, ELECTROEN CLIN NEURO, V103, P386, DOI 10.1016/S0013-4694(97)00022-2; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Scherer R, 2013, TRENDS COGN SCI, V17, P490, DOI 10.1016/j.tics.2013.08.004; Takahashi T, 2011, NEUROIMAGE, V57, P991, DOI 10.1016/j.neuroimage.2011.05.012; DELPY DT, 1988, PHYS MED BIOL, V33, P1433, DOI 10.1088/0031-9155/33/12/008; Donoghue JP, 2008, NEURON, V60, P511, DOI 10.1016/j.neuron.2008.10.037; Wolpaw JR, 2002, CLIN NEUROPHYSIOL, V113, P767, DOI 10.1016/S1388-2457(02)00057-3; Meyer PE, 2008, IEEE J-STSP, V2, P261, DOI 10.1109/JSTSP.2008.923858; Huang GB, 2012, IEEE T SYST MAN CY B, V42, P513, DOI 10.1109/TSMCB.2011.2168604; VIDAL JJ, 1973, ANNU REV BIOPHYS BIO, V2, P157, DOI 10.1146/annurev.bb.02.060173.001105; Bonnet L, 2013, IEEE T COMP INTEL AI, V5, P185, DOI 10.1109/TCIAIG.2012.2237173; McFarland DJ, 2000, BRAIN TOPOGR, V12, P177, DOI 10.1023/A:1023437823106; Huang GB, 2006, NEUROCOMPUTING, V70, P489, DOI 10.1016/j.neucom.2005.12.126; DUNCAN A, 1995, PHYS MED BIOL, V40, P295, DOI 10.1088/0031-9155/40/2/007; Gysels E, 2004, IEEE T NEUR SYS REH, V12, P406, DOI 10.1109/TNSRE.2004.838443; Cui X, 2010, NEUROIMAGE, V49, P3039, DOI 10.1016/j.neuroimage.2009.11.050; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Yu X, 2014, OPTIK, V125, P1498, DOI 10.1016/j.ijleo.2013.09.013; Scholkmann F, 2013, NEUROIMAGE, V66, P71, DOI 10.1016/j.neuroimage.2012.10.025; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Hashimoto Y, 2013, CLIN NEUROPHYSIOL, V124, P2153, DOI 10.1016/j.clinph.2013.05.006; Marshall D, 2013, IEEE T COMP INTEL AI, V5, P82, DOI 10.1109/TCIAIG.2013.2263555; Kirilina E, 2012, NEUROIMAGE, V61, P70, DOI 10.1016/j.neuroimage.2012.02.074; Coyle S, 2004, PHYSIOL MEAS, V25, P815, DOI 10.1088/0967-3334/25/4/003; Fazli S, 2012, NEUROIMAGE, V59, P519, DOI 10.1016/j.neuroimage.2011.07.084; Sun HY, 2011, NEURAL REGEN RES, V6, P2198, DOI 10.3969/j.issn.1673-5374.2011.28.007; Matthews F, 2008, IEEE SIGNAL PROC MAG, V25, P87, DOI [10.1109/MSP.2008.4408445, 10.1109/MSP2007.909011]; Cope M., 1991, THESIS U COLL LONDON; Erdogan SB, 2014, NEUROIMAGE, V87, P490, DOI 10.1016/j.neuroimage.2013.10.024; Friedrich EVC, 2013, CLIN NEUROPHYSIOL, V124, P916, DOI 10.1016/j.clinph.2012.11.010; Gagnon L, 2013, NEUROIMAGE, V85, P127; Hoshi Y, 2005, INT REV NEUROBIOL, V66, P237, DOI 10.1016/S0074-7742(05)66008-4; Hoshi Y, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2804911; Huang G. B., 2004, IEEE INT JOINT C NEU; Jochumsen M, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/5/056015; Kubler A, 2013, BRAIN, V136, P2001, DOI DOI 10.1093/BRAIN/AWT077; Le Van Quyen M, 2001, J NEUROSCI METH, V111, P83, DOI 10.1016/S0165-0270(01)00372-7; Li J, 2009, J CIRCUIT SYST COMP, V18, P1441, DOI 10.1142/S0218126609005861; Liang NY, 2006, INT J NEURAL SYST, V16, P29, DOI 10.1142/S0129065706000482; Rao C R, 1972, P 6 BERK S MATH STAT; Sano A, 2009, INT J NEUROSCI, V119, P639, DOI 10.1080/00207450802325561; Scholkmann F, 2014, NEUROIMAGE, V85, P6, DOI 10.1016/j.neuroimage.2013.05.004; Yoshino K, 2012, NEUROREPORT, V23, P947, DOI 10.1097/WNR.0b013e328359833b; Yuan H, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/2/026001	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	1741-2560	1741-2552		J NEURAL ENG	J. Neural Eng.	JUN	2015	12	3							036004	10.1088/1741-2560/12/3/036004		12	Engineering, Biomedical; Neurosciences	Engineering; Neurosciences & Neurology	CI8DI	WOS:000354998600005		
J	Hatano, T; Motomura, H; Ayabe, S				Hatano, Takaharu; Motomura, Hisashi; Ayabe, Shinobu			Reconstruction Using Locoregional Flaps for Large Skull Base Defects	JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE			English	Article						skull base; skull base defect; locoregional flap reconstruction; free flap	ANTERIOR; RESECTION; TUMOR	We present a modified locoregional flap for the reconstruction of large anterior skull base defects that should be reconstructed with a free flap according to Yano's algorithm. No classification of skull base defects had been proposed for a long time. Yano et al suggested a new classification in 2012. The lb defect of Yano's classification extends horizontally from the cribriform plate to the orbital roof. According to Yano's algorithm for subsequent skull base reconstructive procedures, a lb defect should be reconstructed with a free flap such as an anterolateral thigh free flap or rectus abdominis myocutaneous free flap. However, our modified locoregional flap has also enabled reconstruction of lb defects. In this case series, we used a locoregional flap for lb defects. No major postoperative complications occurred. We present our modified locoregional flap that enables reconstruction of lb defects.	[Hatano, Takaharu; Motomura, Hisashi] Osaka City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Osaka 5458585, Japan; [Ayabe, Shinobu] Yao Tokushukai Gen Hosp, Dept Plast & Reconstruct Surg, Osaka, Japan	Motomura, H (reprint author), Osaka City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	motomura@med.osaka-cu.ac.jp					Kiyokawa K, 1999, SKULL BASE SURG, V9, P211, DOI 10.1055/s-2008-1058149; Gil Z, 2007, SKULL BASE-INTERD AP, V17, P25, DOI 10.1055/s-2006-959333; Biron VL, 2012, J CRANIOFAC SURG, V23, P1763, DOI 10.1097/SCS.0b013e3182653f29; Duchateau NC, 2014, J PLAST SURG HAND SU, V48, P222, DOI 10.3109/2000656X.2013.779795; Neligan PC, 2013, PLAST RECONSTR SURG, V131, p260E, DOI 10.1097/PRS.0b013e3182778938; Thakker JS, 2014, J ORAL MAXIL SURG, V72, P198, DOI 10.1016/j.joms.2013.05.017; Yano T, 2012, J NEUROL SURG PART B, V73, P125, DOI 10.1055/s-0032-1301402; Yano T, 2011, J CRANIOFAC SURG, V22, P482, DOI 10.1097/SCS.0b013e318207b714	8	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6331	2193-634X		J NEUROL SURG PART B	Journal of Neurol. Surg. Part B	JUN	2015	76	3					167	170		10.1055/s-0034-1390397		4	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI2YI	WOS:000354613800001		
J	Shimizu, K; Matsumoto, M; Wada, A; Sugiyama, T; Tanioka, D; Okumura, H; Fujishima, H; Nakajo, T; Nakayama, S; Yabuzaki, H; Mizutani, T				Shimizu, Katsuyoshi; Matsumoto, Masaki; Wada, Akira; Sugiyama, Tatsuya; Tanioka, Daisuke; Okumura, Hirotaka; Fujishima, Hirotake; Nakajo, Takato; Nakayama, Sadayoshi; Yabuzaki, Hajime; Mizutani, Tohoru			Supine No-Retractor Method in Microvascular Decompression for Hemifacial Spasm: Results of 100 Consecutive Operations	JOURNAL OF NEUROLOGICAL SURGERY PART B-SKULL BASE			English	Article						hemifacial spasm; microvascular decompression; supine position; no retractor	COMPRESSION SYNDROMES; VASCULAR COMPRESSION; TRIGEMINAL NEURALGIA; FACIAL-NERVE; ZONE; MYELIN	Objectives In microvascular decompression (MVD) for hemifacial spasm (HFS), the patient is placed in the lateral or park-bench position that is complicated and uncomfortable for anesthesiologists, nurses, and even the patient. Careless retraction of the cerebellum by a spatula could be the major cause of surgical complications. In our method, a patient is laid supine avoiding the complicated positioning. The subfloccular approach from a small cranial window sited on the more lateral and basal side of the occipital cranium enables the surgeon to reach all the segments of the facial nerve root without a spatula. We introduce our surgical procedures in detail along with our excellent results. Methods A total of 100 consecutive patients experiencing primary HFS were operated on with MVD by a single surgeon in our institution from August 2012 to April 2014. Results Overall, 94 patients showed the complete disappearance or a satisfactory alleviation of HFS. De novo neurologic deficits were not encountered after surgery including hearing impairment. In 47 cases, multiple offending vessels were observed in multiple possible affected sites in addition to the root entry/exit zone. Conclusions We believe this approach is superior for the safe and precise decompression of any part of the facial nerve root.	[Shimizu, Katsuyoshi; Matsumoto, Masaki; Wada, Akira; Sugiyama, Tatsuya; Tanioka, Daisuke; Okumura, Hirotaka; Fujishima, Hirotake; Nakajo, Takato; Nakayama, Sadayoshi; Yabuzaki, Hajime; Mizutani, Tohoru] Showa Univ, Sch Med, Dept Neurosurg, Tokyo 1428666, Japan	Shimizu, K (reprint author), Showa Univ, Sch Med, Dept Neurosurg, Shinagawa Ku, 5-8 Hatanodai 1, Tokyo 1428666, Japan.	k.shimizu@med.showa-u.ac.jp					Tomii M, 2003, J NEUROSURG, V99, P121, DOI 10.3171/jns.2003.99.1.0121; Liang QH, 2012, ACTA NEUROCHIR, V154, P1621, DOI 10.1007/s00701-012-1387-0; JANNETTA PJ, 1977, J NEUROSURG, V47, P321, DOI 10.3171/jns.1977.47.3.0321; ADAMS CBT, 1989, J NEUROSURG, V70, P1, DOI 10.3171/jns.1989.70.1.0001; Hitotsumatsu T, 2003, NEUROSURGERY, V53, P1436, DOI 10.1227/01.NEU.0000093431.43456.3B; JANNETTA PJ, 1967, J NEUROSURG, V26, P159, DOI 10.3171/jns.1967.26.1part2.0159; Campos-Benitez M, 2008, J NEUROSURG, V109, P416, DOI 10.3171/JNS/2008/109/9/0416; Zhang M, 2002, OTOLARYNG HEAD NECK, V127, P452, DOI 10.1067/mhn.2002.129823; McLaughlin MR, 1999, J NEUROSURG, V90, P1, DOI 10.3171/jns.1999.90.1.0001; BARKER FG, 1995, J NEUROSURG, V82, P201, DOI 10.3171/jns.1995.82.2.0201; CARLOS R, 1986, NEURORADIOLOGY, V28, P288; De Ridder D, 2002, NEUROSURGERY, V51, P433; De Ridder D, 2002, NEUROSURGERY, V51, P427, DOI 10.1227/01.NEU.0000020080.8116.9D; Fukunaga A, 2013, ACTA NEUROCHIR, V155, P1693, DOI 10.1007/s00701-013-1724-y; GARDNER WJ, 1962, J NEUROSURG, V19, P240, DOI 10.3171/jns.1962.19.3.0240; Guclu B, 2011, ACTA NEUROCHIR, V153, P2365, DOI 10.1007/s00701-011-1168-1; Ishikawa M, 2001, NEUROSURGERY, V49, P847, DOI 10.1097/00006123-200110000-00013; Jannetta PJ, 2005, TECHNICAL NOTE NEURO, V18, pE5; Jannetta PJ, 1982, NEUROLOGICAL SURGERY, V6, P3589; Kim EY, 2001, ACTA NEUROCHIR, V143, P141, DOI 10.1007/s007010170119; KONDO A, 1981, Neurologia Medico-Chirurgica, V21, P287; Li Y, 2013, ACTA NEUROCHIR, V155, P849, DOI 10.1007/s00701-013-1623-2; Lovely TJ, 1998, NEUROSURG QUART, V8, P92, DOI 10.1097/00013414-199806000-00003; NEAGOY DR, 1974, CLEVELAND CLIN Q, V41, P205; NISHIHARA K, 1986, Neurological Surgery, V14, P509; Ruby J R, 1975, Surg Neurol, V4, P369; T Hitotsumatsu, 2003, NEUROSURGERY, V53, P1442; T Nakanishi, 2001, NEUROSURGERY, V49, P854; Takahashi M, 1974, RADIOLOGY SKULL BRAI, P1796	29	0	0	THIEME MEDICAL PUBL INC	NEW YORK	333 SEVENTH AVE, NEW YORK, NY 10001 USA	2193-6331	2193-634X		J NEUROL SURG PART B	Journal of Neurol. Surg. Part B	JUN	2015	76	3					202	207		10.1055/s-0034-1396660		6	Clinical Neurology; Surgery	Neurosciences & Neurology; Surgery	CI2YI	WOS:000354613800007		
J	Kira, J				Kira, Jun-ichi			Helicobacter pylori infection might prove the hygiene hypothesis in multiple sclerosis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Editorial Material							NEUROMYELITIS-OPTICA; PROFILES; RISK		Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci,Higashi Ku, Fukuoka 8128582, Japan	Kira, J (reprint author), Kyushu Univ, Dept Neurol, Neurol Inst, Grad Sch Med Sci,Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	kira@neuro.med.kyushu-u.ac.jp					Pedrini MJF, 2015, J NEUROL NEUROSUR PS, V86, P603, DOI 10.1136/jnnp-2014-309495; Ponsonby AL, 2005, JAMA-J AM MED ASSOC, V293, P463, DOI 10.1001/jama.293.4.463; Li W, 2009, MULT SCLER, V15, P1411, DOI 10.1177/1352458509348961; Stene LC, 2001, LANCET, V357, P607, DOI 10.1016/S0140-6736(00)04067-8; Yoshimura S, 2013, J NEUROL NEUROSUR PS, V84, P29, DOI 10.1136/jnnp-2012-302925; Osoegawa M, 2009, MULT SCLER, V15, P159, DOI 10.1177/1352458508098372; Gavalas E, 2007, J NEUROIMMUNOL, V188, P187, DOI 10.1016/j.jneuroim.2007.06.007; Tanaka M, 2008, NEUROLOGY, V71, P974, DOI 10.1212/01.wnl.0000326589.57128.c3; McCune A, 2003, EUR J GASTROEN HEPAT, V15, P637, DOI 10.1097/01.meg.0000059127.68845.57; Blaser M J, 1993, Trends Microbiol, V1, P255, DOI 10.1016/0966-842X(93)90047-U; GRAHAM DY, 1991, J GASTROEN HEPATOL, V6, P105, DOI 10.1111/j.1440-1746.1991.tb01448.x; Gregory SG, 2007, NAT GENET, V39, P1108; Kero J, 2001, J ALLERGY CLIN IMMUN, V40, P569; Kira J, 2013, CLIN EXP NEUROIMMUNO, V4, P261; Leibowitz U, 1966, J NEUROL NEUROSUR PS, V29, P463; Li W, 2007, J NEUROIMMUNOL, V184, P227, DOI 10.1016/j.jneuroim.2006.12.010; Matsushita T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061835; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Yoshimura S, 2013, CLIN EXP NEUROIMMUNO, V4, P351; Yoshimura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048592	20	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2015	86	6					591	592		10.1136/jnnp-2014-309759		2	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CI1DN	WOS:000354482000001		
J	Uzawa, A; Kawaguchi, N; Kanai, T; Himuro, K; Kuwabara, S				Uzawa, Akiyuki; Kawaguchi, Naoki; Kanai, Tetsuya; Himuro, Keiichi; Kuwabara, Satoshi			Serum high mobility group box 1 is upregulated in myasthenia gravis	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							RECEPTOR	Objective High mobility group box 1 (HMGB1) functions as an inflammatory mediator and is implicated in the pathogenesis of various autoimmune diseases. Our primary aim is to determine whether HMGB1 is involved in the pathogenesis of myasthenia gravis (MG). Methods Serum HMGB1 levels of 60 patients with anti-acetylcholine receptor (AChR) antibody-positive MG without immunosuppressive treatment and of 10 patients with anti-muscle-specific receptor tyrosine kinase (MuSK) antibody-positive MG were compared with those in 40 controls. We also investigated the potential correlation between serum HMGB1 levels and the clinical variables in patients with MG. Results Serum HMGB1 levels in patients with antiAChR antibody-positive MG were higher than those in controls (7.80 +/- 7.47 vs 4.13 +/- 2.55 ng/mL, p=0.004) and were decreased after treatment (p=0.051). Although not significant, patients with anti-MuSK antibody-positive MG showed higher serum HMGB1 levels than the controls (p=0.178). There were correlations between serum HMGB1 levels and phenotypes of anti-AChR antibody-positive MG: patients with generalised MG showed higher HMGB1 levels than those of patients with ocular MG (p=0.059) and controls (p=0.002); patients with thymoma showed higher HMGB1 levels than those without thymoma (p=0.094) and controls (p=0.001). Conclusions Serum HMGB1 is elevated in patients with MG and may play a key role in the inflammation of the neuromuscular junction.	[Uzawa, Akiyuki; Kawaguchi, Naoki; Kanai, Tetsuya; Himuro, Keiichi; Kuwabara, Satoshi] Chiba Univ, Dept Neurol, Grad Sch Med, Chiba 2608670, Japan; [Kawaguchi, Naoki] Neurol Chiba Clin, Dept Neurol, Chiba, Japan	Uzawa, A (reprint author), Chiba Univ, Dept Neurol, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	auzawa@chiba-u.jp					Uzawa A, 2014, CLIN EXP IMMUNOL, V176, P232, DOI 10.1111/cei.12272; Jaretzki A, 2000, NEUROLOGY, V55, P16; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; Meriggioli MN, 2009, LANCET NEUROL, V8, P475, DOI 10.1016/S1474-4422(09)70063-8; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Wolfe GI, 1999, NEUROLOGY, V52, P1487; Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Moser B, 2012, BIOCHEM BIOPH RES CO, V420, P96, DOI 10.1016/j.bbrc.2012.02.121; Moser B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094118; Uzawa A, 2013, J NEUROL NEUROSUR PS, V84, P517, DOI 10.1136/jnnp-2012-304039; Uzawa A, 2013, CLIN EXP IMMUNOL, V172, P37, DOI 10.1111/cei.12036	11	1	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2015	86	6					695	697		10.1136/jnnp-2014-309232		3	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CI1DN	WOS:000354482000019		
J	Carosi, L; Lo Giudice, T; Di Lullo, M; Lombardi, F; Babalini, C; Gaudiello, F; Marfia, GA; Massa, R; Kawarai, T; Orlacchio, A				Carosi, Laura; Lo Giudice, Temistocle; Di Lullo, Martina; Lombardi, Federica; Babalini, Carla; Gaudiello, Fabrizio; Marfia, Girolama Alessandra; Massa, Roberto; Kawarai, Toshitaka; Orlacchio, Antonio			Hereditary spastic paraplegia: a novel mutation and expansion of the phenotype variability in SPG10	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Letter							DISEASE		[Carosi, Laura; Lo Giudice, Temistocle; Di Lullo, Martina; Lombardi, Federica; Babalini, Carla; Gaudiello, Fabrizio; Massa, Roberto; Orlacchio, Antonio] Ist Ricovero & Cura Carattere Sci IRCCS Santa Luc, CERC, Lab Neurogenet, I-00143 Rome, Italy; [Carosi, Laura; Lo Giudice, Temistocle; Marfia, Girolama Alessandra; Massa, Roberto; Orlacchio, Antonio] Univ Roma Tor Vergata, Dipartimento Med Sistemi, Rome, Italy; [Kawarai, Toshitaka] Univ Tokushima, Grad Sch Med, Dept Clin Neurosci, Inst Hlth Biosci, Tokushima 770, Japan	Orlacchio, A (reprint author), Ist Ricovero & Cura Carattere Sci IRCCS Santa Luc, CERC, Lab Neurogenet, 64 Via Fosso di Fiorano, I-00143 Rome, Italy.	a.orlacchio@hsantalucia.it	Massa, Roberto/I-7223-2012; Orlacchio, Antonio/A-1968-2014	Massa, Roberto/0000-0001-7523-6956; Orlacchio, Antonio/0000-0002-2602-3281			Carlesimo GA, 1996, EUR NEUROL, V36, P378, DOI 10.1159/000117297; Su YA, 1996, MOL CARCINOGEN, V15, P270, DOI 10.1002/(SICI)1098-2744(199604)15:4<270::AID-MC4>3.0.CO;2-K; Firth HV, 2009, AM J HUM GENET, V84, P524, DOI 10.1016/j.ajhg.2009.03.010; Schule R, 2006, NEUROLOGY, V67, P430, DOI 10.1212/01.wnl.0000228242.53336.90; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Bayat V, 2011, CURR OPIN NEUROBIOL, V21, P182, DOI 10.1016/j.conb.2010.08.014; Hindocha S, 2006, J HAND SURG-AM, V31A, P204, DOI 10.1016/j.jhsa.2005.09.018; Krause Carola, 2011, Fibrogenesis Tissue Repair, V4, P14, DOI 10.1186/1755-1536-4-14; Meissner MH, 2007, J VASC SURG, V46, p54S, DOI 10.1016/j.jvs.2007.08.038	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2015	86	6					702	704		10.1136/jnnp-2014-308625		3	Clinical Neurology; Psychiatry; Surgery	Neurosciences & Neurology; Psychiatry; Surgery	CI1DN	WOS:000354482000023		
J	Nogalska, A; D'Agostino, C; Engel, WK; Cacciottolo, M; Asada, S; Mori, K; Askanas, V				Nogalska, Anna; D'Agostino, Carla; Engel, W. King; Cacciottolo, Mafalda; Asada, Shinichi; Mori, Kazutoshi; Askanas, Valerie			Activation of the Unfolded Protein Response in Sporadic Inclusion-Body Myositis but Not in Hereditary GNE Inclusion-Body Myopathy	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Cultured human muscle fibers; Endoplasmic reticulum stress; GNE; Hereditary inclusion-body myopathy; Sporadic inclusion-body myositis; UDP-N-acetylglucosamine-2-epimerase/N-acetylmannosamine kinase; Unfolded protein response	ENDOPLASMIC-RETICULUM STRESS; CULTURED HUMAN MUSCLE; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; RIMMED VACUOLES; DISTAL MYOPATHY; BETA-APP; FIBERS; EXPRESSION; RELEVANCE	Muscle fibers in patients with sporadic inclusion-body myositis (s-IBM), the most common age-associated myopathy, are characterized by autophagic vacuoles and accumulation of ubiquitinated and congophilic multiprotein aggregates that contain amyloid-beta and phosphorylated tau. Muscle fibers of autosomal-recessive hereditary inclusion-body myopathy caused by the GNE mutation (GNE-h-IBM) display similar pathologic features, except with less pronounced congophilia. Accumulation of unfolded/misfolded proteins inside the endoplasmic reticulum (ER) lumen leads to ER stress, which elicits the unfolded protein response (UPR) as a protective mechanism. Here we demonstrate for the first time that UPR is activated in s-IBM muscle biopsies, since there was 1) increased activating transcription factor 4 (ATF4) protein and increased mRNA of its target C/EBP homologous protein; 2) cleavage of the ATF6 and increased mRNA of its target glucose-regulated protein 78; and 3) an increase of the spliced form of X-box binding protein 1 and increased mRNA of ER degradation-enhancing >-mannosidase-like protein, target of heterodimer of cleaved ATF6 and spliced X-box binding protein 1. In contrast, we did not find similar evidence of the UPR induction in GNE-h-IBM patient muscle, suggesting that different intracellular mechanisms might lead to similar pathologic phenotypes. Interestingly, cultured GNE-h-IBM muscle fibers had a robust UPR response to experimental ER stress stimuli, suggesting that the GNE mutation per se is not responsible for the lack of UPR in GNE-h-IBM biopsied muscle.	[Nogalska, Anna; D'Agostino, Carla; Engel, W. King; Cacciottolo, Mafalda; Askanas, Valerie] Univ So Calif, Keck Sch Med, Good Samaritan Hosp, USC Neuromuscular Ctr,Dept Neurol, Los Angeles, CA 90033 USA; [Asada, Shinichi; Mori, Kazutoshi] Kyoto Univ, Grad Sch Sci, Dept Biophys, Kyoto, Japan	Askanas, V (reprint author), Good Samaritan Hosp, USC Neuromuscular Ctr, 637 S Lucas Ave, Los Angeles, CA 90017 USA.	askanas@usc.edu					Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Roussel BD, 2013, LANCET NEUROL, V12, P105, DOI 10.1016/S1474-4422(12)70238-7; Dalakas MC, 2011, NEUROPATH APPL NEURO, V37, P226, DOI 10.1111/j.1365-2990.2010.01153.x; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Nogalska A, 2010, AM J PATHOL, V177, P1377, DOI 10.2353/ajpath.2010.100050; Haze K, 1999, MOL BIOL CELL, V10, P3787; Deegan S, 2013, CELL MOL LIFE SCI, V70, P2425, DOI 10.1007/s00018-012-1173-4; Askanas V, 2012, J NEUROPATH EXP NEUR, V71, P680, DOI 10.1097/NEN.0b013e31826183c8; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Back SH, 2005, METHODS, V35, P395, DOI 10.1016/j.ymeth.2005.03.001; Lee AS, 2005, METHODS, V35, P373, DOI 10.1016/j.ymeth.2004.10.010; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Argov Z, 2008, NEUROTHERAPEUTICS, V5, P633, DOI 10.1016/j.nurt.2008.07.004; Askanas Valerie, 2011, Presse Med, V40, pe219, DOI 10.1016/j.lpm.2010.11.024; Askanas V, 1998, AM J PATHOL, V153, P1673, DOI 10.1016/S0002-9440(10)65680-5; ASKANAS V, 1975, NEUROLOGY, V25, P58; ASKANAS V, 1993, NEUROLOGY, V43, P1265; Askanas V, 1998, INCLUSION BODY MYOSI, P3; Askanas Valerie, 1993, Current Opinion in Rheumatology, V5, P732; Askanas V, 2008, MOL GENETIC BASIS NE, P524; Askanas V, 2012, MUSCLE AGEING INCLUS, P111; Askanas V, 2002, CURR OPIN NEUROL, V15, P525, DOI 10.1097/00019052-200210000-00002; Askanas V, 2007, MOL GENETIC BASIS NE; Broccolini A, 2011, Acta Myol, V30, P91; Broccolini A, 2010, NEUROLOGY, V75, P265, DOI 10.1212/WNL.0b013e3181e8e8f1; Broccolini A, 2015, BBA-MOL BASIS DIS, V1852, P644, DOI 10.1016/j.bbadis.2014.08.007; D'Agostino C, 2011, ACTA NEUROPATHOL, V122, P627, DOI 10.1007/s00401-011-0874-3; Dalakas MC, 2008, ANN NEUROL, V64, P1, DOI 10.1002/ana.21452; Desnuelle C, 1987, J NEUROCHEM, V49, P133; Dimachkie MM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-012-0321-4; Engel WK, 2006, NEUROLOGY, V66, pS20, DOI 10.1212/01.wnl.0000192260.33106.bb; Fratta P, 2005, AM J PATHOL, V167, P517, DOI 10.1016/S0002-9440(10)62994-X; Hong M, 2004, J BIOL CHEM, V279, P11354, DOI 10.1074/jbc.M309804200; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; Li HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058116; Malicdan MCV, 2007, HUM MOL GENET, V16, P2669, DOI 10.1093/hmg/ddm220; Malicdan MCV, 2008, CURR OPIN NEUROL, V21, P596, DOI 10.1097/WCO.0b013e32830dd595; McFerrin J, 1998, NEUROREPORT, V9, P3201, DOI 10.1097/00001756-199810050-00013; Mirabella M, 1996, J NEUROPATH EXP NEUR, V55, P774, DOI 10.1097/00005072-199607000-00003; Mori-Yoshimura M, 2012, J NEUROL SCI, V318, P100, DOI 10.1016/j.jns.2012.03.016; Nogalska A, 2010, NEUROBIOL AGING, V31, P1637, DOI 10.1016/j.neurobiolaging.2008.08.021; Nogalska A, 2009, ACTA NEUROPATHOL, V118, P407, DOI 10.1007/s00401-009-0564-6; Nogalska A, 2006, J NEUROCHEM, V96, P1491, DOI 10.1111/j.1471-4159.2006.03668.x; Nogalska A, 2007, EXP NEUROL, V204, P610, DOI 10.1016/j.expneurol.2006.12.014; PEGOLO G, 1990, INT J DEV NEUROSCI, V8, P299, DOI 10.1016/0736-5748(90)90036-2; Ricci E, 2006, NEUROLOGY, V66, P755, DOI 10.1212/01.wnl.0000200956.76449.3f; Sela I, 2013, NEUROMOL MED, V15, P180, DOI 10.1007/s12017-012-8209-7; Wang ZY, 2006, J BIOL CHEM, V281, P27016, DOI 10.1074/jbc.M604903200; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018	52	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6					538	546				9	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800006		
J	Takeda, T; Iijima, M; Uchihara, T; Ohashi, T; Seilhean, D; Duyckaerts, C; Uchiyama, S				Takeda, Takahiro; Iijima, Mutsumi; Uchihara, Toshiki; Ohashi, Takashi; Seilhean, Danielle; Duyckaerts, Charles; Uchiyama, Shinichiro			TDP-43 Pathology Progression Along the Olfactory Pathway as a Possible Substrate for Olfactory Impairment in Amyotrophic Lateral Sclerosis	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Article						Amyotrophic lateral sclerosis; Olfactory bulb; Olfactory impairments; OSIT-J; TDP-43	FRONTOTEMPORAL LOBAR DEGENERATION; SMELL IDENTIFICATION TEST; MOTOR-NEURON DISEASE; SPORADIC PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; DEMENTIA; DIAGNOSIS; BULB; INVOLVEMENT; DYSFUNCTION	Odor impairment and its relationship with TAR DNA-binding protein 43 (TDP-43) pathology in patients with amyotrophic lateral sclerosis (ALS) have not been fully elucidated. We performed the odor stick identification test for Japanese (OSIT-J) in 18 ALS patients and in 18 controls. The score was significantly decreased (6.6 +/- 2.7) in the patients versus the controls (9.2 +/- 2.4) (U = 77.0, p = 0.007). This decrement of the OSIT-J score paralleled the cognitive decline. We then studied samples from a series of 42 postmortem ALS cases. Quantitative analyses demonstrated that TDP-43-positive inclusions were most frequent in the hippocampus and least abundant in the olfactory bulb and were of intermediate density in the primary olfactory cortex. This centrifugal gradient suggests that TDP-43 pathology starts in the hippocampus, spreads into the primary olfactory center, and finally reaches the olfactory bulb. TDP-43, tau, and alpha-synuclein accumulations appeared to be independent. These observations suggest that impaired odor discrimination in ALS patients may be related to TDP-43-positive lesions affecting predominantly secondary olfactory centers (especially the hippocampus) in contrast to decreased odor sensitivity in Parkinson disease in which alpha-synuclein pathology mainly involves the peripheral region (i.e., olfactory bulb). We suggest that detectable odor impairments in ALS patients are useful for predicting the presence of TDP-43 pathology in the extramotor system.	[Takeda, Takahiro; Iijima, Mutsumi; Uchiyama, Shinichiro] Tokyo Womens Med Univ, Dept Neurol, Tokyo 1628666, Japan; [Takeda, Takahiro; Uchihara, Toshiki] Tokyo Metropolitan Inst Med Sci, Lab Struct Neuropathol, Tokyo, Japan; [Ohashi, Takashi] Tokyo Womens Med Univ, Dept Neurol, Yachiyo Med Ctr, Tokyo 1628666, Japan; [Takeda, Takahiro; Seilhean, Danielle; Duyckaerts, Charles] Univ Paris 06, Raymond Escourolle Lab Neuropathol, La Salpetriere Hosp, Assistance Publ Hop Paris, Paris, France	Takeda, T (reprint author), Tokyo Womens Med Univ, Dept Neurol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	ttakeda@nij.twmu.ac.jp					Hawkes CH, 1998, ANN NY ACAD SCI, V855, P608, DOI 10.1111/j.1749-6632.1998.tb10631.x; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239; Del Tredici K, 2002, J NEUROPATH EXP NEUR, V61, P413; Attems J, 2006, CLIN NEUROPATHOL, V25, P265; KOSS E, 1988, NEUROLOGY, V38, P1228; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; Kanouchi T, 2012, J NEUROL NEUROSUR PS, V83, P739, DOI 10.1136/jnnp-2011-301826; TOMBAUGH TN, 1992, J AM GERIATR SOC, V40, P922; Geser F, 2008, ARCH NEUROL-CHICAGO, V65, P636, DOI 10.1001/archneur.65.5.636; Pardini M, 2009, ARCH NEUROL-CHICAGO, V66, P92, DOI 10.1001/archneurol.2008.521; SERBY M, 1991, AM J PSYCHIAT, V148, P357; Baba M, 1998, AM J PATHOL, V152, P879; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Geser F, 2010, NEUROPATHOLOGY, V30, P103, DOI 10.1111/j.1440-1789.2009.01091.x; Muller A, 2002, J CLIN NEUROSCI, V9, P521, DOI 10.1054/jocn.2001.1071; ESIRI MM, 1984, J NEUROL NEUROSUR PS, V47, P56, DOI 10.1136/jnnp.47.1.56; NEARY D, 1990, J NEUROL NEUROSUR PS, V53, P23, DOI 10.1136/jnnp.53.1.23; Braak H, 2013, NAT REV NEUROL, V9, P708, DOI 10.1038/nrneurol.2013.221; DOTY RL, 1995, NEURODEGENERATION, V4, P93, DOI 10.1006/neur.1995.0011; Braak H, 2003, NEUROBIOL AGING, V24, P197, DOI 10.1016/S0197-4580(02)00065-9; Mackenzie IRA, 2011, ACTA NEUROPATHOL, V122, P111, DOI 10.1007/s00401-011-0845-8; Dubois B, 2000, NEUROLOGY, V55, P1621; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Attems J, 2014, ACTA NEUROPATHOL, V127, P459, DOI 10.1007/s00401-014-1261-7; Sengoku R, 2008, J NEUROPATH EXP NEUR, V67, P1072, DOI 10.1097/NEN.0b013e31818b4126; DANIEL SE, 1992, LANCET, V340, P186, DOI 10.1016/0140-6736(92)93275-R; Olofsson JK, 2013, BRAIN, V136, P1245, DOI 10.1093/brain/awt019; Inukai Y, 2008, FEBS LETT, V582, P2899, DOI 10.1016/j.febslet.2008.07.027; Duda JE, 2010, J NEUROL SCI, V289, P49, DOI 10.1016/j.jns.2009.08.042; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; DOTY RL, 1984, LARYNGOSCOPE, V94, P176, DOI 10.1288/00005537-198402000-00004; WITTER MP, 1991, J COMP NEUROL, V307, P437, DOI 10.1002/cne.903070308; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; MURPHY C, 1990, NEUROBIOL AGING, V11, P465, DOI 10.1016/0197-4580(90)90014-Q; Nishihira Y, 2008, ACTA NEUROPATHOL, V116, P169, DOI 10.1007/s00401-008-0385-z; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; Lomen-Hoerth C, 2003, NEUROLOGY, V60, P1094; Saito S, 2006, CHEM SENSES, V31, P379, DOI 10.1093/chemse/bjj042; Arnold SE, 1998, ANN NY ACAD SCI, V855, P762, DOI 10.1111/j.1749-6632.1998.tb10656.x; BIERNAT J, 1992, EMBO J, V11, P1593; ELIAN M, 1991, J NEUROL NEUROSUR PS, V54, P927, DOI 10.1136/jnnp.54.10.927; Hawkes CH, 1998, EXP NEUROL, V150, P248, DOI 10.1006/exnr.1997.6773; HYMAN BT, 1991, ANN N Y ACAD SCI, V640, P14; Iijima M, 2008, INTERNAL MED, V47, P1887, DOI 10.2169/internalmedicine.47.1345; Iijima M, 2011, EUR J NEUROL, V18, P425, DOI 10.1111/j.1468-1331.2010.03167.x; KATO S, 1993, J NEUROL SCI, V116, P52, DOI 10.1016/0022-510X(93)90089-H; Kobayashi M, 2004, ACTA OTO-LARYNGOL, V124, P74, DOI 10.1080/03655230410017715; Mackenzie IRA, 2006, BRAIN, V129, P3081, DOI 10.1093/brain/awl271; Maurage P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023190; Mori H, 2007, AM J NEURORADIOL, V28, P1511, DOI 10.3174/ajnr.A0624; Nakano I, 1992, NEUROPATHOLOGY, V12, P69; Nguyen AD, 2010, HARVARD REV PSYCHIAT, V18, P279, DOI 10.3109/10673229.2010.511060; Price JL, 2004, HUMAN NERVOUS SYSTEM, P1197, DOI 10.1016/B978-012547626-3/50033-8; REZEK DL, 1987, ARCH NEUROL-CHICAGO, V44, P1030; SAJJADIAN A, 1994, NEURODEGENERATION, V3, P153; STERN MB, 1994, NEUROLOGY, V44, P266; Takeda T, 2014, CLIN NEUROPATHOL, V33, P65, DOI 10.5414/NP300661; Takeda T, 2007, EUR J NEUROL, V14, pE5, DOI 10.1111/j.1468-1331.2007.01967.x; Terada T., 2010, CLIN NEUROLOGY, V50, P379; Ubeda-Banon I, 2010, ACTA NEUROPATHOL, V119, P723, DOI 10.1007/s00401-010-0687-9	60	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6					547	556				10	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800007		
J	Uchino, A; Takao, M; Hatsuta, H; Sumikura, H; Nakano, Y; Saito, Y; Nishiyama, K; Murayama, S				Uchino, Akiko; Takao, Masaki; Hatsuta, Hiroyuki; Sumikura, Hiroyuki; Nakano, Yuta; Saito, Yuko; Nishiyama, Kazutoshi; Murayama, Shigeo			TDP-43 accumulation in the aging human brain	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Meeting Abstract	91st Annual Meeting of the American-Association-of-Neuropathologists-Inc	JUN 11-14, 2015	Denver, CO	Amer Assoc Neuropathologists Inc					[Uchino, Akiko; Hatsuta, Hiroyuki; Sumikura, Hiroyuki; Nakano, Yuta; Murayama, Shigeo] Tokyo Metropolitan Geriatr Hosp, Tokyo, Japan; [Uchino, Akiko; Hatsuta, Hiroyuki; Sumikura, Hiroyuki; Nakano, Yuta; Murayama, Shigeo] Inst Gerontol, Tokyo, Japan; [Takao, Masaki] Saitama Med Univ, Int Med Ctr, Dept Neurol, Saitama, Japan; [Saito, Yuko] Natl Ctr Hosp Neurol & Psychiat, Ichikawa, Japan; [Nishiyama, Kazutoshi] Kitasato Med Sch, Dept Neurol, Sagamihara, Kanagawa, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6				43	599	600				2	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800053		
J	Sugita, Y; Muta, H; Ohshima, K; Abe, H				Sugita, Yasuo; Muta, Hiroko; Ohshima, Koichi; Abe, Hideyuki			The immune escape mechanism of primary central nervous system lymphomas: The role of chemokines and endothelin B receptor	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Meeting Abstract	91st Annual Meeting of the American-Association-of-Neuropathologists-Inc	JUN 11-14, 2015	Denver, CO	Amer Assoc Neuropathologists Inc					[Sugita, Yasuo; Muta, Hiroko; Ohshima, Koichi; Abe, Hideyuki] Kurume Univ, Sch Med, Dept Pathol, Kurume, Fukuoka, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6				89	612	612				1	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800099		
J	Takao, M; Hirose, N; Nakano, Y; Kimura, H; Mihara, B; Arai, M; Mimura, M; Mizuno, S; Nagamine, Y; Sano, H; Horiuchi, Y; Maruyama, H; Deguchi, I; Fukuoka, T; Kato, Y; Hayashi, T; Tanahashi, N				Takao, Masaki; Hirose, Nobuyoshi; Nakano, Yuta; Kimura, Hiroaki; Mihara, Ban; Arai, Michiyasu; Mimura, Masaru; Mizuno, Satoko; Nagamine, Yuito; Sano, Hiroyasu; Horiuchi, Yousuke; Maruyama, Hajime; Deguchi, Ichiro; Fukuoka, Takuya; Kato, Yuji; Hayashi, Takeshi; Tanahashi, Norio			Neuropathologic features of two supercentenarians: an autopsy study	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Meeting Abstract	91st Annual Meeting of the American-Association-of-Neuropathologists-Inc	JUN 11-14, 2015	Denver, CO	Amer Assoc Neuropathologists Inc					[Takao, Masaki; Mizuno, Satoko; Nagamine, Yuito; Sano, Hiroyasu; Horiuchi, Yousuke; Maruyama, Hajime; Deguchi, Ichiro; Fukuoka, Takuya; Kato, Yuji; Hayashi, Takeshi; Tanahashi, Norio] Saitama Med Univ, Dept Neurol, Saitama Int Med Ctr, Moroyama, Saitama, Japan; [Hirose, Nobuyoshi; Arai, Michiyasu] Keio Univ, Sch Med, Ctr Supercentenarian Res, Tokyo 108, Japan; [Nakano, Yuta] TMGH, Dept Neuropathol, Tokyo, Japan; [Kimura, Hiroaki; Mihara, Ban] Mihara Mem Hosp, Isesaki, Japan; [Mimura, Masaru] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo 108, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6				128	623	624				2	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800138		
J	Takao, M; Sato, R; Nishihara, H; Omoto, M; Higuchi, Y; Takashima, H; Kawano, H; Ikeda, E; Kanda, T				Takao, Masaki; Sato, Ryota; Nishihara, Hideaki; Omoto, Masatoshi; Higuchi, Yujiro; Takashima, Hiroshi; Kawano, Hiroo; Ikeda, Eiji; Kanda, Takashi			A novel mutation (p.N58fs) of C12orf65 gene: clinical and radiological findings as well as first neuropathologic studies at autopsy	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Meeting Abstract	91st Annual Meeting of the American-Association-of-Neuropathologists-Inc	JUN 11-14, 2015	Denver, CO	Amer Assoc Neuropathologists Inc					[Takao, Masaki] Saitama Med Univ, Dept Neurol, Saitama Int Med Ctr, Moroyama, Saitama, Japan; [Sato, Ryota; Nishihara, Hideaki; Omoto, Masatoshi; Kanda, Takashi] Yamaguchi Univ, Fac Med & Hlth Sci, Dept Neurol, Yamaguchi, Japan; [Higuchi, Yujiro; Takashima, Hiroshi] Kagoshima Univ, Dept Neurol & Geriatr, Kagoshima 890, Japan; [Kawano, Hiroo; Ikeda, Eiji] Yamaguchi Univ, Fac Med & Hlth Sci, Dept Pathol, Yamaguchi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6				141	626	627				2	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800150		
J	Miyata, H; Endo, T; Maeda, M; Hikichi, K; Nanjo, H; Moroi, J				Miyata, Hajime; Endo, Takuro; Maeda, Masaki; Hikichi, Kentaro; Nanjo, Hiroshi; Moroi, Junta			Massive Intratumoral Hemorrhage as an Initial Presentation in a Case of Anaplastic Ganglioglioma with Subarachnoid Invasion and Dural Adhesion	JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY			English	Meeting Abstract	91st Annual Meeting of the American-Association-of-Neuropathologists-Inc	JUN 11-14, 2015	Denver, CO	Amer Assoc Neuropathologists Inc					[Miyata, Hajime] Res Inst Brain & Blood Vessels, Dept Neuropathol, Akita, Japan; [Endo, Takuro; Maeda, Masaki; Hikichi, Kentaro; Moroi, Junta] Res Inst Brain & Blood Vessels, Dept Neurol Surg, Akita, Japan; [Nanjo, Hiroshi] Akita Univ Hosp, Dept Pathol, Akita, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3069			J NEUROPATH EXP NEUR	J. Neuropathol. Exp. Neurol.	JUN	2015	74	6				167	634	634				1	Clinical Neurology; Neurosciences; Pathology	Neurosciences & Neurology; Pathology	CI5UH	WOS:000354824800176		
J	Xu, J; Shoji, T				Xu, Jian; Shoji, Tetsuo			The corrosion behavior of Alloy 52 weld metal in cyclic hydrogenated and oxygenated water chemistry in high temperature aqueous environment	JOURNAL OF NUCLEAR MATERIALS			English	Article							OXIDE-FILM; ELECTROCHEMICAL-BEHAVIOR; DISSOLVED HYDROGEN; STAINLESS-STEEL; PRESSURIZED-WATER; NICKEL-ALLOYS; XPS; SURFACE; GROWTH; ELECTROLYTES	The corrosion behavior of Alloy 52 weld metal in cyclic hydrogenated and oxygenated water chemistry in high temperature water is studied by in situ monitoring corrosion potential (E-corr), contact electric resistance (CER) and electrochemical impedance measurements (EIS), and ex situ scanning electron microscopy (SEM) and X-ray photoelectron spectroscopy (XPS) analysis. The E-corr and film resistance show large change when the environment is changed from hydrogenated water to oxygenated water and changeable with changing environment while the morphology and composition only show obvious distinction in the first cycle. The main factor controlling the electric/electrochemical properties of the oxide film is E-coro. (C) 2015 Elsevier B.V. All rights reserved.	[Xu, Jian; Shoji, Tetsuo] Tohoku Univ, New Ind Creat Hatchery Ctr, Frontier Res Initiat, Aoba Ku, Sendai, Miyagi 9808579, Japan	Xu, J (reprint author), Tohoku Univ, New Ind Creat Hatchery Ctr, Frontier Res Initiat, Aoba Ku, 6-6-10 Aramaki Aoba, Sendai, Miyagi 9808579, Japan.	xujian@fri.niche.tohoku.ac.jp	xu, jian/E-2779-2012				Carrette F, 2002, SURF INTERFACE ANAL, V34, P135, DOI 10.1002/sia.1269; Huang F, 2013, CORROS SCI, V76, P52, DOI 10.1016/j.corsci.2013.06.023; Bojinov M, 2003, CORROSION, V59, P91; Terachi T, 2003, J NUCL SCI TECHNOL, V40, P509, DOI 10.3327/jnst.40.509; Sun H, 2009, CORROS SCI, V51, P2565, DOI 10.1016/j.corsci.2009.06.043; Montemor MF, 2003, CORROSION, V59, P11; Xu J, 2012, ELECTROCHIM ACTA, V71, P219, DOI 10.1016/j.electacta.2012.03.148; Bojinov M, 2007, ELECTROCHIM ACTA, V52, P7475, DOI 10.1016/j.electacta.2007.06.002; Machet A, 2004, ELECTROCHIM ACTA, V49, P3957, DOI 10.1016/j.electacta.2004.04.032; MACDONALD DD, 1979, J ELECTROCHEM SOC, V126, P908, DOI 10.1149/1.2129192; Andresen PL, 2008, CORROSION, V64, P707; Zhang ZM, 2011, CORROS SCI, V53, P3623, DOI 10.1016/j.corsci.2011.07.012; Zhang ZM, 2011, ACTA METALL SIN, V47, P823, DOI 10.3724/SP.J.1037.2011.00206; Machet A, 2002, SURF INTERFACE ANAL, V34, P197, DOI 10.1002/sia.1282; Nakagawa T, 2003, J NUCL SCI TECHNOL, V40, P39, DOI 10.3327/jnst.40.39; Qiu YB, 2011, CORROS SCI, V53, P1983, DOI 10.1016/j.corsci.2011.02.020; Liu JH, 2009, J NUCL MATER, V393, P242, DOI 10.1016/j.jnucmat.2009.06.012; Aronniemi M, 2007, SURF SCI, V601, P479, DOI 10.1016/j.susc.2006.10.010; Attanasio S.A., 2003, P 11 INT C ENV DEGR, P143; Bosch RW, 2007, ELECTROCHIM ACTA, V52, P7538, DOI 10.1016/j.electacta.2007.02.013; Figueiredo CD, 2011, ELECTROCHIM ACTA, V56, P7871, DOI 10.1016/j.electacta.2011.05.077; GONZALEZELIPE AR, 1992, J PHYS CHEM-US, V96, P3080, DOI 10.1021/j100186a056; Hanninen H., 2011, ENV ASSISTED CRACKIN; KIM YJ, 1995, CORROSION, V51, P849; Kuang WJ, 2013, CORROS SCI, V69, P197, DOI 10.1016/j.corsci.2012.12.003; Marichev VA, 1996, CORROS SCI, V38, P531, DOI 10.1016/0010-938X(96)00152-7; Peng Q, 2007, CORROS SCI, V49, P2767, DOI 10.1016/j.corsci.2006.12.022; Peng QJ, 2011, ELECTROCHIM ACTA, V56, P8375, DOI 10.1016/j.electacta.2011.07.032; Sun H, 2012, CORROS SCI, V59, P334, DOI 10.1016/j.corsci.2012.03.022	29	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JUN	2015	461						10	21		10.1016/j.jnucmat.2015.02.033		12	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CI8LN	WOS:000355023900002		
J	Sato, I; Onishi, T; Tanaka, K; Iwasaki, M; Koyama, SI				Sato, Isamu; Onishi, Takashi; Tanaka, Kosuke; Iwasaki, Maho; Koyama, Shin-ichi			Influence of boron vapor on transport behavior of deposited CsI during heating test simulating a BWR severe accident condition	JOURNAL OF NUCLEAR MATERIALS			English	Article								In order to evaluate influence of B on the release and transport of Cs and I during severe accidents, basic experiments have been performed on the interaction between deposited Cs/I compounds and vapor/aerosol B compounds. CsI and B2O3 were utilized as a Cs/I compound and a B compound, respectively. Deposited CsI on the thermal gradient tube (TGT) at temperatures ranging from 423 K to 1023 K was reacted with vapor/aerosol B2O3, and then observed how it changed Cs/I deposition profiles. As a result, vapor/aerosol B2O3 stripped a portion of deposited CsI within a temperature range from 830 K to 920 K to make gaseous CsBO2 and I-2. In addition, gaseous I-2 was re-deposited at a temperature range from 530 K to 740 K, while CsBO2 travelled through the sampling tubes and filters without deposition. It is evident that B enables Cs compounds such as CsBO2 to transport Cs to the colder regions. (C) 2015 Elsevier B.V. All rights reserved.	[Sato, Isamu; Onishi, Takashi; Tanaka, Kosuke; Iwasaki, Maho; Koyama, Shin-ichi] Japan Atom Energy Agcy, Oarai Res & Dev Ctr, Oarai, Ibaraki 3111393, Japan	Sato, I (reprint author), Japan Atom Energy Agcy, Oarai Res & Dev Ctr, 4002 Narita Cho, Oarai, Ibaraki 3111393, Japan.	sato.isamu@jaea.go.jp					Girault N, 2009, NUCL ENG DES, V239, P1162, DOI 10.1016/j.nucengdes.2009.02.008; Gouello M., 2012, P 21 INT C NUCL EN N; Gregoire A., 2012, P 21 INT C NUCL EN N; Hidaka A, 2000, NUCL ENG DES, V200, P303, DOI 10.1016/S0029-5493(99)00328-3; Hirosawa T., INCTN94302001002 JNC; Kurata M., 2014, P WAT REACT FUEL PER; Lide D. R., 1994, CRC HDB THERMOPHYSIC; MINATO K, 1991, J NUCL MATER, V185, P154, DOI 10.1016/0022-3115(91)90330-A; Oarai Research and Development Center (JAEA), 2014, EV FISS PROD ACT REL; Sato I., 2014, P WATER REACTOR FUEL; Sato I, 2013, J NUCL MATER, V437, P275, DOI [10.1016/j.jnucmat.2013.02.026, 10.1016/jnucmat.2013.02.026]; Steinbruck M, 2007, NUCL ENG DES, V237, P161, DOI 10.1016/j.nucengdes.2006.05.011	12	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JUN	2015	461						22	28		10.1016/j.jnucmat.2015.02.032		7	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CI8LN	WOS:000355023900003		
J	Oya, Y; Li, XC; Sato, M; Yuyama, K; Zhang, L; Kondo, S; Hinoki, T; Hatano, Y; Watanabe, H; Yoshida, N; Chikada, T				Oya, Yasuhisa; Li, Xiaochun; Sato, Misaki; Yuyama, Kenta; Zhang, Long; Kondo, Sosuke; Hinoki, Tatsuya; Hatano, Yuji; Watanabe, Hideo; Yoshida, Naoaki; Chikada, Takumi			Thermal desorption behavior of deuterium for 6 MeV Fe ion irradiated W with various damage concentrations	JOURNAL OF NUCLEAR MATERIALS			English	Article							HYDROGEN ISOTOPE RETENTION; DISPLACEMENT DAMAGE; TUNGSTEN; NEUTRON; PLASMAS; DEFECTS; CARBON	W samples were irradiated at 300 K with 6 MeV Fe ion with damage concentrations in the range from 0.0003 to 1.0 displacements per atom (dpa) and then implanted at 300 K with 500 eV D ions to a fluence of 5 x 10(21) D/m(2). Deuterium retention in the damaged samples was examined in situ by thermal desorption spectrometry (TDS). Simulation of the TDS spectra was performed using the Hydrogen Isotope Diffusion and Trapping (HIDT) simulation code to reveal the binding energies for deuterium captured by the ion-induced defects. It has been shown that the deuterium TDS spectra consist of two or three peaks (depending on the damage concentration) at about 400, 600 and 800 K, and can be simulated by the HIDT simulation code with the use of hydrogen-trap binding energies of 0.65, 1.25, and 1.55 eV. (C) 2015 Elsevier B.V. All rights reserved.	[Oya, Yasuhisa; Li, Xiaochun; Sato, Misaki; Yuyama, Kenta; Chikada, Takumi] Shizuoka Univ, Grad Sch Sci, Suruga Ku, Shizuoka 4228529, Japan; [Zhang, Long] Southwestern Inst Phys, Chengdu 610041, Sichuan, Peoples R China; [Kondo, Sosuke; Hinoki, Tatsuya] Kyoto Univ, Inst Adv Energy, Uji, Kyoto 611001, Japan; [Hatano, Yuji] Toyama Univ, Hydrogen Isotope Res Ctr, Toyama 9308555, Japan; [Watanabe, Hideo; Yoshida, Naoaki] Kyushu Univ, Appl Mech Res Inst, Kasuga, Fukuoka 8168580, Japan	Oya, Y (reprint author), Shizuoka Univ, Grad Sch Sci, Suruga Ku, 836 Ohya, Shizuoka 4228529, Japan.	oya.yasuhisa@shizuoka.ac.jp	Kyushu, RIAM/F-4018-2015		Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy, Kyoto University [ZE-26A-2]; Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University; University of Toyama collaboration program [NIFS13KUHR021]; Center for Instrumental Analysis at Shizuoka University	This study was supported by the Joint Usage/Research Program on Zero-Emission Energy Research, Institute of Advanced Energy, Kyoto University (ZE-26A-2), by the Collaborative Research Program of Research Institute for Applied Mechanics, Kyushu University, University of Toyama collaboration program (NIFS13KUHR021) and the Center for Instrumental Analysis at Shizuoka University. The Fe ion irradiation was done in the framework of collaborative research program at JAEA.	Alimov VK, 2013, J NUCL MATER, V438, pS959, DOI 10.1016/j.jnucmat.2013.01.208; Alimov VK, 2013, J NUCL MATER, V441, P280, DOI 10.1016/j.jnucmat.2013.06.005; Ambrosek James, 2008, INEELEXT0401657; Skinner CH, 2008, FUSION SCI TECHNOL, V54, P891; Rieth M, 2013, J NUCL MATER, V432, P482, DOI 10.1016/j.jnucmat.2012.08.018; Ogorodnikova OV, 2015, J NUCL MATER, V460, P60, DOI 10.1016/j.jnucmat.2015.02.004; Tyburska B, 2009, J NUCL MATER, V395, P150, DOI 10.1016/j.jnucmat.2009.10.046; Roth J, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014031; Philipps V, 2011, J NUCL MATER, V415, pS2, DOI 10.1016/j.jnucmat.2011.01.110; Alimov VK, 2012, J NUCL MATER, V420, P370, DOI 10.1016/j.jnucmat.2011.10.025; Hatano Y, 2013, NUCL FUSION, V53, DOI 10.1088/0029-5515/53/7/073006; Miura R, 2013, FUSION ENG DES, V88, P1827, DOI 10.1016/j.fusengdes.2013.04.051; Oya Y, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014050; Tanabe T, 2014, PHYS SCRIPTA, VT159, DOI 10.1088/0031-8949/2014/T159/014044; Shimada M, 2011, PHYS SCRIPTA, VT145, DOI 10.1088/0031-8949/2011/T145/014051; PICK MA, 1985, J NUCL MATER, V131, P208, DOI 10.1016/0022-3115(85)90459-3; Brice O. K., 1984, J NUCL MATER, V120, P230, DOI 10.1016/0022-3115(84)90061-8; Crank J., 1975, MATH DIFFUSION; DOYLE BL, 1984, J NUCL MATER, V123, P1523, DOI 10.1016/0022-3115(84)90295-2; ELEVELD H, 1992, J NUCL MATER, V191, P433; FRAUENFE.R, 1969, J VAC SCI TECHNOL, V6, P388, DOI 10.1116/1.1492699; Hatano Y, 2013, MATER TRANS, V54, P437, DOI 10.2320/matertrans.MG201204; Hatano Y, 2013, J NUCL MATER, V438, pS114, DOI 10.1016/j.jnucmat.2013.01.018; Kobayashi M, 2013, FUSION ENG DES, V88, P1749, DOI 10.1016/j.fusengdes.2013.04.009; Oya Y, 2013, J NUCL MATER, V438, pS1055, DOI 10.1016/j.jnucmat.2013.01.231; Oya Y, 2014, FUSION ENG DES, V89, P1091, DOI 10.1016/j.fusengdes.2013.12.018	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JUN	2015	461						336	340		10.1016/j.jnucmat.2015.03.032		5	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CI8LN	WOS:000355023900043		
J	Sasaki, K; Yabuuchi, K; Nogami, S; Hasegawa, A				Sasaki, Kenta; Yabuuchi, Kiyohiro; Nogami, Shuhei; Hasegawa, Akira			Effects of temperature and strain rate on the tensile properties of potassium-doped tungsten	JOURNAL OF NUCLEAR MATERIALS			English	Article							COMMERCIALLY PURE; WIRE; RECRYSTALLIZATION; DRAWN; ITER	Tensile tests were performed on pure and K-doped tungsten at temperatures from 25 to 700 degrees C and strain rates between 10(-5) and 10(-1) s(-1) in vacuum. The yield strength of both materials increased with increasing strain rate and decreasing temperature. The amount of change in the yield strength decreased with increasing temperature. The determination of activation volumes for plastic deformation highlighted that the rate-controlling process of the deformation behavior at lower temperatures was the same for both materials, namely, kink-pair formation on screw dislocations, and the process was not affected by potassium addition. The fracture strain of both materials increased with increasing strain rate and decreasing temperature, in the temperature range where the materials showed measurable ductility. K-doped W showed higher yield strength and a lower ductile-to-brittle transition temperature than pure W. No negative effect of K addition on strain rate- and temperature-induced changes in tensile properties was found. The analysis also highlighted the effectiveness of K addition, and of the grain refinement induced by it, for improving the mechanical properties of tungsten. (C) 2015 Elsevier B.V. All rights reserved.	[Sasaki, Kenta; Yabuuchi, Kiyohiro; Nogami, Shuhei; Hasegawa, Akira] Tohoku Univ, Dept Quantum Sci & Energy Engn, Sendai, Miyagi 9808579, Japan	Yabuuchi, K (reprint author), Tohoku Univ, Dept Quantum Sci & Energy Engn, 6-6-01-2 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	k.sasaki@jupiter.qse.tohoku.ac.jp; kiyohiro.yabuu-chi@qse.tohoku.ac.jp; shuhei.nogami@qse.tohoku.ac.jp; akira.hasegawa@qse.tohoku.ac.jp			JSPS [24246151]; NIFS Collaborative Research Program [NIFS11KOBF019]	This work was supported by JSPS KAKENHI, Grant Number 24246151, and by the NIFS Collaborative Research Program (NIFS11KOBF019).	Wei Q, 2008, MAT SCI ENG A-STRUCT, V491, P62, DOI 10.1016/j.msea.2008.01.013; CHILTON AC, 1969, J LESS-COMMON MET, V17, P447, DOI 10.1016/0022-5088(69)90071-X; Zinkle SJ, 2000, FUSION ENG DES, V51-52, P55, DOI 10.1016/S0920-3796(00)00320-3; SNOW DB, 1976, METALL TRANS A, V7, P783, DOI 10.1007/BF02644074; Hirai T, 2005, MATER TRANS, V46, P412, DOI 10.2320/matertrans.46.412; Bolt H, 2002, J NUCL MATER, V307, P43, DOI 10.1016/S0022-3115(02)01175-3; Schade P, 2010, INT J REFRACT MET H, V28, P648, DOI 10.1016/j.ijrmhm.2010.05.003; [Anonymous], 2010, E11210 ASTM; RAFFO PL, 1969, J LESS-COMMON MET, V17, P133, DOI 10.1016/0022-5088(69)90047-2; Wei Q, 2004, MAT SCI ENG A-STRUCT, V381, P71, DOI 10.1016/j.msea.2004.03.064; SNOW DB, 1979, METALL TRANS A, V10, P815, DOI 10.1007/BF02658299; PETCH NJ, 1953, J IRON STEEL I, V174, P25; Dummer T, 1998, ACTA MATER, V46, P6267, DOI 10.1016/S1359-6454(98)00255-9; PUGH JW, 1973, METALL TRANS, V4, P533, DOI 10.1007/BF02648706; Rieck G.D., 1967, TUNGSTEN ITS COMPOUN; Siegle L. L., 1963, MET SOC C, V17, P65; Tetelman AS, 1967, FRACTURE STRUCTURAL	17	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-3115	1873-4820		J NUCL MATER	J. Nucl. Mater.	JUN	2015	461						357	364		10.1016/j.jnucmat.2015.03.015		8	Materials Science, Multidisciplinary; Nuclear Science & Technology; Mining & Mineral Processing	Materials Science; Nuclear Science & Technology; Mining & Mineral Processing	CI8LN	WOS:000355023900046		
J	Bhaswant, M; Poudyal, H; Brown, L				Bhaswant, Maharshi; Poudyal, Hemant; Brown, Lindsay			Mechanisms of enhanced insulin secretion and sensitivity with n-3 unsaturated fatty acids	JOURNAL OF NUTRITIONAL BIOCHEMISTRY			English	Review						n-3 polyunsaturated fatty acids; Insulin; Adipokines; Obesity; Inflammation	ALPHA-LINOLENIC ACID; PURIFIED EICOSAPENTAENOIC ACID; TYPE-2 DIABETES-MELLITUS; LONG-CHAIN OMEGA-3-FATTY-ACIDS; ACTIVATED PROTEIN-KINASE; PLASMA VISFATIN CONCENTRATIONS; STIMULATES GLUCOSE-UTILIZATION; ADIPOSE-TISSUE INFLAMMATION; STEAROYL-COA DESATURASE-1; PANCREATIC-ISLET FUNCTION	The widespread acceptance that increased dietary n-3 polyunsaturated fatty acids (PUFAs), especially alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), improve health is based on extensive studies in animals, isolated cells and humans. Visceral adiposity is part of the metabolic syndrome, together with insulin resistance, dyslipidemia, hypertension and inflammation. Alleviation of metabolic syndrome requires normalization of insulin release and responses. This review assesses our current knowledge of the mechanisms that allow n-3 PUFAs to improve insulin secretion and sensitivity. EPA has been more extensively studied than either ALA or DHA. The complex actions of EPA include increased G-protein-receptor-mediated release of glucagon-like peptide 1 (GLP-1) from enteroendocrine L-cells in the intestine, up-regulation of the apelin pathway and down-regulation of other control pathways to promote insulin secretion by the pancreatic beta-cells, together with suppression of inflammatory responses to adipokines, inhibition of peroxisome proliferator-activated receptor alpha actions and prevention of decreased insulin-like growth factor-1 secretion to improve peripheral insulin responses. The receptors involved and the mechanisms of action probably differ for ALA and DHA, with antiobesity effects predominating for ALA and anti-inflammatory effects for DHA. Modifying both GLP-1 release and the actions of adipokines by n-3 PUFAs could lead to additive improvements in both insulin secretion and sensitivity. (C) 2015 Elsevier Inc. All rights reserved.	[Bhaswant, Maharshi] Victoria Univ, Coll Hlth & Biomed, Ctr Chron Dis Prevent & Management, Melbourne, Vic 3021, Australia; [Poudyal, Hemant] Kyoto Univ, Grad Sch Med, Dept Diabet Endocrinol & Nutr, Kyoto 6068302, Japan; [Poudyal, Hemant] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6068302, Japan; [Bhaswant, Maharshi; Brown, Lindsay] Univ So Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia	Brown, L (reprint author), Univ So Queensland, Sch Hlth & Wellbeing, Toowoomba, Qld 4350, Australia.	Lindsay.Brown@usq.edu.au					Adachi T, 2008, BIOL PHARM BULL, V31, P1021, DOI 10.1248/bpb.31.1021; Aldhahi Waleed, 2003, Curr Diab Rep, V3, P293, DOI 10.1007/s11892-003-0020-2; AL-Suhaimi EA, 2013, EUR J MED RES, V18, DOI 10.1186/2047-783X-18-12; American Diabetes Association, 2011, DIABETES CARE S1, V34, pS62, DOI DOI 10.2337/DC11-S062; Guo L, 2009, ENDOCR RES, V34, P142, DOI 10.3109/07435800903287079; Romacho T, 2009, DIABETOLOGIA, V52, P2455, DOI 10.1007/s00125-009-1509-2; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Wei D, 2010, DIABETES, V59, P471, DOI 10.2337/db09-0284; Yu XH, 2013, ACTA BIOCH BIOPH SIN, V45, P817, DOI 10.1093/abbs/gmt082; Xie NL, 2011, ARCH MED RES, V42, P171, DOI 10.1016/j.arcmed.2011.04.008; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Zhong M, 2008, CLIN ENDOCRINOL, V69, P878, DOI 10.1111/j.1365-2265.2008.03248.x; Caughey GE, 1996, AM J CLIN NUTR, V63, P116; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Barnes KM, 2009, CURR PROTEIN PEPT SC, V10, P96; Skelin M, 2010, ALTEX-ALTERN ANIM EX, V27, P105; Fasshauer M, 2004, FEBS LETT, V558, P27, DOI 10.1016/S0014-5793(03)01525-4; Segal KR, 1996, DIABETES, V45, P988, DOI 10.2337/diabetes.45.7.988; Jafari T, 2013, MATURITAS, V74, P303, DOI 10.1016/j.maturitas.2013.01.008; Poulsen LL, 2012, SEMIN CELL DEV BIOL, V23, P631, DOI 10.1016/j.semcdb.2012.01.003; Kamolrat T, 2013, EUR J NUTR, V52, P647, DOI 10.1007/s00394-012-0368-7; Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595; Morton GJ, 2007, J PHYSIOL-LONDON, V583, P437, DOI 10.1113/jphysiol.2007.135590; Shek EW, 1998, HYPERTENSION, V31, P409; Aller R, 2009, DIGEST DIS SCI, V54, P1772, DOI 10.1007/s10620-008-0539-9; Moschen AR, 2007, J IMMUNOL, V178, P1748; Juarez-Lopez C, 2013, PEDIATR DIABETES, V14, P377, DOI 10.1111/pedi.12024; Sivitz WI, 1997, ENDOCRINOLOGY, V138, P3395, DOI 10.1210/en.138.8.3395; Hidaka S, 2002, FASEB J, V16, P509, DOI 10.1096/fj.01-0164com; Cavaghan MK, 2000, J CLIN INVEST, V106, P329, DOI 10.1172/JCI10761; Tilg H, 2008, CLIN SCI, V114, P275, DOI 10.1042/CS20070196; Kratz M, 2002, J CLIN ENDOCR METAB, V87, P5008, DOI 10.1210/jc.2002-020496; Dobbins RL, 1998, DIABETES, V47, P1613, DOI 10.2337/diabetes.47.10.1613; Berg AH, 2001, NAT MED, V7, P947, DOI 10.1038/90992; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Combs TP, 2001, J CLIN INVEST, V108, P1875, DOI 10.1172/JCI14120; Riserus U, 2009, PROG LIPID RES, V48, P44, DOI 10.1016/j.plipres.2008.10.002; Figueras M, 2011, OBESITY, V19, P362, DOI 10.1038/oby.2010.194; Banerjee RR, 2004, SCIENCE, V303, P1195, DOI 10.1126/science.1092341; Clemmons DR, 2004, J CLIN INVEST, V113, P25, DOI 10.1172/JCI200420660; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Ohashi K, 2014, TRENDS ENDOCRIN MET, V25, P348, DOI 10.1016/j.tem.2014.03.009; Perez-Echarri N, 2009, BRIT J NUTR, V101, P1059, DOI 10.1017/S0007114508048307; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Luo ZF, 2009, ENDOCRINE, V36, P60, DOI 10.1007/s12020-009-9198-7; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Mason MM, 1998, ENDOCRINOLOGY, V139, P1013, DOI 10.1210/en.139.3.1013; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Howell G, 2009, BBA-MOL CELL BIOL L, V1791, P1190, DOI 10.1016/j.bbalip.2009.08.008; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Oliva ME, 2013, PROSTAG LEUKOTR ESS, V89, P279, DOI 10.1016/j.plefa.2013.09.010; Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126; Poudyal H, 2013, ENDOCR METAB IMMUNE, V13, P105; Ueno N, 2006, PEPTIDES, V27, P2332, DOI 10.1016/j.peptides.2006.03.006; Hulver MW, 2005, CELL METAB, V2, P251, DOI 10.1016/j.cmet.2005.09.002; Ouchi N, 1999, CIRCULATION, V100, P2473; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Seino S, 2011, J CLIN INVEST, V121, P2118, DOI 10.1172/JCI45680; Lopez-Bermejo A, 2006, DIABETES, V55, P2871, DOI 10.2337/db06-0259; Crujeiras AB, 2010, J CLIN ENDOCR METAB, V95, P5037, DOI 10.1210/jc.2009-2566; Chen MP, 2006, J CLIN ENDOCR METAB, V91, P295, DOI 10.1210/jc.2005-1475; Masson VR, 2008, J NUTR, V138, P1915; McCullough RS, 2011, LIPIDS, V46, P1043, DOI 10.1007/s11745-011-3619-0; Kalupahana NS, 2011, ADV NUTR, V2, P304, DOI [10.3945/​an.111.000505, 10.3945/an.111.000505]; Haider DG, 2006, J CLIN ENDOCR METAB, V91, P1578, DOI 10.1210/jc.2005-2248; Haider DG, 2006, J PEDIATR GASTR NUTR, V43, P548, DOI 10.1097/01.mpg.0000235749.50820.b3; Poudyal H, 2012, J NUTR BIOCHEM, V23, P153, DOI 10.1016/j.jnutbio.2010.11.011; Adachi T, 2006, BIOCHEM BIOPH RES CO, V340, P332, DOI 10.1016/j.bbre.2005.11.162; Poudyal Hemant, 2011, Endocrine Metabolic & Immune Disorders-Drug Targets, V11, P217; Lu LF, 2009, J STROKE CEREBROVASC, V18, P354, DOI 10.1016/j.jstrokecerebrovasdis.2009.01.003; Le KA, 2009, AM J CLIN NUTR, V89, P1760, DOI 10.3945/ajcn.2008.27336; Emilsson V, 1997, DIABETES, V46, P313, DOI 10.2337/diabetes.46.2.313; Poudyal H, 2011, PROG LIPID RES, V50, P372, DOI 10.1016/j.plipres.2011.06.003; Norata GD, 2007, EUR J ENDOCRINOL, V156, P279, DOI 10.1530/eje.1.02338; Gharibeh MY, 2010, DIABETES METAB, V36, P443, DOI 10.1016/j.diabet.2010.05.003; Krssak M, 1999, DIABETOLOGIA, V42, P113, DOI 10.1007/s001250051123; Castillero E, 2011, J ENDOCRINOL, V210, P361, DOI 10.1530/JOE-11-0170; Iyer A, 2010, NAT REV ENDOCRINOL, V6, P71, DOI 10.1038/nrendo.2009.264; Li H, 2005, KIDNEY INT, V67, P867, DOI 10.1111/j.1523-1755.2005.00151.x; Khalfoun B, 1997, ADV EXP MED BIOL, V400, P589; Perez-Matute P, 2005, AM J PHYSIOL-REG I, V288, pR1682, DOI 10.1152/ajpregu.00727.2004; Berndt J, 2005, DIABETES, V54, P2911, DOI 10.2337/diabetes.54.10.2911; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Mori Y, 1999, METABOLISM, V48, P1089, DOI 10.1016/S0026-0495(99)90120-8; Kubota H, 2013, ANTICANCER RES, V33, P4319; Ravussin E, 2002, ANN NY ACAD SCI, V967, P363; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Vemuri Madhuri, 2007, Metabolic Syndrome and Related Disorders, V5, P315, DOI 10.1089/met.2007.0007; Pighin D, 2003, J NUTR, V133, P4095; Lozano A, 2013, NUTR RES, V33, P1012, DOI 10.1016/j.nutres.2013.08.010; Gorboulev V, 2012, DIABETES, V61, P187, DOI 10.2337/db11-1029; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Smith GI, 2011, CLIN SCI, V121, P267, DOI 10.1042/CS20100597; Salt IP, 2000, DIABETES, V49, P1649, DOI 10.2337/diabetes.49.10.1649; O'Rourke RW, 2009, SURGERY, V145, P255, DOI 10.1016/j.surg.2008.08.038; Clemmons DR, 2012, ENDOCRIN METAB CLIN, V41, P425, DOI 10.1016/j.ecl.2012.04.017; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Gingras AA, 2007, J PHYSIOL-LONDON, V579, P269, DOI 10.1113/jphysiol.2006.121079; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536; Degawa-Yamauchi M, 2003, J CLIN ENDOCR METAB, V88, P5452, DOI 10.1210/jc.2002-021808; Satoh N, 2009, HYPERTENS RES, V32, P1004, DOI 10.1038/hr.2009.145; Banga A, 2009, AM J PHYSIOL-ENDOC M, V296, pE480, DOI 10.1152/ajpendo.90892.2008; Andersen G, 2008, ANN NUTR METAB, V52, P250, DOI 10.1159/000140518; Johnson RJ, 2013, OBESITY, V21, P659, DOI 10.1002/oby.20026; Benomar Y, 2006, ENDOCRINOLOGY, V147, P2550, DOI 10.1210/en.2005-1464; Weir GC, 2001, DIABETES, V50, pS154, DOI 10.2337/diabetes.50.2007.S154; Xu SM, 2011, J DIABETES, V3, P225, DOI 10.1111/j.1753-0407.2011.00132.x; Takebayashi K, 2007, METABOLISM, V56, P451, DOI 10.1016/j.metabol.2006.12.001; Fang XL, 2012, MOL BIOL REP, V39, P10987, DOI 10.1007/s11033-012-2000-6; Oliver E, 2012, J NUTR BIOCHEM, V23, P1192, DOI 10.1016/j.jnutbio.2011.06.014; Poudyal H, 2013, J NUTR BIOCHEM, V24, P1041, DOI 10.1016/j.jnutbio.2012.07.014; Neschen S, 2007, DIABETES, V56, P1034, DOI 10.2337/db06-1206; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; Poudyal H, 2012, AM J PHYSIOL-ENDOC M, V302, pE1472, DOI 10.1152/ajpendo.00102.2012; Biddinger SB, 2006, DIABETES, V55, P2032, DOI 10.2337/db05-0742; Kraegen EW, 2008, CURR OPIN LIPIDOL, V19, P235, DOI 10.1097/01.mol.0000319118.44995.9a; Wendland E, 2006, HEART, V92, P166, DOI 10.1136/hrt.2004.053538; Minokoshi Y, 1999, DIABETES, V48, P287, DOI 10.2337/diabetes.48.2.287; Kintscher U, 2005, AM J PHYSIOL-ENDOC M, V288, pE287, DOI 10.1152/ajpendo.00440.2004; Moriya R, 2009, AM J PHYSIOL-ENDOC M, V297, pE1358, DOI 10.1152/ajpendo.00412.2009; Valsamakis G, 2004, METABOLISM, V53, P430, DOI 10.1016/j.metabol.2003.11.022; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Yamauchi T, 2003, J BIOL CHEM, V278, P2461, DOI 10.1074/jbc.M209033200; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Zhao GX, 2004, J NUTR, V134, P2991; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Xiao C, 2006, DIABETOLOGIA, V49, P1371, DOI 10.1007/s00125-006-0211-x; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Agrawal R, 2012, J PHYSIOL-LONDON, V590, P2485, DOI 10.1113/jphysiol.2012.230078; Murali G, 2014, PROSTAG LEUKOTR ESS, V90, P13, DOI 10.1016/j.plefa.2013.10.002; Fedor D, 2009, CURR OPIN CLIN NUTR, V12, P138, DOI 10.1097/MCO.0b013e3283218299; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Allred CD, 2008, J NUTR, V138, P250; Shimura T, 1997, BIOL PHARM BULL, V20, P507; Yoon MJ, 2006, DIABETES, V55, P2562, DOI 10.2337/db05-1322; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Tomas E, 2002, P NATL ACAD SCI USA, V99, P16309, DOI 10.1073/pnas.222657499; Dobbins RL, 1998, J CLIN INVEST, V101, P2370, DOI 10.1172/JCI1813; Reseland JE, 2001, J LIPID RES, V42, P743; Chambrier C, 2002, OBES RES, V10, P518, DOI 10.1038/oby.2002.70; Cha SH, 2001, J NUTR, V131, P2636; Sarbolouki S, 2013, SINGAP MED J, V54, P387, DOI 10.11622/smedj.2013139; Antuna-Puente B, 2008, DIABETES METAB, V34, P2, DOI 10.1016/j.diabet.2007.09.004; Armoni M, 2007, TRENDS ENDOCRIN MET, V18, P100, DOI 10.1016/j.tem.2007.02.001; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Berti L, 1997, DIABETOLOGIA, V40, P606, DOI 10.1007/s001250050722; Bertrand C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078874; Blüher Matthias, 2014, Mol Metab, V3, P230, DOI 10.1016/j.molmet.2014.01.005; Boden G, 1998, DIABETES, V47, P1609, DOI 10.2337/diabetes.47.10.1609; Pereira S, 2015, METABOLISM, V64, P315, DOI 10.1016/j.metabol.2014.10.019; Cancelas J, 2007, HORM METAB RES, V39, P823, DOI 10.1055/s-2007-991171; Carbonelli MG, 2010, CURR PHARM DESIGN, V16, P840, DOI 10.2174/138161210790883589; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Ceddia RB, 1999, INT J OBESITY, V23, P75, DOI 10.1038/sj.ijo.0800762; Chavali SR, 1998, PROSTAG LEUKOTR ESS, V58, P185, DOI 10.1016/S0952-3278(98)90112-0; Chicco A, 1996, ANN NUTR METAB, V40, P61, DOI 10.1159/000177897; Choi YJ, 2014, HORM METAB RES, V46, P233, DOI 10.1055/s-0034-1370907; DeCaterina R, 1996, LIPIDS, V31, pS57; Della-Fera MA, 2005, OBES RES, V13, P1540, DOI 10.1038/oby.2005.189; Denroche HC, 2012, J DIABETES INVEST, V3, P115, DOI 10.1111/j.2040-1124.2012.00203.x; Di Lorenzo C, 2013, EVID-BASED COMPL ALT, DOI 10.1155/2013/782461; Djousse L, 2006, OBESITY, V14, P295, DOI 10.1038/oby.2006.38; Dogru T, 2007, DIABETES RES CLIN PR, V76, P24, DOI 10.1016/j.diabres.2006.07.031; Ferre P, 2010, DIABETES OBES METAB, V12, P83, DOI 10.1111/j.1463-1326.2010.01275.x; Fukumitsu S, 2013, CYTOTECHNOLOGY, V65, P899, DOI 10.1007/s10616-012-9510-x; Galgani JE, 2008, BRIT J NUTR, V100, P471, DOI 10.1017/S0007114508894408; Ghafoorunissa, 2005, BIOCHIM BIOPHYS ACTA, V21, P67; Graveleau C, 2005, J BIOL CHEM, V280, P31679, DOI 10.1074/jbc.M504008200; Gueugnon C, 2012, APPL PHYSIOL NUTR ME, V37, P672, DOI [10.1139/h2012-045, 10.1139/H2012-045]; Haluzik MM, 2006, PHYSIOL RES, V55, P115; Haugen F, 2005, J LIPID RES, V46, P143, DOI 10.1194/jlr.M400348-JLR200; Hoist J.J., 2007, PHYSIOL REV, V87, P1409; Holness MJ, 2003, ENDOCRINOLOGY, V144, P3958, DOI 10.1210/en.2003-0479; Holness MJ, 2004, DIABETES, V53, pS166, DOI 10.2337/diabetes.53.2007.S166; International Diabetes Federation, 2013, IDF DIABETES ATLAS; Jin H, 2008, DIABETES RES CLIN PR, V79, P412, DOI 10.1016/j.diabres.2007.09.019; Kaji Izumi, 2014, Digestion, V89, P31, DOI 10.1159/000356211; Kato T, 2008, DIABETES, V57, P2382, DOI 10.2337/db06-1806; Kelley DS, 2009, BRIT J NUTR, V101, P701, DOI 10.1017/S0007114508027451; Kogure R, 2011, BIOCHEM BIOPH RES CO, V416, P58, DOI 10.1016/j.bbrc.2011.10.141; Konard R J, 1996, Pancreas, V13, P253; Kwon Hyokjoon, 2013, Front Endocrinol (Lausanne), V4, P71, DOI 10.3389/fendo.2013.00071; Leguisamo NM, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-100; Liu SW, 2009, CLIN ENDOCRINOL, V71, P202, DOI 10.1111/j.1365-2265.2008.03453.x; Liu XF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-109; Lopez S, 2011, AM J CLIN NUTR, V93, P494, DOI 10.3945/ajcn.110.003251; Lorente-Cebrian S, 2006, J PHYSIOL BIOCHEM, V62, P61; Louchami K, 2006, INT J MOL MED, V18, P1047; Martins AR, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-30; Mellouk Z, 2012, INT J MOL MED, V29, P285, DOI 10.3892/ijmm.2011.812; Mori Y, 1997, METABOLISM, V46, P1458, DOI 10.1016/S0026-0495(97)90148-7; Morishita M, 2008, J CONTROL RELEASE, V132, P99, DOI 10.1016/j.jconrel.2008.09.001; Muhlhausler BS, 2010, J NUTR METAB, V2010; Muramatsu T, 2010, PREV MED, V50, P272, DOI 10.1016/j.ypmed.2010.02.014; Murase T, 2005, BBA-MOL CELL BIOL L, V1733, P224, DOI 10.1016/j.bbalip.2004.12.015; Nelson TL, 2007, METABOLISM, V56, P1209, DOI 10.1016/j.metabol.2007.04.017; Nobukata H, 2000, METABOLISM, V49, P912, DOI 10.1053/meta.2000.6739; Oguzhan B, 2006, ENDOCRINE, V29, P457, DOI 10.1385/ENDO:29:3:457; OPARA EC, 1992, ENDOCRINOLOGY, V130, P657, DOI 10.1210/en.130.2.657; Oribe Junya, 2012, Obes Res Clin Pract, V6, pe175, DOI 10.1016/j.orcp.2011.10.004; Paulsen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088227; Peng J, 2014, PPAR RES, DOI 10.1155/2014/538183; Perez-Echarri N, 2009, J NUTR BIOCHEM, V20, P705, DOI 10.1016/j.jnutbio.2008.06.013; Perez-Matute P, 2007, BRIT J NUTR, V97, P389, DOI 10.1017/S0007114507207627; Raclot T, 1997, J LIPID RES, V38, P1963; Rahmouni K, 2008, CIRC RES, V103, P565, DOI 10.1161/CIRCRESAHA.108.184366; Rhee Y, 2011, NUTR J, V10, DOI 10.1186/1475-2891-10-44; Saddi-Rosa P, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-21; Sainz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029389; Sato A, 2010, DIABETES, V59, P2495, DOI 10.2337/db09-1554; Sekine S, 2008, INT J VITAM NUTR RES, V78, P223, DOI [10.1024/0300-9831.78.45.223, 10.1024/0300-9831.78.4/5.223]; Sener A, 2009, INT J MOL MED, V24, P125, DOI 10.3892/ijmm_00000215; Sener A, 2006, ENDOCRINE, V30, P207, DOI 10.1385/ENDO:30:2:207; Shao SY, 2010, J CELL BIOCHEM, V111, P634, DOI 10.1002/jcb.22750; Shida T, 2013, INT J PHARMACEUT, V450, P63, DOI 10.1016/j.ijpharm.2013.04.029; Stofkova A, 2010, Endocr Regul, V44, P25; Thompson AK, 2011, EUR J CLIN NUTR, V65, P553, DOI 10.1038/ejcn.2010.240; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; Tuo Y, 2012, CLIN EXP PHARMACOL P, V39, P423, DOI 10.1111/j.1440-1681.2012.05691.x; Wang Hao, 2009, Chinese Medical Sciences Journal, V24, P161; Xiong YM, 2013, MOL CELL ENDOCRINOL, V369, P119, DOI 10.1016/j.mce.2013.01.009; Yang LJ, 2013, ONCOL LETT, V6, P197, DOI 10.3892/ol.2013.1336; Yaspelkis BB, 2004, LIFE SCI, V74, P1801, DOI 10.1016/j.lfs.2003.08.037; Zahorska-Markiewicz B, 2007, METABOLISM, V56, P1131, DOI 10.1016/j.metabol.2007.04.007; Zhang W, 2007, NUTRITION, V23, P762, DOI 10.1016/j.nut.2007.07.003; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068489; Zhang Y, 2006, AM J PHYSIOL-ENDOC M, V291, pE441, DOI 10.1152/ajpendo.00455.2005	232	3	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0955-2863	1873-4847		J NUTR BIOCHEM	J. Nutr. Biochem.	JUN	2015	26	6					571	584		10.1016/j.jnutbio.2015.02.001		14	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CI6ZM	WOS:000354912700001		
J	Arisaka, O; Ichikawa, G; Koyama, S; Shimura, N				Arisaka, Osamu; Ichikawa, Go; Koyama, Satomi; Shimura, Naoto			Anthropometric indices and metabolic co-morbidities	JOURNAL OF PEDIATRICS			English	Letter							ADIPOSITY		[Arisaka, Osamu; Ichikawa, Go; Koyama, Satomi; Shimura, Naoto] Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi, Japan	Arisaka, O (reprint author), Dokkyo Med Univ, Dept Pediat, Mibu, Tochigi, Japan.						Arisaka O, 2014, J PEDIATR-US, V164, P1502, DOI 10.1016/j.jpeds.2014.02.050; Arisaka O, 2012, J PEDIATR-US, V160, P531, DOI 10.1016/j.jpeds.2011.11.050; Huang RC, 2012, J CLIN ENDOCR METAB, V97, P1014; Koyama S, 2014, PEDIATRICS, V133, pE114, DOI 10.1542/peds.2013-0966; McCrindle BW, 2014, J PEDIATR-US, V165, P1083, DOI 10.1016/j.jpeds.2014.08.037; Morandi A, 2014, J PEDIATR-US, V165, P1178, DOI 10.1016/j.jpeds.2014.07.004	6	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	JUN	2015	166	6					1548	1549		10.1016/j.jpeds.2015.02.005		4	Pediatrics	Pediatrics	CI8JI	WOS:000355018200049		
J	Izaki, S; Kurinomaru, T; Maruyama, T; Uchida, T; Handa, K; Kimoto, T; Shiraki, K				Izaki, Shunsuke; Kurinomaru, Takaaki; Maruyama, Takuya; Uchida, Takayuki; Handa, Kenji; Kimoto, Tomoaki; Shiraki, Kentaro			Feasibility of Antibody-Poly(Glutamic Acid) Complexes: Preparation of High-Concentration Antibody Formulations and Their Pharmaceutical Properties	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						complexation; dissolution; polyelectrolytes; precipitation; formulation; suspensions	RECOMBINANT ANTIBODIES; MONOCLONAL-ANTIBODIES; SUBCUTANEOUS DELIVERY; PROTEIN ADSORPTION; BLOCK-COPOLYMER; MICELLES; SYSTEM; PRECIPITATION; INJECTION; VISCOSITY	Development of high-concentration antibody formulations for subcutaneous administration remains challenging. Recently, a precipitation-redissolution method was proposed to prepare suspensions or precipitates of salt-dissociable protein-poly(amino acid) complexes. To elucidate the utility of this method for protein therapy, we investigated the feasibility of a precipitation-redissolution method using poly(amino acid) for high-concentration antibody formulation. Omalizumab and adalimumab formulations of 150 mg/mL could be prepared using poly-l-glutamic acid (polyE) from low-concentration stock solutions. Enzyme-linked immunosorbent assay, circular dichroism, and size-exclusion chromatography revealed that the formation of antibody-polyE complex and precipitation-redissolution process did not significantly affect the immunoreactivity or secondary structure of the antibodies. The precipitation-redissolution method was less time-consuming and more effective than lyophilization-redissolution, evaporation-redissolution, and ultrafiltration from the viewpoint of final yield. Scalability was confirmed from 400 L to 1.0 L. The general toxicity and pharmacokinetic profiles of the antibody-polyE complex formulations were similar to those of conventional antibody formulations. These results suggested that the precipitation-redissolution method using poly(amino acid) has great potential as a concentration method for antibody formulation and medicinal use. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:1929-1937, 2015	[Izaki, Shunsuke; Uchida, Takayuki; Handa, Kenji; Kimoto, Tomoaki] Terumo Co Ltd, Ctr Res & Dev, Ashigarakamigun, Kanagawa 2590151, Japan; [Kurinomaru, Takaaki; Maruyama, Takuya; Shiraki, Kentaro] Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan	Shiraki, K (reprint author), Univ Tsukuba, Fac Pure & Appl Sci, Tsukuba, Ibaraki 3058573, Japan.	shiraki@bk.tsukuba.ac.jp			University of Tsukuba; Terumo Corporation	This study was supported financially by University of Tsukuba and Terumo Corporation.	Bowen M, 2012, J PHARM SCI-US, V101, P4433, DOI 10.1002/jps.23324; Inoue N, 2014, J BIOSCI BIOENG, V117, P539, DOI 10.1016/j.jbiosc.2013.10.016; TEH LC, 1987, J BIOL CHEM, V262, P6472; Dani B, 2007, J PHARM SCI-US, V96, P1504, DOI 10.1002/jps.20508; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Kontermann RE, 2009, BIODRUGS, V23, P93, DOI 10.2165/00063030-200923020-00003; Yang MX, 2003, P NATL ACAD SCI USA, V100, P6934, DOI 10.1073/pnas.1131899100; Carlsson F, 2003, J AM CHEM SOC, V125, P3140, DOI 10.1021/ja020935a; Tomita S, 2011, J POLYM SCI POL CHEM, V49, P3835, DOI 10.1002/pola.24822; Bae Y, 2009, ADV DRUG DELIVER REV, V61, P768, DOI 10.1016/j.addr.2009.04.016; Kurinomaru T, 2012, LANGMUIR, V28, P4334, DOI 10.1021/la2043312; Ganguli S, 2009, J AM CHEM SOC, V131, P6549, DOI 10.1021/ja900786z; Wang W, 2007, J PHARM SCI-US, V96, P1, DOI 10.1002/jps.20727; Shire SJ, 2004, J PHARM SCI-US, V93, P1390, DOI 10.1002/jps.20079; Matheus S, 2009, J PHARM SCI-US, V98, P3043, DOI 10.1002/jps.21526; Harris RJ, 2004, DRUG DEVELOP RES, V61, P137, DOI 10.1002/ddr.10344; Reichert JM, 2005, NAT BIOTECHNOL, V23, P1073, DOI 10.1038/nbt0905-1073; DUNCAN MR, 1995, INT J PHARM, V120, P179, DOI 10.1016/0378-5173(94)00402-Q; Tomita S, 2010, SOFT MATTER, V6, P5320, DOI 10.1039/c000930j; Bromberg L, 2005, BIOPHYS J, V89, P3424, DOI 10.1529/biophysj.105.062802; Weiner LM, 2010, NAT REV IMMUNOL, V10, P317, DOI 10.1038/nri2744; Sliwkowski MX, 2013, SCIENCE, V341, P1192, DOI 10.1126/science.1241145; Nishi H, 2010, PHARM RES-DORDR, V27, P1348, DOI 10.1007/s11095-010-0125-7; Kayitmazer AB, 2013, SOFT MATTER, V9, P2553, DOI 10.1039/c2sm27002a; Inoue N, 2014, MOL PHARMACEUT, V11, P1889, DOI 10.1021/mp5000218; Rosenberg E, 2009, J MEMBRANE SCI, V342, P50, DOI 10.1016/j.memsci.2009.06.028; Kakizawa Y, 2002, ADV DRUG DELIVER REV, V54, P203, DOI 10.1016/S0169-409X(02)00017-0; Kurinomaru T, 2014, LANGMUIR, V30, P3826, DOI 10.1021/la500575c; Genovese MC, 2011, ARTHRITIS RHEUM-US, V63, P2854, DOI 10.1002/art.30463; Johnson HR, 2013, MOL PHARMACEUT, V10, P3582, DOI 10.1021/mp400006g; Kurinomaru T, 2014, J PHARM SCI-US, V103, P2248, DOI 10.1002/jps.24025; Lavasanifar A, 2002, ADV DRUG DELIVER REV, V54, P169, DOI 10.1016/S0169-409X(02)00015-7; Ni R, 2008, J PHYS CHEM B, V112, P4393, DOI 10.1021/jp076348z; Norde W, 1995, ACS SYM SER, V602, P26; Osada K, 2009, J R SOC INTERFACE, V6, pS325, DOI 10.1098/rsif.2008.0547.focus; PETTY C, 1974, ANESTHESIOLOGY, V40, P400, DOI 10.1097/00000542-197404000-00018; Tomisawa N, 2009, J ARTIF ORGANS, V12, P194, DOI 10.1007/s10047-009-0469-0; Tsuboi A, 1996, LANGMUIR, V12, P6295, DOI 10.1021/la960653m; Wells Alvin F, 2014, Biologics, V8, P41, DOI 10.2147/BTT.S55783	39	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	JUN	2015	104	6					1929	1937		10.1002/jps.24422		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CI0WB	WOS:000354458800007		
J	Arunkumar, R; Prashanth, KVH; Manabe, Y; Hirata, T; Sugawara, T; Dharmesh, SM; Baskaran, V				Arunkumar, Ranganathan; Prashanth, Keelara Veerappa Harish; Manabe, Yuki; Hirata, Takashi; Sugawara, Tatsuya; Dharmesh, Shylaja Mallaiah; Baskaran, Vallikannan			Biodegradable Poly (Lactic-co-Glycolic Acid)-Polyethylene Glycol Nanocapsules: An Efficient Carrier for Improved Solubility, Bioavailability, and Anticancer Property of Lutein	JOURNAL OF PHARMACEUTICAL SCIENCES			English	Article						bioavailability; biodegradable polymers; antioxidants; nanocapsules; pharmacokinetics; poly(lactic; glycolic) acid (PLGA or PLA); polymeric drug carrier; X-ray powder diffractometry; poorly water-soluble drugs	CURCUMIN-LOADED PLGA; IN-VITRO; ORAL BIOAVAILABILITY; NANOPARTICLES; DELIVERY; VIVO; DRUG; FORMULATION; MODEL; ENCAPSULATION	Lutein bioavailability is limited because of its poor aqueous solubility. In this study, lutein-poly (lactic-co-glycolic acid) (PLGA)-polyethylene glycol (PEG) nanocapsules were prepared to improve the solubility, bioavailability, and anticancer property of lutein. The scanning electron microscopy and dynamic light scattering examination revealed that the nanocapsules are smooth and spherical with size ranging from 80 to 500 nm (mean = 200 nm). In vitro lutein release profile from nanocapsules showed controlled sustainable release (66%) up to 72 h. Aqueous solubility of lutein nanocapsules was much higher by 735-fold than the lutein. Fourier transform infrared spectroscopy analyses showed no chemical interaction among PLGA, PEG, and lutein, indicating possible weak intermolecular forces like hydrogen bonds. X-ray diffraction revealed lutein is distributed in a disordered amorphous state in nanocapsules. Postprandial plasma kinetics (area under the curve) of an oral dose of lutein from nanocapsules was higher by 5.4-fold compared with that of micellar lutein (control). The antiproliferative effect of lutein from nanocapsules (IC50 value, 10.9 M) was higher (43.6%) than the lutein (IC50 value, 25 M). Results suggest that PLGA-PEG nanocapsule is an efficient carrier for enhancing hydrophilicity, bioavailability, and anticancer property of lipophilic molecules such as lutein. (c) 2015 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 104:2085-2093, 2015	[Arunkumar, Ranganathan; Baskaran, Vallikannan] CSIR Cent Food Technol Res Inst, Dept Mol Nutr, Mysore 570020, Karnataka, India; [Prashanth, Keelara Veerappa Harish] CSIR Cent Food Technol Res Inst, Dept Meat & Marine Sci, Mysore 570020, Karnataka, India; [Manabe, Yuki; Hirata, Takashi; Sugawara, Tatsuya] Kyoto Univ, Grad Sch Agr, Div Appl Biosci, Kyoto 6068502, Japan; [Dharmesh, Shylaja Mallaiah] CSIR Cent Food Technol Res Inst, Dept Biochem & Nutr, Mysore 570020, Karnataka, India	Baskaran, V (reprint author), CSIR Cent Food Technol Res Inst, Dept Mol Nutr, Mysore 570020, Karnataka, India.	baskaranv@cftri.res.in			Department of Science and Technology, Government of India [DST/INT/JSPS/P-122/11]; Indian Council of Medical Research (ICMR), Government of India, New Delhi	We are grateful to the Department of Science and Technology, Government of India, for the financial support toward the research project (DST/INT/JSPS/P-122/11). R. Arunkumar acknowledges the Indian Council of Medical Research (ICMR), Government of India, New Delhi, for awarding Senior Research Fellowship. The authors thank Dr. Renuka Devi, Anna University, Coimbatore, for AFM facility. Dr. Naveen, DFRL, Mysore, and Mr. Nandaprakash, Department of Physics, University of Mysore, for DLS and XRD facility. N.S. Mahendrakar, retired scientist, editor in chief, JFST is also acknowledged for editing this manuscript with reference to English and grammar.	Budhian A, 2007, INT J PHARM, V336, P367, DOI 10.1016/j.ijpharm.2006.11.061; Dwyer JH, 2001, CIRCULATION, V103, P2922; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Makadia HK, 2011, POLYMERS-BASEL, V3, P1377, DOI 10.3390/polym3031377; Anand P, 2010, BIOCHEM PHARMACOL, V79, P330, DOI 10.1016/j.bcp.2009.09.003; Valko M, 2007, INT J BIOCHEM CELL B, V39, P44, DOI 10.1016/j.biocel.2006.07.001; Sahana DK, 2008, J PHARM SCI-US, V97, P1530, DOI 10.1002/jps.21158; Ali H, 2013, INT J PHARMACEUT, V454, P149, DOI 10.1016/j.ijpharm.2013.07.010; Arunkumar R, 2013, FOOD CHEM, V141, P327, DOI 10.1016/j.foodchem.2013.02.108; Khalil NM, 2013, COLLOID SURFACE B, V101, P353, DOI 10.1016/j.colsurfb.2012.06.024; Ratnam DV, 2006, J CONTROL RELEASE, V113, P189, DOI 10.1016/j.jconrel.2006.04.015; Kotake-Nara E, 2011, MAR DRUGS, V9, P1024, DOI 10.3390/md9061024; Marslin G, 2009, J BIOMED NANOTECHNOL, V5, P464, DOI 10.1166/jbn.2009.1075; Danhier F, 2012, J CONTROL RELEASE, V161, P505, DOI 10.1016/j.jconrel.2012.01.043; Xie XX, 2011, J AGR FOOD CHEM, V59, P9280, DOI 10.1021/jf202135j; Mukerjee A, 2009, ANTICANCER RES, V29, P3867; Wang YF, 2012, EUR FOOD RES TECHNOL, V234, P157, DOI 10.1007/s00217-011-1630-6; Zhao LY, 2010, J PHARM SCI-US, V99, P3552, DOI 10.1002/jps.22113; Landrum JT, 2001, ARCH BIOCHEM BIOPHYS, V385, P28, DOI 10.1006/abbi.2000.2171; Mitri K, 2011, INT J PHARMACEUT, V414, P267, DOI 10.1016/j.ijpharm.2011.05.008; Lakshminarayana R, 2008, FREE RADICAL BIO MED, V45, P982, DOI 10.1016/j.freeradbiomed.2008.06.011; Chew BP, 1996, ANTICANCER RES, V16, P3689; Chitchumroonchokchai C, 2004, J NUTR, V134, P2280; McNeil Scott E., 2005, Journal of Leukocyte Biology, V78, P585, DOI 10.1189/jlb.0205074; Chew BP, 2004, J NUTR, V134, p257S; Pirooznia N, 2012, J NANOBIOTECHNOL, V10, DOI 10.1186/1477-3155-10-20; Shau MD, 2012, EUR J PHARM SCI, V46, P522, DOI 10.1016/j.ejps.2012.04.006; Vishwanathan R., 2009, NANO BIOMED ENG, V1, P38; Zhou JR, 1996, J AM COLL NUTR, V15, P84	29	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3549	1520-6017		J PHARM SCI-US	J. Pharm. Sci.	JUN	2015	104	6					2085	2093		10.1002/jps.24436		9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CI0WB	WOS:000354458800022		
J	Mukae, T; Uchida, H; Ueda, H				Mukae, Takehiro; Uchida, Hitoshi; Ueda, Hiroshi			Donepezil Reverses Intermittent Stress-Induced Generalized Chronic Pain Syndrome in Mice	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							EXPERIMENTAL MOUSE MODEL; NEUROPATHIC PAIN; MOLECULAR-MECHANISMS; FIBROMYALGIA; ANALGESIA; HYPERALGESIA; MORPHINE; DISEASE; SYSTEM; RELIEF	Treatment of fibromyalgia is an unmet medical need. To develop novel therapies for the treatment of fibromyalgia, we explored pain therapeutic actions of existing pharmaceuticals, which inhibit the somatic symptoms frequently observed in fibromyalgia patients. This study first examined the therapeutic actions of pilocarpine, which inhibits dry-eye and dry-mouth symptoms, using an experimental fibromyalgia-like chronic pain model produced by intermittent cold stress (ICS) in mice. A single intraperitoneal and intracerebroventricular, but not intrathecal, pilocarpine administration attenuated ICS-induced thermal hyperalgesia and mechanical allodynia, and this action was abolished by muscarinic antagonist pirenzepine (i.c.v.). Treatment with 1-10 mg/kg donepezil (i.p.), which can easily penetrate into the brain, also showed similar therapeutic effects. Importantly, we found that both pilocarpine and donepezil produced antihyperalgesic effects via supraspinal action. Furthermore, repeated donepezil treatments completely cured the ICS-induced hyperalgesia and allodynia even after the cessation of drug treatments. Acute and chronic treatments of these cholinomimetics had no effects on the nociceptive threshold in control animals. By contrast, the lack of morphine (i.c.v.) analgesia initially observed in the ICS model remained in ICS model mice treated with long-term donepezil. Collectively, these findings suggest that stimulation of the muscarinic cholinergic system effectively inhibits some mechanisms underlying chronic pain in the ICS model, but does not inhibit the lack of descending pain-inhibitory mechanisms, which are driven by central morphine.	[Mukae, Takehiro; Uchida, Hitoshi; Ueda, Hiroshi] Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacol & Therapeut Innovat, Nagasaki 8528521, Japan	Ueda, H (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Dept Pharmacol & Therapeut Innovat, 1-14 Bunkyo Machi, Nagasaki 8528521, Japan.	ueda@nagasaki-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [26253077]; Platform for Drug Discovery, Informatics, and Structural Life Science	This research was supported by the Ministry of Education, Culture, Sports, Science, and Technology of Japan [Grant-in-Aid for Scientific Research 26253077 (to H.Ue.)]; and the Platform for Drug Discovery, Informatics, and Structural Life Science.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Uchida H, 2010, J NEUROSCI, V30, P4806, DOI 10.1523/JNEUROSCI.5541-09.2010; Nasu T, 2010, EUR J PAIN, V14, P236, DOI 10.1016/j.ejpain.2009.05.009; Saxena G, 2008, EUR J PHARMACOL, V581, P283, DOI 10.1016/j.ejphar.2007.12.009; Baraniuk JN, 2004, BMC MUSCULOSKEL DIS, V5, DOI 10.1186/1471-2474-5-48; Kimura M, 2013, ANESTHESIOLOGY, V118, P173, DOI 10.1097/ALN.0b013e318277a81c; Khasar SG, 2003, EUR J NEUROSCI, V17, P909, DOI 10.1046/j.1460-9568.2003.02503.x; Sluka KA, 2001, MUSCLE NERVE, V24, P37, DOI 10.1002/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8; Jones PG, 2007, NEUROPHARMACOLOGY, V53, P197, DOI 10.1016/j.neuropharm.2007.04.002; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Banks WA, 2012, ADV DRUG DELIVER REV, V64, P629, DOI 10.1016/j.addr.2011.12.005; HYLDEN JLK, 1980, EUR J PHARMACOL, V67, P313, DOI 10.1016/0014-2999(80)90515-4; Costigan M, 2009, ANNU REV NEUROSCI, V32, P1, DOI 10.1146/annurev.neuro.051508.135531; Smith HS, 2011, PAIN PHYSICIAN, V14, pE217; Khasar SG, 2009, J PAIN, V10, P1073, DOI 10.1016/j.jpain.2009.04.005; Harris RE, 2007, J NEUROSCI, V27, P10000, DOI 10.1523/JNEUROSCI.2849-07.2007; Harris RE, 2013, ANESTHESIOLOGY, V119, P1453, DOI 10.1097/ALN.0000000000000017; Nagakura Y, 2009, PAIN, V146, P26, DOI 10.1016/j.pain.2009.05.024; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Nishiyori M, 2010, NEUROSCI LETT, V472, P184, DOI 10.1016/j.neulet.2010.01.080; Clauw DJ, 2014, JAMA-J AM MED ASSOC, V311, P1547, DOI 10.1001/jama.2014.3266; Wolfe F, 2010, ARTHRIT CARE RES, V62, P600, DOI 10.1002/acr.20140; Baron R, 2006, NAT CLIN PRACT NEURO, V2, P95, DOI 10.1038/ncpneuro0113; Arnold Lesley M, 2009, Am J Med, V122, pS31, DOI 10.1016/j.amjmed.2009.09.009; Bennett R, 2005, NEUROLOGIC FEATURES; Clauw Daniel J, 2009, Am J Med, V122, pS3, DOI 10.1016/j.amjmed.2009.09.006; DeSantana JM, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4402; Devor M, 2013, NEUROPATHIC PAIN PAT; De Vos F, 2000, NUCL MED BIOL, V27, P745, DOI 10.1016/S0969-8051(00)00166-9; Hill RG, 2013, ANALGESIC DRUGS DEV; Nishiyori M, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-69; Nishiyori M, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-52; OHARA H, 1991, JPN J PHARMACOL, V57, P243, DOI 10.1254/jjp.57.243; Omiya Y, 2000, PHARMACOL BIOCHEM BE, V65, P261, DOI 10.1016/S0091-3057(99)00215-4; Ossipov MH, 2013, ANIMAL MODELS EXPT N; Russell IJ, 2013, FIBROMYALGIA SYNDROM; Seymour B, 2013, EMOTION MOVIVATION P; Toelle TR, 2013, PHARM THERAPY NEUROP; Ueda H, 2006, PHARMACOL THERAPEUT, V109, P57, DOI 10.1016/j.pharmthera.2005.06.003; Ueda H, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-11	40	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	JUN	2015	353	3					471	479		10.1124/jpet.114.222414		9	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CH9YA	WOS:000354391400004		
J	Sano, H; Ichioka, S				Sano, Hitomi; Ichioka, Shigeru			Influence of oxygen on wound healing dynamics in healing-impaired diabetic mice	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Chronic wound; diabetic ulcer; oxygen; wound healing	COLLAGEN-SYNTHESIS; HEMOGLOBIN; MELLITUS; HYPOXIA; DELIVERY; DISEASE; ANEMIA	A previous experiment using an in vivo mouse model has proved that hypoxia increased angiogenesis during wound healing. It was hypothesised that one of the mechanisms for wound healing impairment in diabetes includes insufficient angiogenic ability in response to hypoxia. The current study aims to investigate the influence of hypoxia on wound healing in diabetic mice. Oxygen-impermeable (hypoxic group) and -permeable membranes (normoxic group) were used to control topical oxygen tension. Membranes were applied to symmetrical excisional wounds on diabetic mice. Wound area, granulated tissue thickness, and vascular density were analyzed. As results, a decrease in wound size on day 7 was observed in the normoxic group (20.7 +/- 3.64%) compared with the hypoxic group (34.1 +/- 4.98%). The normoxic group also showed significantly thicker granulated tissue than the hypoxic group (225.7 +/- 54.7 vs 128.7 +/- 42.4 mu m). There was no significant difference in mean vascular density between normoxic and hypoxic groups (0.046 +/- 0.022 vs 0.038 +/- 0.017 mm(2)/mm(2), p = 0.80). Contrary to healthy mice, diabetic mice have shown no enhancement of angiogenesis in hypoxic condition. The findings illustrate that neovascularisation in response to hypoxia is diminished in diabetic wounds.	[Sano, Hitomi] Univ Tokyo, Grad Sch Med, Dept Surg Sci, Tokyo 1138603, Japan; [Sano, Hitomi; Ichioka, Shigeru] Saitama Med Univ Hosp, Dept Plast & Reconstruct Surg, Saitama, Japan	Sano, H (reprint author), Univ Tokyo, Grad Sch Med, Dept Surg Sci, Bunkyo Ku, Sendagi 1-1-5, Tokyo 1138603, Japan.	sasasa116sasasa@hotmail.com					Gatenby VK, 2010, EXPERT OPIN THER TAR, V14, P1333, DOI 10.1517/14728222.2010.528930; TSUBOI R, 1990, J EXP MED, V172, P245, DOI 10.1084/jem.172.1.245; Sutter CH, 2000, P NATL ACAD SCI USA, V97, P4748, DOI 10.1073/pnas.080072497; Semenza GL, 2010, ARTERIOSCL THROM VAS, V30, P648, DOI 10.1161/ATVBAHA.108.181644; Capla JM, 2007, PLAST RECONSTR SURG, V119, P59, DOI 10.1097/01.prs.0000244830.16906.3f; KNIGHTON DR, 1981, SURGERY, V90, P262; ALVAREZ OM, 1983, J SURG RES, V35, P142, DOI 10.1016/0022-4804(83)90136-1; Kahle B, 2011, DTSCH ARZTEBL INT, V108, P231, DOI 10.3238/arztebl.2011.0231; Thangarajah H, 2010, CELL CYCLE, V9, P75, DOI 10.4161/cc.9.1.10371; Fries RB, 2005, MUTAT RES-FUND MOL M, V579, P172, DOI 10.1016/j.mrfmmm.2005.02.023; HUNT TK, 1972, SURG GYNECOL OBSTETR, V135, P561; JONSSON K, 1991, ANN SURG, V214, P605, DOI 10.1097/00000658-199111000-00011; Said HK, 2005, ARCH SURG-CHICAGO, V140, P998, DOI 10.1001/archsurg.140.10.998; El-Ftesi S, 2009, PLAST RECONSTR SURG, V123, P475, DOI 10.1097/PRS.0b013e3181954d08; BUNN HF, 1978, SCIENCE, V200, P21, DOI 10.1126/science.635569; Mehdi U, 2009, DIABETES CARE, V32, P1320, DOI 10.2337/dc08-0779; Heise HM, 2003, SKIN RES TECHNOL, V9, P295, DOI 10.1034/j.1600-0846.2003.00036.x; Niinikoski J, 1969, Acta Physiol Scand Suppl, V334, P1; Niwa T, 2000, CLIN CHEM, V46, P82; ORIORDAN JF, 1984, ADV EXP MED BIOL, V169, P187; Sano H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050212; Sonveaux P, 2007, PHYSIOLOGY, V22, P97, DOI 10.1152/physiol.00042.2006; Weinheimer-Haus EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091355	23	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	JUN	2015	49	3					135	140		10.3109/2000656X.2014.964723		6	Orthopedics; Surgery	Orthopedics; Surgery	CI0EI	WOS:000354408600002		
J	Hu, B; Hu, N; Wu, LK; Liu, F; Liu, YL; Ning, HM; Atobe, S; Fukunaga, H				Hu, Bin; Hu, Ning; Wu, Liangke; Liu, Feng; Liu, Yaolu; Ning, Huiming; Atobe, Satoshi; Fukunaga, Hisao			Effects of initial crystallization process on piezoelectricity of PVDF-HFP films	JOURNAL OF POLYMER ENGINEERING			English	Article						crystalline structure; initial crystallization process; piezoelectricity; PVDF-HFP	POLY(VINYLIDENE FLUORIDE); PHASE-TRANSFORMATION; ALPHA-PHASE; BETA-PHASE; IMPROVEMENT	The effects of some important factors in the initial crystallization process of the solution casting method on the piezoelectricity of poly(vinylidene fluoride-co-hexafluoropropylene) (PVDF-HFP) films were extensively explored. The experimental results revealed that there is an optimal initial crystallization temperature at around 90 degrees C. The slow cooling speed can moderately enhance the degree of crystallinity. The most important finding was that a bilayer crystalline structure caused by an asymmetrical heating pattern can enhance the formation of packed micro-fibrillar morphologies after drawing. These three points can increase the piezoelectricity of the PVDF-HFP films, indicating the increase of the extended-chain crystals (beta-phase).	[Hu, Ning; Wu, Liangke; Liu, Yaolu; Ning, Huiming] Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China; [Hu, Ning] Chiba Univ, Dept Mech Engn, Inage Ku, Chiba 2638522, Japan; [Hu, Bin] Chongqing Univ Sci & Technol, Coll Met & Mat Engn, Chongqing 401331, Peoples R China; [Liu, Feng] Hunan Univ, Coll Mech & Vehicle Engn, Changsha 412008, Hunan, Peoples R China; [Atobe, Satoshi; Fukunaga, Hisao] Tohoku Univ, Dept Aerosp Engn, Aoba Ku, Sendai, Miyagi 9808579, Japan	Hu, N (reprint author), Chongqing Univ, Coll Aerosp Engn, Chongqing 400044, Peoples R China.	ninghu@cqu.edu.cn			National Natural Science Foundation of China [11372104]; Japanese Ministry of Education, Culture, Sports, Science and Technology [26289319]	This work is partly supported by the Research Funds from National Natural Science Foundation of China (No. 11372104) and Grant-in-Aid for Scientific Research (No. 26289319) from the Japanese Ministry of Education, Culture, Sports, Science and Technology to NH and HF.	KAWAI H, 1969, JPN J APPL PHYS, V8, P975, DOI 10.1143/JJAP.8.975; Gregorio R, 2006, J APPL POLYM SCI, V100, P3272, DOI 10.1002/app.23137; Salimi A, 2004, J POLYM SCI POL PHYS, V42, P3487, DOI 10.1002/polb.20223; Sencadas V, 2009, J MACROMOL SCI B, V48, P514, DOI 10.1080/00222340902837527; Levi N, 2004, NANO LETT, V4, P1267, DOI 10.1021/nl0494203; Yu SS, 2009, MACROMOLECULES, V42, P8870, DOI 10.1021/ma901765j; He XJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1862323; LOVINGER AJ, 1983, SCIENCE, V220, P1115, DOI 10.1126/science.220.4602.1115; Kuo WK, 2011, MATER CHEM PHYS, V129, P130, DOI 10.1016/j.matchemphys.2011.03.074; Elvin NG, 2001, SMART MATER STRUCT, V10, P293, DOI 10.1088/0964-1726/10/2/314; Benz M, 2003, J APPL POLYM SCI, V89, P1093, DOI 10.1002/app.12267; Lee JS, 2008, MOL CRYST LIQ CRYST, V491, P247, DOI 10.1080/15421400802330861; Liu YM, 2009, J INTEL MAT SYST STR, V20, P575, DOI 10.1177/1045389X08098195; Guyomar D, 2005, IEEE T ULTRASON FERR, V52, P584, DOI 10.1109/TUFFC.2005.1428041; Branciforti NC, 2007, J POLYM SCI POL LETT, V45, P2793; Dadi S, 1996, FERROELECTRICS, V186, P255, DOI 10.1080/00150199608218078; Fukuda E., 2006, IEEE T DIELECT EL IN, V13, P1110; Fukuda E., 2000, IEEE T ULTRASON FERR, V47, P1277; GREGORIO R, 1995, J PHYS D APPL PHYS, V28, P432, DOI 10.1088/0022-3727/28/2/028; Hattori T, 1996, J APPL PHYS, V111; Huan Y, 2007, POLYM ENG SCI, V47, P1630, DOI 10.1002/pen.20843; KAURA T, 1991, J PHYS D APPL PHYS, V24, P1848, DOI 10.1088/0022-3727/24/10/020; Kim GH, 2009, PHYS CHEM CHEM PHYS, V11, P11506; Kim NK, 2014, INT J POLYM MATER PO, V63, P23, DOI 10.1080/00914037.2013.769244; Li SG, 2011, J APPL PHYS, V109, DOI 10.1063/1.3525045; Neese B, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2748076; Ng KL, 2000, IEEE T ULTRASON FERR, V47, P1308, DOI 10.1109/58.883519; Ning HM, 2013, SMART MATER STRUCT, V22; Rao MB, 2006, P NAT SEM NOND EV HY; Shalu, 2014, RSC ADV, V4, P50914; Wu LK, 2013, ADV COMPOS MATER, V22, P49, DOI 10.1080/09243046.2013.764780; Wu LK, 2014, RSC ADV, V4, P35896, DOI 10.1039/c4ra03382e; Xue J. M., 2012, NANOSCALE, V4, P7250; Ye Y, 2006, INTEGR FERROELECTR, V80, P245, DOI 10.1080/10584580600659423	34	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0334-6447	2191-0340		J POLYM ENG	J. Polym. Eng.	JUN	2015	35	5					451	461		10.1515/polyeng-2014-0239		11	Polymer Science	Polymer Science	CI5FJ	WOS:000354778900006		
J	Ivanova, MY; Achenbach, TM; Rescorla, LA; Turner, LV; Ahmeti-Pronaj, A; Au, A; Maese, CA; Bellina, M; Caldas, JC; Chen, YC; Csemy, L; da Rocha, MM; Decoster, J; Dobrean, A; Ezpeleta, L; Fontaine, JRJ; Funabiki, Y; Guomundsson, HS; Harder, V; de la Cabada, ML; Leung, P; Liu, JH; Mahr, S; Malykh, S; Maras, JS; Markovic, J; Ndetei, DM; Oh, KJ; Petot, JM; Riad, G; Sakarya, D; Samaniego, VC; Sebre, S; Shahini, M; Silvares, E; Simulioniene, R; Sokoli, E; Talcott, JB; Vazquez, N; Zasepa, E				Ivanova, Masha Y.; Achenbach, Thomas M.; Rescorla, Leslie A.; Turner, Lori V.; Ahmeti-Pronaj, Adelina; Au, Alma; Maese, Carmen Avila; Bellina, Monica; Caldas, J. Carlos; Chen, Yi-Chuen; Csemy, Ladislav; da Rocha, Marina M.; Decoster, Jeroen; Dobrean, Anca; Ezpeleta, Lourdes; Fontaine, Johnny R. J.; Funabiki, Yasuko; Guomundsson, Halldor S.; Harder, Valerie S.; de la Cabada, Marie Leiner; Leung, Patrick; Liu, Jianghong; Mahr, Safia; Malykh, Sergey; Maras, Jelena Srdanovic; Markovic, Jasminka; Ndetei, David M.; Oh, Kyung Ja; Petot, Jean-Michel; Riad, Geylan; Sakarya, Direnc; Samaniego, Virginia C.; Sebre, Sandra; Shahini, Mimoza; Silvares, Edwiges; Simulioniene, Roma; Sokoli, Elvisa; Talcott, Joel B.; Vazquez, Natalia; Zasepa, Ewa			Syndromes of Self-Reported Psychopathology for Ages 18-59 in 29 Societies	JOURNAL OF PSYCHOPATHOLOGY AND BEHAVIORAL ASSESSMENT			English	Article						Psychopathology; Adult self-report; Syndromes; Cross-cultural; International	CHILD-BEHAVIOR CHECKLIST; YOUNG ADULTHOOD; FIT INDEXES; LONG-TERM; PERSONALITY; DEPRESSION; PREVALENCE; DISORDERS; CULTURES; MODEL	This study tested the multi-society generalizability of an eight-syndrome assessment model derived from factor analyses of American adults' self-ratings of 120 behavioral, emotional, and social problems. The Adult Self-Report (ASR; Achenbach and Rescorla 2003) was completed by 17,152 18-59-year-olds in 29 societies. Confirmatory factor analyses tested the fit of self-ratings in each sample to the eight-syndrome model. The primary model fit index (Root Mean Square Error of Approximation) showed good model fit for all samples, while secondary indices showed acceptable to good fit. Only 5 (0.06%) of the 8,598 estimated parameters were outside the admissible parameter space. Confidence intervals indicated that sampling fluctuations could account for the deviant parameters. Results thus supported the tested model in societies differing widely in social, political, and economic systems, languages, ethnicities, religions, and geographical regions. Although other items, societies, and analytic methods might yield different results, the findings indicate that adults in very diverse societies were willing and able to rate themselves on the same standardized set of 120 problem items. Moreover, their self-ratings fit an eight-syndrome model previously derived from self-ratings by American adults. The support for the statistically derived syndrome model is consistent with previous findings for parent, teacher, and self-ratings of 1A1/2-18-year-olds in many societies. The ASR and its parallel collateral-report instrument, the Adult Behavior Checklist (ABCL), may offer mental health professionals practical tools for the multi-informant assessment of clinical constructs of adult psychopathology that appear to be meaningful across diverse societies.	[Ivanova, Masha Y.; Achenbach, Thomas M.; Turner, Lori V.; Harder, Valerie S.] Univ Vermont, Burlington, VT 05401 USA; [Rescorla, Leslie A.] Bryn Mawr Coll, Dept Psychol, Bryn Mawr, PA 19010 USA; [Ahmeti-Pronaj, Adelina; Shahini, Mimoza] Univ Clin Ctr Kosova, Dept Child & Adolescent Psychiat, Prishtine 10000, Kosovo; [Au, Alma] Hong Kong Polytech Univ, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China; [Maese, Carmen Avila] El Colegio Chihuahua, Anillo Envolvente PRONAF & Calle Partido Diaz, Sin Numero, Colonia Progresista, Cd Juarez 32300, Chihuahua, Mexico; [Bellina, Monica] Eugenio Medea Sci Inst, Dept Child Psychiat, I-23842 Bosisio Parini, Lecco, Italy; [Caldas, J. Carlos] Inst Super Ciencias Saude Norte, Dept Ciencias Sociais & Comportamento, P-4585116 Gandra, PRD, Portugal; [Chen, Yi-Chuen] Natl Chung Cheng Univ, Dept Psychol, Min Hsiung 62102, Chia Yi, Taiwan; [Csemy, Ladislav] Prague Psychiat Ctr, Lab Social Psychiat, Prague 18103 8, Czech Republic; [da Rocha, Marina M.] Univ Paulista Unip, Inst Human Sci, BR-04182020 Sao Paulo, Brazil; [Decoster, Jeroen; Fontaine, Johnny R. J.] Univ Ghent, Dept Personnel Management Work & Org Psychol, B-9000 Ghent, Belgium; [Dobrean, Anca] Univ Babes Bolyai, Dept Clin Psychol & Psychotherapy, Cluj Napoca 400015, Romania; [Ezpeleta, Lourdes] Univ Autonoma Barcelona, Dept Psicol, Clin Salut, Edifici B, Bellaterra 08193, Spain; [Funabiki, Yasuko] Kyoto Univ Hosp, Dept Psychiat, Sakyo Ku, Kyoto 6068507, Japan; [Guomundsson, Halldor S.] Univ Iceland, Fac Social Work, Gimli V Saemundargata, IS-101 Reykjavik, Iceland; [de la Cabada, Marie Leiner] Texas Tech Univ, Hlth Sci Ctr, Dept Pediat, Lubbock, TX 79409 USA; [Leung, Patrick] Chinese Univ Hong Kong, Dept Psychol, Shatin, Hong Kong, Peoples R China; [Liu, Jianghong] Univ Penn, Sch Nursing & Med, Philadelphia, PA 19104 USA; [Mahr, Safia; Petot, Jean-Michel] Univ Paris Ouest Nanterre Defense, Dept Psychol, Lab EVACLIPSY, Batiment C, F-92001 Nanterre, France; [Malykh, Sergey] Psychol Inst Russian Acad Educ, Moscow 125009, Russia; [Maras, Jelena Srdanovic] Clin Ctr Vojvodina, Novi Sad 21000, Serbia; [Markovic, Jasminka] Univ Novi Sad, Med Fac Novi Sad, Clin Ctr Vojvodina, Novi Sad 21000, Serbia; [Ndetei, David M.] Africa Mental Hlth Fdn, Nairobi, Kenya; [Oh, Kyung Ja] Yonsei Univ, Dept Psychol, Seoul 120749, South Korea; [Riad, Geylan] Helwan Univ, Cairo, Egypt; [Sakarya, Direnc] Ankara Univ, Fac Med, Dept Psychiat, TR-06100 Ankara, Turkey; [Samaniego, Virginia C.; Vazquez, Natalia] Pontificia Univ Catolica Argentina, Buenos Aires, DF, Argentina; [Sebre, Sandra] Univ Latvia, Dept Psychol, LV-1083 Riga, Latvia; [Silvares, Edwiges] Univ Sao Paulo, Inst Psicol, BR-05508030 Sao Paulo, Brazil; [Simulioniene, Roma] Klaipeda Univ, Dept Psychol, LT-92294 Klaipeda, Lithuania; [Sokoli, Elvisa] Univ Tirana, Dept Psychol, Tirana, Albania; [Talcott, Joel B.] Aston Univ, Aston Brain Ctr, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Zasepa, Ewa] Maria Grzegorzewska Acad Special Educ, PL-02353 Warsaw, Poland	Ivanova, MY (reprint author), Univ Vermont, 1 South Prospect St, Burlington, VT 05401 USA.	Masha.Ivanova@uvm.edu; Thomas.Achenbach@uvm.edu; lrescorl@brynmawr.edu; Lori.Turner@uvm.edu; Alma.Au@inet.polyu.edu.hk; mavila@colech.edu.mx; monica.bellina@bp.lnf.it; jcarloscaldas@gmail.com; psyycc@ccu.edu.tw; csemy@pcp.lf3.cuni.cz; marinamonzani@gmail.com; Jeroen.Decoster@UGent.be; AncaDobrean@psychology.ro; lourdes.ezpeleta@uab.cat; johnny.fontaine@ugent.be; funaysk@kuhp.kyoto-u.ac.jp; halldorg@hi.is; Valerie.Harder@uvm.edu; Marie.Leiner@ttuhsc.edu; pleung@cuhk.edu.hk; jhliu@nursing.upenn.edu; safia.mahr@gmail.com; malykhsb@mail.ru; markovic09@open.telekom.rs; dmndetei@amhf.or.ke; kjoh@yonsei.ac.kr; jmpetot@u-paris10.fr; geylanriad@gmail.com; direnc@gmail.com; corina_samaniego@uca.edu.ar; sebre@lanet.lv; mimoza.shahini@gmail.com; efdmsilv@usp.br; roma.simulioniene@ku.lt; Elvisa_sokoli@yahoo.com; j.b.talcott@aston.ac.uk; natalia_vazquez@uca.edu.ar; zasepa@aps.edu.pl		Samaniego, Virginia Corina/0000-0001-8962-7640			Achenbach T. M., 1997, MANUAL YOUNG ADULT S; Achenbach TM, 2005, J PERS ASSESS, V84, P49, DOI 10.1207/s15327752jpa8401_10; Achenbach TM, 2003, MANUAL ASEBA ADULT F; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Ivanova MY, 2007, J CONSULT CLIN PSYCH, V75, P729, DOI 10.1037/0022-006X.75.5.729; Reef J, 2009, ACTA PSYCHIAT SCAND, V120, P230, DOI 10.1111/j.1600-0447.2009.01422.x; Ivanova MY, 2007, SCHOOL PSYCHOL REV, V36, P468; DuPaul GJ, 2001, J LEARN DISABIL-US, V34, P370, DOI 10.1177/002221940103400412; Smith PB, 2004, J CROSS CULT PSYCHOL, V35, P50, DOI 10.1177/0022022103260380; Schmitt DP, 2007, J CROSS CULT PSYCHOL, V38, P173, DOI 10.1177/0022022106297299; McCrae RR, 2001, J PERS, V69, P819, DOI 10.1111/1467-6494.696166; Berry JW, 1999, CULT PSYCHOL, V5, P165, DOI 10.1177/1354067X9952004; van der Ende J, 2012, PSYCHOL ASSESSMENT, V24, P293, DOI 10.1037/a0025500; Ezpeleta L, 2014, SOC PSYCH PSYCH EPID, V49, P145, DOI 10.1007/s00127-013-0683-1; Krueger RF, 2003, J ABNORM PSYCHOL, V112, P437, DOI 10.1037/0021-843X.112.3.437; Benet-Martinez V, 1998, J PERS SOC PSYCHOL, V75, P729, DOI 10.1037//0022-3514.75.3.729; Ivanova MY, 2007, J CLIN CHILD ADOLESC, V36, P405; Hayatbakhsh MR, 2007, J AM ACAD CHILD PSY, V46, P408, DOI 10.1091/CHI.0b013e31802dc54d; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Weisz JR, 2006, J CONSULT CLIN PSYCH, V74, P1098, DOI 10.1037/0022-006X.74.6.1098; Eysenck S, 2013, PERS INDIV DIFFER, V54, P485, DOI 10.1016/j.paid.2012.09.022; [Anonymous], 2002, 5 FACTOR MODEL PERSO; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561; Ivanova MY, 2010, J AM ACAD CHILD PSY, V49, P1215, DOI 10.1016/j.jaac.2010.08.019; Cheung FM, 2011, AM PSYCHOL, V66, P593, DOI 10.1037/a0022389; Way BM, 2010, SOC COGN AFFECT NEUR, V5, P203, DOI 10.1093/scan/nsq059; Forsman M, 2010, J CHILD PSYCHOL PSYC, V51, P39, DOI 10.1111/j.1469-7610.2009.02141.x; Haavisto A, 2005, SOC PSYCH PSYCH EPID, V40, P912, DOI 10.1007/s00127-005-0966-2; Barrett PT, 1998, PERS INDIV DIFFER, V25, P805, DOI 10.1016/S0191-8869(98)00026-9; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Buysse CMP, 2010, CRIT CARE, V14, DOI 10.1186/cc9087; Chen F., 2001, SOCIOLOGICAL METHODS, V25, P223, DOI 10.1177/0049124101029004003; Costa P., 1992, REVISED NEO PERSONAL; Dana RH, 2008, INT CULT PSYCHOL, P25; De Los Reyes A, 2011, J CLIN CHILD ADOLESC, V40, P1, DOI DOI 10.1080/15374416.2011.533405; Eysenck H. J., 1975, MANUAL EYSENCK PERSO; Halvorsen I, 2005, EUR CHILD ADOLES PSY, V14, P397, DOI 10.1007/s00787-005-0489-0; Ivanova M. Y., 2014, INT J CLIN HLTH PSYC; Ivanova M. Y., 2011, J EARLY CHILDHOOD IN, V7, P99; Kim H. J., 2009, ANN C KOR PSYCH ASS; Leynet A., 2013, PREVALENCE SEL UNPUB; Mahr S., 2013, FACTOR STRUCTU UNPUB; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; MCCRAE RR, 1992, J PERS, V60, P175, DOI 10.1111/j.1467-6494.1992.tb00970.x; McCrae R. R., 2008, MULTILEVEL ANAL INDI, P249; Muthen L., 1998, MPLUS USERS GUIDE; Nuevo R, 2009, J AFFECT DISORDERS, V114, P156, DOI 10.1016/j.jad.2008.06.021; Paunonen SV, 1996, J CROSS CULT PSYCHOL, V27, P339, DOI 10.1177/0022022196273006; PAUNONEN SV, 1992, J PERS SOC PSYCHOL, V62, P447, DOI 10.1037/0022-3514.62.3.447; Rescorla L, 2012, J AM ACAD CHILD PSY, V51, P1273, DOI 10.1016/j.jaac.2012.09.012; Rescorla L. A., 2014, COMP SELF REPO UNPUB; Retz W, 2004, EUR ARCH PSY CLIN N, V254, P201, DOI 10.1007/s00406-004-0470-9; Saavedra LM, 2010, J CHILD PSYCHOL PSYC, V51, P924, DOI 10.1111/j.1469-7610.2010.02242.x; Samaniego V. C., 2012, 30 INT C PSYCH; Sheu H.-B., 2008, HDB COUNSELING PSYCH, P103; Steinhausen HC, 2004, ACTA PSYCHIAT SCAND, V110, P438, DOI 10.1111/j.1600-0447.2004.00364.x; Demyttenaere K, 2004, JAMA-J AM MED ASSOC, V291, P2581; Wolanczyk T., 2011, INT J CHILD HLTH HUM, V4, P327; Yu C. Y., 2002, TECHNICAL REPORT; Zakaitiene A., 2010, PSICHOLOGIJA, V42, P23	60	0	0	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0882-2689	1573-3505		J PSYCHOPATHOL BEHAV	J. Psychopathol. Behav. Assess.	JUN	2015	37	2					171	183		10.1007/s10862-014-9448-8		13	Psychology, Clinical	Psychology	CI1GX	WOS:000354492900001		
J	Nishinaka, I; Yokoyama, A; Washiyama, K; Maeda, E; Watanabe, S; Hashimoto, K; Ishioka, NS; Makii, H; Toyoshima, A; Yamada, N; Amano, R				Nishinaka, I.; Yokoyama, A.; Washiyama, K.; Maeda, E.; Watanabe, S.; Hashimoto, K.; Ishioka, N. S.; Makii, H.; Toyoshima, A.; Yamada, N.; Amano, R.			Production and separation of astatine isotopes in the Li-7 + Pb-nat reaction	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Nuclear reaction; Production cross section; Excitation function; Astatine; Distillation	CYCLOTRON PRODUCTION; CROSS-SECTIONS; AT-211; BI-209; AT-211/PO-211G; OPTIMIZATION; FUSION; TARGET	Production cross sections of astatine isotopes At207-211 in the 29-57 MeV Li-7 + Pb-nat reaction have been measured by alpha- and gamma-ray spectrometry. Excitation functions of production cross sections have been compared with a statistical calculation to study the reaction mechanism of the Li-7 + Pb-nat reaction. Production reactions of At207-211 in the Li-7 + Pb-nat have been derived. Considerably small experimental cross sections of At-210 and At-209 compared with the statistical calculation were clearly observed at incident energies higher than 44 MeV, indicating that the effects of breakup reaction play a role. A chemical separation of astatine from an irradiated lead target has been studied with a dry-distillation method. A complementary way to produce astatine isotopes has been developed.	[Nishinaka, I.; Makii, H.; Toyoshima, A.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Yokoyama, A.; Maeda, E.; Yamada, N.] Kanazawa Univ, Inst Sci & Engn, Kanazawa, Ishikawa 9201192, Japan; [Washiyama, K.; Amano, R.] Kanazawa Univ, Inst Med Pharmaceut & Hlth Sci, Kanazawa, Ishikawa 9200942, Japan; [Watanabe, S.; Hashimoto, K.; Ishioka, N. S.] Japan Atom Energy Agcy, Quantum Beam Sci Directorate, Takasaki, Gumma 3701292, Japan	Nishinaka, I (reprint author), Japan Atom Energy Agcy, Adv Sci Res Ctr, Shirakata Shirane 2-4, Tokai, Ibaraki 3191195, Japan.	nishinaka.ichiro@jaea.go.jp			JSPS KAKENHI [2360013]	The authors thank the crew of the JAEA Tandem Accelerator for the accelerator operation. We are thankful to M. Asai for his help for gamma-ray and alpha-ray spectroscopies. This work was supported by JSPS KAKENHI Grant Number 2360013.	Dasgupta M, 2004, PHYS REV C, V70, DOI 10.1103/PhysRevC.70.024606; FERNANDEZNIELLO J, 1989, COMPUT PHYS COMMUN, V54, P409, DOI 10.1016/0010-4655(89)90100-8; Nishio K, 2000, PHYS REV C, V62, DOI 10.1103/PhysRevC.62.014602; Dasgupta M, 2002, PHYS REV C, V66, DOI 10.1103/PhysRevC.66.041602; Firestone R.B., 1996, TABLE ISOTOPES; FREIESLE.H, 1974, PHYS REV C, V10, P245, DOI 10.1103/PhysRevC.10.245; Groppi F, 2005, APPL RADIAT ISOTOPES, V63, P621, DOI 10.1016/j.apradiso.2005.05.041; Henriksen G, 2001, APPL RADIAT ISOTOPES, V54, P839, DOI 10.1016/S0969-8043(00)00346-8; Hermanne A, 2005, APPL RADIAT ISOTOPES, V63, P1, DOI 10.1016/j.apradiso.2005.01.015; LAMBRECHT RM, 1985, INT J APPL RADIAT IS, V36, P443, DOI 10.1016/0020-708X(85)90207-8; Larsen RH, 1996, APPL RADIAT ISOTOPES, V47, P135, DOI 10.1016/0969-8043(95)00285-5; Lebeda O, 2005, APPL RADIAT ISOTOPES, V63, P49, DOI 10.1016/j.apradiso.2005.02.006; Maiti M, 2011, PHYS REV C, V84, DOI 10.1103/PhysRevC.84.067601; Morzenti S, 2008, J RADIOANAL NUCL CH, V276, P843, DOI 10.1007/s10967-008-0642-6; Penionzhkevich YE, 2009, J PHYS G, V36; REISDORF W, 1992, Z PHYS A-HADRON NUCL, V343, P47, DOI 10.1007/BF01291597; Roy K, 2008, APPL RADIAT ISOTOPES, V55, P571; Ziegler J. F., 1985, STOPPING RANGE IONS; Ziegler JF, 2013, SRIM 2013 CODE	19	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JUN	2015	304	3					1077	1083		10.1007/s10967-015-3975-y		7	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CH5RX	WOS:000354094100011		
J	Kardos, R; Gregoric, A; Jonas, J; Vaupotic, J; Kovacs, T; Ishimori, Y				Kardos, Richard; Gregoric, Asta; Jonas, Jacint; Vaupotic, Janja; Kovacs, Tibor; Ishimori, Yuu			Dependence of radon emanation of soil on lithology	JOURNAL OF RADIOANALYTICAL AND NUCLEAR CHEMISTRY			English	Article						Radon; Radium; Soil samples; Emanation fraction; Lithology; Slovenia	NATURAL RADIOACTIVITY; MOISTURE-CONTENT; TRACK DETECTORS; SLOVENIA; TRANSPORT; ENTRY; MAP; VARIABILITY; INDOOR; RN-222	In soil samples collected from 58 points of 7 different lithological units that appear most often in Slovenia, emanation fraction of Rn-222 and porosity have been determined. Emanation fraction ranged from 0.010 to 0.547 and varied substantially among lithological units, as well as within the same lithological unit. The highest average value was found in soil over sea and lake deposits (0.340) and the lowest, over metamorphic rocks (0.029). Based on the data measured, radon concentration in soil gas was calculated and compared with the values obtained previously at the same points by exposing solid state nuclear track detectors.	[Kardos, Richard; Jonas, Jacint; Kovacs, Tibor] Univ Pannonia, Inst Radiochem & Radioecol, Veszprem, Hungary; [Gregoric, Asta; Vaupotic, Janja] Jozef Stefan Inst, Ljubljana 1001, Slovenia; [Ishimori, Yuu] Japan Atom Energy Agcy, Ningyo Toge Environm Engn Ctr, Kagamino, Okayama 7080698, Japan	Gregoric, A (reprint author), Jozef Stefan Inst, POB 3000, Ljubljana 1001, Slovenia.	asta.gregoric@gmail.com			Slovenian Research Agency [P1-0143]; Slovenia-Hungary cooperation in science and technology [BI-HU/08-016]; Slovenian Nuclear Safety Administration [2513-06-397005]; Hungarian State; European Union [TAMOP-4.2.2.A-11/1/KONV-2012-0071]	The study was financed by the Slovenian Research Agency under the programme contract no. P1-0143, the Slovenia-Hungary cooperation in science and technology under the contract no. BI-HU/08-016, the Slovenian Nuclear Safety Administration under the project no. 2513-06-397005, and the Hungarian State and the European Union projects Grant No. TAMOP-4.2.2.A-11/1/KONV-2012-0071. The authors thank undergraduate students of the Department of Geology at the Faculty of Natural Science and Engineering, University of Ljubljana for their excellently executed field work, and land owners who kindly permitted us to carry out sampling on their land.	Abbady A, 2004, APPL RADIAT ISOTOPES, V61, P1469, DOI 10.1016/j.apradiso.2004.03.065; Abumurad KM, 2001, RADIAT MEAS, V34, P423, DOI 10.1016/S1350-4487(01)00199-8; Andersen CE, 2001, SCI TOTAL ENVIRON, V272, P33, DOI 10.1016/S0048-9697(01)00662-3; Bossew P, 2003, APPL RADIAT ISOTOPES, V59, P389, DOI 10.1016/j.apradiso.2003.07.001; NAZAROFF WW, 1992, REV GEOPHYS, V30, P137, DOI 10.1029/92RG00055; Etiope G, 2002, PHYS EARTH PLANET IN, V129, P185, DOI 10.1016/S0031-9201(01)00292-8; Griffiths AD, 2010, ATMOS CHEM PHYS, V10, P8969, DOI 10.5194/acp-10-8969-2010; De Martino S, 1998, APPL RADIAT ISOTOPES, V49, P407, DOI 10.1016/S0969-8043(96)00300-4; Sakoda A, 2011, APPL RADIAT ISOTOPES, V69, P1422, DOI 10.1016/j.apradiso.2011.06.009; Somlai J, 2008, RADIAT MEAS, V43, P72, DOI 10.1016/j.radmeas.2007.10.028; Efstathiou M, 2013, J RADIOANAL NUCL CH, V298, P673, DOI 10.1007/s10967-013-2468-0; Greeman DJ, 1996, CHEM GEOL, V129, P1, DOI 10.1016/0009-2541(95)00128-X; Barillon R, 2005, GEOCHIM COSMOCHIM AC, V69, P2735, DOI 10.1016/j.gca.2004.11.021; BRAJNIK D, 1992, RADIAT PROT DOSIM, V45, P273; Breitner D, 2010, J ENVIRON RADIOACTIV, V101, P1002, DOI 10.1016/j.jenvrad.2010.07.008; Font L, 2001, SCI TOTAL ENVIRON, V272, P25, DOI 10.1016/S0048-9697(01)00661-1; Friedmann H, 2010, J ENVIRON RADIOACTIV, V101, P804, DOI 10.1016/j.jenvrad.2009.11.008; HUMAR M, 1992, RADIAT PROT DOSIM, V45, P549; Iskandar D, 2005, APPL RADIAT ISOTOPES, V63, P401, DOI 10.1016/j.apradiso.2005.03.012; Jobbagy V, 2009, J HAZARD MATER, V172, P1258, DOI 10.1016/j.jhazmat.2009.07.131; Kemski J, 2001, SCI TOTAL ENVIRON, V272, P217, DOI 10.1016/S0048-9697(01)00696-9; Kovacs T, 2013, J ENVIRON RADIOACTIV, V122, P70, DOI 10.1016/j.jenvrad.2013.02.007; Lee KY, 2012, J RADIOANAL NUCL CH, V291, P197, DOI 10.1007/s10967-011-1306-5; Lee KY, 2010, J RADIOANAL NUCL CH, V286, P381, DOI 10.1007/s10967-010-0730-2; MARKKANEN M, 1992, RADIAT PROT DOSIM, V45, P269; Miklyaev PS, 2011, WATER RESOUR+, V38, P868, DOI 10.1134/S0097807811070116; Misdaq MA, 1999, J RADIOANAL NUCL CH, V242, P41, DOI 10.1007/BF02345893; Nazaroff W, 1988, RADON ITS DECAY PROD; Nero A.V., 1988, RADON ITS DECAY PROD; Neznal M, 1996, ENV INT S1, V22, P819, DOI 10.1016/S0160-4120(96)00189-4; Sakoda A, 2010, RADIAT MEAS, V45, P204, DOI 10.1016/j.radmeas.2010.01.010; Sakoda A, 2010, APPL RADIAT ISOTOPES, V68, P1180, DOI 10.1016/j.apradiso.2009.12.036; Sakoda A, 2010, APPL RADIAT ISOTOPES, V68, P1169, DOI 10.1016/j.apradiso.2009.11.070; Sakoda A, 2008, APPL RADIAT ISOTOPES, V66, P648, DOI 10.1016/j.apradiso.2007.11.015; Sas Z, 2011, 6 HUNG RAD FOR VESZP; Savovic S, 2012, RADIAT PROT DOSIM, V150, P213, DOI 10.1093/rpd/ncr397; Schumann RR, 1996, ENV INT S1, V22, P439, DOI 10.1016/S0160-4120(96)00144-4; UNSCEAR, 2000, SOURC EFF ION RAD; Vaupotic J, 2010, NUKLEONIKA, V55, P565; Vaupotic J, 2010, NUKLEONIKA, V55, P579; Vaupotic J, 2008, 33 INT GEOL C OSL NO; Wang F, 2000, BUILD ENVIRON, V35, P615, DOI 10.1016/S0360-1323(99)00052-9; WASHINGTON JW, 1992, J GEOPHYS RES-SOL EA, V97, P9145, DOI 10.1029/92JB00479	43	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0236-5731	1588-2780		J RADIOANAL NUCL CH	J. Radioanal. Nucl. Chem.	JUN	2015	304	3					1321	1327		10.1007/s10967-015-3954-3		7	Chemistry, Analytical; Chemistry, Inorganic & Nuclear; Nuclear Science & Technology	Chemistry; Nuclear Science & Technology	CH5RX	WOS:000354094100040		
J	Trieu, DBK; Maruyama, T				Trieu, Dang Ba Khac; Maruyama, Tsutomu			Real-time color image segmentation based on mean shift algorithm using an FPGA	JOURNAL OF REAL-TIME IMAGE PROCESSING			English	Article						Mean shift algorithm; Segmentation; Region merging real time; FPGA	TRACKING	Image segmentation is one of the most important tasks in the image processing, and mean shift algorithm is often used for color image segmentation because of its high quality. The computational cost of the mean shift algorithm, however, is high, and it is difficult to realize its real time processing on microprocessors, though many techniques for reducing the cost have been researched. In this paper, we describe an FPGA system for the image segmentation based on the mean shift algorithm. In the image segmentation based on the mean shift algorithm, the image is once over-segmented, and then the small regions are merged considering the similarity between the over-segmented regions to obtain better segmentation. In our system, the mean shift filter is accelerated using a cache memory which can access to all pixels in a w (s) x w (s) pixel window at arbitrary position. This cache memory allows us to process w (s) x w (s) pixels in parallel every clock cycle. The region merging is also accelerated by not strictly managing the list structures used for the merging. This loose management causes the redundant and out-of-date data into the list structures, but it makes the pointer dereferences unnecessary, and the overhead by those data can be hidden by pipeline processing. The performance for 768 x 512 pixel images is fast enough for real-time applications.	[Trieu, Dang Ba Khac; Maruyama, Tsutomu] Univ Tsukuba, Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Trieu, DBK (reprint author), Univ Tsukuba, Syst & Informat Engn, 1-1-1 Ten Nou Dai, Tsukuba, Ibaraki 3058573, Japan.	dangtrieu@darwin.esys.tsukuba.ac.jp; maruyama@darwin.esys.tsukuba.ac.jp					Ali U, 2010, J SYST ARCHITECT, V56, P317, DOI 10.1016/j.sysarc.2010.04.008; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Ugarriza LG, 2009, IEEE T IMAGE PROCESS, V18, P2275, DOI 10.1109/TIP.2009.2025555; Ma WY, 1997, PROC CVPR IEEE, P744, DOI 10.1109/CVPR.1997.609409; CHENG YZ, 1995, IEEE T PATTERN ANAL, V17, P790; Appiah K, 2010, COMPUT VIS IMAGE UND, V114, P1282, DOI 10.1016/j.cviu.2010.03.021; Beucher S., 1993, MATH MORPHOLOGY IMAG, P433; Bitsakos K, 2010, LECT NOTES COMPUT SC, V6312, P506, DOI 10.1007/978-3-642-15552-9_37; Dillinger P., 2010, IEEE T NUCL SCI, V53, P2097; Guo H, 2006, IEEE SYS MAN CYBERN, P2385, DOI 10.1109/ICSMC.2006.385220; Li PH, 2009, LECT NOTES COMPUT SC, V5524, P120; Luo QM, 2004, PROC INT C TOOLS ART, P337; Qian Z., 2010, INT C COMP APPL SYST, P116; Saegusa T, 2007, J REAL-TIME IMAGE PR, V2, P309, DOI 10.1007/s11554-007-0055-8; SCHMIDT C, 2003, INT C FIELD PROGR LO, V2778, P1083; Shi JB, 1997, PROC CVPR IEEE, P731, DOI 10.1109/CVPR.1997.609407; Stawiaski Jean, 2008, Image Analysis & Stereology, V27; Trieu D.B.K., 2007, J REAL-TIME IMAGE PR, V2, P319, DOI 10.1007/s11554-007-0051-z; Zhu S., 2002, PATTERN ANAL MACH IN, V18, P884	20	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1861-8200	1861-8219		J REAL-TIME IMAGE PR	J. Real-Time Image Process.	JUN	2015	10	2			SI		345	356		10.1007/s11554-012-0319-9		12	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic; Imaging Science & Photographic Technology	Computer Science; Engineering; Imaging Science & Photographic Technology	CI4JU	WOS:000354715300011		
J	Okuno, T; Kawamura, G; Muto, H; Matsuda, A				Okuno, Teruhisa; Kawamura, Go; Muto, Hiroyuki; Matsuda, Atsunori			Three modes of high-efficient photocatalysis using composites of TiO2-nanocrystallite-containing mesoporous SiO2 and Au nanoparticles	JOURNAL OF SOL-GEL SCIENCE AND TECHNOLOGY			English	Article						Mesoporous; Titania; Photocatalysis; Surface plasmon resonance	LIGHT-INDUCED PHOTOCATALYSIS; VISIBLE-LIGHT; GOLD NANOPARTICLES; CALCINATION TEMPERATURE; TIO2 DISPERSIONS; NANOSTRUCTURES; TITANIA; SILICA; SIZE; UV	A mesoporous SiO2 template containing TiO2 nanocrystals is synthesized via a sol-gel route, and Au nanoparticles (NPs) are deposited in the tubular mesochannels of the template by a photodeposition method (Au/SiO2-TiO2). Both of the photocatalytic activities under ultraviolet (UV) and visible (Vis) light irradiation are improved by the deposition of Au NPs. A commercially available photocatalyst, Degussa P25 is employed as a reference, and a comparative study shows that Au/SiO2-TiO2 possesses higher photocatalytic activity than that of P25. An action spectrum of methylene blue (MB) photobleaching using Au/SiO2-TiO2 reveals that the photocatalysis of Au/SiO2-TiO2 is carried out by three triggers: UV absorption by TiO2, and Vis light absorptions by Au NPs and MB.	[Okuno, Teruhisa; Kawamura, Go; Muto, Hiroyuki; Matsuda, Atsunori] Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, Toyohashi, Aichi 4418580, Japan	Kawamura, G (reprint author), Toyohashi Univ Technol, Dept Elect & Elect Informat Engn, 1-1 Hibarigaoka,Tempaku Cho, Toyohashi, Aichi 4418580, Japan.	t093507@edu.imc.tut.ac.jp; gokawamura@ee.tut.ac.jp; muto@ee.tut.ac.jp; matsuda@ee.tut.ac.jp	Kawamura, Go/I-5214-2013	Kawamura, Go/0000-0001-6585-7636			Zhang FL, 1998, APPL CATAL B-ENVIRON, V15, P147, DOI 10.1016/S0926-3373(97)00043-X; Zhao DY, 1998, SCIENCE, V279, P548, DOI 10.1126/science.279.5350.548; Kowalska E, 2010, PHYS CHEM CHEM PHYS, V12, P2344, DOI 10.1039/b917399d; Gorska P, 2008, APPL CATAL B-ENVIRON, V84, P440, DOI 10.1016/j.apcatb.2008.04.028; Lindner M, 1997, WATER SCI TECHNOL, V35, P79, DOI 10.1016/S0273-1223(97)00012-7; McEvoy JG, 2013, CATAL TODAY, V207, P191, DOI 10.1016/j.cattod.2012.04.015; Bannat I, 2009, CHEM MATER, V21, P1645, DOI 10.1021/cm803455k; Zaleska A, 2007, APPL CATAL B-ENVIRON, V76, P1, DOI 10.1016/j.apcatb.2007.05.005; Iliev V, 2007, J MOL CATAL A-CHEM, V263, P32, DOI 10.1016/j.molcata.2006.08.019; Sahu DR, 2009, MICROPOR MESOPOR MAT, V117, P640, DOI 10.1016/j.micromeso.2008.08.013; Yu KF, 2006, PHYS CHEM CHEM PHYS, V8, P5417, DOI 10.1039/b610720f; Epling GA, 2002, CHEMOSPHERE, V46, P561, DOI 10.1016/S0045-6535(01)00173-4; Wiley B, 2007, ACCOUNTS CHEM RES, V40, P1067, DOI 10.1021/ar7000974; Li D, 2005, J SOLID STATE CHEM, V178, P3293, DOI 10.1016/j.jssc.2005.08.008; [Anonymous], 2009, PDF CARD 00 001 0562; HERRMANN JM, 1984, CHEM PHYS LETT, V108, P618, DOI 10.1016/0009-2614(84)85067-8; Sakthivel S, 2004, WATER RES, V38, P3001, DOI 10.1016/j.watres.2004.04.046; FOX MA, 1993, CHEM REV, V93, P341, DOI 10.1021/cr00017a016; Zhang TY, 2001, J PHOTOCH PHOTOBIO A, V140, P163, DOI 10.1016/S1010-6030(01)00398-7; Sakthivel S, 2003, ANGEW CHEM INT EDIT, V42, P4908, DOI 10.1002/anie.200351577; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Tian Y, 2004, CHEM COMMUN, P1810, DOI 10.1039/b405061d; [Anonymous], 2009, PDF CARD 00 001 0172; Tian Y, 2005, J AM CHEM SOC, V127, P7632, DOI 10.1021/ja042192u; Kochuveedu ST, 2012, J PHYS CHEM C, V116, P2500, DOI 10.1021/jp209520m; Beck A, 2008, CATAL TODAY, V139, P180, DOI 10.1016/j.cattod.2008.05.039; Centeno MA, 2008, CATAL LETT, V123, P198, DOI 10.1007/s10562-008-9448-y; Fujishima M, 2011, J COLLOID INTERF SCI, V361, P628, DOI 10.1016/j.jcis.2011.06.024; Kawamura G, 2011, RSC ADV, V1, P584, DOI 10.1039/c1ra00317h; Kawamura G, 2014, J NANOSCI NANOTECHNO, V14, P2225, DOI 10.1166/jnn.2014.8476; Kawamura G, 2012, SCRIPTA MATER, V66, P479, DOI 10.1016/j.scriptamat.2011.12.023; Kawamura G, 2012, NANOSCALE RES LETT, V7, P1, DOI 10.1186/1556-276X-7-27; Li Z, 2008, ACS NANO, V2, P1205, DOI 10.1021/nn800137x; Ohtani B., 2008, CHEM LETT, V37, P216, DOI 10.1246/cl.2008.216; Ohtani B, 1998, CHEM LETT, P579, DOI 10.1246/cl.1998.579; Perez MD, 2004, LANGMUIR, V20, P6879, DOI 10.1021/la0497898; Perez-Juste J, 2005, COORDIN CHEM REV, V249, P1870, DOI 10.1016/j.ccr.2005.01.030; Qiao WT, 2009, MAT SCI ENG C-BIO S, V29, P1498, DOI 10.1016/j.msec.2008.12.010	39	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0928-0707	1573-4846		J SOL-GEL SCI TECHN	J. Sol-Gel Sci. Technol.	JUN	2015	74	3					748	755		10.1007/s10971-015-3658-8		8	Materials Science, Ceramics	Materials Science	CH9UN	WOS:000354382000021		
J	Tamagawa-Mineoka, R; Teramukai, S; Katoh, N				Tamagawa-Mineoka, Risa; Teramukai, Satoshi; Katoh, Norito			Reply to: "A note on normality''	JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY			English	Letter							INCREASED SERUM-LEVELS; ATOPIC-DERMATITIS; INTERLEUKIN 33		[Tamagawa-Mineoka, Risa; Katoh, Norito] Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kyoto 6028566, Japan; [Teramukai, Satoshi] Kyoto Prefectural Univ Med, Dept Biostat, Grad Sch Med Sci, Kyoto 6028566, Japan	Tamagawa-Mineoka, R (reprint author), Kyoto Prefectural Univ Med, Dept Dermatol, Grad Sch Med Sci, Kamigyo Ku, 465 Kajii Cho, Kyoto 6028566, Japan.	risat@koto.kpu-m.ac.jp					Tamagawa-Mineoka R, 2015, J AM ACAD DERMATOL, V72, P200, DOI 10.1016/j.jaad.2014.09.026; Tamagawa-Mineoka R, 2014, J AM ACAD DERMATOL, V70, P882, DOI 10.1016/j.jaad.2014.01.867	2	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0190-9622			J AM ACAD DERMATOL	J. Am. Acad. Dermatol.	JUN	2015	72	6					E171	E172		10.1016/j.jaad.2015.02.1105		2	Dermatology	Dermatology	CI2VA	WOS:000354604200015		
J	Shinohara, H; Haruta, S; Ohkura, Y; Udagawa, H; Sakai, Y				Shinohara, Hisashi; Haruta, Shusuke; Ohkura, Yu; Udagawa, Harushi; Sakai, Yoshiharu			Tracing Dissectable Layers of Mesenteries Overcomes Embryologic Restrictions when Performing Infrapyloric Lymphadenectomy in Laparoscopic Gastric Cancer Surgery	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article							SURGICAL COMPLICATIONS; CLASSIFICATION; GASTRECTOMY; CARCINOMA; EXCISION; ANATOMY		[Shinohara, Hisashi; Haruta, Shusuke; Ohkura, Yu; Udagawa, Harushi] Toranomon Gen Hosp, Dept Surg Gastroenterol, Tokyo 1058470, Japan; [Shinohara, Hisashi; Sakai, Yoshiharu] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan	Shinohara, H (reprint author), Toranomon Gen Hosp, Dept Surg Gastroenterol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	shinohara@toranomon.gr.jp					Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Gilchrist RK, 1938, ANN SURG, V108, P621, DOI 10.1097/00000658-193810000-00011; Clavien PA, 2009, ANN SURG, V250, P187, DOI 10.1097/SLA.0b013e3181b13ca2; Miki Y, 2011, J GASTROINTEST SURG, V15, P1969, DOI 10.1007/s11605-011-1628-1; Shinohara H, 2013, GASTRIC CANCER, V16, P615, DOI 10.1007/s10120-012-0229-3; Noshiro H, 2014, SURG ENDOSC, V28, P1180, DOI 10.1007/s00464-013-3304-x; Kanaya S, 2011, SURG ENDOSC, V25, P3928, DOI 10.1007/s00464-011-1792-0; SASAKO M, 1995, BRIT J SURG, V82, P346, DOI 10.1002/bjs.1800820321; HEALD RJ, 1986, LANCET, V1, P1479; Hohenberger W, 2009, COLORECTAL DIS, V11, P354, DOI 10.1111/j.1463-1318.2008.01735.x; Coller FA, 1941, ANN SURG, V114, P56, DOI 10.1097/00000658-194107000-00007; Japanese Gastric Canc Assoc, 2011, GASTRIC CANCER, V14, P101, DOI 10.1007/s10120-011-0041-5; Katai Hitoshi, 2005, Gastric Cancer, V8, P137, DOI 10.1007/s10120-005-0317-8; Kitagawa H, 2013, MOL CLIN ONCOL, V1, P418; Perlemuter L, 1980, CACHIERS ANATOMIE AB; Sadler T.W., 2009, LANGMANS MED EMBRYOL, V11th; Sano T, 1997, BRIT J SURG, V84, P1310; Sasako M, 2012, MAINGOTS ABDOMINAL O, P489; SATO T, 1984, Bulletin of Tokyo Medical and Dental University, V31, P21; Uyama Ichiro, 2013, J Gastric Cancer, V13, P19, DOI 10.5230/jgc.2013.13.1.19; von Navratil D, 1903, Z KLIN CHIR, V69, P421	22	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	JUN	2015	220	6					E81	E87		10.1016/j.jamcollsurg.2015.02.037		7	Surgery	Surgery	CI5VC	WOS:000354826900002		
J	Ando, H; Imamura, T; Tsuda, T; Tellmann, S; Patzold, M; Hausler, B				Ando, Hiroki; Imamura, Takeshi; Tsuda, Toshitaka; Tellmann, Silvia; Paetzold, Martin; Haeusler, Bernd			Vertical Wavenumber Spectra of Gravity Waves in the Venus Atmosphere Obtained from Venus Express Radio Occultation Data: Evidence for Saturation	JOURNAL OF THE ATMOSPHERIC SCIENCES			English	Article							PLANETARY-SCALE WAVES; MIDDLE ATMOSPHERE; TEMPERATURE-FLUCTUATIONS; INSTABILITY DYNAMICS; VERA ONBOARD; MESOSPHERE; STRATOSPHERE; IONOSPHERE; TURBULENCE; EVOLUTION	By using the vertical temperature profiles obtained by the radio occultation measurements on the European Space Agency (ESA)'s Venus Express, the vertical wavenumber spectra of small-scale temperature fluctuations that are thought to be manifestations of gravity waves are studied. Wavenumber spectra covering wavelengths of 1.4-7.5 km were obtained for two altitude regions (65-80 and 75-90 km) and seven latitude bands. The spectra show a power-law dependence on the high-wavenumber side with the logarithmic spectral slope ranging from -3 to -4, which is similar to the features seen in Earth's and Martian atmospheres. The power-law portion of the spectrum tends to follow the semiempirical spectrum of saturated gravity waves, suggesting that the gravity waves are dissipated by saturation as well as radiative damping. The spectral power is larger at 75-90 km than at 65-80 km at low wavenumbers, suggesting amplitude growth with height of unsaturated waves. It was also found that the wave amplitude is larger at higher latitudes and that the amplitude is maximized in the northern high latitudes. On the assumption that gravity waves are saturated in the Venusian atmosphere, the turbulent diffusion coefficient was estimated. The diffusion coefficient in the Venusian atmosphere is larger than those in Earth's atmosphere because of the longer characteristic vertical wavelength of the saturated waves.	[Ando, Hiroki; Imamura, Takeshi] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Tsuda, Toshitaka] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Tellmann, Silvia; Paetzold, Martin] Univ Cologne, Abt Planetenforsch, Rhein Inst Umweltforsch, D-50931 Cologne, Germany; [Haeusler, Bernd] Univ Bundeswehr Munchen, Inst Raumfahrttech & Weltraumnutzung, Neubiberg, Germany	Ando, H (reprint author), Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Chuo Ku, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2298510, Japan.	hando@ac.jaxa.jp					Ando H, 2012, J ATMOS SCI, V69, P2906, DOI 10.1175/JAS-D-11-0339.1; Fritts DC, 2009, J ATMOS SCI, V66, P1149, DOI 10.1175/2008JAS2727.1; Patzold M, 2007, NATURE, V450, P657, DOI 10.1038/nature06239; SCHOFIELD JT, 1983, Q J ROY METEOR SOC, V109, P57, DOI 10.1002/qj.49710945904; IMAMURA T, 1995, GEOPHYS RES LETT, V22, P267, DOI 10.1029/94GL02998; Kursinski ER, 1997, J GEOPHYS RES-ATMOS, V102, P23429, DOI 10.1029/97JD01569; DELGENIO AD, 1990, J ATMOS SCI, V47, P293, DOI 10.1175/1520-0469(1990)047<0293:PSWATC>2.0.CO;2; HINSON DP, 1995, ICARUS, V114, P310, DOI 10.1006/icar.1995.1064; Zhang X, 2012, ICARUS, V217, P714, DOI 10.1016/j.icarus.2011.06.016; Fritts DC, 2009, J ATMOS SCI, V66, P1126, DOI 10.1175/2008JAS2726.1; CRISP D, 1989, ICARUS, V77, P391, DOI 10.1016/0019-1035(89)90096-1; Tellmann S, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003204; Wu DL, 1996, GEOPHYS RES LETT, V23, P3631, DOI 10.1029/96GL02907; Hausler B, 2006, PLANET SPACE SCI, V54, P1315, DOI 10.1016/j.pss.2006.04.032; FELS SB, 1982, J ATMOS SCI, V39, P1141; Piccialli A, 2012, ICARUS, V217, P669, DOI 10.1016/j.icarus.2011.07.016; Markiewicz WJ, 2007, NATURE, V450, P633, DOI 10.1038/nature06320; HOLTON JR, 1984, J ATMOS SCI, V41, P2653, DOI 10.1175/1520-0469(1984)041<2653:AFSOGW>2.0.CO;2; Tellmann S, 2012, ICARUS, V221, P471, DOI 10.1016/j.icarus.2012.08.023; Achatz U, 2007, J ATMOS SCI, V64, P74, DOI 10.1175/JAS3827.1; Creasey JE, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024037; SMITH SA, 1987, J ATMOS SCI, V44, P1404, DOI 10.1175/1520-0469(1987)044<1404:EFASSO>2.0.CO;2; LINDZEN RS, 1981, J GEOPHYS RES-OC ATM, V86, P9707, DOI 10.1029/JC086iC10p09707; Counselman C.C., 1980, J GEOPHYS RES, V85, P8026, DOI 10.1029/JA085iA13p08026; Dewan E, 1997, J GEOPHYS RES-ATMOS, V102, P29799, DOI 10.1029/97JD02151; Fritts DC, 2003, REV GEOPHYS, V41, DOI 10.1029/2001RG000106; FRITTS DC, 1988, J ATMOS SCI, V45, P1741, DOI 10.1175/1520-0469(1988)045<1741:OEOASG>2.0.CO;2; FUKAO S, 1994, J GEOPHYS RES-ATMOS, V99, P18973, DOI 10.1029/94JD00911; Garcia RF, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2008JE003073; HINES CO, 1991, J ATMOS SCI, V48, P1360; Imamura T, 1997, J GEOPHYS RES-PLANET, V102, P6615, DOI 10.1029/96JE03882; Imamura T, 2006, J ATMOS SCI, V63, P1623, DOI 10.1175/JAS3684.1; Imamura T, 2014, ICARUS, V228, P181, DOI 10.1016/j.icarus.2013.10.012; Imamura T, 2011, EARTH PLANETS SPACE, V63, P493, DOI [10.5047/eps.2011.0.1.009, 10.5047/eps.2011.03.009]; Kliore A.J., 1980, J GEOPHYS RES, V85, P7957, DOI DOI 10.1029/JA085IA13P07957; KOLOSOV MA, 1980, ACTA ASTRONAUT, V7, P219, DOI 10.1016/0094-5765(80)90062-4; Lebonnois S, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003458; Peralta J, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2008JE003185; SAGDEEV RZ, 1986, SCIENCE, V231, P1411, DOI 10.1126/science.231.4744.1411; Sato K, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD003219; Seiff A., 1980, J GEOPHYS RES, V85, P7903, DOI DOI 10.1029/JA085IAL3P07903; TSUDA T, 1991, J GEOPHYS RES-ATMOS, V96, P17265, DOI 10.1029/91JD01944; TSUDA T, 1989, J ATMOS SCI, V46, P2440, DOI 10.1175/1520-0469(1989)046<2440:MROOAS>2.0.CO;2; Tsuda T, 2002, J METEOROL SOC JPN, V80, P925, DOI 10.2151/jmsj.80.925; WEINSTOCK J, 1985, RADIO SCI, V20, P1295, DOI 10.1029/RS020i006p01295; WOO R, 1981, NATURE, V289, P383, DOI 10.1038/289383a0; YAKOVLEV OI, 1991, ICARUS, V94, P493, DOI 10.1016/0019-1035(91)90243-M; YOUNG RE, 1994, J ATMOS SCI, V51, P1857, DOI 10.1175/1520-0469(1994)051<1857:COFASG>2.0.CO;2; YOUNG RE, 1987, J ATMOS SCI, V44, P2628, DOI 10.1175/1520-0469(1987)044<2628:COGWGB>2.0.CO;2; ZHU X, 1994, J ATMOS SCI, V51, P3615, DOI 10.1175/1520-0469(1994)051<3615:ANTOTS>2.0.CO;2	50	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0022-4928	1520-0469		J ATMOS SCI	J. Atmos. Sci.	JUN	2015	72	6					2318	2329		10.1175/JAS-D-14-0315.1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CI9RW	WOS:000355108500008		
J	Sharifi, A; Amini, J; Sumantyo, JTS; Tateishi, R				Sharifi, Alireza; Amini, Jalal; Sumantyo, Josaphat Tetuko Sri; Tateishi, Ryutaro			Speckle Reduction of PolSAR Images in Forest Regions Using Fast ICA Algorithm	JOURNAL OF THE INDIAN SOCIETY OF REMOTE SENSING			English	Article						Independent component analysis; PolSAR; Speckle; Remote sensing	INDEPENDENT COMPONENT ANALYSIS; SAR IMAGES; NOISE; CLASSIFICATION; DECOMPOSITION; ENHANCEMENT; MODEL	Advancement in Polarimetric synthetic aperture radar technology (PolSAR) and its ability to capture images in different polarizations, facilitate accessing large volumes of information from a scene. These images as well as conventional SAR images are degraded by speckle noise. Processing and reducing the speckle of all the images separately is time consuming. So applying methods to simultaneously process different channels information can be very helpful. Several methods have been proposed for speckle reduction and each has advantages and disadvantages. In this paper, a despeckling approach based on fast independent component analysis (Fast ICA) algorithm is proposed for improving of the results when polarimetric channels are added. The results show the more input images to Fast ICA algorithm leads to better separation between signal components and the speckle. Analysis of the results for the ALOS (Advanced Land Observing Satellite) PALSAR polarimetric images showed that combination of polarimetric channels improved 37 % the ENL value in comparison with only using the HH (horizontal-horizontal)-, HV (horizontal-vertical)-, and VV (vertical-vertical)- polarized channels.	[Sharifi, Alireza; Amini, Jalal] Univ Tehran, Dept Surveying & Geomat Engn, Tehran 111554563, Iran; [Sumantyo, Josaphat Tetuko Sri; Tateishi, Ryutaro] Chiba Univ, Ctr Environm Remote Sensing, Chiba 2638522, Japan	Amini, J (reprint author), Univ Tehran, Dept Surveying & Geomat Engn, Tehran 111554563, Iran.	alirezasharifi@ut.ac.ir; jamini@ut.ac.ir; jtetukoss@faculty.chiba-u.jp; tateishi@faculty.chiba-u.jp					Amini J, 2009, IEEE T GEOSCI REMOTE, V47, P4020, DOI 10.1109/TGRS.2009.2034464; Chen FR, 2011, INT J REMOTE SENS, V32, P2745, DOI 10.1080/01431161003743207; Gao G, 2010, SENSORS-BASEL, V10, P775, DOI 10.3390/s100100775; Achim A, 2003, IEEE T GEOSCI REMOTE, V41, P1773, DOI 10.1109/TGRS.2003.813488; ARSENAULT HH, 1976, J OPT SOC AM, V66, P1160, DOI 10.1364/JOSA.66.001160; Yu YJ, 2002, IEEE T IMAGE PROCESS, V11, P1260, DOI [10.1109/TIP.2002.804276, 10.1109/TIP.2002.804279]; Lopez-Martinez C, 2003, IEEE T GEOSCI REMOTE, V41, P2232, DOI 10.1109/TGRS.2003.815240; KUAN DT, 1987, IEEE T ACOUST SPEECH, V35, P373, DOI 10.1109/TASSP.1987.1165131; Huang SQ, 2009, PATTERN RECOGN, V42, P1533, DOI 10.1016/j.patcog.2009.01.013; Antico A, 2012, REMOTE SENS LETT, V3, P383, DOI 10.1080/01431161.2011.603376; Ballatore P, 2011, INT J REMOTE SENS, V32, P3807, DOI 10.1080/01431161003777213; Cheng XG, 2013, REMOTE SENS LETT, V4, P1176, DOI 10.1080/2150704X.2013.858840; Chitroub S., 2007, IEEE INT C SIGN PROC; Dabboor M, 2013, INT J REMOTE SENS, V34, P1492, DOI 10.1080/01431161.2012.727040; Frost VS, 1982, IEEE T PAMI, V4, P1982, DOI DOI 10.1109/TPAMI.1982.4767223; Gonzalez A. A., 2012, IEEE T GEOSCI REMOTE, V50, P593, DOI [10.1109/TGRS.2011.2160647, DOI 10.1109/TGRS.2011.2160647]; Kharbouchea S., 2013, INT J IMAGE DATA FUS, V4, P146, DOI [10.1080/19479832.2012.710270, DOI 10.1080/19479832.2012.710270]; KUAN DT, 1985, IEEE T PATTERN ANAL, V7, P165; LEE JS, 1992, IEEE T GEOSCI REMOTE, V30, P686, DOI 10.1109/36.158862; LEE JS, 1991, IEEE T GEOSCI REMOTE, V29, P535, DOI 10.1109/36.135815; LEE JS, 2009, OPT SCI ENG CRC, P1; Li HG, 2010, EURASIP J ADV SIG PR, DOI 10.1155/2010/745129; Lopes A., 1990, IEEE T GEOSCI REMOTE, V28, P92; LEE JS, 1980, IEEE T PATTERN ANAL, V2, P165; Solbo S, 2008, IEEE T GEOSCI REMOTE, V46, P1219, DOI 10.1109/TGRS.2007.912718; Wang H., 2009, IEEE AS PAC C INF PR; Wang H, 2008, INT J REMOTE SENS, V29, P1649, DOI 10.1080/01431160701395211; Xing XW, 2013, INT J REMOTE SENS, V34, P7925, DOI 10.1080/01431161.2013.827812; Yusheng F., 2005, J ELECT, V22, P288, DOI [10.1007/BF02687985, DOI 10.1007/BF02687985]; Zhang LM, 2011, INT J REMOTE SENS, V32, P4893, DOI 10.1080/01431161.2010.492251	30	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0255-660X	0974-3006		J INDIAN SOC REMOTE	J. Indian Soc. Remote Sens.	JUN	2015	43	2					339	346		10.1007/s12524-014-0423-3		8	Environmental Sciences; Remote Sensing	Environmental Sciences & Ecology; Remote Sensing	CI6TI	WOS:000354894500012		
J	Hohzaki, R; Chiba, T				Hohzaki, Ryusuke; Chiba, Takashi			An attrition game on an acyclic network	JOURNAL OF THE OPERATIONAL RESEARCH SOCIETY			English	Article						game theory; military; linear programming; attrition; network; interdiction	CRITICAL INFRASTRUCTURE; OPTIMAL INTERDICTION; INFILTRATION GAME; FLOW NETWORK; DESIGN; OPTIMIZATION; SECURITY; MODEL; ARCS	This paper deals with noncooperative games in which two players conflict on a network through an attrition phenomenon. The associated problem has a variety of applications, but we model the problem as a military conflict between an attacker and a defender on an acyclic network. The attacker marches from a starting node to a destination node, expecting to keep his initial members untouched during the march. The defender deploys his forces on arcs to intercept the attacker. If the attacker goes through an arc with deployed defenders, the attacker incurs casualties according to Lanchester's linear law. In this paper, we discuss two games having the number of remaining attackers as the payoff and propose systems of linear programming formulations to derive their equilibrium points. One game is a two-person zero-sum (TPZS) one-shot game with no information and the other is a TPZS game with two stages separated by information acquisition about players' opponents.	[Hohzaki, Ryusuke] Natl Def Acad, Yokosuka, Kanagawa 2398686, Japan; [Chiba, Takashi] Japan Ground Self Def Force, Tokyo, Japan	Hohzaki, R (reprint author), Natl Def Acad, Dept Comp Sci, 1-10-20 Hashirimizu, Yokosuka, Kanagawa 2398686, Japan.	hozaki@cc.nda.ac.jp					Ahuja RK, 1993, NETWORK FLOWS, P566; Akgun I, 2011, EUR J OPER RES, V211, P241, DOI 10.1016/j.ejor.2010.12.011; Alveras D., 1998, IEEE Communications Magazine, V36, DOI 10.1109/35.663332; Church RL, 2004, ANN ASSOC AM GEOGR, V94, P491, DOI 10.1111/j.1467-8306.2004.00410.x; WOLLMER R, 1964, OPER RES, V12, P934, DOI 10.1287/opre.12.6.934; FULKERSON DR, 1977, MATH PROGRAM, V13, P116, DOI 10.1007/BF01584329; Bell MGH, 2008, PHILOS T R SOC A, V366, P1893, DOI 10.1098/rsta.2008.0019; Brown G, 2005, OPER RES, V53, P745, DOI 10.1287/opre.1050.0231; WASHBURN A, 1995, OPER RES, V43, P243, DOI 10.1287/opre.43.2.243; Salmeron J, 2004, IEEE T POWER SYST, V19, P905, DOI 10.1109/TPWRS.2004.825888; Perea F, 2013, EUR J OPER RES, V226, P286, DOI 10.1016/j.ejor.2012.11.015; Scaparra MP, 2008, COMPUT OPER RES, V35, P1905, DOI 10.1016/j.cor.2006.09.019; Assimakopoulos N, 1987, BIO MED, V17, P413; AUGER JM, 1991, NAV RES LOG, V38, P511, DOI 10.1002/1520-6750(199108)38:4<511::AID-NAV3220380406>3.0.CO;2-U; Bakir NO, 2011, ANN OPER RES, V187, P5, DOI 10.1007/s10479-010-0793-z; Cappanera P., 2010, TRANSPORT SCI, V45, P64; CAULKINS JP, 1993, MATH COMPUT MODEL, V17, P37, DOI 10.1016/0895-7177(93)90238-T; Desai J, 2010, EUR J OPER RES, V200, P1, DOI 10.1016/j.ejor.2008.12.016; Dresher M., 1962, RM2972ARPA RAND CORP; Ford LR, 1962, FLOWS NETWORKS, P14; GHARE PM, 1971, NAV RES LOGIST Q, V18, P37, DOI 10.1002/nav.3800180103; GIBBENS RJ, 1990, IMA J MATH CONTROL I, V7, P77, DOI 10.1093/imamci/7.1.77; GOLDEN B, 1978, NAV RES LOG, V25, P711, DOI 10.1002/nav.3800250412; Hohzaki R, 2013, ENCY OPERATIONS RES, P1; Kodialam M, 2003, IEEE INFOCOM SER, P1880; Lanchester F. W., 1916, AIRCRAFT WARFARE DAW; Lawler EL, 1976, COMBINATORIAL OPTIMI, P134; MCMASTER.AW, 1970, NAV RES LOGIST Q, V17, P261, DOI 10.1002/nav.3800170302; Mitchell T, 1980, DRUG INTERDICTION OP; Morse Philip M., 1951, METHODS OPERATIONS R; Myung YS, 1999, MANAGE SCI, V45, P238, DOI 10.1287/mnsc.45.2.238; Ouveysi I, 1999, EUR J OPER RES, V117, P30, DOI 10.1016/S0377-2217(98)00015-0; Ruckle WH, 1983, GEOMETRIC GAMES THEI; Ruclde WH, 1976, OPER RES, V24, P314; Salmeron J, 2012, NETWORKS, V60, P45, DOI 10.1002/net.20458; Smith JC, 2007, J GLOBAL OPTIM, V38, P181, DOI 10.1007/s10898-006-9067-3; THOMAS MU, 1976, NAV RES LOG, V23, P297, DOI 10.1002/nav.3800230211; Whiteman P. S., 1999, MILITARY OPERATIONS, V4, P15; Wood K, 1993, MATH COMPUT MODEL, V17, P1	39	0	0	PALGRAVE MACMILLAN LTD	BASINGSTOKE	BRUNEL RD BLDG, HOUNDMILLS, BASINGSTOKE RG21 6XS, HANTS, ENGLAND	0160-5682	1476-9360		J OPER RES SOC	J. Oper. Res. Soc.	JUN	2015	66	6					979	992		10.1057/jors.2014.61		14	Management; Operations Research & Management Science	Business & Economics; Operations Research & Management Science	CI8KQ	WOS:000355021600008		
J	Demircan, O; Ashibe, S; Kosui, T; Nakai, A				Demircan, Ozgur; Ashibe, Shinsuke; Kosui, Tatsuya; Nakai, Asami			Effect of various knitting techniques on mechanical properties of biaxial weft-knitted thermoplastic composites	JOURNAL OF THERMOPLASTIC COMPOSITE MATERIALS			English	Article						Knitting; plain; interlock; tuck; tuck-miss; biaxial weft-knitted composites; thermoplastic composites; tensile; bending and impact properties	TEXTILE COMPOSITES	Within the scope of experiments, five kinds of biaxial weft-knitted (BWK) fabrics with various knitting techniques (plain, interlock, tuck, tuck-miss, and interlock2) were used as reinforcement systems to fabricate thermoplastic composites with polypropylene (PP) resin yarn. Then, the final composite became BWK composites with various knitting types. The mechanical properties of composites were investigated by conducting tensile, three-point bending, and three-point bending impact tests on specimens. In all specimens, PP was commingled with glass yarn. Glass was used as reinforcement. Fiber volume fraction (V-f) of weft fibers of the interlock2 was the highest, and the length of straight part of loop shape was the longest in the interlock2 compared with the other four types of specimens. Because of the higher V-f of the BWK composites with the interlock2, tensile, three-point bending, and three-point bending impact properties of the interlock2 was higher than the other four types (plain, interlock, tuck, and tuck-miss) of composite structures.	[Demircan, Ozgur] Kyoto Inst Technol, Dept Adv Fibro Sci, Grad Sch Sci & Technol, Sakyo Ku, Kyoto 606, Japan; [Demircan, Ozgur] Sabanci Univ, Fac Engn & Nat Sci, Dept Mat Sci & Engn, TR-34956 Istanbul, Turkey; [Demircan, Ozgur] Ondokuz Mayis Univ, Mat Sci & Engn Dept, Fac Engn, Samsun, Turkey; [Ashibe, Shinsuke; Kosui, Tatsuya] Shima Seiki Mfg Ltd, R&D New Technol Applicat, Wakayama, Japan; [Nakai, Asami] Gifu Univ, Fac Engn, Dept Mech Engn, Gifu 50111, Japan	Demircan, O (reprint author), Sabanci Univ, Fac Engn & Nat Sci, Dept Mat Sci & Engn, TR-34956 Istanbul, Turkey.	ozgurd@sabanciuniv.edu					Abounaim M, 2010, COMPOS SCI TECHNOL, V70, P363, DOI 10.1016/j.compscitech.2009.11.008; Khondker OA, 2006, COMPOS PART A-APPL S, V37, P2285, DOI 10.1016/j.compositesa.2005.12.032; Haller P, 2006, COMPOS PART B-ENG, V37, P278, DOI 10.1016/j.compositesb.2006.01.003; Hufenbach W, 2009, COMPOS SCI TECHNOL, V69, P1422, DOI 10.1016/j.compscitech.2008.09.033; Rios CR, 2007, COMPOS PART A-APPL S, V38, P1773, DOI 10.1016/j.compositesa.2006.02.027; Anwar KO, 1997, 11 C COMP MAT ICCM 1, P388; Bernhardsson J, 2000, J THERMOPLAST COMPOS, V13, P292, DOI 10.1106/X5VY-2TF0-Y3UA-D5DQ; Demircan O, 2011, P ASME 2011 INT MECH; Demircan O, 2011, EFFECT STITCH REINFO; Demircan O, 2012, 8 AS AUSTR C COMP MA; Hamada H, 2000, J REINF PLAST COMP, V19, P364, DOI 10.1106/FQTH-LFTG-UKLR-D55M; Hou M, 1997, COMPOS PART A-APPL S, V28, P695, DOI 10.1016/S1359-835X(97)00013-4; Khondker OA, 2004, COMPOS PART A-APPL S, V35, P1185, DOI 10.1016/j.compositesa.2004.03.003; Khondker OA, 2004, COMPOS PART A-APPL S, V35, P1195, DOI 10.1016/j.compositesa.2004.03.004; LI JJ, 2010, J TEXT I, V101, P33; Spacer DJ., 2001, KNITTING TECHNOLOGY, V3rd; Xue P, 2002, COMPOS PART A-APPL S, V33, P113, DOI 10.1016/S1359-835X(01)00067-7; Ye L, 1995, APPL COMPOSITE MAT, V1, P415, DOI DOI 10.1007/BF00706502; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P473, DOI 10.1177/0892705707082326; Zaixia F, 2006, J THERMOPLAST COMPOS, V19, P113, DOI 10.1177/0892705706055446; Fan ZX, 2007, J THERMOPLAST COMPOS, V20, P487, DOI 10.1177/0892705707082327	21	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0892-7057	1530-7980		J THERMOPLAST COMPOS	J. Thermoplast. Compos. Mater.	JUN	2015	28	6					896	910		10.1177/0892705713519121		15	Materials Science, Composites	Materials Science	CI2GC	WOS:000354562600011		
J	Gonzalez, G; Koyanagi, KO; Aoki, K; Watanabe, H				Gonzalez, Gabriel; Koyanagi, Kanako O.; Aoki, Koki; Watanabe, Hidemi			Interregional Coevolution Analysis Revealing Functional and Structural Interrelatedness between Different Genomic Regions in Human Mastadenovirus D	JOURNAL OF VIROLOGY			English	Article							ADENOVIRUS DNA-POLYMERASE; HOMOLOGOUS RECOMBINATION; SEROTYPE SPECIFICITY; SEQUENCE ALIGNMENT; MOSAIC STRUCTURE; SPECIES D; PROTEIN; IDENTIFICATION; RECEPTOR-1; APOPTOSIS	Human mastadenovirus D (HAdV-D) is exceptionally rich in type among the seven human adenovirus species. This feature is attributed to frequent intertypic recombination events that have reshuffled orthologous genomic regions between different HAdV-D types. However, this trend appears to be paradoxical, as it has been demonstrated that the replacement of some of the interacting proteins for a specific function with other orthologues causes malfunction, indicating that intertypic recombination events may be deleterious. In order to understand why the paradoxical trend has been possible in HAdV-D evolution, we conducted an interregional coevolution analysis between different genomic regions of 45 different HAdV-D types and found that ca. 70% of the genome has coevolved, even though these are fragmented into several pieces via short intertypic recombination hot spot regions. Since it is statistically and biologically unlikely that all of the coevolving fragments have synchronously recombined between different genomes, it is probable that these regions have stayed in their original genomes during evolution as a platform for frequent intertypic recombination events in limited regions. It is also unlikely that the same genomic regions have remained almost untouched during frequent recombination events, independently, in all different types, by chance. In addition, the coevolving regions contain the coding regions of physically interacting proteins for important functions. Therefore, the coevolution of these regions should be attributed at least in part to natural selection due to common biological constraints operating on all types, including protein-protein interactions for essential functions. Our results predict additional unknown protein interactions. IMPORTANCE Human mastadenovirus D, an exceptionally type-rich human adenovirus species and causative agent of different diseases in a wide variety of tissues, including that of ocular region and digestive tract, as well as an opportunistic infection in immunocompromised patients, is known to have highly diverged through frequent intertypic recombination events; however, it has also been demonstrated that the replacement of a component protein of a multiprotein system with a homologous protein causes malfunction. The present study solved this apparent paradox by looking at which genomic parts have coevolved using a newly developed method. The results revealed that intertypic recombination events have occurred in limited genomic regions and been avoided in the genomic regions encoding proteins that physically interact for a given function. This approach detects purifying selection against recombination events causing the replacement of partial components of multiprotein systems and therefore predicts physical and functional interactions between different proteins and/or genomic elements.	[Gonzalez, Gabriel; Koyanagi, Kanako O.; Watanabe, Hidemi] Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan; [Aoki, Koki] Hokkaido Univ, Grad Sch Med, Dept Ophthalmol, Sapporo, Hokkaido, Japan	Watanabe, H (reprint author), Hokkaido Univ, Grad Sch Informat Sci & Technol, Sapporo, Hokkaido, Japan.	watanabe@ist.hokudai.ac.jp			MEXT KAKENHI [22125009]	This work was partly supported by MEXT KAKENHI grant number 22125009 (to H.W.).	MANTEL N, 1967, CANCER RES, V27, P209; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; JAVIER RT, 1994, J VIROL, V68, P3917; MATTHEWS DA, 1995, J GEN VIROL, V76, P1959, DOI 10.1099/0022-1317-76-8-1959; McSharry BP, 2008, J VIROL, V82, P4585, DOI 10.1128/JVI.02251-07; Dehghan S, 2012, J VIROL, V86, P635, DOI 10.1128/JVI.06593-11; Perez-Berna AJ, 2012, J BIOL CHEM, V287, P31582, DOI 10.1074/jbc.M112.389957; TAMURA K, 1993, MOL BIOL EVOL, V10, P512; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Krejci L, 2012, NUCLEIC ACIDS RES, V40, P5795, DOI 10.1093/nar/gks270; Walsh MP, 2011, J CLIN MICROBIOL, V49, P3482, DOI 10.1128/JCM.00156-11; Bille P, 2005, THEOR COMPUT SCI, V337, P217, DOI 10.1016/j.tcs.2004.12.030; Blackford AN, 2009, J VIROL, V83, P4000, DOI 10.1128/JVI.02417-08; Lefeuvre P, 2009, J VIROL, V83, P2697, DOI 10.1128/JVI.02152-08; Martin D, 2000, BIOINFORMATICS, V16, P562, DOI 10.1093/bioinformatics/16.6.562; Posada D, 2001, P NATL ACAD SCI USA, V98, P13757, DOI 10.1073/pnas.241370698; SMITH JM, 1992, J MOL EVOL, V34, P126; Gahery-Segard H, 1998, J VIROL, V72, P2388; Robinson CM, 2011, INFECT GENET EVOL, V11, P1208, DOI 10.1016/j.meegid.2011.04.031; Martin DP, 2005, AIDS RES HUM RETROV, V21, P98, DOI 10.1089/aid.2005.21.98; Liu HR, 2010, SCIENCE, V329, P1038, DOI 10.1126/science.1187433; Benedict CA, 2001, J BIOL CHEM, V276, P3270, DOI 10.1074/jbc.M008218200; Lee D, 2007, NAT REV MOL CELL BIO, V8, P995, DOI 10.1038/nrm2281; Leppard KN, 1997, J GEN VIROL, V78, P2131; Tollefson AE, 2001, J VIROL, V75, P8875, DOI 10.1128/JVI.75.19.8875-8887.2001; Boni MF, 2007, GENETICS, V176, P1035, DOI 10.1534/genetics.106.068874; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Davison AJ, 2003, J GEN VIROL, V84, P2895, DOI 10.1099/vir.0.19497-0; Harada JN, 2002, J VIROL, V76, P9194, DOI 10.1128/JVI.76.18.9194-9206.2002; Berk AJ, 2005, ONCOGENE, V24, P7673, DOI 10.1038/sj.onc.1209040; Russell WC, 2009, J GEN VIROL, V90, P1, DOI 10.1099/vir.0.003087-0; Gibbs MJ, 2000, BIOINFORMATICS, V16, P573, DOI 10.1093/bioinformatics/16.7.573; Zheng ZM, 2010, INT J BIOL SCI, V6, P730; Heath L, 2006, J VIROL, V80, P11827, DOI 10.1128/JVI.01100-06; Aoki K, 2011, J VIROL, V85, P5703, DOI 10.1128/JVI.00491-11; Boyer JL, 2000, J BIOL CHEM, V275, P14969, DOI 10.1074/jbc.M000566200; Brenkman AB, 2002, J VIROL, V76, P8200, DOI 10.1128/JVI.76.16.8200-8207.2002; Chinnadurai G, 1998, SEMIN VIROL, V8, P399, DOI 10.1006/smvy.1997.0139; De Jong RN, 2003, CURR TOP MICROBIOL, V272, P187; Gonzalez G, 2014, GENE, V547, P10, DOI 10.1016/j.gene.2014.04.018; Harrach B., 2011, VIRUS TAXONOMY, V9, P125; Kaneko H, 2011, J GEN VIROL, V92, P1251, DOI 10.1099/vir.0.030361-0; Kato SEM, 2011, VIROLOGY, V417, P9, DOI 10.1016/j.virol.2011.04.014; Lapointe FJ, 2001, J CLASSIF, V18, P109, DOI 10.1007/s00357-001-0007-0; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; LIPPE R, 1989, J VIROL, V63, P5133; Liu HT, 2000, J VIROL, V74, P11681, DOI 10.1128/JVI.74.24.11681-11689.2000; Ma HC, 2011, J VIROL, V85, P7849, DOI 10.1128/JVI.00467-11; Matsushima Y, 2013, GENOME ANNOUNC, V1, DOI DOI 10.1128/GEN0MEA.00068-12.EPUB; Matsushima Y, 2011, J GEN VIROL, V92, P2770, DOI 10.1099/vir.0.034744-0; Miron MJ, 2004, ONCOGENE, V23, P7458, DOI 10.1038/sj.onc.1207919; Querido E, 2001, J VIROL, V75, P699, DOI 10.1128/JVI.75.2.699-709.2001; Rubenwolf S, 1997, J VIROL, V71, P1115; SAITOU N, 1987, MOL BIOL EVOL, V4, P406; Schneider-Brachert W, 2006, J CLIN INVEST, V116, P2901, DOI 10.1172/JCI23771; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Webster A, 1997, J VIROL, V71, P6381; Wohl BP, 2008, J VIROL, V82, P5089, DOI 10.1128/JVI.00040-08	58	0	0	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JUN	2015	89	12					6209	6217		10.1128/JVI.00515-15		9	Virology	Virology	CI3OU	WOS:000354657900006		
J	Kuroda, M; Fujikura, D; Nanbo, A; Marzi, A; Noyori, O; Kajihara, M; Maruyama, J; Matsuno, K; Miyamoto, H; Yoshida, R; Feldmann, H; Takada, A				Kuroda, Makoto; Fujikura, Daisuke; Nanbo, Asuka; Marzi, Andrea; Noyori, Osamu; Kajihara, Masahiro; Maruyama, Junki; Matsuno, Keita; Miyamoto, Hiroko; Yoshida, Reiko; Feldmann, Heinz; Takada, Ayato			Interaction between TIM-1 and NPC1 Is Important for Cellular Entry of Ebola Virus	JOURNAL OF VIROLOGY			English	Article							NIEMANN-PICK C1; MARBURG VIRUS; DC-SIGN; PHOSPHATIDYLSERINE RECEPTORS; ENVELOPE GLYCOPROTEIN; APOPTOTIC CELLS; PROTEIN; INFECTION; ANTIBODIES; FILOVIRUS	Multiple host molecules are known to be involved in the cellular entry of filoviruses, including Ebola virus (EBOV); T-cell immunoglobulin and mucin domain 1 (TIM-1) and Niemann-Pick C1 (NPC1) have been identified as attachment and fusion receptors, respectively. However, the molecular mechanisms underlying the entry process have not been fully understood. We found that TIM-1 and NPC1 colocalized and interacted in the intracellular vesicles where EBOV glycoprotein (GP)-mediated membrane fusion occurred. Interestingly, a TIM-1-specific monoclonal antibody (MAb), M224/1, prevented GP-mediated membrane fusion and also interfered with the binding of TIM-1 to NPC1, suggesting that the interaction between TIM-1 and NPC1 is important for filovirus membrane fusion. Moreover, MAb M224/1 efficiently inhibited the cellular entry of viruses from all known filovirus species. These data suggest a novel mechanism underlying filovirus membrane fusion and provide a potential cellular target for antiviral compounds that can be universally used against filovirus infections.	[Kuroda, Makoto; Noyori, Osamu; Kajihara, Masahiro; Maruyama, Junki; Matsuno, Keita; Miyamoto, Hiroko; Yoshida, Reiko; Takada, Ayato] Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan; [Fujikura, Daisuke] Hokkaido Univ, Div Infect & Immun, Res Ctr Zoonosis Control, Sapporo, Hokkaido, Japan; [Nanbo, Asuka] Hokkaido Univ, Grad Sch Med, Dept Cell Physiol, Sapporo, Hokkaido, Japan; [Marzi, Andrea; Feldmann, Heinz] NIAID, Virol Lab, Div Intramural Res, NIH, Hamilton, MT USA; [Takada, Ayato] Hokkaido Univ, Global Inst Collaborat Res & Educ, Sapporo, Hokkaido, Japan	Takada, A (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Global Epidemiol, Sapporo, Hokkaido, Japan.	atakada@czc.hokudai.ac.jp	Maruyama, Junki/H-7993-2013				BECKER S, 1995, J GEN VIROL, V76, P393, DOI 10.1099/0022-1317-76-2-393; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.21.12090-12095.2004; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Cote M, 2011, NATURE, V477, P344, DOI 10.1038/nature10380; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Kobayashi N, 2007, IMMUNITY, V27, P927, DOI 10.1016/j.immuni.2007.11.011; Hashimoto J, 2009, J BIOMOL SCREEN, V14, P970, DOI 10.1177/1087057109341406; McIntire JJ, 2004, SPRINGER SEMIN IMMUN, V25, P335, DOI 10.1007/s00281-003-0141-3; Schornberg K, 2006, J VIROL, V80, P4174, DOI 10.1128/JVI.80.8.4174-4178.2006; Ichimura T, 2008, J CLIN INVEST, V118, P1657, DOI 10.1172/JCI34487; Seitz HM, 2007, J IMMUNOL, V178, P5635; Meertens L, 2012, CELL HOST MICROBE, V12, P544, DOI 10.1016/j.chom.2012.08.009; Lin G, 2003, J VIROL, V77, P1337, DOI 10.1128/JVI.77.2.1337-1346.2003; Ueyama T, 2008, J IMMUNOL, V181, P629; Bukreyev AA, 2014, ARCH VIROL, V159, P821, DOI 10.1007/s00705-013-1846-9; Morizono K, 2011, CELL HOST MICROBE, V9, P286, DOI 10.1016/j.chom.2011.03.012; Misasi J, 2012, J VIROL, V86, P3284, DOI 10.1128/JVI.06346-11; Maruyama J, 2014, J VIROL, V88, P99, DOI 10.1128/JVI.02265-13; Kajihara M, 2012, J VIROL, V86, P13467, DOI 10.1128/JVI.01896-12; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Aleksandrowicz P, 2011, J INFECT DIS, V204, pS957, DOI 10.1093/infdis/jir326; Takada A, 2001, J VIROL, V75, P2324, DOI 10.1128/JVI.75.5.2324-2330.2001; Gramberg T, 2005, VIROLOGY, V340, P224, DOI 10.1016/j.virol.2005.06.026; Takada A, 1997, P NATL ACAD SCI USA, V94, P14764, DOI 10.1073/pnas.94.26.14764; Takada A, 2004, J VIROL, V78, P2943, DOI 10.1128/JVI.78.6.2943-2947.2004; Kondratowicz AS, 2011, P NATL ACAD SCI USA, V108, P8426, DOI 10.1073/pnas.1019030108; Carette JE, 2011, NATURE, V477, P340, DOI 10.1038/nature10348; Geisbert Thomas W., 2004, Expert Reviews in Molecular Medicine, V6, P1, DOI 10.1017/S1462399404008300; Miller EH, 2012, EMBO J, V31, P1947, DOI 10.1038/emboj.2012.53; Licata JM, 2004, J VIROL, V78, P7344, DOI 10.1128/JVI.78.14.7344-7351.2004; Chandran K, 2005, SCIENCE, V308, P1643, DOI 10.1126/science.1110656; Wool-Lewis RJ, 1998, J VIROL, V72, P3155; Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13; Lasala F, 2003, ANTIMICROB AGENTS CH, V47, P3970, DOI 10.1128/AAC.47.12.3970-3972.2003; Baize S, 2014, NEW ENGL J MED, V371, P1418, DOI 10.1056/NEJMoa1404505; Balasubramanian S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003200; Changula K, 2013, VIRUS RES, V176, P83, DOI 10.1016/j.virusres.2013.05.004; Feldmann H, 1996, MED MICROBIOLOGY, V4th; Higgins ME, 1999, MOL GENET METAB, V68, P1, DOI 10.1006/mgme.1999.2882; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Kajihara M, 2013, J GEN VIROL, V94, P876, DOI 10.1099/vir.0.049114-0; Matsuno K, 2010, J VIROL, V84, P5140, DOI 10.1128/JVI.02021-09; REED L. J., 1938, AMER JOUR HYG, V27, P493; Nakayama E, 2011, J INFECT DIS, V204, pS978, DOI 10.1093/infdis/jir334; Nanbo A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001121; Negredo A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002304; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Patel SC, 1999, P NATL ACAD SCI USA, V96, P1657, DOI 10.1073/pnas.96.4.1657; Saeed MF, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001110; Shahhosseini S, 2007, J VIROL METHODS, V143, P29, DOI 10.1016/j.jviromet.2007.02.004; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086	52	2	3	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JUN	2015	89	12					6481	6493		10.1128/JVI.03156-14		13	Virology	Virology	CI3OU	WOS:000354657900029		
J	Deng, GH; Shi, JZ; Wang, J; Kong, HH; Cui, PF; Zhang, F; Tan, D; Suzuki, Y; Liu, LL; Jiang, YP; Guan, YT; Chen, HL				Deng, Guohua; Shi, Jianzhong; Wang, Jing; Kong, Huihui; Cui, Pengfei; Zhang, Fang; Tan, Dan; Suzuki, Yasuo; Liu, Liling; Jiang, Yongping; Guan, Yuntao; Chen, Hualan			Genetics, Receptor Binding, and Virulence in Mice of H10N8 Influenza Viruses Isolated from Ducks and Chickens in Live Poultry Markets in China	JOURNAL OF VIROLOGY			English	Article							AVIAN INFLUENZA; A VIRUS; WILD WATERFOWL; SURVEILLANCE; BIRDS; MINK; HEMAGGLUTININ; HEMISPHERE; AUSTRALIA; INFECTION	We analyzed eight H10N8 viruses isolated from ducks and chickens in live poultry markets from 2009 to 2013 in China. These viruses showed distinct genetic diversity and formed five genotypes: the four duck isolates formed four different genotypes, whereas the four chicken viruses belong to a single genotype. The viruses bound to both human-and avian-type receptors, and four of the viruses caused 12.7% to 22.5% body weight loss in mice.	[Deng, Guohua; Shi, Jianzhong; Wang, Jing; Kong, Huihui; Cui, Pengfei; Zhang, Fang; Tan, Dan; Liu, Liling; Jiang, Yongping; Guan, Yuntao; Chen, Hualan] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Suzuki, Yasuo] Chubu Univ, Coll Life & Hlth Sci, Kasugai, Aichi 487, Japan	Chen, HL (reprint author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	chenhualan@caas.cn					Alexander DJ, 2003, AVIAN DIS, V47, P792, DOI 10.1637/0005-2086-47.s3.792; Zhang T, 2014, EMERG INFECT DIS, V20, P2076, DOI 10.3201/eid2012.140911; Chen HY, 2014, LANCET, V383, P714, DOI 10.1016/S0140-6736(14)60111-2; Zhang QY, 2013, SCIENCE, V341, P410, DOI 10.1126/science.1240532; Pasick J, 2012, AVIAN DIS, V56, P845, DOI 10.1637/10206-041512-Reg.1; Kayali G, 2010, ZOONOSES PUBLIC HLTH, V57, P265, DOI 10.1111/j.1863-2378.2009.01231.x; Fries AC, 2014, INFLUENZA OTHER RESP, V8, P493, DOI 10.1111/irv.12250; BERG M, 1990, ARCH VIROL, V113, P61, DOI 10.1007/BF01318353; Okamatsu M, 2013, VIRUS GENES, V47, P317, DOI 10.1007/s11262-013-0954-7; Arzey GG, 2012, EMERG INFECT DIS, V18, P814, DOI 10.3201/eid1805.111852; Wang GJ, 2014, J VIROL, V88, P3953, DOI 10.1128/JVI.03292-13; Vijaykrishna D, 2013, J VIROL, V87, P10182, DOI 10.1128/JVI.03437-12; Bonfante F, 2014, VET MICROBIOL, V173, P189, DOI 10.1016/j.vetmic.2014.07.023; De Marco MA, 2004, VET MICROBIOL, V98, P197, DOI 10.1016/j.vetmic.2003.10.018; Englund L, 1998, ARCH VIROL, V143, P653, DOI 10.1007/s007050050321; FELDMANN H, 1988, VIROLOGY, V165, P428, DOI 10.1016/0042-6822(88)90586-7; Ferro PJ, 2010, EMERG INFECT DIS, V16, P1224, DOI 10.3201/eid1608.091864; Kim HR, 2012, VET MICROBIOL, V161, P222, DOI 10.1016/j.vetmic.2012.07.014; Langstaff IG, 2009, NEW ZEAL VET J, V57, P160, DOI 10.1080/00480169.2009.36896; Li XY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004508; Ni X, 2014, MICROBES INFECT; Pfitzer S, 2000, AVIAN DIS, V44, P655, DOI 10.2307/1593107; Raleigh PJ, 2011, EPIDEMIOL INFECT, V139, P1191, DOI 10.1017/S0950268810002372; Senne DA, 2003, AVIAN DIS, V47, P798, DOI 10.1637/0005-2086-47.s3.798; Slavec B, 2012, AVIAN DIS, V56, P999, DOI 10.1637/10175-041012-ResNote.1; Su S, 2014, CLIN INFECT DIS, V59, DOI 10.1093/cid/ciu345; Vachieri SG, 2014, NATURE, V511, P475, DOI 10.1038/nature13443; Vittecoq M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043974; Wood GW, 1996, AVIAN PATHOL, V25, P799, DOI 10.1080/03079459608419182	29	1	1	AMER SOC MICROBIOLOGY	WASHINGTON	1752 N ST NW, WASHINGTON, DC 20036-2904 USA	0022-538X	1098-5514		J VIROL	J. Virol.	JUN	2015	89	12					6506	6510		10.1128/JVI.00017-15		5	Virology	Virology	CI3OU	WOS:000354657900031		
J	Nakahara, H; Okazaki, K; Hamai, S; Okamoto, S; Kuwashima, U; Higaki, H; Iwamoto, Y				Nakahara, Hiroyuki; Okazaki, Ken; Hamai, Satoshi; Okamoto, Shigetoshi; Kuwashima, Umito; Higaki, Hidehiko; Iwamoto, Yukihide			Does knee stability in the coronal plane in extension affect function and outcome after total knee arthroplasty?	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Coronal laxity; Lift-off; Walking; Patient-reported outcome	CONDYLAR LIFT-OFF; PATIENT SATISFACTION; SCORING SYSTEM; LAXITY	The aim of the present study was to clarify whether varus-valgus laxities under static stress in extension, femoral condylar lift-off during walking, and patient-reported outcomes after total knee arthroplasty (TKA) were correlated with each other. Ninety-four knees, which had undergone posterior-stabilized TKA, were analysed. The varus-valgus laxity during knee extension was measured using a stress radiograph. New Knee Society Score (KSS) questionnaires were mailed to all patients. Correlations between the values of stress radiographs and KSS were analysed. Additionally, continuous radiological images were taken of 15 patients while each walked on a treadmill to determine condylar lift-off from the tibial tray using a 3D-to-2D image-to-model registration technique. Correlations between the amount of lift-off and either the stress radiograph or the KSS were also analyzed. The mean angle measured was 5.9 +/- A 2.7A degrees with varus stress and 5.0 +/- A 1.6A degrees with valgus stress. The difference between them was 0.9 +/- A 2.8A degrees. Varus-valgus laxities, or the differences between them, did not show any statistically significant correlation with either component of the KSS (p > 0.05). The average amount of femoral condylar lift-off during walking was 1.4 +/- A 0.8 mm (medial side) and 1.3 +/- A 0.6 mm (lateral side). The amount of lift-off did not correlate with either varus-valgus laxities or the KSS (p > 0.05). No correlations were found among varus-valgus laxities under static stress in extension, femoral condylar lift-off during walking, or patient-reported outcomes after well-aligned TKA. This study suggests that small variations in coronal laxities do not influence lift-off during walking and the patient-reported outcomes. IV.	[Nakahara, Hiroyuki; Okazaki, Ken; Hamai, Satoshi; Okamoto, Shigetoshi; Kuwashima, Umito; Iwamoto, Yukihide] Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Higashi Ku, Fukuoka 8128582, Japan; [Higaki, Hidehiko] Kyushu Sangyo Univ, Dept Biorobot, Fac Engn, Fukuoka, Japan	Okazaki, K (reprint author), Kyushu Univ, Dept Orthopaed Surg, Grad Sch Med Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	okazaki@med.kyushu-u.ac.jp			Japan Society for the Promotion of Science [23000011]	This work was supported by institutional funding from the Grant-in-Aid for Specially Promoted Research of Japan Society for the Promotion of Science (23000011).	Insall JN, 2002, CLIN ORTHOP RELAT R, P143, DOI 10.1097/01.blo.0000022171.66847.55; Dennis DA, 2010, CLIN ORTHOP RELAT R, V468, P102, DOI 10.1007/s11999-009-1112-3; Noble PC, 2012, CLIN ORTHOP RELAT R, V470, P20, DOI 10.1007/s11999-011-2152-z; Merle-Vincent F, 2011, JOINT BONE SPINE, V78, P383, DOI 10.1016/j.jbspin.2010.11.013; Hamai S, 2008, J ORTHOP RES, V26, P435, DOI 10.1002/jor.20512; Jennings LM, 2007, P I MECH ENG H, V221, P305, DOI 10.1243/09544119JEIM215; Schnurr C, 2013, INT ORTHOP, V37, P1257, DOI 10.1007/s00264-013-1862-0; Scuderi GR, 2012, CLIN ORTHOP RELAT R, V470, P3, DOI 10.1007/s11999-011-2135-0; van Hal CTH, 2007, KNEE SURG SPORT TR A, V15, P1019, DOI 10.1007/s00167-007-0333-9; Okazaki K, 2006, J ORTHOP SCI, V11, P264, DOI 10.1007/s00776-006-1009-x; Berend ME, 2004, CLIN ORTHOP RELAT R, P26, DOI 10.1097/01.blo.0000148578.22729.0e; Turcot K, 2013, J ARTHROPLASTY, V28, P1297, DOI 10.1016/j.arth.2013.01.031; Bejek Z, 2011, KNEE SURG SPORT TR A, V19, P285, DOI 10.1007/s00167-010-1219-9; Clement ND, 2013, KNEE SURG SPORT TR A, V21, P2638, DOI 10.1007/s00167-013-2523-y; Draganich LF, 2000, J ARTHROPLASTY, V15, P102, DOI 10.1016/S0883-5403(00)91363-9; Hamai S, 2014, KNEE SURG SPORT TR A, V22, P1799, DOI 10.1007/s00167-013-2500-5; Ishii Y, 2007, KNEE, V14, P269, DOI 10.1016/j.knee.2007.04.002; Ishii Yoshinori, 2003, J Orthop Sci, V8, P538, DOI 10.1007/s00776-003-0668-0; Kawahara S, 2013, J ARTHROPLAST, DOI [10.1016/S0883-5403(13)00862-0, DOI 10.1016/S0883-5403(13)00862-0]; Kuster MS, 2004, ARCH ORTHOP TRAUM SU, V124, P415, DOI 10.1007/s00402-004-0700-7; MATSUDA Y, 2004, CLIN ORTHOP RELA FEB, P138, DOI DOI 10.1097/01.BLO.0000081937.75404.ED; Moynihan AL, 2010, INT ORTHOP, V34, P497, DOI 10.1007/s00264-009-0777-2; Stiehl JB, 1999, J ARTHROPLASTY, V14, P293, DOI 10.1016/S0883-5403(99)90054-2; WARREN PJ, 1994, CLIN ORTHOP RELAT R, P200	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JUN	2015	23	6					1693	1698		10.1007/s00167-014-3122-2		6	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CI6TO	WOS:000354895200015		
J	Fujimoto, E; Sasashige, Y; Tomita, T; Kashiwagi, K; Inoue, A; Sawa, M; Ota, Y				Fujimoto, Eisaku; Sasashige, Yoshiaki; Tomita, Tetsuya; Kashiwagi, Kenji; Inoue, Amiko; Sawa, Mikiya; Ota, Yuki			Different femorotibial contact on the weight-bearing: midflexion between normal and varus aligned knees after total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Kinematics; Cruciate-retaining total knee arthroplasty; 2D/3D registration; Posterior cruciate ligament; Postoperative alignment; Varus; Screw-home movement	VIVO FLUOROSCOPIC ANALYSIS; POSTERIOR CONDYLAR OFFSET; MULTICENTER ANALYSIS; TIBIAL SLOPE; KINEMATICS; ALIGNMENT; REPLACEMENT; COMPONENT; FAILURE; MALALIGNMENT	The influence of residual malalignment on biomechanical analysis after total knee arthroplasty (TKA) is currently uncertain. The hypothesis is that postoperative alignment would influence the in vivo kinematics after TKA, under weight-bearing conditions but not under non-weight-bearing condition. The purpose of the present study was to compare weight-bearing and non-weight-bearing conditions and to evaluate the effect of the postoperative alignment on the in vivo kinematics after posterior cruciate ligament-retaining TKA during midflexion using 2-dimensional/3-dimensional registration. Thirty knees of 30 patients with pre-operative varus deformity were divided into 2 groups according to their postoperative alignment: the normal alignment group (N = 21) and the varus alignment group (N = 9). Under weight-bearing conditions, the varus alignment group showed a significant posterior displacement of the medial femoral condyle (flexion: 80A degrees, 90A degrees P < 0.05) and a significant anterior displacement of the lateral femoral condyle (flexion: 10A degrees P < 0.01, 20A degrees P < 0.05, and extension: 10A degrees, 20A degrees P < 0.01, 30A degrees, 40A degrees P < 0.05) as compared with the normal alignment group. In contrast, no significant difference in the medial and lateral femoral condyle positions under non-weight-bearing conditions was observed between the normal and varus alignment groups. The postoperative alignment influenced knee kinematics under weight-bearing conditions. The weight load influenced knee kinematics through posterior tibial slope and induced greater lateral femoral condyle mobility, which might explain the better clinical and functional outcome. These findings contribute to gaining a proper understanding of the in vivo kinematics of the postoperative varus alignment and might be useful for orthopaedic surgeons in the achievement of patient satisfaction. III.	[Fujimoto, Eisaku; Sasashige, Yoshiaki; Kashiwagi, Kenji; Inoue, Amiko; Sawa, Mikiya; Ota, Yuki] Chugoku Rousai Hosp, Dept Orthoped Surg, Kure, Hiroshima 7370193, Japan; [Tomita, Tetsuya] Osaka Univ, Dept Orthoped Biomat Sci, Grad Sch Med, Suita, Osaka, Japan	Fujimoto, E (reprint author), Chugoku Rousai Hosp, Dept Orthoped Surg, 1-5-1 Hirotagaya, Kure, Hiroshima 7370193, Japan.	eisaku-fjm@umin.ac.jp					Victor J, 2005, J BONE JOINT SURG BR, V87B, P646, DOI 10.1302/0301-620X.87B5.15602; Bellemans J, 2002, J BONE JOINT SURG BR, V84B, P50, DOI 10.1302/0301-620X.84B1.12432; Green GV, 2002, J ARTHROPLASTY, V17, P1033, DOI 10.1054/arth.2002.35796; Dennis DA, 1998, CLIN ORTHOP RELAT R, P47; Han HS, 2008, KNEE SURG SPORT TR A, V16, P373, DOI 10.1007/s00167-008-0486-1; Liau JJ, 2002, CLIN BIOMECH, V17, P140, DOI 10.1016/S0268-0033(01)00109-7; Banks SA, 1997, J ARTHROPLASTY, V12, P297, DOI 10.1016/S0883-5403(97)90026-7; Wong J, 2011, J ORTHOP RES, V29, P347, DOI 10.1002/jor.21221; Massin P, 2006, J ARTHROPLASTY, V21, P889, DOI 10.1016/j.arth.2005.10.019; Howell SM, 2013, CLIN ORTHOP RELAT R, V471, P1000, DOI 10.1007/s11999-012-2613-z; Ritter MA, 2011, J BONE JOINT SURG AM, V93A, P1588, DOI 10.2106/JBJS.J.00772; JEFFERY RS, 1991, J BONE JOINT SURG BR, V73, P709; Dennis DA, 2004, CLIN ORTHOP RELAT R, P180, DOI 10.1097/01.blo.0000148777.98244.84; Sikorski JM, 2008, J BONE JOINT SURG BR, V90B, P1121, DOI 10.1302/0301-620X.90B9.20793; Halder A, 2012, J BONE JOINT SURG AM, V94A, P1023, DOI 10.2106/JBJS.K.00927; Ritter MA, 2009, J BONE JOINT SURG BR, V91B, P745, DOI 10.1302/0301-620X.91B6.21854; Howell SM, 2013, KNEE SURG SPORT TR A, V21, P2271, DOI 10.1007/s00167-013-2621-x; Chong DYR, 2010, J BIOMECH, V43, P1074, DOI 10.1016/j.jbiomech.2009.12.006; Vanlommel L, 2013, KNEE SURG SPORT TR A, V21, P2325, DOI 10.1007/s00167-013-2481-4; Yoshiya S, 2005, J ARTHROPLASTY, V20, P777, DOI 10.1016/j.arth.2004.11.012; Komistek RD, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000062384.79828.3b; Bellemans J, 2005, KNEE SURG SPORT TR A, V13, P193, DOI 10.1007/s00167-004-0557-x; LOTKE PA, 1977, J BONE JOINT SURG AM, V59, P77; HALLEN LG, 1966, ACTA ORTHOP SCAND, V37, P97; Zuffi S, 1999, IEEE T MED IMAGING, V18, P981, DOI 10.1109/42.811310; Dennis DA, 2005, J BIOMECH, V38, P241, DOI 10.1016/j.jbiomech.2004.02.042; Fang DM, 2009, J ARTHROPLASTY, V24, P39, DOI 10.1016/j.arth.2009.04.034; Berend ME, 2004, CLIN ORTHOP RELAT R, P26, DOI 10.1097/01.blo.0000148578.22729.0e; Dennis DA, 2003, CLIN ORTHOP RELAT R, P114, DOI 10.1097/01.blo.0000062385.79828.72; BARGREN JH, 1983, CLIN ORTHOP RELAT R, P178; Fujimoto E, 2014, J ARTHROPLASTY, V29, P2324, DOI 10.1016/j.arth.2013.10.018; Horiuchi H, 2012, J ARTHROPLASTY, V27, P1196, DOI 10.1016/j.arth.2012.01.017; Komistek RD, 2008, J ARTHROPLASTY, V23, P41, DOI 10.1016/j.arth.2007.01.016; MORELAND JR, 1988, CLIN ORTHOP RELAT R, P49; Panel NIHC, 2004, J BONE JOINT SURG AM, V86, P1328; STIEHL JB, 1995, J BONE JOINT SURG BR, V77B, P884; Stiehl JB, 1999, CLIN ORTHOP RELAT R, P139; Yamazaki Takaharu, 2005, Nihon Hoshasen Gijutsu Gakkai Zasshi, V61, P79	38	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JUN	2015	23	6					1720	1728		10.1007/s00167-014-3194-z		9	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CI6TO	WOS:000354895200019		
J	Ishida, K; Shibanuma, N; Matsumoto, T; Sasaki, H; Takayama, K; Toda, A; Kuroda, R; Kurosaka, M				Ishida, Kazunari; Shibanuma, Nao; Matsumoto, Tomoyuki; Sasaki, Hiroshi; Takayama, Koji; Toda, Akihiko; Kuroda, Ryosuke; Kurosaka, Masahiro			Factors affecting intraoperative kinematic patterns and flexion angles in navigated total knee arthroplasty	KNEE SURGERY SPORTS TRAUMATOLOGY ARTHROSCOPY			English	Article						Total knee arthroplasty; Navigation; Kinematics; Maximum flexion angle; Flexion contracture; Varus deformity	ROTATION; MOTION; RANGE; SYSTEM; WEAR	To investigate the factors affecting intraoperative kinematics, as measured with a navigation system, and their effect on maximum flexion angles during total knee arthroplasty (TKA). One hundred posterior stabilised (PS) TKAs performed using an image-free navigation system were evaluated. Tibial internal rotation angles at maximum extension, 30A degrees, 45A degrees, 60A degrees, 90A degrees, and maximum flexion were collected at registration and after implantation. The varus angles from the coronal mechanical axis were also collected. The rotational patterns were divided into four groups to investigate whether flexion contracture and varus deformity affected the kinematic patterns, and correlated with the maximum pre- and post-operative flexion angles. At registration, the flexion angles at maximum extension differed significantly between the kinematic groups; the flexion angle at maximum extension at registration was negatively correlated with the pre-operative maximum flexion angle (R (2) = 0.226, p < 0.0001) and the post-operative maximum flexion angle (R (2) = 0.059, p = 0.0167). Varus deformity at registration also differed significantly between the kinematic groups; varus deformity at registration was negatively correlated with the pre-operative maximum flexion angle (R (2) = 0.087, p = 0.0036) and post-operative maximum flexion angle (R (2) = 0.101, p = 0.0027). Navigation-based measurements in patients undergoing PS TKA indicated that pre-operative flexion contracture and varus deformity are negatively correlated with both pre- and post-operative maximum flexion angles. The results may improve the ease with which surgeons can interpret intraoperative kinematics, by providing a multi-dimensional perspective. With further knowledge regarding intraoperative kinematics, it might be possible to improve surgical approach, prosthesis design, and clinical outcomes. II.	[Ishida, Kazunari; Shibanuma, Nao; Sasaki, Hiroshi; Toda, Akihiko] Kobe Kaisei Hosp, Dept Orthopaed Surg, Nada Ku, Kobe, Hyogo 6570068, Japan; [Matsumoto, Tomoyuki; Takayama, Koji; Kuroda, Ryosuke; Kurosaka, Masahiro] Kobe Univ, Dept Orthopaed Surg, Grad Sch Med, Chuo Ku, Kobe, Hyogo 6500017, Japan	Ishida, K (reprint author), Kobe Kaisei Hosp, Dept Orthopaed Surg, Nada Ku, 3-11-15 Shinohara Kita, Kobe, Hyogo 6570068, Japan.	wavedreamer17@yahoo.co.jp					Akagi M, 2005, CLIN ORTHOP RELAT R, P172, DOI 10.1097/01.blo.0000160027.52481.32; Mochizuki T, 2013, J ORTHOP SCI, V18, P54, DOI 10.1007/s00776-012-0322-9; Matsuzaki T, 2013, INT ORTHOP, V37, P803, DOI 10.1007/s00264-013-1803-y; Dennis DA, 2004, CLIN ORTHOP RELAT R, P180, DOI 10.1097/01.blo.0000148777.98244.84; HARVEY IA, 1993, J BONE JOINT SURG BR, V75, P950; Schurman DJ, 1998, CLIN ORTHOP RELAT R, P175; Matsuda S, 2013, CLIN ORTHOP RELAT R, V471, P127, DOI 10.1007/s11999-012-2533-y; Komistek RD, 2003, CLIN ORTHOP RELAT R, P69, DOI 10.1097/01.blo.0000062384.79828.3b; Dennis DA, 1996, CLIN ORTHOP RELAT R, P107; Chinzei N, 2014, INT ORTHOP, V38, P509, DOI 10.1007/s00264-013-2043-x; Ritter MA, 2003, J BONE JOINT SURG AM, V85A, P1278; Cavaignac E, 2014, KNEE SURG SPORT TR A, DOI [10.1007/s00167-014-3095-1, DOI 10.1007/S00167-014-3095-1]; Cromie MJ, 2008, J ORTHOP RES, V26, P1494, DOI 10.1002/jor.20664; Goudie Stuart T, 2011, Orthopedics, V34, pe855, DOI 10.3928/01477447-20111021-18; Ho FY, 2007, CLIN ORTHOP RELAT R, P143, DOI 10.1097/BLO.0b013e31806dba05; Ishida K, 2014, KNEE SURG SPORT TR A, DOI [10.1007/s00167-014-3340-7, DOI 10.1007/S00167-014-3340-7]; Kitagawa A, 2014, KNEE SURG SPORT TR A, V22, P1599, DOI 10.1007/s00167-012-2315-9; Klein GR, 2004, J ARTHROPLASTY, V19, P986, DOI 10.1016/j.arth.2004.07.002; Matsuzaki T, 2014, KNEE SURG SPORT TR A, V22, P615, DOI 10.1007/s00167-013-2627-4; Mochizuki T, 2014, KNEE SURG SPORT TR A, V22, P1911, DOI 10.1007/s00167-013-2767-6; Moschella D, 2006, CLIN BIOMECH, V21, P152, DOI 10.1016/j.clinbiomech.2005.09.001; Ngai V, 2009, J BIOMECH, V42, P2363, DOI 10.1016/j.jbiomech.2009.06.030; Nishio Y, 2014, J ARTHROPLASTY, V29, P702, DOI 10.1016/j.arth.2013.06.035; Tei Katsumasa, 2012, Orthopedics, V35, pe1711, DOI 10.3928/01477447-20121120-14; Yoon J-R, 2014, KNEE SURG SPORT TR A, DOI [10.1007/s00167-014-2879-7, DOI 10.1007/S00167-014-2879-7]	25	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0942-2056	1433-7347		KNEE SURG SPORT TR A	Knee Surg. Sports Traumatol. Arthrosc.	JUN	2015	23	6					1741	1747		10.1007/s00167-015-3572-1		7	Orthopedics; Sport Sciences; Surgery	Orthopedics; Sport Sciences; Surgery	CI6TO	WOS:000354895200022		
J	Mizokami, M; Yokosuka, O; Takehara, T; Sakamoto, N; Korenaga, M; Mochizuki, H; Nakane, K; Enomoto, H; Ikeda, F; Yanase, M; Toyoda, H; Genda, T; Umemura, T; Yatsuhashi, H; Ide, T; Toda, N; Nirei, K; Ueno, Y; Nishigaki, Y; Betular, J; Gao, B; Ishizaki, A; Omote, M; Mo, HM; Garrison, K; Pang, PS; Knox, SJ; Symonds, WT; McHutchison, JG; Izumi, N; Omata, M				Mizokami, Masashi; Yokosuka, Osamu; Takehara, Tetsuo; Sakamoto, Naoya; Korenaga, Masaaki; Mochizuki, Hitoshi; Nakane, Kunio; Enomoto, Hirayuki; Ikeda, Fusao; Yanase, Mikio; Toyoda, Hidenori; Genda, Takuya; Umemura, Takeji; Yatsuhashi, Hiroshi; Ide, Tatsuya; Toda, Nobuo; Nirei, Kazushige; Ueno, Yoshiyuki; Nishigaki, Yoichi; Betular, Juan; Gao, Bing; Ishizaki, Akinobu; Omote, Masa; Mo, Hongmei; Garrison, Kim; Pang, Phillip S.; Knox, Steven J.; Symonds, William T.; McHutchison, John G.; Izumi, Namiki; Omata, Masao			Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial	LANCET INFECTIOUS DISEASES			English	Article							CHRONIC HCV; INFECTION; SIMEPREVIR	Background Compared with other countries, patients with chronic hepatitis C infection in Japan tend to be older, have more advanced liver disease, and are more likely to have been previously treated for hepatitis C. We aimed to assess the efficacy and safety of an all-oral, fixed-dose combination of the hepatitis C virus NS5A inhibitor ledipasvir and the NS5B nucleotide polymerase inhibitor sofosbuvir with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with chronic genotype 1 hepatitis C virus infection. Methods In this randomised, open-label study, we enrolled patients from 19 clinical Japanese centres. Patients were randomly assigned (1: 1) to receive either ledipasvir (90 mg) and sofosbuvir (400 mg) or ledipasvir, sofosbuvir, and ribavirin (dosed according to the Japanese Copegus product label-ie, patients <= 60 kg received 600 mg daily, patients >60 kg to <= 80 kg received 800 mg daily, and patients >80 kg received 1000 mg daily) orally once daily for 12 weeks. After completion or early discontinuation of treatment, patients were followed up off-treatment for 24 weeks. Eligible patients were at least 20 years of age with chronic genotype 1 hepatitis C virus infection with serum hepatitis C virus RNA concentrations of at least 5 log(10) IU/mL, creatinine clearance of at least 1.0 mL/s, and a platelet count of at least 50 x 10(9) per L. An interactive web response system was used to manage patient randomisation and treatment assignment. Randomisation was stratified by the presence or absence of cirrhosis for treatment-naive patients and stratified by presence or absence of cirrhosis and by previous treatment category (relapser or breakthrough, non-responder, or interferon-intolerant) for previously treated patients. Within each strata, patients were sequentially assigned to either treatment with ledipasvir-sofosbuvir or ledipasvir-sofosbuvir plus ribavirin in a 1:1 ratio with block size of 4. The primary endpoint was sustained virological response 12 weeks after completion of treatment (SVR12) assessed in all patients who were randomly assigned and received at least one dose of study drug; safety outcomes were assessed in all patients who received at least one dose of study drug. This trial is registered with ClinicalTrials.gov,number NCT01975675. Findings Between Oct 15, 2013 and Dec 13, 2013, 341 patients were randomly assigned to treatment groups and received at least one dose of study treatment. SVR12 was achieved in all 171 (100%) patients (83 of 83 treatment naive and 88 of 88 treatment experienced) receiving ledipasvir-sofosbuvir (95% CI 98-100) and 167 (98%) of 170 patients (80 of 83 treatment naive and 87 of 87 treatment experienced) receiving ledipasvir-sofosbuvir plus ribavirin (95% CI 95-100). Of the 76 patients with baseline NS5A resistant variants, 75 (99%) achieved SVR12. Two (1.2%) of 170 patients in the ledipasvir-sofosbuvir plus ribavirin group discontinued treatment because of adverse events. The most common adverse events were nasopharyngitis (50 [29.2%] of 171), headache (12 [7.0%] of 171), and malaise (nine [5.3%] of 171) in patients receiving ledipasvir-sofosbuvir; and nasopharyngitis (40 [23.5%] of 170), anaemia (23 [13.5%] of 170), and headache in those receiving ledipasvir-sofosbuvir and ribavirin (15 [8.8%] of 170). Interpretation Although existing regimens for the treatment of hepatitis C virus are effective for many patients, medical needs remain unmet, particularly in Japan where the population with hepatitis C virus genotype 1 is generally older and treatment-experienced, with advanced liver disease. The efficacy, tolerability, and absence of drug-drug interactions of ledipasvir-sofosbuvir suggest that it could be an important option for treatment of genotype 1 hepatitis C virus in Japanese patients.	[Mizokami, Masashi; Korenaga, Masaaki] Kohnodai Hosp, Natl Ctr Global Hlth & Med, Chiba, Japan; [Yokosuka, Osamu] Chiba Univ, Chiba, Japan; [Takehara, Tetsuo] Osaka Univ, Osaka, Japan; [Sakamoto, Naoya] Hokkaido Univ, Sapporo, Hokkaido 060, Japan; [Mochizuki, Hitoshi; Omata, Masao] Yamanashi Prefectural Hosp Org, Yamanashi, Japan; [Nakane, Kunio; Omata, Masao] Akita City Hosp, Akita, Japan; [Enomoto, Hirayuki] Hyogo Coll Med, Nishinomiya, Hyogo, Japan; [Ikeda, Fusao] Okayama Univ, Okayama 7008530, Japan; [Yanase, Mikio] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Toyoda, Hidenori] Ogaki Municipal Hosp, Gifu, Japan; [Genda, Takuya] Juntendo Univ, Shizuoka Hosp, Shizuoka, Japan; [Umemura, Takeji] Shinshu Univ, Nagano, Japan; [Yatsuhashi, Hiroshi] Natl Hosp Org, Nagasaki Med Ctr, Nagasaki, Japan; [Ide, Tatsuya] Kurume Univ, Fukuoka, Japan; [Toda, Nobuo] Mitsui Mem Hosp, Tokyo 101, Japan; [Nirei, Kazushige] Nihon Univ, Sch Med, Tokyo, Japan; [Ueno, Yoshiyuki] Yamagata Univ, Yamagata 990, Japan; [Nishigaki, Yoichi] Gifu Municipal Hosp, Gifu, Japan; [Betular, Juan; Gao, Bing; Mo, Hongmei; Garrison, Kim; Pang, Phillip S.; Knox, Steven J.; Symonds, William T.; McHutchison, John G.] Gilead Sci, Foster City, CA USA; [Izumi, Namiki] Musashino Red Cross Hosp, Tokyo, Japan; [Ishizaki, Akinobu; Omote, Masa] Gilead Sci KK, Tokyo, Japan	Mizokami, M (reprint author), Natl Kohnodai Hosp, Natl Ctr Global Hlth & Med, Chiba 2728516, Japan.	mmizokami@hospk.ncgm.go.jp			Gilead Sciences	Gilead Sciences.	Kumada H, 2015, HEPATOL RES, V45, P501, DOI 10.1111/hepr.12375; [Anonymous], 2003, REBETOL RIBAVIRIN CA; Afdhal N, 2014, NEW ENGL J MED, V370, P1483, DOI 10.1056/NEJMoa1316366; Hayashi N, 2014, J HEPATOL, V61, P219, DOI 10.1016/j.jhep.2014.04.004; Izumi N, 2014, J GASTROENTEROL, V49, P941, DOI 10.1007/s00535-014-0949-8; Jacobson IM, 2013, NEW ENGL J MED, V368, P1867, DOI 10.1056/NEJMoa1214854; Chung H, 2010, INTERVIROLOGY, V53, P39, DOI 10.1159/000252782; [Anonymous], 2014, DAKLINZA DACLATASVIR; [Anonymous], 2013, SOVALDI SOFOSBUVIR T; Kowdley KV, 2014, NEW ENGL J MED, V370, P1879, DOI 10.1056/NEJMoa1402355; [Anonymous], 2014, SUNVEPRA ASUNAPREVIR; Afdhal N, 2014, NEW ENGL J MED, V370, P1889, DOI 10.1056/NEJMoa1402454; Kumada H, 2014, HEPATOLOGY, V59, P2083, DOI 10.1002/hep.27113; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Drafting Committee for Hepatitis Management Guidelines the Japan Society of Hepatology, 2014, HEPATOL RES SS1, V44, P59; Gane E, 2014, LANCET, V384, P1557, DOI 10.1016/S0140-6736(14)61225-3; Kirby B, 2013, HEPATOL INT S1, V7, pS375; Zeuzem S, 2014, GASTROENTEROLOGY, V146, P430, DOI 10.1053/j.gastro.2013.10.058	18	7	7	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1473-3099	1474-4457		LANCET INFECT DIS	Lancet Infect. Dis.	JUN	2015	15	6					645	653		10.1016/S1473-3099(15)70099-X		9	Infectious Diseases	Infectious Diseases	CI3HI	WOS:000354638000029		
J	Kazui, H; Miyajima, M; Mori, E; Ishikawa, M				Kazui, Hiroaki; Miyajima, Masakazu; Mori, Etsuro; Ishikawa, Masatsune		SINPHONI-2 Investigators	Lumboperitoneal shunt surgery for idiopathic normal pressure hydrocephalus (SINPHONI-2): an open-label randomised trial	LANCET NEUROLOGY			English	Article							DIAGNOSIS; GUIDELINES; MANAGEMENT; OUTCOMES	Background Lumboperitoneal shunt surgery has the potential to alleviate symptoms of normal pressure hydrocephalus but the benefits of such surgery have not been tested in a randomised trial. The aim of this trial was to determine the safety and efficacy of the lumboperitoneal shunt surgery for this disorder. Methods For the open-label randomised SINPHONI-2 trial, eligible participants (60-85 years of age) with idiopathic normal pressure hydrocephalus, with ventriculomegaly, and tightness of the high-convexity and medial subarachnoid spaces on MRI, were recruited from 20 neurological and neurosurgical centres in Japan. Enrolled participants were randomly assigned in a 1:1 ratio according to a random code generated by the trial statistician, with a permuted block design (using a block size of 4 or 6) within each centre, to receive lumboperitoneal shunt surgery within 1 month after randomisation, or to surgery postponed for 3 months. Patients and assessors were not masked to treatment assignment. The primary endpoint was favourable outcome, defined as an improvement of one point or more on the modified Rankin scale (mRS) at 3 months after randomisation, analysed by intention to treat, and the main secondary endpoint was the same outcome 12 months after surgery, analysed per protocol. This trial is registered with the University Hospital Medical Information Network Clinical Trials Registry (UMIN-CTR), number UMIN000002730. Findings Between March 1, 2010, and Oct 19, 2011, 93 patients with idiopathic normal pressure hydrocephalus were enrolled and randomly assigned to the immediate treatment group (n=49) or the postponed treatment group (n=44). More patients in the immediate treatment group than in the postponed treatment group had an improvement of one point or more on the mRS at 3 months: 32 (65%) of 49 in the immediate group vs 2 (5%) of 44 in the postponed group (difference 61% [95% CI 42-68]; p<0.0001). The number of patients who had an improvement of one point or more on the mRS at 12 months after surgery was similar between the two groups: 30 (67%) of 45 patients in the immediate group vs 22 (58%) of 38 in the postponed group (difference 9% [95% CI 14 to 31]; p=0.496). The proportions of patients with serious adverse events did not differ significantly between the groups during the 3 months post-randomisation (7 [15%] of 46 in the immediate group vs 1 [2%] of 42 in the postponed group; p=0.060). During the 12 months after surgery, 19 (22%) of 87 patients had serious adverse events, the most common of which was cerebral infarction (six patients [7%]). Interpretation Our results suggest that lumboperitoneal shunt surgery might be beneficial for patients with idiopathic normal pressure hydrocephalus and, if these findings are confirmed in larger studies, could be a first-line treatment option for this disease.	[Kazui, Hiroaki] Osaka Univ, Grad Sch Med, Dept Psychiat, Suita, Osaka 5650871, Japan; [Miyajima, Masakazu] Juntendo Univ, Grad Sch Med, Dept Neurosurg, Tokyo, Japan; [Mori, Etsuro] Tohoku Univ, Grad Sch Med, Dept Behav Neurol & Cognit Neurosci, Sendai, Miyagi 980, Japan; [Ishikawa, Masatsune] Otowa Hosp, Normal Pressure Hydrocephalus Ctr, Kyoto, Japan	Kazui, H (reprint author), Osaka Univ, Grad Sch Med, Dept Psychiat, D3 2-2, Suita, Osaka 5650871, Japan.	kazui@psy.med.osaka-u.ac.jp			Johnson Johnson; Nihon Medi-Physics	Johnson & Johnson and Nihon Medi-Physics.	Andren K, 2014, J NEUROL NEUROSUR PS, V85, P806, DOI 10.1136/jnnp-2013-306117; ADAMS RD, 1965, NEW ENGL J MED, V273, P117, DOI 10.1056/NEJM196507152730301; McGirt MJ, 2005, NEUROSURGERY, V57, P699, DOI 10.1227/01.NEU.0000175724.00147.10; Mori E, 2012, NEUROL MED-CHIR, V52, P775; Toma AK, 2013, ACTA NEUROCHIR, V155, P1977, DOI 10.1007/s00701-013-1835-5; Klinge P, 2012, ACTA NEUROL SCAND, V126, P145, DOI 10.1111/j.1600-0404.2012.01676.x; VANSWIETEN JC, 1988, STROKE, V19, P604; ZARIT SH, 1980, GERONTOLOGIST, V20, P649; Tarnaris A, 2011, CLIN NEUROL NEUROSUR, V113, P477, DOI 10.1016/j.clineuro.2011.02.008; Dubois B, 2000, NEUROLOGY, V55, P1621; Kubo Y, 2008, DEMENT GERIATR COGN, V25, P37, DOI 10.1159/000111149; [Anonymous], 1999, STAT MED, V18, P1905; Marmarou A, 2005, J NEUROSURG, V102, P987, DOI 10.3171/jns.2005.102.6.0987; Tisell M, 2011, J NEUROSURG, V114, P1432, DOI 10.3171/2010.11.JNS10967; Bergsneider Marvin, 2005, Neurosurgery, V57, pS29; Eide PK, 2010, NEUROSURGERY, V66, P80; Esmonde T, 2002, COCHRANE DB SYST REV, V3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Hashimoto Masaaki, 2010, Cerebrospinal Fluid Res, V7, P18, DOI 10.1186/1743-8454-7-18; Hebb AO, 2001, NEUROSURGERY, V49, P1166, DOI 10.1097/00006123-200111000-00028; Ishikawa M, 2008, NEUROL MED-CHIR, V48, pS1, DOI 10.2176/nmc.48.S1; Jaraj D, 2014, NEUROLOGY, V82, P1449; Kaijima Mitsunobu, 2011, No Shinkei Geka, V39, P497; Kanazawa R, 2011, WORLD NEUROSURG, V76, P347, DOI 10.1016/j.wneu.2011.02.024; Kawahara T, 2013, INN NEUROSURG, V1, P169; Kitagaki H, 1998, AM J NEURORADIOL, V19, P1277; Miyake H, 2008, NEUROL MED-CHIR, V48, P427, DOI 10.2176/nmc.48.427; Nakajima M, 2015, WORLD NEUROSURG, V83, P387, DOI 10.1016/j.wneu.2014.08.004; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Relkin Norman, 2005, Neurosurgery, V57, pS4; SELMAN WR, 1980, NEUROSURGERY, V6, P255; Torsnes Linnea, 2014, Dan Med J, V61, pA4911; Virhammar J, 2014, AM J NEURORADIOL, V35, P2311, DOI 10.3174/ajnr.A4046; Wang VY, 2007, NEUROSURGERY, V60, P1045, DOI 10.1227/01.NEU.0000255469.68129.81; Wechsler D, 1997, WECHSLER ADULT INTEL	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2015	14	6					585	594		10.1016/S1474-4422(15)00046-0		10	Clinical Neurology	Neurosciences & Neurology	CI5WG	WOS:000354829900010		
J	Debette, S; Compter, A; Labeyrie, MA; Uyttenboogaart, M; Metso, TM; Majersik, JJ; Goeggel-Simonetti, B; Engelter, ST; Pezzini, A; Bijlenga, P; Southerland, AM; Naggara, O; Bejot, Y; Cole, JW; Ducros, A; Giacalone, G; Schilling, S; Reiner, P; Sarikaya, H; Welleweerd, JC; Kappelle, LJ; de Borst, GJ; Bonati, LH; Jung, S; Thijs, V; Martin, JJ; Brandt, T; Grand-Ginsbach, C; Kloss, M; Mizutani, T; Minematsu, K; Meschia, JF; Pereira, VM; Bersano, A; Touze, E; Lyrer, PA; Leys, D; Chabriat, H; Markus, HS; Worrall, BB; Chabrier, S; Baumgartner, R; Stapf, C; Tatlisumak, T; Arnold, M; Bousser, MG				Debette, Stephanie; Compter, Annette; Labeyrie, Marc-Antoine; Uyttenboogaart, Maarten; Metso, Tina M.; Majersik, Jennifer J.; Goeggel-Simonetti, Barbara; Engelter, Stefan T.; Pezzini, Alessandro; Bijlenga, Philippe; Southerland, Andrew M.; Naggara, Olivier; Bejot, Yannick; Cole, John W.; Ducros, Anne; Giacalone, Giacomo; Schilling, Sabrina; Reiner, Peggy; Sarikaya, Hakan; Welleweerd, Janna C.; Kappelle, L. Jaap; de Borst, Gert Jan; Bonati, Leo H.; Jung, Simon; Thijs, Vincent; Martin, Juan J.; Brandt, Tobias; Grand-Ginsbach, Caspar; Kloss, Manja; Mizutani, Tohru; Minematsu, Kazuo; Meschia, James F.; Pereira, Vitor M.; Bersano, Anna; Touze, Emmanuel; Lyrer, Philippe A.; Leys, Didier; Chabriat, Hugues; Markus, Hugh S.; Worrall, Bradford B.; Chabrier, Stephane; Baumgartner, Ralph; Stapf, Christian; Tatlisumak, Turgut; Arnold, Marcel; Bousser, Marie-Germaine			Epidemiology, pathophysiology, diagnosis, and management of intracranial artery dissection	LANCET NEUROLOGY			English	Review							UNITED-STATES REGISTRY; VASCULAR RISK-FACTORS; ACUTE ISCHEMIC-STROKE; SYNDROME TYPE-IV; VERTEBRAL ARTERY; CAROTID-ARTERY; FIBROMUSCULAR DYSPLASIA; SUBARACHNOID HEMORRHAGE; ENDOVASCULAR TREATMENT; CEREBRAL-ARTERIES	Spontaneous intracranial artery dissection is an uncommon and probably underdiagnosed cause of stroke that is defined by the occurrence of a haematoma in the wall of an intracranial artery. Patients can present with headache, ischaemic stroke, subarachnoid haemorrhage, or symptoms associated with mass effect, mostly on the brainstem. Although intracranial artery dissection is less common than cervical artery dissection in adults of European ethnic origin, intracranial artery dissection is reportedly more common in children and in Asian populations. Risk factors and mechanisms are poorly understood, and diagnosis is challenging because characteristic imaging features can be difficult to detect in view of the small size of intracranial arteries. Therefore, multimodal follow-up imaging is often needed to confirm the diagnosis. Treatment of intracranial artery dissections is empirical in the absence of data from randomised controlled trials. Most patients with subarachnoid haemorrhage undergo surgical or endovascular treatment to prevent rebleeding, whereas patients with intracranial artery dissection and cerebral ischaemia are treated with antithrombotics. Prognosis seems worse in patients with subarachnoid haemorrhage than in those without.	[Debette, Stephanie; Reiner, Peggy; Chabriat, Hugues; Stapf, Christian; Bousser, Marie-Germaine] Univ Paris 07, Lariboisiere Hosp, Dept Neurol, DHU Neurovasc Sorbonne Paris Cite, Paris, France; [Debette, Stephanie; Schilling, Sabrina] Bordeaux Univ, INSERM U897, F-33000 Bordeaux, France; [Compter, Annette; Kappelle, L. Jaap] Univ Med Ctr Utrecht, Brain Ctr Rudolf Magnus, Dept Neurol & Neurosurg, Utrecht, Netherlands; [Labeyrie, Marc-Antoine] Univ Paris 07, Lariboisiere Hosp, Dept Neuroradiol, DHU Neurovasc Sorbonne Paris Cite, Paris, France; [Uyttenboogaart, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, NL-9713 AV Groningen, Netherlands; [Uyttenboogaart, Maarten] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, NL-9713 AV Groningen, Netherlands; [Metso, Tina M.; Tatlisumak, Turgut] Univ Helsinki, Cent Hosp, Dept Neurol, Helsinki, Finland; [Majersik, Jennifer J.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Goeggel-Simonetti, Barbara; Sarikaya, Hakan; Jung, Simon; Arnold, Marcel] Univ Hosp Bern, Inselspital, Dept Neurol, CH-3010 Bern, Switzerland; [Goeggel-Simonetti, Barbara; Sarikaya, Hakan; Jung, Simon; Arnold, Marcel] Univ Bern, Bern, Switzerland; [Engelter, Stefan T.; Bonati, Leo H.; Lyrer, Philippe A.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland; [Engelter, Stefan T.; Bonati, Leo H.; Lyrer, Philippe A.] Univ Basel Hosp, Stroke Ctr, CH-4031 Basel, Switzerland; [Engelter, Stefan T.] Felix Platter Hosp, Univ Ctr Med Aging & Rehabil Basel, Neurorehabil Unit, Basel, Switzerland; [Pezzini, Alessandro] Brescia Univ Hosp, Neurol Clin, Dept Clin & Expt Sci, Brescia, Italy; [Bijlenga, Philippe] Univ Geneva, Med Ctr, Fac Med, Dept Clin Neurosci,Neurosurg Div, CH-1211 Geneva, Switzerland; [Southerland, Andrew M.; Worrall, Bradford B.] Univ Virginia, Dept Neurol, Charlottesville, VA USA; [Southerland, Andrew M.; Worrall, Bradford B.] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA; [Naggara, Olivier] Univ Paris 05, Ctr Hosp St Anne, DHU Neurovasc Paris Sorbonne, Dept Neuroradiol,INSERM UMR 894, Paris, France; [Bejot, Yannick] Dijon Univ Hosp, Dept Neurol, Dijon, France; [Cole, John W.] Univ Maryland, Sch Med, Dept Neurol, Baltimore, MD 21201 USA; [Ducros, Anne] Univ Montpellier I, Gui de Chauliac Hosp, Dept Neurol, Montpellier, France; [Giacalone, Giacomo] IRCCS San Raffaele, Inst Expt Neurol INSPE, Dept Neurol, Milan, Italy; [Sarikaya, Hakan] Univ Zurich Hosp, Dept Neurol, CH-8091 Zurich, Switzerland; [Welleweerd, Janna C.; de Borst, Gert Jan] Univ Med Ctr Utrecht, Dept Vasc Surg, Utrecht, Netherlands; [Thijs, Vincent] Univ Leuven, KU Leuven, Neurobiol Lab, Dept Neurosci,Expt Neurol, Leuven, Belgium; [Thijs, Vincent] VIB, Vesalius Res Ctr, Leuven, Belgium; [Thijs, Vincent] Univ Hosp Leuven, Dept Neurol, Leuven, Belgium; [Martin, Juan J.] Sanatorio Allende, Dept Neurol, Cordoba, Argentina; [Brandt, Tobias] Kliniken Schmieder, Clin Neurol Rehabil, Heidelberg, Germany; [Grand-Ginsbach, Caspar; Kloss, Manja] Heidelberg Univ, Dept Neurol, Heidelberg, Germany; [Mizutani, Tohru] Showa Univ, Dept Neurosurg, Tokyo, Japan; [Minematsu, Kazuo] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka, Japan; [Meschia, James F.] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA; [Pereira, Vitor M.] Univ Hlth Network, Toronto Western Hosp, Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada; [Pereira, Vitor M.] Univ Hlth Network, Toronto Western Hosp, Dept Surg, Div Neurosurg, Toronto, ON, Canada; [Bersano, Anna] IRCCS Fdn C Besta Neurol Inst, Cerebrovasc Dis Unit, Milan, Italy; [Touze, Emmanuel] Univ Caen Basse Normandie, Inserm U919, Dept Neurol, CHU Cote Nacre, Caen, France; [Leys, Didier] Lille Univ Hosp, Dept Neurol, Lille, France; [Markus, Hugh S.] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Chabrier, Stephane] St Etienne Univ Hosp, French Ctr Paediat Stroke, St Etienne, France; [Chabrier, Stephane] St Etienne Univ Hosp, EA3065, St Etienne, France; [Baumgartner, Ralph] Clin Hirslanden Zurich, NeuroCtr, Zurich, Switzerland	Debette, S (reprint author), Bordeaux Univ, INSERM U897, F-33000 Bordeaux, France.	stephanie.debette@u-bordeaux.fr	Thijs, Vincent/C-3647-2009; Bonati, Leo/G-4058-2012	Thijs, Vincent/0000-0002-6614-8417; Bonati, Leo/0000-0003-1163-8133	Emil Aaltonen Foundation; Maud Kuistila Memorial Foundation; Helsinki University Central Hospital Research Fund; Biomedicum Helsinki Foundation; Helsinki University Medical Foundation; BMS; Pfizer; Bayer; Boston Scientific; Boehringer Ingelheim; Johnson and Johnson; Lundbeck; Mitsubishi Pharma; H Lundbeck A/S; Sanofi-Aventis; PhotoThera Inc; BrainsGate; Orion Pharma; Schering Plough; Concentric Medical; Helsinki University Central Hospital; Sigrid Juselius Foundation; Liv och Halsa Foundation; Biocenter Finland; Biocentrum Helsinki; European Union; Finnish Academy of Sciences; National Institutes of Health; Professio Finland; University of Helsinki; Finnish Medical Association; Finnish Neurological Association; University of Donau (Krems); Salus Ansvar Foundation Award; Finnish Medical Association Quality Award; European Stroke Conference; European Federation of Neurological Societies Conference; European Stroke Organisation; University of Rostock; University of Bielefeld, Australia; New Zealand Stroke Society; Austrian Stroke Society; University of Leuven; University of Tarto; Nordic Stroke Conference; Polish Neuroscience Society; Greek Internal Medicine Society; University of Donau, Krems; Thrombolysis and Thrombectomy Acute Stroke Treatment Conference; World Stroke Conference; University of Bern; University of Tuebingen; German Psychological Society; Covidien; Swiss National Science Foundation; Swiss Heart Foundation; SHIRE; Nestle Health Services; Agence Nationale de la Recherche; Dutch Heart Foundation [2007/B45]; National Institute of Health [U10 NS086606-01]; American Heart Association/American Stroke Association (AHA/ASA) National Clinical Research Program [AHA 3CRP141400001]; National Institute of Health and Research senior investigator award	TMM reports grants from The Emil Aaltonen Foundation and Maud Kuistila Memorial Foundation; and grants from Helsinki University Central Hospital Research Fund, Biomedicum Helsinki Foundation, and Helsinki University Medical Foundation, outside the submitted work AD is an employee of Cephalgia. VT reports other relationships from Boehringer Ingelheim, Medtronic, Pfizer, and Bayer, outside the submitted work. ET reports personal fees from BMS, Pfizer, Bayer, Boston Scientific, and Boehringer Ingelheim, outside the submitted work. HC reports personal fees from Johnson and Johnson and Lundbeck, outside the submitted work. TT reports grants from Boehringer Ingelheim and Mitsubishi Pharma, H Lundbeck A/S, Sanofi-Aventis, PhotoThera Inc, Mitsubishi Pharma, BrainsGate, Orion Pharma, Schering Plough, Bayer, Pfizer, Concentric Medical, Helsinki University Central Hospital, Sigrid Juselius Foundation, Liv och Halsa Foundation, Biocenter Finland, Biocentrum Helsinki, European Union, Finnish Academy of Sciences, and from National Institutes of Health. IT reports personal fees from Bayer, Pfizer, Professio Finland, University of Helsinki, Finnish Medical Association, Finnish Neurological Association, and the University of Donau (Krems). IT reports other payments to his institution from Salus Ansvar Foundation Award, Finnish Medical Association Quality Award (2011 and 2014), and personal fees from other relationships from European Stroke Conference, European Federation of Neurological Societies Conference, European Stroke Organisation, University of Rostock, University of Bielefeld, Australia and New Zealand Stroke Society, Austrian Stroke Society, University of Leuven, University of Tarto, Nordic Stroke Conference, Polish Neuroscience Society, Greek Internal Medicine Society, University of Donau, Krems, Thrombolysis and Thrombectomy Acute Stroke Treatment Conference, World Stroke Conference, University of Bern, University of Tuebingen, German Psychological Society, outside the submitted work. MA reports personal fees (speaker's fee, advisory board honoraria) from Covidien, Boehringer Ingelheim, and BMS, outside the submitted work MA reports research grants from Swiss National Science Foundation, Swiss Heart Foundation, SHIRE, Nestle Health Services, outside the submitted work SD is supported by the Agence Nationale de la Recherche. AC is supported by the Dutch Heart Foundation (2007/B45). JJMaj is supported by the National Institute of Health (U10 NS086606-01). AMS and BBW are both supported by the American Heart Association/American Stroke Association (AHA/ASA) National Clinical Research Program (AHA 3CRP141400001). HSM is supported by a National Institute of Health and Research senior investigator award. M-AL, MU, BG-S, STE, AP, PB, ON, YB, JWC, GG, SS, PR, HS, JCW, LJK, GJdB, LHB, SJ, JJMar, TB, CG-G, MK, TM, KM, JFM, VMP, AB, PAL, DL, SC, RB, CS, and M-GB dedare no competing interests.	ADAMS HP, 1982, ARCH NEUROL-CHICAGO, V39, P773; Khan S, 2007, J NEUROL NEUROSUR PS, V78, P1218, DOI 10.1136/jnnp.2006.111716; Ishikawa T, 1997, NEUROSURGERY, V40, P403, DOI 10.1097/00006123-199702000-00038; Rodrigues VJ, 2009, AM J NEURORADIOL, V30, P1614, DOI 10.3174/ajnr.A1651; Nakatomi H, 2000, STROKE, V31, P896; Pepin M, 2000, NEW ENGL J MED, V342, P673, DOI 10.1056/NEJM200003093421001; Shin DH, 2014, EUR NEUROL, V71, P305, DOI 10.1159/000357867; Touze E, 2010, INT J STROKE, V5, P296, DOI 10.1111/j.1747-4949.2010.00445.x; Peluso JPP, 2008, AM J NEURORADIOL, V29, P102, DOI 10.3174/ajnr.A077l; Mizutani T, 2001, J NEUROSURG, V94, P712, DOI 10.3171/jns.2001.94.5.0712; Santos-Franco JA, 2008, NEUROSURG REV, V31, P131, DOI 10.1007/s10143-008-0124-x; Bejot Y, 2014, INT J STROKE, V9, P879, DOI 10.1111/ijs.12154; Arnold M, 2006, STROKE, V37, P2499, DOI 10.1161/01.STR.0000240493.88473.39; Fullerton HJ, 2001, NEUROLOGY, V57, P1155; Gaughen JR, 2010, AM J NEURORADIOL, V31, P640, DOI 10.3174/ajnr.A1893; Ahn SS, 2012, RADIOLOGY, V264, P196, DOI 10.1148/radiol.12112331; Arauz A, 2013, EUR J NEUROL, V20, P167, DOI 10.1111/j.1468-1331.2012.03825.x; Olin JW, 2012, CIRCULATION, V125, P3182, DOI 10.1161/CIRCULATIONAHA.112.091223; Kim BM, 2011, NEUROLOGY, V76, P1735, DOI 10.1212/WNL.0b013e31821a7d94; Caplan LR, 2008, NAT CLIN PRACT NEURO, V4, P34, DOI 10.1038/ncpneuro0683; Rafay MF, 2006, J CHILD NEUROL, V21, P8, DOI 10.2310/7010.2006.00002; Amlie-Lefond C, 2009, CIRCULATION, V119, P1417, DOI 10.1161/CIRCULATIONAHA.108.806307; Lee VH, 2006, NEUROLOGY, V67, P1809, DOI 10.1212/01.wnl.0000244486.30455.71; Menghini VV, 1998, NEUROLOGY, V51, P405; Kim ESH, 2013, J AM COLL CARDIOL, V62, P2026, DOI 10.1016/j.jacc.2013.07.038; Kai Y, 2011, NEUROSURGERY, V69, P1085, DOI 10.1227/NEU.0b013e3182262adf; Slavin RE, 2009, CARDIOVASC PATHOL, V18, P352, DOI 10.1016/j.carpath.2008.09.001; Debette S, 2011, NEUROLOGY, V77, P1174, DOI 10.1212/WNL.0b013e31822f03fc; Bejot Y, 2014, STROKE, V45, P37, DOI 10.1161/STROKEAHA.113.001654; Debette S, 2011, CIRCULATION, V123, P1537, DOI 10.1161/CIRCULATIONAHA.110.000125; Moon Y, 2012, NEUROLOGIST, V18, P136, DOI 10.1097/NRL.0b013e318253f8dc; Jin SC, 2009, AM J NEURORADIOL, V30, P1518, DOI 10.3174/ajnr.A1621; CAPLAN LR, 1988, NEUROLOGY, V38, P868; Putaala J, 2009, STROKE, V40, P1195, DOI 10.1161/STROKEAHA.108.529883; Leys D, 2002, NEUROLOGY, V59, P26; Loeys BL, 2005, NAT GENET, V37, P275, DOI 10.1038/ng1511; Narata AP, 2012, NEUROSURGERY, V70, P982, DOI 10.1227/NEU.0b013e318236715e; Bijlenga P, 2013, STROKE, V44, P3018, DOI 10.1161/STROKEAHA.113.001667; Engelter ST, 2013, NEUROLOGY, V80, P1950, DOI 10.1212/WNL.0b013e318293e2eb; Kennedy F, 2012, NEUROLOGY, V79, P686, DOI 10.1212/WNL.0b013e318264e36b; Mizutani T, 1999, NEUROSURGERY, V45, P253, DOI 10.1097/00006123-199908000-00010; Mizutani T, 2011, J NEUROSURG, V114, P1037, DOI 10.3171/2010.9.JNS10668; Swartz RH, 2009, NEUROLOGY, V72, P627, DOI 10.1212/01.wnl.0000342470.69739.b3; Kashiwazaki D, 2013, NEURORADIOLOGY, V55, P201, DOI 10.1007/s00234-012-1114-9; Mizutani T, 1996, J NEUROSURG, V84, P962, DOI 10.3171/jns.1996.84.6.0962; YONAS H, 1977, SURG NEUROL, V8, P407; Ro A, 2009, J NEUROSURG, V110, P948, DOI 10.3171/2008.11.JNS08951; Kim BM, 2011, STROKE, V42, P2425, DOI 10.1161/STROKEAHA.111.617381; Lasjaunias PL, 2000, INTERV NEURORADIOL, V6, P113; North KN, 1995, ANN NEUROL, V38, P960, DOI 10.1002/ana.410380620; Yeung TW, 2012, J NEUROSURG, V116, P882, DOI 10.3171/2011.12.JNS111514; MIZUTANI T, 1995, NEUROSURGERY, V36, P905; WALMSLEY JG, 1979, BLOOD VESSELS, V16, P43; Arnold M, 2006, NEUROLOGY, V67, P1050, DOI 10.1212/01.wnl.0000237341.30854.6a; Arnold M, 2011, INT J STROKE, V6, P213, DOI 10.1111/j.1747-4949.2011.00605.x; Arnold M, 2009, J NEUROL NEUROSUR PS, V80, P232, DOI 10.1136/jnnp.2008.151324; Markus HS, 2015, LANCET NEUROL, V14, P361, DOI 10.1016/S1474-4422(16)70018-9; Chabrier S, 2003, EUR J PAEDIATR NEURO, V7, P39, DOI 10.1016/S1090-3798(02)00138-1; Chen M, 2005, FRONT NEUROL NEUROSC, V20, P160; Debette S, 2009, LANCET NEUROL, V8, P668, DOI 10.1016/S1474-4422(09)70084-5; Doijiri R, 2012, J STROKE CEREBROVASC, V21; Edjlali M, 2013, AM J NEURORADIOL, V34, pE103, DOI 10.3174/ajnr.A3261; Fujimoto M, 2013, J NEUROINTERV SURG, V5, pE43, DOI 10.1136/neurintsurg-2012-010474.rep; Gonzalez AM, 2014, EUR J RADIOL, V83, P197, DOI 10.1016/j.ejrad.2013.09.017; Han M, 2014, EUR RADIOL, V24, P3017, DOI 10.1007/s00330-014-3296-5; Hegedus K, 1984, ARCH NEUROL-CHICAGO, V41, P440; Huang YC, 2009, SURG NEUROL, V72, P20, DOI 10.1016/j.surneu.2008.10.002; Jeon P, 2010, AM J NEURORADIOL, V31, P1529, DOI 10.3174/ajnr.A2115; KALYANRAMAN UP, 1983, ARCH NEUROL-CHICAGO, V40, P120; Kwak Jae Hyuk, 2011, Neurointervention, V6, P78, DOI 10.5469/neuroint.2011.6.2.78; Lai YJ, 2010, PEDIATR NEUROL, V42, P291, DOI 10.1016/j.pediatrneurol.2009.12.002; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; Lyrer P, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000255.pub2; Maski KP, 2011, PEDIATR NEUROL, V45, P39, DOI 10.1016/j.pediatrneurol.2010.12.011; Masuoka T, 2010, NEUROL MED-CHIR, V50, P179; Matsukawa H, 2014, J NEUROL NEUROSUR PS, V85, P1049, DOI 10.1136/jnnp-2013-306931; Matsukawa H, 2012, CEREBROVASC DIS, V34, P393, DOI 10.1159/000345079; Metso TM, 2007, STROKE, V38, P1837, DOI 10.1161/STROKEAHA.106.479501; Naggara O, 2010, J NEURORADIOLOGY, V37, P136, DOI 10.1016/j.neurad.2009.07.002; Nakajima S, 2010, ACT NEUR S, V107, P45, DOI 10.1007/978-3-211-99373-6_7; Nakazawa T, 2011, Neuroradiol J, V24, P699; Ono H, 2013, STROKE, V44, P126, DOI 10.1161/STROKEAHA.112.670745; RATINOV G, 1964, ARCH NEUROL-CHICAGO, V10, P66; Sakata N, 2001, HISTOPATHOLOGY, V38, P325, DOI 10.1046/j.1365-2559.2001.01081.x; Sakata N, 2002, PATHOL RES PRACT, V198, P493, DOI 10.1078/0344-0338-00290; Sanai N, 2008, VASCULAR NEUROSURGER, P102; Sarikaya H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072697; SASAKI O, 1991, J NEUROSURG, V75, P874, DOI 10.3171/jns.1991.75.6.0874; Schievink WI, 2001, NEW ENGL J MED, V344, P898, DOI 10.1056/NEJM200103223441206; SCHIEVINK WI, 1994, NEUROLOGY, V44, P1607; Songsaeng D, 2010, J NEUROSURG-PEDIATR, V6, P233, DOI 10.3171/2010.6.PEDS09290; Takaba M, 1998, ACTA NEUROCHIR, V140, P411, DOI 10.1007/s007010050118; Takemoto K, 2010, ACTA NEUROCHIR SUPPL, V107, P51, DOI 10.1007/978-3-211-99373-6_8; Sandercock P, 1997, LANCET, V349, P1569; van Oel LI, 2013, AM J NEURORADIOL, V34, P589, DOI 10.3174/ajnr.A3255; Volker W, 2011, NEUROLOGY, V76, P1463, DOI 10.1212/WNL.0b013e318217e71c; WILKINSO.IM, 1972, ARCH NEUROL-CHICAGO, V27, P392; Yamaura A, 2000, NEUROPATHOLOGY, V20, P85, DOI 10.1046/j.1440-1789.2000.00276.x; Yoshimoto Y, 1997, STROKE, V28, P370; Zhao KJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067169; Zhao KJ, 2014, EUR RADIOL, V24, P2088, DOI 10.1007/s00330-014-3225-7	101	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1474-4422	1474-4465		LANCET NEUROL	Lancet Neurol.	JUN	2015	14	6					640	654				15	Clinical Neurology	Neurosciences & Neurology	CI5WG	WOS:000354829900015		
J	Larson-Hall, J; Plonsky, L				Larson-Hall, Jenifer; Plonsky, Luke			Reporting and Interpreting Quantitative Research Findings: What Gets Reported and Recommendations for the Field	LANGUAGE LEARNING			English	Article						confidence intervals; effect sizes; language; L2; mean; meta-analysis; methodology; quantitative; raw data; reporting practices; standard deviation	ACQUISITION RESEARCH; L2 RESEARCH; METAANALYSIS; LANGUAGE; INSTRUCTION; PSYCHOLOGY; QUALITY; SLA; AGE	This paper presents a set of guidelines for reporting on five types of quantitative data issues: (1) Descriptive statistics, (2) Effect sizes and confidence intervals, (3) Instrument reliability, (4) Visual displays of data, and (5) Raw data. Our recommendations are derived mainly from various professional sources related to L2 research but motivated by results from investigations into how well the field as a whole is following these guidelines for best methodological practices, and illustrated by L2 examples. Although recent surveys of L2 reporting practices have found that more researchers are including important data such as effect sizes, confidence intervals, reliability coefficients, research questions, a priori alpha levels, graphics, and so forth in their research reports, we call for further improvement so that research findings may build upon each other and lend themselves to meta-analyses and a mindset that sees each research project in the context of a coherent whole.	[Larson-Hall, Jenifer] Fukuoka Jo Gakuin, Fukuoka, Osa 3421, Japan; [Plonsky, Luke] No Arizona Univ, Flagstaff, AZ 86011 USA	Larson-Hall, J (reprint author), Fukuoka Jo Gakuin, Ctr Study English Language Teaching, Minami Ku, Fukuoka, Osa 3421, Japan.	drlarsonhall@gmail.com					Adesope OO, 2011, BRIT J EDUC PSYCHOL, V81, P629, DOI 10.1111/j.2044-8279.2010.02015.x; American Educational Research Association, 2006, ED RES, V35, P33, DOI [10.3102/0013189X035006033, DOI 10.3102/0013189X035006033]; American Psychological Association, 2010, PUBL MAN AM PSYCH AS; Norris JM, 2000, LANG LEARN, V50, P417, DOI 10.1111/0023-8333.00136; Chaudron C, 2001, MOD LANG J, V85, P57, DOI 10.1111/0026-7902.00097; Abraham LB, 2008, COMPUT ASSIST LANG L, V21, P199, DOI 10.1080/09588220802090246; Plonsky L, 2011, LANG LEARN, V61, P325, DOI 10.1111/j.1467-9922.2011.00640.x; Grgurovic M, 2013, RECALL, V25, P165, DOI 10.1017/S0958344013000013; Wainer H, 1996, AM STAT, V50, P101, DOI 10.2307/2684419; Wilkinson L, 1999, AM PSYCHOL, V54, P594, DOI 10.1037//0003-066X.54.8.594; Vines TH, 2014, CURR BIOL, V24, P94, DOI 10.1016/j.cub.2013.11.014; Plonsky L, 2011, LANG LEARN, V61, P993, DOI 10.1111/j.1467-9922.2011.00663.x; Adesope OO, 2010, REV EDUC RES, V80, P207, DOI 10.3102/0034654310368803; Lee SK, 2008, STUD SECOND LANG ACQ, V30, P307, DOI 10.1017/S0272263108080479; Larson-Hall J, 2008, SECOND LANG RES, V24, P35, DOI 10.1177/0267658307082981; Li SF, 2010, LANG LEARN, V60, P309, DOI 10.1111/j.1467-9922.2010.00561.x; [Anonymous], 2008, AM PSYCHOL, V63, P839; Larson-Hall J, 2010, APPL LINGUIST, V31, P368, DOI 10.1093/applin/amp038; Lyster R, 2004, STUD SECOND LANG ACQ, V26, P399, DOI 10.1017/S0272263104043025; Plonsky L, 2013, STUD SECOND LANG ACQ, V35, P655, DOI 10.1017/S0272263113000399; [Anonymous], 2013, OPEN SCI FRAMEWORK B; Biber D., 2011, TOEFLIBT14 ED TEST S; Bowles M., 2010, THINK ALOUD CONTROVE; Breckler S., 2009, DEALING DATA AM PSYC; Brown D., LANGUAGE TE IN PRESS; Byrnes H, 2013, MOD LANG J, V97, P825, DOI 10.1111/j.1540-4781.2013.12051.x; Catford JC, 1998, LANG LEARN, V48, P465, DOI 10.1111/0023-8333.00054; Cooper H. M., 2011, REPORTING RES PSYCHO; CROOKES G, 1991, TESOL QUART, V25, P762, DOI 10.2307/3587103; Cumming G, 2012, UNDERSTANDING NEW ST; DeKeyser R., 1997, STUDIES 2 LANGUAGE A, V19, P195, DOI DOI 10.1017/S0272263197002040; Dinsmore TH, 2006, LANG LEARN LANG TEAC, V13, P53; Ellis N, 2000, LANG LEARN, V50, pXI; Funder D., 2013, PERSONALITY SOCIAL P, V18, P3; Goldschneider JM, 2001, LANG LEARN, V51, P1, DOI 10.1111/1467-9922.00147; Good J., 2010, OPEN ACCESS NEW 0111; HENNING G, 1986, TESOL QUART, V20, P701, DOI 10.2307/3586520; Hudson T., ADV QUANTIT IN PRESS; Jeon EH, 2006, LANG LEARN LANG TEAC, V13, P165; Kalinowski P., 2014, UNDERSTANDING CONFID; Keck CM, 2006, LANG LEARN LANG TEAC, V13, P91; Kieffer MJ, 2009, REV EDUC RES, V79, P1168, DOI 10.3102/0034654309332490; Larson-Hall J., 2015, MOVING BAR PLO UNPUB; Larson-Hall J., 2015, GUIDE DOING STAT 2 L; Larson-Hall J., 2010, GUIDE DOING STAT 2 L; Lee J., APPL LINGUI IN PRESS; Lin WC, 2013, LANG LEARN TECHNOL, V17, P123; Loewen S, 2009, LANG TEACH, V42, P181, DOI 10.1017/S0261444808005624; Mackey A., 2007, CONVERSATIONAL INTER, P407; Nekrasova T., 2009, EFFECTIVENESS UNPUB; Nicol A. A. M., 2010, PRESENTING YOUR FIND; Nicol A. M., 2010, DISPLAYING YOUR FIND; Norris JM, 2015, LANG LEARN, V65, P97, DOI 10.1111/lang.12114; Norris JM, 2006, LANG LEARN LANG TEAC, V13, P3; Nunan D., 1991, STUDIES 2 LANGUAGE A, V13, P249, DOI 10.1017/S0272263100009967; Pennock-Roman M., 2011, ED MEASUREMENT ISSUE, V30, P10; Phakiti A, 2010, CONTINUUM COMPANION, P39; Plonsky L., APPL LINGUI IN PRESS, DOI 10.1093/applin/amu001; Plonsky L, 2014, MOD LANG J, V98, P450, DOI 10.1111/j.1540-4781.2014.12058.x; Plonsky L, 2014, LANG LEARN, V64, P878, DOI 10.1111/lang.12079; Plonsky L., 2015, METAANALYSIS R UNPUB; Russell J, 2006, LANG LEARN LANG TEAC, V13, P133; Tufte E., 2014, SPARKLINE THEORY PRA; Tufte ER, 2001, VISUAL DISPLAY QUANT; Wa-Mbaleka S., 2006, THESIS NO ARIZONA U; Wang L.-J., 2010, THESIS NATL TSING HU; Wu C., 1991, THESIS U SAN FRANCIS; Ziegler N., 2013, THESIS GEORGETOWN U	68	6	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-8333	1467-9922		LANG LEARN	Lang. Learn.	JUN	2015	65			1	SI		127	159		10.1111/lang.12115		33	Education & Educational Research; Linguistics	Education & Educational Research; Linguistics	CI6PT	WOS:000354883600007		
J	Mizokami, D; Araki, K; Tanaka, N; Suzuki, H; Tomifuji, M; Yamashita, T; Matsushita, K; Shimada, H; Shiotani, A				Mizokami, Daisuke; Araki, Koji; Tanaka, Nobuaki; Suzuki, Hiroshi; Tomifuji, Masayuki; Yamashita, Taku; Matsushita, Kazuyuki; Shimada, Hideaki; Shiotani, Akihiro			Tacrolimus prevents laryngotracheal stenosis in an acute-injury rat model	LARYNGOSCOPE			English	Article						Calcineurin inhibitor; immunosuppressive agent; laryngotracheal stenosis; rat; tacrolimus	VASCULAR SMOOTH-MUSCLE; SUBGLOTTIC STENOSIS; DISEASE; IMMUNOSUPPRESSION; TRANSPLANTATION; THERAPY; GROWTH; STENTS; FK506; CELLS	Objectives/HypothesisAcquired laryngotracheal stenosis is a challenging problem for otolaryngologists. Several studies suggest tacrolimus may inhibit post-transplant airway stenosis that occurs with coronary drug-eluting stents. The objective of the present study was to determine whether tacrolimus modulates wound healing of the airway mucosa and prevents laryngotracheal stenosis in an acute injury animal model. Study DesignBasic science. MethodsThe laryngotracheal mucosa of rats was scraped with a nylon brush through the tracheostoma. Tacrolimus (0.2 mg/kg or 1.0 mg/kg) was systemically administered intramuscularly for 5 days. Nine days after scraping, the pathological changes and the degree of stenosis were assessed by hematoxylin and eosin staining or by immunohistochemical staining for nuclear factor of activated T cell and interleukin 2. ResultsLumen stenosis resulted from hyperplasia of the airway epithelium and a thickened submucosal layer with extensive fibrosis, angiogenesis, and collagen deposition. There was a significant preventive effect on airway stenosis at the tracheal and cricoid levels in the low-dose (0.2 mg/kg) tacrolimus-treated animals, compared to the untreated animals (P<.05). This effect was insignificant with treatment by high-dose tacrolimus (1.0 mg/kg). Immunohistochemistry showed that, after tacrolimus treatment, the expressions of nuclear factor of activated T cell and interleukin 2 were downregulated in submucosal fibroblasts, neovascular cells, and glandular cells. ConclusionsThis study suggests that low-dose systemic tacrolimus has a preventive effect on laryngotracheal stenosis by inhibiting the activation of immune cells in the injured airway mucosa via the calcineurin/nuclear factor of activated T cell/interleukin 2 pathway. Level of EvidenceNA Laryngoscope, 125:E210-E215, 2015	[Mizokami, Daisuke; Araki, Koji; Tanaka, Nobuaki; Suzuki, Hiroshi; Tomifuji, Masayuki; Yamashita, Taku; Shiotani, Akihiro] Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, Tokorozawa, Saitama 3598513, Japan; [Matsushita, Kazuyuki] Chiba Univ, Grad Sch Med, Div Clin Genet & Prote, Dept Mol Diag, Chiba, Chiba, Japan; [Shimada, Hideaki] Toho Univ, Sch Med, Dept Surg, Ota Ku, Tokyo, Japan	Araki, K (reprint author), Natl Def Med Coll, Dept Otolaryngol Head & Neck Surg, 3-2 Namiki, Tokorozawa, Saitama 3598513, Japan.	kojaraki@ndmc.ac.jp		Matsushita, Kazuyuki/0000-0001-6742-0761	National Defense Medical College Special Research Grant; Research Promotion-Grant on Defense Medicine; JSPS KAKENHI [23592545, 23592544, 25462699, 25670723]	This work was supported by grants from the National Defense Medical College Special Research Grant, Research Promotion-Grant on Defense Medicine, and Grant-in-Aid for Scientific Research (C) (JSPS KAKENHI No. 23592545, 23592544, and 25462699), and Grant-in-Aid for Challenging Exploratory Research (JSPS KAKENHI No. 25670723).	Matter CM, 2006, J CARDIOVASC PHARM, V48, P286, DOI 10.1097/01.fjc.0000248233.22570.8b; Wu CS, 2012, BRIT J DERMATOL, V167, P532, DOI 10.1111/j.1365-2133.2012.11023.x; Sun J, 2001, CIRCULATION, V103, P2967; Finn AV, 2007, CIRCULATION, V115, P2435, DOI 10.1161/CIRCULATIONAHA.107.693739; Serruys PW, 2006, NEW ENGL J MED, V354, P483, DOI 10.1056/NEJMra051091; THOMSON AW, 1995, THER DRUG MONIT, V17, P584, DOI 10.1097/00007691-199512000-00007; Hartnick CJ, 2001, ANN OTO RHINOL LARYN, V110, P1109; Hamada N, 2010, ATHEROSCLEROSIS, V208, P97, DOI 10.1016/j.atherosclerosis.2009.07.040; Bent JP, 2010, ANN OTO RHINOL LARYN, V119, P619; Deuse T, 2005, J HEART LUNG TRANSPL, V24, P1844, DOI 10.1016/j.healun.2005.03.005; Gallo A, 2012, ACTA OTORHINOLARYNGO, V32, P182; George M, 2005, EUR ARCH OTO-RHINO-L, V262, P609, DOI 10.1007/s00405-004-0887-9; Hisamatsu C, 2006, PEDIATR SURG INT, V22, P881, DOI 10.1007/s00383-006-1757-x; Manica D, 2013, LARYNGOSCOPE, V123, P1049, DOI 10.1002/lary.23771; Matia I, 2010, EUR J VASC ENDOVASC, V39, P478, DOI 10.1016/j.ejvs.2009.11.016; Mizokami D, 2013, LARYNGOSCOPE, V123, P1717, DOI 10.1002/lary.23917; Neuringer IP, 2005, AM J TRANSPLANT, V5, P2660, DOI 10.1111/j.1600-6143.2005.01071.x; Shlomi D, 2008, LARYNGOSCOPE, V118, P1383, DOI 10.1097/MLG.0b013e318172d686; Stepkowski S M, 2000, Expert Rev Mol Med, V2, P1; vansDieren JM, 2010, DIGEST DIS SCI, V55, P2514	20	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	JUN	2015	125	6					E210	E215		10.1002/lary.25178		6	Medicine, Research & Experimental; Otorhinolaryngology	Research & Experimental Medicine; Otorhinolaryngology	CI4RW	WOS:000354741600004		
J	Tomita, N; Suzuki, T; Ishiyama, Y; Miyashita, K; Takahashi, H; Numata, A; Ito, S; Motohashi, K; Tachibana, T; Takasaki, H; Kawasaki, R; Hagihara, M; Hashimoto, C; Yamazaki, E; Taguchi, J; Fujimaki, K; Sakai, R; Fujisawa, S; Motomura, S; Ishigatsubo, Y				Tomita, Naoto; Suzuki, Taisei; Ishiyama, Yasufumi; Miyashita, Kazuho; Takahashi, Hiroyuki; Numata, Ayumi; Ito, Satomi; Motohashi, Kenji; Tachibana, Takayoshi; Takasaki, Hirotaka; Kawasaki, Rika; Hagihara, Maki; Hashimoto, Chizuko; Yamazaki, Etsuko; Taguchi, Jun; Fujimaki, Katsumichi; Sakai, Rika; Fujisawa, Shin; Motomura, Shigeki; Ishigatsubo, Yoshiaki			R-CHOP therapy alone for limited-stage follicular lymphoma	LEUKEMIA RESEARCH			English	Article						Follicular lymphoma; Immunochemotherapy; Limited-stage; Rituximab; R-CHOP	NON-HODGKINS-LYMPHOMA; TERM-FOLLOW-UP; INVOLVED-FIELD RADIOTHERAPY; BONE-MARROW; STRATEGIES; MANAGEMENT; DISEASE; BLOOD	Irradiation therapy alone is a standard strategy for limited-stage FL, leading to a 10-year progression-free survival (PFS) rate of 30-50%. However, we have been administering R-CHOP therapy alone to patients with limited-stage FL. A total of 35 patients with newly diagnosed FL received R-CHOP therapy with curative intent between 2002 and 2009. The median age of the 35 patients was 61 years; 7 patients had in CS 1 FL, and 28 patients, CS 2 FL. The median number of R-CHOP cycles was 6. On completion of the R-CHOP therapy, 33 patients achieved complete response and 1 showed partial response (PR). The patient showing PR after the completion of R-CHOP was administered additional irradiation. The remaining 1 patient was not evaluated because of discontinuation of hospital visit. In all the 35 patients, the 5-year PFS rate was 70%, and the 5-year overall survival rate was 92%. In the 15 patients with a PFS > 5 years, only 1 patient showed disease progression. The outcome of R-CHOP therapy alone in patients with limited-stage FL was at least equivalent to the reported outcome of irradiation therapy alone. R-CHOP therapy could be an alternative to irradiation therapy in limited-stage FL patients. (C) 2015 Elsevier Ltd. All rights reserved.	[Tomita, Naoto; Tachibana, Takayoshi; Yamazaki, Etsuko; Ishigatsubo, Yoshiaki] Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Yokohama, Kanagawa 2360004, Japan; [Suzuki, Taisei; Ito, Satomi; Taguchi, Jun] Shizuoka Red Cross Hosp, Dept Hematol, Shizuoka, Japan; [Ishiyama, Yasufumi] Yokosuka City Hosp, Dept Hematol, Yokosuka, Kanagawa, Japan; [Miyashita, Kazuho; Kawasaki, Rika; Fujimaki, Katsumichi] Fujisawa City Hosp, Dept Hematol Immunol, Fujisawa, Kanagawa, Japan; [Takahashi, Hiroyuki; Takasaki, Hirotaka; Sakai, Rika; Motomura, Shigeki] Kanagawa Canc Ctr, Dept Med Oncol, Yokohama, Kanagawa, Japan; [Numata, Ayumi; Motohashi, Kenji; Hagihara, Maki; Fujisawa, Shin] Yokohama City Univ, Med Ctr, Dept Hematol, Yokohama, Kanagawa 2360004, Japan; [Hashimoto, Chizuko] Yamato Municipal Hosp, Dept Hematol Oncol, Yamato, Kanagawa, Japan	Tomita, N (reprint author), Yokohama City Univ, Grad Sch Med, Dept Internal Med & Clin Immunol, Kanazawa Ku, 3-9 Fukuura, Yokohama, Kanagawa 2360004, Japan.	cavalier@ch-yamate.dlenet.com					Advani R, 2004, J CLIN ONCOL, V22, P1454, DOI 10.1200/JCO.2004.10.086; Ahmed N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065156; Seymour JF, 2003, J CLIN ONCOL, V21, P2115, DOI 10.1200/JCO.2003.07.111; Solal-Celigny P, 2004, BLOOD, V104, P1258, DOI 10.1182/blood-2003-12-4434; Hoppe RT, 2011, BEST PRACT RES CL HA, V24, P179, DOI 10.1016/j.beha.2011.02.008; Chan WC, 1997, BLOOD, V89, P3909; BERINSTEIN NL, 1993, J CLIN ONCOL, V11, P1344; Denham JW, 1996, EUR J CANCER, V32A, P480, DOI 10.1016/0959-8049(95)00635-4; Friedberg JW, 2012, J CLIN ONCOL, V30, P3368, DOI 10.1200/JCO.2011.40.6546; HORNING SJ, 1984, NEW ENGL J MED, V311, P1471, DOI 10.1056/NEJM198412063112303; MacManus MP, 1996, J CLIN ONCOL, V14, P1282; Pulsoni A, 2007, BRIT J HAEMATOL, V137, P216, DOI 10.1111/j.1365-2141.2007.06545.x; SMITHERS DW, 1971, CANCER RES, V31, P1869; Tomita N, 2006, INT J HEMATOL, V83, P370, DOI 10.1532/IJH97.06041; Wilder RB, 2001, INT J RADIAT ONCOL, V51, P1219, DOI 10.1016/S0360-3016(01)01747-3; Wirth A, 2008, INT J RADIAT ONCOL, V71, P213, DOI 10.1016/j.ijrobp.2007.09.051	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	JUN	2015	39	6					582	585		10.1016/j.leukres.2015.03.008		4	Oncology; Hematology	Oncology; Hematology	CI5EP	WOS:000354776600006		
J	Konuma, T; Kato, S; Ishii, H; Oiwa-Monna, M; Asano, S; Tojo, A; Takahashi, S				Konuma, Takaaki; Kato, Seiko; Ishii, Hiroto; Oiwa-Monna, Maki; Asano, Shigetaka; Tojo, Arinobu; Takahashi, Satoshi			Long-term outcomes of granulocyte colony-stimulating factor-combined conditioning in allogeneic hematopoietic stem cell transplantation from HLA-identical family donors for myeloid malignancies	LEUKEMIA RESEARCH			English	Article						Allogeneic hematopoietic stem cell; transplantation; Granulocyte colony-stimulating factor; Cytarabine arabinoside; Conditioning regimen; Myeloid leukemia; Myelodysplastic syndrome	TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; HIGH-DOSE CYTARABINE; ADVANCED MYELODYSPLASTIC SYNDROME; CORD BLOOD TRANSPLANTATION; CYTOSINE-ARABINOSIDE; RETROSPECTIVE ANALYSIS; FOLLOW-UP; REGIMEN	Dormant leukemia cells, which might escape the cytotoxic effect of conditioning before hematopoietic stem cell transplantation (HSCT), could be induced to enter the cell cycle by granulocyte colony-stimulating factor (G-CSF) and become more susceptible to the cell-cycle-specific agent cytarabine arabinoside (Ara-C). Based on this effect, we have utilized G-CSF-combined high-dose Ara-C in myeloablative conditioning for allogeneic bone marrow or peripheral blood stem cell transplantation from HLA-identical family donors since 1988. We report on the long-term outcomes of allogeneic HSCT using a conditioning regimen of 12 Gy total body irradiation and G-CSF-combined high-dose Ara-C in 89 adult patients with acute myeloid leukemia, chronic myelogenous leukemia, or myelodysplastic syndrome. With a median follow-up of 135 months, the probability of overall survival and cumulative incidence of relapse at 5 years were 67.8% and 19.4%, respectively. In multivariate analysis, disease status at HSCT was associated with survival and relapse. These data demonstrate that G-CSF-combined myeloablative conditioning could be safely and effectively used for patients with myeloid malignancies. (C) 2015 Elsevier Ltd. All rights reserved.	[Konuma, Takaaki; Kato, Seiko; Ishii, Hiroto; Oiwa-Monna, Maki; Tojo, Arinobu; Takahashi, Satoshi] Univ Tokyo, Dept Hematol Oncol, Inst Med Sci, Tokyo 1088639, Japan; [Asano, Shigetaka] Waseda Univ, Sch Adv Sci & Engn, Syst Med Biol Lab, Tokyo, Japan	Konuma, T (reprint author), Univ Tokyo, Dept Hematol Oncol, Inst Med Sci, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	tkonuma@ims.u-tokyo.ac.jp			Chugai Pharmaceuticals; Kobayashi Foundation	This work was supported in part by grants from Chugai Pharmaceuticals and from the Kobayashi Foundation. S.A., A.T., and S.T. received research grants from Chugai Pharmaceuticals. S.T. has received honoraria from Chugai Pharmaceuticals. The other authors declare no competing financial interests.	Pabst T, 2012, BLOOD, V119, P5367, DOI 10.1182/blood-2011-11-389841; SHULMAN HM, 1980, AM J MED, V69, P204, DOI 10.1016/0002-9343(80)90380-0; Lowenberg B, 2003, NEW ENGL J MED, V349, P743, DOI 10.1056/NEJMoa025406; RIDDELL S, 1988, J CLIN ONCOL, V6, P576; Hsu KC, 2005, BLOOD, V105, P4878, DOI 10.1182/blood-2004-12-4825; Craddock C, 2011, LEUKEMIA, V25, P808, DOI 10.1038/leu.2011.13; Duval M, 2010, J CLIN ONCOL, V28, P3730, DOI 10.1200/JCO.2010.28.8852; Takahashi S, 2007, BLOOD, V109, P1322, DOI 10.1182/blood-2006-04-020172; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; PRZEPIORKA D, 1995, BONE MARROW TRANSPL, V15, P825; YAMADA K, 1995, LEUKEMIA, V9, P10; Buchner T, 2004, NEW ENGL J MED, V350, P2215, DOI 10.1056/NEJM200405203502124; ESTEY E, 1994, J CLIN ONCOL, V12, P671; Gao L, 2014, BIOL BLOOD MARROW TR, V20, P1932, DOI [10.1016/j.bbmt.2014.08.001, 10.1016/j.bbmt2014.08.001]; Gordon BG, 1997, BONE MARROW TRANSPL, V20, P5, DOI 10.1038/sj.bmt.1700827; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Konuma T, 2014, HAEMATOLOGICA, V99, DOI 10.3324/haematol.2014.114504; Kumar M, 1997, BONE MARROW TRANSPL, V19, P1061, DOI 10.1038/sj.bmt.1700797; MIYAUCHI J, 1989, BLOOD, V73, P1272; Mori T, 2008, BIOL BLOOD MARROW TR, V14, P651, DOI 10.1016/j.bbmt.2008.03.006; Mori T, 2007, BONE MARROW TRANSPL, V39, P217, DOI 10.1038/sj.bmt.1705578; Okamoto S, 1999, BRIT J HAEMATOL, V104, P569, DOI 10.1046/j.1365-2141.1999.01205.x; Takahashi S, 1998, AM J HEMATOL, V57, P303, DOI 10.1002/(SICI)1096-8652(199804)57:4<303::AID-AJH6>3.0.CO;2-Y; TAKAHASHI S, 1994, BONE MARROW TRANSPL, V13, P239; Todisco E, 2013, LEUKEMIA, V27, P2086, DOI 10.1038/leu.2013.208; WEYMAN C, 1993, BONE MARROW TRANSPL, V11, P43; WOODS WG, 1990, BONE MARROW TRANSPL, V6, P9	27	3	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	JUN	2015	39	6					625	631		10.1016/j.leukres.2015.03.022		7	Oncology; Hematology	Oncology; Hematology	CI5EP	WOS:000354776600012		
J	Nagata, Y; Ishizaki, I; Waki, M; Ide, Y; Hossen, MA; Ohnishi, K; Miyayama, T; Setou, M				Nagata, Yasuyuki; Ishizaki, Itsuko; Waki, Michihiko; Ide, Yoshimi; Hossen, Md Amir; Ohnishi, Kazunori; Miyayama, Takuya; Setou, Mitsutoshi			Palmitic acid, verified by lipid profiling using secondary ion mass spectrometry, demonstrates anti-multiple myeloma activity	LEUKEMIA RESEARCH			English	Article						Multiple myeloma; Time-of-flight secondary ion mass; spectrometry; Palmitic acid; Fatty acid; Apoptosis	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; ACTIVATED-RECEPTOR-GAMMA; SATURATED FATTY-ACIDS; TOF-SIMS; ENDOTHELIAL-CELLS; INDUCE APOPTOSIS; PLASMA-CELLS; CANCER; MODEL	Recent studies indicate that lipid metabolic changes affect the survival of multiple myeloma (MM) cells. Time-of-flight secondary ion mass spectrometry (TOF-SIMS), an imaging mass spectrometry technique, is used to visualize the subcellular distribution of biomolecules including lipids. We therefore applied this method to human clinical specimens to analyze the membrane fatty acid composition and determine candidate molecules for MM therapies. We isolated MM cells and normal plasma cells (PCs) from bone marrow aspirates of MM patients and healthy volunteers, respectively, and these separated cells were analyzed by TOF-SIMS. Multiple ions including fatty acids were detected and their ion counts were estimated. In MM cells, the mean intensity of palmitic acid was significantly lower than the mean intensity in PCs. In a cell death assay, palmitic acid reduced U266 cell viability dose-dependently at doses between 50 and 1000 mu M. The percentage of apoptotic cells increased from 24 h after palmitic acid administration. In contrast, palmitic acid had no effect on the viability of normal peripheral blood mononuclear cells (PBMCs). The results of this study indicated that palmitic acid is a potential candidate for novel therapeutic agents that specifically attack MM cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Nagata, Yasuyuki; Waki, Michihiko; Ide, Yoshimi; Hossen, Md Amir; Setou, Mitsutoshi] Hamamatsu Univ, Sch Med, Dept Cell Biol & Anat, Higashi Ku, Hamamatsu, Shizuoka 4313192, Japan; [Nagata, Yasuyuki; Ohnishi, Kazunori] Hamamatsu Univ, Sch Med, Ctr Oncol, Hamamatsu, Shizuoka 4313192, Japan; [Ishizaki, Itsuko; Miyayama, Takuya] ULVAC PHI Inc, Chigasaki, Kanagawa 2538522, Japan; [Ide, Yoshimi] Hamamatsu Univ, Sch Med, Dept Surg 1, Hamamatsu, Shizuoka 4313192, Japan	Setou, M (reprint author), Hamamatsu Univ, Sch Med, Dept Cell Biol & Anat, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 4313192, Japan.	setou@hama-med.ac.jp			Japan Society for the Promotion of Science [25293044]; Ministry of Education, Culture, Sports, Science and Technology [25116712]; Ministry of Health, Labor, and Welfare [H23-Iryoukiki-Ippan-001]	This work was supported by grants from the Japan Society for the Promotion of Science, (Grant Number 25293044), the Ministry of Education, Culture, Sports, Science and Technology (Grant Number 25116712) and the Ministry of Health, Labor, and Welfare (Grant Number H23-Iryoukiki-Ippan-001). Y.N is a Ph.D. candidate at the Hamamatsu University School of Medicine and this work is submitted in partial fulfillment of the requirement for a Ph.D. The authors thank the members of our laboratory for their cooperation and kind advice, the entire staff at the Department of Hematology (Hamamatsu University School of Medicine) for sample collection, Dr. Satoki Nakamura (Department of Tumor Pathology, Hamamatsu University School of Medicine) for constructive advice, and Mr. Shibata (Center of Facilities for Common Use, Hamamatsu University School of Medicine) for cell sorting.	Colliver TL, 1997, ANAL CHEM, V69, P2225, DOI 10.1021/ac9701748; Debois D, 2009, ANAL CHEM, V81, P2823, DOI 10.1021/ac900045m; Russo MF, 2006, ANAL CHEM, V78, P7206, DOI 10.1021/ac061180j; Kurabe N, 2013, CANCER SCI, V104, P1295, DOI 10.1111/cas.12221; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Yang HJ, 2010, SURF INTERFACE ANAL, V42, P1606, DOI 10.1002/sia.3581; Staiger K, 2006, DIABETES, V55, P3121, DOI 10.2337/db06-0188; Yang HJ, 2010, MED MOL MORPHOL, V43, P158, DOI 10.1007/s00795-009-0487-2; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Hou NS, 2014, P NATL ACAD SCI USA, V111, pE2271, DOI 10.1073/pnas.1318262111; Muir K, 2013, CANCER RES, V73, P4722, DOI 10.1158/0008-5472.CAN-12-3797; Yang FG, 2005, ACTA PHARMACOL SIN, V26, P753, DOI 10.1111/j.1745.7254.2005.00103.x; Bosma M, 2014, BBA-MOL CELL BIOL L, V1841, P1648, DOI 10.1016/j.bbalip.2014.09.012; Shimma S, 2007, J CHROMATOGR B, V855, P98, DOI 10.1016/j.jchromb.2007.02.037; Kitai Y, 2013, GENES CELLS, V18, P798, DOI 10.1111/gtc.12074; Wei YR, 2009, MOL CELL BIOCHEM, V331, P31, DOI 10.1007/s11010-009-0142-1; Passarelli MK, 2013, ANAL CHEM, V85, P2231, DOI 10.1021/ac303038j; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Jiang CY, 1998, NATURE, V391, P82; Obeng EA, 2006, BLOOD, V107, P4907, DOI 10.1182/blood-2005-08-3531; Matsuzaka T, 2002, J LIPID RES, V43, P911; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Park EJ, 2014, FOOD CHEM TOXICOL, V67, P26, DOI 10.1016/j.fct.2014.01.027; Ulloth JE, 2003, J NEUROCHEM, V84, P655, DOI 10.1046/j.0022-3042.2003.01571.x; Bich C, 2013, ANAL CHEM, V85, P7745, DOI 10.1021/ac4009513; Artwohl M, 2004, FASEB J, V18, P146, DOI 10.1096/fj.03-0301fje; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Matsuzaka T, 2012, HEPATOLOGY, V56, P2199, DOI 10.1002/hep.25932; Shimabukuro M, 1998, P NATL ACAD SCI USA, V95, P2498, DOI 10.1073/pnas.95.5.2498; Manier S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/157496; Lauta VM, 2001, CYTOKINE, V16, P79, DOI 10.1006/cyto.2001.0982; Fletcher JS, 2013, ANAL CHEM, V85, P610, DOI 10.1021/ac303088m; Lee ES, 2013, ATHEROSCLEROSIS, V226, P378, DOI 10.1016/j.atherosclerosis.2012.11.003; Morita Y, 2013, J HEPATOL, V59, P292, DOI 10.1016/j.jhep.2013.02.030; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Rhodes DR, 2004, NEOPLASIA, V6, P1; Doria ML, 2014, FASEB J, V28, P4247, DOI 10.1096/fj.14-249672; Eucker J, 2004, ANTI-CANCER DRUG, V15, P955, DOI 10.1097/00001813-200411000-00004; Guo S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05959; Gupta R, 2009, AM J CLIN PATHOL, V132, P728, DOI 10.1309/AJCP1GYI7EHQYUYK; Ide Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061204; Jurczyszyn A, 2014, LEUKEMIA RES, V38, P1260, DOI 10.1016/j.leukres.2014.08.009; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Medina EA, 2014, LEUKEMIA, V28, P2080, DOI 10.1038/leu.2014.112; Nagata Y, 2014, SURF INTERFACE ANAL, V46, P185, DOI 10.1002/sia.5522; Oh JM, 2012, TOXICOL IN VITRO, V26, P783, DOI 10.1016/j.tiv.2012.05.013; Passarelli MK, 2013, SURF INTERFACE ANAL, V45, P298, DOI 10.1002/sia.5036; Rabbani S., 2013, ANAL CHEM, V85, P5654; Rawstron AC, 1997, BRIT J HAEMATOL, V97, P46, DOI 10.1046/j.1365-2141.1997.72653.x; Rawstron AC, 2002, BLOOD, V100, P3095, DOI 10.1182/blood-2001-12-0297; Tirado-Velez JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046484; Venkateshaiah SU, 2011, BLOOD, V118, P1685; Wintrobe MM, 2009, WINTROBES CLIN HEMAT, V12th, P300	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	JUN	2015	39	6					638	645		10.1016/j.leukres.2015.02.011		8	Oncology; Hematology	Oncology; Hematology	CI5EP	WOS:000354776600014		
J	Shibasaki, Y; Seki, Y; Tanaka, T; Miyakoshi, S; Fuse, K; Kozakai, T; Kobayashi, H; Ushiki, T; Abe, T; Yano, T; Moriyama, M; Kuroha, T; Isahai, N; Takizawa, J; Narita, M; Koyama, S; Furukawa, T; Sone, H; Masuko, M				Shibasaki, Yasuhiko; Seki, Yoshinobu; Tanaka, Tomoyuki; Miyakoshi, Syukuko; Fuse, Kyoko; Kozakai, Takashi; Kobayashi, Hironori; Ushiki, Takashi; Abe, Takashi; Yano, Toshio; Moriyama, Masato; Kuroha, Takashi; Isahai, Noriatsu; Takizawa, Jun; Narita, Miwako; Koyama, Satoru; Furukawa, Tatsuo; Sone, Hirohito; Masuko, Masayoshi			The association of level of reduction of Wilms' tumor gene 1 mRNA transcript in bone marrow and outcome in acute myeloid leukemia patients	LEUKEMIA RESEARCH			English	Article						AML; WT1; Minimal residual disease; Level of reduction of WT1; Prognosis	MINIMAL RESIDUAL DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; PERIPHERAL-BLOOD; FLOW-CYTOMETRY; WT1 EXPRESSION; DIAGNOSTICS; CONSOLIDATION; CYTOGENETICS; MUTATIONS	We focused on the level of reduction of Wilms' tumor gene 1 (WT1) mRNA in bone marrow as minimal residual disease during chemotherapies in adult acute myeloid leukemia (AML) patients. Forty-eight patients were enrolled in this study. Log levels of reduction of WT1 mRNA transcript after induction therapy compared with those at diagnosis were associated with disease-free survival (DFS) (P = 0.0066) and overall survival (OS) (P = 0.0074) in patients who achieved complete remission. Also log levels of reduction of WT1 mRNA transcript after final consolidation therapy compared with those at diagnosis were associated with DFS (P = 0.015) and OS (P = 0.012). By multivariate analysis, log levels of reduction of WT1 mRNA transcript after induction therapy and after final consolidation therapy compared with those at diagnosis were extracted as risk factors for outcome. Our results suggest that early and deep reduction of tumor burden may be important for the outcome of AML patients. In addition, it may be useful for the decision to proceed with allogeneic SCT as post-remission therapy. (C) 2015 Elsevier Ltd. All rights reserved.	[Shibasaki, Yasuhiko; Furukawa, Tatsuo; Masuko, Masayoshi] Niigata Univ, Dept Stem Cell Transplantat, Med & Dent Hosp, Niigata, Japan; [Seki, Yoshinobu; Moriyama, Masato] Niigata Prefectural Shibata Hosp, Shibata, Niigata, Japan; [Tanaka, Tomoyuki; Miyakoshi, Syukuko; Fuse, Kyoko; Kozakai, Takashi; Kobayashi, Hironori; Ushiki, Takashi; Takizawa, Jun; Narita, Miwako; Sone, Hirohito] Niigata Univ, Fac Med, Dept Hematol, Niigata, Japan; [Abe, Takashi] Niigata City Gen Hosp, Niigata, Japan; [Yano, Toshio; Kuroha, Takashi; Furukawa, Tatsuo] Nagaoka Red Cross Hosp, Nagaoka, Niigata, Japan; [Isahai, Noriatsu] Niigata Prefectural Cent Hosp, Joetsu, Niigata, Japan; [Koyama, Satoru] Saiseikai Niigata Second Hosp, Niigata, Japan	Shibasaki, Y (reprint author), Niigata Univ, Dept Stem Cell Transplantat, Med & Dent Hosp, Chuo Ku, 1-754 Asahimachi Dori, Niigata, Niigata 9518510, Japan.	ya-shiba@med.niigata-u.ac.jp					Baird PN, 1997, EXP HEMATOL, V25, P312; Miyawaki S, 2010, LEUKEMIA LYMPHOMA, V51, P1855, DOI 10.3109/10428194.2010.507829; Liersch R, 2014, BRIT J HAEMATOL, V165, P17, DOI 10.1111/bjh.12750; Cilloni D, 2009, J CLIN ONCOL, V27, P5195, DOI 10.1200/JCO.2009.22.4865; Andersson C, 2012, DIAGN MOL PATHOL, V21, P225, DOI 10.1097/PDM.0b013e318257ddb9; Mossallam GI, 2013, HEMATOLOGY, V18, P69, DOI 10.1179/1607845412Y.0000000048; Grimwade D, 1998, BLOOD, V92, P2322; INOUE K, 1994, BLOOD, V84, P3071; Ribera JM, 2014, J CLIN ONCOL, V32, P1595, DOI 10.1200/JCO.2013.52.2425; Miyawaki S, 2011, BLOOD, V117, P2366, DOI 10.1182/blood-2010-07-295279; Fernandez HF, 2009, NEW ENGL J MED, V361, P1249, DOI 10.1056/NEJMoa0904544; Ogawa H, 2003, BLOOD, V101, P1698, DOI 10.1182/blood-2002-06-1831; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Schultz KR, 2007, BLOOD, V109, P926, DOI 10.1182/blood-2006-01-024729; Kottaridis PD, 2003, BRIT J HAEMATOL, V122, P523; Gray JX, 2012, LEUKEMIA RES, V36, P453, DOI 10.1016/j.leukres.2011.09.005; Schlenk RF, 2008, NEW ENGL J MED, V358, P1909, DOI 10.1056/NEJMoa074306; Mrozek K, 2004, BLOOD REV, V18, P115, DOI 10.1016/S0268-960X(03)00040-7; Bacher U, 2009, BONE MARROW TRANSPL, V43, P745, DOI 10.1038/bmt.2009.54; Bacher U, 2008, BONE MARROW TRANSPL, V42, P145, DOI 10.1038/bmt.2008.185; de Labarthe A, 2005, BONE MARROW TRANSPL, V35, P767, DOI 10.1038/sj.bmt.1704884; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Rossi G, 2014, ANN HEMATOL, V93, P1149, DOI 10.1007/s00277-014-2029-9; Stahl T, 2010, LEUKEMIA LYMPHOMA, V51, P1837, DOI 10.3109/10428194.2010.508822	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0145-2126			LEUKEMIA RES	Leuk. Res.	JUN	2015	39	6					667	671		10.1016/j.leukres.2015.03.021		5	Oncology; Hematology	Oncology; Hematology	CI5EP	WOS:000354776600018		
J	Takahashi, H; Tsuboi, H; Kurata, I; Takahashi, H; Inoue, S; Ebe, H; Yokosawa, M; Hagiwara, S; Hirota, T; Asashima, H; Kaneko, S; Kawaguchi, H; Kurashima, Y; Miki, H; Umeda, N; Kondo, Y; Ogishima, H; Suzuki, T; Matsumoto, I; Sumida, T				Takahashi, H.; Tsuboi, H.; Kurata, I.; Takahashi, H.; Inoue, S.; Ebe, H.; Yokosawa, M.; Hagiwara, S.; Hirota, T.; Asashima, H.; Kaneko, S.; Kawaguchi, H.; Kurashima, Y.; Miki, H.; Umeda, N.; Kondo, Y.; Ogishima, H.; Suzuki, T.; Matsumoto, I.; Sumida, T.			Predictors of the response to treatment in acute lupus hemophagocytic syndrome	LUPUS			English	Article						Response to therapy; corticosteroids; cyclosporine A; acute lupus hemophagocytic syndrome	MACROPHAGE ACTIVATION SYNDROME; ERYTHEMATOSUS; LYMPHOHISTIOCYTOSIS; RITUXIMAB; THERAPY; PATIENT; METHYLPREDNISOLONE; MANIFESTATIONS; ETANERCEPT; HEMORRHAGE	Objective The objective of this paper is to identify predictors for the response to treatment of acute lupus hemophagocytic syndrome (ALHS). Methods We reviewed seven cases with ALHS admitted to our hospital and published ALHS cases identified in the 2001-2014 Medline database, and then conducted univariate and multivariate analyses to identify predictors for the response to treatment. Results Review of our cases showed a significant and negative correlation between serum ferritin and anti-DNA antibody (p=0.0025). All three patients treated with cyclosporine A (CsA) were considered responders despite high serum ferritin and corticosteroid resistance. We also reviewed 93 patients with ALHS identified in 46 articles. Multiple logistic regression analysis identified C-reactive protein (CRP) (OR 0.83, p=0.042) and hemoglobin (OR 1.53, p=0.026) measured at diagnosis of ALHS as significant predictors of the response to corticosteroid monotherapy. Moreover, among 32 patients treated with CsA, serum ferritin was significantly higher in CsA responders (1216316864 mu g/l, n=22) than in non-responders (3456 +/- 6267/mu g/l, p=0.020, n=10). Leukocyte count was significantly lower in the CsA responders (1940.0 +/- 972.3/mu l) than in the non-responders (3253 +/- 2198/mu l, p=0.034). Conclusion Low CRP and high hemoglobin can predict a positive response to corticosteroid monotherapy while high serum ferritin and low leukocyte count can predict a positive response to CsA in patients with ALHS and therefore, when corticosteroid monotherapy is not effective in such cases, CsA could be the first choice of an additional immunosuppressive agent.	[Takahashi, H.; Tsuboi, H.; Kurata, I.; Takahashi, H.; Inoue, S.; Ebe, H.; Yokosawa, M.; Hagiwara, S.; Hirota, T.; Asashima, H.; Kaneko, S.; Kawaguchi, H.; Kurashima, Y.; Miki, H.; Umeda, N.; Kondo, Y.; Ogishima, H.; Suzuki, T.; Matsumoto, I.; Sumida, T.] Univ Tsukuba, Dept Internal Med, Fac Med, Tsukuba, Ibaraki 3058575, Japan	Sumida, T (reprint author), Univ Tsukuba, Dept Internal Med, Fac Med, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	tsumida@md.tsukuba.ac.jp					Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Kim JM, 2013, RHEUMATOL INT, V33, P767, DOI 10.1007/s00296-010-1654-4; Villanueva J, 2005, ARTHRITIS RES THER, V7, pR30, DOI 10.1186/ar1453; Perard L, 2007, ANN HEMATOL, V86, P541, DOI 10.1007/s00277-007-0277-7; Fukaya S, 2008, RHEUMATOLOGY, V47, P1686, DOI 10.1093/rheumatology/ken342; Larroche C, 2012, JOINT BONE SPINE, V79, P356, DOI 10.1016/j.jbspin.2011.10.015; McCann LJ, 2006, J RHEUMATOL, V33, P438; Watanabe H, 2012, MOD RHEUMATOL, V22, P284, DOI 10.1007/s10165-011-0491-y; Henzan T, 2006, AM J HEMATOL, V81, P59, DOI 10.1002/ajh.20462; Shimizu M, 2013, CLIN IMMUNOL, V146, P73, DOI 10.1016/j.clim.2012.11.004; Imashuku S, 1997, INT J HEMATOL, V66, P135; So MW, 2014, MOD RHEUMATOL, V24, P855, DOI 10.3109/14397595.2013.874740; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Kounami S, 2005, ACTA HAEMATOL-BASEL, V113, P124, DOI 10.1159/000083450; Lin CI, 2012, CLIN RHEUMATOL, V31, P1223, DOI 10.1007/s10067-012-1998-0; Kampitak T, 2008, CLIN RHEUMATOL, V27, P1073, DOI 10.1007/s10067-008-0902-4; Lambotte O, 2006, MEDICINE, V85, P169, DOI 10.1097/01.md.0000227708.62510.d1; Arnez Marco Antonio Cuellar, 2012, Rev Bras Reumatol, V52, P790; Avcin T, 2006, J PEDIATR-US, V148, P683, DOI 10.1016/j.jpeds.2005.12.070; Bakshi J, 2013, LUPUS, V22, P1544, DOI 10.1177/0961203313504634; Botelho C, 2010, NEFROLOGIA, V30, P247, DOI 10.3265/Nefrologia.pre2009.Dic.5499; Campos LMA, 2010, LUPUS, V19, P1654, DOI 10.1177/0961203310378863; Carvalheiras G, 2010, LUPUS, V19, P756, DOI 10.1177/0961203309354906; Funauchi M, 2003, LUPUS, V12, P483, DOI 10.1191/0961203303lu373oa; Hagiwara Kiyofumi, 2006, Mod Rheumatol, V16, P169, DOI 10.1007/s10165-006-0473-7; Hasegawa H, 2013, LUPUS, V22, P316, DOI 10.1177/0961203313476355; Hoshi K, 2004, CLIN RHEUMATOL, V23, P252, DOI 10.1007/s10067-003-0859-2; Ideguchi H, 2007, RHEUMATOLOGY, V46, P1621, DOI 10.1093/rheumatology/kem205; Inamo Y, 2002, Mod Rheumatol, V12, P72, DOI 10.3109/s101650200012; Jung SY, 2013, JCR-J CLIN RHEUMATOL, V19, P449, DOI 10.1097/RHU.0000000000000040; Kamiya K, 2010, MOD RHEUMATOL, V20, P81, DOI 10.1007/s10165-009-0231-8; Kaneko K, 2005, CLIN RHEUMATOL, V24, P158, DOI 10.1007/s10067-004-0985-5; Keith MP, 2012, JCR-J CLIN RHEUMATOL, V18, P134, DOI 10.1097/RHU.0b013e31824e8d9b; Kikuchi H, 2012, MOD RHEUMATOL, V22, P308, DOI 10.1007/s10165-011-0500-1; Kim JM, 2012, J RHEUMATOL, V39, P86, DOI 10.3899/jrheum.110639; Kumakura Shunichi, 2004, Mod Rheumatol, V14, P205; Mehta B, 2012, INT J INFLAM, V2012; Mootsikapun Piroon, 2004, Journal of the Medical Association of Thailand, V87, P333; Mori Y, 2001, Ryumachi, V41, P31; Moriguchi Naohiko, 2002, Rinsho Ketsueki, V43, P931; Okada M, 2001, INTERNAL MED, V40, P1263, DOI 10.2169/internalmedicine.40.1263; Qian J, 2007, CLIN RHEUMATOL, V26, P807, DOI 10.1007/s10067-006-0245-y; Rajam L, 2008, INDIAN J PEDIATR, V75, P1261, DOI 10.1007/s12098-008-0170-y; Romanou V, 2006, JCR-J CLIN RHEUMATOL, V12, P301, DOI 10.1097/01.rhu.0000249897.14441.c6; Rosario C, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-185; Tabata R, 2009, CLIN RHEUMATOL, V28, P461, DOI 10.1007/s10067-009-1086-2; Takahashi N, 2008, MOD RHEUMATOL, V18, P72, DOI 10.1007/s10165-007-0006-z; Taki H, 2010, RHEUMATOL INT, V30, P387, DOI 10.1007/s00296-009-0932-5; Takizawa Y, 2009, SCAND J RHEUMATOL, V38, P492, DOI 10.3109/03009740902971221; Ueda Y, 2014, CLIN RHEUMATOL, V33, P281, DOI 10.1007/s10067-013-2451-8; WONG KF, 1991, ANN INTERN MED, V114, P387; Yamada Teruchika, 2006, Nihon Rinsho Meneki Gakkai Kaishi, V29, P384; Yamamura K, 2011, LUPUS, V20, P871, DOI 10.1177/0961203310392429; Yeap Say-Tin, 2008, Pediatr Neonatol, V49, P39, DOI 10.1016/S1875-9572(08)60010-8; Yoshida Shuzo, 2009, Nihon Rinsho Meneki Gakkai Kaishi, V32, P66; Zulian F, 2009, J PAEDIATR CHILD H, V45, P621, DOI 10.1111/j.1440-1754.2009.01582.x	56	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	JUN	2015	24	7					659	668		10.1177/0961203314559086		10	Rheumatology	Rheumatology	CI2EX	WOS:000354558900002		
J	Iwata, S; Yamaoka, K; Niiro, H; Jabbarzadeh-Tabrizi, S; Wang, SP; Kondo, M; Yoshikawa, M; Akashi, K; Tanaka, Y				Iwata, S.; Yamaoka, K.; Niiro, H.; Jabbarzadeh-Tabrizi, S.; Wang, S-P; Kondo, M.; Yoshikawa, M.; Akashi, K.; Tanaka, Y.			Increased Syk phosphorylation leads to overexpression of TRAF6 in peripheral B cells of patients with systemic lupus erythematosus	LUPUS			English	Article						Systemic lupus erythematosus; renal lupus; neuropsychiatric lupus; Syk; TRAF6; B cell	SPLEEN TYROSINE KINASE; DISEASE-ACTIVITY; RHEUMATOID-ARTHRITIS; SIGNAL-TRANSDUCTION; INHIBITOR; TOLL; ACTIVATION; SLE; EXPRESSION; RECEPTORS	Objective Activation of B cells is a hallmark of systemic lupus erythematosus (SLE). Syk and TRAF6 are key signaling molecules in B-cell activation through BCR and CD40/TLR, respectively. Nevertheless, whether expression of Syk and TRAF6 is altered in SLE B cells remains unknown. Methods Phosphorylation and/or expression of Syk and TRAF6 were analyzed by flow cytometry in peripheral blood mononuclear cells isolated from SLE patients. Results Pronounced phosphorylation and expression of Syk were noted in B cells from SLE patients compared with healthy donors. Levels of Syk phosphorylation correlated with the disease activity score. TRAF6 was significantly over-expressed in B cells of SLE patients as compared with healthy donors, and significant correlation of levels of TRAF6 expression and Syk phosphorylation was observed in SLE patients. Levels of TRAF6 expression were more pronounced in CD27+ memory B cells than in CD27-naive B cells. Invitro treatment of SLE B cells with a Syk inhibitor (BAY61-3606) reduced Syk phosphorylation as well as TRAF6 expression. Conclusion Our results suggest that the activated Syk-mediated TRAF6 pathway leads to aberrant activation of B cells in SLE, and also highlight Syk as a potential target for B-cell-mediated processes in SLE.	[Iwata, S.; Yamaoka, K.; Wang, S-P; Kondo, M.; Yoshikawa, M.; Tanaka, Y.] Univ Occupat & Environm Hlth, Dept Internal Med 1, Kitakyushu, Fukuoka 8078555, Japan; [Niiro, H.; Jabbarzadeh-Tabrizi, S.; Akashi, K.] Kyushu Univ, Grad Sch Med Sci, Dept Med & Biosyst Sci, Fukuoka 812, Japan	Tanaka, Y (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Internal Med 1, Japan 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	tanaka@med.uoeh-u.ac.jp			Ministry of Health, Labor and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; University of Occupational and Environmental Health, Japan	This work was supported in part by a Research Grant-In-Aid for Scientific Research from the Ministry of Health, Labor and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and the University of Occupational and Environmental Health, Japan.	Jalukar SV, 2000, J IMMUNOL, V164, P623; Podolanczuk A, 2009, BLOOD, V113, P3154, DOI 10.1182/blood-2008-07-166439; HAY EM, 1993, Q J MED, V86, P447; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; TANIGUCHI T, 1991, J BIOL CHEM, V266, P15790; Weinblatt ME, 2010, NEW ENGL J MED, V363, P1303, DOI 10.1056/NEJMoa1000500; Bernasconi NL, 2003, BLOOD, V101, P4500, DOI 10.1182/blood-2002-11-3569; Ruprecht CR, 2006, EUR J IMMUNOL, V36, P810, DOI 10.1002/eji.200535744; Meltzer EO, 2005, J ALLERGY CLIN IMMUN, V115, P791, DOI 10.1016/j.jaci.2005.01.040; Jacobi AM, 2008, ARTHRITIS RHEUM-US, V58, P1762, DOI 10.1002/art.23498; Ehlers M, 2006, J EXP MED, V203, P553, DOI 10.1084/jem.20052438; Martin F, 2006, ANNU REV IMMUNOL, V24, P467, DOI 10.1146/annurev.immunol.24.021605.090517; Bajpai M, 2009, IDRUGS, V12, P174; Weinblatt ME, 2008, ARTHRITIS RHEUM-US, V58, P3309, DOI 10.1002/art.23992; Liossis SNC, 1996, J CLIN INVEST, V98, P2549, DOI 10.1172/JCI119073; Bahjat FR, 2008, ARTHRITIS RHEUM, V58, P1433, DOI 10.1002/art.23428; Nicholas MIW, 2008, CLIN IMMUNOL, V126, P189, DOI 10.1016/j.clim.2007.10.004; Namjou B, 2012, ARTHRITIS RHEUM-US, V64, P1960, DOI 10.1002/art.34361; Fujimoto M, 1999, J IMMUNOL, V162, P7088; Kulathu Y, 2009, IMMUNOL REV, V232, P286, DOI 10.1111/j.1600-065X.2009.00837.x; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Deng GM, 2010, ARTHRITIS RHEUM-US, V62, P2086, DOI 10.1002/art.27452; BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549; Iwata S, 2011, J RHEUMATOL, V38, P633, DOI 10.3899/jrheum.100729; Bishop GA, 2004, NAT REV IMMUNOL, V4, P775, DOI 10.1038/nri1462; Rowland SL, 2007, J IMMUNOL, V179, P4645; Beaven MA, 1996, CURR OPIN IMMUNOL, V8, P766, DOI 10.1016/S0952-7915(96)80002-1; Iwata S, 2012, ANN RHEUM DIS, V71, P1749, DOI 10.1136/annrheumdis-2012-201317; Iwata S, 2012, J ALLERGY CLIN IMMUN, V129, P1594, DOI 10.1016/j.jaci.2012.03.014; Kobayashi T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004736; Krieg AM, 2002, NAT IMMUNOL, V3, P423, DOI 10.1038/ni0502-423; Wong WSF, 2004, BBA-PROTEINS PROTEOM, V1697, P53, DOI 10.1016/j.bbapap.2003.11.013	32	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	JUN	2015	24	7					695	704		10.1177/0961203314560424		10	Rheumatology	Rheumatology	CI2EX	WOS:000354558900006		
J	Oku, K; Amengual, O; Bohgaki, T; Horita, T; Yasuda, S; Atsumi, T				Oku, K.; Amengual, O.; Bohgaki, T.; Horita, T.; Yasuda, S.; Atsumi, T.			An independent validation of the Global Anti-Phospholipid Syndrome Score in a Japanese cohort of patients with autoimmune diseases	LUPUS			English	Letter							DIAGNOSIS		[Oku, K.; Amengual, O.; Bohgaki, T.; Horita, T.; Yasuda, S.; Atsumi, T.] Hokkaido Univ, Grad Sch Med, Dept Rheumatol Endocrinol & Nephrol, Sapporo, Hokkaido 0608638, Japan	Oku, K (reprint author), Hokkaido Univ, Grad Sch Med, Dept Med 2, Kita Ku, N15 W7, Sapporo, Hokkaido 0608638, Japan.	kenoku@med.hokudai.ac.jp					Otomo K, 2012, ARTHRITIS RHEUM-US, V64, P504, DOI 10.1002/art.33340; Sciascia S, 2013, RHEUMATOLOGY, V52, P1397, DOI 10.1093/rheumatology/kes388; Sciascia S, 2013, ANN RHEUM DIS, V72, P142, DOI 10.1136/annrheumdis-2012-201985	3	1	1	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0961-2033	1477-0962		LUPUS	Lupus	JUN	2015	24	7					774	775		10.1177/0961203314561284		2	Rheumatology	Rheumatology	CI2EX	WOS:000354558900018		
J	Murase, K; Assanai, P; Takata, H; Matsumoto, N; Saito, S; Nishiura, M				Murase, Kenya; Assanai, Purapan; Takata, Hiroshige; Matsumoto, Nozomi; Saito, Shigeyoshi; Nishiura, Motoko			Kinetic analysis of superparamagnetic iron oxide nanoparticles in the liver of body-temperature-controlled mice using dynamic susceptibility contrast magnetic resonance imaging and an empirical mathematical model	MAGNETIC RESONANCE IMAGING			English	Article						Body temperature; Superparamagnetic iron oxide nanoparticles; Kupffer cells; Phagocytic activity; GdCl3; Zymosan	GD-EOB-DTPA; NONALCOHOLIC STEATOHEPATITIS; GADOLINIUM CHLORIDE; KUPFFER CELLS; RAT-LIVER; HYPOTHERMIA; INJURY; PHAGOCYTOSIS; EXPRESSION; ZYMOSAN	The purpose of this study was to develop a method for analyzing the kinetic behavior of superparamagnetic iron oxide nanoparticles (SPIONs) in the murine liver under control of body temperature using dynamic susceptibility contrast magnetic resonance imaging (DSC-MRI) and an empirical mathematical model (EMM). First, we investigated the influence of body temperature on the kinetic behavior of SPIONs in the liver by controlling body temperature using our temperature-control system. Second, we investigated the kinetic behavior of SPIONs in the liver when mice were injected with various doses of GdCl3, while keeping the body temperature at 36 degrees C. Finally, we investigated it when mice were injected with various doses of zymosan, while keeping the body temperature at 36 degrees C. We also investigated the effect of these substances on the number of Kupffer cells by immunohistochemical analysis using the specific surface antigen of Kupffer cells (CD68). To quantify the kinetic behavior of SPIONs in the liver, we calculated the upper limit of the relative enhancement (A), the rates of early contrast uptake (alpha) and washout or late contrast uptake (beta), the parameter related to the slope of early uptake (q), the area under the curve (AUC), the maximum change of transverse relaxation rate (Delta R-2) (Delta R-2(max)), the time to Delta R-2(max) (T-max ), and Delta R-2 at the last time point (Delta R-2(last)) from the time courses of Delta R-2 using the EMM. The beta and T-max values significantly decreased and increased, respectively, with decreasing body temperature, suggesting that the phagocytic activity of Kupffer cells is significantly affected by body temperature. The AUC, Delta R-2(max), and Delta R-2(last) values decreased significantly with increasing dose of GdCl3, which was consistent with the change in the number of CD68-positive cells. They increased with increasing dose of zymosan, which was also consistent with the change in the number of CD68-positive cells. These results suggest that AUC, Delta R-2(max), and Delta R-2(last) reflect the number of Kupffer cells. In conclusion, we presented a method for analyzing the kinetic behavior of SPIONs in the liver using DSC-MRI and EMM, and investigated the influence of body temperature, GdCl3, and zymosan using body-temperature-controlled mice. The present study suggests that control of body temperature is essential for investigating the kinetic behavior of SPIONs in the liver and that our method will be applicable and useful for quantifying the responses of Kupffer cells to various drugs under control of body temperature. (C) 2015 Elsevier Inc. All rights reserved.	[Murase, Kenya; Assanai, Purapan; Takata, Hiroshige; Matsumoto, Nozomi; Saito, Shigeyoshi; Nishiura, Motoko] Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, Suita, Osaka 5650871, Japan	Murase, K (reprint author), Osaka Univ, Grad Sch Med, Fac Hlth Sci, Dept Med Phys & Engn,Div Med Technol & Sci, 1-7 Yamadaoka, Suita, Osaka 5650871, Japan.	murase@sahs.med.osaka-u.ac.jp			Japan Society for the Promotion of Science [25282131]	This work was supported by a Grant-in-Aid for Scientific Research (B) (grant no. 25282131) from the Japan Society for the Promotion of Science. The authors thank the editors and reviewers who spent a great deal of time and gave us informative advice for improving our manuscript.	Ando S, 2012, J NUTR SCI VITAMINOL, V58, P143, DOI 10.3177/jnsv.58.143; Tian YH, 2006, P NATL ACAD SCI USA, V103, P4598, DOI 10.1073/pnas.0600499103; Steib CJ, 2007, J HEPATOL, V47, P228, DOI 10.1016/j.jhep.2007.03.019; Brunt EM, 2005, SEMIN DIAGN PATHOL, V22, P330, DOI 10.1053/j.semdp.2006.04.002; Tonan T, 2012, J GASTROEN HEPATOL, V27, P789, DOI 10.1111/j.1440-1746.2011.07057.x; Vazquez-Romero A, 2013, J AM CHEM SOC, V135, P16018, DOI 10.1021/ja408093p; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Yanagisawa K, 2007, ULTRASOUND MED BIOL, V33, P318, DOI 10.1016/j.ultrasmedbio.2006.08.008; HUSZTIK E, 1980, BRIT J EXP PATHOL, V61, P624; KOREN G, 1985, CRIT CARE MED, V13, P844, DOI 10.1097/00003246-198510000-00014; Nishida K, 2007, BIOL PHARM BULL, V30, P1763, DOI 10.1248/bpb.30.1763; Kumagai K, 2007, TOXICOLOGY, V241, P106, DOI 10.1016/j.tox.2007.08.090; HARDONK MJ, 1992, J LEUKOCYTE BIOL, V52, P296; DAEMEN MJAP, 1986, J PHARM PHARMACOL, V38, P122; Moriconi F, 2009, LAB INVEST, V89, P1252, DOI 10.1038/labinvest.2009.92; BELLIN MF, 1994, RADIOLOGY, V193, P657; BENACERRAF B, 1959, P SOC EXP BIOL MED, V100, P796; BOUWENS L, 1985, J LEUKOCYTE BIOL, V37, P531; Cheong H, 2014, J MAGN RESO IN PRESS; Ding H, 2003, INT J MOL MED, V12, P549; HALPERN BN, 1951, CR SOC BIOL, V145, P503; Nestares O, 2000, MAGNET RESON MED, V43, P705, DOI 10.1002/(SICI)1522-2594(200005)43:5<705::AID-MRM13>3.0.CO;2-R; Kawakami Kazunori, 2004, Magn Reson Med Sci, V3, P105, DOI 10.2463/mrms.3.105; Kobayashi Shuichiro, 2012, Radiol Phys Technol, V5, P27, DOI 10.1007/s12194-011-0130-5; Kosciolek E, 1967, ACTA PHYS POL, V17, P319; Li JY, 2009, HEPATOB PANCREAT DIS, V8, P518; Moriyama Y, 2012, MAGN RESON MED SCI, V11, P53; Murase Kenya, 2011, Radiol Phys Technol, V4, P194, DOI 10.1007/s12194-011-0123-4; Murase Kenya, 2013, Radiol Phys Technol, V6, P115, DOI 10.1007/s12194-012-0177-y; Murase K, 2013, MAGN RESON IMAGING, V31, P1744, DOI 10.1016/j.mri.2013.08.005; OKAZAKI M, 1985, JPN J PHARMACOL, V39, P503, DOI 10.1254/jjp.39.503; Press W.H., 1992, NUMERICAL RECIPES C; Rekka E, 2002, BIOCHEM PHARMACOL, V64, P633, DOI 10.1016/S0006-2952(02)01258-3; THEYE RA, 1975, BRIT J ANAESTH, V47, P813, DOI 10.1093/bja/47.8.813-a; Tsujimoto T, 2008, WORLD J GASTROENTERO, V14, P6036, DOI 10.3748/wjg.14.6036; vanRijen EAM, 1997, SHOCK, V7, P300	36	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JUN	2015	33	5					600	610		10.1016/j.mri.2015.02.007		11	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI5WW	WOS:000354831500013		
J	Yamamoto, T; Isobe, T; Akutsu, H; Masumoto, T; Ando, H; Sato, E; Takada, K; Anno, I; Matsumura, A				Yamamoto, Tetsuya; Isobe, Tomonori; Akutsu, Hiroyoshi; Masumoto, Tomohiko; Ando, Hiroki; Sato, Eisuke; Takada, Kenta; Anno, Izumi; Matsumura, Akira			Influence of echo time in quantitative proton MR spectroscopy using LCModel	MAGNETIC RESONANCE IMAGING			English	Article						LCModel; MRS; Quantitative analysis; Echo time; T2 relaxation	GRAPHICAL USER-INTERFACE; HUMAN-BRAIN; IN-VIVO; CEREBRAL METABOLITES; NMR-SPECTROSCOPY; SPECTRA; QUANTIFICATION; TUMORS; RADIATION; PACKAGE	Objective: The objective of this study was to elucidate the influence on quantitative analysis using LCModel with the condition of echo time (TE) longer than the recommended values in the spectrum acquisition specifications. Methods: A 3 T magnetic resonance system was used to perform proton magnetic resonance spectroscopy. The participants were 5 healthy volunteers and 11 patients with glioma. Data were collected at TE of 72, 144 and 288 ms. LCModel was used to quantify several metabolites (N-acetylaspartate, creatine and phosphocreatine, and choline-containing compounds). The results were compared with quantitative values obtained by using the T2-corrected internal reference method. Results: In healthy volunteers, when TE was long, the quantitative values obtained using LCModel were up to 6.8-fold larger (p < 0.05) than those obtained using the T2-corrected internal reference method. The ratios of the quantitative values obtained by the two methods differed between metabolites (p < 0.05). In patients with glioma, the ratios of quantitative values obtained by the two methods tended to be larger at longer TE, similarly to the case of healthy volunteers, and large between-individual variation in the ratios was observed. Conclusions: In clinical practice, TE is sometimes set longer than the value recommended for LCModel. If TE is long, LCModel overestimates the quantitative value since it cannot compensate for signal attenuation, and this effect is different for each metabolite and condition. Therefore, if TE is longer than recommended, it is necessary to account for the possibly reduced reliability of quantitative values calculated using LCModel. (C) 2015 Elsevier Inc. All rights reserved.	[Yamamoto, Tetsuya; Akutsu, Hiroyoshi; Matsumura, Akira] Univ Tsukuba, Fac Med, Dept Neurosurg, Tsukuba, Ibaraki 3058575, Japan; [Isobe, Tomonori; Ando, Hiroki; Sato, Eisuke; Takada, Kenta] Univ Tsukuba, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Masumoto, Tomohiko] Univ Tsukuba, Dept Radiol, Fac Med, Tsukuba, Ibaraki 3058575, Japan; [Anno, Izumi] Ibaraki Prefectural Univ Hlth Sci, Dept Radiol Sci, Ami, Ibaraki, Japan	Isobe, T (reprint author), Univ Tsukuba, Grad Sch Comprehens Human Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058575, Japan.	tiso@md.tsukuba.ac.jp					Zeng QS, 2007, J NEURO-ONCOL, V84, P63, DOI 10.1007/s11060-007-9341-3; ERNST T, 1993, J MAGN RESON SER B, V102, P1, DOI 10.1006/jmrb.1993.1055; Naressi A, 2001, MAGN RESON MATER PHY, V12, P141, DOI 10.1007/BF02668096; MICHAELIS T, 1993, RADIOLOGY, V187, P219; OTT D, 1993, RADIOLOGY, V186, P745; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; POPTANI H, 1995, AM J NEURORADIOL, V16, P1593; FRAHM J, 1989, MAGNET RESON MED, V11, P47, DOI 10.1002/mrm.1910110105; CHRISTIANSEN P, 1994, MAGN RESON IMAGING, V12, P1237, DOI 10.1016/0730-725X(94)90088-9; DEMAEREL P, 1991, J COMPUT ASSIST TOMO, V15, P67, DOI 10.1097/00004728-199101000-00009; Isobe T, 2005, JPN J MED PHYS, V25, P68; Isobe T, 2007, AUSTRALAS RADIOL, V51, P330, DOI 10.1111/j.1440-1673.2007.01745.x; Isobe T, 2002, MAGN RESON IMAGING, V20, P343, DOI 10.1016/S0730-725X(02)00500-3; Isobe Tomonori, 2002, Brain and Nerve (Tokyo), V54, P163; Isobe T, 2010, JPN J MAGN RESON MED, V30, P122; Jiru F, 2003, MAGN RESON MATER PHY, V16, P135, DOI 10.1007/s10334-003-0018-4; Provencher SW, 2001, NMR BIOMED, V14, P260, DOI 10.1002/nbm.698; PROVENCHER SW, 1993, MAGNET RESON MED, V30, P672, DOI 10.1002/mrm.1910300604; Shimizu H, 1996, AM J NEURORADIOL, V17, P737; SZIGETY SK, 1993, INT J RADIAT ONCOL, V25, P695	20	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0730-725X	1873-5894		MAGN RESON IMAGING	Magn. Reson. Imaging	JUN	2015	33	5					644	648		10.1016/j.mri.2015.01.015		5	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI5WW	WOS:000354831500018		
J	Yamada, I; Hikishima, K; Miyasaka, N; Tokairin, Y; Ito, E; Kawano, T; Kobayashi, D; Eishi, Y; Okano, H				Yamada, Ichiro; Hikishima, Keigo; Miyasaka, Naoyuki; Tokairin, Yutaka; Ito, Eisaku; Kawano, Tatsuyuki; Kobayashi, Daisuke; Eishi, Yoshinobu; Okano, Hideyuki			Esophageal carcinoma: Evaluation with q-space diffusion-weighted MR imaging ex vivo	MAGNETIC RESONANCE IN MEDICINE			English	Article						esophagus; esophageal carcinoma; q-space imaging; diffusion-weighted imaging; MR imaging	SQUAMOUS-CELL CARCINOMA; HIGH-RESOLUTION; IN-VITRO; ENDOSCOPIC ULTRASONOGRAPHY; CERVICAL LYMPHADENOPATHY; ESOPHAGOGASTRIC JUNCTION; PRELIMINARY EXPERIENCE; MULTIDETECTOR CT; PROSTATE-CANCER; SURFACE-COIL	PurposeTo determine the usefulness of q-space MR imaging as means of evaluating the depth of mural invasion, the histologic grades, and lymph node metastasis in esophageal carcinomas. MethodsTwenty esophageal specimens each containing a carcinoma were studied with a 7.0 Tesla MR imaging system. q-Space MR images were obtained with a 50-60 mm x 25-30 mm field of view, 256 x 128 matrix, 2 mm section thickness, 10 b values ranging from 0 to 7163 s/mm(2), and a motion-probing gradient in the y-direction, and the MR images were compared with the histopathologic findings. ResultsThe mean displacement maps, probability for zero displacement maps, and kurtosis maps in all 20 carcinomas (100%) made it possible to identify the depth of tumor invasion of the esophageal wall. These q-space MR imaging parameters were significantly correlated with the histologic grades of the esophageal carcinomas (P<0.01), and also significantly correlated with their nuclear-cytoplasmic ratios (P<0.01 or P<0.001) and tumor cellularity (cell density) (P<0.01 or P<0.001). The q-space MR imaging parameters were also capable of differentiating between the metastatic lymph nodes and nonmetastatic lymph nodes (P<0.01). Conclusionq-Space MR imaging ex vivo provides excellent diagnostic accuracy for evaluating mural invasion by esophageal carcinomas, the histologic grades of esophageal carcinomas, and lymph node metastasis by esophageal carcinomas. Magn Reson Med 73:2262-2273, 2015. (c) 2014 Wiley Periodicals, Inc.	[Yamada, Ichiro] Tokyo Med & Dent Univ, Grad Sch, Dept Diagnost Radiol & Oncol, Tokyo 1138519, Japan; [Hikishima, Keigo; Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Hikishima, Keigo] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Miyasaka, Naoyuki] Tokyo Med & Dent Univ, Dept Pediat Perinatal & Maternal Med, Tokyo 1138519, Japan; [Tokairin, Yutaka; Kawano, Tatsuyuki] Tokyo Med & Dent Univ, Dept Esophagogastr Surg, Tokyo 1138519, Japan; [Ito, Eisaku; Kobayashi, Daisuke; Eishi, Yoshinobu] Tokyo Med & Dent Univ, Dept Pathol, Tokyo 1138519, Japan	Yamada, I (reprint author), Tokyo Med & Dent Univ, Grad Sch, Dept Diagnost Radiol & Oncol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	yamada.crad@tmd.ac.jp	Okano, Hideyuki/J-5973-2013		MEXT, Japan [23591753]	Grant sponsor: Grant-in-Aid for Scientific Research (C) of MEXT, Japan; Grant number: 23591753.	Anaby D, 2013, MAGN RESON IMAGING, V31, P1097, DOI 10.1016/j.mri.2013.03.020; Assaf Y, 2000, MAGNET RESON MED, V44, P713, DOI 10.1002/1522-2594(200011)44:5<713::AID-MRM9>3.0.CO;2-6; King AD, 2007, RADIOLOGY, V245, P806, DOI 10.1148/radiol.2451061804; Sugahara T, 1999, JMRI-J MAGN RESON IM, V9, P53, DOI 10.1002/(SICI)1522-2586(199901)9:1<53::AID-JMRI7>3.0.CO;2-2; Yamada I, 1999, RADIOLOGY, V210, P617; Bar-Shir A, 2009, NEUROIMAGE, V48, P109, DOI 10.1016/j.neuroimage.2009.06.019; Rosenkrantz AB, 2012, RADIOLOGY, V264, P126, DOI 10.1148/radiol.12112290; Dave UR, 2004, RADIOLOGY, V230, P281, DOI 10.1148/radiol.2301021047; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Rice TW, 2010, CANCER-AM CANCER SOC, V116, P3763, DOI 10.1002/cncr.25146; Yamada I, 2006, J MAGN RESON IMAGING, V24, P1326, DOI 10.1002/jmri.20741; Cohen Y, 2002, NMR BIOMED, V15, P516, DOI 10.1002/nbm.778; Kono K, 2001, AM J NEURORADIOL, V22, P1081; Vandecaveye V, 2009, RADIOLOGY, V251, P134, DOI 10.1148/radiol.2511080128; Koral K, 2013, RADIOLOGY, V268, P532, DOI 10.1148/radiol.13121362; Riddell AM, 2006, BRIT J RADIOL, V79, P873, DOI 10.1259/bjr/36989440; Ong HH, 2008, NEUROIMAGE, V40, P1619, DOI 10.1016/j.neuroimage.2008.01.017; Liu JG, 2012, EUR J CARDIO-THORAC, V41, pE7, DOI 10.1093/ejcts/ezr240; Bourne R, 2011, MAGN RESON MED, V66, P244, DOI 10.1002/mrm.22778; Edge S, 2010, AJCC CANC STAGING MA, P103; Esophageal Cancer, 1996, ES CANC; Feldman DR, 1997, RADIOLOGY, V202, P868; Hikishima K, 2008, MAGN RESON IMAGING, V26, P437, DOI 10.1016/j.mri.2007.09.001; Li R, 2013, RADIOLOGY, V269, P130, DOI 10.1148/radiol.13122269; Lu Y, 2012, RADIOLOGY, V36, P1088; Onbas O, 2006, EUR J RADIOL, V57, P90, DOI 10.1016/j.ejrad.2005.07.012; Panebianco V, 2006, EUR RADIOL, V16, P414, DOI 10.1007/s00330-005-2851-5; Preston SR, 2003, BRIT J SURG, V90, P1220, DOI 10.1002/bjs.4268; Riddell AM, 2007, AM J ROENTGENOL, V188, pW37, DOI 10.2214/AJR.05.1795; Riddell AM, 2006, AM J ROENTGENOL, V187, P1280, DOI 10.2214/AJR.05.0559; Riddell AM, 2007, EUR RADIOL, V17, P391, DOI 10.1007/s00330-006-0363-6; Schlick T, 1999, SURG ENDOSC-ULTRAS, V13, P894, DOI 10.1007/s004649901128; Sumi M, 2003, AM J NEURORADIOL, V24, P1627; Treatment Option. Esophageal Cancer, 1996, TREATM OPT ES CANC; Wakelin SJ, 2002, EUR J RADIOL, V41, P161, DOI 10.1016/S0720-048X(01)00418-1; Williams MC, 2004, P INT SOC MAGN RESON, V11, P2064; Wu LM, 2013, J MAGN RESON IMAGING, V38, P663, DOI 10.1002/jmri.24014; Xu JQ, 2009, MAGN RESON MED, V61, P842, DOI 10.1002/mrm.21896; Yamada I, 2014, J MAGN RESON IMAGING, V40, P567, DOI 10.1002/jmri.24411; Yamada I, 2001, J MAGN RESON IMAGING, V13, P225, DOI 10.1002/1522-2586(200102)13:2<225::AID-JMRI1033>3.0.CO;2-Z; Yamada I, 2014, RADIOLOGY, V272, P164, DOI 10.1148/radiol.14132170; Yamada I, 1997, RADIOLOGY, V204, P521; Yuequan Jiang, 2010, Ann Thorac Surg, V90, P908, DOI 10.1016/j.athoracsur.2010.05.060	43	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0740-3194	1522-2594		MAGN RESON MED	Magn. Reson. Med.	JUN	2015	73	6					2262	2273		10.1002/mrm.25334		12	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI4OA	WOS:000354729100025		
J	Narazaki, T; Sato, K; Miyazaki, N				Narazaki, Tomoko; Sato, Katsufumi; Miyazaki, Nobuyuki			Summer migration to temperate foraging habitats and active winter diving of juvenile loggerhead turtles Caretta caretta in the western North Pacific	MARINE BIOLOGY			English	Article							SEA-TURTLES; KUROSHIO-EXTENSION; SATELLITE TRACKING; MEDITERRANEAN SEA; MARINE TURTLES; CHELONIA-MYDAS; LIFE-HISTORY; CONSERVATION; POPULATION; JAPAN	Endangered loggerhead turtles (Caretta caretta) are highly migratory marine reptiles that spend extended maturation periods at sea. Although an understanding of the biology and ecology of juveniles is essential for effective conservation of this species, such information is still limited, especially for the North Pacific population. The first quantitative bycatch survey in northern Japan revealed that the Sanriku coastal area served as an important summer foraging habitat for large juvenile loggerhead turtles in the western North Pacific. To examine their year-round distribution and diving behaviour, we deployed satellite-relayed data loggers on six turtles (mean SCLn-t +/- A SD = 69.2 +/- A 9.2 cm, range = 58.3-82.5 cm). While turtles predominantly utilize the Sanriku coastal area and surrounding oceanic waters during summer, all turtles spent most of their time travelling in oceanic waters (> 200 m) several kilometres east of Japan and sometimes in association with the Kuroshio Extension Current during winter. Although water temperature experienced by turtles significantly decreased during winter, they predominantly stayed in water > 15 A degrees C. There was no strong seasonal pattern in diving behaviour, and daily average dive duration was 20.9 +/- A 11.6 min regardless of summer or winter. In addition, turtles sporadically performed deep dives, including the deepest dive (> 340 m) ever recorded for this species, during winter. These results suggest that juveniles remained active and possibly foraging in oceanic habitats throughout the winter rather than adopting the quiescent overwintering strategy (i.e. undertaking prolonged dives lasting > 300 min) previously reported in adult females.	[Narazaki, Tomoko] Univ St Andrews, Sea Mammal Res Unit, Sch Biol, St Andrews KY16 9TS, Fife, Scotland; [Sato, Katsufumi] Univ Tokyo, Atmosphere & Ocean Res Inst, Kashiwa, Chiba 2778564, Japan; [Miyazaki, Nobuyuki] Japan Marine Sci Fdn, Taito Ku, Tokyo 1100008, Japan	Narazaki, T (reprint author), Univ St Andrews, Sea Mammal Res Unit, Sch Biol, St Andrews KY16 9TS, Fife, Scotland.	naratomoz@gmail.com			program 'Bio-logging Science', The University of Tokyo (UTBLS); JSPS [24241001, TN (21-7432)]; Japan Science Society [TN (19-526)]	This study was conducted with permission from the Ethics Committee of the University of Tokyo. This study could not be achieved without great volunteers from Fisheries Cooperative Association of Funakoshi Bay, Hirota Bay, Kamaishi Bay, Kamaishi-Tobu, Miyako, Ofunato, Okirai, Omoe, Otsuchi, Ryori, Sanriku-Yamada, Sasaki, Toni and Yoshihama for providing us with wild-caught sea turtles. We are grateful to Y. Fujiwara, H. Murasaki, K. Onizuka and S. Takuma for their assistance in collecting, measuring and handling the turtles. We gratefully acknowledge M. Kurosawa, K. Morita, J. Takada, M. Hirano, A. Koshida, R. Koshida, Y. Watanabe, N. Katsumata, E. Sawai and I. Nakamura for their assistance in the field. We also acknowledge NPO Everlasting Nature of Asia for recovering satellite-relayed data logger from a stranded turtle. Special thanks go to K. Aoki, H. Shimadzu, S. Isojunno and Y. Papastamatiou for lots of useful advices. This work was supported by the program 'Bio-logging Science', The University of Tokyo (UTBLS), a JSPS research grant (24241001 to KS), a JSPS Research Fellowship for Young Scientists to TN (21-7432) and a Sasakawa Scientific Research Grant from The Japan Science Society to TN (19-526). We also acknowledge the use of the Maptool (http://www.seaturtle.org/) program for the maps of study site. The AVHRR Oceans Pathfinder SST data were obtained from Physical Oceanography Distributed Active Archive Center (http://podaac.jpl.asa.gov). We thank two anonymous reviewers for the constructive comments. Finally, we would like to dedicate our work to all the people in our study site who were severely suffered by tsunami in 11 March 2011.	MORREALE SJ, 1992, J HERPETOL, V26, P301, DOI 10.2307/1564885; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Angel MV, 2000, HYDROBIOLOGIA, V440, P161, DOI 10.1023/A:1004115010030; Broderick AC, 2007, P R SOC B, V274, P1533, DOI 10.1098/rspb.2007.0211; Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Watanabe Y, 2006, J EXP BIOL, V209, P3269, DOI 10.1242/jeb.02402; Zbinden JA, 2008, MAR BIOL, V153, P899, DOI 10.1007/s00227-007-0862-2; CROWDER LB, 1994, ECOL APPL, V4, P437, DOI 10.2307/1941948; Minamikawa S, 2000, J EXP BIOL, V203, P2967; Ishihara T, 2011, CHELONIAN CONSERV BI, V10, P281; Houghton JDR, 2008, J EXP BIOL, V211, P2566, DOI 10.1242/jeb.020065; Hatase H, 2002, MAR ECOL PROG SER, V233, P273, DOI 10.3354/meps233273; McClellan CM, 2007, BIOLOGY LETT, V3, P592, DOI 10.1098/rsbl.2007.0355; Casale P, 2012, AQUAT CONSERV, V22, P144, DOI 10.1002/aqc.2222; Hochscheid S, 2005, BIOL LETT-UK, V1, P82, DOI 10.1098/rsbl.2004.0250; Polovina J, 2006, DEEP-SEA RES PT II, V53, P326, DOI 10.1016/j.dsr2.2006.01.006; Ultsch GR, 2006, BIOL REV, V81, P339, DOI 10.1017/S1464793106007032; WITHERINGTON BE, 1989, COPEIA, P696; Polovina JJ, 2004, FISH OCEANOGR, V13, P36, DOI 10.1046/j.1365-2419.2003.00270.x; Hawkes LA, 2011, DIVERS DISTRIB, V17, P624, DOI 10.1111/j.1472-4642.2011.00768.x; Hochscheid S, 2007, MAR ECOL PROG SER, V340, P287, DOI 10.3354/meps340287; Mansfield KL, 2009, MAR BIOL, V156, P2555, DOI 10.1007/s00227-009-1279-x; Seo Y, 2014, J CLIMATE, V27, P5929, DOI 10.1175/JCLI-D-13-00641.1; Ishihara Takashi, 2011, Current Herpetology, V30, P63; Lewison RL, 2004, ECOL LETT, V7, P221, DOI 10.1111/j.1461-0248.2004.00573.x; BOWEN BW, 1995, P NATL ACAD SCI USA, V92, P3731, DOI 10.1073/pnas.92.9.3731; Qiu B, 2002, J OCEANOGR, V58, P57, DOI 10.1023/A:1015824717293; Hatase H, 2007, J ZOOL, V273, P46, DOI 10.1111/j.1469-7998.2007.00298.x; Hawkes LA, 2006, CURR BIOL, V16, P990, DOI 10.1016/j.cub.2006.03.063; Hatase H, 2002, MAR BIOL, V141, P299, DOI 10.1007/s00227-002-0819-4; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Fedak M, 2002, INTEGR COMP BIOL, V42, P3, DOI 10.1093/icb/42.1.3; LUTCAVAGE M, 1985, COPEIA, P449, DOI 10.2307/1444857; Plotkin P, 2003, CRC MAR BIOL SER, P225; Hamann M., 2010, Endangered Species Research, V11, P245, DOI 10.3354/esr00279; Balazs GH, 2004, MAR BIOL, V145, P1043, DOI 10.1007/s00227-004-1387-6; Kimura S, 2000, ICES J MAR SCI, V57, P133, DOI 10.1006/jmsc.1999.0564; Roe JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.2559; Hawkes LA, 2007, DIVERS DISTRIB, V13, P447, DOI 10.1111/j.1472-4642.2007.00354.x; Casale P, 2008, MAR ECOL PROG SER, V372, P265, DOI 10.3354/meps07702; Baba N, 2000, FISHERIES SCI, V66, P180, DOI 10.1046/j.1444-2906.2000.00030.x; Bolten AB, 1999, IUCN SSC MARINE TURT, V4, P110; CARR A, 1980, BIOL CONSERV, V19, P7, DOI 10.1016/0006-3207(80)90011-7; Coles WC, 2000, COPEIA, P551, DOI 10.1643/0045-8511(2000)000[0551:SSSTAA]2.0.CO;2; CROUSE DT, 1987, ECOLOGY, V68, P1412, DOI 10.2307/1939225; DODD C.K., 1988, US FISH WILDL SERV B, V88, P1; Doyle TK, 2013, NAT SERIES, V1, P15; Hanawa K., 1987, J OCEANOGR SOC JAPAN, V42, P435; Hatase H, 2002, MAR ECOL PROG SER, V245, P299, DOI 10.3354/meps245299; Hochscheid S, 2004, PHYSIOL BIOCHEM ZOOL, V77, P209, DOI 10.1086/381472; Kamezaki N, 1997, WILDL CONSERV JPN, V3, P29; Lohrenz S. E., 2006, SEA A, V14, P3; LUTZ PL, 1989, J EXP BIOL, V144, P155; MATSUZAWA Y, 2003, LOGGERHEAD SEA TURTL, P210; MENDONCA MT, 1982, COPEIA, P161; Milton SL, 2003, CRC MAR BIOL SER, P163; Musick JA, 1997, BIOL SEA TURTLES, V1, P137; Narazaki T, 2009, THESIS U TOKYO; Narazaki T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066043; Nishizawa H, 2014, ENDANGER SPECIES RES, V24, P85, DOI 10.3354/esr00588; Norse Elliott A., 2005, P1; Parker DM, 2005, FISH B-NOAA, V103, P142; Parrish Julia K., 2005, P80; SAKAMOTO W, 1990, NIPPON SUISAN GAKK, V56, P1435; SATO K, 1994, MAR BIOL, V118, P343, DOI 10.1007/BF00349802; Sato K, 2014, J EXP BIOL, V217, P3607, DOI 10.1242/jeb.109470; Sato K, 2007, ANN REPORT INT COAST, V32, P37; Suganuma H, 1991, MAR TURT NEWSL, V54, P16; Takasugi S, 1992, FISH OCEANOGR, V56, P434	69	0	1	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	JUN	2015	162	6					1251	1263		10.1007/s00227-015-2666-0		13	Marine & Freshwater Biology	Marine & Freshwater Biology	CI3AK	WOS:000354619600009		
J	Miyamoto, A; Sakai, A; Nakano, R; Yusa, Y				Miyamoto, Ayaka; Sakai, Atsushi; Nakano, Rie; Yusa, Yoichi			Phototaxis of sacoglossan sea slugs with different photosynthetic abilities: a test of the 'crawling leaves' hypothesis	MARINE BIOLOGY			English	Article							HORIZONTAL GENE-TRANSFER; MOLLUSK ELYSIA-VIRIDIS; OPISTHOBRANCHIA; RETENTION; CHLOROPLASTS; CHLOROTICA; GASTROPODA; PACIFIC; TIMIDA	Several sacoglossan sea slugs utilise chloroplasts ingested from algae for photosynthesis (kleptoplasty), a unique trophic strategy unknown in other animals. Its adaptive significance, especially the behavioural adaptations involved in this phenomenon, has not been fully explored. To address this issue, the effects of kleptoplasty on phototaxis were investigated, both across and within species, using sacoglossans collected along Japanese coasts in 2012 and 2013. First, the presence of phototaxis and preferred light intensity was studied in five sacoglossans with various photosynthetic capabilities using an I-maze with a light gradient (4-330 mu mol photons m(-2) s(-1)). Each individual was allowed to move for 30 min to choose the optimal light intensity. Elysia hamatanii, E. trisinuata, and Plakobranchus ocellatus, all with high photosynthetic activity (i.e. kleptoplastic), showed positive phototaxis. Among them, E. hamatanii preferred the highest light intensity followed by P. ocellatus and E. trisinuata, and the order corresponded with the shallowness of their habitats. Conversely, Stiliger ornatus and Placida sp., with virtually no photosynthetic activity (non-kleptoplastic), showed neutral and negative phototaxis, respectively. Next, the phototaxis of E. hamatanii individuals with (fed) and without (starved) functional chloroplasts was compared to examine the effects of the presence of kleptoplasts on phototaxis within a species. Both fed and starved individuals showed positive phototaxis, but the preferred light intensity of starved individuals was lower than that of fed individuals. These results suggest that sacoglossans with functional chloroplasts exhibit positive phototaxis towards a preferred light intensity which may benefit photosynthesis efficiency.	[Miyamoto, Ayaka; Sakai, Atsushi; Yusa, Yoichi] Nara Womens Univ, Dept Biol Sci, Nara 6308506, Japan; [Nakano, Rie] Kuroshio Biol Res Fdn, Kochi 7880333, Japan	Yusa, Y (reprint author), Nara Womens Univ, Dept Biol Sci, Nara 6308506, Japan.	yusa@cc.nara-wu.ac.jp			JSPS KAKENHI [26650132]; Research Institute of Marine Invertebrates (Tokyo)	We thank N. Kumagai, M. Yorifuji, N. Yamaguchi, and the members of our laboratory for their support during this study. We also thank K. Wada and S. Tamotsu for their critical reading of the manuscript and constructive comments. This work was partly supported by JSPS KAKENHI (No. 26650132) and Research Institute of Marine Invertebrates (Tokyo).	Krug PJ, 2013, MOL PHYLOGENET EVOL, V69, P1101, DOI 10.1016/j.ympev.2013.07.009; Cruz S, 2013, J EXP BOT, V64, P3999, DOI 10.1093/jxb/ert197; Rumpho ME, 2008, P NATL ACAD SCI USA, V105, P17867, DOI 10.1073/pnas.0804968105; Wagele H, 2011, MOL BIOL EVOL, V28, P699, DOI 10.1093/molbev/msq239; Bhattacharya D, 2013, MOL BIOL EVOL, V30, P1843, DOI 10.1093/molbev/mst084; Akimoto A, 2014, MAR BIOL, V161, P1095, DOI 10.1007/s00227-014-2402-1; Cimino G, 1998, CHEMOECOLOGY, V8, P51, DOI 10.1007/PL00001804; Baumgartner FA, 2009, MAR ECOL PROG SER, V396, P1, DOI 10.3354/meps08359; CLARK KB, 1990, VELIGER, V33, P339; Cummins SF, 2004, J BIOL CHEM, V279, P25614, DOI 10.1074/jbc.M313585200; Evertsen J, 2007, MAR BIOL, V151, P2159, DOI 10.1007/s00227-007-0648-6; GALLOP A, 1980, PROC R SOC SER B-BIO, V207, P335, DOI 10.1098/rspb.1980.0027; Gimenez-Casalguero F, 2008, J EXP MAR BIOL ECOL, V357, P181, DOI DOI 10.1016/J.JEMBE.2008.01.020; Handeler K., 2009, FRONTIERS ZOOLOGY, V6, P1, DOI DOI 10.1186/1742-9994-6-28; HINDE R, 1975, BIOL J LINN SOC, V7, P161, DOI 10.1111/j.1095-8312.1975.tb00738.x; LEONARD JL, 1985, CAN J ZOOL, V63, P2719; Marin A, 2004, SCI MAR, V68, P227; Schmitt V, 2011, THALASSAS, V27, P225; Schreiber U., 1995, ECOPHYSIOLOGY PHOTOS, P49; Schwartz JA, 2010, EVOL BIOL, V37, P29, DOI 10.1007/s11692-010-9079-2; Serodio J, 2011, J MAR BIOL ASSOC UK, V91, P163, DOI 10.1017/S0025315410001001; Trench R.K., 1975, Symposia Soc exp Biol, VNo. 29, P229; Trowbridge Cynthia D., 2008, Venus (Tokyo), V66, P175; Vieira S, 2009, MAR BIOL, V156, P1007, DOI 10.1007/s00227-009-1144-y; WEAVER S, 1981, MAR BEHAV PHYSIOL, V7, P297; Yamamoto S, 2013, J MAR BIOL ASSOC UK, V93, P209, DOI 10.1017/S0025315412000628; Yamamoto Y. Y., 2009, ENDOCYT CELL RES, V19, P112	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0025-3162	1432-1793		MAR BIOL	Mar. Biol.	JUN	2015	162	6					1343	1349		10.1007/s00227-015-2673-1		7	Marine & Freshwater Biology	Marine & Freshwater Biology	CI3AK	WOS:000354619600016		
J	Saito, H				Saito, Hirokazu			On the R-boundedness of solution operator families of the generalized Stokes resolvent problem in an infinite layer	MATHEMATICAL METHODS IN THE APPLIED SCIENCES			English	Article						Stokes equations; infinite layer; R-boundedness; maximal regularity	FOURIER MULTIPLIER THEOREMS; ASYMPTOTICALLY FLAT LAYERS; INITIAL-VALUE-PROBLEM; SMALL-TIME EXISTENCE; FREE-SURFACE; BOUNDARY-CONDITION; DECAYING SOLUTION; EQUATIONS; REGULARITY; TENSION	In this paper, we prove the R-boundedness of solution operator families of the generalized Stokes resolvent problem in an infinite layer with resolvent parameter lambda is an element of Sigma(epsilon,gamma 0), where Sigma(epsilon,gamma 0)={lambda is an element of C||arg lambda|-<= pi-epsilon,|lambda|>=gamma(0)} (0<epsilon<pi/2, gamma(0)>0), and our boundary conditions are nonhomogeneous Neumann on upper boundary and Dirichlet on lower boundary. We want to emphasize that we can choose 0<epsilon<pi/2 and gamma(0)>0 arbitrarily, although usual parabolic theorem tells us that we must choose a large gamma(0)>0 for given 0<epsilon<pi/2. We also prove the maximal L-p-L-q regularity theorem of the nonstationary Stokes problem as an application of the R-boundedness. The key of our approach is to apply several technical lemmas to the exact solution formulas of a resolvent problem. The formulas are obtained through the solutions of the ODEs, in the Fourier space, driven by the partial Fourier transform with respect to tangential space variable x' = (x(1),...,x(N-1)). Copyright (c) 2014 John Wiley & Sons, Ltd.	Waseda Univ, Dept Pure & Appl Math, Grad Sch Fundamental Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan	Saito, H (reprint author), Waseda Univ, Dept Pure & Appl Math, Grad Sch Fundamental Sci & Engn, Shinjuku Ku, Okubo 3-4-1, Tokyo 1698555, Japan.	s-hirokazu0704@toki.waseda.jp					Abe T., 2003, J MATH FLUID MECH, V5, P245; Abe T, 2004, MATH METHOD APPL SCI, V27, P1007, DOI 10.1002/mma.483; Abels H, 2005, J MATH FLUID MECH, V7, P201, DOI 10.1007/s00021-004-0116-8; Abels H, 2005, J MATH FLUID MECH, V7, P223, DOI 10.1007/s00021-004-0117-7; Abels H, 2005, ADV DIFFERENTIAL EQU, V10, P45; Abels H, 2002, J EVOL EQU, V2, P439, DOI 10.1007/PL00012599; Abels H, 2005, DIFFER INTEGRAL EQU, V18, P1081; Abels H, 2006, MATH NACHR, V279, P351, DOI 10.1002/mana.200310365; ALLAIN G, 1987, APPL MATH OPT, V16, P37, DOI 10.1007/BF01442184; Abe T, 2003, J MATH SOC JPN, V55, P469, DOI 10.2969/jmsj/1191419127; Denk R, 2007, MATH Z, V257, P193, DOI 10.1007/s00209-007-0120-9; FARWIG R, 1994, J MATH SOC JPN, V46, P607, DOI 10.2969/jmsj/04640607; BEALE JT, 1981, COMMUN PUR APPL MATH, V34, P359, DOI 10.1002/cpa.3160340305; Beale J.T., 1985, N HOLLAND MATH STUD, V128, P1; BEALE JT, 1984, ARCH RATION MECH AN, V84, P307; Denk R, 2013, OPERATOR THEORY ADV, V239; Denk R., 2003, MEMOIRS AM MATH SOC, V166; Enomoto Y, R SECTORIAL IN PRESS; Hataya Y, 2009, NONLINEAR ANAL-THEOR, V71, pE2535, DOI 10.1016/j.na.2009.05.061; Hataya Y, 2009, J MATH KYOTO U, V49, P691; Kunstmann PC, 2004, FOURIER MULTIPLIER T; Mikhlin S.G., 1965, MULTIDIMENSIONAL SIN; Shibata Y, 2012, J MATH SOC JPN, V64, P561, DOI 10.2969/jmsj/06420561; Shibata Y., 2001, J MATH FLUID MECH, V3, P213, DOI DOI 10.1007/PL00000970; Shibata Y, 2003, DIFFERENTIAL INTEGRA, V16, P385; Shibata Y, 2013, J MATH FLUID MECH, V15, P1, DOI 10.1007/s00021-012-0130-1; Shibata Y, 2008, J REINE ANGEW MATH, V615, P157, DOI 10.1515/CRELLE.2008.013; TANI A, 1995, ARCH RATION MECH AN, V130, P303, DOI 10.1007/BF00375142; Tani A, 1996, ARCH RATION MECH AN, V133, P299, DOI 10.1007/BF00375146; Weis L, 2001, MATH ANN, V319, P735, DOI 10.1007/PL00004457; ZIMMERMANN F, 1989, STUD MATH, V93, P201	31	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0170-4214	1099-1476		MATH METHOD APPL SCI	Math. Meth. Appl. Sci.	JUN	2015	38	9					1888	1925		10.1002/mma.3201		38	Mathematics, Applied	Mathematics	CI2HV	WOS:000354567800015		
J	Egami, Y; Ueyama, J; Furukawa, S; Kameya, T; Matsuda, Y; Yamaguchi, H; Niimi, T				Egami, Y.; Ueyama, J.; Furukawa, S.; Kameya, T.; Matsuda, Y.; Yamaguchi, H.; Niimi, T.			Development of fast response bi-luminophore pressure-sensitive paint by means of an inkjet printing technique	MEASUREMENT SCIENCE & TECHNOLOGY			English	Article						bi-luminophore pressure-sensitive paint; temperature-sensitive paint; unsteady flows; inkjet printing	SENSOR; NANOPARTICLES; FLOW	A novel fast response bi-luminophore pressure-sensitive paint (PSP) by inkjet printing of sensor-dot arrays on an anodized aluminum (AA) substrate has been developed for unsteady flow measurements. A bi-luminophore AA-PSP, which is a combination of PSP and temperature-sensitive paint (TSP), is essential for precise pressure measurements, because the PSP result needs the temperature correction. However, a conventional bi-luminophore AA-PSP prepared by a dipping method does not work well due to the interference between the PSP and TSP luminophores. To overcome this problem, we have developed isolated dot arrays of PSP and TSP formed on an anodized aluminum substrate by an inkjet printing method. In this study, platinum tetrakis (pentafluorophenyl) porphyrin (PtTFPP) and ZnS-AgInS2 (ZAIS) were employed as pressure- and temperature-sensitive dyes, respectively. A suitable solvent was chosen for each dye to form the dots with uniform, high luminescence intensity, and high sensitivity. The developed bi-luminophore AA-PSP could simultaneously measure pressure and temperature and could reduce the temperature effect of the PSP from -0.97%/K (without temperature correction) to -0.01%/K (with temperature correction). It showed a pressure response time of 17.8 +/- 0.8 mu s at 90% pressure rise to a step change of pressure, which is in the same range as a conventional AA-PSP.	[Egami, Y.; Ueyama, J.; Furukawa, S.] Aichi Inst Technol, Dept Mech Engn, Toyota, Aichi 4700392, Japan; [Kameya, T.] Toba Coll, Natl Inst Technol, Dept Elect Mech Engn, Toba, Mie 5178501, Japan; [Matsuda, Y.; Yamaguchi, H.; Niimi, T.] Nagoya Univ, Dept Micronano Syst Engn, Nagoya, Aichi 4648603, Japan	Egami, Y (reprint author), Aichi Inst Technol, Dept Mech Engn, 1247 Yachigusa, Toyota, Aichi 4700392, Japan.	egami@aitech.ac.jp			JKA; AUTO RACE	The authors would like to thank Kazutaka Kitagawa and Taiga Okuya for their support during wind tunnel testing. This work was partly supported by JKA and its promotion funds from AUTO RACE.	Deegan RD, 1997, NATURE, V389, P827, DOI 10.1038/39827; Kameya T, 2014, SENSOR ACTUAT B-CHEM, V190, P70, DOI 10.1016/j.snb.2013.08.011; Matsuda Y, 2013, SENSOR ACTUAT B-CHEM, V176, P505, DOI 10.1016/j.snb.2012.09.005; Bell JH, 2001, ANNU REV FLUID MECH, V33, P155, DOI 10.1146/annurev.fluid.33.1.155; Gregory JW, 2014, ANNU REV FLUID MECH, V46, P303, DOI 10.1146/annurev-fluid-010313-141304; Torimoto T, 2007, J AM CHEM SOC, V129, P12388, DOI 10.1021/ja0750470; Torimoto T, 2010, CHEM COMMUN, V46, P2082, DOI 10.1039/b924186h; Fujii S, 2013, 51 AIAA AER SCI M IN, P1023; Kameda M, 2012, T JAPAN SOC MECH E B, V78, P1942; Lee SK, 1997, ANAL COMMUN, V34, P185, DOI 10.1039/a701130j; Liu T, 2005, PRESSURE TEMPERATURE; Matsuda Y, 2012, T JPN SOC MECH ENG-B, V78, P1260; Sakaue H, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1988007; Yamada Y, 2013, 44 AIAA THERM C SAN, P2899	14	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	JUN	2015	26	6							064004	10.1088/0957-0233/26/6/064004		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI4VR	WOS:000354752500005		
J	Okamoto, K				Okamoto, Koji			The 16th International Symposium on Flow Visualization (ISFV16)	MEASUREMENT SCIENCE & TECHNOLOGY			English	Editorial Material									Univ Tokyo, Chair ISFV16, Bunkyo Ku, Tokyo 1138654, Japan	Okamoto, K (reprint author), Univ Tokyo, Chair ISFV16, Bunkyo Ku, Tokyo 1138654, Japan.	okamoto@n.t.u-tokyo.ac.jp						0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	JUN	2015	26	6							060201	10.1088/0957-0233/26/6/060201		1	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI4VR	WOS:000354752500001		
J	Sakamura, Y; Suzuki, T; Kawabata, S				Sakamura, Y.; Suzuki, T.; Kawabata, S.			Development and characterization of a pressure-sensitive luminescent coating based on Pt(II)-porphyrin self-assembled monolayers	MEASUREMENT SCIENCE & TECHNOLOGY			English	Article						pressure-sensitive paint; self-assembled monolayer; flow visualization; micro-scale flow; porphyrin	MOLECULAR FILM; PAINTS; FLOWS	A pressure-sensitive luminescent coating (PSLC) applicable to the visualization of pressure distributions in micro-scale flow devices was developed. Pt(II)-porphyrin was synthesized and covalently attached to the surface of indium tin oxide (ITO) glass plates by a self-assembled monolayer (SAM) process. The UV-visible absorption spectrum, pressure and temperature sensitivities and photostability of the PSLC were then measured to characterize the developed PSLC. It was found that (a) the chemisorption of the porphyrin did not greatly perturb the molecular orbitals of the porphyrin responsible for its photophysics, (b) the pressure dependency of the luminescent intensity of the PSLC obeyed a power function curve and the pressure sensitivities at 273, 293, 313 and 333 K were obtained in the pressure range from 5 to 120 kPa, (c) the luminescent intensity of the PSLC almost linearly decreased with temperature and the temperature sensitivities at 5, 40, 100 and 120 kPa evaluated in the temperature range from 273 to 333 K were -0.67, -0.72, -0.75 and -0.78%/K, respectively and (d) the decrease in the luminescent intensity of the PSLC after a 30 min exposure to an excitation light was 1.23% of its initial intensity and much smaller than that of Pt(II)-porphyrin absorbed on a TLC (thin-layer chromatography) sheet.	[Sakamura, Y.; Suzuki, T.; Kawabata, S.] Toyama Prefectural Univ, Imizu, Toyama 9390398, Japan	Sakamura, Y (reprint author), Toyama Prefectural Univ, Imizu, Toyama 9390398, Japan.	sakamura@pu-toyama.ac.jp			JSPS KAKENHI [26420120]	The authors would like to express their sincere gratitude to H Sakaue, Y Iijima, K Morita and K Nakakita from JAXA for their support during the calibration tests. Comments given by M Oshima from Toyama Prefectural University have been a great help in preparing the manuscript. This work was supported by JSPS KAKENHI (Grant Number 26420120).	Matsuda Y, 2011, MICROFLUID NANOFLUID, V10, P165, DOI 10.1007/s10404-010-0664-6; Sakaue H, 2013, SENSOR ACTUAT A-PHYS, V199, P74, DOI 10.1016/j.sna.2013.04.040; Carroll BF, 1996, AIAA J, V34, P521, DOI 10.2514/3.13099; MANZ A, 1990, SENSOR ACTUAT B-CHEM, V1, P244, DOI 10.1016/0925-4005(90)80209-I; Efimov A, 2003, J PORPHYR PHTHALOCYA, V7, P610; Holmes-Smith AS, 2006, MEAS SCI TECHNOL, V17, P3328, DOI 10.1088/0957-0233/17/12/020; Huang C Y, 2002, MEMS 40 AIAA AER SCI; Isosomppi M, 2005, J MATER CHEM, V15, P4546, DOI 10.1039/b508941g; Kameya T, 2012, T JAPAN SOC MECH ENG, V78, P1327; Liu T, 2005, PRESSURE TEMPERATURE; Matsuda Y, 2007, EXP FLUIDS, V42, P543, DOI 10.1007/s00348-007-0259-5; Matsuda Y, 2009, EXP FLUIDS, V47, P1025, DOI 10.1007/s00348-009-0694-6; Milgrom L. R., 1997, COLORS LIFE INTRO CH; Nagai H, 2006, P 12 INT S FLOW VIS; Quinn MK, 2011, SENSORS-BASEL, V11, P11649, DOI 10.3390/s111211649; Sakaue H, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1988007; Ulman A., 1991, INTRO ULTRATHIN ORGA; Valeur B., 2002, MOL FLUORESCENCE; Veselov A, 2010, MEAS SCI TECHNOL, V21, DOI 10.1088/0957-0233/21/11/115205; Vincenti W G, 1975, INTRO PHYS GAS DYNAM, P77	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0957-0233	1361-6501		MEAS SCI TECHNOL	Meas. Sci. Technol.	JUN	2015	26	6							064002	10.1088/0957-0233/26/6/064002		8	Engineering, Multidisciplinary; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI4VR	WOS:000354752500003		
J	Yamazaki, J; Gilgien, M; Kleiven, S; Mcintosh, AS; Nachbauer, W; Muller, E; Bere, T; Bahr, R; Krosshaug, T				Yamazaki, Junya; Gilgien, Matthias; Kleiven, Svein; Mcintosh, Andrew S.; Nachbauer, Werner; Mueller, Erich; Bere, Tone; Bahr, Roald; Krosshaug, Tron			Analysis of a Severe Head Injury in World Cup Alpine Skiing	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						TRAUMATIC BRAIN INJURY; SKIING INJURY; ALPINE SKIING; HELMET; BIOMECHANICS; MODEL-BASED IMAGE MATCHING TECHNIQUE	VIDEO SEQUENCES; HELMET USE; SKIERS; SNOWBOARDERS; RISK; RECONSTRUCTION; MECHANISMS; MOTION; COHORT	Traumatic brain injury (TBI) is the leading cause of death in alpine skiing. It has been found that helmet use can reduce the incidence of head injuries between 15% and 60%. However, knowledge on optimal helmet performance criteria in World Cup alpine skiing is currently limited owing to the lack of biomechanical data from real crash situations. Purpose: This study aimed to estimate impact velocities in a severe TBI case in World Cup alpine skiing. Methods: Video sequences from a TBI case in World Cup alpine skiing were analyzed using a model-based image matching technique. Video sequences from four camera views were obtained in full high-definition (1080p) format. A three-dimensional model of the course was built based on accurate measurements of piste landmarks and matched to the background video footage using the animation software Poser 4. A trunk-neck-head model was used for tracking the skier's trajectory. Results: Immediately before head impact, the downward velocity component was estimated to be 8 m.s(-1). After impact, the upward velocity was 3 m.s(-1), whereas the velocity parallel to the slope surface was reduced from 33 m.s(-1) to 22 m.s(-1). The frontal plane angular velocity of the head changed from 80 radIsj1 left tilt immediately before impact to 20 rad.s(-1) right tilt immediately after impact. Conclusions: A unique combination of high-definition video footage and accurate measurements of landmarks in the slope made possible a high-quality analysis of head impact velocity in a severe TBI case. The estimates can provide crucial information on how to prevent TBI through helmet performance criteria and design.	[Yamazaki, Junya; Bahr, Roald; Krosshaug, Tron] Oslo Sports Trauma Res Ctr, Oslo, Norway; [Yamazaki, Junya] Tokyo Med & Dent Univ Hosp, Sch Med, Sect Orthoped Surg, Tokyo, Japan; [Gilgien, Matthias] Norwegian Sch Sport Sci, Dept Phys Performance, Oslo, Norway; [Kleiven, Svein] Royal Inst Technol, Stockholm, Sweden; [Mcintosh, Andrew S.] Federat Univ Australia, ACRISP, Ballarat, Vic, Australia; [Nachbauer, Werner] Univ Innsbruck, Dept Sport Sci, A-6020 Innsbruck, Austria; [Mueller, Erich] Salzburg Univ, Dept Sport & Exercise Sci, A-5020 Salzburg, Austria; [Bere, Tone] Aspetar Orthopaed & Sports Med Hosp, Doha, Qatar	Yamazaki, J (reprint author), 1-5-45 Yushima,Bunkyo Ku, Tokyo 1138519, Japan.	kuma-kuma@yd5.so-net.ne.jp			Royal Norwegian Ministry of Culture; South-Eastern Norway Regional Health Authority; International Olympic Committee; Norwegian Olympic Committee & Confederation of Sport; Norsk Tipping AS	The Oslo Sports Trauma Research Center has been established at the Norwegian School of Sport Sciences through generous grants from the Royal Norwegian Ministry of Culture, the South-Eastern Norway Regional Health Authority, the International Olympic Committee, the Norwegian Olympic Committee & Confederation of Sport, and Norsk Tipping AS.	Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Westin M, 2012, KNEE SURG SPORT TR A, V20, P1175, DOI 10.1007/s00167-012-1921-x; Sulheim S, 2006, JAMA-J AM MED ASSOC, V295, P919, DOI 10.1001/jama.295.8.919; Krosshaug T, 2005, J BIOMECH, V38, P919, DOI 10.1016/j.jbiomech.2004.04.033; Koga H, 2010, AM J SPORT MED, V38, P2218, DOI 10.1177/0363546510373570; Krosshaug T, 2007, SCAND J MED SCI SPOR, V17, P508, DOI 10.1111/j.1600-0838.2006.00558.x; Florenes TW, 2009, BRIT J SPORT MED, V43, P973, DOI 10.1136/bjsm.2009.068759; Ruedl G, 2011, WILD ENVIRON MED, V22, P326, DOI 10.1016/j.wem.2011.06.008; Bere T, 2014, BRIT J SPORT MED, V48, P36, DOI 10.1136/bjsports-2013-092206; Chinn B., 2001, COST 327 MOTORCYCLE; Ekeland A, 2006, SKI TRAU SAF, V16, P1; Fauve M, 2002, PREPARATION MAINTENA, P134; FURRER M, 1995, J TRAUMA, V39, P737, DOI 10.1097/00005373-199510000-00024; Gilgien M, 2014, BRIT J SPORT MED, V48, P742, DOI 10.1136/bjsports-2013-092994; Gilgien M., 2014, THESIS NORWEGIAN SCH; Gilgien M, 2014, J SPORTS SC IN PRESS; Gilgien M, 2013, SENSORS-BASEL, V13, P9821, DOI 10.3390/s130809821; Hagel B, 2005, ACCIDENT ANAL PREV, V37, P103, DOI 10.1016/j.aap.2004.04.003; International Ski Federation, 2013, SPEC COMP EQ COMM MA; Koehle MS, 2002, SPORTS MED, V32, P785, DOI 10.2165/00007256-200232120-00003; McIntosh AS, 2011, BRIT J SPORT MED, V45, P1258, DOI 10.1136/bjsports-2011-090509; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; McIntosh AS, 2012, P I MECH ENG P-J SPO, V226, P193, DOI 10.1177/1754337111431024; Russell K, 2010, CAN MED ASSOC J, V182, P333, DOI 10.1503/cmaj.091080; Steenstrup SE, 2014, BRIT J SPORT MED, V48, P41, DOI 10.1136/bjsports-2013-093145; Wolfsperger F, 2013, 6 INT C SCI SKIING	26	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2015	47	6					1113	1118		10.1249/MSS.0000000000000511		6	Sport Sciences	Sport Sciences	CI4TC	WOS:000354745500002		
J	Sugiyama, T; Shibata, A; Koohsari, MJ; Tanamas, SK; Oka, K; Salmon, J; Dunstan, DW; Owen, N				Sugiyama, Takemi; Shibata, Ai; Koohsari, Mohammad J.; Tanamas, Stephanie K.; Oka, Koichiro; Salmon, Jo; Dunstan, David W.; Owen, Neville			Neighborhood Environmental Attributes and Adults' Maintenance of Regular Walking	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						PHYSICAL ACTIVITY; ADHERENCE; CROSS-SECTIONAL STUDIES; PROSPECTIVE STUDIES	PHYSICAL-ACTIVITY; BUILT ENVIRONMENT; OLDER-ADULTS; RECREATIONAL WALKING; PUBLIC-HEALTH; LIFE-STYLE; ASSOCIATIONS; OBESITY; CRIME; ATHEROSCLEROSIS	Purpose: Environmental initiatives to support walking are keys to noncommunicable disease prevention, but the relevant evidence comes mainly from cross-sectional studies. We examined neighborhood environmental attributes associated cross-sectionally with walking and those associated prospectively with walking maintenance. Methods: Data were from the Australian Diabetes, Obesity and Lifestyle study collected in 2004-2005 (baseline) and in 2011-2012 (follow-up). Participants who did not move residence during the study period (n = 2684, age range: 30-77 yr at baseline) were categorized as regular walkers (walked five times per week or more) or not at baseline. Regular walkers were divided into those who stopped and those who maintained regular walking at follow-up. Regression analyses examined relationships of regular walking and walking maintenance with perceived attributes of neighborhood destinations and pedestrian environments. Results: Regular walking at baseline was significantly associated with availability of shops (odds ratio [OR] = 1.13, 95% confidence interval [CI] = 1.04-1.22), many alternative routes (OR = 1.12, 95% CI = 1.01-1.23), park or nature reserve (OR = 1.13, 95% CI = 1.02-1.26), bicycle or walking tracks (OR = 1.08, 95% CI = 1.00-1.17), and feeling safe to walk (OR = 1.18, 95% CI = 1.01-1.38). Maintenance of regular walking was associated with the availability of multiple alternative routes (OR = 1.19, 95% CI = 1.03-1.38). Having many alternative routes and walking tracks was associated with walking maintenance among those who were not or had stopped working. Conclusions: Neighborhood destinations (shops and parks) and pedestrian environments (alternative routes, walking trails, and safety from crime) were found to be associated with regular walking, but only pedestrian environment attributes were found to be related to the maintenance of regular walking. Further evidence from prospective studies is required to identify other neighborhood environmental attributes that might support walking maintenance.	[Sugiyama, Takemi] Univ S Australia, Sch Populat Hlth, Adelaide, SA 5001, Australia; [Sugiyama, Takemi; Shibata, Ai; Koohsari, Mohammad J.; Tanamas, Stephanie K.; Oka, Koichiro; Dunstan, David W.; Owen, Neville] Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia; [Shibata, Ai] Univ Tsukuba, Fac Hlth & Sport Sci, Tsukuba, Ibaraki, Japan; [Koohsari, Mohammad J.; Owen, Neville] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Vic, Australia; [Oka, Koichiro] Waseda Univ, Sch Sport Sci, Tokyo, Japan; [Salmon, Jo; Dunstan, David W.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, Vic, Australia; [Dunstan, David W.; Owen, Neville] Univ Queensland, Sch Populat Hlth, Brisbane, Qld, Australia; [Dunstan, David W.] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia; [Dunstan, David W.] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Owen, Neville] Monash Univ, Cent Clin Sch, Melbourne, Vic 3004, Australia	Owen, N (reprint author), Baker IDI Heart & Diabet Inst, Behav Epidemiol Lab, 99 Commercial Rd, Melbourne, Vic 3004, Australia.	neville.owen@bakeridi.edu.au	Koohsari, Mohammad Javad/O-3530-2015	Koohsari, Mohammad Javad/0000-0001-9384-5456	National Health and Medical Research Council (NHMRC) [233200, 1007544]; Australian Government Department of Health and Ageing; Abbott Australasia Pty Ltd.; Alphapharm Pty Ltd.; Amgen Australia; AstraZeneca; Bristol-Myers Squibb; City Health Centre - Diabetes Service - Canberra; Department of Health and Community Services - Northern Territory; Department of Health and Human Services - Tasmania; Department of Health - New South Wales; Department of Health - Western Australia; Department of Health - South Australia; Department of Human Services - Victoria; Diabetes Australia; Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline; Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian FH Flack Trust; Menzies Research Institute; Merck Sharp Dohme; Novartis Pharmaceuticals; Novo Nordisk Pharmaceuticals; Pfizer Pty Ltd.; Pratt Foundation; Queensland Health; Roche Diagnostics Australia; Royal Prince Alfred Hospital, Sydney; Sanofi Aventis; sanofi-synthelabo; NHMRC [569940, 1026216, 1003960]; Australian Research Council Future Fellowship; Victorian Government's Operational Infrastructure Support Program	The AusDiab study was co-coordinated by the Baker IDI Heart and Diabetes Institute. We gratefully acknowledge the support and assistance given by: K. Anstey, B. Atkins, B. Balkau, E. Barr, A. Cameron, S. Chadban, M. de Courten, A. Kavanagh, D. Magliano, S. Murray, K. Polkinghorne, J. Shaw, T. Welborn, P. Zimmet, and all the study participants. For funding or logistical support, the authors thank the National Health and Medical Research Council (NHMRC; nos. 233200 and 1007544), Australian Government Department of Health and Ageing, Abbott Australasia Pty Ltd., Alphapharm Pty Ltd., Amgen Australia, AstraZeneca, Bristol-Myers Squibb, City Health Centre - Diabetes Service - Canberra, Department of Health and Community Services - Northern Territory, Department of Health and Human Services - Tasmania, Department of Health - New South Wales, Department of Health - Western Australia, Department of Health - South Australia, Department of Human Services - Victoria, Diabetes Australia, Diabetes Australia Northern Territory, Eli Lilly Australia, Estate of the Late Edward Wilson, GlaxoSmithKline, Jack Brockhoff Foundation, Janssen-Cilag, Kidney Health Australia, Marian & FH Flack Trust, Menzies Research Institute, Merck Sharp & Dohme, Novartis Pharmaceuticals, Novo Nordisk Pharmaceuticals, Pfizer Pty Ltd., Pratt Foundation, Queensland Health, Roche Diagnostics Australia, Royal Prince Alfred Hospital, Sydney, Sanofi Aventis, and sanofi-synthelabo. M. J. K. was supported by NHMRC Program Grant no. 569940. J. S. was supported by NHMRC Principal Research Fellowship no. 1026216. D.W.D. was supported by Australian Research Council Future Fellowship. N.O. was supported by NHMRC Program Grant no. 569940 and NHMRC Senior Principal Research Fellowship no. 1003960. Authors from Baker IDI Heart and Diabetes Institute were supported by the Victorian Government's Operational Infrastructure Support Program.	Saelens BE, 2003, ANN BEHAV MED, V25, P80, DOI 10.1207/S15324796ABM2502_03; Saelens BE, 2008, MED SCI SPORT EXER, V40, pS550, DOI [10.1249/MSS.0b013e31817c67a4, 10.1249/MSS.0b013e31817e67a4]; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Merom D, 2010, AM J PREV MED, V39, P113, DOI 10.1016/j.amepre.2010.04.007; Sugiyama T, 2012, MED SCI SPORT EXER, V44, P1275, DOI 10.1249/MSS.0b013e318247d286; Owen N, 2004, AM J PREV MED, V27, P67, DOI 10.1016/j.amepre.2004.03.006; Thorp AA, 2010, DIABETES CARE, V33, P327, DOI 10.2337/dc09-0493; Lee IM, 2008, MED SCI SPORT EXER, V40, pS512, DOI 10.1249/MSS.0b013e31817c65d0; Rzewnicki R, 2003, PUBLIC HEALTH NUTR, V6, P299, DOI 10.1079/PHN2002427; Li FZ, 2005, J EPIDEMIOL COMMUN H, V59, P558, DOI 10.1136/jech.2004.028399; Forsyth A, 2009, TRANSPORT RES D-TR E, V14, P42, DOI 10.1016/j.trd.2008.10.003; Sugiyama T, 2013, PREV MED, V57, P178, DOI 10.1016/j.ypmed.2013.05.015; Murtagh EM, 2010, CURR OPIN CARDIOL, V25, P490, DOI 10.1097/HCO.0b013e32833ce972; Sugiyama T, 2014, HEALTH PLACE, V28, P22, DOI 10.1016/j.healthplace.2014.03.003; Frank LD, 2007, SOC SCI MED, V65, P1898, DOI 10.1016/j.soescimed.2007.05.053; Marshall WE, 2010, TRANSP RES RECORD, P103, DOI 10.3141/2198-12; Dunstan DW, 2002, DIABETES RES CLIN PR, V57, P119, DOI 10.1016/S0168-8227(02)00025-6; Fitzhugh EC, 2010, AM J PREV MED, V39, P259, DOI 10.1016/j.amepre.2010.05.010; Conroy DE, 2010, ANN BEHAV MED, V39, P112, DOI 10.1007/s12160-010-9161-0; Stessman J, 2009, ARCH INTERN MED, V169, P1476, DOI 10.1001/archinternmed.2009.248; Kruger J, 2008, PREV MED, V47, P329, DOI 10.1016/j.ypmed.2008.02.018; Foster S, 2008, PREV MED, V47, P241, DOI 10.1016/j.ypmed.2008.03.017; Armstrong T, 2000, PHYS ACTIVITY PATTER; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV US G; Brown WJ, 2008, AUST NZ J PUBL HEAL, V32, P535, DOI 10.1111/j.1753-6405.2008.00305.x; Evenson KR, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-146; Gauvin L, 2012, J GERONTOL B-PSYCHOL, V67, P76, DOI 10.1093/geronb/gbr134; Li FZ, 2005, J AGING PHYS ACTIV, V13, P145; Mason P, 2013, SOC SCI MED, V91, P15, DOI 10.1016/j.socscimed.2013.04.011; McCormack GR, 2008, PREV MED, V46, P33, DOI 10.1016/j.ypmed.2007.01.013; Nathan A, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-133; Ranchod YK, 2014, AM J EPIDEMIOL, V179, P335, DOI 10.1093/aje/kwt263; Sallis J. F., 2008, HLTH BEHAV HLTH ED T, P465, DOI DOI 10.1016/J.YPMED.2004.04.002; Van Holle V, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-807; West ST, 2011, J PHYS ACT HEALTH, V8, P1092; Wilson Lee-Ann M, 2011, Am J Health Promot, V25, pe12, DOI 10.4278/ajhp.090421-QUAN-144	36	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUN	2015	47	6					1204	1210		10.1249/MSS.0000000000000528		7	Sport Sciences	Sport Sciences	CI4TC	WOS:000354745500013		
J	Robertson, IM; Sofronis, P; Nagao, A; Martin, ML; Wang, S; Gross, DW; Nygren, KE				Robertson, Ian M.; Sofronis, P.; Nagao, A.; Martin, M. L.; Wang, S.; Gross, D. W.; Nygren, K. E.			Hydrogen Embrittlement Understood	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							TRANSMISSION ELECTRON-MICROSCOPE; AUSTENITIC STAINLESS-STEEL; STRESS-CORROSION CRACKING; LATH MARTENSITIC STEEL; GRAIN-BOUNDARIES; DISLOCATION INTERACTIONS; INTERGRANULAR FRACTURE; FCC METALS; NUMERICAL SIMULATIONS; INSITU DEFORMATION	The connection between hydrogen-enhanced plasticity and the hydrogen-induced fracture mechanism and pathway is established through examination of the evolved microstructural state immediately beneath fracture surfaces including voids, "quasi-cleavage," and intergranular surfaces. This leads to a new understanding of hydrogen embrittlement in which hydrogen-enhanced plasticity processes accelerate the evolution of the microstructure, which establishes not only local high concentrations of hydrogen but also a local stress state. Together, these factors establish the fracture mechanism and pathway.	[Robertson, Ian M.] Univ Wisconsin, Coll Engn, Madison, WI 53706 USA; [Robertson, Ian M.] Univ Wisconsin, Dept Mat Sci & Engn, Madison, WI 53706 USA; [Robertson, Ian M.] Univ Wisconsin, Dept Engn Phys, Madison, WI 53706 USA; [Robertson, Ian M.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Nishi Ku, Fukuoka, Fukuoka 8190395, Japan; [Sofronis, P.; Gross, D. W.; Nygren, K. E.] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Sofronis, P.; Nagao, A.; Wang, S.] Kyushu Univ, Int Inst Carbon Neutral Energy Res WPI I2CNER, Fukuoka, Fukuoka 8190395, Japan; [Nagao, A.] JFE Steel Corp, Steel Res Lab, Mat Surface & Interface Sci Res Dept, Kawasaki Ku, Kawasaki, Kanagawa 2100855, Japan; [Martin, M. L.] Univ Gottingen, Inst Mat Phys, D-37077 Gottingen, Germany; [Wang, S.] Hokkaido Univ, Grad Sch Engn, Div Mat Sci & Engn, Sapporo, Hokkaido 0608628, Japan	Robertson, IM (reprint author), Univ Wisconsin, Coll Engn, Madison, WI 53706 USA.	Ian.Robertson@wisc.edu			Department of Energy, Office of Science, Basic Energy Sciences [ACO9-76EROll98]; Department of Energy, Energy Efficiency and Renewable Energy [GO15045]; International Institute for Carbon-Neutral Energy Research (WPI-I2CNER) - World Premier International Research Center Initiative (WPI), MEXT, Japan; National Science Foundation [CMMI-1406462]	This manuscript is the results of decades of work by many students and post-docs who were part of the Illinois group. They are too many to name but they know who they are; it was a pleasure to work with all of them. They will understand when this manuscript is dedicated to three of the team: Howard Birnbaum, Teizo Tabata, and Keith Tappin. The work would not have been possible without the support from the Department of Energy, Office of Science, Basic Energy Sciences (Contract No. ACO9-76EROll98); Department of Energy, Energy Efficiency and Renewable Energy (Grant GO15045); International Institute for Carbon-Neutral Energy Research (WPI-I2CNER), sponsored by the World Premier International Research Center Initiative (WPI), MEXT, Japan, and, finally, the National Science Foundation, through Award No. CMMI-1406462 (IMR).	Solanki KN, 2013, METALL MATER TRANS A, V44A, P1365, DOI 10.1007/s11661-012-1430-z; Keller C, 2010, MECH MATER, V42, P44, DOI 10.1016/j.mechmat.2009.09.002; Cui B, 2014, ACTA MATER, V65, P150, DOI 10.1016/j.actamat.2013.11.033; WESTLAKE DG, 1968, J NUCL MATER, V26, P208, DOI 10.1016/0022-3115(68)90072-X; TABATA T, 1983, SCRIPTA METALL MATER, V17, P947, DOI 10.1016/0036-9748(83)90268-5; Bechtle S, 2009, ACTA MATER, V57, P4148, DOI 10.1016/j.actamat.2009.05.012; Song J, 2013, NAT MATER, V12, P145, DOI [10.1038/nmat3479, 10.1038/NMAT3479]; LEE TC, 1990, METALL TRANS A, V21, P2437, DOI 10.1007/BF02646988; BOND GM, 1988, ACTA METALL MATER, V36, P2193, DOI 10.1016/0001-6160(88)90320-3; Chateau JP, 2002, ACTA MATER, V50, P1523, DOI 10.1016/S1359-6454(02)00009-5; Novak P, 2010, J MECH PHYS SOLIDS, V58, P206, DOI 10.1016/j.jmps.2009.10.005; Nagao A, 2012, ACTA MATER, V60, P5182, DOI 10.1016/j.actamat.2012.06.040; Kirchheim R, 2009, INT J MATER RES, V100, P483, DOI 10.3139/146.110065; McMahon CJ, 2001, ENG FRACT MECH, V68, P773, DOI 10.1016/S0013-7944(00)00124-7; Song J, 2011, ACTA MATER, V59, P1557, DOI 10.1016/j.actamat.2010.11.019; SOFRONIS P, 1995, J MECH PHYS SOLIDS, V43, P49, DOI 10.1016/0022-5096(94)00056-B; TETELMAN AS, 1963, ACTA METALL MATER, V11, P415, DOI 10.1016/0001-6160(63)90166-4; ELIEZER D, 1979, METALL TRANS A, V10, P935, DOI 10.1007/BF02658313; Gerberich W, 2012, WOODHEAD PUBL MATER, P209; Ramasubramaniam A, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.174101; Fukai Y, 2003, J ALLOY COMPD, V356, P263, DOI 10.1016/S0925-8388(02)01269-0; ORIANI RA, 1979, ACTA METALL MATER, V27, P997, DOI 10.1016/0001-6160(79)90187-1; LEE TC, 1990, PHILOS MAG A, V62, P131; Chateau JP, 2002, ACTA MATER, V50, P1507, DOI 10.1016/S1359-6454(02)00008-3; McMurtrey MD, 2014, INT J PLASTICITY, V56, P219, DOI 10.1016/j.ijplas.2014.01.001; Kacher J, 2012, ACTA MATER, V60, P6657, DOI 10.1016/j.actamat.2012.08.036; Nagao A, 2014, ACTA MATER, V74, P244, DOI 10.1016/j.actamat.2014.04.051; SIROIS E, 1992, ACTA METALL MATER, V40, P1377, DOI 10.1016/0956-7151(92)90438-K; DAW MS, 1983, PHYS REV LETT, V50, P1285, DOI 10.1103/PhysRevLett.50.1285; Nagumo M, 2004, MATER SCI TECH-LOND, V20, P940, DOI 10.1179/026708304225019687; LEE TC, 1991, REV SCI INSTRUM, V62, P1438, DOI 10.1063/1.1142464; Neeraj T, 2012, ACTA MATER, V60, P5160, DOI 10.1016/j.actamat.2012.06.014; Geng WT, 2005, MATER TRANS, V46, P756, DOI 10.2320/matertrans.46.756; OHR SM, 1985, MATER SCI ENG, V72, P1, DOI 10.1016/0025-5416(85)90064-3; Martin ML, 2012, ACTA MATER, V60, P2739, DOI 10.1016/j.actamat.2012.01.040; Martin ML, 2011, ACTA MATER, V59, P1601, DOI 10.1016/j.actamat.2010.11.024; ABRAHAM DP, 1995, METALL MATER TRANS A, V26, P2859, DOI 10.1007/BF02669644; TABATA T, 1984, SCRIPTA METALL MATER, V18, P231, DOI 10.1016/0036-9748(84)90513-1; Ghoniem NM, 2001, PHILOS MAG A, V81, P2743, DOI 10.1080/01418610110049725; NARITA N, 1982, METALL TRANS A, V13, P1355, DOI 10.1007/BF02642872; Ferreira PJ, 1998, ACTA MATER, V46, P1749, DOI 10.1016/S1359-6454(97)00349-2; Robertson IM, 2001, ENG FRACT MECH, V68, P671, DOI 10.1016/S0013-7944(01)00011-X; Srinivasan R, 2014, JOM-US, V66, P1377, DOI 10.1007/s11837-014-1054-4; Martin ML, 2011, ACTA MATER, V59, P3680, DOI 10.1016/j.actamat.2011.03.002; BEACHEM CD, 1972, METALL TRANS, V3, P437; ROZENAK P, 1990, ACTA METALL MATER, V38, P2031, DOI 10.1016/0956-7151(90)90070-W; Doshida T, 2013, ACTA MATER, V61, P7755, DOI 10.1016/j.actamat.2013.09.015; Luo J, 2011, SCIENCE, V333, P1730, DOI 10.1126/science.1208774; ULMER DG, 1993, ACTA METALL MATER, V41, P2235, DOI 10.1016/0956-7151(93)90393-7; Wang S, 2014, ACTA MATER, V69, P275, DOI 10.1016/j.actamat.2014.01.060; PLIMPTON S, 1995, J COMPUT PHYS, V117, P1, DOI 10.1006/jcph.1995.1039; Lynch S, 2012, CORROS REV, V30, P105, DOI 10.1515/corrrev-2012-0502; Hughes DA, 2003, PHILOS MAG, V83, P3871, DOI 10.1080/14786430310001605560; Aravas N., 2014, PRIVATE COMMUNICATIO; Bailat C, 2000, J NUCL MATER, V276, P283, DOI 10.1016/S0022-3115(99)00222-6; Baluc N., 1999, P 20 RISO INT S MAT, P245; BAMFORD TA, 1986, SCRIPTA METALL MATER, V20, P253, DOI 10.1016/0036-9748(86)90137-7; BARANOWS.B, 1972, BERICH BUNSEN GESELL, V76, P714; BIRNBAUM HK, 1994, MAT SCI ENG A-STRUCT, V176, P191, DOI 10.1016/0921-5093(94)90975-X; BIRNBAUM HK, 1984, J LESS-COMMON MET, V104, P31, DOI 10.1016/0022-5088(84)90433-8; BOND GM, 1986, SCRIPTA METALL MATER, V20, P653, DOI 10.1016/0036-9748(86)90484-9; BOND GM, 1987, ACTA METALL MATER, V35, P2289, DOI 10.1016/0001-6160(87)90076-9; BOND GM, 1989, ACTA METALL MATER, V37, P1407, DOI 10.1016/0001-6160(89)90172-7; Chassagne M, 2011, ACTA MATER, V59, P1456, DOI 10.1016/j.actamat.2010.11.007; CHEN X, 1990, ENG FRACT MECH, V35, P997, DOI 10.1016/0013-7944(90)90128-4; CLARK WAT, 1992, SCRIPTA METALL MATER, V26, P203, DOI 10.1016/0956-716X(92)90173-C; Cui B, 2014, PHILOS MAG, V94, P4197, DOI 10.1080/14786435.2014.982744; Dadfarnia M, 2009, J PRESS VESS-T ASME, V131, DOI 10.1115/1.3027497; DEWALD DK, 1990, METALL TRANS A, V21, P2411, DOI 10.1007/BF02646985; Fenske JA, 2012, METALL MATER TRANS A, V43A, P3011, DOI 10.1007/s11661-012-1129-1; Ferreira P. J., 1996, HYDROGEN EFFECTS CRY; FOILES SM, 1986, PHYS REV B, V33, P7983, DOI 10.1103/PhysRevB.33.7983; Gangloff R. P., 2009, P 2008 INT HYDR C EF, P1; Gangloff RP, 2012, GASEOUS HYDROGEN EMB; George E. P., 1995, REV ENV EFFECTS INTE; Gerberich W., 2012, GASEOUS HYDROGEN EMB, V1, P209; Gross DW, 2013, ACTA MATER, V61, P5768, DOI 10.1016/j.actamat.2013.06.020; HOBSON JD, 1953, J IRON STEEL I, V173, P131; HORTON JA, 1982, SCRIPTA METALL MATER, V16, P621, DOI 10.1016/0036-9748(82)90283-6; Hughes DA, 2002, SCRIPTA MATER, V47, P697, DOI 10.1016/S1359-6462(02)00186-0; JOHN CS, 1973, METALL TRANS, V4, P589, DOI 10.1007/BF02648714; Johnson W. H., 1875, P ROY SOC LONDON, V23, P168; Kacher J, 2014, PHILOS MAG, V94, P814, DOI 10.1080/14786435.2013.868942; Kacher J, 2014, CURR OPIN SOLID ST M, V18, P227, DOI 10.1016/j.cossms.2014.05.004; Kacher J. P., 2012, QUASI 4 DIMENSIONAL; Kazinczy F. D., 1954, J IRON STEEL I, V177, P85; LASSILA DH, 1987, ACTA METALL MATER, V35, P1815, DOI 10.1016/0001-6160(87)90127-1; LEE TC, 1989, ACTA METALL MATER, V37, P407, DOI 10.1016/0001-6160(89)90225-3; Liang Y, 2008, MECH MATER, V40, P115, DOI 10.1016/j.mechmat.2007.07.001; LIN JK, 1983, ACTA METALL MATER, V31, P1071, DOI 10.1016/0001-6160(83)90203-1; Liu XY, 2008, MAT SCI ENG A-STRUCT, V492, P218, DOI 10.1016/j.msea.2008.03.012; Martin ML, 2012, J NUCL MATER, V426, P71, DOI 10.1016/j.jnucmat.2012.03.040; Martin ML, 2013, INT J FATIGUE, V57, P28, DOI 10.1016/j.ijfatigue.2012.08.009; McMahon CJ, 2004, INTERFACE SCI, V12, P141; Nagao A., 2015, ENCY IRON STEEL THEI; Nagumo M., 2007, ZAIR KANKYO, V56, P382, DOI 10.3323/jcorr.56.382; Nagumo M., 2007, ZAIR KANKYO, V56, P343, DOI 10.3323/jcorr.56.343; Nagumo M, 2001, ISIJ INT, V41, P590, DOI 10.2355/isijinternational.41.590; OHR SM, 1986, SCRIPTA METALL MATER, V20, P1501, DOI 10.1016/0036-9748(86)90383-2; Oriani R. A., 1972, MECH THEORY HYDROGEN; ORIANI RA, 1979, SCRIPTA METALL MATER, V13, P469, DOI 10.1016/0036-9748(79)90071-1; ORIANI RA, 1987, CORROSION, V43, P390; PETCH NJ, 1956, PHILOS MAG, V1, P331, DOI 10.1080/14786435608238106; Robertson I. M., 2009, DISLOCATIONS SOLIDS, V19, P249; ROBERTSON IM, 1986, ACTA METALL MATER, V34, P353, DOI 10.1016/0001-6160(86)90071-4; SHEN Z, 1988, ACTA METALL MATER, V36, P3231, DOI 10.1016/0001-6160(88)90058-2; SHIH DS, 1988, ACTA METALL MATER, V36, P111, DOI 10.1016/0001-6160(88)90032-6; SHIN KS, 1983, ACTA METALL MATER, V31, P1559, DOI 10.1016/0001-6160(83)90153-0; Skipper C., 2008, EFFECT INTERNAL HYDR, P139; Somerday B. P., 2013, HYDROGEN MAT INTERAC; Tabata T., 1984, UNPUB; THOMSON RM, 1987, J PHYS CHEM SOLIDS, V48, P965, DOI 10.1016/0022-3697(87)90114-4; Troiano A, 1960, T AM SOC MET, V52, P54; TROMANS D, 1994, ACTA METALL MATER, V42, P2043, DOI 10.1016/0956-7151(94)90029-9; von Pezold J, 2011, ACTA MATER, V59, P2969, DOI 10.1016/j.actamat.2011.01.037; Wang S, 2013, ACTA MATER, V61, P4734, DOI 10.1016/j.actamat.2013.05.007; Wang S., 2015, UNPUB; Zapffe CA, 1941, T AM I MIN MET ENG, V145, P225	118	2	2	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	JUN	2015	46	3					1085	1103		10.1007/s11663-015-0325-y		19	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CI4JZ	WOS:000354715800001		
J	Wu, ZH; Zheng, W; Li, GQ; Matsuura, H; Tsukihashi, F				Wu, Zhenhua; Zheng, Wan; Li, Guangqiang; Matsuura, Hiroyuki; Tsukihashi, Fumitaka			Effect of Inclusions' Behavior on the Microstructure in Al-Ti Deoxidized and Magnesium-Treated Steel with Different Aluminum Contents	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							INTRAGRANULAR ACICULAR FERRITE; HYDROGEN-INDUCED CRACKING; HEAT-AFFECTED ZONE; C-MN STEEL; NONMETALLIC INCLUSIONS; FE-10MASS-PERCENT-NI ALLOY; COMPLEX DEOXIDATION; MECHANICAL-PROPERTIES; PIPELINE STEELS; SULFIDE SHAPE	To clarify the precipitation behavior of beneficial inclusions and mechanism of their effects on microstructure, the effect of aluminum content on inclusion's characteristics and their influence on the refinement of microstructure in Al-Ti complex deoxidized magnesium-treated steels were systematically investigated based on experiment and calculation. The results showed that due to the dual effects of Ti and Mg deoxidation, a large amount of finely dispersed Al2O3-TiO (x) -MgO inclusions in low aluminum steel with a complex multilayer or mosaic structure were formed, whereas a relatively smaller amount of Al2O3-MgO inclusions with the simple bundle structure were observed in high aluminum steel. The Al2O3-TiO (x) -MgO core oxides are more conducive to the precipitation of multiple manganese sulfides with thinner thickness on their local surfaces. Thus, the inclusion deformation, which mainly depends on the surface manganese sulfides layer, is smaller in low aluminum steel than that in high aluminum steel. Complex inclusions in low aluminum steel can pin austenite grain boundaries and induce interlocking acicular ferrite effectively. In addition to the small size and chemical composition of inclusions, the complex structure of oxides and the precipitation of multiple MnS on their surface are important to the nucleation of interlocking AFs on inclusions in Ti-deoxidized Mg-treated steel. The AFs quantity is much more, and the grain size is more uniform in low aluminum steel than that in high aluminum steel.	[Wu, Zhenhua; Zheng, Wan; Li, Guangqiang] Wuhan Univ Sci & Technol, State Kay Lab Refractories & Met, Wuhan 430081, Peoples R China; [Wu, Zhenhua; Zheng, Wan; Li, Guangqiang] Wuhan Univ Sci & Technol, Minist Educ, Key Lab Ferrous Met & Resources Utilizat, Wuhan 430081, Peoples R China; [Li, Guangqiang] Hubei Collaborat Innovat Ctr Adv Steels, Wuhan 430081, Peoples R China; [Matsuura, Hiroyuki; Tsukihashi, Fumitaka] Univ Tokyo, Grad Sch Frontier Sci, Dept Adv Mat Sci, Chiba 2778561, Japan	Li, GQ (reprint author), Wuhan Univ Sci & Technol, State Kay Lab Refractories & Met, Wuhan 430081, Peoples R China.	liguangqiang@wust.edu.cn			National Natural Science Foundation of China [51210007, 51104109]; Hubei province Natural Science Fund [2008CDA010]; Foundation of Key Laboratory for Ferrous Metallurgy and Resources Utilization of Ministry of Education [FMRU201201]; Wuhan University of Science and Technology	The authors wish to express their appreciation to the National Natural Science Foundation of China (Grant No. 51210007, No. 51104109), Hubei province Natural Science Fund (2008CDA010) and the Foundation of Key Laboratory for Ferrous Metallurgy and Resources Utilization of Ministry of Education (FMRU201201), Wuhan University of Science and Technology for providing financial support which enabled this study to be carried out.	Fassina P, 2013, ENG FRACT MECH, V103, P10, DOI 10.1016/j.engfracmech.2012.09.023; Sun MK, 2008, MET MATER INT, V14, P791, DOI 10.3365/met.mat.2008.12.791; Enomoto M, 1998, MET MATER-KOREA, V4, P115; Chai F, 2009, J IRON STEEL RES INT, V16, P69, DOI 10.1016/S1006-706X(09)60013-3; Xiao GH, 2011, J IRON STEEL RES INT, V18, P58, DOI 10.1016/S1006-706X(11)60105-2; Kimura S, 2001, METALL MATER TRANS B, V32, P79, DOI 10.1007/s11663-001-0010-1; Ohta H, 2006, ISIJ INT, V46, P14, DOI 10.2355/isijinternational.46.14; Zhuo XJ, 2010, J IRON STEEL RES INT, V17, P10, DOI 10.1016/S1006-706X(10)60051-9; Zheng W, 2014, ISIJ INT, V54, P1755, DOI 10.2355/isijinternational.54.1755; Medina SF, 1999, ISIJ INT, V39, P930, DOI 10.2355/isijinternational.39.930; Verma N, 2012, METALL MATER TRANS B, V43, P830, DOI 10.1007/s11663-012-9660-4; Verma N, 2011, METALL MATER TRANS B, V42, P711, DOI 10.1007/s11663-011-9516-3; Kim HS, 2005, SCRIPTA MATER, V53, P1253, DOI 10.1016/j.scriptamat.2005.08.001; BRAMFITT BL, 1970, METALL TRANS, V1, P1987, DOI 10.1007/BF02642799; Wang C, 2009, METALL MATER TRANS B, V40, P1022, DOI 10.1007/s11663-009-9290-7; Byun JS, 2003, ACTA MATER, V51, P1593, DOI 10.1016/S1359-6454(02)00560-8; Cheng L, 2009, ACTA MATER, V57, P3754, DOI 10.1016/j.actamat.2009.04.045; Ohta H, 2006, ISIJ INT, V46, P480, DOI 10.2355/isijinternational.46.480; Wang C, 2009, METALL MATER TRANS B, V40, P1005, DOI 10.1007/s11663-009-9267-6; Sung HK, 2011, MAT SCI ENG A-STRUCT, V528, P3350, DOI 10.1016/j.msea.2011.01.031; Seo JD, 2000, STEEL RES, V71, P101; Jin TY, 2010, INT J HYDROGEN ENERG, V35, P8014, DOI 10.1016/j.ijhydene.2010.05.089; Xue HB, 2011, CORROS SCI, V53, P1201, DOI 10.1016/j.corsci.2010.12.011; Zhang D, 2010, ACTA MATER, V58, P1369, DOI 10.1016/j.actamat.2009.10.043; Fattahi M, 2013, MICRON, V45, P107, DOI 10.1016/j.micron.2012.11.004; Beidokhti B, 2009, J MATER PROCESS TECH, V209, P4027, DOI 10.1016/j.jmatprotec.2008.09.021; Enno Z., 2012, ISIJ INT, V52, P52; FAULRING GM, 1980, METALL TRANS B, V11, P125, DOI 10.1007/BF02657181; Gatellier D.C., 1984, TETSU TO HAGANE, V70, pS872; Genichi S., 2001, TETSU TO HAGANE, V87, P93; Guan Z.D., 1992, PHYSICAL PROPERTIES, V1st, P127; [胡春林 Hu Chunlin], 2013, [材料热处理学报, Transactions of Materials and Heat Treatment], V34, P37; Huang F, 2010, MAT SCI ENG A-STRUCT, V527, P6997, DOI 10.1016/j.msea.2010.07.022; Juvonen P., 2004, THESIS HELSINKI U TE; Karasev AV, 2008, ISIJ INT, V48, P1507, DOI 10.2355/isijinternational.48.1507; Kaushik P, 2012, METALL MATER TRANS B, V43, P710, DOI 10.1007/s11663-012-9646-2; Kivio M, 2012, METALL MATER TRANS B, V43, P233, DOI 10.1007/s11663-011-9603-5; Kojima A., 2003, CAMP ISIJ, V16, P360; LEE JL, 1995, ISIJ INT, V35, P1027, DOI 10.2355/isijinternational.35.1027; Lind M, 2010, METALL MATER TRANS B, V41, P359, DOI 10.1007/s11663-009-9337-9; Liu C, 2013, SCI TECHNOL WELD JOI, V18, P169, DOI 10.1179/1362171812Y.0000000090; LUYCKX L, 1970, METALL TRANS, V1, P3341; MAITI R, 1985, J MATER ENG, V6, P242, DOI 10.1007/BF02833513; Mitsutaka H., 2010, THERMODYNAMIC DATA S, P1; Pan T, 2003, ACTA METALL SIN, V39, P1037; Park SC, 2004, ISIJ INT, V44, P1016, DOI 10.2355/isijinternational.44.1016; Piao R, 2013, ACTA MATER, V61, P683, DOI 10.1016/j.actamat.2012.10.018; Ren Y, 2014, METALL MATER TRANS B, V45, P2057, DOI 10.1007/s11663-014-0121-0; Takata R, 2007, ISIJ INT, V47, P1379, DOI 10.2355/isijinternational.47.1379; Yamamoto K, 2011, ISIJ INT, V51, P1987, DOI 10.2355/isijinternational.51.1987; [于庆波 Yu Qingbo], 2011, [机械工程学报, Chinese Journal of Mechanical Engineering], V47, P44; Zener C., 1948, T AIME, V175, P15; Zhang SH, 1996, ISIJ INT, V36, P1301, DOI 10.2355/isijinternational.36.1301; [赵辉 Zhao Hui], 2010, [钢铁, Iron and Steel], V45, P82; Zhu K, 2011, METALL MATER TRANS A, V42A, P2207, DOI 10.1007/s11661-011-0647-6	55	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	JUN	2015	46	3					1226	1241		10.1007/s11663-015-0311-4		16	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CI4JZ	WOS:000354715800015		
J	Unterweger, M; Johansson, L; Karam, L; Rodrigues, M; Yunoki, A				Unterweger, M.; Johansson, L.; Karam, L.; Rodrigues, M.; Yunoki, A.			Uncertainties in internal gas counting	METROLOGIA			English	Article						gas counting; uncertainties; metrology		The uncertainties in internal gas counting will be broken down into counting uncertainties and gas handling uncertainties. Counting statistics, spectrum analysis, and electronic uncertainties will be discussed with respect to the actual counting of the activity. The effects of the gas handling and quantities of counting and sample gases on the uncertainty in the determination of the activity will be included when describing the uncertainties arising in the sample preparation.	[Unterweger, M.; Karam, L.] NIST, Gaithersburg, MD 20899 USA; [Johansson, L.] Natl Phys Lab, Teddington TW11 0LW, Middx, England; [Rodrigues, M.] Lab Natl Henri Becquerel, Saclay, France; [Yunoki, A.] Natl Metrol Inst Japan, Tsukuba, Ibaraki, Japan	Unterweger, M (reprint author), NIST, Gaithersburg, MD 20899 USA.	michael.unterweger@nist.gov					Bouchard J, 2000, APPL RADIAT ISOTOPES, V52, P441, DOI 10.1016/S0969-8043(99)00192-X; Garfinkel S B, 1972, NUCL INSTRUM METHODS, V112, P59; Lansiart A, 1993, RAPPORT CEA; MAKEPEACE JL, 1994, NUCL INSTRUM METH A, V339, P343, DOI 10.1016/0168-9002(94)91829-5; Mann W B, 1973, NOBL GAS S LAS VEG N; Marouli M, 2010, APPL RADIAT ISOTOPES, V68, P1378, DOI 10.1016/j.apradiso.2009.11.014; MORI C, 1998, INT J APPL RADIAT IS, V49, P1107; Phillips HC, 2010, APPL RADIAT ISOTOPES, V68, P1335, DOI 10.1016/j.apradiso.2009.12.009; Rodrigues M, 2014, APPL RADIAT ISOTOPES, V87, P342, DOI 10.1016/j.apradiso.2013.11.066; Simpson B, 2007, METROLOGIA, V44, pS79; Stanga D, 2002, APPL RADIAT ISOTOPES, V56, P231, DOI 10.1016/S0969-8043(01)00193-2; WATT DE, 1961, INT J APPL RADIAT IS, V11, P68, DOI 10.1016/0020-708X(61)90133-8; Yunoki A, 2010, APPL RADIAT ISOTOPES, V68, P1340, DOI 10.1016/j.apradiso.2009.12.030	13	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0026-1394	1681-7575		METROLOGIA	Metrologia	JUN	2015	52	3					S156	S164		10.1088/0026-1394/52/3/S156		9	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CI8CY	WOS:000354997100014		
J	Miyata, H; Okanoya, K; Kawai, N				Miyata, Hiromitsu; Okanoya, Kazuo; Kawai, Nobuyuki			Mindfulness and Psychological Status of Japanese Yoga Practitioners: a Cross-Sectional Study	MINDFULNESS			English	Article						Yoga; Meditation; Mindfulness; Well-being; Long-termpractice; Japanese	COMPASSION MEDITATION; STRESS REDUCTION; CONTROLLED-TRIAL; SELF-CARE; PROGRAM; QUESTIONNAIRE; NEUROSCIENCE; VALIDATION; EXPERIENCE; EMPATHY	A growing body of evidence suggests that meditation-based mental practices cause desirable changes to the psychological status. Little is known how enduring changes to multiple aspects of emotions are observed for Japanese long-term practitioners. The present study using a cross-sectional design investigated mindfulness and relevant psychological functions in a population of Japanese yoga practitioners, who routinely practiced classical hatha yoga, breathing techniques, as well as focused attention-based meditation. Training period ranged from 0.3 to 34.0 years. Participants completed a battery of five established Japanese versions of questionnaires, each of which concerned mindfulness, subjective well-being, depression, positive/negative affect, and empathy. Compared with age- and sex-matched control participants, yoga practitioners self-reported significantly higher scores on mindfulness, well-being, positive affect, and empathy, and lower scores on depression and negative affect. Among the practitioners, period and amount of yoga/meditation practice, regardless of ages, predicted higher scores on mindfulness and well-being and lower scores on depression, negative affect, and empathy. These data overall suggest desirable psychological status associated with continued yoga practice among Japanese contemplatives. Implications for comparisons with different cultures and with other traditional practices are discussed.	[Miyata, Hiromitsu; Okanoya, Kazuo; Kawai, Nobuyuki] Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Okanoya Emot Informat Project, Wako, Saitama 3510198, Japan	Kawai, N (reprint author), Japan Sci & Technol Agcy, Exploratory Res Adv Technol, Okanoya Emot Informat Project, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	kawai@is.nagoya-u.ac.jp			Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project	This study was supported by the funding from the Japan Science and Technology Agency, Exploratory Research for Advanced Technology, Okanoya Emotional Information Project. The authors thank Masaharu Naruse, Hisami Sakurai, and Yoko Cashell for their assistance in recruiting the participants.	Uchida Y, 2009, EMOTION, V9, P441, DOI 10.1037/a0015634; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037//0022-3514.44.1.113; Davidson RJ, 2003, PSYCHOPHYSIOLOGY, V40, P655, DOI 10.1111/1469-8986.00067; Bijlani RL, 2005, J ALTERN COMPLEM MED, V11, P267, DOI 10.1089/acm.2005.11.267; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2009, J NEUROSCI, V29, P13418, DOI 10.1523/JNEUROSCI.1614-09.2009; Carmody J, 2008, J BEHAV MED, V31, P23, DOI 10.1007/s10865-007-9130-7; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Lutz A, 2013, NEUROIMAGE, V64, P538, DOI 10.1016/j.neuroimage.2012.09.030; Cahn BR, 2006, PSYCHOL BULL, V132, P180, DOI 10.1037/0033-2909.132.2.180; Khalsa SBS, 2004, APPL PSYCHOPHYS BIOF, V29, P269, DOI 10.1007/s10484-004-0387-0; Decety J, 2006, THESCIENTIFICWORLDJO, V6, P1146, DOI 10.1100/tsw.2006.221; Lutz A, 2009, NEUROIMAGE, V47, P1038, DOI 10.1016/j.neuroimage.2009.04.081; Sugiura Y, 2012, MINDFULNESS, V3, P85, DOI 10.1007/s12671-011-0082-1; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; John PJ, 2007, HEADACHE, V47, P654, DOI 10.1111/j.1526-4610.2007.00789.x; Lazar SW, 2005, NEUROREPORT, V16, P1893, DOI 10.1097/01.wnr.0000186598.66243.19; Sherman KJ, 2005, ANN INTERN MED, V143, P849; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561; Shapiro SL, 2007, TRAIN EDUC PROF PSYC, V1, P105, DOI 10.1037/1931-3918.1.2.105; Carson JW, 2004, BEHAV THER, V35, P471, DOI 10.1016/S0005-7894(04)80028-5; Weng HY, 2013, PSYCHOL SCI, V24, P1171, DOI 10.1177/0956797612469537; Beck A. T., 1979, COGNITIVE THERAPY DE; Csikszentmihalyi M., 1990, FLOW PSYCHOL OPTIMAL; Ferrarelli F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073417; Field Tiffany, 2011, Complement Ther Clin Pract, V17, P1, DOI 10.1016/j.ctcp.2010.09.007; Field Tiffany, 2010, Complement Ther Clin Pract, V16, P235, DOI 10.1016/j.ctcp.2010.05.014; Finger A., 2000, YOGA ZONE INTRO YOGA; Gupta Nidhi, 2006, Indian J Physiol Pharmacol, V50, P41; Hayashi K., 1991, MEMOIRES SHIRAUMEGAK, V27, P43; Hayashi K., 1988, STUDENT COUNSELING J, V9, P97; Ito M., 2011, J RELIG STUDIES, V84, P1255; Ito Y., 2003, JAPANESE J PSYCHOL, V74, P276; KABATZINN J, 1982, GEN HOSP PSYCHIAT, V4, P33, DOI 10.1016/0163-8343(82)90026-3; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; Kaiya H., 2007, MINDFULNESS MEISO ZA; Kato H., 1997, J FACULTY LETT KOMAZ, V55, pA1; Kubo K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033006; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Madanmohan Udupa K., 2004, INDIAN J PHYSL PHARM, V48, P461; Michalsen A., 2005, MED SCI MONITOR, V11, P555; Nagashima Y., 2012, THESIS WASEDA U; Nagpal R., 1992, ASSESSMENT SUBJECTIV; Orlick T., 1990, PURSUIT EXCELLENCE; Sakurai S., 1988, B NARA U ED CULTURAL, V37, P149; Sato T., 2001, JAPANESE J PERSONALI, V9, P138; Segal Z. V., 2002, MINDFULNESS BASED CO; Shapiro S. L., 2002, HDB POSITIVE PSYCHOL; Sharma Ratna, 2008, Indian J Physiol Pharmacol, V52, P123; Slagter HA, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00017; Tonan K., 1995, JAPANESE J HLTH PSYC, V8, P12; Uchida Y., 2013, PSYCHOL WORLD, V60, P5; Uebelacker LA, 2010, BEHAV MODIF, V34, P247, DOI 10.1177/0145445510368845; Walters J. D., 2011, ART SCI RAJA YOGA GU	55	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1868-8527	1868-8535		MINDFULNESS	Mindfulness	JUN	2015	6	3					560	571		10.1007/s12671-014-0288-0		12	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CI0SP	WOS:000354448500015		
J	Sugiura, T; Sugiura, Y				Sugiura, Tomoko; Sugiura, Yoshinori			Common Factors of Meditation, Focusing, and Cognitive Behavioral Therapy: Longitudinal Relation of Self-Report Measures to Worry, Depressive, and Obsessive-Compulsive Symptoms Among Nonclinical Students	MINDFULNESS			English	Article						Refraining from catastrophic thinking; Detached coping; Self-observation; Longitudinal design; Mediator; Metacognitions	GENERALIZED ANXIETY DISORDER; PSYCHOMETRIC PROPERTIES; MINDFULNESS; QUESTIONNAIRE; VALIDATION; THOUGHTS; CONSCIOUSNESS; STRATEGIES; INVENTORY; RELAPSE	Meditation has a long tradition with substantial implications for many psychotherapies. It has been postulated that meditation may cultivate therapeutic processes similar to various psychotherapies. A previous study used joint factor analysis to identify five common factors of items of scales purported to capture psychological states cultivated by meditation, focusing, and cognitive behavioral therapy, namely, refraining from catastrophic thinking, logical objectivity, self-observation, acceptance, and detached coping. The present study aimed to extend previous research on these five factors by examining their longitudinal relationship to symptoms of depression, obsession and compulsion, and worrying, with two correlational surveys without intervention. Potential mediators of their effect on worrying were also explored. Longitudinal questionnaire studies from two student samples (n = 157 and 232, respectively) found that (a) detached coping was inversely related to obsessive-compulsive symptoms about 5 weeks later; (b) detached coping was inversely related to depressive symptoms about 5 weeks later; (c) refraining from catastrophic thinking was inversely related to worrying, while self-observation was positively related to worrying about 2 months later; and (d) the relation of refraining from catastrophic thinking to worrying was mediated by negative beliefs about worrying, while the relation of self-observation to worrying was mediated by negative beliefs about worrying and monitoring of one's cognitive processes. As refraining from catastrophic thinking involves being detached from one's negative thinking and detached coping involves distancing oneself from external circumstances and problems, the results suggest that distancing attitudes are useful for long-term reduction of various psychological symptoms.	[Sugiura, Tomoko] Japan Soc Promot Sci, Tokyo, Japan; [Sugiura, Yoshinori] Hiroshima Univ, Grad Sch Integrated Arts & Sci, Higashi Hiroshima City, Hiroshima 7398521, Japan	Sugiura, Y (reprint author), Hiroshima Univ, Grad Sch Integrated Arts & Sci, 1-7-1 Kagamiyama, Higashi Hiroshima City, Hiroshima 7398521, Japan.	ysugiura@hiroshima-u.ac.jp			Japan Society for the Promotion of Science; MEXT	This research was supported by a grant from the Japan Society for the Promotion of Science and MEXT.	Amari T., 2002, J GRADUATE SCH HOME, V8, P29; Muris P, 1997, BEHAV RES THER, V35, P249, DOI 10.1016/S0005-7967(96)00114-3; Trapnell PD, 1999, J PERS SOC PSYCHOL, V76, P284, DOI 10.1037/0022-3514.76.2.284; Selfhout MHW, 2008, YOUTH SOC, V39, P435, DOI 10.1177/0044118X07308069; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Ma SH, 2004, J CONSULT CLIN PSYCH, V72, P31, DOI 10.1037/0022-006X.72.1.31; Carmody J, 2009, J CLIN PSYCHOL, V65, P613, DOI 10.1002/jclp.20579; Mor N, 2002, PSYCHOL BULL, V128, P638, DOI 10.1037//0033-2909.128.4.638; Teasdale JD, 2002, J CONSULT CLIN PSYCH, V70, P275, DOI 10.1037//0022-006X.70.2.275; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Hayley S, 2005, NEUROSCIENCE, V135, P659, DOI 10.1016/j.neuroscience.2005.03.051; Flett GL, 1997, PSYCHOL BULL, V121, P395, DOI 10.1037/0033-2909.121.3.395; Fresco DM, 2007, BEHAV THER, V38, P234, DOI 10.1016/j.beth.2006.08.003; Foa EB, 2002, PSYCHOL ASSESSMENT, V14, P485, DOI 10.1037//1040-3590.14.4.485; Hanstede M, 2008, J NERV MENT DIS, V196, P776, DOI 10.1097/NMD.0b013e31818786b8; Olatunji BO, 2010, BEHAV THER, V41, P212, DOI 10.1016/j.beth.2009.03.001; Baer RA, 2006, ASSESSMENT, V13, P27, DOI 10.1177/1073191105283504; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Fresco DM, 2007, J CONSULT CLIN PSYCH, V75, P447, DOI 10.1037/0022-006X.75.3.447; Ruscio AM, 2004, BEHAV RES THER, V42, P1469, DOI 10.1016/j.brat.2003.10.007; BORKOVEC TD, 1995, J BEHAV THER EXP PSY, V26, P25, DOI 10.1016/0005-7916(94)00064-S; Kazdin AE, 2007, ANNU REV CLIN PSYCHO, V3, P1, DOI 10.1146/annurev.clinpsy.3.022806.091432; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Wells A, 2004, BEHAV RES THER, V42, P385, DOI 10.1016/S0005-7967(03)00147-5; Baer RA, 2008, ASSESSMENT, V15, P329, DOI 10.1177/1073191107313003; Wells A, 1998, BEHAV RES THER, V36, P899, DOI 10.1016/S0005-7967(98)00070-9; Wells A, 2001, BEHAV THER, V32, P85, DOI 10.1016/S0005-7894(01)80045-9; Wilkinson-Tough M, 2010, CLIN PSYCHOL PSYCHOT, V17, P250, DOI 10.1002/cpp.665; WELLS A, 1994, BEHAV RES THER, V32, P867, DOI 10.1016/0005-7967(94)90167-8; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Roemer L, 2008, J CONSULT CLIN PSYCH, V76, P1083, DOI 10.1037/a0012720; RACHMAN S, 1978, BEHAV RES THER, V16, P233, DOI 10.1016/0005-7967(78)90022-0; Mallinckrodt B, 2006, J COUNS PSYCHOL, V53, P372, DOI 10.1037/0022-0167.53.3.372; Evans S, 2008, J ANXIETY DISORD, V22, P716, DOI 10.1016/j.janxdis.2007.07.005; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Yilmaz AE, 2011, J ANXIETY DISORD, V25, P389, DOI 10.1016/j.janxdis.2010.11.001; Kertz SJ, 2012, J ANXIETY DISORD, V26, P126, DOI 10.1016/j.janxdis.2011.10.005; CartwrightHatton S, 1997, J ANXIETY DISORD, V11, P279, DOI 10.1016/S0887-6185(97)00011-X; Clark D. A., 2005, INTRUSIVE THOUGHTS C, P1; D'Zurilla T. J., 1986, PROBLEM SOLVING THER; D'Zurilla T. J., 1990, PSYCHOL ASSESSMENT J, V2, P156, DOI DOI 10.1037/1040-3590.2.2.156; de Bruin GO, 2005, PSYCHOL REP, V96, P222, DOI 10.2466/pr0.96.1.222-224; de Bruin GO, 2007, PERS INDIV DIFFER, V42, P689, DOI 10.1016/j.paid.2006.08.015; ENDLER NS, 1990, J PERS SOC PSYCHOL, V58, P844, DOI 10.1037//0022-3514.58.5.844; Freeman A., 1990, CLIN APPL COGNITIVE; Frye AA, 2000, COGNITIVE THER RES, V24, P637, DOI 10.1023/A:1005583210589; Fukumori H., 2003, J JAPANESE CLIN PSYC, V20, P580; Goldberg D. P., 1978, MANUAL GEN HLTH QUES; Hayes S. C., 1999, ACCEPTANCE COMMITMEN; Hayes-Skelton S., 2012, BEHAV COGN PSYCHOTH, V1, P1; Holaway RM, 2006, WORRY ITS PSYCHOL DI, P3; Ito Y., 2009, JAPANESE J PSYCHOSOM, V49, P233; Janeck AS, 2003, J ANXIETY DISORD, V17, P181, DOI 10.1016/S0887-6185(02)00198-6; Katsukura R., 2008, JAPANESE J PSYCHOSOM, V48, P139; Kivimaki M, 2000, SOC SCI MED, V50, P583, DOI 10.1016/S0277-9536(99)00326-3; Knowles ES, 1996, J PERS SOC PSYCHOL, V71, P352, DOI 10.1037//0022-3514.71.2.352; Langer E., 1989, MINDFULNESS; Martin JR, 1997, J PSYCHOTHER INTEGR, V7, P291, DOI 10.1023/B:JOPI.0000010885.18025.bc; Martin J. R., 2002, J PSYCHOTHERAPY INTE, V12, P139, DOI 10.1037//1053-0479.12.2.139; Matthews G., 1994, ATTENTION EMOTION CL; MaydeuOlivares A, 1996, COGNITIVE THER RES, V20, P115, DOI 10.1007/BF02228030; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Mohlman J, 2009, AGING MENT HEALTH, V13, P246, DOI 10.1080/13607860802428026; Okumura Y, 2009, AUST NZ J PSYCHIAT, V43, P666, DOI 10.1080/00048670902970841; Pirson M., 2012, DEV VALIDATION LANGE; Radel R, 2009, J RES PERS, V43, P695, DOI 10.1016/j.jrp.2009.02.011; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Roemer L, 1997, J NERV MENT DIS, V185, P314, DOI 10.1097/00005053-199705000-00005; ROGER D, 1993, PERS INDIV DIFFER, V15, P619, DOI 10.1016/0191-8869(93)90003-L; Sakairi Y., 2004, RELEVANCE WISDOM TRA, P199; SALKOVSKIS PM, 1985, BEHAV RES THER, V23, P571, DOI 10.1016/0005-7967(85)90105-6; Segal Z. V., 2002, MINDFULNESS BASED CO; Sica C, 2007, CLIN PSYCHOL PSYCHOT, V14, P258, DOI 10.1002/cpp.520; Startup H. M., 2008, WORRY ITS PSYCHOL DI, P101; Sugiura T, 2013, PSYCHOL REP, V113, P1, DOI 10.2466/02.09.PR0.113x14z3; Sugiura T., 2003, J GRADUATE SCH HOME, V9, P13; Sugiura T., 2003, JAPANESE J HLTH PSYC, V16, P31; Sugiura T., 2007, COGNITIVE RESILIENCE; Sugiura T., 2009, CURRENT RES PRACTICE, P30; Sugiura Y, 2007, BEHAV RES THER, V45, P1619, DOI 10.1016/j.brat.2006.08.001; Sugiura Y., 2006, HORIZONS BUDDHIST PS, P251; SUGIURA Y., 2000, ARCH PSYCHIAT DIAGNO, V11, P175; Takata K., 2012, 76 C JAP PSYCH ASS T; Takizaki N., 2000, 64 C JAP PSYCH ASS K; Tanaka K., 2011, JAPANESE J COGNITIVE, V4, P46; TURNER SM, 1992, CLIN PSYCHOL REV, V12, P257, DOI 10.1016/0272-7358(92)90117-Q; Wells A., 2005, J RATION-EMOT COGN-B, V23, P337, DOI DOI 10.1007/S10942-005-0018-6; Wells A., 2006, WORRY ITS PSYCHOL DI, VWiley, P179, DOI DOI 10.1002/9780470713143; Wells A, 2000, EMOTIONAL DISORDERS; Yatomi Y., 1993, SOCIAL GERONTOLOGY, V37, P37	90	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1868-8527	1868-8535		MINDFULNESS	Mindfulness	JUN	2015	6	3					610	623		10.1007/s12671-014-0296-0		14	Psychology, Clinical; Psychiatry	Psychology; Psychiatry	CI0SP	WOS:000354448500020		
J	Shibao, K; Sato, N; Higure, A; Yamaguchi, K				Shibao, Kazunori; Sato, Norihiro; Higure, Aiichiro; Yamaguchi, Koji			A new oval multichannel port to facilitate reduced port distal gastrectomy	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						Reduced port surgery; single port surgery; gastric cancer; E.Z Access (TM)	INCISION LAPAROSCOPIC SURGERY; SINGLE-INCISION; GASTRIC-CANCER; CHOLECYSTECTOMY; EXPERIENCE	Background: This report describes the techniques and outcomes of reduced port distal gastrectomy (RPDG) using a new oval multichannel port. Material and methods: We performed reduced port distal gastrectomy through the E.Z Access (TM) oval type device with three trocars in the umbilical incision, plus the use of additional 5 mm and 2 mm ports. All routine procedures performed in conventional laparoscopic distal gastrectomy (CLDG) were achieved in RPDG. Results: We employed this technique without the use of additional trocars or conversion to laparotomy in all 25 patients. The median length of the operation was 340 (range, 220-487) minutes, and the median estimated blood loss was 30 (range, 5-440) ml. Neither major postoperative complications, such as anastomotic leakage and stricture, nor postoperative mortality were observed. The mean length of the hospital stay was 11 days. The umbilical wound was indistinct. The patients were also highly satisfied with the cosmetic outcome. Conclusion: Reduced port surgery using the E.Z Access (TM) oval type device was successfully applied for gastric cancer. This method is technically feasible, produces superior cosmetic results and thus could be an attractive surgical option for gastric cancer patients.	[Shibao, Kazunori; Sato, Norihiro; Higure, Aiichiro] Univ Occupat & Environm Hlth Japan, Sch Med, Dept Surg 1, Kitakyushu, Fukuoka 8078555, Japan; [Yamaguchi, Koji] Univ Occupat & Environm Hlth Japan, Sch Med, Dept Adv Treatment Pancreat Dis, Kitakyushu, Fukuoka 8078555, Japan	Shibao, K (reprint author), Univ Occupat & Environm Hlth Japan, Sch Med, Dept Surg 1, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	shibao@med.uoeh-u.ac.jp					Kim JJ, 2008, SURG ENDOSC, V22, P436, DOI 10.1007/s00464-007-9446-y; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Gill IS, 2010, SURG ENDOSC, V24, P762, DOI 10.1007/s00464-009-0688-8; Pfluke JM, 2011, J AM COLL SURGEONS, V212, P113, DOI 10.1016/j.jamcollsurg.2010.09.008; Rao PP, 2011, J MINIM ACCESS SURG, V7, P6, DOI 10.4103/0972-9941.72360; Kim MG, 2011, SURG ENDOSC, V25, P1076, DOI 10.1007/s00464-010-1319-0; Kanaya S, 2011, GASTRIC CANCER, V14, P365, DOI 10.1007/s10120-011-0054-0; Curcillo PG, 2010, SURG ENDOSC, V24, P1854, DOI 10.1007/s00464-009-0856-x; Shibao K, 2013, SURG ENDOSC, V27, P3009, DOI 10.1007/s00464-013-2837-3; Lee JH, 2005, SURG ENDOSC, V19, P168, DOI 10.1007/s00464-004-8808-y; Noshiro H, 2005, SURG ENDOSC, V19, P1592, DOI 10.1007/s00464-005-0175-9; Gagner M, 1998, SURG LAPAROSC ENDOSC, V8, P171, DOI 10.1097/00019509-199806000-00002; Du JJ, 2012, J GASTROINTEST SURG, V16, P738, DOI 10.1007/s11605-011-1796-z; Greaves N, 2011, ANN ROY COLL SURG, V93, P437, DOI 10.1308/003588411X590358; Kim HH, 2010, ANN SURG, V251, P417, DOI 10.1097/SLA.0b013e3181cc8f6b; Jung YW, 2010, SURG ENDOSC, V24, P1686, DOI 10.1007/s00464-009-0830-7; Inufusa H, 2000, J SOC ENDO SURG, V5, P361; Kawamura H, 2011, SURG LAPARO ENDO PER, V21, P429, DOI 10.1097/SLE.0b013e318238063c; Khanna Rakesh, 2011, Curr Urol Rep, V12, P94, DOI 10.1007/s11934-011-0174-4; KITANO S, 1994, SURG LAPAROSC ENDOSC, V4, P146; Markar SR, 2011, SURG ENDOSC, V26, P1205; Nakagoe T, 2001, SURG TODAY, V31, P850; Navarra G, 1997, BRIT J SURG, V84, P695, DOI 10.1002/bjs.1800840536; Omori T, 2011, SURG ENDOSC, V25, P2400, DOI 10.1007/s00464-010-1563-3; Romanelli JR, 2009, SURG ENDOSC, V23, P1420; Shibao K, 2014, REDUCED PORT LAPAROS, P44; Shibao Kazunori, 2011, Surg Technol Int, V21, P101; Shibao Kazunori, 2010, Surg Technol Int, V20, P133; Shibao K, 2013, SURG TECHNOL INT, V23, P76; Tagaya N, 2011, J HEPATO-BIL-PAN SCI, V18, P516, DOI 10.1007/s00534-011-0398-1; Takaori K, 2005, AM J SURG, V189, P178, DOI 10.1016/j.amjsurg.2004.09.008; Uyama Ichiro, 2005, Gastric Cancer, V8, P253, DOI 10.1007/s10120-005-0344-5	32	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	JUN	2015	24	3					135	140		10.3109/13645706.2014.985684		6	Surgery	Surgery	CI8HC	WOS:000355010800002		
J	Ishii, T; Nakamura, K; Naya, Y; Igarashi, T				Ishii, Takuro; Nakamura, Kazuyoshi; Naya, Yukio; Igarashi, Tatsuo			Therapeutic designing for urethral obstruction by virtual urethra and flow dynamics simulation	MINIMALLY INVASIVE THERAPY & ALLIED TECHNOLOGIES			English	Article						3D virtual endoscopy; computational fluid dynamics; minimally invasive procedure; endoscopy; voiding dysfunction	BENIGN PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION; SEXUAL FUNCTION; CT; ENDOSCOPY; BIPOLAR; IMPACT; RECONSTRUCTION; URETHROGRAPHY; VISUALIZATION	Introduction: Transurethral surgery is widely accepted as standard therapy for male urethral obstruction. The present study was undertaken to identify and select lesions to be managed by processing endoscopic images of the urethra for assisting less invasive therapy in patients with voiding dysfunction. Material and methods: Cystourethroscopic video files of 25 patients with lower urinary tract symptoms were recorded before and after administration of alpha-1 adrenoceptor antagonists. Each video frame was restored and tagged with information indicating the position in the panoramic image of the urethra. A three-dimensional virtual urethra was created to indicate critical lesions for voiding dysfunction, together with fluid dynamics simulation of urine flow. Results: The urine stream was depicted in the virtual urethras in 19 patients. Before therapy, 17 patients showed vortex formation that was diminished after therapy in nine patients with a significant relationship in improvement of relative energy loss of flow (p=0.025). The narrowing points proximal to the vortex, candidate of lesions, were identified in the panoramic image and linked to the endoscopic image. Discussion: Therapeutic designing for endoscopic management was possible in patients with voiding dysfunction based on computational fluid dynamics, and would be promising as "focal" therapy for aging males.	[Ishii, Takuro] Chiba Univ, Grad Sch Engn, Div Artificial Syst Sci, Chiba 2638522, Japan; [Nakamura, Kazuyoshi] Chiba Univ, Grad Sch Engn, Dept Urol, Chiba 2638522, Japan; [Naya, Yukio] Teikyo Univ, Chiba Med Ctr, Dept Urol, Ichihara, Chiba, Japan; [Igarashi, Tatsuo] Chiba Univ, Ctr Frontier Med Engn, Chiba 2638522, Japan	Ishii, T (reprint author), Chiba Univ, Ctr Frontier Med Engn, Inage Ku, 1-33 Yayoi Cho, Chiba 2638522, Japan.	igarashi@faculty.chiba-u.jp	Ishii, Takuro/E-8375-2014	Ishii, Takuro/0000-0002-7411-3919	National grant of Ministry of Culture, Education and Sports in Japan [23659753]	The research is sponsored by National grant of Ministry of Culture, Education and Sports in Japan (No.23659753). We thank Drs. Sazuka T from Department of Urology, Chiba University, Dr. Mikami K. from Department of Urology, Saiseikai Narashino Hospital, for their efforts to collect patients' data, and to Mr. Kambara Y., Graduate School Engineering, Chiba University, for supporting to analyze hydraulic calculation.	Alloussi SH, 2014, J ENDOUROL, V28, P84, DOI 10.1089/end.2013.0093; Muntener M, 2007, EUR UROL, V52, P510, DOI 10.1016/j.eururo.2007.01.088; Marberger M, 2013, EUR UROL, V63, P496, DOI 10.1016/j.eururo.2012.10.005; Briganti A, 2006, J UROLOGY, V175, P1817, DOI 10.1016/S0022-5347(05)00983-3; Michielsen DPJ, 2010, MINIM INVASIV THER, V19, P207, DOI 10.3109/13645706.2010.496963; Ford MD, 2005, IEEE T MED IMAGING, V24, P1586, DOI 10.1109/TMI.2005.859204; Rassweiler J, 2007, MINIM INVASIV THER, V16, P11, DOI 10.1080/13645700601159410; Mamoulakis C, 2013, BJU INT, V112, P109, DOI 10.1111/j.1464-410X.2012.11662.x; Remy J, 1998, EUR RADIOL, V8, P335, DOI 10.1007/s003300050391; Rassweiler J, 2006, EUR UROL, V50, P969, DOI 10.1016/j.eururo.2005.12.042; Brambs HJ, 2003, MINIM INVASIV THER, V12, P207, DOI 10.1080/13645700310015572; Chou CP, 2005, AM J ROENTGENOL, V184, P1882; EKENGREN J, 1993, SCAND J UROL NEPHROL, V27, P501; El-Kassaby AW, 2003, BJU INT, V92, P993, DOI 10.1046/j.1464-410X.2003.04502.x; Schreyer AG, 2003, MINIM INVASIV THER, V12, P217, DOI 10.1080/13645700310014942; Hahn RG, 1997, SCAND J UROL NEPHROL, V31, P259, DOI 10.3109/00365599709070344; Haker S, 2000, IEEE T MED IMAGING, V19, P665, DOI 10.1109/42.875181; Igarashi T, 2009, J MECH MED BIOL, V9, P609, DOI 10.1142/S0219519409003164; Igarashi Tatsuo, 2008, J Endourol, V22, P1569, DOI 10.1089/end.2008.0150; Ishii T, 2011, J MED IMAG HEALTH IN, V1, P13, DOI 10.1166/jmihi.2011.1002; Kim DY, 2006, MED ENG PHYS, V28, P339, DOI 10.1016/j.medengphy.2005.07.011; Kumar A, 2012, J ENDOUROL; Leira HO, 2011, MINIM INVASIV THER, V20, P30, DOI 10.3109/13645706.2010.518747; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063227; Manstad-Hulaas F, 2011, MINIM INVASIV THER, V20, P282, DOI 10.3109/13645706.2010.536244; Nadeem A, 2010, JCPSP-J COLL PHYSICI, V20, P51, DOI 01.2010/JCPSP.5154; Negahdar Mohamadreza, 2006, Conf Proc IEEE Eng Med Biol Soc, V1, P156; Rodenwaldt J, 1997, J COMPUT ASSIST TOMO, V21, P405, DOI 10.1097/00004728-199705000-00013; SALMELA L, 1993, BRIT J UROL, V72, P599, DOI 10.1111/j.1464-410X.1993.tb16217.x; Sazuka T, 2012, J ENDOUROL, V26, P1216, DOI 10.1089/end.2012.0078; Zhang XM, 2011, ABDOM IMAGING, V36, P771, DOI 10.1007/s00261-010-9676-7	31	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1364-5706	1365-2931		MINIM INVASIV THER	Minim. Invasive Ther. Allied Technol.	JUN	2015	24	3					141	147		10.3109/13645706.2014.964260		7	Surgery	Surgery	CI8HC	WOS:000355010800003		
J	Otsuka, S; Miyoshi, T				Otsuka, Shigenori; Miyoshi, Takemasa			A Bayesian Optimization Approach to Multimodel Ensemble Kalman Filter with a Low-Order Model	MONTHLY WEATHER REVIEW			English	Article							ADAPTIVE COVARIANCE INFLATION; DATA ASSIMILATION; PARAMETER-ESTIMATION; INITIAL CONDITION; WEATHER; ERRORS; MESOSCALE; FORECASTS; SYSTEMS	Multimodel ensemble data assimilation may account for uncertainties of numerical models due to different dynamical cores and physics parameterizations. In the previous studies, the ensemble sizes for each model are prescribed subjectively, for example, uniformly distributed to each model. In this study, a Bayesian filter approach to a multimodel ensemble Kalman filter is adopted to objectively estimate the optimal combination of ensemble sizes for each model. An effective inflation method to make the discrete Bayesian filter work without converging to a single imperfect model was developed. As a first step, the proposed approach was tested with the 40-variable Lorenz-96 model. Different values of the model parameter F are used to mimic the multimodel ensemble. The true F is first chosen to be [GRAPHICS] , and the observations are generated by adding independent Gaussian noise to the true time series. When the multimodel ensemble consists of [GRAPHICS] , 7, 8, 9, and 10, the Bayesian filter finds the true model and converges to [GRAPHICS] quickly. When [GRAPHICS] , 7, 9, and 10, the closest two models, [GRAPHICS] and F = 9, are selected. When the true F has a periodic variation about [GRAPHICS] with a time scale much longer than the observation frequency, the proposed system follows the temporal change, and the error becomes less than that of the time-invariant optimal combination. Sensitivities to several parameters in the proposed system were also investigated, and the system was found to show improvements in a wide range of parameters.	[Otsuka, Shigenori; Miyoshi, Takemasa] RIKEN Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Miyoshi, Takemasa] Univ Maryland, College Pk, MD 20742 USA; [Miyoshi, Takemasa] Japan Agcy Marine Earth Sci & Technol, Yokohama, Kanagawa, Japan	Otsuka, S (reprint author), RIKEN Adv Inst Computat Sci, Chuo Ku, 7-1-26 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	shigenori.otsuka@riken.jp	Miyoshi, Takemasa/C-2768-2009	Miyoshi, Takemasa/0000-0003-3160-2525	JST, CREST	The authors thank three anonymous reviewers for their helpful comments. The authors thank the members of the Data Assimilation Research Team of RIKEN Advanced Institute for Computational Science for the fruitful discussions. The figures were produced by the GFD-DENNOU Library. This research was partially supported by JST, CREST.	Ruiz JJ, 2013, J METEOROL SOC JPN, V91, P79, DOI 10.2151/jmsj.2013-201; Li H, 2009, Q J ROY METEOR SOC, V135, P523, DOI 10.1002/qj.371; Ebert EE, 2001, MON WEATHER REV, V129, P2461, DOI 10.1175/1520-0493(2001)129<2461:AOAPMS>2.0.CO;2; Stensrud DJ, 2000, MON WEATHER REV, V128, P2077, DOI 10.1175/1520-0493(2000)128<2077:UICAMP>2.0.CO;2; Krishnamurti TN, 1999, SCIENCE, V285, P1548, DOI 10.1126/science.285.5433.1548; Anderson JL, 2007, TELLUS A, V59, P210, DOI 10.1111/j.1600-0870.2006.00216.x; Meng ZY, 2007, MON WEATHER REV, V135, P1403, DOI 10.1175/MWR3352.1; Lorenz EN, 1998, J ATMOS SCI, V55, P399, DOI 10.1175/1520-0469(1998)055<0399:OSFSWO>2.0.CO;2; Whitaker JS, 2002, MON WEATHER REV, V130, P1913, DOI 10.1175/1520-0493(2002)130<1913:EDAWPO>2.0.CO;2; Annan JD, 2004, TELLUS A, V56, P520, DOI 10.1111/j.1600-0870.2004.00073.x; Miyoshi T, 2011, MON WEATHER REV, V139, P1519, DOI 10.1175/2010MWR3570.1; Houtekamer PL, 2009, MON WEATHER REV, V137, P2126, DOI 10.1175/2008MWR2737.1; Anderson JL, 2009, TELLUS A, V61, P72, DOI 10.1111/j.1600-0870.2008.00361.x; Evans RE, 2000, MON WEATHER REV, V128, P3104, DOI 10.1175/1520-0493(2000)128<3104:JMREFT>2.0.CO;2; Fujita T, 2007, MON WEATHER REV, V135, P1846, DOI 10.1175/MWR3391.1; Hacker JP, 2013, MON WEATHER REV, V141, P1804, DOI 10.1175/MWR-D-12-00280.1; Bellsky T, 2014, MON WEATHER REV, V142, P2150, DOI 10.1175/MWR-D-13-00200.1; Koyama H, 2010, MON WEATHER REV, V138, P3316, DOI 10.1175/2010MWR3067.1; Lorenz E. N., 1996, P SEM PRED, V1, P1, DOI DOI 10.1017/CBO9780511617652.004; Matsueda M, 2006, SOLA, V2, P33, DOI 10.2151/sola.2006-009; Wilks D S, 2006, INT GEOPHYS SERIES, V59, P627; Yoden S, 2007, J METEOROL SOC JPN, V85B, P77, DOI 10.2151/jmsj.85B.77	22	0	0	AMER METEOROLOGICAL SOC	BOSTON	45 BEACON ST, BOSTON, MA 02108-3693 USA	0027-0644	1520-0493		MON WEATHER REV	Mon. Weather Rev.	JUN	2015	143	6					2001	2012		10.1175/MWR-D-14-00148.1		12	Meteorology & Atmospheric Sciences	Meteorology & Atmospheric Sciences	CJ0TL	WOS:000355190900002		
J	Ikegami, Y; Tsuruta, S				Ikegami, Yukino; Tsuruta, Setsuo			Hybrid method for modeless Japanese input using N-gram based binary classification and dictionary	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Multilingual documents; Modeless Japanese input		The rapid growth of globalization requires handling a large number of multilingual documents, where Japanese input co-exist with English and other languages, which use the Roman alphabet. Conventional methods for Japanese input require Japanese users to switch the input mode between Japanese and the Latin alphabet. As current solution, there is a modeless Japanese input method that automatically switches the input mode. However, those need training with a large amount of text data for improving the performance. This paper proposes a hybrid modeless Japanese input method that is based on the non-Japanese word dictionary and n-gram character sequence features to decide whether to convert and switch to Kana input or not. The aim of using the non-Japanese word dictionary is decreasing false positive against non-Japanese language words. This dictionary is composed by text data available on the Web. The n-gram based discriminative model are learned by a Support Vector Machine from a balanced corpus, which contains various domain texts. The evaluation of our method has shown that its statistical accuracy according to F-measure for prediction of non-Kana characters improves 7.7 % compared to n-gram only based method. In addition, the real user test has shown the average value of inputted time was agreeside for our method, against disagree side for conventional Japanese input method that requires switching input mode.	[Ikegami, Yukino; Tsuruta, Setsuo] Tokyo Denki Univ, Inzai, Chiba, Japan	Ikegami, Y (reprint author), Tokyo Denki Univ, 2-1200 MuzaiGakuendai, Inzai, Chiba, Japan.	12jkm03@ms.dendai.ac.jp; tsuruta@sie.dendai.ac.jp			Scientific Research of the government of Japan [KAKENHI 24700214]	This work was supported by Grant-in-Aid for Scientific Research of the government of Japan (KAKENHI 24700214). The authors are also thankful to Ms. Yukiko Yamamoto, a student of Tokyo Denki University, for her miscellaneous help such as English translation and check.	Davies M, 2009, INT J CORPUS LINGUIS, V14, P159, DOI 10.1075/ijcl.14.2.02dav; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Hakkani-Tur DZ, 2002, COMPUT HUMANITIES, V36, P381, DOI 10.1023/A:1020271707826; Beesley Kenneth, 1988, P 29 ANN C AM TRANSL, P47; Bellandi V, 2012, 8TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY & INTERNET BASED SYSTEMS (SITIS 2012), P637, DOI 10.1109/SITIS.2012.96; Cavnar W. B., 1994, P 3 ANN S DOC AN INF, P161; Chang C.C., 2001, LIBSVM LIB SUPPORT V; Chen Z, 2000, P 38 ANN M ASS COMP, P241, DOI 10.3115/1075218.1075249; Damiani E., 2004, ISCA 17th International Conference "Parallel and Distributed Computing Systems"; Dumais S, 1998, IEEE INTELL SYST APP, V13, P21; Ehara Y., 2008, P 3 INT JOINT C NAT, P441; Grudin J. T., 1983, COGNITIVE ASPECTS SK, P121, DOI 10.1007/978-1-4612-5470-6_6; Ikegami Y, 2012, 8TH INTERNATIONAL CONFERENCE ON SIGNAL IMAGE TECHNOLOGY & INTERNET BASED SYSTEMS (SITIS 2012), P613, DOI 10.1109/SITIS.2012.93; Internet.com K.K. (Japan), 2009, ROM KAN INP US 90 DI; Japanese Ministry of Internal Affairs and Communications, 2009, UT SIT INT; Joachims T., 2006, P 12 ACM SIGKDD INT, P217, DOI DOI 10.1145/1150402.1150429; Kasahara S, 2011, P WORKSH ADV TEXT IN, P38; Kerkhofs R, 2006, BRAIN RES, V1068, P170, DOI 10.1016/j.brainres.2005.10.087; Kudo T., 2004, P 2004 C EMP METH NA, V2004, P230; Maekawa Kikuo, 2008, P 6 WORKSH AS LANG R, P101; Neubig G, 2013, P AAAI 13 SPRING S A; Neubig G, 2011, P 49 ANN M ASS COMP, V2, P529; Pouliquen B, 2006, ARXIVCS0609059; Roeber H, 2003, P C HUM FACT COMP SY, P712; Shalev-Shwartz S., 2007, P 24 INT C MACH LEAR, P807, DOI DOI 10.1145/1273496.1273598; Suzumegano F, 1995, IPSJ SIG TECHNICAL R, V1995-HI-42, P9; Teahan William John, 2000, P 6 INT C RECH INF A, P943; Zheng YF, 2002, P SOC PHOTO-OPT INS, V4670, P49	28	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	JUN	2015	74	11					3933	3946		10.1007/s11042-013-1805-1		14	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CI6UQ	WOS:000354898800015		
J	Hu, ZZ; Matsuyama, T; Nobuhara, S				Hu, Zhaozheng; Matsuyama, Takashi; Nobuhara, Shohei			Cell-based visual surveillance with active cameras for 3D human gaze computation	MULTIMEDIA TOOLS AND APPLICATIONS			English	Article						Cell-based surveillance; Active cameras; Camera layout; Cell partition; Cell-based calibration		Capturing fine resolution and well-calibrated video images with good object visual coverage in a wide space is a tough task for visual surveillance. Although the use of active cameras is an emerging method, it suffers from the problems of online camera calibration difficulty, mechanical delay handling, image blurring from motions, and algorithm un-friendly due to dynamic backgrounds, etc. This paper proposes a cell-based visual surveillance system by using N (N a parts per thousand yenaEuro parts per thousand 2) active cameras. We propose the camera scan speed map (CSSM) to deal with the practical mechanical delay problem for active camera system design. We formulate the three mutually-coupled problems of camera layout, surveillance space partition with cell sequence, and camera parameter control, into an optimization problem by maximizing the object resolution while meeting various constraints such as system mechanical delay, full visual coverage, minimum object resolution, etc. The optimization problem is solved by using a full searching approach. The cell-based calibration method is proposed to compute both the intrinsic and exterior parameters of active cameras for different cells. With the proposed system, the foreground object is detected based on motion and appearance features and tracked by dynamically switching the two groups of cameras across different cells. The proposed algorithms and system have been validated by an in-door surveillance experiment, where the surveillance space was partitioned into four cells. We used two active cameras with one camera in one group. The active cameras were configured with the optimized pan, tilt, and zooming parameters for different cells. Each camera was calibrated with the cell-based calibration method for each configured pan, tilt, and zooming parameters. The algorithms and system were applied to monitor freely moving peoples within the space. The system can capture good resolution, well-calibrated, and good visual coverage video images with static background in support of automatic object detection and tracking. The proposed system performed better than traditional single or multiple fixed camera system in term of image resolution, surveillance space, etc. We further demonstrated that advanced 3D features, such as 3D gazes, were successfully computed from the captured good-quality images for intelligent surveillance.	[Hu, Zhaozheng] Wuhan Univ Technol, ITS Res Ctr, Wuhan 430063, Peoples R China; [Hu, Zhaozheng; Matsuyama, Takashi; Nobuhara, Shohei] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto 6068501, Japan	Hu, ZZ (reprint author), Wuhan Univ Technol, ITS Res Ctr, Wuhan 430063, Peoples R China.	zhaozheng.hu@gmail.com			National Natural Science Foundation of China (NSFC) [51208168]; Tianjin Natural Science Foundation [13JCYBJC37700]; Youth Top-Notch Talent Plan of Hebei Province, China; Japan Society for the Promotion of Science (JSPS) [10049]	The work presented in this paper was sponsored by grants from National Natural Science Foundation of China (NSFC) (No. 51208168), Tianjin Natural Science Foundation (No. 13JCYBJC37700), the Youth Top-Notch Talent Plan of Hebei Province, China, and the Grant-in-Aid for Scientific Research Program (No. 10049) from the Japan Society for the Promotion of Science (JSPS).	Viola P, 2001, PROC CVPR IEEE, P511; Morris BT, 2008, IEEE T CIRC SYST VID, V18, P1114, DOI 10.1109/TCSVT.2008.927109; Hu WM, 2004, IEEE T SYST MAN CY C, V34, P334, DOI 10.1109/TSMCC.2004.829274; Erdem UM, 2006, COMPUT VIS IMAGE UND, V103, P156, DOI 10.1016/j.cviu.2006.06.005; Zheng WS, 2011, PROC CVPR IEEE, P649; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Wang XG, 2013, PATTERN RECOGN LETT, V34, P3, DOI 10.1016/j.patrec.2012.07.005; Loy CC, 2011, PATTERN RECOGN, V44, P117, DOI 10.1016/j.patcog.2010.07.023; Bellotto N, 2013, COMPUT VIS IMAGE UND, V116, P457; Bradski G.R., 1998, INTEL TECHNOLOGY J Q, VQ2, P1998; Chen KW, 2011, IEEE T MULTIMEDIA, V13, P1256, DOI 10.1109/TMM.2011.2165055; DE D, 2005, PREMI, V3776, P413, DOI 10.1007/11590316_63; Hartley R. I., 2004, MULTIPLE VIEW GEOMET; Matsuyama T, 2002, P IEEE, V90, P1136, DOI 10.1109/JPROC.2002.801442; Saini M, 2012, MULTIMEDIA TOOLS APP; Sankaranarayanan K, 2011, IEEE C COMP VIS PATT, P3433; Shi Q., 2012, IPSJ T COMPUT VIS AP, V4, P149; Stauffer C., 1999, P IEEE C COMP VIS PA, V2, P246; Yamaguchi T, 2010, GEOM COMPUT, V5, P171, DOI 10.1007/978-3-642-12392-4_8; Yamaguchi Tatsuhisa, 2010, IPSJ Transactions on Computer Vision and Applications, V2, DOI 10.2197/ipsjtcva.2.169; Yonetani R, 2010, IEEE INT C PATT REC, P101	21	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	1380-7501	1573-7721		MULTIMED TOOLS APPL	Multimed. Tools Appl.	JUN	2015	74	11					4161	4185		10.1007/s11042-013-1816-y		25	Computer Science, Information Systems; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic	Computer Science; Engineering	CI6UQ	WOS:000354898800025		
J	Yokotani, K				Yokotani, Kenji			Japanese Young Adults' Disrespectful Forms of Address for Fathers Predict Feelings of Rejection and Depression	NAMES-A JOURNAL OF ONOMASTICS			English	Article						Japan; kinship terms; psychology; honorifics; child; depression	PARENTAL BONDING INSTRUMENT; AUTHORITY; ADOLESCENCE; ATTACHMENT; PATTERNS; STYLES; LINKS	Japanese young adults' forms of address for their parents (e.g., Dad) reportedly demonstrate their respect for their parents. Such respect has been linked to young adults' interpersonal attitudes as well as depressive symptoms. Given these relationships, the present study identified possible links between young adults' forms of address for their parents, perceived parent-child relationships, interpersonal attitudes, and depressive symptoms. Participants were 226 Japanese college students. Young adults' disrespectful forms of address for parents were positively correlated with feelings of rejection and depressive symptoms. Furthermore, young adults' disrespectful forms of address for fathers predicted the adults' feelings of rejection and depressive symptoms, although there were no such relationships for disrespectful forms of address for mothers. These findings indicated that young adults' disrespectful forms of address for parents, especially fathers, were linked to their negative interpersonal attitudes and depressive symptoms.	Niigata Seiryo Univ, Grad Sch Clin Psychol, Niigata, Niigata 9518121, Japan	Yokotani, K (reprint author), Niigata Seiryo Univ, Grad Sch Clin Psychol, Suidocho 1-5939, Niigata, Niigata 9518121, Japan.	yokotani@n-seiryo.ac.jp					Akita-kenritsu-akita toshokan, 1979, KOKUTENRUISYO; ARMSDEN GC, 1990, J ABNORM CHILD PSYCH, V18, P683, DOI 10.1007/BF01342754; IDE S, 1982, LINGUA, V57, P357, DOI 10.1016/0024-3841(82)90009-2; CHAO RK, 1994, CHILD DEV, V65, P1111, DOI 10.1111/j.1467-8624.1994.tb00806.x; SANTOR DA, 1995, PSYCHOL ASSESSMENT, V7, P131, DOI 10.1037/1040-3590.7.2.131; Wilhelm K, 2005, PSYCHOL MED, V35, P387, DOI 10.1017/S0033291704003538; BAUMRIND D, 1971, DEV PSYCHOL, V4, P1, DOI 10.1037/h0030372; SMETANA JG, 1995, CHILD DEV, V66, P299, DOI 10.1111/j.1467-8624.1995.tb00872.x; PARKER G, 1979, BRIT J MED PSYCHOL, V52, P1; Keltner D, 2003, PSYCHOL REV, V110, P265, DOI 10.1037/0033-295X.110.2.265; Bowlby J., 1973, ATTACHMENT LOSS, V2; Brown R., 1960, STYLE LANG, P253; BURI JR, 1991, J PERS ASSESS, V57, P110, DOI 10.1207/s15327752jpa5701_13; Crozier Ray, 1999, BRIT J EDUC PSYCHOL, V69, P505; Crozier Ray, 2002, ED PSYCHOL, V22, P113; Dickey E, 1997, J LINGUIST, V33, P255, DOI 10.1017/S0022226797006488; Hotta Yukiyoshi, 2007, KINSEIBUKE NO KO TO; Hozumi Nobushige, 1926, JITSUMEI KEIHIZOKU K; Hwang K., 1999, ASIAN J SOC PSYCHOL, V2, P163, DOI DOI 10.1111/1467-839X.00031; Kerns KA, 1996, J YOUTH ADOLESCENCE, V25, P323, DOI 10.1007/BF01537388; Kerr M, 2012, DEV PSYCHOL, V48, P1540, DOI 10.1037/a0027720; Kim Seran, 2002, GENDAISHAKAIBUNKA KE, V24, P269; KITAMURA T, 1993, JPN J PSYCHIAT NEUR, V47, P29; Koo John, 1992, KOREA J, V32, P27; Kuroda Motoki, 1997, NIHONSHI KENKYU, V414, P1; Lawson E. D., 1984, NAMES, V32, P45; LEARY MR, 1995, J PERS SOC PSYCHOL, V68, P518, DOI 10.1037//0022-3514.68.3.518; LILLIEFO.HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Mitsui-bunko, 1971, MITS GIG SHIR HEN DA; Mizuno Noriko, 1992, JURISUTO, V1000, P163; Otoh Osamu, 2012, NIHONJIN NO SEI MYOJ; Patock-Peckham JA, 2007, PSYCHOL ADDICT BEHAV, V21, P297, DOI 10.1037/0893-164X.21.3.297; Peng Fred, 1974, LANG SCI, V31, P32; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Sato Minoru, 2007, YOMINIKUI NAMAE HA N; Shima S., 1985, SEISHIN IGAKU, V27, P717; Sugiyama Takashi, 2006, JAPANESE J HLTH PSYC, V19, P1; Suzuki Keisuke, 1993, TOZAINANBOKU, V1993, P112; Unser-Schutz G, 2014, NAMES, V62, P202, DOI 10.1179/0027773814Z.00000000086; Wood L. A., 1991, J LANG SOC PSYCHOL, V10, P145, DOI 10.1177/0261927X91103001; Yokotani K, 2013, PSYCHOLOGIA, V56, P20; Yokotani K, 2012, ASIAN J SOC PSYCHOL, V15, P284, DOI 10.1111/j.1467-839X.2012.01382.x; Yokotani K., 2013, PSYCHOL LANGUAGE COM, V17, P65; Yokotani Kenji, 2014, J LANGUAGE IN PRESS; Yokotani Kenji, 2014, KAZOKUNAI KOSHO NO S; Yokotani Kenji, 2011, JAPANESE J FAMILY PS, V25, P45	46	0	0	MANEY PUBLISHING	LEEDS	STE 1C, JOSEPHS WELL, HANOVER WALK, LEEDS LS3 1AB, W YORKS, ENGLAND	0027-7738	1756-2279		NAMES	Names	JUN	2015	63	2					96	108		10.1179/0027773815Z.000000000112		13	Linguistics; Language & Linguistics	Linguistics	CI6OI	WOS:000354879300005		
J	Greer, AL				Greer, A. Lindsay			New horizons for glass formation and stability	NATURE MATERIALS			English	Editorial Material							PHASE-CHANGE MATERIALS; CHANGE MEMORY; DATA-STORAGE; SOLIDIFICATION; GROWTH; CRYSTALLIZATION; ALLOYS; LIQUID; DROPLETS; RATES	It has long been thought impossible for pure metals to form stable glasses. Recent work supports earlier evidence of glass formation in pure metals, shows the potential for devices based on rapid glass-crystal phase change, and highlights the lack of an adequate theory for fast crystal growth.	[Greer, A. Lindsay] Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England; [Greer, A. Lindsay] Tohoku Univ, WPI Adv Inst Mat Res, Sendai, Miyagi 9808577, Japan	Greer, AL (reprint author), Univ Cambridge, Dept Mat Sci & Met, Cambridge CB3 0FS, England.	alg13@cam.ac.uk					Singh S, 2013, NAT MATER, V12, P139, DOI [10.1038/nmat3521, 10.1038/NMAT3521]; CORIELL SR, 1982, ACTA METALL MATER, V30, P2135, DOI 10.1016/0001-6160(82)90134-1; Wang Q, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.014202; ANGELL CA, 1995, SCIENCE, V267, P1924, DOI 10.1126/science.267.5206.1924; Loke D, 2012, SCIENCE, V336, P1566, DOI 10.1126/science.1221561; Herlach DM, 2007, MAT SCI ENG A-STRUCT, V449, P34, DOI 10.1016/j.msea.2006.02.303; Zhong L, 2014, NATURE, V512, P177, DOI 10.1038/nature13617; Mear FO, 2009, J ALLOY COMPD, V483, P256, DOI 10.1016/j.jallcom.2007.12.105; Orava J, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4880959; Mendelev MI, 2010, MODEL SIMUL MATER SC, V18, DOI 10.1088/0965-0393/18/7/074002; Wright CD, 2013, ADV FUNCT MATER, V23, P2248, DOI 10.1002/adfm.201202383; Burr GW, 2012, J APPL PHYS, V111, DOI 10.1063/1.4718574; Raoux S, 2014, MRS BULL, V39, P703, DOI 10.1557/mrs.2014.139; TURNBULL D, 1969, CONTEMP PHYS, V10, P473, DOI 10.1080/00107516908204405; Orava J, 2012, NAT MATER, V11, P279, DOI [10.1038/nmat3275, 10.1038/NMAT3275]; BEHRNDT KH, 1970, J VAC SCI TECHNOL, V7, P385, DOI 10.1116/1.1492879; An Q, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3675909; Celestini F, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041605; AZIZ MJ, 1994, ACTA METALL MATER, V42, P527, DOI 10.1016/0956-7151(94)90507-X; Wilde G, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3602315; KLEMENT W, 1960, NATURE, V187, P869, DOI 10.1038/187869b0; BROUGHTON JQ, 1982, PHYS REV LETT, V49, P1496, DOI 10.1103/PhysRevLett.49.1496; Wuttig M, 2007, NAT MATER, V6, P824, DOI 10.1038/nmat2009; Na JH, 2014, P NATL ACAD SCI USA, V111, P9031, DOI 10.1073/pnas.1407780111; FELSCH W, 1966, Z PHYS, V195, P201, DOI 10.1007/BF01328888; Ashkenazy Y, 2010, ACTA MATER, V58, P524, DOI 10.1016/j.actamat.2009.09.030; Ovshinsky SR, 2004, JPN J APPL PHYS 1, V43, P4695, DOI 10.1143/JJAP.43.4695; BUCKEL W, 1954, Z PHYS, V138, P109, DOI 10.1007/BF01337903; DAVIES HA, 1976, J MATER SCI, V11, P215, DOI 10.1007/BF00551430; Eckler K, 1997, MAT SCI ENG A-STRUCT, V226, P410, DOI 10.1016/S0921-5093(96)10654-7; Ediger MD, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4747326; Herlach D. M., 2007, METASTABLE SOLIDS UN, P197; KIM YW, 1989, ACTA METALL MATER, V37, P247, DOI 10.1016/0001-6160(89)90283-6; KIM YW, 1991, ACTA METALL MATER, V39, P3237, DOI 10.1016/0956-7151(91)90058-9; Lin PH, 2014, J CHEM PHYS, V140, DOI 10.1063/1.4876078; Salinga M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3371; Spaepen F., 1984, Amorphous Metals and Non-Equilibrium Processing; Wuttig M, 2012, PHYS STATUS SOLIDI B, V249, P1843, DOI 10.1002/pssb.201200582; Zhang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06529	39	4	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JUN	2015	14	6					542	546				5	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CI5MP	WOS:000354801500002		
J	He, JF; Hogan, T; Mion, TR; Hafiz, H; He, Y; Denlinger, JD; Mo, SK; Dhital, C; Chen, X; Lin, QS; Zhang, Y; Hashimoto, M; Pan, H; Lu, DH; Arita, M; Shimada, K; Markiewicz, RS; Wang, Z; Kempa, K; Naughton, MJ; Bansil, A; Wilson, SD; He, RH				He, Junfeng; Hogan, T.; Mion, Thomas R.; Hafiz, H.; He, Y.; Denlinger, J. D.; Mo, S-K.; Dhital, C.; Chen, X.; Lin, Qisen; Zhang, Y.; Hashimoto, M.; Pan, H.; Lu, D. H.; Arita, M.; Shimada, K.; Markiewicz, R. S.; Wang, Z.; Kempa, K.; Naughton, M. J.; Bansil, A.; Wilson, S. D.; He, Rui-Hua			Spectroscopic evidence for negative electronic compressibility in a quasi-three-dimensional spin-orbit correlated metal	NATURE MATERIALS			English	Article							2-DIMENSIONAL ELECTRON; QUANTUM CAPACITANCE; COMPOSITE-MATERIALS; GRAPHENE	Negative compressibility is a sign of thermodynamic instability of open(1-3) or non-equilibrium(4,5) systems. In quantum materials consisting of multiple mutually coupled subsystems, the compressibility of one subsystem can be negative if it is countered by positive compressibility of the others. Manifestations of this effect have so far been limited to low-dimensional dilute electron systems(6-11). Here, we present evidence from angle-resolved photoemission spectroscopy (ARPES) for negative electronic compressibility (NEC) in the quasi-three-dimensional (3D) spin-orbit correlated metal (Sr1-xLax)(3)Ir2O7. Increased electron filling accompanies an anomalous decrease of the chemical potential, as indicated by the overall movement of the deep valence bands. Such anomaly, suggestive of NEC, is shown to be primarily driven by the lowering in energy of the conduction band as the correlated bandgap reduces. Our finding points to a distinct pathway towards an uncharted territory of NEC featuring bulk correlated metals with unique potential for applications in low-power nanoelectronics and novel metamaterials.	[He, Junfeng; Hogan, T.; Mion, Thomas R.; Dhital, C.; Chen, X.; Lin, Qisen; Pan, H.; Wang, Z.; Kempa, K.; Naughton, M. J.; Wilson, S. D.; He, Rui-Hua] Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA; [Hafiz, H.; Markiewicz, R. S.; Bansil, A.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA; [He, Y.; Hashimoto, M.; Lu, D. H.] SLAC Natl Accelerator Lab, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [He, Y.; Hashimoto, M.; Lu, D. H.] SLAC Natl Accelerator Lab, Stanford Inst Mat & Energy Sci, Menlo Pk, CA 94025 USA; [Denlinger, J. D.; Mo, S-K.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Zhang, Y.] Peking Univ, Int Ctr Quantum Mat, Beijing 100871, Peoples R China; [Arita, M.; Shimada, K.] Hiroshima Univ, Hiroshima Synchrotron Radiat Ctr, Hiroshima 7390046, Japan; [Wilson, S. D.] Univ Calif Santa Barbara, Dept Mat, Santa Barbara, CA 93106 USA	He, RH (reprint author), Boston Coll, Dept Phys, Chestnut Hill, MA 02467 USA.	ruihua.he@bc.edu	He, Junfeng/J-2664-2014; Mo, Sung-Kwan/F-3489-2013	Mo, Sung-Kwan/0000-0003-0711-8514	BC start-up fund; US NSF [DMR-1454926, DMR-1056625]; NSF Graduate Research Fellowship [GRFP-5100141]; DOE [DE-SC0002554, DE-FG02-99ER45747]; W. M. Keck Foundation; DOE, BES [DE-FG02-07ER46352]; NERSC through DOE [DE-AC02-05CH11231]; US DOE BES [DE-AC02-05CH11231, DE-AC02-76SF00515]	We thank K. S. Burch, T-R. Chang, Y-H. Chu, A. Fujimori, Z. Hussain, S. A. Kivelson, H. Lin, V. Madhavan, Z-X. Shen, Q. Si, C. M. Varma, Z-Y. Weng, H. Yao and X. J. Zhou for discussions, and K. Tanaka for measuring sample work functions at UVSOR, Japan. The work at Boston College was supported by a BC start-up fund (J.H., R-H.H.), the US NSF CAREER Awards DMR-1454926 (R-H.H., in part) and DMR-1056625 (T.H., C.D., X.C., S.D.W.), NSF Graduate Research Fellowship GRFP-5100141 (T.R.M.), DOE DE-SC0002554 and DE-FG02-99ER45747 (Z.W.) and the W. M. Keck Foundation (M.J.N.). The work at Northeastern University (NU) was supported by the DOE, BES Contract No. DE-FG02-07ER46352, and benefited from NU's ASCC and the allocation of supercomputer time at NERSC through DOE grant DE-AC02-05CH11231. Photoemission experiments were performed at the SSRL and ALS, supported respectively by the US DOE BES Contract Nos. DE-AC02-76SF00515 and DE-AC02-05CH11231, at HSRC and SPring-8 (preliminary) with the approval of Proposal Nos 14-A-1 and 2014B1501.	Ishii K, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.115121; Kim BJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076402; Fang N, 2006, NAT MATER, V5, P452, DOI 10.1038/nmat1644; Shen KM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.267002; Armitage NP, 2010, REV MOD PHYS, V82, P2421, DOI 10.1103/RevModPhys.82.2421; Moon SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.226402; Arita R, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.086403; VAN DE WALLE CG, 1989, PHYS REV LETT, V62, P2028, DOI 10.1103/PhysRevLett.62.2028; KRAVCHENKO SV, 1990, PHYS REV B, V42, P3741, DOI 10.1103/PhysRevB.42.3741; Lee JD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035101; Lee K, 2014, SCIENCE, V345, P58, DOI 10.1126/science.1251003; Ilani S, 2006, NAT PHYS, V2, P687, DOI 10.1038/nphys412; Liu GQ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.026408; Jaglinski T, 2007, SCIENCE, V315, P620, DOI 10.1126/science.1135837; Caprara S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.196401; EISENSTEIN JP, 1992, PHYS REV LETT, V68, P674, DOI 10.1103/PhysRevLett.68.674; Li L, 2011, SCIENCE, V332, P825, DOI 10.1126/science.1204168; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; Li QZ, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.235407; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Lakes RS, 2001, NATURE, V410, P565, DOI 10.1038/35069035; Imada M, 1998, REV MOD PHYS, V70, P1039, DOI 10.1103/RevModPhys.70.1039; Yu GL, 2013, P NATL ACAD SCI USA, V110, P3282, DOI 10.1073/pnas.1300599110; Das T, 2011, EPL-EUROPHYS LETT, V96, DOI 10.1209/0295-5075/96/27004; Dhital C, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.100401; Fujimori A, 2002, J ELECTRON SPECTROSC, V124, P127, DOI 10.1016/S0368-2048(02)00049-X; King PDC, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.241106; Kopp T, 2009, J APPL PHYS, V106, DOI 10.1063/1.3197246; Li L, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.235127; Okada Y, 2013, NAT MATER, V12, P707, DOI [10.1038/nmat3653, 10.1038/NMAT3653]; Veillette M, 1999, PHYS REV LETT, V83, P2413, DOI 10.1103/PhysRevLett.83.2413; Wang Q, 2013, PHYS REV B, V87, DOI 10.1103/PhysRevB.87.245109; Yagi H, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.172503	33	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JUN	2015	14	6					577	U54		10.1038/NMAT4273		7	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CI5MP	WOS:000354801500019		
J	Wan, CL; Gu, XK; Dang, F; Itoh, T; Wang, YF; Sasaki, H; Kondo, M; Koga, K; Yabuki, K; Snyder, GJ; Yang, RG; Koumoto, K				Wan, Chunlei; Gu, Xiaokun; Dang, Feng; Itoh, Tomohiro; Wang, Yifeng; Sasaki, Hitoshi; Kondo, Mami; Koga, Kenji; Yabuki, Kazuhisa; Snyder, G. Jeffrey; Yang, Ronggui; Koumoto, Kunihito			Flexible n-type thermoelectric materials by organic intercalation of layered transition metal dichalcogenide TiS2	NATURE MATERIALS			English	Article							THIN-FILM; THERMAL-CONDUCTIVITY; TRANSPORT; POLYMER; NANOTUBES; DEVICES	Organic semiconductors are attracting increasing interest as flexible thermoelectric materials owing to material abundance, easy processing and low thermal conductivity. Although progress in p-type polymers and composites has been reported, their n-type counterpart has fallen behind owing to diffculties in n-type doping of organic semiconductors. Here, we present an approach to synthesize n-type flexible thermoelectric materials through a facile electrochemical intercalation method, fabricating a hybrid superlattice of alternating inorganic TiS2 monolayers and organic cations. Electrons were externally injected into the inorganic layers and then stabilized by organic cations, providing n-type carriers for current and energy transport. An electrical conductivity of 790 S cm(-1) and a power factor of 0.45 mW m(-1) K-2 were obtained for a hybrid superlattice of TiS2/[(hexylammonium)(x)(H2O)(y)(DMSO)(z)], with an in-plane lattice thermal conductivity of 0.12 +/- 0.03 W m(-1) K-1, which is two orders of magnitude smaller than the thermal conductivities of the single-layer and bulk TiS2. High power factor and low thermal conductivity contributed to a thermoelectric figure of merit, ZT, of 0.28 at 373 K, which might find application in wearable electronics.	[Wan, Chunlei; Dang, Feng; Itoh, Tomohiro; Sasaki, Hitoshi; Kondo, Mami; Koumoto, Kunihito] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Wan, Chunlei] Tsinghua Univ, Sch Mat Sci & Engn, State Key Lab New Ceram & Fine Proc, Beijing 100084, Peoples R China; [Gu, Xiaokun; Yang, Ronggui] Univ Colorado, Dept Mech Engn, Boulder, CO 80309 USA; [Wang, Yifeng] Nanjing Univ Technol, Coll Mat Sci & Engn, Nanjing 210009, Jiangsu, Peoples R China; [Koga, Kenji; Yabuki, Kazuhisa] KOBELCO Res Inst, Kobe, Hyogo 6512271, Japan; [Snyder, G. Jeffrey] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA	Wan, CL (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	chunlei.wan@gmail.com; koumoto@apchem.nagoya-u.ac.jp	Gu, Xiaokun/H-4069-2011; Snyder, G/I-2263-2015; Yang, Ronggui/H-1278-2011; Snyder, Jeff/E-4453-2011	Gu, Xiaokun/0000-0003-3803-3951; Snyder, Jeff/0000-0003-1414-8682	Murata Science Foundation; Thermal and Electrical Energy Technology Foundation Research Grant; Takahashi Industrial and Economic Research Foundation; JSPS KAKENHI Grant [26820295, 25289226]; TherMAT; AFOSR-MURI; DOE-EFRC [DE-SC0001299]; NSF [0846561, 0821794]; AFOSR [FA9550-11-1-0109]	The authors thank R. Sasai for polarized FTIR measurements. C.W. acknowledges financial support from a Murata Science Foundation Research Grant, a Thermal and Electrical Energy Technology Foundation Research Grant, Takahashi Industrial and Economic Research Foundation and JSPS KAKENHI Grant Number 26820295. K. Koumoto acknowledges financial support from JSPS KAKENHI Grant Number 25289226 and TherMAT. G.J.S. acknowledges support from AFOSR-MURI and DOE-EFRC (S3TEC) award number DE-SC0001299. X.G. and R.Y. acknowledge the partial support for this work from the NSF CAREER award (0846561) and AFOSR (FA9550-11-1-0109). The simulation work used the Janus supercomputer, supported by NSF (0821794).	Bubnova O, 2011, NAT MATER, V10, P429, DOI [10.1038/nmat3012, 10.1038/NMAT3012]; BURROUGHES JH, 1990, NATURE, V347, P539, DOI 10.1038/347539a0; Fang CM, 1997, PHYS REV B, V56, P4455, DOI 10.1103/PhysRevB.56.4455; Ouyang JY, 2004, NAT MATER, V3, P918, DOI 10.1038/nmat1269; Dimitrakopoulos CD, 2002, ADV MATER, V14, P99, DOI 10.1002/1521-4095(20020116)14:2<99::AID-ADMA99>3.0.CO;2-9; Ong WL, 2013, NAT MATER, V12, P410, DOI [10.1038/nmat3596, 10.1038/NMAT3596]; Losego MD, 2013, NANO LETT, V13, P2215, DOI 10.1021/nl4007326; Kim GH, 2013, NAT MATER, V12, P719, DOI [10.1038/nmat3635, 10.1038/NMAT3635]; Janata J, 2003, NAT MATER, V2, P19, DOI 10.1038/nmat768; Li YDD, 2002, J AM CHEM SOC, V124, P1411, DOI 10.1021/ja012055m; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Thomas JA, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.081411; Sun YM, 2012, ADV MATER, V24, P932, DOI 10.1002/adma.201104305; Losego MD, 2012, NAT MATER, V11, P502, DOI [10.1038/nmat3303, 10.1038/NMAT3303]; Lu ZY, 2014, SMALL, V10, P3551, DOI 10.1002/smll.201303126; Yadav A, 2008, J POWER SOURCES, V175, P909, DOI 10.1016/j.jpowsour.2007.09.096; HARSHMAN DR, 1992, PHYS REV B, V45, P10684, DOI 10.1103/PhysRevB.45.10684; Jena D, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.136805; Tynell T, 2013, J MATER CHEM A, V1, P13619, DOI 10.1039/c3ta12909h; BARRY JJ, 1983, J PHYS C SOLID STATE, V16, P393, DOI 10.1088/0022-3719/16/2/022; Ferrari AM, 2010, J PHYS CHEM LETT, V1, P2854, DOI 10.1021/jz101184f; Imai H, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241104; KUKKONEN CA, 1981, PHYS REV B, V24, P1691, DOI 10.1103/PhysRevB.24.1691; Liu JP, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002968; SCHOLLHO.R, 1974, J LESS-COMMON MET, V36, P229, DOI 10.1016/0022-5088(74)90106-4; SCHOLLHO.R, 1974, MATER RES BULL, V9, P1237, DOI 10.1016/0025-5408(74)90042-7; Tibbetts K, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.014102; Zawilski BM, 2001, REV SCI INSTRUM, V72, P1770, DOI 10.1063/1.1347980	28	9	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1476-1122	1476-4660		NAT MATER	Nat. Mater.	JUN	2015	14	6					622	627		10.1038/NMAT4251		6	Chemistry, Physical; Materials Science, Multidisciplinary; Physics, Applied; Physics, Condensed Matter	Chemistry; Materials Science; Physics	CI5MP	WOS:000354801500026		
J	Sandberg, E				Sandberg, Eric			"A peculiar day in the annals": the collision of modernity and aristocracy in Hjalmar Bergman's The Markurells of Wadkoping	NEOHELICON			English	Article						Hjalmar Bergman; Modernism; Aristocracy; Nobility		Hjalmar Bergman's formally innovative 1919 novel The Markurells of Wadkoping deals with the clash between the traditional aristocratic dispensation and the socially disruptive forces of modernity. These opposed orders are embodied in two characters, Carl-Magnus de Lorche and Herr Markurell, whose connections and conflicts come to represent the destiny of society as a whole as it attempts to cope with the emergence of the new.	Miyazaki Int Coll, Kiyotake, Miyazaki, Japan	Sandberg, E (reprint author), Miyazaki Int Coll, Kiyotake, Miyazaki, Japan.	esandberg@sky.miyazaki-mic.ac.jp					Bergman H., 1982, MARKURELLS WADKOPING; Bock S., 1991, THESIS UPPSALA U; Borgstrom I, 2004, THESIS STOCKHOLMS U; Dahlback K., 1994, CENTURY SWEDISH NARR, P91; Frye Northrop, 1990, ANATOMY CRITICISM 4; Gramsci A., 1971, SELECTIONS PRISON NO; KENT N., 2008, CONCISE HIST SWEDEN; Lonnroth L., 1989, SVENSKA LIT STORSVEN, V4; Mayer Arno, 2010, PERSISTENCE OLD REGI; Petherick K., 1975, HJ BERGMAN MARKURELL; Petherick K., 2007, MEMOIRS DEAD MAN, P344; Platt L., 2001, ARISTOCRACIES FICTIO; Quint D, 2010, COMP LITERATURE, V62, P103, DOI 10.1215/00104124-2010-001; Venuti L., 1995, TRANSLATORS INVISIBI; Wallroth P, 1992, ELANDETS TRIUMFATOR; Woolf Virginia, 2000, DALLOWAY	16	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0324-4652	1588-2810		NEOHELICON	Neohelicon	JUN	2015	42	1					71	84		10.1007/s11059-014-0272-7		14	Literature	Literature	CI6UW	WOS:000354899600005		
J	Furukawa, H				Furukawa, Hiroko			Intracultural translation into an ideological language: the case of the Japanese translations of Anne of Green Gables	NEOHELICON			English	Article						Ideology; Japanese translation; Women's language; Children's literature; Anne of Green Gables		In Japanese literature, both original and translated, a virtual language that is not used by actual Japanese-speaking people has been used since the late nineteenth century. The language is named "yakuwarigo [role language]" because it can be employed in different ways to create different images of the speaker. During the period, the feminine ideal was related to women's language, which is a type of yakuwarigo, and girls were instructed about how women should behave and speak. The function of yakuwarigo has been strengthened and repeatedly imparted to children, and consequently it has helped to instil women's language in readers' minds, and arguably reinforced the subordinate role of women in Japanese society. Therefore, this paper first investigates the history of yakuwarigo since the nineteenth century, and then explores the link between yakuwarigo and ideology by analysing the three Japanese translations of one of the most influential examples of children's literature in Japan, Montgomery's Anne of Green Gables, from polysystem and feminist perspectives.	Tohoku Gakuin Univ, Dept English, Aoba Ku, Sendai, Miyagi 9808851, Japan	Furukawa, H (reprint author), Tohoku Gakuin Univ, Dept English, Aoba Ku, 1-3-1 Tsuchitoi, Sendai, Miyagi 9808851, Japan.	f.hiroko@mail.tohoku-gakuin.ac.jp					Akamatsu Y., 1999, LM MONTGOMERY CANADI, P201; Atwood M., 1999, LM MONTGOMERY CANADI, P222; Austen Jane, 2005, EMMA; Bhabha H., 1994, LOCATION CULTURE, DOI New York; Butler J, 2006, GENDER TROUBLE FEMIN; Downes William, 1998, LANGUAGE SOC; Endo O., 1997, ONNA NO KOTOBA NO BU; Fairclough Norman, 2001, LANGUAGE POWER; Fowler R., 1996, LINGUISTIC CRITICISM; Furukawa H., TRANSLATING WOMEN AN; Furukawa H., 2010, TRANSLATION THEORY P, P181; Gillen M., 1976, WHEEL THINGS BIOGRAP; Hall J., 1993, CULTURE SOCIOLOGICAL; Harding S., 1997, EMA; Hatch E., 1985, SOCIAL SCI ENCY, P178; Ichigaya Keizai Shinbun, 2009, DANJ NO KOT HA CHUS; Inoue M., 2004, JAPANESE LANGUAGE GE, P57; Inoue M, 1994, CULTURAL PERFORMANCES, P322; Inoue M, 2006, ASIA-LOCAL STUD GLOB, V11, P1; Kakegawa Y., 2006, AKAGE NO AN; Kindaichi H., 1988, NIHONGO; Kinsui S., 2003, VARCHARU NIHONGO YAK; Kinsui S., 2000, KOKUGORON KENKYU, P311; Kobayashi C., 2007, ONNA KOTOBA HA DOKOH; Komori Y., 1998, YURAGI NO HINONBUNGA; Kudo M., 2007, EMA; Lebra T., 1984, JAPANESE WOMEN CONST; Matsumoto Y., 2000, DAREMO SHIRANAI AKAG; Matsumoto Y., 2000, AKAGE NO AN; Matsunaga-Watson N., 2005, TRANSLATION CULTURAL, P161; McConnell-Ginet S., 2003, LANGUAGE GENDER; Montgomery L. M., 1977, ANNE GREEN GABLES; Muraoka H., 2003, AKAGE NO AN; Nakamura M., 2007, ONNAKOTOBA HA TSUKUR; Nakamura M., 2007, SEI TO NIHONGO; Nakamura M., 2010, JENDA MANABU GENGOGA; Nakano K., 2005, EMA, V1; Nakano K., 2005, EMA, V2; Nolte H., 1991, RECREATING JAPANESE, P151; Okamoto S., 1992, LOCATING POWER, V1, P478; Okamoto S., 2010, JENDA MANABU GENGOKA, P129; Ozaki R., 2007, WAKAMATSU SHIZUKO RE; Seelye J., 2005, JANE EYRES AM DAUGHT; Takada H., 1994, GIRL READING GIRL JA, P92; Tanaka Lidia, 2004, GENDER LANGUAGE CULT; Toury Gideon, 1995, DESCRIPTIVE TRANSLAT; Uchiyama A., 2011, GIRL READING GIRL JA, P92; Venuti L., 2012, TRANSLATION STUDIES, P126; Venuti L., 2008, TRANSLATORS INVISIBI; Walker R., 1999, CHRISTIAN SCI MONITO, V91	50	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0324-4652	1588-2810		NEOHELICON	Neohelicon	JUN	2015	42	1					297	312		10.1007/s11059-015-0299-4		16	Literature	Literature	CI6UW	WOS:000354899600018		
J	Kato, T; Hino, H; Murata, N				Kato, Toshiyuki; Hino, Hideitsu; Murata, Noboru			Multi-frame image super resolution based on sparse coding	NEURAL NETWORKS			English	Article						Image super resolution; Multi-frame super-resolution; Sparse coding	SUPERRESOLUTION; REGISTRATION; REPRESENTATION; DICTIONARIES; ALGORITHMS; REGRESSION; SYSTEMS; MOTION	An image super-resolution method from multiple observation of low-resolution images is proposed. The method is based on sub-pixel accuracy block matching for estimating relative displacements of observed images, and sparse signal representation for estimating the corresponding high-resolution image, where correspondence between high- and low-resolution images are modeled by a certain degradation process. Relative displacements of small patches of observed low-resolution images are accurately estimated by a computationally efficient block matching method. The matching scores of the block matching are used to select a subset of low-resolution patches for reconstructing a high-resolution patch, that is, an adaptive selection of informative low-resolution images is realized. The proposed method is shown to perform comparable or superior to conventional super-resolution methods through experiments using various images. (C) 2015 Elsevier Ltd. All rights reserved.	[Kato, Toshiyuki; Murata, Noboru] Waseda Univ, Sch Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Hino, Hideitsu] Univ Tsukuba, Dept Comp Sci, Tsukuba, Ibaraki 3058573, Japan	Hino, H (reprint author), Univ Tsukuba, Dept Comp Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058573, Japan.	hinohide@cs.tsukuba.ac.jp		Murata, Noboru/0000-0002-4258-6877	JSPS [25120009, 26120504, 25870811]	The authors would like to express their special thanks to the editor, the associate editor and anonymous reviewers whose comments led to valuable improvements of the manuscript. Part of this work was supported by JSPS Grant-in-Aid for Scientific Research on Innovative Areas No. 25120009, 26120504 and Grant-in-Aid for Young Scientists (B) No. 25870811.	AGGARWAL JK, 1988, P IEEE, V76, P917, DOI 10.1109/5.5965; Aharon M, 2006, IEEE T SIGNAL PROCES, V54, P4311, DOI 10.1109/TSP.2006.881199; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; NATARAJAN BK, 1995, SIAM J COMPUT, V24, P227, DOI 10.1137/S0097539792240406; Yang JC, 2010, IEEE T IMAGE PROCESS, V19, P2861, DOI 10.1109/TIP.2010.2050625; Tian J, 2011, SIGNAL IMAGE VIDEO P, V5, P329, DOI 10.1007/s11760-010-0204-6; Chen SSB, 1998, SIAM J SCI COMPUT, V20, P33, DOI 10.1137/S1064827596304010; Olshausen BA, 2005, NEURAL COMPUT, V17, P1665, DOI 10.1162/0899766054026639; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Yang JC, 2012, IEEE T IMAGE PROCESS, V21, P3467, DOI 10.1109/TIP.2012.2192127; Szeliski R, 2002, LECT NOTES COMPUT SC, V2351, P525; Chen XX, 2014, SIGNAL PROCESS, V94, P6, DOI 10.1016/j.sigpro.2013.06.016; Dong WS, 2011, IEEE T IMAGE PROCESS, V20, P1838, DOI 10.1109/TIP.2011.2108306; MALLAT SG, 1993, IEEE T SIGNAL PROCES, V41, P3397, DOI 10.1109/78.258082; Freeman WT, 2002, IEEE COMPUT GRAPH, V22, P56, DOI 10.1109/38.988747; Chang H, 2004, PROC CVPR IEEE, P275; Engan K, 1999, INT CONF ACOUST SPEE, P2443; CHEN S, 1989, INT J CONTROL, V50, P1873, DOI 10.1080/00207178908953472; TIAN Q, 1986, COMPUT VISION GRAPH, V35, P220, DOI 10.1016/0734-189X(86)90028-9; Farsiu S, 2004, IEEE T IMAGE PROCESS, V13, P1327, DOI 10.1109/TIP.2004.834669; Callico GM, 2008, IEEE T CONSUM ELECTR, V54, P1430, DOI 10.1109/TCE.2008.4637637; Li XL, 2010, SIGNAL PROCESS, V90, P405, DOI 10.1016/j.sigpro.2009.05.028; Hardie RC, 1997, IEEE T IMAGE PROCESS, V6, P1621, DOI 10.1109/83.650116; Barreto D., 2005, VIRTUAL OBSERVATORY, P254; BARRON JL, 1994, INT J COMPUT VISION, V12, P43, DOI 10.1007/BF01420984; Borman S., 1998, TECHNICAL REPORT; Brandt JW, 1997, INT J COMPUT VISION, V25, P5, DOI 10.1023/A:1007987001439; Chang K. -T., 2009, INTRO GEOGRAPHIC INF, V5th; Davis G, 1997, CONSTR APPROX, V13, P57, DOI 10.1007/BF02678430; DVORNYCHENKO VN, 1983, IEEE T PATTERN ANAL, V5, P206; Efron B, 2004, ANN STAT, V32, P407; Elad M, 2010, SPARSE AND REDUNDANT REPRESENTATIONS, P3, DOI 10.1007/978-1-4419-7011-4_1; Irani M., 1993, Journal of Visual Communication and Image Representation, V4, DOI 10.1006/jvci.1993.1030; Kamimura K., 2007, ACM SIGGRAPH 2007 PO, P63; Kanemura A, 2009, NEURAL NETWORKS, V22, P1025, DOI 10.1016/j.neunet.2008.12.005; Katsuki T, 2012, IEEE T IMAGE PROCESS, V21, P3182, DOI 10.1109/TIP.2012.2189578; Lee H., 2007, ADV NEURAL INFORM PR, V19, P801; Lucas B. D., 1981, P 7 INT JOINT C ART, V2, P674; Pati Y. C., 1993, C REC 27 AS C SIGN S, V1, P40; Shimizu M, 2006, INT J COMPUT VISION, V67, P327, DOI 10.1007/s11263-006-5632-3; Sun C., 2003, AUSTR JAP ADV WORKSH; Sun J., 2003, P IEEE C COMP VIS PA, V2, P729; Wang P., 2011, INT C MULT SIGN PROC, V1, P357; Yang J., 2008, IEEE C COMP VIS PATT, P1; Zeyde R., 2010, LEC NOTES COMPUT SCI, V6920, P711	46	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0893-6080	1879-2782		NEURAL NETWORKS	Neural Netw.	JUN	2015	66						64	78		10.1016/j.neunet.2015.02.009		15	Computer Science, Artificial Intelligence; Neurosciences	Computer Science; Neurosciences & Neurology	CI8NR	WOS:000355029500006		
J	Adachi, R; Yamada, R; Kuba, H				Adachi, Ryota; Yamada, Rei; Kuba, Hiroshi			Plasticity of the Axonal Trigger Zone	NEUROSCIENTIST			English	Review						axon initial segment; action potential; plasticity; potassium channel; sodium channel	ACTION-POTENTIAL INITIATION; HIPPOCAMPAL PYRAMIDAL NEURONS; ACTIVITY-DEPENDENT RELOCATION; GATED SODIUM-CHANNELS; SPIKE INITIATION; SEGMENT; EXCITABILITY; CYTOSKELETON; STIMULATION; GENERATION	The axon initial segment (AIS) is a specialized axonal compartment that is involved in conversion of synaptic potentials into action potentials. Recent studies revealed that structural properties of the AIS, such as length and position relative to the soma, are differentiated in a cell-specific manner and shape signal processing of individual neurons. Moreover, these structural properties are not fixed but vary in response to prolonged changes of neuronal activity, which readjusts action potential threshold and compensates for the changes of activity, indicating that this structural plasticity of the AIS works as a homeostatic mechanism and contributes to maintain neuronal activity. Neuronal activity plays a crucial role in formation, maintenance, and refinement of neural circuits as well as in pathogenesis and/or pathophysiology of diseases. Thus, this plasticity should be a key to understand physiology and pathology of the brain.	[Adachi, Ryota; Yamada, Rei; Kuba, Hiroshi] Nagoya Univ, Grad Sch Med, Dept Cell Physiol, Nagoya, Aichi 4668550, Japan; [Kuba, Hiroshi] JST, PRESTO, Saitama, Japan	Kuba, H (reprint author), Nagoya Univ, Dept Cell Physiol, Grad Sch Med, Showa Ku, 4-20 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kuba@med.nagoya-u.ac.jp	Kuba, Hiroshi/I-7519-2014		MEXT [52460285]; JST PRESTO	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by a Grant-in-Aid from the MEXT (52460285 to R.Y.) and JST PRESTO to H.K.	Yu YG, 2010, J NEUROSCI, V30, P11858, DOI 10.1523/JNEUROSCI.2651-10.2010; Kuba H, 2006, NATURE, V444, P1069, DOI 10.1038/nature05347; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Schafer DP, 2009, J NEUROSCI, V29, P13242, DOI 10.1523/JNEUROSCI.3376-09.2009; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; WESTENBROEK RE, 1990, NATURE, V347, P281, DOI 10.1038/347281a0; Lorincz A, 2010, SCIENCE, V328, P906, DOI 10.1126/science.1187958; Hinman JD, 2013, STROKE, V44, P182, DOI 10.1161/STROKEAHA.112.668749; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Kuba H, 2014, J NEUROSCI, V34, P3443, DOI 10.1523/JNEUROSCI.4357-13.2014; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; Kole MHP, 2008, NAT NEUROSCI, V11, P178, DOI 10.1038/nn2040; Harty RC, 2013, EPILEPSY RES, V105, P272, DOI 10.1016/j.eplepsyres.2013.03.004; Kuba H, 2012, J PHYSIOL-LONDON, V590, P5571, DOI 10.1113/jphysiol.2012.237305; Hu WQ, 2009, NAT NEUROSCI, V12, P996, DOI 10.1038/nn.2359; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Grubb MS, 2011, J NEUROSCI, V31, P16049, DOI 10.1523/JNEUROSCI.4064-11.2011; Boiko T, 2003, J NEUROSCI, V23, P2306; Shu YS, 2007, J NEUROPHYSIOL, V97, P746, DOI 10.1152/jn.00922.2006; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Battefeld A, 2014, J NEUROSCI, V34, P3719, DOI 10.1523/JNEUROSCI.4206-13.2014; Cruz DA, 2009, J COMP NEUROL, V514, P353, DOI 10.1002/cne.22006; Dodson PD, 2002, J NEUROSCI, V22, P6953; Goldberg EM, 2008, NEURON, V58, P387, DOI 10.1016/j.neuron.2008.03.003; Fleidervish IA, 2010, NAT NEUROSCI, V13, P852, DOI 10.1038/nn.2574; Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188; Evans MD, 2013, J NEUROSCI, V33, P6950, DOI 10.1523/JNEUROSCI.0277-13.2013; Kuba H, 2009, J PHYSIOL-LONDON, V587, P87, DOI 10.1113/jphysiol.2008.162651; COOMBS JS, 1957, J PHYSIOL-LONDON, V139, P198; Grubb MS, 2010, NATURE, V465, P1070, DOI 10.1038/nature09160; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006; Trunova S, 2011, J NEUROSCI, V31, P10451, DOI 10.1523/JNEUROSCI.0117-11.2011; Jenkins SM, 2001, J CELL BIOL, V155, P739, DOI 10.1083/jcb.200109026; Lorincz A, 2008, J NEUROSCI, V28, P14329, DOI 10.1523/JNEUROSCI.4833-08.2008; Foust A, 2010, J NEUROSCI, V30, P6891, DOI 10.1523/JNEUROSCI.0552-10.2010; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Shah MM, 2008, P NATL ACAD SCI USA, V105, P7869, DOI [10.1073/pnas.0802805105, 10.1072/pnas.0802805105]; Kaphzan H, 2011, J NEUROSCI, V31, P17637, DOI 10.1523/JNEUROSCI.4162-11.2011; Baalman KL, 2013, J NEUROTRAUM, V30, P741, DOI 10.1089/neu.2012.2478; Bender KJ, 2009, NEURON, V61, P259, DOI 10.1016/j.neuron.2008.12.004; Van Wart A, 2007, J COMP NEUROL, V500, P339, DOI 10.1002/cne.21173; Nelson SB, 2008, NEURON, V60, P477, DOI 10.1016/j.neuron.2008.10.020; Baranauskas G, 2013, P NATL ACAD SCI USA, V110, P4051, DOI 10.1073/pnas.1215125110; Fried SI, 2009, J NEUROPHYSIOL, V101, P1972, DOI 10.1152/jn.91081.2008; Kole MHP, 2012, NEURON, V73, P235, DOI 10.1016/j.neuron.2012.01.007; Kuba H, 2010, NATURE, V465, P1075, DOI 10.1038/nature09087; Kim SH, 2010, NEURON, V67, P797, DOI 10.1016/j.neuron.2010.08.003; Galiano MR, 2012, CELL, V149, P1125, DOI 10.1016/j.cell.2012.03.039; ARAKI T, 1955, J NEUROPHYSIOL, V18, P472; Buffington SA, 2011, EUR J NEUROSCI, V34, P1609, DOI 10.1111/j.1460-9568.2011.07875.x; Colbert CM, 2002, NAT NEUROSCI, V5, P533, DOI 10.1038/nn857; Del Puerto A., 2014, CEREB CORTEX; Gutzmann A, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00011; Hallermann S, 2012, NAT NEUROSCI, V15, P1007, DOI 10.1038/nn.3132; Namba T, 2014, NEURON, V81, P814, DOI 10.1016/j.neuron.2013.12.015; Ogawa Y, 2008, CURR OPIN NEUROBIOL, V18, P307, DOI 10.1016/j.conb.2008.08.008; Schmidt-Hieber C, 2010, J NEUROSCI, V30, P10233, DOI 10.1523/JNEUROSCI.6335-09.2010; Wimmer VC, 2010, J PHYSIOL-LONDON, V588, P1829, DOI 10.1113/jphysiol.2010.188417	59	1	1	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-8584	1089-4098		NEUROSCIENTIST	Neuroscientist	JUN	2015	21	3					255	265		10.1177/1073858414535986		11	Clinical Neurology; Neurosciences	Neurosciences & Neurology	CI5DR	WOS:000354773600007		
J	Takahashi, H; Kamei, A; Osawa, T; Kawahara, T; Takizawa, O; Maruyama, K				Takahashi, Hideyuki; Kamei, Akiko; Osawa, Takuya; Kawahara, Takashi; Takizawa, Osamu; Maruyama, Katsuya			C-13 MRS reveals a small diurnal variation in the glycogen content of human thigh muscle	NMR IN BIOMEDICINE			English	Article						muscle glycogen; diurnal variation; C-13 MRS; human muscle	LOW-INTENSITY EXERCISE; HUMAN SKELETAL-MUSCLE; ENERGY-METABOLISM; CIRCADIAN-RHYTHM; INSULIN; RESYNTHESIS; GLUCOSE; FIBERS; TISSUE; LIVER	There is marked diurnal variation in the glycogen content of skeletal muscles of animals, but few studies have addressed such variations in human muscles. C-13 MRS can be used to noninvasively measure the glycogen content of human skeletal muscle, but no study has explored the diurnal variations in this parameter. This study aimed to investigate whether a diurnal variation in glycogen content occurs in human muscles and, if so, to what extent it can be identified using C-13 MRS. Six male volunteers were instructed to maintain their normal diet and not to perform strenuous exercise for at least 3 days before and during the experiment. Muscle glycogen and blood glucose concentrations were measured six times in 24 h under normal conditions in these subjects. The glycogen content in the thigh muscle was determined noninvasively by natural abundance C-13 MRS using a clinical MR system at 3 T. Nutritional analysis revealed that the subjects' mean carbohydrate intake was 463 +/- 137 g, being approximately 6.8 +/- 2.4 g/kg body weight. The average sleeping time was 5.9 +/- 1.0 h. The glycogen content in the thigh muscle at the starting point was 64.8 +/- 20.6 mM. Although absolute and relative individual variations in muscle glycogen content were 7.0 +/- 2.1 mM and 11.3 +/- 4.6%, respectively, no significant difference in glycogen content was observed among the different time points. This study demonstrates that normal food intake (not fat and/or carbohydrate rich), sleep and other daily activities have a negligible influence on thigh muscle glycogen content, and that the diurnal variation of the glycogen content in human muscles is markedly smaller than that in animal muscles. Moreover, the present results also support the reproducibility and availability of C-13 MRS for the evaluation of the glycogen content in human muscles. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Takahashi, Hideyuki; Kamei, Akiko; Osawa, Takuya] Japan Inst Sports Sci, Dept Sports Sci, Tokyo 1150056, Japan; [Kawahara, Takashi] Japan Inst Sports Sci, Med Ctr, Tokyo 1150056, Japan; [Takizawa, Osamu; Maruyama, Katsuya] Siemens Japan KK, Res & Collaborat Dept, Tokyo, Japan	Takahashi, H (reprint author), Japan Inst Sports Sci, Dept Sports Sci, Kita Ku, 3-15-1 Nishigaoka, Tokyo 1150056, Japan.	hideyuki.takahashi@jpnsport.go.jp			Japan Society for the Promotion of Science (JSPS) [21300241]; Japan Institute of Sports Sciences	This study was supported by a Grant-in-Aid for Scientific Research (B) (21300241) from the Japan Society for the Promotion of Science (JSPS) and a Grant for Research Project from the Japan Institute of Sports Sciences.	AHLERSOVA E, 1980, PHYSIOL BOHEMOSLOV, V29, P515; TAYLOR R, 1992, MAGNET RESON MED, V27, P13, DOI 10.1002/mrm.1910270103; COSTILL DL, 1992, SPORTS MED, V13, P86; Casey A, 2000, AM J PHYSIOL-ENDOC M, V278, pE65; GREENHAFF PL, 1993, J PHYSIOL-LONDON, V460, P443; Price TB, 1996, P NATL ACAD SCI USA, V93, P5329, DOI 10.1073/pnas.93.11.5329; BERGSTRO.J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; CHEN CB, 1992, INT J OBESITY, V16, P913; CONLEE RK, 1976, AM J PHYSIOL, V231, P614; EDSTROM L, 1982, J PHYSIOL-LONDON, V332, P47; GREEN HJ, 1981, J NEUROL SCI, V52, P201, DOI 10.1016/0022-510X(81)90005-8; Heerschap A, 1989, NMR Biomed, V2, P124, DOI 10.1002/nbm.1940020309; HULTMAN E, 1967, SCAND J CLIN LAB INV, V19, P209, DOI 10.3109/00365516709090628; LEIGHTON B, 1988, AM J PHYSIOL, V255, pE41; PESSACQ MT, 1975, METABOLISM, V24, P737, DOI 10.1016/0026-0495(75)90041-4; Price TB, 1998, J APPL PHYSIOL, V84, P1178; PRICE TB, 1994, MED SCI SPORT EXER, V26, P983; PRICE TB, 1991, J APPL PHYSIOL, V70, P1836; PRICE TB, 1994, J APPL PHYSIOL, V76, P104; Rico-Sanz J, 1999, MED SCI SPORT EXER, V31, P1587, DOI 10.1097/00005768-199911000-00014; Saltin B, 1983, HDB PHYSL 10, P555; SODERLUND K, 1992, ACTA PHYSIOL SCAND, V144, P15, DOI 10.1111/j.1748-1716.1992.tb09262.x; Stephenson MC, 2013, NMR BIOMED, V26, P1518, DOI 10.1002/nbm.2985; Takahashi H, 1996, NMR BIOMED, V9, P8, DOI 10.1002/(SICI)1099-1492(199602)9:1<8::AID-NBM387>3.0.CO;2-F; Van Den Berghs AJ, 2000, EUR J CLIN INVEST, V30, P122	25	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	JUN	2015	28	6					650	655		10.1002/nbm.3298		6	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	CI0GY	WOS:000354416300006		
J	Nanto, H; Nakagawa, R; Takei, Y; Hirasawa, K; Miyamoto, Y; Masai, H; Kurobori, T; Yanagida, T; Fujimoto, Y				Nanto, H.; Nakagawa, R.; Takei, Y.; Hirasawa, K.; Miyamoto, Y.; Masai, H.; Kurobori, T.; Yanagida, T.; Fujimoto, Y.			Optically stimulated luminescence in x-ray irradiated xSnO-(25-x)SrO-75B(2)O(3) glass	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	OSL; Botrate glass; Dosimeter; Luminescence	IMAGING PLATE; PHOSPHORS	An intense optically stimulated luminescence (OSL) was observed, for the first time, in x-ray irradiated xSnO-(25-x)SrO-75B(2)O(3) glass. It was found that the peak wavelength of OSL emission spectrum and its stimulation spectrum is about 400 nm and 600 nm, respectively. The OSL intensity is depended on the SnO contents (x=0.05-1.5) and the most intense OSL was observed in 1.0 mol% SnO doped glass. It was found that the OSL intensity is increased with increasing x-ray absorbed dose. Fairly good fading characteristics were observed in the x-ray irradiated glass, showing that this glass is useful as a candidate for OSL sensor materials for ionizing radiation monitoring. (C) 2015 Elsevier B.V. All rights reserved.	[Nanto, H.; Nakagawa, R.; Takei, Y.; Hirasawa, K.] Kanazawa Inst Technol, Adv Mat Sci R&D Ctr, Haku San, Ishikawa 0240838, Japan; [Miyamoto, Y.] Chiyoda Technol Co, Oarai Res Ctr, Oarai, Ibaraki 3111313, Japan; [Masai, H.] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Kurobori, T.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Yanagida, T.; Fujimoto, Y.] Kyushu Inst Technol, Kitakyushu, Fukuoka 8080196, Japan	Nanto, H (reprint author), Kanazawa Inst Technol, Adv Mat Sci R&D Ctr, 3-1 Yatsukaho, Haku San, Ishikawa 0240838, Japan.						TAKAHASHI K, 1985, J ELECTROCHEM SOC, V132, P1492, DOI 10.1149/1.2114149; Masai H, 2013, SCI REP-UK, V3, DOI 10.1038/srep03541; Nanto H, 2007, NUCL INSTRUM METH A, V580, P278, DOI 10.1016/j.nima.2007.05.155; TAKEBE M, 1994, NUCL INSTRUM METH A, V345, P606, DOI 10.1016/0168-9002(94)90522-3; Yanagida T., 2014, RAD MEASASU IN PRESS	5	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						14	16		10.1016/j.nima.2014.12.033		3	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300004		
J	Fukuda, K; Yanagida, T; Fujimoto, Y				Fukuda, Kentaro; Yanagida, Takayuki; Fujimoto, Yutaka			Thermally and optically stimulated radiative processes in Eu and Y co-doped LiCaAlF6 crystal	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Scintillator; OSL; TSL; Dosimeter; LiCaAlF6; Neutron	CE; SCINTILLATION	Yttrium co-doping was attempted to enhance dosimeter performance of Eu doped LiCaAlF6 crystal. Eu doped and Eu, Y co-doped LiCaAlF6 were prepared by the micro-pulling-down technique, and their dosimeter characteristics such as optically stimulated luminescence (OSL) and thermally stimulated luminescence (TSL) were investigated. By yttrium co-doping, emission intensities of OSL and TSL were enhanced by some orders of magnitude. In contrast, scintillation characteristics of yttrium co-doped crystal such as intensity of prompt luminescence induced by X-ray and light yield under neutron irradiation were degraded. (C) 2015 Elsevier B.V. All rights reserved.	[Fukuda, Kentaro] Tokuyama Corp, Shunan, Yamaguchi 7458648, Japan; [Yanagida, Takayuki; Fujimoto, Yutaka] Kyushu Inst Technol, Kitakyushu, Fukuoka 8080196, Japan	Fukuda, K (reprint author), Tokuyama Corp, 1-1 Mikage Cho, Shunan, Yamaguchi 7458648, Japan.	ken-fukuda@tokuyama.co.jp					Amaral JB, 2004, NUCL INSTRUM METH B, V218, P232, DOI 10.1016/j.nimb.2003.12.027; Totsuka D, 2011, NUCL INSTRUM METH A, V659, P399, DOI 10.1016/j.nima.2011.08.014; Yanagida T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.106401; Pang R, 2009, MATER CHEM PHYS, V113, P215, DOI 10.1016/j.matchemphys.2008.07.061; Yanagida T, 2013, OPT MATER, V35, P1987, DOI 10.1016/j.optmat.2012.11.002; Yanagida T, 2013, OPT MATER, V35, P2480, DOI 10.1016/j.optmat.2013.07.002; Yanagida T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.062401; Yanagida T, 2010, IEEE T NUCL SCI, V57, P1492, DOI 10.1109/TNS.2009.2032265; Yanagida T, 2013, NUCL INSTRUM METH A, V729, P58, DOI 10.1016/j.nima.2013.07.010; Yanagida T, 2014, RADIAT MEAS, V71, P162, DOI 10.1016/j.radmeas.2014.03.020; Yanagida T, 2011, OPT MATER, V33, P1243, DOI 10.1016/j.optmat.2011.02.016; Yanagida T, 2014, RADIAT MEAS, V71, P148, DOI 10.1016/j.radmeas.2014.02.021; Ito T., 2006, IEEE T NUCL SCI, V53, P2983; McKeever S.W.S., 1985, THERMOLUMINESCENCE S; Miyamoto Y, 2013, RADIAT MEAS, V55, P72, DOI 10.1016/j.radmeas.2012.10.018; Yanagida T., 2013, J CERAM SOC JPN, V121, P989; Yanagida T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.076401; Yukihara E G, 2011, OPTICALLY STIMULATED	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						29	32		10.1016/j.nima.2014.12.039		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300007		
J	Yanagida, T; Watanabe, K; Fujimoto, Y				Yanagida, Takayuki; Watanabe, Kenichi; Fujimoto, Yutaka			Comparative study of neutron and gamma-ray pulse shape discrimination of anthracene, stilbene, and p-terphenyl	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Scintillator; Organic; Anthracene; Stilbene; p-Terphenyl; PSD	PLASTIC SCINTILLATOR	Solid state organic scintillators, such as anthracene, stilbene, and p-terphenyl were investigated on their basic scintillation properties and neutron-gamma discrimination capabilities. Scintillation wavelengths under X-ray irradiation of anthracene, stilbene, and p-terphenyl were 445-525, 400-500, and 350-450 nm, respectively. Scintillation light yields of anthracene, stilbene, and p-terphenyl under Cs-137 gamma-ray irradiation were 20100, 16000, and 19400 ph/MeV, respectively. Neutron and gamma-ray events discrimination capabilities were examined and anthracene exhibited the best figure of merit among three organic scintillators. (C) 2014 Elsevier B.V. All rights reserved.	[Yanagida, Takayuki; Fujimoto, Yutaka] Kyushu Inst Technol, Kitakyushu, Fukuoka 8080196, Japan; [Watanabe, Kenichi] Nagoya Univ, Chikusa Ku, Nagoya, Aichi 4648603, Japan	Yanagida, T (reprint author), Kyushu Inst Technol, 2-4 Hibikino, Kitakyushu, Fukuoka 8080196, Japan.	yanagida@lsse.kyutech.ac.jp					Angelone M, 2014, IEEE T NUCL SCI, V61, P1483, DOI 10.1109/TNS.2014.2322106; Yamazaki A, 2011, NUCL INSTRUM METH A, V652, P435, DOI 10.1016/j.nima.2011.02.064; Zhmurin PN, 2014, NUCL INSTRUM METH A, V761, P92, DOI 10.1016/j.nima.2014.05.084; Yanagida T, 2013, OPT MATER, V35, P1987, DOI 10.1016/j.optmat.2012.11.002; Yanagida T, 2013, OPT MATER, V35, P2480, DOI 10.1016/j.optmat.2013.07.002; Yanagida T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.062401; Gamage KAA, 2011, NUCL INSTRUM METH A, V642, P78, DOI 10.1016/j.nima.2011.03.065; Pozzi SA, 2013, NUCL INSTRUM METH A, V723, P19, DOI 10.1016/j.nima.2013.04.085; Hawkes NP, 2013, NUCL INSTRUM METH A, V729, P522, DOI 10.1016/j.nima.2013.07.071; Hamel M, 2014, NUCL INSTRUM METH A, V768, P26, DOI 10.1016/j.nima.2014.09.029; HARIHAR P, 1991, NUCL INSTRUM METH A, V302, P469, DOI 10.1016/0168-9002(91)90361-S; Iwanowska J, 2011, J INSTRUM, V6, DOI 10.1088/1748-0221/6/07/P07007; Knoll G.F., 2001, RAD DETECTION MEASUR, V3rd; Kouzes R. T., 2009, PNNL18388; Kovash M.A., 2011, ADV NUCL INSTRUMENTA; Pawelczak L.A., 2014, NUCL INSTRUMENTS M A, V751, P62; Santiago LM, 2014, APPL RADIAT ISOTOPES, V93, P18, DOI 10.1016/j.apradiso.2014.04.002; Zaitseva N.P., P SPIE, V7449	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						111	114		10.1016/j.nima.2014.12.031		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300021		
J	Kurosawa, S; Shishido, T; Suzuki, A; Sugawara, T; Nomura, A; Yubuta, K; Shoji, Y; Yokota, Y; Pejchal, J; Ohashi, Y; Kamada, K; Yoshikawa, A				Kurosawa, Shunsuke; Shishido, Toetsu; Suzuki, Akira; Sugawara, Takamasa; Nomura, Akiko; Yubuta, Kunio; Shoji, Yasuhiro; Yokota, Yuui; Pejchal, Jan; Ohashi, Yuji; Kamada, Kei; Yoshikawa, Akira			Scintillation properties of a La, Lu-admix gadolinium pyrosilicate crystal	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Scintillator; Pyrosilicate crystal; Ce-doped (La, Lu, Gd)(2)Si2O7	ENERGY-RESOLUTION	In order to obtain new scintillator with higher effective atomic number, a pyrosilicate crystal with a composition (Ce-0.01, Gd-0.54, La-0.25, Lu-0.20)(2)Si2O7 (Ce:LaLu-GPS) was grown by the floating zone method. Emission wavelengths of this material were at 370 and 390 nm. Gamma-ray-excited pulse height and scintillation decay measurement showed that Ce:LaLu-GPS had a light output of 34,000 +/- 2000 photons/MeV, an FWHM energy resolution of 6.9 +/- 0.2%, and the decay time components of 59 +/- 1 ns (13%) and 570 +/- 20 ns (87%). (C) 2015 Elsevier B.V. All rights reserved.	[Kurosawa, Shunsuke; Shishido, Toetsu; Suzuki, Akira; Sugawara, Takamasa; Nomura, Akiko; Yubuta, Kunio; Shoji, Yasuhiro; Ohashi, Yuji; Yoshikawa, Akira] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Kurosawa, Shunsuke; Pejchal, Jan; Kamada, Kei; Yoshikawa, Akira] New Ind Creat Hatchery Ctr NICHe, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Shoji, Yasuhiro; Kamada, Kei; Yoshikawa, Akira] C&A Corp, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Pejchal, Jan] Acad Sci Czech Republic, Inst Phys, Prague 16253, Czech Republic	Kurosawa, S (reprint author), Tohoku Univ, Inst Mat Res, Aoba Ku, 2-1-1 Katahira, Sendai, Miyagi 9808577, Japan.	kurosawa@imr.tohoku.ac.jp					van Eijk CWE, 2001, RADIAT MEAS, V33, P521, DOI 10.1016/S1350-4487(01)00045-2; Moszynski M, 1999, IEEE T NUCL SCI, V46, P880, DOI 10.1109/23.790697; Kurosawa S, 2014, NUCL INSTRUM METH A, V744, P30, DOI 10.1016/j.nima.2014.01.018; van Loef EVD, 2001, APPL PHYS LETT, V79, P1573, DOI 10.1063/1.1385342; Kaneko JH, 2004, NUCL INSTRUM METH A, V529, P307, DOI 10.1016/j.nima.2004.04.169; Kaneko Junichi H., 2012, AMITY I NUCL SCI TEC, V3, P109; Kawamura S, 2006, IEEE NUCL SCI CONF R, P1160, DOI 10.1109/NSSMIC.2006.356049; Kawamura S, 2007, NUCL INSTRUM METH A, V583, P356, DOI 10.1016/j.nima.2007.09.021; Mayneord W., 1937, CONTRA CANCRUM, V2, P271; Melcher C.L, 1996, INORGANIC SCINTILLAT; SAKAI E, 1987, IEEE T NUCL SCI, V34, P418, DOI 10.1109/TNS.1987.4337375; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Suzuki A, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.102601; Taylor ML, 2012, MED PHYS, V39, P1769, DOI 10.1118/1.3689810; Toropov N. A., 1961, RUSS CHEM B, V10, P497	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						115	118		10.1016/j.nima.2014.12.108		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300022		
J	Sato, Y; Shimaoka, T; Kaneko, JH; Murakami, H; Isobe, M; Osakabe, M; Tsubota, M; Ochiai, K; Chayahara, A; Umezawa, H; Shikata, S				Sato, Yuki; Shimaoka, Takehiro; Kaneko, Junichi H.; Murakami, Hiroyuki; Isobe, Mitsutaka; Osakabe, Masaki; Tsubota, Masakatsu; Ochiai, Kentaro; Chayahara, Akiyoshi; Umezawa, Hitoshi; Shikata, Shinichi			Radiation hardness of a single crystal CVD diamond detector for MeV energy protons	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Plasma diagnostics; Diamond detector; Single-crystal CVD diamond; Radiation hardness	SILICON; DIAGNOSTICS; SURFACE; TFTR	We have fabricated a particle detector using single crystal diamond grown by chemical vapor deposition. The irradiation dose dependence of the output pulse height from the diamond detector was measured using 3 MeV protons. The pulse height of the output signals from the diamond detector decreases as the amount of irradiation increases at count rates of 1.6-8.9 kcps because of polarization effects inside the diamond crystal. The polarization effect can be cancelled by applying a reverse bias voltage, which restores the pulse heights. Additionally, the radiation hardness performance for MeV energy protons was compared with that of a silicon surface barrier detector. (C) 2014 Elsevier B.V. All rights reserved.	[Sato, Yuki; Murakami, Hiroyuki] RIKEN, Inst Phys & Chem Res, Wako, Saitama 3510198, Japan; [Shimaoka, Takehiro; Kaneko, Junichi H.; Tsubota, Masakatsu] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Isobe, Mitsutaka; Osakabe, Masaki] Natl Inst Nat Sci, Natl Inst Fus Sci, Toki, Gifu 5095292, Japan; [Ochiai, Kentaro] Japan Atom Energy Agcy, Fus Res & Dev Directorate, Tokai, Ibaraki 3191195, Japan; [Chayahara, Akiyoshi; Umezawa, Hitoshi; Shikata, Shinichi] Natl Inst Adv Ind Sci & Technol, Ikeda, Osaka 5638577, Japan	Sato, Y (reprint author), RIKEN, Inst Phys & Chem Res, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	y.sato@riken.jp	Umezawa, Hitoshi/C-9629-2011	Umezawa, Hitoshi/0000-0002-0838-4497			Sasao M, 2008, FUSION SCI TECHNOL, V53, P604; Balmer RS, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/36/364221; CANALI C, 1979, NUCL INSTRUM METHODS, V160, P73, DOI 10.1016/0029-554X(79)90167-8; KOIKE J, 1992, APPL PHYS LETT, V60, P1450, DOI 10.1063/1.107267; Krasilnikov AV, 1997, REV SCI INSTRUM, V68, P553, DOI 10.1063/1.1147651; JACOBONI C, 1977, SOLID STATE ELECTRON, V20, P77, DOI 10.1016/0038-1101(77)90054-5; Bale DS, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.035205; Darrow DS, 1997, FUSION ENG DES, V34-35, P53, DOI 10.1016/S0920-3796(96)00690-4; Funaki M., 2007, INT WORKSH SEM PET; IKOMA T, 1974, APPL PHYS, V3, P431, DOI 10.1007/BF00885852; Kaneko JH, 2012, DIAM RELAT MATER, V26, P45, DOI 10.1016/j.diamond.2012.03.001; Knoll G. F., 2000, RAD DETECTION MEASUR; Krasilnikov A.V., 1998, DIAGNOSTICS EXPT THE, V2, P439; Loffe Physical Technical Institute, NEW SEM MAT CHAR PRO; NAKAMOTO S, 1974, JPN J APPL PHYS, V13, P524, DOI 10.1143/JJAP.13.524; Pierson H. O., 1993, HDB CARBON GRAPHITE; Ziegler J.F., SRIM 2008 SOFTWARE P	17	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						147	150		10.1016/j.nima.2014.12.036		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300028		
J	Toh, K; Nakamura, T; Sakasai, K; Soyama, K; Yamagishi, H				Toh, K.; Nakamura, T.; Sakasai, K.; Soyama, K.; Yamagishi, H.			Development of a ceramic-insulated ball-anode element for neutron detection	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Neutron; Two-dimensional detector; Ceramic insulator; Ball anode	PARTICLE; CHAMBER	A novel ceramic-insulated detector element was developed for two-dimensional neutron measurement, and an irradiation experiment was performed using a Cf-252 neutron source. The element consisted of a ceramic insulator and a ball-shaped anode. It is estimated that a ceramic insulator can suppress the background noise caused by unintentionally scattered neutrons. An electrical field of 1.60 x 10(7) V/m was obtained based on a calculation at the top of the ball-shaped anode. Neutron signals were clearly observed using the detector element, thus validating its operation. (C) 2014 Elsevier B.V. All rights reserved.	[Toh, K.; Nakamura, T.; Sakasai, K.; Soyama, K.; Yamagishi, H.] Japan Atom Energy Agcy, J PARC Ctr, Tokai, Ibaraki 3191195, Japan; [Yamagishi, H.] Nippon Adv Technol, Tokai, Ibaraki 3191112, Japan	Toh, K (reprint author), Japan Atom Energy Agcy, J PARC Ctr, Tokai, Ibaraki 3191195, Japan.	toh.kentaro@jaea.go.jp					Giomataris Y, 1996, NUCL INSTRUM METH A, V376, P29, DOI 10.1016/0168-9002(96)00175-1; Sato T, 2013, J NUCL SCI TECHNOL, V50, P913, DOI 10.1080/00223131.2013.814553; BOUCLIER R, 1992, NUCL INSTRUM METH A, V323, P240, DOI 10.1016/0168-9002(92)90296-G; Ochi A, 2001, NUCL INSTRUM METH A, V471, P264, DOI 10.1016/S0168-9002(01)00996-2; Sauli F, 1997, NUCL INSTRUM METH A, V386, P531, DOI 10.1016/S0168-9002(96)01172-2; Toh K, 2009, IEEE T NUCL SCI, V56, P2410, DOI 10.1109/TNS.2009.2022941; Toh K, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01025	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						194	197		10.1016/j.nima.2014.11.029		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300037		
J	Nakamura, T; Toh, K; Kawasaki, T; Ebine, M; Birumachi, A; Sakasai, K; Soyama, K				Nakamura, T.; Toh, K.; Kawasaki, T.; Ebine, M.; Birumachi, A.; Sakasai, K.; Soyama, K.			A two-dimensional scintillation-based neutron detector with wavelength-shifting fibers and incorporating an interpolation method	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	High spatial resolution; Scintillator-based neutron detector; Wavelength-shifting fiber; Interpolation method; Photon counting method		A two-dimensional scintillation-based neutron detector with wavelength-shifting (WLS) fibers was developed that incorporated a novel data interpolation method. The interpolation method, which was developed for a photon-counting detector, produced an effective pixel size smaller than the physical pitch of the WLS fibers in the array. The WLS-fibers array was constructed by placing fibers at a regular pitch of 2.5 mm in both the x and y directions. The two crossed fiber arrays were sandwiched with two scintillator screens. Detectors with half- and quarter-pitch calculation logics exhibited spatial resolutions of 2.7 +/- 0.1 and 2.5 +/- 0.1 mm, respectively, for the full width at half maximum (for a 1-mm beam width). The corresponding effective pixel sizes were 1.25 and 0.625 mm. The measured spatial resolutions were approximately 1.3-fold better than that with the standard-pitch calculation logic. The presented results demonstrate the feasibility of using the developed interpolation method with a collimated neutron beam. (C) 2014 Elsevier B.V. All rights reserved.	[Nakamura, T.; Toh, K.; Kawasaki, T.; Sakasai, K.; Soyama, K.] Japan Atom Energy Agcy, J PARC, Naka, Ibaraki 3191195, Japan; [Ebine, M.; Birumachi, A.] Japan Atom Energy Agcy, Inst Nucl Sci, Ibaraki 3191195, Japan	Nakamura, T (reprint author), Japan Atom Energy Agcy, J PARC, 2-4 Shirakatashirane, Naka, Ibaraki 3191195, Japan.	nakamura.tatsuya@jaea.go.jp					ANGER HO, 1958, REV SCI INSTRUM, V29, P27, DOI 10.1063/1.1715998; Nakamura T, 2012, NUCL INSTRUM METH A, V686, P64, DOI 10.1016/j.nima.2012.05.038; Gorin A, 2002, NUCL INSTRUM METH A, V479, P456, DOI 10.1016/S0168-9002(01)00907-X; Hosoya T, 2009, NUCL INSTRUM METH A, V600, P217, DOI 10.1016/j.nima.2008.11.123; FORSYTH JB, 1988, NUCL INSTRUM METH A, V273, P741, DOI 10.1016/0168-9002(88)90089-7; Katagiri M, 2007, NUCL INSTRUM METH A, V573, P149, DOI 10.1016/j.nima.2006.11.011; Nakamura T, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/02/C02003; SNS facilities in the United States, [No title captured], Patent No. 8253107	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						202	207		10.1016/j.nima.2014.12.035		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300039		
J	Kataoka, J; Kishimoto, A; Fujita, T; Nishiyama, T; Kurei, Y; Tsujikawa, T; Oshima, T; Taya, T; Iwamoto, Y; Ogata, H; Okochi, H; Ohsuka, S; Ikeda, H; Yamamoto, S				Kataoka, J.; Kishimoto, A.; Fujita, T.; Nishiyama, T.; Kurei, Y.; Tsujikawa, T.; Oshima, T.; Taya, T.; Iwamoto, Y.; Ogata, H.; Okochi, H.; Ohsuka, S.; Ikeda, H.; Yamamoto, S.			Recent progress of MPPC-based scintillation detectors in high precision X-ray and gamma-ray imaging	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Multi-pixel photon counter (MPPC); Scintillator; Next generation PET; Compton camera	AVALANCHE PHOTODIODES; SMALL ANIMALS; PET SCANNERS; CAMERA; PERFORMANCE; SYSTEM; MODULE; ARRAY	The multi-pixel photon counter (MPPC) is a promising light sensor for various applications, not only in physics experiments but also in nuclear medicine, industry, and even high-energy astrophysics. In this paper, we present the current status and most recent progress of the MPPC-based scintillation detectors, such as (1) a high-precision X-ray and gamma-ray spectral image sensor, (2) next-generation PET detectors with MRI, TOF, and DOI measurement capabilities, and (3) a compact gamma camera for environmental radiation surveys. We first present a new method of fabricating a Ce:GAGG scintillator plate (1 or 2 mm thick) with ultra-fine resolution (0.2 mm/pixel), cut using a dicing saw to create 50 mu m wide micro-grooves. When the plate is optically coupled with a large-area MPPC array, excellent spatial resolution of 0.48 mm (FWHM) and energy resolution of 14% (FWHM) are obtained for 122 keV gamma rays. Hence, the detector can act as a convenient "multi-color" imaging device that can potentially be used for future SPECT and photon-counting CT. We then show a prototype system for a high-resolution MPPC-based PET scanner that can realize similar or equal to 1 mm (FWHM) spatial resolution, even under a strong magnetic field of 4.7 T. We develop a front-end ASIC intended for future TOF-PET scanner with a 16-channel readout that achieves a coincidence time resolution of 489 ps (FWHM). A novel design for a module with DOI-measurement capability for gamma rays is also presented by measuring the pulse height ratio of double-sided MPPCs coupled at both ends of scintillation crystal block. Finally, we present the concept of a two-plane Compton camera consisting of Ce:GAGG scintillator arrays coupled with thin MPPC arrays. As a result of the thin and compact features of the MPPC device, the camera not only achieves a small size (14 x 14 x 15 cm(3)) and light weight (1.9 kg) but also excellent sensitivity, compared to the conventional PMT-based pinhole camera used in Fukushima. Finally, we briefly describe a new product recently developed in conjunction with Hamamatsu Photonics K.K. that offers improved sensitivity and angular resolution of Delta theta similar to 8 degrees (FWHM) at 662 key, by incorporating DOI-segmented scintillator arrays. (C) 2014 Elsevier B.V. All rights reserved.	[Kataoka, J.; Kishimoto, A.; Fujita, T.; Nishiyama, T.; Kurei, Y.; Tsujikawa, T.; Oshima, T.; Taya, T.; Iwamoto, Y.; Ogata, H.; Okochi, H.] Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Ohsuka, S.] Hamamatsu Photon KK, Cent Res Lab, Hamakita Ku, Hamamatsu, Shizuoka, Japan; [Ikeda, H.] ISAS JAXA, Chuo Ku, Sagamihara, Kanagawa, Japan; [Yamamoto, S.] Nagoya Univ, Dept Radiol & Med Lab Sci, Showa Ku, Nagoya, Aichi, Japan	Kataoka, J (reprint author), Waseda Univ, Res Inst Sci & Engn, Shinjuku Ku, 3-4-1 Okubo, Tokyo 1698555, Japan.	kataoka.jun@waseda.jp					Ambe T., 2014, NUCL INSTRUMENTS M A; Kishimoto A, 2013, IEEE T NUCL SCI, V60, P38, DOI 10.1109/TNS.2012.2233215; Kataoka J, 2013, NUCL INSTRUM METH A, V732, P403, DOI 10.1016/j.nima.2013.07.018; WEBB PP, 1974, RCA REV, V35, P234; Yamamoto S, 2011, PHYS MED BIOL, V56, P4147, DOI 10.1088/0031-9155/56/13/026; Kataoka J, 2005, NUCL INSTRUM METH A, V541, P398, DOI 10.1016/j.nima.2005.01.081; Yamamoto S, 2010, PHYS MED BIOL, V55, P5817, DOI 10.1088/0031-9155/55/19/013; Nakamori T, 2012, J INSTRUM, V7, DOI 10.1088/1748-0221/7/01/C01083; Yamamoto S, 2013, PHYS MED BIOL, V58, P7875, DOI 10.1088/0031-9155/58/21/7875; Kato T, 2013, NUCL INSTRUM METH A, V699, P235, DOI 10.1016/j.nima.2012.04.008; Delifino E.P., 2010, IEEE NUCL SCI S, P3442; Dokhale P, 2009, IEEE NUCL SCI CONF R, P2809, DOI 10.1109/NSSMIC.2009.5401653; Fujita T, 2014, NUCL INSTRUM METH A, V765, P262, DOI 10.1016/j.nima.2014.04.060; Hall DJ, 2012, NUCL INSTRUM METH A, V678, P64, DOI 10.1016/j.nima.2012.03.013; Inadama N, 2014, IEEE T NUCL SCI, V61, P53, DOI 10.1109/TNS.2013.2293599; Kataoka J., 2010, IEEE T NUCL SCI, V57, P2448; Kato T., 2011, J INSTRUM, V638, P83; Kishimoto A., 2014, J INSTRUMEN IN PRESS; Kurei Y., 2014, J INSTRUMEN IN PRESS; Kurei Y, 2014, NUCL INSTRUM METH A, V765, P275, DOI 10.1016/j.nima.2014.04.040; Matsuda H, 2013, NUCL INSTRUM METH A, V699, P211, DOI 10.1016/j.nima.2012.05.040; Nishiyama T., 2013, IEEE NUCL SCI S NSSM, V2013; Pani R, 2003, NUCL INSTRUM METH A, V513, P36, DOI 10.1016/S0168-9002(03)02132-6; Suzuki H., 2013, IEEE NUCL SCI S, V2013; Taghibakhsh F, 2009, IEEE NUCL SCI CONF R, P2821, DOI 10.1109/NSSMIC.2009.5401646; Takeuchi K, 2014, NUCL INSTRUM METH A, V765, P187, DOI 10.1016/j.nima.2014.04.039; Takeuchi K., 2013, IEEE NUCL SCI S, V2013; Tsujikawa T, 2014, NUCL INSTRUM METH A, V765, P247, DOI 10.1016/j.nima.2014.06.033; Xi W., 2010, NUCL MED BIOL, V37, P24; Yamamoto K., 2006, IEEE NUCL SCI S, VN30-102, P1094; Yamamoto K, 2013, NUCL INSTRUM METH A, V732, P547, DOI 10.1016/j.nima.2013.07.004	31	2	2	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						248	254		10.1016/j.nima.2014.11.004		7	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300047		
J	Watanabe, K; Yamazaki, T; Sugimoto, D; Yamazaki, A; Uritani, A; Iguchi, T; Fukuda, K; Ishidu, S; Yanagida, T; Fujimoto, Y				Watanabe, Kenichi; Yamazaki, Takuya; Sugimoto, Dai; Yamazaki, Atsushi; Uritani, Akira; Iguchi, Tetsuo; Fukuda, Kentaro; Ishidu, Sumito; Yanagida, Takayuki; Fujimoto, Yutaka			Wavelength-shifting fiber signal readout from Transparent RUbber SheeT (TRUST) type LiCaAlF6 neutron scintillator	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	He-3 alternatives; Neutron detector; TRUST Eu:LiCAF; Neutron scintillator		As an alternative to the standard He-3 neutron detector, we are developing the Transparent RUbber SheeT type (TRUST) Eu doped LiCaAlF6 (Eu:LiCAF) scintillator. This type of neutron scintillator can easily be fabricated as a large area sheet. In order to take advantage of a large area detector, we try to readout scintillation photons using a wavelength-shifting fiber (WLSF) from a TRUST Eu:LiCAF scintillator. The TRUST Eu:LiCAF scintillator with the size of 50 x 50 x 5 mm(3) was mounted on the WLSF plate and the end of the WLSFs was connected with a PMT. In order to reject high pulse height events induced in the WLSFs, we applied the pulse shape discrimination technique. The gamma-ray intrinsic and neutron absolute detection efficiency is evaluated to be 8.8 x 10(-7) and 9 x 10(-3) cps/ng Cf (2 m) for the TRUST Eu: LiCAF scintillator with the size of 50 x 50 x 5 mm(3). (C) 2014 Elsevier B.V. All rights reserved.	[Watanabe, Kenichi; Yamazaki, Takuya; Sugimoto, Dai; Yamazaki, Atsushi; Uritani, Akira; Iguchi, Tetsuo] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Fukuda, Kentaro; Ishidu, Sumito] Tokuyama Corp, Shunan 7458648, Japan; [Yanagida, Takayuki; Fujimoto, Yutaka] Kyushu Inst Technol, Kitakyushu, Fukuoka 8080196, Japan	Watanabe, K (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	k-watanabe@nucl.nagoya-u.ac.jp					Yanagida T, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.106401; Yoshikawa A, 2009, IEEE T NUCL SCI, V56, P3796, DOI 10.1109/TNS.2009.2033115; Yamazaki A, 2011, NUCL INSTRUM METH A, V652, P435, DOI 10.1016/j.nima.2011.02.064; Kouzes RT, 2010, NUCL INSTRUM METH A, V623, P1035, DOI 10.1016/j.nima.2010.08.021; Yanagida T, 2011, OPT MATER, V33, P1243, DOI 10.1016/j.optmat.2011.02.016; Kouzes R. T., 2009, PNNL18388; Lintereur A.T., 2009, PNNL18938; Watanabe K, 2013, IEEE T NUCL SCI, V60, P959, DOI 10.1109/TNS.2012.2228233	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						260	263		10.1016/j.nima.2014.11.109		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300049		
J	Shimazoe, K; Horiki, K; Takahashi, H				Shimazoe, K.; Horiki, K.; Takahashi, H.			Development of a prototype scintillator-based portable gamma-ray imager with coded aperture for intraoperative applications	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Lymph node; Coded aperture; Time-over-threshold	PROBES	In surgical treatment, the intraoperative detection of tissues is becoming important in order to localize malignant functionality. Visual inspection, which is mostly used, results in lower contrast whereas dual inspection with radio and optical sensors is more promising for accurate detection. A scintillator-based portable gamma-ray imager with a coded aperture has been designed and fabricated for exploring the use of coded-aperture imaging in intraoperative applications. The gamma-ray detector is composed of a 12 x 12 array of 2 x 2 x 10 mm(3) Ce:GAGG (Ce doped Gd3Al2Ga3O12) crystals individually coupled to a 12 x 12 avalanche photodiode (APD) array. The APDs are individually read out using a custom-designed readout system using a time-over-threshold application-specific integrated circuit and field-programmable gate array. The coded aperture consists of M-array based holes of 0.5 mm size on a 0.3-mm thickness tungsten collimator. The imaging performance in the x, y, and z directions is measured and characterized for 122-keV gamma rays. (C) 2015 Elsevier B.V. All rights reserved.	[Shimazoe, K.; Horiki, K.; Takahashi, H.] Univ Tokyo, Tokyo 1138656, Japan	Shimazoe, K (reprint author), Univ Tokyo, Dept Nucl Engn & Management, Bunkyo Ku, Tokyo 1138656, Japan.	Shimazoe@bioeng.t.u-tokyo.ac.jp					Hoffman EJ, 1999, EUR J NUCL MED, V26, P913, DOI 10.1007/s002590050468; Wendler T, 2007, LECT NOTES COMPUT SC, V4792, P909; Frisch B, 2013, NUCL INSTRUM METH A, V732, P577, DOI 10.1016/j.nima.2013.05.027; Fujii H, 2012, MOL IMAGING BIOL, V14, P173, DOI 10.1007/s11307-011-0494-2; Fujimura Sadao, 1992, KEISOKU JIDO SEIGYO, V28, P426; Gal O, 2006, NUCL INSTRUM METH A, V563, P233, DOI 10.1016/j.nima.2006.01.119; Shimazoe Kenji, 2013, DETECTORS ASS EQUIPM, V731, P109	7	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						394	397		10.1016/j.nima.2015.01.077		4	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300071		
J	Kim, NY; Abe, K; Hieda, K; Hiraid, K; Hirano, S; Kishimoto, Y; Kobayashi, K; Moriyama, S; Nakagawa, K; Nakahata, M; Nishiie, H; Ogawa, H; Oka, N; Sekiya, H; Shinozaki, A; Suzuki, Y; Takeda, A; Takachio, O; Ueshima, K; Umemoto, D; Yamashita, M; Yang, BS; Tasaka, S; Liu, J; Martens, K; Hosokawa, K; Miuchi, K; Murata, A; Onishi, Y; Otsuka, Y; Takeuchi, Y; Kim, YH; Lee, KB; Lee, MK; Lee, JS; Fukuda, Y; Itow, Y; Nishitani, Y; Masuda, K; Takiya, H; Uchida, H; Kim, YD; Kusaba, F; Motoki, D; Nishijima, K; Fujii, K; Murayama, I; Nakamura, S				Kim, N. Y.; Abe, K.; Hieda, K.; Hiraid, K.; Hirano, S.; Kishimoto, Y.; Kobayashi, K.; Moriyama, S.; Nakagawa, K.; Nakahata, M.; Nishiie, H.; Ogawa, H.; Oka, N.; Sekiya, H.; Shinozaki, A.; Suzuki, Y.; Takeda, A.; Takachio, O.; Ueshima, K.; Umemoto, D.; Yamashita, M.; Yang, B. S.; Tasaka, S.; Liu, J.; Martens, K.; Hosokawa, K.; Miuchi, K.; Murata, A.; Onishi, Y.; Otsuka, Y.; Takeuchi, Y.; Kim, Y. H.; Lee, K. B.; Lee, M. K.; Lee, J. S.; Fukuda, Y.; Itow, Y.; Nishitani, Y.; Masuda, K.; Takiya, H.; Uchida, H.; Kim, Y. D.; Kusaba, F.; Motoki, D.; Nishijima, K.; Fujii, K.; Murayama, I.; Nakamura, S.			Micro-source development for XMASS experiment	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Dark matter search; Calibration source; Micro-size radioactive source	DETECTOR; SEARCH	XMASS is a multipurpose liquid-xenon detector that currently aims to directly detect dark matter. In this paper, we describe the fabrication and characterization of reference sources used for the energy calibration and position reconstruction of the present XMASS detector. Several gamma-ray sources were produced in the form of a sealed needle-source. A thin-wall tube with a diameter of approximately 0.2 mm was sealed at both ends, with the Am-241 or Co-57 source material contained inside. The active region of the source was observed to be 1-2 mm long, close to the tip of the needle. These sources were tested in the XMASS detector, and the results were compared with Monte-Carlo simulations. (C) 2014 Elsevier B.V. All rights reserved.	[Abe, K.; Hieda, K.; Hiraid, K.; Hirano, S.; Kishimoto, Y.; Kobayashi, K.; Moriyama, S.; Nakagawa, K.; Nakahata, M.; Nishiie, H.; Ogawa, H.; Oka, N.; Sekiya, H.; Shinozaki, A.; Suzuki, Y.; Takeda, A.; Takachio, O.; Ueshima, K.; Umemoto, D.; Yamashita, M.; Yang, B. S.] Univ Tokyo, Inst Cosm Ray Res, Kamioka Observ, Gifu 5061205, Japan; [Tasaka, S.] Gifu Univ, Informat & Multimedia Ctr, Gifu 5011193, Japan; [Abe, K.; Hiraid, K.; Kishimoto, Y.; Kobayashi, K.; Moriyama, S.; Nakahata, M.; Ogawa, H.; Sekiya, H.; Suzuki, Y.; Takeda, A.; Yamashita, M.; Martens, K.; Takeuchi, Y.] Univ Tokyo, Kavli Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778582, Japan; [Itow, Y.] Nagoya Univ, Kobayashi Maskawa Inst Origin Particles & Univers, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Hosokawa, K.; Miuchi, K.; Murata, A.; Onishi, Y.; Otsuka, Y.; Takeuchi, Y.] Kobe Univ, Dept Phys, Kobe, Hyogo 6578501, Japan; [Kim, N. Y.; Kim, Y. H.; Lee, K. B.; Lee, M. K.; Lee, J. S.] Korea Res Inst Stand & Sci, Taejon 305340, South Korea; [Fukuda, Y.] Miyagi Univ Educ, Dept Phys, Sendai, Miyagi 9800845, Japan; [Itow, Y.; Nishitani, Y.; Masuda, K.; Takiya, H.; Uchida, H.] Nagoya Univ, Solar Terr Environm Lab, Nagoya, Aichi 4648602, Japan; [Kim, N. Y.; Kim, Y. D.] Sejong Univ, Dept Phys, Seoul 143747, South Korea; [Kusaba, F.; Nishijima, K.] Tokai Univ, Dept Phys, Hiratsuka, Kanagawa 2591292, Japan; [Motoki, D.] Tokai Univ, Sch Sci & Technol, Hiratsuka, Kanagawa 2591292, Japan; [Fujii, K.; Murayama, I.; Nakamura, S.] Yokohama Natl Univ, Fac Engn, Dept Phys, Yokohama, Kanagawa 2408501, Japan	Kim, NY (reprint author), Ctr Underground Phys, Inst Basic Sci, Taejon 305811, South Korea.	nykim@ibs.re.kr					Abe K, 2013, PHYS LETT B, V719, P78, DOI 10.1016/j.physletb.2013.01.001; Abe K, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.121301; Agostinelli S., 2003, NUCL INSTRUMENTS M A, V506, P418; Abe K, 2013, PHYS LETT B, V724, P46, DOI 10.1016/j.physletb.2013.05.060; Abe K, 2013, NUCL INSTRUM METH A, V716, P78, DOI 10.1016/j.nima.2013.03.059; BEGEMAN KG, 1991, MON NOT R ASTRON SOC, V249, P523; Jungman G, 1996, PHYS REP, V267, P195, DOI 10.1016/0370-1573(95)00058-5; Cheng HC, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.211301; Knop RA, 2003, ASTROPHYS J, V598, P102, DOI 10.1086/378560; Ellis J, 2005, PHYS REV D, V71, DOI 10.1103/PhysRevD.71.075007; Birkedal-Hansen A, 2004, PHYS REV D, V69, DOI 10.1103/PhvsRevD.69.065022; Bottino A., 2004, PHYS REV D, V69; Dunkley J., 2009, ASTROPHYSICAL J SUPP, V180, P102; Komatsu E, 2011, ASTROPHYS J SUPPL S, V192, DOI 10.1088/0067-0049/192/2/18; Suzuki Y., ARXIVHEPPH10008296; Uchida H, 2014, PROG THEOR EXP PHYS, DOI 10.1093/ptep/ptu064	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						499	503		10.1016/j.nima.2014.11.012		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300088		
J	Shane, R; McIntosh, AB; Isobe, T; Lynch, WG; Baba, H; Barney, J; Chajecki, Z; Chartier, M; Estee, J; Famiano, M; Hong, B; Ieki, K; Jhang, G; Lemmon, R; Lu, F; Murakami, T; Nakatsuka, N; Nishimura, M; Olsen, R; Powell, W; Sakurai, H; Taketani, A; Tangwancharoen, S; Tsang, MB; Usukura, T; Wang, R; Yennello, SJ; Yurkon, J				Shane, R.; McIntosh, A. B.; Isobe, T.; Lynch, W. G.; Baba, H.; Barney, J.; Chajecki, Z.; Chartier, M.; Estee, J.; Famiano, M.; Hong, B.; Ieki, K.; Jhang, G.; Lemmon, R.; Lu, F.; Murakami, T.; Nakatsuka, N.; Nishimura, M.; Olsen, R.; Powell, W.; Sakurai, H.; Taketani, A.; Tangwancharoen, S.; Tsang, M. B.; Usukura, T.; Wang, R.; Yennello, S. J.; Yurkon, J.			S pi RIT: A time-projection chamber for symmetry-energy studies	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Time projection chamber; Rare isotope beams; Equation of state		A time-projection chamber (TPC) called the SAMURAI Pion-Reconstruction and Ion-Tracker (S pi RIT) has recently been constructed at Michigan State University as part of an international effort to constrain the symmetry-energy term in the nuclear Equation of State (EoS). The S pi RIT TPC will be used in conjunction with the SAMURAI spectrometer at the Radioactive Isotope Beam Factory (RIBF) at RIKEN to measure yield ratios for pions and other light isospin multiplets produced in central collisions of neutron-rich heavy ions, such as Sn-132+Sn-124. The S pi RIT TPC can function both as a TPC detector and as an active target. It has a vertical drift length of 50 cm, parallel to the magnetic field. Gas multiplication is achieved through the use of a multi-wire anode plane. Image charges, produced in the 12096 pads, are read out with the recently developed Generic Electronics for TPCs. (C) 2015 Published by Elsevier B.V.	[Shane, R.; Lynch, W. G.; Barney, J.; Chajecki, Z.; Estee, J.; Lu, F.; Tangwancharoen, S.; Tsang, M. B.; Yurkon, J.] Michigan State Univ, NSCL, E Lansing, MI 48824 USA; [Shane, R.; Lynch, W. G.; Barney, J.; Chajecki, Z.; Estee, J.; Lu, F.; Tangwancharoen, S.; Tsang, M. B.; Yurkon, J.] Michigan State Univ, Dept Phys & Astron, E Lansing, MI 48824 USA; [McIntosh, A. B.; Olsen, R.; Yennello, S. J.] Texas A&M Univ, Inst Cyclotron, College Stn, TX 77843 USA; [Isobe, T.; Baba, H.; Nishimura, M.; Sakurai, H.; Taketani, A.] RIKEN, Nishina Ctr, Wako, Saitama 3510198, Japan; [Chartier, M.; Powell, W.] Univ Liverpool, Dept Phys, Liverpool L69 7ZE, Merseyside, England; [Famiano, M.] Western Michigan Univ, Dept Phys, Kalamazoo, MI 49008 USA; [Hong, B.; Jhang, G.] Korea Univ, Dept Phys, Seoul 136701, South Korea; [Ieki, K.; Usukura, T.] Rikkyo Univ, Dept Phys, Toshima Ku, Tokyo 1718501, Japan; [Lemmon, R.] STFC Daresbury Lab, Nucl Phys Grp, Daresbury WA4 4AD, Cheshire, England; [Lu, F.] Chinese Acad Sci, Shanghai Inst Appl Phys, Shanghai 201800, Peoples R China; [Murakami, T.; Nakatsuka, N.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Wang, R.] Tsinghua Univ, Dept Phys, Beijing 100084, Peoples R China	Lynch, WG (reprint author), Michigan State Univ, NSCL, E Lansing, MI 48824 USA.	lynch@nscl.msu.edu	SAKURAI, HIROYOSHI/G-5085-2014				Anderson M, 2003, NUCL INSTRUM METH A, V499, P659, DOI 10.1016/S0168-9002(02)01964-2; Horowitz CJ, 2014, J PHYS G NUCL PARTIC, V41, DOI 10.1088/0954-3899/41/9/093001; Li BA, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.192701; Rizzo J, 2005, PHYS REV C, V72, DOI 10.1103/PhysRevC.72.064609; Jun Hong, 2014, ARXIV13077654; Kobayashi T, 2013, NUCL INSTRUM METH B, V317, P294, DOI 10.1016/j.nimb.2013.05.089; Pollacco E, 2012, PHYSCS PROC, V37, P1799, DOI 10.1016/j.phpro.2012.02.506; RAI G, 1990, IEEE T NUCL SCI, V37, P56, DOI 10.1109/23.106592; Veenhof R., 1998, GARFIELD DRIFT CHAMB; Yano Y, 2007, NUCL INSTRUM METH B, V261, P1009, DOI 10.1016/j.nimb.2007.04.174	10	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						513	517		10.1016/j.nima.2015.01.026		5	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300091		
J	Bronson, F; Hayano, R; Oginni, B; Jaderstrom, H; Ilie, G; Yamanaka, S; Muramatsu, I				Bronson, Frazier; Hayano, Ryugo; Oginni, Babatunde; Jaderstrom, Henrik; Ilie, Gabriela; Yamanaka, Shunji; Muramatsu, Isamu			Design, development, and initial operation of BabyScan: An in-vivo counter for children around Fukushima	NUCLEAR INSTRUMENTS & METHODS IN PHYSICS RESEARCH SECTION A-ACCELERATORS SPECTROMETERS DETECTORS AND ASSOCIATED EQUIPMENT			English	Article; Proceedings Paper	15th Symposium on Radiation Measurements and Applications (SORMA)	JUN 09-12, 2014	Univ Michigan Campus, Ann Arbor, MI	Dept Energy, Univ Michigan, Coll Engn, Dept Nucl Engn & Radiol Sci	Univ Michigan Campus	Fukushima Dai-ichi accident; Whole Body Counting; In-vivo counting; Radioactive cesium; WBC of babies; Internal radioactivity		The Fukushima Dai-ichi accident has released large quantities of radionuclides, including I-131, Cs-134, and Cs-137. These radionuclides, when inhaled or ingested, cause internal dose to the individual. Whole Body Counting [WBC], also known as in-vivo counting is a common method to assess internal radioactivity as a tool to evaluate internal dose. The FastScan WBC system was widely used following the Chernobyl and the Fukushima accidents for in-vivo measurements of the population. Although the FastScan was designed for adults, it was successfully used for children by having them stand on a small stool. However small children and infants cannot stand, and have a much lower quantity of radioactive cesium. That required the development of a much more sensitive WBC system, called the BabyScan. A very important element of the project was to make the unit look esthetically pleasing, while not compromising performance. The steel shield was enclosed in a molded fiberglass exterior skin, whereas a carbon-fiber liner was used on the interior, to keep the background low. The system was calibrated using MCNP; on-site testing with phantoms confirmed the adequacy of the mathematical efficiency calibrations. The system has a Minimum Detectable Activity with a 4-min measurement of approximately 20 Bq for infants approximately 10 kg in weight, and similar to 40 Bq for children approximately 30 kg in weight. The K-40 that is naturally present is also reliably detected at the appropriate quantity for infants as small as 6 kg. Data from the first 365 subjects counted showed that K-40 was detected in all of them, and that there was no Cs-134 or Cs-137 above the MDA levels. (C) 2014 Elsevier B.V. All rights reserved.	[Bronson, Frazier; Oginni, Babatunde; Jaderstrom, Henrik; Ilie, Gabriela] Canberra Ind Inc, Meriden, CT 06450 USA; [Hayano, Ryugo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Yamanaka, Shunji] Univ Tokyo, Inst Ind Sci, Dept Mech & Biofunct Syst, Meguro Ku, Tokyo 1538505, Japan; [Muramatsu, Isamu] Canberra Japan KK, Taito Ku, Tokyo 1110053, Japan	Bronson, F (reprint author), Canberra Ind Inc, 800 Res Pkwy, Meriden, CT 06450 USA.	fbronson@canberra.com	Hayano, Ryugo/F-7889-2012				American National Standard Institute, 1999, N13351999 ANSIHPS; Hayano RS, 2014, J RADIOL PROT, V34, P645, DOI 10.1088/0952-4746/34/3/645; Bronson F.L., 1984, P 17 MIDY TOP S HLTH; Hill P., 2001, P 5 REG C RAD PROT S; Momose T., 2012, P 1 NIRS S REC EARL, P67; Schlager M., 2004, P 11 INT C INT RAD P; United Nations, 2008, UNSCEAR 2008 REP, VI; Waters L, 2002, LAUR022607 LOS AL NA	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0168-9002	1872-9576		NUCL INSTRUM METH A	Nucl. Instrum. Methods Phys. Res. Sect. A-Accel. Spectrom. Dect. Assoc. Equip.	JUN 1	2015	784						610	615		10.1016/j.nima.2014.09.028		6	Instruments & Instrumentation; Nuclear Science & Technology; Physics, Particles & Fields; Spectroscopy	Instruments & Instrumentation; Nuclear Science & Technology; Physics; Spectroscopy	CI2QO	WOS:000354592300108		
J	Iizuka, N; Terashima, S				Iizuka, Norihiro; Terashima, Seiji			Brick walls for black holes in AdS/CFT	NUCLEAR PHYSICS B			English	Article							ENTROPY; THERMODYNAMICS; BACKGROUNDS; HORIZON; FIELDS; MODEL	We study the 't Hooft's brick wall model for black holes in a holographic context. The brick wall model suggests that without an appropriate near horizon IR cut-off, the free energy of the probe fields shows the divergence due to the large degenerate states near the horizons. After studying the universal nature of the divergence in various holographic settings in various dimensions, we interpret the nature of the divergence in a holographic context. The free energy divergence is due to the large degeneracy and continuity of the low energy spectrum in the boundary theory at the deconfinement phase. These divergence and continuity should be removed by finite N effects, which make the spectrum discrete even at the deconfinement phase. On the other hand, in the bulk, these degenerate states are localized near the horizon, and the universal divergence of these degenerate states implies that the naive counting of the degrees of freedom in bulk should be modified once we take into account the non-perturbative quantum gravity effects near the horizon. Depending on the microscopic degrees of freedom, the position, where the effective field theory description to count the states breaks down, has different Planck scale dependence. It also implies the difficulty to have an electron like gauge-singlet elementary field in the boundary theory Lagrangian. These singlet fields are at most composite fields, because they show divergent free energy, suggesting a positive power of N at the deconfinement phase. (C) 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license.	[Iizuka, Norihiro; Terashima, Seiji] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan	Iizuka, N (reprint author), Osaka Univ, Dept Phys, Toyonaka, Osaka 5600043, Japan.	iizuka@yukawa.kyoto-u.ac.jp; terasima@yukawa.kyoto-u.ac.jp			JSPS [25800143, 23740189]	We would like to thank especially Dan Kabat, Shinji Mukohyama, and Rob Myers for helpful discussions and comments on the draft. We would also like to thank Masanori Hanada, Kinya Oda, Naoki Sasakura, Masaki Shigemori, Tadashi Takayanagi, Tomonori Ugajin, and Satoshi Yamaguchi for helpful discussions. N.I. was supported in part by JSPS KAKENHI Grant No. 25800143. S.T. was supported in part by JSPS KAKENHI Grant No. 23740189.	Almheiri A, 2013, J HIGH ENERGY PHYS, DOI 10.1007/JHEP02(2013)062; THOOFT G, 1985, NUCL PHYS B, V256, P727, DOI 10.1016/0550-3213(85)90418-3; Goldstein K, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.124021; Gubser SS, 1998, PHYS LETT B, V428, P105, DOI 10.1016/S0370-2693(98)00377-3; Aharony O, 2007, ANN PHYS-NEW YORK, V322, P1420, DOI 10.1016/j.aop.2006.11.002; Peet AW, 1999, PHYS REV D, V59, DOI 10.1103/PhysRevD.59.065011; Strominger A, 1996, PHYS LETT B, V379, P99, DOI 10.1016/0370-2693(96)00345-0; Mateos D, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.091601; CALLAN C, 1994, PHYS LETT B, V333, P55, DOI 10.1016/0370-2693(94)91007-3; DEALWIS SP, 1995, PHYS REV D, V52, P3529, DOI 10.1103/PhysRevD.52.3529; Babington J, 2004, PHYS REV D, V69, DOI 10.1103/PhysRevD.69.066007; Horowitz GT, 2000, PHYS REV D, V62, DOI 10.1103/PhysRevD.62.024027; GIBBONS GW, 1977, PHYS REV D, V15, P2752, DOI 10.1103/PhysRevD.15.2752; KABAT D, 1994, PHYS LETT B, V329, P46, DOI 10.1016/0370-2693(94)90515-0; Mathur SD, 2005, FORTSCHR PHYS, V53, P793, DOI 10.1002/prop.200410203; GIDDINGS SB, 1994, PHYS REV D, V49, P4078, DOI 10.1103/PhysRevD.49.4078; DEMERS JG, 1995, PHYS REV D, V52, P2245, DOI 10.1103/PhysRevD.52.2245; Mathur SD, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/22/224001; Erdmenger J, 2008, EUR PHYS J A, V35, P81, DOI 10.1140/epja/i2007-10540-1; Banks T, 1997, PHYS REV D, V55, P5112, DOI 10.1103/PhysRevD.55.5112; Gubser SS, 1996, PHYS REV D, V54, P3915, DOI 10.1103/PhysRevD.54.3915; Sakai T, 2005, PROG THEOR PHYS, V113, P843, DOI 10.1143/PTP.113.843; SUSSKIND L, 1993, PHYS REV D, V48, P3743, DOI 10.1103/PhysRevD.48.3743; Azeyanagi T, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.121601; Azeyanagi T., ARXIV13070809HEPTH; BARBON JLF, 1994, PHYS REV D, V50, P2712, DOI 10.1103/PhysRevD.50.2712; Charmousis C., 2010, JHEP, V1011, P151; EMPARAN R, 1995, PHYS REV D, V51, P5716, DOI 10.1103/PhysRevD.51.5716; Festuccia G, 2006, J HIGH ENERGY PHYS; Festuccia G, 2007, J HIGH ENERGY PHYS; Goldstein K, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP08(2010)078; Goldstein K, 2010, J HIGH ENERGY PHYS, DOI 10.1007/JHEP10(2010)027; Gubser SS, 1998, NUCL PHYS B, V534, P202, DOI 10.1016/S0550-3213(98)00514-8; Gubser SS, 2001, J HIGH ENERGY PHYS; Iizuka N, 2012, J HIGH ENERGY PHYS, DOI 10.1007/JHEP01(2012)094; Iizuka N., 2008, JHEP, V0810; Iizuka N, 2003, PHYS REV D, V68, DOI 10.1103/PhysRevD.68.084021; Iizuka N., 2010, J HIGH ENERGY PHYS, V1002; Iqbal N, 2009, FORTSCHR PHYS, V57, P367, DOI 10.1002/prop.200900057; Karch A, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/06/043; Klebanov IR, 2000, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2000/08/052; Kruczenski M, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/05/041; Lin H, 2004, J HIGH ENERGY PHYS; Liu H, 2011, PHYS REV D, V83, DOI 10.1103/PhysRevD.83.065029; Maldacena J M, 1998, ADV THEOR MATH PHYS, V2, P231, DOI DOI 10.1023/A:1026654312961; Maldacena J, 2003, J HIGH ENERGY PHYS; MANN RB, 1992, CLASSICAL QUANT GRAV, V9, P1487, DOI 10.1088/0264-9381/9/6/006; Mateos D., 2007, JHEP, V0705; Mathur S.D., ARXIV11080302HEPTH; Mukohyama S, 1998, PHYS REV D, V58, DOI 10.1103/PhysRevD.58.104005; Polchinski J, 1999, PROG THEOR PHYS SUPP, P158; Son DT, 2002, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2002/09/042; Susskind L., ARXIVHEPTH9704080; Susskind L., ARXIVHEPTH9805114; Taylor M., ARXIV08120530HEPTH; Witten E., 1998, ADV THEOR MATH PHYS, V2, P253, DOI DOI 10.1016/S0370-1573(99)00083-6; Witten E., 1998, ADV THEORY MATH PHYS, V2, P505	57	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUN	2015	895						1	32		10.1016/j.nuclphysb.2015.03.018		32	Physics, Particles & Fields	Physics	CI8OZ	WOS:000355032900001		
J	Nitta, M				Nitta, Muneto			Non-Abelian sine-Gordon solitons	NUCLEAR PHYSICS B			English	Article							GLOBAL STRINGS; VORTICES; SUPERCONDUCTORS; PHASE; MONOPOLES; CONFINEMENT; INSTANTONS; SKYRMIONS; MODELS; MODULI	We point out that non-Abelian sine-Gordon solitons stably exist in the U(N) chiral Lagrangian. They also exist in a U(N) gauge theory with two N by N complex scalar fields coupled to each other. One non-Abelian sine-Gordon soliton can terminate on one non-Abelian global vortex. They are relevant in chiral Lagrangian of QCD or in color-flavor locked phase of high density QCD, where the anomaly is suppressed at asymptotically high temperature or density, respectively. (C) 2015 The Author. Published by Elsevier B.V.	[Nitta, Muneto] Keio Univ, Dept Phys, Yokohama, Kanagawa 2238521, Japan; [Nitta, Muneto] Keio Univ, Res & Educ Ctr Nat Sci, Yokohama, Kanagawa 2238521, Japan	Nitta, M (reprint author), Keio Univ, Dept Phys, Hiyoshi 4-1-1, Yokohama, Kanagawa 2238521, Japan.	nitta@phys-h.keio.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [25103720, 25400268]	This work is supported in part by Grant-in-Aid for Scientific Research No. 25400268 and by the "Topological Quantum Phenomena" Grant-in-Aid for Scientific Research on Innovative Areas (No. 25103720) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	Alford M, 2001, ANNU REV NUCL PART S, V51, P131, DOI 10.1146/annurev.nucl.51.101701.132449; Babaev E, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.067001; Eto M, 2008, PHYS REV D, V77, DOI 10.1103/PhysRevD.77.125008; Cipriani M, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.170401; Eto M, 2009, NUCL PHYS B, V815, P495, DOI 10.1016/j.nuclphysb.2009.01.019; Eto M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.125011; LUND F, 1976, PHYS REV D, V14, P1524, DOI 10.1103/PhysRevD.14.1524; Eto M, 2008, PHYS LETT B, V669, P98, DOI 10.1016/j.physletb.2008.09.007; Eto M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.161601; Eto M, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.065021; Auzzi R, 2003, NUCL PHYS B, V673, P187, DOI 10.1016/j.nuclphysb.2003.09.029; Auzzi R, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.045007; Shifman M, 2007, REV MOD PHYS, V79, P1139, DOI 10.1103/RevModPhys.79.1139; Bakas I, 1996, PHYS LETT B, V372, P45, DOI 10.1016/0370-2693(96)00026-3; Eto M, 2009, PHYS REV D, V80, DOI 10.1103/PhysRevD.80.125007; Nakano E, 2008, PHYS REV D, V78, DOI 10.1103/PhysRevD.78.045002; Smiseth J, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.214509; Ustinov AV, 1998, PHYSICA D, V123, P315, DOI 10.1016/S0167-2789(98)00131-6; Tanaka Y, 2001, J PHYS SOC JPN, V70, P2844, DOI 10.1143/JPSJ.70.2844; MANTON NS, 1982, PHYS LETT B, V110, P54, DOI 10.1016/0370-2693(82)90950-9; Jennings P, 2013, J PHYS A-MATH THEOR, V46, DOI 10.1088/1751-8113/46/46/465401; Eto M, 2009, NUCL PHYS B, V821, P129, DOI 10.1016/j.nuclphysb.2009.06.013; Kasamatsu K, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.250406; Balachandran AP, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.074009; Babaev E, 2004, NUCL PHYS B, V686, P397, DOI 10.1016/j.nuciphysb.2004.02.021; Eto M, 2005, PHYS REV D, V72, DOI 10.1103/PhysRevD.72.025011; Shifman M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.045004; POHLMEYER K, 1976, COMMUN MATH PHYS, V46, P207, DOI 10.1007/BF01609119; Gudnason SB, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.085022; Shifman M, 2004, PHYS REV D, V70, DOI 10.1103/PhysRevD.70.025013; Gurevich A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047004; Son DT, 2002, PHYS REV A, V65, DOI 10.1103/PhysRevA.65.063621; Ferretti L, 2008, NUCL PHYS B, V789, P84, DOI 10.1016/j.nuclphysb.2007.07.021; PERRING JK, 1962, NUCL PHYS, V31, P550, DOI 10.1016/0029-5582(62)90774-5; Nitta M, 2013, NUCL PHYS B, V872, P62, DOI 10.1016/j.nuclphysb.2013.03.003; BLATTER G, 1994, REV MOD PHYS, V66, P1125, DOI 10.1103/RevModPhys.66.1125; Nitta M, 2008, PHYS LETT B, V658, P143, DOI 10.1016/j.physletb.2007.10.055; Agterberg DF, 1998, PHYS REV LETT, V80, P5184, DOI 10.1103/PhysRevLett.80.5184; Eto M, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.161601; Kobayashi M, 2014, PHYS LETT B, V728, P314, DOI 10.1016/j.physletb.2013.12.002; Eto M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.091602; Auzzi R, 2004, NUCL PHYS B, V686, P119, DOI 10.1016/j.nuciphysb.2004.03.003; BAKAS I, 1994, INT J MOD PHYS A, V9, P3443, DOI 10.1142/S0217751X94001369; Balachandran AP, 2002, PHYS REV D, V66, DOI 10.1103/PhysRevD.66.034018; Chen C. W., 1977, MAGNETISM METALLURGY; Eto M, 2012, PHYS REV A, V85, DOI 10.1103/PhysRevA.85.053645; Eto M, 2006, PHYS REV D, V73, DOI [10.1103/PhysRevD.73.125008, 10.1103/PhysRevD.73.085008]; Eto M, 2006, J PHYS A-MATH GEN, V39, pR315, DOI 10.1088/0305-4470/39/26/R01; Eto M., 2014, PTEP, V2014; Eto M, 2011, J HIGH ENERGY PHYS, DOI 10.1007/JHEP12(2011)017; Eto M., 2009, J HIGH ENERGY PHYS, V0906, P004; Eto M., 2015, PHYS REV D IN PRESS; Eto M., 2014, PROG THEOR EXP PHYS, V2014; Eto M, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.252003; Eto M, 2007, NUCL PHYS B, V780, P161, DOI 10.1016/j.nuclphysb.2007.03.040; Eto M, 2013, EPL-EUROPHYS LETT, V103, DOI 10.1209/0295-5075/103/60006; Garaud J, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.060514; GEPNER D, 1985, NUCL PHYS B, V252, P481, DOI 10.1016/0550-3213(85)90458-4; Goryo J, 2007, EPL-EUROPHYS LETT, V80, DOI 10.1209/0295-5075/80/17002; Gudnason SB, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.085007; Gudnason SB, 2015, PHYS REV D, V91, DOI 10.1103/PhysRevD.91.045027; Gudnason S.B., ARXIV14072822HEPTH; Hanany A, 2003, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2003/07/037; Hanany A, 2004, J HIGH ENERGY PHYS, DOI 10.1088/1126-6708/2004/04/066; Kaurov VM, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.011601; Kaurov VM, 2006, PHYS REV A, V73, DOI 10.1103/PhysRevA.73.013627; Kitano R, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.014510; Kobayashi M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.085003; Kobayashi M., ARXIV13044737HEPTH; Malozemoff A. P., 1979, MAGNETIC DOMAIN WALL; Manton N., 2004, TOPOLOGICAL SOLITONS; Naganuma M, 2002, PHYS REV D, V65, DOI 10.1103/PhysRevD.65.045016; Nakano E, 2009, PHYS LETT B, V672, P61, DOI 10.1016/j.physletb.2008.11.049; Nakano E, 2008, PROG THEOR PHYS SUPP, P254, DOI 10.1143/PTPS.174.254; Nitta M, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.025013; Nitta M, 2014, NUCL PHYS B, V885, P493, DOI 10.1016/j.nuclphysb.2014.05.032; Nitta M, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.084711; Nitta M, 2012, PHYS REV D, V86, DOI 10.1103/PhysRevD.86.125004; Nitta M., 2013, J LOW TEMP PHYS, V175, P177; Nitta M., ARXIV150302060HEPTH; Nitta M., ARXIV150202525HEPTH; Park QH, 1996, NUCL PHYS B, V458, P327, DOI 10.1016/0550-3213(95)00539-0; Rajaraman R., 1982, SOLITONS INSTANTONS; Shifman M, 2009, CAM M MATH, P1, DOI 10.1017/CBO9780511575693; STRATOPOULOS GN, 1993, Z PHYS C PART FIELDS, V59, P307, DOI 10.1007/BF01566696; SUTCLIFFE PM, 1992, PHYS LETT B, V283, P85, DOI 10.1016/0370-2693(92)91432-9; Tanake Y., 2001, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.017002; Tong D., ARXIVHEPTH0509216; Vilenkin A., 2000, CAMBRIDGE MONOGRAPHS; Volovik G. E., 2003, UNIVERSE HELIUM DROP	90	3	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0550-3213	1873-1562		NUCL PHYS B	Nucl. Phys. B	JUN	2015	895						288	302		10.1016/j.nuclphysb.2015.04.006		15	Physics, Particles & Fields	Physics	CI8OZ	WOS:000355032900011		
J	Lu, LF; Onishi, R; Takahashi, K				Lu, Li-Feng; Onishi, Ryo; Takahashi, Keiko			The effect of wind on long-term summer water temperature trends in Tokyo Bay, Japan	OCEAN DYNAMICS			English	Article						Water temperature trends; Wind; Tokyo Bay; Heat transport	SEA-SURFACE TEMPERATURE; CIRCULATION; OCEAN; MODEL	The effect of wind on summer water temperature trends in a semi-closed bay (Tokyo Bay, Japan) is examined through several numerical experiments using a high-resolution three-dimensional ocean model. The model is executed under no-wind and uniform southerly/northerly wind conditions, and monthly mean currents and temperature distributions and heat transport in Tokyo Bay for July are calculated. The model results show that wind has a significant effect on heat transport and temperature distribution in the bay. (1) When a southerly wind prevails northward cool water transport intensifies while southward warm water transport declines, thus decreasing the water temperature in the central bay area while increasing temperature at the bay head. (2) A northerly wind has an opposing effect and decreases the water temperature in coastal bay head area while increase the temperature along the southwest coast. The results also suggest that the trend of increasing southerly wind amplitude may have affected water temperature trends in Tokyo Bay from 1979 to 1997. The model results demonstrated that the an intensified southerly wind lowers water temperatures in most areas of the bay by enhancing upwelling and open ocean-water intrusion near the bay mouth while increases temperatures in the bottom layer of the bay head by suppressing southward warm water transport.	[Lu, Li-Feng; Onishi, Ryo; Takahashi, Keiko] Japan Agcy Marine Earth Sci & Technol, Ctr Earth Informat Sci & Technol, Yokohama, Kanagawa 2360001, Japan	Lu, LF (reprint author), Japan Agcy Marine Earth Sci & Technol, Ctr Earth Informat Sci & Technol, Yokohama, Kanagawa 2360001, Japan.	lifeng_lu@jamstec.go.jp			Research Program on Climate Change Adaptatoin (RECCA)	This study was supported by the Research Program on Climate Change Adaptatoin (RECCA) led by the Ministry of Education, Culture, Sports, Science and Technology of Japan. The numerical simulations presented in this study were conducted on the Earth Simulator II supercomputer based at the Japan Agency for Marine-Earth Science and Technology. Two anonymous reviewers are thanked for their valuable and constructive comments and suggestions.	Ando H., 2003, OCEANOGRAPHY JAPAN, V12, P407; MELLOR GL, 1982, REV GEOPHYS, V20, P851, DOI 10.1029/RG020i004p00851; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Fairall CW, 2003, J CLIMATE, V16, P571, DOI 10.1175/1520-0442(2003)016<0571:BPOASF>2.0.CO;2; Shearman RK, 2010, J PHYS OCEANOGR, V40, P1004, DOI 10.1175/2009JPO4300.1; Nixon SX, 2004, ESTUARIES, V27, P397, DOI 10.1007/BF02803532; Nakayama K, 2014, J GEOPHYS RES-OCEANS, V119, P1977, DOI 10.1002/2013JC009396; Antonov JI, 2010, NOAA ATLAS NESD IS, V2; Aoki K, 2006, J OCEANOGR, V62, P207, DOI 10.1007/s10872-006-0045-7; Chang YL, 2010, J PHYS OCEANOGR, V40, P2728, DOI 10.1175/2010JPO4474.1; Guo X, 1996, J OCEANOGR, V52, P597, DOI DOI 10.1007/BF02238323; Hinata H, 2001, J JSCE, V684, P93; Locarnini RA, 2010, NOAA ATLAS NESDIS, V1; Magome S, 2012, J JSCE B2, V68, P956; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5733, DOI 10.1029/96JC02776; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Nomura H, 1996, B COAST OCEANOGR, V34, P25; Oda R, 2009, J APPL METEOROL CLIM, V48, P2054, DOI 10.1175/2009JAMC2163.1; Onishi Y, 1975, J OCEANOGR SOC JAPAN, V31, P243; Preston BL, 2004, ENV ASSESS, DOI [10.1007/s00267-004-0159x, DOI 10.1007/S00267-004-0159X]; Smagorinsky J., 1963, MON WEATHER REV, V91, P99, DOI [DOI 10.1175/1520-0493(1963)091<0099:GCEWTP>2.3.C0;2, 10.1175/1520-0493(1963)091&LT;0099:GCEWTP&GT;2.3.CO;2(1963)]; Suzuki T, 2000, ESTUAR COAST SHELF S, V50, P17, DOI 10.1006/ecss.1999.0527; Tabeta S, 1996, J MAR SCI TECHNOL, V1, P94, DOI 10.1007/BF02391165; Unoki S, 1980, 4 I PHYS CHEM RES PH; Yagi H, 2004, P COAST ENG, V51, P1236; Yanagi T, 2008, J DISASTER RES, V3, P113	26	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1616-7341	1616-7228		OCEAN DYNAM	Ocean Dyn.	JUN	2015	65	6					919	930		10.1007/s10236-015-0848-4		12	Oceanography	Oceanography	CI4KR	WOS:000354718000011		
J	Watanabe, M				Watanabe, Mamoru			Larval community dynamics in an artificial habitat created for conservation of a local population of the endangered brackish water damselfly, Mortonagrion hirosei (Odonata: Coenagrionidae)	ODONATOLOGICA			English	Article						Dragonfly; Zygoptera; salinity; Common reed; Phragmites australis; Japan	ZYGOPTERA COENAGRIONIDAE; ASAHINA ZYGOPTERA; PONDS; ADULT; INDICATORS; ENGLAND	Brackish water ecosystems in estuaries are highly threatened due to land development, the improvement of embankments, and reclamation. Several threatened species of dragonflies and damselflies inhabit these ecosystems. The brackish water damselfly, Mortonagrion hirosei Asahina, 1972, has been an important focus of conservation studies. Here, we describe a conservation project for M. hirosei begun in 2003, and review the data collected in order to quantify details of the species' life cycle, especially larvae and larval environment. An artificially established reed community was created as a habitat for this damselfly, and water depth, salinity, and water temperature in the reed bed were continuously monitored thereafter. Because this damselfly is univoltine, the number and distribution of the odonate larvae in the experimental habitat in May, or presence of last-instar larvae of M. hirosei, were considered suitable indices of colonisation success. Since many odonate adults, including M. hirosei, visited the habitat in the first year and laid eggs, high larval diversity was found in the second year. Although the salinity of water in the reed bed varied because cyclical tidal fluctuations, the saline water gradually excluded odonate larvae that inhabit freshwater only. However, M. hirosei survived, and the larval population increased year by year. Consequently, the odonate larval diversity in the artificial habitat decreased, while the population of M. hirosei was maintained.	Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	Watanabe, M (reprint author), Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan.	watanabe@kankyo.envr.tsukuba.ac.jp					Hofmann TA, 2005, HYDROBIOLOGIA, V539, P137, DOI 10.1007/s10750-004-3916-1; D'Amico F, 2004, RESTOR ECOL, V12, P439, DOI 10.1111/j.1061-2971.2004.00319.x; Kadoya T, 2004, ECOL RES, V19, P461, DOI 10.1111/j.1440-1703.2004.00659.x; McCauley SJ, 2006, ECOGRAPHY, V29, P585; Williams DD, 1997, AQUAT CONSERV, V7, P105; Raebel EM, 2012, INSECT CONSERV DIVER, V5, P422, DOI 10.1111/j.1752-4598.2011.00178.x; Painter D, 1999, J APPL ECOL, V36, P33, DOI 10.1046/j.1365-2664.1999.00376.x; STEYTLER NS, 1995, BIOL CONSERV, V72, P381, DOI 10.1016/0006-3207(94)00052-R; LLOYD M, 1967, J ANIM ECOL, V36, P1, DOI 10.2307/3012; Campbell SP, 2002, ECOL APPL, V12, P674, DOI 10.2307/3060977; FINCKE OM, 1986, BEHAV ECOL SOCIOBIOL, V18, P405, DOI 10.1007/BF00300514; Watanabe M, 2006, ODONATOLOGICA, V35, P159; MORIN PJ, 1984, ECOLOGY, V65, P1866, DOI 10.2307/1937784; Chovanec Andreas, 1997, Limnologica, V27, P381; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; De Marco P, 1999, AQUAC RES, V30, P357, DOI 10.1046/j.1365-2109.1999.00338.x; HIROSE M., 1985, COLLECTING BREEDING, V47, P390; Iwao S., 1968, Researches on Population Ecology Kyoto University, V10, P1, DOI 10.1007/BF02514729; Iwata S, 2009, ODONATOLOGICA, V38, P307; Iwata Shu-ko, 2004, Japanese Journal of Entomology (New Series), V7, P133; Foote AL, 2005, ECOL ENTOMOL, V30, P273, DOI 10.1111/j.0307-6946.2005.00701.x; McPeek Mark A., 2008, P51; MOORE N W, 1991, Odonatologica, V20, P203; Morimoto M, 2010, ODONATOLOGICA, V39, P333; Watanabe M, 2004, ODONATOLOGICA, V33, P303; Watanabe M, 2008, J INSECT CONSERV, V12, P663, DOI 10.1007/s10841-007-9108-3; WATANABE M., 2012, ODONATOLOGICA, V41, P159; Watanabe Mamoru, 2003, International Journal of Odonatology, V6, P65; WATANABE M., 2004, JAP J CONSERV ECOL, V9, P165; Raab R., 1996, Odonatologica, V25, P387	30	0	0	SOC INT ODONATOLOGICA	BILTHOVEN	PO BOX 256, 3720 AG BILTHOVEN, NETHERLANDS	0375-0183			ODONATOLOGICA	Odonatologica	JUN 1	2015	44	1-2					45	62				18	Entomology	Entomology	CI8JT	WOS:000355019300004		
J	Jinguji, H; Ueda, T				Jinguji, Hiroshi; Ueda, Tetsuyuki			Can the use of more selective insecticides promote the conservation of Sympetrum frequens in Japanese rice paddy fields (Odonata: Libellulidae)?	ODONATOLOGICA			English	Article						Dragonfly; Anisoptera; microcosm; cartap; imidacloprid; fipronil	CHRONIC TOXICITY; FIPRONIL; CARTAP; NYMPHS; FATE	The effect of two relatively selective nursery-box-applied insecticides on Sympetrum frequens larvae and adults as substitutes for the commonly used insecticides, imidacloprid and fipronil, was examined using an experimental micro-paddy lysimeter (MPL) system. Fifty hatched larvae were placed on the soil surface of separate MPLs that had been treated with imidadoprid, fipronil, dinotefuran, and cartap hydrochloride, as well as an untreated control MPL. At 30 days after transplantation, the complete absence of S. frequens larvae and exuviae in the imidacloprid and fipronil-treated MPLs was remarkable. In the control, cartap- and dinotefuran-treated MPLs, the mean number of larvae was 31.0 +/- 6.0, 27.0 +/- 6.0, and 6.3 +/- 1.5, respectively. No S. frequens adults were observed later in the imidadoprid- and fipronil-treated MPLs. The rate of emergence did not differ significantly among the control, cartap- and dinotefuran-treated MPLs. However, the mean head width of S. frequens in the dinotefuran-treated MPL was significantly narrower than that of S. frequens in the control and cartap-treated MPLs. The mean EM50 in the cartap-treated MPL was significantly longer than that in the control- and dinotefuran-treated MPLs. The findings showed that the ecological impact of cartap on S. frequens was slightly less than the application of fipronil, imidacloprid and dinotefuran to rice paddy fields.	[Jinguji, Hiroshi] Miyagi Univ, Sch Food Agr & Environm Sci, Taihaku Ku, Sendai, Miyagi 9820215, Japan; [Ueda, Tetsuyuki] Ishikawa Prefectural Univ, Environm Sci, Nonoshi, Ishikawa 9218836, Japan	Jinguji, H (reprint author), Miyagi Univ, Sch Food Agr & Environm Sci, Taihaku Ku, 2-2-1 Hatatate, Sendai, Miyagi 9820215, Japan.	jinguji@myu.ac.jp			Japan Society for the Promotion of Science [22580278]	We thank K. Goka, T. Tsubaki, and K. Miyai for their valuable contributions to the study. This work was primarily supported by a Grant-in-Aid for Biological Studies on Wildlife under the Framework of ExTEND2005, and a Grant-in-Aid for Scientific Research (No. 22580278) from Japan Society for the Promotion of Science.	Thuyet DQ, 2011, J PESTIC SCI, V36, P9, DOI 10.1584/jpestics.G10-49; Zhou SL, 2009, AQUAT TOXICOL, V95, P339, DOI 10.1016/j.aquatox.2009.10.006; Stoughton SJ, 2008, ARCH ENVIRON CON TOX, V54, P662, DOI 10.1007/s00244-007-9073-6; Gunasekara AS, 2007, J PESTIC SCI, V32, P189, DOI 10.1584/jpestics.RO7-02; Tomizawa M, 2000, J AGR FOOD CHEM, V48, P6016, DOI 10.1021/jf000873c; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; Aajoud A, 2003, J AGR FOOD CHEM, V51, P1347, DOI 10.1021/jf025843j; Roessink I, 2013, ENVIRON TOXICOL CHEM, V32, P1096, DOI 10.1002/etc.2201; ASAKA S, 1978, J PESTIC SCI, V3, P305; Ateyyat M., 2012, World Applied Sciences Journal, V16, P1060; DENNIS K.D., 2008, ENVIRON POLLUT, V152, P491; Hayasaka D, 2012, ECOTOX ENVIRON SAFE, V80, P355, DOI 10.1016/j.ecoenv.2012.04.004; HAYASAKA D., 2011, ECOTOXICOLOGY, V21, P191; ISHIDA K., 1992, SCI REPORTS FACULTY, V28, P1; JEPSEN P.U., 2012, J ENVIRON IMMUNOL TO, V1, P3; Jinguji H, 2013, PADDY WATER ENVIRON, V11, P277, DOI 10.1007/s10333-012-0317-3; JINGUJI H., 2009, T JSIDRE, V259, P355; Kim Y, 2008, J ENVIRON SCI HEAL B, V43, P56, DOI 10.1080/03601230701735029; Kobori Y, 2004, APPL ENTOMOL ZOOL, V39, P255, DOI 10.1303/aez.2004.255; Lannacone Jose, 2007, Gayana, V71, P170; Liu WP, 2002, J AGR FOOD CHEM, V50, P6823, DOI 10.1021/jf0204194; Srinivas K., 2005, Pest Management and Economic Zoology, V13, P71; NISHIZAWA Y., 2004, P ASS PLANT PROTECTI, V53, P37; Overmyer JP, 2005, B ENVIRON CONTAM TOX, V74, P872, DOI 10.1007/s00128-005-0662-7; OZAWA T., 1982, B IWATE KEN AGR EXPT, V23, P91; SAITO M., 2010, T JAPANESE SOC IRRIG, V267, P79; Sanchez-Bayo F, 2006, ENVIRON TOXICOL CHEM, V25, P1677, DOI 10.1897/05-404R.1; Sanchez-Bayo F, 2006, AQUAT TOXICOL, V78, P262, DOI 10.1016/j.aquatox.2006.03.009; Sugimura M, 1999, DRAGONFLIES JAPANESE; TAKEDA Y., 2001, J ECON ENTOMOL, V94, P1340; Thuyet DQ, 2011, B ENVIRON CONTAM TOX, V86, P548, DOI 10.1007/s00128-011-0243-x; Thuyet D. Q., 2010, Paddy and Water Environment, V8, P235; UEDA T., 1988, B ISHIKAWA AGR COLL, V17, P41; UEDA T., 1998, CONSERVATION WETLAND, P93; Ueda Tetsuyuki, 2013, Tombo (Tokyo), V55, P1; UEDA T., 2008, SYMNET, V10, P6; Ueda Tetsuyuki, 1993, Insectarium, V30, P292; UEDA T., 2008, SYMNET, V10, P8; UNEME H, 2003, DEV AGROCHEMICALS JA, P116; URABE K, 1986, JPN J APPL ENTOMOL Z, V30, P129; Van Dijk TC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062374	41	0	0	SOC INT ODONATOLOGICA	BILTHOVEN	PO BOX 256, 3720 AG BILTHOVEN, NETHERLANDS	0375-0183			ODONATOLOGICA	Odonatologica	JUN 1	2015	44	1-2					63	80				18	Entomology	Entomology	CI8JT	WOS:000355019300005		
J	Miyauchi, A; Sukegawa, N				Miyauchi, Atsushi; Sukegawa, Noriyoshi			Maximizing Barber's bipartite modularity is also hard	OPTIMIZATION LETTERS			English	Article						Network analysis; Community detection; Modularity maximization; Bipartite networks; Computational complexity	COMMUNITY STRUCTURES; COMPLEX NETWORKS; OPTIMIZATION	Modularity introduced by Newman and Girvan (Phys Rev E 69:026113, 2004) is a quality function for community detection in networks. Numerous methods for modularity maximization have been developed so far. In 2007, Barber (Phys Rev E 76:066102, 2007) introduced a variant of modularity called bipartite modularity which is appropriate for bipartite networks. Although maximizing the standard modularity is known to be NP-hard, the computational complexity of maximizing bipartite modularity has yet to be revealed. In this study, we prove that maximizing bipartite modularity is also NP-hard. More specifically, we show the NP-completeness of its decision version by constructing a reduction from a classical partitioning problem.	[Miyauchi, Atsushi; Sukegawa, Noriyoshi] Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, Tokyo 1528552, Japan	Miyauchi, A (reprint author), Tokyo Inst Technol, Grad Sch Decis Sci & Technol, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	miyauchi.a.aa@m.titech.ac.jp					Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Medus A, 2005, PHYSICA A, V358, P593, DOI 10.1016/j.physa.2005.04.022; Brandes U, 2008, IEEE T KNOWL DATA EN, V20, P172, DOI 10.1109/TKDE.2007.190689; Guimera R, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.036102; Agarwal G, 2008, EUR PHYS J B, V66, P409, DOI 10.1140/epjb/e2008-00425-1; Fortunato S, 2007, P NATL ACAD SCI USA, V104, P36, DOI 10.1073/pnas.0605965104; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Zhan WH, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.066120; Barber MJ, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.066102; Xu G, 2007, EUR PHYS J B, V60, P231, DOI 10.1140/epjb/e2007-00331-0; Cafieri S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.056105; Aloise D, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046112; Blondel VD, 2008, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2008/10/P10008; Boccaletti S, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.045102; Cafieri S, 2014, ANN OPER RES, V222, P213, DOI 10.1007/s10479-012-1286-z; Clauset A, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.066111; Costa A, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.058101; Costa A, 2014, OPTIM LETT, V8, P903, DOI 10.1007/s11590-013-0621-x; Duch J, 2005, PHYS REV E, V72, DOI [10.1103/PhysRevE.72.027104, 10.1103/PhysRecE.72.027104]; Garey M.R., 1979, COMPUTERS INTRACTABI; Good BH, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046106; Guimera R, 2005, NATURE, V433, P895, DOI 10.1038/nature03288; Massen CP, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.046101; Miyauchi A, 2013, EUR PHYS J B, V86, DOI 10.1140/epjb/e2013-40006-7; Newman M., 2009, NETWORKS INTRO; Newman M.E., 2004, PHYS REV E, V69, P26113, DOI DOI 10.1103/PHYSREVE.69.026113	27	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1862-4472	1862-4480		OPTIM LETT	Optim. Lett.	JUN	2015	9	5					897	913		10.1007/s11590-014-0818-7		17	Operations Research & Management Science; Mathematics, Applied	Operations Research & Management Science; Mathematics	CI7NB	WOS:000354949200006		
J	Muraki, S; Akune, T; En-yo, Y; Yoshida, M; Suzuki, T; Yoshida, H; Ishibashi, H; Tokimura, F; Yamamoto, S; Tanaka, S; Nakamura, K; Kawaguchi, H; Oka, H; Yoshimura, N				Muraki, S.; Akune, T.; En-yo, Y.; Yoshida, M.; Suzuki, T.; Yoshida, H.; Ishibashi, H.; Tokimura, F.; Yamamoto, S.; Tanaka, S.; Nakamura, K.; Kawaguchi, H.; Oka, H.; Yoshimura, N.			Joint space narrowing, body mass index, and knee pain: the ROAD study (OAC1839R1)	OSTEOARTHRITIS AND CARTILAGE			English	Article						Cohort study; Epidemiology; Osteoarthritis; Pain	QUALITY-OF-LIFE; INDIVIDUAL RADIOGRAPHIC FEATURES; MIDDLE-AGED WOMEN; RISK-FACTORS; BONE-MARROW; OSTEOARTHRITIS; ASSOCIATION; POPULATION; COHORT; PROGRESSION	Objective: The objective of the present study was to clarify the association of joint space narrowing with knee pain in Japanese men and women using a large-scale population-based cohort of the Research on Osteoarthritis/osteoporosis Against Disability (ROAD) study. Methods: This study examined the association between minimum joint space width (mJSW) in the medial compartment and pain at the knee. mJSW was measured in the medial and lateral compartments of the knee using a knee osteoarthritis (OA) computer-aided diagnosis system. Results: From the 3040 participants in the ROAD study, the present study analyzed 2733 participants who completed the radiographic examinations and questionnaires regarding knee pain (975 men and 1758 women; mean age, 69.9 +/- 11.2 years). Subjects with lateral knee OA were excluded. After adjustment for age and Body mass index (BMI), medial mJSW, as well as medial mJSW/lateral mJSW, was significantly associated with knee pain. Sex and BMI affected the association of medial mJSW with knee pain. The threshold of medial mJSW was approximately 3 mm in men and 2 mm in women, while that of medial mJSW/lateral mJSW was approximately 60% in both men and women. BMI was found to have a distinct effect on the association of mJSW with pain. Conclusion: The present cross-sectional study using a large-scale population from the ROAD study showed that joint space narrowing had a significant association with knee pain. The thresholds of joint space narrowing for knee pain were also established. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Muraki, S.; Akune, T.] Univ Tokyo, 22nd Century Med & Res Ctr, Dept Clin Motor Syst Med, Fac Med, Tokyo 1138655, Japan; [En-yo, Y.; Yoshida, M.] Wakayama Med Univ, Dept Orthopaed Surg, Wakayama, Japan; [Suzuki, T.] Natl Ctr Geriatr & Gerontol, Obu, Aichi, Japan; [Yoshida, M.] Tokyo Metropolitan Inst Gerontol, Res Team Promoting Independence Elderly, Tokyo, Japan; [Ishibashi, H.] Ina Hosp, Dept Orthopaed Surg, Saitama, Japan; [Tokimura, F.] Tokyo Geriatr Med Ctr, Dept Orthopaed Surg, Tokyo, Japan; [Yamamoto, S.] Toranomon Gen Hosp, Dept Orthopaed Surg, Tokyo, Japan; [Tanaka, S.] Univ Tokyo, Fac Med, Dept Orthopaed Surg, Tokyo 113, Japan; [Nakamura, K.] Natl Rehabil Ctr Persons Disabil, Saitama, Japan; [Kawaguchi, H.] Tokyo Shinjuku Med Ctr, Japan Community Hlth Care Org, Dept Orthopaed Surg, Tokyo, Japan; [Oka, H.; Yoshimura, N.] Univ Tokyo, 22nd Century Med & Res Ctr, Dept Joint Dis Res, Fac Med, Tokyo 1138655, Japan	Muraki, S (reprint author), Univ Tokyo, 22nd Century Med & Res Ctr, Dept Clin Motor Syst Med,Fac Med, Bunkyo Ku, Hongo 7-3-1, Tokyo 1138655, Japan.	murakis-ort@h.u-tokyo.ac.jp			Japanese Ministry of Education, Culture, Sports, Science, and Technology [S19109007, B20390182, C20591737, C20591774, A18689031, 19659305]; Ministry of Health, Labour and Welfare [H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H21-Chouju-Wakate-011, H22-Chouju-Wakate-007]; Japanese Orthopaedic Association [2006-1]; Japan Orthopaedics and Traumatology Foundation [166]	This work was supported by Grants-in-Aid for Scientific Research (S19109007, B20390182, C20591737, C20591774), for Young Scientists (A18689031), and for Exploratory Research (19659305) from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, grants (H17-Men-eki-009, H18-Choujyu-037, H20-Choujyu-009, H21-Chouju-Wakate-011 and H22-Chouju-Wakate-007) from the Ministry of Health, Labour and Welfare, a Research Aid from the Japanese Orthopaedic Association (JOA-Subsidized Science Project Research 2006-1), and Grant No. 166 from the Japan Orthopaedics and Traumatology Foundation.	Altman RD, 2007, OSTEOARTHR CARTILAGE, V15, pA1, DOI 10.1016/j.joca.2006.11.009; ALTMAN RD, 1987, ARTHRITIS RHEUM, V30, P1214, DOI 10.1002/art.1780301103; Yoshimura N, 2009, J BONE MINER METAB, V27, P620, DOI 10.1007/s00774-009-0080-8; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Hart DJ, 1999, ARTHRITIS RHEUM, V42, P17, DOI 10.1002/1529-0131(199901)42:1<17::AID-ANR2>3.0.CO;2-E; Chan WP, 2008, SKELETAL RADIOL, V37, P917, DOI 10.1007/s00256-008-0530-8; Bollet AJ, 2001, ANN INTERN MED, V134, P591; Teichtahl AJ, 2006, J RHEUMATOL, V33, P1845; Woo J, 2004, J RHEUMATOL, V31, P2433; Coggon D, 2001, INT J OBESITY, V25, P622, DOI 10.1038/sj.ijo.0801585; SUMMERS MN, 1988, ARTHRITIS RHEUM, V31, P204, DOI 10.1002/art.1780310208; Thorp LE, 2007, ARTHRIT RHEUM-ARTHR, V57, P1254, DOI 10.1002/art.22991; Felson DT, 1998, ARTHRITIS RHEUM, V41, P1343, DOI 10.1002/1529-0131(199808)41:8<1343::AID-ART3>3.0.CO;2-9; GUCCIONE AA, 1994, AM J PUBLIC HEALTH, V84, P351, DOI 10.2105/AJPH.84.3.351; Wluka AE, 2004, ANN RHEUM DIS, V63, P264, DOI 10.1136/ard/2003.007666; ALTMAN RD, 1995, OSTEOARTHR CARTILAGE, V3, P3; Muraki S, 2009, OSTEOARTHR CARTILAGE, V17, P1137, DOI 10.1016/j.joca.2009.04.005; Macfarlane GJ, 2011, RHEUMATOLOGY, V50, P2251, DOI 10.1093/rheumatology/ker276; Felson DT, 2007, ARTHRITIS RHEUM, V56, P2986, DOI 10.1002/art.22851; Muraki S, 2010, OSTEOARTHR CARTILAGE, V18, P1227, DOI 10.1016/j.joca.2010.06.001; Muraki S, 2011, ARTHRITIS RHEUM-US, V63, P3859, DOI 10.1002/art.30641; Oka H, 2008, OSTEOARTHR CARTILAGE, V16, P1300, DOI 10.1016/j.joca.2008.03.011; Yoshimura N, 2010, INT J EPIDEMIOL, V39, P988, DOI 10.1093/ije/dyp276; Altman R, 1996, OSTEOARTHR CARTILAGE, V4, P217, DOI 10.1016/S1063-4584(05)80101-3; Cicuttini FM, 1996, OSTEOARTHR CARTILAGE, V4, P143, DOI 10.1016/S1063-4584(05)80323-1; Saito T, 2000, CLIN ORTHOP RELAT R, P172; Brazier JE, 1999, RHEUMATOLOGY, V38, P870, DOI 10.1093/rheumatology/38.9.870; Linaker CH, 1999, BEST PRACT RES CL RH, V13, P197, DOI 10.1053/berh.1999.0016; Felson DT, 2002, ARTHRITIS RHEUM, V46, P1217, DOI 10.1002/art.10293; D'Arcy Y., 2012, NURS MANAGE, V43, P21; Hill CL, 1999, J RHEUMATOL, V26, P2029; Kellgren JH, 1963, EPIDEMIOLOGY CHRONIC; Kinds MB, 2014, J RHEUMATOL, V40, P58; Ministry of Health Labour and Welfare, 2010, OUTL RES NAT LIV SUR; Oka H, 2010, J ORTHOP SCI, V15, P781, DOI 10.1007/s00776-010-1545-2; Schouten JSAG, 1991, THESIS ERASMUS U MED; Sharma L., 2007, OSTEOARTHRITIS DIAGN, P3; van der Esch M, 2014, RHEUMATOLOGY, V53, P540, DOI 10.1093/rheumatology/ket393	38	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	JUN	2015	23	6					874	881		10.1016/j.joca.2015.01.011		8	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CI9VA	WOS:000355116900006		
J	Ishikawa, G; Koya, Y; Tanaka, H; Nagakura, Y				Ishikawa, G.; Koya, Y.; Tanaka, H.; Nagakura, Y.			Long-term analgesic effect of a single dose of anti-NGF antibody on pain during motion without notable suppression of joint edema and lesion in a rat model of osteoarthritis	OSTEOARTHRITIS AND CARTILAGE			English	Article						Antibody of nerve growth factor; Osteoarthritis; Pain during motion; Sodium monoiodoacetate; Joint edema and lesion	NERVE GROWTH-FACTOR; DOUBLE-BLIND; ANIMAL-MODELS; CATWALK TESTS; KNEE-BEND; ARTHRITIS; MOVEMENT; EFFICACY; HYPERALGESIA; DICLOFENAC	Objective: Osteoarthritis (OA) patients experience exaggerated pain during movements such as walking. Anti-nerve growth factor (NGF) antibodies have recently shown analgesic effects in OA patients. We examined the effect of a single dose of anti-NGF antibody on pain during motion, joint edema and lesion in a rat model of OA to determine whether the analgesic effect demonstrated in clinical studies can be translated to a preclinical model. Methods: Sodium monoiodoacetate (MIA)-induced arthritic rats that develop a right-left gait imbalance when walking as an index of pain during motion. This imbalance was assessed using a gait analysis system called "CatWalk". Edema size and lesion score in the relevant knee joint were also measured. The effect of a single intravenous injection of an anti-NGF monoclonal antibody AS2886401-00 on these parameters was assessed. Results: AS2886401-00 administered at 0.3 or 1 mg/kg on Day 3 post-MIA injection resulted in a statistically significant improvement in gait imbalance even on Day 35. When gait measurement was set on Week 3 post-MIA administration, administration of the antibody at a timing close to the gait measurement, i.e., 1 or 24 h prior to the measurement, was less effective. AS2886401-00 did not suppress either edema or lesion. Conclusions: A single dose of anti-NGF antibody exerts a long-lasting analgesic effect on pain during motion in a rat model of OA. This finding could be associated with the analgesic efficacies that anti-NGF antibodies have exhibited in clinical studies. It appears unlikely that analgesia is secondary to inhibition of joint edema and lesion. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Ishikawa, G.; Koya, Y.; Tanaka, H.; Nagakura, Y.] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Ishikawa, G (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	go.ishikawa@astellas.com; yukari.koya@astellas.com; hirotsugu.tanaka@astellas.com; yukinori.nagakura@astellas.com			Astellas Pharma Inc. (Tokyo, Japan)	This work was funded by Astellas Pharma Inc. (Tokyo, Japan). The sponsor did not have any role in the conduct of the study.	Bove SE, 2003, OSTEOARTHR CARTILAGE, V11, P821, DOI 10.1016/S1063-4584(03)0163-8; Vincent TL, 2012, RHEUMATOLOGY, V51, P1931, DOI 10.1093/rheumatology/kes035; Manni L, 2003, CLIN EXP RHEUMATOL, V21, P617; Iannone F, 2002, RHEUMATOLOGY, V41, P1413, DOI 10.1093/rheumatology/41.12.1413; Ji RR, 2002, NEURON, V36, P57, DOI 10.1016/S0896-6273(02)00908-X; Sabsovich I, 2008, PAIN, V138, P47, DOI 10.1016/j.pain.2007.11.004; LEVIMONTALCINI R, 1987, SCIENCE, V237, P1154, DOI 10.1126/science.3306916; Watson JJ, 2008, BIODRUGS, V22, P349, DOI 10.2165/0063030-200822060-00002; Bjordal JM, 2004, BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; Ishikawa G, 2014, EUR J PHARMACOL, V738, P111, DOI 10.1016/j.ejphar.2014.05.048; Gehling M, 2011, SCHMERZ, V25, P296, DOI 10.1007/s00482-011-1057-9; Petrella RJ, 2002, ARCH INTERN MED, V162, P292, DOI 10.1001/archinte.162.3.292; Pezet S, 2006, ANNU REV NEUROSCI, V29, P507, DOI 10.1146/annurev.neuro.29.051605.112929; Lane NE, 2010, NEW ENGL J MED, V363, P1521, DOI 10.1056/NEJMoa0901510; Brown MT, 2012, J PAIN, V13, P790, DOI 10.1016/j.jpain.2012.05.006; Tiseo PJ, 2014, PAIN, V155, P1245, DOI 10.1016/j.pain.2014.03.018; Shelton DL, 2005, PAIN, V116, P8, DOI 10.1016/j.pain.2005.03.039; Ashraf S, 2014, ANN RHEUM DIS, V73, P1710, DOI 10.1136/annrheumdis-2013-203416; Fernihough J, 2004, PAIN, V112, P83, DOI 10.1016/j.pain.2004.08.004; Ferreira-Gomes J, 2008, J PAIN, V9, P945, DOI 10.1016/j.jpain.2008.05.012; Benyamin R, 2008, PAIN PHYSICIAN, V11, pS105; BRADLEY JD, 1991, NEW ENGL J MED, V325, P87, DOI 10.1056/NEJM199107113250203; Ferreira-Gomes J, 2012, PHARMACOL BIOCHEM BE, V101, P617, DOI 10.1016/j.pbb.2012.03.003; Herrmann G, 2000, CLIN RHEUMATOL, V19, P99, DOI 10.1007/s100670050025; Indo Y, 1996, NAT GENET, V13, P485, DOI 10.1038/ng0896-485; Kobayashi K, 2003, J VET MED SCI, V65, P1195, DOI 10.1292/jvms.65.1195; Orita S, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-134; Pecchi E, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4443; Pons J, 2004, United States patent US, Patent No. 20040237124; Schnitzer TJ, 2014, ANN RHEUM DIS; Sinkov V, 2003, J NATL MED ASSOC, V95, P475; Takeshita N, 2011, J PHARMACOL SCI, V115, P481, DOI 10.1254/jphs.10319FP; Yoshimi E, 2010, J PHARMACOL EXP THER, V334, P955, DOI 10.1124/jpet.110.167924	33	2	2	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	JUN	2015	23	6					925	932		10.1016/j.joca.2015.02.002		8	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CI9VA	WOS:000355116900012		
J	Dyment, NA; Hagiwara, Y; Jiang, X; Huang, J; Adams, DJ; Rowe, DW				Dyment, N. A.; Hagiwara, Y.; Jiang, X.; Huang, J.; Adams, D. J.; Rowe, D. W.			Response of knee fibrocartilage to joint destabilization	OSTEOARTHRITIS AND CARTILAGE			English	Article						Knee destabilization; GFP reporter; Non-decalcified cryohistology; TRAP in chondrocytes; Mineral apposition of fibrocartilage	PHOSPHATASE ACP 5; POSTTRAUMATIC OSTEOARTHRITIS; MOUSE MODEL; TEMPOROMANDIBULAR-JOINT; CEREBRAL CALCIFICATIONS; CONDYLAR CARTILAGE; FRACTURE REPAIR; MICE; EXPRESSION; CELLS	Objective: A major challenge to understanding osteoarthritis (OA) pathology is identifying the cellular events that precede the onset of cartilage damage. The objective of this study is to determine the effect of joint destabilization on early changes to fibrocartilage in the joint. Design/Methods: The anterior cruciate ligament was transected in collagen reporter mice (Col1CFP and ColXRFP). Mineralization labels were given every 2 weeks to measure new mineralized cartilage apposition. Novel fluorescent histology of mineralized tissue was used to characterize the changes in fibrocartilage at 2 and 4 weeks post-injury. Results: Changes in fibrocartilaginous structures of the joint occur as early as 2 weeks after injury and are well developed by 4 weeks. The alterations are seen in multiple entheses and in the medial surface of the femoral and tibial condyles. In the responding entheses, mineral apposition towards the ligament midsubstance results in thickening of the mineralize fibrocartilage. These changes are associated with increases in ColX-RFP, Col1-CFP reporter activity and alkaline phosphatase enzyme activity. Mineral apposition also occurs in the fibrocartilage of the non-articular regions of the medial condyles by 2 weeks and develops into osteophytes by 4 weeks post-injury. An unexpected observation is punctate expression of tartrate resistant acid phosphatase activity in unmineralized fibrochondrocytes adjacent to active appositional mineralization. Discussion: These observations suggest that fibrocartilage activates prior to degradation of the articular cartilage. Thus clinical and histological imaging of fibrocartilage may be an earlier indicator of disease initiation and may indicate a more appropriate time to start preventative treatment. (C) 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.	[Dyment, N. A.; Hagiwara, Y.; Jiang, X.; Huang, J.; Adams, D. J.; Rowe, D. W.] Univ Connecticut, Ctr Hlth, Sch Dent Med, Ctr Regenerat Med & Skeletal Dev, Farmington, CT 06032 USA; [Dyment, N. A.; Hagiwara, Y.; Jiang, X.; Huang, J.; Adams, D. J.; Rowe, D. W.] Univ Connecticut, Ctr Hlth, Dept Orthopaed Surg, New England Musculoskeletal Inst, Farmington, CT 06032 USA; [Hagiwara, Y.] Nippon Med Coll Hosp, Dept Orthoped Surg, Tokyo 113, Japan	Rowe, DW (reprint author), Univ Connecticut, Ctr Hlth, Ctr Regenerat Med & Skeletal Dev, Dept Reconstruct Sci Biomat & Skeletal Dev,Sch De, Farmington, CT 06030 USA.	dyment@uchc.edu; ysk@nms.ac.jp; xijiang@neuron.uchc.edu; jphuang@nso.uchc.edu; dadams@uchc.edu; rowe@neuron.uchc.edu			National Institutes of Health [R21-AR055750, R01-AR052374, T90-DE021989]	All funding sources had no influence on the design, collection, or analysis of data in this study. Funding sources are National Institutes of Health R21-AR055750, R01-AR052374, T90-DE021989 (support for NAD).	Ackerman Ilana N, 2013, Phys Ther, V93, P889, DOI 10.2522/ptj.20120423; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8; Christiansen BA, 2012, OSTEOARTHR CARTILAGE, V20, P773, DOI 10.1016/j.joca.2012.04.014; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Grcevic D, 2012, STEM CELLS, V30, P187, DOI 10.1002/stem.780; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Fukada K, 1999, J ANAT, V195, P321, DOI 10.1046/j.1469-7580.1999.19530321.x; Maye P, 2011, GENESIS, V49, P410, DOI 10.1002/dvg.20733; Fang H, 2014, NAT REV RHEUMATOL, V10, P413, DOI 10.1038/nrrheum.2014.46; Hernandez-Molina G, 2008, ARTHRITIS RHEUM, V58, P130, DOI 10.1002/art.23173; Benjamin M, 2007, ARTHRITIS RHEUM, V56, P3601, DOI 10.1002/art.23078; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Litwic A, 2013, BRIT MED BULL, V105, P185, DOI 10.1093/bmb/lds038; Shen J, 2013, ARTHRITIS RHEUM-US, V65, P3107, DOI 10.1002/art.38122; McGonagle D, 2010, J ANAT, V216, P279, DOI 10.1111/j.1469-7580.2009.01186.x; Chiu WSM, 2004, GENESIS, V39, P178, DOI 10.1002/gene.20041; Hayman AR, 2008, AUTOIMMUNITY, V41, P218, DOI 10.1080/08916930701694667; Chen J, 2012, CELLS TISSUES ORGANS, V195, P232, DOI 10.1159/000325148; Briggs TA, 2011, NAT GENET, V43, P127, DOI 10.1038/ng.748; Kalajzic I, 2002, J BONE MINER RES, V17, P15, DOI 10.1359/jbmr.2002.17.1.15; Onur TS, 2014, J ORTHOP RES, V32, P318, DOI 10.1002/jor.22509; Lockwood KA, 2014, J ORTHOP RES, V32, P79, DOI 10.1002/jor.22480; Lausch E, 2011, NAT GENET, V43, P132, DOI 10.1038/ng.749; Dyment NA, 2012, J ORTHOP RES, V30, P28, DOI 10.1002/jor.21484; Baht GS, 2014, J ORTHOP RES, V32, P581, DOI 10.1002/jor.22562; Blaney Davidson EN, 2014, ANN RHEUM D IN PRESS; Blaney Davidson EN, 2006, ANN RHEUM DIS, V65, P1414; Blankenbaker DG, 2005, SKELETAL RADIOL, V34, P462, DOI 10.1007/s00256-005-0931-x; Habib Hasina, 2007, Congenital Anomalies, V47, P53, DOI 10.1111/j.1741-4520.2007.00143.x; Hayman AR, 2000, J HISTOCHEM CYTOCHEM, V48, P219; Hayman AR, 2000, J ANAT, V196, P433, DOI 10.1046/j.1469-7580.2000.19630433.x; Hayman AR, 1996, DEVELOPMENT, V122, P3151; Hayman AR, 2003, J BONE MINER RES, V18, P1905, DOI 10.1359/jbmr.2003.18.10.1905; Jones RK, 2013, J RHEUMATOL, V40, P309, DOI 10.3899/jrheum.120589; Kozawa E, 2012, ARTHRITIS RHEUM-US, V64, P454, DOI 10.1002/art.33398; Man G S, 2014, J Med Life, V7, P37; Nho SJ, 2013, J AM ACAD ORTHOP SUR, V21, pS1, DOI 10.5435/JAAOS-21-07-S1; Ochiai T, 2010, J DENT RES, V89, P349, DOI 10.1177/0022034510363078; Renella R, 2006, AM J MED GENET A, V140A, P541, DOI 10.1002/ajmg.a.31081; Shibukawa Y, 2007, DEV DYNAM, V236, P426, DOI 10.1002/dvdy.21036; Tan AL, 2006, ANN RHEUM DIS, V65, P1267, DOI 10.1136/ard.2005.050112; TURNER RT, 1994, ENDOCRINOLOGY, V134, P461, DOI 10.1210/en.134.1.461; Ushiku C, 2010, J ORTHOP RES, V28, P1338, DOI 10.1002/jor.21105; Vilim V, 1992, FUNCT DEV MORPHOL, V2, P163; Zhou JM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4437	46	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	JUN	2015	23	6					996	1006		10.1016/j.joca.2015.01.017		11	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CI9VA	WOS:000355116900020		
J	Nakagawa, Y; Muneta, T; Kondo, S; Mizuno, M; Takakuda, K; Ichinose, S; Tabuchi, T; Koga, H; Tsuji, K; Sekiya, I				Nakagawa, Y.; Muneta, T.; Kondo, S.; Mizuno, M.; Takakuda, K.; Ichinose, S.; Tabuchi, T.; Koga, H.; Tsuji, K.; Sekiya, I.			Synovial mesenchymal stem cells promote healing after meniscal repair in microminipigs	OSTEOARTHRITIS AND CARTILAGE			English	Article						Meniscus repair; Meniscus injury; Mesenchymal stem cells; Synovium; Pig	PARTIAL MEDIAL MENISCECTOMY; BONE-MARROW; CARTILAGE DEFECTS; AVASCULAR ZONE; INTRAARTICULAR INJECTION; LIGAMENT INJURY; FLUID INCREASE; RABBITS; MODEL; CHONDROGENESIS	Objective: The induction of synovial tissue to the meniscal lesion is crucial for meniscal healing. Synovial Mesenchymal stem cells (MSCs) are an attractive cell source because of their high proliferative and chondrogenic potentials. We examined whether transplantation of synovial MSCs promoted healing after meniscal repair of extended longitudinal tear of avascular area in a microminipig model. Design: Longitudinal tear lesion was made in medial menisci and sutured in both knees, and then a synovial MSC suspension was administered for 10 min only in unilateral knee. The sutured meniscus was evaluated morphologically and biomechanically at 2, 4, and 12 weeks. The behavior of transplanted MSCs was also examined. Results: The meniscal healing at 12 weeks was significantly better in the MSC group than in the control group; macroscopically, histologically and by T1rho mapping analysis. Transmission electron microscopic analysis demonstrated that the meniscus lesion was occupied by dense collagen fibrils only in the MSC group. Biomechanical analysis revealed that the tensile strength to failure of the meniscus higher in the MSC group than in the control group in each microminipig. Synovial tissue covered better along the superficial layer from the outer zone into the lesion of the meniscus in the MSC group at 2 and 4 weeks in each microminipig. Synovial MSCs labeled with ferucarbotran were detected in the meniscus lesion and adjacent synovium by MRI at 2 weeks. Conclusion: Transplantation of synovial MSCs promoted healing after meniscal repair with induction of synovium into the longitudinal tear in the avascular zone of meniscus in pigs. (C) 2015 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International.	[Nakagawa, Y.; Muneta, T.; Kondo, S.; Koga, H.; Tsuji, K.] Tokyo Med & Dent Univ, Dept Joint Surg & Sports Med, Grad Sch, Tokyo 1138519, Japan; [Mizuno, M.; Sekiya, I.] Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Tokyo 1138519, Japan; [Takakuda, K.] Tokyo Med & Dent Univ, Dept Biodesign, Inst Biomat & Bioengn, Tokyo 1138519, Japan; [Ichinose, S.] Tokyo Med & Dent Univ, Res Ctr Med & Dent Sci, Tokyo 1138519, Japan; [Tabuchi, T.] Yaesu Clin, Tokyo, Japan	Sekiya, I (reprint author), Tokyo Med & Dent Univ, Ctr Stem Cell & Regenerat Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	ynakagawa.orj@tmd.ac.jp; muneta.orj@tmd.ac.jp; kondo.orj@tmd.ac.jp; mizuno.arm@tmd.ac.jp; takakuda.mech@tmd.ac.jp; ichinose.bioa@tmd.ac.jp; t.tabuchi@adic.or.jp; koga.orj@tmd.ac.jp; tsuji.orj@tmd.ac.jp; sekiya.arm@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency (JST); Ministry of Health, Labor and Welfare (MHLW)	This study was supported by the Highway Program for Realization of Regenerative Medicine from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan Science and Technology Agency (JST) and a grant-in-aid for Research on Regenerative Medicine for Clinical Application from the Ministry of Health, Labor and Welfare (MHLW).	Mills PM, 2008, OSTEOARTHR CARTILAGE, V16, P1526, DOI 10.1016/j.joca.2008.04.014; De Bari C, 2001, ARTHRITIS RHEUM, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Sekiya I, 2012, J ORTHOP RES, V30, P943, DOI 10.1002/jor.22029; Kawarasaki T, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3241985; Koga H, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2460; Akioka K, 2014, IN VIVO, V28, P81; Matsukura Y, 2014, CLIN ORTHOP RELAT R, V472, P1357, DOI 10.1007/s11999-013-3418-4; Sekiya I, 2002, P NATL ACAD SCI USA, V99, P4397, DOI 10.1073/pnas.052716199; NEWMAN AP, 1989, AM J SPORT MED, V17, P164, DOI 10.1177/036354658901700205; Koike Y, 2005, J ORTHOP RES, V23, P1433, DOI 10.1016/j.orthres.2005.02.015; Sakaguchi Y, 2005, ARTHRITIS RHEUM, V52, P2521, DOI 10.1002/art.21212; Morito T, 2008, RHEUMATOLOGY, V47, P1137, DOI 10.1093/rheumatology/ken114; Englund M, 2012, NAT REV RHEUMATOL, V8, P412, DOI 10.1038/nrrheum.2012.69; Fenty MC, 2012, J MAGN RESON IMAGING, V35, P891, DOI 10.1002/jmri.22867; Koga H, 2008, CELL TISSUE RES, V333, P207, DOI 10.1007/s00441-008-0633-5; Hatsushika D, 2014, OSTEOARTHR CARTILAGE, V22, P941, DOI 10.1016/j.joca.2014.04.028; Sekiya I, 2004, J BONE MINER RES, V19, P256, DOI 10.1359/JBMR.0301220; Salata MJ, 2010, AM J SPORT MED, V38, P1907, DOI 10.1177/0363546510370196; Nimura A, 2008, ARTHRITIS RHEUM, V58, P501, DOI 10.1002/art.23219; Pabbruwe MB, 2010, BIOMATERIALS, V31, P2583, DOI 10.1016/j.biomaterials.2009.12.023; Horie M, 2009, STEM CELLS, V27, P878, DOI 10.1634/stemcells.2008-0616; Yoshimura H, 2007, CELL TISSUE RES, V327, P449, DOI 10.1007/s00441-006-0308-z; Nepple JJ, 2012, J BONE JOINT SURG AM, V94A, P2222, DOI 10.2106/JBJS.K.01584; CISA J, 1995, ACTA ORTHOP SCAND, V66, P38, DOI 10.3109/17453679508994636; Hanson SE, 2013, J TISSUE ENG REGEN M; Hatsushika D, 2013, J ORTHOP RES, V31, P1354, DOI 10.1002/jor.22370; Ichinose S, 2010, LAB INVEST, V90, P210, DOI 10.1038/labinvest.2009.125; JITSUIKI J, 1994, ARTHROSCOPY, V10, P659, DOI 10.1016/S0749-8063(05)80065-9; KING D, 1990, CLIN ORTHOP RELAT R, P4; van Buul GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017001; Matsukura Y, 2015, J ORTHOP RES, V33, P246, DOI 10.1002/jor.22753; Nakagawa Y, 2013, J NANOMATER, V2013, P13; Nakamura T, 2012, CYTOTHERAPY, V14, P327, DOI 10.3109/14653249.2011.638912; Ruiz-Iban MA, 2011, ARTHROSCOPY, V27, P1688, DOI 10.1016/j.arthro.2011.06.041; Shimaya M, 2010, OSTEOARTHR CARTILAGE, V18, P1300, DOI 10.1016/j.joca.2010.06.005; Starke C, 2009, ARTHROSCOPY, V25, P1033, DOI 10.1016/j.arthro.2008.12.010; Uchio Y, 2003, ARTHROSCOPY, V19, P463, DOI 10.1053/jars.2003.50109; Vangsness CT, 2014, J BONE JOINT SURG AM, V96A, P90, DOI 10.2106/JBJS.M.00058; Zellner J, 2013, J BIOMED MATER RES B, V101, P1133, DOI 10.1002/jbm.b.32922; ZHANG ZN, 1995, AM J SPORT MED, V23, P35	40	3	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	JUN	2015	23	6					1007	1017		10.1016/j.joca.2015.02.008		11	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CI9VA	WOS:000355116900021		
J	McAlindon, TE; Bannuru, RR; Sullivan, MC; Arden, NK; Berenbaum, F; Bierma-Zeinstra, SM; Hawker, GA; Henrotin, Y; Hunter, DJ; Kawaguchi, H; Kwoh, K; Lohmander, S; Rannou, F; Roos, EM; Underwood, M				McAlindon, T. E.; Bannuru, R. R.; Sullivan, M. C.; Arden, N. K.; Berenbaum, F.; Bierma-Zeinstra, S. M.; Hawker, G. A.; Henrotin, Y.; Hunter, D. J.; Kawaguchi, H.; Kwoh, K.; Lohmander, S.; Rannou, F.; Roos, E. M.; Underwood, M.			2014 OARSI Guidelines for the Non-Surgical Management of Knee Osteoarthritis (vol 22, pg 363, 2014)	OSTEOARTHRITIS AND CARTILAGE			English	Correction									[McAlindon, T. E.; Bannuru, R. R.; Sullivan, M. C.] Tufts Med Ctr, Div Rheumatol, Boston, MA 02111 USA; [Arden, N. K.] Univ Oxford, NIHR Musculoskeletal Biomed Res Unit, Oxford OX1 2JD, England; [Berenbaum, F.] Univ Paris 06, Paris, France; [Berenbaum, F.] Hop St Antoine, AP HP, F-75571 Paris, France; [Bierma-Zeinstra, S. M.] Erasmus MC, Dept Gen Practice, Rotterdam, Netherlands; [Hawker, G. A.] Womens Coll Hosp, Dept Med, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Henrotin, Y.] Univ Liege, Bone & Cartilage Res Unit, Liege, Belgium; [Henrotin, Y.] Princess Paola Hosp, Dept Phys Therapy & Rehabil, Marche En Famenne, Belgium; [Hunter, D. J.] Royal N Shore Hosp, Dept Rheumatol, St Leonards, NSW, Australia; [Hunter, D. J.] Univ Sydney, Northern Clin Sch, Sydney, NSW 2006, Australia; [Kawaguchi, H.] Univ Tokyo, Fac Med, Sensory & Motor Syst Med, Bunkyo Ku, Tokyo 113, Japan; [Kwoh, K.] Univ Arizona, Arthrit Ctr Excellence, Div Rheumatol & Clin Immunol, Tucson, AZ 85721 USA; [Lohmander, S.] Lund Univ, Clin Sci Lund, Dept Orthopaed, Lund, Sweden; [Rannou, F.] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Roos, E. M.] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Underwood, M.] Warwick Clin Trials Unit, Coventry, W Midlands, England	McAlindon, TE (reprint author), Tufts Med Ctr, Dept Rheumatol, 800 Washington St, Boston, MA 02111 USA.	tmcalindon@tuftsmedicalcenter.org; nigel.arden@ndorms.ox.ac.uk; francis.berenbaum@sat.aphp.fr; s.bierma-zeinstra@erasmusmc.nl; gillian.hawker@wchospital.ca; yhenrotin@ulg.ac.be; david.hunter@sydney.edu.au; kawaguchi-ort@h.u-tokyo.ac.jp; kwoh@arthritis.arizona.edu; stefan.lohmander@med.lu.se; francois.rannou@cch.aphp.fr; eroos@health.sdu.dk; m.underwood@warwick.ac.uk					McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003	1	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1063-4584	1522-9653		OSTEOARTHR CARTILAGE	Osteoarthritis Cartilage	JUN	2015	23	6					1026	1034		10.1016/j.joca.2015.02.014		9	Orthopedics; Rheumatology	Orthopedics; Rheumatology	CI9VA	WOS:000355116900023		
J	Watanabe, T; Ito, T; Furukawa, T; Futai, K; Kubota, T; Kanoto, M; Toyoguchi, Y; Hosoya, T; Kakehata, S				Watanabe, Tomoo; Ito, Tsukasa; Furukawa, Takatoshi; Futai, Kazunori; Kubota, Toshinori; Kanoto, Masafumi; Toyoguchi, Yuuki; Hosoya, Takaaki; Kakehata, Seiji			The Efficacy of Color Mapped Fusion Images in the Diagnosis and Treatment of Cholesteatoma Using Transcanal Endoscopic Ear Surgery	OTOLOGY & NEUROTOLOGY			English	Article						Cholesteatoma; Color mapped fusion image; Magnetic resonance cisternography; Non-echo planar diffusion-weighted imaging; T1-weighted image; Transcanal endoscopic ear surgery	ULTRASONIC BONE CURETTE; RECURRENT CHOLESTEATOMA; ATTIC CHOLESTEATOMA; MANAGEMENT	Objective: To assess the efficacy of color mapped fusion images (CMFIs) in preoperatively evaluating the anatomic location of cholesteatomas and determining whether a patient is indicated for transcanal endoscopic ear surgery. Study Design: Prospective case study. Setting: A single university hospital. Patients: Ninety-two patients scheduled for middle ear cholesteatoma surgery. Intervention: Imaging analysis was first performed using echo planar diffusion-weighted imaging (EPI) for the first patient group with mixed results. Imaging analysis was then performed using 1-mm thin-slice non-EPI combined with magnetic resonance cisternography in a second group. The resulting image was then processed using color mapping to create a CMFI that enhanced cholesteatoma visualization. A second non-EPI was also performed on the third group, incorporating a T1-weighted image (T1WI) to reduce false-positives. Main Outcome Measure(s): Preoperative findings from EPI, nonEPI/CMFIs, and non-EPI/T1WI-enhanced CMFIs were compared with intraoperative findings. The positive predictive value and negative predictive value were also evaluated for each group. Results: Both the positive predictive value and negative predictive value obtained from the CMFIs were high in all areas of the middle ear, and CMFI facilitated accurate detection of the anatomic location of cholesteatomas of 3 mm or larger. The incidence of false-positives was further reduced in the final 18 patients by performing T1WI to distinguish between cholesteatomas and cholesterin granulomas. Conclusion: CMFI combined with T1WI is a reliable diagnostic modality for evaluating the anatomic location of cholesteatomas 3 mm or larger and determining whether transcanal endoscopic ear surgery is indicated for treatment in such cases.	[Watanabe, Tomoo; Ito, Tsukasa; Furukawa, Takatoshi; Futai, Kazunori; Kubota, Toshinori; Kakehata, Seiji] Yamagata Univ, Fac Med, Dept Otolaryngol Head & Neck Surg, Yamagata 990, Japan; [Kanoto, Masafumi; Toyoguchi, Yuuki; Hosoya, Takaaki] Yamagata Univ, Fac Med, Dept Diagnost Radiol, Yamagata 990, Japan	Watanabe, T (reprint author), 2-2-2 Iida Nishi, Yamagata, Yamagata 9909585, Japan.	watanatm@med.id.yamagata-u.ac.jp					Marchioni D, 2009, ACTA OTO-LARYNGOL, V129, P946, DOI 10.1080/00016480802468187; Dremmen MHG, 2012, AM J NEURORADIOL, V33, P439, DOI 10.3174/ajnr.A2824; Barath K, 2011, AM J NEURORADIOL, V32, P221, DOI 10.3174/ajnr.A2052; Yamashita K, 2011, AM J NEURORADIOL, V32, P1915, DOI 10.3174/ajnr.A2651; Khemani S, 2011, CLIN RADIOL, V66, P760, DOI 10.1016/j.crad.2010.12.019; Tarabichi M, 2004, LARYNGOSCOPE, V114, P1157, DOI 10.1097/00005537-200407000-00005; Bammer R, 2003, EUR J RADIOL, V45, P169, DOI 10.1016/S0720-048X(02)00303-0; Mas-Estelles F, 2012, RADIOGRAPHICS, V32, P1197, DOI 10.1148/rg.324115109; Migirov L, 2014, OTOL NEUROTOL, V35, P121, DOI 10.1097/MAO.0000000000000234; Jindal M, 2011, OTOL NEUROTOL, V32, P1243, DOI 10.1097/MAO.0b013e31822e938d; Ito T, 2014, OTOL NEUROTOL, V35, pE135, DOI 10.1097/MAO.0000000000000209; Kakehata S, 2014, OTOL NEUROTOL, V35, P101, DOI 10.1097/MAO.0b013e3182a446bc; Schwartz KM, 2011, AM J NEURORADIOL, V32, P430, DOI 10.3174/ajnr.A2129; Schwartz Kara M, 2010, Ear Nose Throat J, V89, pE14; Tarabichi M, 1997, AM J OTOL, V18, P544; Tos M., 1995, MASTOID SURG RECONST, P54	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JUN	2015	36	5					763	768				6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CI4GT	WOS:000354707200002		
J	Hashimoto, K; Yanagihara, N; Hyodo, J; Sakagami, M				Hashimoto, Kengo; Yanagihara, Naoaki; Hyodo, Jun; Sakagami, Masafumi			Osseous Eustachian Tube and Peritubal Cells in Patients With Unilateral Cholesteatoma: Comparison Between Healthy and Diseased Sides Using High-Resolution Cone-Beam Computed Tomography	OTOLOGY & NEUROTOLOGY			English	Article						Cholesteatoma; Cone-beam computed tomography; Eustachian tube; Mastoid cell; Osseous eustachian tube; Peritubal cell; Unilateral cholesteatoma	TYMPANOPLASTY; AERATION	Objectives: We investigated the factors that may possibly cause primary acquired cholesteatoma. Setting: University-affiliated hospital. Subjects and Methods: In 20 adult patients with unilateral cholesteatoma, the sizes of the osseous eustachian tubes (ETs) and the extent of peritubal and mastoid cell development in healthy and diseased ears were examined using high-resolution cone-beam computed tomography. The height and width of the ET were measured at the tympanic orifice, the isthmus, and the midpoint, as was the length of its axis. We also assessed the extent of development of peritubal and mastoid cells. Results: There were no significant differences in the size of the osseous ET between the healthy and cholesteatoma sides, but significant correlations were found in height and width between the sides at the tympanic orifice and at the isthmus. In 80% of ears with cholesteatoma, the development of both peritubal and mastoid cells was poor and, in 5% more, one or the other was poor. Mastoid and peritubal cell development was good in 60% of healthy ears and poor in 20%. In the remaining 20%, only peritubal cell development was poor. Conclusion: There were no significant differences in the size of the osseous ET between the healthy and diseased sides of patients with unilateral cholesteatoma. Our results indicate that inhibition of air cell development in not only the mastoid region but also the peritubal region may contribute to cholesteatoma development.	[Hashimoto, Kengo; Yanagihara, Naoaki; Hyodo, Jun] Takanoko Hosp, Dept Otolaryngol, Matsuyama, Ehime 7900925, Japan; [Hashimoto, Kengo; Sakagami, Masafumi] Hyogo Coll Med, Dept Otolaryngol, Nishinomiya, Hyogo 6638501, Japan	Hashimoto, K (reprint author), Takanoko Hosp, Dept Otolaryngol, 525-1 Takanoko Cho, Matsuyama, Ehime 7900925, Japan.	littlewing.kenbow1210@gmail.com					Yanagihara N, 2009, OTOL NEUROTOL, V30, P766, DOI 10.1097/MAO.0b013e3181b23698; [Anonymous], 2010, OTOL JPN, V20, P743; Jahnke K, 2004, MIDDLE EAR SURG RECE, P1; Kashiba K, 2010, OTOL NEUROTOL, V32, P71; Komori M, 2012, OTOL NEUROTOL, V33, P1353, DOI 10.1097/MAO.0b013e31826a5260; Komori M, 2012, J INT ADV OTOL, V8, P57; Ohta S, 2008, OTOL NEUROTOL, V30, P48; PROCTOR B, 1973, ARCH OTOLARYNGOL, V97, P2; Proctor B, 1989, SURG ANATOMY EAR TEM, P54; Sade J, 1987, THE EUSTACHIAN TUBE, P31; SADE J, 1995, ANN OTO RHINOL LARYN, V104, P369; Takahashi H, 2001, MIDDLE EAR ROLE VENT, P63; Takahashi H, 1997, LARYNGOSCOPE, V107, P1117, DOI 10.1097/00005537-199708000-00020; YANAGIHARA N, 1993, AM J OTOL, V14, P590	14	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JUN	2015	36	5					776	781				6	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CI4GT	WOS:000354707200004		
J	Takeda, T; Takeda, S; Okada, T; Kakigi, A; Yamasoba, T				Takeda, Taizo; Takeda, Setsuko; Okada, Teruhiko; Kakigi, Akinobu; Yamasoba, Tatsuya			Experimental Studies on the Recovery Processes From Severe Facial Palsy and the Development of Its Sequelae	OTOLOGY & NEUROTOLOGY			English	Article						Axon count; Guinea pig; Facial nerve; Facial palsy; Postparalytic sequelae; Synkinesis	NERVE REGENERATION; EPHAPTIC TRANSMISSION; SYNKINESIS; MUSCLE; ELIMINATION; MOVEMENT; NUCLEUS; FIBERS; AXON; RATS	Objective: To experimentally elucidate the pathogenesis of inappropriate co-contraction of facially innervated muscles after severe facial palsy. Methods: Twenty-two guinea pigs with severe facial palsy induced by the interruption of the petrosal artery were used to follow up behavioral facial movement, including the degree of facial palsy and abnormal hyperkinetic facial movement of synkinesis and mass contracture. At the end of the follow-up, the evoked facial compound muscle action potential (evoked FCMP) and antidromically evoked facial nerve response (AFNR) were examined in a few typical cases with complete recovery and with incomplete recovery accompanied by synkinesis. After the followup, all animals were sacrificed for morphological studies, which consisted of a light-microscopic study (by Luxol fast blue and hematoxylin and eosin staining or toluidine blue staining) and/or an electron-microscopic study. Results: The initial sign of recovery was mass contracture or spasm. This condition continued for 2 weeks or more. As voluntary facial movement recovered, the mass contracture became unnoticeable. It could not be distinguished when the so-called synkinesis developed. Synkinesis usually developed during the persisted or progressed once it appeared. Histologically, unmyelinated fibers were intermingled with myelinated fibers in an early stage of recovery with mass contracture. In the late stage with the development of synkinesis, however, such an intermingling of unmyelinated and myelinated axons was not observed. In this stage, axons became well myelinated, but they were irregular in shape in cases with synkinesis. Especially, axons irregularly ran at the level of the G(1) (at the region of the second genu) segment, and bifurcated axons were sporadically found. The axon count had a tendency to increase toward the periphery. AFNR was not detected, although evoked FCMP could be clearly detected in cases with synkinesis. Conclusion: Misguidance of regenerated axons is an important cause of facial synkinesis in the ischemia-induced facial palsy model. Ephaptic transmission between unmyelinated and myelinated axons is also likely to be responsible for mass contracture manifested in the early stage of the recovery process.	[Takeda, Taizo] Nishinomiya Municipal Cent Hosp, Dept Otolaryngol, Kobe, Hyogo, Japan; [Takeda, Taizo] Kochi Med Sch, Dept Otolaryngol, Kochi, Japan; [Okada, Teruhiko] Aichi Med Univ, Ctr Multidisciplinary Pain, Nagakute, Aichi, Japan; [Kakigi, Akinobu; Yamasoba, Tatsuya] Univ Tokyo, Dept Otolaryngol, Fac Med, Tokyo 1138655, Japan	Kakigi, A (reprint author), Univ Tokyo, Dept Otolaryngol, Fac Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kakigi-tky@umin.ac.jp					Guntinas-Lichius O, 2005, EUR J NEUROSCI, V21, P391, DOI 10.1111/j.1460-9568.2005.03877.x; CRUMLEY RL, 1979, LARYNGOSCOPE, V89, P1847; Choi D, 2002, NEUROSURGERY, V50, P355, DOI 10.1097/00006123-200202000-00022; BROWN MC, 1976, J PHYSIOL-LONDON, V261, P387; RICH MM, 1989, J NEUROSCI, V9, P1781; EVINGER C, 1984, J NEUROPHYSIOL, V52, P323; Arvanitaki A, 1942, J NEUROPHYSIOL, V5, P89; BLUMBERG H, 1982, EXP NEUROL, V76, P468, DOI 10.1016/0014-4886(82)90117-0; Choi D, 2002, NEUROSURGERY, V50, P362; FERNANDEZ E, 1995, NEUROSURGERY, V37, P456; ITO M, 1994, ACTA ANAT, V151, P124; Kamijo Y, 2003, NEUROSCI RES, V46, P135, DOI 10.1016/S0168-0102(03)00035-X; Kanaya K, 2009, OTOL NEUROTOL, V30, P640, DOI 10.1097/MAO.0b013e3181ab31af; Nakatani Hiroaki, 2010, ORL J Otorhinolaryngol Relat Spec, V71 Suppl 1, P105, DOI 10.1159/000265112; Romansky R. K., 2003, Archives of Physiology and Biochemistry, V111, P273, DOI 10.1076/apab.111.3.273.23460; SADJADPOUR K, 1975, BRAIN RES, V95, P403, DOI 10.1016/0006-8993(75)90117-1; Skouras E, 2010, ANATOMY, V4, P1; Takeda S, 2008, ORL J OTO-RHINO-LARY, V70, P215, DOI 10.1159/000130868; Takeda T, 1994, EUR ARCH OTO-RHINO-L, VS4, P18; Tashima Kazuyuki, 2010, ORL J Otorhinolaryngol Relat Spec, V71 Suppl 1, P85, DOI 10.1159/000265110; THOMANDER L, 1984, ACTA OTO-LARYNGOL, V97, P619, DOI 10.3109/00016488409132939; Valls-Sole J, 2003, MOVEMENT DISORD, V18, P1424, DOI 10.1002/mds.10605; Yamada H, 2010, LARYNGOSCOPE, V120, P1022, DOI 10.1002/lary.20840	23	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1531-7129	1537-4505		OTOL NEUROTOL	Otol. Neurotol.	JUN	2015	36	5					896	903				8	Clinical Neurology; Otorhinolaryngology	Neurosciences & Neurology; Otorhinolaryngology	CI4GT	WOS:000354707200023		
J	Mohanta, UK; Ichikawa-Seki, M; Hayashi, K; Itagaki, T				Mohanta, Uday Kumar; Ichikawa-Seki, Madoka; Hayashi, Kei; Itagaki, Tadashi			Morphological and molecular characterization of Eurytrema cladorchis parasitizing cattle (Bos indicus) in Bangladesh	PARASITOLOGY RESEARCH			English	Article						Eurytrema cladorchis; Morphology; Phylogeny; 18S rRNA; Bangladesh	RIBOSOMAL-RNA GENE; PHYLOGENETIC-RELATIONSHIPS; SEQUENCES; PANCREATICUM; ITS-2; RDNA	There is always controversy regarding identification of different species in the genus Eurytrema. Identification has been based mainly on morphology, which can be misleading and subject to differing interpretation among the scientists. Therefore, the aim of this study was to identify Eurytrema flukes both by morphology and molecular properties on the basis of 18-subunit ribosomal RNA (18S rRNA) gene as well as internal transcribed spacer 2 (ITS2) to clarify their phylogenetic status. Among six different agroecological areas of Bangladesh, 22 Eurytrema flukes were recovered from the bile ducts of 22 cattle in Bandarban, a hill district. The flukes were identified as Eurytrema cladorchis through morphometric and morphological studies. Phylogenetic analyses were conducted by neighbor-joining phylogram inferred from both 18S rRNA (1784 bp) gene and ITS2 (229 bp) sequences. A monophyletic clade was constructed by the E. cladorchis from Bangladesh; however, the clade was distinct from those formed by Eurytrema pancreaticum and Eurytrema coelomaticum. This study first described the existence of E. cladorchis from Bangladesh and may provide useful information for both morphological and molecular properties that may further help to clarify phylogenetic relationships within the genus Eurytrema and also for other digeneans.	[Mohanta, Uday Kumar; Ichikawa-Seki, Madoka; Hayashi, Kei; Itagaki, Tadashi] Iwate Univ, Lab Vet Parasitol, Fac Agr, Morioka, Iwate 0208550, Japan; [Mohanta, Uday Kumar; Ichikawa-Seki, Madoka; Hayashi, Kei; Itagaki, Tadashi] Gifu Univ, Dept Pathogenet Vet Sci, United Grad Sch Vet Sci, Gifu 5011193, Japan	Itagaki, T (reprint author), Gifu Univ, Dept Pathogenet Vet Sci, United Grad Sch Vet Sci, Yanagido 1-1, Gifu 5011193, Japan.	itagaki@iwate-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [23405044, 24580420, 22405037]	This study was supported in part by a Grant-in-Aid for Science Research (B) and (C) (nos. 23405044, 24580420, 22405037) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Cai ZH, 2012, PARASITOL RES, V111, P1637, DOI 10.1007/s00436-012-3002-y; Orosova M, 2010, PARASITOL INT, V59, P351, DOI 10.1016/j.parint.2010.04.007; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI 10.1093/molbev/mst197; BLAIR D, 1993, INT J PARASITOL, V23, P527, DOI 10.1016/0020-7519(93)90042-W; Itagaki T, 1998, INT J PARASITOL, V28, P777, DOI 10.1016/S0020-7519(98)00037-X; Jin DX, 1965, ACTA PARASITOL SIN, V2, P28; JONES A, 1985, SYST PARASITOL, V7, P43; Kumar V, 1998, TREMATODE INFECT DIS, P230; Swofford D.L., 2001, PAUP PHYLOGENETIC AN; TANG CC, 1950, J PARASITOL, V36, P559, DOI 10.2307/3273289; Tang CC, 1978, J XIAMEN U, V4, P64; Tang CC, 1977, ACTA ZOOL SINICA, V23, P267; Tang CT, 1978, XIAMEN DAXUE XUEBAO, V14, P104; TANG CG, 1980, ACTA ZOOL SINICA, V26, P42; WIRORENO W, 1987, P HELM SOC WASH, V54, P73; Yamada S, 2012, JPN J VET RES, V60, P15; Zheng YD, 2007, PARASITOL RES, V100, P645, DOI 10.1007/s00436-006-0281-1; Zheng Ya-dong, 2006, Chinese Journal of Parasitology and Parasitic Diseases, V24, P345	18	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0932-0113	1432-1955		PARASITOL RES	Parasitol. Res.	JUN	2015	114	6					2099	2105		10.1007/s00436-015-4398-y		7	Parasitology	Parasitology	CI0CT	WOS:000354404100008		
J	Toda, N; Okamura, T				Toda, Noboru; Okamura, Tomio			Recent advances in research on nitrergic nerve-mediated vasodilatation	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Review						Nitrergic nerve; Vasodilatation; Nitric oxide; Cerebral artery; Peripheral arteries; Nitrergic and adrenergic nerve interaction	NITRIC-OXIDE SYNTHASE; BLOOD-FLOW REGULATION; SPONTANEOUSLY HYPERTENSIVE-RATS; MONKEY CEREBRAL-ARTERIES; NICOTINE-INDUCED RELAXATION; CENTRAL RETINAL ARTERY; HUMAN NASAL-MUCOSA; NEUROGENIC VASODILATATION; NITROXIDERGIC NERVE; MESENTERIC-ARTERIES	Cerebral vascular resistance and blood flow were widely considered to be regulated solely by tonic innervation of vasoconstrictor adrenergic nerves. However, pieces of evidence suggesting that parasympathetic nitrergic nerve activation elicits vasodilatation in dog and monkey cerebral arteries were found in 1990. Nitric oxide (NO) as a neurotransmitter liberated from parasympathetic postganglionic neurons decreases cerebral vascular tone and resistance and increases cerebral blood flow, which overcome vasoconstrictor responses to norepinephrine liberated from adrenergic nerves. Functional roles of nitrergic vasodilator nerves are found also in peripheral vasculature, including pulmonary, renal, mesenteric, hepatic, ocular, uterine, nasal, skeletal muscle, and cutaneous arteries and veins; however, adrenergic nerve-induced vasoconstriction is evidently greater than nitrergic vasodilatation in these vasculatures. In coronary arteries, neurogenic NO-mediated vasodilatation is not clearly noted; however, vasodilatation is induced by norepinephrine released from adrenergic nerves that activates beta(1)-adrenoceptors. Impaired actions of NO liberated from the endothelium and nitrergic neurons are suggested to participate in cerebral hypoperfusion, leading to brain dysfunction, like that in Alzheimer's disease. Nitrergic neural dysfunction participates in impaired circulation in peripheral organs and tissues and also in systemic blood pressure increase. NO and vasodilator peptides, as sensory neuromediators, are involved in neurogenic vasodilatation in the skin. Functioning of nitrergic vasodilator nerves is evidenced not only in a variety of mammals, including humans and monkeys, but also in non-mammals. The present review article includes recent advances in research on the functional importance of nitrergic nerves concerning the control of cerebral blood flow, as well as other regions, and vascular resistance. Although information is still insufficient, the nitrergic nerve histology and function in vasculatures of non-mammals are also summarized.	[Toda, Noboru] Toyama Inst Cardiovasc Pharmacol Res, Chuo Ku, Otsu, Shiga 5410052, Japan; [Toda, Noboru; Okamura, Tomio] Shiga Univ Med Sci, Dept Pharmacol, Otsu, Shiga 5202192, Japan	Toda, N (reprint author), Toyama Inst Cardiovasc Pharmacol Res, Chuo Ku, 7-13 1 Cho Me,Azuchi Machi, Otsu, Shiga 5410052, Japan.	n.toda.toyama-bldg@orion.ocn.ne.jp			Ministry of Education, Culture, Sport, Science and Technology of Japan [23390055]	This work was supported in part by grant-in-aid for scientific research from the Ministry of Education, Culture, Sport, Science and Technology of Japan (23390055).	Lau KS, 2000, PHYSIOL GENOMICS, V2, P21; Huang CF, 2013, EUR J PHARMACOL, V699, P233, DOI 10.1016/j.ejphar.2012.11.034; Sequeira IM, 2005, ANN ANAT, V187, P345, DOI 10.1016/j.aanat.2005.05.003; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Selley ML, 2003, NEUROBIOL AGING, V24, P903, DOI 10.1016/S0197=4580(03)00007-1; Seddon MD, 2008, CIRCULATION, V117, P1991, DOI 10.1161/CIRCULATIONAHA.107.744540; Johnson JM, 2010, J APPL PHYSIOL, V109, P1229, DOI 10.1152/japplphysiol.00407.2010; Talman WT, 2007, BRAIN RES, V1139, P126, DOI 10.1016/j.brainres.2007.01.008; Dautzenberg M, 2011, J PHYSIOL-LONDON, V589, P4731, DOI 10.1113/jphysiol.2011.215897; Ichihara A, 1998, AM J PHYSIOL-RENAL, V274, pF516; Toda N, 2012, PHARMACOL THERAPEUT, V133, P159, DOI 10.1016/j.pharmthera.2011.10.004; FARACI FM, 1990, CIRC RES, V66, P8; Faraci FM, 2011, AM J PHYSIOL-HEART C, V300, pH1566, DOI 10.1152/ajpheart.01310.2010; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Merhi M, 1998, BRIT J PHARMACOL, V123, P863, DOI 10.1038/sj.bjp.0701696; Toda N, 2012, J ALZHEIMERS DIS, V32, P569, DOI 10.3233/JAD-2012-120670; YOSHIDA K, 1993, BRAIN RES, V629, P67, DOI 10.1016/0006-8993(93)90482-3; Yoshida T, 2007, ANN NUCL MED, V21, P257, DOI 10.1007/s12149-007-0022-2; Toda N, 2010, EUR J PHARMACOL, V649, P1, DOI 10.1016/j.ejphar.2010.09.042; Toda N, 2000, NEUROSCIENCE, V96, P393, DOI 10.1016/S0306-4522(99)00557-6; Ayajiki K, 2001, EUR J PHARMACOL, V423, P179, DOI 10.1016/S0014-2999(01)01068-8; Savvidou MD, 2003, LANCET, V361, P1511, DOI 10.1016/S0140-6736(03)13177-7; Aras-Lopez R, 2009, CLIN SCI, V117, P305, DOI 10.1042/CS20080178; Biecker E, 2004, LIVER INT, V24, P345, DOI 10.1111/j.1478-3231.2004.0933.x; Berg T, 2005, CARDIOVASC RES, V67, P736, DOI 10.1016/j.cardiores.2005.04.006; Eppel GA, 2003, PFLUG ARCH EUR J PHY, V447, P205, DOI 10.1007/s00424-003-1149-1; de la Torre JC, 2005, J CEREBR BLOOD F MET, V25, P663, DOI 10.1038/sj.jcbfm.9600057; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Nangle MR, 2006, PLANTA MED, V72, P494, DOI 10.1055/s-2006-916262; Ratliff B, 2009, PEDIATR NEPHROL, V24, P355, DOI 10.1007/s00467-008-0977-9; Toda N, 2013, EUR J PHARMACOL, V714, P414, DOI 10.1016/j.ejphar.2013.07.006; Axelsson M, 2001, GEN COMP ENDOCR, V122, P198, DOI 10.1006/gcen.2001.7627; Seddon M, 2009, CIRCULATION, V119, P2656, DOI 10.1161/CIRCULATIONAHA.108.822205; Wang XM, 2009, CAN J PHYSIOL PHARM, V87, P29, DOI 10.1139/Y08-102; Aoki H, 2013, ENDOCR J, V60, P571; Aoki T, 2011, LAB INVEST, V91, P619, DOI 10.1038/labinvest.2010.204; Ayajiki K, 2002, JPN J PHARMACOL, V89, P197, DOI 10.1254/jjp.89.197; AYAJIKI K, 1993, NEUROSCIENCE, V54, P819, DOI 10.1016/0306-4522(93)90251-A; Ayajiki K, 2008, HYPERTENS RES, V31, P1425, DOI 10.1291/hypres.31.1425; Ayajiki K, 2001, EUR J PHARMACOL, V420, P67, DOI 10.1016/S0014-2999(01)01019-6; Bergua A, 2003, EXP EYE RES, V77, P367, DOI 10.1016/S0014-4835(03)00121-0; Broughton BRS, 2005, J COMP PHYSIOL B, V175, P157, DOI 10.1007/s00360-005-0471-7; Brown LA, 2000, NEUROSCI LETT, V294, P9, DOI 10.1016/S0304-3940(00)01521-4; Burke M, 2006, NEUROIMAGE, V32, P1, DOI 10.1016/j.neuroimage.2006.03.035; Cellek S, 2005, DIABETES, V54, P212, DOI 10.2337/diabetes.54.1.212; Chang HH, 2012, AM J PHYSIOL-HEART C, V302, pH1123, DOI 10.1152/ajpheart.01016.2011; Esteban FJ, 1998, J ANAT, V193, P241, DOI 10.1046/j.1469-7580.1998.19320241.x; Esteban FJ, 2001, LIVER, V21, P372; Fischer A, 1996, ANN NY ACAD SCI, V805, P717; Furchgott R.F., 1988, MECHANISMS VASODILAT, V4, P401; FURFINE ES, 1994, J BIOL CHEM, V269, P26677; Ghorbani A, 2010, NEUROSCIENCES, V15, P172; Gonzalez-Luis G, 2007, J PHYSIOL PHARMACOL, V58, P45; Gottanka J, 2005, J ANAT, V206, P225, DOI 10.1111/j.1469-7580.2005.00391.x; Haberberger R, 1997, J APPL PHYSIOL, V82, P426; Hoffman B.B., 2001, GOODMAN GILMANS PHAR, P115; Hojna S, 2010, PHYSIOL RES, V59, P997; Hudetz AG, 2000, J CEREBR BLOOD F MET, V20, P220; Ignacio CS, 1997, AM J PHYSIOL-REG I, V273, pR661; Jennings BL, 2008, AM J PHYSIOL-REG I, V295, pR1640, DOI 10.1152/ajpregu.00057.2008; Jennings BL, 2004, J EXP BIOL, V207, P1295, DOI 10.1242/jeb.00883; Jiang F, 1997, EUR J PHARMACOL, V340, P181, DOI 10.1016/S0014-2999(97)01381-2; Jimenez A, 2001, J CHEM NEUROANAT, V21, P289, DOI 10.1016/S0891-0618(01)00116-8; Jurzik L, 2005, J HEPATOL, V43, P258, DOI 10.1016/j.jhep.2005.02.036; Knipping S, 2005, OTOLARYNG HEAD NECK, V132, P620, DOI 10.1016/j.otohns.2005.01.025; Koyama T, 2010, HYPERTENS RES, V33, P485, DOI 10.1038/hr.2010.48; LEE TJF, 1975, EXPERIENTIA, V31, P1424, DOI 10.1007/BF01923224; LEE TJF, 1991, BLOOD VESSELS, V28, P407; LINNIK MD, 1989, J CEREBR BLOOD F MET, V9, P219; MARTIN W, 1985, J PHARMACOL EXP THER, V233, P679; Mattson DL, 2005, AM J PHYSIOL-REG I, V289, pR991, DOI 10.1152/ajpregu.00207.2005; McCuskey RS, 2004, ANAT REC PART A, V280A, P821, DOI 10.1002/ar.a.20087; Moleda L, 2010, WORLD J GASTROENTERO, V16, P1837, DOI 10.3748/wjg.v16.i15.1837; MOORE PK, 1993, BRIT J PHARMACOL, V108, P296; Ogawa F, 2010, ANN OTO RHINOL LARYN, V119, P424; Okamura T, 1999, J PHARMACOL EXP THER, V288, P1031; OKAMURA T, 1995, HYPERTENSION, V25, P1090; Okamura T, 1996, HYPERTENSION, V28, P341; OKAMURA T, 1994, EUR J PHARMACOL, V263, P85, DOI 10.1016/0014-2999(94)90527-4; Okamura T, 2001, HYPERTENS RES, V24, P47, DOI 10.1291/hypres.24.47; Okita W, 1998, ACTA OTO-LARYNGOL, P76; Overend J, 2005, BRIT J PHARMACOL, V145, P1001, DOI 10.1038/sj.bjp.0706264; Patterson ME, 2008, AM J PHYSIOL-RENAL, V294, pF205, DOI 10.1152/ajprenal.00150.2007; Possas OS, 1997, AM J PHYSIOL-HEART C, V273, pH234; Radegran G, 2000, ACTA PHYSIOL SCAND, V168, P575, DOI 10.1046/j.1365-201x.2000.00705.x; Riederer A, 1999, ANN OTO RHINOL LARYN, V108, P869; Sastre E, 2012, CLIN SCI, V122, P337, DOI 10.1042/CS20110303; Sawada K, 1997, ACTA ANAT, V160, P239; Scott JA, 1999, CAN J PHYSIOL PHARM, V77, P89, DOI 10.1139/cjpp-77-2-89; Shareef S, 1999, ISOFORMS NITRIC OXID; Shiraishi S, 1998, J CARDIOVASC PHARM, V31, P372, DOI 10.1097/00005344-199803000-00007; SHIRAISHI S, 1994, JPN J PHARMACOL, V66, P481, DOI 10.1254/jjp.66.481; Stefanovic B, 2007, J CEREBR BLOOD F MET, V27, P741, DOI 10.1038/sj.jcbfm.9600377; Tain YL, 2011, EUR J PHARMACOL, V670, P561, DOI 10.1016/j.ejphar.2011.09.005; Tanaka T, 2003, J PHARMACOL SCI, V92, P93; Tasatargil A, 2003, Auton Autacoid Pharmacol, V23, P117, DOI 10.1046/j.1474-8673.2003.00284.x; Tatchum-Talom R, 2000, AM J PHYSIOL-HEART C, V279, pH1757; Toda N, 1996, INVEST OPHTH VIS SCI, V37, P2177; Toda N, 1997, J PHYSIOL-LONDON, V498, P453; TODA N, 1975, J PHARMACOL EXP THER, V193, P376; Toda N, 1997, AM J PHYSIOL-HEART C, V272, pH1582; TODA N, 1982, EUR J PHARMACOL, V80, P73, DOI 10.1016/0014-2999(82)90179-0; Toda N, 2003, PHARMACOL REV, V55, P271, DOI 10.1124/pr.55.2.3; TODA N, 1993, EXPERIENTIA, V49, P51, DOI 10.1007/BF01928789; TODA N, 1993, CIRC RES, V72, P206; TODA N, 1990, BIOCHEM BIOPH RES CO, V170, P308, DOI 10.1016/0006-291X(90)91275-W; Toda N, 2000, J CEREBR BLOOD F MET, V20, P700; TODA N, 1994, AM J PHYSIOL, V266, pH1985; Toda N, 2001, J ETHNOPHARMACOL, V76, P109, DOI 10.1016/S0378-8741(01)00217-3; Toda N, 2014, J CLIN PHARMACOL, V53, P1228; TODA N, 1990, AM J PHYSIOL, V259, pH1511; Toda N, 2009, J HYPERTENS, V27, P1929, DOI 10.1097/HJH.0b013e32832e8ddf; Toda N, 1991, J VASC MED BIOL, V3, P235; TODA N, 1988, J CEREBR BLOOD F MET, V8, P46; Tojo Akihiro, 2004, Medical Electron Microscopy, V37, P236, DOI 10.1007/s00795-004-0263-2; Tong XK, 2000, EUR J NEUROSCI, V12, P2769, DOI 10.1046/j.1460-9568.2000.00158.x; Uchiyama M, 1997, EUR J PHARMACOL, V321, P19, DOI 10.1016/S0014-2999(96)00925-9; Van Genechten J, 2003, ANAT REC PART A, V272A, P446, DOI 10.1002/ar.a.10053; Veerareddy S, 2004, AM J OBSTET GYNECOL, V191, P334, DOI 10.1016/j.ajog.2003.12.030; Walkowska A, 2004, KIDNEY INT, V66, P705, DOI 10.1111/j.1523-1755.2004.00792.x; Wang SC, 2014, J AM SOC HYPERTENS, V8, P5, DOI 10.1016/j.jash.2013.07.010; Watanabe H, 1998, JPN J PHARMACOL, V77, P287, DOI 10.1254/jjp.77.287; YOSHIDA K, 1994, JPN J PHARMACOL, V65, P351, DOI 10.1254/jjp.65.351; Zaccone G, 2004, ACTA HISTOCHEM, V106, P179, DOI 10.1016/j.acthis.2003.12.001; Zhang HQ, 1997, J MED CHEM, V40, P3869, DOI 10.1021/jm970550g	125	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JUN	2015	467	6					1165	1178		10.1007/s00424-014-1621-0		14	Physiology	Physiology	CI3DZ	WOS:000354629100002		
J	Mitsui, R; Hashitani, H				Mitsui, Retsu; Hashitani, Hikaru			Functional properties of submucosal venules in the rat stomach	PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY			English	Article						Microvasculature; Smooth muscle; Vasomotion; Autonomic nerves; Digestive tract	GUINEA-PIG ILEUM; MOUSE GASTROINTESTINAL-TRACT; GENE-RELATED PEPTIDE; SMOOTH-MUSCLE-CELLS; MUCOSAL BLOOD-FLOW; INTERSTITIAL-CELLS; SUBUROTHELIAL VENULES; NERVE-STIMULATION; ARTERIOLES; VESSELS	Venules in the stomach may have intrinsic properties for maintaining active microcirculation drainage even during gastric filling. Properties of spontaneous and nerve-mediated activity of submucosal venules in the rat stomach were investigated. Changes in vasodiameter and intracellular Ca2+ in venular smooth muscle cells (SMCs) were monitored by video tracking and Fluo-8 Ca2+ imaging, respectively. Venular SMCs developed synchronous spontaneous Ca2+ transients and corresponding rhythmic constrictions of the venules. Nominally Ca2+-free solution or an L-type Ca2+ channel blocker (1 mu M nifedipine) disrupted the Ca2+ transient synchrony and abolished spontaneous constrictions. Spontaneous constrictions were also prevented by inhibitors of sarcoplasmic reticulum Ca2+-ATPase (10 mu M cyclopiazonic acid (CPA)), IP3 receptors (100 mu M 2-APB) or Ca2+-activated Cl- channels (100 mu M niflumic acid). Transmural nerve stimulation (TNS) induced a long-lasting venular constriction that was abolished by alpha-adrenoceptor antagonist (1 mu M phentolamine), while TNS evoked a sympathetic transient constriction of arterioles that was abolished by a combination of phentolamine and a P2 purinoceptor antagonist (10 mu M pyridoxal-phosphate-6-azophenyl-2',4'-disulfonic acid (PPADS)). Consistently, P2X(1) purinoceptor immunoreactivity was detected in arteriolar but not venular SMCs. Primary afferent nerve stimulation (300 nM capsaicin) caused a venular dilatation by releasing calcitonin gene-related peptide. Thus, Ca2+ release from the sarcoplasmic reticulum may play a fundamental role in the generation of spontaneous Ca2+ transients, while electrical coupling amongst venular SMCs via L-type Ca2+ channel activation appears to be critical for Ca2+ transient synchrony as well as spontaneous contractions. Sympathetic venular constrictions appear to be exclusively mediated by noradrenaline due to the lack of P2X(1) receptor in venular SMCs.	[Mitsui, Retsu; Hashitani, Hikaru] Nagoya City Univ, Grad Sch Med Sci, Dept Cell Physiol, Mizuho Ku, Nagoya, Aichi 4678601, Japan	Mitsui, R (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Cell Physiol, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	mitsui@med.nagoya-cu.ac.jp			Ichihara International Scholarship Foundation; Japan Society for Promotion of the Science (JSPS) [22390304, 21659377, 26860521]	The authors wish to thank Dr. Richard Lang (Monash University) for critical reading of the manuscript. This study was supported by Grant-in-Aid for Research in Nagoya City University to R.M., a research grant from Ichihara International Scholarship Foundation to R.M., Grant-in-Aid for Scientific Research (B) (No. 22390304) from Japan Society for Promotion of the Science (JSPS) to H.H., Grant-in-Aid for Challenging Exploratory Research (No. 21659377) from JSPS to H.H. and Grant-in-Aid for Young Scientists (B) (No. 26860521) from JSPS to R.M..	ANDERSSON PO, 1984, SCAND J GASTROENTERO, V19, P65; Gomez-Pinilla PJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1370, DOI 10.1152/ajpgi.00074.2009; Mazzone A, 2012, BIOCHEM BIOPH RES CO, V427, P248, DOI 10.1016/j.bbrc.2012.09.022; NEILD TO, 1990, J PHYSIOL-LONDON, V420, P247; Hashitani H, 2011, J UROLOGY, V185, P2382, DOI 10.1016/j.juro.2011.02.046; Shimizu Y, 2014, VASC PHARMACOL, V60, P84, DOI 10.1016/j.vph.2014.01.002; EVANS RJ, 1992, BRIT J PHARMACOL, V106, P242; Johnstone S, 2009, INT REV CEL MOL BIO, V278, P69, DOI 10.1016/S1937-6448(09)78002-5; Mitsui R, 2013, BRIT J PHARMACOL, V170, P968, DOI 10.1111/bph.12347; Sergeant GP, 2001, AM J PHYSIOL-CELL PH, V280, pC1349; HIROSE K, 1993, BIOCHEM BIOPH RES CO, V194, P726, DOI 10.1006/bbrc.1993.1882; Peng HL, 2001, CIRC RES, V88, P810, DOI 10.1161/hh0801.089603; HIRST GDS, 1977, J PHYSIOL-LONDON, V273, P263; Kotecha N, 1995, J PHYSIOL-LONDON, V489, P849; Hashitani H, 2012, BRIT J PHARMACOL, V167, P1723, DOI 10.1111/j.1476-5381.2012.02125.x; Ralevic V, 2009, CURR VASC PHARMACOL, V7, P3; Mitsui R, 2013, HISTOCHEM CELL BIOL, V140, P189, DOI 10.1007/s00418-012-1074-5; Bultynck G, 2003, PFLUG ARCH EUR J PHY, V445, P629, DOI 10.1007/s00424-002-0971-1; CHEN RYZ, 1992, AM J PHYSIOL, V262, pH1350; De Fontgalland D, 2008, NEUROGASTROENT MOTIL, V20, P1212, DOI 10.1111/j.1365-2982.2008.01150.x; Figini M, 1997, AM J PHYSIOL-GASTR L, V272, pG785; FOLKOW B, 1964, ACTA PHYSIOL SCAND, V61, P445; FURNESS JB, 1974, J PHYSIOL-LONDON, V239, P75; GALLIGAN JJ, 1995, J PHARMACOL EXP THER, V274, P1425; GUTH PH, 1975, GASTROENTEROLOGY, V69, P935; Haddock RE, 2002, J PHYSIOL-LONDON, V545, P615, DOI 10.1113/jphysiol.2002.027904; Hashitani H, 1999, J PHYSIOL-LONDON, V514, P459, DOI 10.1111/j.1469-7793.1999.459ae.x; HIRST GDS, 1989, BRIT J PHARMACOL, V96, P993; HOLZER P, 1991, GASTROENTEROLOGY, V101, P416; Kunisawa Y, 2008, NEUROSCI LETT, V434, P273, DOI 10.1016/j.neulet.2008.01.063; Lamont C, 2006, AM J PHYSIOL-HEART C, V291, pH3106, DOI 10.1152/ajpheart.00466.2006; IINO M, 1989, Journal of General Physiology, V94, P363, DOI 10.1085/jgp.94.2.363; MORGAN KG, 1983, J PHYSIOL-LONDON, V345, P135; NEILD TO, 1989, BLOOD VESSELS, V26, P48; Nilsson Holger, 2003, Mol Interv, V3, P79, DOI 10.1124/mi.3.2.79; PARKER I, 1991, J PHYSIOL-LONDON, V433, P229; Reed DE, 2003, J PHYSIOL-LONDON, V553, P911, DOI 10.1113/jphysiol.2003.053140; STERNINI C, 1987, GASTROENTEROLOGY, V93, P852; SU HC, 1987, J NEUROSCI, V7, P2674; SUZUKI H, 1981, J PHYSIOL-LONDON, V321, P495; Tamada H, 2012, CELL TISSUE RES, V347, P319, DOI 10.1007/s00441-011-1312-5; VANNER S, 1994, AM J PHYSIOL-GASTR L, V267, pG650	42	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0031-6768	1432-2013		PFLUG ARCH EUR J PHY	Pflugers Arch.	JUN	2015	467	6					1327	1342		10.1007/s00424-014-1576-1		16	Physiology	Physiology	CI3DZ	WOS:000354629100015		
J	Inoue, Y; Kenzo, T; Tanaka-Oda, A; Yoneyama, A; Ichie, T				Inoue, Y.; Kenzo, T.; Tanaka-Oda, A.; Yoneyama, A.; Ichie, T.			Leaf water use in heterobaric and homobaric leafed canopy tree species in a Malaysian tropical rain forest	PHOTOSYNTHETICA			English	Article						bundle-sheath extension; Dipterocarpaceae; gas exchange; leaf morphology; wood density	BUNDLE-SHEATH EXTENSIONS; PATCHY STOMATAL BEHAVIOR; LATERAL CO2 DIFFUSION; EFFICIENCY TRADE-OFF; WOOD DENSITY; PHOTOSYNTHETIC CAPACITY; HYDRAULIC EFFICIENCY; COMMUNITY STRUCTURE; CLIMATE-CHANGE; CARBON GAIN	Tropical canopy tree species can be classified into two types by their heterobaric and homobaric leaves. We studied the relation between both leaf types and their water use, together with the morphological characteristics of leaves and xylem, in 23 canopy species in a tropical rain forest. The maximum rates of photosynthesis and transpiration were significantly higher in heterobaric leaf species, which also underwent larger diurnal variations of leaf water potential compared to homobaric leaf species. The vessel diameter was significantly larger and the stomatal pore index (SPI) was significantly higher in heterobaric than that in homobaric leaf species. There was a significant positive correlation between the vessel diameter, SPI, and maximum transpiration rates in all the studied species of both leaf types. However, there was no significant difference in other properties, such as leaf water-use efficiency, leaf mass per area, leaf nitrogen content, and leaf delta C-13 between heterobaric and homobaric leaf species. Our results indicate that leaf and xylem morphological differences between heterobaric and homobaric leaf species are closely related to leaf water-use characteristics, even in the same habitat: heterobaric leaf species achieved a high carbon gain with large water use under strong light conditions, whereas homobaric leaf species can maintain a high leaf water potential even at midday as a result of low water use in the canopy environment.	[Inoue, Y.; Yoneyama, A.] Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan; [Kenzo, T.; Tanaka-Oda, A.] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Inoue, Y.; Ichie, T.] Kochi Univ, Fac Agr, Nankoku, Kochi 7838502, Japan	Inoue, Y (reprint author), Ehime Univ, United Grad Sch Agr Sci, Matsuyama, Ehime 7908566, Japan.	inoueyu03@gmail.com			JSPS [23255002, 244050321]; Research Institute for Humanity and Nature [D-04]; Environment Research and Technology Development Fund of the Ministry of the Environment, Japan [RF-1010, S-9]	We are grateful to the Forest Department, Sarawak, and Prof. N. Yamamura for their kind support of this study. We thank Prof. S. Fujiwara for his help with microscopic analysis, Dr. M. Nakagawa for providing tree census data, and Dr. Kume for providing meteorological data. We also thank two anonymous reviewers for constructive critique. This research was partly supported by the Grant-in-Aid for Scientific Research from JSPS (No. 23255002, 244050321), the Research Institute for Humanity and Nature (project No. D-04), and the Environment Research and Technology Development Fund (RF-1010, S-9) of the Ministry of the Environment, Japan.	Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Hacke UG, 2006, TREE PHYSIOL, V26, P689; BUCK AL, 1981, J APPL METEOROL, V20, P1527, DOI 10.1175/1520-0450(1981)020<1527:NEFCVP>2.0.CO;2; McKown AD, 2010, AM NAT, V175, P447, DOI 10.1086/650721; Beyschlag W, 2001, ACTA OECOL, V22, P161, DOI 10.1016/S1146-609X(01)01110-9; Nikolopoulos D, 2002, PLANT PHYSIOL, V129, P235, DOI 10.1104/pp.010943; McCulloh K, 2010, NEW PHYTOL, V186, P439, DOI 10.1111/j.1469-8137.2010.03181.x; Xu Z, 2008, J EXP BOT, V59, P3317, DOI 10.1093/jxb/ern185; Overpeck JT, 2007, NATURE, V445, P270, DOI 10.1038/445270a; Karabourniotis G, 2000, PLANT CELL ENVIRON, V23, P423, DOI 10.1046/j.1365-3040.2000.00558.x; Brodribb TJ, 2013, NEW PHYTOL, V199, P559, DOI 10.1111/nph.12300; Kenzo T, 2006, TREE PHYSIOL, V26, P865; TYREE MT, 1986, PHYSIOL PLANTARUM, V66, P397, DOI 10.1111/j.1399-3054.1986.tb05941.x; Martinez-Vilalta J, 2002, OECOLOGIA, V133, P19, DOI 10.1007/s00442-002-1009-2; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Anfodillo T, 2006, NEW PHYTOL, V169, P279, DOI 10.1111/j.1469-8137.2005.01587.x; Tanaka Y, 2013, NEW PHYTOL, V198, P757, DOI 10.1111/nph.12186; Zwieniecki MA, 2007, PLANT CELL ENVIRON, V30, P910, DOI 10.1111/j.1365-3040.2007.001681.x; Boyce CK, 2009, P R SOC B, V276, P1771, DOI 10.1098/rspb.2008.1919; Brodribb TJ, 2011, NEW PHYTOL, V192, P437, DOI 10.1111/j.1469-8137.2011.03795.x; Santiago LS, 2004, OECOLOGIA, V140, P543, DOI 10.1007/s00442-004-1624-1; Sack L, 2006, ECOLOGY, V87, P483, DOI 10.1890/05-0710; Brodribb TJ, 2010, NEW PHYTOL, V188, P533, DOI 10.1111/j.1469-8137.2010.03393.x; WYLIE RB, 1951, AM J BOT, V38, P355, DOI 10.2307/2437823; Wheeler JK, 2005, PLANT CELL ENVIRON, V28, P800, DOI 10.1111/j.1365-3040.2005.01330.x; Brodribb TJ, 2000, PLANT CELL ENVIRON, V23, P1381, DOI 10.1046/j.1365-3040.2000.00647.x; Tanaka-Oda A, 2010, FOREST ECOL MANAG, V259, P953, DOI 10.1016/j.foreco.2009.11.037; Sack L, 2003, PLANT CELL ENVIRON, V26, P1343, DOI 10.1046/j.0016-8025.2003.01058.x; Corlett RT, 1998, CLIMATIC CHANGE, V39, P439, DOI 10.1023/A:1005328124567; Cai J, 2010, PLANT CELL ENVIRON, V33, P1059, DOI 10.1111/j.1365-3040.2010.02127.x; Engelbrecht BMJ, 2007, NATURE, V447, P80, DOI 10.1038/nature05747; Manzoni S, 2013, NEW PHYTOL, V198, P169, DOI 10.1111/nph.12126; Lintunen A, 2010, TREE PHYSIOL, V30, P1433, DOI 10.1093/treephys/tpq085; West JD, 2005, PLANT CELL ENVIRON, V28, P633, DOI 10.1111/j.1365-3040.2005.01309.x; Pons TL, 2002, PLANT CELL ENVIRON, V25, P1367, DOI 10.1046/j.1365-3040.2002.00911.x; Buckley TN, 2002, SILVA FENN, V36, P639, DOI 10.14214/sf.531; Jones HG, 1999, PLANT CELL ENVIRON, V22, P1043, DOI 10.1046/j.1365-3040.1999.00468.x; Zhang JL, 2009, FUNCT ECOL, V23, P658, DOI 10.1111/j.1365-2435.2009.01552.x; Brodribb TJ, 2010, FUNCT PLANT BIOL, V37, P488, DOI 10.1071/FP10010; Tsumura Y, 2011, J PLANT RES, V124, P35, DOI 10.1007/s10265-010-0348-z; Ashton PS, 2005, ECOL STU AN, V174, P191; Bebber D. P., 2002, Journal of Tropical Forest Science, V14, P425; Buckley TN, 2011, PLANT PHYSIOL, V156, P962, DOI 10.1104/pp.111.175638; Christensen JH, 2007, CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Christman MA, 2012, NEW PHYTOL, V193, P713, DOI 10.1111/j.1469-8137.2011.03984.x; Crocker WM, 1919, BOT GAZ, V67, P517; Hiromi T, 2012, J FOREST RES-JPN, V17, P369, DOI 10.1007/s10310-011-0303-4; Hiromi Toru, 1999, Japanese Journal of Ecology (Otsu), V49, P83; Ishida A, 1996, TREE PHYSIOL, V16, P779; Ishida A, 2008, OECOLOGIA, V156, P193, DOI 10.1007/s00442-008-0965-6; Kamakura M, 2011, TREE PHYSIOL, V31, P160, DOI 10.1093/treephys/tpq102; Kenzo T, 2004, TREE PHYSIOL, V24, P1187; Kenzo T, 2003, PHOTOSYNTHETICA, V41, P551, DOI 10.1023/B:PHOT.0000027519.26832.f3; Kenzo T, 2007, AM J BOT, V94, P764, DOI 10.3732/ajb.94.5.764; Kimmins J.P., 1997, FOREST ECOLOGY FDN S; Koike T., 1998, FOREST RESOURCES ENV, V36, P55; Koike T., 1997, FOR RESOUR ENV, V35, P9; Kumagai T, 2012, ECOL MODEL, V246, P91, DOI 10.1016/j.ecolmodel.2012.07.014; Kumagai T, 2004, WATER RESOUR RES, V40, DOI 10.1029/2003WR002226; Kume T, 2011, AGR FOREST METEOROL, V151, P1183, DOI 10.1016/j.agrformet.2011.04.005; Kume T, 2008, AGR FOREST METEOROL, V148, P1181, DOI 10.1016/j.agrformet.2008.02.010; Lawson T, 2006, NEW PHYTOL, V169, P641, DOI 10.1111/j.1469-8137.2006.01655.x; Liakoura V, 2009, AM J BOT, V96, P612, DOI 10.3732/ajb.0800166; Lynch DJ, 2012, AM J BOT, V99, P1197, DOI 10.3732/ajb.1100525; Morison JIL, 2007, PLANT PHYSIOL, V145, P680, DOI 10.1104/pp.107.107318; Mott KA, 2007, ANN BOT-LONDON, V99, P219, DOI 10.1093/aob/mcl234; Nakagawa M, 2000, J TROP ECOL, V16, P355, DOI 10.1017/S0266467400001450; Nakagawa M, 2013, BIODIVERS CONSERV, V22, P127, DOI 10.1007/s10531-012-0405-0; Nardini A, 2005, FUNCT PLANT BIOL, V32, P953, DOI 10.1071/FP05100; Nobel P.S., 1999, PHYSICOCHEMICAL ENV; Osunkoya OO, 2007, AUSTRAL ECOL, V32, P191, DOI 10.1111/j.1442-9993.2007.01678.x; Pieruschka R, 2006, NEW PHYTOL, V169, P779, DOI 10.1111/j.1469-8137.2005.01605.x; Pieruschka R, 2008, NEW PHYTOL, V178, P335, DOI [10.1111/j.1469-8137.2008.02368.x, 10.1111/j.1469-8137.2007.02368.x]; Pieruschka R, 2010, J EXP BOT, V61, P1031, DOI 10.1093/jxb/erp368; Roth I, 1984, STRATIFICATION TROPI; Sack L, 2005, NEW PHYTOL, V167, P403, DOI 10.1111/j.1469-8137.2005.01432.x; Sakai S., 2002, GLOBAL CANOPY HDB, P77; Schuldt B, 2013, TREE PHYSIOL, V33, P161, DOI 10.1093/treephys/tps122; Scoffoni C, 2008, PLANT CELL ENVIRON, V31, P1803, DOI 10.1111/j.1365-3040.2008.01884.x; Takanashi S, 2006, TREE PHYSIOL, V26, P1565; TERASHIMA I, 1992, PHOTOSYNTH RES, V31, P195, DOI 10.1007/BF00035537; Walls RL, 2011, AM J BOT, V98, P244, DOI 10.3732/ajb.1000154; Whitmore TC, 1998, INTRO TROPICAL RAIN; Wright SJ, 2010, ANN NY ACAD SCI, V1195, P1, DOI 10.1111/j.1749-6632.2010.05455.x; WYLIE RB, 1952, AM J BOT, V39, P645, DOI 10.2307/2438370; Yanez-Espinosa L, 2003, CAN J BOT, V81, P398, DOI [10.1139/B03-031, 10.1139/b03-031]; YODA K, 1974, Japanese Journal of Ecology, V24, P247; Zach A, 2010, FLORA, V205, P506, DOI 10.1016/j.flora.2009.12.008	88	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-3604	1573-9058		PHOTOSYNTHETICA	Photosynthetica	JUN	2015	53	2					177	186		10.1007/s11099-015-0105-6		10	Plant Sciences	Plant Sciences	CI7OZ	WOS:000354955000003		
J	Hazama, K; Nagata, S; Fujimori, T; Yanagisawa, S; Yoneyama, T				Hazama, Kenji; Nagata, Shinji; Fujimori, Tamaki; Yanagisawa, Shuichi; Yoneyama, Tadakatsu			Concentrations of metals and potential metal-binding compounds and speciation of Cd, Zn and Cu in phloem and xylem saps from castor bean plants (Ricinus communis) treated with four levels of cadmium	PHYSIOLOGIA PLANTARUM			English	Article							ORYZA-SATIVA L.; LONG-DISTANCE TRANSPORT; NICOTIANAMINE-SYNTHASE; IRON TRANSLOCATION; SACCHAROMYCES-CEREVISIAE; PHYTOCHELATIN SYNTHASE; ARABIDOPSIS-THALIANA; MASS-SPECTROMETRY; CHEMICAL FORMS; RICE SEEDS	We examined the concentrations of metals (Cd, Zn, Cu, Fe and Mn) and potential metal-binding compounds [nicotianamine (NA), thiol compounds and citrate] in xylem and phloem saps from 4-week-old castor bean plants (Ricinus communis) treated with 0 (control), 0.1, 1.0, and 10 M Cd for 3 weeks. Treatment with 0.1 and 1 M Cd produced no visible damage, while 10 M Cd retarded growth. Cadmium concentrations in both saps were higher than those in the culture solution at 0.1 M, similar at 1.0 M and lower at 10 M. Cd at 10 M reduced Cu and Fe concentrations in both saps. NA concentrations measured by capillary electrophoresis-mass spectrometry (MS) in xylem sap (20 M) were higher than the Cu concentrations, and those in phloem sap (150 M) were higher than those of Zn, Fe and Cu combined. Reduced glutathione concentrations differed in xylem and phloem saps (1-2 and 30-150 M, respectively), but oxidized glutathione concentrations were similar. Phloem sap phytochelatin 2 concentration increased from 0.8 M in controls to 8 M in 10 M Cd. Free citrate was 2-4 M in xylem sap and 70-100 M in phloem sap. Total bound forms of Cd in phloem and xylem saps from 1 M Cd-treated plants were 54 and 8%, respectively. Treatment of phloem sap with proteinaseK reduced high-molecular compounds while increasing fractions of low-molecular Cd-thiol complexes. Zinc-NA, Fe-NA and Cu-NA were identified in the phloem sap fraction of control plants by electrospray ionization time-of-flight MS, and the xylem sap contained Cu-NA.	[Hazama, Kenji; Nagata, Shinji; Fujimori, Tamaki; Yanagisawa, Shuichi; Yoneyama, Tadakatsu] Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Tokyo 1138657, Japan	Yoneyama, T (reprint author), Univ Tokyo, Dept Appl Biol Chem, Bunkyo Ku, Yayoi 1-1-1, Tokyo 1138657, Japan.	tadakatsu_yoneyama@opal.ocn.ne.jp					Alvarez-Fernandez A, 2014, PLANT SCI, V5, P1; Kramer U, 1996, NATURE, V379, P635, DOI 10.1038/379635a0; Mendoza-Cozatl DG, 2008, PLANT J, V54, P249, DOI 10.1111/j.1365-313X.2008.03410.x; Lee S, 2009, P NATL ACAD SCI USA, V106, P22014, DOI 10.1073/pnas.0910950106; Rellan-Alvarez R, 2010, PLANT CELL PHYSIOL, V51, P91, DOI 10.1093/pcp/pcp170; Gong JM, 2003, P NATL ACAD SCI USA, V100, P10118, DOI 10.1073/pnas.1734072100; Wintz H, 2003, J BIOL CHEM, V278, P47644, DOI 10.1074/jbc.M309338200; Ando Y, 2013, FUNCT PLANT BIOL, V40, P89, DOI 10.1071/FP12158; Kruger C, 2002, J BIOL CHEM, V277, P25062, DOI 10.1074/jbc.M201896200; Li ZS, 1997, P NATL ACAD SCI USA, V94, P42, DOI 10.1073/pnas.94.1.42; Deinlein U, 2012, PLANT CELL, V24, P708, DOI 10.1105/tpc.111.095000; Lopez-Millan AF, 2004, PLANT MOL BIOL, V54, P583, DOI 10.1023/B:PLAN.0000038271.96019.aa; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; White PJ, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00080; Haydon MJ, 2007, NEW PHYTOL, V174, P499, DOI 10.1111/j.1469-8137.2007.02051.x; Cailliatte R, 2010, PLANT CELL, V22, P904, DOI 10.1105/tpc.109.073023; Ueno D, 2008, PLANT CELL PHYSIOL, V49, P540, DOI 10.1093/pcp/pcn026; Nishiyama R, 2012, PLANT CELL PHYSIOL, V53, P381, DOI 10.1093/pcp/pcr188; Durrett TP, 2007, PLANT PHYSIOL, V144, P197, DOI 10.1104/pp.107.097162; HALL SM, 1972, PLANTA, V106, P131, DOI 10.1007/BF00383992; Kato M, 2010, SOIL SCI PLANT NUTR, V56, P839, DOI 10.1111/j.1747-0765.2010.00514.x; Haydon MJ, 2012, PLANT CELL, V24, P724, DOI 10.1105/tpc.111.095042; Schmidke I, 1999, PHYSIOL PLANTARUM, V106, P82, DOI 10.1034/j.1399-3054.1999.106112.x; Masuda H, 2009, RICE, V2, P155, DOI 10.1007/s12284-009-9031-1; Takahashi R, 2011, J EXP BOT, V62, P4843, DOI 10.1093/jxb/err136; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Ariga T, 2014, SOIL SCI PLANT NUTR, V60, P460, DOI 10.1080/00380768.2014.922406; Barnes A, 2004, J EXP BOT, V55, P1473, DOI 10.1093/jxb/erh161; Bene I., 1983, CELL MOL LIFE SCI, V39, P261; Dorak V, 2003, DALTON T, V2003, P2253; Erk M, 1998, ANAL CHIM ACTA, V360, P189, DOI 10.1016/S0003-2670(97)00729-0; Lattanzio G, 2013, PROTEOMICS, V13, P2283, DOI 10.1002/pmic.201200515; Lee S, 2011, PLANT BIOTECHNOL J, V9, P865, DOI 10.1111/j.1467-7652.2011.00606.x; Martell A. E., 1974, CRITICAL STABILITY C; Matsumoto S, 2004, SCI TECHNOL ADV MAT, V5, P377, DOI 10.1016/j.stam.2003.01.005; Pich A, 1996, J EXP BOT, V47, P41, DOI 10.1093/jxb/47.1.41; Rellan-Alvarez R, 2008, RAPID COMMUN MASS SP, V22, P1553, DOI 10.1002/rcm.3523; SCHMIDKE I, 1995, PHYSIOL PLANTARUM, V95, P147, DOI 10.1034/j.1399-3054.1995.950122.x; Sillen LG, 1964, SPECIAL PUBLICATION, V17; Tanaka K, 2003, SOIL SCI PLANT NUTR, V49, P311; TIFFIN LO, 1966, PLANT PHYSIOL, V41, P510, DOI 10.1104/pp.41.3.510	41	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0031-9317	1399-3054		PHYSIOL PLANTARUM	Physiol. Plant.	JUN	2015	154	2					243	255		10.1111/ppl.12309		13	Plant Sciences	Plant Sciences	CI3KG	WOS:000354646000005		
J	Sunagawa, K; Nagamine, I; Fujino, T; Nakatsu, Y; Hikosaka, K				Sunagawa, Katsunori; Nagamine, Itsuki; Fujino, Tetsuya; Nakatsu, Yoshifumi; Hikosaka, Kazuo			Stereotaxic atlas of the goat brain for an accurate approach to the hypothalamic nuclei	PHYSIOLOGY & BEHAVIOR			English	Article						Approaching hypothalamic nuclei; Eliminating brain coordinate's deviation; Stereotaxic goat forebrain atlas; Lateral radiography; Visualized brain landmark	FREELY BEHAVING RATS; NEURONS	While the external acoustic meatus of mice, rats and cats are at right angles to the side of the head, they are angled forward in ruminants. Because of this, the coordinates of stereotaxic atlases created using the same methods as for small animals were not suitable for practical use and made it very difficult to place electrodes in hypothalamic nuclei. The aim of this study was to produce a highly accurate stereotaxic atlas for goats that enables precise placement of electrodes in the hypothalamic nuclei. A method of fixing the head in place so as to maintain the basis cranii interna in a horizontal position was established allowing right angled three dimensional axes to be superimposed in the brains of Japanese Saanen goats. This research attempted to establish a new landmark alternative to the external acoustic meatus. The new landmark is the extremitas posterior clivus presphenoidale (EPCP) at the base of cranial bone. This landmark can easily be visualized through lateral radiography. This enabled the AP (anterior-posterior) and H (height) coordinates of the position to be fixed at 30 and 5, respectively. The A30 and H5 coordinates of the serial frontal, sagittal, and horizontal stereotaxic atlases in the present experiment were set to coincide with the position of the EPCP. In order to clarify whether the deviation of the stereotaxic brain coordinates due to inconsistent immobilization the goat's head was eliminated, the AP and H coordinates of the extremitas anterior fossa hypophysialis and the extremitas posterior fossa hypophysialis were measured using the corrected axes. In the three dimensional stereotaxic atlas created using the new landmark, it became possible to approach the hypothalamic nuclei of goats accurately. This method significantly differentiates the stereotaxic atlas from its predecessors. (C) 2015 Elsevier Inc. All rights reserved.	[Sunagawa, Katsunori; Nagamine, Itsuki; Fujino, Tetsuya; Nakatsu, Yoshifumi] Univ Ryukyus, Lab Anim Physiol & Anat, Fac Agr, Nishihara, Okinawa 9030213, Japan; [Hikosaka, Kazuo] Tokyo Metropolitan Inst Neurosci, Dept Psychol, Fuchu, Tokyo 1838526, Japan	Sunagawa, K (reprint author), Univ Ryukyus, Lab Anim Physiol & Anat, Fac Agr, 1 Senbaru, Nishihara, Okinawa 9030213, Japan.	b986094@agr.u-iyukyu.ac.jp					TAKAKI A, 1992, AM J PHYSIOL, V262, pR586; OOMURA Y, 1969, NATURE, V222, P282, DOI 10.1038/222282a0; TINDAL JS, 1968, J ANAT, V103, P457; Felix B, 1999, BRAIN RES BULL, V49, P1, DOI 10.1016/S0361-9230(99)00012-X; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Arai H., 1939, Zeitschrift fuer Mikroskopisch-Anatomische Forschung, V45, P563; Bleier R., 1984, HYPOTHALAMUS RHESUS, P1; Hirata Y., 2006, MACRO MICROGRAPHIC A; Hirata Y., 1977, OBSERVATION BRAIN TI, P2; Japanese committee on veterinary anatomical terminology, 2000, JUI KAIB SOS HASS YO; MORI Y, 1990, JPN J VET SCI, V52, P339; Nagamine I, 2003, J ANIM SCI, V81, P529; Nagamine I., 2006, ANIM SCI J, V81, P529; Niimi K., 1988, THALAMENCEPHALON; Okamura H., 2001, BRAIN ATLAS CATTLE; ONO T, 1987, J PHYSIOL-LONDON, V394, P221; ONO T, 1986, BRAIN RES, V373, P92, DOI 10.1016/0006-8993(86)90319-7; Oomura Y., 1964, SCIENCE, V143, P485; Paxinos G., 1986, RAT BRAIN STEREOTAXI; Paxinos G., 2004, MOUSE BRAIN STEREOTA; Paxinos G., 2000, RHESUS MONKEY BRAIN; Snider R. S., 1961, STEREOTAXIC ATLAS CA; Yoshikawa T., 1967, ATLAS BRAIN DOMESTIC; ZUCCOLILLI GO, 1995, J VET MED SCI, V57, P459	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	JUN 1	2015	145						91	105		10.1016/j.physbeh.2015.03.030		15	Psychology, Biological; Behavioral Sciences	Psychology; Behavioral Sciences	CI8WE	WOS:000355051600013		
J	Noguchi, R; Kurita, K				Noguchi, Rina; Kurita, Kei			Unique characteristics of cones in Central Elysium Planitia, Mars	PLANETARY AND SPACE SCIENCE			English	Article						Mars; Cone; Central Elysium Planitia; Athabasca Valles	ATHABASCA VALLES; SCORIA CONES; CERBERUS FOSSAE; GROUND ICE; LAVA; FEATURES; PLAINS; REGION; MORPHOMETRY; MORPHOLOGY	Martian magmatism within recent several hundreds of millions years is still controversial. Central Elysium Planitia (CEP) is suspected as a site of the latest magmatism on Mars, but hot debates have been caused as for the origin of this flat plain. Cones in CEP are expected to be a key to resolve this controversy. In previous works, there are 2 models proposed for the origin of CEP cones: volcanic rootless cone (e.g. Jaeger et al., 2007) and periglacial pingo (e.g. Burr et al., 2002; Page et al., 2009). In this study, we described detail morphology, distribution and size of CEP cones by using high-resolution images and topographic data. CEP cones are classified into 3 morphological types: Single Cone (SC), Double Cone (DC), and Lotus Fruit Cone (LC). DC has an inner cone in the summit crater of the outer cone, and LC has several inner cones in the summit crater of the outer cone. Several cones have moat structure around the edifice with peripheral rise. DCs and LCs are located in very flat areas of Athabasca Valles in the vicinity of Cerberus Fossae, while SCs distribute in the entire region of CEP. We compared CEP cones with terrestrial rootless cones and pingos in aerial photos. In Lake Myvatn, Iceland, there. exist rootless cones which resemble DCs and LCs in CEP. Based on the similarities with terrestrial analogies, we concluded that the most feasible origin of CEP cones is rootless cones. (C) 2015 Elsevier Ltd. All rights reserved.	[Noguchi, Rina; Kurita, Kei] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Noguchi, R (reprint author), Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1130032, Japan.	rina@eri.u-tokyo.ac.jp			Global COE Program; Earth to Earths; Ministry of Education, Culture, Sports, Science and Technology of Japan	We appreciate Dr. Christopher W. Hamilton and Dr. Armann Hoskuldsson for their constructive comments for this study. We are grateful to Dr. M.A. de Pablo for his insightful reviews and encouragement. JMARS which is produced by ASU was powerful tool in this study. This research was supported by a grant for the Global COE Program, From the Earth to Earths, from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Plescia JB, 2003, ICARUS, V164, P79, DOI 10.1016/S0019-1035(03)00139-8; Kirk RL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003000; de Pablo MA, 2009, ICARUS, V199, P49, DOI 10.1016/j.icarus.2008.09.007; Greeley R, 2001, J GEOPHYS RES-PLANET, V106, P20527, DOI 10.1029/2000JE001378; PORTER SC, 1972, GEOL SOC AM BULL, V83, P3607, DOI 10.1130/0016-7606(1972)83[3607:DMASFO]2.0.CO;2; Kereszturi G, 2012, B VOLCANOL, V74, P2171, DOI 10.1007/s00445-012-0658-1; Hamilton CW, 2010, B VOLCANOL, V72, P449, DOI 10.1007/s00445-009-0330-6; Lanagan PD, 2001, GEOPHYS RES LETT, V28, P2365, DOI 10.1029/2001GL012932; WILSON L, 1994, REV GEOPHYS, V32, P221, DOI 10.1029/94RG01113; Thordarson T, 2008, JOKULL, V58, P197; Vaucher J, 2009, ICARUS, V204, P418, DOI 10.1016/j.icarus.2009.06.032; Hauber E, 2009, J VOLCANOL GEOTH RES, V185, P69, DOI 10.1016/j.jvolgeores.2009.04.015; Kleinhans MG, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2011JE003865; Broz P, 2012, ICARUS, V218, P88, DOI 10.1016/j.icarus.2011.11.030; Jaeger WL, 2007, SCIENCE, V317, P1709, DOI 10.1126/science.1143315; LUCCHITTA BK, 1981, ICARUS, V45, P264, DOI 10.1016/0019-1035(81)90035-X; Lynch DK, 2013, GEOMORPHOLOGY, V195, P27, DOI 10.1016/j.geomorph.2013.04.022; Watters TR, 2007, SCIENCE, V318, P1125, DOI 10.1126/science.1148112; Dimitrov LI, 2002, EARTH-SCI REV, V59, P49, DOI 10.1016/S0012-8252(02)00069-7; Burr DM, 2002, ICARUS, V159, P53, DOI 10.1006/icar.2002.6921; Berman DC, 2002, ICARUS, V159, P1, DOI 10.1006/icar.2002.6920; Jaeger WL, 2010, ICARUS, V205, P230, DOI 10.1016/j.icarus.2009.09.011; Favalli M, 2009, J VOLCANOL GEOTH RES, V186, P320, DOI 10.1016/j.jvolgeores.2009.07.011; [Anonymous], 2007, J GEOPHYS RES-PLANET; Bleacher JE, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002873; Skinner JA, 2009, MAR PETROL GEOL, V26, P1866, DOI 10.1016/j.marpetgeo.2009.02.006; Broz P, 2014, EARTH PLANET SC LETT, V406, P14, DOI 10.1016/j.epsl.2014.09.002; Keszthelyi LP, 2010, ICARUS, V205, P211, DOI 10.1016/j.icarus.2009.08.020; Sato H, 1997, GEOPHYS RES LETT, V24, P205, DOI 10.1029/96GL04004; Balme MR, 2009, EARTH PLANET SC LETT, V285, P1, DOI 10.1016/j.epsl.2009.05.031; Smith DE, 2001, J GEOPHYS RES-PLANET, V106, P23689, DOI 10.1029/2000JE001364; Balme M. R., 2012, LAKES MARS, P275; Broz P., 2013, J GEOPHYS RES, V118, P1; Burr DA, 2005, ICARUS, V178, P56, DOI 10.1016/j.icarus.2005.04.012; Burr DM, 2009, PLANET SPACE SCI, V57, P579, DOI 10.1016/j.pss.2008.11.011; Burr DM, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL028011; Christensen P. R., 2009, AGU FALL M; COURTLAND L, 2013, B VOLCANOL, V75, DOI DOI 10.1007/S00445-013; EINARSSON A, 1982, FRESHWATER BIOL, V12, P63, DOI 10.1111/j.1365-2427.1982.tb00603.x; Fagents SA, 2007, CAMB PLANET, P151, DOI 10.1017/CBO9780511536014.007; Fagents SA, 2002, GEOL SOC SPEC PUBL, V202, P295, DOI 10.1144/GSL.SP.2002.202.01.15; Farrand WH, 2005, J GEOPHYS RES-PLANET, V110, DOI 10.1029/2004JE002297; FREY H, 1982, J GEOPHYS RES, V87, P9867, DOI 10.1029/JB087iB12p09867; Frey H., 1979, J GEOPHYS RES, V84, P8066; Hamilton CW, 2010, B VOLCANOL, V72, P469, DOI 10.1007/s00445-009-0331-5; Hamilton CW, 2011, J GEOPHYS RES-PLANET, V116, DOI 10.1029/2010JE003657; Hamilton CW, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003546; Hartmann WK, 2000, J GEOPHYS RES-PLANET, V105, P15011, DOI 10.1029/1999JE001189; Hovland M., 2007, GEOMORPHOLOGY, V21, P1; JAEGER WL, 2008, SCIENCE, V320, pC1588, DOI DOI 10.1126/SCIENCE.1155124; Jones BM, 2012, GEOMORPHOLOGY, V138, P1, DOI 10.1016/j.geomorph.2011.08.007; Keszthelyi L. P., 2015, GEOMORPHOLOGY; Keszthelyi L.P., 2000, ICARUS, V205, P211; Malin M.C., 2007, J GEOPHYS RES, V112, P5, DOI DOI 10.1029/2006JE002808; Page DP, 2010, PLANET SPACE SCI, V58, P1406, DOI 10.1016/j.pss.2010.06.010; Page David P, 2008, Science, V320, P1588, DOI 10.1126/science.1154849; Page DP, 2009, ICARUS, V203, P376, DOI 10.1016/j.icarus.2009.05.012; Page DP, 2006, ICARUS, V183, P46, DOI 10.1016/j.icarus.2006.01.017; PLESCIA JB, 1990, ICARUS, V88, P465, DOI 10.1016/0019-1035(90)90095-Q; Rittmann A., 1938, B VOLCANOL, V4, P3, DOI 10.1007/BF02596438; Ryan AJ, 2012, SCIENCE, V336, P449, DOI 10.1126/science.1219437; Schmincke H.-U., 2004, VOLCANISM; Tanaka K. L., 1986, P 17 LUN PLAN SCI C, P865; Thorarinsson S., 1953, B VOLCANOL, V2, P1; Vetterlein J, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003356; Wilson L, 2014, ICARUS, V233, P268, DOI 10.1016/j.icarus.2014.01.041; Wood, 1980, J VOLCANOL GEOTHERM, V7, P387; Wood C. A., 1979, P LUN PLAN SCI C 10, P2815	68	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0032-0633			PLANET SPACE SCI	Planet Space Sci.	JUN	2015	111						44	54		10.1016/j.pss.2015.03.007		11	Astronomy & Astrophysics	Astronomy & Astrophysics	CI8XJ	WOS:000355054700003		
J	Muller, D; Waldie, T; Miyawaki, K; To, JPC; Melnyk, CW; Kieber, JJ; Kakimoto, T; Leyser, O				Mueller, Doerte; Waldie, Tanya; Miyawaki, Kaori; To, Jennifer P. C.; Melnyk, Charles W.; Kieber, Joseph J.; Kakimoto, Tatsuo; Leyser, Ottoline			Cytokinin is required for escape but not release from auxin mediated apical dominance	PLANT JOURNAL			English	Article						cytokinin; auxin; shoot branching; apical dominance; Arabidopsis thaliana; Isopentenyltransferase; type-A Arabidopsis response regulators	LATERAL BUD OUTGROWTH; PISUM-SATIVUM-L; RESPONSE REGULATORS; ARABIDOPSIS-THALIANA; PLANT DEVELOPMENT; AXILLARY BUDS; ATP/ADP ISOPENTENYLTRANSFERASES; TRANSCRIPTION FACTOR; PHASEOLUS-VULGARIS; MERISTEM FUNCTION	Auxin produced by an active primary shoot apex is transported down the main stem and inhibits the growth of the axillary buds below it, contributing to apical dominance. Here we use Arabidopsis thaliana cytokinin (CK) biosynthetic and signalling mutants to probe the role of CK in this process. It is well established that bud outgrowth is promoted by CK, and that CK synthesis is inhibited by auxin, leading to the hypothesis that release from apical dominance relies on an increased supply of CK to buds. Our data confirm that decapitation induces the expression of at least one ISOPENTENYLTRANSFERASE (IPT) CK biosynthetic gene in the stem. We further show that transcript abundance of a clade of the CK-responsive type-A Arabidopsis response regulator (ARR) genes increases in buds following CK supply, and that, contrary to their typical action as inhibitors of CK signalling, these genes are required for CK-mediated bud activation. However, analysis of the relevant arr and ipt multiple mutants demonstrates that defects in bud CK response do not affect auxin-mediated bud inhibition, and increased IPT transcript levels are not needed for bud release following decapitation. Instead, our data suggest that CK acts to overcome auxin-mediated bud inhibition, allowing buds to escape apical dominance under favourable conditions, such as high nitrate availability.	[Mueller, Doerte; Leyser, Ottoline] Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England; [Waldie, Tanya; Melnyk, Charles W.; Leyser, Ottoline] Univ Cambridge, Sainsbury Lab, Cambridge CB2 1LR, England; [Miyawaki, Kaori; Kakimoto, Tatsuo] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [To, Jennifer P. C.; Kieber, Joseph J.] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Toyonaka, Osaka 5600043, Japan	Leyser, O (reprint author), Univ York, Dept Biol, York YO10 5DD, N Yorkshire, England.	ol235@cam.ac.uk		Waldie, Tanya/0000-0001-7760-0950	UK Biotechnology and Biological Sciences Research Council via the European Research Area Plant Genomics programme [R1039101]; European Research Council [294514 - EnCoDe]; Gatsby Foundation [GAT3272C]; US National Science Foundation [IOS1022053]; Japan Society for the Promotion of Science [15107001]; Ministry of Education, Sports, Science, and Technology [17027017]; Precursory Research for Embryonic Science and Technology, Japan Science and Technology	DM and OL were funded by the UK Biotechnology and Biological Sciences Research Council via the European Research Area Plant Genomics programme (R1039101). TW and OL are funded the European Research Council (no 294514 - EnCoDe) and the Gatsby Foundation (GAT3272C). JK and JT were funded by the US National Science Foundation (IOS1022053). KM and TK were supported by Grants-in-Aid for Scientific Research 15107001 (Japan Society for the Promotion of Science) and 17027017 (Ministry of Education, Sports, Science, and Technology), and Precursory Research for Embryonic Science and Technology, Japan Science and Technology. We thank Lisa Williamson for technical support, the Technology Facility at the University of York for carrying out the microarray experiments and General Bioinformatics for analysis of the microarray data.	Takei K, 2004, PLANT CELL PHYSIOL, V45, P1053, DOI 10.1093/pcp/pch119; Cline M, 1997, PLANT CELL PHYSIOL, V38, P659; Scheible WR, 1997, PLANT CELL, V9, P783; Zhang SY, 2010, J INTEGR PLANT BIOL, V52, P626, DOI 10.1111/j.1744-7909.2010.00960.x; Sachs T, 2000, PLANT CELL PHYSIOL, V41, P649; Miyawaki K, 2004, PLANT J, V37, P128, DOI 10.1046/j.1365-313X.2003.01945.x; Ljung K, 2001, PLANT J, V28, P465, DOI 10.1046/j.1365-313X.2001.01173.x; Takei K, 2001, PLANT CELL PHYSIOL, V42, P85, DOI 10.1093/pcp/pce009; CLINE MG, 1994, PHYSIOL PLANTARUM, V90, P230, DOI 10.1034/j.1399-3054.1994.900133.x; SACHS T, 1981, ADV BOT RES, V9, P151, DOI 10.1016/S0065-2296(08)60351-1; Aguilar-Martinez JA, 2007, PLANT CELL, V19, P458, DOI 10.1105/tpc.106.048934; Shimizu-Sato S, 2009, PLANT MOL BIOL, V69, P429, DOI 10.1007/s11103-008-9416-3; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Sakai H, 2001, SCIENCE, V294, P1519, DOI 10.1126/science.1065201; Foo E, 2005, PLANT CELL, V17, P464, DOI 10.1105/tpc.104.026716; D'Agostino IB, 2000, PLANT PHYSIOL, V124, P1706, DOI 10.1104/pp.124.4.1706; To JPC, 2004, PLANT CELL, V16, P658, DOI 10.1105/tpc.018978; Arite T, 2007, PLANT J, V51, P1019, DOI 10.1111/j.1365-313X.2007.03210.x; Bhargava A, 2013, PLANT PHYSIOL, V162, P272, DOI 10.1104/pp.113.217026; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gomez-Roldan V, 2008, NATURE, V455, P189, DOI 10.1038/nature07271; Schmulling T, 2003, J PLANT RES, V116, P241, DOI 10.1007/s10265-003-0096-4; Hamiaux C, 2012, CURR BIOL, V22, P2032, DOI 10.1016/j.cub.2012.08.007; Zhang WJ, 2011, PLANT J, V68, P1, DOI 10.1111/j.1365-313X.2011.04668.x; Kiba T, 2011, J EXP BOT, V62, P1399, DOI 10.1093/jxb/erq410; Brewer PB, 2009, PLANT PHYSIOL, V150, P482, DOI 10.1104/pp.108.134783; Booker J, 2003, PLANT CELL, V15, P495, DOI 10.1105/tpc.007542; Johnson X, 2006, PLANT PHYSIOL, V142, P1014, DOI 10.1104/pp.106.087676; Chen XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061717; Miyawaki K, 2006, P NATL ACAD SCI USA, V103, P16598, DOI 10.1073/pnas.0603522103; DREW MC, 1975, NEW PHYTOL, V75, P479, DOI 10.1111/j.1469-8137.1975.tb01409.x; Waters MT, 2012, PLANT PHYSIOL, V159, P1073, DOI 10.1104/pp.112.196253; Higuchi M, 2004, P NATL ACAD SCI USA, V101, P8821, DOI 10.1073/pnas.0402887101; Chatfield SP, 2000, PLANT J, V24, P159, DOI 10.1046/j.1365-313x.2000.00862.x; Takei K, 2002, J EXP BOT, V53, P971, DOI 10.1093/jexbot/53.370.971; Zou JH, 2006, PLANT J, V48, P687, DOI 10.1111/j.1365-313X.2006.02916.x; Prusinkiewicz P, 2009, P NATL ACAD SCI USA, V106, P17431, DOI 10.1073/pnas.0906696106; Taniguchi M, 2007, PLANT CELL PHYSIOL, V48, P263, DOI 10.1093/pcp/pcl063; WILSON AK, 1990, MOL GEN GENET, V222, P377, DOI 10.1007/BF00633843; Takei K, 2001, J BIOL CHEM, V276, P26405, DOI 10.1074/jbc.M102130200; Liang JL, 2010, J EXP BOT, V61, P3069, DOI 10.1093/jxb/erq133; Gordon SP, 2009, P NATL ACAD SCI USA, V106, P16529, DOI 10.1073/pnas.0908122106; Ward SP, 2013, PLANT PHYSIOL, V162, P800, DOI 10.1104/pp.113.218461; Braun N, 2012, PLANT PHYSIOL, V158, P225, DOI 10.1104/pp.111.182725; Sakai H, 2000, PLANT J, V24, P703, DOI 10.1046/j.1365-313x.2000.00909.x; Tokunaga H, 2012, PLANT J, V69, P355, DOI 10.1111/j.1365-313X.2011.04795.x; Thimann KV, 1933, P NATL ACAD SCI USA, V19, P714, DOI 10.1073/pnas.19.7.714; Dun EA, 2012, PLANT PHYSIOL, V158, P487, DOI 10.1104/pp.111.186783; Sorefan K, 2003, GENE DEV, V17, P1469, DOI 10.1101/gad.256603; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; Nordstrom A, 2004, P NATL ACAD SCI USA, V101, P8039, DOI 10.1073/pnas.0402504101; Werner T, 2003, PLANT CELL, V15, P2532, DOI 10.1105/tpc.014928; Doebley J, 1997, NATURE, V386, P485, DOI 10.1038/386485a0; Ruffel S, 2011, P NATL ACAD SCI USA, V108, P18524, DOI 10.1073/pnas.1108684108; Tanaka M, 2006, PLANT J, V45, P1028, DOI 10.1111/j.1365-313X.2006.02656.x; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Riou-Khamlichi C, 1999, SCIENCE, V283, P1541, DOI 10.1126/science.283.5407.1541; Imamura A, 1998, P NATL ACAD SCI USA, V95, P2691, DOI 10.1073/pnas.95.5.2691; Minakuchi K, 2010, PLANT CELL PHYSIOL, V51, P1127, DOI 10.1093/pcp/pcq083; Marhavy P, 2011, DEV CELL, V21, P796, DOI 10.1016/j.devcel.2011.08.014; Petrasek J, 2009, DEVELOPMENT, V136, P2675, DOI 10.1242/dev.030353; Wang Y, 2014, PLANT CELL, V26, P2055, DOI 10.1105/tpc.114.123083; Marhavy P, 2014, CURR BIOL, V24, P1031, DOI 10.1016/j.cub.2014.04.002; Hwang I, 2012, ANNU REV PLANT BIOL, V63, P353, DOI 10.1146/annurev-arplant-042811-105503; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; To JPC, 2007, PLANT CELL, V19, P3901, DOI 10.1105/tpc.107.052662; Sakakibara H, 2006, ANNU REV PLANT BIOL, V57, P431, DOI 10.1146/annurev.arplant.57.032905.105231; Brandstatter I, 1998, PLANT CELL, V10, P1009, DOI 10.1105/tpc.10.6.1009; Bangerth F, 2000, PLANT GROWTH REGUL, V32, P205, DOI 10.1023/A:1010742721004; Crawford S, 2010, DEVELOPMENT, V137, P2905, DOI 10.1242/dev.051987; Kamimoto Y, 2012, PLANT CELL PHYSIOL, V53, P2090, DOI 10.1093/pcp/pcs149; Ongaro V, 2008, MOL PLANT, V1, P388, DOI 10.1093/mp/ssn007; Tatematsu K, 2005, PLANT PHYSIOL, V138, P757, DOI 10.1104/pp.104.057984; Hayward A, 2009, PLANT PHYSIOL, V151, P400, DOI 10.1104/pp.109.137646; Turnbull CGN, 2002, PLANT J, V32, P255, DOI 10.1046/j.1365-313X.2002.01419.x; Brenner W. G., 2012, FRONT PLANT SCI, V3, P1; desJong M., 2014, PLANT PHYSIOL, V166, P384; Ding YanFeng, 1995, Journal of Nanjing Agricultural University, V18, P14; HALL SM, 1975, PLANTA, V123, P137, DOI 10.1007/BF00383862; Kakimoto T, 2001, PLANT CELL PHYSIOL, V42, P677, DOI 10.1093/pcp/pce112; Lindsay DL, 2006, PLANT SCI, V170, P1111, DOI 10.1016/j.plantsci.2006.01.015; Liu Y, 2011, AUST J CROP SCI, V5, P1019; Martin-Trillo M, 2011, PLANT J, V67, P701, DOI 10.1111/j.1365-313X.2011.04629.x; McIntyre GI, 2001, PHYSIOL PLANTARUM, V113, P165, DOI 10.1034/j.1399-3054.2001.1130203.x; MCINTYRE GI, 1975, CAN J BOT, V53, P3012; MCINTYRE GI, 1991, CAN J BOT, V69, P1337; MORRIS DA, 1977, PLANTA, V136, P91, DOI 10.1007/BF00387930; Müller Dörte, 2011, Ann Bot, V107, P1203, DOI 10.1093/aob/mcr069; PILLAY I, 1983, PLANT PHYSIOL, V71, P972, DOI 10.1104/pp.71.4.972; PRASAD TK, 1993, ANN BOT-LONDON, V71, P223, DOI 10.1006/anbo.1993.1028; Shinohara N, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001474; Suzuki T, 2001, PLANT CELL PHYSIOL, V42, P37, DOI 10.1093/pcp/pce011; Turnbull CGN, 1997, PLANTA, V202, P271, DOI 10.1007/s004250050128; Wahl V, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-285; WICKSON M, 1958, PHYSIOL PLANTARUM, V11, P62, DOI 10.1111/j.1399-3054.1958.tb08426.x	96	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0960-7412	1365-313X		PLANT J	Plant J.	JUN	2015	82	5					874	886		10.1111/tpj.12862		13	Plant Sciences	Plant Sciences	CJ1CO	WOS:000355219800012		
J	Saqib, M; Wylie, SJ; Jones, MGK				Saqib, M.; Wylie, S. J.; Jones, M. G. K.			Serendipitous identification of a new Iflavirus-like virus infecting tomato and its subsequent characterization	PLANT PATHOLOGY			English	Article						insect virus; next-generation sequencing; picornavirus-like; plant virus	PICORNA-LIKE VIRUS; DEFORMED-WING-VIRUS; NUCLEOTIDE-SEQUENCE; GENOME ORGANIZATION; VARROA DESTRUCTOR; SPHERICAL VIRUS; SACBROOD VIRUS; RNA VIRUSES; FAMILY; HONEYBEES	The genomic sequence of a previously undescribed virus was identified from symptomless tomato plants (Solanum lycopersicum). The viral genome is a positive-sense ssRNA molecule of 8506 nucleotides. It is predicted to encode a single polyprotein of 3145 kDa that is subsequently processed into three coat protein components of 137, 179 and 135 kDa, and a viral replicase of approximately 207 kDa with conserved motifs for a helicase, a protease and RNA-dependent RNA polymerase (RdRp). Pairwise analysis of the deduced amino acid sequence of the RdRp revealed that it shares closest identity with members of the family Iflaviridae, genus Iflavirus (19-47% identity). Evidence of replication in plants was detected by RT-PCR of the viral replicative strand, and short interfering RNAs (siRNAs) matching the virus. The name Tomato matilda virus (TMaV) is proposed, and furthermore, that the genus Tomavirus (Tomato matilda virus) be created within the family Iflaviridae. This is the first report of a plant-infecting virus resembling members of the Iflaviridae.	[Saqib, M.] Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Plant Gene Regulat Res Grp, Tsukuba, Ibaraki 3058566, Japan; [Saqib, M.; Wylie, S. J.; Jones, M. G. K.] Murdoch Univ, Sch Vet & Life Sci, Western Australian State Agr Biotechnol Ctr, Plant Virus Sect,Plant Biotechnol Res Grp, Perth, WA 6150, Australia	Saqib, M (reprint author), Natl Inst Adv Ind Sci & Technol, Bioprod Res Inst, Plant Gene Regulat Res Grp, Tsukuba Cent 6,1-1-1 Higashi, Tsukuba, Ibaraki 3058566, Japan.	msaqib787@gmail.com			Murdoch University Institute for Crop and Plant Science Research (CaPRI); Murdoch University Division of Research and Development; JSPS	M. S. was supported by contributions from the Murdoch University Institute for Crop and Plant Science Research (CaPRI) and Murdoch University Division of Research and Development and JSPS fellowship. The authors thank Dr Nobutaka Mitsuda from AIST for providing bioinformatics support. All authors have no conflict of interest to declare.	AIZAWA K, 1964, J INSECT PATHOL, V6, P130; Yamashita T, 1998, J VIROL, V72, P8408; Lanzi G, 2006, J VIROL, V80, P4998, DOI 10.1128/JVI.80.10.4998-5009.2006; Moore J, 2011, J GEN VIROL, V92, P156, DOI 10.1099/vir.0.025965-0; Ongus JR, 2004, J GEN VIROL, V85, P3747, DOI 10.1099/vir.0.80470-0; Coetzee B, 2010, VIROLOGY, V400, P157, DOI 10.1016/j.virol.2010.01.023; Sanfacon H, 2009, ARCH VIROL, V154, P899, DOI 10.1007/s00705-009-0367-z; Ehrenfeld E, 2009, EXPERT REV VACCINES, V8, P899, DOI [10.1586/erv.09.49, 10.1586/ERV.09.49]; Mason PW, 2003, J GEN VIROL, V84, P1583, DOI 10.1099/vir.0.18669-0; Johnson KN, 1998, J GEN VIROL, V79, P191; Fujiyuki T, 2004, J VIROL, V78, P1093, DOI 10.1128/JVI.78.3.1093-1100.2004; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Kapoor A, 2010, J VIROL, V84, P10322, DOI 10.1128/JVI.00601-10; Ma MX, 2011, J VIROL METHODS, V176, P115, DOI 10.1016/j.jviromet.2011.05.028; WALKER JE, 1982, EMBO J, V1, P945; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; Donaldson EF, 2010, J VIROL, V84, P13004, DOI 10.1128/JVI.01255-10; Li CJ, 2000, J GEN VIROL, V81, P541; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Kim MC, 2007, ARCH VIROL, V152, P2059, DOI 10.1007/s00705-007-1023-0; Kreuze JF, 2009, VIROLOGY, V388, P1, DOI 10.1016/j.virol.2009.03.024; Valles SM, 2009, VIROLOGY, V388, P354, DOI 10.1016/j.virol.2009.03.028; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; BRADBEAR N, 1988, BEE WORLD, V69, P15; Christian PD, 1998, VIRUSES, P301; desMiranda JR, 2010, J GEN VIROL, V91, P2524; desMiranda JR, 2004, J GEN VIROL, V85, P2263; Drummond AJ, 2010, GENEIOUS V 4 8; Ghosh RC, 1999, J GEN VIROL, V80, P1541; Hall T. A., 1999, NUCL ACIDS S SER, V4, P95, DOI DOI 10.1111/J.1469-8137.2009.02874.X; Hunter WB, 2006, J INSECT SCI, V6; LesGall O, 2008, ARCH VIROL, V153, P715; LOMONOSSOFF GP, 1983, EMBO J, V2, P2253; Reddick BB, 1997, J GEN VIROL, V78, P1165; Roossinck MJ, 2012, ANNU REV GENET, V46, P357; ROTT ME, 1995, J GEN VIROL, V76, P465, DOI 10.1099/0022-1317-76-2-465; Ryabov EV, 2007, J GEN VIROL, V88, P2590, DOI 10.1099/vir.0.83050-0; SHEN P, 1993, VIROLOGY, V193, P621, DOI 10.1006/viro.1993.1170; TURNBULLROSS AD, 1993, J GEN VIROL, V74, P555, DOI 10.1099/0022-1317-74-4-555; Ullman DE, 2005, P NATL ACAD SCI USA, V102, P4931, DOI 10.1073/pnas.0501341102; van Oers MM, 2010, INSECT VIROLOGY, P231; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Wylie SJ, 2013, VIRUS RES, V171, P22, DOI 10.1016/j.virusres.2012.10.003; Wylie SJ, 2012, ARCH VIROL, V157, P271, DOI 10.1007/s00705-011-1166-x; Wylie SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079587; ZUCKERKANDL EMILE, 1965, P97	46	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-0862	1365-3059		PLANT PATHOL	Plant Pathol.	JUN	2015	64	3					519	527		10.1111/ppa.12293		9	Agronomy; Plant Sciences	Agriculture; Plant Sciences	CH8GZ	WOS:000354275700003		
J	Shafiee, H; Beppu, S; Iwasaki, S; Tagaya, A; Koike, Y				Shafiee, Houran; Beppu, Shotaro; Iwasaki, Shuhei; Tagaya, Akihiro; Koike, Yasuhiro			Mechanisms of orientational and photoelastic birefringence generation of methacrylates for the design of zero-zero-birefringence polymers	POLYMER ENGINEERING AND SCIENCE			English	Article							POLY(METHYL METHACRYLATE); INTRINSIC BIREFRINGENCE; ATACTIC POLYSTYRENE; COMPENSATION; RELAXATION; SPECTRA; BLENDS	The intrinsic birefringence n(0) and photoelastic coefficient C of poly(methyl methacrylate), poly(2,2,2-trifluroethyl methacrylate), poly(phenyl methacrylate), and poly(2,2,3,3,3-pentafluorophenyl methacrylate) were determined. We categorized these methacrylate polymers into four birefringence-types, even though their molecular structures differed only by the substituents on the side chains. Based on the results of n(0) and C, novel polymers that exhibit neither orientational nor photoelastic birefringence, i.e., zero-zero-birefringence polymers, were designed and synthesized by quaternary copolymerization system. Furthermore, we confirmed that the mechanisms of orientational birefringence and photoelastic birefringence generation were different in these methacrylate polymers. The conformation of the repeat unit of the polymers was nearly constant during the generation of orientational birefringence. In contrast, the conformation of the repeat unit of the polymers changed during the generation of photoelastic birefringence in the glassy state. These findings demonstrated the reasonability of evaluating orientational and photoelastic birefringence separately, as well as the adequacy of the classification of polymers into four birefringence-types. Given these results and the fact that zero-zero-birefringence polymers could be prepared successfully by four-birefringence type monomers, we demonstrated the reasonability of the method for designing the zero-zero-birefringence polymers. POLYM. ENG. SCI., 55:1330-1338, 2015. (c) 2015 Society of Plastics Engineers	[Shafiee, Houran; Beppu, Shotaro; Iwasaki, Shuhei; Tagaya, Akihiro; Koike, Yasuhiro] Keio Univ, Keio Photon Res Inst, Grad Sch Sci & Technol, Kawasaki, Kanagawa 2120032, Japan	Shafiee, H (reprint author), Keio Univ, Keio Photon Res Inst, Grad Sch Sci & Technol, Kawasaki, Kanagawa 2120032, Japan.	shafiee@kpri.keio.ac.jp	Koike, Yasuhiro /G-2104-2014		Japan Society for the Promotion of Science (JSPS) through "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)"	Contract grant sponsor: Japan Society for the Promotion of Science (JSPS) through its "Funding Program for World-Leading Innovative R&D on Science and Technology (FIRST Program)."	Tagaya A, 2012, POLYM J, V44, P306, DOI 10.1038/pj.2011.141; WILLIS HA, 1969, POLYMER, V10, P737, DOI 10.1016/0032-3861(69)90101-3; LIANG CY, 1958, J POLYM SCI, V27, P241, DOI 10.1002/pol.1958.1202711520; LIPSCHITZ I, 1982, POLYM-PLAST TECHNOL, V19, P53, DOI 10.1080/03602558208067727; BOUTON C, 1989, POLYMER, V30, P1414, DOI 10.1016/0032-3861(89)90209-7; Everall N.J., 2007, VIBRATIONAL SPECTROS; FRASER RDB, 1958, J CHEM PHYS, V28, P1113, DOI 10.1063/1.1744353; GURNEE EF, 1954, J APPL PHYS, V25, P1232, DOI 10.1063/1.1721535; HUIJTS RA, 1994, POLYMER, V35, P3119, DOI 10.1016/0032-3861(94)90429-4; Iwasaki S, 2012, POLYMER, V53, P3287, DOI 10.1016/j.polymer.2012.05.025; Iwasaki S, 2013, J APPL POLYM SCI, V130, P138, DOI 10.1002/app.39136; Iwata S., 1997, APPL OPTICS, V36, P19; JABARIN SA, 1991, POLYM ENG SCI, V31, P638, DOI 10.1002/pen.760310904; JASSE B, 1979, J POLYM SCI POL PHYS, V17, P799, DOI 10.1002/pol.1979.180170506; JASSE B, 1979, J MACROMOL SCI R M C, VC17, P61; Johnson III R. D., 2013, NIST STANDARD REFERE; LI D, 1994, POLYMER, V35, P2078, DOI 10.1016/0032-3861(94)90231-3; Lin-Vien D., 1991, HDB INFRARED RAMAN C; Milagin M.F., 1970, VYSOKOMOL SOYED, V3, P513; Ohkita H, 2005, JPN J APPL PHYS 1, V44, P3975, DOI 10.1143/JJAP.44.3975; OULTACHE AK, 1994, POLYMER, V35, P681, DOI 10.1016/0032-3861(94)90862-1; Samuels R. J., 1974, STRUCTURED POLYM PRO; SAMUELS RJ, 1965, J POLYM SCI PART A, V3, P1741, DOI 10.1002/pol.1965.100030507; Shafiee H, 2010, J POLYM SCI POL PHYS, V48, P2029, DOI 10.1002/polb.22082; Socrates G., 1994, INFRARED CHARACTERIS; Tagaya A., 2009, SEIKEI KAKOU, V21, P426; Tagaya A, 2006, MACROMOLECULES, V39, P3019, DOI 10.1021/ma0527000; Ward I.M., 1997, STRUCTURE PROPERTIES; WU MSS, 1986, J APPL POLYM SCI, V32, P3263, DOI 10.1002/app.1986.070320129; ZHAO Y, 1986, MAKROMOL CHEM-M SYMP, V5, P87, DOI 10.1002/masy.19860050110	30	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0032-3888	1548-2634		POLYM ENG SCI	Polym. Eng. Sci.	JUN	2015	55	6					1330	1338		10.1002/pen.24072		9	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CI4RM	WOS:000354740200014		
J	Namwong, S; Noppalit, S; Okubo, M; Moonmungmee, S; Chaiyasat, P; Chaiyasat, A				Namwong, Sililuk; Noppalit, Sayrung; Okubo, Masayoshi; Moonmungmee, Somporn; Chaiyasat, Preeyaporn; Chaiyasat, Amorn			Latent Heat Enhancement of Paraffin Wax in Poly(divinylbenzene-co-methyl methacrylate) Microcapsule	POLYMER-PLASTICS TECHNOLOGY AND ENGINEERING			English	Article						Latent heats; Heat storage material; Microsuspension polymerization; Poly(divinylbenzene-methyl methacrylate) microcapsule	PHASE-CHANGE MATERIAL; MICROENCAPSULATED N-OCTADECANE; THERMAL-ENERGY STORAGE; ENCAPSULATED HEXADECANE; POLYMER SHELLS; PARTICLES; POLYELECTROLYTE; DELIVERY	The preparation of divinylbenzene (DVB)-methyl methacrylate (MMA) copolymer microcapsule encapsulated Rubitherm27 (RT27) P(DVB-co-MMA)/RT27 used as heat storage material by the microsuspension polymerization was studied to improve the latent heats of the encapsulated RT27 with sufficient polymer shell strength. Percent loading of RT27 and DVB:MMA ratio were optimized. The optimal condition was 30% loading of RT27 and 30:70 (% w/w) of DVB:MMA ratio. The nonspherical microcapsules with a dent having core-shell morphology were obtained. The thermal properties of the encapsulated RT27 in the P(DVB-co-MMA)/RT27 capsules were measured by thermogravimetric analyzer and differential scanning calorimeter. The heats of melting (Delta H-m; 153J/g-RT27) and crystallization (Delta H-c; 164J/g-RT27) of the encapsulated RT27 in the prepared copolymer capsules were higher than those in PDVB and closed to those of bulk RT27 (162 and 168J/g-RT27 for Delta H-m and Delta H-c, respectively).	[Namwong, Sililuk; Noppalit, Sayrung; Okubo, Masayoshi; Chaiyasat, Preeyaporn; Chaiyasat, Amorn] Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Dept Chem, Thanyaburi 12110, Pathumthani, Thailand; [Okubo, Masayoshi] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 657, Japan; [Moonmungmee, Somporn] Thailand Inst Sci & Technol Res, Klongluang, Pathumthani, Thailand	Chaiyasat, P (reprint author), Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Dept Chem, Klong 6, Thanyaburi 12110, Pathumthani, Thailand.	p_chaiyasat@mail.rmutt.ac.th			National Research Council, Thailand [79955]; Thailand Institute of Scientific and Technological Research	This work was partially supported by The National Research Council, Thailand (No. 79955; given to A.C. and P.C.) and Thailand Institute of Scientific and Technological Research (given to S. N.).	Ai Y., 2007, E-POLYMERS, V7, P1124; Chaiyasat P, 2013, RSC ADV, V3, P10202, DOI 10.1039/c3ra40802g; Mochane MJ, 2012, THERMOCHIM ACTA, V544, P63, DOI 10.1016/j.tca.2012.06.017; Rodrigues SN, 2009, CHEM ENG J, V149, P463, DOI 10.1016/j.cej.2009.02.021; Qiu XL, 2012, SOL ENERG MAT SOL C, V98, P283, DOI 10.1016/j.solmat.2011.11.018; Chaiyasat P, 2009, J APPL POLYM SCI, V112, P3257, DOI 10.1002/app.29648; Fang GY, 2009, CHEM ENG J, V153, P217, DOI 10.1016/j.cej.2009.06.019; Devi N, 2011, INT J POLYM MATER, V60, P1091, DOI 10.1080/00914037.2011.553851; Chaiyasat A, 2012, EXPRESS POLYM LETT, V6, P70, DOI 10.3144/expresspolymlett.2012.8; Sanchez P, 2010, THERMOCHIM ACTA, V498, P16, DOI 10.1016/j.tca.2009.09.005; Sharma A, 2009, RENEW SUST ENERG REV, V13, P318, DOI 10.1016/j.rser.2007.10.005; You M, 2011, J POLYM RES, V18, P49, DOI 10.1007/s10965-010-9390-8; Okubo M, 1998, COLLOID POLYM SCI, V276, P638, DOI 10.1007/s003960050291; Sanchez L, 2008, IND ENG CHEM RES, V47, P9783, DOI 10.1021/ie801107e; Sanchez-Silva L, 2010, CHEM ENG J, V157, P216, DOI 10.1016/j.cej.2009.12.013; Brandrup J., 1999, POLYM HDB; Chaiyasat P, 2015, PHYS CHEM CHEM PHYS, V17, P1053, DOI 10.1039/c4cp03458a; CHAIYASAT P, 2011, MAT SCI APPL, V2, P1007, DOI DOI 10.4236/MSA.2011.28136; Chaiyasat P, 2008, COLLOID POLYM SCI, V286, P753, DOI 10.1007/s00396-007-1831-5; Chaiyasat P, 2008, COLLOID POLYM SCI, V286, P217, DOI 10.1007/s00396-007-1764-z; Devi N, 2010, INT J POLYM MATER, V59, P828, DOI 10.1080/00914037.2010.484792; Farid MM, 2004, ENERG CONVERS MANAGE, V45, P1597, DOI 10.1016/j.enconman.2003.09.015; Iamphaojeen Y, 2014, INT J POLYM MATER PO, V63, P918, DOI 10.1080/00914037.2014.886229; Namazi H, 2011, INT J POLYM MATER, V60, P603, DOI 10.1080/00914037.2010.531824; Ogino Y, 2007, KOBUNSHI RONBUNSHU, V64, P171, DOI 10.1295/koron.64.171; Okubo M, 2003, J APPL POLYM SCI, V89, P706, DOI 10.1002/app.12209; Sanchez-Silva L, 2010, IND ENG CHEM RES, V49, P12204, DOI 10.1021/ie101727b; Sanchez-Silva L, 2012, J APPL POLYM SCI, V124, P4809, DOI 10.1002/app.35546; Sar A, 2010, APPL ENERG, V87, P1529; Supatimusro D, 2012, POLYM-PLAST TECHNOL, V51, P1167, DOI 10.1080/03602559.2012.694949; Wu K, 2010, POLYM-PLAST TECHNOL, V49, P1527, DOI 10.1080/03602559.2010.512331; Zhuo L., 2004, INT J POLYM MATER, V53, P21, DOI 10.1080/00914030490263423	32	0	0	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0360-2559	1525-6111		POLYM-PLAST TECHNOL	Polym.-Plast. Technol. Eng.	JUN 1	2015	54	8					779	785		10.1080/03602559.2014.974282		7	Polymer Science	Polymer Science	CJ0IU	WOS:000355159800002		
J	Holliday, GL; Bairoch, A; Bagos, PG; Chatonnet, A; Craik, DJ; Finn, RD; Henrissat, B; Landsman, D; Manning, G; Nagano, N; O'Donovan, C; Pruitt, KD; Rawlings, ND; Saier, M; Sowdhamini, R; Spedding, M; Srinivasan, N; Vriend, G; Babbitt, PC; Bateman, A				Holliday, Gemma L.; Bairoch, Amos; Bagos, Pantelis G.; Chatonnet, Arnaud; Craik, David J.; Finn, Robert D.; Henrissat, Bernard; Landsman, David; Manning, Gerard; Nagano, Nozomi; O'Donovan, Claire; Pruitt, Kim D.; Rawlings, Neil D.; Saier, Milton; Sowdhamini, Ramanathan; Spedding, Michael; Srinivasan, Narayanaswamy; Vriend, Gert; Babbitt, Patricia C.; Bateman, Alex			Key challenges for the creation and maintenance of specialist protein resources	PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS			English	Editorial Material						specialist protein resource; key challenges; biocuration; longevity; big data; misannotation	FAMILIES DATABASE; INFORMATION; KNOWLEDGE; UPDATE; COLLECTION; DIVERSITY; DISCOVERY; SEQUENCES; ENZYMES; BIOLOGY	As the volume of data relating to proteins increases, researchers rely more and more on the analysis of published data, thus increasing the importance of good access to these data that vary from the supplemental material of individual articles, all the way to major reference databases with professional staff and long-term funding. Specialist protein resources fill an important middle ground, providing interactive web interfaces to their databases for a focused topic or family of proteins, using specialized approaches that are not feasible in the major reference databases. Many are labors of love, run by a single lab with little or no dedicated funding and there are many challenges to building and maintaining them. This perspective arose from a meeting of several specialist protein resources and major reference databases held at the Wellcome Trust Genome Campus (Cambridge, UK) on August 11 and 12, 2014. During this meeting some common key challenges involved in creating and maintaining such resources were discussed, along with various approaches to address them. In laying out these challenges, we aim to inform users about how these issues impact our resources and illustrate ways in which our working together could enhance their accuracy, currency, and overall value. Proteins 2015; 83:1005-1013. (c) 2015 The Authors. Proteins: Structure, Function, and Bioinformatics Published by Wiley Periodicals, Inc.	[Holliday, Gemma L.; Babbitt, Patricia C.] Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA; [Bairoch, Amos] Univ Geneva, SIB, Geneva, Switzerland; [Bagos, Pantelis G.] Univ Thessaly, Dept Comp Sci & Biomed Informat, Lamia 35100, Greece; [Chatonnet, Arnaud] INRA, Dynam Musculaire & Metab Umr866, F-34000 Montpellier, France; [Chatonnet, Arnaud] Univ Montpellier, F-34000 Montpellier, France; [Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Finn, Robert D.; O'Donovan, Claire; Rawlings, Neil D.; Bateman, Alex] EBI, EMBL, Cambridge CB10 1SD, England; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, F-13288 Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah 21413, Saudi Arabia; [Landsman, David; Pruitt, Kim D.] Natl Lib Med, Natl Ctr Biotechnol Informat, NIH, Bethesda, MD 20892 USA; [Manning, Gerard] Genentech Inc, Dept Bioinformat & Computat Biol, San Francisco, CA USA; [Nagano, Nozomi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Tokyo 1350064, Japan; [Rawlings, Neil D.] Wellcome Trust Sanger Inst, Cambridge CB10 1SD, England; [Saier, Milton] Univ Calif San Diego, Dept Mol Biol, La Jolla, CA 92093 USA; [Sowdhamini, Ramanathan] TIFR, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Spedding, Michael] Spedding Res Solut SARL, Chair NC IUPHAR, F-78110 Le Vesinet, France; [Srinivasan, Narayanaswamy] Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India; [Vriend, Gert] Radboud Univ Nijmegen, Med Ctr, CMBI, NL-6525 GA Nijmegen, Netherlands	Holliday, GL (reprint author), Univ Calif San Francisco, Dept Bioengn & Therapeut Sci, San Francisco, CA 94158 USA.	gemma.holliday@ucsf.edu	Craik, David/B-1695-2010; Vriend, G./H-8112-2014; Fac Sci,  KAU,  Biol Sci Dept/L-4228-2013; Rawlings, Neil/M-5566-2013; 	Craik, David/0000-0003-0007-6796; Rawlings, Neil/0000-0001-5557-7665; Bateman, Alex/0000-0002-6982-4660; Landsman, David/0000-0002-9819-6675; Bairoch, Amos/0000-0003-2826-6444; Holliday, Gemma/0000-0002-6731-6398; Spedding, Michael/0000-0002-1248-8221; Finn, Robert/0000-0001-8626-2148			Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI 10.1093/nar/gkt1030; Akiva E, 2014, NUCLEIC ACIDS RES, V42, pD521, DOI 10.1093/nar/gkt1130; Rawlings ND, 2014, NUCLEIC ACIDS RES, V42, pD503, DOI 10.1093/nar/gkt953; Alexander SPH, 2013, BRIT J PHARMACOL, V170, P1449, DOI 10.1111/bph.12444; Tsirigos KD, 2011, NUCLEIC ACIDS RES, V39, pD324, DOI 10.1093/nar/gkq863; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Orchard S, 2014, BBA-PROTEINS PROTEOM, V1844, P82, DOI 10.1016/j.bbapap.2013.03.011; Wang CKL, 2008, NUCLEIC ACIDS RES, V36, pD206, DOI 10.1093/nar/gkm953; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI 10.1093/nar/gkt1223; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Gandhimathi A, 2012, NUCLEIC ACIDS RES, V40, pD531, DOI 10.1093/nar/gkr1096; Vroling B, 2011, NUCLEIC ACIDS RES, V39, pD309, DOI 10.1093/nar/gkq1009; Joosten RP, 2011, NUCLEIC ACIDS RES, V39, pD411, DOI 10.1093/nar/gkq1105; Haft DH, 2013, NUCLEIC ACIDS RES, V41, pD387, DOI 10.1093/nar/gks1234; Fernandez-Suarez XM, 2014, NUCLEIC ACIDS RES, V42, pD1, DOI 10.1093/nar/gkt1282; Ashburner M, 2000, NAT GENET, V25, P25; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; Lane L, 2012, NUCLEIC ACIDS RES, V40, pD76, DOI 10.1093/nar/gkr1179; Orchard S, 2012, NAT METHODS, V9, P345, DOI [10.1038/nmeth.1931, 10.1038/NMETH.1931]; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; HARDIN G, 1968, SCIENCE, V162, P1243; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Umemura M, 2014, FUNGAL GENET BIOL, V68, P23, DOI 10.1016/j.fgb.2014.04.011; Holliday GL, 2012, NUCLEIC ACIDS RES, V40, pD783, DOI 10.1093/nar/gkr799; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Saier MH, 2014, NUCLEIC ACIDS RES, V42, pD251, DOI 10.1093/nar/gkt1097; Berman H.M., 2014, J COMPUT AID MOL DES, V10, P1009, DOI DOI 10.1007/S10822-014-9770-Y; Boratyn GM, 2013, NUCLEIC ACIDS RES, V41, pW29, DOI 10.1093/nar/gkt282; Chibucos MC, 2014, DATABASE OXFORD, V2014; Grosjean Julien, 2014, Stud Health Technol Inform, V205, P1008; Kaas Q, 2012, NUCLEIC ACIDS RES, V40, pD325, DOI 10.1093/nar/gkr886; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kosuge T, 2014, NUCLEIC ACIDS RES, V42, pD44, DOI 10.1093/nar/gkt1066; Krupa A, 2004, NUCLEIC ACIDS RES, V32, pD153, DOI 10.1093/nar/gkh019; Lenfant N, 2013, NUCLEIC ACIDS RES, V41, pD423, DOI 10.1093/nar/gks1154; Marino-Ramirez L, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar048; Nagano N, 2015, NUCLEIC ACIDS RES, V43, pD453, DOI 10.1093/nar/gku946; Nagy A, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-353; Nawrocki EP, 2015, NUCLEIC ACIDS RES, V43, pD130, DOI 10.1093/nar/gku1063; Pakseresht N, 2014, NUCLEIC ACIDS RES, V42, pD38, DOI 10.1093/nar/gkt1082; Pettifer S, 2010, NUCLEIC ACIDS RES, V38, pW683, DOI 10.1093/nar/gkq297; Schnoes AM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000605; Spedding M, 2011, NEUROPHARMACOLOGY, V60, P3, DOI 10.1016/j.neuropharm.2010.08.002; Theodoropoulou MC, 2008, BIOINFORMATICS, V24, P1471, DOI 10.1093/bioinformatics/btn206; Tsaousis GN, 2010, BIOINFORMATICS, V26, P2490, DOI 10.1093/bioinformatics/btq362; UniProt Consortium, 2014, Nucleic Acids Res, V42, pD191, DOI 10.1093/nar/gkt1140; Ursing BM, 2002, NUCLEIC ACIDS RES, V30, P50, DOI 10.1093/nar/30.1.50; Wang QH, 2012, DATABASE-OXFORD, DOI 10.1093/database/bar064; Wren JD, 2008, BIOINFORMATICS, V24, P1381, DOI 10.1093/bioinformatics/btn127	50	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0887-3585	1097-0134		PROTEINS	Proteins	JUN	2015	83	6					1005	1013		10.1002/prot.24803		9	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CJ0CA	WOS:000355138800001		
J	Sato, T; Tamada, T; Watanabe, S; Nishimura, H; Kanki, A; Noda, Y; Higaki, A; Yamamoto, A; Ito, K				Sato, Tomohiro; Tamada, Tsutomu; Watanabe, Shigeru; Nishimura, Hirotake; Kanki, Akihiko; Noda, Yasufumi; Higaki, Atsushi; Yamamoto, Akira; Ito, Katsuyoshi			Tissue gadolinium deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA: evaluation with inductively coupled plasma mass spectrometry (ICP-MS)	RADIOLOGIA MEDICA			English	Article						Nephrogenic systemic fibrosis (NSF); Gd-EOB-DTPA; Gadolinium (Gd)-based contrast agents (GBCAs); Hepatorenally impaired rats; Inductively coupled plasma mass spectrometry (ICP-MS)	NEPHROGENIC SYSTEMIC FIBROSIS; MRI CONTRAST AGENTS; KIDNEY-DISEASE; PHARMACOKINETICS; DERMOPATHY; CHELATE; LIVER	This study was undertaken to quantify tissue gadolinium (Gd) deposition in hepatorenally impaired rats exposed to gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) by means of inductively coupled plasma mass spectrometry (ICP-MS) and to compare differences in Gd distribution among major organs as possible triggers for nephrogenic systemic fibrosis. Five hepatorenally impaired rats (5/6-nephrectomized, with carbon-tetrachloride-induced liver fibrosis) were injected with Gd-EOB-DTPA. Histological assessment was conducted and Gd content of the skin, liver, kidneys, lungs, heart, spleen, diaphragm, and femoral muscle was measured by inductively coupled plasma mass spectrometry (ICP-MS) at 7 days after last injection. In addition, five renally impaired rats were injected with Gd-EOB-DTPA and the degree of tissue Gd deposition was compared with that in the hepatorenally impaired rats. ICP-MS analysis revealed significantly higher Gd deposition in the kidneys, spleen, and liver (p = 0.009-0.047) in the hepatorenally impaired group (42.6 +/- A 20.1, 17.2 +/- A 6.1, 8.4 +/- A 3.2 mu g/g, respectively) than in the renally impaired group (17.2 +/- A 7.7, 5.4 +/- A 2.1, 2.8 +/- A 0.7 mu g/g, respectively); no significant difference was found for other organs. In the hepatorenally impaired group, Gd was predominantly deposited in the kidneys, followed by the spleen, liver, lungs, skin, heart, diaphragm, and femoral muscle. Histopathological investigation revealed hepatic fibrosis in the hepatorenally impaired group. Compared with renally impaired rats, tissue Gd deposition in hepatorenally impaired rats exposed to Gd-EOB-DTPA was significantly increased in the kidneys, spleen, and liver, probably due to the impairment of the dual excretion pathways of the urinary and biliary systems.	[Sato, Tomohiro; Tamada, Tsutomu; Watanabe, Shigeru; Kanki, Akihiko; Noda, Yasufumi; Higaki, Atsushi; Yamamoto, Akira; Ito, Katsuyoshi] Kawasaki Med Univ, Dept Radiol, Kurashiki, Okayama 7010192, Japan; [Nishimura, Hirotake] Kawasaki Med Univ, Dept Pathol, Kurashiki, Okayama 7010192, Japan	Sato, T (reprint author), Kawasaki Med Univ, Dept Radiol, 577 Matsushima, Kurashiki, Okayama 7010192, Japan.	tomohiro@med.kawasaki-m.ac.jp			Japan Society for the Promotion of Science [23791458]; Kawasaki Medical School Project [22-A37, 23-61]	None of the authors have any conflicts of interest associated with this study. This study was supported by a Japan Society for the Promotion of Science Grant-in-Aid for Young Scientists (B) (Grant 23791458) and the Kawasaki Medical School Project (Grants 22-A37 and 23-61).	Morcos SK, 2007, BRIT J RADIOL, V80, P73, DOI 10.1259/bjr/17111243; Sadowski EA, 2007, RADIOLOGY, V243, P148, DOI 10.1148/radiol.2431062144; HAMM B, 1995, RADIOLOGY, V195, P785; Thomsen HS, 2009, RADIOL CLIN N AM, V47, P827, DOI 10.1016/j.rcl.2009.05.003; Cowper SE, 2001, AM J DERMATOPATH, V23, P383, DOI 10.1097/00000372-200110000-00001; Caravan P, 1999, CHEM REV, V99, P2293, DOI 10.1021/cr980440x; WEINMANN HJ, 1991, MAGNET RESON MED, V22, P233, DOI 10.1002/mrm.1910220214; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; Cowper SE, 2003, CURR OPIN RHEUMATOL, V15, P785, DOI 10.1097/00002281-200311000-00017; DeHoratius DM, 2006, SEMIN DIALYSIS, V19, P191, DOI 10.1111/j.1525-139X.2006.00152.x; Gschwend S, 2011, INVEST RADIOL, V46, P556, DOI 10.1097/RLI.0b013e31821a218a; Morcos SK, 2011, EUR RADIOL, V21, P496, DOI 10.1007/s00330-010-1951-z; MUHLER A, 1994, INVEST RADIOL, V29, P213, DOI 10.1097/00004424-199402000-00017; Perazella MA, 2007, SEMIN DIALYSIS, V20, P179, DOI 10.1111/j.1525-139X.2007.00269.x; Perazella MA, 2007, CLIN J AM SOC NEPHRO, V2, P200, DOI 10.2215/CJN.00030107; Sato T, 2013, MAGN RESON IMAGING, V31, P1412, DOI 10.1016/j.mri.2013.03.025; Schmook T, 2005, NEPHROL DIAL TRANSPL, V20, P220, DOI 10.1093/ndt/gfh473; SCHUHMANNGIAMPIERI G, 1993, ARZNEIMITTEL-FORSCH, V43-2, P927; Thomsen HS, 2004, EUR RADIOL, V14, P1654, DOI 10.1007/s00330-004-2379-0	19	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	0033-8362	1826-6983		RADIOL MED	Radiol. Med.	JUN	2015	120	6					557	562		10.1007/s11547-014-0492-y		6	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CI3GP	WOS:000354636100009		
J	Katayama, K; Suzuki, Y; Hoshikawa, M; Ohya, T; Oriishi, M; Itoh, Y; Ishida, K				Katayama, Keisho; Suzuki, Yasuhiro; Hoshikawa, Masako; Ohya, Toshiyuki; Oriishi, Marie; Itoh, Yuka; Ishida, Koji			Hypoxia exaggerates inspiratory accessory muscle deoxygenation during hyperpnoea	RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY			English	Article						Respiratory muscle; NIRS; Surface electromyography; Hyperventilation	NEAR-INFRARED SPECTROSCOPY; SYMPATHETIC VASOMOTOR OUTFLOW; INDUCED DIAPHRAGMATIC FATIGUE; LEG BLOOD-FLOW; HEALTHY HUMANS; RESPIRATORY MUSCLES; EXERCISE; WORK; OXYGENATION; FATIGABILITY	The purpose of this study was to elucidate inspiratory accessory muscle deoxygenation and myoelectric activity during isolated volitional hyperpnoea under hypoxic conditions. Subjects performed voluntary isocapnic hyperpnoea (tidal volume = 30-40% of forced vital capacity, breathing frequency = 60 breaths/min) in normoxia [inspired gas fraction (F-IO2) = 0.21] and hypoxia (F-IO2 = 0.10-0.12). Muscle deoxyhemoglobin/myoglobin (Deoxy-Hb/Mb) and muscle oxygen saturation (Sm-O2) using near-infrared spectroscopy and surface electromyography were measured from sternocleidomastoid (SCM) and intercostal (IC) muscles. During hyperpnoea, increases in Deoxy-Hb/Mb and reductions of Sm-O2 in the SCM and IC muscles were larger (P < 0.05) in hypoxia than those in normoxia. Under hypoxic conditions, the electromyogram increases from the SCM and IC muscles during hyperpnoea were greater than that under the normoxic conditions. These results suggest that inspiratory accessory muscle deoxygenation during isolated hyperpnoea is exaggerated in hypoxia compared with normoxia and that hypoxia has a significant impact on inspiratory accessory muscle activation. (C) 2015 Elsevier B.V. All rights reserved.	[Katayama, Keisho; Ishida, Koji] Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan; [Katayama, Keisho; Itoh, Yuka; Ishida, Koji] Nagoya Univ, Grad Sch Med, Nagoya, Aichi 4648601, Japan; [Suzuki, Yasuhiro; Hoshikawa, Masako; Ohya, Toshiyuki] Japan Inst Sports Sci, Tokyo, Japan; [Oriishi, Marie] Natl Inst Fitness & Sports Kanoya, Grad Sch Phys Educ, Kanoya, Japan	Katayama, K (reprint author), Nagoya Univ, Res Ctr Hlth Phys Fitness & Sports, Nagoya, Aichi 4648601, Japan.	katayama@htc.nagoya-u.ac.jp	ISHIDA, Koji/M-8850-2014		Japanese Ministry of Education, Science, Sports, and Culture [26560348]	The authors acknowledge Mr. S. Yamashita (Nagoya University) and Dr. E. Iwamoto (Sapporo Medical University) for their assistance during the study. This study was supported in part by Grant-in-Aid for Scientific Research from the Japanese Ministry of Education, Science, Sports, and Culture (grant no. 26560348).	Watanabe K, 2012, J ELECTROMYOGR KINES, V22, P251, DOI 10.1016/j.jelekin.2011.11.004; VICTOR RG, 1989, CIRC RES, V65, P468; Downey AE, 2007, RESP PHYSIOL NEUROBI, V156, P137, DOI 10.1016/j.resp.2006.08.006; Dempsey JA, 2006, RESP PHYSIOL NEUROBI, V151, P242, DOI 10.1016/j.resp.2005.12.015; JOHNSON BD, 1993, J PHYSIOL-LONDON, V460, P385; Ferrari M, 2004, CAN J APPL PHYSIOL, V29, P463; Hogan MC, 1999, J APPL PHYSIOL, V86, P1367; Subudhi AW, 2007, J APPL PHYSIOL, V103, P177, DOI 10.1152/japplphysiol.01460.2006; Amann M, 2010, AM J PHYSIOL-REG I, V299, pR314, DOI 10.1152/ajpregu.00183.2010; Harms CA, 1997, J APPL PHYSIOL, V82, P1573; Amann M, 2006, J APPL PHYSIOL, V101, P119, DOI 10.1152/jappalphysiol.01596.2005; Katayama K, 2010, MED SCI SPORT EXER, V42, P1269, DOI 10.1249/MSS.0b013e3181cae12f; Katayama K, 2007, AM J PHYSIOL-REG I, V292, pR1279, DOI 10.1152/ajpregu.00554.2006; Nielsen HB, 2001, ACTA PHYSIOL SCAND, V171, P63, DOI 10.1046/j.1365-201x.2001.171001063.x; BABCOCK MA, 1995, J APPL PHYSIOL, V78, P82; Harms CA, 2000, J APPL PHYSIOL, V89, P131; Spencer MD, 2012, J APPL PHYSIOL, V112, P1023, DOI 10.1152/japplphysiol.01215.2011; Shadgan B, 2011, RESP PHYSIOL NEUROBI, V178, P202, DOI 10.1016/j.resp.2011.06.001; Cannon DT, 2007, J PHYSIOL SCI, V57, P127, DOI 10.2170/physiolsci.RP001807; de Bisschop C, 2014, RESP PHYSIOL NEUROBI, V196, P8, DOI 10.1016/j.resp.2014.02.011; Fujioka M, 2010, ADV EXP MED BIOL, V662, P359, DOI 10.1007/978-1-4419-1241-1_52; Gagnon P, 2012, AM J RESP CRIT CARE, V186, P606, DOI 10.1164/rccm.201203-0404OC; Gonzales JU, 2006, MED SCI SPORT EXER, V38, P472, DOI 10.1249/01.mss.0000189318.80061.fe; Gudjonsdottir M, 2001, EUR RESPIR J, V17, P674, DOI 10.1183/09031936.01.17406740; Guenette JA, 2008, J APPL PHYSIOL, V104, P1202, DOI 10.1152/japplphysiol.01160.2007; Hill JM, 2000, BRAIN RES, V856, P240, DOI 10.1016/S0006-8993(99)02366-5; JARDIM J, 1981, AM REV RESPIR DIS, V124, P274; Katayama K, 2013, AM J PHYSIOL-REG I, V304, pR374, DOI 10.1152/ajpregu.00489.2012; Katayama K, 2012, AM J PHYSIOL-REG I, V302, pR1167, DOI 10.1152/ajpregu.00006.2012; Miura H, 2000, INT J SPORTS MED, V21, P180, DOI 10.1055/s-2000-301; MIZUNO M, 1991, EUR RESPIR J, V4, P587; REDFERN MS, 1993, CLIN BIOMECH, V8, P44, DOI 10.1016/S0268-0033(05)80009-9; ROUSSOS CS, 1977, J APPL PHYSIOL, V43, P189; Sheel AW, 2001, J PHYSIOL-LONDON, V537, P277, DOI 10.1111/j.1469-7793.2001.0277k.x; St Croix CM, 2000, J PHYSIOL-LONDON, V529, P493; Takagi S, 2014, MED SCI SPORT EXER, V46, P2062, DOI 10.1249/MSS.0000000000000334; Taylor AD, 1997, EUR J APPL PHYSIOL O, V75, P151, DOI 10.1007/s004210050140; Verges S, 2007, AM J PHYSIOL-REG I, V292, pR1246, DOI 10.1152/ajpregu.00409.2006; Verges S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-109; Vogiatzis I, 2007, J PHYSIOL-LONDON, V581, P299, DOI 10.1113/jphysiol.2006.126136; Witt JD, 2007, J PHYSIOL-LONDON, V584, P1019, DOI 10.1113/jphysiol.2007.140855	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1569-9048	1878-1519		RESP PHYSIOL NEUROBI	Respir. Physiol. Neuro.	JUN	2015	211						1	8		10.1016/j.resp.2015.02.005		8	Physiology; Respiratory System	Physiology; Respiratory System	CI8LM	WOS:000355023800001		
J	Kawashima, H; Tomizawa, H				Kawashima, Hirotaka; Tomizawa, Hiroyuki			Accuracy evaluation of Scopus Author ID based on the largest funding database in Japan	SCIENTOMETRICS			English	Article						Author ID; Scopus; Accuracy evaluation; Bibliometrics; KAKEN; Japan	SCIENTIFIC MIGRATION; NAME DISAMBIGUATION; RESEARCHERS; PUBLICATION	In this study, the accuracy of the Author ID (author identification) in the Scopus bibliographic database was evaluated. For this purpose, we adopted the KAKEN database as the source of "correct data". KAKEN is an open database and is the biggest funding database in Japan because it manages all the information of the largest public fund for academic researchers. In the KAKEN database, each researcher has a unique Researcher Number, which must be used when a proposal or annual report is submitted to the database. Thus, the concordance between each researcher and the associated Researcher Number is checked automatically and constantly. For this reason, we used this number to evaluate the Scopus Author ID. After matching bibliographic records between Scopus and KAKEN, we calculated recall and precision of the Scopus Author ID for Japanese researchers. We found that recall and precision were around 98 and 99 % respectively. This result showed the Author ID, though not perfectly accurate in terms of individual identification, was reliable enough to be used as a new tool for bibliometrics. We hope that academic researchers outside Japan will also evaluate the accuracy of the Scopus Author ID as a tool to uniquely identify individual researchers.	[Kawashima, Hirotaka; Tomizawa, Hiroyuki] Natl Inst Sci & Technol Policy NISTEP, Res Unit Sci & Technol Anal & Indicators, Minist Educ Culture Sports Sci & Technol MEXT, Chiyoda Ku, Tokyo 1000013, Japan	Kawashima, H (reprint author), Natl Inst Sci & Technol Policy NISTEP, Res Unit Sci & Technol Anal & Indicators, Minist Educ Culture Sports Sci & Technol MEXT, Chiyoda Ku, 16th Floor,Cent Govt Bldg 7 East Wing, Tokyo 1000013, Japan.	kwsmhr@gmail.com					Jonkers K, 2008, SCIENTOMETRICS, V77, P309, DOI 10.1007/s11192-007-1971-x; Strotmann A, 2012, J AM SOC INF SCI TEC, V63, P1820, DOI 10.1002/asi.22695; Ferreira AA, 2012, SIGMOD REC, V41, P15, DOI 10.1145/2350036.2350040; Beall Jeffrey, 2010, Future Internet, V2, DOI 10.3390/fi2010001; Conchi S., 2014, FRAUNHOFER ISI DISCU, V41, P1; Furukawa T, 2011, SCIENTOMETRICS, V87, P451, DOI 10.1007/s11192-011-0360-7; Ioannidis JPA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101698; Kurakawa Kei, 2014, International Journal on Digital Libraries, V14, DOI 10.1007/s00799-014-0109-z; Laudel G, 2003, SCIENTOMETRICS, V57, P215, DOI 10.1023/A:1024137718393; Moed H, 2014, SCIENTOMETRICS, V101, P1987, DOI 10.1007/s11192-014-1307-6; Moed HF, 2013, SCIENTOMETRICS, V94, P929, DOI 10.1007/s11192-012-0783-9; Reijnhoudt L, 2014, SCIENTOMETRICS, V101, P1403, DOI 10.1007/s11192-014-1256-0; Roberge G., 2012, 17 INT C SCI TECHN I; Scopus, 2014, SCOP AUTH ID; Smalheiser N. R., 2009, ANNU REV INFORM SCI, V43, P1, DOI DOI 10.1002/ARIS.2009.1440430113; Tran HN, 2014, LECT NOTES COMPUT SC, V8397, P123, DOI 10.1007/978-3-319-05476-6_13; Yamashita Y, 2014, SCIENTOMETRICS, V101, P1475, DOI 10.1007/s11192-014-1384-6	17	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0138-9130	1588-2861		SCIENTOMETRICS	Scientometrics	JUN	2015	103	3					1061	1071		10.1007/s11192-015-1580-z		11	Computer Science, Interdisciplinary Applications; Information Science & Library Science	Computer Science; Information Science & Library Science	CI1FX	WOS:000354489600014		
J	Loizeau, F; Akiyama, T; Gautsch, S; Vettiger, P; Yoshikawa, G; de Rooij, NF				Loizeau, Frederic; Akiyama, Terunobu; Gautsch, Sebastian; Vettiger, Peter; Yoshikawa, Genki; de Rooij, Nico F.			Comparing membrane- and cantilever-based surface stress sensors for reproducibility	SENSORS AND ACTUATORS A-PHYSICAL			English	Article						Bio/chemical sensor; Nanomechanical sensor; Surface stress; Piezoresistive readout; Reproducibility	ARRAY; SENSITIVITY; BIOSENSORS; POLYMERS; POINT	Point-of-care (PoC) applications require small, fast, and low power sensors with high reliability. Despite showing promising performances, nanomechanical sensors have not yet demonstrated the excellent reproducibility of measurements necessary to be incorporated-in such systems. Coffee-ring effect usually occurs during the deposition of the functionalization layer and produces an inhomogeneous and poorly repeatable profile on the sensor surface. In this study, we investigated how cantilever-based sensors and the previously developed membrane-type surface stress sensor (MSS) are affected by an inhomogeneous functionalization. We functionalized 8 piezoresistive cantilevers and 16 MSS with a dextran solution that formed an inhomogeneous layer due to the coffee ring effect. During expositions to humidity pulses, MSS was five times more reproducible (standard deviations between 5% and 6%) compared to the cantilever-based sensors (standard deviations between 25% and 28%). In fact, the cantilever-based sensors were as reproducible as their functionalization layer while the reproducibility of MSS was only limited by the tolerances of their fabrication. This sensor-to-sensor reproducibility, combined with a high sensitivity, makes the MSS a promising bio/chemical sensor platform for reliable and label-free detection of substances to be integrated into PoC systems. (C) 2015 Elsevier B.V. All rights reserved.	[Loizeau, Frederic; Akiyama, Terunobu; Gautsch, Sebastian; Vettiger, Peter; de Rooij, Nico F.] Ecole Polytech Fed Lausanne, Sensors Actuators & Microsyst Lab, CH-2002 Neuchatel, Switzerland; [Yoshikawa, Genki] Natl Inst Mat Sci, Int Ctr Mat Nanoarchitecton WPI MANA, Tsukuba, Ibaraki 3050047, Japan	Loizeau, F (reprint author), Stanford Univ, 496 Lomita Mall,Durand 102, Stanford, CA 94305 USA.	loizeau@stanford.edu	Gautsch, Sebastian/G-2561-2015		Nano-Tera.ch Program - Swiss Confederation	This project is funded by the Nano-Tera.ch Program, which is financed by the Swiss Confederation and scientifically evaluated by the SNSF. We gratefully thank the staff from the Microsystems Technology Division of CSEM SA and Laure Aeschimann from Nano World AG for their technical assistance and support during the microfabrication of the devices. We also would like to acknowledge Hans Peter Lang from the University of Basel for his help during the dextran functionalization and Giorgio Mattana from SAMLAB for his advice during the characterization of the sensor platforms.	Fritz J, 2008, ANALYST, V133, P855, DOI 10.1039/b718174d; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Yoshikawa G, 2011, NANO LETT, V11, P1044, DOI 10.1021/nl103901a; Marie R, 2002, ULTRAMICROSCOPY, V91, P29, DOI 10.1016/S0304-3991(02)00079-7; Peng G, 2009, NAT NANOTECHNOL, V4, P669, DOI 10.1038/nnano.2009.235; Chaki NK, 2002, BIOSENS BIOELECTRON, V17, P1, DOI 10.1016/S0956-5663(01)00277-9; SMITH CS, 1954, PHYS REV, V94, P42, DOI 10.1103/PhysRev.94.42; Yarin AL, 2006, ANNU REV FLUID MECH, V38, P159, DOI 10.1146/annurev.fluid.38.050304.092144; Ndieyira JW, 2014, NAT NANOTECHNOL, V9, P225, DOI [10.1038/nnano.2014.33, 10.1038/NNANO.2014.33]; Bosco FG, 2012, SENSOR ACTUAT B-CHEM, V171, P1054, DOI 10.1016/j.snb.2012.06.033; Penner RM, 2012, ANNU REV ANAL CHEM, V5, P461, DOI 10.1146/annurev-anchem-062011-143007; Fang Q, 2002, SENSOR ACTUAT B-CHEM, V84, P66, DOI 10.1016/S0925-4005(01)01076-0; Gubala V, 2012, ANAL CHEM, V84, P487, DOI 10.1021/ac2030199; Arntz Y, 2003, NANOTECHNOLOGY, V14, P86, DOI 10.1088/0957-4484/14/1/319; Tekin E, 2004, J MATER CHEM, V14, P2627, DOI 10.1039/b407478e; Homola J, 2008, CHEM REV, V108, P462, DOI 10.1021/cr068107d; Lange K, 2008, ANAL BIOANAL CHEM, V391, P1509, DOI 10.1007/s00216-008-1911-5; Bietsch A, 2004, NANOTECHNOLOGY, V15, P873, DOI 10.1088/0957-4484/15/8/002; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Ehrenkranz J., 2002, EPIDEMIOLOGY, V13, P15; Hones J., 2008, DIABETES TECHNOL THE, V10, pS; Kanda Y., 1982, ELECT DEVICES IEEE T, V29, P64; Kassegne S, 2002, P SOC PHOTO-OPT INS, V4693, P588, DOI 10.1117/12.475257; Lee-Lewandrowski E, 2009, CLIN LAB MED, V29, P479, DOI 10.1016/j.cll.2009.07.001; Loizeau F, 2013, PROC IEEE MICR ELECT, P621, DOI 10.1109/MEMSYS.2013.6474318; Perelaer J, 2009, MACROMOL CHEM PHYSIC, V210, P495, DOI 10.1002/macp.200800569; Privorotskaya N. L., 2008, MICROSYST TECHNOL, V15, P333; Rasmussen PA, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1900299; Yoshikawa G, 2012, SENSORS-BASEL, V12, P15873, DOI 10.3390/s121115873	29	0	0	ELSEVIER SCIENCE SA	LAUSANNE	PO BOX 564, 1001 LAUSANNE, SWITZERLAND	0924-4247			SENSOR ACTUAT A-PHYS	Sens. Actuator A-Phys.	JUN 1	2015	228						9	15		10.1016/j.sna.2015.02.039		7	Engineering, Electrical & Electronic; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CI8TE	WOS:000355043800002		
J	Tanaka, M; Furuya, R; Irie, S; Kanayama, A; Kobayashi, I				Tanaka, Masatoshi; Furuya, Ryusaburo; Irie, Shinichiro; Kanayama, Akiko; Kobayashi, Intetsu			High Prevalence of Azithromycin-Resistant Neisseria gonorrhoeae Isolates With a Multidrug Resistance Phenotype in Fukuoka, Japan	SEXUALLY TRANSMITTED DISEASES			English	Article							TREATMENT FAILURE; PHARYNGEAL GONORRHEA; SUSCEPTIBILITY; CEPHALOSPORINS; IDENTIFICATION; CLUSTERS; SWEDEN; STRAIN	Background: The current guidelines recommend a combination of ceftriaxone and azithromycin as a first-line treatment of gonorrhea in the United States and Europe. Despite not being recommended as a first-line regimen in Japan, an oral 2-g dose of azithromycin did become available for gonococcal infections in 2009. Recently, the emergence of azithromycin-resistant Neisseria gonorrhoeae isolates has been reported in several countries, including Japan. Methods: Antimicrobial susceptibility testing was performed on a total of 677 clinical isolates of N. gonorrhoeae obtained from January 2010 to December 2013 in Fukuoka, Japan. A molecular analysis by N. gonorrhoeae multiantigen sequence typing was conducted on the azithromycin-resistant isolates. Results: The proportion of azithromycin-resistant isolates (minimum inhibitory concentration > 0.5 mu g/mL) increased significantly from 1.8% in 2010 to 22.6% in 2013 (P < 0.001). Among 50 azithromycin-resistant isolates, 30 (60%) exhibited a resistant phenotype to multiple drugs including cefixime. The 2 predominant sequence types (STs) identified by N. gonorrhoeae multiantigen sequence typing were ST6798 (por allele 4033 and tbpB allele 110) and ST1407 (por allele 908 and tbpB allele 110) at 40.0% (20/50) and 12.0% (6/50), respectively. There was a statistically significant increase of the proportion of ST6798 from 0% (0/19) in 2010-2012 to 64.5% (20/31) in 2013 (P < 0.001). Conclusions: Over the previous 4 years, an increasing prevalence of azithromycin-resistant N. gonorrhoeae isolates with a multidrug-resistant phenotype was observed. Furthermore, the azithromycin-resistant isolates seemed to belong to 2 predominant STs. As a result, continued surveillance of gonococci resistant to antimicrobial agents, including azithromycin in Fukuoka, Japan, is necessary.	[Tanaka, Masatoshi; Furuya, Ryusaburo; Irie, Shinichiro] Fukuoka Univ, Fac Med, Dept Urol, Fukuoka 8140180, Japan; [Kanayama, Akiko; Kobayashi, Intetsu] Toho Univ, Fac Med, Dept Infect Control & Prevent, Tokyo, Japan	Tanaka, M (reprint author), Fukuoka Univ, Fac Med, Dept Urol, Jonan Ku, 7-45-1 Nanakuma, Fukuoka 8140180, Japan.	matanaka@cis.fukuoka-u.ac.jp					Martin IMC, 2004, J INFECT DIS, V189, P1497, DOI 10.1086/383047; Bignell C, 2013, INT J STD AIDS, V24, P85, DOI 10.1177/0956462412472837; Starnino S, 2009, J ANTIMICROB CHEMOTH, V63, P1200, DOI 10.1093/jac/dkp118; Hottes TS, 2013, SEX TRANSM DIS, V40, P46, DOI 10.1097/OLQ.0b013e31827bd64c; Unemo M, 2012, FUTURE MICROBIOL, V7, P1401, DOI [10.2217/fmb.12.117, 10.2217/FMB.12.117]; Allen VG, 2014, ANTIMICROB AGENTS CH, V58, P2528, DOI 10.1128/AAC.02608-13; Lewis DA, 2014, CURR OPIN INFECT DIS, V27, P62, DOI 10.1097/QCO.0000000000000025; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Brunner A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-433; Carannante A, 2014, ANTIMICROB AGENTS CH, V58, P5871, DOI 10.1128/AAC.00103-14; del Rio Carlos, 2012, Morbidity and Mortality Weekly Report, V61, P590; Clinical and Laboratory Standards Institute, 2012, M100S22 CLSI; Endimiani A, 2014, BMC INFECT DIS, V14, P106; EUCAST, 2014, BREAKP TABL INT MICS; European Centre for Disease Prevention and Control, 2012, MOL TYP NEISS GON RE; Japanese Society of Sexually Transmitted Infections, 2011, JPN J STI, V22, P52; Mlynarczyk-Bonikowska B, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-65; Morita-Ishihara T, 2014, J ANTIMICROB CHEMOTH, V69, P2086, DOI 10.1093/jac/dku118; Takayama Y, 2014, J INFECT CHEMOTHER, V20, P339, DOI 10.1016/j.jiac.2014.01.007; Tanaka M, 2011, SEX TRANSM DIS, V38, P871, DOI 10.1097/OLQ.0b013e31821d0f98; Tapsall John W, 2009, Expert Rev Anti Infect Ther, V7, P821, DOI 10.1586/eri.09.63; Unemo M, 2014, ANTIMICROB AGENTS CH, V58, P624, DOI 10.1128/AAC.02093-13; Unemo M, 2011, EUROSURVEILLANCE, V16, P5; Unemo M, 2012, EUROSURVEILLANCE, V17, P2; Yasuda M, 2014, J ANTIMICROB CHEMOTH, V69, P3116, DOI 10.1093/jac/dku221	25	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-5717	1537-4521		SEX TRANSM DIS	Sex. Transm. Dis.	JUN	2015	42	6					337	341		10.1097/OLQ.0000000000000279		5	Infectious Diseases	Infectious Diseases	CI4MP	WOS:000354724100008		
J	Mitamura, T; Watari, H; Yamashiro, K; Kato, T; Hosaka, M; Shimada, C; Fukumoto, S; Noshiro, K; Sasaki, T; Sakuragi, N				Mitamura, Takashi; Watari, Hidemichi; Yamashiro, Katsushige; Kato, Tatsuya; Hosaka, Masayoshi; Shimada, Chisa; Fukumoto, Shun; Noshiro, Kiwamu; Sasaki, Takayuki; Sakuragi, Noriaki			Human Papillomavirus Type 16 Sequence Variation in Concurrent Vulvar and Penile Carcinoma in a Married Couple	SEXUALLY TRANSMITTED DISEASES			English	Article							CERVICAL-CANCER; VARIANTS; E7; E6	We encountered an elderly married couple with concurrent vulvar and penile carcinoma with an Asian variant of human papillomavirus type 16. Asian variants might have an elevated risk of concurrent external genital carcinomas of a male and a female, and analysis of human papillomavirus variants might be important to understand the mechanism of carcinogenesis.	[Mitamura, Takashi; Watari, Hidemichi; Kato, Tatsuya; Hosaka, Masayoshi; Shimada, Chisa; Fukumoto, Shun; Noshiro, Kiwamu; Sakuragi, Noriaki] Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Yamashiro, Katsushige] Hokkaido Canc Ctr, Div Pathol, Shiroishi Ku, Sapporo, Hokkaido, Japan; [Sasaki, Takayuki] Hokkaido Canc Soc, Dept Gynecol, Higashi Ku, Sapporo, Hokkaido, Japan	Mitamura, T (reprint author), Hokkaido Univ, Grad Sch Med, Dept Obstet & Gynecol, Kita Ku, North 15,West 7, Sapporo, Hokkaido 0608638, Japan.	takami@huhp.hokudai.ac.jp					Sichero L, 2007, INT J CANCER, V120, P1763, DOI 10.1002/ijc.22481; Nishiwaki M, 2008, J CLIN MICROBIOL, V46, P1161, DOI 10.1128/JCM.00793-07; Xi LF, 2006, J NATL CANCER I, V98, P1045, DOI 10.1093/jnci/djj297; de Boer MA, 2004, GYNECOL ONCOL, V94, P488, DOI 10.1016/j.ygyno.2004.05.037; Hildesheim A, 2001, J NATL CANCER I, V93, P315, DOI 10.1093/jnci/93.4.315; Chopjitt P, 2009, INT J INFECT DIS, V13, P212, DOI 10.1016/j.ijid.2008.06.017; Kurman RJ, 2011, BLAUSTEIN'S PATHOLOGY OF THE FEMALE GENITAL TRACT, SIXTH EDITION, P1, DOI 10.1007/978-1-4419-0489-8; Lee CW, 2011, J OBSTET GYNAECOL RE, V37, P1320, DOI 10.1111/j.1447-0756.2010.01520.x; Yamada T, 1997, J VIROL, V71, P2463	9	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0148-5717	1537-4521		SEX TRANSM DIS	Sex. Transm. Dis.	JUN	2015	42	6					342	343		10.1097/OLQ.0000000000000274		2	Infectious Diseases	Infectious Diseases	CI4MP	WOS:000354724100009		
J	Hagisawa, K; Kinoshita, M; Miyawaki, H; Miyazaki, H				Hagisawa, K.; Kinoshita, M.; Miyawaki, H.; Miyazaki, H.			FIBRINOGEN GAMMA-CHAIN PEPTIDE-COATED, ADP-ENCAPSULATED LIPOSOMES RESCUE MICE FROM LETHAL BLAST LUNG INJURY	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Hagisawa, K.; Kinoshita, M.; Miyawaki, H.; Miyazaki, H.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		15	23	23				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000016		
J	Takeyama, N; Tomino, A; Hashiba, M; Ando, M; Gocho, T; Miyabe, H; Kano, H; Tsuda, M; Hattori, T; Hirakawa, A				Takeyama, N.; Tomino, A.; Hashiba, M.; Ando, M.; Gocho, T.; Miyabe, H.; Kano, H.; Tsuda, M.; Hattori, T.; Hirakawa, A.			INCREASED PD-1 EXPRESSION AND ALTERED T CELL REPERTOIRE DIVERSITY IN SEPTIC SHOCK PATIENTS	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Takeyama, N.; Tomino, A.; Hashiba, M.; Ando, M.; Gocho, T.; Miyabe, H.; Kano, H.; Tsuda, M.; Hattori, T.; Hirakawa, A.] Fujita Hlth Univ, Dept Emergency & Acute Intens Care Med, Totoake, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		23	27	27				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000024		
J	Kinoshita, M; Miyazaki, H; Ono, S; Hagisawa, K; Seki, S; Saitoh, D				Kinoshita, M.; Miyazaki, H.; Ono, S.; Hagisawa, K.; Seki, S.; Saitoh, D.			BURN-EVOKED ROS IMMEDIATELY AFTER INJURY ARE CRUCIAL TO RESTORE THE NEUTROPHIL FUNCTION AGAINST POST-BURN INFECTION IN MICE	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Kinoshita, M.; Miyazaki, H.; Hagisawa, K.; Seki, S.; Saitoh, D.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan; [Ono, S.] Tokyo Med Univ, Hachioji, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P14	38	38				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000052		
J	Miyazaki, H; Kinoshita, M; Seki, S; Saitoh, D				Miyazaki, H.; Kinoshita, M.; Seki, S.; Saitoh, D.			PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-GAMMA AGONIST IMPROVES SURVIVAL IN A MURINE MODEL OF POST-BURN INFECTION BY MODULATING THE MACROPHAGE FUNCTION	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Miyazaki, H.; Kinoshita, M.; Seki, S.; Saitoh, D.] Natl Def Med Coll, Tokorozawa, Saitama 359, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P13	38	38				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000051		
J	Sakamoto, W; Masuno, T; Tsukamoto, T; Jun, H; Takayuki, A; Naing, BT; Zhao, D; Takizawa, T; Yokota, H				Sakamoto, W.; Masuno, T.; Tsukamoto, T.; Jun, H.; Takayuki, A.; Naing, B. T.; Zhao, D.; Takizawa, T.; Yokota, H.			COMPREHENSIVE ANALYSIS OF MICRORNA PROFILES IN NORMAL RODENT MESENTERIC LYMPH	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Sakamoto, W.; Masuno, T.; Tsukamoto, T.; Jun, H.; Takayuki, A.; Yokota, H.] Nihon Med Sch, Dept Emergency & Crit Care Med, Tokyo, Japan; [Naing, B. T.; Zhao, D.; Takizawa, T.] Dept Mol Med & Anat, Tokyo, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P23	41	42				2	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000061		
J	Shibamoto, T; Wang, M; Kuda, Y; Tanida, M; Kurata, Y				Shibamoto, T.; Wang, M.; Kuda, Y.; Tanida, M.; Kurata, Y.			THE HEMODYNAMIC CHARACTERISTICS OF MOUSE ANAPHYLACTIC SHOCK	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Shibamoto, T.; Wang, M.; Kuda, Y.; Tanida, M.; Kurata, Y.] Kanazawa Med Univ, Uchinada, Ishikawa 92002, Japan; [Wang, M.] China Med Univ, Affiliated Hosp 4, Shenyang 110001, Peoples R China								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P37	47	47				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000075		
J	Matsuda, A; Miyashita, M; Yamada, M; Matsutani, T; Takahashi, G; Uchida, E				Matsuda, A.; Miyashita, M.; Yamada, M.; Matsutani, T.; Takahashi, G.; Uchida, E.			THE PREDICTIVE IMPACT OF LYSOPHOSPHATIDYLCHOLINE LEVEL FOR POSTOPERATIVE COMPLICATIONS AFTER GASTROINTESTINAL SURGERY	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Matsuda, A.; Miyashita, M.; Yamada, M.] Chiba Hokusoh Hosp, Nippon Med Sch, Dept Surg, Chiba, Japan; [Matsutani, T.; Takahashi, G.; Uchida, E.] Nippon Med Sch, Dept Surg, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P50	52	52				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000088		
J	Huq, MA; Tomino, A; Hashiba, M; Ando, M; Gocho, T; Miyabe, H; Kano, H; Tsuda, M; Hattori, T; Hirakawa, A; Takeyama, N				Huq, M. A.; Tomino, A.; Hashiba, M.; Ando, M.; Gocho, T.; Miyabe, H.; Kano, H.; Tsuda, M.; Hattori, T.; Hirakawa, A.; Takeyama, N.			PLASMA MYELOPEROXIDASE- AND NEUTROPHIL ELASTASE-DNA ASSAY FOR MEASUREMENT OF NEUTROPHIL EXTRACELLULAR TRAPS	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Huq, M. A.; Tomino, A.; Hashiba, M.; Ando, M.; Gocho, T.; Miyabe, H.; Kano, H.; Tsuda, M.; Hattori, T.; Hirakawa, A.; Takeyama, N.] Fujita Hlth Univ, Sch Med, Toyoake, Aichi 47011, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P59	55	56				2	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000097		
J	Sueyoshi, K; Sumi, Y; Inoue, Y; Kuroda, Y; Ishii, K; Nakayama, H; Iwabuchi, K; Shigemitsu, H; Hamachi, I; Tanaka, H				Sueyoshi, K.; Sumi, Y.; Inoue, Y.; Kuroda, Y.; Ishii, K.; Nakayama, H.; Iwabuchi, K.; Shigemitsu, H.; Hamachi, I.; Tanaka, H.			VISUALIZATION OF ATP IN SEPSIS PATIENTS' PMNS WITH ORGANELLE-LOCALIZABLE FLUORESCENT CHEMOSENSORS	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Sueyoshi, K.; Sumi, Y.; Inoue, Y.; Kuroda, Y.; Tanaka, H.] Juntendo Univ, Urayasu Hosp, Urayasu, Japan; [Ishii, K.] Riken Adv Sci Inst, Wako, Saitama, Japan; [Nakayama, H.; Iwabuchi, K.] Juntendo Univ, Inst Environm & Gender Specif Med, Urayasu, Japan; [Shigemitsu, H.; Hamachi, I.] Kyoto Univ, Grad Sch Engn, Kyoto, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P66	58	58				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000104		
J	Watanabe, E; Oda, S; Sakamoto, T; Takasu, O; Ikeda, T; Kotani, J; Kitamura, N; Schneider, E				Watanabe, E.; Oda, S.; Sakamoto, T.; Takasu, O.; Ikeda, T.; Kotani, J.; Kitamura, N.; Schneider, E.			GENETIC POLYMORPHISMS AND SEVERE SEPSIS - A MULTI-CENTER STUDY IN THE JAPANESE ICU POPULATION	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Watanabe, E.; Oda, S.] Chiba Univ, Chiba, Japan; [Sakamoto, T.; Takasu, O.] Kurume Univ, Kurume, Fukuoka 830, Japan; [Kotani, J.] Hyogo Coll Med, Nishinomiya, Hyogo 6638501, Japan; [Ikeda, T.] Tokyo Med Univ, Hachioji Med Ctr, Hachioji, Tokyo, Japan; [Kitamura, N.] Kimitsu Chuo Hosp, Kisarazu City, Japan; [Schneider, E.] Univ Ulm, D-89069 Ulm, Germany								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P95	71	71				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000132		
J	Sato, N; Kitaguchi, A; Irahara, T; Ohtake, K; Inoue, K; Murata, S; Kawashima, S; Koike, K				Sato, N.; Kitaguchi, A.; Irahara, T.; Ohtake, K.; Inoue, K.; Murata, S.; Kawashima, S.; Koike, K.			ETAS, AN ENZYME-TREATED ASPARAGUS, ATTENUATES OXIDANT INJURY IN RAT EPITHELIAL CELLS	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Sato, N.; Kitaguchi, A.; Irahara, T.; Ohtake, K.; Inoue, K.; Murata, S.; Kawashima, S.; Koike, K.] Kyoto Univ, Kyoto, Japan; [Irahara, T.; Ohtake, K.] Nippon Med Sch, Tokyo 113, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P118	81	82				2	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000155		
J	Suzuki, K; Okada, H; Takemura, G; Hotta, Y; Takada, C; Yoshida, S; Ushikoshi, H; Toyoda, I; Ogura, S				Suzuki, K.; Okada, H.; Takemura, G.; Hotta, Y.; Takada, C.; Yoshida, S.; Ushikoshi, H.; Toyoda, I.; Ogura, S.			ULTRASTRUCTURAL ANALYSIS OF ENDOTHELIAL DISORDER IN ACUTE KIDNEY INJURY BY SEPSIS	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Suzuki, K.; Okada, H.; Takada, C.; Yoshida, S.; Ushikoshi, H.; Toyoda, I.; Ogura, S.] Gifu Univ, Dept Emergency & Disaster Med, Grad Sch Med, Gifu, Japan; [Takemura, G.] Asahi Univ, Sch Dent, Dept Internal Med, Mizuho, Japan; [Hotta, Y.] Asahi Univ, Sch Dent, Cent Res Inst Oral Sci, Mizuho, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P125	85	85				1	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000162		
J	Irahara, T; Sato, N; Inoue, K; Ishihara, K; Fujitani, M; Manio, M; Otake, K; Koike, K; Fushiki, T; Yokota, H				Irahara, T.; Sato, N.; Inoue, K.; Ishihara, K.; Fujitani, M.; Manio, M.; Otake, K.; Koike, K.; Fushiki, T.; Yokota, H.			THE ALTERATION OF ENERGY SUBSTRATE METABOLISM IN DIFFERENT DEGREE OF LPS-INDUCED SEPTIC MICE	SHOCK			English	Meeting Abstract	38th Annual Conference of the Shock-Society on Shock	JUN 06-09, 2015	Denver, CO	Shock Soc					[Irahara, T.; Otake, K.; Yokota, H.] Nippon Med Sch, Grad Sch Emergency & Crit Care Med, Tokyo 113, Japan; [Sato, N.; Koike, K.] Kyoto Univ, Dept Primary Care & Emergency Med, Kyoto, Japan; [Inoue, K.; Fujitani, M.; Manio, M.; Fushiki, T.] Kyoto Univ, Nutr Chem Lab, Div Food Sci & Biotechnol, Grad Sch Agr, Kyoto, Japan; [Ishihara, K.] Sugiyama Jogakuen Univ, Sch Life Studies, Dept Human Nutr, Nagoya, Aichi, Japan								0	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1073-2322	1540-0514		SHOCK	Shock	JUN	2015	43	6		1		P194	114	115				2	Critical Care Medicine; Hematology; Surgery; Peripheral Vascular Disease	General & Internal Medicine; Hematology; Surgery; Cardiovascular System & Cardiology	CI4QC	WOS:000354736000231		
